PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Forsyth, DM; Woodford, L; Moloney, PD; Hampton, JO; Woolnough, AP; Tucker, M				Forsyth, David M.; Woodford, Luke; Moloney, Paul D.; Hampton, Jordan O.; Woolnough, Andrew P.; Tucker, Mark			How Does a Carnivore Guild Utilise a Substantial but Unpredictable Anthropogenic Food Source? Scavenging on Hunter-Shot Ungulate Carcasses by Wild Dogs/Dingoes, Red Foxes and Feral Cats in South-Eastern Australia Revealed by Camera Traps	PLOS ONE			English	Article							MESOPREDATOR RELEASE; FEEDING ECOLOGY; VULPES-VULPES; DINGO; MANAGEMENT; PREY; COMPETITION; ABUNDANCE; DEER; DOGS	There is much interest in understanding how anthropogenic food resources subsidise carnivore populations. Carcasses of hunter-shot ungulates are a potentially substantial food source for mammalian carnivores. The sambar deer (Rusa unicolor) is a large (>= 150 kg) exotic ungulate that can be hunted throughout the year in south-eastern Australia, and hunters are not required to remove or bury carcasses. We investigated how wild dogs/dingoes and their hybrids (Canis lupus familiaris/dingo), red foxes (Vulpes vulpes) and feral cats (Felis catus) utilised sambar deer carcasses during the peak hunting seasons (i.e. winter and spring). We placed carcasses at 1-km intervals along each of six transects that extended 4-km into forest from farm boundaries. Visits to carcasses were monitored using camera traps, and the rate of change in edible biomass estimated at,14-day intervals. Wild dogs and foxes fed on 70% and 60% of 30 carcasses, respectively, but feral cats seldom (10%) fed on carcasses. Spatial and temporal patterns of visits to carcasses were consistent with the hypothesis that foxes avoid wild dogs. Wild dog activity peaked at carcasses 2 and 3 km from farms, a likely legacy of wild dog control, whereas fox activity peaked at carcasses 0 and 4 km from farms. Wild dog activity peaked at dawn and dusk, whereas nearly all fox activity occurred after dusk and before dawn. Neither wild dogs nor foxes remained at carcasses for long periods and the amount of feeding activity by either species was a less important predictor of the loss of edible biomass than season. Reasons for the low impacts of wild dogs and foxes on sambar deer carcass biomass include the spatially and temporally unpredictable distribution of carcasses in the landscape, the rapid rate of edible biomass decomposition in warm periods, low wild dog densities and the availability of alternative food resources.	[Forsyth, David M.; Woodford, Luke; Moloney, Paul D.] Dept Environm & Primary Ind, Arthur Rylah Inst Environm Res, Heidelberg, Vic, Australia; [Hampton, Jordan O.] Ecotone Wildlife Vet Serv, Canberra, ACT, Australia; [Woolnough, Andrew P.] Dept Environm & Primary Ind, Biosecur Div, Invas Plants & Anim Branch, Melbourne, Vic, Australia; [Tucker, Mark] Melbourne Water, Reefton, Vic, Australia	Arthur Rylah Institute for Environmental Research (ARI)	Forsyth, DM (corresponding author), Dept Environm & Primary Ind, Arthur Rylah Inst Environm Res, Heidelberg, Vic, Australia.	dave.forsyth@depi.vic.gov.au	Hampton, Jordan/AAV-7736-2020	Hampton, Jordan/0000-0003-0472-3241; Forsyth, David/0000-0001-5356-9573; Woolnough, Andrew/0000-0002-6369-0294; Moloney, Paul/0000-0002-5010-214X	Victorian Department of Environment and Primary Industries	Victorian Department of Environment and Primary Industries	The work presented was funded by the Victorian Department of Environment and Primary Industries (www.depi.vic.gov.au). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of four of the authors being employees within the organisation.	Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Apollonio M., 2010, EUROPEAN UNGULATES T; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Bentley A., 1998, INTRO DEER AUSTR SPE; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Brawata RL, 2011, WILDLIFE RES, V38, P426, DOI 10.1071/WR10169; Bridges AS, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P57, DOI 10.1007/978-4-431-99495-4_5; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Claridge AW, 2009, FOREST ECOL MANAG, V258, P814, DOI 10.1016/j.foreco.2009.05.030; Coe M., 1978, Journal of Arid Environments, V1, P71; Colman NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3094; Congdon P. D, 2010, APPL BAYESIAN HIERAR, V1st; Corbett L. K., 1995, DINGO AUSTR ASIA; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; Creel S, 2001, CONSERV BIOL SER, V5, P35; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Department of Primary Industries, 2013, VICT HUNT GUID 2013; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dickman C., 1996, OVERVIEW IMPACTS FER; DICKMAN CR, 1992, TRENDS ECOL EVOL, V7, P194, DOI 10.1016/0169-5347(92)90072-J; Doncaster CP, 1997, J ZOOL, V241, P73, DOI 10.1111/j.1469-7998.1997.tb05500.x; Downes M, 1983, FOREST DEER PROJECT, VII; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Forsyth DM, 2011, J WILDLIFE MANAGE, V75, P1488, DOI 10.1002/jwmg.179; Forsyth DM, 2009, WILDLIFE RES, V36, P231, DOI 10.1071/WR08075; FRUMP R. R., 2006, MAN EATERS EDEN LIFE; GALLOWAY A, 1989, J FORENSIC SCI, V34, P607; Gelman A., 2004, BAYESIAN DATA ANAL; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Gormley AM, 2010, A RYLAH I ENV RES TE, V210; Gormley AM, 2009, A RYLAH I ENV RES TE, V196; Gormley AM, 2011, A RYLAH I ENV RES TE, V224; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Green GI, 1997, J WILDLIFE MANAGE, V61, P1040, DOI 10.2307/3802101; HARDEN RH, 1985, AUST WILDLIFE RES, V12, P25; HENRY JD, 1977, BEHAVIOUR, V61, P82, DOI 10.1163/156853977X00496; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kennedy M, 2012, AUSTRAL ECOL, V37, P134, DOI 10.1111/j.1442-9993.2011.02256.x; Lazenby BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059846; Leslie David M. Jr., 2011, Mammalian Species, P1, DOI 10.1644/871.1; Letnic M, 2013, OIKOS, V122, P761, DOI 10.1111/j.1600-0706.2012.20425.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lunn D., 2012, BUGS BOOK PRACTICAL; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Menkhorst P., 1995, MAMMALS VICTORIA DIS; Mitchell BD, 2005, AUSTRAL ECOL, V30, P581, DOI 10.1111/j.1442-9993.2005.01473.x; Mittermeier R. A, 2011, HDB MAMMALS WORLD, P350; Moloney PD, 2013, A RYLAH I ENV RES TE, V251; Moloney PD, 2012, A RYLAH I ENV RES TE, V239; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Moriarty A, 2004, WILDLIFE RES, V31, P291, DOI 10.1071/WR02100; Moseby Katherine E., 2012, International Journal of Ecology, P1; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; NEWSOME AE, 1983, AUST WILDLIFE RES, V10, P477; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; PAQUET PC, 1992, J MAMMAL, V73, P337, DOI 10.2307/1382067; Peterson Rolf O., 2003, P104; Pierce BM, 2000, ECOLOGY, V81, P1533; Plummer M., 2003, P 3 INT WORKSH DISTR; Pople AR, 2000, WILDLIFE RES, V27, P269, DOI 10.1071/WR99030; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Read JL, 2004, WILDLIFE RES, V31, P51, DOI 10.1071/WR02051; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; Robley Alan, 2010, Australian Mammalogy, V32, P23, DOI 10.1071/AM09030; Saunders G, 1995, MANAGING VERTEBRATE, P141; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Thomson P., 2001, MANAGING IMPACT DING; Towerton AL, 2011, WILDLIFE RES, V38, P208, DOI 10.1071/WR10213; Victoria Government, 2013, VICTORIA GOVT G 0926; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; Welton NJ, 2005, MED DECIS MAKING, V25, P633, DOI 10.1177/0272989X05282637; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yirga G, 2012, J ANIM ECOL, V81, P1052, DOI 10.1111/j.1365-2656.2012.01977.x	88	36	39	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97937	10.1371/journal.pone.0097937	http://dx.doi.org/10.1371/journal.pone.0097937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918425	Green Published, gold			2022-12-27	WOS:000338631000011
J	Lv, T; Gong, HQ; Liang, PJ				Lv, Ting; Gong, Hai-Qing; Liang, Pei-Ji			Caffeine-Induced Ca2+ Oscillations in Type I Horizontal Cells of the Carp Retina and the Contribution of the Store-Operated Ca2+ Entry Pathway	PLOS ONE			English	Article							CAPACITATIVE CALCIUM-ENTRY; GAP-JUNCTION CHANNELS; ENDOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; GLUTAMATE RECEPTORS; CRAC CHANNEL; RELEASE; MODULATION; INHIBITION; RYANODINE	The mechanisms of release, depletion, and refilling of endoplasmic reticulum (ER) Ca2+ were investigated in type I horizontal cells of the carp retina using a fluo-3-based Ca2+ imaging technique. Exogenous application of caffeine, a ryanodine receptor agonist, induced oscillatory intracellular free Ca2+ concentration ([Ca2+](i)) responses in a duration-and concentration-dependent manner. In Ca2+-free Ringer's solution [Ca2+](i) transients could also be induced by a brief caffeine application, whereas subsequent caffeine application induced no [Ca2+](i) increase, which implied that extracellular Ca2+ was required for ER refilling, confirming the necessity of a Ca2+ influx pathway for ER refilling. Depletion of ER Ca2+ by thapsigargin triggered a Ca2+ influx which could be blocked by the store-operated channel inhibitor 2-APB, which proved he existence of the store-operated Ca2+ entry pathway. Taken together, these results suggested that after being depleted caffeine he ER was replenished by Ca2+ influx via store-operated channels. These results reveal the fine modulation of ling, and the activation of the store-operated Ca2+ entry pathway guarantees the replenishment of the ER so can be ready for response to the subsequent stimulus.	[Lv, Ting; Gong, Hai-Qing; Liang, Pei-Ji] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liang, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	pjliang@sjtu.edu.cn			National Natural Science Foundation of China [30870836]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30870836, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian A, 1997, BRAIN RES, V762, P121, DOI 10.1016/S0006-8993(97)00374-0; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; BYRNE NG, 1988, J PHYSIOL-LONDON, V404, P557, DOI 10.1113/jphysiol.1988.sp017306; Carrasco S, 2010, NAT CELL BIOL, V12, P416, DOI 10.1038/ncb0510-416; CURRIE KPM, 1992, BRIT J PHARMACOL, V106, P593, DOI 10.1111/j.1476-5381.1992.tb14381.x; Daher JPL, 2009, MOL CELL BIOCHEM, V327, P15, DOI 10.1007/s11010-009-0036-2; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; FABIATO A, 1977, CIRC RES, V40, P119, DOI 10.1161/01.RES.40.2.119; FLOCKERZI V, 2007, TRANSIENT RECEPTOR P; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; Hayashida Y, 1998, NEUROSCI RES, V31, P189, DOI 10.1016/S0168-0102(98)00037-6; Hayashida Y, 2002, J NEUROPHYSIOL, V87, P172, DOI 10.1152/jn.00778.2000; Hong J, 2012, STORE OPERATED CA2 E, P57; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang Shi-Yong, 2006, Shengli Xuebao, V58, P407; Huang SY, 2005, NEUROREPORT, V16, P263, DOI 10.1097/00001756-200502280-00012; Huang SY, 2004, NEUROREPORT, V15, P2311, DOI 10.1097/00001756-200410250-00002; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; Jiang XD, 2008, BRAIN RES, V1240, P105, DOI 10.1016/j.brainres.2008.08.094; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; Kreitzer MA, 2003, J PHYSIOL-LONDON, V546, P717, DOI 10.1113/jphysiol.2002.034421; Linn CL, 2001, J PHYSIOL-LONDON, V535, P47, DOI 10.1111/j.1469-7793.2001.00047.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lu T, 1994, CHINESE J NEUROANATO, V11, P299; MALCHOW RP, 1993, J NEUROSCI RES, V35, P237, DOI 10.1002/jnr.490350303; Manjarres IM, 2011, CELL CALCIUM, V49, P153, DOI 10.1016/j.ceca.2011.01.007; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; McMahon DG, 1996, BRAIN RES, V718, P89, DOI 10.1016/0006-8993(96)00043-1; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Morton-Jones RT, 2008, CELL CALCIUM, V43, P356, DOI 10.1016/j.ceca.2007.07.003; NEERING IR, 1984, NATURE, V309, P158, DOI 10.1038/309158a0; NOHMI M, 1992, J PHYSIOL-LONDON, V450, P513, DOI 10.1113/jphysiol.1992.sp019140; NORMANN RA, 1976, J PHYSIOL-LONDON, V261, P15, DOI 10.1113/jphysiol.1976.sp011546; Okada T, 1999, EUR J NEUROSCI, V11, P1085, DOI 10.1046/j.1460-9568.1999.00516.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Porta M, 2011, BIOPHYS J, V100, P931, DOI 10.1016/j.bpj.2011.01.017; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 2003, CELL CALCIUM, V34, P339, DOI 10.1016/S0143-4160(03)00143-X; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schoppe J, 1997, CELL CALCIUM, V22, P385, DOI 10.1016/S0143-4160(97)90023-3; Shen Y, 2006, NEUROSIGNALS, V15, P174, DOI 10.1159/000096350; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Sun Z, 2012, J NEUROPHYSIOL, V107, P2624, DOI 10.1152/jn.01126.2011; Sun Z, 2009, J NEUROPHYSIOL, V101, P1774, DOI 10.1152/jn.90581.2008; Sutko JL, 1997, PHARMACOL REV, V49, P53; TACHIBANA M, 1981, J PHYSIOL-LONDON, V321, P141, DOI 10.1113/jphysiol.1981.sp013976; TACHIBANA M, 1983, J PHYSIOL-LONDON, V345, P329, DOI 10.1113/jphysiol.1983.sp014981; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Alonso MT, 2012, MOL CELL ENDOCRINOL, V353, P37, DOI 10.1016/j.mce.2011.08.021; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thomas NL, 2012, WILEY INTERDISCIP RE, V1, P383, DOI DOI 10.1002/WMTS.34; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WALZ B, 1995, J GEN PHYSIOL, V105, P537, DOI 10.1085/jgp.105.4.537; Wang XL, 2008, NEUROREPORT, V19, P675, DOI 10.1097/WNR.0b013e3282fb7902; Weiler R, 1996, VISION RES, V36, P3891, DOI 10.1016/S0042-6989(96)00148-4; Wu D, 1999, NEUROREPORT, V10, P3897, DOI 10.1097/00001756-199912160-00032; YAGI T, 1988, J NEUROPHYSIOL, V59, P482, DOI 10.1152/jn.1988.59.2.482; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang DQ, 2001, MOL VIS, V7, P247; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	78	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100095	10.1371/journal.pone.0100095	http://dx.doi.org/10.1371/journal.pone.0100095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918937	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000128
J	Scott, DM; Berg, MJ; Tolhurst, BA; Chauvenet, ALM; Smith, GC; Neaves, K; Lochhead, J; Baker, PJ				Scott, Dawn M.; Berg, Maureen J.; Tolhurst, Bryony A.; Chauvenet, Alienor L. M.; Smith, Graham C.; Neaves, Kelly; Lochhead, Jamie; Baker, Philip J.			Changes in the Distribution of Red Foxes (Vulpes vulpes) in Urban Areas in Great Britain: Findings and Limitations of a Media-Driven Nationwide Survey	PLOS ONE			English	Article							MANGE SARCOPTES-SCABIEI; BADGERS MELES-MELES; ECHINOCOCCUS-MULTILOCULARIS; RABIES; CITY; URBANIZATION; POPULATIONS; DISPERSAL; SELECTION; PATTERNS	Urbanization is one of the major forms of habitat alteration occurring at the present time. Although this is typically deleterious to biodiversity, some species flourish within these human-modified landscapes, potentially leading to negative and/or positive interactions between people and wildlife. Hence, up-to-date assessment of urban wildlife populations is important for developing appropriate management strategies. Surveying urban wildlife is limited by land partition and private ownership, rendering many common survey techniques difficult. Garnering public involvement is one solution, but this method is constrained by the inherent biases of non-standardised survey effort associated with voluntary participation. We used a television-led media approach to solicit national participation in an online sightings survey to investigate changes in the distribution of urban foxes in Great Britain and to explore relationships between urban features and fox occurrence and sightings density. Our results show that media-based approaches can generate a large national database on the current distribution of a recognisable species. Fox distribution in England and Wales has changed markedly within the last 25 years, with sightings submitted from 91% of urban areas previously predicted to support few or no foxes. Data were highly skewed with 90% of urban areas having >30 fox sightings per 1000 people km(-2). The extent of total urban area was the only variable with a significant impact on both fox occurrence and sightings density in urban areas; longitude and percentage of public green urban space were respectively, significantly positively and negatively associated with sightings density only. Latitude, and distance to nearest neighbouring conurbation had no impact on either occurrence or sightings density. Given the limitations associated with this method, further investigations are needed to determine the association between sightings density and actual fox density, and variability of fox density within and between urban areas in Britain.	[Scott, Dawn M.; Berg, Maureen J.; Tolhurst, Bryony A.] Univ Brighton, Div Biol & Biomed Sci, Brighton, E Sussex, England; [Chauvenet, Alienor L. M.; Smith, Graham C.] Anim Hlth & Vet Labs Agcy, Natl Wildlife Management Ctr, York, Yorks, England; [Neaves, Kelly; Lochhead, Jamie] Windfall Films, London, England; [Baker, Philip J.] Univ Reading, Sch Biol Sci, Reading, Berks, England	University of Brighton; University of Reading	Scott, DM (corresponding author), Univ Brighton, Div Biol & Biomed Sci, Brighton, E Sussex, England.	dawn.scott@brighton.ac.uk	Chauvenet, Alienor/L-9135-2015; Tolhurst, Bryony/AAT-9022-2020; Smith, Graham C/J-2593-2013	Chauvenet, Alienor/0000-0002-3743-7375; Tolhurst, Bryony/0000-0002-0198-5046; Smith, Graham C/0000-0002-9897-6794; Scott, Dawn/0000-0002-9570-2739	Channel 4	Channel 4	The research was funded by Channel 4. The funders had input into the final web site design which aided data collection, however the funders had no role in data analysis or preparation of the manuscript.	Adams J, 2008, EUR J PUBLIC HEALTH, V18, P335, DOI 10.1093/eurpub/ckm100; Baker P, 2004, 2004 MAY 1 5 TUCS AR, P153; Baker Philip, 2001, British Wildlife, V12, P411; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Battersby J, 2005, TRACKING MAMMALS PAR, V1; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bowler DE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/147-2458-10-456; Brochier B, 2007, PREV VET MED, V80, P65, DOI 10.1016/j.prevetmed.2007.01.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell SaH G, 2007, URBAN FOX POPULATION; Cassidy A, 2012, ENVIRON COMMUN, V6, P494, DOI 10.1080/17524032.2012.716370; CEH, 2011, LAND COV MAP 2007; Chappuis F, 2012, Rev Med Suisse, V8, P989; Chappuis F, 2012, REV MED SUISSE, V8, P992; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Crooks KR, 2010, COMMUNITY ECOLOGY UR; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; Devenish-Nelson ES, 2013, OIKOS, V122, P705, DOI 10.1111/j.1600-0706.2012.20706.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Eigenbrod F, 2011, P ROY SOC B-BIOL SCI, V278, P3201, DOI 10.1098/rspb.2010.2754; ESRI, 2011, ARCGIS DESKT REL 10; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller TK, 2010, CARNIVORE BEHAV ECOL; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gloor S, 2001, MAMM BIOL, V66, P155; Gosselink TE, 2010, J WILDLIFE MANAGE, V74, P1204, DOI 10.2193/2009-108; HARRIS S, 1977, MAMMAL REV, V7, P25, DOI 10.1111/j.1365-2907.1977.tb00360.x; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; HARRIS S, 1986, J ANIM ECOL, V55, P605, DOI 10.2307/4742; HARRIS S, 1986, J ANIM ECOL, V55, P593, DOI 10.2307/4741; HARRIS S, 1981, J APPL ECOL, V18, P455, DOI 10.2307/2402406; HARRIS S, 1984, BIOL CONSERV, V28, P349, DOI 10.1016/0006-3207(84)90041-7; Harris S., 1987, Symposia of the Zoological Society of London, P313; Harris S., 2008, MAMMALS BRIT ISLES H, V4th; Harris S., 1995, REV BRIT MAMMALS POP; Harris S, 2001, URBAN FOXES; Hof Anouschka R., 2009, Lutra, V52, P69; Hunter J, 2013, CONCURR COMP-PRACT E, V25, P454, DOI 10.1002/cpe.2923; Iossa G, 2010, TAXONOMIC ANAL URBAN; Iossa G, 2009, BEHAV ECOL, V20, P385, DOI 10.1093/beheco/arn149; JENKINS DJ, 1992, MED J AUSTRALIA, V157, P754; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Knapp S, 2008, BIODIVERS CONSERV, V17, P1595, DOI 10.1007/s10531-008-9369-5; Learmount J, 2012, VET PARASITOL, V190, P447, DOI 10.1016/j.vetpar.2012.07.003; Lloyd HG, 1980, HABITAT REQUIREMENTS, pP7; Lye GC, 2012, J INSECT CONSERV, V16, P697, DOI 10.1007/s10841-011-9450-3; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Newman TJ, 2003, ACTA THERIOL, V48, P79, DOI 10.1007/BF03194268; Office for National Statistics [ONS], 2004, CENS 2001; ONS, 2010, CENS 2010; ONS, 2011, 2010 BAS STAT B; Patton V, 2010, MAMMAL REV, V40, P313, DOI 10.1111/j.1365-2907.2010.00162.x; Pauleit S, 2005, LANDSCAPE URBAN PLAN, V71, P295, DOI [10.1016/S0169-2046(04)00083-0, 10.1016/j.landurbplan.2004.03.009]; R Core Development Team, 2013, R LANG ENV STAT COMP; Reading CJ, 1996, J BIOGEOGR, V23, P657, DOI 10.1111/j.1365-2699.1996.tb00026.x; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; Ritter P, 2004, J MED INTERNET RES, V6, P19, DOI 10.2196/jmir.6.3.e29; SAMUEL WM, 1981, J WILDLIFE DIS, V17, P343, DOI 10.7589/0090-3558-17.3.343; Selonen V, 2007, P ROY SOC B-BIOL SCI, V274, P2063, DOI 10.1098/rspb.2007.0570; Smith GC, 2006, DEV BIOLOGICALS, V125, P113; SMITH GC, 1991, PHILOS T ROY SOC B, V334, P459, DOI 10.1098/rstb.1991.0127; Smith GC, 2003, VET PARASITOL, V118, P133, DOI 10.1016/j.vetpar.2003.09.017; Smith GC, 2003, J WILDLIFE DIS, V39, P278, DOI 10.7589/0090-3558-39.2.278; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2010, RED FOXES VULPES VUL; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Thorn M, 2011, ORYX, V45, P579, DOI 10.1017/S0030605311000123; Toms MP, 2006, MAMMAL REV, V36, P309, DOI 10.1111/j.1365-2907.2006.00094.x; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tregidgo DJ, 2013, ENVIRON POLLUT, V182, P448, DOI 10.1016/j.envpol.2013.03.034; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; UNFPA, 2007, STAT WORLD POP; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; White Lynsey A., 2009, Human Dimensions of Wildlife, V14, P419; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Wilkinson D, 2001, MAMMAL REV, V31, P107, DOI 10.1046/j.1365-2907.2001.00076.x	83	65	71	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99059	10.1371/journal.pone.0099059	http://dx.doi.org/10.1371/journal.pone.0099059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919063	Green Published, Green Accepted, gold			2022-12-27	WOS:000338631000045
J	Canivell, S; Ruano, EG; Siso-Almirall, A; Kostov, B; Gonzalez-de Paz, L; Fernandez-Rebollo, E; Hanzu, FA; Parrizas, M; Novials, A; Gomis, R				Canivell, Silvia; Ruano, Elena G.; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis; Fernandez-Rebollo, Eduardo; Hanzu, Felicia A.; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon			Differential Methylation of TCF7L2 Promoter in Peripheral Blood DNA in Newly Diagnosed, Drug-Naive Patients with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; HOMEOSTASIS MODEL; GENOME; PATHOGENESIS; EPIGENETICS; MECHANISMS; MELLITUS; OBESITY	TCF7L2 is the susceptibility gene for Type 2 diabetes (T2D) with the largest effect on disease risk that has been discovered to date. However, the mechanisms by which TCF7L2 contributes to the disease remain largely elusive. In addition, epigenetic mechanisms, such as changes in DNA methylation patterns, might have a role in the pathophysiology of T2D. This study aimed to investigate the differences in terms of DNA methylation profile of TCF7L2 promoter gene between type 2 diabetic patients and age- and Body Mass Index (BMI)-matched controls. We included 93 type 2 diabetic patients that were recently diagnosed for T2D and exclusively on diet (without any pharmacological treatment). DNA was extracted from whole blood and DNA methylation was assessed using the Sequenom EpiTYPER system. Type 2 diabetic patients were more insulin resistant than their matched controls (mean HOMA IR 2.6 vs 1.8 in controls, P<0.001) and had a poorer beta-cell function (mean HOMA B 75.7 vs. 113.6 in controls, P<0.001). Results showed that 59% of the CpGs analyzed in TCF7L2 promoter had significant differences between type 2 diabetic patients and matched controls. In addition, fasting glucose, HOMA-B, HOMA-IR, total cholesterol and LDL-cholesterol correlated with methylation in specific CpG sites of TCF7L2 promoter. After adjustment by age, BMI, gender, physical inactivity, waist circumference, smoking status and diabetes status uniquely fasting glucose, total cholesterol and LDL-cholesterol remained significant. Taken together, newly diagnosed, drug-naive type 2 diabetic patients display specific epigenetic changes at the TCF7L2 promoter as compared to age- and BMI-matched controls. Methylation in TCF7L2 promoter is further correlated with fasting glucose in peripheral blood DNA, which sheds new light on the role of epigenetic regulation of TCF7L2 in T2D.	[Canivell, Silvia; Hanzu, Felicia A.; Novials, Anna; Gomis, Ramon] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Canivell, Silvia; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis] IDIBAPS, PHC Res Grp, Les Corts Primary Hlth Care Ctr, Barcelona, Spain; [Canivell, Silvia; Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Hanzu, Felicia A.; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon] IDIBAPS, Diabet & Obes Lab, Barcelona, Spain; [Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Novials, Anna; Gomis, Ramon] CIBERDEM, Barcelona, Spain; [Siso-Almirall, Antoni; Gomis, Ramon] Univ Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Gomis, R (corresponding author), Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain.	ramon.gomis@idibaps.org	, EFR1981/AAV-6334-2020; Parrizas, Marcelina/AAS-3629-2021	, EFR1981/0000-0002-4378-7590; Kostov, Belchin/0000-0002-2126-3892; Siso Almirall, Antoni/0000-0001-9832-2689; Gonzalez de Paz, Luis/0000-0002-4767-8121; Novials, Anna/0000-0003-0465-2949; Parrizas, Marcelina/0000-0003-1296-8302; Canivell, Silvia/0000-0002-0280-5035; Hanzu, Felicia Alexandra/0000-0002-2399-4023	FIS [PI 1000219]; MEDIGENE project - EC Seventh Framework Programme theme FP7-HEALTH [279171]; Spanish Ministry of Science and Innovation [SAF 2010-19527]; Spanish Ministry of Science and Innovation	FIS(Instituto de Salud Carlos III); MEDIGENE project - EC Seventh Framework Programme theme FP7-HEALTH; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the FIS Grant PI 1000219, the MEDIGENE project, grant agreement number 279171, funded by the EC Seventh Framework Programme theme FP7-HEALTH-2011 and by the Spanish Ministry of Science and Innovation (under the grant agreement number SAF 2010-19527). CIBER de Diabetes y Enfermedades Metabolicas is an initiative of ISCIII (Spanish Ministry of Science and Innovation). Dr. Canivell was awarded with the Rio Hortega Grant from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; [Anonymous], 2011, DIABETES CARE, V35, pS11; Blaha MJ, 2008, OBESITY, V16, P869, DOI 10.1038/oby.2008.12; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Canivell S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075474; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ferrannini E, 2003, DIABETOLOGIA, V46, P1211, DOI 10.1007/s00125-003-1169-6; Fradin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036278; Gilbert ER, 2012, EPIGENETICS-US, V7, P841, DOI 10.4161/epi.21238; Gloyn AL, 2009, DIABETES, V58, P800, DOI 10.2337/db09-0099; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hu Y, 2014, EXP CLIN ENDOCR DIAB, V122, P71, DOI 10.1055/s-0033-1363231; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Majithia AR, 2009, CURR OPIN ENDOCRINOL, V16, P100, DOI 10.1097/MED.0b013e3283292354; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Polonsky KS, 2000, INT J OBESITY, V24, pS29, DOI 10.1038/sj.ijo.0801273; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Prokunina-Olsson L, 2009, HUM MOL GENET, V18, P3795, DOI 10.1093/hmg/ddp321; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; van den Boom D EM, 2008, DNA METHYLATION METH, P207; Volkmar M, 2012, EMBO J; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wren JD, 2005, J BIOMED BIOTECHNOL, P104, DOI 10.1155/JBB.2005.104	39	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99310	10.1371/journal.pone.0099310	http://dx.doi.org/10.1371/journal.pone.0099310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914535	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700083
J	Gao, J; Zhang, Y; Zhang, CL; Qi, FY; Li, XP; Mu, SH; Peng, ZH				Gao, Jian; Zhang, Ying; Zhang, Chunling; Qi, Feiyan; Li, Xueping; Mu, Shaohua; Peng, Zhenhua			Characterization of the Floral Transcriptome of Moso Bamboo (Phyllostachys edulis) at Different Flowering Developmental Stages by Transcriptome Sequencing and RNA-Seq Analysis	PLOS ONE			English	Article							DNA-BINDING; FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; LEAF SENESCENCE; FACTOR FAMILY; GENE; EXPRESSION; CONSTANS; GENOME; MEMBER	Background: As an arborescent and perennial plant, Moso bamboo (Phyllostachys edulis (Carriere) J. Houzeau, synonym Phyllostachys heterocycla Carriere) is characterized by its infrequent sexual reproduction with flowering intervals ranging from several to more than a hundred years. However, little bamboo genomic research has been conducted on this due to a variety of reasons. Here, for the first time, we investigated the transcriptome of developing flowers in Moso bamboo by using high-throughput Illumina GAII sequencing and mapping short reads to the Moso bamboo genome and reference genes. We performed RNA-seq analysis on four important stages of flower development, and obtained extensive gene and transcript abundance data for the floral transcriptome of this key bamboo species. Results: We constructed a cDNA library using equal amounts of RNA from Moso bamboo leaf samples from non-flowering plants (CK) and mixed flower samples (F) of four flower development stages. We generated more than 67 million reads from each of the CK and F samples. About 70% of the reads could be uniquely mapped to the Moso bamboo genome and the reference genes. Genes detected at each stage were categorized to putative functional categories based on their expression patterns. The analysis of RNA-seq data of bamboo flowering tissues at different developmental stages reveals key gene expression properties during the flower development of bamboo. Conclusion: We showed that a combination of transcriptome sequencing and RNA-seq analysis was a powerful approach to identifying candidate genes related to floral transition and flower development in bamboo species. The results give a better insight into the mechanisms of Moso bamboo flowering and ageing. This transcriptomic data also provides an important gene resource for improving breeding for Moso bamboo.	[Gao, Jian; Zhang, Ying; Zhang, Chunling; Qi, Feiyan; Li, Xueping; Mu, Shaohua; Peng, Zhenhua] State Forestry Adm, Key Lab Bamboo & Rattan Sci & Technol, Int Ctr Bamboo & Rattan, Beijing, Peoples R China	International Centre for Bamboo & Rattan	Gao, J (corresponding author), State Forestry Adm, Key Lab Bamboo & Rattan Sci & Technol, Int Ctr Bamboo & Rattan, Beijing, Peoples R China.	gaojian@icbr.ac.cn; pengzhenhua@icbr.ac.cn			National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research'' [2013AA102607-4]	National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research''(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China "Moso Bamboo Functional Genomics Research'' (grant No. 2013AA102607-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2013, RUSS J PLANT PHYSL+, V60, P116, DOI 10.1134/S1021443712060027; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Benjamini Y, 2001, ANN STAT, V29, P1165; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Cui XW, 2013, BOTANY, V91, P486, DOI 10.1139/cjb-2012-0219; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Dreni L, 2011, PLANT CELL, V23, P2850, DOI 10.1105/tpc.111.087007; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Franklin DC, 2004, J BIOGEOGR, V31, P773, DOI 10.1111/j.1365-2699.2003.01057.x; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; Gielis J., 1999, Systematics and Geography of Plants, V68, P147, DOI 10.2307/3668597; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; INBAR, 1999, SOC ISS CONSTR BAMB; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Jeon JS, 2000, PLANT CELL, V12, P871, DOI 10.1105/tpc.12.6.871; Judziewicz EJ, 1999, AM BAMBOOS; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Li DJ, 2009, PLANTA, V229, P1159, DOI 10.1007/s00425-009-0893-7; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin EP, 2009, PLANTA, V231, P109, DOI 10.1007/s00425-009-1033-0; Lin XC, 2010, GENET MOL RES, V9, P1085, DOI 10.4238/vol9-2gmr804; Lobovikov M., 2007, WORLD BAMBOO RESOURC, P1; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Maria DL, 2011, BMC GENOMICS, V30, P1471; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; NADGAUDA RS, 1990, NATURE, V344, P335, DOI 10.1038/344335a0; Papi M, 2002, PLANT PHYSIOL, V128, P411, DOI 10.1104/pp.010488; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Park DH, 2003, PLANT J, V34, P161, DOI 10.1046/j.1365-313X.2003.01710.x; Pelucchi N, 2002, SEX PLANT REPROD, V15, P113, DOI 10.1007/s00497-002-0151-7; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Science Press, 2006, FLORA CHINA, V22, P163; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Skirycz A, 2007, NEW PHYTOL, V175, P425, DOI 10.1111/j.1469-8137.2007.02129.x; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tian B, 2005, CHINESE SCI BULL, V50, P145; Tian B, 2006, DNA SEQUENCE, V17, P143, DOI 10.1080/10425170600699877; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; YANAGISAWA S, 1995, NUCLEIC ACIDS RES, V23, P3403, DOI 10.1093/nar/23.17.3403; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang J, 2011, PLANT SCI, V181, P667, DOI 10.1016/j.plantsci.2011.05.003; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082	78	68	76	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98910	10.1371/journal.pone.0098910	http://dx.doi.org/10.1371/journal.pone.0098910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915141	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700043
J	Gajendragadkar, PR; Hubsch, A; Maki-Petaja, KM; Serg, M; Wilkinson, IB; Cheriyan, J				Gajendragadkar, Parag R.; Hubsch, Annette; Maeki-Petaejae, Kaisa M.; Serg, Martin; Wilkinson, Ian B.; Cheriyan, Joseph			Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial	PLOS ONE			English	Article							IMPROVES ENDOTHELIAL FUNCTION; MEDITERRANEAN DIET; NITRIC-OXIDE; VITAMIN-C; SECONDARY PREVENTION; AORTIC PRESSURE; BLOOD-PRESSURE; RISK; ANTIOXIDANT; ATHEROSCLEROSIS	Aims: The mechanisms by which a 'Mediterranean diet' reduces cardiovascular disease (CVD) burden remain poorly understood. Lycopene is a potent antioxidant found in such diets with evidence suggesting beneficial effects. We wished to investigate the effects of lycopene on the vasculature in CVD patients and separately, in healthy volunteers (HV). Methods and Results: We randomised 36 statin treated CVD patients and 36 healthy volunteers in a 2: 1 treatment allocation ratio to either 7 mg lycopene or placebo daily for 2 months in a double-blind trial. Forearm responses to intraarterial infusions of acetylcholine (endothelium-dependent vasodilatation; EDV), sodium nitroprusside (endothelium-independent vasodilatation; EIDV), and NG-monomethyl-L-arginine (basal nitric oxide (NO) synthase activity) were measured using venous plethysmography. A range of vascular and biochemical secondary endpoints were also explored. EDV in CVD patients post-lycopene improved by 53% (95% CI: +9% to +93%, P = 0.03 vs. placebo) without changes to EIDV, or basal NO responses. HVs did not show changes in EDV after lycopene treatment. Blood pressure, arterial stiffness, lipids and hsCRP levels were unchanged for lycopene vs. placebo treatment groups in the CVD arm as well as the HV arm. At baseline, CVD patients had impaired EDV compared with HV (30% lower; 95% CI: -45% to -10%, P = 0.008), despite lower LDL cholesterol (1.2 mmol/L lower, 95% CI: -1.6 to -0.9 mmol/L, P<0.001). Post-therapy EDV responses for lycopene-treated CVD patients were similar to HVs at baseline (2% lower, 95% CI: -30% to +30%, P = 0.85), also suggesting lycopene improved endothelial function. Conclusions: Lycopene supplementation improves endothelial function in CVD patients on optimal secondary prevention, but not in HVs.	[Gajendragadkar, Parag R.; Hubsch, Annette; Maeki-Petaejae, Kaisa M.; Serg, Martin; Wilkinson, Ian B.; Cheriyan, Joseph] Univ Cambridge, Clin Pharmacol Unit, Cambridge, England; [Serg, Martin] Univ Tartu, Dept Cardiol, EE-50090 Tartu, Estonia; [Wilkinson, Ian B.; Cheriyan, Joseph] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge Clin Trials Unit, Cambridge, England; [Cheriyan, Joseph] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge, England	University of Cambridge; University of Tartu	Cheriyan, J (corresponding author), Univ Cambridge, Clin Pharmacol Unit, Cambridge, England.	jc403@cam.ac.uk	Gajendragadkar, Parag/AAM-2281-2021; Cheriyan, Joseph/B-2596-2009; Cheriyan, Joseph/M-3414-2019	Gajendragadkar, Parag/0000-0003-3312-0183; Cheriyan, Joseph/0000-0001-6921-1592; Cheriyan, Joseph/0000-0001-6921-1592; Maki-Petaja, Kaisa/0000-0001-7312-6200; wilkinson, ian/0000-0001-6598-9399	Cambridge University Hospitals NHS Foundation Trust; Wellcome Trust; British Heart Foundation; Estonian Science Foundation; European Union Social Fund; National Institute of Health Research Cambridge Comprehensive Biomedical Research Centre; British Heart Foundation [FS/12/8/29377] Funding Source: researchfish	Cambridge University Hospitals NHS Foundation Trust; Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Estonian Science Foundation; European Union Social Fund(European Commission); National Institute of Health Research Cambridge Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was funded and sponsored by Cambridge University Hospitals NHS Foundation Trust. P.R.G. was funded by the Wellcome Trust for his Translational Medicine and Therapeutics MPhil. K.M.M-P. and I.B.W. are funded by the British Heart Foundation. M.S. was funded by the Estonian Science Foundation and the European Union Social Fund. I.B.W. and J.C. received funding from the National Institute of Health Research Cambridge Comprehensive Biomedical Research Centre. The sponsor/funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 1998, LIPIDS, V33, P981, DOI 10.1007/s11745-998-0295-6; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Blum A, 2007, CLIN INVEST MED, V30, pE70; Cheetham C, 2000, J AM COLL CARDIOL, V36, P1461, DOI 10.1016/S0735-1097(00)00933-5; Chen CH, 1997, CIRCULATION, V95, P1827; Chowienczyk PJ, 1998, CLIN SCI, V94, P129, DOI 10.1042/cs0940129; COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067; Darko D, 2002, CLIN SCI, V103, P339, DOI 10.1042/cs1030339; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Denniss SG, 2008, VASC HEALTH RISK MAN, V4, P213, DOI 10.2147/vhrm.2008.04.01.213; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Erdman JW, 2009, ARCH BIOCHEM BIOPHYS, V483, P229, DOI 10.1016/j.abb.2008.10.022; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Forte P, 1997, LANCET, V349, P837, DOI 10.1016/S0140-6736(96)07631-3; Gazis A, 1999, DIABETIC MED, V16, P304, DOI 10.1046/j.1464-5491.1999.00049.x; Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490; Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001; Kim JY, 2011, ATHEROSCLEROSIS, V215, P189, DOI 10.1016/j.atherosclerosis.2010.11.036; Kim OY, 2010, ATHEROSCLEROSIS, V208, P581, DOI 10.1016/j.atherosclerosis.2009.08.009; Kohlmeier L, 1997, AM J EPIDEMIOL, V146, P618, DOI 10.1093/oxfordjournals.aje.a009327; Kris-Etherton P, 2001, CIRCULATION, V103, P1823, DOI 10.1161/01.CIR.103.13.1823; Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO;2-6; Lind L, 2011, CIRCULATION, V123, P1545, DOI 10.1161/CIRCULATIONAHA.110.984047; Loke WM, 2008, BIOCHEM PHARMACOL, V75, P1045, DOI 10.1016/j.bcp.2007.11.002; Mora S, 2012, CIRCULATION, V125, P1979, DOI 10.1161/CIRCULATIONAHA.111.088591; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1; O'Brien, 1996, Blood Press Monit, V1, P55; O'Driscoll G, 1999, J AM COLL CARDIOL, V33, P1506, DOI 10.1016/S0735-1097(99)00065-0; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Ried K, 2011, MATURITAS, V68, P299, DOI 10.1016/j.maturitas.2010.11.018; Rissanen TH, 2003, AM J CLIN NUTR, V77, P133, DOI 10.1093/ajcn/77.1.133; Rissanen TH, 2001, BRIT J NUTR, V85, P749, DOI 10.1079/BJN2001357; Serra-Majem L, 2006, NUTR REV, V64, pS27, DOI 10.1301/nr.2006.feb.S27-S47; Sharman JE, 2008, HYPERTENSION, V51, P856, DOI 10.1161/HYPERTENSIONAHA.107.102558; Stangl V, 2011, BRIT J NUTR, V105, P263, DOI 10.1017/S0007114510003284; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Thies F, 2012, AM J CLIN NUTR, V95, P1013, DOI 10.3945/ajcn.111.026286; Ting HH, 1997, CIRCULATION, V95, P2617, DOI 10.1161/01.CIR.95.12.2617; Toledo E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-207; Upritchard JE, 2000, DIABETES CARE, V23, P733, DOI 10.2337/diacare.23.6.733; VALLANCE P, 1989, LANCET, V2, P997; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Waddington E, 2004, AM J CLIN NUTR, V79, P54; Wilkinson IB, 2004, HYPERTENSION, V44, P112, DOI 10.1161/01.HYP.0000138068.03893.40; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Wilkinson IB, 2001, BRIT J CLIN PHARMACO, V52, P631, DOI 10.1046/j.0306-5251.2001.01495.x; Winkens B, 2007, CONTEMP CLIN TRIALS, V28, P713, DOI 10.1016/j.cct.2007.04.002; Xaplanteris P, 2012, NUTR RES, V32, P390, DOI 10.1016/j.nutres.2012.03.011	51	75	77	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99070	10.1371/journal.pone.0099070	http://dx.doi.org/10.1371/journal.pone.0099070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911964	gold, Green Published			2022-12-27	WOS:000337165600038
J	Santovito, E; Mascia, T; Siddiqui, SA; Minutillo, SA; Valkonen, JPT; Gallitelli, D				Santovito, Elisa; Mascia, Tiziana; Siddiqui, Shahid A.; Minutillo, Serena Anna; Valkonen, Jari P. T.; Gallitelli, Donato			Infection Cycle of Artichoke Italian Latent Virus in Tobacco Plants: Meristem Invasion and Recovery from Disease Symptoms	PLOS ONE			English	Article							SMALL INTERFERING RNAS; MOSAIC-VIRUS; NICOTIANA-BENTHAMIANA; RINGSPOT-VIRUS; SILENCING SUPPRESSORS; SEED TRANSMISSION; TOMATO PLANTS; PROTEIN; THERMOTHERAPY; POTYVIRUS	Nepoviral infections induce recovery in fully expanded leaves but persist in shoot apical meristem (SAM) by a largely unknown mechanism. The dynamics of infection of a grapevine isolate of Artichoke Italian latent virus (AILV-V, genus Nepovirus) in tobacco plants, including colonization of SAM, symptom induction and subsequent recovery of mature leaves from symptoms, were characterized. AILV-V moved from the inoculated leaves systemically and invaded SAM in 7 days post-inoculation (dpi), remaining detectable in SAM at least up to 40 dpi. The new top leaves recovered from viral symptoms earliest at 21 dpi. Accumulation of viral RNA to a threshold level was required to trigger the overexpression of RDR6 and DCL4. Consequently, accumulation of viral RNA decreased in the systemically infected leaves, reaching the lowest concentration in the 3rd and 4th leaves at 23 dpi, which was concomitant with recovery of the younger, upper leaves from disease symptoms. No evidence of virus replication was found in the recovered leaves, but they contained infectious virus particles and were protected against re-inoculation with AILV-V. In this study we also showed that AILV-V did not suppress initiation or maintenance of RNA silencing in transgenic plants, but was able to interfere with the cell-to-cell movement of the RNA silencing signal. Our results suggest that AILV-V entrance in SAM and activation of RNA silencing may be distinct processes since the latter is triggered in fully expanded leaves by the accumulation of viral RNA above a threshold level rather than by virus entrance in SAM.	[Santovito, Elisa; Mascia, Tiziana; Minutillo, Serena Anna; Gallitelli, Donato] Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy; [Mascia, Tiziana; Gallitelli, Donato] CNR, Ist Virol Vegetale, Unita Operat Supporto Bari, I-70126 Bari, Italy; [Siddiqui, Shahid A.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); University of Helsinki	Mascia, T (corresponding author), Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy.	tiziana.mascia@uniba.it	Santovito, Elisa/P-6553-2018	Santovito, Elisa/0000-0001-8793-6351; Gallitelli, Donato/0000-0003-3699-2681; Valkonen, Jari/0000-0002-3704-9911	University of Bari, Italy [ORBA10Q104]; Academy of Finland [1253126]	University of Bari, Italy; Academy of Finland(Academy of Finland)	This work was supported, by a grant of University of Bari (http://www.uniba.it), Italy in the framework of Research funds 2010 "Study of plant-pathogen interactions in Artichoke'' grant ORBA10Q104. Financial support from the Academy of Finland (http://www.aka.fi/en-GB/A/), grant 1253126 to JPTV, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2010, PLANT CELL TISS ORG, V100, P329, DOI 10.1007/s11240-009-9654-3; Adams M, 2011, VIRUS TAXONOMY; Bedoya LC, 2012, PLANT PHYSIOL, V158, P1130, DOI 10.1104/pp.111.192922; Bottalico G, 2002, J PLANT PATHOL, V84, P167; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cheng NH, 2000, PLANT J, V23, P349, DOI 10.1046/j.1365-313x.2000.00788.x; Cillo F, 2004, MOL PLANT MICROBE IN, V17, P98, DOI 10.1094/MPMI.2004.17.1.98; Dong F, 2010, EUR J PLANT PATHOL, V126, P117, DOI 10.1007/s10658-009-9518-z; Faccioli G, 1998, PLANT VIRUS DISEASE CONTROL, P346; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Gallitelli D, 2012, ADV VIRUS RES, V84, P289, DOI 10.1016/B978-0-12-394314-9.00008-7; Gammelgard E, 2007, J GEN VIROL, V88, P2337, DOI 10.1099/vir.0.82928-0; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hirai K, 2008, J VIROL, V82, P3250, DOI 10.1128/JVI.02139-07; Holmes FO, 1930, AM J BOT, V17, P789, DOI 10.2307/2435688; Hull R., 2002, MATTHEWS PLANT VIROL; Jovel J, 2007, J VIROL, V81, P12285, DOI 10.1128/JVI.01192-07; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martelli GP, 1977, CMI AAB DESCR PLANT; Martin-Hernandez AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Matthews REF., 2002, PLANT VIROLOGY; Mink GI, 1998, PLANT VIRUS DISEASE CONTROL, P332; Minutillo SA, 2012, EUR J PLANT PATHOL, V134, P459, DOI 10.1007/s10658-012-0032-3; Mochizuki Tomofumi, 2004, Journal of General Plant Pathology, V70, P363, DOI 10.1007/s10327-004-0140-9; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Puurand U, 1996, VIRUS RES, V40, P135, DOI 10.1016/0168-1702(95)01263-X; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; ROBERTS DA, 1970, VIROLOGY, V42, P217, DOI 10.1016/0042-6822(70)90255-2; Sanfacon H, 2011, VIRUS TAXONOMY, P881; Savenkov EI, 2002, J GEN VIROL, V83, P2325, DOI 10.1099/0022-1317-83-9-2325; SAVINO V, 1977, PHYTOPATHOL MEDITERR, V16, P41; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Sharma S, 2008, PLANT CELL TISS ORG, V92, P85, DOI 10.1007/s11240-007-9307-3; Siddiqui SA, 2008, J GEN VIROL, V89, P1502, DOI 10.1099/vir.0.83621-0; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; Sunpapao A, 2009, J GEN VIROL, V90, P3015, DOI 10.1099/vir.0.013219-0; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang DW, 1997, VIROLOGY, V234, P112, DOI 10.1006/viro.1997.8637; Wang MB, 2012, MOL PLANT MICROBE IN, V25, P1275, DOI 10.1094/MPMI-04-12-0093-CR; Wang QC, 2008, MOL PLANT PATHOL, V9, P237, DOI [10.1111/j.1364-3703.2007.00456.x, 10.1111/J.1364-3703.2007.00456.X]	46	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99446	10.1371/journal.pone.0099446	http://dx.doi.org/10.1371/journal.pone.0099446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911029	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600090
J	Tang, HY; Huang, CH; Zhuang, YH; Christianson, JC; Chen, X				Tang, Hsiang-Yun; Huang, Chih-Hsiang; Zhuang, Ya-Han; Christianson, John C.; Chen, Xin			EDEM2 and OS-9 Are Required for ER-Associated Degradation of Non-Glycosylated Sonic Hedgehog	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; UBIQUITIN LIGASE COMPLEX; ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; RETRO-TRANSLOCATION; ALPHA-MANNOSIDASES; IDENTIFIES YOS9P; N-GLYCOSYLATION	Misfolded proteins of the endoplasmic reticulum (ER) are eliminated by the ER-associated degradation (ERAD) in eukaryotes. In S. cerevisiae, ER-resident lectins mediate substrate recognition through bipartite signals consisting of an unfolded local structure and the adjacent glycan. Trimming of the glycan is essential for the directional delivery of the substrates. Whether a similar recognition and delivery mechanism exists in mammalian cells is unknown. In this study, we systematically study the function and substrate specificity of known mammalian ER lectins, including EDEM1/2/3, OS-9 and XTP-3B using the recently identified ERAD substrate sonic hedgehog (SHH), a soluble protein carrying a single N-glycan, as well as its nonglycosylated mutant N278A. Efficient ERAD of N278A requires the core processing complex of HRD1, SEL1L and p97, similar to the glycosylated SHH. While EDEM2 was required for ERAD of both glycosylated and non-glycosylated SHHs, EDEM3 was only necessary for glycosylated SHH and EDEM1 was dispensable for both. Degradation of SHH and N278A also required OS-9, but not the related lectin XTP3-B. Robust interaction of both EDEM2 and OS-9 with a non-glycosylated SHH variant indicates that the misfolded polypeptide backbone, rather than a glycan signature, functions as the predominant signal for recognition for ERAD. Notably, SHH-N278A is the first nonglycosylated substrate to require EDEM2 for recognition and targeting for ERAD. EDEM2 also interacts with calnexin and SEL1L, suggesting a potential avenue by which misfolded glycoproteins may be shunted towards SEL1L and ERAD rather than being released into the secretory pathway. Thus, ER lectins participate in the recognition and delivery of misfolded ER substrates differently in mammals, with an underlying mechanism distinct from that of S. cerevisiae.	[Tang, Hsiang-Yun; Huang, Chih-Hsiang; Zhuang, Ya-Han; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Chunan Town, Miaoli, Taiwan; [Christianson, John C.] Univ Oxford, Ludwig Inst Canc Res, ORCRB, Oxford, England; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Ludwig Institute for Cancer Research; University of Oxford; China Medical University Taiwan	Chen, X (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Chunan Town, Miaoli, Taiwan.	xchen@nhri.org.tw	Christianson, John C/Y-4567-2019	Christianson, John/0000-0002-0474-1207	NRPGM, National Science Council, Taiwan; National Health Research Institutes, Taiwan, ROC; Medical Research Council [MR/L001209/1] Funding Source: researchfish	NRPGM, National Science Council, Taiwan; National Health Research Institutes, Taiwan, ROC(National Health Research Institutes - Taiwan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by NRPGM, National Science Council, Taiwan and National Health Research Institutes, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BISCHOFF J, 1986, J BIOL CHEM, V261, P4766; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Huang CH, 2013, J BIOL CHEM, V288, P25330, DOI 10.1074/jbc.M113.455212; Jakob CA, 2001, EMBO REP, V2, P423; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Plemper RK, 1999, J CELL SCI, V112, P4123; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Sato T, 2012, MOL CELL, V47, P99, DOI 10.1016/j.molcel.2012.04.015; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e92164	10.1371/journal.pone.0092164	http://dx.doi.org/10.1371/journal.pone.0092164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910992	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600120
J	Kim, JT; Heo, SH; Lee, JS; Park, MH; Oh, DS; Choi, KH; Kim, IG; Ha, YS; Chang, H; Choo, IS; Ahn, SH; Jeong, SK; Shin, BS; Park, MS; Cho, KH				Kim, Joon-Tae; Heo, Suk-Hee; Lee, Ji Sung; Park, Myeong-Ho; Oh, Dong-Seok; Choi, Kang-Ho; Kim, Ihn-Gyu; Ha, Yeon Soo; Chang, Hyuk; Choo, In Sung; Ahn, Seong Hwan; Jeong, Seul-Ki; Shin, Byoung-Soo; Park, Man-Seok; Cho, Ki-Hyun			To Do or Not to Do; Dilemma of Intra-Arterial Revascularization in Acute Ischemic Stroke	PLOS ONE			English	Article							IMAGING LESION VOLUME; EARLY CT SCORE; PLASMINOGEN-ACTIVATOR; NONCONTRAST CT; MECHANICAL THROMBECTOMY; ENDOVASCULAR TREATMENT; COMPUTED-TOMOGRAPHY; DWI-ASPECTS; THERAPY; DIFFUSION	Background: There has still been lack of evidence for definite imaging criteria of intra-arterial revascularization (IAR). Therefore, IAR selection is left largely to individual clinicians. In this study, we sought to investigate the overall agreement of IAR selection among different stroke clinicians and factors associated with good agreement of IAR selection. Methods: From the prospectively registered data base of a tertiary hospital, we identified consecutive patients with acute ischemic stroke. IAR selection based on the provided magnetic resonance imaging (MRI) results and clinical information were independently performed by 5 independent stroke physicians currently working at 4 different university hospitals. MRI results were also reviewed by 2 independent experienced neurologists blinded to clinical data and physicians' IAR selection. The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) was calculated on initial DWI and MU. We arbitrarily used ASPECTS differences between DWI and MU (D-M ASPECTS) to quantitatively evaluate mismatch. Results: The overall interobserver agreement of IAR selection was fair (kappa = 0.398). In patients with DWI-ASPECTS >6, interobserver agreement was moderate to substantial (0.398-0.620). In patients with D-M ASPECTS >4, interobserver agreement was moderate to almost perfect (0.532-1.000). Patients with higher DWI or D-M ASPECTS had better agreement of IAR selection. Conclusion: Our study showed that DWI-ASPSECTS >6 and D-M ASPECTS >4 had moderate to substantial agreement of IAR selection among different stroke physicians. However, there is still poor agreement as to whether IAR should not be performed in patients with lower DWI and D-M ASPECTS.	[Kim, Joon-Tae; Park, Myeong-Ho; Oh, Dong-Seok; Choi, Kang-Ho; Kim, Ihn-Gyu; Park, Man-Seok; Cho, Ki-Hyun] Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea; [Heo, Suk-Hee] Chonnam Natl Univ, Dept Radiol, Hwasun Hosp, Hwasun, South Korea; [Lee, Ji Sung] Soonchunhyang Univ, Biostat Consulting Unit, Med Ctr, Seoul, South Korea; [Ha, Yeon Soo; Chang, Hyuk] Wonkwang Univ Hosp, Dept Neurol, Iksan, South Korea; [Choo, In Sung; Ahn, Seong Hwan] Chosun Univ Hosp, Dept Neurol, Kwangju, South Korea; [Jeong, Seul-Ki; Shin, Byoung-Soo] Chonbuk Natl Univ Med Sch & Hosp, Dept Neurol, Jeonju, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Soonchunhyang University; Wonkwang University; Chosun University; Jeonbuk National University; Jeonbuk National University Hospital	Kim, JT (corresponding author), Chonnam Natl Univ Hosp, Cerebrovasc Ctr, Dept Neurol, Kwangju, South Korea.	alldelight2@jnu.ac.kr; mspark@jnu.ac.kr		Jeong, Seul-Ki/0000-0002-9868-621X	Chonnam National University Hospital Biomedical Research Institute [CRI 13041-21]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]; Honam Stroke Society	Chonnam National University Hospital Biomedical Research Institute; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Honam Stroke Society	This study was supported by a grant (CRI 13041-21) Chonnam National University Hospital Biomedical Research Institute. This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). This study was supported by a research grant from the Honam Stroke Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshekhlee A, 2012, NEUROLOGY, V79, pS126, DOI 10.1212/WNL.0b013e3182697e89; Aoki J, 2013, STROKE, V44, P534, DOI 10.1161/STROKEAHA.112.675470; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; de Margerie-Mellon C, 2013, STROKE, V44, P3565, DOI 10.1161/STROKEAHA.113.003047; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Finlayson O, 2013, STROKE, V44, P234, DOI 10.1161/STROKEAHA.112.665208; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gupta AC, 2012, AM J NEURORADIOL, V33, P1046, DOI 10.3174/ajnr.A2942; Hill MD, 2002, STROKE, V33, P279, DOI 10.1161/hs0102.101900; Hussain SI, 2012, NEUROLOGY, V79, pS135, DOI 10.1212/WNL.0b013e31826958a8; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kim JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070996; Kim JT, 2009, CEREBROVASC DIS, V28, P259, DOI 10.1159/000228256; Kimura K, 2008, STROKE, V39, P2388, DOI 10.1161/STROKEAHA.107.510917; Kruetzelmann A, 2011, STROKE, V42, P1251, DOI 10.1161/STROKEAHA.110.600148; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Lin K, 2008, AM J NEURORADIOL, V29, P931, DOI 10.3174/ajnr.A0975; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Morita N, 2009, MAGN RESON MED SCI, V8, P47, DOI 10.2463/mrms.8.47; Nezu T, 2010, NEUROLOGY, V75, P555, DOI 10.1212/WNL.0b013e3181eccf78; Nogueira RG, 2013, STROKE, V44, P3272, DOI 10.1161/STROKEAHA.113.002380; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Psychogios MN, 2013, STROKE, V44, P2188, DOI 10.1161/STROKEAHA.113.001068; Rajajee V, 2006, NEUROLOGY, V67, P980, DOI 10.1212/01.wnl.0000237520.88777.71; Rubiera M, 2011, STROKE, V42, P993, DOI 10.1161/STROKEAHA.110.597104; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Schellinger PD, 2010, NEUROLOGY, V75, P177, DOI 10.1212/WNL.0b013e3181e7c9dd; Tei H, 2011, J NEUROL, V258, P559, DOI 10.1007/s00415-010-5787-x; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99261	10.1371/journal.pone.0099261	http://dx.doi.org/10.1371/journal.pone.0099261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906122	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000115
J	Abrahao, KP; Goeldner, FO; Souza-Formigoni, MLO				Abrahao, Karina Possa; Goeldner, Francine Oliveira; Oliveira Souza-Formigoni, Maria Lucia			Individual Differences in Ethanol Locomotor Sensitization Are Associated with Dopamine D1 Receptor Intra-Cellular Signaling of DARPP-32 in the Nucleus Accumbens	PLOS ONE			English	Article							BEHAVIORAL SENSITIZATION; ALCOHOL; TOLERANCE; EXPRESSION; PHOSPHOPROTEIN; SENSITIVITY; INCREASES; C57BL/6J; DRINKING; DBA/2J	In mice there are clear individual differences in the development of behavioral sensitization to ethanol, a progressive potentiation of its psychomotor stimulant effect. Variability in the behavioral responses to ethanol has been associated with alcohol preference. Here we investigated if the functional hyperresponsiveness of D1 receptors observed in ethanol sensitized mice leads to an increased activation of DARPP-32, a central regulatory protein in medium spiny neurons, in the nucleus accumbens - a brain region known to play a role in drug reinforcement. Swiss Webster mice received ethanol (2.2 g/kg/day) or saline i.p. administrations for 21 days and were weekly evaluated regarding their locomotor activity. From those treated with ethanol, the 33% with the highest levels of locomotor activity were classified as "sensitized'' and the 33% with the lowest levels as "non-sensitized''. The latter presented similar locomotor levels to those of saline-treated mice. Different subgroups of mice received intra-accumbens administrations of saline and, 48 h later, SKF-38393, D1 receptor agonist 0.1 or 1 mg/side. Indeed, sensitized mice presented functional hyperresponsiveness of D1 receptors in the accumbens. Two weeks following the ethanol treatment, other subgroups received systemic saline or SKF 10 mg/kg, 20 min before the euthanasia. The nucleus accumbens were dissected for the Western Blot analyses of total DARPP-32 and phospho-Thr34-DARPP-32 expression. D1 receptor activation induced higher phospho-Thr34-DARPP-32 expression in sensitized mice than in non-sensitized or saline. The functionally hyperresponsiveness of D1 receptors in the nucleus accumbens is associated with an increased phospho-Thr34-DARPP-32 expression after D1 receptor activation. These data suggest that an enduring increase in the sensitivity of the dopamine D1 receptor intracellular pathway sensitivity represents a neurobiological correlate associated with the development of locomotor sensitization to ethanol.	[Abrahao, Karina Possa; Goeldner, Francine Oliveira; Oliveira Souza-Formigoni, Maria Lucia] Univ Fed Sao Paulo, Escola Paulista Med, Dept Psicobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Souza-Formigoni, MLO (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Psicobiol, Sao Paulo, Brazil.	mlosformigoni@unifesp.br	Souza-Formigoni, Maria Lucia O/B-5736-2011; Abrahao, Karina/R-3267-2017	Souza-Formigoni, Maria Lucia O/0000-0002-6361-5630; Abrahao, Karina/0000-0002-4528-2430	Fundacao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/01819-5]; Associacao Fundo Incentivo a Pesquisa (AFIP); Conselho Nacional de de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Fundo Incentivo a Pesquisa (AFIP); Conselho Nacional de de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by Fundacao Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2008/01819-5), Associacao Fundo Incentivo a Pesquisa (AFIP), Conselho Nacional de de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Abrahao KP, 2009, BEHAV BRAIN RES, V197, P404, DOI 10.1016/j.bbr.2008.10.009; Abrahao KP, 2013, J NEUROSCIE IN PRESS; Abrahao KP, 2011, NEUROPHARMACOLOGY; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; DIANA M, 1992, ALCOHOL ALCOHOLISM, V27, P329; Fidler TL, 2011, GENES BRAIN BEHAV, V10, P264, DOI 10.1111/j.1601-183X.2010.00664.x; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Grahame NJ, 2000, PSYCHOPHARMACOLOGY, V151, P252, DOI 10.1007/s002130000388; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Lessov CN, 2001, PSYCHOPHARMACOLOGY, V155, P91, DOI 10.1007/s002130100699; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; MASUR J, 1988, PSYCHOPHARMACOLOGY, V96, P547, DOI 10.1007/BF02180038; MASUR J, 1986, PHARMACOL BIOCHEM BE, V24, P1225, DOI 10.1016/0091-3057(86)90175-9; Melon LC, 2011, ALCOHOL CLIN EXP RES, V35, P1351, DOI 10.1111/j.1530-0277.2011.01471.x; Newlin DB, 1999, EXP CLIN PSYCHOPHARM, V7, P234, DOI 10.1037/1064-1297.7.3.234; Nuutinen S, 2011, NEUROSCI LETT, V503, P31, DOI 10.1016/j.neulet.2011.08.002; PAXINOS G, 2004, MOUSE BRAIN; Quadros IMH, 2002, ADDICT BIOL, V7, P291, DOI 10.1080/13556210220139505; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reis HJ, 2007, EXPERT OPIN THER TAR, V11, P1649, DOI 10.1517/14728222.11.12.1649; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Scott L, 2005, PEDIATR RES, V58, P779, DOI 10.1203/01.PDR.0000180553.23507.31; SEGAL DS, 1974, PHARMACOL BIOCHEM BE, V2, P249, DOI 10.1016/0091-3057(74)90060-4; Snyder GL, 1998, J NEUROSCI, V18, P10297; Souza-Formigoni MLO, 1999, PSYCHOPHARMACOLOGY, V146, P262, DOI 10.1007/s002130051115; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 1999, PSYCHOPHARMACOLOGY, V143, P244, DOI 10.1007/s002130050943; Yim HJ, 2000, ALCOHOL, V22, P107, DOI 10.1016/S0741-8329(00)00121-X	34	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98296	10.1371/journal.pone.0098296	http://dx.doi.org/10.1371/journal.pone.0098296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919054	gold, Green Published			2022-12-27	WOS:000338631000015
J	Castillo, MG; Gillespie, DOS; Allen, K; Bandosz, P; Schmid, V; Capewell, S; O'Flaherty, M				Castillo, Maria Guzman; Gillespie, Duncan O. S.; Allen, Kirk; Bandosz, Piotr; Schmid, Volker; Capewell, Simon; O'Flaherty, Martin			Future Declines of Coronary Heart Disease Mortality in England and Wales Could Counter the Burden of Population Ageing	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; SECULAR TRENDS; UNITED-STATES; IMPACT; COHORT; PERIOD; RATES	Background: Coronary Heart Disease (CHD) remains a major cause of mortality in the United Kingdom. Yet predictions of future CHD mortality are potentially problematic due to population ageing and increase in obesity and diabetes. Here we explore future projections of CHD mortality in England & Wales under two contrasting future trend assumptions. Methods: In scenario A, we used the conventional counterfactual scenario that the last-observed CHD mortality rates from 2011 would persist unchanged to 2030. The future number of deaths was calculated by applying those rates to the 20122030 population estimates. In scenario B, we assumed that the recent falling trend in CHD mortality rates would continue. Using Lee-Carter and Bayesian Age Period Cohort (BAPC) models, we projected the linear trends up to 2030. We validate our methods using past data to predict mortality from 2002-2011. Then, we computed the error between observed and projected values. Results: In scenario A, assuming that 2011 mortality rates stayed constant by 2030, the number of CHD deaths would increase 62% or approximately 39,600 additional deaths. In scenario B, assuming recent declines continued, the BAPC model (the model with lowest error) suggests the number of deaths will decrease by 56%, representing approximately 36,200 fewer deaths by 2030. Conclusions: The decline in CHD mortality has been reasonably continuous since 1979, and there is little reason to believe it will soon halt. The commonly used assumption that mortality will remain constant from 2011 therefore appears slightly dubious. By contrast, using the BAPC model and assuming continuing mortality falls offers a more plausible prediction of future trends. Thus, despite population ageing, the number of CHD deaths might halve again between 2011 and 2030. This has implications for how the potential benefits of future cardiovascular strategies might best be calculated and presented.	[Castillo, Maria Guzman; Gillespie, Duncan O. S.; Allen, Kirk; Bandosz, Piotr; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Schmid, Volker] Univ Munich, Dept Stat, Munich, Germany	University of Liverpool; University of Munich	Castillo, MG (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	M.Guzman-Castillo@liverpoola.c.uk	Gillespie, Duncan/G-1401-2013; Bandosz, Piotr/E-4964-2017; Schmid, Volker/F-3251-2010	Gillespie, Duncan/0000-0003-3450-5747; Schmid, Volker/0000-0003-2195-8130; O'Flaherty, Martin/0000-0001-8944-4131	MRC NPRI 3 Scheme; School of Public Health Research project: Modelling preventive interventions to address inequalities in CVD; MRC [G0900847] Funding Source: UKRI	MRC NPRI 3 Scheme; School of Public Health Research project: Modelling preventive interventions to address inequalities in CVD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was in part funded by the MRC NPRI 3 Scheme (http://www.mrc.ac.uk/Ourresearch/ResearchInitiatives/NPRI/index.htm) and the School of Public Health Research project: Modelling preventive interventions to address inequalities in CVD (http://sphr.nihr.ac.uk/wp-content/uploads/2013/06/SummarySPHR-LIL-PH1-MCD1.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; BAKER D, 1993, J PUBLIC HEALTH MED, V15, P243; Bell A, 2013, SOCIAL SCI MED; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bobak M, 2005, EPIDEMIOLOGY CORONAR, V2, P83; Booth H, 2008, ANN ACTUAR SCI, V3, P3, DOI 10.1017/S1748499500000440; Booth H, 2002, POP STUD-J DEMOG, V56, P325, DOI 10.1080/00324720215935; (C-Projections) CPN, 2010, LONG TERM PROJ METH; Capewell S, 2012, MODELLING UK BURDEN; Capewell S, 2012, NUTR METAB CARDIOVAS, V22, P307, DOI 10.1016/j.numecd.2012.01.005; Carter LawrenceR., 2001, METHODEN ZIELE, V39; Darkiewicz G, 2004, COINTEGRATION ANAL C, V0406, P1; Di Cesare M, 2009, BRIT ACTUARIAL J, V15, P185; Do Health, 2013, FREE NHS HLTH CHECK; Dye C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Health Do, 2008, EC MOD VASC CHECKS; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huffman MD, 2013, CIRCULATION; HUGHES K, 1986, INT J EPIDEMIOL, V15, P44, DOI 10.1093/ije/15.1.44; Huovinen E, 2006, INT J EPIDEMIOL, V35, P1246, DOI 10.1093/ije/dyl128; Hyndman R, 2013, DEMOGRAPHY FORECASTI; Jones DS, 2013, AM J PUBLIC HEALTH, pe1; Knorr-Held L, 2001, Biostatistics, V2, P109, DOI 10.1093/biostatistics/2.1.109; Kuulasmaa K, 2000, LANCET; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Murray C. J. L., 2013, LANCET; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Ovbiagele B, 2013, STROKE; Schmid VJ, 2007, J STAT SOFTW, V21, P1; Shkolnikov V, 1996, Popul, V8, P155; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SVERRE JM, 1993, AM J EPIDEMIOL, V137, P301, DOI 10.1093/oxfordjournals.aje.a116677; Tabeau E, 2001, FORECASTING MORTALIT; Taleb N. N., 2010, BLACK SWAN, DOI DOI 10.1176/PS.2009.60.11.1564; Taylor R, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.109538; Tobias M, 2006, LOW CAN IT GO PROJEC; Vaartjes I, 2011, HEART, V97, P569, DOI 10.1136/hrt.2010.206565; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wood J, 1999, Popul Trends, P21; WOOD SN, 1994, SIAM J SCI COMPUT, V15, P1126, DOI 10.1137/0915069; YU TS, 1995, J EPIDEMIOL COMMUN H, V49, P16, DOI 10.1136/jech.49.1.16; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1	55	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99482	10.1371/journal.pone.0099482	http://dx.doi.org/10.1371/journal.pone.0099482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918442	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000089
J	Chen, YA; Tripathi, LP; Dessailly, BH; Nystrom-Persson, J; Ahmad, S; Mizuguchi, K				Chen, Yi-An; Tripathi, Lokesh P.; Dessailly, Benoit H.; Nystroem-Persson, Johan; Ahmad, Shandar; Mizuguchi, Kenji			Integrated Pathway Clusters with Coherent Biological Themes for Target Prioritisation	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; SEMANTIC SIMILARITY; HCV INFECTION; DATABASE; METABOLISM	Prioritising candidate genes for further experimental characterisation is an essential, yet challenging task in biomedical research. One way of achieving this goal is to identify specific biological themes that are enriched within the gene set of interest to obtain insights into the biological phenomena under study. Biological pathway data have been particularly useful in identifying functional associations of genes and/or gene sets. However, biological pathway information as compiled in varied repositories often differs in scope and content, preventing a more effective and comprehensive characterisation of gene sets. Here we describe a new approach to constructing biologically coherent gene sets from pathway data in major public repositories and employing them for functional analysis of large gene sets. We first revealed significant overlaps in gene content between different pathways and then defined a clustering method based on the shared gene content and the similarity of gene overlap patterns. We established the biological relevance of the constructed pathway clusters using independent quantitative measures and we finally demonstrated the effectiveness of the constructed pathway clusters in comparative functional enrichment analysis of gene sets associated with diverse human diseases gathered from the literature. The pathway clusters and gene mappings have been integrated into the TargetMine data warehouse and are likely to provide a concise, manageable and biologically relevant means of functional analysis of gene sets and to facilitate candidate gene prioritisation.	[Chen, Yi-An; Tripathi, Lokesh P.; Dessailly, Benoit H.; Nystroem-Persson, Johan; Ahmad, Shandar; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Ibaraki, Osaka, Japan	National Institute of Health Sciences - Japan	Chen, YA (corresponding author), Natl Inst Biomed Innovat, Ibaraki, Osaka, Japan.	chenyian@nibio.go.jp; lokesh@nibio.go.jp; kenji@nibio.go.jp	Mizuguchi, Kenji/GVS-5857-2022	Mizuguchi, Kenji/0000-0003-3021-7078; Ahmad, Shandar/0000-0002-7287-305X; Nystrom Persson, Johan/0000-0002-7951-4762	Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan [07C46056a]; Ministry of Education, Culture, Sports, Science, and Technology [25430186, 25293079]; Ministry of Health, Labor, and Welfare	Industrial Technology Research Grant Program from New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was in part supported by the Industrial Technology Research Grant Program in 2007 (Grant Number 07C46056a) from New Energy and Industrial Technology Development Organization (NEDO) of Japan, and also by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (Grant Numbers 25430186, 25293079) and from the Ministry of Health, Labor, and Welfare ("The Adjuvant database project") to K.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornsiripanitch N, 2010, CLIN CANCER RES, V16, P3226, DOI 10.1158/1078-0432.CCR-10-0321; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Camargo LM, 2011, USE COMPUTATIONAL ME; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chowbina SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S5; Cui TT, 2011, INT J ONCOL, V39, P161, DOI 10.3892/ijo.2011.1010; Doderer MS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S18; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihara S, 2012, CANCER RES, V72, P2990, DOI 10.1158/0008-5472.CAN-11-4062; Jiang XC, 2011, ADV EXP MED BIOL, V721, P19, DOI 10.1007/978-1-4614-0650-1_2; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Soh D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-449; Stobbe M.D., 2012, BRIEF BIOINFORM; Stobbe MD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-165; Tripathi LP, 2013, J PROTEOME RES, V12, P2537, DOI 10.1021/pr3011217; Tripathi LP, 2012, J PROTEOME RES, V11, P3664, DOI 10.1021/pr300121a; Wallig MA, 1998, DIGESTION, V59, P13, DOI 10.1159/000051439; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Watts GF, 2012, INT J EVID-BASED HEA, V10, P211, DOI 10.1111/j.1744-1609.2012.00272.x; Yu N, 2012, NUCLEIC ACIDS RES, V40, pD797, DOI 10.1093/nar/gkr1127; Zhang F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S7; Zhou HF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S2	31	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99030	10.1371/journal.pone.0099030	http://dx.doi.org/10.1371/journal.pone.0099030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918583	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000042
J	Dorado-Garcia, I; Medina-Sanchez, JM; Herrera, G; Cabrerizo, MJ; Carrillo, P				Dorado-Garcia, Irene; Manuel Medina-Sanchez, Juan; Herrera, Guillermo; Cabrerizo, Marco J.; Carrillo, Presentacion			Quantification of Carbon and Phosphorus Co-Limitation in Bacterioplankton: New Insights on an Old Topic	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; PHYTOPLANKTON NUTRIENT LIMITATION; BACTERIAL-GROWTH; FRESH-WATER; CLIMATE-CHANGE; DUST INPUTS; TEMPERATURE REGULATION; PLANKTONIC BACTERIA; COMMUNITY STRUCTURE; SURFACE WATERS	Because the nature of the main resource that limits bacterioplankton (e.g. organic carbon [C] or phosphorus [P]) has biogeochemical implications concerning organic C accumulation in freshwater ecosystems, empirical knowledge is needed concerning how bacteria respond to these two resources, available alone or together. We performed field experiments of resource manipulation (262 factorial design, with the addition of C, P, or both combined) in two Mediterranean freshwater ecosystems with contrasting trophic states (oligotrophy vs. eutrophy) and trophic natures (autotrophy vs. heterotrophy, measured as gross primary production: respiration ratio). Overall, the two resources synergistically co-limited bacterioplankton, i.e. the magnitude of the response of bacterial production and abundance to the two resources combined was higher than the additive response in both ecosystems. However, bacteria also responded positively to single P and C additions in the eutrophic ecosystem, but not to single C in the oligotrophic one, consistent with the value of the ratio between bacterial C demand and algal C supply. Accordingly, the trophic nature rather than the trophic state of the ecosystems proves to be a key feature determining the expected types of resource co-limitation of bacteria, as summarized in a proposed theoretical framework. The actual types of co-limitation shifted over time and partially deviated (a lesser degree of synergism) from the theoretical expectations, particularly in the eutrophic ecosystem. These deviations may be explained by extrinsic ecological forces to physiological limitations of bacteria, such as predation, whose role in our experiments is supported by the relationship between the dynamics of bacteria and bacterivores tested by SEMs (structural equation models). Our study, in line with the increasingly recognized role of freshwater ecosystems in the global C cycle, suggests that further attention should be focussed on the biotic interactions that modulate resource co-limitation of bacteria.	[Dorado-Garcia, Irene; Herrera, Guillermo; Cabrerizo, Marco J.; Carrillo, Presentacion] Univ Granada, Inst Agua, Granada, Spain; [Manuel Medina-Sanchez, Juan] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain	University of Granada; University of Granada	Dorado-Garcia, I (corresponding author), Univ Granada, Inst Agua, Granada, Spain.	idorado@ugr.es	Carrillo, Presentación/I-1601-2015; Cabrerizo, Marco J./A-5962-2018; Cabrerizo, Marco J./O-4677-2019; Medina-Sánchez, Juan Manuel/A-4703-2013	Carrillo, Presentación/0000-0003-3794-4294; Cabrerizo, Marco J./0000-0001-5576-6095; Cabrerizo, Marco J./0000-0001-5576-6095; Medina-Sánchez, Juan Manuel/0000-0003-0991-9331	Junta de Andalucia [P09-RNM-5376]; Spanish Ministry Ciencia e Innovacion [CGL2011-23681]	Junta de Andalucia(Junta de Andalucia); Spanish Ministry Ciencia e Innovacion	This research was supported by Junta de Andalucia (Excelencia P09-RNM-5376 to JMMS) and the Spanish Ministry Ciencia e Innovacion (CGL2011-23681 to PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier JE, 2011, J APPL ECOL, V48, P96, DOI 10.1111/j.1365-2664.2010.01894.x; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; APHA, 2011, STANDARD METHODS EXA; Apple JK, 2006, AQUAT MICROB ECOL, V43, P243, DOI 10.3354/ame043243; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BELL RT, 1993, HDB METHODS AQUATIC, P495; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; BENNER R, 1993, MAR CHEM, V41, P153, DOI 10.1016/0304-4203(93)90113-3; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Berggren M, 2010, MICROB ECOL, V60, P894, DOI 10.1007/s00248-010-9751-1; Bertoni R, 2008, J LIMNOL, V67, P120, DOI 10.4081/jlimnol.2008.120; BILLEN G, 1990, HYDROBIOLOGIA, V207, P37, DOI 10.1007/BF00041438; Bollen KA, 1989, STRUCTURAL EQUATIONS; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlsson P, 2012, J EXP MAR BIOL ECOL, V418, P37, DOI 10.1016/j.jembe.2012.03.012; Carrillo P, 2002, LIMNOL OCEANOGR, V47, P1294, DOI 10.4319/lo.2002.47.5.1294; Cherrier J, 1999, LIMNOL OCEANOGR, V44, P730, DOI 10.4319/lo.1999.44.3.0730; Coelho FJRC, 2013, ECOL EVOL, V3, P1808, DOI 10.1002/ece3.565; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; de Vicente I, 2012, BIOGEOSCIENCES, V9, P5049, DOI 10.5194/bg-9-5049-2012; Degerman R, 2013, AQUAT MICROB ECOL, V68, P131, DOI 10.3354/ame01609; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dodds WK, 2007, AQUAT SCI, V69, P427, DOI 10.1007/s00027-007-0922-1; Ducklow H, 2008, AQUAT MICROB ECOL, V53, P13, DOI 10.3354/ame01220; Edenhofer O., 2014, CONTRIBUTION WORKING; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, ECOLOGY, V90, P3062, DOI 10.1890/08-1742.1; Faithfull CL, 2011, LIMNOL OCEANOGR, V56, P1703, DOI 10.4319/lo.2011.56.5.1703; Farjalla VF, 2002, HYDROBIOLOGIA, V489, P197, DOI 10.1023/A:1023288922394; Farjalla VF, 2006, MICROB ECOL, V52, P334, DOI 10.1007/s00248-006-9021-4; Farjalla VF, 2009, ENVIRON SCI POLLUT R, V16, P531, DOI 10.1007/s11356-009-0165-x; Felip M, 1996, MICROBIAL ECOL, V31, P15, DOI 10.1007/BF00175072; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Gasol JM, 2009, AQUAT MICROB ECOL, V56, P1, DOI 10.3354/ame01310; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Graneli W, 2004, AQUAT SCI, V66, P430, DOI 10.1007/s00027-004-0732-7; Hall EK, 2007, AQUAT MICROB ECOL, V49, P35, DOI 10.3354/ame01124; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Herndl GJ, 2008, AQUAT MICROB ECOL, V53, P59, DOI 10.3354/ame01225; Hoikkala L, 2009, ESTUAR COAST, V32, P720, DOI 10.1007/s12237-009-9154-z; Jansson M, 2006, MICROB ECOL, V52, P358, DOI 10.1007/s00248-006-9013-4; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kamiya E, 2007, J OCEANOGR, V63, P101, DOI 10.1007/s10872-007-0008-7; Kritzberg ES, 2006, ECOSYSTEMS, V9, P489, DOI 10.1007/s10021-005-0115-5; Kritzberg ES, 2005, AQUAT MICROB ECOL, V38, P103, DOI 10.3354/ame038103; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Lohelin JC, 1992, LATENT VARIABLE MODE; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Medina-Sanchez JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060223; Medina-Sanchez JM, 2010, FEMS MICROBIOL ECOL, V74, P554, DOI 10.1111/j.1574-6941.2010.00969.x; MARTINEZ R, 1975, Cuadernos de Ciencias Biologicas Universidad de Granada, V4, P223; Medina-Sanchez JM, 2004, LIMNOL OCEANOGR, V49, P1722, DOI 10.4319/lo.2004.49.5.1722; Medina-Sanchez JM, 2002, FRESHWATER BIOL, V47, P2191, DOI 10.1046/j.1365-2427.2002.00969.x; Mladenov N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1411; Morales-Baquero R, 2006, LIMNOL OCEANOGR, V51, P830, DOI 10.4319/lo.2006.51.2.0830; Nurnberg Gertrud K., 1996, Lake and Reservoir Management, V12, P432; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Ortega-Retuerta E, 2007, MICROB ECOL, V54, P161, DOI 10.1007/s00248-006-9186-x; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Reche I, 2001, ARCT ANTARCT ALP RES, V33, P426, DOI 10.2307/1552552; Reche I, 2009, LIMNOL OCEANOGR, V54, P869, DOI 10.4319/lo.2009.54.3.0869; ROCHA O, 1985, J PLANKTON RES, V7, P279, DOI 10.1093/plankt/7.2.279; ROTT E, 1981, SCHWEIZ Z HYDROL, V43, P34, DOI 10.1007/BF02502471; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Solic M, 2009, AQUAT MICROB ECOL, V58, P15, DOI 10.3354/ame01342; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Stets EG, 2008, LIMNOL OCEANOGR, V53, P137, DOI 10.4319/lo.2008.53.1.0137; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.1111/j.1467-8624.1987.tb03495.x; Thingstad TF, 1997, LIMNOL OCEANOGR, V42, P398, DOI 10.4319/lo.1997.42.2.0398; Vadstein O, 2003, FEMS MICROBIOL ECOL, V46, P307, DOI 10.1016/S0168-6496(03)00195-8; Vadstein O, 2000, ADV MICROB ECOL, V16, P115; Vidal LO, 2011, J PLANKTON RES, V33, P1747, DOI 10.1093/plankt/fbr059; Villar-Argaiz M, 2002, AQUAT MICROB ECOL, V29, P253, DOI 10.3354/ame029253; Vrede K, 2005, MICROB ECOL, V49, P245, DOI 10.1007/s00248-004-0259-4; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Xenopoulos MA, 2003, LIMNOL OCEANOGR, V48, P2321, DOI 10.4319/lo.2003.48.6.2321; Zubkov MV, 2006, CYTOM PART A, V69A, P1010, DOI 10.1002/cyto.a.20332; Zubkov M, 2007, J PLANKTON RES, V29, P79	91	14	14	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99288	10.1371/journal.pone.0099288	http://dx.doi.org/10.1371/journal.pone.0099288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918445	Green Published, gold			2022-12-27	WOS:000338631000071
J	Galvin, JJ; Oba, S; Fu, QJ; Baskent, D				Galvin, John J., III; Oba, Sandy; Fu, Qian-Jie; Baskent, Deniz			Single- and Multi-Channel Modulation Detection in Cochlear Implant Users	PLOS ONE			English	Article							CARRIER PULSE-RATE; AMPLITUDE-MODULATION; INTENSITY DISCRIMINATION; SPEECH RECOGNITION; STIMULATION RATE; LOUDNESS; PERCEPTION; LISTENERS; NOISE; SITE	Single-channel modulation detection thresholds (MDTs) have been shown to predict cochlear implant (CI) users' speech performance. However, little is known about multi-channel modulation sensitivity. Two factors likely contribute to multichannel modulation sensitivity: multichannel loudness summation and the across-site variance in single-channel MDTs. In this study, single- and multi-channel MDTs were measured in 9 CI users at relatively low and high presentation levels and modulation frequencies. Single-channel MDTs were measured at widely spaced electrode locations, and these same channels were used for the multichannel stimuli. Multichannel MDTs were measured twice, with and without adjustment for multichannel loudness summation (i.e., at the same loudness as for the single-channel MDTs or louder). Results showed that the effect of presentation level and modulation frequency were similar for single- and multi-channel MDTs. Multichannel MDTs were significantly poorer than single-channel MDTs when the current levels of the multichannel stimuli were reduced to match the loudness of the single-channel stimuli. This suggests that, at equal loudness, single-channel measures may over-estimate CI users' multichannel modulation sensitivity. At equal loudness, there was no significant correlation between the amount of multichannel loudness summation and the deficit in multichannel MDTs, relative to the average single-channel MDT. With no loudness compensation, multichannel MDTs were significantly better than the best single-channel MDT. The across-site variance in single-channel MDTs varied substantially across subjects. However, the across-site variance was not correlated with the multichannel advantage over the best single channel. This suggests that CI listeners combined envelope information across channels instead of attending to the best channel.	[Galvin, John J., III; Oba, Sandy; Fu, Qian-Jie] House Res Inst, Div Commun & Auditory Neurosci, Los Angeles, CA 90057 USA; [Galvin, John J., III; Oba, Sandy; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Galvin, John J., III; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Galvin, John J., III; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Groningen; University of Groningen	Galvin, JJ (corresponding author), House Res Inst, Div Commun & Auditory Neurosci, Los Angeles, CA 90057 USA.	Jgalvin@ucla.edu		Baskent, Deniz/0000-0002-6560-1451	National Institutes of Health [R01-DC004993]; VIDI from the Netherlands Organization for Scientific Research (NWO) [016.096.397]; Netherlands Organization for Health Research and Development (ZonMw); Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIDI from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Mr. Galvin, Ms. Oba, and Dr. Fu were supported by National Institutes of Health grant R01-DC004993. Dr. Baskent was supported by VIDI grant 016.096.397 from the Netherlands Organization for Scientific Research (NWO) and the Netherlands Organization for Health Research and Development (ZonMw), and a Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora K, 2011, INT J AUDIOL, V50, P123, DOI 10.3109/14992027.2010.527860; BUSBY PA, 1993, J ACOUST SOC AM, V94, P124, DOI 10.1121/1.408212; CAZALS Y, 1994, J ACOUST SOC AM, V96, P2048, DOI 10.1121/1.410146; Chatterjee M, 2005, J ACOUST SOC AM, V118, P993, DOI 10.1121/1.1929258; Chatterjee M, 2003, J ACOUST SOC AM, V113, P2042, DOI 10.1121/1.1555613; Chatterjee M, 2001, JARO-J ASSOC RES OTO, V2, P159, DOI 10.1007/s101620010079; Chatterjee M, 2011, J ACOUST SOC AM, V130, P1567, DOI 10.1121/1.3621445; Colletti V, 2005, LARYNGOSCOPE, V115, P1974, DOI 10.1097/01.mlg.0000178327.42926.ec; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Donaldson GS, 2000, J ACOUST SOC AM, V108, P760, DOI 10.1121/1.429609; Fraser M, 2012, HEARING RES, V283, P59, DOI 10.1016/j.heares.2011.11.009; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Galvin JJ, 2005, JARO-J ASSOC RES OTO, V6, P269, DOI 10.1007/s10162-005-0007-6; Galvin JJ, 2013, J NEUROSCI METHODS D, DOI [10.1016/j.jneu-meth.2013.10.016, DOI 10.1016/J.JNEU-METH.2013.10.016]; Galvin JJ, 2009, HEARING RES, V250, P46, DOI 10.1016/j.heares.2009.01.009; Garadat SN, 2012, J ACOUST SOC AM, V131, P4030, DOI 10.1121/1.3701879; Geurts L, 2001, J ACOUST SOC AM, V109, P713, DOI 10.1121/1.1340650; Green T, 2012, EAR HEARING, V33, P233, DOI 10.1097/AUD.0b013e318230fff8; JESTEADT W, 1980, PERCEPT PSYCHOPHYS, V28, P85, DOI 10.3758/BF03204321; Kreft HA, 2013, JARO-J ASSOC RES OTO, V14, P591, DOI 10.1007/s10162-013-0391-2; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; McKay CM, 2003, J ACOUST SOC AM, V113, P2054, DOI 10.1121/1.1558378; McKay CM, 2001, J ACOUST SOC AM, V110, P1514, DOI 10.1121/1.1394222; McKay CM, 2010, JARO-J ASSOC RES OTO, V11, P101, DOI 10.1007/s10162-009-0188-5; Pfingst BE, 2007, J ACOUST SOC AM, V121, P2236, DOI 10.1121/1.2537501; SHANNON RV, 1992, J ACOUST SOC AM, V91, P2156, DOI 10.1121/1.403807; Wygonski J, 2002, HEL NUCLEUS RES INTE; ZENG FG, 1991, Q J EXP PSYCHOL-A, V43, P565, DOI 10.1080/14640749108400987; Zhou N, 2012, J ACOUST SOC AM, V132, P994, DOI 10.1121/1.4730907	30	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99338	10.1371/journal.pone.0099338	http://dx.doi.org/10.1371/journal.pone.0099338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918605	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000078
J	Ohshima, C; Takahashi, H; Phraephaisarn, C; Vesaratchavest, M; Keeratipibul, S; Kuda, T; Kimura, B				Ohshima, Chihiro; Takahashi, Hajime; Phraephaisarn, Chirapiphat; Vesaratchavest, Mongkol; Keeratipibul, Suwimon; Kuda, Takashi; Kimura, Bon			Establishment of a Simple and Rapid Identification Method for Listeria spp. by Using High-Resolution Melting Analysis, and Its Application in Food Industry	PLOS ONE			English	Article							SP NOV.; MONOCYTOGENES; CURVE; TOOL; PCR	Listeria monocytogenes is the causative bacteria of listeriosis, which has a higher mortality rate than that of other causes of food poisoning. Listeria spp., of which L. monocytogenes is a member, have been isolated from food and manufacturing environments. Several methods have been published for identifying Listeria spp.; however, many of the methods cannot identify newly categorized Listeria spp. Additionally, they are often not suitable for the food industry, owing to their complexity, cost, or time consumption. Recently, high-resolution melting analysis (HRMA), which exploits DNA-sequence differences, has received attention as a simple and quick genomic typing method. In the present study, a new method for the simple, rapid, and low-cost identification of Listeria spp. has been presented using the genes rarA and ldh as targets for HRMA. DNA sequences of 9 Listeria species were first compared, and polymorphisms were identified for each species for primer design. Species specificity of each HRM curve pattern was estimated using type strains of all the species. Among the 9 species, 7 were identified by HRMA using rarA gene, including 3 new species. The remaining 2 species were identified by HRMA of ldh gene. The newly developed HRMA method was then used to assess Listeria isolates from the food industry, and the method efficiency was compared to that of identification by 16S rDNA sequence analysis. The 2 methods were in coherence for 92.6% of the samples, demonstrating the high accuracy of HRMA. The time required for identifying Listeria spp. was substantially low, and the process was considerably simplified, providing a useful and precise method for processing multiple samples per day. Our newly developed method for identifying Listeria spp. is highly valuable; its use is not limited to the food industry, and it can be used for the isolates from the natural environment.	[Ohshima, Chihiro; Takahashi, Hajime; Kuda, Takashi; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Minato Ku, Tokyo, Japan; [Phraephaisarn, Chirapiphat; Vesaratchavest, Mongkol] BETAGRO Grp, Ctr Res & Dev, Klongluang, Pathumthani, Thailand; [Phraephaisarn, Chirapiphat] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok, Thailand; [Keeratipibul, Suwimon] Chulalongkorn Univ, Fac Sci, Dept Food Technol, Bangkok, Thailand	Tokyo University of Marine Science & Technology; Chulalongkorn University; Chulalongkorn University	Takahashi, H (corresponding author), Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Dept Food Sci & Technol, Minato Ku, Tokyo, Japan.	hajime@kaiyodai.ac.jp	KUDA, Takashi/O-1974-2014; Kimbo, Bon/O-1879-2014	Kimbo, Bon/0000-0002-3071-1343; keeratipibul, suwimon/0000-0001-7708-3084	Ministry of Education, Science, Sports and Culture of Japan [B 24380115]; Research and Development Center of BETAGRO Group	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research and Development Center of BETAGRO Group	This work was supported by Grant-in-Aid for Scientific Research (B 24380115) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Chirapiphat Phraephaisarn and Mongkol Vesaratchavest are employed by Research and Development Center of BETAGRO Group. Research and Development Center of BETAGRO Group provided support in the form of salaries for authors CP and MV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bertsch D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/ijs.0.036947-0; Cai XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067082; Cartwright EJ, 2013, LSITERIOSIS OUTBREAK; den Bakker HC, 2010, APPL ENVIRON MICROB, V76, P6085, DOI 10.1128/AEM.00447-10; Fox E, 2011, INT J FOOD MICROBIOL, V145, pS39, DOI 10.1016/j.ijfoodmicro.2010.10.012; Ganopoulos I, 2013, J SCI FOOD AGR, V93, P2281, DOI 10.1002/jsfa.6040; Gasanov U, 2005, FEMS MICROBIOL REV, V29, P851, DOI 10.1016/j.femsre.2004.12.002; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Halter EL, 2013, INT J SYST EVOL MICR, V63, P641, DOI 10.1099/ijs.0.036830-0; Hellberg RS, 2013, FOOD MICROBIOL, V36, P231, DOI 10.1016/j.fm.2013.06.001; Huang BX, 2007, J FOOD PROTECT, V70, P1874, DOI 10.4315/0362-028X-70.8.1874; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Jin DZ, 2012, FEMS MICROBIOL LETT, V330, P72, DOI 10.1111/j.1574-6968.2012.02535.x; Leclercq A, 2010, INT J SYST EVOL MICR, V60, P2210, DOI 10.1099/ijs.0.017376-0; McLauchlin J, 1997, INT J FOOD MICROBIOL, V38, P77, DOI 10.1016/S0168-1605(97)00086-X; Miettinen H., 2005, INT J FOOD MICROBIOL, V112, P138; Miya S, 2010, APPL ENVIRON MICROB, V76, P3383, DOI 10.1128/AEM.01456-09; Ngui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041996; Oliveira M, 2011, FOOD MICROBIOL, V28, P590, DOI 10.1016/j.fm.2010.11.004; Pietzka AT, 2011, J MOL DIAGN, V13, P57, DOI 10.1016/j.jmoldx.2010.11.002; Rodriguez-Lazaro D, 2004, APPL ENVIRON MICROB, V70, P6299, DOI 10.1128/AEM.70.10.6299-6301.2004; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Swaminathan B., 2001, FOOD MICROBIOLOGY FU, P383; Vogel BF, 2001, APPL ENVIRON MICROB, V67, P2586, DOI 10.1128/AEM.67.6.2586-2595.2001; Vongkamjan K, 2012, APPL ENVIRON MICROB, V78, P8666, DOI 10.1128/AEM.01859-12; Wang J, 2010, CAN J MICROBIOL, V56, P676, DOI [10.1139/w10-054, 10.1139/W10-054]; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zeinzinger J, 2012, APPL ENVIRON MICROB, V78, P3352, DOI 10.1128/AEM.07668-11	28	12	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99223	10.1371/journal.pone.0099223	http://dx.doi.org/10.1371/journal.pone.0099223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918440	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000059
J	Du, ZM; Xie, Y; Hu, LQ; Hu, LX; Xu, SD; Li, DX; Wang, GF; Fu, JM				Du, Zhimin; Xie, Yan; Hu, Liqun; Hu, Longxing; Xu, Shendong; Li, Daoxin; Wang, Gongfang; Fu, Jinmin			Effects of Fertilization and Clipping on Carbon, Nitrogen Storage, and Soil Microbial Activity in a Natural Grassland in Southern China	PLOS ONE			English	Article							COMMUNITY STRUCTURE; TALLGRASS PRAIRIE; CROPPING SYSTEMS; ORGANIC-CARBON; CLIMATE-CHANGE; SEQUESTRATION; DIVERSITY; DYNAMICS; DECOMPOSITION; MITIGATION	Grassland managements can affect carbon (C) and nitrogen (N) storage in grassland ecosystems with consequent feedbacks to climate change. We investigated the impacts of compound fertilization and clipping on grass biomass, plant and soil (0-20 cm depth) C, N storage, plant and soil C:N ratios, soil microbial activity and diversity, and C, N sequestration rates in grassland in situ in the National Dalaoling Forest Park of China beginning July, 2011. In July, 2012, the fertilization increased total biomass by 30.1%, plant C by 34.5%, plant N by 79.8%, soil C by 18.8% and soil N by 23.8% compared with the control, respectively. Whereas the clipping decreased total biomass, plant C and N, soil C and N by 24.9%, 30.3%, 39.3%, 18.5%, and 19.4%, respectively, when compared to the control. The plant C:N ratio was lower for the fertilization than for the control and the clipping treatments. The soil microbial activity and diversity indices were higher for the fertilization than for the control. The clipping generally exhibited a lower level of soil microbial activity and diversity compared to the control. The principal component analysis indicated that the soil microbial communities of the control, fertilization and clipping treatments formed three distinct groups. The plant C and N sequestration rates of the fertilization were significantly higher than the clipping treatment. Our results suggest that fertilization is an efficient management practice in improving the C and N storage of the grassland ecosystem via increasing the grass biomass and soil microbial activity and diversity.	[Du, Zhimin; Xie, Yan; Hu, Liqun; Hu, Longxing; Fu, Jinmin] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China; [Du, Zhimin; Xie, Yan; Hu, Longxing; Fu, Jinmin] Chinese Acad Sci, Grad Univ, Beijing, Hebei, Peoples R China; [Xu, Shendong; Li, Daoxin; Wang, Gongfang] Natl Dalaoling Forest Pk, Yichang, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fu, JM (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Hubei, Peoples R China.	jfu@wbgcas.cn	Hu, Longxing/AAS-8287-2020	Du, Zhimin/0000-0002-3287-738X	Chinese Academy of Sciences [XDA0505040704]; National Natural Science Foundation of China [31272194]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding came from the "Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues'' of the Chinese Academy of Sciences (No. XDA0505040704), and the National Natural Science Foundation of China (No. 31272194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anindo D. O., 1994, East African Agricultural and Forestry Journal, V59, P177; Buresh RJ, 1997, SSSA SPECIAL PUBLICA, V51, P193, DOI DOI 10.2136/SSSASPECPUB51.C8; Chang EH, 2007, SOIL SCI PLANT NUTR, V53, P132, DOI 10.1111/j.1747-0765.2007.00122.x; Chen HM., 2005, ENV SOIL SCI; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Cheng XL, 2011, J PLANT ECOL, V4, P228, DOI 10.1093/jpe/rtr024; COLLINS HP, 1992, SOIL SCI SOC AM J, V56, P783, DOI 10.2136/sssaj1992.03615995005600030018x; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Deng YL, 2010, ASIAN J WATER ENVIRO, V7, P1; Dersch G, 2001, NUTR CYCL AGROECOSYS, V60, P49, DOI 10.1023/A:1012607112247; Dhillon RS, 2013, BIOMASS BIOENERG, V48, P75, DOI 10.1016/j.biombioe.2012.11.005; Dong M., 1996, SURVEY OBSERVATION A; Dumanski J, 1998, CLIMATIC CHANGE, V40, P81, DOI 10.1023/A:1005390815340; FILSER J, 1995, PLANT SOIL, V170, P123, DOI 10.1007/BF02183060; Fox CA, 2003, CAN J SOIL SCI, V83, P231, DOI 10.4141/S01-059; Fynn RWS, 2004, APPL VEG SCI, V7, P1, DOI 10.1111/j.1654-109X.2004.tb00589.x; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; GOETZ H, 1969, J RANGE MANAGE, V22, P384, DOI 10.2307/3895847; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Izaurralde RC, 2001, ADV AGRON, V70, P1; Joffre R, 2001, TERRESTRIAL GLOBAL P, P83; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Klimes L, 2001, EVOL ECOL, V15, P363, DOI 10.1023/A:1016041100087; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lal R, 2003, CRIT REV PLANT SCI, V22, P151, DOI 10.1080/713610854; Larkin RP, 2003, SOIL BIOL BIOCHEM, V35, P1451, DOI 10.1016/S0038-0717(03)00240-2; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; Lu R.K, 2000, ANAL METHOD SOIL AGR; Magill AH, 2000, SOIL BIOL BIOCHEM, V32, P597, DOI 10.1016/S0038-0717(99)00186-8; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Masto RE, 2006, SOIL BIOL BIOCHEM, V38, P1577, DOI 10.1016/j.soilbio.2005.11.012; Melillo JM, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P445; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; Paul E. A., 1989, Soil microbiology and biochemistry.; Porporato A, 2003, ADV WATER RESOUR, V26, P45, DOI 10.1016/S0309-1708(02)00094-5; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Powlson DS, 2011, EUR J SOIL SCI, V62, P42, DOI 10.1111/j.1365-2389.2010.01342.x; PYSEK P, 1991, J VEG SCI, V2, P237, DOI 10.2307/3235956; Qiu LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055433; Rochette P, 1998, CAN J SOIL SCI, V78, P283, DOI 10.4141/S97-066; RUESS RW, 1983, OECOLOGIA, V59, P253, DOI 10.1007/BF00378845; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Sainju UM, 2008, AGR ECOSYST ENVIRON, V127, P234, DOI 10.1016/j.agee.2008.04.006; Schlesinger W.H., 1995, BIOTIC FEEDBACKS GLO, V1st, P159; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Sekiguchi H, 2007, MICROBES ENVIRON, V22, P327, DOI 10.1264/jsme2.22.327; SH Lv, 2005, J SICHUAN GRASSLAND, V6, P37; Silveira ML, 2013, SOIL BIOL BIOCHEM, V58, P42, DOI 10.1016/j.soilbio.2012.11.003; Smith J. L., 1992, Soil microbial ecology: applications in agricultural and environmental management., P65; Smith P, 1998, GLOB CHANGE BIOL, V4, P679, DOI 10.1046/j.1365-2486.1998.00185.x; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Staddon WJ, 1997, MICROB ECOL, V34, P125, DOI 10.1007/s002489900042; TANS PP, 1995, AMBIO, V24, P376; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thibodeau L, 2000, CAN J FOREST RES, V30, P229, DOI 10.1139/cjfr-30-2-229; THORNLEY JHM, 1991, PLANT CELL ENVIRON, V14, P1007, DOI 10.1111/j.1365-3040.1991.tb00972.x; Tian G, 2009, J ENVIRON QUAL, V38, P61, DOI 10.2134/jeq2007.0471; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; ZAK DR, 1994, ECOLOGY, V75, P2333, DOI 10.2307/1940888; Zhang QF, 1990, ACTA PHYTOECOLOGICA, V14, P110; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001; Zhou J, 2008, J ENVIRON SCI-CHINA, V20, P981, DOI 10.1016/S1001-0742(08)62197-X	66	8	10	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99385	10.1371/journal.pone.0099385	http://dx.doi.org/10.1371/journal.pone.0099385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914540	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700092
J	Ingicco, T; de Vos, J; Huffman, OF				Ingicco, Thomas; de Vos, John; Huffman, O. Frank			The Oldest Gibbon Fossil (Hylobatidae) from Insular Southeast Asia: Evidence from Trinil, (East Java, Indonesia), Lower/Middle Pleistocene	PLOS ONE			English	Article							EARLY-MIDDLE PLEISTOCENE; RAIN-FOREST FAUNA; HOMO-ERECTUS; AGE; NGANDONG; SANGIRAN; QUATERNARY; SAPIENS; DUBOIS	A fossil femur excavated by Eugene Dubois between 1891-1900 in the Lower/Middle Pleistocene bonebed of the Trinil site (Java, Indonesia) was recognised by us as that of a Hylobatidae. The specimen, Trinil 5703 of the Dubois Collection (Leiden, The Netherlands), has the same distinctive form of fossilization that is seen in many of the bonebed fossils from Trinil in the collection. Anatomical comparison of Trinil 5703 to a sample of carnivore and primate femora, supported by morphometric analyses, lead to the attribution of the fossil to gibbon. Trinil 5703 therefore provides the oldest insular record of this clade, one of the oldest known Hylobatidae fossils from Southeast Asia. Because living Hylobatidae only inhabit evergreen rain forests, the paleoenvironment within the river drainage in the greater Trinil area evidently included forests of this kind during the Lower/Middle Pleistocene as revealed here.	[Ingicco, Thomas] Univ Philippines, Archaeol Studies Program, Quezon City 1101, Diliman, Philippines; [Ingicco, Thomas] MNHN CNRS, Dept Prehist, Paris, France; [Ingicco, Thomas] MNHN CNRS, UMR 7194, Paris, France; [de Vos, John] Naturalis Biodivers Ctr, Leiden, Netherlands; [Huffman, O. Frank] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	University of the Philippines System; University of the Philippines Diliman; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Naturalis Biodiversity Center; University of Texas System; University of Texas Austin	Ingicco, T (corresponding author), Univ Philippines, Archaeol Studies Program, Quezon City 1101, Diliman, Philippines.	thomas.ingicco@upd.edu.ph	Ingicco, Thomas/AAT-2641-2020	Ingicco, Thomas/0000-0001-5576-5084				Aiello L, 1990, INTRO HUMAN EVOLUTIO; Andrews P, 1998, B SOC GEOL FR, V169, P433; [Anonymous], 1985, GEOLOGICAL RES DEV C, P49; Ansyori M, 2010, THESIS MUSEUM NATL H; Bacon AM, 2001, CAHIERS PALEOANTHROP; Badoux DM, 1959, FOSSIL MAMMALS 2 FIS; BARTSTRA GJ, 1988, J HUM EVOL, V17, P325, DOI 10.1016/0047-2484(88)90074-7; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Bettis EA, 2009, J HUM EVOL, V56, P11, DOI 10.1016/j.jhevol.2008.09.003; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bouteaux, 2005, THESIS MUSEUM NATL H; Bouteaux A, 2010, QUATERN INT, V223, P220, DOI 10.1016/j.quaint.2009.10.007; Brasseur B., 2009, THESIS MUSEUM NATL H; Carthaus E, 1911, PITHECANTHROPUSSCHIC, P1; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Claude J, 2008, MORPHOMETRICS R; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Day M.H., 1973, HUMAN EVOLUTION S SO, V11, P127; de Vos J., 1989, P225; de Vos J., 1982, Modern Quaternary Research in Southeast Asia, V7, P35; DEVOS J, 1982, GEOL MIJNBOUW, V61, P207; DEVOS J, 1989, J ANTHROPOL SOC NIP, V97, P407; Dubois E, 1896, PITHECANTHROPUS EREC, VXII, P1; Dubois E., 1894, PITHECANTHROPUS EREC; Dubois E, 1891, PALEONTOLOGISCHE OND; Dubois E, 1895, B SOC BELG GEOL, V9, P151; Dubois E, 1892, PALEONTOLOGISCHE OND; Dubois E, 1924, PITHECANTHROPUS EREC, V35, P443; Duyfies J., 1936, MIJNINGENIEUR, V3, P136; Flenley J.R., 1979, EQUATORIAL RAIN FORE; Grun R, 1997, SCIENCE, V276, P1575, DOI 10.1126/science.276.5318.1575; Gupta AK, 2004, PRIMATE COMMUNITIES, P38; Hooijer D. A., 1962, Zoologische Verhandelingen, VNo. 55, P1; Hooijer D. A., 1960, Zoologische Verhandelingen, VNo. 46, P1; Huffman OF, 2001, SANGIRAN MAN CULTURE, P231; Huffman OF, 2010, PALEOANTHROPOLOGY SO, V2010, pA14; Huffman OF, 2003, J MINEARL TECHNOLOGY, V10; Indriati E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021562; Jablonski NG, 1999, INT J PRIMATOL, V20, P319, DOI 10.1023/A:1020544519463; Jablonski Nina G., 2009, P111, DOI 10.1007/978-0-387-88604-6_7; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; Jutting T. van B., 1937, Zoologische Mededeelingen Leiden, V20, P83; Kappeler M., 1984, P19; Koenigswald G. H. R.von, 1934, De Ingenieur Ned-Indie IV Mijnbouw en Geologie "De Mijnengenieur", VNo.1, P185; Kohler M, 2002, AM J PHYS ANTHROPOL, V119, P297, DOI 10.1002/ajpa.10140; Larick R, 2000, INT J PRIMATOL, V21, P731; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LEINDERS JJM, 1985, GEOL MIJNBOUW, V64, P167; Lomolino MV, 2013, J BIOGEOGR, V40, P1427, DOI 10.1111/jbi.12096; Lyras GA, 2010, J BIOGEOGR, V37, P1007, DOI 10.1111/j.1365-2699.2010.02312.x; Manouvrier L, 1889, COMP REND C INT ANTH, P363; Mayr E., 1944, NATL RES COUNCIL B, V262, P11; Moigne A.-M., 2004, MODERN QUATERNARY RE, V19, P31; Nijman V, 2004, RAFFLES B ZOOL, V52, P271; Piganiol G, 1959, COMPTES RENDUS ASS A, V104, P660; R Core Team, 2020, R LANG ENV STAT COMP; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Richmond BG, 2001, PHYLOGENY NEOGENE HO, P338; Rozzi R, 2013, PALAEOGEOGR PALAEOCL, V377, P73, DOI 10.1016/j.palaeo.2013.03.012; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; Rumbaugh DM, 1976, SUSPENSORY BEHAV LOC, V4; Saleki H, 1997, THESIS MUSEUM NATL H; Scherf H, 2007, THESIS U DARMSTADT; Schultz AH, 1944, AM J PHYS ANTHROP-NE, V2, P1, DOI 10.1002/ajpa.1330020102; Schuster J, 1911, MONOGRAPHIE FOSSILEN; Selenka L, 1911, PITHECANTHROPUS SCHI; Semah A-M, 1986, THESIS U PROVENCE; Semah AM, 2012, QUATERN INT, V249, P120, DOI 10.1016/j.quaint.2011.06.013; Semah AM, 2010, QUATERN INT, V223, P451, DOI 10.1016/j.quaint.2009.07.017; Semah F, 2000, J ARCHAEOL SCI, V27, P763, DOI 10.1006/jasc.1999.0482; Semah F, 2011, 1 C EUR SOC STUD HUM; Storm P, 2005, J HUM EVOL, V49, P536, DOI 10.1016/j.jhevol.2005.06.003; Storm P, 2013, J HUM EVOL, V64, P356, DOI 10.1016/j.jhevol.2012.11.002; Storm P, 2012, CR PALEVOL, V11, P191, DOI 10.1016/j.crpv.2011.04.002; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Todd TW, 1930, CHILD DEV, V1, P79; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; van den Bergh Gert D., 1999, Scripta Geologica, V117, P1; Van der Geer A., 2010, EVOLUTION ISLAND MAM; Van Der Geer AAE, 2008, J VERTEBR PALEONTOL, V28, P1238, DOI 10.1671/0272-4634-28.4.1238; VANDERPLICHT J, 1989, APPL GEOCHEM, V4, P339; Von Koenigswald GHR, 1940, WET MEDED K NED NATU, V28, P1; Watanabe N, 1985, GEOLOGICAL RESEARCG; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; Yokoyama Y, 2008, J HUM EVOL, V55, P274, DOI 10.1016/j.jhevol.2008.01.006	85	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99531	10.1371/journal.pone.0099531	http://dx.doi.org/10.1371/journal.pone.0099531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914951	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700113
J	Kalogeris, TJ; Baines, C; Korthuis, RJ				Kalogeris, Theodore J.; Baines, Christopher; Korthuis, Ronald J.			Adenosine Prevents TNF alpha-Induced Decrease in Endothelial Mitochondrial Mass via Activation of eNOS-PGC-1 alpha Regulatory Axis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANTECEDENT ETHANOL INGESTION; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; NITRIC-OXIDE; MITOTIC COMPETENT; INDUCED APOPTOSIS; PROTEIN-KINASE; BIOGENESIS; PGC-1-ALPHA	We tested whether adenosine, a cytoprotective mediator and trigger of preconditioning, could protect endothelial cells from inflammation-induced deficits in mitochondrial biogenesis and function. We examined this question using human microvascular endothelial cells exposed to TNF alpha. TNF alpha produced time and dose-dependent decreases in mitochondrial membrane potential, cellular ATP levels, and mitochondrial mass, preceding an increase in apoptosis. These effects were prevented by co-incubation with adenosine, a nitric oxide (NO) donor, a guanylate cyclase (GC) activator, or a cell-permeant cyclic GMP (cGMP) analog. The effects of adenosine were blocked by a nitric oxide synthase inhibitor, a soluble guanylate cyclase inhibitor, a morpholino antisense oligonucleotide to endothelial nitric oxide synthase (eNOS), or siRNA knockdown of the transcriptional coactivator, PGC-1 alpha. Incubation with exogenous NO, a GC activator, or a cGMP analog reversed the effect of eNOS knockdown, while the effect of NO was blocked by inhibition of GC. The protective effects of NO and cGMP analog were prevented by siRNA to PGC-1 alpha. TNF alpha also decreased expression of eNOS, cellular NO levels, and PGC-1 alpha expression, which were reversed by adenosine. Exogenous NO, but not adenosine, rescued expression of PGC-1 alpha in cells in which eNOS expression was knocked down by eNOS antisense treatment. Thus, TNF alpha elicits decreases in endothelial mitochondrial function and mass, and an increase in apoptosis. These effects were reversed by adenosine, an effect mediated by eNOS-synthesized NO, acting via soluble guanylate cyclase/cGMP to activate a mitochondrial biogenesis regulatory program under the control of PGC-1 alpha. These results support the existence of an adenosine-triggered, mito-and cytoprotective mechanism dependent upon an eNOS-PGC-1 alpha regulatory pathway, which acts to preserve endothelial mitochondrial function and mass during inflammatory challenge.	[Kalogeris, Theodore J.; Korthuis, Ronald J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Baines, Christopher] Univ Missouri, Dept Biomed Sci, Columbia, MO USA; [Baines, Christopher; Korthuis, Ronald J.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kalogeris, TJ (corresponding author), Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA.	kalogerist@health.missouri.edu		Baines, Christopher/0000-0002-4473-3869	National Institutes of Health (NIH) [AA014945, HL095486]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014945] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (NIH) grants: AA014945, HL095486. http://www.niaaa.nih.gov/, http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Bell C, 2013, MOL CELL PROTEOMICS, V12, P2394, DOI 10.1074/mcp.M112.025775; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Bossy-Wetzel E, 2003, CELL DEATH DIFFER, V10, P757, DOI 10.1038/sj.cdd.4401244; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Chen XP, 2008, CURR HYPERTENS REV, V4, P245, DOI 10.2174/157340208786241336; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Dayton C, 2004, MICROCIRCULATION, V11, P709, DOI 10.1080/10739680490521014; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Drabarek B, 2012, INT J BIOCHEM CELL B, V44, P1390, DOI 10.1016/j.biocel.2012.05.022; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gaskin FS, 2007, AM J PHYSIOL-HEART C, V292, pH326, DOI 10.1152/ajpheart.00744.2006; Gonzalez-Fernandez F, 2001, ATHEROSCLEROSIS, V155, P61, DOI 10.1016/S0021-9150(00)00535-9; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hatoum OA, 2006, ANN NY ACAD SCI, V1072, P78, DOI 10.1196/annals.1326.003; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Kamada Kazuma, 2004, Pathophysiology, V10, P131, DOI 10.1016/j.pathophys.2003.10.010; Kavazis AN, 2009, AM J PHYSIOL-HEART C, V297, pH144, DOI 10.1152/ajpheart.01278.2008; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Liu YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG44, DOI 10.1152/ajpgi.00413.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubkovic M, 2007, AM J PHYSIOL-CELL PH, V292, pC1583, DOI 10.1152/ajpcell.00221.2006; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; McLeod CJ, 2005, TRENDS CARDIOVAS MED, V15, P118, DOI 10.1016/j.tcm.2005.05.001; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015; Ozacmak VH, 2007, WORLD J GASTROENTERO, V13, P538, DOI 10.3748/wjg.v13.i4.538; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Paz Y, 2003, J AM COLL CARDIOL, V42, P1299, DOI 10.1016/S0735-1097(03)00992-6; Pias EK, 2002, CELL DEATH DIFFER, V9, P1007, DOI 10.1038/sj.cdd.4401064; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Spaulding HL, 2006, AM J PHYSIOL-CELL PH, V290, pC95, DOI 10.1152/ajpcell.00388.2005; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yamaguchi T, 2007, AM J PHYSIOL-HEART C, V292, pH1435, DOI 10.1152/ajpheart.00282.2006; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang X, 2002, J BIOL CHEM, V277, P48472, DOI 10.1074/jbc.M209130200; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46	64	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98459	10.1371/journal.pone.0098459	http://dx.doi.org/10.1371/journal.pone.0098459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914683	Green Published, gold			2022-12-27	WOS:000340947700021
J	Zhou, M; Fu, J; Huang, W; Shen, LC; Xiao, L; Song, Y; Liu, Y				Zhou, Min; Fu, Jing; Huang, Wei; Shen, Licong; Xiao, Li; Song, Yong; Liu, Ying			Increased Cystic Fibrosis Transmembrane Conductance Regulators Expression and Decreased Epithelial Sodium Channel Alpha Subunits Expression in Early Abortion: Findings from a Mouse Model and Clinical Cases of Abortion	PLOS ONE			English	Article							CFTR GENE-EXPRESSION; MURINE ABORTION; NA+ CHANNEL; ENDOMETRIAL EPITHELIUM; INTERFERON-GAMMA; TNF-ALPHA; CELLS; PREGNANCY; ACTIVATION; REACTIVITY	The status of the maternal endometrium is vital in regulating humoral homeostasis and for ensuring embryo implantation. Cystic fibrosis transmembrane conductance regulators (CFTR) and epithelial sodium channel alpha subunits (ENaC-alpha) play an important role in female reproduction by maintaining humoral and cell homeostasis. However, it is not clear whether the expression levels of CFTR and ENaC-alpha in the decidual component during early pregnancy are related with early miscarriage. CBAxDBA/2 mouse mating has been widely accepted as a classical model of early miscarriage. The abortion rate associated with this mating was 33.33% in our study. The decidua of abortion-prone CBA female mice (DBA/2 mated) had higher CFTR mRNA and protein expression and lower ENaC-alpha mRNA and protein expression, compared to normal pregnant CBA mice (BLAB/C mated). Furthermore, increased CFTR expression and decreased ENaC-alpha expression were observed in the uterine tissue from women with early miscarriage, as compared to those with successful pregnancy. In conclusion, increased CFTR expression and decreased ENaC-alpha expression in the decidua of early abortion may relate with failure of early pregnancy.	[Zhou, Min; Fu, Jing; Huang, Wei; Shen, Licong; Xiao, Li; Song, Yong] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China; [Liu, Ying] Sichuan Univ, West China Univ Hosp 2, West China Inst Women & Childrens Hlth, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu 610064, Peoples R China	Sichuan University; Chinese University of Hong Kong; Sichuan University	Huang, W (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Peoples R China.	weihuang64@163.com	Song, Yong/AAX-5509-2021					Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Arck PC, 1997, AM J REPROD IMMUNOL, V37, P262; Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Braun C, 2005, J IMMUNOL, V175, P3402, DOI 10.4049/jimmunol.175.5.3402; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chan LN, 2001, PFLUG ARCH EUR J PHY, V443, pS132; Chan LN, 2002, J MEMBRANE BIOL, V185, P165, DOI 10.1007/s00232-001-0117-y; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Chaouat G, 1988, 18 R C O G STUD GROU, P89, DOI DOI 10.1007/978-1-4471-1658-5_10; Chen MH, 2010, HUM REPROD, V25, P1744, DOI 10.1093/humrep/deq094; Chien LW, 2002, HUM REPROD, V17, P351, DOI 10.1093/humrep/17.2.351; Clark DA, 1999, AM J REPROD IMMUNOL, V41, P5; Cummins JM, 2001, HUM REPROD UPDATE, V7, P217, DOI 10.1093/humupd/7.2.217; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; del Monaco SM, 2009, J MEMBRANE BIOL, V232, P1, DOI 10.1007/s00232-009-9206-0; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Galietta LJV, 2000, AM J PHYSIOL-LUNG C, V278, pL1186, DOI 10.1152/ajplung.2000.278.6.L1186; HAMILTON MS, 1987, J REPROD IMMUNOL, V11, P237, DOI 10.1016/0165-0378(87)90060-X; Inagaki N, 2003, HUM REPROD, V18, P608, DOI 10.1093/humrep/deg139; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Lane M, 2005, REPROD FERT DEVELOP, V17, P371, DOI 10.1071/RD04102; Matthews CJ, 1998, J PHYSIOL-LONDON, V513, P443, DOI 10.1111/j.1469-7793.1998.443bb.x; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; TANGRI S, 1994, J IMMUNOL, V152, P4903; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zenclussen AC, 2003, CYTOKINE, V24, P150, DOI 10.1016/j.cyto.2003.08.002	34	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99521	10.1371/journal.pone.0099521	http://dx.doi.org/10.1371/journal.pone.0099521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914548	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700110
J	Jung, KS; Kim, JH; Kim, SU; Song, K; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Moon, DC; Song, IJ; Choi, GH; Park, YN; Han, KH				Jung, Kyu Sik; Kim, Ji Hong; Kim, Seung Up; Song, Kijun; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Moon, Do Chang; Song, In Ji; Choi, Gi Hong; Park, Young Nyun; Han, Kwang-Hyub			Liver Stiffness Value-Based Risk Estimation of Late Recurrence after Curative Resection of Hepatocellular Carcinoma: Development and Validation of a Predictive Model	PLOS ONE			English	Article							LATE INTRAHEPATIC RECURRENCE; HEPATITIS-B; POSTOPERATIVE RECURRENCE; TRANSIENT ELASTOGRAPHY; MULTIVARIATE-ANALYSIS; GENE-EXPRESSION; PROGNOSIS; HEPATECTOMY; PREVENTION; CIRRHOSIS	Background: Preoperative liver stiffness (LS) measurement using transient elastography (TE) is useful for predicting late recurrence after curative resection of hepatocellular carcinoma (HCC). We developed and validated a novel LS value-based predictive model for late recurrence of HCC. Methods: Patients who were due to undergo curative resection of HCC between August 2006 and January 2010 were prospectively enrolled and TE was performed prior to operations by study protocol. The predictive model of late recurrence was constructed based on a multiple logistic regression model. Discrimination and calibration were used to validate the model. Results: Among a total of 139 patients who were finally analyzed, late recurrence occurred in 44 patients, with a median follow-up of 24.5 months (range, 12.4-68.1). We developed a predictive model for late recurrence of HCC using LS value, activity grade II-III, presence of multiple tumors, and indocyanine green retention rate at 15 min (ICG R15), which showed fairly good discrimination capability with an area under the receiver operating characteristic curve (AUROC) of 0.724 (95% confidence intervals [CIs], 0.632-0.816). In the validation, using a bootstrap method to assess discrimination, the AUROC remained largely unchanged between iterations, with an average AUROC of 0.722 (95% CIs, 0.718-0.724). When we plotted a calibration chart for predicted and observed risk of late recurrence, the predicted risk of late recurrence correlated well with observed risk, with a correlation coefficient of 0.873 (P< 0.001). Conclusion: A simple LS value-based predictive model could estimate the risk of late recurrence in patients who underwent curative resection of HCC.	[Jung, Kyu Sik; Kim, Ji Hong; Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Moon, Do Chang; Song, In Ji; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Song, Kijun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Choi, Gi Hong] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Liver Canc Special Clin, Seoul, South Korea; [Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ksukorea@yuhs.ac	Park, Jun Yong/H-7127-2019	Han, Kwang-Hyub/0000-0003-3960-6539; Kim, Beom Kyung/0000-0002-5363-2496; Park, Jun Yong/0000-0001-6324-2224; Ahn, Sang Hoon/0000-0002-3629-4624; Choi, Gi Hong/0000-0002-1593-3773; Song, Ki Jun/0000-0003-2505-4112; Park, Young Nyun/0000-0003-0357-7967; Kim, Seung Up/0000-0002-9658-8050	Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]; sanofi-aventis Korea	Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea; sanofi-aventis Korea(Sanofi-Aventis)	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. HI10C2020), and by the Yonsei Liver Blood Bank (YLBB), in part by a grant from sanofi-aventis Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheong JY, 2011, LIVER INT, V31, P1352, DOI 10.1111/j.1478-3231.2011.02570.x; Chon YE, 2012, J CLIN GASTROENTEROL, V46, P518, DOI 10.1097/MCG.0b013e31825079f1; Edge S, 2010, AJCC CANC STAGING MA, V7th, P237; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Friedman Lawrence S, 2010, Trans Am Clin Climatol Assoc, V121, P192; Friedman LS, 2010, T AM CLIN CLIMAT ASS, V121, P205; Hanazaki K, 2005, HEPATO-GASTROENTEROL, V52, P580; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang XH, 2013, HEPATO-GASTROENTEROL, V60, P225, DOI [10.5754/hge12630, 10.5754/hge]; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Jung KS, 2012, ANN SURG ONCOL, V19, P4278, DOI 10.1245/s10434-012-2422-3; Jung KS, 2012, CLIN MOL HEPATOL, V18, P163, DOI 10.3350/cmh.2012.18.2.163; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2008, HEPATOL INT, V2, P471, DOI 10.1007/s12072-008-9091-0; Ko S, 1996, ANN SURG, V224, P591, DOI 10.1097/00000658-199611000-00001; Ko S, 2002, BRIT J SURG, V89, P57, DOI 10.1046/j.0007-1323.2001.01969.x; Li T, 2013, CANCER-AM CANCER SOC, V119, P126, DOI 10.1002/cncr.27697; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Makuuchi Masatoshi, 2004, Liver Transpl, V10, pS46, DOI 10.1002/lt.20044; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; NG IOL, 1995, CANCER, V76, P2443, DOI 10.1002/1097-0142(19951215)76:12<2443::AID-CNCR2820761207>3.0.CO;2-F; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Oliveri F, 2008, WORLD J GASTROENTERO, V14, P6154, DOI 10.3748/wjg.14.6154; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Qu LS, 2010, J GASTROINTEST SURG, V14, P1111, DOI 10.1007/s11605-010-1211-1; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SASAKI Y, 1992, SURGERY, V112, P515; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; Wong JSW, 2013, ANN SURG, V257, P922, DOI 10.1097/SLA.0b013e318269d2ec; Woo HG, 2008, CLIN CANCER RES, V14, P2056, DOI 10.1158/1078-0432.CCR-07-1473; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yamamoto J, 1996, BRIT J SURG, V83, P1219; Zhao WH, 2002, WORLD J GASTROENTERO, V8, P237	42	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99167	10.1371/journal.pone.0099167	http://dx.doi.org/10.1371/journal.pone.0099167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910997	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600049
J	Yang, RY; Dong, J; Zhao, HJ; Li, HX; Guo, HB; Wang, S; Zhang, CB; Wang, SM; Wang, M; Yu, SL; Chen, WX				Yang, Ruiyue; Dong, Jun; Zhao, Haijian; Li, Hongxia; Guo, Hanbang; Wang, Shu; Zhang, Chuanbao; Wang, Siming; Wang, Mo; Yu, Songlin; Chen, Wenxiang			Association of Branched-Chain Amino Acids with Carotid Intima-Media Thickness and Coronary Artery Disease Risk Factors	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; METABOLIC PROFILE; OBESE; ATHEROSCLEROSIS; PATHWAYS	Background: Recent studies have determined that branched-chain (BCAAs) and aromatic (AAAs) amino acids are strongly correlated with obesity and atherogenic dyslipidemia and are strong predictors of diabetes. However, it is not clear if these amino acids are capable of identifying subjects with coronary artery disease (CAD), particularly with subclinical atherosclerosis who are at risk of developing CAD. Methods: Four hundred and seventy two Chinese subjects (272 males and 200 females, 42-97 y of age) undergoing physical exams were recruited at random for participation in the cross-sectional study. Serum BCAAs and AAAs were measured using our previously reported isotope dilution liquid chromatography tandem mass spectrometry method. Bilateral B-mode carotid artery images for carotid intima-media thickness (cIMT) were acquired at end diastole and cIMT values more than 0.9 mm were categorized as increased. Correlations of BCAAs with cIMT and other CAD risk factors were analyzed. Results: BCAAs and AAAs were significantly and positively associated with risk factors of CAD, e. g., cIMT, BMI, waist circumference, blood pressure, fasting blood glucose, TG, apoB, apoB/apoAI ratio, apoCII, apoCIII and hsCRP, and were significantly and negatively associated with HDL-C and apoAI. Stepwise multiple linear regression analysis revealed that age (beta= 0.175, P<0.001), log BCAA (beta= 0.147, P<0.001) and systolic blood pressure (beta= 0.141, P = 0.012) were positively and independently associated with cIMT. In the logistic regression model, the most and only powerful laboratory factor correlated with increased cIMT was BCAA (the odds ratio of the fourth quartile compared to the first quartile was 2.679; P = 0.009). Conclusion: BCAAs are independently correlated with increased cIMT. This correlation would open a new field of research in the mechanistic understanding and risk assessment of CAD.	[Yang, Ruiyue; Dong, Jun; Li, Hongxia; Guo, Hanbang; Wang, Shu; Wang, Siming; Chen, Wenxiang] Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Yang, Ruiyue; Dong, Jun; Li, Hongxia; Guo, Hanbang; Wang, Shu; Wang, Siming; Chen, Wenxiang] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Zhao, Haijian; Zhang, Chuanbao; Wang, Mo; Yu, Songlin; Chen, Wenxiang] Minist Hlth, Beijing Hosp, Beijing, Peoples R China; [Zhao, Haijian; Zhang, Chuanbao; Wang, Mo; Yu, Songlin; Chen, Wenxiang] Minist Hlth, Natl Ctr Clin Labs, Beijing, Peoples R China	Beijing Hospital; Beijing Hospital	Chen, WX (corresponding author), Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	wchen@bjhmoh.cn	Yang, Ruiyue/HDN-2405-2022	Yang, Ruiyue/0000-0002-2304-6728	National Science & Technology Pillar Program under the Twelfth Five-year Plan of China [2012BAI37B01]; National Natural Science Foundation of China [81171647, 81301487]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201002011, 201302008]	National Science & Technology Pillar Program under the Twelfth Five-year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation by Ministry of Health P. R. China	This study was supported by research grants from the National Science & Technology Pillar Program under the Twelfth Five-year Plan of China (2012BAI37B01), the National Natural Science Foundation of China (81171647 and 81301487) and the National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201002011 and 201302008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fernandes VRS, 2006, J AM COLL CARDIOL, V47, P2420, DOI 10.1016/j.jacc.2005.12.075; Gilstrap LG, 2012, CLIN CHEM, V58, P72, DOI 10.1373/clinchem.2011.165712; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Yang RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081144	23	58	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99598	10.1371/journal.pone.0099598	http://dx.doi.org/10.1371/journal.pone.0099598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910999	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600109
J	Ejarque-Gonzalez, E; Butturini, A				Ejarque-Gonzalez, Elisabet; Butturini, Andrea			Self-Organising Maps and Correlation Analysis as a Tool to Explore Patterns in Excitation-Emission Matrix Data Sets and to Discriminate Dissolved Organic Matter Fluorescence Components	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; PARALLEL FACTOR-ANALYSIS; REGIONAL-INTEGRATION; QUANTIFY SPECTRA; CALIBRATION; DOM; CLASSIFICATION; SPECTROSCOPY; ABSORBENCY; WATERS	Dissolved organic matter (DOM) is a complex mixture of organic compounds, ubiquitous in marine and freshwater systems. Fluorescence spectroscopy, by means of Excitation-Emission Matrices (EEM), has become an indispensable tool to study DOM sources, transport and fate in aquatic ecosystems. However the statistical treatment of large and heterogeneous EEM data sets still represents an important challenge for biogeochemists. Recently, Self-Organising Maps (SOM) has been proposed as a tool to explore patterns in large EEM data sets. SOM is a pattern recognition method which clusterizes and reduces the dimensionality of input EEMs without relying on any assumption about the data structure. In this paper, we show how SOM, coupled with a correlation analysis of the component planes, can be used both to explore patterns among samples, as well as to identify individual fluorescence components. We analysed a large and heterogeneous EEM data set, including samples from a river catchment collected under a range of hydrological conditions, along a 60-km downstream gradient, and under the influence of different degrees of anthropogenic impact. According to our results, chemical industry effluents appeared to have unique and distinctive spectral characteristics. On the other hand, river samples collected under flash flood conditions showed homogeneous EEM shapes. The correlation analysis of the component planes suggested the presence of four fluorescence components, consistent with DOM components previously described in the literature. A remarkable strength of this methodology was that outlier samples appeared naturally integrated in the analysis. We conclude that SOM coupled with a correlation analysis procedure is a promising tool for studying large and heterogeneous EEM data sets.	[Ejarque-Gonzalez, Elisabet; Butturini, Andrea] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Catalunya, Spain	University of Barcelona	Ejarque-Gonzalez, E (corresponding author), Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Catalunya, Spain.	elisabet.ejarque@ub.edu	Butturini, Andrea/K-4991-2014; Ejarque, Elisabet/Q-9444-2016	Butturini, Andrea/0000-0002-7712-6328; Ejarque, Elisabet/0000-0002-9399-968X	Spanish Ministry of Economy and Competitiveness [CGL2011-30151-C02-02]; FPU doctoral scholarship from the MEC [AP2008-03431]	Spanish Ministry of Economy and Competitiveness(Spanish Government); FPU doctoral scholarship from the MEC(German Research Foundation (DFG))	This research was funded by the Spanish Ministry of Economy and Competitiveness (CGL2011-30151-C02-02). Elisabet Ejarque-Gonzalez's research was in part supported by an FPU doctoral scholarship from the MEC (AP2008-03431). Both authors are members of the GRACCIE consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACA, 2013, CONS DAD XARX CONTR; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baker A, 2004, SCI TOTAL ENVIRON, V333, P217, DOI 10.1016/j.scitotenv.2004.04.013; Baker A, 2001, ENVIRON SCI TECHNOL, V35, P948, DOI 10.1021/es000177t; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Benner R., 2002, BIOGEOCHEMISTRY MARI, P5990, DOI DOI 10.1016/B978-012323841-2/50005-1; Bertilsson S, 2000, LIMNOL OCEANOGR, V45, P753, DOI 10.4319/lo.2000.45.4.0753; Bieroza M, 2012, ADV ENG SOFTW, V44, P126, DOI 10.1016/j.advengsoft.2011.05.031; Bieroza M, 2012, EDUC CHEM ENG, V7, pE22, DOI 10.1016/j.ece.2011.10.002; Bieroza M, 2011, ENVIRONMETRICS, V22, P256, DOI 10.1002/env.1045; Bieroza M, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000940; Boehme JR, 2000, ENVIRON SCI TECHNOL, V34, P3283, DOI 10.1021/es9911263; Borisover M, 2011, WATER AIR SOIL POLL, V222, P255, DOI 10.1007/s11270-011-0821-x; Brereton RG, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-S2-S1; Bro R, 2011, CHEMOMETR INTELL LAB, V106, P86, DOI 10.1016/j.chemolab.2010.06.005; Brooks ML, 2007, LIMNOL OCEANOGR, V52, P766, DOI 10.4319/lo.2007.52.2.0766; Cammack WKL, 2004, LIMNOL OCEANOGR, V49, P2034, DOI 10.4319/lo.2004.49.6.2034; Cattell R.B., 1952, FACTOR ANAL INTRO MA; Cereghino R, 2009, ENVIRON MODELL SOFTW, V24, P945; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Cinar O, 2009, ECOL RES, V24, P163, DOI 10.1007/s11284-008-0495-z; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cory RM, 2012, LIMNOL OCEANOGR, V57, P1347, DOI 10.4319/lo.2012.57.5.1347; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; Cottrell M, 2001, ADVANCES IN SELF-ORGANISING MAPS, P7; de Bodt E, 2002, NEURAL NETWORKS, V15, P967, DOI 10.1016/S0893-6080(02)00071-0; Elkins KM, 2002, COORDIN CHEM REV, V228, P205, DOI 10.1016/S0010-8545(02)00040-1; Engelen S, 2011, ANAL CHIM ACTA, V705, P155, DOI 10.1016/j.aca.2011.04.043; Fellman JB, 2010, LIMNOL OCEANOGR, V55, P2452, DOI 10.4319/lo.2010.55.6.2452; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Foden J, 2008, ESTUAR COAST SHELF S, V79, P707, DOI 10.1016/j.ecss.2008.06.015; Gardecki JA, 1998, APPL SPECTROSC, V52, P1179, DOI 10.1366/0003702981945192; Goletz C, 2011, TALANTA, V85, P650, DOI 10.1016/j.talanta.2011.04.045; Henderson RK, 2009, WATER RES, V43, P863, DOI 10.1016/j.watres.2008.11.027; Hudson N, 2007, RIVER RES APPL, V23, P631, DOI 10.1002/rra.1005; Huguet A, 2009, ORG GEOCHEM, V40, P706, DOI 10.1016/j.orggeochem.2009.03.002; Hur J, 2009, CHEMOSPHERE, V75, P483, DOI 10.1016/j.chemosphere.2008.12.056; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Kohonen T., 1998, Neurocomputing, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Kohonen T., 2001, SELF ORG MAPS, V3rd ed.; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Larsson T, 2007, ANAL CHIM ACTA, V583, P357, DOI 10.1016/j.aca.2006.09.067; Lawaetz AJ, 2009, APPL SPECTROSC, V63, P936, DOI 10.1366/000370209788964548; Legendre P., 2012, NUMERICAL ECOLOGY; Lloyd GR, 2008, ANALYST, V133, P1046, DOI 10.1039/b715390b; Marhuenda-Egea FC, 2007, CHEMOSPHERE, V68, P301, DOI 10.1016/j.chemosphere.2006.12.075; Mat-Desa WNS, 2011, ANAL CHEM, V83, P7745, DOI 10.1021/ac202315y; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Mostofa KMG, 2007, GEOCHEM J, V41, P323, DOI 10.2343/geochemj.41.323; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Oja M, 2006, COMPUTATIONAL STAT A, P61; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Osburn CL, 2009, MAR CHEM, V115, P10, DOI 10.1016/j.marchem.2009.05.003; Park YS, 2006, ECOL INFORM, V1, P247, DOI 10.1016/j.ecoinf.2006.03.005; Parlanti E, 2000, ORG GEOCHEM, V31, P1765, DOI 10.1016/S0146-6380(00)00124-8; Quinn MJ, 2010, UNDUE INFLUENCE DEFI; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; S MAB, 2007, LECT NOTES COMPUT SC, V4669, P379; Shao ZH, 2009, J HAZARD MATER, V164, P1191, DOI 10.1016/j.jhazmat.2008.09.035; SOM toolbox team, 2000, NEURAL NETWORK TOOL; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; ULTSCH A, 1990, INTERNATIONAL NEURAL NETWORK CONFERENCE, VOLS 1 AND 2, P305; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 1999, Intelligent Data Analysis, V3, P111, DOI 10.1016/S1088-467X(99)00013-X; Vesanto J, 2002, LECT NOTES COMPUT SC, V2415, P951; Wang ZW, 2009, WATER RES, V43, P1533, DOI 10.1016/j.watres.2008.12.033; Wehrens R, 2007, J STAT SOFTW, V21, P1; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Yamashita Y, 2003, MAR CHEM, V82, P255, DOI 10.1016/S0304-4203(03)00073-2; Zhou J, 2013, J ENVIRON QUAL, V42, P925, DOI 10.2134/jeq2012.0460; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0	74	19	20	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99618	10.1371/journal.pone.0099618	http://dx.doi.org/10.1371/journal.pone.0099618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906009	Green Published, gold			2022-12-27	WOS:000341869000125
J	Francescato, MP; Stel, G; Geat, M; Cauci, S				Francescato, Maria Pia; Stel, Giuliana; Geat, Mario; Cauci, Sabina			Oxidative Stress in Patients with Type 1 Diabetes Mellitus: Is It Affected by a Single Bout of Prolonged Exercise?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; URIC-ACID; ANTIOXIDANT; RADICALS; DISEASE; YOUNG; COMPLICATIONS; HYPERGLYCEMIA; HYPOGLYCEMIA; ASSOCIATION	Presently, no clear-cut guidelines are available to suggest the more appropriate physical activity for patients with type 1 diabetes mellitus due to paucity of experimental data obtained under patients' usual life conditions. Accordingly, we explored the oxidative stress levels associated with a prolonged moderate intensity, but fatiguing, exercise performed under usual therapy in patients with type 1 diabetes mellitus and matched healthy controls. Eight patients (4 men, 4 women; 49 +/- 11 years; Body Mass Index 25.0 +/- 3.2 kg.m(-2); HbA(1c) 57 +/- 10 mmol.mol(-1)) and 14 controls (8 men, 6 women; 47 +/- 11 years; Body Mass Index 24.3 +/- 3.3 kg.m(-2)) performed a 3-h walk at 30% of their heart rate reserve. Venous blood samples were obtained before and at the end of the exercise for clinical chemistry analysis and antioxidant capacity. Capillary blood samples were taken at the start and thereafter every 30 min to determine lipid peroxidation. Patients showed higher oxidative stress values as compared to controls (95.9 +/- 9.7 vs. 74.1 +/- 12.2 mg.L-1 H2O2; p<0.001). In both groups, oxidative stress remained constant throughout the exercise (p = NS), while oxidative defence increased significantly at the end of exercise (p<0.02) from 1.16 +/- 0.13 to 1.19 +/- 0.10 mmol.L-1 Trolox in patients and from 1.09 +/- 0.21 to 1.22 +/- 0.14 mmol.L-1 Trolox in controls, without any significant difference between the two groups. Oxidative stress was positively correlated to HbA(1c) (p<0.005) and negatively related with uric acid (p<0.005). In conclusion, we were the first to evaluate the oxidative stress in patients with type 1 diabetes exercising under their usual life conditions (i.e. usual therapy and diet). Specifically, we found that the oxidative stress was not exacerbated due to a single bout of prolonged moderate intensity aerobic exercise, a condition simulating several outdoor leisure time physical activities. Oxidative defence increased in both patients and controls, suggesting beneficial effects of prolonged aerobic fatiguing exercise.	[Francescato, Maria Pia; Stel, Giuliana; Geat, Mario; Cauci, Sabina] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Francescato, MP (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	maria.francescato@uniud.it	Francescato, Maria Pia/O-7010-2014	Francescato, Maria Pia/0000-0002-7892-863X; Cauci, Sabina/0000-0001-7443-1899				Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Berg TJ, 1998, DIABETES CARE, V21, P1295, DOI 10.2337/diacare.21.8.1295; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Chokkalingam K, 2007, DIABETOLOGIA, V50, P414, DOI 10.1007/s00125-006-0520-0; Davison GW, 2002, FREE RADICAL BIO MED, V33, P1543, DOI 10.1016/S0891-5849(02)01090-0; De Cosmo S, 2006, DIABETES CARE, V29, P2467, DOI 10.2337/dc06-0940; Di Santolo M, 2009, EUR J APPL PHYSIOL, V105, P111, DOI 10.1007/s00421-008-0880-x; Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Francescato MP, 2011, CURR DIABETES REV, V7, P253, DOI 10.2174/157339911796397875; Francescato MP, 2011, MED SCI SPORT EXER, V43, P2, DOI 10.1249/MSS.0b013e3181e6d6a1; Garelnabi MO, 2008, CLIN BIOCHEM, V41, P1250, DOI 10.1016/j.clinbiochem.2008.07.009; Geat M, 2013, METABOLISM, V62, P836, DOI 10.1016/j.metabol.2013.01.004; Gilbert J, 2004, DIABETES CARE, V27, P990, DOI 10.2337/diacare.27.4.990; Golbidi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/941868; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Goodarzi MT, 2010, J CLIN LAB ANAL, V24, P72, DOI 10.1002/jcla.20328; Grimm JJ, 2004, DIABETES METAB, V30, P465, DOI 10.1016/S1262-3636(07)70144-1; Jenni S, 2008, DIABETOLOGIA, V51, P1457, DOI 10.1007/s00125-008-1045-5; Kamhieh-Milz J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/720347; Laaksonen DE, 1996, DIABETES CARE, V19, P569, DOI 10.2337/diacare.19.6.569; Lippi G, 2008, CLIN CHIM ACTA, V392, P1, DOI 10.1016/j.cca.2008.02.024; Mantovani G, 2004, CANCER EPIDEM BIOMAR, V13, P1651; Marra G, 2002, DIABETES CARE, V25, P370, DOI 10.2337/diacare.25.2.370; Menon V, 2004, DIABETIC MED, V21, P1346, DOI 10.1111/j.1464-5491.2004.01417.x; Owen WE, 2004, CLIN CHEM, V50, P257, DOI 10.1373/clinchem.2003.026625; Pavlatou MG, 2009, METABOLISM, V58, P1657, DOI 10.1016/j.metabol.2009.05.022; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Reis JS, 2012, DIABETES VASC DIS RE, V9, P309, DOI 10.1177/1479164111436316; Sharma A, 2000, METABOLISM, V49, P160, DOI 10.1016/S0026-0495(00)91117-X; Stettler C, 2006, DIABETES-METAB RES, V22, P300, DOI 10.1002/dmrr.608; Takahashi M, 2013, EUR J APPL PHYSIOL, V113, P1117, DOI 10.1007/s00421-012-2531-5; Tamborlane WV, 2007, J CLIN ENDOCR METAB, V92, P815, DOI 10.1210/jc.2007-0016; VanderJagt DJ, 2001, CLIN BIOCHEM, V34, P265, DOI 10.1016/S0009-9120(01)00204-1; Vessby J, 2002, J INTERN MED, V251, P69, DOI 10.1046/j.1365-2796.2002.00927.x; Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99062	10.1371/journal.pone.0099062	http://dx.doi.org/10.1371/journal.pone.0099062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905823	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000101
J	Page, P; Favre, A; Schiestl, FP; Karrenberg, S				Page, Paul; Favre, Adrien; Schiestl, Florian P.; Karrenberg, Sophie			Do Flower Color and Floral Scent of Silene Species affect Host Preference of Hadena bicruris, a Seed-Eating Pollinator, under Field Conditions?	PLOS ONE			English	Article							NEIGHBORING UNINFECTED PLANTS; MILL GARCKE CARYOPHYLLACEAE; NURSERY POLLINATION; DIOICA CARYOPHYLLACEAE; REPRODUCTIVE ISOLATION; VOLATILE INDUCTION; CO-POLLINATORS; MODEL SYSTEM; S-DIOICA; LATIFOLIA	Specialization in plant-insect interactions is an important driver of evolutionary divergence; yet, plant traits mediating such interactions are poorly understood. In this study, we investigated how flower color and floral scent are related to seed predation by a seed-eating pollinator. We used field-transplanted recombinant F-2 hybrids between Silene latifolia and S. dioica that are the preferred and alternative hosts of the moth Hadena bicruris and crosses within these species for comparison. We scored seed predation and flower color and analyzed floral scent. Pinker S. dioica-like flowers and emission of a-pinene decreased the odds of seed predation while emission of benzyl acetate and 6-methyl-5-hepten-2-one increased the odds of seed predation. Emission of these compounds did not differ significantly between the two Silene species. Our results suggest that flower color plays an important role in the specific interaction of H. bicruris with its preferred host S. latifolia. The compounds alpha-pinene, benzyl acetate and 6-methyl-5-hepten-2-one could represent non-specific deterrents and attractants to ovipositing moths. Alternatively, emission of these compounds could be related to herbivory or pathogen attack and act as a signal for host quality. This would weaken the predictability of the plant's costs and benefits of the interaction and act to maintain an imperfect degree of specialization.	[Page, Paul; Favre, Adrien; Schiestl, Florian P.; Karrenberg, Sophie] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland; [Favre, Adrien] Univ Leipzig, Inst Biol, Dept Mol Evolut & Systemat Plants, D-04109 Leipzig, Germany; [Schiestl, Florian P.] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Karrenberg, Sophie] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University; University of Zurich; Uppsala University	Karrenberg, S (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	sophie.karrenberg@ebc.uu.se	Favre, Adrien/J-8989-2019	Favre, Adrien/0000-0001-6132-2992; Schiestl, Florian/0000-0001-7637-6918	Swiss National Science Foundation [31003A-112342, 31003A-118221]; Swedish Research Council (VR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Research Council (VR)(Swedish Research Council)	This research was funded by the Swiss National Science Foundation (http://www.snf.ch/), grants no. 31003A-112342 to FPS and no. 31003A-118221 to SK and a project grant of the Swedish Research Council (VR, http://www.vr.se) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Biere A, 1996, OIKOS, V77, P467, DOI 10.2307/3545936; Biere A, 2006, NEW PHYTOL, V169, P719, DOI 10.1111/j.1469-8137.2005.01511.x; Biere A, 1998, INT J PLANT SCI, V159, P228, DOI 10.1086/297543; Bopp S, 2004, OIKOS, V105, P221, DOI 10.1111/j.0030-1299.2004.12625.x; BRANTJES NBM, 1976, OECOLOGIA, V24, P1, DOI 10.1007/BF00545483; BRANTJES NBM, 1976, P K NED AKAD C BIOL, V79, P127; BRANTJES NBM, 1976, P K NED AKAD C BIOL, V79, P1; Brothers AN, 2014, INT J PLANT SCI, V175, P287, DOI 10.1086/673883; Burkhardt A, 2009, OECOLOGIA, V161, P87, DOI 10.1007/s00442-009-1359-0; Crawley M.J., 2007, R BOOK; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; Dotterl S, 2009, J CHEM ECOL, V35, P307, DOI 10.1007/s10886-009-9601-0; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Dotterl S, 2006, NEW PHYTOL, V169, P707, DOI 10.1111/j.1469-8137.2005.01509.x; Dotterl S, 2005, PLANT SYST EVOL, V255, P99, DOI 10.1007/s00606-005-0344-2; Dufay M, 2003, OIKOS, V100, P3, DOI 10.1034/j.1600-0706.2003.12053.x; Elzinga JA, 2005, OECOLOGIA, V144, P416, DOI 10.1007/s00442-005-0096-2; Elzinga JA, 2009, J ECOL, V97, P1010, DOI 10.1111/j.1365-2745.2009.01534.x; Faegri K, 1971, PRINCIPLES POLLINATI; Favre A, 2010, THESIS ETH ZURICH ZU; Favre A, 2011, J ECOL, V99, P1415, DOI 10.1111/j.1365-2745.2011.01865.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Goulson D, 1997, OIKOS, V79, P115, DOI 10.2307/3546096; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Hirota SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039010; Holland JN, 2002, OECOLOGIA, V133, P534, DOI 10.1007/s00442-002-1061-y; Hothorn T., 2006, EXACTRANKTESTS EXACT; Jurgens A, 2002, BIOCHEM SYST ECOL, V30, P383, DOI 10.1016/S0305-1978(01)00106-5; Karrenberg S, 2008, EVOLUTION, V62, P763, DOI 10.1111/j.1558-5646.2008.00330.x; Kephart S, 2006, NEW PHYTOL, V169, P667, DOI 10.1111/j.1469-8137.2005.01619.x; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2011, ECOLOGY, V92, P1769, DOI 10.1890/10-1945.1; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Kessler D, 2012, ENTOMOL EXP APPL, V144, P112, DOI 10.1111/j.1570-7458.2012.01270.x; Kigathi RN, 2009, J CHEM ECOL, V35, P1335, DOI 10.1007/s10886-009-9716-3; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Knudsen GK, 2008, PHYSIOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-3032.2007.00592.x; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Labouche AM, 2013, FUNCT ECOL, V27, P509, DOI [10.1111/1365-2435.12062, 10.1111/j.1468-3083.2011.04323.x]; Labouche AM, 2010, FUNCT ECOL, V24, P534, DOI 10.1111/j.1365-2435.2009.01658.x; Lexer C, 2003, ECOLOGY, V84, P1688, DOI 10.1890/0012-9658(2003)084[1688:EHAATF]2.0.CO;2; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Lynch M., 1998, GENETICS ANAL QUANTI; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; Muhlemann JK, 2006, J CHEM ECOL, V32, P1855, DOI 10.1007/s10886-006-9113-0; Pareja M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031971; Piesik D, 2013, J APPL ENTOMOL, V137, P296, DOI 10.1111/j.1439-0418.2012.01742.x; Piesik D, 2011, J PLANT PHYSIOL, V168, P1534, DOI 10.1016/j.jplph.2011.01.032; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Reisenman CE, 2010, P ROY SOC B-BIOL SCI, V277, P2371, DOI 10.1098/rspb.2010.0163; Reynolds RJ, 2012, OECOLOGIA, V168, P439, DOI 10.1007/s00442-011-2095-9; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schiestl FP, 2011, EVOL ECOL, V25, P237, DOI 10.1007/s10682-010-9409-y; Schiestl FP, 2003, J CHEM ECOL, V29, P253, DOI 10.1023/A:1021932131526; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Tang RB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045597, 10.1371/journal.pone.0049256]; THOMPSON JN, 1992, ECOLOGY, V73, P1780, DOI 10.2307/1940029; van Putten WF, 2007, INT J PLANT SCI, V168, P421, DOI 10.1086/511050; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Waelti MO, 2008, J EVOLUTION BIOL, V21, P111, DOI 10.1111/j.1420-9101.2007.01461.x; Waelti MO, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-190; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Wolfe LM, 2004, ECOL LETT, V7, P813, DOI 10.1111/j.1461-0248.2004.00649.x; Young HJ, 2002, AM J BOT, V89, P1237, DOI 10.3732/ajb.89.8.1237; Young HJ, 2002, AM J BOT, V89, P433, DOI 10.3732/ajb.89.3.433	73	12	12	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98755	10.1371/journal.pone.0098755	http://dx.doi.org/10.1371/journal.pone.0098755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905986	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341869000059
J	Salomon, C; Torres, MJ; Kobayashi, M; Scholz-Romero, K; Sobrevia, L; Dobierzewska, A; Illanes, SE; Mitchell, MD; Rice, GE				Salomon, Carlos; Jose Torres, Maria; Kobayashi, Miharu; Scholz-Romero, Katherin; Sobrevia, Luis; Dobierzewska, Aneta; Illanes, Sebastian E.; Mitchell, Murray D.; Rice, Gregory E.			A Gestational Profile of Placental Exosomes in Maternal Plasma and Their Effects on Endothelial Cell Migration	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; 1ST-ENA OBSERVATIONS; PREGNANT-WOMEN; MARS; EXPRESSION; MICRORNAS; RECEPTOR; BLOOD	Studies completed to date provide persuasive evidence that placental cell-derived exosomes play a significant role in intercellular communication pathways that potentially contribute to placentation and development of materno-fetal vascular circulation. The aim of this study was to establish the gestational-age release profile and bioactivity of placental cell-derived exosome in maternal plasma. Plasma samples (n = 20 per pregnant group) were obtained from non-pregnant and pregnant women in the first (FT, 6-12 weeks), second (ST, 22-24 weeks) and third (TT, 32-38 weeks) trimester. The number of exosomes and placental exosome contribution were determined by quantifying immunoreactive exosomal CD63 and placenta-specific marker (PLAP), respectively. The effect of exosomes isolated from FT, ST and TT on endothelial cell migration were established using a real-time, live-cell imaging system (Incucyte). Exosome plasma concentration was more than 50-fold greater in pregnant women than in non-pregnant women (p<0.001). During normal healthy pregnancy, the number of exosomes present in maternal plasma increased significantly with gestational age by more that two-fold (p<0.001). Exosomes isolated from FT, ST and TT increased endothelial cell migration by 1.9 +/- 0.1, 1.6 +/- 0.2 and 1.3 +/- 0.1-fold, respectively compared to the control. Pregnancy is associated with a dramatic increase in the number of exosomes present in plasma and maternal plasma exosomes are bioactive. While the role of placental cell-derived exosome in regulating maternal and/or fetal vascular responses remains to be elucidated, changes in exosome profile may be of clinical utility in the diagnosis of placental dysfunction.	[Salomon, Carlos; Kobayashi, Miharu; Scholz-Romero, Katherin; Sobrevia, Luis; Illanes, Sebastian E.; Mitchell, Murray D.; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld 4072, Australia; [Jose Torres, Maria; Dobierzewska, Aneta; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Dept Obstetr & Gynaecol, Santiago, Chile; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol, Santiago, Chile	Royal Brisbane & Women's Hospital; University of Queensland; Universidad de los Andes - Chile; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld 4072, Australia.	c.salomongallo@uq.edu.au	Torres, Maria/GVU-3391-2022; RICE, GREGORY E/F-2412-2010; Salomon, Carlos F/L-2167-2013; Sobrevia, Luis/H-9608-2016; Mitchell, Murray/A-8639-2010	RICE, GREGORY E/0000-0001-7177-0246; Salomon, Carlos F/0000-0003-4474-0046; Illanes, Sebastian/0000-0001-5433-9315; Sobrevia, Luis/0000-0001-5802-2243; Mitchell, Murray/0000-0002-6167-7176	CONICYT (ACT-73 PIA, PasantA-a Doctoral en el Extranjero BECAS Chile); FONDECYT [1110977]; CONICYT; Faculty of Medicine/PUC; University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC; CIEF grant (University of Queensland); Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government); Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government)	CONICYT (ACT-73 PIA, PasantA-a Doctoral en el Extranjero BECAS Chile); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine/PUC; University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIEF grant (University of Queensland); Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government); Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government)(Australian Government)	This investigation was supported by CONICYT (ACT-73 PIA, PasantA-a Doctoral en el Extranjero BECAS Chile), FONDECYT (1110977). CS hold CONICYT-PhD fellowships and Faculty of Medicine/PUC-PhD fellowships. CS holds a Postdoctoral Fellowship at The University of Queensland Centre for Clinical Research, Brisbane, Australia. GER was in receipt of an NHMRC Principal Research Fellowship. The work described herein was partially funded by a CIEF grant (University of Queensland), a Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government) and a Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Biswas S, 2008, J OBSTET GYNAECOL RE, V34, P487, DOI 10.1111/j.1447-0756.2008.00719.x; Brinkfeldt K, 2006, ICARUS, V182, P439, DOI 10.1016/j.icarus.2005.12.023; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Chen YW, 2012, INT J MOL MED, V29, P601, DOI 10.3892/ijmm.2012.894; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Denzer K, 2000, J CELL SCI, V113, P3365; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Futaana Y, 2006, ICARUS, V182, P413, DOI 10.1016/j.icarus.2005.08.024; Illsley NP, 2011, PLACENTA DEV DIS, P50, DOI [10.1002/9781444393927, DOI 10.1002/9781444393927]; Kshirsagar SK, 2012, PLACENTA; Liersch R, 2010, ONKOLOGIE, V33, P230; Lok CAR, 2012, AM J REPROD IMMUNOL, V67, P206, DOI 10.1111/j.1600-0897.2011.01079.x; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Lundin R, 2006, ICARUS, V182, P308, DOI 10.1016/j.icarus.2005.10.035; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Orozco AF, 2010, CYTOM PART A, V77A, P502, DOI 10.1002/cyto.a.20886; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079636; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; van der Post JAM, 2011, SEMIN THROMB HEMOST, V37, P146, DOI 10.1055/s-0030-1270342; Verweij Frederik J, 2012, Commun Integr Biol, V5, P88; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155	39	224	232	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98667	10.1371/journal.pone.0098667	http://dx.doi.org/10.1371/journal.pone.0098667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905832	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000046
J	Chang, LG; Tian, XQ; Lu, YH; Jia, M; Wu, P; Huang, PL				Chang, Ligong; Tian, Xiaoqiang; Lu, Yinghui; Jia, Min; Wu, Peng; Huang, Peilin			Alpha-2-Glycoprotein 1(AZGP1) Regulates Biological Behaviors of LoVo Cells by Down-Regulating mTOR Signaling Pathway and Endogenous Fatty Acid Synthesis	PLOS ONE			English	Article							LIPID MOBILIZING FACTOR; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; SYNTHASE; EXPRESSION; BREAST; ZINC-ALPHA-2-GLYCOPROTEIN; AZGP1	AZGP1 is a multifaceted protein associated with lipid mobilization, a process that is regulated by FASN and other metabolic pathways such as mTOR signaling. The active mTOR signaling pathway has been found to be involved in a variety of tumors. However, it remains unclear whether it is involved in the regulation of AZGP1 and FASN. An AZGP1-expressing plasmid was transfected into a human colorectal cancer cell line (LoVo) with a low expression of AZGP1. The expression of AZGP1, FASN, eIF4E, p-mTOR, p-S6, and S6K1 were measured by Western blot analysis, and target genes were detected by RT-PCR. Cell proliferation was studied using the MTT and colony formation assays. The analysis of apoptosis and the cell cycle phase were assessed by flow cytometry. The capacity of cell migration was investigated using the transwell migration assay. We found that the expression of AZGP1 was up-regulated while the expression of FASN, eIF4E, p-mTOR, p-S6, and S6K1 were down-regulated in LoVo cells after AZGP1 was expressed. The proliferation of malignant cells was reduced in AZGP1-overexpression cells, which is consistent with an increased in the G(2)-arrest and apoptosis rate. Furthermore, the migration of AZGP1-overexpression cells was decreased. The overexpression of AZGP1 suppressed the activation of the mTOR pathway and endogenous FASN-regulated fatty acid synthesis, mitigating the malignant phenotype of LoVo cells. Herein, we provide evidence that AZGP1 may constitute a novel tumor suppressor for LoVo colorectal cancer cells.	[Chang, Ligong; Jia, Min; Huang, Peilin] Southeast Univ, Sch Med, Dept Internal Med, Nanjing, Jiangsu, Peoples R China; [Tian, Xiaoqiang] Southeast Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Lu, Yinghui] Nanjing Mil Command, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China; [Wu, Peng] Jiangsu Jiankang Vocat Coll, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Nanjing General Hospital	Huang, PL (corresponding author), Southeast Univ, Sch Med, Dept Internal Med, Nanjing, Jiangsu, Peoples R China.	seuhpl@163.com			National Natural Science Foundation of China [81150028]; Natural Science Foundation of Jiangsu Province, China [BK2012749]; The Fundamental Research Funds for the Central Universities [CXLX13_120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); The Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (81150028), the Natural Science Foundation of Jiangsu Province, China (BK2012749) and the The Fundamental Research Funds for the Central Universities (CXLX13_120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Alo P L, 1999, Ann Diagn Pathol, V3, P287, DOI 10.1016/S1092-9134(99)80024-0; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Bing C, 2010, INT J OBESITY, V34, P1559, DOI 10.1038/ijo.2010.105; BUERGI W, 1961, J BIOL CHEM, V236, P1066; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Di Vizio D, 2007, CANCER BIOL THER, V6, P1263; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; FREIJE JP, 1991, FEBS LETT, V290, P247, DOI 10.1016/0014-5793(91)81271-9; Grunt TW, 2009, BIOCHEM BIOPH RES CO, V385, P454, DOI 10.1016/j.bbrc.2009.05.085; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Huang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069155; Huang Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-106; Ji DB, 2013, CARCINOGENESIS, V34, P1265, DOI 10.1093/carcin/bgt056; Kong B, 2010, ONCOGENE, V29, P5146, DOI 10.1038/onc.2010.258; Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542; Li N, 2012, LIPIDS, V47, P403, DOI 10.1007/s11745-011-3649-7; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; Vazquez-Martin A, 2007, ONCOL REP, V18, P973; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Yip PY, 2011, PROSTATE, V71, P1638, DOI 10.1002/pros.21381	30	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99254	10.1371/journal.pone.0099254	http://dx.doi.org/10.1371/journal.pone.0099254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918753	Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000067
J	Favaron, PO; Mess, A; Will, SE; Maiorka, PC; de Oliveira, MF; Miglino, MA				Favaron, Phelipe Oliveira; Mess, Andrea; Will, Sonia Elisabete; Maiorka, Paulo Cesar; de Oliveira, Moacir Franco; Miglino, Maria Angelica			Yolk Sac Mesenchymal Progenitor Cells from New World Mice (Necromys lasiurus) with Multipotent Differential Potential	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; MOUSE; PLACENTA; BIOLOGY; IDENTIFICATION; PLURIPOTENCY; ANGIOGENESIS	Fetal membranes are abundant, ethically acceptable and readily accessible sources of stem cells. In particular, the yolk sac is a source of cell lineages that do not express MHCs and are mainly free from immunological incompatibles when transferred to a recipient. Although data are available especially for hematopoietic stem cells in mice and human, whereas other cell types and species are dramatically underrepresented. Here we studied the nature and differentiation potential of yolk sac derived mesenchymal stem cells from a New World mouse, Necromys lasiurus. Explants from mid-gestation were cultured in DMEM-High glucose medium with 10% defined fetal bovine serum. The cells were characterized by standard methods including immunophenotyping by fluorescence and flow cytometry, growth and differentiation potential and tumorigenicity assays. The first adherent cells were observed after 7 days of cell culture and included small, elongated fibroblast-like cells (92.13%) and large, round epithelial-like cells with centrally located nuclei (6.5%). Only the fibroblast-like cells survived the first passages. They were positive to markers for mesenchymal stem cells (Stro-1, CD90, CD105, CD73) and pluripotency (Oct3/4, Nanog) as well as precursors of hematopoietic stem cells (CD117). In differentiation assays, they were classified as a multipotent lineage, because they differentiated into osteogenic, adipogenic, and chondrogenic lineages and, finally, they did not develop tumors. In conclusion, mesenchymal progenitor cells with multipotent differentiation potential and sufficient growth and proliferation abilities were able to be obtained from Necromys yolk sacs, therefore, we inferred that these cells may be promising for a wide range of applications in regenerative medicine.	[Favaron, Phelipe Oliveira; Mess, Andrea; Will, Sonia Elisabete; Maiorka, Paulo Cesar; Miglino, Maria Angelica] Univ Sao Paulo, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [de Oliveira, Moacir Franco] Univ Fed Rural Semi Arido, Dept Anim Sci, Mossoro, RN, Brazil	Universidade de Sao Paulo; Universidade Federal Rural do Semi-Arido (UFERSA)	Favaron, PO (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Sao Paulo, Brazil.	Phelipe.favaron@yahoo.com.br	Maiorka, Paulo/ABG-1405-2020; Miglino, Maria Angelica/B-9519-2012	Miglino, Maria Angelica/0000-0003-4979-115X; Favaron, Phelipe/0000-0002-6431-6886	FAPESP [09/53392-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by a grant from FAPESP (Process number: 09/53392-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach R, 1998, DEV COMP IMMUNOL, V22, P333, DOI 10.1016/S0145-305X(98)00005-6; Auerbach R, 1996, STEM CELLS, V14, P269, DOI 10.1002/stem.140269; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cooper GM, 2007, CELULA UMA ABORDAGEM; Corn BJ, 1991, CLIN BIOTECHNOL, V3, P15; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Favaron PO, 2012, PLACENTA, V33, P578, DOI 10.1016/j.placenta.2012.02.011; Fernandes R. A., 2012, Open Journal of Animal Sciences, V2, P166, DOI 10.4236/ojas.2012.23023; GLOBERSON A, 1987, DIFFERENTIATION, V36, P185, DOI 10.1111/j.1432-0436.1987.tb00192.x; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jaffredo T, 2005, INT J DEV BIOL, V49, P269, DOI 10.1387/ijdb.041948tj; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Mambelli LI, 2009, TISSUE ENG PART C-ME, V15, P87, DOI 10.1089/ten.tec.2008.0186; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; [那晓东 Na Xiaodong], 2003, [中国病理生理杂志, Chinese Journal of Pathophysiology], V19, P1316; [那晓东 Na Xiaodong], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P636; Nakagawa S, 2000, ARCH HISTOL CYTOL, V63, P229, DOI 10.1679/aohc.63.229; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Pessolato AGT, 2011, THESIS U SAO PAULO B; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; Sinowatz F., 2010, ESSENTIALS DOMESTIC, V1st ed., P317; VANDENHEUVEL RL, 1987, BRIT J HAEMATOL, V66, P15, DOI 10.1111/j.1365-2141.1987.tb06884.x; Wang XY, 2008, BLOOD, V111, P2436, DOI 10.1182/blood-2007-07-099333; Wenceslau CV, 2011, TISSUE ENG PT A, V17, P2165, DOI [10.1089/ten.TEA.2010.0678, 10.1089/ten.tea.2010.0678]; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zhao Zi-ping, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P41; Zhao ZP, 2003, THESIS CENTRAL S U C; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e95575	10.1371/journal.pone.0095575	http://dx.doi.org/10.1371/journal.pone.0095575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918429	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000005
J	Jackson, CR; Power, RJ; Groom, RJ; Masenga, EH; Mjingo, EE; Fyumagwa, RD; Roskaft, E; Davies-Mostert, H				Jackson, Craig R.; Power, R. John; Groom, Rosemary J.; Masenga, Emmanuel H.; Mjingo, Ernest E.; Fyumagwa, Robert D.; Roskaft, Eivin; Davies-Mostert, Harriet			Heading for the Hills: Risk Avoidance Drives Den Site Selection in African Wild Dogs	PLOS ONE			English	Article							NATAL DENS; PACK SIZE; COMPETITION; POPULATION; EXTINCTION; SOCIALITY; DYNAMICS; WOLVES	Compared to their main competitors, African wild dogs (Lycaon pictus) have inferior competitive abilities and interspecific competition is a serious fitness-limiting factor. Lions (Panthera leo) are the dominant large carnivore in African savannah ecosystems and wild dogs avoid them both spatially and temporally. Wild dog young are particularly vulnerable and suffer high rates of mortality from lions. Since lions do not utilize all parts of the landscape with an equal intensity, spatial variation in lion densities can be exploited by wild dogs both during their general ranging behaviour, but more specifically when they are confined to a den with vulnerable young. Since patches of rugged terrain are associated with lower lion densities, we hypothesized that these comparatively safe habitats should be selected by wild dogs for denning. We investigated the relationship between the distribution of 100 wild dog den sites and the occurrence of rugged terrain in four wild dog populations located in Tanzania, Zimbabwe and South Africa. A terrain ruggedness index was derived from a 90 m digital elevation model and used to map terrain ruggedness at each site. We compared characteristics of actual and potential (random) den sites to determine how wild dogs select den sites. The distributions of wild dog dens were strongly associated with rugged terrain and wild dogs actively selected terrain that was more rugged than that available on average. The likelihood of encountering lions is reduced in these habitats, minimizing the risk to both adults and pups. Our findings have important implications for the conservation management of the species, especially when assessing habitat suitability for potential reintroductions. The simple technique used to assess terrain ruggedness may be useful to investigate habitat suitability, and even predict highly suitable denning areas, across large landscapes.	[Jackson, Craig R.; Roskaft, Eivin] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Power, R. John] North West Prov Govt, Dept Econ Dev Environm Conservat & Tourism, Mmabatho, South Africa; [Groom, Rosemary J.] Univ Johannesburg, Dept Zool, Johannesburg, South Africa; [Groom, Rosemary J.] African Wildlife Conservat Fund, Chishakwe Ranch, Zimbabwe; [Masenga, Emmanuel H.; Mjingo, Ernest E.; Fyumagwa, Robert D.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Davies-Mostert, Harriet] Endangered Wildlife Trust, Johannesburg, South Africa; [Davies-Mostert, Harriet] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England	Norwegian University of Science & Technology (NTNU); University of Johannesburg; University of Oxford	Jackson, CR (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	craig.jackson@bio.ntnu.no	Power, Richard John/AAT-2039-2021; Jackson, Craig/AAT-9335-2021; Røskaft, Eivin/N-7476-2019	Power, Richard John/0000-0002-0684-4007; Røskaft, Eivin/0000-0003-0262-8443; Davies-Mostert, Harriet/0000-0001-7824-4863; Jackson, Craig/0000-0002-3918-1721	Work in Zimbabwe: Rufford Small Grants Foundation [16.04.08, 50.10.09]; Columbus Zoo and Aquarium; Disney Worldwide Conservation Fund; National Geographic Conservation Trust [C183-10]; USFWS Wildlife Without Borders [96200-1-G236]; Sea World and Busch Gardens	Work in Zimbabwe: Rufford Small Grants Foundation; Columbus Zoo and Aquarium; Disney Worldwide Conservation Fund; National Geographic Conservation Trust(National Geographic Society); USFWS Wildlife Without Borders; Sea World and Busch Gardens	Financial support for work in the various study areas was received from the following: Work in Zimbabwe: Rufford Small Grants Foundation (1st and 2nd Rufford Small Grant; Reference: 16.04.08 and 50.10.09) (http://www.rufford.org/); Columbus Zoo and Aquarium (http://www.colszoo.org/); Disney Worldwide Conservation Fund (http://thewaltdisneycompany.com/citizenship/environmental-stewardship/disney-worldwide-conservation-fund); National Geographic Conservation Trust (Grant C183-10) (http://www.nationalgeographic.com/explorers/grants-programs/conservation-trust-application/); USFWS Wildlife Without Borders (Agreement number 96200-1-G236) (http://www.fws.gov/international/wildlife-without-borders/); and Sea World and Busch Gardens (www.swbg-conservationfund.org). Work in South Africa (Venetia Limpopo Nature Reserve): The Endangered Wildlife Trust (www.ewt.org.za); Land Rover Jaguar South Africa (www.jlrcorp.co.za); and De Beers Consolidated Mines (www.debeersgroup.com/operations/mining/mining-operations/de-beers-consolidated-mines). Work in Tanzania: Frankfurt Zoological Society (www.zgf.de/?id=8&language=en) and Vodacom Tanzania (www.vodacom.co.tz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjo WM, 2003, CAN J ZOOL, V81, P96, DOI 10.1139/Z02-232; Carbone C, 1997, J ANIM ECOL, V66, P318, DOI 10.2307/5978; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S, 2001, CONSERV BIOL SER, V5, P35; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Creel S., 2002, AFRICAN WILD DOG BEH; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Eide NE, 2001, POLAR BIOL, V24, P132; Hanby J. P., 1995, SERENGETI, P315; Homewood K, 2001, P NATL ACAD SCI USA, V98, P12544, DOI 10.1073/pnas.221053998; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Kaartinen S, 2010, J ZOOL, V281, P99, DOI 10.1111/j.1469-7998.2009.00678.x; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; Manly B., 2002, RESOURCE SELECTION A, V2, DOI 10.1007/978-94-011-1558-2; Masenga E, 2011, THESIS SOKOINE U AGR; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Mizutani F, 1999, AFR J ECOL, V37, P226, DOI 10.1046/j.1365-2028.1999.00171.x; Moehlmann PD, 1989, CARNIVORE BEHAV ECOL; Mucina Ladislav, 2006, V19, P2; Pruss SD, 1999, CAN J ZOOL, V77, P646, DOI 10.1139/cjz-77-4-646; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Ruggiero LF, 1998, J WILDLIFE MANAGE, V62, P663, DOI 10.2307/3802342; Saleni P, 2007, CANID NEWS, V10, P2; Slough BG, 1999, CAN FIELD NAT, V113, P605; SMITS CMM, 1988, ARCTIC, V41, P12; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Steyn V, 2009, S AFR J WILDL RES, V39, P126, DOI 10.3957/056.039.0203; Theuerkauf J, 2003, CAN J ZOOL, V81, P163, DOI 10.1139/Z02-190; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Trapp JR, 2008, CAN FIELD NAT, V122, P49, DOI 10.22621/cfn.v122i1.543; van der Meer E, 2013, MAMM BIOL, V78, P336, DOI 10.1016/j.mambio.2013.04.006; van Dyk G, 2003, AFR ZOOL, V38, P79; Viljoen R, 2007, GUIDE GEOLOGY MADIKW; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	38	24	25	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99686	10.1371/journal.pone.0099686	http://dx.doi.org/10.1371/journal.pone.0099686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918935	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000104
J	Nava, E; Bottari, D; Villwock, A; Fengler, I; Buchner, A; Lenarz, T; Roder, B				Nava, Elena; Bottari, Davide; Villwock, Agnes; Fengler, Ineke; Buechner, Andreas; Lenarz, Thomas; Roeder, Brigitte			Audio-Tactile Integration in Congenitally and Late Deaf Cochlear Implant Users	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; RACE MODEL INEQUALITY; MULTISENSORY INTEGRATION; SPEECH-PERCEPTION; DEPRIVATION; FACILITATION; EXPERIENCE; ACTIVATION; CHILDREN; FUSION	Several studies conducted in mammals and humans have shown that multisensory processing may be impaired following congenital sensory loss and in particular if no experience is achieved within specific early developmental time windows known as sensitive periods. In this study we investigated whether basic multisensory abilities are impaired in hearing restored individuals with deafness acquired at different stages of development. To this aim, we tested congenitally and late deaf cochlear implant (CI) recipients, age-matched with two groups of hearing controls, on an audio-tactile redundancy paradigm, in which reaction times to unimodal and crossmodal redundant signals were measured. Our results showed that both congenitally and late deaf CI recipients were able to integrate audio-tactile stimuli, suggesting that congenital and acquired deafness does not prevent the development and recovery of basic multisensory processing. However, we found that congenitally deaf CI recipients had a lower multisensory gain compared to their matched controls, which may be explained by their faster responses to tactile stimuli. We discuss this finding in the context of reorganisation of the sensory systems following sensory loss and the possibility that these changes cannot be "rewired'' through auditory reafferentation.	[Nava, Elena; Bottari, Davide; Villwock, Agnes; Fengler, Ineke; Roeder, Brigitte] Univ Hamburg, Hamburg, Germany; [Buechner, Andreas; Lenarz, Thomas] Med Clin Hannover, German Hearing Ctr, Hannover, Germany	University of Hamburg	Nava, E (corresponding author), Univ Hamburg, Hamburg, Germany.	elena.nava@uni-hamburg.de	Bottari, Davide/H-1694-2018	Bottari, Davide/0000-0001-6843-1569; Nava, Elena/0000-0002-7496-9565	European Research Council [ERC-2009-AdG 249425-CriticalBrainChanges]	European Research Council(European Research Council (ERC)European Commission)	The study was supported by the European Research Council (ERC-2009-AdG 249425-CriticalBrainChanges) to BR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Buckley KA, 2011, EAR HEARING, V32, P2, DOI 10.1097/AUD.0b013e3181fa41bb; Carriere BN, 2007, J NEUROPHYSIOL, V98, P2858, DOI 10.1152/jn.00587.2007; Colonius H, 2006, PSYCHOL REV, V113, P148, DOI 10.1037/0033-295X.113.1.148; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gilley PM, 2010, RESTOR NEUROL NEUROS, V28, P207, DOI 10.3233/RNN-2010-0525; Gondan M, 2004, PSYCHON B REV, V11, P307, DOI 10.3758/BF03196575; Hotting K, 2004, PSYCHOL SCI, V15, P60, DOI 10.1111/j.0963-7214.2004.01501010.x; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Landry SP, 2013, PSYCHOL SCI, V24, P1260, DOI 10.1177/0956797612471142; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee HJ, 2007, CEREB CORTEX, V17, P909, DOI 10.1093/cercor/bhl001; Levanen S, 1998, CURR BIOL, V8, P869, DOI 10.1016/S0960-9822(07)00348-X; Levanen S, 2001, NEUROSCI LETT, V301, P75, DOI 10.1016/S0304-3940(01)01597-X; Lewkowicz D, 2011, NEW HDB MULTISENSORY; Lewkowicz DJ, 2009, TRENDS COGN SCI, V13, P470, DOI 10.1016/j.tics.2009.08.004; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Occelli V, 2011, PSYCHON B REV, V18, P429, DOI 10.3758/s13423-011-0070-4; Pavani F., 2012, NEW HDB MULTISENSORY, P737; Putzar L, 2007, NAT NEUROSCI, V10, P1243, DOI 10.1038/nn1978; Putzar L, 2012, DEV NEUROPSYCHOL, V37, P697, DOI 10.1080/87565641.2012.696756; Putzar L, 2010, RESTOR NEUROL NEUROS, V28, P251, DOI 10.3233/RNN-2010-0526; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; Sandmann P, 2012, BRAIN, V135, P555, DOI 10.1093/brain/awr329; Schorr EA, 2005, P NATL ACAD SCI USA, V102, P18748, DOI 10.1073/pnas.0508862102; Slater A, 1998, EXP BRAIN RES, V123, P90, DOI 10.1007/s002210050548; Tremblay C, 2010, RESTOR NEUROL NEUROS, V28, P283, DOI 10.3233/RNN-2010-0498; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004; Yu LP, 2010, J NEUROSCI, V30, P4904, DOI 10.1523/JNEUROSCI.5575-09.2010	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99606	10.1371/journal.pone.0099606	http://dx.doi.org/10.1371/journal.pone.0099606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918766	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000097
J	Ghiani, A; Fumagalli, P; Van, TN; Gentili, R; Citterio, S				Ghiani, Alessandra; Fumagalli, Pietro; Tho Nguyen Van; Gentili, Rodolfo; Citterio, Sandra			The Combined Toxic and Genotoxic Effects of Cd and As to Plant Bioindicator Trifolium repens L	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CADMIUM TOXICITY; HEAVY-METALS; MECHANISMS; RESPONSES; ARSENATE; MIXTURES; ARSENITE; SOILS; LEAD	This study was undertaken to investigate combined toxic and genotoxic effects of cadmium (Cd) and arsenic (As) on white clover, a pollutant sensitive plant frequently used as environmental bioindicator. Plants were exposed to soil spiked with increasing concentrations of cadmium sulfate (20, 40 and 60 mg Kg(-1)) or sodium arsenite (5, 10 and 20 mg Kg(-1)) as well as with their combinations. Metal(loid) bioavailability was assessed after soil contamination, whereas plant growth, metal(loid) concentration in plant organs and DNA damage were measured at the end of plant exposition. Results showed that individual and joint toxicity and genotoxicity were related to the concentration of Cd and As measured in plant organs, and that As concentration was the most relevant variable. Joint effects on plant growth were additive or synergistic, whereas joint genotoxic effects were additive or antagonistic. The interaction between Cd and As occurred at both soil and plant level. In soil the presence of As limited the bioavailability of Cd, whereas the presence of Cd increased the bioavailability of As. Nevertheless only As biovailability determined the amount of As absorbed by plants. The amount of Cd absorbed by plant was not linearly correlated with the fraction of bioavailable Cd in soil suggesting the involvement of additional factors, such as plant uptake mechanisms. These results reveal that the simultaneous presence in soil of Cd and As, although producing an additive or synergistic toxic effect on Trifolium repens L. growth, generates a lower DNA damage.	[Ghiani, Alessandra; Fumagalli, Pietro; Tho Nguyen Van; Gentili, Rodolfo; Citterio, Sandra] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy	University of Milano-Bicocca	Citterio, S (corresponding author), Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy.	sandra.citterio@unimib.it	Gentili, Rodolfo/I-5613-2016	Gentili, Rodolfo/0000-0002-9332-7963	Ministry of University, Research, Science and Technology; Italian Lombardy Region	Ministry of University, Research, Science and Technology; Italian Lombardy Region	This work was supported by the Ministry of University, Research, Science and Technology and Italian Lombardy Region (Project: Soil mapping). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2005, CERCLA PRIOR LIST HA; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Dabt DEK, 2011, LABMEDICINE, V42, P735, DOI 10.1309/LMYKGUO5BEPE7IAW; Fayiga AO, 2006, SCI TOTAL ENVIRON, V359, P17, DOI 10.1016/j.scitotenv.2005.06.001; Gonzaga MIS, 2008, ENVIRON POLLUT, V154, P212, DOI 10.1016/j.envpol.2007.10.011; HAGHIRI F, 1973, Journal of Environmental Quality, V2, P93, DOI 10.2134/jeq1973.00472425000200010012x; Hartwig A, 2010, BIOMETALS, V23, P951, DOI 10.1007/s10534-010-9330-4; Heger TJ, 2012, EUR J SOIL BIOL, V49, P1, DOI 10.1016/j.ejsobi.2012.02.001; Huang M, 2009, J TOXICOL ENV HEAL A, V72, P1493, DOI 10.1080/15287390903213095; Ince NH, 1999, ARCH ENVIRON CON TOX, V36, P365, DOI 10.1007/PL00006607; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; Karak T, 2011, CHEMOSPHERE, V85, P948, DOI 10.1016/j.chemosphere.2011.06.061; Linsday W.L, 1969, AGRON ABSTR, V69, P87; Liu XL, 2007, J ENVIRON SCI, V19, P1221, DOI 10.1016/S1001-0742(07)60199-5; Luan ZQ, 2008, PLANT SOIL ENVIRON, V54, P403, DOI 10.17221/409-PSE; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Piraino F, 2006, SCI TOTAL ENVIRON, V372, P350, DOI 10.1016/j.scitotenv.2006.09.009; Polle A, 2003, TOP CURR GENET, V4, P187; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Smith E, 1999, J ENVIRON QUAL, V28, P1719, DOI 10.2134/jeq1999.00472425002800060005x; Sun YH, 2008, ENVIRON EXP BOT, V64, P264, DOI 10.1016/j.envexpbot.2008.05.009; Tkalec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087582; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Wang GS, 2008, TOXICOL APPL PHARM, V233, P92, DOI 10.1016/j.taap.2008.01.017; Zhou QX, 2006, J ENVIRON SCI-CHINA, V18, P741; Zhu XF, 2013, J HAZARD MATER, V263, P398, DOI 10.1016/j.jhazmat.2013.09.018	29	37	37	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99239	10.1371/journal.pone.0099239	http://dx.doi.org/10.1371/journal.pone.0099239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914541	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700074
J	Li, CQ; Zhou, Y; Wang, HW; Liu, J; Xiang, LB				Li, Changqing; Zhou, Yue; Wang, Hongwei; Liu, Jun; Xiang, Liangbi			Treatment of Unstable Thoracolumbar Fractures through Short Segment Pedicle Screw Fixation Techniques Using Pedicle Fixation at the Level of the Fracture: A Finite Element Analysis	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; BURST FRACTURES; TRANSPEDICULAR FIXATION; INSTRUMENTATION; ADJACENT; ANTERIOR; STABILIZATION; INSERTION; FAILURE; STRESS	Objective: To compare the von Mises stresses of the internal fixation devices among different short segment pedicle screw fixation techniques to treat thoracic 12 vertebral fractures, especially the mono-segment pedicle screw fixation and intermediate unilateral pedicle screw fixation techniques. Methods: Finite element methods were utilised to investigate the biomechanical comparison of the four posterior short segment pedicle screw fixation techniques (S4+2: traditional short-segment 4 pedicle screw fixation [SPSF]; M4+2: monosegment pedicle screw fixation; I6+2: intermediate bilateral pedicle screw fixation; and I5+2: intermediate unilateral pedicle screw fixation). Results: The range of motion (ROM) in flexion, axial rotation, and lateral bending was the smallest in the I6+2 fixation model, followed by the I5+2 and S4+2 fixation models, but lateral bending was the largest in the M4+2 fixation model. The maximal stress of the upper pedicle screw is larger than the lower pedicle screw in S4+2 and M4+2. The largest maximal von Mises stress was observed in the upper pedicle screw in the S4+2 and M4+2 fixation models and in the lower pedicle screw in the I6+2 and I5+2 fixation models. The values of the largest maximal von Mises stress of the pedicle screws and rods during all states of motion were 263.1 MPa and 304.5 MPa in the S4+2 fixation model, 291.6 MPa and 340.5 MPa in the M4+2 fixation model, 182.9 MPa and 263.2 MPa in the I6+2 fixation model, and 269.3 MPa and 383.7 MPa in the I5+2 fixation model, respectively. Comparing the stress between different spinal loadings, the maximal von Mises stress of the implants were observed in flexion in all implanted models. Conclusion: Additional bilateral pedicle screws at the level of the fracture to SPSF may result in a stiffer construct and less von Mises stress for pedicle screws and rods. The largest maximal von Mises stress of the pedicle screws during all states of motion were observed in the mono-segment pedicle screw fixation technique.	[Li, Changqing; Zhou, Yue] Third Mil Med Univ, Dept Orthoped, Xinqiao Hosp, Chongqing, Peoples R China; [Wang, Hongwei; Liu, Jun; Xiang, Liangbi] Gen Hosp Shenyang Mil Area Command Chinese PLA, Dept Orthoped, Shenyang, Liaoning, Peoples R China	Army Medical University	Wang, HW (corresponding author), Gen Hosp Shenyang Mil Area Command Chinese PLA, Dept Orthoped, Shenyang, Liaoning, Peoples R China.	cplawhw@163.com; xiangliangbi1963@163.com			Chinese National High Technology Research and Development program [2011AA030106]; Chinese Ministry of Health [201002018]; Foundation of the State Key Laboratory of Robotics [2011-O01]	Chinese National High Technology Research and Development program(National High Technology Research and Development Program of China); Chinese Ministry of Health; Foundation of the State Key Laboratory of Robotics	This work was supported by the Chinese National High Technology Research and Development program (No. 2011AA030106), the Key Project of the Chinese Ministry of Health (No. 201002018), and the Foundation of the State Key Laboratory of Robotics (No. 2011-O01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamaru T, 2005, SPINE, V30, P2783, DOI 10.1097/01.brs.0000192281.53603.3f; Alanay A, 2001, SPINE, V26, P213, DOI 10.1097/00007632-200101150-00017; Anekstein Y, 2007, J SPINAL DISORD TECH, V20, P72, DOI 10.1097/01.bsd.0000211240.98963.f6; Baaj AA, 2011, J NEUROSURG-SPINE, V14, P192, DOI 10.3171/2010.10.SPINE10222; Chen CS, 2005, MED ENG PHYS, V27, P487, DOI 10.1016/j.medengphy.2004.12.007; Chen CS, 2001, MED ENG PHYS, V23, P483; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Dai LY, 2007, SURG NEUROL, V67, P221, DOI 10.1016/j.surneu.2006.08.081; Defino Helton L A, 2007, Indian J Orthop, V41, P337, DOI 10.4103/0019-5413.36998; Defino HL, 2005, INJURY, V36, P90, DOI 10.1016/j.injury.2005.06.019; Denoziere G, 2006, J BIOMECH, V39, P766, DOI 10.1016/j.jbiomech.2004.07.039; Guven O, 2009, J SPINAL DISORD TECH, V22, P417, DOI 10.1097/BSD.0b013e3181870385; Jahng TA, 2013, SPINE J, V13, P85, DOI 10.1016/j.spinee.2012.11.014; Kim HJ, 2012, SPINE, V37, P1637, DOI 10.1097/BRS.0b013e31823f2115; Kim HJ, 2010, MED BIOL ENG COMPUT, V48, P703, DOI 10.1007/s11517-010-0621-2; Kim Y, 2007, SPINE, V32, P2558, DOI 10.1097/BRS.0b013e318158cdd8; Kim Y, 2010, SPINE, V35, P599, DOI 10.1097/BRS.0b013e3181b6258a; KRAMER DL, 1995, J ORTHOP TRAUMA, V9, P499, DOI 10.1097/00005131-199509060-00007; Liu SY, 2009, J SPINAL DISORD TECH, V22, P38, DOI 10.1097/BSD.0b013e3181679ba3; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Mahar A, 2007, SPINE, V32, P1503, DOI 10.1097/BRS.0b013e318067dd24; MCLAIN RF, 1993, J BONE JOINT SURG AM, V75A, P162, DOI 10.2106/00004623-199302000-00002; Pflugmacher R, 2004, SPINE, V29, P1413, DOI 10.1097/01.BRS.0000129895.90939.1E; Shen WJ, 2001, SPINE, V26, P1038, DOI 10.1097/00007632-200105010-00010; SUK SI, 1995, SPINE, V20, P1399, DOI 10.1097/00007632-199506000-00012; Tang SJ, 2011, TURK NEUROSURG, V21, P296, DOI 10.5137/1019-5149.JTN.4018-10.0; Tang SJ, 2011, J ORTHOP SCI, V16, P221, DOI 10.1007/s00776-011-0037-3; Tian JW, 2011, ORTHOPEDICS, V34, P594, DOI 10.3928/01477447-20110627-08; Wang HW, 2012, INDIAN J ORTHOP, V46, P395, DOI 10.4103/0019-5413.98827; Wei FX, 2010, SPINE, V35, pE714, DOI 10.1097/BRS.0b013e3181d7ad1d; Wood KB, 2005, J SPINAL DISORD TECH, V18, pS15, DOI 10.1097/01.bsd.0000132287.65702.8a; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020; ZINDRICK MR, 1991, ORTHOP CLIN N AM, V22, P333	33	34	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99156	10.1371/journal.pone.0099156	http://dx.doi.org/10.1371/journal.pone.0099156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914815	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700067
J	Martin, KR; Cooper, R; Harris, TB; Brage, S; Hardy, R; Kuh, D				Martin, Kathryn R.; Cooper, Rachel; Harris, Tamara B.; Brage, Soren; Hardy, Rebecca; Kuh, Diana		NSHD Sci Data Collection Team	Patterns of Leisure-Time Physical Activity Participation in a British Birth Cohort at Early Old Age	PLOS ONE			English	Article							UNITED-STATES; HEALTH SURVEY; ADULTS; TRENDS; DETERMINANTS; DISABILITY; COMPENDIUM; FITNESS; BARRIER; OBESITY	Using data from a nationally representative British birth cohort we characterized the type and diversity of leisure-time physical activity that 2,188 participants (age 60-64 years) engaged in throughout the year by gender and obesity. Participants most commonly reported walking (71%), swimming (33%), floor exercises ( 24%) and cycling (15%). Sixty-two percent of participants reported >= 2 activities in the past year and 40% reported diversity on a regular basis. Regular engagement in different types of activity (cardio-respiratory, balance/flexibility and strength) was reported by 67%, 19% and 11% of participants, respectively. We found gender differences, as well as differences by obesity status, in the activities reported, the levels of activity diversity and activity type. Non-obese participants had greater activity diversity, and more often reported activities beneficial for cardio-respiratory health and balance/flexibility than obese participants. These findings may be used to inform the development of trials of physical activity interventions targeting older adults, and those older adults with high body mass index.	[Martin, Kathryn R.] Univ Aberdeen, Sch Med & Dent, Epidemiol Grp, Aberdeen, Scotland; [Martin, Kathryn R.; Cooper, Rachel; Hardy, Rebecca; Kuh, Diana] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Martin, Kathryn R.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Brage, Soren] Univ Cambridge, Inst Metab Sci, Sch Clin Med, MRC,Epidemiol Unit, Cambridge, England	University of Aberdeen; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cambridge	Martin, KR (corresponding author), Univ Aberdeen, Sch Med & Dent, Epidemiol Grp, Aberdeen, Scotland.	kathryn.martin@abdn.ac.uk	Cooper, Rachel/ABE-3768-2021; Wong, Andrew/M-8899-2016; Brage, Soren/C-6415-2013; Hardy, Rebecca/AFR-1989-2022; Kuh, Diana/L-6019-2014; Osika, Walter/AAH-7966-2020	Cooper, Rachel/0000-0003-3370-5720; Wong, Andrew/0000-0003-2079-4779; Brage, Soren/0000-0002-1265-7355; Kuh, Diana/0000-0001-7386-2857; Osika, Walter/0000-0002-1583-7319; Chowienczyk, Phil/0000-0003-4507-038X; Hardy, Rebecca/0000-0001-9949-0799; Masi, Stefano/0000-0002-7591-3686; Westgate, Kate/0000-0002-0283-3562	Intramural Research Program of the National Institute on Aging, NIH; UK Medical Research Council [MC_UU_12019/1, MC_UU_12015/3]; Medical Research Council [MC_U106179473, MC_UU_12015/3, MC_UU_12019/1] Funding Source: researchfish; MRC [MC_UU_12019/1, MC_UU_12015/3, MC_U106179473] Funding Source: UKRI	Intramural Research Program of the National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, and was carried out while KRM was an IRTA postdoctoral research fellow in the Laboratory of Epidemiology and Population Sciences at the National Institute of Aging, National Institutes of Health. This work was supported by the UK Medical Research Council (programme codes MC_UU_12019/1 and MC_UU_12015/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Ball K, 2000, AUST NZ J PUBL HEAL, V24, P331, DOI 10.1111/j.1467-842X.2000.tb01579.x; Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Chen Y, 2006, PREV MED, V42, P261, DOI 10.1016/j.ypmed.2006.01.006; Chipperfield JG, 2008, J GERONTOL B-PSYCHOL, V63, pS211, DOI 10.1093/geronb/63.4.S211; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Craig R, 2009, HEALTH SURVEY FOR EN, V1, P8; Dafna M, 2012, J SCI MED SPORT, V15, P213, DOI 10.1016/j.jsams.2011.10.009; de Almeida MDV, 1999, PUBLIC HEALTH NUTR, V2, P105, DOI 10.1017/S1368980099000154; Deaner RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049168; Department of Health PAHIaP, 2011, START ACTIVE STAY AC; Espana-Romero V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087085; Finch C, 2001, MED SCI SPORT EXER, V33, P778; Golubic R, 2013, INT J OBESITY, V37, P404, DOI 10.1038/ijo.2012.58; Hallal Pedro C, 2011, Rev. bras. epidemiol., V14, P53, DOI 10.1590/S1415-790X2011000500006; Hughes JP, 2008, J PHYS ACT HEALTH, V5, P347, DOI 10.1123/jpah.5.3.347; Juneau CE, 2010, PREV MED, V51, P384, DOI 10.1016/j.ypmed.2010.09.002; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; KUH DJL, 1992, J EPIDEMIOL COMMUN H, V46, P114, DOI 10.1136/jech.46.2.114; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Livingstone MBE, 2001, PUBLIC HEALTH NUTR, V4, P1107, DOI 10.1079/PHN2001192; Loney T, 2011, J PHYS ACT HEALTH, V8, P62, DOI 10.1123/jpah.8.1.62; Moore LV, 2012, RES Q EXERCISE SPORT, V83, P587; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Moschny A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-121; NICE, 2013, PUBLIC HEALTH GUIDAN, V44; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sport England, 2014, ACTIVE PEOPLE SURVEY; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Stamatakis E, 2008, BRIT J SPORT MED, V42, P901, DOI 10.1136/bjsm.2008.048082; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Waumsley J, 2011, OBESITY IN THE UK A, P5; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Xue QL, 2012, AM J EPIDEMIOL, V176, P534, DOI 10.1093/aje/kws125; YOUNG A, 1994, BRIT MED J, V309, P331, DOI 10.1136/bmj.309.6950.331	47	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98901	10.1371/journal.pone.0098901	http://dx.doi.org/10.1371/journal.pone.0098901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911018	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000337165600020
J	Sun, YY; Morozov, YM; Yang, D; Li, YK; Dunn, RS; Rakic, P; Chan, PH; Abe, K; Lindquist, DM; Kuan, CY				Sun, Yu-Yo; Morozov, Yury M.; Yang, Dianer; Li, Yikun; Dunn, R. Scott; Rakic, Pasko; Chan, Pak H.; Abe, Koji; Lindquist, Diana M.; Kuan, Chia-Yi			Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke	PLOS ONE			English	Article							FREE-RADICAL SCAVENGER; ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; CEREBRAL-ISCHEMIA; BRAIN-INJURY; ANTIOXIDANT EDARAVONE; RAT MODEL; REPERFUSION; RECANALIZATION; THROMBOLYSIS	Edaravone, a potent antioxidant, may improve thrombolytic therapy because it benefits ischemic stroke patients on its own and mitigates adverse effects of tissue plasminogen activator (tPA) in preclinical models. However, whether the combined tPA-edaravone therapy is more effective in reducing infarct size than singular treatment is uncertain. Here we investigated this issue using a transient hypoxia-ischemia (tHI)-induced thrombotic stroke model, in which adult C57BL/6 mice were subjected to reversible ligation of the unilateral common carotid artery plus inhalation of 7.5% oxygen for 30 min. While unilateral occlusion of the common carotid artery suppressed cerebral blood flow transiently, the addition of hypoxia triggered reperfusion deficits, endogenous thrombosis, and attenuated tPA activity, leading up to infarction. We compared the outcomes of vehicle-controls, edaravone treatment, tPA treatment at 0.5, 1, or 4 h post-tHI, and combined tPA-edaravone therapies with mortality rate and infarct size as the primary end-points. The best treatment was further compared with vehicle-controls in behavioral, biochemical, and diffusion tensor imaging (DTI) analyses. We found that application of tPA at 0.5 or 1 h - but not at 4 h post-tHI - significantly decreased infarct size and showed synergistic (p, 0.05) or additive benefits with the adjuvant edaravone treatment, respectively. The acute tPA-edaravone treatment conferred >50% reduction of mortality, similar to 80% decline in infarct size, and strong white-matter protection. It also improved vascular reperfusion and decreased oxidative stress, inflammatory cytokines, and matrix metalloproteinase activities. In conclusion, edaravone synergizes with acute tPA treatment in experimental thrombotic stroke, suggesting that clinical application of the combined tPA-edaravone therapy merits investigation.	[Sun, Yu-Yo; Yang, Dianer; Li, Yikun; Kuan, Chia-Yi] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Sun, Yu-Yo; Yang, Dianer; Li, Yikun; Kuan, Chia-Yi] Childrens Healthcare Atlanta, Atlanta, GA USA; [Morozov, Yury M.; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Dunn, R. Scott; Lindquist, Diana M.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Imaging Res Ctr, Cincinnati, OH 45229 USA; [Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama, Japan	Emory University; Children's Healthcare of Atlanta (CHOA); Yale University; Cincinnati Children's Hospital Medical Center; Stanford University; Okayama University	Kuan, CY (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	alex.kuan@emory.edu		Sun, Yu-Yo/0000-0002-6608-1347; Morozov, Yury/0000-0002-3679-6819	NIH [NS074559]; Children's Healthcare of Atlanta Research Centers Pilot Project grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta Research Centers Pilot Project grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the NIH grant NS074559 and a Children's Healthcare of Atlanta Research Centers Pilot Project grant (to CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; Barreto AD, 2012, STROKE, V43, P591, DOI 10.1161/STROKEAHA.111.617902; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; De Silva DA, 2009, STROKE, V40, P2872, DOI 10.1161/STROKEAHA.108.543595; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; Haelewyn B, 2010, J CEREBR BLOOD F MET, V30, P900, DOI 10.1038/jcbfm.2010.33; Heiss WD, 2011, CEREBROVASC DIS, V32, P307, DOI 10.1159/000330462; Hossmann KA, 2012, J CEREBR BLOOD F MET, V32, P1310, DOI 10.1038/jcbfm.2011.186; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Khatri P, 2005, STROKE, V36, P2400, DOI 10.1161/01.STR.0000185698.45720.58; Kimura K, 2012, J NEUROL SCI, V313, P132, DOI 10.1016/j.jns.2011.09.006; KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P561; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lapchak PA, 2009, EXP NEUROL, V215, P95, DOI 10.1016/j.expneurol.2008.09.004; Lee BJ, 2010, BRAIN RES, V1307, P22, DOI 10.1016/j.brainres.2009.10.026; Li PA, 1998, NEUROSCI LETT, V253, P191, DOI 10.1016/S0304-3940(98)00643-0; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Matute C, 2013, STROKE, V44, P1204, DOI 10.1161/STROKEAHA.112.658328; Murakami K, 1998, J NEUROSCI, V18, P205; Niessen F, 2003, STROKE, V34, P2019, DOI 10.1161/01.STR.0000080941.73934.30; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Shereen A, 2011, J CEREBR BLOOD F MET, V31, P1155, DOI 10.1038/jcbfm.2010.212; Sun YY, 2012, J NEUROSCI METH, V203, P122, DOI 10.1016/j.jneumeth.2011.09.029; Sun YY, 2010, J NEUROSCI, V30, P9621, DOI 10.1523/JNEUROSCI.2295-10.2010; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Watanabe T, 2008, CARDIOVASC THER, V26, P101, DOI 10.1111/j.1527-3466.2008.00041.x; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yamauchi H, 2012, BRAIN, V135, P2515, DOI 10.1093/brain/aws131; Yang D, 2013, CEREB CORTEX, V23, P1218, DOI 10.1093/cercor/bhs115; Yang D, 2009, J NEUROSCI, V29, P8669, DOI 10.1523/JNEUROSCI.1117-09.2009; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058	43	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98807	10.1371/journal.pone.0098807	http://dx.doi.org/10.1371/journal.pone.0098807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911517	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600015
J	Fischer, C; Roscher, C; Jensen, B; Eisenhauer, N; Baade, J; Attinger, S; Scheu, S; Weisser, WW; Schumacher, J; Hildebrandt, A				Fischer, Christine; Roscher, Christiane; Jensen, Britta; Eisenhauer, Nico; Baade, Jussi; Attinger, Sabine; Scheu, Stefan; Weisser, Wolfgang W.; Schumacher, Jens; Hildebrandt, Anke			How Do Earthworms, Soil Texture and Plant Composition Affect Infiltration along an Experimental Plant Diversity Gradient in Grassland?	PLOS ONE			English	Article							SATURATED HYDRAULIC CONDUCTIVITY; WATER INFILTRATION; PREFERENTIAL FLOW; TILLAGE; CLAY; MACROPORES; BURROWS; MOVEMENT; INFILTROMETERS; PRODUCTIVITY	Background: Infiltration is a key process in determining the water balance, but so far effects of earthworms, soil texture, plant species diversity and their interaction on infiltration capacity have not been studied. Methodology/Principal Findings: We measured infiltration capacity in subplots with ambient and reduced earthworm density nested in plots of different plant species (1, 4, and 16 species) and plant functional group richness and composition (1 to 4 groups; legumes, grasses, small herbs, tall herbs). In summer, earthworm presence significantly increased infiltration, whereas in fall effects of grasses and legumes on infiltration were due to plant-mediated changes in earthworm biomass. Effects of grasses and legumes on infiltration even reversed effects of texture. We propose two pathways: (i) direct, probably by modifying the pore spectrum and (ii) indirect, by enhancing or suppressing earthworm biomass, which in turn influenced infiltration capacity due to change in burrowing activity of earthworms. Conclusions/Significance: Overall, the results suggest that spatial and temporal variations in soil hydraulic properties can be explained by biotic processes, especially the presence of certain plant functional groups affecting earthworm biomass, while soil texture had no significant effect. Therefore biotic parameters should be taken into account in hydrological applications.	[Fischer, Christine; Attinger, Sabine; Hildebrandt, Anke] Univ Jena, Inst Geosci, Jena, Germany; [Fischer, Christine; Hildebrandt, Anke] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] UFZ, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Jensen, Britta; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Eisenhauer, Nico] Univ Jena, Inst Ecol, Jena, Germany; [Baade, Jussi] Univ Jena, Dept Geog, Jena, Germany; [Attinger, Sabine] UFZ, Helmholtz Ctr Environm Res, Dept Computat Hydrosyst, Leipzig, Germany; [Weisser, Wolfgang W.] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Ctr Food & Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; Friedrich Schiller University of Jena	Fischer, C (corresponding author), Univ Jena, Inst Geosci, Jena, Germany.	Fischer.christine@uni-jena.de	Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-3191-2019; Eisenhauer, Nico/I-5932-2012; Hildebrandt, Anke/J-7062-2012; Scheu, Stefan/H-7049-2015; Baade, Jussi/D-4281-2013	Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Hildebrandt, Anke/0000-0001-8643-1634; Baade, Jussi/0000-0001-9878-7232	German Science Foundation (DFG) [FOR456/1451]; Friedrich Schiller University Jena; Max Planck Society; Helmholtz Impulse and Networking Fund through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); AquaDiv@Jena; initiative "ProExzellenz" of the German Federal State of Thuringia	German Science Foundation (DFG)(German Research Foundation (DFG)); Friedrich Schiller University Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Impulse and Networking Fund through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE); AquaDiv@Jena; initiative "ProExzellenz" of the German Federal State of Thuringia	The Jena Experiment was funded by the German Science Foundation (DFG, FOR456/1451, www.dfg.de, http://www.dfg.de.), with additional support from the Friedrich Schiller University Jena and the Max Planck Society. This specific research project was further supported by the Helmholtz Impulse and Networking Fund through the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE) and AquaDiv@Jena, a project funded by the initiative "ProExzellenz" of the German Federal State of Thuringia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I, 1981, SOIL BIOL BIOCHEM, V13, P191, DOI 10.1016/0038-0717(81)90019-5; Alaoui A, 2011, SOIL TILL RES, V115, P1, DOI 10.1016/j.still.2011.06.002; Angers DA, 1998, BIOGEOCHEMISTRY, V42, P55, DOI 10.1023/A:1005944025343; Angulo-Jaramillo R, 2000, SOIL TILL RES, V55, P1, DOI 10.1016/S0167-1987(00)00098-2; Archer NAL, 2002, J ARID ENVIRON, V52, P535, DOI 10.1006/jare.2002.1011; Azooz RH, 1996, CAN J SOIL SCI, V76, P143, DOI 10.4141/cjss96-021; BARLEY KP, 1954, SOIL SCI, V78, P205, DOI 10.1097/00010694-195409000-00005; Bens O, 2007, EUR J FOREST RES, V126, P101, DOI 10.1007/s10342-006-0133-7; Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; BEVEN K, 1982, WATER RESOUR RES, V18, P1311, DOI 10.1029/WR018i005p01311; Beven K, 2013, WATER RESOUR RES, V49, P3071, DOI 10.1002/wrcr.20156; BLACKBURN WH, 1975, WATER RESOUR RES, V11, P929, DOI 10.1029/WR011i006p00929; Bodner G, 2008, GEODERMA, V146, P317, DOI 10.1016/j.geoderma.2008.06.012; BONSU M, 1992, HYDROLOG SCI J, V37, P599, DOI 10.1080/02626669209492626; Bouche MB, 1977, ECOL B STOCKHOLM, V25, P122, DOI DOI 10.2307/20112572; Bretz F., 2010, MULTIPLE COMP USING; Chan KY, 2004, APPL SOIL ECOL, V27, P89, DOI 10.1016/j.apsoil.2004.02.001; DEKKER LW, 1994, WATER RESOUR RES, V30, P2507, DOI 10.1029/94WR00749; DEXTER AR, 1988, SOIL TILL RES, V11, P199, DOI 10.1016/0167-1987(88)90002-5; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; EDWARDS WM, 1990, GEODERMA, V46, P73, DOI 10.1016/0016-7061(90)90008-W; EHLERS W, 1975, SOIL SCI, V119, P242, DOI 10.1097/00010694-197503000-00010; Eisenhauer N, 2008, EUR J SOIL BIOL, V44, P141, DOI 10.1016/j.ejsobi.2007.10.002; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Eisenhauer N, 2009, SOIL BIOL BIOCHEM, V41, P2430, DOI 10.1016/j.soilbio.2009.09.001; Eisenhauer N, 2009, OECOLOGIA, V161, P291, DOI 10.1007/s00442-009-1374-1; ELA SD, 1992, SOIL SCI SOC AM J, V56, P714, DOI 10.2136/sssaj1992.03615995005600030007x; FAO-UNESCO, 1997, SOIL MAP WORLD REV L; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; FLURY M, 1994, WATER RESOUR RES, V30, P1945, DOI 10.1029/94WR00871; GISH TJ, 1983, T ASAE, V26, P440; Grace J.B., 2006, STRUCT EQ MOD NAT; GREVERS MCJ, 1990, CAN J SOIL SCI, V70, P93, DOI 10.4141/cjss90-010; Hillel D, 1998, ENV SOIL PHYS; JARVIS NJ, 1995, SOIL SCI SOC AM J, V59, P27, DOI 10.2136/sssaj1995.03615995005900010004x; JARVIS NJ, 1987, J SOIL SCI, V38, P633, DOI 10.1111/j.1365-2389.1987.tb02160.x; JOSCHKO M, 1992, SOIL BIOL BIOCHEM, V24, P1545, DOI 10.1016/0038-0717(92)90148-Q; Kluge G, 2000, BERICHTE DTSCH WETTE, V213; Kordel W, 2008, PURE APPL CHEM, V80, P105, DOI 10.1351/pac200880010105; Kohler-Milleret R, 2013, PLANT SOIL, V370, P251, DOI 10.1007/s11104-013-1621-4; Kutilek M, 2004, SOIL TILL RES, V79, P175, DOI 10.1016/j.still.2004.07.006; Lachnicht SL, 1997, SOIL BIOL BIOCHEM, V29, P493, DOI 10.1016/S0038-0717(96)00106-X; LEE KE, 1991, AUST J SOIL RES, V29, P745, DOI 10.1071/SR9910745; Lin HS, 1999, SOIL SCI SOC AM J, V63, P948, DOI 10.2136/sssaj1999.634948x; Lipiec J, 2006, SOIL TILL RES, V89, P210, DOI 10.1016/j.still.2005.07.012; Logsdon SD, 2000, SOIL SCI SOC AM J, V64, P710, DOI 10.2136/sssaj2000.642710x; MEEK BD, 1989, SOIL SCI SOC AM J, V53, P238, DOI 10.2136/sssaj1989.03615995005300010042x; MESSING I, 1990, J SOIL SCI, V41, P229, DOI 10.1111/j.1365-2389.1990.tb00059.x; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; MITCHELL AR, 1995, COMMUN SOIL SCI PLAN, V26, P2655, DOI 10.1080/00103629509369475; MYTTON LR, 1993, GRASS FORAGE SCI, V48, P84, DOI 10.1111/j.1365-2494.1993.tb01840.x; NUUTINEN V, 1992, SOIL TILL RES, V23, P221, DOI 10.1016/0167-1987(92)90102-H; Obi ME, 1999, PLANT SOIL, V211, P165, DOI 10.1023/A:1004609104524; Ortlepp S, 2004, HOLOZANE FLUVIALE DY; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P137, DOI 10.1016/S0167-8809(99)00034-1; Peres G, 2013, PLANT SOIL, V373, P285, DOI 10.1007/s11104-013-1791-0; Peres G, 1998, BIOL FERT SOILS, V27, P417, DOI 10.1007/s003740050452; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Pucheta E, 2004, AUSTRAL ECOL, V29, P201, DOI 10.1111/j.1442-9993.2004.01337.x; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; RAWLS WJ, 1982, T ASAE, V25, P1316; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schwarzel K, 2007, SOIL SCI SOC AM J, V71, P1438, DOI 10.2136/sssaj2006.0104; SHIPITALO MJ, 1994, J ENVIRON QUAL, V23, P1345, DOI 10.2134/jeq1994.00472425002300060031x; SHIPITALO MJ, 1988, SOIL SCI SOC AM J, V52, P764, DOI 10.2136/sssaj1988.03615995005200030030x; Shipley B., 2000, CAUSE CORRELATIONS B; Shuster WD, 2002, APPL SOIL ECOL, V21, P159, DOI 10.1016/S0929-1393(02)00063-X; Simmonds LP, 1998, NUTR CYCL AGROECOSYS, V50, P65, DOI 10.1023/A:1009790803137; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; SLATER C. S., 1957, SOIL SCI SOC AMER PROC, V21, P457; Soto B., 1994, SOIL DEGRADATION DES, P91; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STOCKDILL S. M. J., 1966, PROC N Z ECOL SOC, V13, P68; THIELEMANN U, 1986, PEDOBIOLOGIA, V29, P296; Thompson SE, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001134; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TIPPKOTTER R, 1983, GEODERMA, V29, P355, DOI 10.1016/0016-7061(83)90021-6; van Schaik L, 2014, ECOHYDROLOGY, V7, P401, DOI 10.1002/eco.1358; VEREECKEN H, 1995, GEODERMA, V65, P81, DOI 10.1016/0016-7061(95)92543-X; Ward A.D., 2004, ENV HYDROLOGY; WATSON KW, 1986, SOIL SCI SOC AM J, V50, P578, DOI 10.2136/sssaj1986.03615995005000030007x; Weiler M, 2003, HYDROL PROCESS, V17, P477, DOI 10.1002/hyp.1136; WOODING RA, 1968, WATER RESOUR RES, V4, P1259, DOI 10.1029/WR004i006p01259; WOSTEN JHM, 1988, SOIL SCI SOC AM J, V52, P1762, DOI 10.2136/sssaj1988.03615995005200060045x; Wuest SB, 2001, APPL SOIL ECOL, V18, P187, DOI 10.1016/S0929-1393(01)00145-7; Zacharias S, 2007, SOIL SCI SOC AM J, V71, P43, DOI 10.2136/sssaj2006.0098; ZACHMANN JE, 1987, SOIL SCI SOC AM J, V51, P1580, DOI 10.2136/sssaj1987.03615995005100060032x; ZACHMANN JE, 1989, SOIL SCI SOC AM J, V53, P1846, DOI 10.2136/sssaj1989.03615995005300060038x; Zartman R. E., 2012, Applied and Environmental Soil Science, V2012, P642791; Zehe E, 2001, J HYDROL, V247, P116, DOI 10.1016/S0022-1694(01)00371-7	91	74	78	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98987	10.1371/journal.pone.0098987	http://dx.doi.org/10.1371/journal.pone.0098987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918943	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000038
J	Heo, SK; Noh, EK; Yoon, DJ; Jo, JC; Park, JH; Kim, H				Heo, Sook-Kyoung; Noh, Eui-Kyu; Yoon, Dong-Joon; Jo, Jae-Cheol; Park, Jae-Hoo; Kim, Hawk			Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity	PLOS ONE			English	Article							KINASE INHIBITOR P21(WAF1/CIP1/MDA6); AML CELLS; IMATINIB MESYLATE; INDUCED APOPTOSIS; FUNCTIONAL-ROLE; RETINOIC ACID; IN-VITRO; PROLIFERATION; EXPRESSION; THERAPY	Dasatinib is a compound developed for chronic myeloid leukemia as a multi-targeted kinase inhibitor against wild-type BCR-ABL and SRC family kinases. Valproic acid (VPA) is an anti-epileptic drug that also acts as a class I histone deacetylase inhibitor. The aim of this research was to determine the anti-leukemic effects of dasatinib and VPA in combination and to identify their mechanism of action in acute myeloid leukemia (AML) cells. Dasatinib was found to exert potent synergistic inhibitory effects on VPA-treated AML cells in association with G1 phase cell cycle arrest and apoptosis induction involving the cleavage of poly (ADP-ribose) polymerase and caspase-3, -7 and -9. Dasatinib/VPA-induced cell death thus occurred via caspase-dependent apoptosis. Moreover, MEK/ERK and p38 MAPK inhibitors efficiently inhibited dasatinib/VPA-induced apoptosis. The combined effect of dasatinib and VPA on the differentiation capacity of AML cells was more powerful than the effect of each drug alone, being sufficiently strong to promote AML cell death through G(1) cell cycle arrest and caspasedependent apoptosis. MEK/ERK and p38 MAPK were found to control dasatinib/VPA-induced apoptosis as upstream regulators, and co-treatment with dasatinib and VPA to contribute to AML cell death through the regulation of differentiation capacity. Taken together, these results indicate that combined dasatinib and VPA treatment has a potential role in anti-leukemic therapy.	[Heo, Sook-Kyoung; Yoon, Dong-Joon; Kim, Hawk] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea; [Noh, Eui-Kyu; Jo, Jae-Cheol; Park, Jae-Hoo; Kim, Hawk] Univ Ulsan, Coll Med, Div Hematol & Hematol Malignancies, Dept Hematol & Oncol,Ulsan Univ Hosp, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Kim, H (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 680749, South Korea.	kimhawkmd@gmail.com	Jo, Jae-Cheol/CAE-9453-2022	Jo, Jae-Cheol/0000-0001-6014-7977	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094050]	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0094050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2006, ANTI-CANCER DRUG, V17, P1141, DOI 10.1097/01.cad.0000236302.89843.fc; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Aurelius J, 2012, BLOOD, V119, P5832, DOI 10.1182/blood-2011-11-391722; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Chen XF, 2011, MOL CANCER RES, V9, P448, DOI 10.1158/1541-7786.MCR-10-0471; Chen Y, 2011, ANTICANCER RES, V31, P2231; Chevalier N, 2010, LEUKEMIA, V24, P1779, DOI 10.1038/leu.2010.151; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Deschesnes RG, 2001, MOL BIOL CELL, V12, P1569, DOI 10.1091/mbc.12.6.1569; Fang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066915; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Heo SK, 2009, J VASC RES, V46, P375, DOI 10.1159/000189798; Jonsson S, 2010, LEUKEMIA, V24, P1357, DOI 10.1038/leu.2010.84; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kircher B, 2009, EUR J HAEMATOL, V83, P48, DOI 10.1111/j.1600-0609.2009.01242.x; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Leiva M, 2012, LEUKEMIA, V26, P1630, DOI 10.1038/leu.2012.39; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Mazharian A, 2011, BLOOD, V117, P5198, DOI 10.1182/blood-2010-12-326850; Miranda MB, 2008, LEUKEMIA, V22, P1624, DOI 10.1038/leu.2008.28; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; Rosato RR, 2004, MOL PHARMACOL, V65, P571, DOI 10.1124/mol.65.3.571; Schiffer CA, 2002, LEUKEMIA, V16, P745, DOI 10.1038/sj.leu.2402487; Schuchmann M, 2006, ONCOL REP, V15, P227; Shen WT, 2005, SURGERY, V138, P979, DOI 10.1016/j.surg.2005.09.019; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Torgersen ML, 2013, BLOOD, V122, P2467, DOI 10.1182/blood-2013-05-500629; Wang AH, 2011, ANN HEMATOL, V90, P917, DOI 10.1007/s00277-011-1175-6; Wang ZL, 1999, CANCER RES, V59, P1259; Wang ZL, 1998, EXP CELL RES, V244, P105, DOI 10.1006/excr.1998.4191; WHITE E, 1993, GENE DEV, V7, P2277, DOI 10.1101/gad.7.12a.2277; Woods WG, 1996, BLOOD, V87, P4979, DOI 10.1182/blood.V87.12.4979.bloodjournal87124979; Zurlo D, 2013, MOL CARCINOGEN, V52, P1, DOI 10.1002/mc.20872	45	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98859	10.1371/journal.pone.0098859	http://dx.doi.org/10.1371/journal.pone.0098859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918603	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000030
J	Malik, D; Hsu, T; Falatoonzadeh, P; Caceres-del-Carpio, J; Tarek, M; Chwa, M; Atilano, SR; Ramirez, C; Nesburn, AB; Boyer, DS; Kuppermann, BD; Jazwinski, SM; Miceli, MV; Wallace, DC; Udar, N; Kenney, MC				Malik, Deepika; Hsu, Tiffany; Falatoonzadeh, Payam; Caceres-del-Carpio, Javier; Tarek, Mohamed; Chwa, Marilyn; Atilano, Shari R.; Ramirez, Claudio; Nesburn, Anthony B.; Boyer, David S.; Kuppermann, Baruch D.; Jazwinski, S. Michal; Miceli, Michael V.; Wallace, Douglas C.; Udar, Nitin; Kenney, M. Cristina			Human Retinal Transmitochondrial Cybrids with J or H mtDNA Haplogroups Respond Differently to Ultraviolet Radiation: Implications for Retinal Diseases	PLOS ONE			English	Article							MITOCHONDRIAL-DNA HAPLOGROUPS; GROWTH-FACTOR-ALPHA; MACULAR DEGENERATION; PIGMENT EPITHELIUM; CELL-DEATH; ABERRANT ACCUMULATION; INFLAMMATORY CYTOKINE; NUCLEOTIDE EXCISION; COMPLEMENT-SYSTEM; OXIDATIVE STRESS	Background: It has been recognized that cells do not respond equally to ultraviolet (UV) radiation but it is not clear whether this is due to genetic, biochemical or structural differences of the cells. We have a novel cybrid (cytoplasmic hybrids) model that allows us to analyze the contribution of mitochondrial DNA (mtDNA) to cellular response after exposure to sub-lethal dose of UV. mtDNA can be classified into haplogroups as defined by accumulations of specific single nucleotide polymorphisms (SNPs). Recent studies have shown that J haplogroup is high risk for age-related macular degeneration while the H haplogroup is protective. This study investigates gene expression responses in J cybrids versus H cybrids after exposure to sub-lethal doses of UV-radiation. Methodology/Principal Findings: Cybrids were created by fusing platelets isolated from subjects with either H (n = 3) or J (n = 3) haplogroups with mitochondria-free (Rho 0) ARPE-19 cells. The H and J cybrids were cultured for 24 hours, treated with 10 mJ of UV-radiation and cultured for an additional 120 hours. Untreated and treated cybrids were analyzed for growth rates and gene expression profiles. The UV-treated and untreated J cybrids had higher growth rates compared to H cybrids. Before treatment, J cybrids showed lower expression levels for CFH, CD55, IL-33, TGF-A, EFEMP-1, RARA, BCL2L13 and BBC3. At 120 hours after UV-treatment, the J cybrids had decreased CFH, RARA and BBC3 levels but increased CD55, IL-33 and EFEMP-1 compared to UV-treated H cybrids. Conclusion/Significance: In cells with identical nuclei, the cellular response to sub-lethal UV-radiation is mediated in part by the mtDNA haplogroup. This supports the hypothesis that differences in growth rates and expression levels of complement, inflammation and apoptosis genes may result from population-specific, hereditary SNP variations in mtDNA. Therefore, when analyzing UV-induced damage in tissues, the mtDNA haplogroup background may be important to consider.	[Malik, Deepika; Hsu, Tiffany; Falatoonzadeh, Payam; Caceres-del-Carpio, Javier; Tarek, Mohamed; Chwa, Marilyn; Atilano, Shari R.; Ramirez, Claudio; Nesburn, Anthony B.; Kuppermann, Baruch D.; Udar, Nitin; Kenney, M. Cristina] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Tarek, Mohamed] El Minya Univ, Dept Ophthalmol, El Minya, Egypt; [Nesburn, Anthony B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA; [Jazwinski, S. Michal; Miceli, Michael V.] Tulane Univ, Tulane Ctr Aging, New Orleans, LA 70118 USA; [Wallace, Douglas C.] Univ Penn, Childrens Hosp Philadelphia, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Wallace, Douglas C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Kenney, M. Cristina] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University of California System; University of California Irvine; Egyptian Knowledge Bank (EKB); Minia University; Cedars Sinai Medical Center; Retina Vitreous Associates Medical Group; Tulane University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Irvine	Kenney, MC (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA.	mkenney@uci.edu		Udar, Nitin/0000-0001-8533-9190; CACERES DEL CARPIO, JAVIER/0000-0001-5673-5709; Moustafa, M. Tarek/0000-0003-4545-6012; Atilano, Shari/0000-0002-7729-7864	Discovery Eye Foundation; Guenther Foundation; Beckman Initiative for Macular Research; Polly and Michael Smith Foundation; Max Factor Family Foundation; Skirball Foundation; Lincy Foundation, Iris; B. Gerald Cantor Foundation; Research to Prevent Blindness;  [AG006168]; NATIONAL INSTITUTE ON AGING [R01AG006168, R37AG006168] Funding Source: NIH RePORTER	Discovery Eye Foundation; Guenther Foundation; Beckman Initiative for Macular Research; Polly and Michael Smith Foundation; Max Factor Family Foundation; Skirball Foundation; Lincy Foundation, Iris; B. Gerald Cantor Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Discovery Eye Foundation, Guenther Foundation, Beckman Initiative for Macular Research, Polly and Michael Smith Foundation, Max Factor Family Foundation, Skirball Foundation, Lincy Foundation, Iris and B. Gerald Cantor Foundation, and unrestricted grant from Research to Prevent Blindness. National Institute on Aging grant (AG006168) to SMJ and MVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimjongjun S, 2013, J PHOTOCH PHOTOBIO B, V124, P34, DOI 10.1016/j.jphotobiol.2013.04.003; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Andreozzi R, 2008, WATER RES, V42, P1684, DOI 10.1016/j.watres.2007.10.018; Artigas JM, 2013, J FR OPHTALMOL, V36, P23, DOI 10.1016/j.jfo.2012.03.018; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Baynes JW, 2002, ANN NY ACAD SCI, V959, P360, DOI 10.1111/j.1749-6632.2002.tb02107.x; Bellizzi D, 2009, CELL STRESS CHAPERON, V14, P265, DOI 10.1007/s12192-008-0081-x; Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x; Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; CHAKRABARTY S, 1994, CANCER LETT, V79, P157, DOI 10.1016/0304-3835(94)90254-2; Chien CH, 1997, GYNECOL ONCOL, V66, P405, DOI 10.1006/gyno.1997.4794; CORONEO MT, 1990, OPHTHALMIC SURG LAS, V21, P60; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; D'Aquila P, 2012, GENE, V497, P323, DOI 10.1016/j.gene.2012.01.042; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Doonan F, 2007, J NEUROSCI, V27, P10887, DOI 10.1523/JNEUROSCI.0903-07.2007; Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Felipe A, 2012, J REFRACT SURG, V28, P335, DOI 10.3928/1081597X-20120321-01; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Gomez-Vicente V, 2006, EUR J NEUROSCI, V24, P981, DOI 10.1111/j.1460-9568.2006.04990.x; Hain JHW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054340; Harman DG, 2006, CHEM COMMUN, P859, DOI 10.1039/b516408g; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339; Kenney MC, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-4; Kenney MC, 2014, HUM MOL GEN IN PRESS; Khaper N, 2010, ANTIOXID REDOX SIGN, V13, P1033, DOI 10.1089/ars.2009.2930; Klein BEK, 2011, ARCH OPHTHALMOL-CHIC, V129, P56, DOI 10.1001/archophthalmol.2010.322; Lau LI, 2011, INVEST OPHTH VIS SCI, V52, P6832, DOI 10.1167/iovs.11-7815; Liu XC, 2012, INFLAMMATION, V35, P776, DOI 10.1007/s10753-011-9379-4; Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Marti A, 1998, INVEST OPHTH VIS SCI, V39, P846; MOSKAL TL, 1995, CANCER EPIDEM BIOMAR, V4, P127; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030874; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Pierron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021543; Pochampalli MR, 2007, CANCER RES, V67, P6591, DOI 10.1158/0008-5472.CAN-06-4518; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Ratnapriya R, 2013, CLIN GENET, V84, P160, DOI 10.1111/cge.12206; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roduit R, 2008, APOPTOSIS, V13, P343, DOI 10.1007/s10495-008-0179-8; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Sacca SC, 2013, MUTAT RES-REV MUTAT, V752, P153, DOI 10.1016/j.mrrev.2013.01.001; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Sliney DH, 2005, PHOTOCHEM PHOTOBIOL, V81, P483, DOI 10.1562/2005-02-14-RA-439.1; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Wang QE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-24; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Youn HY, 2011, MOL VIS, V17; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou GM, 2001, MOL VIS, V7, P253	69	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99003	10.1371/journal.pone.0099003	http://dx.doi.org/10.1371/journal.pone.0099003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919117	Green Published, gold			2022-12-27	WOS:000338631000039
J	Mokshina, N; Gorshkova, T; Deyholos, MK				Mokshina, Natalia; Gorshkova, Tatyana; Deyholos, Michael K.			Chitinase-Like (CTL) and Cellulose Synthase (CESA) Gene Expression in Gelatinous-Type Cellulosic Walls of Flax (Linum usitatissimum L.) Bast Fibers	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; ARABINOGALACTAN PROTEINS; PLANT CHITINASES; PHLOEM FIBERS; TENSION WOOD; BIOSYNTHESIS; MECHANISM; FAMILY; TRANSCRIPTS; POPULUS	Plant chitinases (EC 3.2.1.14) and chitinase-like (CTL) proteins have diverse functions including cell wall biosynthesis and disease resistance. We analyzed the expression of 34 chitinase and chitinase-like genes of flax (collectively referred to as LusCTLs), belonging to glycoside hydrolase family 19 (GH19). Analysis of the transcript expression patterns of LusCTLs in the stem and other tissues identified three transcripts (LusCTL19, LusCTL20, LusCTL21) that were highly enriched in developing bast fibers, which form cellulose-rich gelatinous-type cell walls. The same three genes had low relative expression in tissues with primary cell walls and in xylem, which forms a xylan type of secondary cell wall. Phylogenetic analysis of the LusCTLs identified a flax-specific sub-group that was not represented in any of other genomes queried. To provide further context for the gene expression analysis, we also conducted phylogenetic and expression analysis of the cellulose synthase (CESA) family genes of flax, and found that expression of secondary wall-type LusCESAs (LusCESA4, LusCESA7 and LusCESA8) was correlated with the expression of two LusCTLs (LusCTL1, LusCTL2) that were the most highly enriched in xylem. The expression of LusCTL19, LusCTL20, and LusCTL21 was not correlated with that of any CESA subgroup. These results defined a distinct type of CTLs that may have novel functions specific to the development of the gelatinous (G-type) cellulosic walls.	[Mokshina, Natalia; Gorshkova, Tatyana] Russian Acad Sci, Kazan Inst Biochem & Biophys, Kazan, Russia; [Deyholos, Michael K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Russian Academy of Sciences; Kazan Scientific Centre of the Russian Academy of Sciences; Kazan Institute of Biochemistry & Biophysics; University of Alberta	Deyholos, MK (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	deyholos@ualberta.ca	Gorshkova, Tatyana/C-4299-2014	Gorshkova, Tatyana/0000-0003-0342-8195; Mokshina, Natalia/0000-0002-6434-7404	Russian Foundation for Basic Research [12-04-31418]; President of the Russian Federation "Support of Leading Scientific Schools" [NSh_825.2012.4]; Genome Canada; Natural Sciences and Engineering Research Council (Canada)	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); President of the Russian Federation "Support of Leading Scientific Schools"; Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was partially supported by the Russian Foundation for Basic Research (project no. 12-04-31418) and a grant of the President of the Russian Federation "Support of Leading Scientific Schools (NSh_825.2012.4)" and by Genome Canada and the Natural Sciences and Engineering Research Council (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageeva MV, 2005, PLANTA, V222, P565, DOI 10.1007/s00425-005-1536-2; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brameld KA, 1998, P NATL ACAD SCI USA, V95, P4276, DOI 10.1073/pnas.95.8.4276; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Gorshkova T, 2006, PLANTA, V223, P149, DOI 10.1007/s00425-005-0118-7; Gorshkova TA, 2010, RUSS J PLANT PHYSL+, V57, P328, DOI 10.1134/S1021443710030040; Gorshkova TA, 2003, IND CROP PROD, V18, P213, DOI 10.1016/S0926-6690(03)00043-8; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Grushetskaya ZE, 2010, CYTOL GENET+, V44, P195, DOI 10.3103/S0095452710040018; Haigler CH, 2005, PHYSIOL PLANTARUM, V124, P285, DOI 10.1111/j.1399-3054.2005.00480.x; Hamel F, 1997, J MOL EVOL, V44, P614, DOI 10.1007/PL00006184; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Hobson N, 2010, RUSS J PLANT PHYSL+, V57, P321, DOI 10.1134/S1021443710030039; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jiang C, 2013, J GENET, V92, P121, DOI 10.1007/s12041-013-0222-6; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; KOMBRINK E, 1988, P NATL ACAD SCI USA, V85, P782, DOI 10.1073/pnas.85.3.782; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mellerowicz EJ, 2012, J EXP BOT, V63, P551, DOI 10.1093/jxb/err339; Mokshina NE, 2012, RUSS J PLANT PHYSL+, V59, P246, DOI 10.1134/S1021443712020082; Passarinho Paul A, 2002, Arabidopsis Book, V1, pe0023, DOI 10.1199/tab.0023; Roach MJ, 2007, MOL GENET GENOMICS, V278, P149, DOI 10.1007/s00438-007-0241-1; Roach MJ, 2011, PLANT PHYSIOL, V156, P1351, DOI 10.1104/pp.111.172676; Robert S, 2004, CELLULOSE, V11, P351, DOI 10.1023/B:CELL.0000046415.45774.80; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Takenaka Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1066, DOI 10.1271/bbb.80837; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CM, 2004, PLANT MOL BIOL, V56, P285, DOI 10.1007/s11103-004-3382-1; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; van Hengel AJ, 2001, PLANT PHYSIOL, V125, P1880, DOI 10.1104/pp.125.4.1880; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Witmer X, 2003, SEED SCI RES, V13, P167, DOI 10.1079/SSR2003134; WOJTASZEK P, 1995, PLANT PHYSIOL, V108, P1001, DOI 10.1104/pp.108.3.1001; Wu B, 2012, PLANT PHYSIOL, V159, P1440, DOI 10.1104/pp.112.195529; Zhang DS, 2004, PLANT MOL BIOL, V54, P353, DOI 10.1023/B:PLAN.0000036369.55253.dd; Zhong RQ, 2002, PLANT CELL, V14, P165, DOI 10.1105/tpc.010278	50	43	45	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97949	10.1371/journal.pone.0097949	http://dx.doi.org/10.1371/journal.pone.0097949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918577	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000012
J	Becquart, P; Mahlakoiv, T; Nkoghe, D; Leroy, EM				Becquart, Pierre; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Leroy, Eric M.			Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus	PLOS ONE			English	Article							MATRIX PROTEIN VP40; HEMORRHAGIC-FEVER; MONOCLONAL-ANTIBODIES; ZAIRE-EBOLAVIRUS; PHYLOGENETIC CHARACTERIZATION; PROTECTIVE EFFICACY; INFECTED PATIENTS; IMMUNE-RESPONSES; RECEPTOR-BINDING; IMMUNOGLOBULIN-G	Ebola virus (EBOV) is a highly virulent human pathogen. Recovery of infected patients is associated with efficient EBOV-specific immunoglobulin G (IgG) responses, whereas fatal outcome is associated with defective humoral immunity. As B-cell epitopes on EBOV are poorly defined, we sought to identify specific epitopes in four EBOV proteins (Glycoprotein (GP), Nucleoprotein (NP), and matrix Viral Protein (VP)40 and VP35). For the first time, we tested EBOV IgG+ sera from asymptomatic individuals and symptomatic Gabonese survivors, collected during the early humoral response (seven days after the end of symptoms) and the late memory phase (7-12 years post-infection). We also tested sera from EBOV-seropositive patients who had never had clinical signs of hemorrhagic fever or who lived in non-epidemic areas (asymptomatic subjects). We found that serum from asymptomatic individuals was more strongly reactive to VP40 peptides than to GP, NP or VP35. Interestingly, anti-EBOV IgG from asymptomatic patients targeted three immunodominant regions of VP40 reported to play a crucial role in virus assembly and budding. In contrast, serum from most survivors of the three outbreaks, collected a few days after the end of symptoms, reacted mainly with GP peptides. However, in asymptomatic subjects the longest immunodominant domains were identified in GP, and analysis of the GP crystal structure revealed that these domains covered a larger surface area of the chalice bowl formed by three GP(1) subunits. The B-cell epitopes we identified in the EBOV VP35, VP40, NP and GP proteins may represent important tools for understanding the humoral response to this virus and for developing new antibody-based therapeutics or detection methods.	[Becquart, Pierre; Leroy, Eric M.] Inst Rech Dev, UMR MIVEGEC 264, Montpellier, France; [Becquart, Pierre; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Leroy, Eric M.] Ctr Int Rech Med Franceville, Franceville, Gabon	Institut de Recherche pour le Developpement (IRD)	Becquart, P (corresponding author), Inst Rech Dev, UMR MIVEGEC 264, Montpellier, France.	pierre.becquart@ird.fr	LEROY, Eric M/I-4347-2016; Becquart, Pierre/GLT-0845-2022	LEROY, Eric M/0000-0003-0022-0890; Mahlakoiv, Tanel/0000-0001-9059-0486; Becquart, Pierre/0000-0002-0980-1678	Institut pour la Recherche et le Developpement; Total; Government of Gabon; Total-Fina-Elf Gabon; French Ministere des affaires Etrangeres et Europeennes, France	Institut pour la Recherche et le Developpement; Total(Total SA); Government of Gabon; Total-Fina-Elf Gabon; French Ministere des affaires Etrangeres et Europeennes, France	This work was supported by a special credits incitatifs grant from Institut pour la Recherche et le Developpement and by a grant from Total. CIRMF is supported by the Government of Gabon, Total-Fina-Elf Gabon, and the French Ministere des affaires Etrangeres et Europeennes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, B WHO, V56, P247; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Bradfute SB, 2008, J IMMUNOL, V180, P4058, DOI 10.4049/jimmunol.180.6.4058; Brindley MA, 2007, J VIROL, V81, P7702, DOI 10.1128/JVI.02433-06; Changula K, 2013, VIRUS RES, V176, P83, DOI 10.1016/j.virusres.2013.05.004; Dessen A, 2000, ACTA CRYSTALLOGR D, V56, P758, DOI 10.1107/S0907444900004388; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Dowling W, 2007, J VIROL, V81, P1821, DOI 10.1128/JVI.02098-06; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Feldmann H, 2001, J GEN VIROL, V82, P2839, DOI 10.1099/0022-1317-82-12-2839; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Francica JR, 2009, VIROLOGY, V383, P237, DOI 10.1016/j.virol.2008.10.029; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; GeorgesCourbot MC, 1997, EMERG INFECT DIS, V3, P59, DOI 10.3201/eid0301.970107; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Klenk Hans Dieter, 2001, Virus Research, V80, P117, DOI 10.1016/S0168-1702(01)00258-1; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kuhn JH, 2006, J BIOL CHEM, V281, P15951, DOI 10.1074/jbc.M601796200; Kuhn JH, 2010, ARCH VIROL, V155, P445, DOI 10.1007/s00705-010-0600-9; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Leroy EM, 2001, CLIN EXP IMMUNOL, V124, P453, DOI 10.1046/j.1365-2249.2001.01517.x; LINDE A, 1990, J CLIN MICROBIOL, V28, P211, DOI 10.1128/JCM.28.2.211-215.1990; Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005; Maruyama T, 1999, J INFECT DIS, V179, pS235, DOI 10.1086/514280; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Onyango CO, 2007, J INFECT DIS, V196, pS193, DOI 10.1086/520609; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575; Razumov IA, 1998, VOP VIRUSOL+, V43, P274; Reynard O, 2009, J VIROL, V83, P9596, DOI 10.1128/JVI.00784-09; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Shahhosseini S, 2007, J VIROL METHODS, V143, P29, DOI 10.1016/j.jviromet.2007.02.004; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Sobarzo A, 2013, NEW ENGL J MED, V369, P492, DOI 10.1056/NEJMc1300266; Sobarzo A, 2013, J INFECT DIS, V208, P299, DOI 10.1093/infdis/jit162; Sullivan NJ, 2005, J VIROL, V79, P547, DOI 10.1128/JVI.79.1.547-553.2005; Takada A, 2007, J INFECT DIS, V196, pS347, DOI 10.1086/520581; Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076; Toyoda H, 2005, CLIN INFECT DIS, V40, pE49, DOI 10.1086/428128; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; Volchkov V, 1997, VIROLOGY, V232, P139, DOI 10.1006/viro.1997.8529; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wauquier N, 2009, EMERG INFECT DIS, V15, P1136, DOI 10.3201/eid1507.090402; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	73	46	51	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96360	10.1371/journal.pone.0096360	http://dx.doi.org/10.1371/journal.pone.0096360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914933	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700005
J	Qi, L; Meinel, FG; Zhou, CS; Zhao, YE; Schoepf, UJ; Zhang, LJ; Lu, GM				Qi, Li; Meinel, Felix G.; Zhou, Chang Sheng; Zhao, Yan E.; Schoepf, U. Joseph; Zhang, Long Jiang; Lu, Guang Ming			Image Quality and Radiation Dose of Lower Extremity CT Angiography Using 70 kVp, High Pitch Acquisition and Sinogram-Affirmed Iterative Reconstruction	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; DUAL-SOURCE CT; ANKLE-BRACHIAL INDEX; DIAGNOSTIC PERFORMANCE; OCCLUSIVE DISEASE; CHINESE PATIENTS; RISK-FACTORS; ACCURACY; CONTRAST; STENOSES	Objectives: The purpose of this study was to assess image quality and radiation dose of lower extremity CT angiography (CTA) with 70 kVp, high pitch acquisition and sinogram-affirmed iterative reconstruction (SAFIRE). Methods: Lower extremity CTAs were performed on 44 patients: 22 patients were examined using protocol A (120 kVp, pitch of 0.85 and 120 ml of contrast agent on a first-generation dual-source CT) (120 kVp group) and 22 patients were evaluated with protocol B (70 kVp, pitch of 2.2 and 80 ml of contrast agent on a second-generation dual-source CT) (70 kVp group). Images from the 120 kVp group were reconstructed with filtered back projection (FBP) and images from the 70 kVp group with SAFIRE. The attenuation, image noise, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated. Two radiologists subjectively assessed image quality of lower extremity arteries, plantar arterial enhancement and venous contamination of all patients. Radiation dose was compared between the two groups. Results: Higher mean intravascular attenuation was obtained in the 70 kVp group (70 vs. 120 kVp group, 555.4 +/- 83.4 HU vs. 300.9 +/- 81.4 HU, P<0.001), as well as image noise (20.0 +/- 2.8 HU vs. 17.5 +/- 3.2 HU, P = 0.010), SNR (32.0 +/- 7.0 vs. 19.1 +/- 6.9, P<0.001) and CNR (28.1 +/- 6.6 vs 15.9 +/- 6.3, P<0.001). No difference in subjective image quality and plantar arterial enhancement was found between 120 kVp group and 70 kVp group (all P>0.05). The venous contamination score was 1.5 +/- 0.8 for 120 kVp group while no venous contamination was found in 70 kVp group. The inter-observer agreement was moderate to good for both groups (0.515 similar to 1, P<0.001). The effective dose was lower in 70 kVp group (0.3 +/- 0.1 mSv) than in 120 kVp group (1.6 +/- 0.7 mSv)(P<0.001). Conclusions: Lower extremity CTA using 70 kVp, high pitch acquisition and SAFIRE, except increasing imaging noise, allows for lower radiation dose and contrast material volume without compromising image quality.	[Qi, Li; Zhou, Chang Sheng; Zhao, Yan E.; Schoepf, U. Joseph; Zhang, Long Jiang; Lu, Guang Ming] South Med Univ, Sch Clin, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China; [Meinel, Felix G.; Schoepf, U. Joseph] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA	Southern Medical University - China; Medical University of South Carolina	Zhang, LJ (corresponding author), South Med Univ, Sch Clin, Jinling Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China.	kevinzhlj@163.com; cjr.luguangming@vip.163.com		Meinel, Felix/0000-0002-3201-1033	Program for New Century Excellent Talents in University [NCET-12-0260]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was all supported by the Program for New Century Excellent Talents in University (NCET-12-0260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Amacker NA, 2012, EUR J RADIOL, V81, pE392, DOI 10.1016/j.ejrad.2011.12.017; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Catalano C, 2004, RADIOLOGY, V231, P555, DOI 10.1148/radiol.2312020920; De Zordo T, 2012, EUR RADIOL, V22, P279, DOI 10.1007/s00330-011-2251-y; Duan YH, 2013, AM J ROENTGENOL, V201, pW906, DOI 10.2214/AJR.12.10209; Foley WD, 2010, RADIOL CLIN N AM, V48, P367, DOI 10.1016/j.rcl.2010.02.008; Fraioli F, 2006, EUR RADIOL, V16, P137, DOI 10.1007/s00330-005-2812-z; Grant K, 2013, SAFIRE SIMOGRAM AFFI; Gunn MLD, 2010, EMERG RADIOL, V17, P209, DOI 10.1007/s10140-009-0850-6; Han BK, 2012, J CARDIOVASC COMPUT, V6, P200, DOI 10.1016/j.jcct.2012.04.008; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Huang SY, 2012, ACAD RADIOL, V19, P1149, DOI 10.1016/j.acra.2012.04.014; Iezzi R, 2012, RADIOLOGY, V263, P287, DOI 10.1148/radiol.11110700; Li J, 2006, J HEALTH SCI, V52, P97, DOI 10.1248/jhs.52.97; Luo YY, 2007, J HUM HYPERTENS, V21, P461, DOI 10.1038/sj.jhh.1002177; Napoli A, 2011, RADIOLOGY, V261, P976, DOI 10.1148/radiol.11103564; Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091123; Park CK, 2013, INT J CARDIOVAS IMAG, V29, P47, DOI 10.1007/s10554-013-0252-4; Redmond JM, 2008, ORTHOPEDICS, V31, P761, DOI 10.3928/01477447-20080801-27; Romano M, 2004, EUR J RADIOL, V50, P303, DOI 10.1016/S0720-048X(03)00118-9; Schuhbaeck A, 2013, EUR RADIOL, V23, P597, DOI 10.1007/s00330-012-2656-2; Shrimpton P., 2004, EUROPEAN COMMISSION; Utsunomiya D, 2010, EUR RADIOL, V20, P2758, DOI 10.1007/s00330-010-1841-4; von Spiczak J, 2013, J CARDIOVASC COMPUT, V7, P215, DOI 10.1016/j.jcct.2013.08.003; Yang WJ, 2013, J COMPUT ASSIST TOMO, V37, P301, DOI 10.1097/RCT.0b013e31827b8c66; Yang WJ, 2013, INT J CARDIOVAS IMAG, V29, P245, DOI 10.1007/s10554-012-0068-7	27	26	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99112	10.1371/journal.pone.0099112	http://dx.doi.org/10.1371/journal.pone.0099112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915439	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700063
J	Ryan, A; Kaplan, E; Nebel, JC; Polycarpou, E; Crescente, V; Lowe, E; Preston, GM; Sim, E				Ryan, Ali; Kaplan, Elise; Nebel, Jean-Christophe; Polycarpou, Elena; Crescente, Vincenzo; Lowe, Edward; Preston, Gail M.; Sim, Edith			Identification of NAD(P)H Quinone Oxidoreductase Activity in Azoreductases from P. aeruginosa: Azoreductases and NAD(P)H Quinone Oxidoreductases Belong to the Same FMN-Dependent Superfamily of Enzymes	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; N-ACETYLTRANSFERASE 1; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; HETEROLOGOUS EXPRESSION; SUBSTRATE-SPECIFICITY; STRESS RESISTANCE; DOWN-REGULATION	Water soluble quinones are a group of cytotoxic anti-bacterial compounds that are secreted by many species of plants, invertebrates, fungi and bacteria. Studies in a number of species have shown the importance of quinones in response to pathogenic bacteria of the genus Pseudomonas. Two electron reduction is an important mechanism of quinone detoxification as it generates the less toxic quinol. In most organisms this reaction is carried out by a group of flavoenzymes known as NAD(P)H quinone oxidoreductases. Azoreductases have previously been separate from this group, however using azoreductases from Pseudomonas aeruginosa we show that they can rapidly reduce quinones. Azoreductases from the same organism are also shown to have distinct substrate specificity profiles allowing them to reduce a wide range of quinones. The azoreductase family is also shown to be more extensive than originally thought, due to the large sequence divergence amongst its members. As both NAD(P)H quinone oxidoreductases and azoreductases have related reaction mechanisms it is proposed that they form an enzyme superfamily. The ubiquitous and diverse nature of azoreductases alongside their broad substrate specificity, indicates they play a wide role in cellular survival under adverse conditions.	[Ryan, Ali; Kaplan, Elise; Crescente, Vincenzo; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ryan, Ali; Nebel, Jean-Christophe; Polycarpou, Elena; Crescente, Vincenzo; Sim, Edith] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Lowe, Edward] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QT, England; [Preston, Gail M.] Univ Oxford, Dept Plant Sci, Oxford OX1 3QT, England	University of Oxford; Kingston University; University of Oxford; University of Oxford	Ryan, A (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	a.ryan@kingston.ac.uk	ryan, ali/AAB-1659-2022; Nebel, Jean-Christophe/B-5655-2009; Lowe, Edward/AAP-5381-2021; ryan, ali/J-5815-2012	Nebel, Jean-Christophe/0000-0003-1812-5269; Lowe, Edward/0000-0002-1757-0208; Preston, Gail/0000-0003-3882-4438; KAPLAN, Elise/0000-0003-4985-1482; ryan, ali/0000-0002-4627-8185				Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; Ahn KS, 2007, CANCER RES, V67, P10004, DOI 10.1158/0008-5472.CAN-07-2213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Burger S, 2010, APPL MICROBIOL BIOT, V87, P2067, DOI 10.1007/s00253-010-2669-1; Butcher NJ, 2012, PHARMACOL REV, V64, P147, DOI 10.1124/pr.110.004275; Cai J, 1998, MICROBIOL-SGM, V144, P2705, DOI 10.1099/00221287-144-10-2705; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; CHATTERJEE PK, 1995, P NATL ACAD SCI USA, V92, P8950, DOI 10.1073/pnas.92.19.8950; Chen HZ, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-13; Chen HZ, 2005, MICROBIOL-SGM, V151, P1433, DOI 10.1099/mic.0.27805-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHESIS PL, 1984, P NATL ACAD SCI-BIOL, V81, P1696, DOI 10.1073/pnas.81.6.1696; Clark W. M., 1960, OXIDATION REDUCTION; Ding JL, 2005, GENES IMMUN, V6, P557, DOI 10.1038/sj.gene.6364240; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer TC, 2012, J AGR FOOD CHEM, V60, P12074, DOI 10.1021/jf303584r; Goncalves AMD, 2013, FEBS J, V280, P6643, DOI 10.1111/febs.12568; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Gorman J, 2005, PROTEIN SCI, V14, P3004, DOI 10.1110/ps.051680805; Green L, 2012, VITRO VIVO CHARACTER; Hayashi M, 1996, BBA-BIOENERGETICS, V1273, P165, DOI 10.1016/0005-2728(95)00138-7; Hervas M, 2012, BIOCHEMISTRY-US, V51, P1178, DOI 10.1021/bi201904p; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Ito K, 2008, J BIOL CHEM, V283, P13889, DOI 10.1074/jbc.M710070200; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laurieri N, 2010, J AM CHEM SOC, V132, P3238, DOI 10.1021/ja909165u; Liu GF, 2008, APPL MICROBIOL BIOT, V80, P409, DOI 10.1007/s00253-008-1555-6; Liu GF, 2008, BIOTECHNOL LETT, V30, P869, DOI 10.1007/s10529-007-9627-8; Liu ZJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P68, DOI 10.1016/j.abb.2007.03.003; Lyngberg L, 2011, J BACTERIOL, V193, P4925, DOI 10.1128/JB.05272-11; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mendes S, 2011, APPL MICROBIOL BIOT, P1; Miseviciene L, 2006, ACTA BIOCHIM POL, V53, P569; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi M, 2001, J BIOL CHEM, V276, P46394, DOI 10.1074/jbc.M104483200; Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Prosser GA, 2010, BIOCHEM PHARMACOL, V79, P678, DOI 10.1016/j.bcp.2009.10.008; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rakhimova E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001685; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Rompel A, 1999, FEBS LETT, V445, P103, DOI 10.1016/S0014-5793(99)00106-4; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Ryan A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00063; Ryan A, 2010, PROTEIN CELL, V1, P780, DOI 10.1007/s13238-010-0090-2; Ryan A, 2010, J MOL BIOL, V400, P24, DOI 10.1016/j.jmb.2010.04.023; Salgado A, 2006, RAPID COMMUN MASS SP, V20, P512, DOI 10.1002/rcm.2330; Saravanakumar D, 2008, J APPL ENTOMOL, V132, P469, DOI 10.1111/j.1439-0418.2008.01278.x; Sedlacek V, 2009, ARCH BIOCHEM BIOPHYS, V483, P29, DOI 10.1016/j.abb.2008.12.016; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; Skelly JV, 1999, J MED CHEM, V42, P4325, DOI 10.1021/jm991060m; SolerRivas C, 1997, MYCOL RES, V101, P375, DOI 10.1017/S0953756296002729; Sparla F, 1999, FEBS LETT, V463, P382, DOI 10.1016/S0014-5793(99)01625-7; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; TEDESCHI G, 1995, J BIOL CHEM, V270, P2512, DOI 10.1074/jbc.270.6.2512; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Turner KH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000779; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wang CJ, 2007, J MOL BIOL, V373, P1213, DOI 10.1016/j.jmb.2007.08.048; Wang CJ, 2010, ACTA CRYSTALLOGR F, V66, P2, DOI 10.1107/S1744309109044741; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Xu JK, 2012, J BIOL CHEM, V287, P41608, DOI 10.1074/jbc.M112.387738; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; Yang Z, 2007, J BACTERIOL, V189, P3945, DOI 10.1128/JB.00261-07; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039	87	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98551	10.1371/journal.pone.0098551	http://dx.doi.org/10.1371/journal.pone.0098551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915188	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000340947700025
J	Xerri, C; Zennou-Azogui, Y				Xerri, Christian; Zennou-Azogui, Yoh'i			Early and Moderate Sensory Stimulation Exerts a Protective Effect on Perilesion Representations of Somatosensory Cortex after Focal Ischemic Damage	PLOS ONE			English	Article							INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; INDUCED CORTICAL INFARCTS; NEUROTROPHIC FACTOR; ENVIRONMENTAL ENRICHMENT; SENSORIMOTOR CORTEX; RECEPTIVE-FIELDS; FOREPAW REPRESENTATION; CEREBRAL INFARCTION; MOTOR RECOVERY	Previous studies have shown that intensive training within an early critical time window after focal cortical ischemia increases the area of damaged tissue and is detrimental to behavioral recovery. We postulated that moderate stimulation initiated soon after the lesion could have protective effects on peri-infarct cortical somatotopic representations. Therefore, we have assessed the effects of mild cutaneous stimulation delivered in an attention-demanding behavioral context on the functional organization of the perilesion somatosensory cortex using high-density electrophysiological mapping. We compared the effects of 6-day training initiated on the 3rd day postlesion (early training; ET) to those of same-duration training started on the 8th day (delayed training; DT). Our findings confirm previous work showing that the absence of training aggravates representational loss in the perilesion zone. In addition, ET was found to be sufficient to limit expansion of the ischemic lesion and reduce tissue loss, and substantially maintain the neuronal responsiveness to tactile stimulation, thereby preserving somatotopic map arrangement in the peri-infarct cortical territories. By contrast, DT did not prevent tissue loss and only partially reinstated lost representations in a use-dependent manner within the spared peri-infarct cortical area. This study differentiates the effects of early versus delayed training on perilesion tissue and cortical map reorganization, and underscores the neuroprotective influence of mild rehabilitative stimulation on neuronal response properties in the peri-infarct cortex during an early critical period.	[Xerri, Christian; Zennou-Azogui, Yoh'i] Aix Marseille Univ, CNRS, Unite Mixte Rech 7260, Federat Rech Comportement Cerveau Cognit 3512, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Xerri, C (corresponding author), Aix Marseille Univ, CNRS, Unite Mixte Rech 7260, Federat Rech Comportement Cerveau Cognit 3512, Marseille, France.	christian.xerri@univ-amu.fr			Ministere de l'Enseignement Superieur et de la Recherche; CNRS	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADACHI H, 1995, INT J HYPERTHER, V11, P587, DOI 10.3109/02656739509022492; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; BROWN AG, 1989, J PHYSIOL-LONDON, V413, P119, DOI 10.1113/jphysiol.1989.sp017645; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Burnett MG, 2005, BRAIN RES, V1047, P112, DOI 10.1016/j.brainres.2005.04.024; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Chu CJ, 2000, EXP NEUROL, V166, P403, DOI 10.1006/exnr.2000.7509; Clarkson AN, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/708428; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; Coq JO, 1999, EUR J NEUROSCI, V11, P2597, DOI 10.1046/j.1460-9568.1999.00673.x; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Davis MF, 2011, STROKE, V42, P792, DOI 10.1161/STROKEAHA.110.607135; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; DOETSCH GS, 1990, EXP NEUROL, V108, P162, DOI 10.1016/0014-4886(90)90024-M; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Eysel UT, 1997, ADV NEUROL, V73, P195; EYSEL UT, 1991, NEUROSCI LETT, V131, P45, DOI 10.1016/0304-3940(91)90333-O; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Frostig RD, 2013, NEUROSCIENTIST, V19, P313, DOI 10.1177/1073858412462607; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Goubard V, 2011, J PHYSIOL-LONDON, V589, P2301, DOI 10.1113/jphysiol.2010.203125; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; HICKS TP, 1983, BRAIN RES, V274, P160, DOI 10.1016/0006-8993(83)90533-4; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Joo HW, 2012, EUR J NEUROSCI, V36, P3691, DOI 10.1111/ejn.12014; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; LASKIN SE, 1979, J NEUROPHYSIOL, V42, P1061, DOI 10.1152/jn.1979.42.4.1061; Lay CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011270; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; Martinez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016726; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Neumann-Haefelin T, 1998, NEUROSCIENCE, V87, P871, DOI 10.1016/S0306-4522(98)00124-9; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Ohmoto Y, 1996, INT J HYPERTHER, V12, P321, DOI 10.3109/02656739609022521; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PETERSON BE, 1995, J NEUROSCI METH, V57, P133, DOI 10.1016/0165-0270(94)00103-N; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Que M, 1999, NEUROSCIENCE, V93, P1233, DOI 10.1016/S0306-4522(99)00197-9; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Tang AC, 2002, BEHAV BRAIN RES, V131, P1, DOI 10.1016/S0166-4328(01)00330-8; Taub E, 1999, J REHABIL RES DEV, V36, P237; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; WATERS RS, 1995, EXP BRAIN RES, V103, P183; Winship IR, 2009, NEUROSCIENTIST, V15, P507, DOI 10.1177/1073858409333076; Xerri C, 2004, ARCH ITAL BIOL, V142, P217; Xerri C, 2003, NEUROSCIENCE, V118, P161, DOI 10.1016/S0306-4522(02)00911-9; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Xerri C, 2010, BRAIN MAPPING NEURAL, P111; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zepeda A, 2003, J CEREBR BLOOD F MET, V23, P811, DOI 10.1097/01.WCB.0000075010.31477.1E; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	87	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99767	10.1371/journal.pone.0099767	http://dx.doi.org/10.1371/journal.pone.0099767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914807	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700130
J	Zupancic, T; Stojan, J; Lane, EB; Komel, R; Bedina-Zavec, A; Liovic, M				Zupancic, Tina; Stojan, Jure; Lane, Ellen Birgitte; Komel, Radovan; Bedina-Zavec, Apolonija; Liovic, Mirjana			Intestinal Cell Barrier Function In Vitro Is Severely Compromised by Keratin 8 and 18 Mutations Identified in Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							PATHOGENESIS; RESISTANCE; APOPTOSIS; MIGRATION; FILAMENTS; NETWORK; SKIN	Keratin 8 and 18 (K8/K18) mutations have been implicated in the aetiology of certain pathogenic processes of the liver and pancreas. While some K8 mutations (K8 G62C, K8 K464N) are also presumed susceptibility factors for inflammatory bowel disease (IBD), the only K18 mutation (K18 S230T) discovered so far in an IBD patient is thought to be a polymorphism. The aim of our study was to demonstrate that these mutations might also directly affect intestinal cell barrier function. Cell monolayers of genetically engineered human colonocytes expressing these mutations were tested for permeability, growth rate and resistance to heat-stress. We also calculated the change in dissociation constant (K-d, measure of affinity) each of these mutations introduces into the keratin protein, and present the first model of a keratin dimer L12 region with in silico clues to how the K18 S230T mutation may affect keratin function. Physiologically, these mutations cause up to 30% increase in paracellular permeability in vitro. Heat-stress induces little keratin clumping but instead cell monolayers peel off the surface suggesting a problem with cell junctions. K18 S230T has pronounced pathological effects in vitro marked by high K-d, low growth rate and increased permeability. The latter may be due to the altered distribution of tight junction components claudin-4 and ZO-1. This is the first time intestinal cells have been suggested also functionally impaired by K8/K18 mutations. Although an in vitro colonocyte model system does not completely mimic the epithelial lining of the intestine, nevertheless the data suggest that K8/K18 mutations may be also able to produce a phenotype in vivo.	[Zupancic, Tina; Komel, Radovan; Bedina-Zavec, Apolonija; Liovic, Mirjana] Natl Inst Chem, Ljubljana, Slovenia; [Stojan, Jure; Komel, Radovan; Liovic, Mirjana] Univ Ljubljana, Fac Med, Med Ctr Mol Biol, Ljubljana, Slovenia; [Lane, Ellen Birgitte] Inst Med Biol, Singapore, Singapore	National Institute of Chemistry - Slovenia; University of Ljubljana; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Liovic, M (corresponding author), Natl Inst Chem, Ljubljana, Slovenia.	mirjana.liovic@mf.uni-lj.si			Slovenian Research Agency [J3-2274, J3-3617, P1-0104]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency grants J3-2274 and J3-3617 to M. Liovic and P1-0104 to R. Komel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar J, 2013, J INVEST DERMATOL, DOI [10.1038/jid.2013.416, DOI 10.1038/JID.2013.416]; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Bevc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022265; Buning C, 2004, DIGEST LIVER DIS, V36, P388, DOI 10.1016/S1590-8658(04)00086-6; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Kucharzik T, 2006, INFLAMM BOWEL DIS, V12, P1068, DOI 10.1097/01.mib.0000235827.21778.d5; Kurokawa H, 2009, MOL CELL BIOL, V29, P6232, DOI 10.1128/MCB.00708-09; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; Liovic M, 2003, J CELL SCI, V116, P1417, DOI 10.1242/jcs.00363; Liovic M, 2008, EXP CELL RES, V314, P2066, DOI 10.1016/j.yexcr.2008.02.020; Liovic M, 2009, EXP CELL RES, V315, P2995, DOI 10.1016/j.yexcr.2009.07.013; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Majumdar D, 2012, INT J EXP PATHOL, V93, P305, DOI 10.1111/j.1365-2613.2012.00830.x; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Owens DW, 2004, J CELL SCI, V117, P1989, DOI 10.1242/jcs.01043; Roth W, 2012, J CELL SCI, V125, P5269, DOI 10.1242/jcs.116574; Russell D, 2010, J INVEST DERMATOL, V130, P671, DOI 10.1038/jid.2009.327; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Valentin MD, 2012, BREAST CANCER RES TR, V134, P21, DOI 10.1007/s10549-011-1934-z; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	38	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99398	10.1371/journal.pone.0099398	http://dx.doi.org/10.1371/journal.pone.0099398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915158	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700097
J	Feres, MC; Cintra, FD; Rizzi, CF; Mello-Fujita, L; de Souza, AAL; Tufik, S; Poyares, D				Feres, Marcia C.; Cintra, Fatima D.; Rizzi, Camila F.; Mello-Fujita, Luciane; Lino de Souza, Altay A.; Tufik, Sergio; Poyares, Dalva			Evaluation and Validation of a Method for Determining Platelet Catecholamine in Patients with Obstructive Sleep Apnea and Arterial Hypertension	PLOS ONE			English	Article							SYMPATHETIC ACTIVITY; HIGH PREVALENCE; PLASMA; ASSOCIATION; BLOOD; PHEOCHROMOCYTOMA; DIAGNOSIS; CHILDREN; URINE; ACID	Background: Measurements of plasma and urinary catecholamine are susceptible to confounding factors that influence the results, complicating the interpretation of sympathetic nervous system (SNS) activity in the Obstructive sleep apnea (OSA) and arterial hypertension (HYP) conditions. Objective: In this study, we validated a test for platelet catecholamine and compared the catecholamine levels (adrenaline and noradrenaline) in urine, plasma and platelets in patients with OSA and HYP compared with controls. Methods: In the validation, 30 healthy, nonsmoking volunteers who were not currently undergoing treatment or medication were selected as the control group. One hundred fifty-four individuals (114 OSA, 40 non-OSA) were consecutively selected from the outpatient clinic of the Sleep Institute and underwent clinical, polysomnographic and laboratory evaluation, including the urinary, plasma and platelet levels of adrenaline (AD) and noradrenaline (NA). Patients were then allocated to groups according to the presence of OSA and/or hypertension. Results: A logistic regression model, controlled for age and BMI, showed that urinary AD and urinary NA were risk factors in the OSA+HYP group and the HYP group; however, the model showed higher levels of platelet NA for OSA without HYP. After 1 year of CPAP (continuous upper airway pressure) treatment, patients (n = 9) presented lower levels of urinary NA (p = 0.04) and platelet NA (p = 0.05). Conclusion: Urinary NA and AD levels were significantly associated with the condition of hypertension with and without OSA, whereas platelet NA with OSA without comorbidity. These findings suggest that platelet catecholamine levels might reflect nocturnal sympathetic activation in OSA patients without hypertension.	[Feres, Marcia C.; Rizzi, Camila F.; Mello-Fujita, Luciane; Lino de Souza, Altay A.; Tufik, Sergio; Poyares, Dalva] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Cintra, Fatima D.] Univ Fed Sao Paulo, Dept Cardiol, Sao Paulo, Brazil; [Tufik, Sergio] Assoc Fundo Incent & Pesquisa, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Feres, MC (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	marcia.feres@unifesp.br	de Souza, Altay A Lino/K-7797-2012; Cintra, Fatima Dumas/T-8276-2019	de Souza, Altay A Lino/0000-0002-3331-4087; Dumas Cintra, Fatima/0000-0002-3361-7061	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Associacao Fundo de Pesquisa a Psicobiologia (AFIP), Brazil; CNPQ	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Fundo de Pesquisa a Psicobiologia (AFIP), Brazil; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and from Associacao Fundo de Pesquisa a Psicobiologia (AFIP), Brazil. Dr. Dalva Poyares and Sergio Tufik are the recipients of the CNPQ grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad VC, 2009, CURR TREAT OPTION NE, V11, P358, DOI 10.1007/s11940-009-0040-6; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Baguet JP, 2009, J HUM HYPERTENS, V23, P431, DOI 10.1038/jhh.2008.147; BLANDINI F, 1995, LIFE SCI, V56, P1113, DOI 10.1016/0024-3205(95)00048-B; Boyle JG, 2007, J CLIN ENDOCR METAB, V92, P4602, DOI 10.1210/jc.2005-2668; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; CARSTENSEN E, 1994, CLIN SCI, V86, P35, DOI 10.1042/cs0860035; CHAMBERLAIN KG, 1990, AM J PHYSIOL, V259, pE141, DOI 10.1152/ajpendo.1990.259.2.E141; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Christensen N J, 1991, Clin Auton Res, V1, P167, DOI 10.1007/BF01826215; Christensen NJ, 2005, J APPL PHYSIOL, V99, P1552, DOI 10.1152/japplphysiol.00017.2005; Cintra F, 2011, ARQ BRAS CARDIOL, V96, P293, DOI 10.1590/S0066-782X2011005000030; Comondore VR, 2009, LUNG, V187, P17, DOI 10.1007/s00408-008-9115-5; Coy TV, 1996, J SLEEP RES, V5, P42, DOI 10.1046/j.1365-2869.1996.00006.x; Elmasry A, 2002, EUR RESPIR J, V19, P511, DOI 10.1183/09031936.02.00106402; Feres MC, 2011, CLIN CHIM ACTA, V412, P2322, DOI 10.1016/j.cca.2011.08.033; FLETCHER EC, 1995, AM J MED, V98, P118, DOI 10.1016/S0002-9343(99)80395-7; Floras JS, 2014, J CARDIOL, V63, P3, DOI 10.1016/j.jjcc.2013.08.009; Garcia-Rio F, 2000, CHEST, V117, P1417, DOI 10.1378/chest.117.5.1417; Goldstein DS, 2010, CLIN AUTON RES, V20, P331, DOI 10.1007/s10286-010-0065-7; Grassi G, 1998, CIRCULATION, V97, P2037, DOI 10.1161/01.CIR.97.20.2037; Guilleminault C, 2005, SLEEP MED, V6, P451, DOI 10.1016/j.sleep.2005.03.014; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Hakim Fahed, 2012, Front Neurol, V3, P7, DOI 10.3389/fneur.2012.00007; Iber C, 2007, AASM MANUAL SCORING; Kanbay A, 2013, BLOOD COAGUL FIBRIN, V24, P532, DOI 10.1097/MBC.0b013e32835e98da; Kheirandish-Gozal L, 2013, CHEST, V143, P1576, DOI 10.1378/chest.12-2606; Kondo Yusuke, 2011, Tokai J Exp Clin Med, V36, P79; Konecny T, 2014, HYPERTENSION, V63, P203, DOI 10.1161/HYPERTENSIONAHA.113.00613; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Driscoll DM, 2011, SLEEP MED, V12, P483, DOI 10.1016/j.sleep.2010.09.015; OSHIMA T, 1978, FOLIA PHARMACOL JPN, V74, P885, DOI 10.1254/fpj.74.885; Peaston RT, 2004, ANN CLIN BIOCHEM, V41, P17, DOI 10.1258/000456304322664663; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Prasad B, 2010, SLEEP BREATH, V14, P101, DOI 10.1007/s11325-009-0285-z; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Sondergaard SB, 1999, INT J OBESITY, V23, P810, DOI 10.1038/sj.ijo.0800930; Tasali E, 2011, J CLIN ENDOCR METAB, V96, P365, DOI 10.1210/jc.2010-1187; Toraldo DM, 2013, LUNG, V191, P1, DOI 10.1007/s00408-012-9427-3; TROISI RJ, 1991, HYPERTENSION, V17, P669, DOI 10.1161/01.HYP.17.5.669; Tsunoda M, 2006, ANAL BIOANAL CHEM, V386, P506, DOI 10.1007/s00216-006-0675-z; WEIR TB, 1986, CLIN CHEM, V32, P882; Westgard JO, 2008, CLIN CHEM, V54, P612, DOI 10.1373/clinchem.2007.094060; Whiting Malcolm J, 2009, Clin Biochem Rev, V30, P3; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; ZWEIFLER AJ, 1982, NEW ENGL J MED, V306, P890, DOI 10.1056/NEJM198204153061502	53	2	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98407	10.1371/journal.pone.0098407	http://dx.doi.org/10.1371/journal.pone.0098407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911183	gold, Green Submitted, Green Published			2022-12-27	WOS:000337165600004
J	Gijezen, LC; Vernooij, M; Martens, H; Oduber, CEU; Henquet, CJM; Starink, TM; Prins, MH; Menko, FH; Nelemans, PJ; van Steensel, MAM				Gijezen, LiekeM. C.; Vernooij, Marigje; Martens, Herm; Oduber, Charlene E. U.; Henquet, Charles J. M.; Starink, Theo M.; Prins, Martin H.; Menko, Fred H.; Nelemans, Patty J.; van Steensel, Maurice A. M.			Topical Rapamycin as a Treatment for Fibrofolliculomas in Birt-Hogg-Dube Syndrome: A Double-Blind Placebo-Controlled Randomized Split-Face Trial	PLOS ONE			English	Article							TUBEROUS-SCLEROSIS; FACIAL-ANGIOFIBROMAS; SPONTANEOUS PNEUMOTHORAX; FLUOCINOLONE ACETONIDE; POLYCYSTIC KIDNEYS; MTOR ACTIVATION; BHD GENE; NEOPLASIA; VEHICLE; FOLLICULIN	Background: Birt-Hogg-Dube syndrome (BHD) is a rare autosomal dominant disorder characterised by the occurrence of benign, mostly facial, skin tumours called fibrofolliculomas, multiple lung cysts, spontaneous pneumothorax and an increased renal cancer risk. Current treatments for fibrofolliculomas have high rates of recurrence and carry a risk of complications. It would be desirable to have a treatment that could prevent fibrofolliculomas from growing. Animal models of BHD have previously shown deregulation of mammalian target of rapamycin (mTOR). Topical use of the mTOR inhibitor rapamycin is an effective treatment for the skin tumours (angiofibromas) in tuberous sclerosis complex, which is also characterised by mTOR deregulation. In this study we aimed to determine if topical rapamycin is also an effective treatment for fibrofolliculomas in BHD. Methods: We performed a double blinded, randomised, facial left-right controlled trial of topical rapamycin 0.1% versus placebo in 19 BHD patients. Trial duration was 6 months. The primary outcome was cosmetic improvement as measured by doctors and patients. Changes in fibrofolliculoma number and size were also measured, as was occurrence of side effects. Results: No change in cosmetic status of fibrofolliculomas was reported in the majority of cases for the rapamycin treated (79% by doctors, 53% by patients) as well as the placebo treated facial sides (both 74%). No significant differences between rapamycin and placebo treated facial halves were observed (p = 1.000 for doctors opinion, p = 0.344 for patients opinion). No significant difference in fibrofolliculoma number or change in size of the fibrofolliculomas was seen after 6 months. Side effects occurred more often after rapamycin treatment (68% of patients) than after placebo (58% of patients; p = 0.625). A burning sensation, erythema, itching and dryness were most frequently reported. Conclusions: This study provides no evidence that treatment of fibrofolliculomas with topical rapamycin in BHD results in cosmetic improvement.	[Gijezen, LiekeM. C.; Vernooij, Marigje; Martens, Herm; Oduber, Charlene E. U.; Henquet, Charles J. M.; van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Dermatol, Maastricht, Netherlands; [Starink, Theo M.] Vrije Univ Amsterdam Med Ctr, Dept Dermatol, Amsterdam, Netherlands; [Prins, Martin H.; Nelemans, Patty J.] Maastricht Univ, Med Ctr, CAPHRI Res Sch Publ Hlth Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Menko, Fred H.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Clin Genet, Maastricht, Netherlands; [van Steensel, Maurice A. M.] Inst Med Biol, Singapore, Singapore	Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	van Steensel, MAM (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Dermatol, Maastricht, Netherlands.	maurice.vansteensel@imb.a-star.sg.edu	van Steensel, Maurice A.M./V-3852-2019	van Steensel, Maurice/0000-0002-7507-2442	Myrovlytis Trust [1122073]; Dutch Cancer Society [UM2009-4352]	Myrovlytis Trust; Dutch Cancer Society(KWF Kankerbestrijding)	This study was financed by the Myrovlytis Trust (UK Charity Commission number 1122073, http://www.myrovlytistrust.org/). MAMvS and MV are additionally supported by the Dutch Cancer Society, grant UM2009-4352 (http://www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daraji WI, 2005, CLIN EXP DERMATOL, V30, P309, DOI 10.1111/j.1365-2230.2005.01764.x; Arellano A, 1999, EUR J PHARM SCI, V7, P129, DOI 10.1016/S0928-0987(98)00010-4; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BARRETT CW, 1965, BRIT J DERMATOL, V77, P576, DOI 10.1111/j.1365-2133.1965.tb14578.x; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Claessens T, 2010, NAT REV UROL, V7, P583, DOI 10.1038/nrurol.2010.140; DeKlotz CMC, 2011, ARCH DERMATOL, V147, P1116, DOI 10.1001/archdermatol.2011.254; Farrant PBJ, 2007, DERMATOL SURG, V33, P1287, DOI 10.1111/j.1524-4725.2007.33270.x; Foster RS, 2012, AUSTRALAS J DERMATOL, V53, P52, DOI 10.1111/j.1440-0960.2011.00837.x; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; Gambichler T, 2000, J AM ACAD DERMATOL, V43, P856, DOI 10.1067/mjd.2000.109294; Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hofbauer GFL, 2008, BRIT J DERMATOL, V159, P473, DOI 10.1111/j.1365-2133.2008.08677.x; HORNSTEIN OP, 1975, ARCH DERMATOL FORSCH, V253, P161, DOI 10.1007/BF00582068; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacob CI, 2001, ARCH DERMATOL, V137, P98; Leyden JJ, 2005, CLIN THER, V27, P216, DOI 10.1016/j.clinthera.2005.02.009; Liu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065869; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; McNamara EK, 2012, J DERMATOL TREAT, V23, P46, DOI 10.3109/09546634.2010.489598; Mutizwa MM, 2011, BRIT J DERMATOL, V165, P922, DOI 10.1111/j.1365-2133.2011.10476.x; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nicolazzo JA, 2005, J CONTROL RELEASE, V103, P577, DOI 10.1016/j.jconrel.2004.12.007; Ozolins M, 2005, HLTH TECHNOL ASSESS, V9, piii, DOI DOI 10.3310/HTA9010; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; POULSEN BJ, 1968, J PHARM SCI, V57, P928, DOI 10.1002/jps.2600570603; ROTH JS, 1993, J AM ACAD DERMATOL, V29, P1055, DOI 10.1016/S0190-9622(08)82049-X; Schaffer JV, 2005, J AM ACAD DERMATOL, V53, pS108, DOI 10.1016/j.jaad.2004.11.021; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Toro J. R., 2008, GENEREVIEWS; Toro JR, 2007, AM J RESP CRIT CARE, V175, P1044, DOI 10.1164/rccm.200610-1483OC; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; Truchuelo Teresa, 2012, Dermatol Online J, V18, P15; TSUN ZY, 2013, MOL CELL; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; van Steensel MAM, 2007, J INVEST DERMATOL, V127, P588, DOI 10.1038/sj.jid.5700592; Vernooij M, 2013, FAM CANCER, V12, P381, DOI 10.1007/s10689-013-9600-8; Wataya-Kaneda M, 2011, BRIT J DERMATOL, V165, P912, DOI 10.1111/j.1365-2133.2011.10471.x	44	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99071	10.1371/journal.pone.0099071	http://dx.doi.org/10.1371/journal.pone.0099071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910976	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600039
J	Hsieh, JY; Liu, JH; Yang, PC; Lin, CL; Liu, GY; Hung, HC				Hsieh, Ju-Yi; Liu, Jyung-Hurng; Yang, Pai-Chun; Lin, Chi-Li; Liu, Guang-Yaw; Hung, Hui-Chih			Fumarate Analogs Act as Allosteric Inhibitors of the Human Mitochondrial NAD(P)(+) -Dependent Malic Enzyme	PLOS ONE			English	Article							FUNCTIONAL ROLES; OXIDATIVE DECARBOXYLASES; CATALYTIC MECHANISM; CDNA CLONING; PURIFICATION; METABOLISM; EXPRESSION; SUBSTRATE; SITE; ATP	Human mitochondrial NAD(P)(+)-dependent malic enzyme (m-NAD(P)-ME) is allosterically activated by the four-carbon trans dicarboxylic acid, fumarate. Previous studies have suggested that the dicarboxylic acid in a trans conformation around the carbon-carbon double bond is required for the allosteric activation of the enzyme. In this paper, the allosteric effects of fumarate analogs on m-NAD(P)-ME are investigated. Two fumarate-insensitive mutants, m-NAD(P)-ME_R67A/R91A and mNAD( P)-ME_K57S/E59N/K73E/D102S, as well as c-NADP-ME, were used as the negative controls. Among these analogs, mesaconate, trans-aconitate, monomethyl fumarate and monoethyl fumarate were allosteric activators of the enzyme, while oxaloacetate, diethyl oxalacetate, and dimethyl fumarate were found to be allosteric inhibitors of human m-NAD(P)-ME. The IC50 value for diethyl oxalacetate was approximately 2.5 mM. This paper suggests that the allosteric inhibitors may impede the conformational change from open form to closed form and therefore inhibit m-NAD(P)-ME enzyme activity.	[Hsieh, Ju-Yi; Liu, Jyung-Hurng; Yang, Pai-Chun; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Jyung-Hurng; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Lin, Chi-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Liu, GY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	hchung@dragon.nchu.edu.tw; liugy@csmu.edu.tw	Hung, Hui-Chih/L-8061-2019; Liu, Jyung-Hurng/C-1340-2010; Lin, Chih-Li/H-9515-2019; Lin, Chih-Li/GQZ-6480-2022; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Liu, Jyung-Hurng/0000-0002-7173-0372; Lin, Chih-Li/0000-0003-4553-3727; Hung, Hui-Chih/0000-0003-0180-1822; YANG, PAN-CHYR/0000-0001-6330-6048	Ministry of Science and Technology, ROC [NSC 101-2311-B-005-005-MY3]; Ministry of Education, Taiwan, R.O.C. under the ATU plan	Ministry of Science and Technology, ROC; Ministry of Education, Taiwan, R.O.C. under the ATU plan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology, ROC (NSC 101-2311-B-005-005-MY3 to H.-C.H.) and in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Bhargava G, 1999, J STRUCT BIOL, V127, P72, DOI 10.1006/jsbi.1999.4126; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1992, ARCH BIOCHEM BIOPHYS, V296, P468, DOI 10.1016/0003-9861(92)90599-R; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; Hsieh JY, 2009, J BIOL CHEM, V284, P18096, DOI 10.1074/jbc.M109.005082; Hsieh JY, 2009, BIOCHEM J, V420, P201, DOI 10.1042/BJ20090076; Hsieh JY, 2009, FEBS J, V276, P983, DOI 10.1111/j.1742-4658.2008.06834.x; Hsieh JY, 2009, J BIOL CHEM, V284, P4536, DOI 10.1074/jbc.M807008200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Jiang DD, 2013, CELL RES, V23, P739, DOI 10.1038/cr.2013.34; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Murugan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050143; Rao GSJ, 2000, PROTEIN PEPTIDE LETT, V7, P297; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Su KL, 2009, BIOORGAN MED CHEM, V17, P5414, DOI 10.1016/j.bmc.2009.06.052; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8	33	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98385	10.1371/journal.pone.0098385	http://dx.doi.org/10.1371/journal.pone.0098385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911153	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600003
J	Jickling, GC; Ander, BP; Zhan, XH; Noblett, D; Stamova, B; Liu, DZ				Jickling, Glen C.; Ander, Bradley P.; Zhan, Xinhua; Noblett, Dylan; Stamova, Boryana; Liu, Dazhi			microRNA Expression in Peripheral Blood Cells following Acute Ischemic Stroke and Their Predicted Gene Targets	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; SUPPRESSOR; LET-7I; RNA	Background: microRNA (miRNA) are important regulators of gene expression. In patients with ischemic stroke we have previously shown that differences in immune cell gene expression are present. In this study we sought to determine the miRNA that are differentially expressed in peripheral blood cells of patients with acute ischemic stroke and thus may regulate immune cell gene expression. Methods: miRNA from peripheral blood cells of forty-eight patients with ischemic stroke and vascular risk factor controls were compared. Differentially expressed miRNA in patients with ischemic stroke were determined by microarray with qRT-PCR confirmation. The gene targets and pathways associated with ischemic stroke that may be regulated by the identified miRNA were characterized. Results: In patients with acute ischemic stroke, miR-122, miR-148a, let-7i, miR-19a, miR-320d, miR-4429 were decreased and miR-363, miR-487b were increased compared to vascular risk factor controls. These miRNA are predicted to regulate several genes in pathways previously identified by gene expression analyses, including toll-like receptor signaling, NF-kappa b signaling, leukocyte extravasation signaling, and the prothrombin activation pathway. Conclusions: Several miRNA are differentially expressed in blood cells of patients with acute ischemic stroke. These miRNA may regulate leukocyte gene expression in ischemic stroke including pathways involved in immune activation, leukocyte extravasation and thrombosis.	[Jickling, Glen C.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Jickling, GC (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.	gcjickling@ucdavis.edu	Jickling, Glen/J-8790-2019; Stamova, Boryana/ABA-2981-2020	Jickling, Glen/0000-0003-3543-0820; Stamova, Boryana/0000-0002-5440-8816; Noblett, Dylan/0000-0002-1328-5274	American Heart Association; National Institutes of Health [NS075035, NS079153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075035, R01NS079153, R01NS101718] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Heart Association (GJ, DL) and the National Institutes of Health (NS075035, NS079153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of	Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Camaioni C, 2013, INTERN EMERG MED, V8, P291, DOI 10.1007/s11739-011-0705-5; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Dangwal S, 2013, HAMOSTASEOLOGIE, V33, P17, DOI 10.5482/HAMO-13-01-0002; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Gan CS, 2012, GENET MOL RES, V11, P147, DOI 10.4238/2012.January.27.1; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jickling GC, 2012, STROKE, V43, P1006, DOI 10.1161/STROKEAHA.111.638577; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; Koutsis G, 2013, CURR TOP MED CHEM, V13, P1573, DOI 10.2174/15680266113139990106; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; O'Carroll D, 2012, NEUROPSYCHOPHARMACOL; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Stamova B, 2010, STROKE, V41, P2171, DOI 10.1161/STROKEAHA.110.588335; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; Tsai PC, 2013, J VASC RES, V50, P346, DOI 10.1159/000351767; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Zeng Lili, 2011, Front Biosci (Elite Ed), V3, P1265; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937	33	137	143	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99283	10.1371/journal.pone.0099283	http://dx.doi.org/10.1371/journal.pone.0099283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911610	Green Published, gold			2022-12-27	WOS:000337165600066
J	Luo, J; Hou, BW; Niu, ZT; Liu, W; Xue, QY; Ding, XY				Luo, Jing; Hou, Bei-Wei; Niu, Zhi-Tao; Liu, Wei; Xue, Qing-Yun; Ding, Xiao-Yu			Comparative Chloroplast Genomes of Photosynthetic Orchids: Insights into Evolution of the Orchidaceae and Development of Molecular Markers for Phylogenetic Applications	PLOS ONE			English	Article							PLASTID GENOME; PHALAENOPSIS-APHRODITE; SEQUENCE; DNA; GENES; IDENTIFICATION; ANGIOSPERMS; DIVERGENCE; MORPHOLOGY; PLASTOMES	The orchid family Orchidaceae is one of the largest angiosperm families, including many species of important economic value. While chloroplast genomes are very informative for systematics and species identification, there is very limited information available on chloroplast genomes in the Orchidaceae. Here, we report the complete chloroplast genomes of the medicinal plant Dendrobium officinale and the ornamental orchid Cypripedium macranthos, demonstrating their gene content and order and potential RNA editing sites. The chloroplast genomes of the above two species and five known photosynthetic orchids showed similarities in structure as well as gene order and content, but differences in the organization of the inverted repeat/small single-copy junction and ndh genes. The organization of the inverted repeat/small single-copy junctions in the chloroplast genomes of these orchids was classified into four types; we propose that inverted repeats flanking the small single-copy region underwent expansion or contraction among Orchidaceae. The AT-rich regions of the ycf1 gene in orchids could be linked to the recombination of inverted repeat/small single-copy junctions. Relative species in orchids displayed similar patterns of variation in ndh gene contents. Furthermore, fifteen highly divergent protein-coding genes were identified, which are useful for phylogenetic analyses in orchids. To test the efficiency of these genes serving as markers in phylogenetic analyses, coding regions of four genes (accD, ccsA, matK, and ycf1) were used as a case study to construct phylogenetic trees in the subfamily Epidendroideae. High support was obtained for placement of previously unlocated subtribes Collabiinae and Dendrobiinae in the subfamily Epidendroideae. Our findings expand understanding of the diversity of orchid chloroplast genomes and provide a reference for study of the molecular systematics of this family.	[Luo, Jing; Hou, Bei-Wei; Niu, Zhi-Tao; Liu, Wei; Xue, Qing-Yun; Ding, Xiao-Yu] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Ding, XY (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	dingxynj@263.net			National Natural Science Foundation of China [31170300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work supported by the National Natural Science Foundation of China (No. 31170300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CF, 2008, MOL PHYLOGENET EVOL, V47, P665, DOI 10.1016/j.ympev.2008.02.014; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Burns-Balogh P., 1986, PHYLOGENETIC ANAL OR; Burns-Balogh P, 1986, LINDLEYANA, V1, P131; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase M.W., 2003, ORCHID CONSERV, P69; Chase Mark W., 2005, Curtis's Botanical Magazine, V22, P2, DOI 10.1111/j.1355-4905.2005.00466.x; Chen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-616; Chen X.Q., 2009, FLORA CHINA, V25, P22; Chinese Pharmacopoeia Commission, 2020, PHARMACOPOEIA PEOPLE; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Cox AV, 1997, PLANT SYST EVOL, V208, P197, DOI 10.1007/BF00985442; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Dong WP, 2013, GENOME BIOL EVOL, V5, P989, DOI 10.1093/gbe/evt063; Doyle J. J., 1987, PHYTOCHEM B, P11; DRESSLER R L, 1990, Lindleyana, V5, P117; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1986, LINDLEYANA, V1, P5; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Freudenstein JV, 2002, AM J BOT, V89, P1747, DOI 10.3732/ajb.89.11.1747; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; Fu L.K., 1992, CHINA PLANT RED DATA; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Grennan AK, 2011, PLANT PHYSIOL, V156, P453, DOI 10.1104/pp.111.900412; Grewe F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-8; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Guzowska-Nowowiejska M, 2009, GENE, V434, P1, DOI 10.1016/j.gene.2008.12.017; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Lalitha S., 2000, BIOTECH SOFTWARE INT, V1, P270, DOI [10.1089/152791600459894, DOI 10.1089/152791600459894]; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2012, MOL PHYLOGENET EVOL, V64, P545, DOI 10.1016/j.ympev.2012.05.010; Liu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056562, 10.1371/journal.pone.0055853]; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Lutz KA, 2007, METHOD ENZYMOL, V424, P501, DOI 10.1016/S0076-6879(07)24023-6; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; ROBINSON SP, 1984, ARCH BIOCHEM BIOPHYS, V228, P197, DOI 10.1016/0003-9861(84)90061-4; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Watanabe S, 2013, GENOME BIOL EVOL, V5, P1644, DOI 10.1093/gbe/evt117; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058; Zhu G.H., 2009, FLORA CHINA, V25, P367	84	71	80	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99016	10.1371/journal.pone.0099016	http://dx.doi.org/10.1371/journal.pone.0099016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911363	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600034
J	Mueller, C; Blum, CA; Trummler, M; Stolz, D; Bingisser, R; Mueller, C; Tamm, M; Mueller, B; Schuetz, P; Christ-Crain, M				Mueller, Cornelia; Blum, Claudine A.; Trummler, Michael; Stolz, Daiana; Bingisser, Roland; Mueller, Christian; Tamm, Michael; Mueller, Beat; Schuetz, Philipp; Christ-Crain, Mirjam			Association of Adrenal Function and Disease Severity in Community- Acquired Pneumonia	PLOS ONE			English	Article							DEHYDROEPIANDROSTERONE-SULFATE; CORTISOL; SEPSIS; DHEA	Introduction: Rapid and accurate risk stratification in patients with community-acquiredpneumonia (CAP) is an unmet clinical need. Cortisol to dehydroepiandrosterone (DHEA) ratio was put forward as a prognostic marker in sepsis. We herein validatedthe prognostic value of the adrenal hormones DHEA, DHEA-Sulfate (DHEAS), cortisol/DHEA-, cortisol/DHEAS- and DHEA/DHEAS - ratios in patients with CAP. Methods: We assessed severity of illness using the pneumonia severityindex (PSI) and measured adrenal hormone concentrations in 179 serumsamples of prospectively recruited patients hospitalized with CAP. We calculatedspearman rank correlation, logistic regression analysis and Kaplan Meier curvesto study associations of adrenal hormones and outcomes. Results: There was a significant correlation between PSI score and totalcortisol (r = 0.24, p = 0.001), DHEAS (r = -0.23, p = 0.002), cortisol/DHEA (r = 0.23, p = 0.003), cortisol/ DHEAS (r = 0.32, p =, 0.0001) and DHEA/DHEAS (r = 0.20, p = 0.009). In age and gender adjusted logistic regression analysis, cortisol (OR: 2.8, 95% CI: 1.48- 5.28) and DHEA (OR: 2.62,95% CI: 1.285.34), but not DHEAS and the differentratios were associated with all- cause mortality. The discriminatoryaccuracy of cortisol and DHEA in ROC analysis (area under the curve) was 0.74 and 0.61. In Kaplan Meier analysis, patients in the highest decilesof cortisol and DHEA (p = 0.005 and p = 0.015), and toa lesser extent of cortisol/ DHEAS ratio (p = 0.081) hada higher risk of death. Conclusion: Cortisol, DHEAS and their ratios correlate with CAP severity, and cortisol and DHEA predict mortality. Adrenal function in severe pneumoniamay be an important factor for CAP outcomes.	[Mueller, Cornelia; Blum, Claudine A.; Christ-Crain, Mirjam] UniversityHosp, Dept Endocrinol Diabetol & Metab, Basel, Switzerland; [Trummler, Michael] Bioanalytica AG, Luzern, Switzerland; [Stolz, Daiana; Tamm, Michael] Univ Basel Hosp, Dept Pneumol, CH-4031 Basel, Switzerland; [Bingisser, Roland] Univ Basel Hosp, Dept Emergency Med, CH-4031 Basel, Switzerland; [Mueller, Christian] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Mueller, Beat; Schuetz, Philipp] Med Univ Clin, CantonalHosp, Dept Endocrinol, Aarau, Switzerland	University of Basel; University of Basel; University of Basel	Mueller, C (corresponding author), UniversityHosp, Dept Endocrinol Diabetol & Metab, Basel, Switzerland.	muellerc.mail@gmail.com	schuetz, philipp/C-8475-2013; Mueller, Beat/G-2662-2012; Blum, Claudine Angela A/G-8467-2016; Müller, Christian/AAB-4783-2022	schuetz, philipp/0000-0001-6400-4949; Blum, Claudine Angela A/0000-0003-0487-5587; Müller, Christian/0000-0002-1120-6405; Christ-Crain, Mirjam/0000-0002-6336-0965; Stolz, Daiana/0000-0003-0099-882X	Department of Endocrinology, Diabetology, Clinical Nutrition of theUniversity Hospital of Basel; University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation [PP00P3-12346]	Department of Endocrinology, Diabetology, Clinical Nutrition of theUniversity Hospital of Basel; University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by in-house grantsfrom the Department of Endocrinology, Diabetology, Clinical Nutrition of theUniversity Hospital of Basel, as well as by a grant for young research scientistsof the University of Basel, Switzerland, a grant from the Bangerter-Rhyner-Foundation, Basel, Switzerland, to CAB and by research grants of the Swiss National Foundation, PP00P3-12346, to MCC. MT of Bioanalytica AG, Lucerne, Switzerland, granted a discount for analyzing DHEA and DHEAS. The funders had no role instudy design, data collection and analysis, decision to publish, or preparationof the manuscript.	Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Beishuizen A, 2002, CRIT CARE, V6, P434, DOI 10.1186/cc1530; Blum CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063224; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Christ-Crain M, 2007, AM J RESP CRIT CARE, V176, P913, DOI 10.1164/rccm.200702-307OC; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Girard TD, 2007, CLIN GERIATR MED, V23, P633, DOI 10.1016/j.cger.2007.05.003; Kolditz M, 2010, EUR RESPIR J, V36, P615, DOI 10.1183/09031936.00191709; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; Oberbeck R, 2001, CRIT CARE MED, V29, P380, DOI 10.1097/00003246-200102000-00029; Oberbeck R, 2010, CURR MED CHEM, V17, P1039; Radford DJ, 2010, MOL ENDOCRINOL, V24, P813, DOI 10.1210/me.2009-0390; ROSENFELD RS, 1971, J CLIN ENDOCR METAB, V33, P87, DOI 10.1210/jcem-33-1-87; Schmitz D, 2010, J SURG RES, V163, pE73, DOI 10.1016/j.jss.2010.05.017; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; Vermes I, 2001, BEST PRACT RES CL EN, V15, P495, DOI 10.1053/beem.2001.0166; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99518	10.1371/journal.pone.0099518	http://dx.doi.org/10.1371/journal.pone.0099518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910975	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600099
J	Niu, XL; Zhao, LY; Li, X; Xue, YS; Wang, B; Lv, ZQ; Chen, JH; Sun, DD; Zheng, QS				Niu, Xiaolin; Zhao, Lianyou; Li, Xue; Xue, Yusheng; Wang, Bin; Lv, Zongqiang; Chen, Jianghong; Sun, Dongdong; Zheng, Qiangsun			beta 3-Adrenoreceptor Stimulation Protects against Myocardial Infarction Injury via eNOS and nNOS Activation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; HUMAN FAILING MYOCARDIUM; HUMAN HEART; BETA(3)-ADRENOCEPTOR STIMULATION; CARDIOVASCULAR-SYSTEM; PHOSPHORYLATION; RECEPTOR; FAILURE; DEFICIENCY	beta 3-adrenergic receptor (AR) and the downstream signaling, nitric oxide synthase (NOS) isoforms, have been emerged as novel modulators of heart function and even potential therapeutic targets for cardiovascular diseases. However, it is not known whether beta 3-AR plays cardioprotective effects against myocardial infarction (MI) injury. Therefore, the present study was designed to determine the effects of beta 3-AR on MI injury and to elucidate the underlying mechanism. MI model was constructed by left anterior descending (LAD) artery ligation. Animals were administrated with beta 3-AR agonist BRL37344 (BRL) or beta 3-AR inhibitor SR59230A (SR) respectively at 0.1 mg/kg/hour one day after MI operation. The scar area, cardiac function and the apoptosis of myocardial were assessed by Masson's trichrome stain, echocardiography and TUNEL assay respectively. Western blot analysis was performed to elucidate the expressions of target proteins. beta 3-AR activation with BRL administration significantly attenuated fibrosis and decreased scar area after MI. Moreover, BRL also preserved heart function, and reduced the apoptosis of cardiomyocyte induced by MI. Furthermore, BRL treatment altered the phosphorylation status of endothelial NOS (eNOS) and increased the expression of neuronal NOS (nNOS). These results suggested that beta 3-AR stimulation has a substantial effect on recovery of heart function. In addition, the activations of both eNOS and nNOS may be associated with the cardiac protective effects of beta 3-AR.	[Niu, Xiaolin; Zhao, Lianyou; Li, Xue; Xue, Yusheng; Wang, Bin; Chen, Jianghong; Zheng, Qiangsun] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Sun, Dongdong] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Lv, Zongqiang] Fourth Mil Med Univ, Cadet Brigade, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Sun, DD (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China.	dongdongSun@163.com; zhengqiangsun123@163.com		niu, xiaolin/0000-0002-8320-5516	National Nature Science Foundation of China [81200099]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (No. 81200099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Balligand JL, 2009, J AM COLL CARDIOL, V53, P1539, DOI 10.1016/j.jacc.2009.01.048; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Braunwald E, 2000, CIRCULATION, V102, P14; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Brixius K, 2006, CAN J PHYSIOL PHARM, V84, P1051, DOI 10.1139/Y06-033; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Mishra OP, 2009, NEUROSCI LETT, V462, P64, DOI 10.1016/j.neulet.2009.06.075; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; Napp A, 2009, J CARD FAIL, V15, P57, DOI 10.1016/j.cardfail.2008.08.006; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rozec B, 2003, ARCH MAL COEUR VAISS, V96, P905; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Rozec B, 2009, J AM COLL CARDIOL, V53, P1532, DOI 10.1016/j.jacc.2008.11.057; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Sharp BR, 2002, AM J PHYSIOL-HEART C, V282, pH2422, DOI 10.1152/ajpheart.00855.2001; Simard P M, 1994, Obes Res, V2, P424; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Varghese P, 2000, J CLIN INVEST, V106, P697, DOI 10.1172/JCI9323; Zhang Z, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0333-5; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	39	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98713	10.1371/journal.pone.0098713	http://dx.doi.org/10.1371/journal.pone.0098713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911015	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600010
J	Hartnack, S; Nathues, C; Nathues, H; Beilage, EG; Lewis, FI				Hartnack, Sonja; Nathues, Christina; Nathues, Heiko; Beilage, Elisabeth Grosse; Lewis, Fraser Iain			Estimating Diagnostic Test Accuracies for Brachyspira hyodysenteriae Accounting for the Complexities of Population Structure in Food Animals	PLOS ONE			English	Article							LAWSONIA-INTRACELLULARIS; CONDITIONAL DEPENDENCE; DISEASE PREVALENCE; GOLD STANDARD; SPECIFICITY; SENSITIVITY; PCR; PILOSICOLI; ABSENCE; MODEL	For swine dysentery, which is caused by Brachyspira hyodysenteriae infection and is an economically important disease in intensive pig production systems worldwide, a perfect or error-free diagnostic test ("gold standard") is not available. In the absence of a gold standard, Bayesian latent class modelling is a well-established methodology for robust diagnostic test evaluation. In contrast to risk factor studies in food animals, where adjustment for within group correlations is both usual and required for good statistical practice, diagnostic test evaluation studies rarely take such clustering aspects into account, which can result in misleading results. The aim of the present study was to estimate test accuracies of a PCR originally designed for use as a confirmatory test, displaying a high diagnostic specificity, and cultural examination for B. hyodysenteriae. This estimation was conducted based on results of 239 samples from 103 herds originating from routine diagnostic sampling. Using Bayesian latent class modelling comprising of a hierarchical beta-binomial approach (which allowed prevalence across individual herds to vary as herd level random effect), robust estimates for the sensitivities of PCR and culture, as well as for the specificity of PCR, were obtained. The estimated diagnostic sensitivity of PCR (95% CI) and culture were 73.2% (62.3; 82.9) and 88.6% (74.9; 99.3), respectively. The estimated specificity of the PCR was 96.2% (90.9; 99.8). For test evaluation studies, a Bayesian latent class approach is well suited for addressing the considerable complexities of population structure in food animals.	[Hartnack, Sonja; Lewis, Fraser Iain] Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland; [Nathues, Christina] Vetsuisse Fac, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Nathues, Heiko] Univ London Royal Vet Coll, Dept Prod & Populat Hlth, London, England; [Nathues, Heiko] Vetsuisse Fac, Dept Clin Vet Med, Zurich, Switzerland; [Beilage, Elisabeth Grosse] Univ Vet Med Hannover, Field Stn Epidemiol, Bakum, Germany	University of London; University of London Royal Veterinary College; University of Veterinary Medicine Hannover, Foundation	Hartnack, S (corresponding author), Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland.	sonja.hartnack@access.uzh.ch	Hartnack, Sonja/B-4328-2010; Lewis, Fraser I/A-3635-2011; Nathues, Heiko/AAZ-2712-2020	Hartnack, Sonja/0000-0002-5757-5708; Lewis, Fraser I/0000-0003-4580-2712; Nathues, Heiko/0000-0002-0285-3731; Nathues, Christina/0000-0003-0336-1955				Alvarez-Ordonez A, 2013, INT J ENV RES PUB HE, V10, P1927, DOI 10.3390/ijerph10051927; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Burrough ER, 2012, J VET DIAGN INVEST, V24, P1025, DOI 10.1177/1040638712457927; Dohoo IR, 2008, PREV VET MED, V86, P260, DOI 10.1016/j.prevetmed.2008.02.012; DONALD AW, 1994, PREV VET MED, V19, P167, DOI 10.1016/0167-5877(94)90087-6; ELDER RO, 1994, J CLIN MICROBIOL, V32, P1497, DOI 10.1128/JCM.32.6.1497-1502.1994; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Georgiadis MP, 2003, J ROY STAT SOC C-APP, V52, P63, DOI 10.1111/1467-9876.00389; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Hanson T, 2003, J AGR BIOL ENVIR ST, V8, P223, DOI 10.1198/1085711031526; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; La T, 2003, J CLIN MICROBIOL, V41, P3372, DOI 10.1128/JCM.41.7.3372-3375.2003; Lewis FI, 2011, VET J, V187, P104, DOI 10.1016/j.tvjl.2009.10.024; Lewis FI, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-9; Nathues H, 2007, J VET MED A, V54, P532, DOI 10.1111/j.1439-0442.2007.00995.x; OIE, 2009, STAND OP PROC SOP VA; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rasback T, 2006, J MICROBIOL METH, V66, P347, DOI 10.1016/j.mimet.2005.12.008; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Suess EA, 2002, PREV VET MED, V55, P155, DOI 10.1016/S0167-5877(02)00092-2; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; VACEK PM, 1985, BIOMETRICS, V41, P959, DOI 10.2307/2530967; Willems H, 2010, BERL MUNCH TIERARZTL, V123, P205, DOI 10.2376/0005-9366-123-205	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98534	10.1371/journal.pone.0098534	http://dx.doi.org/10.1371/journal.pone.0098534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906140	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000341869000038
J	Li, M; Zhang, YJ; Zhang, L; Yang, XY; Jiang, XL				Li, Mei; Zhang, Yujie; Zhang, Lin; Yang, Xiaoyan; Jiang, Xiliang			Exploring the Electron Transfer Pathway in the Oxidation of Avermectin by CYP107Z13 in Streptomyces ahygroscopicus ZB01	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; CYTOCHROME-P450 COMPLEMENT; BIOCATALYTIC CONVERSION; HYDROXYLATION; COELICOLOR; FERREDOXIN; REDUCTASE; CLONING; 4''-OXO-AVERMECTIN; MONOOXYGENASE	Streptomyces ahygroscopicus ZB01 can effectively oxidize 4 ''-OH of avermectin to form 4 ''-oxo-avermectin. CYP107Z13 is responsible for this site-specific oxidation in ZB01. In the present study, we explored the electron transfer pathway in oxidation of avermectin by CYP107Z13 in ZB01. A putative [3Fe-4S] ferredoxin gene fd68 and two possible NADH-dependent ferredoxin reductase genes fdr18 and fdr28 were cloned from the genomic DNA of ZB01. fd68 gene disruption mutants showed no catalytic activity in oxidation of avermectin to form 4 ''-oxo-avermectin. To clarify whether FdR18 and FdR28 participate in the electron transfer during avermectin oxidation by CYP107Z13, two whole-cell biocatalytic systems were designed in E. coli BL21 (DE3), with one co-expressing CYP107Z13, Fd68 and FdR18 and the other co-expressing CYP107Z13, Fd68 and FdR28. Both of the two biocatalytic systems were found to be able to mediate the oxidation of avermectin to form 4 ''-oxo-avermectin. Thus, we propose an electron transfer pathway NADH -> FdR18/FdR28 -> Fd68 -> CYP107Z13 for oxidation of avermectin to form 4 ''-oxo-avermectin in ZB01.	[Li, Mei; Zhang, Yujie; Zhang, Lin; Yang, Xiaoyan; Jiang, Xiliang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Jiang, XL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	jiangxiliang@caas.cn			National Natural Science Foundation of China [31101484]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grant No. 31101484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SG, 2010, APPL MICROBIOL BIOT, V86, P163, DOI 10.1007/s00253-009-2234-y; Bell SG, 2010, MOL BIOSYST, V6, P206, DOI 10.1039/b913487e; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Choi KY, 2013, CHEMBIOCHEM, V14, P1231, DOI 10.1002/cbic.201300212; Chun YJ, 2006, BIOCHEM SOC T, V34, P1183, DOI 10.1042/BST0341183; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Cornelissen S, 2013, BIOTECHNOL BIOENG, V110, P1282, DOI 10.1002/bit.24801; Duetz WA, 2001, CURR OPIN BIOTECH, V12, P419, DOI 10.1016/S0958-1669(00)00237-8; Green AJ, 2003, J INORG BIOCHEM, V93, P92, DOI 10.1016/S0162-0134(02)00456-7; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hopwood D. A., 1985, GENETIC MANIPULATION; [黄敏红 HUANG Min-hong], 2010, [微生物学杂志, Journal of Mirobiology], V30, P75; Jiang XL, 2012, APPL MICROBIOL BIOT, V93, P1957, DOI 10.1007/s00253-011-3490-1; Joo YC, 2012, BIOCHIMIE, V94, P907, DOI 10.1016/j.biochi.2011.12.011; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kleser M, 2012, J BIOTECHNOL, V157, P405, DOI 10.1016/j.jbiotec.2011.12.006; Lamb DC, 2003, BIOCHEM BIOPH RES CO, V307, P610, DOI 10.1016/S0006-291X(03)01231-2; [李梅 LI Mei], 2008, [微生物学通报, Microbiology], V35, P1107; Lim YR, 2012, ARCH BIOCHEM BIOPHYS, V528, P111, DOI 10.1016/j.abb.2012.09.001; Liu Weide, 2011, Weishengwu Xuebao, V51, P410; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; Molnar I, 2006, BIOCHEM SOC T, V34, P1236, DOI 10.1042/BST0341236; Molnar I, 2005, APPL ENVIRON MICROB, V71, P6977, DOI 10.1128/AEM.71.11.6977-6985.2005; Nie Y, 2014, APPL MICROBIOL BIOT, V98, P163, DOI 10.1007/s00253-013-4821-1; Parajuli N, 2004, ARCH BIOCHEM BIOPHYS, V425, P233, DOI 10.1016/j.abb.2004.03.011; PETERSON JA, 1990, J BIOL CHEM, V265, P6066; Pramod S, 2008, BIOTECHNOL LETT, V30, P1100; [乔峰 Qiao Feng], 2012, [中国医药生物技术, Chinese Medicinal Biotechnolog], V7, P178; RAMACHANDRA M, 1991, J BACTERIOL, V173, P7106, DOI 10.1128/jb.173.22.7106-7112.1991; Roh C, 2009, J MOL CATAL B-ENZYM, V59, P248, DOI 10.1016/j.molcatb.2008.07.005; Sambrook J., 2001, MOL CLONING LAB MANU; Sevrioukova IF, 2011, ARCH BIOCHEM BIOPHYS, V507, P66, DOI 10.1016/j.abb.2010.08.022; Shrestha P, 2008, APPL MICROBIOL BIOT, V79, P555, DOI 10.1007/s00253-008-1455-9; Sielaff B, 2005, MICROBIOL-SGM, V151, P2593, DOI 10.1099/mic.0.28039-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006	38	2	2	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98916	10.1371/journal.pone.0098916	http://dx.doi.org/10.1371/journal.pone.0098916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905717	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000078
J	Shen, MX; Hu, PP; Donskov, F; Wang, GH; Liu, Q; Du, JJ				Shen, Meixiao; Hu, Pingping; Donskov, Frede; Wang, Guanghui; Liu, Qi; Du, Jiajun			Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							INTRATUMORAL NEUTROPHILS; POOR-PROGNOSIS; CELLS; MICROENVIRONMENT; EXPRESSION; SURVIVAL; INFILTRATION; LYMPHOCYTES; MACROPHAGES; RECURRENCE	Purpose: Tumor-associated neutrophils (TAN) have been reported in a variety of malignancies. We conducted an up-to-date meta-analysis to evaluate the prognostic role of TAN in cancer. Method: Pubmed, Embase and web of science databases were searched for studies published up to April 2013. Pooled hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) were calculated. The impact of neutrophils localization and primary antibody were also assessed. Results: A total of 3946 patients with various solid tumors from 20 studies were included. High density of intratumoral neutrophils were independently associated with unfavorable survival; the pooled HRs were 1.68 (95% CI: 1.36-2.07, I-2 = 55.8%, p<0.001) for recurrence-free survival (RFS)/disease-free survival (DFS), 3.36 (95% CI: 2.08-5.42, I-2 = 0%, p<0.001) for cancer-specific survival (CSS) and 1.66 (95% CI: 1.37-2.01, I-2 = 70.5%, p<0.001) for overall survival (OS). Peritumoral and stromal neutrophils were not statistically significantly associated with survival. When grouped by primary antibody, the pooled HRs were 1.80 (95% CI: 1.47-2.22, I-2 = 67.7%, p<0.001) for CD66b, and 1.44 (95% CI: 0.90-2.30, I-2 = 45.9%, p = 0.125) for CD15, suggesting that CD66b positive TAN might have a better prognostic value than CD15. Conclusion: High levels of intratumoral neutrophils are associated with unfavorable recurrence-free, cancer-specific and overall survival.	[Shen, Meixiao; Hu, Pingping; Liu, Qi; Du, Jiajun] Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China; [Donskov, Frede] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Wang, Guanghui; Du, Jiajun] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong University; Aarhus University; Shandong University	Liu, Q (corresponding author), Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn		Donskov, Frede/0000-0002-8449-863X	Provincial science and technology development plan of Shandong [2012GG0021836]; Provincial Natural Science Foundation of Shandong [ZR2013HZ001]; Health Research Fund of Central Denmark Region; Danish Cancer Society	Provincial science and technology development plan of Shandong; Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Health Research Fund of Central Denmark Region; Danish Cancer Society(Danish Cancer Society)	The work was supported by Provincial science and technology development plan of Shandong (2012GG0021836), Provincial Natural Science Foundation of Shandong (ZR2013HZ001). FD has received research grant from Health Research Fund of Central Denmark Region and the Danish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Carus A, 2013, BRIT J CANCER, V108, P2116, DOI 10.1038/bjc.2013.167; Carus A, 2014, J ONCOPATHOLOGY, V2, P1; Carus A, 2013, LUNG CANCER, V81, P130, DOI 10.1016/j.lungcan.2013.03.003; Caruso RA, 2002, MODERN PATHOL, V15, P831, DOI 10.1097/01.MP.0000020391.98998.6B; Castillo JJ, 2011, J CLIN ONCOL, V29, P3900, DOI 10.1200/JCO.2011.35.4449; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Donskov F, 2006, J CLIN ONCOL, V24, P1997, DOI 10.1200/JCO.2005.03.9594; Donskov F, 2004, CANCER IMMUNOL IMMUN, V53, P729, DOI 10.1007/s00262-004-0525-9; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; Dumitru CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056420; Dumitru CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00033; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Gao Q, 2012, CANCER RES, V72, P3546, DOI 10.1158/0008-5472.CAN-11-4032; Gu FM, 2012, ANN SURG ONCOL, V19, P2506, DOI 10.1245/s10434-012-2268-8; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ilie M, 2012, CANCER-AM CANCER SOC, V118, P1726, DOI 10.1002/cncr.26456; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Jang TJ, 2013, KOREAN J PATHOL, V47, P340, DOI 10.4132/KoreanJPathol.2013.47.4.340; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Li YW, 2011, J HEPATOL, V54, P497, DOI 10.1016/j.jhep.2010.07.044; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nedergaard BS, 2007, APMIS, V115, P1321, DOI 10.1111/j.1600-0643.2007.00655.x; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Rao HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030806; Richards CH, 2012, BRIT J CANCER, V106, P2010, DOI 10.1038/bjc.2012.211; RIESCO A, 1970, CANCER, V25, P135, DOI 10.1002/1097-0142(197001)25:1<135::AID-CNCR2820250120>3.0.CO;2-9; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; Tazzyman S, 2013, SEMIN CANCER BIOL, V23, P149, DOI 10.1016/j.semcancer.2013.02.003; Tecchio C, 2013, SEMIN CANCER BIOL, V23, P159, DOI 10.1016/j.semcancer.2013.02.004; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tori A, 1995, HEPATO-GASTROENTEROL, V42, P939; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907	45	195	206	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98259	10.1371/journal.pone.0098259	http://dx.doi.org/10.1371/journal.pone.0098259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906014	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000027
J	Wang, Y; Sun, ZH; Zhou, L; Li, Z; Gui, JF				Wang, Yang; Sun, Zhi-Hui; Zhou, Li; Li, Zhi; Gui, Jian-Fang			Grouper tsh beta Promoter-Driven Transgenic Zebrafish Marks Proximal Kidney Tubule Development	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTOR; THYROTROPIN RECEPTOR; SEX REVERSAL; PRONEPHROS; GENE; SPECIFICATION; REVEALS; PROTEIN; MODEL	Kidney tubule plays a critical role in recovering or secreting solutes, but the detailed morphogenesis remains unclear. Our previous studies have found that grouper tsh beta (gtsh beta) is also expressed in kidney, however, the distribution significance is still unknown. To understand the gtshb role and kidney tubule morphogenesis, here, we have generated a transgenic zebrafish line Tg(gtsh beta: GFP) with green fluorescent protein driven by the gtshb promoter. Similar to the endogenous tshb in zebrafish or in grouper, the gtsh beta promoter-driven GFP is expressed in pituitary and kidney, and the developing details of proximal kidney tubule are marked in the transgenic zebrafish line. The gfp initially transcribes at 16 hours post fertilization (hpf) above the dorsal mesentery, and partially co-localizes with pronephric tubular markers slc20a1a and cdh17. Significantly, the GFP specifically localizes in proximal pronephric segments during embryogenesis and resides at kidney duct epithelium in adult fish. To test whether the gtsh beta promoter-driven GFP may serve as a readout signal of the tubular development, we have treated the embryos with retinoic acid signaing (RA) reagents, in which exogenous RA addition results in a distal extension of the proximal segments, while RA inhibition induces a weakness and shortness of the proximal segments. Therefore, this transgenic line provides a useful tool for genetic or chemical analysis of kidney tubule.	[Wang, Yang; Sun, Zhi-Hui; Zhou, Li; Li, Zhi; Gui, Jian-Fang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; University of Chinese Academy of Sciences, CAS	Gui, JF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn			National Major Basic Research Program [2010CB126301]; National 863 High Technology Research Program [2012AA092201-3]; Ministry of Agriculture of China within the special Fund for Agro-scientific Research in the Public Interest [200903045]; National Natural Science Foundation of China [30971414]	National Major Basic Research Program(National Basic Research Program of China); National 863 High Technology Research Program(National High Technology Research and Development Program of China); Ministry of Agriculture of China within the special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Major Basic Research Program (2010CB126301), the National 863 High Technology Research Program (Grants No 2012AA092201-3), the Ministry of Agriculture of China within the special Fund for Agro-scientific Research in the Public Interest (200903045), the National Natural Science Foundation of China (Grant No. 30971414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER LM, 1989, MOL ENDOCRINOL, V3, P1037, DOI 10.1210/mend-3-7-1037; BauerHofmann R, 1995, NUCLEIC ACIDS RES, V23, P5034, DOI 10.1093/nar/23.24.5034; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Braat AK, 2000, MECH DEVELOP, V95, P271, DOI 10.1016/S0925-4773(00)00344-0; Bricaud O, 2006, J NEUROSCI, V26, P10438, DOI 10.1523/JNEUROSCI.1025-06.2006; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Burrow CR, 2000, EXP NEPHROL, V8, P219; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Dan C, 2013, INT J BIOL SCI, V9, P1043, DOI 10.7150/ijbs.7203; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drummond I, 2003, TRENDS CELL BIOL, V13, P357, DOI 10.1016/S0962-8924(03)00124-7; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; EMERMAN JT, 1977, IN VITRO CELL DEV B, V13, P316, DOI 10.1007/BF02616178; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Gerlach GF, 2013, WIRES DEV BIOL, V2, P559, DOI 10.1002/wdev.92; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Grossmann M, 1997, ENDOCR REV, V18, P476, DOI 10.1210/er.18.4.476; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Heliot C, 2013, DEVELOPMENT, V140, P873, DOI 10.1242/dev.086538; Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Hurtado R, 2006, DEV DYNAM, V235, P2811, DOI 10.1002/dvdy.20909; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Inoue M, 1998, THYROID, V8, P1059, DOI 10.1089/thy.1998.8.1059; Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029; Jin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012883; Jung DO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094904; Koprunner M, 2001, GENE DEV, V15, P2877; Kumar RS, 2001, COMP BIOCHEM PHYS B, V129, P347, DOI 10.1016/S1096-4959(01)00317-7; Lancman JJ, 2013, DEVELOPMENT, V140, P2669, DOI 10.1242/dev.090993; Levenson RM, 2006, CYTOM PART A, V69A, P748, DOI 10.1002/cyto.a.20319; Li Chen-Yu, 2010, Acta Hydrobiologica Sinica, V34, P822, DOI 10.3724/SP.J.1035.2010.00822; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007261; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lyons JP, 2009, MECH DEVELOP, V126, P142, DOI 10.1016/j.mod.2008.11.007; MacKenzie DS, 2009, GEN COMP ENDOCR, V161, P83, DOI 10.1016/j.ygcen.2008.12.010; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mudumana SP, 2008, DEVELOPMENT, V135, P3355, DOI 10.1242/dev.022830; Naylor RW, 2013, J AM SOC NEPHROL, V24, P77, DOI 10.1681/ASN.2012070756; Naylor RW, 2013, PEDIAT NEPHROL; Nichane M, 2006, GENE EXPR PATTERNS, V6, P667, DOI 10.1016/j.modgep.2006.01.005; O'Brien LL, 2011, DEV BIOL, V358, P318, DOI 10.1016/j.ydbio.2011.08.005; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Roelfsema F, 2013, ENDOCRINE REV; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Sellitti DF, 1997, THYROID, V7, P641, DOI 10.1089/thy.1997.7.641; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; VIZE P, 2002, KIDNEY NORMAL DEV CO; Walsh SB, 2012, CLIN MED, V12, P476, DOI 10.7861/clinmedicine.12-5-476; Wang HC, 2003, BLOOD, V101, P119, DOI 10.1182/blood-2002-02-0544; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022555; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Wang Y, 2013, SCI CHINA LIFE SCI, V56, P975, DOI 10.1007/s11427-013-4563-4; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Wingert RA, 2011, DEV DYNAM, V240, P2011, DOI 10.1002/dvdy.22691; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yue HM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108043; Zhong J, 2014, CELL DEATH DIFFERENT; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	79	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97806	10.1371/journal.pone.0097806	http://dx.doi.org/10.1371/journal.pone.0097806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905828	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000013
J	Newman, S; Cheng, T; Ghahate, DM; Bobelu, J; Sandy, P; Faber, T; Shah, VO				Newman, Sara; Cheng, Terri; Ghahate, Donica M.; Bobelu, Jeanette; Sandy, Phillip; Faber, Thomas; Shah, Vallabh O.			Assessing Knowledge and Attitudes of Diabetes in Zuni Indians Using a Culture-Centered Approach	PLOS ONE			English	Article							AFRICAN-AMERICANS; HEALTH; CARE; PERCEPTIONS; BARRIERS; DISEASE; ADULTS	Introduction: The Zuni Pueblo, in collaboration with the University of New Mexico, have formed the Zuni Health Initiative (ZHI) engaged in community-based participatory research to plan and implement educational interventions to reduce health disparities. We conducted the first phase of ZHI study and identified barriers to healthcare. We concluded that the burden presented by these barriers ultimately translates into a lack of patient activation and engagement in their health care including for diabetes, effectively hindering adoption of healthy behaviors. Methods: Community health representatives (CHRs) led 10 one-hour focus group sessions to elicit information on diabetes knowledge and self-management strategies at which a total of 84 people participated. Audiotapes were translated and transcribed by bilingual ZHI staff. We reduced the text to thematic categories, constructed a coding dictionary and inserted the text into NVivo 9 program. Results: The focus groups revealed that despite extensive personal or family experiences with diabetes or complications, participants identified knowledge gaps in the disease progression and disease management. However, we gained insight into how many Zunis conceptualize the etiology of diabetes, risk factors associated with diabetes, sources of knowledge and self-management practices. Conclusion: We concluded that many of the Zuni diabetics experience significant impacts on their life when they were diagnosed with diabetes and suffered the plight of stigmatization. We further concluded that developing Zuni culture specific diabetes care should focus on family involvement with continued education.	[Newman, Sara] Univ Colorado, Denver, CO 80202 USA; [Cheng, Terri; Ghahate, Donica M.; Bobelu, Jeanette; Sandy, Phillip; Shah, Vallabh O.] Univ New Mexico, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA; [Faber, Thomas] Indian Hlth Serv Comprehens Ctr Zuni Pueblo, Zuni, NM USA	University of Colorado System; University of Colorado Denver; University of New Mexico; University of New Mexico's Health Sciences Center	Shah, VO (corresponding author), Univ New Mexico, Hlth Sci Ctr, Sch Med, Albuquerque, NM 87131 USA.	vshah@salud.unm.edu			National Center for research Resources [5P20RR016480-12]; National Institute of General Medical Sciences from NIH [8P20GM103451-12]; National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health [8UL1TR000041]; University of New Mexico Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	National Center for research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of New Mexico Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in full from the grants funded by the National Center for research Resources (5P20RR016480-12) and the National Institute of General Medical Sciences (8P20GM103451-12) from NIH. The authors would also like to acknowledge partial support from the pilot project grant funding from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number 8UL1TR000041, The University of New Mexico Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Anderson RM, 2000, DIABETES EDUCATOR, V26, P280, DOI 10.1177/014572170002600208; Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809; Burt RS, 2005, BROKERAGE CLOSURE IN; Downing-Matibag TM, 2009, QUAL HEALTH RES, V19, P1196, DOI 10.1177/1049732309344206; Dutta MJ, 2007, COMMUN THEORY, V17, P204; Fukunaga LL, 2011, PREV CHRONIC DIS, V8; Lautenschlager L, 2006, J NUTR EDUC BEHAV, V38, P307, DOI 10.1016/j.jneb.2006.04.004; Lukunaga LL, 2011, PREVENTING CHRONIC D, V8; Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; ONEIL JD, 1986, HUM ORGAN, V45, P119, DOI 10.17730/humo.45.2.q34m761r857km8lh; Sarkisian CA, 2005, ETHNIC DIS, V15, P283; Scavini M, 2003, DIABETES CARE, V26, P55, DOI 10.2337/diacare.26.1.55; Shah VO, 2014, CTS-CLIN TRANSL SCI, V7, P6, DOI 10.1111/cts.12127; Shah VN, 2009, INT J DIABETES DEV C, V29, P118, DOI 10.4103/0973-3930.54288; Shah VO, 2003, J AM SOC NEPHROL, V14, P1320, DOI 10.1097/01.ASN.0000059920.00228.A0; Stidley CA, 2003, J AM SOC NEPHROL, V14, pS139, DOI 10.1097/01.ASN.0000070151.95421.87; Thomas D.R., 2003, GEN INDUCTIVE APPROA; Tripp-Reimer T., 2001, DIABETES SPECTR, V14, P13, DOI 10.2337/diaspect.14.1.13; U.S. Department of Health and Human Services, 2007, OB AM IND AL NAT	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99614	10.1371/journal.pone.0099614	http://dx.doi.org/10.1371/journal.pone.0099614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919064	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000099
J	Sudenga, SL; Wiener, HW; King, CC; Rompalo, AM; Cu-Uvin, S; Klein, RS; Shah, KV; Sobel, JD; Jamieson, DJ; Shrestha, S				Sudenga, Staci L.; Wiener, Howard W.; King, Caroline C.; Rompalo, Anne M.; Cu-Uvin, Susan; Klein, Robert S.; Shah, Keerti V.; Sobel, Jack D.; Jamieson, Denise J.; Shrestha, Sadeep			Dense Genotyping of Immune-Related Loci Identifies Variants Associated with Clearance of HPV among HIV-Positive Women in the HIV Epidemiology Research Study (HERS)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; NATURAL-HISTORY; SUSCEPTIBILITY LOCI; G POLYMORPHISMS; YOUNG-WOMEN; RISK; E6; DNA	Persistent high-risk human papillomavirus (HR-HPV) is a necessary and causal factor of cervical cancer. Most women naturally clear HPV infections; however, the biological mechanisms related to HPV pathogenesis have not been clearly elucidated. Host genetic factors that specifically regulate immune response could play an important role. All HIV-positive women in the HIV Epidemiology Research Study (HERS) with a HR-HPV infection and at least one follow-up biannual visit were included in the study. Cervicovaginal lavage samples were tested for HPV using type-specific HPV hybridization assays. Type-specific HPV clearance was defined as two consecutive HPV-negative tests after a positive test. DNA from participants was genotyped for 196,524 variants within 186 known immune related loci using the custom ImmunoChip microarray. To assess the influence of each single-nucleotide polymorphism (SNP) with HR-HPV clearance, the Cox proportional hazards model with the Wei-Lin-Weissfeld approach was used, adjusting for CD4+ count, low risk HPV (LR-HPV) co-infection, and relevant confounders. Three analytical models were performed: race-specific (African Americans (n = 258), European Americans (n = 87), Hispanics (n = 55), race-adjusted combined analysis, and meta-analysis of pooled independent race-specific analyses. Women were followed for a median time of 1,617 days. Overall, three SNPs (rs1112085, rs11102637, and rs12030900) in the MAGI-3 gene and one SNP (rs8031627) in the SMAD3 gene were associated with HR-HPV clearance (p<10(-6)). A variant (rs1633038) in HLA-G were also significantly associated in African American. Results from this study support associations of immune-related genes, having potential biological mechanism, with differential cervical HR-HPV infection outcomes.	[Sudenga, Staci L.; Wiener, Howard W.; Shrestha, Sadeep] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35203 USA; [King, Caroline C.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Rompalo, Anne M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Cu-Uvin, Susan] Brown Univ, Dept Obstet & Gynecol & Med, Providence, RI 02912 USA; [Klein, Robert S.] Mt Sinai Sch Med, New York, NY USA; [Shah, Keerti V.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Sobel, Jack D.] Wayne State Univ, Sch Med, Detroit, MI USA	University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Brown University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University	Shrestha, S (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35203 USA.	sshrestha@uab.edu	Sudenga, Staci/A-7726-2015; Sudenga, Staci/O-1545-2019	Sudenga, Staci/0000-0001-7305-8738; Jamieson, Denise/0000-0003-2597-1201	Pilot Project Award from the Johns Hopkins Cervical Cancer SPORE [(2P50CA098252]; NIH Cancer Prevention and Control Training Program [R25CA47888]; Centers for Disease Control and Prevention [U64/CCU106795, U64/CCU206798, U64/CCU306802, U64/CCU506831]; NATIONAL CANCER INSTITUTE [R25CA047888, P50CA098252] Funding Source: NIH RePORTER	Pilot Project Award from the Johns Hopkins Cervical Cancer SPORE; NIH Cancer Prevention and Control Training Program; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Genotyping efforts were supported by the Pilot Project Award (PI: Sadeep Shrestha) from the Johns Hopkins Cervical Cancer SPORE (2P50CA098252 PI: TC Wu). The work was supported in part by the NIH Cancer Prevention and Control Training Program (R25CA47888 - fellowship of Staci Sudenga). The HIV Epidemiology Research Study (HERS) was funded through Centers for Disease Control and Prevention cooperative agreements U64/CCU106795, U64/CCU206798, U64/CCU306802, and U64/CCU506831. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-67; Bortolotti D, 2014, TISSUE ANTIGENS, V83, P113, DOI 10.1111/tan.12281; Bosch F Xavier, 2002, Curr Oncol Rep, V4, P175, DOI 10.1007/s11912-002-0079-y; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bosch FX, 2003, SALUD PUBLICA MEXICO, V45, pS326; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Chen D, 2013, JNCI-J NATL CANCER I, V105, P624, DOI 10.1093/jnci/djt051; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Demeret C, 1995, NUCLEIC ACIDS RES, V23, P4777, DOI 10.1093/nar/23.23.4777; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Hildesheim A, 1998, CANCER EPIDEM BIOMAR, V7, P1035; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Juran BD, 2012, HUM MOL GENET, V21, P5209, DOI 10.1093/hmg/dds359; Koshiol JE, 2006, INT J CANCER, V119, P1623, DOI 10.1002/ijc.22015; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; Lee SJ, 2001, J IMMUNOL, V167, P497, DOI 10.4049/jimmunol.167.1.497; Mahmud SM, 2007, J INFECT DIS, V196, P82, DOI 10.1086/518612; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Metcalfe S, 2013, HUM IMMUNOL, V74, P1610, DOI 10.1016/j.humimm.2013.08.279; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi YY, 2013, NAT GENET, V45, P918, DOI 10.1038/ng.2687; Silva ID, 2013, HUM IMMUNOL, V74, P452, DOI 10.1016/j.humimm.2012.11.025; Simoes RT, 2009, MODERN PATHOL, V22, P1075, DOI 10.1038/modpathol.2009.67; Simonson SJS, 2005, CANCER RES, V65, P8266, DOI 10.1158/0008-5472.CAN-05-1651; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Sudenga SL, 2013, INT J INFECT DIS; Sudenga SL, 2013, HUM IMMUNOL, V74, P1696, DOI 10.1016/j.humimm.2013.08.010; Sudenga SL, 2011, ADOLESC HEALTH MED T, V2, P63, DOI 10.2147/AHMT.S15941; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546; Yang YC, 2014, EUR J CANCER, V50, P469, DOI 10.1016/j.ejca.2013.10.018	46	10	10	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99109	10.1371/journal.pone.0099109	http://dx.doi.org/10.1371/journal.pone.0099109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918582	Green Published, gold			2022-12-27	WOS:000338631000048
J	Urasaki, Y; Pizzorno, G; Le, TT				Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.			Uridine Affects Liver Protein Glycosylation, Insulin Signaling, and Heme Biosynthesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HOMEOSTATIC REGULATION; TRANSLATIONAL CONTROL; EIF2-ALPHA KINASE; METABOLISM; PHOSPHORYLASE; DISEASE; RESISTANCE; GLUCOSE; CELLS	Purines and pyrimidines are complementary bases of the genetic code. The roles of purines and their derivatives in cellular signal transduction and energy metabolism are well-known. In contrast, the roles of pyrimidines and their derivatives in cellular function remain poorly understood. In this study, the roles of uridine, a pyrimidine nucleoside, in liver metabolism are examined in mice. We report that short-term uridine administration in C57BL/6J mice increases liver protein glycosylation profiles, reduces phosphorylation level of insulin signaling proteins, and activates the HRI-eIF-2 alpha-ATF4 heme-deficiency stress response pathway. Short-term uridine administration is also associated with reduced liver hemin level and reduced ability for insulin-stimulated blood glucose removal during an insulin tolerance test. Some of the short-term effects of exogenous uridine in C57BL/6J mice are conserved in transgenic UPase1(-/-) mice with long-term elevation of endogenous uridine level. UPase1(-/-) mice exhibit activation of the liver HRI-eIF-2 alpha-ATF4 heme-deficiency stress response pathway. UPase1(-/-) mice also exhibit impaired ability for insulin-stimulated blood glucose removal. However, other short-term effects of exogenous uridine in C57BL/6J mice are not conserved in UPase1(-/-) mice. UPase1(-/-) mice exhibit normal phosphorylation level of liver insulin signaling proteins and increased liver hemin concentration compared to untreated control C57BL/6J mice. Contrasting short-term and long-term consequences of uridine on liver metabolism suggest that uridine exerts transient effects and elicits adaptive responses. Taken together, our data support potential roles of pyrimidines and their derivatives in the regulation of liver metabolism.	[Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.] Nevada Canc Inst, Las Vegas, NV 89135 USA; [Urasaki, Yasuyo; Pizzorno, Giuseppe; Le, Thuc T.] Desert Res Inst, Las Vegas, NV USA	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Pizzorno, G (corresponding author), Nevada Canc Inst, Las Vegas, NV 89135 USA.	giuseppe.pizzorno@dri.edu; thuc@uchicago.edu			Nevada INBRE Program of the National Center for Research Resources [P20RR-016464]; American Cancer Society [IRG-08-062-04]; Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	Nevada INBRE Program of the National Center for Research Resources; American Cancer Society(American Cancer Society); Vons Breast Cancer Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Nevada INBRE Program of the National Center for Research Resources (P20RR-016464, TTL), the American Cancer Society (IRG-08-062-04, TTL), and the Vons Breast Cancer Research Award (TTL and GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; ALBERTS B, 2007, MOL BIOL CELL GARLAN; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Cao DL, 2011, MOL CANCER THER, V10, P2330, DOI 10.1158/1535-7163.MCT-11-0202; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; de Cabo R, 2009, CELL METAB, V9, P305, DOI 10.1016/j.cmet.2009.03.009; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Dudzinska W, 2013, PHYSIOL RES, V62, P163, DOI 10.33549/physiolres.932355; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Le TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087179; Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249; Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092; Le TT, 2014, BMC PHARM T IN PRESS; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Li DS, 2005, CELL, V122, P487, DOI 10.1016/j.cell.2005.08.010; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oliveri LM, 2012, BIOCHEM J, V442, P303, DOI 10.1042/BJ20111005; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Walker AK, 2013, FEBS J, V280, P233, DOI 10.1111/febs.12063; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yamamoto T, 2010, NUCLEOS NUCLEOT NUCL, V29, P504, DOI 10.1080/15257771003740986; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2004, MOL ENDOCRINOL, V18, P851, DOI 10.1210/me.2003-0285	45	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99728	10.1371/journal.pone.0099728	http://dx.doi.org/10.1371/journal.pone.0099728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918436	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000107
J	Yang, YX; Xu, SX; Xu, JX; Guo, Y; Yang, G				Yang, Yunxia; Xu, Shixia; Xu, Junxiao; Guo, Yan; Yang, Guang			Adaptive Evolution of Mitochondrial Energy Metabolism Genes Associated with Increased Energy Demand in Flying Insects	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; MUSCLE; FLIGHT; FLIGHTLESSNESS; SUBSTITUTION; PHYLOGENY; PRESSURE; MODELS; ORIGIN; OXYGEN	Insects are unique among invertebrates for their ability to fly, which raises intriguing questions about how energy metabolism in insects evolved and changed along with flight. Although physiological studies indicated that energy consumption differs between flying and non-flying insects, the evolution of molecular energy metabolism mechanisms in insects remains largely unexplored. Considering that about 95% of adenosine triphosphate (ATP) is supplied by mitochondria via oxidative phosphorylation, we examined 13 mitochondrial protein-encoding genes to test whether adaptive evolution of energy metabolism-related genes occurred in insects. The analyses demonstrated that mitochondrial DNA protein-encoding genes are subject to positive selection from the last common ancestor of Pterygota, which evolved primitive flight ability. Positive selection was also found in insects with flight ability, whereas no significant sign of selection was found in flightless insects where the wings had degenerated. In addition, significant positive selection was also identified in the last common ancestor of Neoptera, which changed its flight mode from direct to indirect. Interestingly, detection of more positively selected genes in indirect flight rather than direct flight insects suggested a stronger selective pressure in insects having higher energy consumption. In conclusion, mitochondrial protein-encoding genes involved in energy metabolism were targets of adaptive evolution in response to increased energy demands that arose during the evolution of flight ability in insects.	[Yang, Yunxia; Xu, Shixia; Xu, Junxiao; Guo, Yan; Yang, Guang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Yang, G (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	gyang@njnu.edu.cn			National Science Fund for Distinguished Young Scholars [31325025]; National Natural Science Foundation of China (NSFC) [31172069, 30830016]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education [20113207130001]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was financially supported by the National Science Fund for Distinguished Young Scholars (grant no. 31325025, ULR: http://www.nsfc.gov.cn/) to GY, the National Natural Science Foundation of China (NSFC) (grant no. 31172069 and 30830016 to GY, and grant no. 31172069 to SXX, ULR: http://www.nsfc.gov.cn/), the Priority Academic Program Development of Jiangsu Higher Education Institutions to GY and SXX, and the Specialized Research Fund for the Doctoral Program of Higher Education to GY (grant no. 20113207130001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chapman A, 2009, NUMBERS LIVING SPECI; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Dudley R, 1998, J EXP BIOL, V201, P1043; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Goldsworthy G.J., 1989, INSECT FLIGHT; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; Grimaldi David, 2005, pi; HOCKING B., 1953, TRANS ROY ENT SOC LONDON, V104, P223; Hughes GM, 1974, LOCOMOTION TERRESTRI; Johnson KP, 2003, MOL PHYLOGENET EVOL, V26, P231, DOI 10.1016/S1055-7903(02)00342-1; JOSEPHSON RK, 1985, J EXP BIOL, V118, P185; Josephson RK, 2000, J EXP BIOL, V203, P2713; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; LEHNINGER A L, 1970, Biochemical Journal, V119, P129; Lindstedt SL, 1998, COMP BIOCHEM PHYS B, V120, P35, DOI 10.1016/S0305-0491(98)00021-2; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; Mayhew PJ, 2003, BIOL J LINN SOC, V80, P23, DOI 10.1046/j.1095-8312.2003.00217.x; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Mitterboeck TF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1128; Nei M., 2000, MOL EVOLUTION PHYLOG; Nielsen R, 1998, GENETICS, V148, P929; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Scheffler IE, 1998, PROG NUCLEIC ACID RE, V60, P267, DOI 10.1016/S0079-6603(08)60895-8; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; SMITH DS, 1965, SCI AM, V212, P77; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Weibel ER, 2002, NATURE, V417, P131, DOI 10.1038/417131a; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; WITHERS PC, 1981, J COMP PHYSIOL, V141, P433, DOI 10.1007/BF01101463; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	44	26	26	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99120	10.1371/journal.pone.0099120	http://dx.doi.org/10.1371/journal.pone.0099120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918926	Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000050
J	Everatt, KT; Andresen, L; Somers, MJ				Everatt, Kristoffer T.; Andresen, Leah; Somers, Michael J.			Trophic Scaling and Occupancy Analysis Reveals a Lion Population Limited by Top-Down Anthropogenic Pressure in the Limpopo National Park, Mozambique	PLOS ONE			English	Article							PANTHERA-LEO; SOCIAL-ORGANIZATION; PREY CHOICE; HABITAT; CONSERVATION; EXTINCTION; PROTECTION; CARNIVORES; PREDATORS; DENSITY	The African lion (Panthera Leo) has suffered drastic population and range declines over the last few decades and is listed by the IUCN as vulnerable to extinction. Conservation management requires reliable population estimates, however these data are lacking for many of the continent's remaining populations. It is possible to estimate lion abundance using a trophic scaling approach. However, such inferences assume that a predator population is subject only to bottom-up regulation, and are thus likely to produce biased estimates in systems experiencing top-down anthropogenic pressures. Here we provide baseline data on the status of lions in a developing National Park in Mozambique that is impacted by humans and livestock. We compare a direct density estimate with an estimate derived from trophic scaling. We then use replicated detection/non-detection surveys to estimate the proportion of area occupied by lions, and hierarchical ranking of covariates to provide inferences on the relative contribution of prey resources and anthropogenic factors influencing lion occurrence. The direct density estimate was less than 1/3 of the estimate derived from prey resources (0.99 lions/100 km(2) vs. 3.05 lions/100 km(2)). The proportion of area occupied by lions was Psi= 0.439 (SE = 0.121), or approximately 44% of a 2 400 km(2) sample of potential habitat. Although lions were strongly predicted by a greater probability of encountering prey resources, the greatest contributing factor to lion occurrence was a strong negative association with settlements. Finally, our empirical abundance estimate is approximately 1/3 of a published abundance estimate derived from opinion surveys. Altogether, our results describe a lion population held below resource-based carrying capacity by anthropogenic factors and highlight the limitations of trophic scaling and opinion surveys for estimating predator populations exposed to anthropogenic pressures. Our study provides the first empirical quantification of a population that future change can be measured against.	[Everatt, Kristoffer T.; Andresen, Leah; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Everatt, KT (corresponding author), Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa.	kteveratt@gmail.com	/A-1523-2008	/0000-0002-5836-8823	May and Stanley Smith Trust; Wipplinger KL Bursary Found; Wilderness Wildlife Trust; Canada National Student Grants	May and Stanley Smith Trust; Wipplinger KL Bursary Found; Wilderness Wildlife Trust; Canada National Student Grants	KTE and LA were supported by the May and Stanley Smith Trust, The Wipplinger KL Bursary Found, Wilderness Wildlife Trust and Canada National Student Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARD MS, 1993, HUM ECOL, V21, P355, DOI 10.1007/BF00891140; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Bauer H, 2003, CR BIOL, V326, pS112, DOI 10.1016/S1631-0691(03)00047-7; Bauer H, 2010, MAMMALIA, V74, P363, DOI 10.1515/MAMM.2010.048; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chardonnet P, 2009, CONSERVATION S UNPUB; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Funston PJ, 2003, J ZOOL, V259, P131, DOI 10.1017/S0952836902003126; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Gertenbach W. P. D., 1980, Koedoe, V23, P35; Hanks John, 2000, Conservation Biology Series (Cambridge), V3, P239; Hatton J., 2001, BIODIVERSITY WAR CAS; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; Hines JE., 2006, PRESENCESOFTWARE EST; Huggins G., 2003, LIMPOPO NATL P UNPUB; Iucn Cat Specialist Group, 2006, REG CONS STRAT LION; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Kiffner C, 2009, ORYX, V43, P52, DOI 10.1017/S0030605307002335; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mills MGL, 2001, ANIM CONSERV, V4, P335, DOI 10.1017/S1367943001001391; Ogutu JO, 2005, J ZOOL, V265, P281, DOI 10.1017/S0952836904006302; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Ray J.C., 2005, 24 WILDL CONS SOC; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Schaller G. B., 1972, SERENGETI LION STUDY; SMUTS GL, 1978, CARNIVORE, V1, P17; Stalmans M., 2004, Koedoe, V47, P61; Stephensen A., 2010, PARQUE NACL LI UNPUB; Treves A, 2009, ORYX, V43, P60, DOI 10.1017/S003060530700124X; VANORSDOL KG, 1985, J ZOOL, V206, P97; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	45	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99389	10.1371/journal.pone.0099389	http://dx.doi.org/10.1371/journal.pone.0099389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914934	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700095
J	Firdaus, R; Biswas, A; Saha, K; Mukherjee, A; Chaudhuri, S; Chandra, A; Konar, A; Sadhukhan, PC				Firdaus, Rushna; Biswas, Aritra; Saha, Kallol; Mukherjee, Anirban; Chaudhuri, Sujit; Chandra, Alok; Konar, Asokananda; Sadhukhan, Provash Chandra			Impact of Host IL28B rs12979860, rs8099917 in Interferon Responsiveness and Advanced Liver Disease in Chronic Genotype 3 Hepatitis C Patients	PLOS ONE			English	Article							PLUS RIBAVIRIN; VIRUS; POLYMORPHISM; ASSOCIATION; THERAPY; PATTERN	Background and Aims: Genetic polymorphisms near interleukin 28B gene are associated with spontaneous and treatment induced clearance of hepatitis C virus (HCV). Our objective was to evaluate the impact of interleukin 28B single nucleotide polymorphism (rs12979860, rs8099917) variability in HCV genotype 3 infected populations. Methods: 400 hepatitis C seroreactive patients from different population groups in Eastern and North Eastern part of India were assessed for host and viral genotypic analysis. 83 HCV genotype 3 infected patients were administered pegylated interferon-ribavirin therapy. Viral genotyping was performed using nested reverse transcriptase-PCR followed by direct sequencing methods. Host interleukin 28B genotyping was performed using real-time PCR based single nucleotide polymorphism analysis. Results: Out of 400 hepatitis C seroreactive individuals, 73.25% were found to be RNA positive. HCV genotype 3 (65.87%) was found to be the major circulating strain in this region followed by genotype 1 (32.08%). rs12979860 CC genotype was significantly associated with sustained virological response in HCV genotype 3 infected population. In patients achieving rapid virological response, favourable CC/TT allele at rs12979860, rs8099917 was found to be predominant at both the alleles at 77%, 73.2% respectively; whereas in case of patients with relapsed HCV infection CT, TG alleles were found to be predominant. Additionally, CC genotypes at rs12979860 were found to be associated with sustained virological response in patients with high viral load (OR = 6.75, 0.05<p). HCV unfavourable rs12979860 TT, rs8099917 GG alleles were present in 34%, 27.6% patients with relapsed HCV infection respectively. Also unfavourable CT, TG genotypes were found to be predominant in patients with advanced stages of liver disease. Conclusion: CC, TT the two favourable markers at SNPs rs12979860 and rs8099917 are strongly associated with sustained virological response in genotype 3 infected populations. This information will aid clinicians to effectively design response based treatment regimen.	[Firdaus, Rushna; Biswas, Aritra; Saha, Kallol; Mukherjee, Anirban; Sadhukhan, Provash Chandra] Indian Council Med Res, ICMR Virus Unit Kolkata, Kolkata, India; [Chaudhuri, Sujit] AMRI Hosp Salt Lake, Dept Gastroenterol, Kolkata, India; [Chandra, Alok] Command Hosp, Dept Med & Gastroenterol, Kolkata, India; [Konar, Asokananda] Peerless Hosp, Dept Gastroenterol, Kolkata, India; [Konar, Asokananda] BK Roy Res Ctr, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata	Sadhukhan, PC (corresponding author), Indian Council Med Res, ICMR Virus Unit Kolkata, Kolkata, India.	provash2000@gmail.com		chaudhuri, sujit/0000-0002-6637-2961; SAHA, KALLOL/0000-0002-2292-340X	Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2012, J HEPATOL, V52, P452; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Castera L, 2004, GUT, V53, P420, DOI 10.1136/gut.2002.009936; Chakravarti A, 2011, INDIAN J MED RES, V133, P326; Das B R, 2002, Indian J Pathol Microbiol, V45, P323; Ezzikouri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054793; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez Stevan A, 2011, Gastroenterol Hepatol (N Y), V7, P366; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Kiser JJ, 2013, ANNU REV PHARMACOL, V53, P427, DOI 10.1146/annurev-pharmtox-011112-140254; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lutz P, 2011, EUR J MED RES, V16, P335, DOI 10.1186/2047-783X-16-8-335; McHutchison JG, 2000, GASTROENTEROLOGY, V119, P1317, DOI 10.1053/gast.2000.19289; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Saha K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-116; Sivaprasad S, 2012, J CLIN EXP HEPATOL, V2, P112, DOI 10.1016/S0973-6883(12)60098-X; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Watson J C, 1998, MMWR Recomm Rep, V47, P1; WHO (World Health Organization), HEP C SURV CONTR	25	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99126	10.1371/journal.pone.0099126	http://dx.doi.org/10.1371/journal.pone.0099126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914551	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700065
J	Mor, M; Mulla, W; Elyagon, S; Gabay, H; Dror, S; Etzion, Y; Liel-Cohen, N				Mor, Michal; Mulla, Wesam; Elyagon, Sigal; Gabay, Hovav; Dror, Shani; Etzion, Yoram; Liel-Cohen, Noah			Speckle-Tracking Echocardiography Elucidates the Effect of Pacing Site on Left Ventricular Synchronization in the Normal and Infarcted Rat Myocardium	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; REGIONAL GENE-EXPRESSION; HEART-FAILURE; STRAIN ANALYSIS; SCAR BURDEN; DYSSYNCHRONY; MOUSE; MODEL; MECHANISMS; PREDICTOR	Background: Right ventricular (RV) pacing generates regional disparities in electrical activation and mechanical function (ventricular dyssynchrony). In contrast, left ventricular (LV) or biventricular (BIV) pacing can improve cardiac efficiency in the setting of ventricular dyssynchrony, constituting the rationale for cardiac resynchronization therapy (CRT). Animal models of ventricular dyssynchrony and CRT currently relay on large mammals which are expensive and not readily available to most researchers. We developed a methodology for double-site epicardial pacing in conscious rats. Here, following postoperative recovery, we compared the effects of various pacing modes on LV dyssynchrony in normal rats and in rats with ischemic cardiomyopathy. Methods: Two bipolar electrodes were implanted in rats as follows: Group A (n = 6) right atrial (RA) and RV sites; Group B (n = 7) RV and LV sites; Group C (n = 8) as in group B in combination with left coronary artery ligation. Electrodes were exteriorized through the back. Following post-operative recovery, two-dimensional transthoracic echocardiography was performed during pacing through the different electrodes. Segmental systolic circumferential strain (Ecc) was used to evaluate LV dyssynchrony. Results: In normal rats, RV pacing induced marked LV dyssynchrony compared to RA pacing or sinus rhythm, as measured by the standard deviation (SD) of segmental time to peak Ecc, SD of peak Ecc, and the average delay between opposing ventricular segments. LV pacing and, to a greater extend BIV pacing diminished the LV dyssynchrony compared to RV pacing. In rats with extensive MI, the effects of LV and BIV pacing were markedly attenuated, and the response of individual animals was variable. Conclusions: Rodent cardiac pacing mimics important features seen in humans. This model may be developed as a simple new tool to study the pathophysiology of ventricular dyssynchrony and CRT.	[Mor, Michal; Mulla, Wesam; Elyagon, Sigal; Gabay, Hovav; Dror, Shani; Etzion, Yoram] Ben Gurion Univ Negev, Fac Hlth Sci, Cardiac Arrhythmia Res Lab, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Gabay, Hovav] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Emergency Med, Recanati Sch Community Hlth Profess, Beer Sheva, Israel; [Gabay, Hovav] Ben Gurion Univ Negev, PREPARED Ctr Emergency Response Res, Beer Sheva, Israel; [Etzion, Yoram] Soroka Univ, Med Ctr, Div Internal Med, Beer Sheva, Israel; [Liel-Cohen, Noah] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Etzion, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Cardiac Arrhythmia Res Lab, Dept Physiol & Cell Biol, Beer Sheva, Israel.	tzion@bgu.ac.il	Dror, Shani/ABE-4402-2021; ETZION, YORAM/F-2065-2012	ETZION, YORAM/0000-0002-9930-1035; dror, shani/0000-0002-9909-8110; Mulla, Wesam/0000-0002-7771-6096	Clalit Research Institute, Clalit health services, Israel	Clalit Research Institute, Clalit health services, Israel	This work was supported by a research grant from the Clalit Research Institute, Clalit health services, Israel (Yoram Etzion and Noah Liel-Cohen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein EC, 2011, EUR HEART J, V32, P93, DOI 10.1093/eurheartj/ehq389; Bachner-Hinenzon N, 2012, AM J PHYSIOL-HEART C, V303, pH549, DOI 10.1152/ajpheart.00294.2012; Bachner-Hinenzon N, 2010, AM J PHYSIOL-HEART C, V299, pH664, DOI 10.1152/ajpheart.00017.2010; Bader H, 2004, J AM COLL CARDIOL, V43, P248, DOI 10.1016/j.jacc.2003.08.038; Barth AS, 2009, CIRC-CARDIOVASC GENE, V2, P371, DOI 10.1161/CIRCGENETICS.108.832345; Bilchick KC, 2006, PHYSIOL GENOMICS, V26, P109, DOI 10.1152/physiolgenomics.00281.2005; Bleeker GB, 2006, NAT CLIN PRACT CARD, V3, P213, DOI 10.1038/ncpcardio0505; Bonios M, 2011, J AM SOC ECHOCARDIOG, V24, P808, DOI 10.1016/j.echo.2011.03.003; Chakir K, 2008, CIRCULATION, V117, P1369, DOI 10.1161/CIRCULATIONAHA.107.706291; Cho GY, 2005, J AM COLL CARDIOL, V46, P2237, DOI 10.1016/j.jacc.2004.11.074; Cho HN, 2012, CIRC-ARRHYTHMIA ELEC, V5, P594, DOI 10.1161/CIRCEP.111.962746; Dandel M, 2009, INT J CARDIOL, V132, P11, DOI 10.1016/j.ijcard.2008.06.091; Etzion Y, 2008, AM J PHYSIOL-HEART C, V295, pH1460, DOI 10.1152/ajpheart.00414.2008; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Janousek J, 2013, CIRCULATION, V127, P613, DOI 10.1161/CIRCULATIONAHA.112.115428; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Kontogeorgis Andrianos, 2008, BMC Physiology, V8, P8, DOI 10.1186/1472-6793-8-8; Laughner JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076291; Leclercq C, 2011, EUR HEART J, V32, P1580, DOI 10.1093/eurheartj/ehr016; Ludwig DR, 2013, J CARDIOVASC TRANSL, V6, P425, DOI 10.1007/s12265-013-9457-0; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Popovic ZB, 2007, AM J PHYSIOL-HEART C, V292, pH2809, DOI 10.1152/ajpheart.01176.2006; Prinzen FW, 2011, HEART FAIL REV, V16, P215, DOI 10.1007/s10741-010-9205-3; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Rademakers LM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P361, DOI 10.1161/CIRCEP.109.931865; Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005; Rickard J, 2013, HEART RHYTHM, V10, P55, DOI 10.1016/j.hrthm.2012.09.018; Saba S, 2010, CIRC-ARRHYTHMIA ELEC, V3, P79, DOI 10.1161/CIRCEP.109.889741; Salama G, 2007, J PHYSIOL-LONDON, V578, P43, DOI 10.1113/jphysiol.2006.118745; Strik M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P682, DOI 10.1161/CIRCEP.111.000028; Tomaske M, 2009, EUROPACE, V11, P1168, DOI 10.1093/europace/eup178; Tomaske M, 2009, INT J CARDIOL, V136, P136, DOI 10.1016/j.ijcard.2008.04.048; Tops LF, 2009, J AM COLL CARDIOL, V54, P764, DOI 10.1016/j.jacc.2009.06.006; Ypenburg C, 2007, AM J CARDIOL, V99, P657, DOI 10.1016/j.amjcard.2006.09.115	35	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99191	10.1371/journal.pone.0099191	http://dx.doi.org/10.1371/journal.pone.0099191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915191	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700070
J	Rosazza, C; Aquino, D; D'Incerti, L; Cordella, R; Andronache, A; Zaca, D; Bruzzone, MG; Tringali, G; Minati, L				Rosazza, Cristina; Aquino, Domenico; D'Incerti, Ludovico; Cordella, Roberto; Andronache, Adrian; Zaca, Domenico; Bruzzone, Maria Grazia; Tringali, Giovanni; Minati, Ludovico			Preoperative Mapping of the Sensorimotor Cortex: Comparative Assessment of Task-Based and Resting-State fMRI	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; FUNCTIONAL CONNECTIVITY; BRAIN-TUMORS; INTRAOPERATIVE STIMULATION; SPONTANEOUS FLUCTUATIONS; CLINICAL-APPLICATIONS; HEALTHY-VOLUNTEERS; LANGUAGE AREAS; MRI; LOCALIZATION	Resting state fMRI (rs-fMRI) has recently been considered as a possible complement or alternative to task-based fMRI (tb-fMRI) for presurgical mapping. However, evidence of its usefulness remains scant, because existing studies have investigated relatively small samples and focused primarily on qualitative evaluation. The aim of this study is to investigate the clinical usefulness of rs-fMRI in the context of presurgical mapping of motor functions, and in particular to determine the degree of correspondence with tb-fMRI which, while not a gold-standard, is commonly used in preoperative setting. A group of 13 patients with lesions close to the sensorimotor cortex underwent rs-fMRI and tb-fMRI to localize the hand, foot and mouth motor areas. We assessed quantitatively the degree of correspondence between multiple rs-fMRI analyses (independent-component and seed-based analyses) and tb-fMRI, with reference to sensitivity and specificity of rs-fMRI with respect to tb-fMRI, and centre-of-mass distances. Agreement with electro-cortical stimulation (ECS) was also investigated, and a traditional map thresholding approach based on agreement between two experienced operators was compared to an automatic threshold determination method. Rs-fMRI can localize the sensorimotor cortex successfully, providing anatomical specificity for hand, foot and mouth motor subregions, in particular with seed-based analyses. Agreement with tb-fMRI was only partial and rs-fMRI tended to provide larger patterns of correlated activity. With respect to the ECS data available, rs-fMRI and tb-fMRI performed comparably, even though the shortest distance to stimulation points was observed for the latter. Notably, the results of both were on the whole robust to thresholding procedure. Localization performed by rs-fMRI is not equivalent to tb-fMRI, hence rs-fMRI cannot be considered as an outright replacement for tb-fMRI. Nevertheless, since there is significant agreement between the two techniques, rs-fMRI can be considered with caution as a potential alternative to tb-fMRI when patients are unable to perform the task.	[Rosazza, Cristina; Aquino, Domenico; D'Incerti, Ludovico; Andronache, Adrian; Bruzzone, Maria Grazia] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroradiol, Milan, Italy; [Rosazza, Cristina; Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Dept Sci, Milan, Italy; [Cordella, Roberto; Tringali, Giovanni] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neurosurg, Milan, Italy; [Zaca, Domenico; Minati, Ludovico] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Trento, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Italfarmaco; IRCCS Istituto Neurologico Besta; University of Trento	Rosazza, C (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroradiol, Milan, Italy.	cristina.rosazza@istituto-besta.it	Minati, Ludovico/R-1076-2017; zaca, domenico/AAM-4360-2020; Aquino, Domenico/AAK-3047-2021; Rosazza, Cristina/B-3959-2016; Bruzzone, Maria/AAM-4478-2021; Tringali, Giovanni/E-1834-2014	Minati, Ludovico/0000-0002-2532-1674; Aquino, Domenico/0000-0002-1289-9573; Rosazza, Cristina/0000-0002-7799-415X; Bruzzone, Maria/0000-0002-2786-1471; cordella, roberto/0000-0003-4803-2952; Tringali, Giovanni/0000-0003-1493-4034; D'Incerti, Ludovico/0000-0002-4092-9290	Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Scienze Mente-Cervello (Rovereto, Italy)	Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Scienze Mente-Cervello (Rovereto, Italy)	This study was funded by the Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy, without involvement of external funders in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors were funded by their respective institutions during the study period. LM gratefully acknowledges additional funding by Scienze Mente-Cervello (Rovereto, Italy).	Alkadhi H, 2002, AM J NEURORADIOL, V23, P1524; Andronache A, 2013, FRONT NEUROINFORM, V22, P7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bizzi A, 2008, RADIOLOGY, V248, P579, DOI 10.1148/radiol.2482071214; Bizzi A, 2009, NEUROIMAG CLIN N AM, V19, P573, DOI 10.1016/j.nic.2009.08.010; Blatow M, 2011, J MAGN RESON IMAGING, V34, P429, DOI 10.1002/jmri.22629; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Cordella R, 2013, CLIN NEUROPHYSIOL, V124, P1244, DOI 10.1016/j.clinph.2012.11.005; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fandino J, 1999, J NEUROSURG, V91, P238, DOI 10.3171/jns.1999.91.2.0238; Fesl G, 2008, EUR RADIOL, V18, P1031, DOI 10.1007/s00330-008-0850-z; Francis S, 2009, NEUROIMAGE, V44, P469, DOI 10.1016/j.neuroimage.2008.09.017; Haberg A, 2004, NEUROSURGERY, V54, P902, DOI 10.1227/01.NEU.0000114510.05922.F8; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Kekhia H, 2011, NEUROSURG CLIN N AM, V22, P111, DOI 10.1016/j.nec.2011.01.004; Kokkonen SM, 2009, MAGN RESON IMAGING, V27, P733, DOI 10.1016/j.mri.2008.11.002; Kollndorfer K, 2013, FRONT HUM NEUROSCI, P7; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lehericy S, 2000, J NEUROSURG, V92, P589, DOI 10.3171/jns.2000.92.4.0589; Leuthardt EC, 2013, NEUROSURGERY, V60, P64, DOI 10.1227/01.neu.0000430311.63702.77; Liu HS, 2009, J NEUROSURG, V111, P746, DOI 10.3171/2008.10.JNS08846; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marshall I, 2004, RADIOLOGY, V233, P868, DOI 10.1148/radiol.2333031782; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; Minati L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073746; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Orringer DA, 2012, SEMIN NEUROL, V32, P466, DOI 10.1055/s-0032-1331816; Otten ML, 2012, BRAIN, V135, P1017, DOI 10.1093/brain/aws041; Petrella JR, 2006, RADIOLOGY, V240, P793, DOI 10.1148/radiol.2403051153; Porro CA, 1996, J NEUROSCI, V16, P7688; Pouratian N, 2002, J NEUROSURG, V97, P21, DOI 10.3171/jns.2002.97.1.0021; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Roessler K, 2005, J NEUROL NEUROSUR PS, V76, P1152, DOI 10.1136/jnnp.2004.050286; Rosazza C, 2012, AM J NEURORADIOL, V33, P180, DOI 10.3174/ajnr.A2733; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Rutten GJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09251; Rutten GJM, 2002, ANN NEUROL, V51, P350, DOI 10.1002/ana.10117; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Stippich C, 2002, NEUROSCI LETT, V331, P50, DOI 10.1016/S0304-3940(02)00826-1; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Tie YM, 2014, HUM BRAIN MAPP, V35, P1018, DOI 10.1002/hbm.22231; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Meulen M, 2014, HUM BRAIN MAPP, V35, P455, DOI 10.1002/hbm.22192; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Voyvodic JT, 2006, MAGN RESON IMAGING, V24, P1249, DOI 10.1016/j.mri.2006.04.020; Zaca D, 2013, J MAGN RESON IMAGING; Zaca D, 2011, WORLD J CLIN ONCOL, V2, P289, DOI 10.5306/wjco.v2.i7.289; Zhang DY, 2009, NEUROSURGERY, V65, P226, DOI 10.1227/01.NEU.0000350868.95634.CA	64	65	67	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98860	10.1371/journal.pone.0098860	http://dx.doi.org/10.1371/journal.pone.0098860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914775	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700040
J	Shak, JR; Cremers, AJH; Gritzfeld, JF; de Jonge, MI; Hermans, PWM; Vidal, JE; Klugman, KP; Gordon, SB				Shak, Joshua R.; Cremers, Amelieke J. H.; Gritzfeld, Jenna F.; de Jonge, Marien I.; Hermans, Peter W. M.; Vidal, Jorge E.; Klugman, Keith P.; Gordon, Stephen B.			Impact of Experimental Human Pneumococcal Carriage on Nasopharyngeal Bacterial Densities in Healthy Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; HAEMOPHILUS-INFLUENZAE; MORAXELLA-CATARRHALIS; COLONIZATION; PATHOGENS; CHILDREN; EPIDEMIOLOGY; ASSOCIATION; ACQUISITION	Colonization of the nasopharynx by Streptococcus pneumoniae is a necessary precursor to pneumococcal diseases that result in morbidity and mortality worldwide. The nasopharynx is also host to other bacterial species, including the common pathogens Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis. To better understand how these bacteria change in relation to pneumococcal colonization, we used species-specific quantitative PCR to examine bacterial densities in 52 subjects 7 days before, and 2, 7, and 14 days after controlled inoculation of healthy human adults with S. pneumoniae serotype 6B. Overall, 33 (63%) of subjects carried S. pneumoniae post-inoculation. The baseline presence and density of S. aureus, H. influenzae, and M. catarrhalis were not statistically associated with likelihood of successful pneumococcal colonization at this study's sample size, although a lower rate of pneumococcal colonization in the presence of S. aureus (7/14) was seen compared to that in the presence of H. influenzae (12/16). Among subjects colonized with pneumococci, the number also carrying either H. influenzae or S. aureus fell during the study and at 14 days post-inoculation, the proportion carrying S. aureus was significantly lower among those who were colonized with S. pneumoniae (p = 0.008) compared to non-colonized subjects. These data on bacterial associations are the first to be reported surrounding experimental human pneumococcal colonization and show that co-colonizing effects are likely subtle rather than absolute.	[Shak, Joshua R.; Vidal, Jorge E.; Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Cremers, Amelieke J. H.; de Jonge, Marien I.; Hermans, Peter W. M.] Radboudumc, Dept Pediat, Lab Pediat Infect Dis, Nijmegen, Netherlands; [Gritzfeld, Jenna F.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Resp Infect Grp, Liverpool L3 5QA, Merseyside, England	Emory University; Rollins School Public Health; Radboud University Nijmegen; Liverpool School of Tropical Medicine; University of Liverpool	Shak, JR (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jshak@emory.edu; sbgordon@liverpool.ac.uk	Cremers, Amelieke/R-5197-2019; de Jonge, Marien I./P-5869-2015; Hermans, Peter W.M./H-8042-2014; Cremers, Amelieke J.H./A-5536-2016	Cremers, Amelieke/0000-0003-4704-4978; de Jonge, Marien I./0000-0003-2812-5895; Cremers, Amelieke J.H./0000-0003-4704-4978; Gordon, Stephen/0000-0001-6576-1116	Bill and Melinda Gates Foundation [OPP1035281]; Molecules to Mankind Program at Emory's Laney Graduate School; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; Medical Scientist Training Program at Emory University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Molecules to Mankind Program at Emory's Laney Graduate School; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Medical Scientist Training Program at Emory University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the financial support of the Bill and Melinda Gates Foundation (Experimental Human Pneumococcal Carriage model; OPP1035281). JRS acknowledges financial support from the Molecules to Mankind Program at Emory's Laney Graduate School and the Medical Scientist Training Program at Emory University School of Medicine. Statistical consultation at the ACTSI was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Bae S, 2012, J MED MICROBIOL, V61, P678, DOI 10.1099/jmm.0.040584-0; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Das Bhattacharya S, 2012, INDIAN J PEDIATR, V79, P1447, DOI 10.1007/s12098-012-0762-4; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Ferreira DM, 2011, TRENDS MICROBIOL, V19, P464, DOI 10.1016/j.tim.2011.06.003; Gritzfeld JF, 2013, JOVE-J VIS EXP, DOI 10.3791/50115; Gritzfeld Jenna F, 2011, BMC Res Notes, V4, P122, DOI 10.1186/1756-0500-4-122; Jacoby P, 2007, VACCINE, V25, P2458, DOI 10.1016/j.vaccine.2006.09.020; Jourdain S, 2011, CLIN MICROBIOL INFEC, V17, P907, DOI 10.1111/j.1469-0691.2010.03410.x; Kilic A, 2010, DIAGN MICR INFEC DIS, V66, P349, DOI 10.1016/j.diagmicrobio.2009.11.010; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lijek RS, 2012, P NATL ACAD SCI USA, V109, P13823, DOI 10.1073/pnas.1208075109; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; McAvin JC, 2001, J CLIN MICROBIOL, V39, P3446, DOI 10.1128/JCM.39.10.3446-3451.2001; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Nizet V, 1996, J INFECT DIS, V173, P180, DOI 10.1093/infdis/173.1.180; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Wright AKA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002622	32	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98829	10.1371/journal.pone.0098829	http://dx.doi.org/10.1371/journal.pone.0098829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915552	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000340947700037
J	Hanafi, LA; Gauchat, D; Godin-Ethier, J; Possamai, D; Duvignaud, JB; Leclerc, D; Grandvaux, N; Lapointe, R				Hanafi, Laila-Aicha; Gauchat, Dominique; Godin-Ethier, Jessica; Possamai, David; Duvignaud, Jean-Baptiste; Leclerc, Denis; Grandvaux, Nathalie; Lapointe, Rejean			Fludarabine Downregulates Indoleamine 2,3-Dioxygenase in Tumors via a Proteasome-Mediated Degradation Mechanism	PLOS ONE			English	Article							INTERFERON-GAMMA; DENDRITIC CELLS; EXPRESSION; CANCER; IDO; INHIBITION; TRYPTOPHAN; THERAPY; STAT1; CHEMOTHERAPY	Indoleamine 2,3-dioxygenase (IDO) is found in multiple malignancies and exerts immunosuppressive effects that are central in protecting tumors from host T lymphocyte rejection. IDO is an enzyme involved in the catabolism of tryptophan resulting in inhibition of T lymphocyte function. While inhibition of IDO enzymatic activity results in tumor rejection, it is still unknown how we can directly target IDO expression within tumors using drugs. We have chosen to interfere with IDO expression by targeting the key-signaling event signal transducer and activator of transcription 1 (STAT1). We evaluated the efficacy of fludarabine, previously described to inhibit STAT1 phosphorylation. Interestingly, fludarabine was efficient in suppressing protein expression and consequently IDO activity in two different cell lines derived from breast cancer and melanoma when IDO was activated with interferon-gamma (IFN-gamma) or supernatants prepared from activated T lymphocytes. However, fludarabine had no inhibitory effect on STAT1 phosphorylation. Other IFN-gamma-responsive genes were only marginally inhibited by fludarabine. The level of IDO transcript was unaffected by this inhibitor, suggesting the involvement of post-transcriptional control. Strikingly, we have found that the inhibition of proteasome partially protected IDO from fludarabine-induced degradation, indicating that fludarabine induces IDO degradation through a proteasome-dependent pathway. Currently used in the clinic to treat some malignancies, fludarabine has the potential for use in the treatment of human tumors through induction of IDO degradation and consequently, for the promotion of T cell-mediated anti-tumor response.	[Hanafi, Laila-Aicha; Gauchat, Dominique; Godin-Ethier, Jessica; Possamai, David; Grandvaux, Nathalie; Lapointe, Rejean] Univ Montreal, Res Ctr, Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada; [Hanafi, Laila-Aicha; Gauchat, Dominique; Godin-Ethier, Jessica; Possamai, David; Lapointe, Rejean] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Duvignaud, Jean-Baptiste; Leclerc, Denis] Univ Laval, Ctr Rech & Infectiol, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Duvignaud, Jean-Baptiste; Leclerc, Denis] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Duvignaud, Jean-Baptiste] Univ Laval, PROTEO, Quebec City, PQ, Canada; [Grandvaux, Nathalie] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Laval University; Laval University; Laval University; Universite de Montreal	Lapointe, R (corresponding author), Univ Montreal, Res Ctr, Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada.	rejean.lapointe@umontreal.ca	Leclerc, Denis/AAG-6112-2019; Leclerc, Denis/P-1604-2019	Grandvaux, Nathalie/0000-0003-0567-0284	Canadian Institutes of Health Research [MOP-89727]; Fonds de la recherche Quebec - Sante; Canada Research Chair Tier II	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Canada Research Chair Tier II(Canada Research Chairs)	This work was supported by an operating grant from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) [Grant number MOP-89727] and by fellowships from Fonds de la recherche Quebec - Sante (.qc.ca) [RL and LAH]. NG is supported by a Canada Research Chair Tier II (www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Cheng CW, 2010, J AGR FOOD CHEM, V58, P887, DOI 10.1021/jf903377e; de Souza JA, 2009, BONE MARROW TRANSPL, V44, P81, DOI 10.1038/bmt.2009.101; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dudley ME, 2002, J IMMUNOTHER, V25, P243, DOI 10.1097/00002371-200205000-00007; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Gamberale R, 2006, HAEMATOLOGICA, V91, P574; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Godin-Ethier J, 2011, MOL IMMUNOL, V49, P253, DOI 10.1016/j.molimm.2011.08.017; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Heitger A, 2011, CURR MED CHEM, V18, P2222, DOI 0929-8673/11 $58.00+.00; Hernandez-Breijo B, 2011, WORLD J GASTROENTERO, V17, P3899, DOI 10.3748/wjg.v17.i34.3899; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Jiang GM, 2010, INT J BIOCHEM CELL B, V42, P1840, DOI 10.1016/j.biocel.2010.07.020; Lee HJ, 2007, BIOCHEM PHARMACOL, V73, P1412, DOI 10.1016/j.bcp.2006.12.018; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lu K, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-55; Mailankot M, 2010, INT J BIOCHEM CELL B, V42, P1446, DOI 10.1016/j.biocel.2010.04.014; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Munn David H, 2012, Front Biosci (Elite Ed), V4, P734; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Noh KT, 2013, BIOCHEM BIOPH RES CO, V431, P348, DOI 10.1016/j.bbrc.2012.12.093; Novitskiy SV, 2012, CANCER DISCOV, V2, P673, DOI 10.1158/2159-8290.CD-12-0311; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Pallotta MT, 2010, INT J TRYPTOPHAN RES, V3, P91, DOI 10.4137/IJTR.S3971; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Rachakatla RS, 2008, CANCER INVEST, V26, P662, DOI 10.1080/07357900701871134; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; RIVOLTINI L, 1995, CANCER RES, V55, P3149; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yuan BF, 2011, CANCER RES, V71, P1904, DOI 10.1158/0008-5472.CAN-10-3430	44	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99211	10.1371/journal.pone.0099211	http://dx.doi.org/10.1371/journal.pone.0099211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911872	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600057
J	Jurgens, TP; Sawatzki, A; Henrich, F; Magerl, W; May, A				Juergens, Tim P.; Sawatzki, Alexander; Henrich, Florian; Magerl, Walter; May, Arne			An Improved Model of Heat-Induced Hyperalgesia-Repetitive Phasic Heat Pain Causing Primary Hyperalgesia to Heat and Secondary Hyperalgesia to Pinprick and Light Touch	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CENTRAL SENSITIZATION; C-FIBER; ELECTRICAL-STIMULATION; NOCICEPTIVE AFFERENTS; SEROTONERGIC SYSTEMS; EVOKED-POTENTIALS; NEUROPATHIC PAIN; CUTANEOUS PAIN	This study tested a modified experimental model of heat-induced hyperalgesia, which improves the efficacy to induce primary and secondary hyperalgesia and the efficacy-to-safety ratio reducing the risk of tissue damage seen in other heat pain models. Quantitative sensory testing was done in eighteen healthy volunteers before and after repetitive heat pain stimuli (60 stimuli of 48 degrees C for 6 s) to assess the impact of repetitive heat on somatosensory function in conditioned skin (primary hyperalgesia area) and in adjacent skin (secondary hyperalgesia area) as compared to an unconditioned mirror image control site. Additionally, areas of flare and secondary hyperalgesia were mapped, and time course of hyperalgesia determined. After repetitive heat pain conditioning we found significant primary hyperalgesia to heat, and primary and secondary hyperalgesia to pinprick and to light touch (dynamic mechanical allodynia). Acetaminophen (800 mg) reduced pain to heat or pinpricks only marginally by 11% and 8%, respectively (n.s.), and had no effect on heat hyperalgesia. In contrast, the areas of flare (-31%) and in particular of secondary hyperalgesia (-59%) as well as the magnitude of hyperalgesia (-59%) were significantly reduced (all p, 0.001). Thus, repetitive heat pain induces significant peripheral sensitization (primary hyperalgesia to heat) and central sensitization (punctate hyperalgesia and dynamic mechanical allodynia). These findings are relevant to further studies using this model of experimental heat pain as it combines pronounced peripheral and central sensitization, which makes a convenient model for combined pharmacological testing of analgesia and anti-hyperalgesia mechanisms related to thermal and mechanical input.	[Juergens, Tim P.; Sawatzki, Alexander; May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Henrich, Florian; Magerl, Walter] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol, Chair Neurophysiol, Mannheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Jurgens, TP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	t.juergens@uke.de			DFG [Ma1251/9-1, Ma1251/9-2]; German Research Foundation (Deutsche Forschungsgemeinschaft DFG)	DFG(German Research Foundation (DFG)); German Research Foundation (Deutsche Forschungsgemeinschaft DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG) "Sonderforschungsbereich 936'' (Project A5: Central networks in pain habituation). Part of this work was funded by a grant of the DFG to WM. (FOR926, grant Ma1251/9-1 and 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Baldwin A, 2012, J BURN CARE RES, V33, P176, DOI 10.1097/BCR.0b013e3182331cfe; Bandschapp O, 2010, ANESTHESIOLOGY, V113, P421, DOI 10.1097/ALN.0b013e3181e33ac8; Barriere DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070690; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bjorkman R, 1995, Acta Anaesthesiol Scand Suppl, V103, P1; Breimhorst M, 2012, EUR J PAIN, V16, P1281, DOI 10.1002/j.1532-2149.2012.00133.x; CAMPBELL JN, 1979, J NEUROPHYSIOL, V42, P1669, DOI 10.1152/jn.1979.42.6.1669; CERVERO F, 1993, PAIN, V54, P181, DOI 10.1016/0304-3959(93)90207-6; Defrin R, 2006, CLIN J PAIN, V22, P130, DOI 10.1097/01.ajp.0000154048.68273.d8; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Doganci B, 2011, EUR J PAIN, V15, P384, DOI 10.1016/j.ejpain.2010.09.003; Elia N, 2005, ANESTHESIOLOGY, V103, P1296, DOI 10.1097/00000542-200512000-00025; Filitz J, 2008, PAIN, V136, P262, DOI 10.1016/j.pain.2007.06.036; Fissmer I, 2011, ANESTHESIOLOGY, V115, P387, DOI 10.1097/ALN.0b013e318219509e; FORSTER C, 1992, AGENTS ACTIONS, V35, P112, DOI 10.1007/BF01990960; GREENSPAN JD, 1991, SOMATOSENS MOT RES, V8, P137, DOI 10.3109/08990229109144738; Greffrath W, 2007, PAIN, V132, P301, DOI 10.1016/j.pain.2007.04.026; Gustorff B, 2013, PAIN, V154, P586, DOI 10.1016/j.pain.2012.12.020; Hansen N, 2007, J NEUROPHYSIOL, V97, P2559, DOI 10.1152/jn.01125.2006; Hashmi JA, 2010, PAIN, V151, P737, DOI 10.1016/j.pain.2010.08.046; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Hoppe F, 1991, HAMBURGER SCHMERZ AD; Jurgens TP, 2012, EUR J PAIN, V16, P1251, DOI 10.1002/j.1532-2149.2012.00135.x; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Klein T, 2008, PAIN, V139, P507, DOI 10.1016/j.pain.2008.06.001; Klein T, 2006, J NEUROPHYSIOL, V96, P3551, DOI 10.1152/jn.00755.2006; Koppert W, 2004, PAIN, V108, P148, DOI 10.1016/j.pain.2003.12.017; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; Kuhtz-Buschbeck JP, 2010, ADV PHYSIOL EDUC, V34, P25, DOI 10.1152/advan.00002.2010; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Lang S, 2007, PAIN, V128, P254, DOI 10.1016/j.pain.2006.09.026; LAUTENBACHER S, 1995, SOMATOSENS MOT RES, V12, P59, DOI 10.3109/08990229509063142; Liu XG, 1998, NEUROSCIENCE, V86, P1209, DOI 10.1016/S0306-4522(98)00107-9; Magerl W, 1996, J PHYSIOL-LONDON, V497, P837, DOI 10.1113/jphysiol.1996.sp021814; Magerl W, 2004, NEUROSCI LETT, V361, P136, DOI 10.1016/j.neulet.2003.12.001; MAGERL W, 1987, NEUROSCI LETT, V82, P349, DOI 10.1016/0304-3940(87)90281-3; Magerl W, 1998, PAIN, V74, P257, DOI 10.1016/S0304-3959(97)00177-2; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Magerl W, 2006, HAND CLINIC, V81, P503, DOI 10.1016/S0072-9752(06)80037-0; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; May A, 2012, EUR J PAIN, V16, P401, DOI 10.1002/j.1532-2149.2011.00023.x; May A, 2011, EUR J PAIN IN PRESS; MORITZ AR, 1947, AM J PATHOL, V23, P695; Ong CKS, 2010, ANESTH ANALG, V110, P1170, DOI 10.1213/ANE.0b013e3181cf9281; Pedersen JL, 1998, PAIN, V76, P377, DOI 10.1016/S0304-3959(98)00070-0; Pedersen JL, 2000, DAN MED BULL, V47, P168; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Pickering G, 2008, CLIN PHARMACOL THER, V84, P47, DOI 10.1038/sj.clpt.6100403; Pini LA, 1996, EUR J PHARMACOL, V308, P31, DOI 10.1016/0014-2999(96)00261-0; RAJA SN, 1984, BRAIN, V107, P1179, DOI 10.1093/brain/107.4.1179; Rennefeld C, 2010, PAIN, V148, P503, DOI 10.1016/j.pain.2009.12.014; Rodriguez-Raecke R, 2010, J NEUROSCI, V30, P11363, DOI 10.1523/JNEUROSCI.2197-10.2010; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; Sinclair D, 1967, CATANEOUS SENSATION; Slugg RM, 2000, J NEUROPHYSIOL, V83, P2179, DOI 10.1152/jn.2000.83.4.2179; Stiasny-Kolster K, 2013, PAIN, V154, P1457, DOI 10.1016/j.pain.2013.05.007; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; THALHAMMER JG, 1982, BRAIN RES, V231, P257, DOI 10.1016/0006-8993(82)90364-X; TJOLSEN A, 1991, EUR J PHARMACOL, V193, P193, DOI 10.1016/0014-2999(91)90036-P; TREEDE RD, 1995, ANN MED, V27, P213, DOI 10.3109/07853899509031961; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Vaideanu D, 2006, BRIT J OPHTHALMOL, V90, P713, DOI 10.1136/bjo.2005.076091; Vo L, 2014, EUR J PAIN, V18, P376, DOI 10.1002/j.1532-2149.2013.00370.x; Vo L, 2013, EUR J PAIN, V17, P357, DOI 10.1002/j.1532-2149.2012.00208.x; Werner MU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062733; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245	78	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99507	10.1371/journal.pone.0099507	http://dx.doi.org/10.1371/journal.pone.0099507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911787	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600097
J	Obrochta, KM; Kane, MA; Napoli, JL				Obrochta, Kristin M.; Kane, Maureen A.; Napoli, Joseph L.			Effects of Diet and Strain on Mouse Serum and Tissue Retinoid Concentrations	PLOS ONE			English	Article							VITAMIN-A HOMEOSTASIS; BINDING-PROTEIN; ACID; ACYLTRANSFERASE; QUANTIFICATION; LECITHIN; ESTERS; CELL	The relationship between dietary vitamin A and all-trans-retinoic acid levels in serum and tissues had not been quantified. We determined the impact of dietary vitamin A on retinoid levels in serum, liver, kidney, testis, and epididymal white adipose of five mouse strains: AKR/J; BALB/cByJ; C3H/HeJ; C57BL/6J; 129S1/SvImJ. Retinoids were quantified in mice fed copious vitamin A (lab chow, >= 20 IU/g) followed by one month feeding a vitamin A-sufficient diet (4 IU/g), or after three generations of feeding a vitamin A-sufficient diet. Retinol and retinyl esters were measured by high-performance liquid chromatography with ultraviolet absorbance detection. All-trans-retinoic acid was quantified by liquid chromatography tandem mass spectrometry. The amounts of dietary vitamin A had long-term strain-specific effects on tissue retinyl ester, retinol and all-trans-retinoic acid concentrations. Three generations of feeding a vitamin A-sufficient diet decreased all-transretinoic acid in most tissues of most strains, in some cases more than 60%, compared to a diet with copious vitamin A. With both diets, all-trans-retinoic acid concentrations maintained an order of liver approximate to testis. kidney. white adipose tissue approximate to serum. Neither retinol nor all-trans-retinoic acid in serum reflected all-trans-retinoic acid concentrations in tissues. Strain and tissue-specific differences in retinol and all-trans-retinoic acid altered by different amounts of dietary vitamin A could have profound effects on retinoid action. This would be the case especially with the increased all-trans-retinoic acid values associated with the amounts of vitamin A and its precursors (carotenoids) in chow diets.	[Obrochta, Kristin M.; Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	jna@berkeley.edu			National Institutes of Health USA [DK090522, AA017927]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK090522, T32DK061918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health USA grants DK090522 and AA017927. JLN received this funding (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Benevenga NJ, 1995, NUTR REQUIREMENTS LA; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Liu LM, 2008, BIOCHEM PHARMACOL, V75, P2316, DOI 10.1016/j.bcp.2008.03.012; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; NAPOLI JL, 1986, METHOD ENZYMOL, V123, P112, DOI 10.1016/S0076-6879(86)23015-3; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nau H, 2001, J AM ACAD DERMATOL, V45, pS183, DOI 10.1067/mjd.2001.113720; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reeves PG, 1997, J NUTR, V127, pS838; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Ross AC, 2011, PHYSIOL GENOMICS, V43, P57, DOI 10.1152/physiolgenomics.00182.2010; Savenije B, 2010, NUTR FEEDING ANIMAL, P183; Schreiber R, 2012, BBA-MOL CELL BIOL L, V1821, P113, DOI 10.1016/j.bbalip.2011.05.001; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; X E, 2002, J BIOL CHEM, V277, P36617, DOI [10.1074/jbc.M205519200, DOI 10.1074/JBC.M205519200]; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com	26	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99435	10.1371/journal.pone.0099435	http://dx.doi.org/10.1371/journal.pone.0099435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911926	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600088
J	Dong, J; Guan, HZ; Jiang, ZY; Chen, X				Dong, Jing; Guan, Hong-Zai; Jiang, Zheng-Yao; Chen, Xi			Nesfatin-1 Influences the Excitability of Glucosensing Neurons in the Dorsal Vagal Complex and Inhibits Food Intake	PLOS ONE			English	Article							C-FOS; PARAVENTRICULAR NUCLEUS; SOLITARY TRACT; BRAIN; IMMUNOREACTIVITY; HYPOTHALAMUS; EXPRESSION	Nesfatin-1 is a recently discovered metabolic peptide hormone that decreases food intake after lateral, third, or fourth brain ventricle; cisterna magna; or paraventricular nucleus (PVN) injection in ad libitum fed rats. Additional micro-injection studies will improve the understanding of how nesfatin-1 acts on the brain and define specific nuclei responsive to nesfatin-1, which will provide insight on its effects on food intake. We evaluated how nesfatin-1 injection into the dorsal vagal complex (DVC) modulates food intake response in rats during the dark phase. Consistent with previous observations, nesfatin-1-injected rats significantly reduced cumulative food intake over a 5-h period in rats. Chronic administration of nesfatin-1 into the DVC reduced body weight gain over a 10-day period. Because glucosensing neurons in the DVC are involved in glucoprivic feeding and homeostatic control of blood glucose, we examined the effect of nesfatin-1 on the excitability of DVC glucosensing neurons. Nesfatin-1 inhibited most of the glucose-inhibitory (GI) neurons and excited most of the glucose-excitatory (GE) neurons in the DVC. Current-clamp electrophysiology recordings from DVC glucosensing neurons in slice preparation showed that bath applied nesfatin-1(10 nM) increased the firing frequency of GE neurons and inhibited the firing rate of GI-neurons. Nesfatin-1 inhibited 88.9% (16/18) of gastric distension inhibitory (GD-INH) neurons and excited 76.2% (32/42) of gastric distension excitatory (GD-EXC) neurons. Thus, nesfatin-1 may control food intake by modulating the excitability of glucosensing neurons in the DVC.	[Dong, Jing] Qingdao Univ, Coll Med, Dept Special Med, Qingdao 266071, Peoples R China; [Dong, Jing; Guan, Hong-Zai; Jiang, Zheng-Yao; Chen, Xi] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Jiang, ZY (corresponding author), Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China.	qd-zyj@163.com; casey1201@163.com			National Natural Science Foundation of China [31071013, 31371168, 31200868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31071013 to Z-Y Jiang, 31371168 to J. Dong and 31200868 to X. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet MS, 2013, J NEUROENDOCRINOL, V25, P1, DOI 10.1111/j.1365-2826.2012.02375.x; Bonnet MS, 2013, REGUL PEPTIDES, V187, P17, DOI 10.1016/j.regpep.2013.10.001; Briski KP, 2000, EXP BRAIN RES, V133, P547, DOI 10.1007/s002210000448; Chen X, 2012, REGUL PEPTIDES, V177, P21, DOI 10.1016/j.regpep.2012.04.003; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Dallaporta M, 1999, NEUROREPORT, V10, P2657, DOI 10.1097/00001756-199908200-00040; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Goebel-Stengel M, 2011, BRAIN RES, V1396, P20, DOI 10.1016/j.brainres.2011.04.031; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Noetzel S, 2009, REGUL PEPTIDES, V157, P84, DOI 10.1016/j.regpep.2009.06.009; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ritter S, 1998, BRAIN RES, V805, P41, DOI 10.1016/S0006-8993(98)00655-6; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Vrang N, 2003, AM J PHYSIOL-REG I, V285, pR470, DOI 10.1152/ajpregu.00732.2002; Watts AG, 2010, FRONT NEUROENDOCRIN, V31, P32, DOI 10.1016/j.yfrne.2009.10.006; Willing AE, 1997, AM J PHYSIOL-REG I, V272, pR59, DOI 10.1152/ajpregu.1997.272.1.R59; Yosten GLC, 2009, AM J PHYSIOL-REG I, V297, pR330, DOI 10.1152/ajpregu.90867.2008	22	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98967	10.1371/journal.pone.0098967	http://dx.doi.org/10.1371/journal.pone.0098967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906120	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000082
J	Gomez-Gomez, E; Rios-Martinez, ME; Castro-Rodriguez, EM; Del-Toro-Equihua, M; Ramirez-Flores, M; Delgado-Enciso, I; Perez-Huitimea, AL; Baltazar-Rodriguez, LM; Velasco-Pineda, G; Muniz-Murguia, J				Gomez-Gomez, Eduardo; Efren Rios-Martinez, Martin; Margarita Castro-Rodriguez, Elena; Del-Toro-Equihua, Mario; Ramirez-Flores, Mario; Delgado-Enciso, Ivan; Lilia Perez-Huitimea, Ana; Margarita Baltazar-Rodriguez, Luz; Velasco-Pineda, Gilberto; Muniz-Murguia, Jesus			Carnitine Palmitoyltransferase 1B 531K Allele Carriers Sustain a Higher Respiratory Quotient after Aerobic Exercise, but beta 3-Adrenoceptor 64R Allele Does Not Affect Lipolysis: A Human Model	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISM; FATTY-ACID OXIDATION; TRP64ARG POLYMORPHISM; MUSCLE; ASSOCIATION; AVAILABILITY; METABOLISM; INCREASES; JAPANESE; BMI	Carnitine palmitoyltransferase IB (CPT1B) and adrenoceptor beta-3 (ADRB3) are critical regulators of fat metabolism. CPT1B transports free acyl groups into mitochondria for oxidation, and ADRB3 triggers lipolysis in adipocytes, and their respective polymorphisms E531K and W64R have been identified as indicators of obesity in population studies. It is therefore important to understand the effects of these mutations on ADRB3 and CPT1B function in adipose and skeletal muscle tissue, respectively. This study aimed to analyze the rate of lipolysis of plasma indicators (glycerol, free fatty acids, and beta hydroxybutyrate) and fat oxidation (through the non-protein respiratory quotient). These parameters were measured in 37 participants during 30 min of aerobic exercise at approximately 62% of maximal oxygen uptake, followed by 30 min of recovery. During recovery, mean respiratory quotient values were higher in K allele carriers than in non-carriers, indicating low post-exercise fatty acid oxidation rates. No significant differences in lipolysis or lipid oxidation were observed between R and W allele carriers of ADRB3 at any time during the aerobic load. The substitution of glutamic acid at position 531 by lysine in the CPT1B protein decreases the mitochondrial beta-oxidation pathway, which increases the non-protein respiratory quotient value during recovery from exercise. This may contribute to weight gain or reduced weight-loss following exercise.	[Gomez-Gomez, Eduardo; Efren Rios-Martinez, Martin; Margarita Castro-Rodriguez, Elena; Ramirez-Flores, Mario; Muniz-Murguia, Jesus] Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico; [Del-Toro-Equihua, Mario; Delgado-Enciso, Ivan; Margarita Baltazar-Rodriguez, Luz; Velasco-Pineda, Gilberto] Univ Colima, Fac Med, Colima, Mexico; [Lilia Perez-Huitimea, Ana] Univ Colima, Fac Ciencias & Educ, Colima, Mexico	Universidad de Colima; Universidad de Colima; Universidad de Colima	Muniz-Murguia, J (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico.	mmurguia@ucol.mx	Delgado-Enciso, Ivan/B-1743-2018	Delgado-Enciso, Ivan/0000-0001-9848-862X; Baltazar Rodriguez, Luz Margarita/0000-0002-6531-9624; Ramirez-Flores, Mario/0000-0003-3375-715X	Mexican government through National Council of Science and Technology (CONACYT) [81471]	Mexican government through National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded by the Mexican government through National Council of Science and Technology (CONACYT), www.conacyt.gob.mx: project 81471 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sport Medicine, 1991, AM COLL SPORTS MED G, P55; Auinger A, 2013, BRIT J NUTR, V109, P810, DOI 10.1017/S0007114512002656; Baturin A. K., 2012, Voprosy Pitaniya, V81, P23; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ellsworth DL, 2005, OBES RES, V13, P519, DOI 10.1038/oby.2005.55; Garenc C, 2001, OBES RES, V9, P337, DOI 10.1038/oby.2001.43; Gene cards, HUM GEN COMP; Hargreaves M, 2006, EXERCISE METABOLISM, P291; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; *INT SOC ADV KIN, 2001, INT STANDARDS ANTHRO; Jekal Yoonsuk, 2010, Korean Diabetes J, V34, P182, DOI 10.4093/kdj.2010.34.3.182; Kurokawa N, 2001, OBES RES, V9, P741, DOI 10.1038/oby.2001.102; Leggate M, 2010, CELL STRESS CHAPERON, V15, P827, DOI 10.1007/s12192-010-0192-z; Liu HY, 2007, ARCH BIOCHEM BIOPHYS, V465, P437, DOI 10.1016/j.abb.2007.06.026; Love LK, 2011, J APPL PHYSIOL, V111, P427, DOI 10.1152/japplphysiol.00672.2010; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; McArdle WD, 2010, EXERCISE PHYSL NUTR, P1038; McArdle WD, 2000, ESSENTIALS EXERCISE; Miljkovic I, 2009, OBESITY, V17, P1396, DOI 10.1038/oby.2008.677; Mirrakhimov AE, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-89; Napal L, 2003, J BIOL CHEM, V278, P34084, DOI 10.1074/jbc.M305826200; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Norton K, 1996, ANTHROPOMETRICA TXB; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Rankinen T, 2012, PROG MOL BIOL TRANSL, V108, P447, DOI 10.1016/B978-0-12-398397-8.00017-4; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Robitaille J, 2007, J MOL MED, V85, P129, DOI 10.1007/s00109-006-0116-7; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Levy TS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-152; Tahara Aya, 2010, Environmental Health and Preventive Medicine, V15, P392, DOI 10.1007/s12199-010-0157-y; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; World Health Organization (WHO), GUID DRAW BLOOD BEST; Zhan SY, 2005, OBES RES, V13, P1709, DOI 10.1038/oby.2005.209	37	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96791	10.1371/journal.pone.0096791	http://dx.doi.org/10.1371/journal.pone.0096791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905907	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000002
J	Ing, A; Schwarzbauer, C				Ing, Alex; Schwarzbauer, Christian			Cluster Size Statistic and Cluster Mass Statistic: Two Novel Methods for Identifying Changes in Functional Connectivity Between Groups or Conditions	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; BRAIN CONNECTIVITY; OXYGEN-CONSUMPTION; CARBON-DIOXIDE; ACTIVATION; NETWORKS; LOCALIZATION; PERMUTATION; DEPENDENCE; DISEASE	Functional connectivity has become an increasingly important area of research in recent years. At a typical spatial resolution, approximately 300 million connections link each voxel in the brain with every other. This pattern of connectivity is known as the functional connectome. Connectivity is often compared between experimental groups and conditions. Standard methods used to control the type 1 error rate are likely to be insensitive when comparisons are carried out across the whole connectome, due to the huge number of statistical tests involved. To address this problem, two new cluster based methods - the cluster size statistic (CSS) and cluster mass statistic (CMS) - are introduced to control the family wise error rate across all connectivity values. These methods operate within a statistical framework similar to the cluster based methods used in conventional task based fMRI. Both methods are data driven, permutation based and require minimal statistical assumptions. Here, the performance of each procedure is evaluated in a receiver operator characteristic (ROC) analysis, utilising a simulated dataset. The relative sensitivity of each method is also tested on real data: BOLD (blood oxygen level dependent) fMRI scans were carried out on twelve subjects under normal conditions and during the hypercapnic state (induced through the inhalation of 6% CO2 in 21% O-2 and 73% N-2). Both CSS and CMS detected significant changes in connectivity between normal and hypercapnic states. A family wise error correction carried out at the individual connection level exhibited no significant changes in connectivity.	[Ing, Alex; Schwarzbauer, Christian] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland	University of Aberdeen	Ing, A (corresponding author), Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland.	a.ing@abdn.ac.uk			University of Aberdeen	University of Aberdeen	The study was funded internally (University of Aberdeen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Biswal B, 1997, J CEREBR BLOOD F MET, V17, P301, DOI 10.1097/00004647-199703000-00007; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Calhoun V, 2012, MULTISUBJECT INDEPEN; CHAKRABORTY DP, 1989, MED PHYS, V16, P561, DOI 10.1118/1.596358; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; El-Sayed M, 2010, J PSYCHIATR NEUROSCI, V35, P229, DOI 10.1503/jpn.090051; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Meskaldji DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023009; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Perrin JS, 2012, P NATL ACAD SCI; POLINE JB, 1993, J CEREBR BLOOD F MET, V13, P425, DOI 10.1038/jcbfm.1993.57; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Ward J, 1999, RADIOLOGY, V210, P459, DOI 10.1148/radiology.210.2.r99fe05459; Welvaert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077089; Wise RG, 2007, J CEREBR BLOOD F MET, V27, P1521, DOI 10.1038/sj.jcbfm.9600465; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; Yablonskiy DA, 2011, J CEREBR BLOOD F MET, V31, P1502, DOI 10.1038/jcbfm.2011.32; Zalesky A., 2012, NEUROIMAGE; Zalesky A, 2011, HUM BRAIN MAPP; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98697	10.1371/journal.pone.0098697	http://dx.doi.org/10.1371/journal.pone.0098697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906136	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000049
J	Krishnan, SG; Waters, DLE; Henry, RJ				Krishnan, Gopala S.; Waters, Daniel L. E.; Henry, Robert J.			Australian Wild Rice Reveals Pre-Domestication Origin of Polymorphism Deserts in Rice Genome	PLOS ONE			English	Article							GREEN-REVOLUTION; GIBBERELLIN-SYNTHESIS; GRAIN WIDTH; GENE; ENCODES; SNP; TRANSITION; DIVERSITY; SELECTION; PERICARP	Background: Rice is a major source of human food with a predominantly Asian production base. Domestication involved selection of traits that are desirable for agriculture and to human consumers. Wild relatives of crop plants are a source of useful variation which is of immense value for crop improvement. Australian wild rices have been isolated from the impacts of domestication in Asia and represents a source of novel diversity for global rice improvement. Oryza rufipogon is a perennial wild progenitor of cultivated rice. Oryza meridionalis is a related annual species in Australia. Results: We have examined the sequence of the genomes of AA genome wild rices from Australia that are close relatives of cultivated rice through whole genome re-sequencing. Assembly of the resequencing data to the O. sativa ssp. japonica cv. Nipponbare shows that Australian wild rices possess 2.5 times more single nucleotide polymorphisms than in the Asian wild rice and cultivated O. sativa ssp. indica. Analysis of the genome of domesticated rice reveals regions of low diversity that show very little variation (polymorphism deserts). Both the perennial and annual wild rice from Australia show a high degree of conservation of sequence with that found in cultivated rice in the same 4.58Mbp region on chromosome 5, which suggests that some of the 'polymorphism deserts' in this and other parts of the rice genome may have originated prior to domestication due to natural selection. Conclusions: Analysis of genes in the 'polymorphism deserts' indicates that this selection may have been due to biotic or abiotic stress in the environment of early rice relatives. Despite having closely related sequences in these genome regions, the Australian wild populations represent an invaluable source of diversity supporting rice food security.	[Krishnan, Gopala S.; Waters, Daniel L. E.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia; [Krishnan, Gopala S.] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia	Southern Cross University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Queensland	Henry, RJ (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.	robert.henry@uq.edu.au	Henry, Robert J/B-5824-2008	Henry, Robert J/0000-0002-4060-0292; Subbaiyan, Gopala Krishnan/0000-0003-3443-8767; Waters, Daniel/0000-0002-8622-3162	Australian Research Council; Department of Science and Technology, Government of India; Indian Council for Agricultural Research, New Delhi	Australian Research Council(Australian Research Council); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Council for Agricultural Research, New Delhi	The research was funded by the Australian Research Council, the Department of Science and Technology, Government of India under the BOYSCAST Fellowship and the Indian Council for Agricultural Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Flowers JM, 2012, MOL BIOL EVOL, V29, P675, DOI 10.1093/molbev/msr225; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Henry RJ, 2010, RICE, V3, P235, DOI 10.1007/s12284-009-9034-y; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ishii T, 2011, RICE, V4, P170, DOI 10.1007/s12284-011-9067-x; Kharabian-Masouleh A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00557; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2008, CURR OPIN PLANT BIOL, V11, P193, DOI 10.1016/j.pbi.2007.12.006; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Waters DLE, 2012, ECOL EVOL, V2, P211, DOI 10.1002/ece3.66; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	36	29	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98843	10.1371/journal.pone.0098843	http://dx.doi.org/10.1371/journal.pone.0098843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905808	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000068
J	Porter, KM; Kang, BY; Adesina, SE; Murphy, TC; Hart, CM; Sutliff, RL				Porter, Kristi M.; Kang, Bum-Yong; Adesina, Sherry E.; Murphy, Tamara C.; Hart, C. Michael; Sutliff, Roy L.			Chronic Hypoxia Promotes Pulmonary Artery Endothelial Cell Proliferation through H2O2-Induced 5-Lipoxygenase	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; P38 MAPK; BARRIER DYSFUNCTION; GENE-EXPRESSION; IN-VITRO; HYPERTENSION; GROWTH; OXYGEN; PROTEIN	Pulmonary Hypertension (PH) is a progressive disorder characterized by endothelial dysfunction and proliferation. Hypoxia induces PH by increasing vascular remodeling. A potential mediator in hypoxia-induced PH development is arachidonate 5-Lipoxygenase (ALOX5). While ALOX5 metabolites have been shown to promote pulmonary vasoconstriction and endothelial cell proliferation, the contribution of ALOX5 to hypoxia-induced proliferation remains unknown. We hypothesize that hypoxia exposure stimulates HPAEC proliferation by increasing ALOX5 expression and activity. To test this, human pulmonary artery endothelial cells (HPAEC) were cultured under normoxic (21% O-2) or hypoxic (1% O-2) conditions for 24-, 48-, or 72 hours. In a subset of cells, the ALOX5 inhibitor, zileuton, or the 5-lipoxygenase activating protein inhibitor, MK-886, was administered during hypoxia exposure. ALOX5 expression was measured by qRT-PCR and western blot and HPAEC proliferation was assessed. Our results demonstrate that 24 and 48 hours of hypoxia exposure have no effect on HPAEC proliferation or ALOX5 expression. Seventy two hours of hypoxia significantly increases HPAEC ALOX5 expression, hydrogen peroxide (H2O2) release, and HPAEC proliferation. We also demonstrate that targeted ALOX5 gene silencing or inhibition of the ALOX5 pathway by pharmacological blockade attenuates hypoxia-induced HPAEC proliferation. Furthermore, our findings indicate that hypoxia-induced increases in cell proliferation and ALOX5 expression are dependent on H2O2 production, as administration of the antioxidant PEG-catalase blocks these effects and addition of H2O2 to HPAEC promotes proliferation. Overall, these studies indicate that hypoxia exposure induces HPAEC proliferation by activating the ALOX5 pathway via the generation of H2O2.	[Porter, Kristi M.; Kang, Bum-Yong; Adesina, Sherry E.; Murphy, Tamara C.; Hart, C. Michael; Sutliff, Roy L.] Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Dept Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Sutliff, RL (corresponding author), Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Dept Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	rsutlif@emory.edu			National Science Foundation [0450303, I-66-606-63]; Pharmacological Sciences Training Grant [TM GM 008602]; National Institute of Allergy and Infectious Diseases [1-F31-AI084460, HL 102167];  [HL070892]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167, R01HL070892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI084460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001910] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Pharmacological Sciences Training Grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by HL070892 to RLS, National Science Foundation Award #0450303 Subaward # I-66-606-63 to Emory University, Pharmacological Sciences Training Grant TM GM 008602, National Institute of Allergy and Infectious Diseases 1-F31-AI084460 to KMP, and HL 102167 to RLS and CMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Agbani EO, 2011, PULM PHARMACOL THER, V24, P100, DOI 10.1016/j.pupt.2010.09.003; Banks MF, 2005, J APPL PHYSIOL, V98, P732, DOI 10.1152/japplphysiol.00821.2004; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; BHAT GB, 1992, J CELL PHYSIOL, V151, P228, DOI 10.1002/jcp.1041510203; Birukova AA, 2005, FEBS LETT, V579, P4031, DOI 10.1016/j.febslet.2005.06.018; BOTNEY MD, 1994, AM J PATHOL, V144, P286; Breton-Romero R, 2013, METHOD ENZYMOL, V528, P49, DOI 10.1016/B978-0-12-405881-1.00003-3; Breton-Romero R, 2012, FREE RADICAL BIO MED, V52, P1093, DOI 10.1016/j.freeradbiomed.2011.12.026; Burke DL, 2009, AM J PHYSIOL-LUNG C, V297, pL238, DOI 10.1152/ajplung.90591.2008; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Dishart D, 2005, BBA-MOL CELL BIOL L, V1738, P37, DOI 10.1016/j.bbalip.2005.11.008; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Fresquet F, 2006, BRIT J PHARMACOL, V148, P714, DOI 10.1038/sj.bjp.0706779; FRIEDMAN Z, 1984, PROSTA LEUKOTR MED, V14, P279, DOI 10.1016/0262-1746(84)90211-7; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Green DE, 2012, AM J RESP CELL MOL B; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; HATZELMANN A, 1989, EUR J BIOCHEM, V180, P527, DOI 10.1111/j.1432-1033.1989.tb14678.x; HATZELMANN A, 1987, EUR J BIOCHEM, V169, P175, DOI 10.1111/j.1432-1033.1987.tb13595.x; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; ISHII Y, 1992, J CLIN INVEST, V89, P794, DOI 10.1172/JCI115658; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jin BY, 2012, P NATL ACAD SCI USA, V109, P14864, DOI 10.1073/pnas.1204974109; Jones JE, 2004, AM J PHYSIOL-HEART C, V286, pH1775, DOI 10.1152/ajpheart.00281.2003; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Katryniok C, 2010, BBA-MOL CELL BIOL L, V1801, P49, DOI 10.1016/j.bbalip.2009.09.003; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; Lee YJ, 2004, J APPL PHYSIOL, V96, P793, DOI 10.1152/japplphysiol.00797.2003; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; MEYRICK B, 1979, AM J PATHOL, V96, P51; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; MORGANROTH ML, 1985, AM REV RESPIR DIS, V131, P488, DOI 10.1164/arrd.1985.131.4.488; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Orr R, 2012, CURR OPIN PULM MED, V18, P138, DOI 10.1097/MCP.0b013e32834f2093; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; RABINOVITCH M, 1986, LAB INVEST, V55, P632; Radmark O, 2005, BIOCHEM BIOPH RES CO, V338, P102, DOI 10.1016/j.bbrc.2005.08.013; Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC; RIENDEAU D, 1989, BIOCHEM J, V263, P565, DOI 10.1042/bj2630565; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; SAMUELSSON B, 1991, ADV PROSTAG THROMB L, V21, P1; Schaefer CA, 2006, ATHEROSCLEROSIS, V185, P290, DOI 10.1016/j.atherosclerosis.2005.06.035; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Silverman ES, 2002, AM J RESP CELL MOL, V26, P475, DOI 10.1165/ajrcmb.26.4.4747; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Stanke-Labesque F, 2003, BRIT J PHARMACOL, V140, P186, DOI 10.1038/sj.bjp.0705405; Stanke-Labesque F, 2001, CARDIOVASC RES, V49, P152, DOI 10.1016/S0008-6363(00)00238-8; STENMARK KR, 1985, AM J PHYSIOL, V248, pH859, DOI 10.1152/ajpheart.1985.248.6.H859; Stiebellehner L, 1998, AM J PHYSIOL-LUNG C, V275, pL593, DOI 10.1152/ajplung.1998.275.3.L593; Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, pL600, DOI 10.1152/ajplung.00122.2009; TUDER RM, 1994, AM J PATHOL, V144, P275; TUDER RM, 1995, J CLIN INVEST, V95, P1798, DOI 10.1172/JCI117858; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Voelkel NF, 1997, PULM PHARMACOL THER, V10, P231, DOI 10.1006/pupt.1998.0100; Walker JL, 2002, AM J PHYSIOL-HEART C, V282, pH585, DOI 10.1152/ajpheart.00003.2001; Wang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL570, DOI 10.1152/ajplung.00262.2005; Weerackody RP, 2009, AM J PHYSIOL-HEART C, V296, pH1312, DOI 10.1152/ajpheart.00977.2008; Werz O, 2000, EUR J BIOCHEM, V267, P1263, DOI 10.1046/j.1432-1327.2000.01000.x; WRIGHT JL, 1983, AM REV RESPIR DIS, V128, P702; Yu LY, 2011, J VASC RES, V48, P465, DOI 10.1159/000327005; Zanetti M, 2002, AM J PHYSIOL-HEART C, V283, pH2620, DOI 10.1152/ajpheart.00358.2001; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267	77	33	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98532	10.1371/journal.pone.0098532	http://dx.doi.org/10.1371/journal.pone.0098532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906007	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000037
J	Buj, I; Sanda, R; Marcic, Z; Caleta, M; Mrakovcic, M				Buj, Ivana; Sanda, Radek; Marcic, Zoran; Caleta, Marko; Mrakovcic, Milorad			Combining Morphology and Genetics in Resolving Taxonomy-A Systematic Revision of Spined Loaches (Genus Cobitis; Cypriniformes, Actinopterygii) in the Adriatic Watershed	PLOS ONE			English	Article							DNA-SEQUENCE DATA; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; STATISTICAL-METHOD; TELEOSTEI; DIVERSITY; MODEL; COALESCENT; PISCES; POPULATIONS	Taxonomic investigation of spined loaches from Dalmatia and Herzegovina was conducted on specimens from 14 localities. The results of the detailed morphological investigations were combined with genetic data (based on one mitochondrial and two nuclear genes) in order to resolve the taxonomic status of each Cobitis population. Among the investigated features of external morphology, the appearance of spots on the caudal fin base turned out to have the greatest diagnostic value. Furthermore, the number of branched fin rays enabled the discrimination of several species. No morphometric character alone could ensure determination of any Cobitis species. Nevertheless, groups of populations that are more similar in their body shapes correspond to mitochondrial phylogenetic lineages. Based on molecular genetic markers, Dalmatian and Herzegovinian spined loaches form independent lineages inside the Adriatic phylogenetic group. Mitochondrial DNA phylogenetic reconstruction revealed six monophyletic lineages, corresponding to six species distributed in the investigated area. The population distributed in Mostarsko blato karstic field in Bosnia and Herzegovina is described as a new species based on a unique combination of morphological characters: a single triangular Canestrini scale; usually 5(1)/(2) branched anal fin rays, 6(1)/(2) branched dorsal fin rays, 14 branched caudal fin rays; no spots in the surface pigmentation layer on the caudal fin base; scales on the body very small.	[Buj, Ivana; Marcic, Zoran; Mrakovcic, Milorad] Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia; [Sanda, Radek] Natl Museum, Prague, Czech Republic; [Caleta, Marko] Univ Zagreb, Fac Teacher Educ, Zagreb 41000, Croatia	University of Zagreb; National Museum; University of Zagreb	Buj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Zool, Zagreb 41000, Croatia.	ivaradic@biol.pmf.hr	Ćaleta, Marko/AGT-7655-2022	Ćaleta, Marko/0000-0002-4675-556X	Croatian Ministry of Science, Education and Sport [119-1782739-1233, 119-0000000-3184]; Czech Ministry of Culture [DF12P01OVV021]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Czech Ministry of Culture	This investigation was supported by the Croatian Ministry of Science, Education and Sport (project nos. 119-1782739-1233 and 119-0000000-3184) and by the Czech Ministry of Culture (project no. DF12P01OVV021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banarescu P., 1998, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V100, P405; Bernardi G, 2013, MOL ECOL, V22, P5487, DOI 10.1111/mec.12494; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bogutskaya N. G., 1999, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V101, P509; Bohlen J, 2006, MOL PHYLOGENET EVOL, V39, P552, DOI 10.1016/j.ympev.2005.12.007; Boron A, 2003, FOLIA BIOL-KRAKOW, V51, P49; Buj I, 2008, FOLIA ZOOL, V57, P71; Buj I, 2008, FOLIA ZOOL, V57, P100; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chen X, 2014, MOL PHYLOGENET EVOL, V70, P130, DOI 10.1016/j.ympev.2013.09.003; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Doadrio I, 2005, MOL PHYLOGENET EVOL, V37, P484, DOI 10.1016/j.ympev.2005.07.009; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; ELLIOTT NG, 1995, J FISH BIOL, V46, P202, DOI 10.1111/j.1095-8649.1995.tb05962.x; Freyhof J, 2007, ICHTHYOL EXPLOR FRES, V18, P269; FU YX, 1993, GENETICS, V133, P693; Gambetta L., 1934, Bollettino dei Musei di Zoologia e di Anatomia Comparata Torino, V44, P297; Gamble T, 2008, MOL PHYLOGENET EVOL, V48, P112, DOI 10.1016/j.ympev.2008.03.015; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hey J, 1997, GENETICS, V145, P833; Hrbek T, 2004, MOL PHYLOGENET EVOL, V32, P297, DOI 10.1016/j.ympev.2003.12.017; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janko K, 2005, FOLIA ZOOL, V54, P405; Karaman S, 1928, GLASNIK SKOPSKOG NAU, V6, P163; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kottelat M, 2012, RAFFLES B ZOOL, P1; Kotusz J, 2000, FOLIA ZOOL, V49, P219; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Markova S, 2010, MOL PHYLOGENET EVOL, V55, P488, DOI 10.1016/j.ympev.2010.01.030; Mrakovic M., 2006, RED BOOK FRESHWATER; Mustafic P, 2008, FOLIA ZOOL, V57, P4; Perdices A, 2005, MOL PHYLOGENET EVOL, V37, P460, DOI 10.1016/j.ympev.2005.01.020; Perdices A, 2001, MOL PHYLOGENET EVOL, V19, P468, DOI 10.1006/mpev.2000.0900; Perdices A, 2008, MOL PHYLOGENET EVOL, V46, P382, DOI 10.1016/j.ympev.2007.05.007; Perea S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rab P, 2000, FOLIA ZOOL, V49, P55; Rambaut A., 2007, TRACER V1 4; SAITOH K, 1987, JPN J ICHTHYOL, V34, P334; Sanda R, 2008, FOLIA ZOOL, V57, P20; Sanda R, 2008, FOLIA ZOOL, V57, P42; Schneider D, 2000, FOLIA ZOOL, V49, P159; Schneider D, 2000, FOLIA ZOOL, V49, P227; Schulter D, 1996, PHIL T R SOC LOND B, V351; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turan C, 2004, ICES J MAR SCI, V61, P774, DOI 10.1016/j.icesjms.2004.05.001; Vasil'eva ED, 2000, FOLIA ZOOL, V49, P23; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	65	31	35	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99833	10.1371/journal.pone.0099833	http://dx.doi.org/10.1371/journal.pone.0099833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918426	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000119
J	Jiang, WZ; Yang, B; Weeks, DP				Jiang, WenZhi; Yang, Bing; Weeks, Donald P.			Efficient CRISPR/Cas9-Mediated Gene Editing in Arabidopsis thaliana and Inheritance of Modified Genes in the T2 and T3 Generations	PLOS ONE			English	Article							TARGETED MUTAGENESIS; RNA; CRISPR; CAS9; NUCLEASES; MULTIPLEX; TALEN	The newly developed CRISPR/Cas9 system for targeted gene knockout or editing has recently been shown to function in plants in both transient expression systems as well as in primary T1 transgenic plants. However, stable transmission of genes modified by the Cas9/single guide RNA (sgRNA) system to the T2 generation and beyond has not been demonstrated. Here we provide extensive data demonstrating the efficiency of Cas9/sgRNA in causing modification of a chromosomally integrated target reporter gene during early development of transgenic Arabidopsis plants and inheritance of the modified gene in T2 and T3 progeny. Efficient conversion of a nonfunctional, out-of-frame GFP gene to a functional GFP gene was confirmed in T1 plants by the observation of green fluorescent signals in leaf tissues as well as the presence of mutagenized DNA sequences at the sgRNA target site within the GFP gene. All GFP-positive T1 transgenic plants and nearly all GFP-negative plants examined contained mutagenized GFP genes. Analyses of 42 individual T2 generation plants derived from 6 different T1 progenitor plants showed that 50% of T2 plants inherited a single T-DNA insert. The efficiency of the Cas9/sgRNA system and stable inheritance of edited genes point to the promise of this system for facile editing of plant genes.	[Jiang, WenZhi; Weeks, Donald P.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Yang, Bing] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	University of Nebraska System; University of Nebraska Lincoln; Iowa State University	Weeks, DP (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	dweeks1@unl.edu	Yang, Bing/D-3628-2019	Yang, Bing/0000-0002-2293-3384	National Science Foundation [MCB-0952533, EPSCoR-1004094]; Department of Energy [DOE DE-EE0001052, DOE CAB-COMM DOE DE-EE0003373]; Iowa State University Plant Science Institute Innovation Grant	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Iowa State University Plant Science Institute Innovation Grant	Funding for this research was provided, in part, by the National Science Foundation (MCB-0952533 and EPSCoR-1004094 to D.P.W.) and the Department of Energy (DOE DE-EE0001052 and DOE CAB-COMM DOE DE-EE0003373 to D.P.W.) and Iowa State University Plant Science Institute Innovation Grant (to B.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2006, NAT PROTOC, V1, P46, DOI 10.1038/nprot.2006.7; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Feng Z, 2013, P NATL ACAD SCI US; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gratz SJ, 2013, GENETICS; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xiao A, 2014, BIOINFORMATICS; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	32	113	137	0	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99225	10.1371/journal.pone.0099225	http://dx.doi.org/10.1371/journal.pone.0099225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918588	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000060
J	Ryndock, EJ; Conway, MJ; Alam, S; Gul, S; Murad, S; Christensen, ND; Meyers, C				Ryndock, Eric J.; Conway, Michael J.; Alam, Samina; Gul, Sana; Murad, Sheeba; Christensen, Neil D.; Meyers, Craig			Roles for Human Papillomavirus Type 16 L1 Cysteine Residues 161, 229, and 379 in Genome Encapsidation and Capsid Stability	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SIMIAN-VIRUS-40 VP1; BOVINE PAPILLOMAVIRUS; DISULFIDE BONDS; PROTEIN L1; MATURATION; INFECTION; L2; RECONSTRUCTION; NEUTRALIZATION	Human papillomavirus (HPV) capsids are formed through a network of inter-and intra-pentameric hydrophobic interactions and disulfide bonds. 72 pentamers of the major capsid protein, L1, and an unknown amount of the minor capsid protein, L2, form the structure of the capsid. There are 12 conserved L1 cysteine residues in HPV16. While C175, C185, and C428 have been implicated in the formation of a critical inter-pentameric disulfide bond, no structural or functional roles have been firmly attributed to any of the other conserved cysteine residues. Here, we show that substitution of cysteine residues C161, C229, and C379 for serine hinders the accumulation of endonuclease-resistant genomes as virions mature within stratifying and differentiating human epithelial tissue. C229S mutant virions form, but are non-infectious. These studies add detail to the differentiation-dependent assembly and maturation that occur during the HPV16 life cycle in human tissue.	[Ryndock, Eric J.; Conway, Michael J.; Alam, Samina; Meyers, Craig] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Christensen, Neil D.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Gul, Sana; Murad, Sheeba] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Hlth Care Biotechnol Dept, Islamabad, Pakistan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National University of Sciences & Technology - Pakistan	Meyers, C (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	cmm10@psu.edu	alam, samina/V-1599-2018		PHS Grant from the NIAID [R01AI57988]; NRSA Viruses and Cancer T32 Training Grants from the NIH [56JB, 5CJM]; NATIONAL CANCER INSTITUTE [T32CA060395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	PHS Grant from the NIAID; NRSA Viruses and Cancer T32 Training Grants from the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a PHS Grant from the NIAID (www.niaid.nih.gov) R01AI57988 and NRSA Viruses and Cancer T32 Training Grants from the NIH (www.nih.gov) 56JB and 5CJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1989, BIOPHYS J, V55, P243, DOI 10.1016/S0006-3495(89)82799-7; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022427; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Cruz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068379; Culp TD, 2006, J VIROL, V80, P11381, DOI 10.1128/JVI.01328-06; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Gharakhanian E, 2005, VIRUS RES, V107, P21, DOI 10.1016/j.virusres.2004.06.006; Ishii Y, 2005, VIRUS GENES, V31, P321, DOI 10.1007/s11262-005-3250-3; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Ishii Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-110; Jao CC, 1999, J GEN VIROL, V80, P2481, DOI 10.1099/0022-1317-80-9-2481; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Li ML, 1998, J VIROL, V72, P2160, DOI 10.1128/JVI.72.3.2160-2167.1998; Li PP, 2005, J VIROL, V79, P3859, DOI 10.1128/JVI.79.6.3859-3864.2005; Li PP, 2002, P NATL ACAD SCI USA, V99, P1353, DOI 10.1073/pnas.032668699; Li PP, 2000, J VIROL, V74, P11388, DOI 10.1128/JVI.74.23.11388-11393.2000; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Ozbun MA, 1998, VIROLOGY, V248, P218, DOI 10.1006/viro.1998.9285; Perez-Berna AJ, 2012, J BIOL CHEM, V287, P31582, DOI 10.1074/jbc.M112.389957; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e994880	10.1371/journal.pone.0099488	http://dx.doi.org/10.1371/journal.pone.0099488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918586	Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000090
J	Stark, JS; Kim, SL; Oliver, JS				Stark, Jonathan S.; Kim, Stacy L.; Oliver, John S.			Anthropogenic Disturbance and Biodiversity of Marine Benthic Communities in Antarctica: A Regional Comparison	PLOS ONE			English	Article							SOFT-SEDIMENT ASSEMBLAGES; MCMURDO-STATION; TAXONOMIC DISTINCTNESS; ORGANIC ENRICHMENT; EAST ANTARCTICA; CASEY STATION; MACROBENTHIC ASSEMBLAGES; MULTIVARIATE-ANALYSIS; SPATIAL VARIABILITY; METAL CONTAMINATION	The impacts of two Antarctic stations in different regions, on marine sediment macrofaunal communities were compared: McMurdo, a very large station in the Ross Sea; and Casey, a more typical small station in East Antarctica. Community structure and diversity were compared along a gradient of anthropogenic disturbance from heavily contaminated to uncontaminated locations. We examined some of the inherent problems in comparing data from unrelated studies, such as different sampling methods, spatial and temporal scales of sampling and taxonomic uncertainty. These issues generated specific biases which were taken into account when interpreting patterns. Control sites in the two regions had very different communities but both were dominated by crustaceans. Community responses to anthropogenic disturbance (sediment contamination by metals, oils and sewage) were also different. At McMurdo the proportion of crustaceans decreased in disturbed areas and polychaetes became dominant, whereas at Casey, crustaceans increased in response to disturbance, largely through an increase in amphipods. Despite differing overall community responses there were some common elements. Ostracods, cumaceans and echinoderms were sensitive to disturbance in both regions. Capitellid, dorvelleid and orbiniid polychaetes were indicative of disturbed sites. Amphipods, isopods and tanaids had different responses at each station. Biodiversity and taxonomic distinctness were significantly lower at disturbed locations in both regions. The size of the impact, however, was not related to the level of contamination, with a larger reduction in biodiversity at Casey, the smaller, less polluted station. The impacts of small stations, with low to moderate levels of contamination, can thus be as great as those of large or heavily contaminated stations. Regional broad scale environmental influences may be important in determining the composition of communities and thus their response to disturbance, but there are some generalizations regarding responses which will aid future management of stations.	[Stark, Jonathan S.] Australian Antarctic Div, Terr & Nearshore Ecosyst Program, Kingston, Tas, Australia; [Kim, Stacy L.; Oliver, John S.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA	Australian Antarctic Division; Moss Landing Marine Laboratories	Stark, JS (corresponding author), Australian Antarctic Div, Terr & Nearshore Ecosyst Program, Kingston, Tas, Australia.	jonny.stark@aad.gov.au	Stark, Jonathan/ABF-4025-2020	Stark, Jonathan/0000-0002-4268-8072	Australian Antarctic Division under AAS project; National Science Foundation [DPP 8914858, OPP 97961111, OPP 9615849, OPP 59088, OPP 0126399]	Australian Antarctic Division under AAS project; National Science Foundation(National Science Foundation (NSF))	Work at Casey Station was supported by the Australian Antarctic Division (www.antarctica.gov.au/) under AAS project 2201. Work at McMurdo Station was supported by the National Science Foundation under Grant Nos. DPP 8914858, OPP 97961111, OPP 9615849, OPP 59088 and OPP 0126399. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aronson RB, 2011, ANN NY ACAD SCI, V1223, P82, DOI 10.1111/j.1749-6632.2010.05926.x; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Baird HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034363; Barnes DKA, 1999, J MAR BIOL ASSOC UK, V79, P401, DOI 10.1017/S0025315498000514; Barnes DKA, 2003, MAR ECOL PROG SER, V249, P145, DOI 10.3354/meps249145; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; Bonar Scott A., 2011, P11; Borja A, 2008, ECOL INDIC, V8, P331, DOI 10.1016/j.ecolind.2007.05.004; Borja A, 2009, HYDROBIOLOGIA, V633, P181, DOI 10.1007/s10750-009-9881-y; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; BUSDOSH M, 1982, J EXP MAR BIOL ECOL, V62, P261, DOI 10.1016/0022-0981(82)90206-4; CEP, 2013, 15 CEP M HOB 36 ANT; Chapman PM, 2003, MAR POLLUT BULL, V46, P927, DOI 10.1016/S0025-326X(03)00252-2; Clark GF, 2013, GLOBAL CHANGE BIOL, V19, P3749, DOI 10.1111/gcb.12337; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; COMNAP, 2013, ANT FAC LIST 15 MAY; Conlan KE, 2010, MAR POLLUT BULL, V60, P419, DOI 10.1016/j.marpolbul.2009.10.009; Conlan KE, 2006, MAR POLLUT BULL, V52, P1695, DOI 10.1016/j.marpolbul.2006.06.010; Conlan Kathleen E., 2000, P315; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; Conlan KE, 2004, MAR POLLUT BULL, V49, P43, DOI 10.1016/j.marpolbul.2004.01.007; Corbera J, 1995, SCI MAR, V59, P63; COTTON JH, 1994, ANTARCT SCI, V6, P537, DOI 10.1017/S0954102094000799; Crockett AB, 1997, COMPREHENSIVE CHARAC; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; de-la-Ossa-Carretero JA, 2011, ENVIRON MONIT ASSESS, V184, P2133; Dean HK, 2008, REV BIOL TROP, V56, P11, DOI DOI 10.15517/RBT.V56I4.27162; Duquesne S, 2002, POLAR BIOL, V25, P206, DOI 10.1007/s00300-001-0328-9; Durou C, 2005, ENVIRON TOXICOL, V20, P23, DOI 10.1002/tox.20074; Ellingsen KE, 2001, MAR ECOL PROG SER, V218, P1, DOI 10.3354/meps218001; Gasparon M, 2007, APPL GEOCHEM, V22, P888, DOI 10.1016/j.apgeochem.2006.12.018; Gibson G., 2000, ESTUARINE COASTAL MA; Gillies CL, 2013, MAR ECOL PROG SER, V478, P27, DOI 10.3354/meps10214; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; GOODMAN D, 1975, Q REV BIOL, V50, P237, DOI 10.1086/408563; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRAY JS, 1979, PHILOS T ROY SOC B, V286, P545, DOI 10.1098/rstb.1979.0045; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Grondahl F, 2009, POLAR RES, V28, P298, DOI 10.1111/j.1751-8369.2008.00056.x; Gutt J, 2004, ANTARCT SCI, V16, P11, DOI 10.1017/S0954102004001750; Hale RC, 2008, ENVIRON SCI TECHNOL, V42, P1452, DOI 10.1021/es702547a; Hall JA, 1997, MAR POLLUT BULL, V34, P527, DOI 10.1016/S0025-326X(97)00156-2; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Held C, 2005, SCI MAR, V69, P175, DOI 10.3989/scimar.2005.69s2175; Holte B, 1996, POLAR BIOL, V16, P549; HOWINGTON JP, 1992, MAR POLLUT BULL, V25, P324, DOI 10.1016/0025-326X(92)90690-8; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; *IUCN, 2004, 4 WORLD PARKS C; Kennicutt MC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034010; KENNICUTT MC, 1995, ENVIRON SCI TECHNOL, V29, P1279, DOI 10.1021/es00005a600; Kim S, 2010, INTEGR COMP BIOL, V50, P1031, DOI 10.1093/icb/icq058; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lande R, 2000, OIKOS, V89, P601, DOI 10.1034/j.1600-0706.2000.890320.x; LENIHAN HS, 1995, ECOL APPL, V5, P311, DOI 10.2307/1942024; LENIHAN HS, 1990, MAR POLLUT BULL, V21, P422, DOI 10.1016/0025-326X(90)90761-V; LENIHAN HS, 1992, MAR POLLUT BULL, V25, P318, DOI 10.1016/0025-326X(92)90689-4; Lenihan HS, 2003, MAR ECOL PROG SER, V261, P63, DOI 10.3354/meps261063; Leong LS, 1999, MAR POLLUT BULL, V38, P875, DOI 10.1016/S0025-326X(99)00013-2; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Lohrer AM, 2013, ECOSYSTEMS, V16, P224, DOI 10.1007/s10021-012-9610-7; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P1573, DOI 10.1016/j.dsr.2010.09.003; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2011, BIOL DIVERSITY; May R.M., 1975, P81; Morrisey DJ, 1996, MAR BIOL, V125, P199, DOI 10.1007/BF00350774; MORRISEY DJ, 1992, J EXP MAR BIOL ECOL, V164, P233, DOI 10.1016/0022-0981(92)90177-C; Mouneyrac C, 2003, MAR BIOL, V143, P731, DOI 10.1007/s00227-003-1124-6; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Noren K, 2005, J EXP MAR BIOL ECOL, V317, P53, DOI 10.1016/j.jembe.2004.11.014; OAKDEN JM, 1984, MAR ECOL PROG SER, V14, P253, DOI 10.3354/meps014253; Oliver J, 2011, MAR ECOL-EVOL PERSP, V32, P278, DOI 10.1111/j.1439-0485.2011.00461.x; Osman RW, 1998, HYDROBIOLOGIA, V375-76, P113, DOI 10.1023/A:1017000820646; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; RISEBROUGH RW, 1990, MAR POLLUT BULL, V21, P523, DOI 10.1016/0025-326X(90)90300-W; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Rosenberg R, 2004, MAR POLLUT BULL, V49, P728, DOI 10.1016/j.marpolbul.2004.05.013; Ruiz F, 2005, EARTH-SCI REV, V72, P89, DOI 10.1016/j.earscirev.2005.04.003; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schlacher TA, 1998, MAR ECOL PROG SER, V174, P159, DOI 10.3354/meps174159; Scouller RC, 2006, CHEMOSPHERE, V65, P294, DOI 10.1016/j.chemosphere.2006.02.062; SHULENBERGER E, 1974, MAR BIOL, V28, P185, DOI 10.1007/BF00387296; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Simpson SL, 2005, HDB SEDIMENT QUALITY; SLATTERY PN, 1986, POLAR BIOL, V6, P171, DOI 10.1007/BF00274880; Sleutel S, 2007, COMMUN SOIL SCI PLAN, V38, P2647, DOI 10.1080/00103620701662877; Smale DA, 2008, POLAR BIOL, V31, P189, DOI 10.1007/s00300-007-0346-3; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Snape I., 2001, POLAR REC, V37, P199; Stark Jonathan S., 2006, Ecological Management & Restoration, V7, P21, DOI 10.1111/j.1442-8903.2006.00243.x; Stark JS, 1998, MAR FRESHWATER RES, V49, P533, DOI 10.1071/MF97188; Stark JS, 1998, ECOTOXICOLOGY, V7, P161, DOI 10.1023/A:1014356327595; Stark JS, 2005, MAR POLLUT BULL, V50, P276, DOI 10.1016/j.marpolbul.2004.10.015; Stark JS, 2004, MAR ECOL PROG SER, V276, P53, DOI 10.3354/meps276053; Stark JS, 2003, AUSTRAL ECOL, V28, P287, DOI 10.1046/j.1442-9993.2003.01289.x; Stark JS, 2003, ESTUAR COAST SHELF S, V56, P717, DOI 10.1016/S0272-7714(02)00291-3; Stark JS, 2011, ENV IMPACT ASSESSMEN; STULL JK, 1986, MAR BIOL, V91, P539, DOI 10.1007/BF00392606; Sutherland RA, 1998, HYDROBIOLOGIA, V389, P153, DOI 10.1023/A:1003570219018; Thatje S, 2012, INTEGR COMP BIOL, V52, P470, DOI 10.1093/icb/ics105; Thomas DN, 2004, FROZEN OCEANS FLOATI; Thompson BW, 2003, MAR POLLUT BULL, V46, P232, DOI 10.1016/S0025-326X(02)00366-1; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Tin T., 2014, ANTARCTIC FUTURES; Tomassetti P, 2005, AQUACULT INT, V13, P109, DOI 10.1007/s10499-004-9026-2; United Nations, 2002, WORLD SUMMIT SUSTAIN; Van Gemerden BS, 2005, ECOL APPL, V15, P1747, DOI 10.1890/04-1791; Vanderklift MA, 1996, MAR ECOL PROG SER, V136, P137, DOI 10.3354/meps136137; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wang QR, 2011, ENVIRON MONIT ASSESS, V174, P241, DOI 10.1007/s10661-010-1454-z; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; WARWICK RM, 1988, MAR POLLUT BULL, V19, P259, DOI 10.1016/0025-326X(88)90596-6; WARWICK RM, 1988, MAR ECOL PROG SER, V46, P167, DOI 10.3354/meps046167; Weimin Ying, 1992, Science of the Total Environment, V125, P67, DOI 10.1016/0048-9697(92)90383-4; Weisberg SB, 2008, ECOL INDIC, V8, P389, DOI 10.1016/j.ecolind.2007.04.001; WOODIN SA, 1974, ECOL MONOGR, V44, P171, DOI 10.2307/1942310	127	33	33	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98802	10.1371/journal.pone.0098802	http://dx.doi.org/10.1371/journal.pone.0098802			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919053	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000027
J	Yue, YS; Wang, XD; Xie, B; Li, ZH; Chen, BL; Wang, XQ; Zhu, Y				Yue, Yu-Shan; Wang, Xu-Dong; Xie, Bin; Li, Zhong-Han; Chen, Bing-Lin; Wang, Xue-Qiang; Zhu, Yi			Sling Exercise for Chronic Low Back Pain: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; MOTOR CONTROL EXERCISES; MUSCULOSKELETAL PAIN; GENERAL EXERCISES; MANAGEMENT; DISABILITY; PREVALENCE; ACTIVATION; THERAPY; TRUNK	Background: Trials on sling exercise (SE), commonly performed to manage chronic low back pain (LBP), yield conflicting results. This study aimed to review the effects of SE on chronic LBP. Methods: The randomized controlled trials comparing SE with other treatments or no treatment, published up to August 2013, were identified by electronic searches. Primary outcomes were pain, function, and return to work. The weighted mean difference (WMD) and 95% confidence interval (CI) were calculated, using a random-effects model. Results: Risk of bias was rated as high in 9 included trials, where some important quality components such as blinding were absent and sample sizes were generally small. We found no clinically relevant differences in pain or function between SE and other forms of exercise, traditional Chinese medical therapy, or in addition to acupuncture. Based on two trials, SE was more effective than thermomagnetic therapy at reducing pain (short-term: WMD -13.90, 95% CI -22.19 to -5.62; long-term: WMD -26.20, 95% CI -31.32 to -21.08) and improving function (short-term: WMD -10.54, 95% CI -14.32 to -6.75; long-term: WMD -25.75, 95% CI -30.79 to -20.71). In one trial we found statistically significant differences between SE and physical agents combined with drug therapy (meloxicam combined with eperisone hydrochloride) but of borderline clinical relevance for pain (short-term: WMD -15.00, 95% CI -19.64 to -10.36) and function (short-term: WMD -10.00; 95% CI -13.70 to -6.30). There was substantial heterogeneity among the two trials comparing SE and thermomagnetic therapy; both these trials and the trial comparing SE with physical agents combined with drug therapy had serious methodological limitations. Interpretation: Based on limited evidence from 2 trials, SE was more effective for LBP than thermomagnetic therapy. Clinically relevant differences in effects between SE and other forms of exercise, physical agents combined with drug therapy, traditional Chinese medical therapy, or in addition to acupuncture could not be found. More high-quality randomized trials on the topic are warranted.	[Yue, Yu-Shan; Zhu, Yi] Nanjing Univ Chinese Med, Sch Clin Med 2, Nanjing, Jiangsu, Peoples R China; [Wang, Xu-Dong] Nanjing Univ Chinese Med, Inst Literature Chinese Med, Nanjing, Jiangsu, Peoples R China; [Xie, Bin] Nanjing Univ Chinese Med, Sch Clin Med 1, Nanjing, Jiangsu, Peoples R China; [Li, Zhong-Han] Univ Waterloo, Dept Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada; [Chen, Bing-Lin; Wang, Xue-Qiang] Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; University of Waterloo; Shanghai University of Sport	Wang, XQ (corresponding author), Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China.	qiang897@163.com; zhuyi1010@163.com	Wang, Xueqiang/GPW-9671-2022		Key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport; Ministry of Education; First-class Disciplines of Shanghai Colleges and Universities (Psychology); Supporting Program of the Ministry of Science and Technology of China [2009BAK62B02-002]; Performance (SUS) [11DZ2261100]	Key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport; Ministry of Education; First-class Disciplines of Shanghai Colleges and Universities (Psychology); Supporting Program of the Ministry of Science and Technology of China; Performance (SUS)	This work was supported by Key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport; Ministry of Education, the First-class Disciplines of Shanghai Colleges and Universities (Psychology), Supporting Program of the Ministry of Science and Technology of China (2009BAK62B02-002), Performance (SUS) (11DZ2261100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafeta A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e813; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bombardier C, 2001, J RHEUMATOL, V28, P431; Bowering KJ, 2013, J PAIN, V14, P3, DOI 10.1016/j.jpain.2012.09.007; Bussing A, 2012, J PAIN, V13, P1, DOI 10.1016/j.jpain.2011.10.001; Burns JW, 2006, PSYCHOSOM MED, V68, P786, DOI 10.1097/01.psy.0000238211.89198.e4; Bystrom MG, 2013, SPINE, V38, pE350, DOI 10.1097/BRS.0b013e31828435fb; Carson JW, 2007, J PAIN, V8, P405, DOI 10.1016/j.jpain.2006.11.004; Carvalho ACA, 2010, REV TERAPIA MANUAL, V8, P497; Coskun G, 2012, TURK J PHYSIOTHER R, V23, P65; DEYO RA, 1990, NEW ENGL J MED, V322, P1627, DOI 10.1056/NEJM199006073222303; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Fourney DR, 2011, SPINE, V36, pS1, DOI 10.1097/BRS.0b013e31822f0a0d; [高宝龙 GAO Baolong], 2008, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V23, P1095; Gao MX, 2006, CHINESE J CLIN REHAB, V10, P32; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Goubert L, 2004, EUR J PAIN, V8, P385, DOI 10.1016/j.ejpain.2003.11.004; Guo XF, 2010, THEOR PRACT, V16, P556; Haldeman S, 2008, SPINE J, V8, P1, DOI 10.1016/j.spinee.2007.10.009; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hodges P, 2009, J BIOMECH, V42, P61, DOI 10.1016/j.jbiomech.2008.10.001; [胡鸢 Hu Yuan], 2011, [中国疼痛医学杂志, Chinese Journal of Pain Medicine], V17, P146; Huang JS, 2011, J STRENGTH COND RES, V25, P1673, DOI 10.1519/JSC.0b013e3181da7845; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Jin M, 2011, CLIN EFFICACY SLING; Kirkesola G, 2001, KRANKENGYMNASTIK, V53, P428; Kirkesola G, 2009, J FYSIOTERAPEUTEN, V76, P16; Larroy C, 2002, BEHAV MED, V27, P179, DOI 10.1080/08964280209596043; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu P, 2012, CLIN OBSERVATION ACU; Ljunggren AE, 1997, SPINE, V22, P1610, DOI 10.1097/00007632-199707150-00017; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P149; Martin P R, 1986, Int Rehabil Med, V8, P34; Meier HP, 2006, LEISTUNGSSPORT, V2, P19; Nam H, 2007, J KSSPT, V3, P47; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Parkes MJ, 2013, JAMA-J AM MED ASSOC, V310, P722, DOI 10.1001/jama.2013.243229; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Qin J, 2010, CHINESE J BONE JOINT, V9, P437; [邱燕春 Qiu YC], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P9906; Ricci JA, 2006, SPINE, V31, P3052, DOI 10.1097/01.brs.0000249521.61813.aa; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Saliba Susan A, 2010, N Am J Sports Phys Ther, V5, P63; Tan G, 2001, PAIN, V90, P127, DOI 10.1016/S0304-3959(00)00395-X; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; Unsgaard-Tondel M, 2010, PHYS THER, V90, P1426, DOI 10.2522/ptj.20090421; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; van Tulder MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000335; Vasseljen O, 2012, SPINE, V37, P1101, DOI 10.1097/BRS.0b013e318241377c; Vasseljen O, 2010, MANUAL THER, V15, P482, DOI 10.1016/j.math.2010.04.004; Wang C, 2012, J REHABILITATION MED, V27, P760; Wang XQ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-104; Wang XQ, 2013, MED SCI SPORT EXER, V45, P603, DOI 10.1249/MSS.0b013e3182811213; Wang XQ, 2012, HEALTHMED, V6, P754; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Weiner SS, 2010, BEST PRACT RES CL RH, V24, P267, DOI 10.1016/j.berh.2009.12.001; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yoo YD, 2012, J PHYS THER SCI, V24, P671, DOI 10.1589/jpts.24.671; Zhu DM, 2003, STUDY CURATIVE EFFEC	69	12	18	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99307	10.1371/journal.pone.0099307	http://dx.doi.org/10.1371/journal.pone.0099307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919119	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000075
J	Ammendola, M; Sacco, R; Sammarco, G; Donato, G; Montemurro, S; Ruggieri, E; Patruno, R; Marech, I; Cariello, M; Vacca, A; Gadaleta, CD; Ranieri, G				Ammendola, Michele; Sacco, Rosario; Sammarco, Giuseppe; Donato, Giuseppe; Montemurro, Severino; Ruggieri, Eustachio; Patruno, Rosa; Marech, Ilaria; Cariello, Marica; Vacca, Angelo; Gadaleta, Cosmo Damiano; Ranieri, Girolamo			Correlation between Serum Tryptase, Mast Cells Positive to Tryptase and Microvascular Density in Colo-Rectal Cancer Patients: Possible Biological-Clinical Significance	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THYMIDINE PHOSPHORYLASE EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MICROVESSEL DENSITY; CARCINOMA CELLS; ANGIOGENESIS; TUMOR; CHYMASE; METASTASIS; CONTRIBUTE	Background: Tryptase is a serin protease stored and released from mast cells (MCs) that plays a role in tumour angiogenesis. In this study we aimed to evaluate serum tryptase levels in colo-rectal cancer (CRC) patients before (STLBS) and after (STLAS) radical surgical resection. We also evaluated mast cell density positive to tryptase (MCDPT) and microvascular density (MVD) in primary tumour tissue. Methods: A series of 61 patients with stage B and C CRC (according to the Astler and Coller staging system) were selected. Serum blood samples were collected from patients one day before and one day after surgery. Tryptase levels were measured using the UniCAP Tryptase Fluoroenzymeimmunoassay (Pharmacia, Uppsala, Sweden). Tumour sections were immunostained with a primary anti-tryptase antibody (clone AA1; Dako, Glostrup, Denmark) and an anti CD-34 antibody (QB-END 10; Bio-Optica Milan, Italy) by means of immunohistochemistry and then evaluated by image analysis methods. Results: The mean +/- s.d. STLBS and STLAS was 5.63 +/- 2.61 mu g/L, and 3.39 +/- 1.47 mu g/L respectively and a significant difference between mean levels was found: p = 0.000 by t-test. The mean +/- s.d. of MCDPT and MVD was 8.13 +/- 3.28 and 29.16 +/- 7.39 respectively. A strong correlation between STLBS and MVD (r = 0.83, p = 0.000); STLBS and MCDPT (r = 0.60, p = 0.003); and MCDPT and MVD (r = 0.73; p = 0.001) was found. Conclusion: Results demonstrated higher STLBS in CRC patients, indicating an involvement of MC tryptase in CRC angiogenesis. Data also indicated lower STLAS, suggesting the release of tryptase from tumour-infiltrating MCs. Serum tryptase levels may therefore play a role as a novel bio-marker predictive of response to radical surgery. In this context tryptase inhibitors such as Gabexate and Nafamostat Mesilate might be evaluated in adjuvant clinical trials as a new anti-angiogenic approach.	[Ammendola, Michele; Sacco, Rosario; Sammarco, Giuseppe] Univ Catanzaro Magna Graecia, Sch Med, Clin Surg Unit, Dept Med & Surg Sci, Catanzaro, Italy; [Ammendola, Michele; Montemurro, Severino; Ruggieri, Eustachio] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Surg Unit, Bari, Italy; [Donato, Giuseppe] Univ Catanzaro Magna Graecia, Sch Med, Pathol Unit, Dept Med & Surg Sci, Catanzaro, Italy; [Patruno, Rosa] ASL BAT, Dept Hlth, Bari, Italy; [Marech, Ilaria; Cariello, Marica; Gadaleta, Cosmo Damiano; Ranieri, Girolamo] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Integrated Sect Translat Med Oncol, Intervent Radiol Unit, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Dept Biomed Sci, Bari, Italy; [Vacca, Angelo] Univ Bari, Sch Med, Human Oncol Clin Med G Baccelli, Bari, Italy	Magna Graecia University of Catanzaro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Magna Graecia University of Catanzaro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Ranieri, G (corresponding author), Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Integrated Sect Translat Med Oncol, Intervent Radiol Unit, Bari, Italy.	giroran@tiscalinet.it	Cariello, Marica/K-4064-2018; ruggieri, eustachio/AAJ-5531-2020; Vacca, Angelo/AAC-9558-2022; Sammarco, Giuseppe/ABG-8058-2020; Gadaleta, Cosmo Damiano/AAJ-8712-2020; Ranieri, Girolamo/AAJ-7929-2020; DONATO, GIUSEPPE/E-1080-2016; Marech, Ilaria/AAI-3779-2020	ruggieri, eustachio/0000-0002-0142-3289; Vacca, Angelo/0000-0002-4567-8216; Sammarco, Giuseppe/0000-0003-2898-9626; Ranieri, Girolamo/0000-0002-7952-694X; DONATO, GIUSEPPE/0000-0002-3065-5492; Gadaleta, Cosmo Damiano/0000-0003-2398-691X				Ammendola M, 2013, GASTROENT RES PRACT, V2013; Ammendola M, 2013, ONCOLOGY-BASEL, V85, P111, DOI 10.1159/000351145; Ammendola M, 2013, UPDATES SURG-ITALY, V65, P53, DOI 10.1007/s13304-012-0183-y; Angenete E, 2012, INT J COLORECTAL DIS, V27, P1267, DOI 10.1007/s00384-012-1463-1; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Attoub S, 2002, CANCER RES, V62, P4879; Bellone G, 2001, CANCER RES, V61, P2200; Bellone G, 1997, J CELL PHYSIOL, V172, P1, DOI 10.1002/(SICI)1097-4652(199707)172:1<1::AID-JCP1>3.0.CO;2-S; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; DETHLEFSEN SM, 1994, INVAS METAST, V14, P395; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; Fajardo I, 2003, J IMMUNOL, V171, P1493, DOI 10.4049/jimmunol.171.3.1493; Garlipp B, 2012, BRIT J SURG, V99, P714, DOI 10.1002/bjs.8692; Gulubova M, 2009, J GASTROEN HEPATOL, V24, P1265, DOI 10.1111/j.1440-1746.2007.05009.x; Hallgren J, 2001, BIOCHEMISTRY-US, V40, P7342, DOI 10.1021/bi001988c; Hallgren J, 2006, FEBS J, V25, P234; Igarashi M, 1998, CANCER, V82, P1225, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO;2-E; Kankkunen JP, 1997, INT J CANCER, V72, P385, DOI 10.1002/(SICI)1097-0215(19970729)72:3<385::AID-IJC1>3.0.CO;2-L; Khan JS, 2011, ANN ROY COLL SURG, V93, P603, DOI 10.1308/147870811X13137608455299; Kondo K, 2006, J SURG ONCOL, V93, P36, DOI 10.1002/jso.20394; Liu Y, 2006, BIOCHEM BIOPH RES CO, V344, P1263, DOI 10.1016/j.bbrc.2006.04.005; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; Nakashima M, 2011, SURG LAPARO ENDO PER, V21, P415, DOI 10.1097/SLE.0b013e31823aca96; Nico B, 2008, STEM CELLS DEV, V17, P19, DOI 10.1089/scd.2007.0132; Patruno R, 2009, J CELL MOL MED, V13, P555, DOI 10.1111/j.1582-4934.2008.00355.x; Patruno R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/730246; Polverini PJ, 1996, EUR J CANCER, V32A, P2430, DOI 10.1016/S0959-8049(96)00386-3; Ranieri G, 2007, J CELL MOL MED, V11, P362, DOI 10.1111/j.1582-4934.2007.00007.x; Ranieri G, 2003, ONCOL REP, V10, P1189; Ranieri G, 2004, ONCOL REP, V12, P817; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Ranieri G, 2004, ONCOL REP, V11, P435; Ranieri G, 2012, CURR MED CHEM, V19, P938, DOI 10.2174/092986712799320736; Ranieri G, 2001, Acta Otorhinolaryngol Ital, V21, P171; Ranieri G, 2002, INT J ONCOL, V21, P1317; Ranieri G, 2009, INT J ONCOL, V35, P115, DOI 10.3892/ijo_00000319; Ratto C, 2011, DIS COLON RECTUM, V54, pE232, DOI 10.1097/DCR.0b013e31821def52; Ribatti D, 1999, BRIT J CANCER, V79, P451, DOI 10.1038/sj.bjc.6690070; Ribatti D, 2011, INT J DEV BIOL, V55, P99, DOI 10.1387/ijdb.103138dr; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tonnesen MG, 1997, J CLIN INVEST, V99, P2691; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yano Hiroshi, 1999, Gastric Cancer, V2, P26, DOI 10.1007/s101200050017	46	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99512	10.1371/journal.pone.0099512	http://dx.doi.org/10.1371/journal.pone.0099512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915568	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700109
J	Chen, Y; Norton, D; McBain, R				Chen, Yue; Norton, Daniel; McBain, Ryan			Effects of Domain-Specific Noise on Visual Motion Processing in Schizophrenia	PLOS ONE			English	Article							COGNITIVE NEUROSCIENCE; SMOOTH-PURSUIT; PERCEPTION; DEFICIT; MEMORY; IMPAIRMENT; RELATIVES; DISORDER	Background: Visual perception impairments in schizophrenia stem from abnormal information processing. Information processing requires neural response to a stimulus (signal) against a backdrop of 1) random variation in baseline neural activity (internal noise) and sometimes irrelevant environmental stimulation (external noise). Filtering out noise is a critical aspect of information processing, and needs to be critically examined in schizophrenia. Methods: To understand how noise in the visual system constrains perceptual processing, we devised a novel paradigm to build in both signal and external noise on same visual stimulus. Here, instead of uniformed noise, domain-specific noise-variations in stimulus speed-was introduced to evaluate the performance of schizophrenia patients in speed discrimination. Each motion stimulus-a random dot pattern (RDP) comprising 200 moving dots-included a range of speeds, drawn individually from a Gaussian distribution for each dot. The task for patients (n = 26) and controls (n = 28) was to identify which of two stimuli moved faster based on their mean speeds. Findings: Patients exhibited deficient speed discrimination at baseline, in the absence of speed noise. Their speed discrimination was further degraded in the presence of low and medium levels of external noise. In the presence of a high levels of noise, degradation of patients' speed discrimination leveled-off, resulting in similar performance to controls. Conclusion: These domain-specific noise effects on speed discrimination provide direct evidence for the existence of heightened internal noise within a specific visual motion processing domain in schizophrenia.	[Chen, Yue] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; [Norton, Daniel] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [McBain, Ryan] Harvard Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02115 USA	Harvard University; McLean Hospital; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Chen, Y (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA.	ychen@mclean.harvard.edu		Norton, Daniel/0000-0002-7787-3294	NIH [MH 096793, 061824]; Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from NIH (MH 096793 and 061824) and Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 1998, PSYCHOL AGING, V13, P501, DOI 10.1037/0882-7974.13.3.501; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; BRAFF DL, 1981, AM J PSYCHIAT, V138, P1051; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Carter CS, 2008, BIOL PSYCHIAT, V64, P4, DOI 10.1016/j.biopsych.2008.03.020; Chen Y, 2008, SCHIZOPHR RES, V105, P245, DOI 10.1016/j.schres.2008.06.024; Chen Y, 1999, P NATL ACAD SCI USA, V96, P4724, DOI 10.1073/pnas.96.8.4724; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P149, DOI 10.1001/archpsyc.56.2.149; Chen Y, 2005, SCHIZOPHR RES, V74, P271, DOI 10.1016/j.schres.2004.04.002; Chen Y, 2011, SCHIZOPHRENIA BULL, V37, P709, DOI 10.1093/schbul/sbr020; Chen Y, 2003, SCHIZOPHR RES, V61, P215, DOI 10.1016/S0920-9964(02)00222-0; Chen Y, 2006, CURR PSYCHIATRY REV, V2, P431, DOI 10.2174/157340006778699729; Christensen BK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00401; First M. B., 2002, STRUCTURE CLIN INTER; Garrett DD, 2013, BRAIN SIGNAL VARIABI; HOLZMAN PS, 1985, INT REV NEUROBIOL, V27, P179, DOI 10.1016/S0074-7742(08)60558-9; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00391; KRUEGER LE, 1978, PSYCHOL REV, V85, P278, DOI 10.1037/0033-295X.85.4.278; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Noack H, 2012, PSYCHOL AGING, V27, P627, DOI 10.1037/a0027251; NUECHTERLEIN KH, 1994, ACTA PSYCHIAT SCAND, V90, P71, DOI 10.1111/j.1600-0447.1994.tb05894.x; Rajah MN, 2008, BRAIN RES, V1199, P111, DOI 10.1016/j.brainres.2007.12.051; Ross LA, 2007, SCHIZOPHR RES, V97, P173, DOI 10.1016/j.schres.2007.08.008; SACCUZZO DP, 1981, ARCH GEN PSYCHIAT, V38, P175; Schwartz B D, 1990, Psychiatr Med, V8, P73; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P681, DOI 10.1093/schbul/sbr053; Smucny J, 2013, SCHIZOPHR RES, V147, P196, DOI 10.1016/j.schres.2013.03.025; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Stuve TA, 1997, PSYCHOL MED, V27, P143, DOI 10.1017/S0033291796004230; THOMAS HBG, 1973, J THEOR BIOL, V41, P223, DOI 10.1016/0022-5193(73)90115-X; Tregellas JR, 2009, AM J PSYCHIAT, V166, P354, DOI 10.1176/appi.ajp.2008.08030411; Wechsler D., 1981, MANUAL ADULT INTELLI; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99031	10.1371/journal.pone.0099031	http://dx.doi.org/10.1371/journal.pone.0099031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915023	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700051
J	Horton, LE; Barrantes-Vidal, N; Silvia, PJ; Kwapil, TR				Horton, Leslie E.; Barrantes-Vidal, Neus; Silvia, Paul J.; Kwapil, Thomas R.			Worries about Being Judged versus Being Harmed: Disentangling the Association of Social Anxiety and Paranoia with Schizotypy	PLOS ONE			English	Article							NEGATIVE SCHIZOTYPY; PSYCHOTIC SYMPTOMS; IDEATION; SCHIZOPHRENIA; PSYCHOLOGY; ANHEDONIA; SCALES	Paranoia is a dimension of clinical and subclinical experiences in which others are believed to have harmful intentions. Mild paranoid concerns are relatively common in the general population, and more clinically severe paranoia shares features with social anxiety and is a key characteristic of schizotypy. Given that subclinical manifestations of schizotypy and paranoia may predict the occurrence of more severe symptoms, disentangling the associations of these related constructs may advance our understanding of their etiology; however no known studies to date have comprehensively evaluated how paranoia relates to social anxiety and schizotypy. The current research sought to examine the association of paranoia, assessed across a broad continuum of severity, with 1) the positive and negative schizotypy dimensions and 2) social anxiety. Specifically, the study tested a series of six competing, a priori models using confirmatory factor analysis in a sample of 862 young adults. As hypothesized, the data supported a four-factor model including positive schizotypy, negative schizotypy, social anxiety, and paranoia factors, suggesting that these are distinct constructs with differing patterns of interrelationships. Paranoia had a strong association with positive schizotypy, a moderate association with social anxiety, and a minimal association with negative schizotypy. The results are consistent with paranoia being part of a multidimensional model of schizotypy and schizophrenia. Prior studies treating schizotypy and schizophrenia as homogenous constructs often produce equivocal or non-replicable results because these dimensions are associated with distinct etiologies, presentations, and treatment responses; thus, the present conceptualization of paranoia within a multidimensional schizotypy framework should advance our understanding of these constructs.	[Horton, Leslie E.; Barrantes-Vidal, Neus; Silvia, Paul J.; Kwapil, Thomas R.] Univ N Carolina, Greensboro, NC 27412 USA; [Horton, Leslie E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Barrantes-Vidal, Neus] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Barrantes-Vidal, Neus] St Pere Claver Fdn Sanitaria, Barcelona, Spain; [Barrantes-Vidal, Neus] Inst Salud Carlos III, CIBERSAM, Barcelona, Spain	University of North Carolina; University of North Carolina Greensboro; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Horton, LE (corresponding author), Univ N Carolina, Greensboro, NC 27412 USA.	hortonle2@upmc.edu	Kwapil, Thomas/I-3163-2019; Barrantes-Vidal, Neus/A-9578-2013; Kwapil, Thomas R./L-1127-2014	Barrantes-Vidal, Neus/0000-0002-8671-1238; Kwapil, Thomas R./0000-0003-1116-5954	NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH100187] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barrantes-Vidal N, J ABNORM PS IN PRESS; Ben-Zeev D, 2011, SCHIZOPHRENIA BULL, V37, P1248, DOI 10.1093/schbul/sbq041; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Brown LH, 2008, J SOC CLIN PSYCHOL, V27, P127, DOI 10.1521/jscp.2008.27.2.127; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Claridge G.E., 1997, SCHIZOTYPY IMPLICATI, DOI 10.1093/med:psych/9780198523536.001.0001; Coffman DL, 2005, MULTIVAR BEHAV RES, V40, P235, DOI 10.1207/s15327906mbr4002_4; Collip I, 2011, PSYCHOL MED, V41, P911, DOI 10.1017/S0033291710001558; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Eckblad M, 1982, LEVISED SOCIAL ANHED; Freeman D, 2005, J NERV MENT DIS, V193, P309, DOI 10.1097/01.nmd.0000161686.53245.70; Freeman D, 2005, BRIT J PSYCHIAT, V186, P427, DOI 10.1192/bjp.186.5.427; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Gross GM, 2014, COMP FACTOR ST UNPUB; Hathaway SR, 1989, MANUAL MINNESOTA MUL; Huppert JD, 2005, CNS SPECTRUMS, V10, P721, DOI 10.1017/S1092852900019714; Johns LC, 2004, BRIT J PSYCHIAT, V185, P298, DOI 10.1192/bjp.185.4.298; Kaczorowski JA, 2009, SCHIZOPHR RES, V115, P293, DOI 10.1016/j.schres.2009.06.018; Kline R.B., 2011, PRINCIPLES PRACTICE; Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827; Kwapil TR, 2008, SCHIZOPHRENIA BULL, V34, P444, DOI 10.1093/schbul/sbm098; Kwapil TR, 2013, J ABNORM PSYCHOL, V122, P807, DOI 10.1037/a0033759; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Kwapil TR, 2012, OXFORD HDB PERSONALI; Lenzenweger M.F., 2010, SCHIZOTYPY SCHIZOPHR; Lewandowski KE, 2006, SCHIZOPHR RES, V83, P225, DOI 10.1016/j.schres.2005.11.024; Lincoln TM, 2010, SCHIZOPHRENIA BULL, V36, P1140, DOI 10.1093/schbul/sbp029; Linscott RJ, 2004, PERS INDIV DIFFER, V37, P1503, DOI 10.1016/j.paid.2004.02.007; Martin JA, 2001, BRIT J CLIN PSYCHOL, V40, P261, DOI 10.1348/014466501163670; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Meehl PE., 1990, J PERS DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]; Myin-Germeys I, 2003, CURR OPIN PSYCHIATR, V16, P443, DOI 10.1097/01.yco.0000079208.36371.cd; Paino-Pineiro M, 2008, PERS INDIV DIFFER, V45, P132, DOI 10.1016/j.paid.2008.03.011; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Raine A., 1995, SCHIZOTYPAL PERSONAL; Schutters SIJ, 2012, ACTA PSYCHIAT SCAND, V125, P213, DOI 10.1111/j.1600-0447.2011.01787.x; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; STRAUSS JS, 1969, ARCH GEN PSYCHIAT, V21, P581; Suhr JA, 2001, SCHIZOPHR RES, V52, P231, DOI 10.1016/S0920-9964(00)00170-5; Venables PH, 2000, SCHIZOPHRENIA BULL, V26, P587, DOI 10.1093/oxfordjournals.schbul.a033480; Verdoux H, 1998, PSYCHOL MED, V28, P127, DOI 10.1017/S0033291797005667; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P565, DOI 10.1093/oxfordjournals.schbul.a033478	48	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96269	10.1371/journal.pone.0096269	http://dx.doi.org/10.1371/journal.pone.0096269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24914672	Green Published, Green Accepted, gold			2022-12-27	WOS:000340947700003
J	Jacomy, M; Venturini, T; Heymann, S; Bastian, M				Jacomy, Mathieu; Venturini, Tommaso; Heymann, Sebastien; Bastian, Mathieu			ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software	PLOS ONE			English	Article								Gephi is a network visualization software used in various disciplines (social network analysis, biology, genomics...). One of its key features is the ability to display the spatialization process, aiming at transforming the network into a map, and ForceAtlas2 is its default layout algorithm. The latter is developed by the Gephi team as an all-around solution to Gephi users' typical networks (scale-free, 10 to 10,000 nodes). We present here for the first time its functioning and settings. ForceAtlas2 is a force-directed layout close to other algorithms used for network spatialization. We do not claim a theoretical advance but an attempt to integrate different techniques such as the Barnes Hut simulation, degree-dependent repulsive force, and local and global adaptive temperatures. It is designed for the Gephi user experience (it is a continuous algorithm), and we explain which constraints it implies. The algorithm benefits from much feedback and is developed in order to provide many possibilities through its settings. We lay out its complete functioning for the users who need a precise understanding of its behaviour, from the formulas to graphic illustration of the result. We propose a benchmark for our compromise between performance and quality. We also explain why we integrated its various features and discuss our design choices.	[Jacomy, Mathieu; Venturini, Tommaso] Medialab, Sci Po, Paris, France; [Jacomy, Mathieu] Equipex DIME SHS, Paris, France; [Jacomy, Mathieu; Heymann, Sebastien; Bastian, Mathieu] Gephi Consortium, Paris, France; [Heymann, Sebastien] Univ Paris 06, CNRS, LIP6, Paris, France	Institut d'Etudes Politiques Paris (Sciences Po); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Jacomy, M (corresponding author), Medialab, Sci Po, Paris, France.	mathieu.jacomy@sciencespo.fr	Venturini, Tommaso/B-1472-2016; Jacomy, Mathieu/AAD-5386-2019	Venturini, Tommaso/0000-0003-0004-5308; Jacomy, Mathieu/0000-0002-6417-6895				Adar E., 2006, Conference on Human Factors in Computing Systems. CHI2006, P791; BARNES J, 1986, NATURE, V324, P446, DOI 10.1038/324446a0; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Davidson R, 1996, ACM T GRAPHIC, V15, P301, DOI 10.1145/234535.234538; Diminescu D, 2008, SOC SCI INFORM, V47, P565, DOI 10.1177/0539018408096447; Eades P., 1984, C NUMERANTIUM, V42, P149; Frick A, 1994, FAST ADAPTIVE LAYOUT; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hu Y, 2005, MATH J 10, V10, P37, DOI DOI 10.3402/QHW.V6I2.5918; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Martin S, 2011, SPIE C SERIES, V7868; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, ARXIVCONDMAT0407503; Noack Andreas, 2007, Journal of Graph Algorithms and Applications, V11, P453, DOI 10.7155/jgaa.00154; Noack A., 2007, THESIS BRANDENBURGIS; Noack Andreas, 2009, Phys Rev E Stat Nonlin Soft Matter Phys, V79, P026102, DOI 10.1103/PhysRevE.79.026102; Purchase HC, 2002, J VISUAL LANG COMPUT, V13, P501, DOI 10.1006/S1045-926X(02)00016-2; Walshaw C., 2001, Graph Drawing. 8th International Symposium, GD 2000. Proceedings (Lecture Notes in Computer Science Vol.1984), P171	21	1129	1159	28	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98679	10.1371/journal.pone.0098679	http://dx.doi.org/10.1371/journal.pone.0098679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914678	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700030
J	Mehaney, DA; Darwish, HA; Hegazy, RA; Nooh, MM; Tawdy, AM; Gawdat, HI; El-Sawalhi, MM				Mehaney, Dina A.; Darwish, Hebatallah A.; Hegazy, Rehab A.; Nooh, Mohammed M.; Tawdy, Amira M.; Gawdat, Heba I.; El-Sawalhi, Maha M.			Analysis of Oxidative Stress Status, Catalase and Catechol-O-Methyltransferase Polymorphisms in Egyptian Vitiligo Patients	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; GENE POLYMORPHISMS; ANTIOXIDANT STATUS; T/C EXON-9; ASSOCIATION; SUSCEPTIBILITY; BLOOD; COMT; IDENTIFICATION; EPIDERMIS	Vitiligo is the most common depigmentation disorder of the skin. Oxidative stress is implicated as one of the probable events involved in vitiligo pathogenesis possibly contributing to melanocyte destruction. Evidence indicates that certain genes including those involved in oxidative stress and melanin synthesis are crucial for development of vitiligo. This study evaluates the oxidative stress status, the role of catalase (CAT) and catechol-O-Methyltransferase (COMT) gene polymorphisms in the etiology of generalized vitiligo in Egyptians. Total antioxidant capacity (TAC) and malondialdehyde (MDA) levels as well as CAT exon 9 T/C and COMT 158 G/A polymorphisms were determined in 89 patients and 90 age and sex-matched controls. Our results showed significantly lower TAC along with higher MDA levels in vitiligo patients compared with controls. Meanwhile, genotype and allele distributions of CAT and COMT polymorphisms in cases were not significantly different from those of controls. Moreover, we found no association between both polymorphisms and vitiligo susceptibility. In conclusion, the enhanced oxidative stress with the lack of association between CAT and COMT polymorphisms and susceptibility to vitiligo in our patients suggest that mutations in other genes related to the oxidative pathway might contribute to the etiology of generalized vitiligo in Egyptian population.	[Mehaney, Dina A.] Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt; [Darwish, Hebatallah A.; Nooh, Mohammed M.; El-Sawalhi, Maha M.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Hegazy, Rehab A.; Tawdy, Amira M.; Gawdat, Heba I.] Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Nooh, MM (corresponding author), Cairo Univ, Fac Med, Clin & Chem Pathol Dept, Cairo, Egypt.	mohamed.nooh@pharma.cu.edu.eg		El-Sawalhi, Maha/0000-0002-6598-4392; Darwish, Hebatallah/0000-0001-5482-5559; Nooh, Mohammed/0000-0001-9794-4099	Medical Research Service of the Cairo University	Medical Research Service of the Cairo University(Cairo University)	This research was officially supported by the Medical Research Service of the Cairo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas H, 2013, CLIN TER, V164, pE173, DOI 10.7417/CT.2013.1564; Andersen S, 2009, PHARMACOGENOMICS, V10, P669, DOI 10.2217/PGS.09.13; Arican O, 2008, ACTA DERMATOVEN ALP, V17, P12; Birlea SA, 2013, J INVEST DERMATOL, V133, P1369, DOI 10.1038/jid.2012.501; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Boisseau-Garsaud AM, 2002, INT J DERMATOL, V41, P640, DOI 10.1046/j.1365-4362.2002.01472.x; Bulut H, 2011, GENET MOL RES, V10, P4126, DOI 10.4238/2011.October.31.12; Casp CB, 2002, PIGM CELL RES, V15, P62, DOI 10.1034/j.1600-0749.2002.00057.x; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; Em S, 2007, PIGM CELL RES, V20, P405, DOI 10.1111/j.1600-0749.2007.00406.x; Erdal ME, 2003, DEPRESS ANXIETY, V18, P41, DOI 10.1002/da.10114; Foltynie T, 2004, MOVEMENT DISORD, V19, P885, DOI 10.1002/mds.20118; Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x; Gavalas NG, 2006, BIOCHEM BIOPH RES CO, V345, P1586, DOI 10.1016/j.bbrc.2006.05.063; Goth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4; Goth L, 2001, ELECTROPHORESIS, V22, P49, DOI 10.1002/1522-2683(200101)22:1<49::AID-ELPS49>3.0.CO;2-W; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Ines D, 2006, ARCH DERMATOL RES, V298, P147, DOI 10.1007/s00403-006-0680-2; Jain D, 2008, Indian J Physiol Pharmacol, V52, P297; Kawakami T, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/750342; Khan R, 2009, ARCH DERMATOL RES, V301, P731, DOI 10.1007/s00403-009-0964-4; Koracevic D, 2001, J CLIN PATHOL, V54, P356, DOI 10.1136/jcp.54.5.356; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Laddha NC, 2013, FREE RADICAL BIO MED, V65, P1110, DOI 10.1016/j.freeradbiomed.2013.08.189; Laddha NC, 2013, EXP DERMATOL, V22, P245, DOI 10.1111/exd.12103; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Li K, 2009, ARCH DERMATOL RES, V301, P681, DOI 10.1007/s00403-008-0920-8; Liu L, 2010, J INVEST DERMATOL, V130, P2647, DOI 10.1038/jid.2010.192; LUNDSTROM K, 1995, BBA-PROTEIN STRUCT M, V1251, P1, DOI 10.1016/0167-4838(95)00071-2; Malhotra N, 2013, J CUTAN MED SURG, V17, P153, DOI 10.2310/7750.2012.12005; Mandelcorn-Monson RL, 2003, J INVEST DERMATOL, V121, P550, DOI 10.1046/j.1523-1747.2003.12413.x; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; Njoo MD, 1999, ARCH DERMATOL, V135, P407, DOI 10.1001/archderm.135.4.407; Park HH, 2006, EXP DERMATOL, V15, P377, DOI 10.1111/j.0906-6705.2006.00423.x; Passeron T, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.10.001; PAVEL S, 1983, J CANCER RES CLIN, V105, P275, DOI 10.1007/BF00395758; Pichler R, 2009, WIEN MED WOCHENSCHR, V159, P337, DOI 10.1007/s10354-009-0699-z; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Schallreuter KU, 2007, BIOCHEM BIOPH RES CO, V360, P70, DOI 10.1016/j.bbrc.2007.05.218; Schallreuter KU, 2008, J INVEST DERMATOL, V128, P808, DOI 10.1038/sj.jid.5701100; Schallreuter KU, 2007, LIFE SCI, V80, P2221, DOI 10.1016/j.lfs.2007.01.028; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Schallreuter KU, 2001, J INVEST DERMATOL, V116, P167, DOI 10.1046/j.1523-1747.2001.00220.x; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Singh S, 2011, EGYPTIAN DERMATOL ON, V7, P1; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Spritz RA, 2011, J GENET GENOMICS, V38, P271, DOI 10.1016/j.jgg.2011.05.005; Sravani PV, 2009, INDIAN J DERMATOL VE, V75, P268, DOI 10.4103/0378-6323.48427; Tunbridge EM, 2010, INT REV NEUROBIOL, V95, P7, DOI [10.1016/B978-0-12-381326-8-00002-8, 10.1016/B978-0-12-381326-8.00002-8]; Tursen U, 2002, ARCH DERMATOL RES, V294, P143, DOI 10.1007/s00403-002-0295-1; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Westerhof W, 2011, EXP DERMATOL, V20, P92, DOI 10.1111/j.1600-0625.2010.01200.x; Zhang XJ, 2005, J DERMATOL SCI, V39, P137, DOI 10.1016/j.jdermsci.2005.06.004	54	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99286	10.1371/journal.pone.0099286	http://dx.doi.org/10.1371/journal.pone.0099286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915010	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700078
J	Serrao, NR; Steinke, D; Hanner, RH				Serrao, Natasha R.; Steinke, Dirk; Hanner, Robert H.			Calibrating Snakehead Diversity with DNA Barcodes: Expanding Taxonomic Coverage to Enable Identification of Potential and Established Invasive Species	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; CHANNA-ARGUS; EVOLUTIONARY GENETICS; POTOMAC RIVER; FISH; PERCIFORMES; PUNCTATUS; MACULATA	Detecting and documenting the occurrence of invasive species outside their native range requires tools to support their identification. This can be challenging for taxa with diverse life stages and/or problematic or unresolved morphological taxonomies. DNA barcoding provides a potent method for identifying invasive species, as it allows for species identification at all life stages, including fragmentary remains. It also provides an efficient interim taxonomic framework for quantifying cryptic genetic diversity by parsing barcode sequences into discontinuous haplogroup clusters (typical of reproductively isolated species) and labelling them with unique alphanumeric identifiers. Snakehead fishes are a diverse group of opportunistic predators endemic to Asia and Africa that may potentially pose significant threats as aquatic invasive species. At least three snakehead species (Channa argus, C. maculata, and C. marulius) are thought to have entered North America through the aquarium and live-food fish markets, and have established populations, yet their origins remain unclear. The objectives of this study were to assemble a library of DNA barcode sequences derived from expert identified reference specimens in order to determine the identity and aid invasion pathway analysis of the non-indigenous species found in North America using DNA barcodes. Sequences were obtained from 121 tissue samples representing 25 species and combined with public records from GenBank for a total of 36 putative species, which then partitioned into 49 discrete haplogroups. Multiple divergent clusters were observed within C. gachua, C. marulius, C. punctata and C. striata suggesting the potential presence of cryptic species diversity within these lineages. Our findings demonstrate that DNA barcoding is a valuable tool for species identification in challenging and under-studied taxonomic groups such as snakeheads, and provides a useful framework for inferring invasion pathway analysis.	[Serrao, Natasha R.; Steinke, Dirk; Hanner, Robert H.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Serrao, Natasha R.; Hanner, Robert H.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Serrao, NR (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada.	natasha.rosemary.serrao@gmail.com	Steinke, Dirk/D-4700-2009	Steinke, Dirk/0000-0002-8992-575X	OMAFRA EMergency Management program	OMAFRA EMergency Management program	The authors would like to acknowledge OMAFRA EMergency Management program for funding this project. This work is a contribution to FISH-BOL and the International Barcode of Life (iBOL.org) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2012, FRESHWATER BIOL, V57, P2211, DOI 10.1111/j.1365-2427.2012.02864.x; Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Benziger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021272; Bhat AA, 2012, MOL BIOL REP, V39, P4267, DOI 10.1007/s11033-011-1213-4; Blagoev GA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-44; Britz R, 2007, ICHTHYOL EXPLOR FRES, V18, P335; Bronnenhuber JE, 2013, CONSERV GENET RESOUR, V5, P971, DOI 10.1007/s12686-013-9946-0; CAMP, 1998, REP WORKSH CONS ASS, P1; Courtenay W.R., 2004, US GEOLOGICAL SURVEY; Courtenay WR, 2004, 77 BISH MUS; Cudmore B, 2006, 2006075 CSAS; Eschmeyer WN, CATALOG FISHES; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fuller PF, 2012, CHANNA ARGUS; Geetakumari Khangjrakpam, 2010, Journal of the Bombay Natural History Society, V107, P231; Haniffa MA, 2013, AM J RES BIOL, V1; Haniffa MA, 2007, BIOCHEM GENET, V45, P363, DOI 10.1007/s10528-007-9080-3; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helfman GS, 2007, FISH CONSERVATION GU; Herborg LM, 2007, CAN J FISH AQUAT SCI, V64, P1723, DOI 10.1139/F07-130; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; King TL, 2011, CONSERV GENET RESOUR, V3, P1, DOI 10.1007/s12686-010-9256-8; Lakra WS, 2010, BIOCHEM SYST ECOL, V38, P1212, DOI 10.1016/j.bse.2010.12.012; Lapointe NWR, 2013, HYDROBIOLOGIA, V709, P73, DOI 10.1007/s10750-012-1437-x; Lees DC, 2013, MOL ECOL RESOURC; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; Lowenstein JH, 2011, MITOCHONDR DNA, V22, P52, DOI 10.3109/19401736.2010.537748; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Musikasinthorn P, 1998, ICHTHYOL RES, V45, P355, DOI 10.1007/BF02725188; Nagarajan M, 2006, AQUAC RES, V37, P1151, DOI 10.1111/j.1365-2109.2006.01539.x; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Orrell TM, 2005, P BIOL SOC WASH, V118, P407, DOI 10.2988/0006-324X(2005)118[407:TNSCAA]2.0.CO;2; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Scott D, 2013, MANAGEMENT IN PRESS, V4; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052089; Victor BC, 2009, ZOOTAXA, P24; Wang JL, 2011, MITOCHONDR DNA, V22, P120, DOI 10.3109/19401736.2011.624599; Wang KX, 2013, MITOCHONDR DNA, V24, P362, DOI 10.3109/19401736.2012.762578; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Zhu L, 2011, HUMAN AGR SCI, V7; Zhu SR, 2013, BIOCHEM SYST ECOL, V51, P117, DOI 10.1016/j.bse.2013.08.011; Zhu SR, 2013, MITOCHONDR DNA, V24, P217, DOI 10.3109/19401736.2012.752469	58	25	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99546	10.1371/journal.pone.0099546	http://dx.doi.org/10.1371/journal.pone.0099546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915194	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700115
J	Lam, KN; Hall, MW; Engel, K; Vey, G; Cheng, J; Neufeld, JD; Charles, TC				Lam, Kathy N.; Hall, Michael W.; Engel, Katja; Vey, Gregory; Cheng, Jiujun; Neufeld, Josh D.; Charles, Trevor C.			Evaluation of a Pooled Strategy for High-Throughput Sequencing of Cosmid Clones from Metagenomic Libraries	PLOS ONE			English	Article							SHORT READ ALIGNMENT; WIDE HOST-RANGE; FUNCTIONAL METAGENOMICS; UNCULTURED MICROORGANISMS; MICROBIAL COMMUNITIES; SOIL METAGENOME; ALASKAN SOIL; GENES; DNA; IDENTIFICATION	High-throughput sequencing methods have been instrumental in the growing field of metagenomics, with technological improvements enabling greater throughput at decreased costs. Nonetheless, the economy of high-throughput sequencing cannot be fully leveraged in the subdiscipline of functional metagenomics. In this area of research, environmental DNA is typically cloned to generate large-insert libraries from which individual clones are isolated, based on specific activities of interest. Sequence data are required for complete characterization of such clones, but the sequencing of a large set of clones requires individual barcode-based sample preparation; this can become costly, as the cost of clone barcoding scales linearly with the number of clones processed, and thus sequencing a large number of metagenomic clones often remains cost-prohibitive. We investigated a hybrid Sanger/Illumina pooled sequencing strategy that omits barcoding altogether, and we evaluated this strategy by comparing the pooled sequencing results to reference sequence data obtained from traditional barcode-based sequencing of the same set of clones. Using identity and coverage metrics in our evaluation, we show that pooled sequencing can generate high-quality sequence data, without producing problematic chimeras. Though caveats of a pooled strategy exist and further optimization of the method is required to improve recovery of complete clone sequences and to avoid circumstances that generate unrecoverable clone sequences, our results demonstrate that pooled sequencing represents an effective and low-cost alternative for sequencing large sets of metagenomic clones.	[Lam, Kathy N.; Hall, Michael W.; Engel, Katja; Vey, Gregory; Cheng, Jiujun; Neufeld, Josh D.; Charles, Trevor C.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Charles, TC (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	tcharles@uwaterloo.ca	Charles, Trevor C./A-5014-2010; Cheng, Jiujun/AAG-8193-2019	Charles, Trevor C./0000-0002-0344-5932; Lam, Kathy/0000-0003-1543-0161	Natural Sciences and Engineering Research Council of Canada [381646-09]; Canadian Institutes of Health Research; Genome Canada for the project "Microbial Genomics for Biofuels and Co-Products from Biorefining Processes'' [MGCB2]; University of Waterloo CIHR Research Incentive Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada for the project "Microbial Genomics for Biofuels and Co-Products from Biorefining Processes''; University of Waterloo CIHR Research Incentive Fund	Research funding was provided by a Strategic Projects Grant (381646-09) to TCC and JDN from the Natural Sciences and Engineering Research Council of Canada, by Genome Canada for the project "Microbial Genomics for Biofuels and Co-Products from Biorefining Processes'' (MGCB2), and by a University of Waterloo CIHR Research Incentive Fund. KNL was supported by a CGS-D from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Bazzani RP, 2011, BIOMATERIALS, V32, P9854, DOI 10.1016/j.biomaterials.2011.08.092; Berlemont R, 2009, ISME J, V3, P1070, DOI 10.1038/ismej.2009.48; Cai WW, 2001, GENOME RES, V11, P1619, DOI 10.1101/gr.198101; Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Cheng JJ, 2014, J MICROBIOL METH, V99, P27, DOI 10.1016/j.mimet.2014.01.015; Culligan EP, 2012, ISME J, P1; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Dzunkova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047654; Elend C, 2006, APPL ENVIRON MICROB, V72, P3637, DOI 10.1128/AEM.72.5.3637-3645.2006; Engel K, 2012, J MICROBIOL METH, V88, P35, DOI 10.1016/j.mimet.2011.10.007; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Feng Y, 2007, APPL MICROBIOL BIOT, V75, P319, DOI 10.1007/s00253-006-0820-9; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Gloux K, 2010, P NATL ACAD SCI USA, V2010, P1; Gong Xia, 2012, BMC Res Notes, V5, P566, DOI 10.1186/1756-0500-5-566; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hao YA, 2010, ENVIRON MICROBIOL, V12, P105, DOI 10.1111/j.1462-2920.2009.02049.x; Jeon JH, 2011, APPL ENV MICROBIOL, V77; Jiang CJ, 2009, J MICROBIOL, V47, P542, DOI 10.1007/s12275-009-0024-y; JONES JDG, 1987, GENE, V61, P299, DOI 10.1016/0378-1119(87)90193-4; Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092; Lang KS, 2010, APPL ENVIRON MICROB, V76, P5321, DOI 10.1128/AEM.00323-10; Lee Sangwon, 2009, J Vis Exp, DOI 10.3791/1569; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YG, 2005, ENVIRON MICROBIOL, V7, P1927, DOI 10.1111/j.1462-2920.2005.00853.x; Liu JA, 2011, APPL MICROBIOL BIOT, V89, P1083, DOI 10.1007/s00253-010-2828-4; Lonardi S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003010; Neufeld JD, 2011, STAND GENOMIC SCI, V5, P203, DOI 10.4056/sigs.1974654; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P3753, DOI 10.1128/AEM.03080-09; Pottkamper J, 2009, GREEN CHEM, V11, P957, DOI 10.1039/b820157a; Rabausch U, 2013, APPL ENVIRON MICROB, V79, P4551, DOI 10.1128/AEM.01077-13; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rubinstein ND, 2013, GENOME BIOL EVOL, V5, P1185, DOI 10.1093/gbe/evt081; Schallmey M, 2011, FEMS MICROBIOL LETT, V321, P150, DOI 10.1111/j.1574-6968.2011.02324.x; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Sentchilo V, 2013, ISME J, P1; Simon C, 2009, APPL ENVIRON MICROB, V75, P2964, DOI 10.1128/AEM.02644-08; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer MOA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.16; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Voget S, 2006, J BIOTECHNOL, V126, P26, DOI 10.1016/j.jbiotec.2006.02.011; Wang CX, 2006, APPL ENVIRON MICROB, V72, P384, DOI 10.1128/AEM.72.1.384-391.2006; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078507; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	53	13	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98968	10.1371/journal.pone.0098968	http://dx.doi.org/10.1371/journal.pone.0098968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911009	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600030
J	Lin, P; Pratt, WE				Lin, Peagan; Pratt, Wayne E.			Inactivation of the Nucleus Accumbens Core or Medial Shell Attenuates Reinstatement of Sugar-Seeking Behavior following Sugar Priming or Exposure to Food-Associated Cues	PLOS ONE			English	Article							COCAINE-SEEKING; SUCROSE-SEEKING; HEROIN-SEEKING; YOHIMBINE; RELAPSE; DOPAMINE; RECEPTORS; MOTIVATION; DISSOCIATION; SPECIFICITY	Re-exposure to either palatable food or to conditioned stimuli associated with food is known to reinstate food-seeking after periods of abstinence. The nucleus accumbens core and shell are important for reinstatement in both food-and drug-seeking paradigms, although their potential differential roles have been difficult to delineate due to methodological differences in paradigms across laboratories. The present studies assessed the effects of temporary inactivation of the core or shell on priming-and cue-induced reinstatement of food-seeking in identically-trained rats. Inactivation of either the nucleus accumbens core (Experiment 1A; N = 10) or medial shell (Experiment 1B; N = 12) blocked priming-induced reinstatement in an equivalent manner. Similarly, inactivation of the core or medial shell (Experiments 2A & 2B; N = 11 each) also blocked cue-induced reinstatement, although there was also a significant treatment day X brain region X drug order interaction. Specifically, rats with core inactivation reinstated lever-pressing on the vehicle injection day regardless of whether that was their first or second test, whereas rats that had medial shell inactivation on the first day did not significantly reinstate lever-pressing on the second day of testing (when they received vehicle). Yohimbine, while a reportedly robust pharmacological stressor, was ineffective at inducing reinstatement in the current stress-induced reinstatement procedure. These data suggest that both the nucleus accumbens core and shell serve important roles in reinstatement of food-seeking in response to priming and cues.	[Lin, Peagan; Pratt, Wayne E.] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA	Wake Forest University	Pratt, WE (corresponding author), Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA.	prattwe@wfu.edu		Pratt, Wayne/0000-0001-6627-6825	National Institute of Drug Abuse [R15 DA030618]; Wake Forest University Department of Psychology; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA030618] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wake Forest University Department of Psychology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These experiments were supported by the National Institute of Drug Abuse (R15 DA030618 to WEP) and the Wake Forest University Department of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi F, 2011, J NEUROSCI, V31, P6820, DOI 10.1523/JNEUROSCI.6491-10.2011; Anderson SM, 2006, NEUROPSYCHOPHARMACOL, V31, P1452, DOI 10.1038/sj.npp.1300922; [Anonymous], 2007, LEARNING BEHAV CONT; Baldo BA, 2013, NEUROSCI BIOBEHAV R, V37, P1985, DOI 10.1016/j.neubiorev.2013.02.017; Banna KM, 2010, BEHAV BRAIN RES, V208, P144, DOI 10.1016/j.bbr.2009.11.030; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Brown ZJ, 2012, PSYCHOPHARMACOLOGY, V224, P431, DOI 10.1007/s00213-012-2772-3; Byrne S, 2003, INT J OBESITY, V27, P955, DOI 10.1038/sj.ijo.0802305; Calu DJ, 2014, NEUROPHARMACOLOGY, V76, P395, DOI 10.1016/j.neuropharm.2013.04.030; Chaudhri N, 2008, EUR J NEUROSCI, V28, P2288, DOI 10.1111/j.1460-9568.2008.06517.x; CHOPIN P, 1986, NEUROPHARMACOLOGY, V25, P53, DOI 10.1016/0028-3908(86)90058-4; Corbit LH, 2011, J NEUROSCI, V31, P11786, DOI 10.1523/JNEUROSCI.2711-11.2011; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Floresco SB, 2008, NEUROSCIENCE, V154, P877, DOI 10.1016/j.neuroscience.2008.04.004; Fuchs RA, 2004, PSYCHOPHARMACOLOGY, V176, P459, DOI 10.1007/s00213-004-1895-6; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; Ghods-Sharifi S, 2010, BEHAV NEUROSCI, V124, P179, DOI 10.1037/a0018932; Gorin AA, 2004, INT J OBESITY, V28, P278, DOI 10.1038/sj.ijo.0802550; GRILO CM, 1989, J CONSULT CLIN PSYCH, V57, P488, DOI 10.1037/0022-006X.57.4.488; Guy EG, 2011, BEHAV BRAIN RES, V219, P265, DOI 10.1016/j.bbr.2011.01.024; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; HUBBARD JW, 1988, N-S ARCH PHARMACOL, V337, P583; Hughes CE, 1996, PHARMACOL BIOCHEM BE, V53, P979, DOI 10.1016/0091-3057(95)02151-5; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Jeanblanc J, 2002, NEUROSCIENCE, V111, P315, DOI 10.1016/S0306-4522(02)00019-2; KAYMAN S, 1990, AM J CLIN NUTR, V52, P800, DOI 10.1093/ajcn/52.5.800; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; KRAMER FM, 1989, INT J OBESITY, V13, P123; Le AD, 2011, PSYCHOPHARMACOLOGY, V218, P89, DOI 10.1007/s00213-011-2178-7; McFarland K, 2001, J NEUROSCI, V21, P8655; Meredith GE, 2008, BRAIN STRUCT FUNCT, V213, P17, DOI 10.1007/s00429-008-0175-3; Munzar P, 1999, PSYCHOPHARMACOLOGY, V143, P293, DOI 10.1007/s002130050950; Nair SG, 2008, BRIT J PHARMACOL, V154, P406, DOI 10.1038/bjp.2008.3; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; Ogden Cynthia L, 2012, NCHS Data Brief, P1; PAPESCHI R, 1971, EUR J PHARMACOL, V15, P318, DOI 10.1016/0014-2999(71)90098-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pratt WE, 2013, NEUROSCI LETT, V556, P232, DOI 10.1016/j.neulet.2013.10.030; Richard JM, 2013, NEUROSCI BIOBEHAV R, V37, P1919, DOI 10.1016/j.neubiorev.2012.12.008; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Schiltz CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-16; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; SETHY VH, 1972, PSYCHOPHARMACOLOGIA, V23, P160, DOI 10.1007/BF00401190; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shelton KL, 2005, INT J COMP PSYCHOL, V18, P154; Shepard JD, 2004, BIOL PSYCHIAT, V55, P1082, DOI 10.1016/j.biopsych.2004.02.032; Simms JA, 2011, PSYCHOPHARMACOLOGY, V218, P101, DOI 10.1007/s00213-011-2451-9; Stopper CM, 2011, COGN AFFECT BEHAV NE, V11, P97, DOI 10.3758/s13415-010-0015-9; Torregrossa MM, 2013, J NEUROSCI, V33, P8370, DOI 10.1523/JNEUROSCI.0489-13.2013; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Yee J, 2011, EUR J PHARMACOL, V650, P596, DOI 10.1016/j.ejphar.2010.10.045; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D	61	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99301	10.1371/journal.pone.0099301	http://dx.doi.org/10.1371/journal.pone.0099301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910996	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600069
J	Liu, J; Tong, CX; Liu, J; Jiang, Y; Zhao, XQ; Zhang, YY; Liu, HC; Lu, B; Wan, KL				Liu, Jie; Tong, Chongxiang; Liu, Jiao; Jiang, Yuan; Zhao, Xiuqin; Zhang, Yuanyuan; Liu, Haican; Lu, Bing; Wan, Kanglin			First Insight into the Genotypic Diversity of Clinical Mycobacterium tuberculosis Isolates from Gansu Province, China	PLOS ONE			English	Article							BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; DISCRIMINATORY ABILITY; GENETIC DIVERSITY; COMPLEX STRAINS; LOCI; POLYMORPHISM; FAMILY; SYSTEMS	Background:Investigations of Mycobacterium tuberculosis genetic diversity in China have indicated a significant regional distribution. The aim of this study was to characterize the genotypes of clinical M. tuberculosis isolates obtained from Gansu, which has a special geographic location in China. Methodology/Principal Findings: A total of 467 clinical M. tuberculosis strains isolated in Gansu Province were genotyped by 15-locus mycobacterial interspersed repetitive units-variable number tandem repeats (MIRU-VNTR) and spoligotyping. The results showed that 445 isolates belonged to six known spoligotype lineages, whereas 22 isolates were unknown. The Beijing genotype was the most prevalent (87.58%, n = 409), while the shared type 1 was the dominant genotype (80.94%, n = 378). The second most common lineage was the T lineage, with 25 isolates (5.35%), followed by the H lineage with 5 isolates (1.07%), the MANU family (0.64%, 3 isolates), the U family (0.43%, 2 isolates) and the CAS lineage with 1 isolate (0.21%). By using the VNTR15China method, we observed 15 groups and 228 genotypes among the 467 isolates. We found no association between the five larger groups (including the Beijing genotype) and sex, age, or treatment status, and there was no noticeable difference in the group analysis in different areas. In the present study, seven of the 15 MIRU-VNTR loci were highly or moderately discriminative according to their Hunter-Gaston discriminatory index. Conclusions/Significance: The Beijing genotype is the predominant genotype in Gansu province. We confirm that VNTR15China is suitable for typing Beijing strains in China and that it has a better discriminatory power than spoligotyping. Therefore, the use of both methods is the most suitable for genotyping analysis of M. tuberculosis.	[Liu, Jie; Liu, Jiao; Zhao, Xiuqin; Zhang, Yuanyuan; Liu, Haican; Lu, Bing; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liu, Jie; Zhao, Xiuqin; Zhang, Yuanyuan; Liu, Haican; Lu, Bing; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Tong, Chongxiang; Jiang, Yuan] Lanzhou Pulm Hosp, Lanzhou, Gansu, Peoples R China; [Liu, Jie] Beijing Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn			National Key Program of Mega Infectious Disease [2013ZX10003006-002-001, 2011ZX10004-001]	National Key Program of Mega Infectious Disease	This work was funded by the projects 2013ZX10003006-002-001 and 2011ZX10004-001 of the National Key Program of Mega Infectious Disease. The funders had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish.	Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chai Li-Quan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P785; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dong HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033904; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Jiang Y, 2013, J BASIC MICROB, V53, P562, DOI 10.1002/jobm.201200230; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; JUAN CP, 2007, TUBERCULOSIS 2007 BA; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li Wei-min, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P381; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang SM, 2011, WEISHENG ZHIYE JIAOY, V29, P121; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057660; Zhang L, 2011, CHINESE J ANTITUBERC, V33, P748; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x	34	16	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99357	10.1371/journal.pone.0099357	http://dx.doi.org/10.1371/journal.pone.0099357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911588	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600076
J	Newman, CL; Moe, SM; Chen, NX; Hammond, MA; Wallace, JM; Nyman, JS; Allen, MR				Newman, Christopher L.; Moe, Sharon M.; Chen, Neal X.; Hammond, Max A.; Wallace, Joseph M.; Nyman, Jeffry S.; Allen, Matthew R.			Cortical Bone Mechanical Properties Are Altered in an Animal Model of Progressive Chronic Kidney Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; IN-VIVO MEASUREMENT; HEMODIALYSIS-PATIENTS; RENAL OSTEODYSTROPHY; MINERAL DENSITY; RAT MODEL; HIP FRACTURE; CROSS-LINKS; ZOLEDRONIC ACID; OLDER-ADULTS	Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity, increases therisk of fracture. Animal models have confirmed that these changes compromise whole bone mechanical properties. Estimates from whole bone testing suggest that material properties are negatively affected, though tissue-level assessmentshavenot been conducted. Therefore, the goal of the present study was to examine changes in cortical bone at different length scales using a rat model with theprogressive development of CKD. At 30 weeks of age (similar to 75% reduction in kidney function), skeletally mature male Cy/+ rats were compared to their normal littermates. Cortical bone material propertieswere assessed with reference point indentation (RPI), atomic force microscopy (AFM), Raman spectroscopy, and high performance liquid chromatography (HPLC). Bones from animals with CKD had higher (+18%) indentation distance increase and first cycle energy dissipation (+ 8%) as measured by RPI. AFM indentation revealed a broader distribution of elastic modulus values in CKD animals witha greater proportion of both higher and lower modulus values compared to normal controls. Yet, tissue composition, collagen morphology, and collagen cross-linking fail to account for these differences. Though the specific skeletal tissue alterations responsible for these mechanical differences remain unclear, these results indicate that cortical bone material properties are altered in these animals and may contribute to the increased fracture risk associated with CKD.	[Newman, Christopher L.; Allen, Matthew R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Moe, Sharon M.; Chen, Neal X.] Indiana Univ Sch Med, Div Nephrol, Dept Med, Indianapolis, IN 46202 USA; [Moe, Sharon M.] Roudebush VA Med Ctr, Indianapolis, IN USA; [Hammond, Max A.; Wallace, Joseph M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Nashville, TN USA; [Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, Nashville, TN USA; [Nyman, Jeffry S.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Allen, MR (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	matallen@iupui.edu	Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058; Hammond, Max/0000-0003-2103-7884; Nyman, Jeffry/0000-0001-7403-7605	National Institutes of Health [AR58005, DL100093]; Indiana Clinical Translational Science Institute [TR000162]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical Translational Science Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants AR58005 (SM) and DL100093 (CN); Indiana Clinical Translational Science Institute grant TR000162 (CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2013, OSTEOPOROSIS INT, V24, P1471, DOI 10.1007/s00198-012-2103-x; Aoki C, 2013, LAB INVEST, V93, P1170, DOI 10.1038/labinvest.2013.105; Aref M, 2013, BONE, V56, P449, DOI 10.1016/j.bone.2013.07.009; Arsov S, 2014, CLIN CHEM LAB MED, V52, P11, DOI 10.1515/cclm-2012-0832; BUCKLEY A, 1988, METHOD ENZYMOL, V163, P674; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Cole JH, 2011, CLIN ORTHOP RELAT R, V469, P2139, DOI 10.1007/s11999-011-1784-3; Currey J., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P317; Diez-Perez A, 2010, J BONE MINER RES, V25, P1877, DOI 10.1002/jbmr.73; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Galli F, 2007, NEPHROL DIAL TRANSPL, V22, P20, DOI 10.1093/ndt/gfm294; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Guerri-Fernandez RC, 2013, J BONE MINER RES, V28, P162, DOI 10.1002/jbmr.1731; Hammond MA, 2014, BONE, V60, P26, DOI 10.1016/j.bone.2013.11.015; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Iwamoto J, 2012, CALCIFIED TISSUE INT, V90, P50, DOI 10.1007/s00223-011-9548-3; Iwasaki Y, 2013, BONE, V57, P477, DOI 10.1016/j.bone.2013.07.037; Iwasaki Y, 2011, BONE, V48, P1260, DOI 10.1016/j.bone.2011.03.672; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Jassal SK, 2007, J BONE MINER RES, V22, P203, DOI 10.1359/JBMR.061014; Jokihaara J, 2006, J BONE MINER RES, V21, P745, DOI 10.1359/JBMR.060114; Kadokawa S, 2011, J HARD TISSUE BIOL, V20, P79; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Klawansky S, 2003, OSTEOPOROSIS INT, V14, P570, DOI 10.1007/s00198-003-1435-y; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Malluche HH, 2013, NAT REV NEPHROL, V9, P671, DOI 10.1038/nrneph.2013.198; Malluche HH, 2012, J AM SOC NEPHROL, V23, P525, DOI 10.1681/ASN.2010121253; Mitome J, 2011, CALCIFIED TISSUE INT, V88, P521, DOI 10.1007/s00223-011-9488-y; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Moe SM, 2014, J BONE MINER RES, V29, P902, DOI 10.1002/jbmr.2089; Moe SM, 2011, J BONE MINER RES, V26, P2672, DOI 10.1002/jbmr.485; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Nagao S, 2010, AM J PHYSIOL-RENAL, V299, pF1078, DOI 10.1152/ajprenal.00504.2009; Nickolas TL, 2006, J AM SOC NEPHROL, V17, P3223, DOI 10.1681/ASN.2005111194; Nickolas TL, 2011, J AM SOC NEPHROL, V22, P1560, DOI 10.1681/ASN.2010121275; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Nitsch D, 2009, NEPHROL DIAL TRANSPL, V24, P1539, DOI 10.1093/ndt/gfn678; Nyman JS, 2006, BONE, V39, P1210, DOI 10.1016/j.bone.2006.06.026; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Phelps JB, 2000, J BIOMED MATER RES, V51, P735, DOI 10.1002/1097-4636(20000915)51:4<735::AID-JBM23>3.0.CO;2-G; PIRAINO B, 1988, CLIN NEPHROL, V30, P57; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/jbmr.090316, 10.1359/JBMR.090316]; Stagner EE, 2009, BIOCHEM BIOPH RES CO, V383, P16, DOI 10.1016/j.bbrc.2009.03.113; Wallace JM, 2012, BONE, V50, P420, DOI 10.1016/j.bone.2011.11.008; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Zoccali C, 2001, J NEPHROL, V14, P293	59	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99262	10.1371/journal.pone.0099262	http://dx.doi.org/10.1371/journal.pone.0099262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911162	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600062
J	Oka, S; Furukawa, H; Kawasaki, A; Shimada, K; Sugii, S; Hashimoto, A; Komiya, A; Fukui, N; Ito, S; Nakamura, T; Saisho, K; Katayama, M; Tsunoda, S; Sano, H; Migita, K; Suda, A; Nagaoka, S; Tsuchiya, N; Tohma, S				Oka, Shomi; Furukawa, Hiroshi; Kawasaki, Aya; Shimada, Kota; Sugii, Shoji; Hashimoto, Atsushi; Komiya, Akiko; Fukui, Naoshi; Ito, Satoshi; Nakamura, Tadashi; Saisho, Koichiro; Katayama, Masao; Tsunoda, Shinichiro; Sano, Hajime; Migita, Kiyoshi; Suda, Akiko; Nagaoka, Shouhei; Tsuchiya, Naoyuki; Tohma, Shigeto			Protective Effect of the HLA-DRB1*13: 02 Allele in Japanese Rheumatoid Arthritis Patients	PLOS ONE			English	Article							SHARED EPITOPE HYPOTHESIS; HLA-DRB1 ALLELES; ASSOCIATION; DISEASE; RISK; CLASSIFICATION; SUSCEPTIBILITY; PREDISPOSITION; MOLECULE; MARKER	Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease. Certain HLA-DRB1 "shared-epitope'' alleles are reported to be positively associated with increased RA susceptibility, whereas some of the other alleles may be negatively associated. However, studies on the latter are rare. Here, we focus on the protective effects of DRB1 alleles in Japanese RA patients in an association study. Relative predispositional effects (RPE) were analyzed by sequential elimination of carriers of each allele with the strongest association. The protective effects of DRB1 alleles were investigated in patients stratified according to whether they possessed anti-citrullinated peptide antibodies (ACPA). The DRB1*13:02 allele was found to be negatively associated with RA (P = 4.59x10(-10), corrected P (Pc) = 1.42x10(-8), odds ratio [OR] 0.42, 95% CI 0.32-0.55, P [RPE] = 1.27x10(-6)); the genotypes DRB1*04:05/*13:02 and * 09:01/*13:02 were also negatively associated with RA. The protective effect of * 13:02 was also present in ACPA-positive patients (P = 3.95x10(-8), Pc = 1.22x10(-6), OR 0.42, 95% CI 0.310.58) whereas * 15:02 was negatively associated only with ACPA-negative RA (P = 8.87x10(-5), Pc = 0.0026, OR 0.26, 95% CI 0.12-0.56). Thus, this study identified a negative association of DRB1*13:02 with Japanese RA; our findings support the protective role of DRB1*1 3:02 in the pathogenesis of ACPA-positive RA.	[Oka, Shomi; Furukawa, Hiroshi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Shimada, Kota; Hashimoto, Atsushi] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumatol, Fuchu, Tokyo, Japan; [Ito, Satoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Japan; [Nakamura, Tadashi] Kumamoto Shinto Gen Hosp, Dept Rheumatol, Kumamoto, Japan; [Saisho, Koichiro] Natl Hosp Org, Miyakonojo Hosp, Dept Orthoped Rheumatol, Miyakonojo, Japan; [Katayama, Masao] Natl Hosp Org, Nagoya Med Ctr, Dept Internal Med, Nagoya, Aichi, Japan; [Tsunoda, Shinichiro; Sano, Hajime] Hyogo Coll Med, Dept Internal Med, Div Rheumatol, Nishinomiya, Hyogo 6638501, Japan; [Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan; [Suda, Akiko] Yokohama City Univ, Med Ctr, Ctr Rheumat Dis, Yokohama, Kanagawa 232, Japan	University of Tsukuba; Nagoya Medical Center; Hyogo College of Medicine; Yokohama City University	Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	h-furukawa@sagamihara-hosp.gr.jp	Ito, Satoshi/AAL-9615-2020; Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580	Japan Society for the Promotion of Science [24791018]; Health and Labour Science Research Grants from the Ministry of Health; Labour and Welfare of Japan; National Hospital Organization, Research Grants from Daiwa Securities Health Foundation; Research Grants from Japan Research Foundation for Clinical Pharmacology; Research Grants from The Nakatomi Foundation; Research Grants from Takeda Science Foundation; Research Grants from Mitsui Sumitomo Insurance Welfare Foundation; Research Grants from SENSHIN Medical Research Foundation; Abbott Japan Co., Ltd.; Astellas Pharma Inc.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Mitsubishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited;  [22390199];  [22591090];  [25670458]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Science Research Grants from the Ministry of Health; Labour and Welfare of Japan; National Hospital Organization, Research Grants from Daiwa Securities Health Foundation; Research Grants from Japan Research Foundation for Clinical Pharmacology; Research Grants from The Nakatomi Foundation; Research Grants from Takeda Science Foundation; Research Grants from Mitsui Sumitomo Insurance Welfare Foundation; Research Grants from SENSHIN Medical Research Foundation; Abbott Japan Co., Ltd.(Abbott Laboratories); Astellas Pharma Inc.(Astellas Pharmaceuticals); Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Merck Sharp and Dohme Inc.(Merck & Company); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited); ; ; 	This work was supported by Grants-in-Aid for Scientific Research (B, C) (22390199, 22591090), for Exploratory Research (25670458) and for Young Scientists (B) (24791018) from the Japan Society for the Promotion of Science, Health and Labour Science Research Grants from the Ministry of Health, Labour and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Daiwa Securities Health Foundation, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from The Nakatomi Foundation, Research Grants from Takeda Science Foundation, Research Grants from Mitsui Sumitomo Insurance Welfare Foundation, Research Grants from SENSHIN Medical Research Foundation and research grants from pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited. The funders had no role in study design, data collection and analysis, decision to publish or preparing the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; de Vries N, 2002, ARTHRITIS RHEUM-US, V46, P921, DOI 10.1002/art.10210; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Furukawa H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053910; Furukawa H, 2013, ANN RHEUM DIS, V72, P153, DOI 10.1136/annrheumdis-2012-201944; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Gourraud PA, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2131; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kamatani N, 2004, TISSUE CULTURE RES C, V23, P71; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046806; Lewis SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027175; Liu SC, 2007, J RHEUMATOL, V34, P674; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Mattey DL, 2001, J RHEUMATOL, V28, P232; Mewar D, 2008, ANN RHEUM DIS, V67, P980, DOI 10.1136/ard.2007.075382; Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078699; Mitsunaga S, 2012, TISSUE ANTIGENS, V80, P16, DOI 10.1111/j.1399-0039.2012.01872.x; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scott IC, 2011, BEST PRACT RES CL RH, V25, P447, DOI 10.1016/j.berh.2011.10.010; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Shimane K, 2013, RHEUMATOLOGY, V52, P1172, DOI 10.1093/rheumatology/kes427; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Wakitani S, 1997, BRIT J RHEUMATOL, V36, P630	33	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99453	10.1371/journal.pone.0099453	http://dx.doi.org/10.1371/journal.pone.0099453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911054	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600091
J	Park, IW; Fan, Y; Luo, XY; Ryou, MG; Liu, JF; Green, L; He, JJ				Park, In-Woo; Fan, Yan; Luo, Xiaoyu; Ryou, Myoung-Gwi; Liu, Jinfeng; Green, Linden; He, Johnny J.			HIV-1 Nef Is Transferred from Expressing T Cells to Hepatocytic Cells through Conduits and Enhances HCV Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; KINASE-C-THETA; CHRONIC HEPATITIS-C; NF-KAPPA-B; RNA REPLICATION; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; LIPID RAFTS; IMMUNOLOGICAL SYNAPSE; VIRAL REPLICATION	HIV-1 infection enhances HCV replication and as a consequence accelerates HCV-mediated hepatocellular carcinoma (HCC). However, the precise molecular mechanism by which this takes place is currently unknown. Our data showed that infectious HIV-1 failed to replicate in human hepatocytic cell lines. No discernible virus replication was observed, even when the cell lines transfected with HIV-1 proviral DNA were co-cultured with Jurkat T cells, indicating that the problem of liver deterioration in the co-infected patient is not due to the replication of HIV-1 in the hepatocytes of the HCV infected host. Instead, HIV-1 Nef protein was transferred from nef-expressing T cells to hepatocytic cells through conduits, wherein up to 16% (average 10%) of the cells harbored the transferred Nef, when the hepatocytic cells were co-cultured with nef-expressing Jurkat cells for 24 h. Further, Nef altered the size and numbers of lipid droplets (LD), and consistently upregulated HCV replication by 1.5 similar to 2.5 fold in the target subgenomic replicon cells, which is remarkable in relation to the initially indolent viral replication. Nef also dramatically augmented reactive oxygen species (ROS) production and enhanced ethanol-mediated up-regulation of HCV replication so as to accelerate HCC. Taken together, these data indicate that HIV-1 Nef is a critical element in accelerating progression of liver pathogenesis via enhancing HCV replication and coordinating modulation of key intra-and extra-cellular molecules for liver decay.	[Park, In-Woo; Fan, Yan; Luo, Xiaoyu; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA; [Ryou, Myoung-Gwi] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Park, In-Woo; Fan, Yan; Luo, Xiaoyu; Liu, Jinfeng; Green, Linden; He, Johnny J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Indiana University System; Indiana University Bloomington	Park, IW (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA.	inwoo.park@unthsc.edu	Fan, Yan/F-5107-2018	Luo, Xiaoyu/0000-0001-6059-0434	NIH/NIDDK [R01 DK099055]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099055] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from NIH/NIDDK R01 DK099055 (In- Woo Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.16; Acheampong EA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-183; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; ALLAN JS, 1985, SCIENCE, V230, P810, DOI 10.1126/science.2997921; Altavilla G, 2000, AM J PATHOL, V157, P1081, DOI 10.1016/S0002-9440(10)64622-6; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; ASZTALOS BF, 2010, J INFECT DIS; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70; Caliceti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041246; CAO YZ, 1990, J VIROL, V64, P2553, DOI 10.1128/JVI.64.6.2553-2559.1990; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Chouteau P, 2012, J HEPATOL, V57, P499, DOI 10.1016/j.jhep.2012.04.019; Cubero FJ, 2008, HEPATOLOGY, V48, P2027, DOI 10.1002/hep.22592; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Daar ES, 2001, J ACQ IMMUN DEF SYND, V26, P466, DOI 10.1097/00126334-200104150-00011; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Hage N, 2011, J VIROL, V85, P11601, DOI 10.1128/JVI.05239-11; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fournier M, 2010, MOL IMMUNOL, V47, P2594, DOI 10.1016/j.molimm.2010.06.010; FRANCHINI G, 1986, VIROLOGY, V155, P593, DOI 10.1016/0042-6822(86)90219-9; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; Goedert JJ, 2001, J INFECT DIS, V184, P1202, DOI 10.1086/323665; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hammer GP, 2003, SEX TRANSM DIS, V30, P919, DOI 10.1097/01.OLQ.0000091152.31366.E6; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOUSSET C, 1990, RES VIROLOGY, V141, P153, DOI 10.1016/0923-2516(90)90017-D; Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Kang L, 2012, VIRUS RES, V163, P74, DOI 10.1016/j.virusres.2011.08.011; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Khabar KSA, 1997, J EXP MED, V186, P1077, DOI 10.1084/jem.186.7.1077; Khan KA, 2013, J INNATE IMMUN, V5, P639, DOI 10.1159/000350517; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kusano F, 2000, LAB INVEST, V80, P415, DOI 10.1038/labinvest.3780046; Larbi A, 2004, EXP GERONTOL, V39, P551, DOI 10.1016/j.exger.2003.10.031; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2011, J BIOL CHEM, V286, P2665, DOI 10.1074/jbc.M110.168286; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Masanetz S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-35; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Okiyama W, 2009, J HEPATOL, V50, P1236, DOI 10.1016/j.jhep.2009.01.025; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Olivetta E, 2009, J CELL BIOCHEM, V106, P812, DOI 10.1002/jcb.22041; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Park IW, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-29; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Purohit V, 2013, LIFE SCI, V92, P3, DOI 10.1016/j.lfs.2012.10.009; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; STEFFAN AM, 1992, P NATL ACAD SCI USA, V89, P1582, DOI 10.1073/pnas.89.5.1582; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; VOGEL J, 1991, CANCER RES, V51, P6686; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Witte V, 2008, J IMMUNOL, V181, P8425, DOI 10.4049/jimmunol.181.12.8425; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zhang T, 2003, HEPATOLOGY, V38, P57, DOI 10.1053/jhep.2003.50295	86	18	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99545	10.1371/journal.pone.0099545	http://dx.doi.org/10.1371/journal.pone.0099545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911518	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600105
J	Zhang, J; Xu, ZW; Yu, LX; Chen, ML; Li, K				Zhang, Jun; Xu, Zhiwei; Yu, Lingxiang; Chen, Meilan; Li, Ke			Assessment of the Potential Diagnostic Value of Serum p53 Antibody for Cancer: A Meta-Analysis	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; TEST ACCURACY; CURVE; TESTS; HETEROGENEITY; PERFORMANCE; UTILITY; BIAS	Background: Mutant p53 protein over-expression has been reported to induce serum antibodies against p53. We assessed the diagnostic precision of serum p53 (s-p53) antibodies for diagnosis of cancer patients and compared the positive rates of the s-p53 antibody in different types of cancers. Methods: We systematically searched PubMed and Embase, through May 31, 2012. Studies were assessed for quality using QUADAS (quality assessment of studies of diagnostic accuracy). The positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were pooled separately and compared with overall accuracy measures using diagnostic odds ratios (DORs) and Area under the curve(AUC). Meta regression and subgroup analyses were done, and heterogeneity and publication bias were assessed. Results: Of 1089 studies initially identified, 100 eligible studies with 23 different types of tumor met the inclusion criteria for the meta-analysis (cases = 15953, controls = 8694). However, we could conduct independent meta analysis on only 13 of 36 types of tumors. Approximately 56% (56/100) of the included studies were of high quality (QUADAS score >= 8). The summary estimates for quantitative analysis of serum p53 antibody in the diagnosis of cancers were: PLR 5.75 (95% CI: 4.60-7.19), NLR 0.81 (95% CI: 0.79-0.83) and DOR 7.56 (95% CI: 6.02-9.50). However, for the 13 types of cancers on which meta-analysis was conducted, the ranges for PLR (2.33-11.05), NLR (0.74-0.97), DOR (2.86-13.80), AUC(0.29-0.81), and positive rate (4.47%-28.36%) indicated significant heterogeneity. We found that breast, colorectal, esophageal, gastric, hepatic, lymphoma, lung and ovarian cancer had relatively reasonable diagnostic accuracy. The remaining results of the five types of cancers suggested that s-p53 antibody had limited value. Conclusions: The current evidence suggests that s-p53 antibody has potential diagnostic value for cancer, especially for breast, colorectal, esophageal, gastric, hepatic, lymphoma, lung and ovarian cancer. The results showed that s-p53 antibody had high correlation with cancers.	[Zhang, Jun; Chen, Meilan; Li, Ke] Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Xu, Zhiwei] 302 PLA Hosp, Dept Med Qual Control, Beijing, Peoples R China; [Yu, Lingxiang] 302 PLA Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China	Shantou University; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Li, K (corresponding author), Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	kli@stu.edu.cn	xiaoxiao, zhang/HHN-4916-2022					Clarke M, 2003, COCHRANE REV HDB; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gu P, 2007, J CLIN LAB ANAL, V21, P398, DOI 10.1002/jcla.20208; Honest H, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-4; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; KHAN K, 2001, UNDERTAKING SYSTEMAT; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li LX, 2008, MOL MED REP, V1, P589; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; LUBIN R, 1995, NAT MED, V1, P701, DOI 10.1038/nm0795-701; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smidt N, 2011, COCHRANE HDB SYSTEMA; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; TRIVERS GE, 1995, J NATL CANCER I, V87, P1400, DOI 10.1093/jnci/87.18.1400; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu M, 2010, MOL BIOL REP, V37, P339, DOI 10.1007/s11033-009-9744-7; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052896	28	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99255	10.1371/journal.pone.0099255	http://dx.doi.org/10.1371/journal.pone.0099255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911057	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600061
J	Hanieh, S; Hamaluba, M; Kelly, DF; Metz, JA; Wyres, KL; Fisher, R; Pradhan, R; Shakya, D; Shrestha, L; Shrestha, A; Joshi, A; Habens, J; Maharjan, BD; Thorson, S; Bohler, E; Yu, LM; Kelly, S; Plested, E; John, T; Werno, AM; Adhikari, N; Murdoch, DR; Brueggemann, AB; Pollard, AJ				Hanieh, Sarah; Hamaluba, Mainga; Kelly, Dominic F.; Metz, Jane A.; Wyres, Kelly L.; Fisher, Roberta; Pradhan, Rahul; Shakya, Disuja; Shrestha, Lochan; Shrestha, Amrita; Joshi, Anip; Habens, Jocelyn; Maharjan, Bishnu D.; Thorson, Stephen; Bohler, Erik; Yu, Ly-Mee; Kelly, Sarah; Plested, Emma; John, Tessa; Werno, Anja M.; Adhikari, Neelam; Murdoch, David R.; Brueggemann, Angela B.; Pollard, Andrew J.			Streptococcus pneumoniae Carriage Prevalence in Nepal: Evaluation of a Method for Delayed Transport of Samples from Remote Regions and Implications for Vaccine Implementation	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; SEQUENTIAL MULTIPLEX PCR; DETERMINING CAPSULAR SEROTYPES; NASOPHARYNGEAL CARRIAGE; YOUNG-CHILDREN; EPIDEMIOLOGY; IDENTIFICATION; SURVEILLANCE	Background: Pneumococcal disease is a significant cause of morbidity and mortality in young children in Nepal, and currently available pneumococcal conjugate vaccines offer moderate coverage of invasive disease isolates. Methods: A prevalence study of children aged 1.5 to 24 months in urban and rural Nepal was conducted. In the urban group, nasopharyngeal swabs (NPS) were transported using silica desiccant packages (SDP) with delayed processing (2 weeks), or skim-milk-tryptone-glucose-glycerin (STGG) with immediate processing (within 8 hours). Pneumococcal nasopharyngeal carriage prevalence, serogroup/type distribution and isolate genotypes (as defined by multilocus sequence typing) were determined. Results: 1101 children were enrolled into the study: 574 in the urban group and 527 in the rural group. Overall carriage prevalence based on culture from specimens transported and stored in STGG was 58.7% (337/574), compared to 40.9% (235/574) in SDP. There was concordance of detection of pneumococcus in 67% of samples. Using the SDP method, pneumococcal carriage prevalence was higher in the rural population (69.2%; 364/526) compared to the urban population (40.9%; 235/574). Serogroup/type distribution varied with geographical location. Over half of the genotypes identified in both the urban and rural pneumococcal populations were novel. Conclusion: The combination of delayed culture and transport using SDP underestimates the prevalence of pneumococcal carriage; however, in remote areas, this method could still provide a useful estimate of carriage prevalence and serogroup/type distribution. Vaccine impact is unpredictable in a setting with novel genotypes and limited serotype coverage as described here. Consequently, continued surveillance of pneumococcal isolates from carriage and disease in Nepali children following the planned introduction of pneumococcal conjugate vaccines introduction will be essential.	[Hanieh, Sarah; Hamaluba, Mainga; Kelly, Dominic F.; Metz, Jane A.; Kelly, Sarah; Plested, Emma; John, Tessa; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Hanieh, Sarah; Hamaluba, Mainga; Kelly, Dominic F.; Metz, Jane A.; Kelly, Sarah; Plested, Emma; John, Tessa; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Hanieh, Sarah; Hamaluba, Mainga; Metz, Jane A.; Pradhan, Rahul; Shakya, Disuja; Shrestha, Lochan; Shrestha, Amrita; Joshi, Anip; Habens, Jocelyn; Maharjan, Bishnu D.; Thorson, Stephen; Adhikari, Neelam] Patan Acad Hlth Sci, Patan Acad Paediat Res Unit, Kathmandu, Nepal; [Wyres, Kelly L.; Fisher, Roberta; Brueggemann, Angela B.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bohler, Erik] Okhaldhunga Community Hosp, Okhaldhunga, Nepal; [Yu, Ly-Mee] Univ Oxford, Nuffield Dept Primary Care & Hlth Sci, Oxford, England; [Werno, Anja M.; Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Werno, Anja M.; Murdoch, David R.] Canterbury Hlth Labs, Christchurch, New Zealand	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Otago; Canterbury Health Laboratories	Hanieh, S (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	haniehs@student.unimelb.edu.au	Wyres, Kelly/AAU-7162-2021; Murdoch, David/A-2012-2009; Shrestha, Lochan/J-4687-2013	Wyres, Kelly/0000-0002-4033-6639; Shrestha, Lochan/0000-0003-0814-3332; Hamaluba, Mainga/0000-0002-0266-1414; Kelly, Dominic/0000-0002-6063-8896; Brueggemann, Angela/0000-0002-2329-1934; Yu, Ly-Mee/0000-0003-0331-7364; Metz, Jane/0000-0003-2064-8675	Oxford Vaccine Group at the University of Oxford; NIHR Oxford Biomedical Research Centre; Biologicals SA; Robert Austrian Award in Pneumococcal Vaccinology	Oxford Vaccine Group at the University of Oxford; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Biologicals SA; Robert Austrian Award in Pneumococcal Vaccinology	This work was supported by the Oxford Vaccine Group at the University of Oxford. DFK receives salary support from the NIHR Oxford Biomedical Research Centre. Biologicals SA provided support for the serotyping and genotyping costs of this study. Funds from the Robert Austrian Award in Pneumococcal Vaccinology (awarded to ABB, a Wellcome Trust Career Development Fellow) were also applied towards genotyping costs of this study. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript but the authors are solely responsible for final content and interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Coles CL, 2009, TROP MED INT HEALTH, V14, P1025, DOI 10.1111/j.1365-3156.2009.02331.x; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Enright MC, 2000, EUR J CLIN MICROBIOL, V19, P627, DOI 10.1007/s100960000321; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Jain A, 2005, TROP MED INT HEALTH, V10, P234, DOI 10.1111/j.1365-3156.2004.01379.x; Jebaraj R, 1999, EPIDEMIOL INFECT, V123, P383, DOI 10.1017/S0950268899003131; Joshi HH, 2008, J CLIN MICROBIOL, V46, P3175, DOI 10.1128/JCM.00906-08; Kandasamy, 2014, PNEUMONIA, V3, P290; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; Williams EJ, 2009, CLIN INFECT DIS, V48, pS114, DOI 10.1086/596488; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703; Zangeneh TT, 2011, EXPERT REV VACCINES, V10, P345, DOI [10.1586/ERV.11.1, 10.1586/erv.11.1]	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98739	10.1371/journal.pone.0098739	http://dx.doi.org/10.1371/journal.pone.0098739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905574	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000055
J	Bao, R; Zhuang, K; Liu, JB; Wu, JG; Li, JL; Wang, X; Ho, WZ				Bao, Rong; Zhuang, Ke; Liu, Jinbiao; Wu, Jianguo; Li, Jieliang; Wang, Xu; Ho, Wen-Zhe			Lipopolysaccharide Induces Immune Activation and SIV Replication in Rhesus Macaques of Chinese Origin	PLOS ONE			English	Article							MICROBIAL TRANSLOCATION; T-CELLS; HIV-INFECTION; NATURAL HOSTS; VIRUS	Background: Chronic immune activation is a hallmark of progressive HIV infection and a key determinant of immunodeficiency in HIV-infected individuals. Bacterial lipopolysaccharide (LPS) in the circulation has been implicated as a key factor in HIV infection-related systemic immune activation. We thus investigate the impact of LPS on systemic immune activation in simian immunodeficiency virus (SIV)-infected rhesus macaques of Chinese origin. Methods: The animals were inoculated intravenously with SIVmac239. The levels of plasma viral load and host inflammatory cytokines in PBMC were measured by real-time RT-PCR. CD4/CD8 ratio and systemic immune activation markers were examined by flow cytometric analysis of PBMCs. White blood cell and neutrophil counts and C Reactive Protein levels were determined using biochemistry analyzer. The plasma levels of LPS were determined by Tachypleus Amebocyte Lysate (TAL) test. Results: The animals inoculated with SIVmac239 became infected as evidenced by the increased plasma levels of SIV RNA and decreased CD4/CD8 ratio. LPS administration of SIV-infected animals induced a transient increase of plasma SIV RNA and immune activation, which was indicated by the elevated expression of the inflammatory cytokines and CD4+HLA-DR+ T cells in PBMCs. Conclusions: These data support the concept that LPS is a driving factor in systemic immune activation of HIV disease.	[Bao, Rong; Zhuang, Ke; Liu, Jinbiao; Ho, Wen-Zhe] Wuhan Univ, Anim Biosafety Level Lab 3, Ctr Expt Anim, Wuhan 430072, Hubei, Peoples R China; [Wu, Jianguo; Ho, Wen-Zhe] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Li, Jieliang; Wang, Xu; Ho, Wen-Zhe] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA	Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ho, WZ (corresponding author), Wuhan Univ, Anim Biosafety Level Lab 3, Ctr Expt Anim, Wuhan 430072, Hubei, Peoples R China.	wenzheho@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	National Natural Science Foundation of China [81271334]; Mega-Projects of Science Research for the 11th Five Year Plan, China [2013ZX10003009-003]; Translational Medical Research Fund of Wuhan University School of Medicine; NIDA [DA12815, DA22177, DA036163, DA27550]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-Projects of Science Research for the 11th Five Year Plan, China; Translational Medical Research Fund of Wuhan University School of Medicine; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This study was supported by the grants 81271334 from the National Natural Science Foundation of China, 2013ZX10003009-003 from the Mega-Projects of Science Research for the 11th Five Year Plan, China, theTranslational Medical Research Fund of Wuhan University School of Medicine and NIDA grants DA12815, DA22177, DA036163 and DA27550 (to WZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Boasso A, 2009, J IMMUNOL, V182, P4313, DOI 10.4049/jimmunol.0803314; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; Desrosiers R C, 1995, AIDS, V9 Suppl A, pS137; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Joag SV, 2000, MICROBES INFECT, V2, P223, DOI 10.1016/S1286-4579(00)00266-5; Kadoki M, 2010, INT IMMUNOL, V22, P469, DOI 10.1093/intimm/dxq032; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mattapallil JJ, 2005, MASSIVE INFECT LOSS; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Paiardini M, 2008, AIDS REV, V10, P36; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Pallikkuth S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003471; Pandrea I, 2008, J IMMUNOL, V181, P6687, DOI 10.4049/jimmunol.181.10.6687; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Tanaka J, 2000, AIDS, V14, P1299, DOI 10.1097/00002030-200007070-00001; Ye L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009602; Zhou Y, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-89	26	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98636	10.1371/journal.pone.0098636	http://dx.doi.org/10.1371/journal.pone.0098636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918575	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000024
J	Chen, LH; Zhang, JQ; Chen, YF; Wang, WW; Zhou, XD; Yan, XC; Wang, J				Chen, Lihua; Zhang, Jiuquan; Chen, Yongfeng; Wang, Wenwei; Zhou, Xiangdong; Yan, Xiaochu; Wang, Jian			Relationship between Apparent Diffusion Coefficient and Tumour Cellularity in Lung Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; COMPLICATION RATE; WEIGHTED MRI; EXPERIENCE; LYMPHOMAS; GLIOMAS; BIOPSY	Background and objective: To prospectively investigate the relationship between the apparent diffusion coefficient (ADC) and cellularity in lung cancer. Methods: Sixty patients histopathologically confirmed with lung cancer (41 men, 19 women) underwent diffusion-weighted magnetic resonance imaging of the chest (with b values of 50 and 1000 s/mm(2)). The median mean ADC (ADCmean) value and median minimum ADC (ADCmin) value within each primary tumour were calculated and compared with the median nucleo-cytoplasmic ratio (NCR), which was selected to represent the cellularity. The correlation between the NCR and ADCmean/ADCmin was calculated with SPSS 18.0 software. Results: The mean ADCmean values, ADCmin values and median NCR were (1.07 +/- 0.12) x 10(-3) mm(2)/s, (0.86 +/- 0.14) x 10(-3) mm(2)/s, and (14.9 +/- 2.6) %, respectively, in adenocarcinoma; (0.88 +/- 0.10) x 10(-3) mm(2)/s, (0.73 +/- 0.12) x 10(-3) mm(2)/s, nd (20.6 +/- 4.4) %, respectively, in squamous cell carcinoma; and (0.89 +/- 0.13) x 10(-3) mm(2)/s, (0.67 +/- 0.13) x 10(-3) mm(2)/s, and (18.3 +/- 3.5) %, respectively in small cell lung cancer. The NCR of squamous cell carcinoma and small cell lung cancer is greater than that of adenocarcinoma (P<0.01 and P = 0.002, respectively). There was an inverse relationship between ADCmean/NCR and ADCmin/NCR (r = -0.60, P = 0.001 and r = -0.47, P<0.001, respectively). Conclusion: There is a significant inverse relationship between tumour cellularity and ADC in lung cancer. However, tumour cellularity most likely is not the sole determinant of the ADC.	[Chen, Lihua; Zhang, Jiuquan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Chen, Lihua] PLA 101st Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China; [Chen, Yongfeng; Wang, Wenwei; Zhou, Xiangdong] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China; [Yan, Xiaochu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Yan, XC (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China.	yanxiaochu2002@hotmail.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019	Chen, Lihua/0000-0001-7249-2014; Chen, Lihua/0000-0001-5037-050X; Zhang, Jiuquan/0000-0003-0239-6988				Baysal T, 2009, MAGN RESON IMAGING, V27, P1447, DOI 10.1016/j.mri.2009.05.024; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Chen LH, 2013, J MAGN RESON IMAGING, V37, P1351, DOI 10.1002/jmri.23939; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Fan GG, 2005, ACAD RADIOL, V12, P640, DOI 10.1016/j.acra.2005.01.024; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Henzler T, 2010, EUR J RADIOL, V76, P329, DOI 10.1016/j.ejrad.2010.05.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kikuchi T, 2009, NEUROL RES, V31, P1102, DOI 10.1179/174313209X382539; Kosucu P, 2009, J MAGN RESON IMAGING, V30, P292, DOI 10.1002/jmri.21850; Koyama H, 2010, EUR RADIOL, V20, P790, DOI 10.1007/s00330-009-1615-z; Li Z, 2010, CHINESE GERMAN J CLI, V9, P388; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Matoba M, 2007, RADIOLOGY, V243, P570, DOI 10.1148/radiol.2432060131; Matsumoto Y, 2009, ONCOL REP, V22, P641, DOI 10.3892/or_00000484; Park SH, 2012, EUR RADIOL, V22, P18, DOI 10.1007/s00330-011-2236-x; Poptani H, 1998, CANCER GENE THER, V5, P101; Priola AM, 2010, ACTA RADIOL, V51, P527, DOI 10.3109/02841851003691979; Razek AAKA, 2012, CANCER IMAGING, V12, P452, DOI 10.1102/1470-7330.2012.0041; Razek AAKA, 2011, J COMPUT ASSIST TOMO, V35, P248, DOI 10.1097/RCT.0b013e31820ccf73; Sadeghi N, 2003, AM J ROENTGENOL, V181, P235, DOI 10.2214/ajr.181.1.1810235; Shin HJ, 2012, NMR BIOMED, V25, P1349, DOI 10.1002/nbm.2807; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; Yuan DM, 2011, CHINESE MED J-PEKING, V124, P3227, DOI 10.3760/cma.j.issn.0366-6999.2011.20.04	24	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99865	10.1371/journal.pone.0099865	http://dx.doi.org/10.1371/journal.pone.0099865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919055	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000123
J	Gao, B; Huang, Q; Lin, YS; Wei, BY; Guo, YS; Sun, Z; Wang, L; Fan, J; Zhang, HY; Han, YH; Li, XJ; Shi, J; Liu, J; Yang, L; Luo, ZJ				Gao, Bo; Huang, Qiang; Lin, Yan-Shui; Wei, Bo-Yuan; Guo, Yun-Shan; Sun, Zhen; Wang, Long; Fan, Jing; Zhang, Hong-Yang; Han, Yue-Hu; Li, Xiao-Jie; Shi, Jun; Liu, Jian; Yang, Liu; Luo, Zhuo-Jing			Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; ADIPOCYTIC PHENOTYPE; GENE-EXPRESSION; ADIPOSE-TISSUE; BETA-CATENIN; DIFFERENTIATION; FAMILY; LRP5; PROLIFERATION	Fat infiltration within marrow cavity is one of multitudinous features of estrogen deficiency, which leads to a decline in bone formation functionality. The origin of this fat is unclear, but one possibility is that it is derived from osteoblasts, which transdifferentiate into adipocytes that produce bone marrow fat. We examined the dose-dependent effect of 17 beta-estradiol on the ability of MC3T3-E1 cells and murine bone marrow-derived mesenchymal stem cell (BMMSC)-derived osteoblasts to undergo osteo-adipogenic transdifferentiation. We found that 17 beta-estradiol significantly increased alkaline phosphatase activity (P<0.05); calcium deposition; and Alp, Col1a1, Runx2, and Ocn expression levels dose-dependently. By contrast, 17 beta-estradiol significantly decreased the number and size of lipid droplets, and Fabp4 and PPAR gamma expression levels during osteo-adipogenic transdifferentiation (P<0.05). Moreover, the expression levels of brown adipocyte markers (Myf5, Elovl3, and Cidea) and undifferentiated adipocyte markers (Dlk1, Gata2, and Wnt10b) were also affected by 17 beta-estradiol during osteo-adipogenic transdifferentiation. Western blotting and immunostaining further showed that canonical Wnt signaling can be activated by estrogen to exert its inhibitory effect of osteo-adipogenesis. This is the first study to demonstrate the dose-dependent effect of 17 beta-estradiol on the osteo-adipogenic transdifferentiation of MC3T3-E1 cells and BMMSCs likely via canonical Wnt signaling. In summary, our results indicate that osteo-adipogenic transdifferentiation modulated by canonical Wnt signaling pathway in bone metabolism may be a new explanation for the gradually increased bone marrow fat in estrogen-inefficient condition.	[Gao, Bo; Huang, Qiang; Wei, Bo-Yuan; Guo, Yun-Shan; Sun, Zhen; Wang, Long; Fan, Jing; Zhang, Hong-Yang; Han, Yue-Hu; Li, Xiao-Jie; Shi, Jun; Liu, Jian; Yang, Liu; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China; [Lin, Yan-Shui] Chengdu Med Coll, Affiliated Hosp 1, Dept Orthopaed, Chengdu, Peoples R China	Air Force Military Medical University; Chengdu Medical College	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.	liujianhq@sina.com; yangliufmmu@gmail.com; zjluogb@hotmail.com			Ministry of Science and Technology of China [2011CB964703]; National High Technology Research and Development Program 863 [2012AA020502]; China Postdoctoral Science Foundation [2012T50856]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1053]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Ministry of Science and Technology of China (2011CB964703), the National High Technology Research and Development Program 863 (2012AA020502), and the China Postdoctoral Science Foundation (2012T50856), and the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1053). No benefits in any form have been or will be received from a commercial party directly or indirectly by the authors of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2011, J BONE MINER RES, V26, P1457, DOI 10.1002/jbmr.346; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Burke ZD, 2005, CLIN SCI, V108, P309, DOI 10.1042/CS20040335; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ebeling PR, 2010, CURR OPIN ENDOCRINOL, V17, P284, DOI 10.1097/MED.0b013e328339658c; Foo C, 2007, GYNECOL ENDOCRINOL, V23, P535, DOI 10.1080/09513590701556483; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Govindarajan P, 2014, AM J PATHOL, V184, P765, DOI 10.1016/j.ajpath.2013.11.011; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kamiya Y, 2013, J BONE MINER RES, V28, P1127, DOI 10.1002/jbmr.1835; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2622, DOI 10.1210/en.139.5.2622; Kim MH, 2010, CELL PROLIFERAT, V43, P594, DOI 10.1111/j.1365-2184.2010.00709.x; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li Yongming, 2010, BMC Res Notes, V3, P309, DOI 10.1186/1756-0500-3-309; Li YM, 2013, J BIOMED MATER RES B, V101B, P9, DOI 10.1002/jbm.b.32803; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; McNeilly Thomas, 2013, Ulster Med J, V82, P89; Menagh PJ, 2010, J BONE MINER RES, V25, P757, DOI 10.1359/jbmr.091015; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Park SR, 1999, BONE, V24, P549, DOI 10.1016/S8756-3282(99)00084-8; Pierroz DD, 2009, J BONE MINER RES, V24, P775, DOI [10.1359/JBMR.081237, 10.1359/jbmr.081237]; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Ratti C, 2013, AGING CLIN EXP RES, V25, pS9, DOI 10.1007/s40520-013-0098-6; Rossini M, 2013, CALCIFIED TISSUE INT, V93, P121, DOI 10.1007/s00223-013-9749-z; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Santanam N, 1998, J LIPID RES, V39, P2111; Schiller PC, 2001, J BIOL CHEM, V276, P14133, DOI 10.1074/jbc.M011055200; Schilling T, 2008, J CELL BIOCHEM, V103, P413, DOI 10.1002/jcb.21415; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Weaver CM, 2014, CURR OSTEOPOROS REP; Zhang JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057251	49	26	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99137	10.1371/journal.pone.0099137	http://dx.doi.org/10.1371/journal.pone.0099137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918446	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000053
J	Valiadi, M; Painter, SC; Allen, JT; Balch, WM; Iglesias-Rodriguez, MD				Valiadi, Martha; Painter, Stuart C.; Allen, John T.; Balch, William M.; Iglesias-Rodriguez, M. Debora			Molecular Detection of Bioluminescent Dinoflagellates in Surface Waters of the Patagonian Shelf during Early Austral Summer 2008	PLOS ONE			English	Article							BRAZIL-MALVINAS CONFLUENCE; TAMARENSE LEBOUR BALECH; PHYTOPLANKTON BLOOMS; GONYAULAX-EXCAVATA; ATLANTIC-OCEAN; ARGENTINE SEA; GOLFO-NUEVO; ALEXANDRIUM; CHLOROPHYLL; DIVERSITY	We investigated the distribution of bioluminescent dinoflagellates in the Patagonian Shelf region using "universal'' PCR primers for the dinoflagellate luciferase gene. Luciferase gene sequences and single cell PCR tests, in conjunction with taxonomic identification by microscopy, allowed us to identify and quantify bioluminescent dinoflagellates. We compared these data to coincidental discrete optical measurements of stimulable bioluminescence intensity. Molecular detection of the luciferase gene showed that bioluminescent dinoflagellates were widespread across the majority of the Patagonian Shelf region. Their presence was comparatively underestimated by optical bioluminescence measurements, whose magnitude was affected by interspecific differences in bioluminescence intensity and by the presence of other bioluminescent organisms. Molecular and microscopy data showed that the complex hydrography of the area played an important role in determining the distribution and composition of dinoflagellate populations. Dinoflagellates were absent south of the Falkland Islands where the cold, nutrient-rich, and well-mixed waters of the Falklands Current favoured diatoms instead. Diverse populations of dinoflagellates were present in the warmer, more stratified waters of the Patagonian Shelf and Falklands Current as it warmed northwards. Here, the dinoflagellate population composition could be related to distinct water masses. Our results provide new insight into the prevalence of bioluminescent dinoflagellates in Patagonian Shelf waters and demonstrate that a molecular approach to the detection of bioluminescent dinoflagellates in natural waters is a promising tool for ecological studies of these organisms.	[Valiadi, Martha; Iglesias-Rodriguez, M. Debora] Univ Southampton, Southampton, Hants, England; [Painter, Stuart C.; Allen, John T.] Natl Oceanog Ctr, Southampton, Hants, England; [Balch, William M.] Bigelow Lab Ocean Sci, East Boothbay, ME USA	University of Southampton; NERC National Oceanography Centre; Bigelow Laboratory for Ocean Sciences	Valiadi, M (corresponding author), Univ Southampton, Waterfront Campus, Southampton, Hants, England.	martha.valiadi@gmail.com	Allen, John Taylor/AHB-3419-2022; Valiadi, Martha/U-6718-2019; Painter, Stuart/F-1248-2010	Allen, John Taylor/0000-0001-7357-6623; Valiadi, Martha/0000-0003-0074-554X; Painter, Stuart/0000-0001-7934-7346	Luminescence and Marine Plankton project [1166]; Office of Naval Research (ONR) [N000140410180]; National Science Foundation cruise [OCE-0728582]; NSF [OCE-0961660]; NASA [NNX11AO72G, NNX11AL93G, NNX10AT67G]; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009] Funding Source: researchfish; Directorate For Geosciences [0961660] Funding Source: National Science Foundation	Luminescence and Marine Plankton project; Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation cruise; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding: Financial support for MV, SCP, JTA and DIR was provided by the Luminescence and Marine Plankton project (Defence Science and Technology Laboratory and Natural Environment Research Council joint grant scheme proposal. ref 1166). MV and DIR were additionally supported by the Office of Naval Research (ONR award number N000140410180, awarded to DIR). Support for WMB as well as the ship time for the project was provided by the National Science Foundation cruise (OCE-0728582). Additional support for WMB for this work was also provided by NSF (OCE-0961660) and NASA (NNX11AO72G; NNX11AL93G; NNX10AT67G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, ECOLOGY, V74, P258, DOI 10.2307/1939521; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baker A, 2008, J PHYCOL, V44, P419, DOI 10.1111/j.1529-8817.2008.00474.x; Balch WM, 2011, DEEP-SEA RES PT II, V58, P400, DOI 10.1016/j.dsr2.2010.08.004; Bianchi AA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004854; BISBAL GA, 1995, MAR POLICY, V19, P21, DOI 10.1016/0308-597X(95)92570-W; Brandini FP, 2000, DEEP-SEA RES PT I, V47, P1015, DOI 10.1016/S0967-0637(99)00075-8; BUSKEY E, 1983, LIMNOL OCEANOGR, V28, P575, DOI 10.4319/lo.1983.28.3.0575; BUSKEY EJ, 1994, MAR BIOL, V121, P373, DOI 10.1007/BF00346747; BUSKEY EJ, 1992, J EXP MAR BIOL ECOL, V159, P37, DOI 10.1016/0022-0981(92)90256-A; CARRETO JI, 1986, J PLANKTON RES, V8, P15, DOI 10.1093/plankt/8.1.15; CARRETO JI, 1995, CONT SHELF RES, V15, P315, DOI 10.1016/0278-4343(94)E0001-3; Carreto JI, 2003, MAR BIOL, V143, P1013, DOI 10.1007/s00227-003-1147-z; Carreto JI, 2008, CONT SHELF RES, V28, P1589, DOI 10.1016/j.csr.2007.02.012; Cussatlegras AS, 2007, J EXP MAR BIOL ECOL, V343, P74, DOI 10.1016/j.jembe.2006.11.009; DESA R, 1968, J GEN PHYSIOL, V51, P105, DOI 10.1085/jgp.51.1.105; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Esaias WE, 1973, J CELL PHYSL, V82; Fleisher KJ, 1995, BIOL BULL, V189, P263, DOI 10.2307/1542143; Franco BC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032066; Garcia VMT, 2008, DEEP-SEA RES PT I, V55, P1150, DOI 10.1016/j.dsr.2008.04.011; Gayoso AM, 2006, HARMFUL ALGAE, V5, P233, DOI 10.1016/j.hal.2004.12.010; Gayoso AM, 1996, J PLANKTON RES, V18, P941, DOI 10.1093/plankt/18.6.941; Gayoso AM, 2001, J PLANKTON RES, V23, P463, DOI 10.1093/plankt/23.5.463; Gentile G, 2009, DEEP-SEA RES PT II, V56, P763, DOI 10.1016/j.dsr2.2008.07.023; Godhe A, 2001, MAR BIOTECHNOL, V3, P152, DOI 10.1007/s101260000052; GORDON AL, 1989, DEEP-SEA RES, V36, P359, DOI 10.1016/0198-0149(89)90042-3; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Guillou L, 2002, PROTIST, V153, P223, DOI 10.1078/1434-4610-00100; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; KELLY MG, 1968, BIOL BULL, V135, P279, DOI 10.2307/1539782; LAPOTA D, 1992, MAR BIOL, V112, P665, DOI 10.1007/BF00346185; LAPOTA D, 1984, J EXP MAR BIOL ECOL, V77, P209, DOI 10.1016/0022-0981(84)90121-7; Levitus S., 1982, 13 NOAA; Li YQ, 1996, J PHYCOL, V32, P974, DOI 10.1111/j.0022-3646.1996.00974.x; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; Liu LY, 2004, P NATL ACAD SCI USA, V101, P16555, DOI 10.1073/pnas.0407597101; Lynch RV, 1978, OCCURENCE DISTRIBUTI, P49; Marcinko CLJ, 2013, PROG OCEANOGR, V109, P117, DOI 10.1016/j.pocean.2012.10.008; Marcinko CLJ, 2013, J PLANKTON RES, V35, P177, DOI 10.1093/plankt/fbs081; Moline MA, 2009, DEEP-SEA RES PT II, V56, P232, DOI 10.1016/j.dsr2.2008.08.002; NEGRI RM, 1992, J PLANKTON RES, V14, P261, DOI 10.1093/plankt/14.2.261; Olguin HF, 2006, J PLANKTON RES, V28, P1107, DOI 10.1093/plankt/fbl045; OLSON DB, 1988, DEEP-SEA RES, V35, P1971, DOI 10.1016/0198-0149(88)90120-3; Painter SC, 2010, CONT SHELF RES, V30, P1907, DOI 10.1016/j.csr.2010.08.013; PIOLA AR, 1989, DEEP-SEA RES, V36, P1, DOI 10.1016/0198-0149(89)90015-0; Poulton AJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P1023, DOI 10.1002/2013GB004641; Poupin J, 1999, PLANCTON MARIN BIOLU, P83; Provost C, 1996, CONT SHELF RES, V16, P215, DOI 10.1016/0278-4343(95)00006-M; RAYMOND JA, 1976, LIMNOL OCEANOGR, V21, P599, DOI 10.4319/lo.1976.21.4.0599; Romero SI, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003244; Sabatini M, 2004, CONT SHELF RES, V24, P1359, DOI 10.1016/j.csr.2004.03.014; Schloss IR, 2007, MAR ECOL PROG SER, V332, P93, DOI 10.3354/meps332093; SCHMIDT RJ, 1978, J PHYCOL, V14, P5, DOI 10.1111/j.1529-8817.1978.tb00624.x; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; Steidinger Karen A., 1997, P387, DOI 10.1016/B978-012693018-4/50005-7; SWEENEY BM, 1959, J GEN PHYSIOL, V43, P285, DOI 10.1085/jgp.43.2.285; SWEENEY BM, 1963, BIOL BULL, V125, P177, DOI 10.2307/1539300; SWIFT E, 1985, J PLANKTON RES, V7, P831, DOI 10.1093/plankt/7.6.831; SWIFT E, 1995, J GEOPHYS RES-OCEANS, V100, P6527, DOI 10.1029/94JC01870; SWIFT E, 1973, J PHYCOL, V9, P420, DOI 10.1111/j.1529-8817.1973.tb04115.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TETT PB, 1971, J MAR BIOL ASSOC UK, V51, P183, DOI 10.1017/S002531540000655X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uribe P, 2008, MAR BIOTECHNOL, V10, P692, DOI 10.1007/s10126-008-9107-8; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Valiadi Martha, 2013, Microorganisms, V1, P3; Valiadi M, 2012, J PHYCOL, V48, P826, DOI 10.1111/j.1529-8817.2012.01144.x; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Willson HR, 2000, PROG OCEANOGR, V45, P415, DOI 10.1016/S0079-6611(00)00011-2; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002	74	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98849	10.1371/journal.pone.0098849	http://dx.doi.org/10.1371/journal.pone.0098849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918444	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338631000029
J	Ziska, LH				Ziska, Lewis H.			Increasing Minimum Daily Temperatures Are Associated with Enhanced Pesticide Use in Cultivated Soybean along a Latitudinal Gradient in the Mid-Western United States	PLOS ONE			English	Article							CLIMATE-CHANGE; FOOD SECURITY; ELEVATED CO2; AGRICULTURE; TRENDS; IMPACT; YIELDS	Assessments of climate change and food security often do not consider changes to crop production as a function of altered pest pressures. Evaluation of potential changes may be difficult, in part, because management practices are routinely utilized in situ to minimize pest injury. If so, then such practices, should, in theory, also change with climate, although this has never been quantified. Chemical (pesticide) applications remain the primary means of managing pests in industrialized countries. While a wide range of climate variables can influence chemical use, minimum daily temperature (lowest 24 h recorded temperature in a given year) can be associated with the distribution and thermal survival of many agricultural pests in temperate regions. The current study quantifies average pesticide applications since 1999 for commercial soybean grown over a 2100 km North-South latitudinal transect for seven states that varied in minimum daily temperature (1999-2013) from -28.6 degrees C (Minnesota) to -5.1 degrees C (Louisiana). Although soybean yields (per hectare) did not vary by state, total pesticide applications (kg of active ingredient, ai, per hectare) increased from 4.3 to 6.5 over this temperature range. Significant correlations were observed between minimum daily temperatures and kg of ai for all pesticide classes. This suggested that minimum daily temperature could serve as a proxy for pesticide application. Longer term temperature data (1977-2013) indicated greater relative increases in minimum daily temperatures for northern relative to southern states. Using these longer-term trends to determine short-term projections of pesticide use (to 2023) showed a greater comparative increase in herbicide use for soybean in northern; but a greater increase in insecticide and fungicide use for southern states in a warmer climate. Overall, these data suggest that increases in pesticide application rates may be a means to maintain soybean production in response to rising minimum daily temperatures and potential increases in pest pressures.	ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Ziska, LH (corresponding author), ARS, Crop Syst & Global Change Lab, USDA, Beltsville, MD 20705 USA.	l.ziska@ars.usda.gov						ADAMS RM, 1990, NATURE, V345, P219, DOI 10.1038/345219a0; [Anonymous], 2012, MAN RISKS EXTR EV DI; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Carpenter J., 1999, AgBioForum, V2, P1; Chen CC, 2001, CLIMATIC CHANGE, V50, P475, DOI 10.1023/A:1010655503471; Delye C, 2013, TRENDS GENET, V29, P649, DOI 10.1016/j.tig.2013.06.001; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Tran JK, 2007, ECOL APPL, V17, P882, DOI 10.1890/06-0512; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; LOUGH JM, 1983, J CLIM APPL METEOROL, V22, P1673, DOI 10.1175/1520-0450(1983)022<1673:CACISF>2.0.CO;2; Malloch G, 2006, B ENTOMOL RES, V96, P573, DOI 10.1017/BER2006459; McDonald A, 2009, AGR ECOSYST ENVIRON, V130, P131, DOI 10.1016/j.agee.2008.12.007; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Patterson DT, 1999, CLIMATIC CHANGE, V43, P711, DOI 10.1023/A:1005549400875; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; Reilly J, 2003, CLIMATIC CHANGE, V57, P43, DOI 10.1023/A:1022103315424; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Scherm H, 2004, CAN J PLANT PATHOL, V26, P267; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Solomon S., 2007, PHYS SCI BASIS WORKI; Southern Weed Science Society (SWSS), 2013, SWSS P, V66, P275; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; TREHARNE K, 1989, CAS PAPER, V19, P67; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; Yang Y, 2010, COMPUT ELECTRON AGR, V71, P77, DOI 10.1016/j.compag.2009.12.006; Zimdahl RL., 2007, WEED CROP COMPETITIO, V2; Ziska L. H., 2010, HDB CLIMATE CHANGE A, P191; Ziska LH, 2012, P ROY SOC B-BIOL SCI, V279, P4097, DOI 10.1098/rspb.2012.1005; Ziska LH, 2007, AGROECOSYSTEMS CHANG, P262	36	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98516	10.1371/journal.pone.0098516	http://dx.doi.org/10.1371/journal.pone.0098516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918585	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000018
J	Brander, S; Mikkelsen, JD; Kepp, KP				Brander, Soren; Mikkelsen, Jorn D.; Kepp, Kasper P.			Characterization of an Alkali- and Halide-Resistant Laccase Expressed in E-coli: CotA from Bacillus clausii	PLOS ONE			English	Article							PH ACTIVITY PROFILE; BILIRUBIN OXIDASE; MULTICOPPER OXIDASE; BACTERIAL LACCASE; TOLERANT LACCASE; FUNGAL LACCASE; REDOX; SUBTILIS; INHIBITION; SUBSTRATE	The limitations of fungal laccases at higher pH and salt concentrations have intensified the search for new extremophilic bacterial laccases. We report the cloning, expression, and characterization of the bacterial cotA from Bacillus clausii, a supposed alkalophilic ortholog of cotA from B. subtilis. Both laccases were expressed in E. coli strain BL21(DE3) and characterized fully in parallel for strict benchmarking. We report activity on ABTS, SGZ, DMP, caffeic acid, promazine, phenyl hydrazine, tannic acid, and bilirubin at variable pH. Whereas ABTS, promazine, and phenyl hydrazine activities vs. pH were similar, the activity of B. clausii cotA was shifted upwards by similar to 0.5-2 pH units for the simple phenolic substrates DMP, SGZ, and caffeic acid. This shift is not due to substrate affinity (K-M) but to pH dependence of catalytic turnover: The k(cat) of B. clausii cotA was 1 s(-1) at pH 6 and 5 s(-1) at pH 8 in contrast to 6 s(-1) at pH 6 and 2 s(-1) at pH 8 for of B. subtilis cotA. Overall, k(cat)/K-M was 10-fold higher for B. subtilis cotA at pH(opt). While both proteins were heat activated, activation increased with pH and was larger in cotA from B. clausii. NaCl inhibited activity at acidic pH, but not up to 500-700 mM NaCl in alkaline pH, a further advantage of the alkali regime in laccase applications. The B. clausii cotA had similar to 20 minutes half-life at 80 degrees C, less than the similar to 50 minutes at 80 degrees C for cotA from B. subtilis. While cotA from B. subtilis had optimal stability at pH similar to 8, the cotA from B. clausii displayed higher combined salt-and alkali-resistance. This resistance is possibly caused by two substitutions (S427Q and V110E) that could repel anions to reduce anion-copper interactions at the expense of catalytic proficiency, a trade-off of potential relevance to laccase optimization.	[Brander, Soren; Mikkelsen, Jorn D.] Tech Univ Denmark, DTU Chem Engn, DK-2800 Lyngby, Denmark; [Brander, Soren; Kepp, Kasper P.] Tech Univ Denmark, DTU Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, DTU Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper Planeta/G-1748-2013; Kepp, Kasper P./AAA-4626-2021	Kepp, Kasper Planeta/0000-0002-6754-7348; Kepp, Kasper P./0000-0002-6754-7348; Brander, Soren/0000-0002-6294-6331	Danish Council for Independent Research | Technology and Production Sciences (FTP) [10-082488]	Danish Council for Independent Research | Technology and Production Sciences (FTP)(Det Frie Forskningsrad (DFF))	The authors wish to thank The Danish Council for Independent Research | Technology and Production Sciences (FTP) (grant # 10-082488) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abari AH, 2012, AFR J MICROBIOL RES, V6, P393, DOI 10.5897/AJMR11.1155; Anwar A, 1998, BIORESOURCE TECHNOL, V64, P175, DOI 10.1016/S0960-8524(97)00182-X; Baril E, 2012, FOOD MICROBIOL, V32, P79, DOI 10.1016/j.fm.2012.04.011; BOND AM, 1988, ANAL CHEM, V60, P1023, DOI 10.1021/ac00161a015; Brissos Vania, 2009, Biotechnology Journal, V4, P558, DOI 10.1002/biot.200800248; Chen CY, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-49; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Costadinnova L, 2012, J U CHEM TECHNOL MET, V47, P289; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Daassi D, 2013, WORLD J MICROB BIOT, V29, P1; Dawkar VV, 2008, J APPL MICROBIOL, V105, P14, DOI 10.1111/j.1365-2672.2008.03738.x; Durand F, 2012, BIOSENS BIOELECTRON, V35, P140, DOI 10.1016/j.bios.2012.02.033; Durao P, 2008, BIOCHEM J, V412, P339, DOI 10.1042/BJ20080166; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Enguita FJ, 2004, J BIOL CHEM, V279, P23472, DOI 10.1074/jbc.M314000200; Fawole OA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-200; Fernandes AT, 2011, J BIOL INORG CHEM, V16, P641, DOI 10.1007/s00775-011-0768-9; Fernandes AT, 2010, FEBS J, V277, P3176, DOI 10.1111/j.1742-4658.2010.07725.x; Ferner-Ortner-Bleckmann J, 2011, BIOINTERPHASES, V6, P63, DOI 10.1116/1.3589284; Giacomelli C, 2002, J BRAZIL CHEM SOC, V13, P332, DOI 10.1590/S0103-50532002000300007; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HAPIOT P, 1993, J ELECTROANAL CHEM, V353, P225, DOI 10.1016/0022-0728(93)80299-W; Held C, 2005, ENVIRON CHEM LETT, V3, P74, DOI 10.1007/s10311-005-0006-1; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Jia HH, 2013, CHEMPLUSCHEM, V78, P451, DOI 10.1002/cplu.201300066; Kageyama Y, 2007, EXTREMOPHILES, V11, P597, DOI 10.1007/s00792-007-0074-1; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kittl R, 2012, J BIOTECHNOL, V157, P304, DOI 10.1016/j.jbiotec.2011.11.021; KOBAYASHI T, 1995, APPL MICROBIOL BIOT, V43, P473; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kudanga T, 2009, J MOL CATAL B-ENZYM, V61, P143, DOI 10.1016/j.molcatb.2009.06.003; Kunamneni Adinarayana, 2008, Recent Pat Biotechnol, V2, P10, DOI 10.2174/187220808783330965; Liu YH, 2011, APPL MICROBIOL BIOT, V91, P667, DOI 10.1007/s00253-011-3292-5; Madzak C, 2006, PROTEIN ENG DES SEL, V19, P77, DOI 10.1093/protein/gzj004; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mate DM, 2013, CHEM BIOL, V20, P223, DOI 10.1016/j.chembiol.2013.01.001; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Mollania N, 2011, ENZYME MICROB TECH, V49, P446, DOI 10.1016/j.enzmictec.2011.08.001; NAQUI A, 1980, FEBS LETT, V113, P157, DOI 10.1016/0014-5793(80)80581-3; Olukanni OD, 2013, J MICROBIOL BIOTECHN, V23, P843, DOI 10.4014/jmb.1211.11077; Pan JB, 2011, ADV MATER RES-SWITZ, V183-185, P773, DOI 10.4028/www.scientific.net/AMR.183-185.773; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Sakasegawa S, 2006, APPL ENVIRON MICROB, V72, P972, DOI 10.1128/AEM.72.1.972-975.2006; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sulistyaningdyah WT, 2004, FEMS MICROBIOL LETT, V230, P209, DOI 10.1016/S0378-1097(03)00892-9; Sung YM, 2013, APPL BIOCHEM BIOTECH, V169, P2420, DOI 10.1007/s12010-013-0165-7; Telke AA, 2011, BIORESOURCE TECHNOL, V102, P1752, DOI 10.1016/j.biortech.2010.08.086; Torres-Salas P, 2013, CHEMBIOCHEM, V14, P934, DOI 10.1002/cbic.201300102; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924; Xu F, 1996, BBA-PROTEIN STRUCT M, V1292, P303, DOI 10.1016/0167-4838(95)00210-3; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Zhang C, 2012, BIORESOURCE TECHNOL, V126, P80, DOI 10.1016/j.biortech.2012.09.055	60	79	85	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99402	10.1371/journal.pone.0099402	http://dx.doi.org/10.1371/journal.pone.0099402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915287	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700098
J	Chen, HM; Zhang, JH; Yuan, G; Liu, C				Chen, Haimei; Zhang, Jianhui; Yuan, George; Liu, Chang			Complex Interplay among DNA Modification, Noncoding RNA Expression and Protein-Coding RNA Expression in Salvia miltiorrhiza Chloroplast Genome	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; GENE-EXPRESSION; EPIGENETIC INHERITANCE; SINGLE-MOLECULE; METHYLATION; SEQ; DANSHEN; PLANTS; SENSE; PCR	Salvia miltiorrhiza is one of the most widely used medicinal plants. As a first step to develop a chloroplast-based genetic engineering method for the over-production of active components from S. miltiorrhiza, we have analyzed the genome, transcriptome, and base modifications of the S. miltiorrhiza chloroplast. Total genomic DNA and RNA were extracted from fresh leaves and then subjected to strand-specific RNA-Seq and Single-Molecule Real-Time (SMRT) sequencing analyses. Mapping the RNA-Seq reads to the genome assembly allowed us to determine the relative expression levels of 80 protein-coding genes. In addition, we identified 19 polycistronic transcription units and 136 putative antisense and intergenic noncoding RNA (ncRNA) genes. Comparison of the abundance of protein-coding transcripts (cRNA) with and without overlapping antisense ncRNAs (asRNA) suggest that the presence of asRNA is associated with increased cRNA abundance (p<0.05). Using the SMRT Portal software (v1.3.2), 2687 potential DNA modification sites and two potential DNA modification motifs were predicted. The two motifs include a TATA box-like motif (CPGDMM1, "TATANNNATNA''), and an unknown motif (CPGDMM2 "WNYANTGAW''). Specifically, 35 of the 97 CPGDMM1 motifs (36.1%) and 91 of the 369 CPGDMM2 motifs (24.7%) were found to be significantly modified (p<0.01). Analysis of genes downstream of the CPGDMM1 motif revealed the significantly increased abundance of ncRNA genes that are less than 400 bp away from the significantly modified CPGDMM1motif (p<0.01). Taking together, the present study revealed a complex interplay among DNA modifications, ncRNA and cRNA expression in chloroplast genome.	[Chen, Haimei; Zhang, Jianhui; Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, IMPLAD PacBio Adv Genom Anal Lab, Beijing 100730, Peoples R China; [Chen, Haimei; Zhang, Jianhui; Liu, Chang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yuan, George] Pacific Biosci, Menlo Pk, CA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, C (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, IMPLAD PacBio Adv Genom Anal Lab, Beijing 100730, Peoples R China.	cliu@implad.ac.cn	Zhang, Jianhui/K-8793-2019; Zhang, Jianhui/ABD-5476-2020; Liu, Chang/A-1148-2014	Zhang, Jianhui/0000-0002-6362-4027; Zhang, Jianhui/0000-0002-6362-4027; 	Chinese Academy of Medical Science [431118]; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives [YZ-12-04]; Ministry of Human Resources [431207]; Program for Changjiang Scholars and Innovative Research Team in University of the Ministry of Education of China [IRT1150]; National Science Foundation [81202859, 81373912]	Chinese Academy of Medical Science; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives; Ministry of Human Resources; Program for Changjiang Scholars and Innovative Research Team in University of the Ministry of Education of China; National Science Foundation(National Science Foundation (NSF))	This work was supported by a start fund from the Chinese Academy of Medical Science (No. 431118) granted to C. Liu, as well as by the Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives (No. YZ-12-04 granted to C. Liu), the research grant for returned Overseas Chinese Scholars, Ministry of Human Resources (No. 431207) granted to C. Liu, the Program for Changjiang Scholars and Innovative Research Team in University of the Ministry of Education of China (IRT1150), and grants from the National Science Foundation, No. 81202859 to HMC and No. 81373912 to C. Liu. Pacific Biosciences provided support in the form of a salary for author GY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahlert D, 2009, MOL GENET GENOMICS, V282, P17, DOI 10.1007/s00438-009-0440-z; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Georg J, 2010, NEW PHYTOL, V186, P615, DOI 10.1111/j.1469-8137.2010.03203.x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Grigoriadis A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-324; He GM, 2011, ANNU REV PLANT BIOL, V62, P411, DOI 10.1146/annurev-arplant-042110-103806; Hegeman CE, 2005, NUCLEIC ACIDS RES, V33, P1454, DOI 10.1093/nar/gki286; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hotto AM, 2011, G3-GENES GENOM GENET, V1, P559, DOI 10.1534/g3.111.000752; Hotto AM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-213; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Ling MHT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-243; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Sharwood RE, 2011, RNA, V17, P2165, DOI 10.1261/rna.028043.111; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stern DB, 1997, TRENDS PLANT SCI, V2, P308, DOI 10.1016/S1360-1385(97)89953-0; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Sultan M, 2012, BIOCHEM BIOPH RES CO, V422, P643, DOI 10.1016/j.bbrc.2012.05.043; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zghidi-Abouzid O, 2011, NUCLEIC ACIDS RES, V39, P5379, DOI 10.1093/nar/gkr143; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	43	16	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99314	10.1371/journal.pone.0099314	http://dx.doi.org/10.1371/journal.pone.0099314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914614	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700084
J	Garrett, N; Sharot, T				Garrett, Neil; Sharot, Tali			How Robust Is the Optimistic Update Bias for Estimating Self-Risk and Population Base Rates?	PLOS ONE			English	Article							UNREALISTIC OPTIMISM	Humans hold unrealistically optimistic predictions of what their future holds. These predictions are generated and maintained as people update their beliefs more readily when receiving information that calls for adjustment in an optimistic direction relative to information that calls for adjustment in a pessimistic direction. Thus far this update bias has been shown when people make estimations regarding the self. Here, we examine whether asymmetric belief updating also exists when making estimations regarding population base rates. We reveal that while participants update beliefs regarding risk in the population in an asymmetric manner, such valence-dependent updating of base rates can be accounted for by priors. In contrast, we show that optimistic updating regarding the self is a robust phenomenon, which holds even under different empirical definitions of desirable information.	[Garrett, Neil; Sharot, Tali] UCL, Affect Brain Lab, London, England	University of London; University College London	Garrett, N (corresponding author), UCL, Affect Brain Lab, London, England.	neil.garrett@gmail.com		Garrett, Neil/0000-0003-1440-472X	UCL Impact Award; Wellcome Trust Career Development Fellowship	UCL Impact Award; Wellcome Trust Career Development Fellowship(Wellcome Trust)	This work was supported by a UCL Impact Award to N. G. and a Wellcome Trust Career Development Fellowship to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER LA, 1993, LAW HUMAN BEHAV, V17, P439, DOI 10.1007/BF01044377; Calderon TG, 1993, MIDATLANTIC J BUS, V29, P41, DOI DOI 10.1016/0001-4575(89)90024-9; CHANG EC, 2000, OPTIMISM PESSIMISM I; Eil D, 2011, AM ECON J-MICROECON, V3, P114, DOI 10.1257/mic.3.2.114; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hardman D., 2009, JUDGMENT DECISION MA; Hoorens V., 1993, EUR REV SOC PSYCHOL, V4, P113, DOI DOI 10.1080/14792779343000040; Isaacowitz DM, 2005, J RES PERS, V39, P224, DOI 10.1016/j.jrp.2004.02.003; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Korn CW, 2014, PSYCHOL MED, V44, P579, DOI 10.1017/S0033291713001074; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Kuhnen CM, 2011, J FINANC QUANT ANAL, V46, P605, DOI 10.1017/S0022109011000123; Kuhnen CM, 2013, WORKING PAPER; Lovallo D, 2003, HARVARD BUS REV, V81, P56; Mobius MM, 2022, MANAGE SCI, DOI 10.1287/mnsc.2021.4294; Moutsiana C, 2013, P NATL ACAD SCI USA, V110, P16396, DOI 10.1073/pnas.1305631110; Puri M, 2007, J FINANC ECON, V86, P71, DOI 10.1016/j.jfineco.2006.09.003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sharot T., 2011, OPTIMISM BIAS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Sharot T, 2012, P NATL ACAD SCI USA, V109, P17058, DOI 10.1073/pnas.1205828109; Sharot T, 2012, CURR BIOL, V22, P1477, DOI 10.1016/j.cub.2012.05.053; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Shefrin H., 2009, VOICES WISDOM UNDERS; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; Ubel P, 2009, FORBES; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Weinstein ND, 1996, J SOC CLIN PSYCHOL, V15, P1, DOI 10.1521/jscp.1996.15.1.1; Wiswall M, 2013, 516 FED RES BANK NEW	32	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98848	10.1371/journal.pone.0098848	http://dx.doi.org/10.1371/journal.pone.0098848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24914643	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000340947700039
J	Grantham, JP; Henneberg, M				Grantham, James P.; Henneberg, Maciej			The Estrogen Hypothesis of Obesity	PLOS ONE			English	Article							URBAN; MENARCHE; WOMEN; FAT; AGE	The explanation of obesity as a simple result of positive energy balance fails to account for the scope of variable responses to diets and lifestyles. It is postulated that individual physiological and anatomical variation may be responsible for developing obesity. Girls in poor families develop greater adiposity than their male siblings, a trend not present in richer environments. This indicates strong influence of estrogen on fat accumulation irrespective of poor socioeconomic conditions. Obesity rates in males and females of developed nations are similar, while in poorer nations obesity is much more prevalent in females. Female to male ratio of obesity correlates inversely with gross domestic product. Therefore, the parity of male and female obesity in developed countries may result from male exposure to environmental estrogen-like substances associated with affluence. These hormonally driven mechanisms may be equally active within both sexes in more developed areas, thereby increasing overall obesity.	[Grantham, James P.; Henneberg, Maciej] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia	University of Adelaide	Henneberg, M (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia.	maciej.henneberg@adelaide.edu.au		Henneberg, Maciej/0000-0003-1941-2286	Medical Research Council of South Africa	Medical Research Council of South Africa(South African Medical Research Council)	Collection of the data on the growth of children was funded by the Medical Research Council of South Africa. The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler GK, 2012, MEDSCAPE; [Anonymous], 2013, OB OV; Bharaktiya S, 2011, MEDSCAPE; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Digate Muth N, 2009, ACE FIT; European Commission, 2004, LIF CYCL ASS PVC PRI; Eurostat, 2011, OV OB BMI STAT; FRISCH RE, 1971, ARCH DIS CHILD, V46, P695, DOI 10.1136/adc.46.249.695; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810; Henneberg M, 1998, AM J HUM BIOL, V10, P73, DOI 10.1002/(SICI)1520-6300(1998)10:1<73::AID-AJHB9>3.0.CO;2-D; HENNEBERG M, 1995, AM J PHYS ANTHROPOL, V96, P1, DOI 10.1002/ajpa.1330960102; HENNEBERG M, 1995, AM J PHYS ANTHROPOL, V96, P329, DOI 10.1002/ajpa.1330960402; HENNEBERG M, 1976, J HUM EVOL, V5, P41, DOI 10.1016/0047-2484(76)90098-1; Henneberg M, 1992, S AFR MED J, V82, P196; Hennenberg R., 1999, PERSPECTIVES HUMAN B, V4, P177; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Kaltsas GA, 2000, CLIN ENDOCRINOL, V53, P493, DOI 10.1046/j.1365-2265.2000.01117.x; McDermott MT, 2001, J CLIN ENDOCR METAB, V86, P4585, DOI 10.1210/jc.86.10.4585; Mutha NH, 2006, RESOUR CONSERV RECY, V47, P222, DOI 10.1016/j.resconrec.2005.09.003; PVC, 2013, PVC HLTH; Roccisano D., 2012, Food and Nutrition Sciences, V3, P260, DOI 10.4236/fns.2012.32038; Ruhli FJ, 2004, EUR SPINE J, V13, P733, DOI 10.1007/s00586-004-0682-8; Santin AP, 2011, J THROID RES, V2011, DOI 10.4061/2011/875125; Schiller JS, 2010, VITAL HLTH STAT, V10, P2012; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E; Soy Connection, 2012, SOYB OIL US OV; Soyfoods Association of North America, 2013, SOY DAIR FREE PROD; Stephan CN, 2001, MED HYPOTHESES, V57, P633, DOI 10.1054/mehy.2001.1431; Turner L, 2012, FIND HORMONAL HARMON; United Nations, 2012, NAT ACC MAIN AGGR DA; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Vinyl in Design, 2013, US VIN; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; WHO, 2013, OB SIT TRENDS; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x	38	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99776	10.1371/journal.pone.0099776	http://dx.doi.org/10.1371/journal.pone.0099776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915457	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700135
J	Greer, AM; Matthay, MA; Kukreja, J; Bhakta, NR; Nguyen, CP; Wolters, PJ; Woodruff, PG; Fahy, JV; Shin, JS				Greer, Alexandra M.; Matthay, Michael A.; Kukreja, Jasleen; Bhakta, Nirav R.; Nguyen, Christine P.; Wolters, Paul J.; Woodruff, Prescott G.; Fahy, John V.; Shin, Jeoung-Sook			Accumulation of BDCA1(+) Dendritic Cells in Interstitial Fibrotic Lung Diseases and Th2-High Asthma	PLOS ONE			English	Article							HUMAN BRONCHOALVEOLAR LAVAGE; EPIDERMAL LANGERHANS CELLS; PULMONARY-FIBROSIS; BRONCHIAL-MUCOSA; MAST-CELLS; IGE; EXPRESSION; RECEPTOR; INDUCTION; FEATURES	Dendritic cells (DCs) significantly contribute to the pathology of several mouse lung disease models. However, little is known of the contribution of DCs to human lung diseases. In this study, we examined infiltration with BDCA1(+) DCs of human lungs in patients with interstitial lung diseases or asthma. Using flow cytometry, we found that these DCs increased by 5,6 fold in the lungs of patients with idiopathic pulmonary fibrosis or hypersensitivity pneumonitis, which are both characterized by extensive fibrosis in parenchyma. The same DC subset also significantly increased in the lung parenchyma of patients with chronic obstructive pulmonary disease, although the degree of increase was relatively modest. By employing immunofluorescence microscopy using Fc epsilon RI and MHCII as the specific markers for BDCA1(+) DCs, we found that the numbers of BDCA1(+) DCs also significantly increased in the airway epithelium of Th2 inflammation-associated asthma. These findings suggest a potential contribution of BDCA1(+) DCs in human lung diseases associated with interstitial fibrosis or Th2 airway inflammation.	[Greer, Alexandra M.; Shin, Jeoung-Sook] Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med & Anesthesia, San Francisco, CA 94143 USA; [Kukreja, Jasleen] Univ Calif San Francisco, Div Cardiothorac Surg, San Francisco, CA 94143 USA; [Bhakta, Nirav R.; Nguyen, Christine P.; Wolters, Paul J.; Woodruff, Prescott G.; Fahy, John V.] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shin, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.	Jeoung-Sook.Shin@ucsf.edu			National Heart, Lung, and Blood Institute [HL51854]; National Institutes of Health [F32 1F32HL110720, T32 5T32HL007185]; UCSF Nina Ireland Lung Disease Program; NIH [HL095372]; American Thoracic Society; UCSF Sandler Asthma Basic Research Center; Genentech; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, F32HL110720, T32HL007185, R01HL095372, R01HL051854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Nina Ireland Lung Disease Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society; UCSF Sandler Asthma Basic Research Center; Genentech(Roche HoldingGenentech); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MAM was supported by National Heart, Lung, and Blood Institute grant #HL51854. NRB was supported by National Institutes of Health grants F32 1F32HL110720 and T32 5T32HL007185. PJW was supported by the UCSF Nina Ireland Lung Disease Program. PGW was supported by a grant from Genentech and from the NIH (HL095372). AMG and JS were supported by the American Thoracic Society and the UCSF Sandler Asthma Basic Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042066; Bantsimba-Malanda C, 2010, AM J RESP CRIT CARE, V182, P385, DOI 10.1164/rccm.200907-1164OC; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; GRUSCHWITZ MS, 1992, J INVEST DERMATOL, V99, P114, DOI 10.1111/1523-1747.ep12611890; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hanak V, 2007, MAYO CLIN PROC, V82, P812, DOI 10.4065/82.7.812; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Luppi F, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002880; Masten BJ, 2006, J IMMUNOL, V177, P7784, DOI 10.4049/jimmunol.177.11.7784; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1111/j.1365-2222.1996.tb00571.x; NELSON DJ, 1995, AM J RESP CRIT CARE, V151, P475, DOI 10.1164/ajrccm.151.2.7842209; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Sallmann E, 2011, J IMMUNOL, V187, P164, DOI 10.4049/jimmunol.1003392; SCADDING JG, 1967, THORAX, V22, P291, DOI 10.1136/thx.22.4.291; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tsoumakidou M, 2009, RESPIRATION, V78, P446, DOI 10.1159/000226244; Tsoumakidou M, 2008, AM J RESP CRIT CARE, V177, P1180, DOI 10.1164/rccm.200711-1727PP; TunonDeLara JM, 1996, CLIN EXP ALLERGY, V26, P648, DOI 10.1046/j.1365-2222.1996.1095481.x; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; VANHAARST JMW, 1994, AM J RESP CELL MOL, V11, P344, DOI 10.1165/ajrcmb.11.3.8086170; vanHaarst JMW, 1996, AM J RESP CELL MOL, V15, P752, DOI 10.1165/ajrcmb.15.6.8969270; Vasudev M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032556; Veres TZ, 2013, J IMMUNOL, V190, P897, DOI 10.4049/jimmunol.1200220; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; ZHOU LJ, 1995, BLOOD, V86, P3295, DOI 10.1182/blood.V86.9.3295.bloodjournal8693295	50	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99084	10.1371/journal.pone.0099084	http://dx.doi.org/10.1371/journal.pone.0099084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915147	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700061
J	Simon, AM; Ingraham, KA; Fey, NP; Finucane, SB; Lipschutz, RD; Young, AJ; Hargrove, LJ				Simon, Ann M.; Ingraham, Kimberly A.; Fey, Nicholas P.; Finucane, Suzanne B.; Lipschutz, Robert D.; Young, Aaron J.; Hargrove, Levi J.			Configuring a Powered Knee and Ankle Prosthesis for Transfemoral Amputees within Five Specific Ambulation Modes	PLOS ONE			English	Article							FOOT PROSTHESIS; STAIR ASCENT; DESCENT; WALKING; GENERATION; AMPUTATION; GAIT	Lower limb prostheses that can generate net positive mechanical work may restore more ambulation modes to amputees. However, configuration of these devices imposes an additional burden on clinicians relative to conventional prostheses; devices for transfemoral amputees that require configuration of both a knee and an ankle joint are especially challenging. In this paper, we present an approach to configuring such powered devices. We developed modified intrinsic control strategies-which mimic the behavior of biological joints, depend on instantaneous loads within the prosthesis, or set impedance based on values from previous states, as well as a set of starting configuration parameters. We developed tables that include a list of desired clinical gait kinematics and the parameter modifications necessary to alter them. Our approach was implemented for a powered knee and ankle prosthesis in five ambulation modes (level-ground walking, ramp ascent/descent, and stair ascent/descent). The strategies and set of starting configuration parameters were developed using data from three individuals with unilateral transfemoral amputations who had previous experience using the device; this approach was then tested on three novice unilateral transfemoral amputees. Only 17% of the total number of parameters (i.e., 24 of the 140) had to be independently adjusted for each novice user to achieve all five ambulation modes and the initial accommodation period (i.e., time to configure the device for all modes) was reduced by 56%, to 5 hours or less. This approach and subsequent reduction in configuration time may help translate powered prostheses into a viable clinical option where amputees can more quickly appreciate the benefits such devices can provide.	[Simon, Ann M.; Ingraham, Kimberly A.; Fey, Nicholas P.; Finucane, Suzanne B.; Lipschutz, Robert D.; Young, Aaron J.; Hargrove, Levi J.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Simon, Ann M.; Fey, Nicholas P.; Lipschutz, Robert D.; Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Young, Aaron J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Simon, AM (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.	annie-simon@northwestern.edu		Simon, Ann/0000-0002-6431-0329	US Army's Telemedicine and Advanced Technology Research Center [81XWH-09-2-0020]	US Army's Telemedicine and Advanced Technology Research Center	This work was supported by the US Army's Telemedicine and Advanced Technology Research Center, grant number 81XWH-09-2-0020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JM, 2012, GAIT POSTURE, V36, P291, DOI 10.1016/j.gaitpost.2012.03.013; Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; Bellman R. D., 2008, IEEE RAS EMBS INT C; Datta D, 1996, CLIN REHABIL, V10, P227, DOI DOI 10.1177/026921559601000307; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Fey N. P., 2013, ANN M AM SOC BIOM OM; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Goldfarb M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007312; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Lawson B., 2012, IEEE T NEURAL SYST R; MCFADYEN BJ, 1988, J BIOMECH, V21, P733, DOI 10.1016/0021-9290(88)90282-5; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Rouse E. J., 2012, IEEE INT C BIOM ROB; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; Sup Frank, 2009, IEEE Int Conf Rehabil Robot, V2009, P638, DOI 10.1109/ICORR.2009.5209625; Sup F, 2009, IEEE-ASME T MECH, V14, P667, DOI 10.1109/TMECH.2009.2032688; Vallery H, 2009, IEEE T NEUR SYS REH, V17, P23, DOI 10.1109/TNSRE.2008.2008278; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	23	119	120	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99387	10.1371/journal.pone.0099387	http://dx.doi.org/10.1371/journal.pone.0099387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914674	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700093
J	Usubuchi, H; Kawase, T; Kanno, A; Yahata, I; Miyazaki, H; Nakasato, N; Kawashima, R; Katori, Y				Usubuchi, Hajime; Kawase, Tetsuaki; Kanno, Akitake; Yahata, Izumi; Miyazaki, Hiromitsu; Nakasato, Nobukazu; Kawashima, Ryuta; Katori, Yukio			Effects of Contralateral Noise on the 20-Hz Auditory Steady State Response - Magnetoencephalography Study	PLOS ONE			English	Article							MODULATION-FOLLOWING RESPONSE; REPETITION RATES PROFILE; EVOKED-POTENTIALS; TEMPORAL ENVELOPE; BRAIN-STEM; WIDE-RANGE; 40-HZ; FREQUENCY; CORTEX; MASKING	The auditory steady state response (ASSR) is an oscillatory brain response, which is phase locked to the rhythm of an auditory stimulus. ASSRs have been recorded in response to a wide frequency range of modulation and/or repetition, but the physiological features of the ASSRs are somewhat different depending on the modulation frequency. Recently, the 20-Hz ASSR has been emphasized in clinical examinations, especially in the area of psychiatry. However, little is known about the physiological properties of the 20-Hz ASSR, compared to those of the 40-Hz and 80-Hz ASSRs. The effects of contralateral noise on the ASSR are known to depend on the modulation frequency to evoke ASSR. However, the effects of contralateral noise on the 20-Hz ASSR are not known. Here we assessed the effects of contralateral white noise at a level of 70 dB SPL on the 20-Hz and 40-Hz ASSRs using a helmet-shaped magnetoencephalography system in 9 healthy volunteers (8 males and 1 female, mean age 31.2 years). The ASSRs were elicited by monaural 1000-Hz 5-s tone bursts amplitude-modulated at 20 and 39 Hz and presented at 80 dB SPL. Contralateral noise caused significant suppression of both the 20-Hz and 40-Hz ASSRs, although suppression was significantly smaller for the 20-Hz ASSRs than the 40-Hz ASSRs. Moreover, the greatest suppression of both 20-Hz and 40-Hz ASSRs occurred in the right hemisphere when stimuli were presented to the right ear with contralateral noise. The present study newly showed that 20-Hz ASSRs are suppressed by contralateral noise, which may be important both for characterization of the 20-Hz ASSR and for interpretation in clinical situations. Physicians must be aware that the 20-Hz ASSR is significantly suppressed by sound (e. g. masking noise or binaural stimulation) applied to the contralateral ear.	[Usubuchi, Hajime; Kawase, Tetsuaki; Yahata, Izumi; Miyazaki, Hiromitsu; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabil Auditory Sci, Sendai, Miyagi 980, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Med, Dept Audiol, Sendai, Miyagi 980, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi 980, Japan; [Nakasato, Nobukazu] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Dept Electromagnet Neurophysiol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kawase, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan.	kawase@orl.med.tohoku.ac.jp	Nakasato, Nobukazu/AAC-3650-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a management grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology for fiscal 2011-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi M, 1999, AUDIOL NEURO-OTOL, V4, P28, DOI 10.1159/000013817; AOYAGI M, 1993, HEARING RES, V65, P253, DOI 10.1016/0378-5955(93)90218-P; COHEN LT, 1991, J ACOUST SOC AM, V90, P2467, DOI 10.1121/1.402050; Cunningham MO, 2004, J PHYSIOL-LONDON, V559, P347, DOI 10.1113/jphysiol.2004.068973; Draganova R, 2008, CEREB CORTEX, V18, P1193, DOI 10.1093/cercor/bhm153; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2683, DOI 10.1121/1.404383; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; HARI R, 1988, EXP BRAIN RES, V71, P87; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; John MS, 2002, EAR HEARING, V23, P106, DOI 10.1097/00003446-200204000-00004; JOHNSON B W, 1988, Brain Topography, V1, P117, DOI 10.1007/BF01129176; Kawase T, 2012, NEUROIMAGE, V59, P1037, DOI 10.1016/j.neuroimage.2011.08.108; Kuriki S, 1995, HEARING RES, V92, P47, DOI 10.1016/0378-5955(95)00195-6; KUWADA S, 1986, HEARING RES, V21, P179, DOI 10.1016/0378-5955(86)90038-9; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; LINDEN RD, 1985, EAR HEARING, V6, P167, DOI 10.1097/00003446-198505000-00008; Maki A, 2009, EAR HEARING, V30, P584, DOI 10.1097/AUD.0b013e3181acfb57; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; Oda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039955; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkkonen L, 2009, HUM BRAIN MAPP, V30, P1772, DOI 10.1002/hbm.20788; Pastor MA, 2002, J NEUROSCI, V22, P10501; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; PLOURDE G, 1990, ANESTH ANALG, V71, P460; Rass O, 2012, SCHIZOPHR RES, V136, P143, DOI 10.1016/j.schres.2012.01.003; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Ross B, 2005, J NEUROPHYSIOL, V94, P4082, DOI 10.1152/jn.00469.2005; Ross B, 2003, HEARING RES, V186, P57, DOI 10.1016/S0378-5955(03)00299-5; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Tlumak AI, 2012, INT J AUDIOL, V51, P480, DOI 10.3109/14992027.2012.664289; Tlumak AI, 2011, INT J AUDIOL, V50, P448, DOI 10.3109/14992027.2011.560903; Tsuchimoto R, 2011, SCHIZOPHR RES, V133, P99, DOI 10.1016/j.schres.2011.07.020; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99457	10.1371/journal.pone.0099457	http://dx.doi.org/10.1371/journal.pone.0099457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915061	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700105
J	Vieira, N; Deng, FM; Liang, FX; Liao, Y; Chang, J; Zhou, G; Zheng, WY; Simon, JP; Ding, MX; Wu, XR; Romih, R; Kreibich, G; Sun, TT				Vieira, Neide; Deng, Fang-Ming; Liang, Feng-Xia; Liao, Yi; Chang, Jennifer; Zhou, Ge; Zheng, Weiyue; Simon, Jean-Pierre; Ding, Mingxiao; Wu, Xue-Ru; Romih, Rok; Kreibich, Gert; Sun, Tung-Tien			SNX31: A Novel Sorting Nexin Associated with the Uroplakin-Degrading Multivesicular Bodies in Terminally Differentiated Urothelial Cells	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-BLADDER EPITHELIUM; ASYMMETRIC UNIT MEMBRANE; TRANSITIONAL EPITHELIUM; UMBRELLA CELLS; PROTEIN TRAFFICKING; SUPERFICIAL CELLS; BARRIER FUNCTION; APICAL MEMBRANE; PLAQUE PARTICLE	Uroplakins (UP), a group of integral membrane proteins, are major urothelial differentiation products that form 2D crystals of 16-nm particles (urothelial plaques) covering the apical surface of mammalian bladder urothelium. They contribute to the urothelial barrier function and, one of them, UPIa, serves as the receptor for uropathogenic Escherichia coli. It is therefore important to understand the mechanism by which these surface-associated uroplakins are degraded. While it is known that endocytosed uroplakin plaques are targeted to and line the multivesicular bodies (MVBs), it is unclear how these rigid-looking plaques can go to the highly curved membranes of intraluminal vesicles (ILVs). From a cDNA subtraction library, we identified a highly urothelium-specific sorting nexin, SNX31. SNX31 is expressed, like uroplakins, in terminally differentiated urothelial umbrella cells where it is predominantly associated with MVBs. Apical membrane proteins including uroplakins that are surface biotin-tagged are endocytosed and targeted to the SNX31-positive MVBs. EM localization demonstrated that SNX31 and uroplakins are both associated not only with the limiting membranes of MVBs containing uroplakin plaques, but also with ILVs. SNX31 can bind, on one hand, the PtdIns3P-enriched lipids via its N-terminal PX-domain, and, on the other hand, it binds uroplakins as demonstrated by co-immunoprecipitation and proximity ligation assay, and by its reduced membrane association in uroplakin II-deficient urothelium. The fact that in urothelial umbrella cells MVBs are the only major intracellular organelles enriched in both PtdIns3P and uroplakins may explain SNX31's MVB-specificity in these cells. However, in MDCK and other cultured cells transfected SNX31 can bind to early endosomes possibly via lipids. These data support a model in which SNX31 mediates the endocytic degradation of uroplakins by disassembling/collapsing the MVB-associated uroplakin plaques, thus enabling the uroplakin-containing (but 'softened') membranes to bud and form the ILVs for lysosomal degradation and/or exosome formation.	[Vieira, Neide; Liao, Yi; Chang, Jennifer; Zheng, Weiyue; Simon, Jean-Pierre; Kreibich, Gert; Sun, Tung-Tien] NYU, Dept Cell Biol, Langone Med Ctr, Inst Canc, New York, NY 10016 USA; [Deng, Fang-Ming; Wu, Xue-Ru] NYU, Langone Med Ctr, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Liang, Feng-Xia; Sun, Tung-Tien] NYU, Langone Med Ctr, Inst Canc, Dept Dermatol, New York, NY 10016 USA; [Zhou, Ge; Sun, Tung-Tien] NYU, Langone Med Ctr, Inst Canc, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Ding, Mingxiao] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Wu, Xue-Ru; Sun, Tung-Tien] NYU, Langone Med Ctr, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru; Sun, Tung-Tien] NYU, Langone Med Ctr, Inst Canc, New York, NY 10016 USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Romih, Rok] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Peking University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Ljubljana	Sun, TT (corresponding author), NYU, Dept Cell Biol, Langone Med Ctr, Inst Canc, 550 1St Ave, New York, NY 10016 USA.	sunt01@nyumc.org	Vieira, Neide/K-7702-2015; Sun, Tung-Tien/J-4425-2015	Vieira, Neide/0000-0002-7166-4336; Sun, Tung-Tien/0000-0002-6841-1063; Liang, Fengxia/0000-0003-0037-4590; Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health [DK52206, DK39753]; NYU Center of Excellence for Urological Diseases; Goldstein Fund for Urological Research of the New York University School of Medicine; NATIONAL CANCER INSTITUTE [P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903, P01DK052206, R01DK039753] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Center of Excellence for Urological Diseases; Goldstein Fund for Urological Research of the New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants DK52206 (T. T. S. and G. K.) and DK39753 (T. T. S.), the NYU Center of Excellence for Urological Diseases, and the Goldstein Fund for Urological Research of the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO O, 1991, ANAT RECORD, V229, P9, DOI 10.1002/ar.1092290103; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; Deng FM, 2001, P NATL ACAD SCI USA, V98, P154, DOI 10.1073/pnas.98.1.154; Derganc J, 2013, TRENDS BIOCHEM SCI, V38, P576, DOI 10.1016/j.tibs.2013.08.006; DeSalle R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-13; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Guo XM, 2009, TRAFFIC, V10, P1350, DOI 10.1111/j.1600-0854.2009.00950.x; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Hanson PI, 2012, ANN REV CELL DEV BIO; Hayashi H, 2012, J BIOL CHEM, V287, P15054, DOI 10.1074/jbc.M111.337931; HICKS RM, 1966, J CELL BIOL, V30, P623, DOI 10.1083/jcb.30.3.623; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu CCA, 2008, BIOCHEM J, V414, P195, DOI 10.1042/BJ20080550; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hudoklin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032935; Hudoklin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023636; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; JEZERNIK K, 1992, CELL BIOL INT REP, V16, P1219, DOI 10.1016/S0309-1651(06)80038-X; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; Katzmann DJ, 2006, DEV CELL, V10, P278, DOI 10.1016/j.devcel.2006.02.005; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Kreft ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038509; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Liang FX, 1999, DIFFERENTIATION, V65, P59, DOI 10.1046/j.1432-0436.1999.6510059.x; Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013; LIN JH, 1994, J BIOL CHEM, V269, P1775; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; ROMIH R, 1994, CELL BIOL INT, V18, P663, DOI 10.1006/cbir.1994.1093; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; SURYA B, 1990, J CELL SCI, V97, P419; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; Veranic P, 2002, CELL MOTIL CYTOSKEL, V53, P317, DOI 10.1002/cm.10077; Wang HB, 2009, J MOL BIOL, V392, P352, DOI 10.1016/j.jmb.2009.06.077; WU XR, 1993, J CELL SCI, V106, P31; WU XR, 1995, J BIOL CHEM, V270, P29752; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; ZHANG SX, 1994, HISTOL HISTOPATHOL, V9, P315; Zhou G, 2001, J CELL SCI, V114, P4095; Zhou G, 2012, MOL BIOL CELL, V23, P1354, DOI 10.1091/mbc.E11-09-0823	75	17	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99644	10.1371/journal.pone.0099644	http://dx.doi.org/10.1371/journal.pone.0099644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914955	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700122
J	Zheng, MH; Seto, WK; Shi, KQ; Wong, DKH; Fung, J; Hung, IFN; Fong, DYT; Yuen, JCH; Tong, T; Lai, CL; Yuen, MF				Zheng, Ming-Hua; Seto, Wai-Kay; Shi, Ke-Qing; Wong, Danny Ka-Ho; Fung, James; Hung, Ivan Fan-Ngai; Fong, Daniel Yee-Tak; Yuen, John Chi-Hang; Tong, Teresa; Lai, Ching-Lung; Yuen, Man-Fung			Artificial Neural Network Accurately Predicts Hepatitis B Surface Antigen Seroclearance	PLOS ONE			English	Article							HBSAG SEROCLEARANCE; MORTALITY; QUANTIFICATION; DETERMINANTS; OUTCOMES	Background & Aims: Hepatitis B surface antigen (HBsAg) seroclearance and seroconversion are regarded as favorable outcomes of chronic hepatitis B (CHB). This study aimed to develop artificial neural networks (ANNs) that could accurately predict HBsAg seroclearance or seroconversion on the basis of available serum variables. Methods: Data from 203 untreated, HBeAg-negative CHB patients with spontaneous HBsAg seroclearance (63 with HBsAg seroconversion), and 203 age-and sex-matched HBeAg-negative controls were analyzed. ANNs and logistic regression models (LRMs) were built and tested according to HBsAg seroclearance and seroconversion. Predictive accuracy was assessed with area under the receiver operating characteristic curve (AUROC). Results: Serum quantitative HBsAg (qHBsAg) and HBV DNA levels, qHBsAg and HBV DNA reduction were related to HBsAg seroclearance (P<0.001) and were used for ANN/LRM-HBsAg seroclearance building, whereas, qHBsAg reduction was not associated with ANN-HBsAg seroconversion (P = 0.197) and LRM-HBsAg seroconversion was solely based on qHBsAg (P = 0.01). For HBsAg seroclearance, AUROCs of ANN were 0.96, 0.93 and 0.95 for the training, testing and genotype B subgroups respectively. They were significantly higher than those of LRM, qHBsAg and HBV DNA (all P<0.05). Although the performance of ANN-HBsAg seroconversion (AUROC 0.757) was inferior to that for HBsAg seroclearance, it tended to be better than those of LRM, qHBsAg and HBV DNA. Conclusions: ANN identifies spontaneous HBsAg seroclearance in HBeAg-negative CHB patients with better accuracy, on the basis of easily available serum data. More useful predictors for HBsAg seroconversion are still needed to be explored in the future.	[Zheng, Ming-Hua; Shi, Ke-Qing] Wenzhou Med Univ, Affiliated Hosp 1, Liver Res Ctr, Dept Infect & Liver Dis, Wenzhou, Zhejiang, Peoples R China; [Zheng, Ming-Hua; Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Hung, Ivan Fan-Ngai; Yuen, John Chi-Hang; Tong, Teresa; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee-Tak] Univ Hong Kong, Queen Mary Hosp, Dept Nursing Studies, Hong Kong, Hong Kong, Peoples R China; [Seto, Wai-Kay; Wong, Danny Ka-Ho; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	Wenzhou Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Wong, Danny/H-6819-2016; SETO, Wai-Kay/H-4452-2012; Shi, KeQing/A-3411-2009; Fung, James/AAG-4832-2020; Zheng, Ming-Hua/H-5584-2019; Hung, Ivan FN/ABD-5916-2021; Wong, Danny/S-6230-2019; Fong, Daniel YT/C-4269-2009	SETO, Wai-Kay/0000-0002-9012-313X; Shi, KeQing/0000-0002-5070-3834; Zheng, Ming-Hua/0000-0003-4984-2631; Hung, Ivan FN/0000-0002-1556-2538; Fong, Daniel YT/0000-0001-7365-9146; /0000-0001-9078-5005; Lai, Ching-Lung/0000-0002-5927-2436; Fung, James/0000-0002-1286-8902	Roche Diagnostics	Roche Diagnostics	The assays used to determine serum hepatitis B virus DNA level (Cobas Taqman assay) and hepatitis B surface antigen level (Elecsys HBsAg II assay) performed in our laboratory were supported by an unrestricted grant from Roche Diagnostics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2005, J HEPATOL, V42, P188, DOI 10.1016/j.jhep.2004.10.026; Arai M, 2012, EUR J GASTROEN HEPAT, V24, P414, DOI 10.1097/MEG.0b013e328350594d; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2011, J INFECT DIS, V204, P408, DOI 10.1093/infdis/jir283; Chen YC, 2012, CLIN GASTROENTEROL H, V10, P297, DOI 10.1016/j.cgh.2011.08.029; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Cucchetti A, 2007, GUT, V56, P253, DOI 10.1136/gut.2005.084434; Cucchetti A, 2010, J HEPATOL, V52, P880, DOI 10.1016/j.jhep.2009.12.037; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Howes P, 1999, NEUROCOMPUTING, V24, P191, DOI 10.1016/S0925-2312(98)00102-7; Idilman R, 2012, J VIRAL HEPATITIS, V19, P220, DOI 10.1111/j.1365-2893.2011.01542.x; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Kobayashi M, 2014, J GASTROENTEROL, V49, P538, DOI 10.1007/s00535-013-0821-2; Kwak MS, 2011, DIGESTION, V84, P23, DOI 10.1159/000333211; Liu J, 2014, GUT, V63, P1648, DOI 10.1136/gutjnl-2013-305785; Liu J, 2013, J HEPATOL, V58, P853, DOI 10.1016/j.jhep.2012.12.006; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Seto WK, 2012, HEPATOLOGY, V56, P812, DOI 10.1002/hep.25718; Tai DI, 2010, AM J GASTROENTEROL, V105, P1102, DOI 10.1038/ajg.2009.669; Tseng TC, 2013, HEPATOLOGY, V57, P441, DOI 10.1002/hep.26041; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Tseng TC, 2009, GASTROENTEROLOGY, V136, P1842, DOI 10.1053/j.gastro.2008.12.074; Wursthorn K, 2011, J CLIN VIROL, V50, P292, DOI 10.1016/j.jcv.2010.12.008; Zheng MH, 2013, J VIRAL HEPATITIS, V20, P248, DOI 10.1111/j.1365-2893.2012.01647.x	28	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99422	10.1371/journal.pone.0099422	http://dx.doi.org/10.1371/journal.pone.0099422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914537	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700101
J	Derycke, L; Eyerich, S; Van Crombruggen, K; Perez-Novo, C; Holtappels, G; Deruyck, N; Gevaert, P; Bachert, C				Derycke, Lara; Eyerich, Stefanie; Van Crombruggen, Koen; Perez-Novo, Claudina; Holtappels, Gabriele; Deruyck, Natalie; Gevaert, Philippe; Bachert, Claus			Mixed T Helper Cell Signatures In Chronic Rhinosinusitis with and without Polyps	PLOS ONE			English	Article							NASAL POLYPS; IFN-GAMMA; DIFFERENTIATION; INTERLEUKIN-10; PATHOGENESIS; CYTOKINES; RESPONSES; DISEASE; PROTEIN; PRODUCE	In chronic rhinosinusitis (CRS) different phenotypes have been reported based on cytokine profile and inflammatory cell patterns. The aim of this study was to characterize the intracytoplasmatic cytokines ofTcells infiltrating theinflamed sinonasal mucosa. Methods: Infiltrated T cells and tissue homogenates from sinonasal mucosal samples of 7 healthy subjects, 9 patients with CRS without nasal polyp (CRSsNP), 15 with CRS with nasal polyps (CRSwNP) and 5cystic fibrosis patients (CF-NP) were analyzed for cytokine expression using flow cytometry and multiplex analysis respectively. Intracytoplasmic cytokinesin T cells were analyzed after stimulation of nasal polyps with Staphylococcus aureus enterotoxin B for 24 hours. Results: The number of T cellsper total living cells was significantly higher in patients with CRSwNP vs. CRSsNP and controls. 85% of the CD4+ Tcells showed to be memory T cells. The effector T cells present in all tissues have apredominantTh1 phenotype. Only in CRSwNP, a significantfraction of T cellsproduced the Th2 cytokinesIL-4 and IL-5, while nasal polyps from CF patients were characterized by a higher CD4/CD8 T cell ratio and an increased number of Th17 cells. 24 h stimulation with SEB resulted in a significant induction of CD4+ T cells producing IL-10 (Tr1 cells). Conclusion: T cell cytokine patternsin healthy and inflamed sinonasal mucosa revealed that Th2 cells (IL-4 and IL-5 producing cells) are significantly increased in CRSwNP mucosal inflammation. Exposure to SEB stimulates Tr1 cellsthat may contribute to the Th2 bias in CRSwNP.	[Derycke, Lara; Van Crombruggen, Koen; Perez-Novo, Claudina; Holtappels, Gabriele; Deruyck, Natalie; Gevaert, Philippe; Bachert, Claus] Ghent Univ Hosp, Upper Airway Res Lab URL, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Div ENT Dis, Stockholm, Sweden; [Eyerich, Stefanie] ZAUM Zentrum Allergie & Umwelt, Munich, Germany	Ghent University; Ghent University Hospital; Karolinska Institutet	Bachert, C (corresponding author), Ghent Univ Hosp, Upper Airway Res Lab URL, Ghent, Belgium.	claus.bachert@Ugent.be	Novo, Claudina Angela Perez/H-9697-2016; Gevaert, Philippe/ABA-4588-2021; Novo, Claudina A Perez/E-6098-2011; Bachert, Claus/J-8825-2012; Gevaert, Philippe/AAP-1892-2020	Novo, Claudina A Perez/0000-0003-4562-4346; Gevaert, Philippe/0000-0002-1629-8468	Scientific Research Flanders [3G.0489.08, G.0642.10N]; Interuniversity Attraction Poles Program (IUAP) - Belgian state - Belgian Science Policy [P6/35, P7/30]	Scientific Research Flanders(FWO); Interuniversity Attraction Poles Program (IUAP) - Belgian state - Belgian Science Policy	This project was supported by the Fund for Scientific Research Flanders (FWO-Vlaanderen - Projects 3G.0489.08 to C.B., G.0642.10N to C.B) and The Interuniversity Attraction Poles Program (IUAP) - Belgian state - Belgian Science Policy P6/35 and P7/30. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Annunziato F, 2013, SEMIN IMMUNOL, V25, P299, DOI 10.1016/j.smim.2013.10.011; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Cheng W, 2007, J INVEST ALLERG CLIN, V17, P297; Derycke L, 2012, J CYST FIBROS, V11, P193, DOI 10.1016/j.jcf.2011.11.007; Faith A, 2012, ALLERGY, V67, P1007, DOI 10.1111/j.1398-9995.2012.02852.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Hirahara K, 2011, IMMUNOLOGY, V134, P235, DOI 10.1111/j.1365-2567.2011.03483.x; Kemeny DM, 1999, AM J RESP CRIT CARE, V160, pS33, DOI 10.1164/ajrccm.160.supplement_1.10; Li ZH, 2011, PROTEIN CELL, V2, P604, DOI 10.1007/s13238-011-1083-5; Lin YT, 2011, CLIN EXP ALLERGY, V41, P516, DOI 10.1111/j.1365-2222.2010.03681.x; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Noel C, 2001, INT IMMUNOL, V13, P431, DOI 10.1093/intimm/13.4.431; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Prussin C, 2010, J ALLERGY CLIN IMMUN, V126, P1094, DOI 10.1016/j.jaci.2010.08.031; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Sanchez-Segura A, 1998, J ALLERGY CLIN IMMUN, V102, P953, DOI 10.1016/S0091-6749(98)70333-1; Tang YF, 2012, J ALLERGY CLIN IMMUN, V129, P1611, DOI 10.1016/j.jaci.2011.12.976; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weiss E, 2004, J AM ACAD DERMATOL, V50, P657, DOI 10.1016/j.jaad.2003.11.075; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	28	99	102	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e97581	10.1371/journal.pone.0097581	http://dx.doi.org/10.1371/journal.pone.0097581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911279	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600124
J	Ge, Y; Schimel, JP; Holden, PA				Ge, Yuan; Schimel, Joshua P.; Holden, Patricia A.			Analysis of Run-to-Run Variation of Bar-Coded Pyrosequencing for Evaluating Bacterial Community Shifts and Individual Taxa Dynamics	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; MULTIPLEX; SCALE	Bar-coded pyrosequencing has been increasingly used due to its fine taxonomic resolution and high throughput. Yet, concerns arise regarding the reproducibility of bar-coded pyrosequencing. We evaluated the run-to-run variation of barcoded pyrosequencing in detecting bacterial community shifts and taxa dynamics. Our results demonstrate that pyrosequencing is reproducible in evaluating community shifts within a run, but not between runs. Also, the reproducibility of pyrosequencing in detecting individual taxa increased as a function of taxa abundance. Based on our findings: (1) for studies with modest sequencing depth, it is doubtful that data from different pyrosequencing runs can be considered comparable; (2) if multiple pyrosequencing runs are needed to increase the sequencing depth, additional sequencing efforts should be applied to all samples, rather than to selected samples; (3) if pyrosequencing is used for estimating bacterial population dynamics, only the abundant taxa should be considered; (4) for less-abundant taxa, the sequencing depth should be increased to ensure an accurate evaluation of taxon variation trends across samples.	[Ge, Yuan; Holden, Patricia A.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Ge, Yuan; Holden, Patricia A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Ge, Yuan; Schimel, Joshua P.; Holden, Patricia A.] Univ Calif Santa Barbara, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA; [Schimel, Joshua P.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Holden, PA (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	holden@bren.ucsb.edu	Schimel, Joshua/AAE-7380-2019; Ge, Yuan/D-2997-2009	Schimel, Joshua/0000-0002-1022-6623; Ge, Yuan/0000-0003-0234-5638	National Science Foundation; Environmental Protection Agency [DBI-0830117]	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the Environmental Protection Agency under Cooperative Agreement DBI-0830117. Any opinions, findings, and conclusions are those of the authors and do not necessarily reflect the views of the National Science Foundation or the Environmental Protection Agency. This work has not been subjected to EPA review and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Delmont TO, 2012, ISME J, V6, P1625, DOI 10.1038/ismej.2012.55; Deng Y, 2012, APPL ENVIRON MICROB, V78, P2991, DOI 10.1128/AEM.06924-11; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Ge Y, 2012, APPL ENVIRON MICROB, V78, P6749, DOI 10.1128/AEM.00941-12; Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Zhou J., 2013, MBIO, V4; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	25	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99414	10.1371/journal.pone.0099414	http://dx.doi.org/10.1371/journal.pone.0099414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911191	Green Published, gold			2022-12-27	WOS:000337165600083
J	Jiang, WS; Li, F; Jiang, HP; Yu, LL; Liu, WB; Li, Q; Zuo, LN				Jiang, Wensheng; Li, Fei; Jiang, Haipeng; Yu, Lili; Liu, Wenbo; Li, Qiang; Zuo, Luning			Core Self-Evaluations Mediate the Associations of Dispositional Optimism and Life Satisfaction	PLOS ONE			English	Article							ORIENTATION TEST; DEFENSIVE PESSIMISM; JOB-SATISFACTION; LOT-R; STRESS; HEALTH; MODEL; ADOLESCENCE; STRATEGIES; VALIDITY	Background: Positive traits, such as life satisfaction, optimism, and core self-evaluation (CSE), have garnered increasing attention from researchers and professionals. However, the trilateral relationship among them remains unclear. Objective: This study examines the effect of dispositional optimism on life satisfaction and primarily verified the mediator role of CSEs. Methods: Six hundred thirty college students from two general universities completed a questionnaire packet containing life orientation test-revised (LOT-R), core self-evaluations, and satisfaction with life scale. Confirmatory factor analysis (CFA) was conducted to assess the dimension of LOT-R. Bootstrap was used in structural equation modeling to analyze mediation effect. Results: Results revealed that dispositional optimism and core self-evaluations were significantly correlated with life satisfaction. CFA identified the bidimensional structure of dispositional optimism. SEM indicated that core self-evaluations partially mediated the effect of dispositional optimism on life satisfaction. The final model also revealed significant paths from optimism and pessimism to life satisfaction through core-self evaluations. Conclusion: The findings extended prior studies and shed light on how dispositional optimism influences life satisfaction. This study provides valuable evidence on how to promote the life satisfaction of human beings in positive psychology. A further study can fully explore the relationship among them in multi-cultural follow-up studies.	[Jiang, Wensheng] Yantaishan Hosp, Dept Cardiac Surg, Yantai, Peoples R China; [Li, Fei; Liu, Wenbo; Li, Qiang; Zuo, Luning] Yantaishan Hosp, Dept Cardiol, Yantai, Peoples R China; [Jiang, Haipeng] Yantaishan Hosp, Dept Rheumatism, Yantai, Peoples R China; [Yu, Lili] Yantaishan Hosp, Dept Pediat, Yantai, Peoples R China		Li, Q (corresponding author), Yantaishan Hosp, Dept Cardiol, Yantai, Peoples R China.	liqiangdoct@sina.com						ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Creed PA, 2002, J CAREER ASSESSMENT, V10, P42, DOI 10.1177/1069072702010001003; Diener E, 2000, CULTURE SUBJECTIVE W; Geers AL, 2013, PSYCHOL HEALTH, V28, P30, DOI 10.1080/08870446.2012.707200; Hei F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082939; Herzberg PY, 2006, PSYCHOL ASSESSMENT, V18, P433, DOI 10.1037/1040-3590.18.4.433; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ji LJ, 2004, ASIAN J SOC PSYCHOL, V7, P25, DOI 10.1111/j.1467-839X.2004.00132.x; Jovanovic V, 2013, J HAPPINESS STUD, V14, P771, DOI 10.1007/s10902-012-9354-2; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2012, ORGAN BEHAV HUM DEC, V117, P208, DOI 10.1016/j.obhdp.2011.08.005; Kostka T, 2010, QUAL LIFE RES, V19, P351, DOI 10.1007/s11136-010-9601-0; Lai JCL, 1998, J RES PERS, V32, P454, DOI 10.1006/jrpe.1998.2232; Lim L, 2009, J PSYCHOL, V143, P318, DOI 10.3200/JRLP.143.3.318-336; Makikangas A, 2004, J RES PERS, V38, P556, DOI 10.1016/j.jrp.2004.02.001; Martin AJ, 2003, CONTEMP EDUC PSYCHOL, V28, P1, DOI 10.1016/S0361-476X(02)00008-5; McPherson J, 2005, PSYCHOL METHODS, V10, P120, DOI 10.1037/1082-989X.10.1.120; METALSKY GI, 1982, J PERS SOC PSYCHOL, V43, P612, DOI 10.1037/0022-3514.43.3.612; Monzani D, 2014, J ADOLESCENCE, V37, P97, DOI 10.1016/j.adolescence.2013.11.006; Newman LS, 2009, EUR J SOC PSYCHOL, V39, P477, DOI 10.1002/ejsp.598; Peng JX, 2014, J BEHAV DECIS MAKING, V27, P11, DOI 10.1002/bdm.1783; Peng JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079181; Peterson C, 2000, AM PSYCHOL, V55, P44, DOI 10.1037/0003-066X.55.1.44; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; SCHEIER MF, 1986, J PERS SOC PSYCHOL, V51, P1257, DOI 10.1037/0022-3514.51.6.1257; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Schweizer K, 2001, PERS INDIV DIFFER, V31, P563, DOI 10.1016/S0191-8869(00)00161-6; Segerstrom SC, 2011, J RES PERS, V45, P126, DOI 10.1016/j.jrp.2010.11.007; Sharpe JP, 2011, PERS INDIV DIFFER, V51, P946, DOI 10.1016/j.paid.2011.07.033; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Vollmann M, 2014, PSYCHOL HEALTH, V29, P81, DOI 10.1080/08870446.2013.828294; Xiao W, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-8; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081169; Zhang JX, 2014, SOC INDIC RES, V119, P757, DOI 10.1007/s11205-013-0520-7; Zhang JX, 2014, SOC INDIC RES, V116, P809, DOI 10.1007/s11205-013-0328-5; Zhang L, 2013, ASIAN J COMMUN, V23, P248, DOI 10.1080/01292986.2012.739187	40	19	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e97752	10.1371/journal.pone.0097752	http://dx.doi.org/10.1371/journal.pone.0097752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911367	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600125
J	Kuznetsov, NA; Kuznetsova, AA; Vorobjev, YN; Krasnoperov, LN; Fedorova, OS				Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Vorobjev, Yuri N.; Krasnoperov, Lev N.; Fedorova, Olga S.			Thermodynamics of the DNA Damage Repair Steps of Human 8-Oxoguanine DNA Glycosylase	PLOS ONE			English	Article							CONFORMATIONAL DYNAMICS; SUBSTRATE RECOGNITION; LESION RECOGNITION; ENZYME; FLUORESCENCE; BINDING; PYRROLOCYTOSINE; 2-AMINOPURINE; COMPONENTS; MECHANISM	Human 8-oxoguanine DNA glycosylase (hOGG1) is a key enzyme responsible for initiating the base excision repair of 7,8dihydro- 8-oxoguanosine (oxoG). In this study a thermodynamic analysis of the interaction of hOGG1 with specific and nonspecific DNA-substrates is performed based on stopped-flow kinetic data. The standard Gibbs energies, enthalpies and entropies of specific stages of the repair process were determined via kinetic measurements over a temperature range using the van't Hoff approach. The three steps which are accompanied with changes in the DNA conformations were detected via 2-aminopurine fluorescence in the process of binding and recognition of damaged oxoG base by hOGG1. The thermodynamic analysis has demonstrated that the initial step of the DNA substrates binding is mainly governed by energy due to favorable interactions in the process of formation of the recognition contacts, which results in negative enthalpy change, as well as due to partial desolvation of the surface between the DNA and enzyme, which results in positive entropy change. Discrimination of non-specific G base versus specific oxoG base is occurring in the second step of the oxoG-substrate binding. This step requires energy consumption which is compensated by the positive entropy contribution. The third binding step is the final adjustment of the enzyme/substrate complex to achieve the catalytically competent state which is characterized by large endothermicity compensated by a significant increase of entropy originated from the dehydration of the DNA grooves.	[Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Krasnoperov, Lev N.] New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; New Jersey Institute of Technology	Fedorova, OS (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	fedorova@niboch.nsc.ru	Kuznetsov, Nikita A/F-3245-2011; Kuznetsov, Nikita/AFU-9897-2022; Fedorova, Olga/ABE-6637-2020; Fedorova, Olga S./E-1291-2013; Kuznetsov, Nikita/CAA-3889-2022; Kuznetsova, Aleksandra A/G-5119-2013	Kuznetsov, Nikita A/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; Fedorova, Olga/0000-0002-4001-7187; Fedorova, Olga S./0000-0002-4001-7187; Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsova, Aleksandra/0000-0002-9805-7050	Program of the Russian Academy of Sciences "Molecular and Cell Biology'' [6.11]; President Grants [SS-1205.2014.4, SP-4012.2013.4]; Russian Scientific Foundation [14-14-00063]; Russian Foundation for Basic Research [13-04-00013, 14-04-31174, 14-04-00531, 12-04-00135]; Russian Science Foundation [14-14-00063] Funding Source: Russian Science Foundation	Program of the Russian Academy of Sciences "Molecular and Cell Biology''; President Grants; Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Program of the Russian Academy of Sciences "Molecular and Cell Biology'' (6.11); President Grants (nos. SS-1205.2014.4 and SP-4012.2013.4); the Grant from Russian Scientific Foundation (14-14-00063); O.S.F., A.A.K.,N.A.K. and Y.N.V. are supported by Russian Foundation for Basic Research (nos. 13-04-00013, 14-04-31174, 14-04-00531 and 12-04-00135, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins P., 2006, ATKINS PHYS CHEM; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; CHENG KC, 1992, J BIOL CHEM, V267, P166; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Hardman SJO, 2006, BIOCHEMISTRY-US, V45, P9145, DOI 10.1021/bi060479t; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Kuznetsova AA, 2009, RUSS CHEM REV+, V78, P659, DOI 10.1070/RC2009v078n07ABEH004038; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Privalov PL, 2011, NUCLEIC ACIDS RES, V39, P2483, DOI 10.1093/nar/gkq984; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; RAGONE R, 1995, J PHYS CHEM-US, V99, P13050, DOI 10.1021/j100034a054; ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121; RUMYANTSEVA GV, 1989, FEBS LETT, V242, P397, DOI 10.1016/0014-5793(89)80509-5; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Vorobjev YN, 1997, BIOPHYS J, V73, P722, DOI 10.1016/S0006-3495(97)78105-0; Vorobjev YN, 2011, ADV PROTEIN CHEM STR, V85, P281, DOI 10.1016/B978-0-12-386485-7.00008-9; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	36	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98495	10.1371/journal.pone.0098495	http://dx.doi.org/10.1371/journal.pone.0098495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911585	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600007
J	Li, L; Men, WW; Chang, YK; Fan, MX; Ji, L; Wei, GX				Li, Lin; Men, Wei-Wei; Chang, Yu-Kai; Fan, Ming-Xia; Ji, Liu; Wei, Gao-Xia			Acute Aerobic Exercise Increases Cortical Activity during Working Memory: A Functional MRI Study in Female College Students	PLOS ONE			English	Article							OLDER-ADULTS; RESISTANCE EXERCISE; EXECUTIVE FUNCTIONS; COGNITIVE FUNCTION; TEST-PERFORMANCE; TASK-DIFFICULTY; BRAIN; ACTIVATION; FMRI; FITNESS	There is increasing evidence that acute aerobic exercise is associated with improved cognitive function. However, neural correlates of its cognitive plasticity remain largely unknown. The present study examined the effect of a session of acute aerobic exercise on working memory task-evoked brain activity as well as task performance. A within-subjects design with a counterbalanced order was employed. Fifteen young female participants (M = 19.56, SD = 0.81) were scanned using functional magnetic resonance imaging while performing a working memory task, the N-back task, both following an acute exercise session with 20 minutes of moderate intensity and a control rest session. Although an acute session of exercise did not improve behavioral performance, we observed that it had a significant impact on brain activity during the 2-back condition of the N-back task. Specifically, acute exercise induced increased brain activation in the right middle prefrontal gyrus, the right lingual gyrus, and the left fusiform gyrus as well as deactivations in the anterior cingulate cortexes, the left inferior frontal gyrus, and the right paracentral lobule. Despite the lack of an effect on behavioral measures, significant changes after acute exercise with activation of the prefrontal and occipital cortexes and deactivation of the anterior cingulate cortexes and left frontal hemisphere reflect the improvement of executive control processes, indicating that acute exercise could benefit working memory at a macro-neural level. In addition to its effects on reversing recent obesity and disease trends, our results provide substantial evidence highlighting the importance of promoting physical activity across the lifespan to prevent or reverse cognitive and neural decline.	[Li, Lin; Ji, Liu] Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China; [Li, Lin; Ji, Liu] E China Normal Univ, Phys Educ & Hlth Sch, Shanghai 200062, Peoples R China; [Men, Wei-Wei; Fan, Ming-Xia] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China; [Chang, Yu-Kai] Natl Taiwan Sport Univ, Grad Inst Athlet & Coaching Sci, Guishan Township, Taoyuan County, Taiwan; [Wei, Gao-Xia] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Wei, Gao-Xia] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	East China Normal University; East China Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Ji, L (corresponding author), Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China.	lji@tyxx.ecnu.edu.cn; weigx@psych.ac.cn	Meijer, Anna/K-5118-2016		Open Research Fund of the Key Laboratory of Adolescent Health Assessment and Exercise Intervention [7823005E]; Research Fund for the Doctoral Program of Higher Education [20110076120029]; large instruments Open Foundation of East China Normal University [2013-46]; National Natural Science Foundation of China [31200794, 91132728]; Open Research Fund of the Key Laboratory of Mental Health of the Chinese Academy of Sciences	Open Research Fund of the Key Laboratory of Adolescent Health Assessment and Exercise Intervention; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); large instruments Open Foundation of East China Normal University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of the Key Laboratory of Mental Health of the Chinese Academy of Sciences	This work was supported by grants from Open Research Fund of the Key Laboratory of Adolescent Health Assessment and Exercise Intervention (7823005E), the Research Fund for the Doctoral Program of Higher Education (20110076120029), large instruments Open Foundation of East China Normal University (2013-46), the National Natural Science Foundation of China (31200794, 91132728 to GXW), the Open Research Fund of the Key Laboratory of Mental Health of the Chinese Academy of Sciences (to GXW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P847, DOI 10.1123/jsep.33.6.847; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; DEMB JB, 1995, J NEUROSCI, V15, P5870; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gothe N, 2012, J PHYS ACT HLTH; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2005, CONSCIOUS COGN, V14, P679, DOI 10.1016/j.concog.2005.04.004; Haller S, 2005, MAGN RESON MATER PHY, V18, P263, DOI 10.1007/s10334-005-0010-2; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lowe PA, 2003, ARCH CLIN NEUROPSYCH, V18, P865, DOI 10.1016/S0887-6177(02)00162-2; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pontifex MB, 2007, CLIN NEUROPHYSIOL, V118, P570, DOI 10.1016/j.clinph.2006.09.029; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; Stratta P, 2001, PSYCHIAT RES, V102, P39, DOI 10.1016/S0165-1781(01)00230-X; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; TOMPOROWSKI PD, 1986, PSYCHOL BULL, V99, P338, DOI 10.1037/0033-2909.99.3.338; Tsujii T, 2013, ADV EXP MED BIOL, V765, P293, DOI 10.1007/978-1-4614-4989-8_41; Voss B, 2012, EUR ARCH PSY CLIN N, V262, P329, DOI 10.1007/s00406-011-0267-6; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	43	115	118	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99222	10.1371/journal.pone.0099222	http://dx.doi.org/10.1371/journal.pone.0099222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911975	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600058
J	Nelson, MC; Reynolds, JD				Nelson, Michelle C.; Reynolds, John D.			Time-Delayed Subsidies: Interspecies Population Effects in Salmon	PLOS ONE			English	Article							JUVENILE COHO SALMON; MARINE-DERIVED NUTRIENTS; ANADROMOUS SOCKEYE-SALMON; FRESH-WATER ECOSYSTEMS; COPPER RIVER DELTA; ONCORHYNCHUS-KISUTCH; PACIFIC SALMON; CARCASS ADDITION; RIPARIAN CANOPY; GROWTH	Cross-boundary nutrient inputs can enhance and sustain populations of organisms in nutrient-poor recipient ecosystems. For example, Pacific salmon (Oncorhynchus spp.) can deliver large amounts of marine-derived nutrients to freshwater ecosystems through their eggs, excretion, or carcasses. This has led to the question of whether nutrients from one generation of salmon can benefit juvenile salmon from subsequent generations. In a study of 12 streams on the central coast of British Columbia, we found that the abundance of juvenile coho salmon was most closely correlated with the abundance of adult pink salmon from previous years. There was a secondary role for adult chum salmon and watershed size, followed by other physical characteristics of streams. Most of the coho sampled emerged in the spring, and had little to no direct contact with spawning salmon nutrients at the time of sampling in the summer and fall. A combination of techniques suggest that subsidies from spawning salmon can have a strong, positive, time-delayed influence on the productivity of salmon-bearing streams through indirect effects from previous spawning events. This is the first study on the impacts of nutrients from naturally-occurring spawning salmon on juvenile population abundance of other salmon species.	[Nelson, Michelle C.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Nelson, Michelle C.] Raincoast Conservat Fdn, Sidney, BC, Canada	Simon Fraser University	Nelson, MC (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	mcnelson@sfu.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	RIX Family Leading Edge student award; Raincoast Conservation Foundation; NSERC; Pacific Salmon Foundation; BC Leading Edge Fund; Simon Fraser University	RIX Family Leading Edge student award; Raincoast Conservation Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Pacific Salmon Foundation; BC Leading Edge Fund; Simon Fraser University	This work was supported by RIX Family Leading Edge student award and NSERC Industrial Post-graduate Scholarship to MN with industrial funding from Raincoast Conservation Foundation (www.raincoast.org); and NSERC Discovery and Accelerator Grants to JDR, and and the Tom Buell Research Chair partnership between the Pacific Salmon Foundation (www.psf.ca), the BC Leading Edge Fund, and Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PUBL HLTH ASS, 1989, STAND METH EX WAST W; Anderson D. R., 2008, MODEL BASED INFERENC; Armstrong JB, 2010, ECOLOGY, V91, P1445, DOI 10.1890/09-0790.1; Bain M.B., 1999, AQUATIC HABITAT ASSE; Barton K., 2012, MULTI MODEL INFERENC; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; Bilby RE, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:PEOTUO>2.0.CO;2; Bradford M, 1997, T AM FISH SOC, V126, P59, DOI DOI 10.1577/1548-8659(1997)126%; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P677, DOI 10.1139/cjfas-57-4-677; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; DEGERMAN E, 1986, WATER AIR SOIL POLL, V30, P665, DOI 10.1007/BF00303330; Dorazio RM, 2005, BIOMETRICS, V61, P1093, DOI 10.1111/j.1541-0420.2005.00360.x; ENGLISH KK, 1992, CAN J FISH AQUAT SCI, V49, P1982, DOI 10.1139/f92-220; Field RD, 2011, P ROY SOC B-BIOL SCI, V278, P3081, DOI 10.1098/rspb.2010.2731; Garcia EA, 2011, OECOLOGIA, V166, P1111, DOI 10.1007/s00442-011-1952-x; Graham MD, 2006, LIMNOL OCEANOGR, V51, P1524, DOI 10.4319/lo.2006.51.3.1524; Gresh T, 2000, FISHERIES, V25, P15, DOI 10.1577/1548-8446(2000)025<0015:AEOHAC>2.0.CO;2; Groot C., 1991, PACIFIC SALMON LIFE; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harding JN, 2014, FRESHWATER BIOL, V59, P1361, DOI 10.1111/fwb.12351; Harding JN, 2014, NUTR SUBSIDIES UNPUB; Harvey BC, 2010, N AM J FISH MANAGE, V30, P1445, DOI 10.1577/M10-022.1; HAWKINS CP, 1983, CAN J FISH AQUAT SCI, V40, P1173, DOI 10.1139/f83-134; Hicks BJ, 2005, OECOLOGIA, V144, P558, DOI 10.1007/s00442-005-0035-2; Hocking MD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2433; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; HUNTER JG, 1959, J FISH RES BOARD CAN, V16, P835, DOI 10.1139/f59-061; IRVINE JR, 1992, CAN J FISH AQUAT SCI, V49, P1972, DOI 10.1139/f92-219; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Kershner JL, 1992, IMPORTANCE HABITAT L, P179; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Lang DW, 2006, CAN J FISH AQUAT SCI, V63, P917, DOI 10.1139/F05-268; Levi PS, 2011, CAN J FISH AQUAT SCI, V68, P1316, DOI [10.1139/F2011-067, 10.1139/f2011-067]; Levi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001303; Marczak LB, 2008, OECOLOGIA, V156, P249, DOI 10.1007/s00442-008-0989-y; MCGARIGAL LS, 2000, MULTIVARIATE STAT WI; MICHAEL JH, 1995, NORTHWEST SCI, V69, P228; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI [10.1139/f04-103, 10.1139/F04-103]; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nelson MC, 2014, EFFECT SUBSIDE UNPUB; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; POJAR J, 1987, FOREST ECOL MANAG, V22, P119, DOI 10.1016/0378-1127(87)90100-9; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; R Core Team, 2020, R LANG ENV STAT COMP; Reisinger AJ, 2013, FRESHWATER BIOL, V58, P938, DOI 10.1111/fwb.12098; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; Rinella DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00112.1; Roni P, 2001, CAN J FISH AQUAT SCI, V58, P282, DOI 10.1139/cjfas-58-2-282; Rosenfeld J, 2000, CAN J FISH AQUAT SCI, V57, P766, DOI 10.1139/cjfas-57-4-766; Ruckelshaus MH, 2002, ANNU REV ECOL SYST, V33, P665, DOI 10.1146/annurev.ecolsys.33.010802.150504; Scheuerell MD, 2007, FRESHWATER BIOL, V52, P1944, DOI 10.1111/j.1365-2427.2007.01823.x; Scheuerell MD, 2005, CAN J FISH AQUAT SCI, V62, P961, DOI 10.1139/F05-113; SCHNUTE J, 1983, CAN J FISH AQUAT SCI, V40, P2153, DOI 10.1139/f83-250; Sharma R, 2001, CAN J FISH AQUAT SCI, V58, P1453, DOI 10.1139/cjfas-58-7-1453; SWAIN DP, 1989, CAN J FISH AQUAT SCI, V46, P1406, DOI 10.1139/f89-180; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Tiegs SD, 2011, ECOSYSTEMS, V14, P598, DOI 10.1007/s10021-011-9431-0; Verspoor JJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00011.1; Verspoor JJ, 2010, ECOSYSTEMS, V13, P1020, DOI 10.1007/s10021-010-9371-0; Wilzbach MA, 2005, CAN J FISH AQUAT SCI, V62, P58, DOI 10.1139/F04-177; Wipfli MS, 1998, CAN J FISH AQUAT SCI, V55, P1503, DOI 10.1139/cjfas-55-6-1503; Wipfli MS, 2003, T AM FISH SOC, V132, P371, DOI 10.1577/1548-8659(2003)132<0371:MSIFES>2.0.CO;2; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; ZIPPIN C, 1956, BIOMETRICS, V12, P163, DOI 10.2307/3001759; Zuur Alain F., 2009, P1	69	8	9	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98951	10.1371/journal.pone.0098951	http://dx.doi.org/10.1371/journal.pone.0098951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911974	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600028
J	Shestopaloff, YK; Sbalzarini, IF				Shestopaloff, Yuri K.; Sbalzarini, Ivo F.			A Method for Modeling Growth of Organs and Transplants Based on the General Growth Law: Application to the Liver in Dogs and Humans	PLOS ONE			English	Article							REGENERATION; MECHANISM; MAMMALS; DONORS	Understanding biological phenomena requires a systemic approach that incorporates different mechanisms acting on different spatial and temporal scales, since in organisms the workings of all components, such as organelles, cells, and organs interrelate. This inherent interdependency between diverse biological mechanisms, both on the same and on different scales, provides the functioning of an organism capable of maintaining homeostasis and physiological stability through numerous feedback loops. Thus, developing models of organisms and their constituents should be done within the overall systemic context of the studied phenomena. We introduce such a method for modeling growth and regeneration of livers at the organ scale, considering it a part of the overall multi-scale biochemical and biophysical processes of an organism. Our method is based on the earlier discovered general growth law, postulating that any biological growth process comprises a uniquely defined distribution of nutritional resources between maintenance needs and biomass production. Based on this law, we introduce a liver growth model that allows to accurately predicting the growth of liver transplants in dogs and liver grafts in humans. Using this model, we find quantitative growth characteristics, such as the time point when the transition period after surgery is over and the liver resumes normal growth, rates at which hepatocytes are involved in proliferation, etc. We then use the model to determine and quantify otherwise unobservable metabolic properties of livers.	[Shestopaloff, Yuri K.] Segmentsoft Inc, Res & Dev Lab, Toronto, ON, Canada; [Sbalzarini, Ivo F.] Max Planck Inst Mol Cell Biol & Genet, Ctr Syst Biol Dresden, MOSAIC Grp, Dresden, Germany	Max Planck Society	Shestopaloff, YK (corresponding author), Segmentsoft Inc, Res & Dev Lab, Toronto, ON, Canada.	shes169@yahoo.ca		Sbalzarini, Ivo Fabian/0000-0003-4414-4340				Arias I M, 2008, LIVER BIOL PATHOBIOL; Furchtgott LA, 2009, BIOPHYS J, V96, P3926, DOI 10.1016/j.bpj.2009.01.061; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Hunter PJ, 2008, BRIEF BIOINFORM, V9, P333, DOI 10.1093/bib/bbn024; Jones GW, 2012, SIAM REV, V54, P52, DOI 10.1137/080731785; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Lui JC, 2011, ENDOCR REV, V32, P422, DOI 10.1210/er.2011-0001; MaalOe O, 1966, CONTROL MACROMOLECUL; Maher B, 2013, NATURE, V499, P20, DOI 10.1038/499020a; Netter FH, 2019, ATLAS HUMAN ANATOMY, VSeventh; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Shestopaloff Y. K., 2012, Biophysical Reviews and Letters, V7, P177, DOI 10.1142/S1793048012500075; Shestopaloff YK, 2010, PHYS GROWTH REPLICAT; Shestopaloff YK, 2012, LAW REPLICATION GROW; Shestopaloff YK, 2014, GROWTH UNION FORM BI; Shestopaloff Yuri K., 2012, Biophysical Reviews and Letters, V7, P71, DOI 10.1142/S1793048012500051; Shestopaloff YK, 2011, INT J BIOMATH, V4, P35, DOI 10.1142/S1793524511001180; Shestopaloff Yuri K., 2010, Biophysical Reviews and Letters, V5, P43, DOI 10.1142/S1793048010001111; SKALAK R, 1982, J THEOR BIOL, V94, P555, DOI 10.1016/0022-5193(82)90301-0; Stewart I, 1998, LIFES OTHER SECRET N; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thompson d'Arcy W., 1992, GROWTH FORM; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799	29	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99275	10.1371/journal.pone.0099275	http://dx.doi.org/10.1371/journal.pone.0099275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911324	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600064
J	Ude, CC; Sulaiman, SB; Ng, MH; Chen, HC; Ahmad, J; Yahaya, NM; Saim, AB; Idrus, RBH				Ude, Chinedu C.; Sulaiman, Shamsul B.; Ng Min-Hwei; Chen Hui-Cheng; Ahmad, Johan; Yahaya, Norhamdan M.; Saim, Aminuddin B.; Idrus, Ruszymah B. H.			Cartilage Regeneration by Chondrogenic Induced Adult Stem Cells in Osteoarthritic Sheep Model	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; BONE-MARROW; ADIPOSE-TISSUE; IN-VITRO; DIFFERENTIATION; THERAPIES; MEDICINE; REPAIR; YIELD	Objectives: In this study, Adipose stem cells (ADSC) and bone marrow stem cells (BMSC), multipotent adult cells with the potentials for cartilage regenerations were induced to chondrogenic lineage and used for cartilage regenerations in surgically induced osteoarthritis in sheep model. Methods: Osteoarthritis was induced at the right knee of sheep by complete resection of the anterior cruciate ligament and medial meniscus following a 3-weeks exercise regimen. Stem cells from experimental sheep were culture expanded and induced to chondrogenic lineage. Test sheep received a single dose of 2610 7 autologous PKH26-labelled, chondrogenically induced ADSCs or BMSCs as 5 mls injection, while controls received 5 mls culture medium. Results: The proliferation rate of ADSCs 34.4 +/- 1.6 hr was significantly higher than that of the BMSCs 48.8 +/- 5.3 hr (P = 0.008). Chondrogenic induced BMSCs had significantly higher expressions of chondrogenic specific genes (Collagen II, SOX9 and Aggrecan) compared to chondrogenic ADSCs (P = 0.031, 0.010 and 0.013). Grossly, the treated knee joints showed regenerated de novo cartilages within 6 weeks post-treatment. On the International Cartilage Repair Society grade scores, chondrogenically induced ADSCs and BMSCs groups had significantly lower scores than controls (P = 0.0001 and 0.0001). Fluorescence of the tracking dye (PKH26) in the injected cells showed that they had populated the damaged area of cartilage. Histological staining revealed loosely packed matrixes of de novo cartilages and immunostaining demonstrated the presence of cartilage specific proteins, Collagen II and SOX9. Conclusion: Autologous chondrogenically induced ADSCs and BMSCs could be promising cell sources for cartilage regeneration in osteoarthritis.	[Ude, Chinedu C.; Sulaiman, Shamsul B.; Ng Min-Hwei; Idrus, Ruszymah B. H.] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Cheras, Selangor, Malaysia; [Chen Hui-Cheng] Univ Putra Malaysia, Fac Vet Med, Dept Clin Vet, Serdang 43400, Selangor, Malaysia; [Ahmad, Johan; Yahaya, Norhamdan M.] Univ Kebangsaan Malaysia, Med Ctr, Dept Orthoped & Traumatol, Cheras, Selangor, Malaysia; [Saim, Aminuddin B.] Ampang Putri Specialist Hosp, ENT Consultant Clin, Ampang, Selangor, Malaysia; [Ude, Chinedu C.; Idrus, Ruszymah B. H.] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Idrus, RBH (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Cheras, Selangor, Malaysia.	ruszyidrus@gmail.com	Ng, Angela Min Hwei/ABC-6726-2020; Sulaiman, Shamsul/AFW-2819-2022	Ng, Angela Min Hwei/0000-0002-5791-639X; Sulaiman, Shamsul/0000-0003-2148-6575; Chen, Hui Cheng/0000-0003-3717-0831; Saim, Aminuddin Bin/0000-0002-8090-0855	Malaysian Ministry of Education [UKM-AP-2011-26, DPP-2013-084]; Universiti Kebangsaan Malaysia Medical Center (Tissue Engineering Center Chemical) [50-67-01-001]	Malaysian Ministry of Education; Universiti Kebangsaan Malaysia Medical Center (Tissue Engineering Center Chemical)	This study was supported by grants from the Malaysian Ministry of Education (UKM-AP-2011-26), (DPP-2013-084) and the grant from the Universiti Kebangsaan Malaysia Medical Center (Tissue Engineering Center Chemical grant: 50-67-01-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICHROTH PM, 1991, INT ORTHOP, V15, P351; Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Alfaqeh H, 2008, Med J Malaysia, V63 Suppl A, P37; Alfaqeh HH, 2011, SAUDI MED J, V32, P640; Aubin PP, 2007, CLIN ORTHOP REL S391, pS318; Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Brian OD, 2010, TISSUE ENG A, V16; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Chen K, 2013, INT J ORAL MAX SURG, V42, P240, DOI 10.1016/j.ijom.2012.05.030; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9; Hamid AA, 2012, CLINICS, V67, P99, DOI 10.6061/clinics/2012(02)03; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766; Maumus M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt55; Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853; Mifune Y, 2013, OSTEOARTHR CARTILAGE, V21, P175, DOI 10.1016/j.joca.2012.09.018; Munirah S, 2005, TISSUE ENG REGEN MED, V2, P347; Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Pak Jaewoo, 2011, J Med Case Rep, V5, P296, DOI 10.1186/1752-1947-5-296; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Saw KY, 2010, J ARTHRO, V11, DOI 10.1016/; Sha'ban M, 2011, TISSUE ENG REGEN MED, V8, P32; Sigma, 1993, RESEARCH, V53, P2360; Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X; Ude CC, 2012, TISSUE CELL, V44, P156, DOI 10.1016/j.tice.2012.02.001; Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca	38	75	77	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98770	10.1371/journal.pone.0098770	http://dx.doi.org/10.1371/journal.pone.0098770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911365	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000337165600014
J	Young, PG; Proft, T; Harris, PWR; Brimble, MA; Baker, EN				Young, Paul G.; Proft, Thomas; Harris, Paul W. R.; Brimble, Margaret A.; Baker, Edward N.			Structure and Activity of Streptococcus pyogenes SipA: A Signal Peptidase-Like Protein Essential for Pilus Polymerisation	PLOS ONE			English	Article							ACUTE RHEUMATIC-FEVER; CRYSTAL-STRUCTURE; STABILIZING ISOPEPTIDE; EXPRESSION; SEQUENCE; ADHESION; GENE; DETERMINANTS; SCATTERING; MUTATIONS	The pili expressed on the surface of the human pathogen Streptococcus pyogenes play an important role in host cell attachment, colonisation and pathogenesis. These pili are built from two or three components, an adhesin subunit at the tip, a major pilin that forms a polymeric shaft, and a basal pilin that is attached to the cell wall. Assembly is carried out by specific sortase (cysteine transpeptidase) enzyme. These components are encoded in a small gene cluster within the S. pyogenes genome, often together with another protein, SipA, whose function is unknown. We show through functional assays, carried out by expressing the S. pyogenes pilus components in Lactococcus lactis, SipA from the clinically important M1T1 strain is essential for pilus assembly, and that SipA function is likely to be conserved in all S. pyogenes. From the crystal structure of SipA we confirm that SipA belongs to the family of bacterial signal peptidases (SPases), which process the signal-peptides of secreted proteins. In contrast to a previous arm-swapped SipA dimer, this present structure shows that its principal domain closely resembles the catalytic domain of SPases and has a very similar peptide-binding cleft, but it lacks the catalytic Ser and Lys residues characteristic of SPases. In SipA these are replaced by Asp and Gly residues, which play no part in activity. We propose that SipA functions by binding a key component at the bacterial cell surface, in a conformation that facilitates pilus assembly.	[Young, Paul G.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Proft, Thomas] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med, Auckland 1, New Zealand; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand; [Proft, Thomas; Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Young, PG (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	p.young@auckland.ac.nz	Proft, Thomas/H-4686-2019	Proft, Thomas/0000-0002-9275-5042; Brimble, Margaret/0000-0002-7086-4096; Baker, Edward/0000-0003-2456-7661	Health Research Council of New Zealand; New Zealand Synchrotron Group Ltd.	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Synchrotron Group Ltd.	This work was supported by the Health Research Council of New Zealand. Access to the Australian Synchrotron was funded by the New Zealand Synchrotron Group Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carlos JL, 2000, J BIOL CHEM, V275, P38813, DOI 10.1074/jbc.M007093200; Carlos JL, 2000, BIOCHEMISTRY-US, V39, P7276, DOI 10.1021/bi000301l; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Choo KH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S15; Cozzi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049048; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; Dubuisson J, 2000, J BIOL CHEM, V275, P30605, DOI 10.1074/jbc.M004326200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Fischer R, 2003, BIOCONJUGATE CHEM, V14, P653, DOI 10.1021/bc025658b; Fittipaldi N, 2007, APPL ENVIRON MICROB, V73, P4359, DOI 10.1128/AEM.00258-07; Fittipaldi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008426; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Harris PWR, 2008, INT J PEPT RES THER, V14, P387, DOI 10.1007/s10989-008-9149-9; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; INADA T, 1989, J BACTERIOL, V171, P585, DOI 10.1128/jb.171.1.585-587.1989; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Luo CY, 2009, BIOCHEMISTRY-US, V48, P8976, DOI 10.1021/bi9009538; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Maguire GP, 2012, MED J AUSTRALIA, V197, P133, DOI 10.5694/mja12.10980; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; OCHMAN H, 1988, GENETICS, V120, P621; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; van Roosmalen ML, 2004, BBA-MOL CELL RES, V1694, P279, DOI 10.1016/j.bbamcr.2004.05.006; Winzor DJ, 2004, J CHROMATOGR A, V1037, P351, DOI 10.1016/j.chroma.2003.11.092; Young PG, 2013, J STRUCT BIOL, V183, P99, DOI 10.1016/j.jsb.2013.05.021; Zahner D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025124; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	62	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99135	10.1371/journal.pone.0099135	http://dx.doi.org/10.1371/journal.pone.0099135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911348	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600044
J	Napolitano, M; Comegna, M; Succoio, M; Leggiero, E; Pastore, L; Faraonio, R; Cimino, F; Passaro, F				Napolitano, Marco; Comegna, Marika; Succoio, Mariangela; Leggiero, Eleonora; Pastore, Lucio; Faraonio, Raffaella; Cimino, Filiberto; Passaro, Fabiana			Comparative Analysis of Gene Expression Data Reveals Novel Targets of Senescence-Associated microRNAs	PLOS ONE			English	Article							CELLULAR SENESCENCE; LIFE-SPAN; EPITHELIAL-CELLS; CANCER CELLS; ID PROTEINS; FIBROBLASTS; SENSITIVITY; APOPTOSIS; P53	In the last decades, cellular senescence is viewed as a complex mechanism involved in different processes, ranging from tumor suppression to induction of age-related degenerative alterations. Senescence-inducing stimuli are myriad and, recently, we and others have demonstrated the role exerted by microRNAs in the induction and maintenance of senescence, by the identification of a subset of Senescence-Associated microRNAs (SAmiRs) up-regulated during replicative or stress-induced senescence and able to induce a premature senescent phenotype when over-expressed in human primary cells. With the intent to find novel direct targets of two specific SAmiRs, SAmiR-494 and -486-5p, and cellular pathways which they are involved in, we performed a comparative analysis of gene expression profiles available in literature to select genes down-regulated upon replicative senescence of human primary fibroblasts. Among them, we searched for SAmiR's candidate targets by analyzing with different target prediction algorithms their 3'UTR for the presence of SAmiR-binding sites. The expression profiles of selected candidates have been validated on replicative and stress-induced senescence and the targeting of the 3'UTRs was assessed by luciferase assay. Results allowed us to identify Cell Division Cycle Associated 2 (CDCA2) and Inhibitor of DNA binding/differentiation type 4 (ID4) as novel targets of SAmiR-494 and SAmiR-486-5p, respectively. Furthermore, we demonstrated that the over-expression of CDCA2 in human primary fibroblasts was able to partially counteract etoposide-induced senescence by mitigating the activation of DNA Damage Response.	[Napolitano, Marco; Cimino, Filiberto] IRCCS SDN Fdn, Naples, Italy; [Comegna, Marika; Succoio, Mariangela; Pastore, Lucio; Faraonio, Raffaella; Cimino, Filiberto; Passaro, Fabiana] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Comegna, Marika; Succoio, Mariangela; Leggiero, Eleonora; Pastore, Lucio; Faraonio, Raffaella; Cimino, Filiberto; Passaro, Fabiana] CEINGE Adv Biotechnol, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; CEINGE Biotecnologie Avanzate	Cimino, F (corresponding author), IRCCS SDN Fdn, Naples, Italy.	cimino@dbbm.unina.it; fabiana.passaro@unina.it	Passaro, Fabiana/I-5941-2012; Pastore, Lucio/F-4668-2010; faraonio, raffaella/K-3802-2018; Pastore, Lucio/AAF-3487-2019	Passaro, Fabiana/0000-0003-0150-5302; Pastore, Lucio/0000-0001-6894-9317; Faraonio, Raffaella/0000-0002-7040-6781; Leggiero, Eleonora/0000-0002-8091-6275; Comegna, Marika/0000-0002-8008-2557	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR PRIN, MIUR MERIT) [RBNE08HWLZ_004]; POR Campania FESR Project BIOFRAME	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR PRIN, MIUR MERIT)(Ministry of Education, Universities and Research (MIUR)); POR Campania FESR Project BIOFRAME	This study was supported by the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (MIUR PRIN 2007, MIUR MERIT RBNE08HWLZ_004) and POR Campania FESR 2007-2013 Project BIOFRAME. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carey JP, 2013, ANTICANCER RES, V33, P4271; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Faraonio R, 2002, CELL DEATH DIFFER, V9, P862, DOI 10.1038/sj.cdd.4401053; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Iavarone A, 2006, TRENDS MOL MED, V12, P588, DOI 10.1016/j.molmed.2006.10.007; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Poele Te RH, 2002, CANCER RES, V62, P1876; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Zhang H, 2004, ONCOGENE, V23, P6193, DOI 10.1038/sj.onc.1207834; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98669	10.1371/journal.pone.0098669	http://dx.doi.org/10.1371/journal.pone.0098669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905922	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000047
J	Ying, W; Kanameni, S; Chang, CA; Nair, V; Safe, S; Bazer, FW; Zhou, BY				Ying, Wei; Kanameni, Srikanth; Chang, Cheng-An; Nair, Vijayalekshmi; Safe, Stephen; Bazer, Fuller W.; Zhou, Beiyan			Interferon Tau Alleviates Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Macrophage Polarization	PLOS ONE			English	Article							PREGNANCY RECOGNITION HORMONE; NF-KAPPA-B; PPAR-GAMMA; T-CELLS; ACTIVATION; ENCEPHALOMYELITIS; INFILTRATION; MODULATION; STEATOSIS	Chronic adipose tissue inflammation is a hallmark of obesity-induced insulin resistance and anti-inflammatory agents can benefit patients with obesity-associated syndromes. Currently available type I interferons for therapeutic immunomodulation are accompanied by high cytotoxicity and therefore in this study we have examined anti-inflammatory effects of interferon tau (IFNT), a member of the type I interferon family with low cellular toxicity even at high doses. Using a diet-induced obesity mouse model, we observed enhanced insulin sensitivity in obese mice administered IFNT compared to control mice, which was accompanied by a significant decrease in secretion of proinflammatory cytokines and elevated anti-inflammatory macrophages (M2) in adipose tissue. Further investigations revealed that IFNT is a potent regulator of macrophage activation that favors anti-inflammatory responses as evidenced by activation of associated surface antigens, production of anti-inflammatory cytokines, and activation of selective cell signaling pathways. Thus, our study demonstrates, for the first time, that IFNT can significantly mitigate obesity-associated systemic insulin resistance and tissue inflammation by controlling macrophage polarization, and thus IFNT can be a novel bio-therapeutic agent for treating obesity-associated syndromes and type 2 diabetes.	[Ying, Wei; Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Kanameni, Srikanth; Chang, Cheng-An; Nair, Vijayalekshmi; Safe, Stephen; Zhou, Beiyan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bazer, FW (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	FBAZER@cvm.tamu.edu; bzhou@cvm.tamu.edu	Ying, Wei/N-5157-2016; Bazer, Fuller/AAF-4317-2021	Bazer, Fuller/0000-0002-5823-5086; Zhou, Beiyan/0000-0003-0638-2428	American Heart Association [13PRE17050104]; American Diabetes Association [1-13-JF-59]; National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases [NIH/NIDDK 1R01DK098662]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098662] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association (13PRE17050104 to W. Ying), American Diabetes Association (1-13-JF-59 to B. Zhou) and National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK 1R01DK098662 to B. Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi AQ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105684; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Bazer FW, 2012, ANN NY ACAD SCI, V1271, P88, DOI 10.1111/j.1749-6632.2012.06741.x; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Bosca L, 2000, GENE THER, V7, P817, DOI 10.1038/sj.gt.3301179; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; Chon TW, 2010, J INTERF CYTOK RES, V30, P477, DOI 10.1089/jir.2009.0089; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jongen PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026568; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Liu YW, 2003, J IMMUNOL, V171, P821, DOI 10.4049/jimmunol.171.2.821; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; PONTZER CH, 1991, CANCER RES, V51, P5304; Roberts RM, 2007, CYTOKINE GROWTH F R, V18, P403, DOI 10.1016/j.cytogfr.2007.06.010; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Sleijfer S, 2005, PHARM WORLD SCI, V27, P423, DOI 10.1007/s11096-005-1319-7; Sobel DO, 2008, AUTOIMMUNITY, V41, P543, DOI 10.1080/08916930802194195; Soos JM, 2002, J IMMUNOL, V169, P2231, DOI 10.4049/jimmunol.169.5.2231; SOOS JM, 1995, J IMMUNOL, V155, P2747; Spencer M, 2013, DIABETES, V62, P1709, DOI 10.2337/db12-1042; Tekwe CD, 2013, BIOFACTORS, V39, P552, DOI 10.1002/biof.1113; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Wang MH, 2003, J CELL BIOCHEM, V89, P38, DOI 10.1002/jcb.10492; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ying W., 2013, JOVE-J VIS EXP, V76; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	39	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98835	10.1371/journal.pone.0098835	http://dx.doi.org/10.1371/journal.pone.0098835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905566	Green Submitted, gold, Green Published			2022-12-27	WOS:000341869000066
J	Herrera, C; Vance, DJ; Eisele, LE; Shoemaker, CB; Mantis, NJ				Herrera, Cristina; Vance, David J.; Eisele, Leslie E.; Shoemaker, Charles B.; Mantis, Nicholas J.			Differential Neutralizing Activities of a Single Domain Camelid Antibody (VHH) Specific for Ricin Toxin's Binding Subunit (RTB)	PLOS ONE			English	Article							B-CHAIN; PROTECTIVE IMMUNITY; A-CHAIN; GALACTOSE; SURFACE; MICE; RETROTRANSLOCATION; MECHANISM; LECTINS; VACCINE	Ricin, a member of the A-B family of ribosome-inactivating proteins, is classified as a Select Toxin by the Centers for Disease Control and Prevention because of its potential use as a biothreat agent. In an effort to engineer therapeutics for ricin, we recently produced a collection of alpaca-derived, heavy-chain only antibody V-H domains (VHH or "nanobody'') specific for ricin's enzymatic (RTA) and binding (RTB) subunits. We reported that one particular RTB-specific VHH, RTB-B7, when covalently linked via a peptide spacer to different RTA-specific V(H)Hs, resulted in heterodimers like VHH D10/B7 that were capable of passively protecting mice against a lethal dose challenge with ricin. However, RTB-B7 itself, when mixed with ricin at a 1: 10 toxin: antibody ratio did not afford any protection in vivo, even though it had demonstrable toxin-neutralizing activity in vitro. To better define the specific attributes of antibodies associated with ricin neutralization in vitro and in vivo, we undertook a more thorough characterization of RTB-B7. We report that RTB-B7, even at 100-fold molar excess (toxin:antibody) was unable to alter the toxicity of ricin in a mouse model. On the other hand, in two well-established cytotoxicity assays, RTB-B7 neutralized ricin with a 50% inhibitory concentration (IC50) that was equivalent to that of 24B11, a well-characterized and potent RTB-specific murine monoclonal antibody. In fact, RTB-B7 and 24B11 were virtually identical when compared across a series of in vitro assays, including adherence to and neutralization of ricin after the toxin was pre-bound to cell surface receptors. RTB-B7 differed from both 24B11 and VHH D10/B7 in that it was relatively less effective at blocking ricin attachment to receptors on host cells and was not able to form high molecular weight toxin:antibody complexes in solution. Whether either of these activities is important in ricin toxin neutralizing activity in vivo remains to be determined.	[Herrera, Cristina; Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12229 USA; [Herrera, Cristina; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Eisele, Leslie E.] New York State Dept Hlth, Sci Cores, Wadsworth Ctr, Albany, NY USA; [Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12229 USA.	nmantis@wadsworth.org	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	Carson Carr Diversity Scholarship from the University at Albany; National Institutes of Health [AI097688]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097688] Funding Source: NIH RePORTER	Carson Carr Diversity Scholarship from the University at Albany; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CH gratefully acknowledges the support of a Carson Carr Diversity Scholarship from the University at Albany. This project was supported in part by a grant from the National Institutes of Health (AI097688) to NJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2007, BIOTECHNIQUES, V43, P806, DOI 10.2144/000112600; Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; COLOMBATTI M, 1986, HYBRIDOMA, V5, P9, DOI 10.1089/hyb.1986.5.9; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FOXWELL BMJ, 1985, TOXICOLOGY, V34, P79, DOI 10.1016/0300-483X(85)90080-0; FRENOY JP, 1986, BIOCHEM J, V240, P221, DOI 10.1042/bj2400221; Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131; Goldman ER, 2009, SENSORS-BASEL, V9, P542, DOI 10.3390/s90100542; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Greene CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069678; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; KIMURA Y, 1988, J BIOCHEM-TOKYO, V103, P944, DOI 10.1093/oxfordjournals.jbchem.a122391; Korcheva V, 2007, MOL IMMUNOL, V44, P2761, DOI 10.1016/j.molimm.2006.10.025; LEWIS MS, 1986, J BIOL CHEM, V261, P1571; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Marconescu PS, 2010, VACCINE, V28, P5315, DOI 10.1016/j.vaccine.2010.05.045; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2013, HISTOCHEM CELL BIOL; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; Tremblay JM, 2013, INFECT IMMUN; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Vance DJ, 2012, TOXICON, V60, P874, DOI 10.1016/j.toxicon.2012.06.014; VILLAFRANCA JE, 1981, J BIOL CHEM, V256, P554; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; Vitetta ES, 2012, CLIN VACCINE IMMUNOL; WALES R, 1991, J BIOL CHEM, V266, P19172; Wolfe DN, 2013, HUM VACCIN IMMUNOTHE, V9; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8; Zhan JB, 1997, FEBS LETT, V407, P271, DOI 10.1016/S0014-5793(97)00341-4	55	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99788	10.1371/journal.pone.0099788	http://dx.doi.org/10.1371/journal.pone.0099788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918772	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000109
J	Janowski, M; Walczak, P; Kropiwnicki, T; Jurkiewicz, E; Domanska-Janik, K; Bulte, JWM; Lukomska, B; Roszkowski, M				Janowski, Miroslaw; Walczak, Piotr; Kropiwnicki, Tomasz; Jurkiewicz, Elzbieta; Domanska-Janik, Krystyna; Bulte, Jeff W. M.; Lukomska, Barbara; Roszkowski, Marcin			Long-Term MRI Cell Tracking after Intraventricular Delivery in a Patient with Global Cerebral Ischemia and Prospects for Magnetic Navigation of Stem Cells within the CSF	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; PARKINSONS-DISEASE; TRANSPLANTATION; SAFETY; BLOOD; NEUROTRANSPLANTATION; THERAPY; GRAFTS; STROKE	Background: The purpose of the study was to evaluate the long-term clinical tracking of magnetically labeled stem cells after intracerebroventricular transplantation as well as to investigate in vitro feasibility for magnetic guidance of cell therapy within large fluid compartments. Method: After approval by our Institutional Review Board, an 18-month-old patient, diagnosed as being in a vegetative state due to global cerebral ischemia, underwent cell transplantation to the frontal horn of the lateral ventricle, with umbilical cord blood-derived stem cells labeled with superparamagnetic iron oxide (SPIO) contrast agent. The patient was followed over 33 months with clinical examinations and MRI. To evaluate the forces governing the distribution of cells within the fluid compartment of the ventricular system in vivo, a gravity-driven sedimentation assay and a magnetic field-driven cell attraction assay were developed in vitro. Results: Twenty-four hours post-transplantation, MR imaging (MRI) was able to detect hypointense cells in the occipital horn of the lateral ventricle. The signal gradually decreased over 4 months and became undetectable at 33 months. In vitro, no significant difference in cell sedimentation between SPIO-labeled and unlabeled cells was observed (p = NS). An external magnet was effective in attracting cells over distances comparable to the size of human lateral ventricles. Conclusions: MR imaging of SPIO-labeled cells allows monitoring of cells within lateral ventricles. While the initial biodistribution is governed by gravity-driven sedimentation, an external magnetic field may possibly be applied to further direct the distribution of labeled cells within large fluid compartments such as the ventricular system.	[Janowski, Miroslaw; Domanska-Janik, Krystyna; Lukomska, Barbara] Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland; [Janowski, Miroslaw] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurosurg, Warsaw, Poland; [Janowski, Miroslaw; Walczak, Piotr; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Magnet Resonance Res, Baltimore, MD USA; [Janowski, Miroslaw; Walczak, Piotr; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Janowski, Miroslaw; Walczak, Piotr; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Walczak, Piotr] Univ Warmia & Mazury, Fac Med Sci, Dept Radiol, Olsztyn, Poland; [Kropiwnicki, Tomasz; Roszkowski, Marcin] Childrens Mem Hlth Inst, Dept Neurosurg, Warsaw, Poland; [Jurkiewicz, Elzbieta] Childrens Mem Hlth Inst, Dept Radiol, Magnet Resonance Unit, Warsaw, Poland; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Warmia & Mazury; Children's Memorial Health Institute; Children's Memorial Health Institute; Johns Hopkins University; Johns Hopkins University	Roszkowski, M (corresponding author), Childrens Mem Hlth Inst, Dept Neurosurg, Warsaw, Poland.	marcroszkowski@gmail.com		Janowski, Miroslaw/0000-0001-5261-7975; Domanska-Janik, Krystyna/0000-0003-0514-7776; Bulte, Jeff/0000-0003-1202-1610; Jurkiewicz, Elzbieta/0000-0003-4505-8815; Walczak, Piotr/0000-0002-3733-3322; Roszkowski, Marcin/0000-0002-8735-8296	Mobility Plus Fellowship from the Polish Ministry of Science and Education [R21NS081544, RO1 NS076573, MSCRFII0193, MSCRFII190, MSCRFE0178]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081544, R01NS076573] Funding Source: NIH RePORTER	Mobility Plus Fellowship from the Polish Ministry of Science and Education; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R21NS081544, RO1 NS076573, MSCRFII0193, MSCRFII190, MSCRFE0178, MJ was supported by a Mobility Plus Fellowship from the Polish Ministry of Science and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwal S, 2009, PEDIATR NEUROL, V40, P227, DOI 10.1016/j.pediatrneurol.2008.09.025; Bates D, 2005, NEUROPSYCHOL REHABIL, V15, P175, DOI 10.1080/09602010443000399; Battistella V, 2011, REGEN MED, V6, P45, DOI 10.2217/RME.10.97; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Buzanska L, 2006, STEM CELLS DEV, V15, P391, DOI 10.1089/scd.2006.15.391; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Deda H, 2009, CYTOTHERAPY, V11, P18, DOI 10.1080/14653240802549470; Farin A, 2009, NEUROSURGERY, V64, P15, DOI 10.1227/01.NEU.0000337580.02706.DC; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Gorelik M, 2012, CELL TRANSP IN PRESS; Habich A, 2006, EXP HEMATOL, V34, P914, DOI 10.1016/j.exphem.2006.03.010; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Huang HY, 2008, CLIN TRANSPLANT, V22, P710, DOI 10.1111/j.1399-0012.2008.00865.x; Huang Hongyun, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P14; Janowski M, 2008, NEUROSCI LETT, V430, P169, DOI 10.1016/j.neulet.2007.10.050; Janowski M, 2010, STEM CELLS DEV, V19, P5, DOI 10.1089/scd.2009.0271; Janowski M, 2009, REV NEUROSCIENCE, V20, P39; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Lin TCY, 2008, CHINESE J PHYSIOL, V51, P197; LINDVALL O, 1988, LANCET, V2, P1483; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442; Richards JMJ, 2012, CIRC-CARDIOVASC IMAG, V5, P509, DOI 10.1161/CIRCIMAGING.112.972596; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Tupitsyn NN, 2006, J BIOL REG HOMEOS AG, V20, P36; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	36	49	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97631	10.1371/journal.pone.0097631	http://dx.doi.org/10.1371/journal.pone.0097631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919061	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000009
J	Kreifelts, B; Bruck, C; Ritter, J; Ethofer, T; Domin, M; Lotze, M; Jacob, H; Schlipf, S; Wildgruber, D				Kreifelts, Benjamin; Bruck, Carolin; Ritter, Jan; Ethofer, Thomas; Domin, Martin; Lotze, Martin; Jacob, Heike; Schlipf, Sarah; Wildgruber, Dirk			They Are Laughing at Me: Cerebral Mediation of Cognitive Biases in Social Anxiety	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; ATTENTIONAL CONTROL; BEHAVIORAL THERAPY; PREFRONTAL CORTEX; ANGRY FACES; PHOBIA; DISORDER; INDIVIDUALS; ACTIVATION; SEVERITY	The fear of embarrassment and humiliation is the central element of social anxiety. This frequent condition is associated with cognitive biases indicating increased sensitivity to signals of social threat, which are assumed to play a causal role in the maintenance of social anxiety. Here, we employed laughter, a potent medium for the expression of acceptance and rejection, as an experimental stimulus in participants selected for varying degrees of social anxiety to identify cerebral mediators of cognitive biases in social anxiety using functional magnetic resonance imaging in combination with mediation analysis. We directly demonstrated that cerebral activation patterns within the dorsal attention network including the left dorsolateral and dorsomedial prefrontal cortex mediate the influence of social anxiety on laughter perception. This mediation proved to be specific for social anxiety after correction for measures of general state and trait anxiety and occurred most prominently under bimodal audiovisual laughter presentation when compared with monomodal auditory or visual laughter cues. Considering the possibility to modulate cognitive biases and cerebral activity by neuropsychological trainings, non-invasive electrophysiological stimulation and psychotherapy, this study represents a starting point for a whole line of translational research projects and identifies promising targets for electrophysiological interventions aiming to alleviate cognitive biases and symptom severity in social anxiety.	[Kreifelts, Benjamin; Bruck, Carolin; Ritter, Jan; Ethofer, Thomas; Jacob, Heike; Schlipf, Sarah; Wildgruber, Dirk] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Domin, Martin; Lotze, Martin] Ernst Moritz Arndt Univ Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ernst Moritz Arndt Universitat Greifswald	Schlipf, S (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	sarahschlipf@gmx.de	Lotze, Martin/D-2964-2012	Lotze, Martin/0000-0003-4519-4956; Kreifelts, Benjamin/0000-0002-9233-3800	Fortune-Program of the University of Tubingen [1997-0-0, 2140-0-0]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tubingen University	Fortune-Program of the University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University	This work was supported by grants of the Fortune-Program of the University of Tubingen (fortune 1997-0-0, and fortune 2140-0-0), by the Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2005, BIOL PSYCHIAT, V57, P975, DOI 10.1016/j.biopsych.2005.01.044; Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445; Browning M, 2010, BIOL PSYCHIAT, V67, P919, DOI 10.1016/j.biopsych.2009.10.031; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dresler T, 2012, J PSYCHIATR RES, V46, P1627, DOI 10.1016/j.jpsychires.2012.09.004; Edwards K., 2010, PSYCHOL TEST ASSESSM, P52; Eibl-Eibesfeldt I., 1970, ETHOLOGY BIOL BEHAV; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fani N, 2012, BIOL PSYCHOL, V90, P134, DOI 10.1016/j.biopsycho.2012.03.001; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; Goldin PR, 2012, J CONSULT CLIN PSYCH, V80, P1034, DOI 10.1037/a0028555; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hofmann SG, 2012, COGNITION EMOTION, V26, P282, DOI 10.1080/02699931.2011.579414; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Laux L., 1981, STATE TRAIT ANGSTINV; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Lipshitz JD, 2000, PHARMACOECONOMICS, V18, P23, DOI 10.2165/00019053-200018010-00003; Machado-de-Sousa JP, 2010, J NEUROSCI METH, V193, P1, DOI 10.1016/j.jneumeth.2010.08.013; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Moritz Steffen, 2007, Cogn Neuropsychiatry, V12, P381, DOI 10.1080/13546800601119982; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Provine RR, 2013, TRENDS COGN SCI, V17, P9, DOI 10.1016/j.tics.2012.11.001; Quadflieg S, 2008, BIOL PSYCHOL, V78, P129, DOI 10.1016/j.biopsycho.2008.01.014; Quadflieg S, 2007, BEHAV RES THER, V45, P3096, DOI 10.1016/j.brat.2007.08.003; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Ross MD, 2009, CURR BIOL, V19, P1106, DOI 10.1016/j.cub.2009.05.028; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stein DJ, 2010, DEPRESS ANXIETY, V27, P390, DOI 10.1002/da.20639; Stein MB, 2000, ARCH GEN PSYCHIAT, V57, P1046, DOI 10.1001/archpsyc.57.11.1046; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Szameitat DP, 2010, NEUROIMAGE, V53, P1264, DOI 10.1016/j.neuroimage.2010.06.028; Szameitat DP, 2009, EMOTION, V9, P397, DOI 10.1037/a0015692; Taylor CT, 2010, J ANXIETY DISORD, V24, P403, DOI 10.1016/j.janxdis.2010.02.004; Telzer EH, 2008, BIOL PSYCHOL, V79, P216, DOI 10.1016/j.biopsycho.2008.05.004; Tobon JI, 2011, J COGN PSYCHOTHER, V25, P114, DOI 10.1891/0889-8391.25.2.114; Vriends N, 2007, J ANXIETY DISORD, V21, P59, DOI 10.1016/j.janxdis.2006.05.002; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Weaver B, 2013, BEHAV RES METHODS, V45, P880, DOI 10.3758/s13428-012-0289-7; Weinstein S, 2007, NEUROIMAGE, V36, P188, DOI 10.1016/j.neuroimage.2007.02.030; Wildgruber D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063441; WITTCHEN HU, 1997, STRUKTURIERTES KLIN, V4; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010	61	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99815	10.1371/journal.pone.0099815	http://dx.doi.org/10.1371/journal.pone.0099815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918625	Green Published, gold			2022-12-27	WOS:000338631000114
J	Singh, P; Indi, SS; Savithri, HS				Singh, Pratibha; Indi, Shantinath S.; Savithri, Handanahal S.			Groundnut Bud Necrosis Virus Encoded NSm Associates with Membranes via Its C-Terminal Domain	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; CELL-TO-CELL; COMPLETE NUCLEOTIDE-SEQUENCE; RNA SILENCING SUPPRESSOR; MOVEMENT PROTEIN NSM; ALFALFA MOSAIC-VIRUS; ENDOPLASMIC-RETICULUM; COILED-COIL; NUCLEOCAPSID PROTEIN; GENOME ORGANIZATION	Groundnut Bud Necrosis Virus (GBNV) is a tripartite ambisense RNA plant virus that belongs to serogroup IV of Tospovirus genus. Non-Structural protein-m (NSm), which functions as movement protein in tospoviruses, is encoded by the M RNA. In this communication, we demonstrate that despite the absence of any putative transmembrane domain, GBNV NSm associates with membranes when expressed in E. coli as well as in N. benthamiana. Incubation of refolded NSm with liposomes ranging in size from 200-250 nm resulted in changes in the secondary and tertiary structure of NSm. A similar behaviour was observed in the presence of anionic and zwitterionic detergents. Furthermore, the morphology of the liposomes was found to be modified in the presence of NSm. Deletion of coiled coil domain resulted in the inability of in planta expressed NSm to interact with membranes. Further, when the C-terminal coiled coil domain alone was expressed, it was found to be associated with membrane. These results demonstrate that NSm associates with membranes via the C-terminal coiled coil domain and such an association may be important for movement of viral RNA from cell to cell.	[Singh, Pratibha; Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Indi, Shantinath S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Savithri, HS (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in		Singh, Pratibha/0000-0003-2190-6576	Indian Institute of Science; JC Bose Fellowship from the Department of Science and Technology; Department of Biotechnology, Government of India	Indian Institute of Science(Indian Institute of Science (IISC) - Bangalore); JC Bose Fellowship from the Department of Science and Technology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The funding agencies are Indian Institute of Science, JC Bose Fellowship from the Department of Science and Technology and funding from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/j.1364-3703.2000.00022.x; Akram M, 2004, ANN APPL BIOL, V145, P285, DOI 10.1111/j.1744-7348.2004.tb00385.x; Andika IB, 2013, VIROLOGY, V435, P493, DOI 10.1016/j.virol.2012.10.024; Bhat AI, 2002, CURR SCI INDIA, V82, P1389; Bhat AS, 2011, ARCH VIROL, V156, P2163, DOI 10.1007/s00705-011-1110-0; Brill LM, 2000, P NATL ACAD SCI USA, V97, P7112, DOI 10.1073/pnas.130187897; Brill LM, 2004, J VIROL, V78, P3372, DOI 10.1128/JVI.78.5.3372-3377.2004; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chowdhury SR, 2011, FEBS J, V278, P257, DOI 10.1111/j.1742-4658.2010.07943.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Goswami S, 2012, VIRUS RES, V163, P368, DOI 10.1016/j.virusres.2011.08.016; Govind K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031190; Haupt S, 2005, PLANT CELL, V17, P164, DOI 10.1105/tpc.104.027821; Heinlein M, 1998, PLANT CELL, V10, P1107, DOI 10.1105/tpc.10.7.1107; Huang M, 1999, MOL PLANT MICROBE IN, V12, P680, DOI 10.1094/MPMI.1999.12.8.680; JANCSO A, 1991, J BIOL CHEM, V266, P5891; Ju HJ, 2005, PLANT PHYSIOL, V138, P1877, DOI 10.1104/pp.105.066019; Kaido M, 2009, VIROLOGY, V395, P232, DOI 10.1016/j.virol.2009.09.022; KINSKY SC, 1969, BIOCHEMISTRY-US, V8, P4149, DOI 10.1021/bi00838a036; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; Lewandowski DJ, 2005, VIROLOGY, V342, P26, DOI 10.1016/j.virol.2005.06.050; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Main G D, 1995, Methods Mol Biol, V44, P405; Makarov VV, 2009, J GEN VIROL, V90, P3022, DOI 10.1099/vir.0.013862-0; Martinez-Gil L, 2009, J VIROL, V83, P5535, DOI 10.1128/JVI.00393-09; Nichol S. T., 2005, 8 INT COMM TAX VIR, P695; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; PARADIES HH, 1980, J PHYS CHEM-US, V84, P599, DOI 10.1021/j100443a008; Peremyslov VV, 2004, J VIROL, V78, P3704, DOI 10.1128/JVI.78.7.3704-3709.2004; Perraki A, 2012, PLANT PHYSIOL, V160, P624, DOI 10.1104/pp.112.200519; Reichel C, 1998, P NATL ACAD SCI USA, V95, P11169, DOI 10.1073/pnas.95.19.11169; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Satyanarayana T, 1996, J GEN VIROL, V77, P2347, DOI 10.1099/0022-1317-77-9-2347; Satyanarayana T, 1996, ARCH VIROL, V141, P85, DOI 10.1007/BF01718590; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Stavolone L, 2005, P NATL ACAD SCI USA, V102, P6219, DOI 10.1073/pnas.0407731102; Storms MMH, 1995, VIROLOGY, V214, P485, DOI 10.1006/viro.1995.0059; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; van der Wel NN, 1998, VIROLOGY, V244, P322, DOI 10.1006/viro.1998.9117; Verchot-Lubicz J, 2010, MOL PLANT MICROBE IN, V23, P1231, DOI 10.1094/MPMI-04-10-0086; Vilar M, 2001, J BIOL CHEM, V276, P18122, DOI 10.1074/jbc.M100706200; Whyte JRC, 2002, J CELL SCI, V115, P2627; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	55	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99370	10.1371/journal.pone.0099370	http://dx.doi.org/10.1371/journal.pone.0099370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919116	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000338631000081
J	Sevane, N; Bialade, F; Velasco, S; Rebole, A; Rodriguez, ML; Ortiz, LT; Canon, J; Dunner, S				Sevane, Natalia; Bialade, Federica; Velasco, Susana; Rebole, Almudena; Luisa Rodriguez, Maria; Ortiz, Luis T.; Canon, Javier; Dunner, Susana			Dietary Inulin Supplementation Modifies Significantly the Liver Transcriptomic Profile of Broiler Chickens	PLOS ONE			English	Article							INTESTINAL MICROFLORA; GROWTH-PERFORMANCE; OLIGOFRUCTOSE; INFLAMMATION; METABOLISM; PROBIOTICS; MORPHOLOGY; INFECTION; HEALTH; TARGET	Inclusion of prebiotics in the diet is known to be advantageous, with positive influences both on health and growth. The current study investigated the differences in the hepatic transcriptome profiles between chickens supplemented with inulin (a storage carbohydrate found in many plants) and controls. Liver is a major metabolic organ and has been previously reported to be involved in the modification of the lipid metabolism in chickens fed with inulin. A nutrigenomic approach through the analysis of liver RNA hybridized to the Affymetrix GeneChip Chicken Genome Array identified 148 differentially expressed genes among both groups: 104 up-regulated (>= 1.4-fold) and 44 down-regulated (<= 0.6-fold). Quantitative real-time PCR analysis validated the microarray expression results for five out of seven genes tested. The functional annotation analyses revealed a number of genes, processes and pathways with putative involvement in chicken growth and performance, while reinforcing the immune status of animals, and fostering the production of long chain fatty acids in broilers supplemented with 5 g of inulin kg(-1) diet. As far as we are aware, this is the first report of a microarray based gene expression study on the effect of dietary inulin supplementation, supporting further research on the use of this prebiotic on chicken diets as a useful alternative to antibiotics for improving performance and general immunity in poultry farming, along with a healthier meat lipid profile.	[Sevane, Natalia; Bialade, Federica; Velasco, Susana; Rebole, Almudena; Luisa Rodriguez, Maria; Ortiz, Luis T.; Canon, Javier; Dunner, Susana] Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Madrid, Spain	Complutense University of Madrid	Dunner, S (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Anim Prod, Madrid, Spain.	dunner@ucm.es	Sevane, Natalia/R-1920-2018; Cañón, Javier/M-5704-2018; Rebolé, Almudena/AAH-6536-2021; Ortiz, Luis/A-7247-2010; Velasco, Susana/C-7064-2012; Dunner, Susana/H-3124-2015	Sevane, Natalia/0000-0003-4766-6291; Cañón, Javier/0000-0003-1137-0958; Ortiz, Luis/0000-0002-1685-7768; Velasco, Susana/0000-0001-6835-2967; REBOLE GARRIGOS, ALMUDENA/0000-0002-9210-2084	UCM-Santander [GR35/10-A-920323]	UCM-Santander	This work has been supported by a grant to Research Group Nutrigenomica Animal from UCM-Santander GR35/10-A-920323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMANI E, 1989, Poultry Science, V68, P167; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anveden A, 2012, OBESITY, V20, P708, DOI 10.1038/oby.2011.268; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bosscher D, 2006, INT DAIRY J, V16, P1092, DOI 10.1016/j.idairyj.2005.10.028; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; Delzenne NM, 2002, BRIT J NUTR, V87, pS255, DOI 10.1079/BJN/2002545; Galton VA, 2005, THYROID, V15, P823, DOI 10.1089/thy.2005.15.823; Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633; Glibowski P, 2011, ACTA SCI POLON-TECHN, V10, P189; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hume ME, 2011, POULTRY SCI, V90, P2663, DOI 10.3382/ps.2010-01030; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Letexier D, 2003, AM J CLIN NUTR, V77, P559, DOI 10.1093/ajcn/77.3.559; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Mateo H, 2007, THESIS U GRANADA; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; NRC, 1994, NUTR REQ POULTR; Ortiz LT, 2013, AQUACULT NUTR, V19, P475, DOI 10.1111/j.1365-2095.2012.00981.x; Pelicano ERL, 2005, Rev. Bras. Cienc. Avic., V7, P221, DOI 10.1590/S1516-635X2005000400005; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rebole A, 2010, POULTRY SCI, V89, P276, DOI 10.3382/ps.2009-00336; Rehman H, 2007, POULTRY SCI, V86, P118, DOI 10.1093/ps/86.1.118; Roberfroid M B, 2001, J Pharm Belg, V56, P43; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; *SAS I INC, 2009, STAT AN SAS STAT SOF; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tacchi L, 2011, FISH SHELLFISH IMMUN, V31, P704, DOI 10.1016/j.fsi.2011.02.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco S, 2010, POULTRY SCI, V89, P1651, DOI 10.3382/ps.2010-00687; Wammes LJ, 2013, J INFECT DIS, V207, P1590, DOI 10.1093/infdis/jit058; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Yusrizal, 2003, International Journal of Poultry Science, V2, P214	42	32	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98942	10.1371/journal.pone.0098942	http://dx.doi.org/10.1371/journal.pone.0098942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915441	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000340947700045
J	Steele, LD; Muir, WM; Seong, KM; Valero, MC; Rangesa, M; Sun, WL; Clark, JM; Coates, B; Pittendrigh, BR				Steele, Laura D.; Muir, William M.; Seong, Keon Mook; Valero, M. Carmen; Rangesa, Madhumitha; Sun, Weilin; Clark, John M.; Coates, Brad; Pittendrigh, Barry R.			Genome-Wide Sequencing and an Open Reading Frame Analysis of Dichlorodiphenyltrichloroethane (DDT) Susceptible (91-C) and Resistant (91-R) Drosophila melanogaster Laboratory Populations	PLOS ONE			English	Article							CROSS-RESISTANCE; DIPTERA; STRAINS; ASSOCIATION; PERMETHRIN; SELECTION; GENE	The Drosophila melanogaster 91-R and 91-C strains are of common origin, however, 91-R has been intensely selected for dichlorodiphenyltrichloroethane (DDT) resistance over six decades while 91-C has been maintained as the non-selected control strain. These fly strains represent a unique genetic resource to understand the accumulation and fixation of mutations under laboratory conditions over decades of pesticide selection. Considerable research has been done to investigate the differential expression of genes associated with the highly DDT resistant strain 91-R, however, with the advent of whole genome sequencing we can now begin to develop an in depth understanding of the genomic changes associated with this intense decades-long xenobiotic selection pressure. Here we present the first whole genome sequencing analysis of the 91-R and 91-C fly strains to identify genome-wide structural changes within the open reading frames. Between-strain changes in allele frequencies revealed a higher percent of new alleles going to fixation for the 91-R strain, as compared to 91-C (P<0.0001). These results suggest that resistance to DDT in the 91-R laboratory strain could potentially be due primarily to new mutations, as well as being polygenic rather than the result of a few major mutations, two hypotheses that remain to be tested.	[Steele, Laura D.; Seong, Keon Mook; Valero, M. Carmen; Rangesa, Madhumitha; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Clark, John M.] Univ Massachusetts, Amherst, MA 01003 USA; [Coates, Brad] Iowa State Univ, USDA, Agr Res Serv, Corn Insects & Crop Genet Res Unit, Ames, IA USA	University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Massachusetts System; University of Massachusetts Amherst; Iowa State University; United States Department of Agriculture (USDA)	Steele, LD (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	steele11@illinois.edu		Coates, Brad/0000-0001-8908-1529; Rangesa, Madhumitha/0000-0002-5825-2775	United States Department of Agriculture, Agricultural Research Service (USDA-ARS) [3625-22000-017-00]; Iowa State University Agriculture and Home Economics Experiment Station, Ames, IA [3543]	United States Department of Agriculture, Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)); Iowa State University Agriculture and Home Economics Experiment Station, Ames, IA	This work was primarily funded by the C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment. Additional funding support came from the United States Department of Agriculture, Agricultural Research Service (USDA-ARS; Appropriated CRIS Project 3625-22000-017-00) and the Iowa State University Agriculture and Home Economics Experiment Station, Ames, IA (Project 3543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Barnola F V, 1971, Int J Neurosci, V1, P309, DOI 10.3109/00207457109147430; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Busvine J R, 1957, Bull World Health Organ, V16, P206; Carson Rachel, 1994, SILENT SPRING; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Conis E, 2010, PUBLIC HEALTH REP, V125, P337, DOI 10.1177/003335491012500224; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; DAPKUS D, 1992, J ECON ENTOMOL, V85, P340, DOI 10.1093/jee/85.2.340; DAPKUS D, 1977, GENETICS, V87, P685; Deus KM, 2012, J MED ENTOMOL, V49, P356, DOI 10.1603/ME11164; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; Greenberg D S, 1963, Science, V140, P878, DOI 10.1126/science.140.3569.878; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Krupke CH, 2007, AM ENTOMOLOGIST; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; MERRELL DAVID J., 1965, AMER NATUR, V99, P411, DOI 10.1086/282383; MERRELL DJ, 1956, J ECON ENTOMOL, V49, P300, DOI 10.1093/jee/49.3.300; MERRELL DJ, 1959, GENETICS, V44, P527; Pedra JHF, 2005, PROTEOMICS, V5, P258, DOI 10.1002/pmic.200400914; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; PRASITTISUK C, 1977, PESTIC SCI, V8, P527, DOI 10.1002/ps.2780080516; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; SCOTT JG, 1981, PESTIC BIOCHEM PHYS, V16, P21, DOI 10.1016/0048-3575(81)90068-7; SHEPANSKI MC, 1977, J ECON ENTOMOL, V70, P539, DOI 10.1093/jee/70.5.539; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]	36	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98584	10.1371/journal.pone.0098584	http://dx.doi.org/10.1371/journal.pone.0098584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915415	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700026
J	Wang, X; Wang, HL; Li, HY; Li, T; Yu, X				Wang, Xiao; Wang, Huali; Li, Huiying; Li, Tao; Yu, Xin			Frequency of the Apolipoprotein E epsilon 4 Allele in a Memory Clinic Cohort in Beijing: A Naturalistic Descriptive Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SPORADIC ALZHEIMERS-DISEASE; APOE GENOTYPE; DIAGNOSTIC-CRITERIA; VASCULAR DEMENTIA; TYPE-4 ALLELE; DECLINE; ASSOCIATION; ONSET; RISK	Objectives: To describe the distribution of apolipoprotein E (APOE) genotypes among an elderly Chinese patient population with memory complaints treated in a memory clinic in Beijing and to compare the epsilon 4 allele frequency among individuals with subjective cognitive impairment (SCI), mild cognitive impairment (MCI) and Alzheimer's disease (AD). Methods: A total of 385 subjects with memory complaints participated in the study, including 216 patients with AD, 56 with MCI, 17 with SCI, and 96 with other types of cognitive impairment. A total of 75 healthy elderly control subjects were also recruited. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used to investigate the APOE genotypes. Results: The frequency of the epsilon 4 allele was 19.6 percent for the entire sample of patients who had memory complaints. The APOE allele distribution differed between women and men (22.6% and 14.9%, respectively; p<0.05) in the individuals with memory complaints. Compared with the control group (7.3%), the prevalence of the APOE epsilon 4 allele was significantly higher in the AD (23.6%) and MCI (21.4%) groups and was slightly increased in the SCI (14.7%) group. Conclusions: In the memory clinic, we observed a higher prevalence of the APOE epsilon 4 allele among Chinese AD and MCI patients. A similar trend was observed in patients with SCI. These findings suggest that nondemented APOE epsilon 4 allele carriers with memory complaints may have a greater genetic risk for AD and should be monitored more closely.	[Wang, Xiao; Wang, Huali; Li, Huiying; Li, Tao; Yu, Xin] Peking Univ, Inst Mental Hlth, Dementia Care & Res Ctr, Hosp 6, Beijing 100871, Peoples R China; [Wang, Xiao; Wang, Huali; Li, Huiying; Li, Tao; Yu, Xin] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Li, Huiying] Chaoyang Dist Third Hosp, Beijing, Peoples R China	Peking University; Peking University	Wang, HL (corresponding author), Peking Univ, Inst Mental Hlth, Dementia Care & Res Ctr, Hosp 6, Beijing 100871, Peoples R China.	huali_wang@hsc.pku.edu.cn	Wang, Huali/S-9848-2018		Natural Science Foundation of China [30971044, 81171018]; National Key RD 863 Project [2007AA02Z421]; Fogarty International Center [R21AG028180-01A2]; Alzheimer's Association [NIRG-04-1184]; National Institute on Aging; NATIONAL INSTITUTE ON AGING [R21AG028180] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD 863 Project(National High Technology Research and Development Program of China); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Natural Science Foundation of China (30971044, HW; 81171018, HW) and National Key R&D 863 Project (2007AA02Z421, HW). The infrastructure of Dementia Care and Research Center was in part supported by National Institute on Aging and the Fogarty International Center (R21AG028180-01A2) and Alzheimer's Association (NIRG-04-1184, HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom ES, 2009, DEMENT GERIATR COGN, V27, P458, DOI 10.1159/000216841; Borenstein AR, 2010, AM J ALZHEIMERS DIS, V25, P233, DOI 10.1177/1533317509357736; Bretsky PM, 1999, ALZ DIS ASSOC DIS, V13, P216, DOI 10.1097/00002093-199910000-00007; Corder EH, 2004, ANN NY ACAD SCI, V1019, P24, DOI 10.1196/annals.1297.005; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craft S, 1998, NEUROLOGY, V51, P149, DOI 10.1212/WNL.51.1.149; Dik MG, 2000, NEUROLOGY, V54, P1492, DOI 10.1212/WNL.54.7.1492; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FESKENS EJM, 1994, BRIT MED J, V309, P1202, DOI 10.1136/bmj.309.6963.1202; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hejl A, 2002, J NEUROL NEUROSUR PS, V73, P390, DOI 10.1136/jnnp.73.4.390; Herukka SK, 2007, NEUROBIOL AGING, V28, P507, DOI 10.1016/j.neurobiolaging.2006.02.001; HIXSON JE, 1990, J LIPID RES, V31, P545; Hsiung GYR, 2004, CAN MED ASSOC J, V171, P863, DOI 10.1503/cmaj.1031789; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Katzman R, 1997, NEUROLOGY, V49, P779, DOI 10.1212/WNL.49.3.779; Lehtovirta M, 1996, NEUROLOGY, V46, P413, DOI 10.1212/WNL.46.2.413; Li G., 1989, CHIN MENTAL HLTH J, V4, P148; Li X, 2003, J CAPITAL U MED SCI, V3, P268; Liao J, 2010, ALZ DIS ASSOC DIS, V24, P317, DOI 10.1097/WAD.0b013e3181df1c7b; Marra C, 2004, DEMENT GERIATR COGN, V18, P125, DOI 10.1159/000079191; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murphy GM, 1997, AM J PSYCHIAT, V154, P603; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Payami H, 1996, AM J HUM GENET, V58, P803; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ramakers IHGB, 2008, DEMENT GERIATR COGN, V26, P101, DOI 10.1159/000144072; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sasaki M, 2009, INT J GERIATR PSYCH, V24, P1119, DOI 10.1002/gps.2234; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Small GW, 1999, AM J PSYCHIAT, V156, P1035; Smith GE, 1998, NEUROLOGY, V50, P355, DOI 10.1212/WNL.50.2.355; Stewart R, 2012, CURR OPIN PSYCHIATR, V25, P445, DOI 10.1097/YCO.0b013e3283586fd8; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van der Flier WM, 2008, DEMENT GERIATR COGN, V25, P433, DOI 10.1159/000124750; van der Flier WM, 2006, NEUROLOGY, V67, P526, DOI 10.1212/01.wnl.0000228222.17111.2a; van der Vlies AE, 2007, DEMENT GERIATR COGN, V24, P98, DOI 10.1159/000104467; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Wang QS, 2002, BRAIN RES, V951, P77, DOI 10.1016/S0006-8993(02)03137-2; Wilson RS, 2002, J NEUROL NEUROSUR PS, V73, P672, DOI 10.1136/jnnp.73.6.672; World Health Organization, 1999, INT CLASS DIS 10 REV; Xu SL, 1984, CLIN MEMORY SCALE; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447; Zhao X, 2003, CHINESE J CLIN REHAB, V31, P4262	53	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99130	10.1371/journal.pone.0099130	http://dx.doi.org/10.1371/journal.pone.0099130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914687	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700066
J	Yea, SS; So, L; Mallya, S; Lee, J; Rajasekaran, K; Malarkannan, S; Fruman, DA				Yea, Sung Su; So, Lomon; Mallya, Sharmila; Lee, Jongdae; Rajasekaran, Kamalakannan; Malarkannan, Subramaniam; Fruman, David A.			Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; TERMINAL MATURATION; ADAPTIVE IMMUNITY; SOLID TUMORS; NK CELLS; PI3K; CANCER; KINASE; P110-DELTA; GAMMA	Phosphoinositide 3-kinases (PI3Ks) are promising targets for therapeutic development in cancer. The class I PI3K isoform p110 alpha has received considerable attention in oncology because the gene encoding p110 alpha (PIK3CA) is frequently mutated in human cancer. However, little is known about the function of p110 alpha in lymphocyte populations that modulate tumorigenesis. We used recently developed investigational inhibitors to compare the function of p110 alpha and other isoforms in natural killer (NK) cells, a key cell type for immunosurveillance and tumor immunotherapy. Inhibitors of all class I isoforms (pan-PI3K) significantly impaired NK cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity against tumor cells, whereas p110 alpha-selective inhibitors had no effect. In NK cells stimulated through NKG2D, p110 alpha inhibition modestly reduced PI3K signaling output as measured by AKT phosphorylation. Production of IFN-gamma and NK cell-derived chemokines was blocked by a pan-PI3K inhibitor and partially reduced by a p110 delta inhibitor, with lesser effects of p110 alpha inhibitors. Oral administration of mice with MLN1117, a p110 alpha inhibitor in oncology clinical trials, had negligible effects on NK subset maturation or terminal subset commitment. Collectively, these results support the targeting of PIK3CA mutant tumors with selective p110 alpha inhibitors to preserve NK cell function.	[Yea, Sung Su; So, Lomon; Mallya, Sharmila; Lee, Jongdae; Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Yea, Sung Su; So, Lomon; Mallya, Sharmila; Lee, Jongdae; Fruman, David A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92717 USA; [Yea, Sung Su] Inje Univ, Coll Med, Dept Biochem, Pusan, South Korea; [Rajasekaran, Kamalakannan; Malarkannan, Subramaniam] Blood Res Inst, Lab Mol Immunol & Immunotherapy, Milwaukee, WI USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Inje University; Versiti Blood Center of Wisconsin	Yea, SS (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	ssyea@inje.ac.kr; dfruman@uci.edu	Malarkannan, Subramaniam/AAQ-3934-2020; Malarkannan, Subra/AAQ-9617-2020; RAJASEKARAN, KAMALAKANNAN/F-7350-2015	Malarkannan, Subramaniam/0000-0002-7511-2731; RAJASEKARAN, KAMALAKANNAN/0000-0001-5634-9007; Lee, Jongdae/0000-0002-6270-4658	Intellikine, Inc.; National Research Foundation of Korea (NRF) - Korea government (MSIP) [R13-2007-023-00000-0]; National Institutes of Health [R21-AI099656]; Immunology Research Training Program [T32 AI 60573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099656, R01AI102893, T32AI060573] Funding Source: NIH RePORTER	Intellikine, Inc.; National Research Foundation of Korea (NRF) - Korea government (MSIP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunology Research Training Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Sponsored Research Agreement with Intellikine, Inc., the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NO. R13-2007-023-00000-0) (to SSY), and by National Institutes of Health research grant R21-AI099656 (to DAF) and Immunology Research Training Program grant T32 AI 60573 (to LS). Intellikine, Inc. was involved in study design, data collection and analysis. Intellikine was acquired by Millennium Pharmaceuticals, and this company approved of the decision to publish and the final manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Millennium would be prepared to supply MLN1117 or MLN1316 subject to the normal process of MTA approval & compound availability.	Aoukaty A, 2002, J BIOL CHEM, V277, P13331, DOI 10.1074/jbc.M112029200; Awasthi A, 2008, GENES IMMUN, V9, P522, DOI 10.1038/gene.2008.45; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fruman DA, 2011, CANCER DISCOV, V1, P562, DOI 10.1158/2159-8290.CD-11-0249; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Guo HL, 2008, J EXP MED, V205, P2419, DOI 10.1084/jem.20072327; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Jessen K, 2011, MOL CANC THER, V10; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; KANAKARAJ P, 1994, J EXP MED, V179, P551, DOI 10.1084/jem.179.2.551; Kim JM, 2013, J EXP MED, V210, P1647, DOI 10.1084/jem.20131625; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Puri KD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00256; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Rewcastle GW, 2011, J MED CHEM, V54, P7105, DOI 10.1021/jm200688y; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Saudemont A, 2009, P NATL ACAD SCI USA, V106, P5795, DOI 10.1073/pnas.0808594106; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; So LM, 2013, J BIOL CHEM, V288, P5718, DOI 10.1074/jbc.M112.379446; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Tassi I, 2007, IMMUNITY, V27, P214, DOI 10.1016/j.immuni.2007.07.014; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Zebedin E, 2008, BLOOD, V112, P4655, DOI 10.1182/blood-2008-02-139105; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99486	10.1371/journal.pone.0099486	http://dx.doi.org/10.1371/journal.pone.0099486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915189	Green Published, gold			2022-12-27	WOS:000340947700106
J	Ding, D; Gebel, K; Phongsavan, P; Bauman, AE; Merom, D				Ding, Ding; Gebel, Klaus; Phongsavan, Philayrath; Bauman, Adrian E.; Merom, Dafna			Driving: A Road to Unhealthy Lifestyles and Poor Health Outcomes	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; TOKYO MEGALOPOLIS; COMMUTING TIME; TRADE-OFFS; COMMUNITY; DURATION; OBESITY; WORKERS; WEIGHT; PEOPLE	Background: Driving is a common part of modern society, but its potential effects on health are not well understood. Purpose: The present cross-sectional study (n = 37,570) examined the associations of driving time with a series of health behaviors and outcomes in a large population sample of middle-aged and older adults using data from the Social, Economic, and Environmental Factor Study conducted in New South Wales, Australia, in 2010. Methods: Multiple logistic regression was used in 2013 to examine the associations of usual daily driving time with healthrelated behaviors (smoking, alcohol use, diet, physical activity, sedentary behavior, sleep) and outcomes (obesity, general health, quality of life, psychological distress, time stress, social functioning), adjusted for socio-demographic characteristics. Results: Findings suggested that longer driving time was associated with higher odds for smoking, insufficient physical activity, short sleep, obesity, and worse physical and mental health. The associations consistently showed a dose-response pattern and more than 120 minutes of driving per day had the strongest and most consistent associations with the majority of outcomes. Conclusion: This study highlights driving as a potential lifestyle risk factor for public health. More population-level multidisciplinary research is needed to understand the mechanism of how driving affects health.	[Ding, Ding; Gebel, Klaus; Phongsavan, Philayrath; Bauman, Adrian E.] Univ Sydney, Prevent Res Collaborat, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Gebel, Klaus] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia; [Merom, Dafna] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	University of Sydney; James Cook University; Western Sydney University	Ding, D (corresponding author), Univ Sydney, Prevent Res Collaborat, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	melody.ding@sydney.edu.au	Merom, Dafna/AAW-5357-2021; Gebel, Klaus/J-5280-2014; Ding, Ding/AAF-9985-2021; Gebel, Klaus/W-5681-2019	Merom, Dafna/0000-0001-6459-8628; Gebel, Klaus/0000-0003-0330-7756; Ding, Ding/0000-0001-9850-9224; Gebel, Klaus/0000-0003-0330-7756; Phongsavan, Philayrath/0000-0003-2460-5031	Australian National Health and Medical Research Council Program [569940]	Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia)	The study is funded by the Australian National Health and Medical Research Council Program Grant (# 569940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; [Anonymous], 1992, EMPLOYEE COUNSELING, DOI DOI 10.1108/13665629210013465; Australian Bureau of Statistics, 2012, STRESS TIM; Australian Bureau of Statistics, 2013, SURV MOT VEH US AUST; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bauman AE, 2013, CURR CARDIOVASC RISK, V7, P293, DOI 10.1007/s12170-013-0316-y; Bouchard C., 2012, PHYS ACTIVITY HLTH; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Christian TJ, 2012, J URBAN HEALTH, V89, P746, DOI 10.1007/s11524-012-9678-6; Christian TJ, 2012, PREV MED, V55, P215, DOI 10.1016/j.ypmed.2012.06.015; Coeugnet S, 2013, TRANSPORT RES F-TRAF, V20, P39, DOI 10.1016/j.trf.2013.05.002; COSTA G, 1988, INT ARCH OCC ENV HEA, V60, P371, DOI 10.1007/BF00405673; Dora C, 2000, WORLD HLTH ORG REGIO, V89, P4; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jacobson SH, 2011, TRANSPORT POLICY, V18, P772, DOI 10.1016/j.tranpol.2011.03.008; Jarvis MJ, 2004, BRIT MED J, V328, P277, DOI 10.1136/bmj.328.7434.277; Kageyama T, 1998, IND HEALTH, V36, P209, DOI 10.2486/indhealth.36.209; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kawada Tomoyuki, 2013, Am J Prev Med, V45, pe1, DOI 10.1016/j.amepre.2013.03.009; Lyons G, 2008, TRANSPORT REV, V28, P181, DOI 10.1080/01441640701559484; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Novaco RW., 2009, TECHNOLOGY PSYCHOL W, P174, DOI DOI 10.1017/CBO9780511635373.008; Rasmussen C, 2000, PERCEPT MOTOR SKILL, V90, P437, DOI 10.2466/PMS.90.2.437-443; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Sugiyama T, 2013, AM J PREV MED, V44, P169, DOI 10.1016/j.amepre.2012.09.063; Trick L. M., 2004, THEOR ISS ERGON SCI, V5, P385, DOI [10.1080/14639220412331298938, DOI 10.1080/14639220412331298938]; Umezaki M, 1999, J BIOSOC SCI, V31, P71, DOI 10.1017/S0021932099000711; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e	32	70	71	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e94602	10.1371/journal.pone.0094602	http://dx.doi.org/10.1371/journal.pone.0094602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911017	gold, Green Published, Green Accepted			2022-12-27	WOS:000337165600121
J	Liu, QQ; Li, WZ; Feng, YL; Tao, CM				Liu, Qianqian; Li, Wenzhang; Feng, Yulin; Tao, Chuanmin			Efficacy and Safety of Polymyxins for the Treatment of Acinectobacter baumannii Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RESISTANT ACINETOBACTER-BAUMANNII; VENTILATOR-ASSOCIATED PNEUMONIA; COLISTIN SULPHOMETHATE SODIUM; IN-VITRO ACTIVITIES; INTRAVENOUS COLISTIN; COMBINATION; TIGECYCLINE; RIFAMPICIN; EMERGENCE; THERAPY	Background: Multi-drug resistance among Acinetobacter baumannii increases the need for polymyxins. We conducted a meta-analysis aimed to assess the efficacy and safety of polymyxins for the treatment of Acinetobacter baumannii infection. Methods: We searched PUBMED, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), CNKI, Chinese Biomedical Literature Database up to November 1, 2013, to identify published studies, and we searched clinical trial registries to identify completed unpublished studies. Randomized controlled trials and cohort studies were considered for inclusion. Data were extracted on clinical response, microbiological response, mortality, length of stay and adverse events. Results: 12 controlled studies, comparing 677 patients, were included. Although clinical (odds ratio 1.421, 95% confidence interval 0.722-2.797) and microbiological (OR 1.416, 95% CI 0.369-5.425) response rates favored the polymyxins group, these differences were not significant. Treatment with polymyxins vs. controls did not affect hospital mortality (OR 0.506, 95% CI 0.101-2.536), lengths of hospital stay (standard mean difference -0.221, 95% CI 0.899-0.458) or nephrotoxicity (OR 1.192, 95% CI 0.436-3.261). The combination of polymyxins with other antibiotics achieved similar clinical response rates to its monotherapy regimen (OR 0.601, 95% CI 0.320-1.130). Conclusions: Our results suggest that polymyxins may be as safe and as efficacious as standard antibiotics for the treatment of A. baumannii infection. There is no strong evidence that combination regimen of polymyxins is superior to monotherapy regimen.	[Liu, Qianqian; Tao, Chuanmin] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China; [Li, Wenzhang] Chengdu Med Coll, Affiliated Hosp 1, Dept Cardiol, Chengdu, Sichuan Provinc, Peoples R China; [Feng, Yulin] Sichuan Univ, Dept Resp Med, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Chengdu Medical College; Sichuan University	Feng, YL (corresponding author), Sichuan Univ, Dept Resp Med, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	hx399@163.com; taochuanmin@sina.com	liu, qian/HDM-2936-2022		National Natural Science Foundation of China [30900658, 81072432, 81301400]; Science & Technology Department of Sichuan Province [2012SZ0126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Department of Sichuan Province	This meta-analysis was supported in part by National Natural Science Foundation of China (30900658 URL: http://isisn.nsfc.gov.cn/egrantindex/ funcindex/prjsearch-list), National Natural Science Foundation of China (81072432 URL: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), National Natural Science Foundation of China (81301400 URL: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), and from Science & Technology Department of Sichuan Province (2012SZ0126 URL: http://xmgl.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal-Shah M, 1998, J ANTIMICROB CHEMOTH, V41, P576, DOI 10.1093/jac/41.5.576; Aydemir H, 2013, EPIDEMIOL INFECT, V141, P1214, DOI 10.1017/S095026881200194X; BAINES RD, 1964, JAMA-J AM MED ASSOC, V190, P278; BENEDICT RG, 1947, J BACTERIOL, V54, P24; Betrosian AP, 2008, J INFECTION, V56, P432, DOI 10.1016/j.jinf.2008.04.002; Chan Jeannie D, 2010, J Intensive Care Med, V25, P343, DOI 10.1177/0885066610377975; Chu HQ, 2013, BRAZ J INFECT DIS, V17, P389, DOI 10.1016/j.bjid.2012.10.029; Durante-Mangoni E, 2013, CLIN INFECT DIS, V57, P349, DOI 10.1093/cid/cit253; El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P596, DOI 10.1007/s10096-006-0191-2; Falagas ME, 2008, EXPERT OPIN INV DRUG, V17, P973, DOI 10.1517/13543784.17.7.973 ; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Garnacho-Montero J, 2005, INTENS CARE MED, V31, P649, DOI 10.1007/s00134-005-2598-0; Garnacho-Montero J, 2003, CLIN INFECT DIS, V36, P1111, DOI 10.1086/374337; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; GO ES, 1994, LANCET, V344, P1329, DOI 10.1016/S0140-6736(94)90694-7; Gounden R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-26; Hawley JS, 2007, ANTIMICROB AGENTS CH, V51, P4529, DOI 10.1128/AAC.01115-07; Holloway KP, 2006, ANN PHARMACOTHER, V40, P1939, DOI 10.1345/aph.1H353; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jain R, 2004, ANN PHARMACOTHER, V38, P1449, DOI 10.1345/aph.1D592; Jang HJ, 2009, TUBERC RESPIR DIS, V67, P212, DOI 10.4046/trd.2009.67.3.212; Kalin G, 2013, INFECTION; Kallel H, 2007, INTENS CARE MED, V33, P1162, DOI 10.1007/s00134-007-0675-2; Kallel H, 2006, INT J ANTIMICROB AG, V28, P366, DOI 10.1016/j.ijantimicag.2006.07.008; Kang CH, 2013, PEDIAT PULMONOL; Ko WC, 2004, J ANTIMICROB CHEMOTH, V53, P393, DOI 10.1093/jac/dkh080; KOCH-WESER J, 1970, Annals of Internal Medicine, V72, P857; Lee YT, 2013, EUR J CLIN MICROBIOL, V32, P1211, DOI 10.1007/s10096-013-1870-4; Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001; Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Linden PK, 2006, CLIN INFECT DIS, V43, pS89, DOI 10.1086/504485; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nakwan N, 2011, PEDIATR PULM, V46, P60, DOI 10.1002/ppul.21324; Nordmann P, 2004, PATHOL BIOL, V52, P301, DOI 10.1016/j.patbio.2004.03.001; Paul M, 2005, J HOSP INFECT, V60, P256, DOI 10.1016/j.jhin.2005.01.007; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pintado V, 2008, J INFECTION, V56, P185, DOI 10.1016/j.jinf.2008.01.003; Pournaras S, 2005, J ANTIMICROB CHEMOTH, V55, P1055, DOI 10.1093/jac/dki115; PRICE DJE, 1970, BMJ-BRIT MED J, V4, P525, DOI 10.1136/bmj.4.5734.525; Reina R, 2005, INTENS CARE MED, V31, P1058, DOI 10.1007/s00134-005-2691-4; Ruiz J, 1999, EUR J CLIN MICROBIOL, V18, P292, DOI 10.1007/s100960050280; Sands M, 2007, EUR J CLIN MICROBIOL, V26, P521, DOI 10.1007/s10096-007-0330-4; Savage PB, 2001, ANN MED, V33, P167, DOI 10.3109/07853890109002073; Shields RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052349; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; STANSLY PG, 1947, B JOHNS HOPKINS HOSP, V81, P43; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tascini C, 1998, J ANTIMICROB CHEMOTH, V42, P270, DOI 10.1093/jac/42.2.270; Tasina E, 2011, LANCET INFECT DIS, V11, P834, DOI 10.1016/S1473-3099(11)70177-3; Timurkaynak F, 2006, INT J ANTIMICROB AG, V27, P224, DOI 10.1016/j.ijantimicag.2005.10.012; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	54	27	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98091	10.1371/journal.pone.0098091	http://dx.doi.org/10.1371/journal.pone.0098091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911658	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600127
J	Munoz, P; Lopez, C; Moralejo, M; Perez-Hedo, M; Eizaguirre, M				Munoz, Pilar; Lopez, Carmen; Moralejo, Marian; Perez-Hedo, Meritxell; Eizaguirre, Matilde			Response of Last Instar Helicoverpa armigera Larvae to Bt Toxin Ingestion: Changes in the Development and in the CYP6AE14, CYP6B2 and CYP9A12 Gene Expression	PLOS ONE			English	Article							SESAMIA-NONAGRIOIDES LEPIDOPTERA; CYTOCHROMES P450; CORN-BORER; INSECTICIDE RESISTANCE; TOBACCO HORNWORM; MAIZE; PERFORMANCE; NOCTUIDAE; INDUCTION; CYP6CM1	Bt crops are able to produce Cry proteins, which were originally present in Bacillus thuringiensis bacteria. Although Bt maize is very efficient against corn borers, Spanish crops are also attacked by the earworm H. armigera, which is less susceptible to Bt maize. Many mechanisms could be involved in this low susceptibility to the toxin, including the insect's metabolic resistance to toxins due to cytochrome P450 monooxygenases. This paper examines the response of last instar H. armigera larvae to feeding on a diet with Bt and non-Bt maize leaves in larval development and in the gene expression of three P450 cytochromes: CYP6AE14, CYP6B2 and CYP9A12. Larvae fed on sublethal amounts of the Bt toxin showed reduced food ingestion and reduced growth and weight, preventing most of them from achieving the critical weight and pupating; additionally, after feeding for one day on the Bt diet the larvae showed a slight increase in juvenile hormone II in the hemolymp. Larvae fed on the non-Bt diet showed the highest CYP6AE14, CYP6B2 and CYP9A12 expression one day after feeding on the non-Bt diet, and just two days later the expression decreased abruptly, a finding probably related to the developmental programme of the last instar. Moreover, although the response of P450 genes to plant allelochemicals and xenobiotics has been related in general to overexpression in the resistant insect, or induction of the genes when feeding takes place, the expression of the three genes studied was suppressed in the larvae feeding on the Bt toxin. The unexpected inhibitory effect of the Cry1Ab toxin in the P450 genes of H. armigera larvae should be thoroughly studied to determine whether this response is somehow related to the low susceptibility of the species to the Bt toxin.	[Munoz, Pilar; Lopez, Carmen; Eizaguirre, Matilde] Univ Lleida, Agrotecnio Ctr, Lleida, Spain; [Perez-Hedo, Meritxell] Univ Lleida, Crop Forest Sci Dept, Lleida, Spain; [Moralejo, Marian] Univ Lleida, Dept Chem, Lleida, Spain	Universitat de Lleida; Universitat de Lleida; Universitat de Lleida	Eizaguirre, M (corresponding author), Univ Lleida, Agrotecnio Ctr, Lleida, Spain.	eizaguirre@pvcf.udl.cat	Eizaguirre, Matilde/B-4109-2011; Lopez, Carmen/K-9280-2014; Muñoz, Pilar/K-9261-2014; Moralejo, Marian/L-5351-2014; Perez-Hedo, Meritxell/O-6441-2019	Eizaguirre, Matilde/0000-0001-9371-3314; Lopez, Carmen/0000-0001-5447-009X; Muñoz, Pilar/0000-0001-9700-374X; Moralejo, Marian/0000-0003-4667-6770; Perez-Hedo, Meritxell/0000-0003-3411-0761	Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia) [AGL2011-23996]	Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia)	This work was supported by a grant from the Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia) through project AGL2011-23996. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, COMPREHENSIVE INSECT; Baek JH, 2010, PESTIC BIOCHEM PHYS, V96, P43, DOI 10.1016/j.pestbp.2009.08.014; Barry BD, 2000, J ECON ENTOMOL, V93, P993, DOI 10.1603/0022-0493-93.3.993; Bautista MAM, 2007, PESTIC BIOCHEM PHYS, V87, P85, DOI 10.1016/j.pestbp.2006.06.004; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; BERNARD L, 1993, PESTIC BIOCHEM PHYS, V46, P171, DOI 10.1006/pest.1993.1048; Brun-Barale A, 2010, PEST MANAG SCI, V66, P900, DOI 10.1002/ps.1960; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; DAUTERMAN WC, 1985, COMPREHENSIVE INSECT, V12, P713; EIZAGUIRRE M, 1992, ENTOMOL GEN, V17, P277; Fan YL, 1999, INSECT BIOCHEM MOLEC, V29, P635, DOI 10.1016/S0965-1748(99)00041-7; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gonzalez-Cabrera J, 2013, INSECT BIOCHEM MOLEC, V43, P635, DOI 10.1016/j.ibmb.2013.04.001; Hodgson E, 1985, COMPREHENSIVE INSECT, P225; Jones CM, 2011, PESTIC BIOCHEM PHYS, V101, P53, DOI 10.1016/j.pestbp.2011.07.004; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; *MAN, 1997, STATGR PLUS VERS 3 0; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Martinez SS, 1999, B ENTOMOL RES, V89, P65, DOI 10.1017/S0007485399000085; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Perez-Hedo M, 2012, B ENTOMOL RES, V102, P737, DOI 10.1017/S0007485312000351; Perez-Hedo M, 2011, IOBC WPRS B, V73, P75; Perez-Hedo M, 2013, ENTOMOL EXP APPL, V148, P56, DOI 10.1111/eea.12074; Perez-Hedo M, 2011, J ECON ENTOMOL, V104, P853, DOI 10.1603/EC10449; Rupasinghe SG, 2007, PROTEIN ENG DES SEL, V20, P615, DOI 10.1093/protein/gzm063; SAS Institute Inc, 2008, JMP 8 0; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Slansky F. Jr, 1985, P87; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vilaro F, 2012, J AGR FOOD CHEM, V60, P3020, DOI 10.1021/jf204621h; Yu YS, 2007, J ECON ENTOMOL, V100, P1188, DOI 10.1603/0022-0493(2007)100[1188:CILOJH]2.0.CO;2; Zhang H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.002287420:615-624., DOI 10.1371/J0URNAL.P0NE.002287420615-624]; Zhang XT, 2013, EUR J ENTOMOL, V110, P39, DOI 10.14411/eje.2013.005; Zhao GD, 2011, PESTIC BIOCHEM PHYS, V100, P251, DOI 10.1016/j.pestbp.2011.04.009; Zhou XJ, 2010, PESTIC BIOCHEM PHYS, V97, P209, DOI 10.1016/j.pestbp.2010.02.003	41	15	15	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99229	10.1371/journal.pone.0099229	http://dx.doi.org/10.1371/journal.pone.0099229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910993	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600059
J	Oliveira, LS; de Queiroz, NMGP; Veloso, LVS; Moreira, TG; Oliveira, FS; Carneiro, MBH; Faria, AM; Vieira, LQ; Oliveira, SC; Horta, MF				Oliveira, Luciana S.; de Queiroz, Nina M. G. P.; Veloso, Laura V. S.; Moreira, Thais G.; Oliveira, Fernanda S.; Carneiro, Matheus B. H.; Faria, Ana M.; Vieira, Leda Q.; Oliveira, Sergio C.; Horta, Maria F.			A Defective TLR4 Signaling for IFN-beta Expression Is Responsible for the Innately Lower Ability of BALB/c Macrophages to Produce NO in Response to LPS as Compared to C57BL/6	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DENDRITIC CELL MATURATION; CYTOKINE PRODUCTION; INTERFERON-GAMMA; LEISHMANIA-BRAZILIENSIS; MOUSE MACROPHAGES; RESISTANCE; INDUCTION; ACTIVATION; MODULATION	C57BL/6 mice macrophages innately produce higher levels of NO than BALB/c cells when stimulated with LPS. Here, we investigated the molecular events that account for this intrinsic differential production of NO. We found that the lower production of NO in BALB/c is not due to a subtraction of L-arginine by arginase, and correlates with a lower iNOS accumulation, which is independent of its degradation rate. Instead, the lower accumulation of iNOS is due to the lower levels of iNOS mRNA, previously shown to be also independent of its stability, suggesting that iNOS transcription is less efficient in BALB/c than in C57BL/6 macrophages. Activation of NFkB is more efficient in BALB/c, thus not correlating with iNOS expression. Conversely, activation of STAT-1 does correlate with iNOS expression, being more prominent in C57BL/6 than in BALB/c macrophages. IFN-beta and IL-10 are more highly expressed in C57BL/6 than in BALB/c macrophages, and the opposite is true for TNF-alpha. Whereas IL-10 and TNF-alpha do not seem to participate in their differential production of NO, IFN-beta has a determinant role since 1) anti-IFN-beta neutralizing antibodies abolish STAT-1 activation reducing NO production in C57BL/6 macrophages to levels as low as in BALB/c cells and 2) exogenous rIFN-beta confers to LPS-stimulated BALB/c macrophages the ability to phosphorylate STAT-1 and to produce NO as efficiently as C57BL/6 cells. We demonstrate, for the first time, that BALB/c macrophages are innately lower NO producers than C57BL/6 cells because they are defective in the TLR-4-induced IFN-beta-mediated STAT-1 activation pathway.	[Oliveira, Luciana S.; de Queiroz, Nina M. G. P.; Veloso, Laura V. S.; Oliveira, Fernanda S.; Carneiro, Matheus B. H.; Faria, Ana M.; Vieira, Leda Q.; Oliveira, Sergio C.; Horta, Maria F.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil; [Moreira, Thais G.] Univ Fed Minas Gerais, Fac Farm, Dept Alimentos, BR-31270901 Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Horta, MF (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.	phorta@icb.ufmg.br	Oliveira, Sergio Costa/AAG-5408-2021; Faria, Ana Maria/AAK-8688-2021; Gual Pimenta de Queiroz, Nina Mari/GMX-3475-2022; de Oliveira, Luciana Souza/AAR-6702-2021	Oliveira, Sergio Costa/0000-0003-4062-5577; Gual Pimenta de Queiroz, Nina Mari/0000-0002-9789-1035; de Oliveira, Luciana Souza/0000-0002-2784-5658; Faria, Ana Maria/0000-0002-0604-8510; Vieira, Leda/0000-0001-5481-9618	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the following Brazilian financing programs or institutions: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). LSO, LVSV, FSO, NMGPQ, and MBHC and were supported by CNPq. TGM was supported by CAPES. SCO, AMF, LQV and MFH are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis RR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001543; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; CUNHA FQ, 1992, BIOCHEM BIOPH RES CO, V182, P1155, DOI 10.1016/0006-291X(92)91852-H; Deng WL, 1996, CELL IMMUNOL, V170, P20, DOI 10.1006/cimm.1996.0129; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; DILEEPAN KN, 1995, J INTERF CYTOK RES, V15, P387, DOI 10.1089/jir.1995.15.387; FUJIHARA M, 1994, J BIOL CHEM, V269, P12773; Ganster RW, 2000, NITRIC OXIDE BIOL PA, P129; Gao JJ, 1998, J IMMUNOL, V161, P4803; GREEN SJ, 1990, IMMUNOL LETT, V25, P15, DOI 10.1016/0165-2478(90)90083-3; GREEN SJ, 1991, J LEUKOCYTE BIOL, V50, P93, DOI 10.1002/jlb.50.1.93; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HOHMANN HP, 1990, J BIOL CHEM, V265, P15183; Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818; Ibraim IC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-54; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Jardim I. S., 1997, Memorias do Instituto Oswaldo Cruz, V92, P217; Jardin I. J., 1999, Memorias do Instituto Oswaldo Cruz, V94, P197; Kaushik RS, 1999, EXP PARASITOL, V92, P131, DOI 10.1006/expr.1999.4408; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816; Lau JF, 2002, MT SINAI J MED, V69, P156; Liew FY, 1999, IMMUNOL LETT, V65, P101, DOI 10.1016/S0165-2478(98)00131-X; LIEW FY, 1990, J IMMUNOL, V144, P4794; LOCKSLEY RM, 1991, IMMUNOPARASITOL TOD, pA58, DOI 10.1016/S0167-5699(05)80017-9; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Mattner J, 2004, J IMMUNOL, V172, P7574, DOI 10.4049/jimmunol.172.12.7574; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Noda T, 1997, J BIOCHEM-TOKYO, V121, P38; OSWALD IP, 1994, COMP BIOCHEM PHYS C, V108, P11, DOI 10.1016/1367-8280(94)90083-3; OSWALD IP, 1992, J LEUKOCYTE BIOL, V52, P315, DOI 10.1002/jlb.52.3.315; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Pindado J, 2007, J IMMUNOL, V179, P4821, DOI 10.4049/jimmunol.179.7.4821; REINER SL, 1993, J CELL BIOCHEM, V53, P323, DOI 10.1002/jcb.240530409; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Santos JL, 2006, J INTERF CYTOK RES, V26, P682, DOI 10.1089/jir.2006.26.682; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; Tacchini-Cottier F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00032; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Whitaker SM, 2008, INFECT IMMUN, V76, P2149, DOI 10.1128/IAI.01528-07; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; ZHANG XO, 1994, INFECT IMMUN, V62, P33, DOI 10.1128/IAI.62.1.33-40.1994; Zidek Z, 2000, PHARMACOGENETICS, V10, P493, DOI 10.1097/00008571-200008000-00002	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98913	10.1371/journal.pone.0098913	http://dx.doi.org/10.1371/journal.pone.0098913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911280	Green Submitted, gold, Green Published			2022-12-27	WOS:000337165600023
J	Phua, DCY; Xu, JL; Ali, SM; Boey, A; Gounko, NV; Hunziker, W				Phua, Dominic C. Y.; Xu, Jianliang; Ali, Safiah Mohamed; Boey, Adrian; Gounko, Natalia V.; Hunziker, Walter			ZO-1 and ZO-2 Are Required for Extra-Embryonic Endoderm Integrity, Primitive Ectoderm Survival and Normal Cavitation in Embryoid Bodies Derived from Mouse Embryonic Stem Cells	PLOS ONE			English	Article							TIGHT-JUNCTION; MOLECULE PODOCALYXIN; BASEMENT-MEMBRANES; LACKING EXPRESSION; ZONULA OCCLUDENS; MAGUK PROTEIN; IDENTIFICATION; POLARIZATION; EZRIN; GENE	The Zonula Occludens proteins ZO-1 and ZO-2 are cell cell junction-associated adaptor proteins that are essential for the structural and regulatory functions of tight junctions in epithelial cells and their absence leads to early embryonic lethality in mouse models. Here, we use the embryoid body, an in vitro pen-implantation mouse embryogenesis model, to elucidate and dissect the roles ZO-1 and ZO-2 play in epithelial morphogenesis and de novo tight junction assembly. Through the generation of individual or combined ZO-1 and ZO-2 null embryoid bodies, we show that their dual deletion prevents tight junction formation, resulting in the disorganization and compromised barrier function of embryoid body epithelial layers. The disorganization is associated with poor microvilli development, fragmented basement membrane deposition and impaired cavity formation, all of which are key epithelial tissue morphogenetic processes. Expression of Podocalyxin, which positively regulates the formation of microvilli and the apical membrane, repressed in embryoid bodies lacking both ZO-1 and ZO-2 and this correlates with an aberrant subrnembranous localization of Ezrin. The null embryoid bodies thus give an insight into how the two ZO proteins influence early mouse embryogenesis and possible mechanisms underlying the embryonic lethal phenotype.	[Phua, Dominic C. Y.; Xu, Jianliang; Ali, Safiah Mohamed; Boey, Adrian; Gounko, Natalia V.; Hunziker, Walter] ASTAR, Inst Mol & Cell Biol IMCB, Epithelial Cell Biol Lab, Singapore, Singapore; [Boey, Adrian; Gounko, Natalia V.] ASTAR, IMB IMCB Joint Electron Microscopy Suite, Singapore, Singapore; [Hunziker, Walter] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Hunziker, Walter] Singapore Eye Res Inst SERI, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Hunziker, W (corresponding author), ASTAR, Inst Mol & Cell Biol IMCB, Epithelial Cell Biol Lab, Singapore, Singapore.	hunziker@imcb.a-star.edu.sg	Gounko, Natalia/N-4102-2019; Hunziker, Walter/B-3140-2010; Gounko, Natalia V/J-9085-2015; Hunziker, Walter/GSM-8190-2022	Gounko, Natalia/0000-0003-0791-9477; Hunziker, Walter/0000-0002-5265-4933; Boey, Adrian/0000-0003-2835-6159; Xu, Jianliang/0000-0002-2277-2197; Mohamed Ali, Safiah/0000-0003-1821-2581	Agency for Science and Technology and Research (A*STAR), Singapore	Agency for Science and Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science and Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, MOL CELL BIOL, V26, P9003, DOI 10.1128/MCB.01811-05; AHMADZADEH C, 1971, IMMUNOLOGY, V21, P1065; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bielinska M, 1996, BLOOD, V88, P3720, DOI 10.1182/blood.V88.10.3720.bloodjournal88103720; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hernandez S, 2007, EXP CELL RES, V313, P1533, DOI 10.1016/j.yexcr.2007.01.026; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2013, J CELL SCI, V126, P3585, DOI 10.1242/jcs.122325; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Li Shaohua, 2006, V329, P113; Liu J, 2009, J CELL SCI, V122, P233, DOI 10.1242/jcs.037663; Lopez-Bayghen Esther, 2006, P76; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sheth B, 2008, EXP CELL RES, V314, P3356, DOI 10.1016/j.yexcr.2008.08.021; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Takeda Tetsuro, 2003, Clin Exp Nephrol, V7, P260, DOI 10.1007/s10157-003-0257-8; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Wang DS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00037; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Xu JL, 2008, MOL CELL BIOL, V28, P1669, DOI 10.1128/MCB.00891-07; Xu JR, 2012, J BIOMOL STRUCT DYN, V30, P30, DOI 10.1080/07391102.2012.674188; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352; Yasuda T, 2012, MOL BIOL CELL, V23, P3229, DOI 10.1091/mbc.E12-02-0104; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	68	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99532	10.1371/journal.pone.0099532	http://dx.doi.org/10.1371/journal.pone.0099532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905925	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000124
J	Picard, N; Liang, JJ				Picard, Nicolas; Liang, Jingjing			Matrix Models for Size-Structured Populations: Unrealistic Fast Growth or Simply Diffusion?	PLOS ONE			English	Article							INTEGRAL PROJECTION MODELS; FINDING CONFIDENCE-LIMITS; ELASTICITY ANALYSIS; DYNAMICS; FOREST; RATES; RECONCILIATION; CONSTRUCTION; HYPOTHESIS; MANAGEMENT	Matrix population models are widely used to study population dynamics but have been criticized because their outputs are sensitive to the dimension of the matrix (or, equivalently, to the class width). This sensitivity is concerning for the population growth rate (lambda) because this is an intrinsic characteristic of the population that should not depend on the model specification. It has been suggested that the sensitivity of lambda to matrix dimension was linked to the existence of fast pathways (i.e. the fraction of individuals that systematically move up a class), whose proportion increases when class width increases. We showed that for matrix population models with growth transition only from class i to class i + 1, lambda was independent of the class width when the mortality and the recruitment rates were constant, irrespective of the growth rate. We also showed that if there were indeed fast pathways, there were also in about the same proportion slow pathways (i.e. the fraction of individuals that systematically remained in the same class), and that they jointly act as a diffusion process (where diffusion here is the movement in size of an individual whose size increments are random according to a normal distribution with mean zero). For 53 tree species from a tropical rain forest in the Central African Republic, the diffusion resulting from common matrix dimensions was much stronger than would be realistic. Yet, the sensitivity of lambda to matrix dimension for a class width in the range 1-10 cm was small, much smaller than the sampling uncertainty on the value of lambda Moreover, lambda could either increase or decrease when class width increased depending on the species. Overall, even if the class width should be kept small enough to limit diffusion, it had little impact on the estimate of lambda for tree species.	[Picard, Nicolas] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Trop BSEF, Montpellier, France; [Liang, Jingjing] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA	CIRAD; West Virginia University	Picard, N (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Trop BSEF, Montpellier, France.	nicolas.picard@cirad.fr	Liang, Jingjing/AAM-1913-2021; Picard, Nicolas/T-2447-2018	Liang, Jingjing/0000-0001-9439-9320; Picard, Nicolas/0000-0001-5548-9171				ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; ANDERSON TW, 1957, ANN MATH STAT, V28, P89, DOI 10.1214/aoms/1177707039; Batabyal AA, 1996, ECOL MODEL, V89, P67, DOI 10.1016/0304-3800(95)00122-0; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; CASWELL H, 1978, ECOLOGY, V59, P53, DOI 10.2307/1936631; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; Coulson T, 2012, OIKOS, V121, P1337, DOI 10.1111/j.1600-0706.2012.00035.x; Cushing J. M., 1998, CBMS NSF REGIONAL C, V71; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; ENRIGHT NJ, 1995, OECOLOGIA, V104, P79, DOI 10.1007/BF00365565; Fiske IJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003080; GOODMAN LA, 1967, J R STAT SOC SER A-G, V130, P541, DOI 10.2307/2982523; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; HARA T, 1994, ANN BOT-LONDON, V73, P285, DOI 10.1006/anbo.1994.1034; HARRISON TP, 1985, FOREST SCI, V31, P850; Henson SM, 1998, J MATH BIOL, V37, P309, DOI 10.1007/s002850050131; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Hooley D.E, 2000, COLL MATH J, V31, P297; HOULLIER F, 1989, MATH BIOSCI, V95, P161, DOI 10.1016/0025-5564(89)90030-8; HOULLIER F, 1986, MATH BIOSCI, V79, P185, DOI 10.1016/0025-5564(86)90147-1; Hurst JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026670; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; ITO K, 1991, SIAM J NUMER ANAL, V28, P923, DOI 10.1137/0728050; KEYFITZ N, 1967, J R STAT SOC SER A-G, V130, P61, DOI 10.2307/2344038; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Liang JJ, 2013, FOREST SCI, V59, P359, DOI 10.5849/forsci.11-123; LIU LF, 1987, J MATH BIOL, V25, P73, DOI 10.1007/BF00275889; Logofet DO, 2008, ECOL MODEL, V216, P217, DOI 10.1016/j.ecolmodel.2008.03.004; Marescot L, 2012, ECOL MODEL, V232, P91, DOI 10.1016/j.ecolmodel.2012.02.017; MOLONEY KA, 1986, OECOLOGIA, V69, P176, DOI 10.1007/BF00377618; Nelson ESD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013628; Pfister CA, 2005, ECOLOGY, V86, P2673, DOI 10.1890/04-1952; Picard N, 2003, FOREST ECOL MANAG, V180, P389, DOI 10.1016/S0378-1127(02)00653-9; Picard N, 2007, ECOL MODEL, V204, P59, DOI 10.1016/j.ecolmodel.2006.12.016; Picard N, 2010, ECOL MODEL, V221, P2270, DOI 10.1016/j.ecolmodel.2010.06.010; Picard N, 2009, CAN J FOREST RES, V39, P2138, DOI 10.1139/X09-103; Picard N, 2009, MATH BIOSCI, V219, P23, DOI 10.1016/j.mbs.2009.02.002; Press W. H., 2007, NUMERICAL RECIPES AR, V3rd, P1235; Ramula S, 2005, OIKOS, V111, P563, DOI 10.1111/j.0030-1299.2005.13808.x; Ramula S, 2009, J APPL ECOL, V46, P1048, DOI 10.1111/j.1365-2664.2009.01706.x; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; Salguero-Gomez R, 2010, AM NAT, V176, P710, DOI 10.1086/657044; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Stott I, 2010, J ECOL, V98, P302, DOI 10.1111/j.1365-2745.2009.01632.x; Suzuki T., 1974, GROWTH MODELS TREE S, P358; Torres L, 2008, ECOL MODEL, V218, P307, DOI 10.1016/j.ecolmodel.2008.07.007; URIBE G., 1993, THESIS U ARIZONA TUC; USHER MB, 1966, J APPL ECOL, V3, P355, DOI 10.2307/2401258; USHER MB, 1969, BIOMETRICS, V25, P309, DOI 10.2307/2528791; VANDERMEER J, 1978, OECOLOGIA, V32, P79, DOI 10.1007/BF00344691; VANDERMEER JH, 1975, BIOMETRICS, V31, P239, DOI 10.2307/2529726; Yearsley JM, 2002, MATH BIOSCI, V179, P131, DOI 10.1016/S0025-5564(02)00119-0; Zavala MA, 2007, J THEOR BIOL, V244, P440, DOI 10.1016/j.jtbi.2006.08.024; Zhou M, 2004, ECOL MODEL, V180, P291, DOI 10.1016/j.ecolmodel.2004.04.023; ZUIDEMA P. A., 2006, DEMOGRAPHY THREATENE, P107; Zuidema PA, 2010, J ECOL, V98, P345, DOI 10.1111/j.1365-2745.2009.01626.x	59	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98254	10.1371/journal.pone.0098254	http://dx.doi.org/10.1371/journal.pone.0098254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905941	Green Published, gold			2022-12-27	WOS:000341869000026
J	Tripathi, R; Rath, G; Jawanjal, P; Sharma, S; Singhal, P; Bhambhani, S; Hussain, S; Bharadwaj, M				Tripathi, Richa; Rath, Gayatri; Jawanjal, Poonam; Sharma, Shweta; Singhal, Pallavi; Bhambhani, Suresh; Hussain, Showket; Bharadwaj, Mausumi			Clinical Impact of De-Regulated Notch-1 and Notch-3 in the Development and Progression of HPV-Associated Different Histological Subtypes of Precancerous and Cancerous Lesions of Human Uterine Cervix	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; GYNECOLOGICAL MALIGNANCIES; DOWN-REGULATION; TUMOR; EXPRESSION; INDIA; CARE; PROLIFERATION; ACTIVATION; SUPPRESSOR	Background: Cervical cancer is the leading cause of cancer related deaths among women in India. Limited reports are available for Notch-1 and Notch-3 protein in cervical carcinoma, which play crucial role in cell proliferation, differentiation, and apoptosis. Methods: This study was designed to evaluate the role of Notch-1 and Notch-3 with context to HPV infection in cervical carcinoma. A total of 168 tissue biopsy samples comprising of tumor specimens (n = 98), precancer (n = 30) and nonneoplastic cervical tissues (n = 40) were screened for HPV infection by PCR and expression of Notch-1 and Notch-3 protein by Immunohistochemistry and Immunoblotting. Results: 80% (24/30) were found to be positive for HPV in precancer and 86.7% (85/98) in cancer patients. Notch-1 expression of precancer and cancer cases was found to be significantly down-regulated with severity of disease in nuclear (3.43 +/- 0.29; 2.04 +/- 0.19, p = 0.0001, p = 0.0001) and cytoplasm (3.07 +/- 0.29; 2.29 +/- 0.17, p = 0.0001, p = 0.0001) obtained from different stages as compared to normal cervix tissue (5.40 +/- 0.19, 4.97 +/- 0.15; p<0.001; p<0.001). However, Notch-3 expression of above cases was significantly up-regulated with severity of disease and showed intense nuclear (4.17 +/- 0.39; 4.74 +/- 0.18, p = 0.0001, p = 0.0001) and cytoplasm (3.67 +/- 0.36; 4.48 +/- 0.18, p = 0.0001, p = 0.0001) of different stages as compared to normal cervix tissue (0.95 +/- 0.20, 0.70 +/- 0.20; p<0.001; p<0.001) respectively. Conclusions: These findings suggest that Notch-1 and Notch-3 may play an important role with synergistic effect of HPV in regulating development and proliferation of cervical cancer through the deregulation of Notch signalling. This study also shows the clinical utility of both proteins which may be used as predictable biomarkers in diagnosing different histological sub-types of HPV associated cervical cancer. Nevertheless, abnormal activation of this pathway may provide legitimate targets for cervical cancer therapy.	[Tripathi, Richa; Sharma, Shweta; Singhal, Pallavi; Hussain, Showket; Bharadwaj, Mausumi] ICMR, Div Mol Genet & Biochem, ICPO, Noida, India; [Rath, Gayatri; Jawanjal, Poonam] VMMC & Safdarjang Hosp, Dept Anat, New Delhi, India; [Bhambhani, Suresh] ICMR, ICPO, Div Pathol, Noida, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Bharadwaj, M (corresponding author), ICMR, Div Mol Genet & Biochem, ICPO, Noida, India.	mausumi.bharadwaj@gmail.com	singhal, Pallavi/Y-6321-2019		Indian Council of Medical Research (ICMR), New Delhi, India [3/1/3/PDF-2010/HRD-11/2nd batch]; Institute of Cytology and Preventive Oncology (ICPO-ICMR), Noida, India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Institute of Cytology and Preventive Oncology (ICPO-ICMR), Noida, India	This study was supported by the Indian Council of Medical Research (ICMR), New Delhi, India (Post-doc fellowship Grant no. 3/1/3/PDF-2010/HRD-11/2nd batch) and core funds of Institute of Cytology and Preventive Oncology (ICPO-ICMR), Noida, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal MGS, 2013, J GENET, V92, P667, DOI 10.1007/s12041-013-0284-5; American Cancer Society, 2012, CANC FACTS FIG; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bahnassy Abeer A, 2006, J Egypt Natl Canc Inst, V18, P292; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Bharadwaj M, 2014, ANIM BIOTECHNOL, P95; Bhatla N, 2008, INT J GYNECOL PATHOL, V27, P426, DOI 10.1097/PGP.0b013e31816085ba; Bhatla N, 2009, INT J GYNECOL OBSTET, V105, P145, DOI 10.1016/j.ijgo.2008.12.010; Brennan K, 2003, BREAST CANCER RES, V5, P69, DOI 10.1186/bcr559; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Cheng F, 2012, FUTURE MICROBIOL, V7, P1191, DOI [10.2217/fmb.12.95, 10.2217/FMB.12.95]; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Ferlay J., 2012, CANC INCIDENCE MORTA; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; Funahashi Y, 2008, J ANGIOGENES RES, V2, P3; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gibb Randall K, 2011, Rev Obstet Gynecol, V4, pS2; Gilbert CA, 2010, AACR M; Gupta S., 2012, Journal of the Indian Institute of Science, V92, P353; Harry TK, 2006, CALIFORNIANO JO HLTH, V4, P146; Hu W, 2011, CANCER RES, V71, P6030, DOI 10.1158/0008-5472.CAN-10-2719; Hussain S, 2012, J MED VIROL, V84, P298, DOI 10.1002/jmv.22261; Hussain S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-329; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kohaar I, 2007, CELL ONCOL, V29, P249; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Sarkar M, 2013, ASIAN PAC J CANCER P, V14, P3541, DOI 10.7314/APJCP.2013.14.6.3541; Sarkar M, 2012, ASIAN PAC J CANCER P, V13, P2997, DOI 10.7314/APJCP.2012.13.6.2997; Sarkar M, 2010, ASIAN PAC J CANCER P, V11, P785; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shekhar S, 2013, ASIAN PAC J CANCER P, V14, P3641, DOI 10.7314/APJCP.2013.14.6.3641; Shepherd JH, 1996, BRIT J OBSTET GYNAEC, V103, P405, DOI 10.1111/j.1471-0528.1996.tb09764.x; Singh N, 2013, GYNECOL ONCOL, V128, P420, DOI 10.1016/j.ygyno.2012.11.041; Sobti RC, 2011, CELL ONCOL, V34, P533, DOI 10.1007/s13402-011-0056-2; Sobti RC, 2009, MOL CELL BIOCHEM, V330, P193, DOI 10.1007/s11010-009-0133-2; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Teruya-Feldstein J, 2010, ARCH PATHOL LAB MED, V134, P1659, DOI 10.1043/2009-0582-RAR1.1; Thomas MB, 2014, SURG ONCOL CLIN N AM, V23, P369, DOI 10.1016/j.soc.2013.11.004; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Tzoneva G, 2012, CURR TOP MICROBIOL, V360, P163, DOI 10.1007/82_2012_232; Wang Chong, 2010, Front Biosci (Elite Ed), V2, P127, DOI 10.2741/e74; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yeasmin S, 2010, GYNECOL ONCOL, V117, P409, DOI 10.1016/j.ygyno.2010.03.004; zur Hausen H, 1996, BIOCHIM BIOPHYS ACTA, V1288, P55	57	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98642	10.1371/journal.pone.0098642	http://dx.doi.org/10.1371/journal.pone.0098642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905589	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000044
J	Leng, YP; Qiu, N; Fang, WJ; Zhang, M; He, ZM; Xiong, Y				Leng, Yi-Ping; Qiu, Ni; Fang, Wei-jin; Zhang, Mei; He, Zhi-Min; Xiong, Yan			Involvement of Increased Endogenous Asymmetric Dimethylarginine in the Hepatic Endoplasmic Reticulum Stress of Type 2 Diabetic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; ER STRESS; KINASE; INHIBITION; APOPTOSIS; HOMEOSTASIS; ACTIVATION; EXPRESSION	Objective: Increasing evidence suggested that endoplasmic reticulum (ER) stress contributes to insulin resistance, which plays an important role in the development of type 2 diabetes mellitus (T2DM). Accumulation of endogenous nitric oxide synthase (NOS) inhibitor, asymmetric dimethylarginine (ADMA), is associated with insulin resistance, T2DM, and diabetic cardiovascular complications, although the mechanisms have not been elucidated. This study was to determine whether elevated endogenous ADMA is involved in hepatic ER stress of type 2 diabetic rats, verify their causal relationship, and elucidate the potential mechanism underlying ADMA induced ER stress in rat hepatocytes. Methods: Immunoglobulin binding protein (Bip) transcription, eukaryotic initiation factor 2 alpha kinase (eIF2 alpha) phosphorylation, X box-binding protein-1 (XBP-1) mRNA splicing and C/EBP homologues protein (CHOP) expression were measured to reflect ER stress. Contents of ADMA and nitrite/nitrate as well as activities or expression of NOS and dimethylarginine dimethylaminohydrolase (DDAH) were detected to show the changes in DDAH/ADMA/NOS/NO pathway. The lipid peroxidation product malondialdehyde content and antioxidant enzyme superoxide dismutase activity were analyzed to evaluate oxidative stress. Results: ER stress was provoked in the liver of type 2 diabetic rats, as expressed by increases of Bip transcription, eIF2a phosphorylation, XBP-1 splicing and CHOP expression, all of which were in parallel with the elevation of serum ADMA, suppression of NO generation, NOS and DDAH activities in the liver. Exposure of hepatocytes to ADMA or hydrogen peroxide also induced ER stress, which was associated with the inhibition of NO production and increase of oxidative stress. Treatment of hepatocytes with antioxidant pyrrolidine dithiocarbamate not only decreased ADMA-induced oxidative stress and inhibition of NO production but also reduced ADMA-triggered ER stress. Conclusions: These results indicate that increased endogenous ADMA contributes to hepatic ER stress in type 2 diabetic rats, and the mechanism underlying ADMA-induced ER stress may relate to oxidative stress via NOS uncoupling.	[Qiu, Ni; Fang, Wei-jin; Zhang, Mei; Xiong, Yan] Guangzhou Med Univ, Guangzhou Res Inst Snake Venom, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Qiu, Ni; Fang, Wei-jin; Zhang, Mei; Xiong, Yan] Guangzhou Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Leng, Yi-Ping; Xiong, Yan] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [He, Zhi-Min] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [He, Zhi-Min] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Central South University; Guangzhou Medical University; Guangzhou Medical University	Xiong, Y (corresponding author), Guangzhou Med Univ, Guangzhou Res Inst Snake Venom, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	Xiongyan2001@yahoo.com	Fang, Weijin/J-3449-2014		Natural Science Research Foundation of China [30873062, 81170778]; Guangzhou Municipal Science and Technology and Information Bureau	Natural Science Research Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Municipal Science and Technology and Information Bureau	This study was supported by the grants from the Natural Science Research Foundation of China (No. 30873062 & 81170778) and from Guangzhou Municipal Science and Technology and Information Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chao PL, 2007, ANN NY ACAD SCI, V1122, P276, DOI 10.1196/annals.1403.020; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Fu YF, 2005, EUR J PHARMACOL, V508, P167, DOI 10.1016/j.ejphar.2004.11.063; Guo WK, 2014, INT J MOL SCI, V15, P484, DOI 10.3390/ijms15010484; Han KL, 2008, DIABETES, V57, P737, DOI 10.2337/db07-0972; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Ji YL, 2013, ASIAN J ANDROL, V15, P290, DOI 10.1038/aja.2012.129; Juan CC, 2005, ENDOCRINOLOGY, V146, P2246, DOI 10.1210/en.2004-1136; Jung TW, 2014, MOL CELL ENDOCRINOL, V382, P66, DOI 10.1016/j.mce.2013.09.013; Kaneto H, 2005, INT J BIOCHEM CELL B, V37, P1595, DOI 10.1016/j.biocel.2005.04.003; Kim SH, 2001, BIOCHEM BIOPH RES CO, V281, P367, DOI 10.1006/bbrc.2001.4376; Lee EK, 2012, NEPHRON EXP NEPHROL, V121, pE38, DOI 10.1159/000342802; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Lim SK, 2013, FOOD CHEM TOXICOL, V62, P763, DOI 10.1016/j.fct.2013.10.014; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lu CW, 2007, NITRIC OXIDE-BIOL CH, V16, P94, DOI 10.1016/j.niox.2006.07.006; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060517; Nakatani Y, 2006, DIABETIC MED, V23, P216, DOI 10.1111/j.1464-5491.2005.01766.x; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Sheikh-Ali M, 2010, NUTRITION, V26, P1146, DOI 10.1016/j.nut.2009.08.019; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Taniguchi Y, 2006, DIABETES, V55, P2371, DOI 10.2337/db06-0268; Tyra HM, 2012, MOL BIOL CELL, V23, P811, DOI 10.1091/mbc.E11-12-1011; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Xiong Y, 2005, LIFE SCI, V77, P149, DOI 10.1016/j.lfs.2004.10.062; Xiong Y, 2003, J CARDIOVASC PHARM, V42, P191, DOI 10.1097/00005344-200308000-00006; Xiong Y, 1997, ACTA PHARMACOL SIN, V18, P511; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yin QF, 2005, J CARDIOVASC PHARM, V45, P525, DOI 10.1097/01.fjc.0000159642.44523.7f; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhou QG, 2009, AM J PHYSIOL-ENDOC M, V296, pE869, DOI 10.1152/ajpendo.91011.2008	44	14	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97125	10.1371/journal.pone.0097125	http://dx.doi.org/10.1371/journal.pone.0097125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918756	gold, Green Submitted, Green Published			2022-12-27	WOS:000338631000007
J	Rong, XZ; Chen, C; Zhou, P; Zhou, YM; Li, Y; Lu, L; Liu, YZ; Zhou, JF; Duan, CM				Rong, Xiaozhi; Chen, Chen; Zhou, Pin; Zhou, Yumei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng; Duan, Cunming			R-Spondin 3 Regulates Dorsoventral and Anteroposterior Patterning by Antagonizing Wnt/beta-Catenin Signaling in Zebrafish Embryos	PLOS ONE			English	Article							BETA-CATENIN; SPEMANN ORGANIZER; GASTRULATION MOVEMENTS; GENE-EXPRESSION; AXIS FORMATION; WNT PATHWAY; RECEPTORS; MESODERM; FAMILY; LRP6	The Wnt/beta-catenin or canonical Wnt signaling pathway plays fundamental roles in early development and in maintaining adult tissue homeostasis. R-spondin 3 (Rspo3) is a secreted protein that has been implicated in activating the Wnt/beta-catenin signaling in amphibians and mammals. Here we report that zebrafish Rspo3 plays a negative role in regulating the zygotic Wnt/beta-catenin signaling. Zebrafish Rspo3 has a unique domain structure. It contains a third furin-like (FU3) domain. This FU3 is present in other four ray-finned fish species studied but not in elephant shark. In zebrafish, rspo3 mRNA is maternally deposited and has a ubiquitous expression in early embryonic stages. After 12 hpf, its expression becomes tissue-specific. Forced expression of rspo3 promotes dorsoanterior patterning and increases the expression of dorsal and anterior marker genes. Knockdown of rspo3 increases ventral-posterior development and stimulates ventral and posterior marker genes expression. Forced expression of rspo3 abolishes exogenous Wnt3a action and reduces the endogenous Wnt signaling activity. Knockdown of rspo3 results in increased Wnt/beta-catenin signaling activity. Further analyses indicate that Rspo3 does not promote maternal Wnt signaling. Human RSPO3 has similar action when tested in zebrafish embryos. These results suggest that Rspo3 regulates dorsoventral and anteroposterior patterning by negatively regulating the zygotic Wnt/beta-catenin signaling in zebrafish embryos.	[Rong, Xiaozhi; Chen, Chen; Zhou, Pin; Zhou, Yumei; Li, Yun; Lu, Ling; Liu, Yunzhang; Zhou, Jianfeng] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Ocean University of China; University of Michigan System; University of Michigan	Zhou, JF (corresponding author), Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China.	jfzhou@ouc.edu.cn; cduan@umich.edu	Zhou, Yu/HHN-3071-2022		Major Science Programs of China [2011CB943800]; National Science Foundation of China [30972238, 40876064, 30970357, 30928021]; US National Science Foundation (NSF) Research Grant [IOS-1051034]; Division Of Integrative Organismal Systems [1051034] Funding Source: National Science Foundation	Major Science Programs of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation (NSF) Research Grant(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from Major Science Programs of China (#2011CB943800) and the National Science Foundation of China (Grant #30972238, #40876064, #30970357 and #30928021). C. D. was supported by US National Science Foundation (NSF) Research Grant IOS-1051034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Baker KD, 2010, DEV DYNAM, V239, P2828, DOI 10.1002/dvdy.22419; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Birchmeier W, 2011, NATURE, V476, P287, DOI 10.1038/476287a; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Erter CE, 2001, DEVELOPMENT, V128, P3571; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Feng Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052674; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Kagermeier-Schenk B, 2011, DEV CELL, V21, P1129, DOI 10.1016/j.devcel.2011.10.015; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; MacDonald BT, 2012, CELL RES, V22, P1410, DOI 10.1038/cr.2012.91; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Reifers F, 1998, DEVELOPMENT, V125, P2381; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Xie Y, 2013, EMBO REP; Yamamoto A, 2005, CELL, V120, P223, DOI 10.1016/j.cell.2004.11.051; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	60	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99514	10.1371/journal.pone.0099514	http://dx.doi.org/10.1371/journal.pone.0099514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918770	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000091
J	Jesudasan, SJB; Todd, KG; Winship, IR				Jesudasan, Sam Joshva Baskar; Todd, Kathryn G.; Winship, Ian R.			Reduced Inflammatory Phenotype in Microglia Derived from Neonatal Rat Spinal Cord versus Brain	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE; INDUCED NEUROTOXICITY; CYTOKINE EXPRESSION; MICE DEFICIENT; TNF-ALPHA; IN-VIVO; INJURY	Microglia are the primary immune cells of the central nervous system (CNS). Membrane bound sensors on their processes monitor the extracellular environment and respond to perturbations of the CNS such as injury or infection. Once activated, microglia play a crucial role in determining neuronal survival. Recent studies suggest that microglial functional response properties vary across different regions of the CNS. However, the activation profiles of microglia derived from the spinal cord have not been evaluated against brain microglia in vitro. Here, we studied the morphological properties and secretion of inflammatory and trophic effectors by microglia derived from the brain or spinal cord of neonatal rats under basal culture conditions and after activation with lipopolysaccharide (LPS). Our results demonstrate that spinal microglia assume a less inflammatory phenotype after LPS activation, with reduced release of the inflammatory effectors tumor necrosis factor alpha, interleukin-1 beta, and nitric oxide, a less amoeboid morphology, and reduced phagocytosis relative to brain-derived microglia. Phenotypic differences between brain and spinal microglia are an important consideration when evaluating anti-inflammatory or immunomodulatory therapies for brain versus spinal injury.	[Jesudasan, Sam Joshva Baskar; Todd, Kathryn G.; Winship, Ian R.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Jesudasan, Sam Joshva Baskar; Todd, Kathryn G.; Winship, Ian R.] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, Canada	University of Alberta; University of Alberta	Winship, IR (corresponding author), Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada.	iwinship@ualberta.ca			Alberta Innovates Health Solutions; Heart and Stroke Foundation of Canada; Natural Science and Engineering Research Council; Canadian Institutes of Health Research; George and Dorthy Davey Endowment Fund for Brain Injury Research	Alberta Innovates Health Solutions; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); George and Dorthy Davey Endowment Fund for Brain Injury Research	This research is funded by Alberta Innovates Health Solutions [IRW], the Heart and Stroke Foundation of Canada [IRW], the Natural Science and Engineering Research Council [IRW], Canadian Institutes of Health Research [KGT, IRW] and George and Dorthy Davey Endowment Fund for Brain Injury Research [KGT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1989, J IMMUNOL, V143, P3517; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Armstrong L, 1996, THORAX, V51, P143, DOI 10.1136/thx.51.2.143; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Broderick C, 2000, INVEST OPHTH VIS SCI, V41, P2613; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Castillo J, 2000, STROKE, V31, P852, DOI 10.1161/01.STR.31.4.852; Centonze D, 2009, J NEUROSCI, V29, P3442, DOI 10.1523/JNEUROSCI.5804-08.2009; Clausen BH, 2005, NEUROSCIENCE, V132, P879, DOI 10.1016/j.neuroscience.2005.01.031; Diab A, 1997, J NEUROPATH EXP NEUR, V56, P641; Downes N, 2013, DEV MYELIN BRAIN JUV; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Gingras M, 2007, J NEUROSCI METH, V163, P111, DOI 10.1016/j.jneumeth.2007.02.024; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hua K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052728; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kurpius D, 2007, GLIA, V55, P873, DOI 10.1002/glia.20509; Lai AY, 2013, NEUROSCIENCE, V254, P185, DOI 10.1016/j.neuroscience.2013.09.010; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lai AY, 2011, NEURON GLIA BIOL, V7, P5, DOI 10.1017/S1740925X12000154; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Ledeboer A, 2002, EUR J NEUROSCI, V16, P1175, DOI 10.1046/j.1460-9568.2002.02200.x; Ma TC, 2000, ARZNEIMITTELFORSCH, V50, P512; Matsui T, 2010, ANESTH ANALG, V111, P554, DOI 10.1213/ANE.0b013e3181e3a2a2; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Olson JK, 2010, ANN NY ACAD SCI, V1198, P271, DOI 10.1111/j.1749-6632.2010.05536.x; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Rezaie P, 1999, MICROSC RES TECHNIQ, V45, P359, DOI 10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.3.CO;2-4; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Siao CJ, 2002, J NEUROSCI, V22, P3352; Smith PD, 2012, CIRCULATION, V126, pS110, DOI 10.1161/CIRCULATIONAHA.111.080275; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Werry EL, 2011, NEUROSCIENCE, V175, P93, DOI 10.1016/j.neuroscience.2010.10.080; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yip PK, 2009, J NEUROSCI METH, V183, P223, DOI 10.1016/j.jneumeth.2009.07.002	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99443	10.1371/journal.pone.0099443	http://dx.doi.org/10.1371/journal.pone.0099443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914808	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700103
J	Mangia, AL; Pirini, M; Simoncini, L; Cappello, A				Mangia, Anna Lisa; Pirini, Marco; Simoncini, Laura; Cappello, Angelo			A Feasibility Study of an Improved Procedure for Using EEG to Detect Brain Responses to Imagery Instruction in Patients with Disorders of Consciousness	PLOS ONE			English	Article							VEGETATIVE STATE; MOTOR IMAGERY; COMPUTER INTERFACE; CHANNEL SELECTION; AWARENESS; CLASSIFICATION; RELIABILITY; MODULATION; ACTIVATION; MOVEMENTS	One of the major concerns of recent studies is the correct discrimination between vegetative and minimally conscious state as the distinction between these two conditions has major implications for subsequent patient rehabilitation. In particular, it would be advantageous to establish communication with these patients. This work describes a procedure using EEG to detect brain responses to imagery instruction in patients with disorders of consciousness. Five healthy subjects and five patients with different disorders of consciousness took part in the study. A support vector machine classifier applied to EEG data was used to distinguish two mental tasks (Imagery Trial) and to detect answers to simple yes or no questions (pre-Communication Trial). The proposed procedure uses feature selection based on a nested-leave-one-out algorithm to reduce the number of electrodes required. We obtained a mean classification accuracy of 82.0% (SD 5.1%) for healthy subjects and 84.6% (SD 9.1%) for patients in the Imagery Trial, and a mean classification accuracy of 80.7% (SD 11.5%) for healthy subjects and 91.7% (SD 7.4%) for patients in the pre-Communication Trial. The subset of electrodes selected was subject and session dependent.	[Mangia, Anna Lisa; Pirini, Marco; Cappello, Angelo] Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy; [Simoncini, Laura] Maggiore Hosp, Rehabil Unit, Bologna, Italy	University of Bologna; AUSL di Bologna	Mangia, AL (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy.	annalisa.mangia2@unibo.it	Simoncini, Laura/AAB-9410-2022	Simoncini, Laura/0000-0002-8853-1791				Arvaneh M, 2011, IEEE T BIO-MED ENG, V58, P1865, DOI 10.1109/TBME.2011.2131142; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chungki L, 2012, P ANN INT C IEEE EMB, P5290; Congedo M, 2008, CLIN NEUROPHYSIOL, V119, P2677, DOI 10.1016/j.clinph.2008.09.007; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; De Massari D, 2013, BIOL PSYCHOL, V92, P267, DOI 10.1016/j.biopsycho.2012.10.015; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gudmundsson S, 2007, CLIN NEUROPHYSIOL, V118, P2162, DOI 10.1016/j.clinph.2007.06.018; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishizu T, 2009, NEUROSCI LETT, V465, P85, DOI 10.1016/j.neulet.2009.08.079; John ER, 2011, BRAIN INJURY, V25, P426, DOI 10.3109/02699052.2011.558045; Kamrunnahar M, 2009, IEEE ENG MED BIO, P6477, DOI 10.1109/IEMBS.2009.5333585; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kotchoubey B, 2003, NEUROSCI LETT, V352, P129, DOI 10.1016/j.neulet.2003.08.045; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kurita T, 2004, JACIII, V8; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Lebon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037850; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Li Y, 2009, NEUROSCI RES, V65, P44, DOI 10.1016/j.neures.2009.05.004; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Munzert J, 2008, EXP BRAIN RES, V188, P437, DOI 10.1007/s00221-008-1376-y; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99289	10.1371/journal.pone.0099289	http://dx.doi.org/10.1371/journal.pone.0099289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915148	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700079
J	Srinivasan, P; Zervantonakis, IK; Kothapalli, CR				Srinivasan, Parthasarathy; Zervantonakis, Ioannis K.; Kothapalli, Chandrasekhar R.			Synergistic Effects of 3D ECM and Chemogradients on Neurite Outgrowth and Guidance: A Simple Modeling and Microfluidic Framework	PLOS ONE			English	Article							GROWTH-FACTOR-I; SIGNALING MECHANISMS; STOCHASTIC-MODEL; RANDOM MOTILITY; GRADIENTS; CHEMOTAXIS; DIFFUSION; MIGRATION; DYNAMICS; CELLS	During nervous system development, numerous cues within the extracellular matrix microenvironment (ECM) guide the growing neurites along specific pathways to reach their intended targets. Neurite motility is controlled by extracellular signal sensing through the growth cone at the neurite tip, including chemoattractive and repulsive cues. However, it is difficult to regenerate and restore neurite tracts, lost or degraded due to an injury or disease, in the adult central nervous system. Thus, it is important to evaluate the dynamic interplay between ECM and the concentration gradients of these cues, which would elicit robust neuritogenesis. Such information is critical in understanding the processes involved in developmental biology, and in developing high-fidelity neurite regenerative strategies post-injury, and in drug discovery and targeted therapeutics for neurodegenerative conditions. Here, we quantitatively investigated this relationship using a combination of mathematical modeling and in vitro experiments, and determined the synergistic role of guidance cues and ECM on neurite outgrowth and turning. Using a biomimetic microfluidic system, we have shown that cortical neurite outgrowth and turning under chemogradients (IGF-1 or BDNF) within 3D scaffolds is highly regulated by the source concentration of the guidance cue and the physical characteristics of the scaffold. A mechanistic-driven partial differential equation model of neurite outgrowth has been proposed, which could also be used prospectively as a predictive tool. The parameters for the chemotaxis term in the model are determined from the experimental data using our microfluidic assay. Resulting model simulations demonstrate how neurite outgrowth was critically influenced by the experimental variables, which was further supported by experimental data on cell-surface-receptor expressions. The model results are in excellent agreement with the experimental findings. This integrated approach represents a framework for further elucidation of biological mechanisms underlying neuronal responses of specialized cell types, during various stages of development, and under healthy or diseased conditions.	[Srinivasan, Parthasarathy] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Zervantonakis, Ioannis K.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; Harvard University; Harvard Medical School; University System of Ohio; Cleveland State University	Kothapalli, CR (corresponding author), Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44115 USA.	c.kothapalli@csuohio.edu	Zervantonakis, Ioannis/C-2890-2011; Zervantonakis, Ioannis/ADS-2519-2022; Zervantonakis, Ioannis/N-9717-2019	Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553	Cleveland State University	Cleveland State University	C. K. would like to express his gratitude for the startup funds, Faculty Research Development Award (2012-2013), and Provost Undergraduate Research and Creative Achievement Award (2012) from the Cleveland State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletti G, 2008, IET SYST BIOL, V2, P150, DOI 10.1049/iet-syb:20070059; Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BUETTNER HM, 1994, DEV BIOL, V163, P407, DOI 10.1006/dbio.1994.1158; BUETTNER HM, 1994, ANN NY ACAD SCI, V745, P210; BUETTNER HM, 1995, CELL MOTIL CYTOSKEL, V32, P187, DOI 10.1002/cm.970320304; Crank J., 1975, MATH DIFFUSION; De Smedt A, 2011, STROKE, V42, P2180, DOI 10.1161/STROKEAHA.110.600783; DECHANT G, 1993, DEVELOPMENT, V119, P545; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Deumens R, 2006, NEUROSCI LETT, V407, P268, DOI 10.1016/j.neulet.2006.08.059; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dontchev V, 2011, CR ACAD BULG SCI, V64, P1347; DUNN GA, 1987, J CELL SCI, P81; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; FORD RM, 1991, BIOTECHNOL BIOENG, V37, P661, DOI 10.1002/bit.260370708; Gates MA, 2004, EUR J NEUROSCI, V19, P831, DOI 10.1111/j.1460-9568.2004.03213.x; Gisladottir S, 2009, GRAEF ARCH CLIN EXP, V247, P1677, DOI 10.1007/s00417-009-1141-3; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1998, NEURAL COMPUT, V10, P521, DOI 10.1162/089976698300017638; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; Goodhill GJ, 1999, J NEUROBIOL, V41, P230, DOI 10.1002/(SICI)1097-4695(19991105)41:2<230::AID-NEU6>3.0.CO;2-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; GUO YS, 1992, GASTROENTEROLOGY, V102, P1101; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; Horstmann D, 2004, JAHRESBER DEUTSCH MA, V106, P51; Horstmann D., 2003, JAHRESBER DTSCH MATH, V105, P103; Isbister CM, 2003, J NEUROSCI, V23, P193; KATZ MJ, 1984, CELL MOTIL CYTOSKEL, V4, P351, DOI 10.1002/cm.970040505; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; Kobayashi T, 2010, J THEOR BIOL, V266, P712, DOI 10.1016/j.jtbi.2010.07.036; Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042; Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LAPIDUS IR, 1976, BIOPHYS J, V16, P779, DOI 10.1016/S0006-3495(76)85728-1; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Loschinger J, 2000, PHILOS T ROY SOC B, V355, P971, DOI 10.1098/rstb.2000.0633; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Maskery S, 2005, ANNU REV BIOMED ENG, V7, P187, DOI 10.1146/annurev.bioeng.7.060804.100446; Maskery SM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-22; Meinhardt H, 1999, J CELL SCI, V112, P2867; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; NOWAKOWSKI RS, 1992, BRAIN RES, V576, P152, DOI 10.1016/0006-8993(92)90622-G; Othmer HG, 1997, SIAM J APPL MATH, V57, P1044, DOI 10.1137/S0036139995288976; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Pearson YE, 2011, B MATH BIOL, V73, P2837, DOI 10.1007/s11538-011-9648-2; Pettet GJ, 1996, MATH BIOSCI, V136, P35, DOI 10.1016/0025-5564(96)00044-2; Polleux F, 2002, DEVELOPMENT, V129, P3147; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Rusu L, 2010, MACROMOL BIOSCI, V10, P1465, DOI 10.1002/mabi.201000033; Salie R, 2005, INT J DEV NEUROSCI, V23, P587, DOI 10.1016/j.ijdevneu.2005.07.003; Sawonik MA, 2013, ADV MICROFLUIDICS NA; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STOKES CL, 1991, J THEOR BIOL, V152, P377, DOI 10.1016/S0022-5193(05)80201-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tharin S, 2012, INTEGR BIOL-UK, V4, P1398, DOI 10.1039/c2ib20019h; Tsaneva-Atanasova K, 2009, BIOPHYS J, V96, P840, DOI 10.1016/j.bpj.2008.10.036; Urbach JS, 1999, NEUROCOMPUTING, V26-7, P39, DOI 10.1016/S0925-2312(99)00086-7; von Philipsborn AC, 2006, DEVELOPMENT, V133, P2487, DOI 10.1242/dev.02412; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Wang FS, 2003, BIOPHYS J, V85, P3319, DOI 10.1016/S0006-3495(03)74751-1; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xiang YJ, 2011, INT J NEUROSCI, V121, P101, DOI 10.3109/00207454.2010.535935; Xu J, 2005, DEVELOPMENT, V132, P4545, DOI 10.1242/dev.02029; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Zervantonakis IK, 2010, INT J MICRONANOSCALE, V1, P27, DOI DOI 10.1260/1759-3093.1.1.27	81	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99640	10.1371/journal.pone.0099640	http://dx.doi.org/10.1371/journal.pone.0099640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914812	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700121
J	Zhao, L; Liu, JX; Zhang, FW; Dong, XL; Peng, YL; Qin, W; Wu, FM; Li, Y; Yuan, K; von Deneen, KM; Gong, QY; Tang, ZL; Liang, FR				Zhao, Ling; Liu, Jixin; Zhang, Fuwen; Dong, Xilin; Peng, Yulin; Qin, Wei; Wu, Fumei; Li, Ying; Yuan, Kai; von Deneen, Karen M.; Gong, Qiyong; Tang, Zili; Liang, Fanrong			Effects of Long-Term Acupuncture Treatment on Resting-State Brain Activity in Migraine Patients: A Randomized Controlled Trial on Active Acupoints and Inactive Acupoints	PLOS ONE			English	Article							CHRONIC PAIN; PHYSIOLOGICAL CONDITION; ABNORMALITIES; PROPHYLAXIS; CONNECTIVITY; HOMOGENEITY; AURA; ELECTROACUPUNCTURE; INTEROCEPTION; STIMULATION	Background: Acupuncture has been commonly used for preventing migraine attacks and relieving pain during a migraine, although there is limited knowledge on the physiological mechanism behind this method. The objectives of this study were to compare the differences in brain activities evoked by active acupoints and inactive acupoints and to investigate the possible correlation between clinical variables and brain responses. Methods and Results: A randomized controlled trial and resting-state functional magnetic resonance imaging (fMRI) were conducted. A total of eighty migraineurs without aura were enrolled to receive either active acupoint acupuncture or inactive acupoint acupuncture treatment for 8 weeks, and twenty patients in each group were randomly selected for the fMRI scan at the end of baseline and at the end of treatment. The neuroimaging data indicated that long-term active acupoint therapy elicited a more extensive and remarkable cerebral response compared with acupuncture at inactive acupoints. Most of the regions were involved in the pain matrix, lateral pain system, medial pain system, default mode network, and cognitive components of pain processing. Correlation analysis showed that the decrease in the visual analogue scale (VAS) was significantly related to the increased average Regional homogeneity (ReHo) values in the anterior cingulate cortex in the two groups. Moreover, the decrease in the VAS was associated with increased average ReHo values in the insula which could be detected in the active acupoint group. Conclusions: Long-term active acupoint therapy and inactive acupoint therapy have different brain activities. We postulate that acupuncture at the active acupoint might have the potential effect of regulating some disease-affected key regions and the pain circuitry for migraine, and promote establishing psychophysical pain homeostasis.	[Zhao, Ling; Dong, Xilin; Peng, Yulin; Wu, Fumei; Li, Ying; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Acupuncture & Tuina Sch, Chengdu, Sichuan, Peoples R China; [Liu, Jixin; Qin, Wei; Yuan, Kai; von Deneen, Karen M.] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Zhang, Fuwen] Chengdu Univ Tradit Chinese Med, Sch Clin Med, Chengdu, Sichuan, Peoples R China; [Gong, Qiyong] West China Hosp Sichuan Univ, Huaxi MR Res Ctr, Ctr Med Imaging, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Tang, Zili] German Canc Consortium DKTK, Heidelberg, Germany	Chengdu University of Traditional Chinese Medicine; Xidian University; Chengdu University of Traditional Chinese Medicine; Sichuan University; Helmholtz Association; German Cancer Research Center (DKFZ)	Liu, JX (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	liujixin@life.xidian.edu.cn; acuresearch@126.com	Yuan, Kai/I-4150-2016; Gong, Qiyong/W-3052-2019; 秦, 伟/J-9770-2016	Yuan, Kai/0000-0002-3098-1124; Gong, Qiyong/0000-0002-5912-4871; 秦, 伟/0000-0003-4583-0406; Liang, Fanrong/0000-0003-2210-2027	National Basic Research Program of China (973 Program) [2012CB518501]; National Natural Science Foundation of China [30901900, 30930112, 81101108]; Project of Administration of Traditional Chinese Medicine of Sichuan Province [2012-E-038]; Project of Innovative Research Team Research Fund of Sichuan Provincial Education Department [12TD002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Administration of Traditional Chinese Medicine of Sichuan Province; Project of Innovative Research Team Research Fund of Sichuan Provincial Education Department	This study was supported by the National Basic Research Program of China (973 Program, No. 2012CB518501), National Natural Science Foundation of China (Nos. 30901900, 30930112, 81101108), the Project of Administration of Traditional Chinese Medicine of Sichuan Province (No. 2012-E-038), and the Project of Innovative Research Team Research Fund of Sichuan Provincial Education Department (No. 12TD002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderjan D, 2010, PAIN, V151, P97, DOI 10.1016/j.pain.2010.06.024; Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Buse DC, 2013, CEPHALALGIA, V33, P885, DOI 10.1177/0333102413477736; Choi EM, 2012, CHIN MED-UK, V7, DOI 10.1186/1749-8546-7-4; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; DEY P K, 1982, Indian Journal of Physiology and Pharmacology, V26, P3; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Granziera C, 2013, CEREBELLUM, V12, P812, DOI 10.1007/s12311-013-0491-x; Granziera C, 2014, HUM BRAIN MAPP, V35, P1461, DOI 10.1002/hbm.22266; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Kim JH, 2010, CEPHALALGIA, V30, P53, DOI 10.1111/j.1468-2982.2009.01890.x; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kou W, 2007, AM J CHINESE MED, V35, P753, DOI 10.1142/S0192415X07005247; Li P, 2004, CLIN AUTON RES, V14, P182, DOI 10.1007/s10286-004-0175-1; Li Y, 2012, CAN MED ASSOC J, V184, P401, DOI 10.1503/cmaj.110551; Li Y, 2009, HEADACHE, V49, P805, DOI 10.1111/j.1526-4610.2009.01424.x; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub2; Linde M, 2005, CEPHALALGIA, V25, P41, DOI 10.1111/j.1468-2982.2004.00803.x; Maleki N, 2013, BRAIN STRUCT FUNCT, V218, P903, DOI 10.1007/s00429-012-0437-y; Maleki N, 2012, BRAIN, V135, P2546, DOI 10.1093/brain/aws175; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Manack AN, 2011, CURR PAIN HEADACHE R, V15, P70, DOI 10.1007/s11916-010-0157-z; Moulton EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003799; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Otti A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-84; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Sheng K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084705; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smallwood RF, 2013, J PAIN, V14, P663, DOI 10.1016/j.jpain.2013.03.001; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stankewitz A, 2011, NEUROLOGY, V77, P476, DOI 10.1212/WNL.0b013e318227e4a8; Tfelt-Hansen P, 2000, CEPHALALGIA, V20, P765; Tjen-A-Looi SC, 2004, AM J PHYSIOL-REG I, V287, pR852, DOI 10.1152/ajpregu.00262.2004; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wang LP, 2011, PAIN, V152, P1864, DOI 10.1016/j.pain.2011.04.006; Xu SB, 2013, CAN MED ASSOC J, V185, P473, DOI 10.1503/cmaj.121108; Xue T, 2013, NMR BIOMED, V26, P1051, DOI 10.1002/nbm.2917; Xue T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052927; Yang J, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-123; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yuan K, 2013, J PAIN, V14, P836, DOI 10.1016/j.jpain.2013.02.010; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhao L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-85; Zhou W, 2005, J APPL PHYSIOL, V98, P872, DOI 10.1152/japplphysiol.01079.2004; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	56	52	66	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99538	10.1371/journal.pone.0099538	http://dx.doi.org/10.1371/journal.pone.0099538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915066	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700114
J	Apenteng, OO; Ismail, NA				Apenteng, Ofosuhene O.; Ismail, Noor Azina			The Impact of the Wavelet Propagation Distribution on SEIRS Modeling with Delay	PLOS ONE			English	Article							EPIDEMIC MODEL	Previous models of disease spread involving delay have used basic SIR (susceptible - infectious - recovery) formulae and approaches. This paper demonstrates how time-varying SEIRS (S - exposed -I -R -S) models can be extended with delay to produce wave propagations that simulate periodic wave fronts of disease spread in the context of population movements. The model also takes into account the natural mortality associated with the disease spread. Understanding the delay of an infectious disease is critical when attempting to predict where and how fast the disease will propagate. We use cellular automata to model the delay and its effect on the spread of infectious diseases where population movement occurs. We illustrate an approach using wavelet transform analysis to understand the impact of the delay on the spread of infectious diseases. The results indicate that including delay provides novel ways to understand the effects of migration and population movement on disease spread.	[Apenteng, Ofosuhene O.; Ismail, Noor Azina] Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia	Universiti Malaya	Apenteng, OO (corresponding author), Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia.	oapenten@siswa.um.edu.my; nazina@um.edu.my	ISMAIL, NOOR AZINA/B-5341-2010	ISMAIL, NOOR AZINA/0000-0001-8032-2162; Apenteng, Ofosuhene O./0000-0001-9991-1709	University of Malaya Research Grant [RP004J-13ICT]	University of Malaya Research Grant	This research is funded by the University of Malaya Research Grant (RP004J-13ICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2010, MODELING PROPAGATION, P1; Apenteng OO, 2012, USE CELLULAR AUTOMAT; Arino J, 2007, MATH BIOSCI, V206, P46, DOI 10.1016/j.mbs.2005.09.002; Athanassopoulos S, 2012, CELLULAR AUTOMATA SI, P63; Bhunu CP., 2011, J MATH MODEL ALGOR, V10, P31, DOI DOI 10.1007/S10852-010-9134-0; Bjornstad O., 2005, SEIR MODELS; Chan T., 2005, IMAGE PROCESSING ANA; Cui X, 2012, WHAT DOES WAVELET TR; Das P., 2011, J MATH MODELLING ALG, V10, P181, DOI [10.1007/s10852-010-9148-7, DOI 10.1007/S10852-010-9148-7]; De la Sen M, 2010, ADV DIFFER EQU-NY, DOI 10.1155/2010/281612; Kaddar A, 2011, COMPARISON DELAYED S, V16; Keeling MJ, 2008, MODELING INFECT DIS, P1; Kim H-J, 2001, CONTINUOUS MODEL TRA; Landguth EL, 2007, CELLULAR AUTOMATA SI, P1; Meng XZ, 2007, APPL MATH MECH-ENGL, V28, P1259, DOI 10.1007/s10483-007-0914-x; Naresh R, 2006, APPL MATH COMPUT, V178, P262, DOI 10.1016/j.amc.2005.11.041; Ozalp N, 2011, MATH COMPUT MODEL, V54, P1, DOI 10.1016/j.mcm.2010.12.051; Shuai Z., 2011, CAN APPL MATH Q, V19, P235; Thornley S, 2008, J THEOR BIOL, V254, P599, DOI 10.1016/j.jtbi.2008.06.022; Van den Driessche P., MATH BIOSCIENCES, V180, P29; Yan P, 2006, ANZIAM J, V48, P119, DOI 10.1017/S144618110000345X	21	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98288	10.1371/journal.pone.0098288	http://dx.doi.org/10.1371/journal.pone.0098288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911023	Green Published, gold			2022-12-27	WOS:000337165600131
J	Gozdzik, W; Adamik, B; Gozdzik, A; Rachwalik, M; Kustrzycki, W; Kubler, A				Gozdzik, Waldemar; Adamik, Barbara; Gozdzik, Anna; Rachwalik, Maciej; Kustrzycki, Wojciech; Kuebler, Andrzej			Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass Use	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; RISK PREDICTION; MORTALITY; RELEASE; SUPAR; ATHEROSCLEROSIS; EXPRESSION; MECHANISMS; MIGRATION; BIOMARKER	Objective and Design: The soluble urokinase plasminogen activator receptor (suPAR) has been recently recognized as a potential biological marker of various disease states, but the impact of a major surgical intervention on the suPAR level has not yet been established. The aim of our study was to investigate if the induction of a systemic inflammatory reaction in response to cardiopulmonary bypass would be accompanied by an increase in the plasma suPAR level. Methods and Subjects: Patients undergoing coronary artery bypass grafting under cardiopulmonary bypass (CPB) were added. Based on the baseline suPAR level, patients were divided into group 1 (suPAR within normal range) or group 2 (suPAR above range). Blood was collected before the induction of anesthesia and 6 and 24 hours after surgery. Plasma suPAR, IL-6, IL-8, TNF-a, troponin I, NT-proBNP, and NGAL were quantified to assess the impact of surgical trauma on these markers. Results: The baseline suPAR level was within the normal range in 31 patients (3.3 ng/mL), and elevated in 29 (5.1 ng/mL) (p, 0.001). Baseline mediators of systemic inflammatory reaction concentrations (IL-6, TNF-alpha, and IL-8) and organ injury indices (troponin I, NT-proBNP, and NGAL) were low and increased after surgery in all patients (p < 0.05). The surgery did not cause significant changes in the suPAR level either at 6 or 24 hours after, however the difference between groups observed at baseline remained substantial during the postoperative period. Conclusions: There was no change in the suPAR level observed in patients subjected to elective cardiac coronary artery bypass surgery and CPB, despite activation of a systemic inflammatory reaction.	[Gozdzik, Waldemar; Adamik, Barbara; Kuebler, Andrzej] Wroclaw Med Univ, Dept Anesthesiol & Intens Therapy, Wroclaw, Poland; [Gozdzik, Anna; Rachwalik, Maciej; Kustrzycki, Wojciech] Wroclaw Med Univ, Dept Cardiac Surg, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University	Gozdzik, W (corresponding author), Wroclaw Med Univ, Dept Anesthesiol & Intens Therapy, Wroclaw, Poland.	waldemar.gozdzik@gmail.com	Adamik, Barbara/H-8696-2016	Adamik, Barbara/0000-0002-0541-841X; Rachwalik, Maciej/0000-0001-9714-4059; Gozdzik, Anna/0000-0002-8182-5586; Gozdzik, Waldemar/0000-0001-8668-1641	Wroclaw Medical University [ST-449, ST-641]	Wroclaw Medical University	This project was supported by grant ST-449 and ST-641 awarded by the Wroclaw Medical University; the funding was given to the Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghel A, 2010, J CARD FAIL, V16, P49, DOI 10.1016/j.cardfail.2009.07.003; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Aouifi A, 2012, BRIT J ANAESTH, V83, P602; Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2; Backes Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10550; Belhaj Asmae, 2012, Recent Pat Cardiovasc Drug Discov, V7, P165; Boeken U, 2002, THORAC CARDIOV SURG, V50, P136, DOI 10.1055/s-2002-32404; Chavakis T, 2001, THROMB HAEMOSTASIS, V86, P686, DOI 10.1055/s-0037-1616105; De Witte H, 1998, INT J CANCER, V77, P236, DOI 10.1002/(SICI)1097-0215(19980717)77:2<236::AID-IJC12>3.0.CO;2-9; Donadello K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-2; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gustafsson A, 2012, BIOMARK INSIGHTS, V7, P39, DOI 10.4137/BMI.S9460; Hammer S, 2012, THORAC CARDIOVASC SU, V49, P349; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Kofoed K, 2008, EUR J CLIN MICROBIOL, V27, P375, DOI 10.1007/s10096-007-0447-5; Kozik DJ, 2006, ANN THORAC SURG, V81, pS2347, DOI 10.1016/j.athoracsur.2006.02.073; Krejsek J, 2011, PERFUSION-UK, V26, P115, DOI 10.1177/0267659110389845; Kruger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058506; Lyngbaek S, 2013, CLIN CHEM, V59, P1621, DOI 10.1373/clinchem.2013.203778; Lyngbaek S, 2013, INT J CARDIOL, V167, P2904, DOI 10.1016/j.ijcard.2012.07.018; Lyngbaek S, 2012, AM J CARDIOL, V110, P1756, DOI 10.1016/j.amjcard.2012.08.008; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Montuori N, 2005, THROMB HAEMOSTASIS, V93, P192, DOI 10.1160/TH04-09-0580; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Ostergaard C, 2004, SCAND J INFECT DIS, V36, P14, DOI 10.1080/00365540310017366; Ostrowski SR, 2005, SCAND J IMMUNOL, V61, P197, DOI 10.1111/j.0300-9475.2005.01547.x; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pedersen TL, 2000, ULTRASTRUCT PATHOL, V24, P175, DOI 10.1080/01913120050132912; Pliyev BK, 2009, MOL CELL BIOCHEM, V321, P111, DOI 10.1007/s11010-008-9925-z; Rabna P, 2010, INFLAMMATION, V33, P374, DOI 10.1007/s10753-010-9195-2; Rossaint J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045738; Samy K, 2012, ANN CARD ANAESTH, V15, P199, DOI 10.4103/0971-9784.97976; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Suberviola B, 2013, INTENS CARE MED, V39, P1945, DOI 10.1007/s00134-013-3056-z; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Wittenhagen P, 2004, CLIN MICROBIOL INFEC, V10, P409, DOI 10.1111/j.1469-0691.2004.00850.x	41	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98923	10.1371/journal.pone.0098923	http://dx.doi.org/10.1371/journal.pone.0098923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911522	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600025
J	Greiman, SE; Tkach, VV; Pulis, E; Fayton, TJ; Curran, SS				Greiman, Stephen E.; Tkach, Vasyl V.; Pulis, Eric; Fayton, Thomas J.; Curran, Stephen S.			Large Scale Screening of Digeneans for Neorickettsia Endosymbionts Using Real-Time PCR Reveals New Neorickettsia Genotypes, Host Associations and Geographic Records	PLOS ONE			English	Article							FLUORESCENT-ANTIBODY TEST; SALMON POISONING DISEASE; RISTICII GENOMIC DNA; TREMATODES; AGENT; FLUKE; FISH; MICROBIOTA; DIVERSITY; SENNETSU	Digeneans are endoparasitic flatworms with complex life cycles including one or two intermediate hosts (first of which is always a mollusk) and a vertebrate definitive host. Digeneans may harbor intracellular endosymbiotic bacteria belonging to the genus Neorickettsia (order Rickettsiales, family Anaplasmataceae). Some Neorickettsia are able to invade cells of the digenean's vertebrate host and are known to cause diseases of wildlife and humans. In this study we report the results of screening 771 digenean samples for Neorickettsia collected from various vertebrates in terrestrial, freshwater, brackish, and marine habitats in the United States, China and Australia. Neorickettsia were detected using a newly designed real-time PCR protocol targeting a 152 bp fragment of the heat shock protein coding gene, GroEL, and verified with nested PCR and sequencing of a 1371 bp long region of 16S rRNA. Eight isolates of Neorickettsia have been obtained. Sequence comparison and phylogenetic analysis demonstrated that 7 of these isolates, provisionally named Neorickettsia sp. 1-7 (obtained from allocreadiid Crepidostomum affine, haploporids Saccocoelioides beauforti and Saccocoelioides lizae, faustulid Bacciger sprenti, deropegid Deropegus aspina, a lecithodendriid, and a pleurogenid) represent new genotypes and one (obtained from Metagonimoides oregonensis) was identical to a published sequence of Neorickettsia known as SF agent. All digenean species reported in this study represent new host records. Three of the 6 digenean families (Haploporidae, Pleurogenidae, and Faustulidae) are also reported for the first time as hosts of Neorickettsia. We have detected Neorickettsia in digeneans from China and Australia for the first time based on PCR and sequencing evidence. Our findings suggest that further surveys from broader geographic regions and wider selection of digenean taxa are likely to reveal new Neorickettsia lineages as well as new digenean host associations.	[Greiman, Stephen E.; Tkach, Vasyl V.] Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Pulis, Eric; Fayton, Thomas J.; Curran, Stephen S.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA	University of North Dakota Grand Forks; University of Southern Mississippi	Greiman, SE (corresponding author), Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA.	stephen.greiman@my.und.edu	Pulis, Eric/AAF-4312-2020	Pulis, Eric/0000-0002-1695-7953; Tkach, Vasyl/0000-0001-5084-7566	National Institutes of Health, USA [R15AI092622]; US Fish and Wildlife Service/Mississippi Department of Marine Resources; MSCIAP [MS.R.798, M10AF20151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI092622] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Fish and Wildlife Service/Mississippi Department of Marine Resources; MSCIAP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the grant R15AI092622 from the National Institutes of Health, USA, and US Fish and Wildlife Service/Mississippi Department of Marine Resources MSCIAP MS.R.798 Award M10AF20151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlough JE, 1997, VET PARASITOL, V68, P367, DOI 10.1016/S0304-4017(96)01083-7; BRAY RA, 1982, J NAT HIST, V16, P23, DOI 10.1080/00222938200770031; BURCH JB, 1989, N AM FRESHWATER SNAI; CHAPIN E. A., 1926, N AM VET, V7, P42; Coimbra H.S., 2005, Arq. Inst. Biol., V72, P325, DOI 10.1590/1808-1657v72p3252005; Cribb TH, 1999, SYST PARASITOL, V44, P119, DOI 10.1023/A:1006248418404; Cribb Thomas H., 2001, Systematics Association Special Volume Series, V60, P168; Donham CR, 1925, SCIENCE, V61, P341, DOI 10.1126/science.61.1578.341; FARRELL RK, 1973, AM J VET RES, V34, P919; FUKUDA T, 1981, JPN J MED SCI BIOL, V34, P103, DOI 10.7883/yoken1952.34.103; Fukuda T, 1973, Kansenshogaku Zasshi, V47, P474; Fukuda T., 1954, MED BIOL, V32, P200; Gibson D. I., 2008, KEYS TREMATODA, V3; Gibson DI, 2005, KEYS TREMATODA, V2; Gibson DI, 2002, KEYS TREMATODA, V1; Gibson KE, 2005, ENVIRON MICROBIOL, V7, P203, DOI 10.1111/j.1462-2920.2004.00683.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Headley SA, 2011, VET J, V187, P165, DOI 10.1016/j.tvjl.2009.11.019; Hirai K, 1966, Kumamoto Igakkai Zasshi, V40, P1159; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNTER WANDA SANBORN, 1961, TRANS AMER MICROS SOC, V80, P176, DOI 10.2307/3223906; KATSUTA I, 1931, TAIWAN IGAKKAI ZASSH, V30, P1404; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Liu Sheng-fa, 2002, Journal of Oceanography in Taiwan Strait, V21, P37; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; MADIGAN JE, 1995, J AM VET MED ASSOC, V207, P1448; Madigan JE, 2000, VET CLIN N AM-EQUINE, V16, P487, DOI 10.1016/S0749-0739(17)30091-3; McCAULEY JAMES E., 1961, TRANS AMER MICROSC, V80, P373, DOI 10.2307/3223651; Mott J, 1997, J CLIN MICROBIOL, V35, P2215, DOI 10.1128/JCM.35.9.2215-2219.1997; Newton PN, 2009, AM J TROP MED HYG, V81, P190, DOI 10.4269/ajtmh.2009.81.190; OVERSTRE.RM, 1971, J PARASITOL, V57, P967, DOI 10.2307/3277846; Philip CB., 1953, 6TH INT C MICR REP P, V2, P256; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pusterla N, 2000, VET PARASITOL, V90, P129, DOI 10.1016/S0304-4017(00)00227-2; Pusterla N, 2003, J HELMINTHOL, V77, P335, DOI 10.1079/JOH2003181; Pusterla N, 2000, VET PARASITOL, V92, P199, DOI 10.1016/S0304-4017(00)00287-9; RIKIHISA Y, 1985, INFECT IMMUN, V49, P513, DOI 10.1128/IAI.49.3.513-517.1985; RIKIHISA Y, 1991, CLIN MICROBIOL REV, V4, P286, DOI 10.1128/CMR.4.3.286-308.1991; Seng P, 2009, CLIN MICROBIOL INFEC, V15, P88, DOI 10.1111/j.1469-0691.2008.02252.x; SHISHIDO A, 1965, JPN J MED SCI BIOL, V18, P73, DOI 10.7883/yoken1952.18.73; Tachibana N., 1986, MICROBIOLOGY 1986, P205; Tkach V, 1999, ACTA PARASITOL, V44, P147; Tkach VV, 2012, ACTA PARASITOL, V57, P285, DOI 10.2478/s11686-012-0043-4; Tkach VV, 2012, J PARASITOL, V99, P1114; Vaughan JA, 2012, ADV PARASIT, V79, P253, DOI 10.1016/B978-0-12-398457-9.00003-2; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Wen BH, 1996, INT J SYST BACTERIOL, V46, P149, DOI 10.1099/00207713-46-1-149	49	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98453	10.1371/journal.pone.0098453	http://dx.doi.org/10.1371/journal.pone.0098453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911315	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600005
J	Hawley, J; Simpson, SJ; Wilder, SM				Hawley, Jesse; Simpson, Stephen J.; Wilder, Shawn M.			Effects of Prey Macronutrient Content on Body Composition and Nutrient Intake in a Web-Building Spider	PLOS ONE			English	Article							PREDATORS; HOMEOSTASIS; INSECTS	The nutritional composition of diets can vary widely in nature and have large effects on the growth, reproduction and survival of animals. Many animals, especially herbivores, will tightly regulate the nutritional composition of their body, which has been referred to as nutritional homeostasis. We tested how experimental manipulation of the lipid and protein content of live prey affected the nutrient reserves and subsequent diet regulation of web-building spiders, Argiope keyserlingi. Live locusts were injected with experimental solutions containing specific amounts of lipid and protein and then fed to spiders. The nutrient composition of the spiders' bodies was directly related to the nutrient composition of the prey on which they fed. We then conducted an experiment where spiders were fed either high lipid or high protein prey and subsequently provided with two large unmanipulated locusts. Prior diet did not affect the amount or ratio of lipid and protein ingested by spiders when feeding on unmanipulated prey. Argiope keyserlingi were flexible in the storage of lipid and protein in their bodies and did not bias their extraction of nutrients from prey to compensate for previously biased diets. Some carnivores, especially those that experience frequent food limitation, may be less likely to strictly regulate their body composition than herbivores because food limitation may encourage opportunistic ingestion and assimilation of nutrients.	[Wilder, Shawn M.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Wilder, SM (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	shawn.wilder@sydney.edu.au		Simpson, Stephen J./0000-0003-0256-7687; Wilder, Shawn/0000-0003-0359-7220	Australian Research Council; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	The Australian Research Council and the University of Sydney funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry KL, 2013, OIKOS, V122, P1058, DOI 10.1111/j.1600-0706.2012.00164.x; BELL WJ, 1975, BIOL REV, V50, P373, DOI 10.1111/j.1469-185X.1975.tb01058.x; Bilde T, 1998, OECOLOGIA, V115, P54, DOI 10.1007/s004420050490; Clissold FJ, 2010, P ROY SOC B-BIOL SCI, V277, P1751, DOI 10.1098/rspb.2009.2045; Jensen K, 2011, ANIM BEHAV, V81, P993, DOI 10.1016/j.anbehav.2011.01.035; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Kim KW, 2012, BEHAV ECOL SOCIOBIOL, V66, P1569, DOI 10.1007/s00265-012-1410-8; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Overgaard J, 2012, COMP PHYSL FASTING S; Pekar S, 2010, ANIM BEHAV, V79, P1301, DOI 10.1016/j.anbehav.2010.03.002; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; Simpson SJ, 2012, NATURE NUTR UNIFYING; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Toft S, 2010, PHYSIOL ENTOMOL, V35, P317, DOI 10.1111/j.1365-3032.2010.00746.x; Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114; Wang H, 2012, ECOL MODEL, V243, P81, DOI 10.1016/j.ecolmodel.2012.06.003; Wilder SM, 2013, ECOL LETT, V16, P895, DOI 10.1111/ele.12116; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Wise DH, 1993, SPIDERS ECOLOGICAL W	24	12	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99165	10.1371/journal.pone.0099165	http://dx.doi.org/10.1371/journal.pone.0099165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911958	gold, Green Submitted, Green Published			2022-12-27	WOS:000337165600048
J	Hur, H; Paik, MJ; Xuan, Y; Nguyen, DT; Ham, IH; Yun, J; Cho, YK; Lee, G; Han, SU				Hur, Hoon; Paik, Man Jeong; Xuan, Yi; Duc-Toan Nguyen; Ham, In-Hye; Yun, Jisoo; Cho, Yong Kwan; Lee, Gwang; Han, Sang-Uk			Quantitative Measurement of Organic Acids in Tissues from Gastric Cancer Patients Indicates Increased Glucose Metabolism in Gastric Cancer	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; POSITRON-EMISSION-TOMOGRAPHY; BREAST-CANCER; CELLS; SPECTROSCOPY; CHEMOTHERAPY; METASTASIS; EXPRESSION; PREDICTION; PHENOTYPE	The levels of organic acids representing metabolic pathway end products are important indicators of physiological status, and may be associated with metabolic changes in cancer. The aim of this study is to investigate the levels of organic acids in cancerous and normal tissues from gastric cancer patients and to confirm the role of metabolic alterations in gastric carcinogenesis. Organic acids in normal and cancerous tissues from forty-five patients with gastric adenocarcinoma were investigated by gas chromatography-mass spectrometry in selected ion monitoring mode as methoxime/ tert-butyldimethylsilyl derivatives. We analysed the significant differences in the levels of organic acids in normal and cancer tissues and investigated the correlation of these levels in cancer tissues with clinicopathological features. The levels of Krebs cycle components, including alpha-ketoglutaric acid, succinic acid, fumaric acid, malic acid and oxaloacetic acid, were significantly increased in cancer tissues compared to normal tissues. In addition, the levels of glycolytic products, including pyruvic acid and lactic acid, as well as the levels of ketone bodies, including 3-hydroxybutyric acid, were also significantly increased in cancer tissues compared to normal tissues. The levels of ketone bodies in cancer tissues with differentiated histology and in intestinal-type cancer tissues were significantly increased. The organic acid profiling analysis described here may be a generally useful clinical tool for understanding the complexity of metabolic events in gastric adenocarcinoma, and organic acids may have potential as metabolic markers for the future discovery of diagnostic and therapeutic modalities.	[Hur, Hoon; Xuan, Yi; Ham, In-Hye; Yun, Jisoo; Cho, Yong Kwan; Han, Sang-Uk] Ajou Univ, Sch Med, Dept Surg, Suwon 441749, South Korea; [Hur, Hoon; Ham, In-Hye; Yun, Jisoo; Lee, Gwang; Han, Sang-Uk] Ajou Univ, Sch Med, Inst Gastr Canc Mech, Suwon 441749, South Korea; [Paik, Man Jeong] Suncheon Natl Univ, Coll Pharm, Sunchon, South Korea; [Xuan, Yi] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Duc-Toan Nguyen] Natl Inst Drug Qual Control, Hanoi, Vietnam; [Lee, Gwang] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea	Ajou University; Ajou University; Sunchon National University; Fudan University; Ajou University	Lee, G (corresponding author), Ajou Univ, Sch Med, Inst Gastr Canc Mech, Suwon 441749, South Korea.	glee@ajou.ac.kr; hansu@ajou.ac.kr	Hur, Hoon/AAI-1396-2019; Ham, in-hye/ABI-7969-2020; Nguyen, Duc Toan/B-3536-2010	Hur, Hoon/0000-0002-5435-5363; Ham, in-hye/0000-0002-3168-5597; Nguyen, Duc Toan/0000-0002-3283-3504	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1012602]; Priority Research Centres Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0093826]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Priority Research Centres Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (2012R1A1A1012602), and the Priority Research Centres Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (2009-0093826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Fujii M, 2010, SURG TODAY, V40, P295, DOI 10.1007/s00595-009-4148-9; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Gribbestad IS, 1999, ANTICANCER RES, V19, P1737; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; KALLINOWSKI F, 1988, CANCER RES, V48, P7264; Kang H, 2011, CURR TREAT OPTION ON, V12, P96, DOI 10.1007/s11864-010-0135-z; Kawamura T, 2001, CANCER-AM CANCER SOC, V92, P634, DOI 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin LL, 2012, J PROTEOMICS, V75, P3081, DOI 10.1016/j.jprot.2012.03.046; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Noguchi Y, 1999, HEPATO-GASTROENTEROL, V46, P2683; Paik MJ, 2008, BIOMED CHROMATOGR, V22, P450, DOI 10.1002/bmc.966; Paik MJ, 2010, CLIN CHIM ACTA, V411, P1532, DOI 10.1016/j.cca.2010.05.034; Paik MJ, 2005, J CHROMATOGR B, V821, P94, DOI 10.1016/j.jchromb.2005.04.011; RICHTSMEIER WJ, 1987, CANCER RES, V47, P5230; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Song H, 2011, ONCOL REP, V26, P431, DOI 10.3892/or.2011.1302; Tian JH, 2004, NUCL MED COMMUN, V25, P825, DOI 10.1097/01.mnm.0000135042.54461.f6; WARBURG O, 1956, SCIENCE, V124, P269; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Wieder HA, 2004, J CLIN ONCOL, V22, P900, DOI 10.1200/JCO.2004.07.122; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	31	30	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98581	10.1371/journal.pone.0098581	http://dx.doi.org/10.1371/journal.pone.0098581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911788	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600001
J	Jang, HC; Choi, OJ; Kim, GS; Jang, MO; Kang, SJ; Jung, SI; Shin, JH; Chun, BJ; Park, KH				Jang, Hee-Chang; Choi, Ok-Ja; Kim, Gwang-Sook; Jang, Mi-Ok; Kang, Seung-Ji; Jung, Sook-In; Shin, Jong-Hee; Chun, Byeong Jo; Park, Kyung-Hwa			Active Surveillance of the Trachea or Throat for MRSA Is More Sensitive than Nasal Surveillance and a Better Predictor of MRSA Infections among Patients in Intensive Care	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; VENTILATOR-ASSOCIATED PNEUMONIA; COLONIZATION; CULTURES; UNIT; SWABS; ADMISSION; BACTEREMIA; CARRIAGE; THERAPY	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of infection in the intensive care unit (ICU). Although surveillance culture for MRSA is recommended for ICU patients, no comparative study investigating the optimal sites and frequency of culture has been performed in this population. Methods: A prospective observational cohort study was performed in an 18-bed emergency intensive care unit (EICU) in a tertiary teaching hospital. A total of 282 patients were included. Samples for MRSA detection were obtained at the time of admission, 48 h after admission, and then weekly thereafter. All subjects were routinely monitored for the development of MRSA infection during their stay in the ICU. Results: MRSA colonization was detected in 129 (46%) patients over the course of the study. The sensitivity of MRSA surveillance culture was significantly higher in throat or tracheal aspirates (82%; 106/129) than in anterior nares (47%; 61/ 129) (P < 0.001). The sensitivity of MRSA surveillance culture for subsequent MRSA infection and MRSA pneumonia was also higher in the throat/trachea (69 and 93%, respectively) than in the anterior nares (48 and 50%, respectively). The area under the curve for subsequent MRSA infection was higher in trachea/throat (0.675) than in the anterior nares (0.648); however, this difference was not significant (P > 0.05). The area under the curve for MRSA pneumonia was significantly higher in trachea/throat (0.791; 95% CI, 0.739-0.837) than anterior nares (0.649; 95% CI, 0.590-0.705) (P = 0.044). Conclusion: MRSA colonization was more common in the trachea/throat than in the anterior nares in ICU patients. Cultures from throat or tracheal aspirates were more sensitive and predictive of subsequent MRSA pneumonia than cultures from the anterior nares in this population.	[Jang, Hee-Chang; Jang, Mi-Ok; Kang, Seung-Ji; Jung, Sook-In; Park, Kyung-Hwa] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Choi, Ok-Ja; Kim, Gwang-Sook; Park, Kyung-Hwa] Chonnam Natl Univ Hosp, Off Infect Control, Kwangju, South Korea; [Shin, Jong-Hee] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea; [Chun, Byeong Jo] Chonnam Natl Univ, Sch Med, Dept Emergency Med, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University	Park, KH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea.	iammedkid@naver.com		Kang, Seung ji/0000-0002-3298-0520; Jang, Hee-Chang/0000-0002-3407-8493; jeon, byeongjo/0000-0002-5240-4213	Chonnam National University Hospital [CRI 10087-1]	Chonnam National University Hospital	This study was supported by research funds from Chonnam National University Hospital, 2010 (CRI 10087-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydiner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043935; Baker SE, 2010, INFECT CONT HOSP EP, V31, P42, DOI 10.1086/649222; Batra R, 2008, INTENS CARE MED, V34, P1703, DOI 10.1007/s00134-008-1153-1; Bignardi GE, 2009, J HOSP INFECT, V71, P373, DOI 10.1016/j.jhin.2009.01.003; Bitterman Y, 2010, EUR J CLIN MICROBIOL, V29, P391, DOI 10.1007/s10096-009-0869-3; Boyce JM, 2013, ANTIMICROB AGENTS CH, V57, P1163, DOI 10.1128/AAC.01965-12; Chan JD, 2012, CRIT CARE MED, V40, P1437, DOI 10.1097/CCM.0b013e318243168e; Depuydt P, 2008, INTENS CARE MED, V34, P675, DOI 10.1007/s00134-007-0953-z; Depuydt PO, 2006, CRIT CARE MED, V34, P653, DOI 10.1097/01.CCM.0000201405.16525.34; Harbarth S, 2007, J CLIN MICROBIOL, V45, P1072, DOI 10.1128/JCM.02121-06; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049136; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Kyaw WM, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-33; Lloyd-Smith E, 2012, EPIDEMIOL INFECT, V140, P1721, DOI 10.1017/S0950268811002421; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P1040, DOI 10.1128/JCM.01745-09; Matheson A, 2012, INFECT CONT HOSP EP, V33, P803, DOI 10.1086/666639; McKinnell JA, 2013, INFECT CONT HOSP EP, V34, P161, DOI 10.1086/669095; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Papadomichelakis E, 2008, INTENS CARE MED, V34, P2169, DOI 10.1007/s00134-008-1247-9; Sarikonda KV, 2010, CRIT CARE MED, V38, P1991, DOI 10.1097/CCM.0b013e3181eeda3f; Senn L, 2012, CLIN MICROBIOL INFEC, V18, pE31, DOI 10.1111/j.1469-0691.2011.03724.x; Toschlog EA, 2012, CRIT CARE MED, V40, P1651, DOI 10.1097/CCM.0b013e3182474b27; Widmer AF, 2008, J CLIN MICROBIOL, V46, P835, DOI 10.1128/JCM.02276-07	29	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99192	10.1371/journal.pone.0099192	http://dx.doi.org/10.1371/journal.pone.0099192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911358	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600054
J	Li, XL; Gao, XY; Ren, ZP; Cao, YX; Wang, JF; Liang, GD				Li, Xiaolong; Gao, Xiaoyan; Ren, Zhoupeng; Cao, Yuxi; Wang, Jinfeng; Liang, Guodong			A Spatial and Temporal Analysis of Japanese Encephalitis in Mainland China, 1963-1975: A Period without Japanese Encephalitis Vaccination	PLOS ONE			English	Article							TORRES STRAIT; VIRUS; ASIA; INFECTIONS; AUSTRALIA; ABUNDANCE; OUTBREAK; DISTRICT; MALAYSIA; CLIMATE	More than a million Japanese encephalitis (JE) cases occurred in mainland China from the 1960s to 1970s without vaccine interventions. The aim of this study is to analyze the spatial and temporal pattern of JE cases reported in mainland China from 1965 to 1973 in the absence of JE vaccination, and to discuss the impacts of climatic and geographical factors on JE during that period. Thus, the data of reported JE cases at provincial level and monthly precipitation and monthly mean temperature from 1963 to 1975 in mainland China were collected. Local Indicators of Spatial Association analysis was performed to identify spatial clusters at the province level. During that period, The epidemic peaked in 1966 and 1971 and the JE incidence reached up to 20.58/100000 and 20.92/100000, respectively. The endemic regions can be divided into three classes including high, medium, and low prevalence regions. Through spatial cluster analysis, JE epidemic hot spots were identified; most were located in the Yangtze River Plain which lies in the southeast of China. In addition, JE incidence was shown to vary among eight geomorphic units in China. Also, the JE incidence in the Loess Plateau and the North China Plain was showed to increase with the rise of temperature. Likewise, JE incidence in the Loess Plateau and the Yangtze River Plain was observed a same trend with the increase of rainfall. In conclusion, the JE cases clustered geographically during the epidemic period. Besides, the JE incidence was markedly higher on the plains than plateaus. These results may provide an insight into the epidemiological characteristics of JE in the absence of vaccine interventions and assist health authorities, both in China and potentially in Europe and Americas, in JE prevention and control strategies.	[Li, Xiaolong; Gao, Xiaoyan; Cao, Yuxi; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Xiaolong; Gao, Xiaoyan; Cao, Yuxi; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Ren, Zhoupeng; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	Ren, Zhoupeng/AAV-2806-2020	Ren, Zhoupeng/0000-0003-1766-2820; Wang, Jinfeng/0000-0002-6687-9420; Li, Xiaolong/0000-0002-8396-2912	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	This work is supported by grants from National Natural Science Foundation of China (81290342), The Ministry of Science and Technology, China (2011CB504702) and Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; ArcGIS help 10.1, 2012, CLUST OUTL AN; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Elias C, 2009, LANCET INFECT DIS, V9, P7, DOI 10.1016/S1473-3099(08)70290-1; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; GINGRICH JB, 1992, J MED ENTOMOL, V29, P436, DOI 10.1093/jmedent/29.3.436; Gregory D., 2009, DICT HUMAN GEOGRAPHY; Halstead SBJJ, 2008, VACCINES-BASEL, V5th; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Hsu SM, 2008, EPIDEMIOL INFECT, V136, P980, DOI 10.1017/S0950268807009454; Impoinvil DE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002334; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Johansen CA, 2001, J MED ENTOMOL, V38, P581, DOI 10.1603/0022-2585-38.4.581; Li YX, 2011, EMERG INFECT DIS, V17, P934, DOI 10.3201/eid1705.101417; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Lindenbach BD, 2007, FIELDS VIROLOGY, P1102; Lvov DK, 1993, SOV MED REV E, P1; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; MOGI M, 1983, AM J TROP MED HYG, V32, P170, DOI 10.4269/ajtmh.1983.32.170; Murty US, 2010, J VECTOR DIS, V47, P26; Openshaw, 1984, CONCEPTS TECHNIQUES, V38; Saxena SK, 2009, J INFECT DEV COUNTR, V3, P517, DOI 10.3855/jidc.470; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; TAKAHASHI M, 1976, J MED ENTOMOL, V13, P275, DOI 10.1093/jmedent/13.3.275; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Vythilingam I, 1997, J MED ENTOMOL, V34, P257, DOI 10.1093/jmedent/34.3.257; Wang G, 2004, CHINESE J APPL METER, V15, P10; Wang LY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002285; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710	35	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99183	10.1371/journal.pone.0099183	http://dx.doi.org/10.1371/journal.pone.0099183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911168	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600052
J	Saliasi, E; Geerligs, L; Lorist, MM; Maurits, NM				Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.			Neural Correlates Associated with Successful Working Memory Performance in Older Adults as Revealed by Spatial ICA	PLOS ONE			English	Article							AGE-RELATED-CHANGES; VENTROLATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; FUNCTIONAL CONNECTIVITY; CORTICAL RECRUITMENT; BRAIN ACTIVATION; CONTROL NETWORK; FMRI; MAINTENANCE; STATE	To investigate which neural correlates are associated with successful working memory performance, fMRI was recorded in healthy younger and older adults during performance on an n-back task with varying task demands. To identify functional networks supporting working memory processes, we used independent component analysis (ICA) decomposition of the fMRI data. Compared to younger adults, older adults showed a larger neural ( BOLD) response in the more complex (2-back) than in the baseline (O-back) task condition, in the ventral lateral prefrontal cortex (VLPFC) and in the right fronto-parietal network (FPN). Our results indicated that a higher BOLD response in the VLPFC was associated with increased performance accuracy in older adults, in both the baseline and the more complex task condition. This `BOLD-performance' relationship suggests that the neural correlates linked with successful performance in the older adults are not uniquely related to specific working memory processes present in the complex but not in the baseline task condition. Furthermore, the selective presence of this relationship in older but not in younger adults suggests that increased neural activity in the VLPFC serves a compensatory role in the aging brain which benefits task performance in the elderly.	[Saliasi, Emi; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Geerligs, Linda; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Saliasi, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	e.saliasi@umcg.nl	Geerligs, Linda/D-5212-2013	Geerligs, Linda/0000-0002-1624-8380; Saliasi, Emi/0000-0003-1009-6010; Lorist, Monicque M./0000-0002-7361-093X; Maurits, Natasha/0000-0001-6231-7044				Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Backman L, 2011, NEUROBIOL AGING, V32, P1849, DOI 10.1016/j.neurobiolaging.2009.10.018; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett IJ, 2013, NEUROIMAGE, V72, P20, DOI 10.1016/j.neuroimage.2013.01.030; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Braver T. S., 2007, EXPLAINING MANY VARI, P76; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calhoun VD, 2004, NEUROIMAGE, V22, P252, DOI 10.1016/j.neuroimage.2003.12.029; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Chen YN, 2008, CLIN NEUROPHYSIOL, V119, P1546, DOI 10.1016/j.clinph.2008.03.003; Cohen J., 1983, APPL MULTIPLE REGRES; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; de Fockert Jan W, 2005, Sci Aging Knowledge Environ, V2005, ppe34, DOI 10.1126/sageke.2005.44.pe34; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Geerligs L, 2012, HUM BRAIN MAPP; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Habeck C, 2012, BRAIN RES, V1467, P27, DOI 10.1016/j.brainres.2012.05.045; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Klarborg B, 2012, HUM BRAIN MAPP; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Meier TB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00281; Morcom AM, 2007, CEREB CORTEX, V17, P2491, DOI 10.1093/cercor/bhl155; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2013, PERSPECT PSYCHOL SCI, V8, P62, DOI 10.1177/1745691612469034; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2007, CORTEX, V43, P65, DOI 10.1016/S0010-9452(08)70446-5; Sala-Llonch R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00152; Saliasi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063701; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schmand B., 1992, NEDERLANDSE LEESTEST; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, NEUROSCI BIOBEHAV R, V34, P1178, DOI 10.1016/j.neubiorev.2010.01.009; Stevens WD, 2008, J NEUROSCI, V28, P12820, DOI 10.1523/JNEUROSCI.2622-08.2008; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Uterwijk J., 2001, WAIS 3 NEDERLANDSTAL; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wolf RC, 2006, NEUROPSYCHOLOGIA, V44, P2558, DOI 10.1016/j.neuropsychologia.2006.05.015; Xu J., 2013, NEUROIMAGE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99250	10.1371/journal.pone.0099250	http://dx.doi.org/10.1371/journal.pone.0099250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911016	Green Published, gold			2022-12-27	WOS:000337165600060
J	Commandeur, S; Coppola, M; Dijkman, K; Friggen, AH; van Meijgaarden, KE; Van den Eeden, SJF; Wilson, L; Van der Ploeg-van Schip, JJ; Franken, KLMC; Geluk, A; Ottenhoff, THM				Commandeur, Susanna; Coppola, Mariateresa; Dijkman, Karin; Friggen, Annemieke H.; van Meijgaarden, Krista E.; Van den Eeden, Susan J. F.; Wilson, Louis; Van der Ploeg-van Schip, Jolien J.; Franken, Kees L. M. C.; Geluk, Annemieke; Ottenhoff, Tom H. M.			Clonal Analysis of the T-Cell Response to In Vivo Expressed Mycobacterium tuberculosis Protein Rv2034, Using a CD154 Expression Based T-Cell Cloning Method	PLOS ONE			English	Article							CD40 LIGAND; TRANSCRIPTION FACTOR; CD4(+); ANTIGENS; IDENTIFICATION; RESTRICTION; PEPTIDES; EPITOPES; VACCINE; TCR	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of death worldwide. A better understanding of the role of CD4(+) and CD8(+) T cells, which are both important to TB protection, is essential to unravel the mechanisms of protection and to identify the key antigens seen by these T cells. We have recently identified a set of in vivo expressed Mtb genes (IVE-TB) which is expressed during in vivo pulmonary infection in mice, and shown that their encoded antigens are potently recognized by polyclonal T cells from tuberculin skin test-positive, in vitro ESAT-6/CFP10-responsive individuals. Here we have cloned T cells specific for one of these newly identified in vivo expressed Mtb (IVE-TB) antigens, Rv2034. T cells were enriched based on the expression of CD154 (CD40L), which represents a new method for selecting antigen-specific (low frequency) T cells independent of their specific function. An Rv2034-specific CD4(+) T-cell done expressed the Th1 markers T-bet, IFN-gamma, TNF-alpha, IL-2 and the cytotoxicity related markers granzyme B and CD107a as measured by flow cytometry. The clone specifically recognized Rv2034 protein, Rv2034 peptide p81-100 and Mtb lysate. Remarkably, while the recognition of the dominant p81-100 epitope was HLA-DR restricted, the T-cell clone also recognized a neighboring epitope (p88-107) in an HLA-DR- as well as HLA-DQ1-restricted fashion. Importantly, the T-cell clone was able to inhibit Mtb outgrowth from infected monocytes significantly. The characterization of the polyfunctional and Mtb inhibitory T-cell response to WE-TB Rv2034 at the clonal level provides detailed further insights into the potential of WE-TB antigens as new vaccine candidate antigens in TB. Our new approach allowed the identification of T-cell subsets that likely play a significant role in controlling Mtb infection, and can be applied to the analysis of T-cell responses in patient populations.	[Commandeur, Susanna; Coppola, Mariateresa; Dijkman, Karin; Friggen, Annemieke H.; van Meijgaarden, Krista E.; Van den Eeden, Susan J. F.; Wilson, Louis; Van der Ploeg-van Schip, Jolien J.; Franken, Kees L. M. C.; Geluk, Annemieke; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	t.h.m.ottenhoff@lumc.nl	Franken, Kees/ABA-7095-2021; Dijkman, Karin/AAR-1994-2020	Franken, Kees/0000-0002-4747-6060; Dijkman, Karin/0000-0002-5395-505X	European Commission FP7 NEWTBVAC project [LSHP-CT-2003-503367]; FP7 VACTRAIN project; FP7 IDEA [FP7-HEALTH-2009-241642]; FP7 ADITEC [FP7-HEALTH-2010-280873]; FP7 EURIPRED, Top Institute Pharma [FP7-INFRA-2012-312661, D-101-1]; EDCTP (AE-TBC project) [IP_09_32040]	European Commission FP7 NEWTBVAC project; FP7 VACTRAIN project; FP7 IDEA; FP7 ADITEC; FP7 EURIPRED, Top Institute Pharma; EDCTP (AE-TBC project)	This study was supported by the European Commission FP7 NEWTBVAC project (LSHP-CT-2003-503367); FP7 VACTRAIN project; FP7 IDEA (FP7-HEALTH-2009-241642); FP7 ADITEC (FP7-HEALTH-2010-280873); FP7 EURIPRED (FP7-INFRA-2012-312661) Top Institute Pharma (project D-101-1); and EDCTP (AE-TBC project grant agreement No. IP_09_32040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Arden Bernhard, 1995, Immunogenetics, V42, P455; Axelsson-Robertson R, 2010, IMMUNOLOGY, V129, P496, DOI 10.1111/j.1365-2567.2009.03201.x; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bastian M, 2008, J IMMUNOL, V180, P3436, DOI 10.4049/jimmunol.180.5.3436; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Boer MC, 2013, EUR J IMMUNOL; Caccamo N, 2003, CLIN EXP IMMUNOL, V133, P260, DOI 10.1046/j.1365-2249.2003.02201.x; Commandeur S, 2013, J IMMUNOL; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Corti D, 2011, CURR OPIN IMMUNOL, V23, P430, DOI 10.1016/j.coi.2011.04.006; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Derrick SC, 2007, IMMUNOLOGY, V120, P192, DOI 10.1111/j.1365-2567.2006.02491.x; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Geluk A, 1997, IMMUNOLOGY, V90, P370, DOI 10.1111/j.1365-2567.1997.00370.x; GELUK A, 1992, J IMMUNOL, V149, P2864; Geluk A, 2012, VACCINE, V30, P7513, DOI 10.1016/j.vaccine.2012.10.045; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Hatton RD, 2003, SCIENCE, V302, P993, DOI 10.1126/science.1092040; HERMANN P, 1995, EUR J IMMUNOL, V25, P2972, DOI 10.1002/eji.1830251039; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HORNER AA, 1995, J EXP MED, V181, P1239, DOI 10.1084/jem.181.3.1239; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lindgren H, 2001, J IMMUNOL, V166, P4578, DOI 10.4049/jimmunol.166.7.4578; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McKinney DM, 2013, IMMUNOGENETICS; Moncrieffe H, 2010, J IMMUNOL, V185, P134, DOI 10.4049/jimmunol.0803474; Mustafa AS, 1999, INFECT IMMUN, V67, P5683, DOI 10.1128/IAI.67.11.5683-5689.1999; MUTIS T, 1993, EUR J IMMUNOL, V23, P2189, DOI 10.1002/eji.1830230921; Ottenhoff THM, 2012, INT J TUBERC LUNG D, V16, P1424, DOI 10.5588/ijtld.12.0479; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; OTTENHOFF THM, 1995, EUR J CLIN INVEST, V25, P371, DOI 10.1111/j.1365-2362.1995.tb01716.x; OTTENHOFF THM, 1986, J EXP MED, V164, P1923, DOI 10.1084/jem.164.6.1923; OTTENHOFF THM, 1986, NATURE, V319, P66, DOI 10.1038/319066a0; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2010, CURR PROTOC CYTOM; Pinheiro MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050923; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sospedra M, 2010, J IMMUNOL METHODS, V353, P93, DOI 10.1016/j.jim.2009.12.006; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Triplett TA, 2012, EUR J IMMUNOL, V42, P1893, DOI 10.1002/eji.201242444; Unger WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049213; Wehler TC, 2008, J IMMUNOL METHODS, V339, P23, DOI 10.1016/j.jim.2008.07.017; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yousef S, 2012, J IMMUNOL, V189, P3618, DOI 10.4049/jimmunol.1201612; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	69	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99203	10.1371/journal.pone.0099203	http://dx.doi.org/10.1371/journal.pone.0099203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905579	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000110
J	Sarkisova, SA; Lotlikar, SR; Guragain, M; Kubat, R; Cloud, J; Franklin, MJ; Patrauchan, MA				Sarkisova, Svetlana A.; Lotlikar, Shalaka R.; Guragain, Manita; Kubat, Ryan; Cloud, John; Franklin, Michael J.; Patrauchan, Marianna A.			A Pseudomonas aeruginosa EF-Hand Protein, EfhP (PA4107), Modulates Stress Responses and Virulence at High Calcium Concentration	PLOS ONE			English	Article							BINDING PROTEIN; SUPEROXIDE-DISMUTASE; OXYGEN LIMITATION; OXIDATIVE STRESS; SIGNAL PEPTIDES; CYSTIC-FIBROSIS; ENDOCARDITIS; EXPRESSION; MULTIPLE; ALGINATE	Pseudomonas aeruginosa is a facultative human pathogen, and a major cause of nosocomial infections and severe chronic infections in endocarditis and in cystic fibrosis (CF) patients. Calcium (Ca2+) accumulates in pulmonary fluids of CF patients, and plays a role in the hyperinflamatory response to bacterial infection. Earlier we showed that P. aeruginosa responds to increased Ca2+ levels, primarily through the increased production of secreted virulence factors. Here we describe the role of putative Ca2+-binding protein, with an EF-hand domain, PA4107 (EfhP), in this response. Deletion mutations of efhP were generated in P. aeruginosa strain PAO1 and CF pulmonary isolate, strain FRD1. The lack of EfhP abolished the ability of P. aeruginosa PAO1 to maintain intracellular Ca2+ homeostasis. Quantitative high-resolution 2D-PAGE showed that the efhP deletion also affected the proteomes of both strains during growth with added Ca2+. The greatest proteome effects occurred when the pulmonary isolate was cultured in biofilms. Among the proteins that were significantly less abundant or absent in the mutant strains were proteins involved in iron acquisition, biosynthesis of pyocyanin, proteases, and stress response proteins. In support, the phenotypic responses of FRD1 DefhP showed that the mutant strain lost its ability to produce pyocyanin, developed less biofilm, and had decreased resistance to oxidative stress (H2O2) when cultured at high [Ca2+]. Furthermore, the mutant strain was unable to produce alginate when grown at high [Ca2+] and no iron. The effect of the DefhP mutations on virulence was determined in a lettuce model of infection. Growth of wild-type P. aeruginosa strains at high [Ca2+] causes an increased area of disease. In contrast, the lack of efhP prevented this Ca2+-induced increase in the diseased zone. The results indicate that EfhP is important for Ca2+ homeostasis and virulence of P. aeruginosa when it encounters host environments with high [Ca2+].	[Sarkisova, Svetlana A.; Lotlikar, Shalaka R.; Guragain, Manita; Kubat, Ryan; Cloud, John; Patrauchan, Marianna A.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Franklin, Michael J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Franklin, Michael J.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Patrauchan, MA (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	m.patrauchan@okstate.edu	Guragain, Manita/AAW-9237-2021	Guragain, Manita/0000-0002-5266-1746; Kubat, Ryan/0000-0001-5899-2418	Public Health Service from the National Institute of Allergy and Infectious Diseases [AI-094268]; American Heart Association [09BGIA2330036]; OCAST [HR12-167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094268] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); OCAST; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI-094268 from the National Institute of Allergy and Infectious Diseases (M.J.F.), and research grants 09BGIA2330036 from American Heart Association and HR12-167 from OCAST (M.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Bicanic TA, 2002, J INFECTION, V44, P137, DOI 10.1053/jinf.2001.0926; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Bredenbruch F, 2006, ENVIRON MICROBIOL, V8, P1318, DOI 10.1111/j.1462-2920.2006.01025.x; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Campbell AK S-NG, 1993, BIOLUMINESCENT CHEMI, P58; Campbell AK, 2007, ARCH BIOCHEM BIOPHYS, V468, P107, DOI 10.1016/j.abb.2007.09.006; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Carty NL, 2006, MOL MICROBIOL, V61, P782, DOI 10.1111/j.1365-2958.2006.05269.x; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Guragain M, 2013, CELL CALCIUM, V54, P350, DOI 10.1016/j.ceca.2013.08.004; Halmerbauer G, 2000, CLIN EXP ALLERGY, V30, P1771, DOI 10.1046/j.1365-2222.2000.00988.x; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Herbaud ML, 1998, BBA-MOL CELL RES, V1448, P212, DOI 10.1016/S0167-4889(98)00145-1; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; Ishiwada N, 2005, CIRC J, V69, P1266, DOI 10.1253/circj.69.1266; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jones HE, 1999, CELL CALCIUM, V25, P265, DOI 10.1054/ceca.1999.0028; Kaye KS, 2006, ANTIMICROB AGENTS CH, V50, P2192, DOI 10.1128/AAC.00060-06; Kim EJ, 2003, MICROBIOL-SGM, V149, P2627, DOI 10.1099/mic.0.26276-0; KOMSHIAN SV, 1990, REV INFECT DIS, V12, P693; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; Lamont IL, 2002, P NATL ACAD SCI USA, V99, P7072, DOI 10.1073/pnas.092016999; Lau ATY, 2004, BIOCHEM J, V382, P641, DOI 10.1042/BJ20040224; Leganes F, 2009, MICROBIOL-SGM, V155, P25, DOI 10.1099/mic.0.022251-0; LORIN MI, 1976, J LAB CLIN MED, V88, P114; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Patrauchan MA, 2007, MICROBIOL-SGM, V153, P3838, DOI 10.1099/mic.0.2007/010371-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rada B, 2008, J IMMUNOL, V181, P4883, DOI 10.4049/jimmunol.181.7.4883; Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Redly GA, 2003, J BACTERIOL, V185, P1261, DOI 10.1128/JB.185.4.1261-1265.2003; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Tossavainen H, 2003, EUR J BIOCHEM, V270, P2505, DOI 10.1046/j.1432-1033.2003.03623.x; van Asselt EJ, 1999, FEBS LETT, V458, P429, DOI 10.1016/S0014-5793(99)01198-9; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; VONRUECKER AA, 1984, PEDIATR RES, V18, P594, DOI 10.1203/00006450-198407000-00005; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wang SL, 2008, J BACTERIOL, V190, P4061, DOI 10.1128/JB.01954-07; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Xi CW, 2000, P NATL ACAD SCI USA, V97, P11114, DOI 10.1073/pnas.210181097; Yonekawa T, 2005, FEMS MICROBIOL LETT, V244, P315, DOI 10.1016/j.femsle.2005.02.003; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	67	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98985	10.1371/journal.pone.0098985	http://dx.doi.org/10.1371/journal.pone.0098985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918783	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000037
J	Guo, J; Zhang, X; Chen, Z; Wen, Y; Li, JL				Guo, Jia; Zhang, Xuan; Chen, Zhi; Wen, Ying; Li, Jilun			Two Adjacent and Similar TetR Family Transcriptional Regulator Genes, SAV577 and SAV576, Co-Regulate Avermectin Production in Streptomyces avermitilis	PLOS ONE			English	Article							ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; BIOSYNTHESIS; COELICOLOR; EXPRESSION; SEQUENCE; HOMOLOG; CLONING; DNA	Streptomyces avermitilis is an important bacterial species used for industrial production of avermectins, a family of broadspectrum anthelmintic agents. We previously identified the protein SAV576, a TetR family transcriptional regulator (TFR), as a downregulator of avermectin biosynthesis that acts by controlling transcription of its major target gene SAV575 (which encodes cytochrome P450/NADPH-ferrihemoprotein reductase) and ave genes. SAV577, another TFR gene, encodes a SAV577 protein that displays high amino acid homology with SAV576. In this study, we examined the effect of SAV577 on avermectin production and the relationships between SAV576 and SAV577. SAV577 downregulated avermectin biosynthesis indirectly, similarly to SAV576. SAV576 and SAV577 both directly repressed SAV575 transcription, and reciprocally repressed each other's expression. SAV575 transcription levels in various S. avermitilis strains were correlated with avermectin production levels. DNase I footprinting and electrophoretic mobility shift assays indicated that SAV576 and SAV577 compete for the same binding regions, and that DNA-binding affinity of SAV576 is much stronger than that of SAV577. GST pull-down assays revealed no direct interaction between the two proteins. Taken together, these findings suggest that SAV577 regulates avermectin production in S. avermitilis by a mechanism similar to that of SAV576, and that the role of SAV576 is dominant over that of SAV577. This is the first report of two adjacent and similar TFR genes that co-regulate antibiotic production in Streptomyces.	[Guo, Jia; Zhang, Xuan; Chen, Zhi; Wen, Ying; Li, Jilun] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Guo, Jia; Zhang, Xuan; Chen, Zhi; Wen, Ying; Li, Jilun] China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Wen, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.; Wen, Y (corresponding author), China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100094, Peoples R China.	wen@cau.edu.cn			National Natural Science Foundation of China [31170045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31170045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chen Z, 2007, CHINESE SCI BULL, V52, P616, DOI 10.1007/s11434-007-0119-y; Choi KY, 2012, FEBS J, V279, P1650, DOI 10.1111/j.1742-4658.2011.08462.x; Craney A, 2013, J ANTIBIOT, V66, P387, DOI 10.1038/ja.2013.25; Demain AL, 2002, NAT BIOTECHNOL, V20, P331, DOI 10.1038/nbt0402-331; Duong CTP, 2009, J MICROBIOL BIOTECHN, V19, P136, DOI 10.4014/jmb.0806.387; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071330; Guo J, 2010, MOL GENET GENOMICS, V283, P123, DOI 10.1007/s00438-009-0502-2; He F, 2014, APPL MICROBIOL BIOT, V98, P399, DOI 10.1007/s00253-013-5348-1; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; IKEDA H, 1988, ANTIMICROB AGENTS CH, V32, P282, DOI 10.1128/AAC.32.2.282; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ikeda H, 1997, CHEM REV, V97, P2591, DOI 10.1021/cr960023p; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu YP, 2013, J BACTERIOL, V195, P4365, DOI 10.1128/JB.00716-13; MACNEIL DJ, 1987, J IND MICROBIOL, V2, P209, DOI 10.1007/BF01569542; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x; Miyamoto KT, 2011, MICROBIOL-SGM, V157, P2266, DOI 10.1099/mic.0.048371-0; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; Zhao JL, 2007, CHINESE SCI BULL, V52, P623, DOI 10.1007/s11434-007-0105-4; Zianni Michael, 2006, J Biomol Tech, V17, P103	29	12	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99224	10.1371/journal.pone.0099224	http://dx.doi.org/10.1371/journal.pone.0099224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915523	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700072
J	Rudolf, AF; Skovgaard, T; Knapp, S; Jensen, LJ; Berthelsen, J				Rudolf, Amalie Frederikke; Skovgaard, Tine; Knapp, Stefan; Jensen, Lars Juhl; Berthelsen, Jens			A Comparison of Protein Kinases Inhibitor Screening Methods Using Both Enzymatic Activity and Binding Affinity Determination	PLOS ONE			English	Article							INTERACTION MAP; ASSAYS	Binding assays are increasingly used as a screening method for protein kinase inhibitors; however, as yet only a weak correlation with enzymatic activity-based assays has been demonstrated. We show that the correlation between the two types of assays can be improved using more precise screening conditions. Furthermore a marked improvement in the correlation was found by using kinase constructs containing the catalytic domain in presence of additional domains or subunits.	[Rudolf, Amalie Frederikke; Skovgaard, Tine; Jensen, Lars Juhl; Berthelsen, Jens] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark; [Berthelsen, Jens] Univ Copenhagen, Fac Hlth Sci, Costerton Biofilm Ctr, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England	University of Copenhagen; University of Copenhagen; University of Oxford	Jensen, LJ (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark.	lars.juhl.jensen@gmail.com; jb@sund.ku.dk	Knapp, Stefan/AAG-2347-2019; Jensen, Lars Juhl/C-6492-2008	Knapp, Stefan/0000-0001-5995-6494; Jensen, Lars Juhl/0000-0001-7885-715X	Novo Nordisk Foundation; FOBI (Research School for Biotechnology); Danish Strategic Research Council; Novo Nordisk Foundation Center for Protein Research [PI Lars Juhl Jensen] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); FOBI (Research School for Biotechnology); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation Center for Protein Research	This work was funded by an Institutional core grant from the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en). AFR was supported by a grant from FOBI (Research School for Biotechnology). JB is funded from a grant from the Danish Strategic Research Council rewarded to Prof Givskov at ISIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Blackwell LJ, 2009, METHODS MOL BIOL, V565, P225, DOI 10.1007/978-1-60327-258-2_11; Card A, 2009, J BIOMOL SCREEN, V14, P31, DOI 10.1177/1087057108326663; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Grant S, 2009, CELL MOL LIFE SCI, V66, P1163, DOI 10.1007/s00018-008-8539-7; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Smyth Lynette A, 2009, J Chem Biol, V2, P131, DOI 10.1007/s12154-009-0023-9; Sutherland JJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1425, DOI 10.1016/j.bbapap.2012.12.023; Williams KP, 2009, METHODS MOL BIOL, V565, P107, DOI 10.1007/978-1-60327-258-2_5; Zhang C, 2011, NAT BIOTECHNOL, V29, P981, DOI 10.1038/nbt.2021	26	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98800	10.1371/journal.pone.0098800	http://dx.doi.org/10.1371/journal.pone.0098800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915177	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700034
J	Somme, L; Mayer, C; Jacquemart, AL				Somme, Laurent; Mayer, Carolin; Jacquemart, Anne-Laure			Multilevel Spatial Structure Impacts on the Pollination Services of Comarum palustre (Rosaceae)	PLOS ONE			English	Article							POLLEN-LIMITATION; PLANT REPRODUCTION; HABITAT FRAGMENTATION; CONNECTIVITY MEASURES; BEE POLLINATORS; LANDSCAPE SCALE; POPULATION-SIZE; SEED PRODUCTION; DENSITY; BUMBLEBEES	Habitat destruction and fragmentation accelerate pollinator decline, consequently disrupting ecosystem processes such as pollination. To date, the impacts of multilevel spatial structure on pollination services have rarely been addressed. We focused on the effects of population spatial structure on the pollination services of Comarum palustre at three levels (i.e. within-population, between-populations and landscape). For three years, we investigated 14 Belgian populations, which differed in their within-population flower density, population surface, closure (i.e. proportion of the population edge that consisted of woody elements) and isolation (i.e. percentage of woody area cover within a 500 m radius from the population centre). We tested whether these spatial characteristics impact on pollinator abundance and visitation rate and thus, reproductive success of C. palustre. Insects were observed in 15 randomly-chosen plots in each population. We tested for pollen limitation with supplemental hand-cross pollination. Bumble bees and solitary bees were the major pollinators through all populations. Within populations, plots with high flower densities attracted high numbers of bumble bees and other insects. High bumble bee and solitary bee abundance was observed in populations presenting high proportions of woody edges and in populations within landscapes presenting high proportions of woody areas. Seed set resulting from open pollination varied with bumble bee and solitary bee visitation rate, leading to increased pollen limitation when pollinators were scarce. Since the reproductive success depended on the visitation rate of the main pollinators, which depended on multilevel spatial structure, wetland management plans should pay special attention to favour a mosaic of biotopes, including nesting sites and food resources for insects. This study particularly supports the relevance of a mix wetlands and woody habitats to bees.	[Somme, Laurent; Mayer, Carolin; Jacquemart, Anne-Laure] Catholic Univ Louvain, Earth & Life Inst Agron, Res Team Genet, Louvain La Neuve, Belgium	Universite Catholique Louvain	Somme, L (corresponding author), Catholic Univ Louvain, Earth & Life Inst Agron, Res Team Genet, Louvain La Neuve, Belgium.	laurent.somme@uclouvain.be			Belgian Fund for Scientific Research (FNRS) [2.4540.09]	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	The Belgian Fund for Scientific Research (FNRS contract 2.4540.09) funded this research. website: http://www.frs-fnrs.be/. L. Somme holds a FRIA fellowship (Funds for training in Industry and Agriculture Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aiken SG, 2003, FLORA CANADIAN ARCTI; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Albert T, 2008, PLANT BIOLOGY, V10, P643, DOI 10.1111/j.1438-8677.2008.00067.x; Artz DR, 2006, J ECOL, V94, P597, DOI 10.1111/j.1365-2745.2006.01109.x; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Bailey S, 2014, ECOL EVOL, V4, P370, DOI 10.1002/ece3.924; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burel F., 2003, LANDSCAPE ECOLOGY CO; Cane J, 2001, CONSERV ECOL, V5, P149; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Diaz-Forero I, 2011, BALT FOR, V17, P235; Eckert CG, 2000, ECOLOGY, V81, P532, DOI 10.1890/0012-9658(2000)081[0532:COAAGT]2.0.CO;2; Elliott SE, 2009, AM J BOT, V96, P912, DOI 10.3732/ajb.0800260; Ewers RM, 2013, INSECT CONSERV DIVER, V6, P598, DOI 10.1111/icad.12014; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Frankard Philippe, 1998, Suo (Helsinki), V49, P33; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; Gonzalez-Varo JP, 2009, BIOL CONSERV, V142, P1058, DOI 10.1016/j.biocon.2009.01.017; Goulson D, 2006, J INSECT CONSERV, V10, P95, DOI 10.1007/s10841-006-6286-3; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Guillen A., 2005, REPROD BIOL, V62, P9; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Joosten H, 2002, WISE USE MIRES PEATL; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; KINDVALL O, 1995, BIOL CONSERV, V73, P51, DOI 10.1016/0006-3207(95)90063-2; Klank C, 2010, J ECOL, V98, P1389, DOI 10.1111/j.1365-2745.2010.01720.x; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Knight TM, 2003, OECOLOGIA, V137, P557, DOI 10.1007/s00442-003-1371-8; Korosi A, 2012, INSECT CONSERV DIVER, V5, P118, DOI 10.1111/j.1752-4598.2011.00138.x; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; KWAK MM, 1991, OECOLOGIA, V86, P99, DOI 10.1007/BF00317395; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Lienert Judit, 2004, Journal for Nature Conservation (Jena), V12, P53, DOI 10.1016/j.jnc.2003.07.002; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Macek P, 2008, EVOL ECOL, V22, P419, DOI 10.1007/s10682-007-9235-z; Mayer C, 2012, BASIC APPL ECOL, V13, P690, DOI 10.1016/j.baae.2012.09.012; Mayer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050353; Michener C.D., 2007, BEES WORLD, Vsecond; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Moron D, 2008, WETLANDS, V28, P975, DOI 10.1672/08-83.1; Murren CJ, 2002, J ECOL, V90, P100, DOI 10.1046/j.0022-0477.2001.00638.x; Nielsen A, 2012, BASIC APPL ECOL, V13, P489, DOI 10.1016/j.baae.2012.08.008; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI 10.1111/j.1600-0587.2011.06870.x; OLESEN I, 1992, NORD J BOT, V12, P373, DOI 10.1111/j.1756-1051.1992.tb01318.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; R Development Core Team, 2012, R LANG ENV STAT COMP; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schleuning M, 2009, BASIC APPL ECOL, V10, P61, DOI 10.1016/j.baae.2007.12.002; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Sepp K, 2004, LANDSCAPE URBAN PLAN, V67, P173, DOI 10.1016/S0169-2046(03)00037-9; Shao JW, 2008, J INTEGR PLANT BIOL, V50, P1151, DOI 10.1111/j.1744-7909.2008.00655.x; Soderstrom B, 2001, BIODIVERS CONSERV, V10, P1839, DOI 10.1023/A:1013153427422; Somme L, 2014, ANN BOT-LONDON, V113, P477, DOI 10.1093/aob/mct280; Somme L, 2012, MOL ECOL RESOUR, V12, P91, DOI 10.1111/j.1755-0998.2011.03072.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stevens VM, 2010, BIOL REV, V85, P625, DOI 10.1111/j.1469-185X.2009.00119.x; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Verte P., 2007, ECHO RESERVES, V3, P4; Vervoort A, 2011, INT J PLANT SCI, V172, P366, DOI 10.1086/658152; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Wesselingh RA, 2007, NEW PHYTOL, V174, P26, DOI 10.1111/j.1469-8137.2007.01997.x; Westrich P., 1996, The conservation of bees., P1; WILLIAMS PH, 1988, ECOL ENTOMOL, V13, P223, DOI 10.1111/j.1365-2311.1988.tb00350.x; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Zurbuchen A, 2010, APIDOLOGIE, V41, P497, DOI 10.1051/apido/2009084; Zuur Alain F., 2009, P1	89	10	10	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99295	10.1371/journal.pone.0099295	http://dx.doi.org/10.1371/journal.pone.0099295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915450	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700081
J	Zhao, FZ; Yang, GH; Han, XH; Feng, YZ; Ren, GX				Zhao, Fazhu; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin			Stratification of Carbon Fractions and Carbon Management Index in Deep Soil Affected by the Grain-to-Green Program in China	PLOS ONE			English	Article							ORGANIC-CARBON; LOESS PLATEAU; TILLAGE CHRONOSEQUENCE; SEQUESTRATION; GRASSLAND; STOCKS; RATIO; AFFORESTATION; CONSERVATION; INDICATOR	Conversion of slope cropland to perennial vegetation has a significant impact on soil organic carbon (SOC) stock in A horizon. However, the impact on SOC and its fraction stratification is still poorly understood in deep soil in Loess Hilly Region (LHR) of China. Samples were collected from three typical conversion lands, Robinia psendoacacia (RP), Caragana Korshinskii Kom (CK), and abandoned land (AB), which have been converted from slope croplands (SC) for 30 years in LHR. Contents of SOC, total nitrogen (TN), particulate organic carbon (POC), and labile organic carbon (LOC), and their stratification ratios (SR) and carbon management indexes (CMI) were determined on soil profiles from 0 to 200 cm. Results showed that the SOC, TN, POC and LOC stocks of RP were significantly higher than that of SC in soil layers of 0-10, 10-40, 40-100 and 100-200 cm (P<0.05). Soil layer of 100-200 cm accounted for 27.38-36.62%, 25.10-32.91%, 21.59-31.69% and 21.08-26.83% to SOC, TN, POC and LOC stocks in lands of RP, CK and AB. SR values were >2.0 in most cases of RP, CK and AB. Moreover, CMI values of RP, CK, and AB increased by 11.61-61.53% in soil layer of 100-200 cm compared with SC. Significant positive correlations between SOC stocks and CMI or SR values of both surface soil and deep soil layers indicated that they were suitable indicators for soil quality and carbon changes evaluation. The Grain-to-Green Program (GTGP) had strong influence on improving quantity and activity of SOC pool through all soil layers of converted lands, and deep soil organic carbon should be considered in C cycle induced by GTGP. It was concluded that converting slope croplands to RP forestlands was the most efficient way for sequestering C in LHR soils.	[Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn; hanxinhui@nwsuaf.edu.cn	Zhao, Fazhu/CAG-5988-2022; Ren, Chengjie/CAF-2259-2022; Feng, Yongzhong/F-5090-2012; ren, guangxin/Q-1234-2015	Zhao, Fazhu/0000-0003-4758-3277; Feng, Yongzhong/0000-0002-5202-4368; ren, guangxin/0000-0001-9895-2680	Special Fund for forest-scientific Research in the Public Interest [201304312]	Special Fund for forest-scientific Research in the Public Interest	This work was supported by Special Fund for forest-scientific Research in the Public Interest (201304312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bao S.D, 2000, SOIL AGR CHEM ANAL; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; [陈奇伯 Chen Qibo], 2003, [生态学报, Acta Ecologica Sinica], V23, P1463; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Davis M, 2007, GLOBAL CHANGE BIOL, V13, P1414, DOI 10.1111/j.1365-2486.2007.01372.x; Diekow J, 2005, PLANT SOIL, V268, P319, DOI 10.1007/s11104-004-0330-4; Eaton J, 2008, CLIMATIC CHANGE, V91, P317, DOI 10.1007/s10584-008-9412-2; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gong ZT, 1999, CHINESE SOIL TAXONOM, P36; Groenendijk FM, 2002, GEODERMA, V108, P91, DOI 10.1016/S0016-7061(02)00125-8; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Jiao JY, 2012, RESTOR ECOL, V20, P240, DOI 10.1111/j.1526-100X.2010.00756.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Li FM, 2004, SOIL BIOL BIOCHEM, V36, P1893, DOI 10.1016/j.soilbio.2004.04.040; Liu GB, 1999, AMBIO, V28, P663; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Moreno F, 2006, SOIL TILL RES, V85, P86, DOI 10.1016/j.still.2004.12.001; PRESCOTT CE, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P377; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Raiesi F, 2012, PLANT SOIL, V351, P161, DOI 10.1007/s11104-011-0941-5; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sa JCD, 2001, SOIL SCI SOC AM J, V65, P1486, DOI 10.2136/sssaj2001.6551486x; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Schnabel RR, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P291; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sparling G. P., 1997, P97; Strahm BD, 2009, FOREST ECOL MANAG, V258, P2347, DOI 10.1016/j.foreco.2009.03.014; VandenBygaart AJ, 2011, SOIL SCI SOC AM J, V75, P226, DOI 10.2136/sssaj2010.0099; VANLEAR DH, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P489; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wang Z, 2012, CATENA, V99, P26, DOI 10.1016/j.catena.2012.07.003; [王征 Wang Zheng], 2010, [生态学报, Acta Ecologica Sinica], V30, P3947; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040123; Wei XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032054; Xue Sha, 2009, Scientia Agricultura Sinica, V42, P1458; ZB Jia, 2009, INVESTIGATION REPORT, P267; Zhang CS, 2004, GEODERMA, V119, P261, DOI 10.1016/j.geoderma.2003.08.004; Zhang Feng, 2007, Acta Ecologica Sinica, V27, P4555; Zhao YT, 2010, ECOLOGICAL EC, V7, P81	46	54	59	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99657	10.1371/journal.pone.0099657	http://dx.doi.org/10.1371/journal.pone.0099657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915425	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700125
J	Aebischer, D; Willrodt, AH; Halin, C				Aebischer, David; Willrodt, Ann-Helen; Halin, Cornelia			Oxazolone-Induced Contact Hypersensitivity Reduces Lymphatic Drainage but Enhances the Induction of Adaptive Immunity	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DENDRITIC CELL-MIGRATION; CHRONIC SKIN INFLAMMATION; IFN-GAMMA PRODUCTION; IN-VIVO; STEADY-STATE; TRANSGENIC MICE; T-CELLS; PSORIASIS; VESSELS	Contact hypersensitivity (CHS) induced by topical application of haptens is a commonly used model to study dermal inflammatory responses in mice. Several recent studies have indicated that CHS-induced skin inflammation triggers lymphangiogenesis but may negatively impact the immune-function of lymphatic vessels, namely fluid drainage and dendritic cell (DC) migration to draining lymph nodes (dLNs). On the other hand, haptens have been shown to exert immune-stimulatory activity by inducing DC maturation. In this study we investigated how the presence of pre-established CHS-induced skin inflammation affects the induction of adaptive immunity in dLNs. Using a mouse model of oxazolone-induced skin inflammation we observed that lymphatic drainage was reduced and DC migration from skin to dLNs was partially compromised. At the same time, a significantly stronger adaptive immune response towards ovalbumin (OVA) was induced when immunization had occurred in CHS-inflamed skin as compared to uninflamed control skin. In fact, immunization with sterile OVA in CHS-inflamed skin evoked a delayed-type hypersensitivity (DTH) response comparable to the one induced by conventional immunization with OVA and adjuvant in uninflamed skin. Striking phenotypic and functional differences were observed when comparing DCs from LNs draining uninflamed or CHS-inflamed skin. DCs from LNs draining CHS-inflamed skin expressed higher levels of co-stimulatory molecules and MHC molecules, produced higher levels of the interleukin-12/23 p40 subunit (IL-12/23-p40) and more potently induced T cell activation in vitro. Immunization experiments revealed that blockade of IL-12/23-p40 during the priming phase partially reverted the CHS-induced enhancement of the adaptive immune response. Collectively, our findings indicate that CHS-induced skin inflammation generates an overall immune-stimulatory milieu, which outweighs the potentially suppressive effect of reduced lymphatic vessel function.	[Aebischer, David; Willrodt, Ann-Helen; Halin, Cornelia] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland	ETH Zurich	Halin, C (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	cornelia.halin@pharma.ethz.ch		Halin, Cornelia/0000-0002-7899-2850	Swiss National Fund [310030_138330]; Swisslife Jubilaumsstiftung; ETH Zurich	Swiss National Fund(Swiss National Science Foundation (SNSF)); Swisslife Jubilaumsstiftung; ETH Zurich(ETH Zurich)	This work was supported by the Swiss National Fund (grant 310030_138330), the Swisslife Jubilaumsstiftung and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2010, J IMMUNOL, V184, P545, DOI 10.4049/jimmunol.0900397; Bianchi R, 1999, J IMMUNOL, V163, P2517; Bouta EM, 2014, J PHYSIOL-LONDON, V592, P1213, DOI 10.1113/jphysiol.2013.266700; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Chu CC, 2011, SEMIN IMMUNOL, V23, P28, DOI 10.1016/j.smim.2011.01.006; Cliff S, 1999, BRIT J DERMATOL, V140, P61; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Heinzel K, 2007, P NATL ACAD SCI USA, V104, P8421, DOI 10.1073/pnas.0608274104; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kratky W, 2011, P NATL ACAD SCI USA, V108, P17414, DOI 10.1073/pnas.1108945108; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lachance PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076078; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Manome H, 1999, IMMUNOLOGY, V98, P481, DOI 10.1046/j.1365-2567.1999.00916.x; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; McFadden JP, 2013, BRIT J DERMATOL, V168, P692, DOI 10.1111/bjd.12145; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shin JY, 2009, CELL IMMUNOL, V256, P72, DOI 10.1016/j.cellimm.2009.01.006; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; THOMAS R, 1994, J IMMUNOL, V152, P2613; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Van Kruiningen HJ, 2008, GUT, V57, P1; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; von der Weid PY, 2010, ANN NY ACAD SCI, V1207, pE69, DOI 10.1111/j.1749-6632.2010.05715.x; von Moos S, 2012, ALLERGY, V67, P638, DOI 10.1111/j.1398-9995.2012.02802.x; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793	51	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99297	10.1371/journal.pone.0099297	http://dx.doi.org/10.1371/journal.pone.0099297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911791	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600067
J	Cui, YL; Qin, S; Jiang, P				Cui, Yulin; Qin, Song; Jiang, Peng			Chloroplast Transformation of Platymonas (Tetraselmis) subcordiformis with the bar Gene as Selectable Marker	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PLASTID TRANSFORMATION; HIGHER-PLANTS; TRANSGENIC CHLOROPLASTS; CHLAMYDOMONAS-REINHARDTII; HERBICIDE RESISTANCE; GLUTAMINE-SYNTHETASE; EXPRESSION; BOMBARDMENT; BIOTECHNOLOGY	The objective of this research was to establish a chloroplast transformation technique for Platymonas (Tetraselmis) subcordiformis. Employing the gfp gene as a reporter and the bar gene as a selectable marker, transformation vectors of P. subcordiformis chloroplast were constructed with endogenous fragments rrn16S-trnl (left) and trnA-rrn23S (right) as a recombination site of the chloroplast genome. The plasmids were transferred into P. subcordiformis via particle bombardment. Confocal laser scanning microscopy indicated that the green fluorescence protein was localized in the chloroplast of P. subcordiformis, confirming the activity of the Chlamydomonas reinhardtii promoter. Cells transformed with the bar gene were selected using the herbicide Basta. Resistant colonies were analyzed by PCR and Southern blotting, and the results indicated that the bar gene was successfully integrated into the chloroplast genome via homologous recombination. The technique will improve genetic engineering of this alga.	[Cui, Yulin; Qin, Song] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Biol Resource Utilizat, Yantai, Shandong, Peoples R China; [Cui, Yulin; Jiang, Peng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Qin, S (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Biol & Biol Resource Utilizat, Yantai, Shandong, Peoples R China.	sqin@yic.ac.cn; jiangpeng@ms.qdio.ac.cn	Jiang, Peng/B-8061-2011	Jiang, Peng/0000-0001-9867-8386	Ocean Public Welfare Scientific Research Project, State Oceanic Administration of China [201205027]; National Natural Science Foundation of China [41176144]	Ocean Public Welfare Scientific Research Project, State Oceanic Administration of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ocean Public Welfare Scientific Research Project, State Oceanic Administration of China (201205027), National Natural Science Foundation of China (41176144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOWERS AD, 1989, PLANT CELL, V1, P123, DOI 10.1105/tpc.1.1.123; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; CARRER H, 1993, MOL GEN GENET, V241, P49, DOI 10.1007/BF00280200; Cui YL, 2012, CHIN J OCEANOL LIMN, V30, P471, DOI 10.1007/s00343-012-1093-z; Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Doetsch NA, 2001, CURR GENET, V39, P49, DOI 10.1007/s002940000174; Ghoshroy S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-198; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Guo Z, 2008, BIOTECHNOL LETT, V30, P877, DOI 10.1007/s10529-008-9637-1; Hibberd JM, 1998, PLANT J, V16, P627, DOI 10.1046/j.1365-313x.1998.00328.x; HIREL B, 1982, PHYSIOL PLANTARUM, V55, P197, DOI 10.1111/j.1399-3054.1982.tb02287.x; Hou BK, 2003, TRANSGENIC RES, V12, P111, DOI 10.1023/A:1022180315462; Kohler RH, 1997, SCIENCE, V276, P2039, DOI 10.1126/science.276.5321.2039; Lapidot M, 2002, PLANT PHYSIOL, V129, P7, DOI 10.1104/pp.011023; Lee SM, 2006, MOL CELLS, V21, P401; Lee SB, 2003, MOL BREEDING, V11, P1, DOI 10.1023/A:1022100404542; Lelivelt CLC, 2005, PLANT MOL BIOL, V58, P763, DOI 10.1007/s11103-005-7704-8; Limaye A, 2006, FASEB J, V20, P959, DOI 10.1096/fj.05-5134fje; Lutz KA, 2001, PLANT PHYSIOL, V125, P1585, DOI 10.1104/pp.125.4.1585; Maliga P, 2004, ANNU REV PLANT BIOL, V55, P289, DOI 10.1146/annurev.arplant.55.031903.141633; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; MCNALLY SF, 1983, PLANT PHYSIOL, V72, P22, DOI 10.1104/pp.72.1.22; Quesada-Vargas T, 2005, PLANT PHYSIOL, V138, P1746, DOI 10.1104/pp.105.063040; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Rieseberg M, 2001, APPL MICROBIOL BIOT, V56, P350, DOI 10.1007/s002530100673; SALISBURY JL, 1981, PROTOPLASMA, V107, P1, DOI 10.1007/BF01275602; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Su ZL, 2005, ACTA BIOCH BIOPH SIN, V37, P709, DOI 10.1111/j.1745-7270.2005.00092.x; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Tan CP, 2005, J MICROBIOL, V43, P361; WHITE J, 1990, NUCLEIC ACIDS RES, V18, P1062, DOI 10.1093/nar/18.4.1062; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yang TT, 1998, J BIOL CHEM, V273, P8212, DOI 10.1074/jbc.273.14.8212; Ye GN, 2003, PLANT PHYSIOL, V133, P402, DOI 10.1104/pp.103.021949; Zhang YC, 2008, SCI CHINA SER C, V51, P1116, DOI 10.1007/s11427-008-0143-4	37	36	36	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98607	10.1371/journal.pone.0098607	http://dx.doi.org/10.1371/journal.pone.0098607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911932	Green Submitted, gold, Green Published			2022-12-27	WOS:000337165600008
J	Ip, P; Lam, TH; Chan, SSC; Ho, FKW; Lo, LA; Chiu, IWS; Wong, WHS; Chow, CB				Ip, Patrick; Lam, Tai-Hing; Chan, Sophia Siu-Chee; Ho, Frederick Ka-Wing; Lo, Lewis A.; Chiu, Ivy Wing-Sze; Wong, Wilfred Hing-Sang; Chow, Chun-Bong			Use of Internet Viral Marketing to Promote Smoke-Free Lifestyles among Chinese Adolescents	PLOS ONE			English	Article							HEALTH-PROMOTION; CHILDREN; TOBACCO; ASSOCIATION; BEHAVIORS; CONSENT; ABILITY; GENDER; MEDIA; MEN	Purpose: Youth smoking is a global public health concern. Health educators are increasingly using Internet-based technologies, but the effectiveness of Internet viral marketing in promoting health remains uncertain. This prospective pilot study assessed the efficacy of an online game-based viral marketing campaign in promoting a smoke-free attitude among Chinese adolescents. Methods: One hundred and twenty-one Hong Kong Chinese adolescents aged 10 to 24 were invited to participate in an online multiple-choice quiz game competition designed to deliver tobacco-related health information. Participants were encouraged to refer others to join. A zero-inflated negative binomial model was used to explore the factors contributing to the referral process. Latent transition analysis utilising a pre-and post-game survey was used to detect attitudinal changes toward smoking. Results: The number of participants increased almost eightfold from 121 to 928 (34.6% current or ex-smokers) during the 22-day campaign. Participants exhibited significant attitudinal change, with 73% holding negative attitudes toward smoking after the campaign compared to 57% before it. The transition probabilities from positive to negative and neutral to negative attitudes were 0.52 and 0.48, respectively. It was also found that attempting every 20 quiz questions was associated with lower perceived smoking decision in future (OR = 0.95, p-value <0.01). Conclusions: Our online game-based viral marketing programme was effective in reaching a large number of smoking and non-smoking participants and changing their attitudes toward smoking. It constitutes a promising practical and cost-effective model for engaging young smokers and promulgating smoking-related health information among Chinese adolescents.	[Ip, Patrick; Ho, Frederick Ka-Wing; Lo, Lewis A.; Chiu, Ivy Wing-Sze; Wong, Wilfred Hing-Sang; Chow, Chun-Bong] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai-Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Sophia Siu-Chee] Govt Hong Kong Special Adm Reg, Food & Hlth Bur, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Ip, P (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	patricip@hku.hk	Ho, Frederick/M-6407-2017; Ho, Frederick/AAS-2647-2021; Wong, Wilfred/Q-8751-2019	Ho, Frederick/0000-0001-7190-9025; Ho, Frederick/0000-0001-7190-9025; Wong, Hing Sang Wilfred/0000-0001-8396-2368				Abroms L, 2005, ADDICTION, V100, P852, DOI 10.1111/j.1360-0443.2005.01090.x; Ajzen I, 2011, HDB THEORY SOCIAL PS; Alderson P, 2007, SOC SCI MED, V65, P2272, DOI 10.1016/j.socscimed.2007.08.005; Berger JA, 2009, J MARKERT RES, V49; Bernhardt JM, 2001, HEALTH EDUC RES, V16, P643, DOI 10.1093/her/16.6.643; Beverland M., 2005, Business Horizons, V48, P143, DOI 10.1016/j.bushor.2004.10.011; Blakely G, 2009, J ADV NURS, V65, P259, DOI 10.1111/j.1365-2648.2008.04843.x; BROWN JJ, 1987, J CONSUM RES, V14, P350, DOI 10.1086/209118; Burns JM, 2010, MED J AUSTRALIA, V192, pS27; Census and Statistics Department Government of Hong Kong Special Adminstrative Region, 2011, 48 GOVT HONG KONG CE; Census and Statistics Department Government of Hong Kong Special Adminstrative Region, 2010, HONG KONG POP PROJ 2; Census and Statistics Department Government of Hong Kong Special Adminstrative Region, 2009, HONG KONG MONTHL DIG; Census and Statistics Department Government of Hong Kong Special Adminstrative Region, 2011, HONG KONG MONTHL DIG; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chan K, 2007, YOUNG CONSUM, V8, P244, DOI 10.1108/17473610710838608; Chang HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-844; De Bruyn A, 2008, INT J RES MARK, V25, P151, DOI 10.1016/j.ijresmar.2008.03.004; Dihoff RE, 2004, PSYCHOL REC, V54, P207, DOI 10.1007/BF03395471; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; FARQUHAR JW, 1977, LANCET, V1, P1192; Ferrand A, 1996, NETWORKS GLOBAL VILL; Gilly MC, 1998, J ACAD MARKET SCI, V26, P83, DOI 10.1177/0092070398262001; Gold J, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1875; Gosselin P, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1127; Griffin EA, 2011, ELABORATION LIKELIHO, P193; Grogan S, 2009, PSYCHOL HEALTH, V24, P301, DOI 10.1080/08870440701746586; Ho S-Y, 2010, J PEDIAT, V157; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Hughes JR, 1999, ADDICTION, V94, P109, DOI 10.1046/j.1360-0443.1999.9411097.x; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Kleinjan M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-196; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lanza S. T., 2003, HDB PSYCHOL RES METH, P663685; Li N, 2007, COMPUT EDUC, V48, P301, DOI 10.1016/j.compedu.2005.01.007; Maher CA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2952; Mak KK, 2012, NICOTINE TOB RES, V14, P1057, DOI 10.1093/ntr/nts008; McGue M, 2005, AM J PSYCHIAT, V162, P1118, DOI 10.1176/appi.ajp.162.6.1118; Myers MG, 1999, J SUBST ABUSE TREAT, V16, P289, DOI 10.1016/S0740-5472(98)00038-5; O'Dell LE, 2009, NEUROPHARMACOLOGY, V56, P263, DOI 10.1016/j.neuropharm.2008.07.039; Ondrusek N, 1998, J MED ETHICS, V24, P158, DOI 10.1136/jme.24.3.158; Pedrana A, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2334; Petty R. E., 1998, HDB SOCIAL PSYCHOL, P323; Petty RE, 1986, J PERS SOC PSYCHOL, V51; Phelps JE, 2004, J ADVERTISING RES, V44, P333, DOI 10.1017/S0021849904040371; Region CaSDGoHKSA, 2012, MED MONTHL DOM HOUS; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Rindskopf D, 2010, REV GUIDE QUANTITATI; Schaefer David R, 2012, Am J Public Health, V102, pe12, DOI 10.2105/AJPH.2012.300705; Song AV, 2009, AM J PUBLIC HEALTH, V99, P487, DOI 10.2105/AJPH.2008.137679; Thackeray R, 2008, HEALTH PROMOT PRACT, V9, P338, DOI 10.1177/1524839908325335; Trusov M, 2008, J MARKETING, P90; United States Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; Webb TP, 2012, J SURG EDUC, V69, P330, DOI 10.1016/j.jsurg.2011.10.002; Wilson N, 2005, SOC SCI MED, V61, P649, DOI 10.1016/j.socscimed.2004.11.070; Windle M, 2012, DRUG ALCOHOL DEPEN, V121, P152, DOI 10.1016/j.drugalcdep.2011.08.024; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	57	11	11	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99082	10.1371/journal.pone.0099082	http://dx.doi.org/10.1371/journal.pone.0099082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911010	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000337165600040
J	Lin, WL; Seak, CJ; Wu, JY; Weng, YM; Chen, HC				Lin, Wen-Ling; Seak, Chen-June; Wu, Jiunn-Yih; Weng, Yi-Ming; Chen, Hang-Cheng			Risk Factors for Development of Chronic Kidney Disease following Renal Infarction: Retrospective Evaluation of Emergency Room Patients from a Single Center	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; SCORE	Background: Previous studies have analyzed factors associated with renal infarction so that patients can be provided with earlier diagnosis and treatment. However, the factors associated with development of chronic kidney disease (CKD) following renal infarction are unknown. Methods: We retrospectively reviewed the records of patients with a diagnosis of renal infarction based on enhanced computed tomography. All patients were admitted to a single emergency department in Taiwan from 1999 to 2008. Univariate and multivariate analysis were used to assess the effect of different factors on development of CKD based on estimates of the glomerular filtration rate (eGFR) at admission and at 3-12 months after discharge. Results: Univariate analysis indicated significantly increased risk of CKD in patients older than 50 years, with symptoms for 24 h or less before admission, lower eGFR at admission, APACHE II score greater than 7, SOFA score greater than 1, ASA score greater than 2, and SAPS II score greater than 15. Multivariate analysis indicated that only SOFA score greater than 1 was significantly and independently associated with CKD at follow-up (p < 0.001). Conclusions: A total of 32.5% of patients admitted for renal infarction over a ten-year period developed CKD at 3-12 months after discharge. A SOFA score greater than 1 was significantly and independently associated with development of CKD in these patients.	[Lin, Wen-Ling; Seak, Chen-June; Weng, Yi-Ming] Chang Gung Mem Hosp, Dept Emergency Med, Taoyuan, Taiwan; [Lin, Wen-Ling; Seak, Chen-June; Wu, Jiunn-Yih; Weng, Yi-Ming; Chen, Hang-Cheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Jiunn-Yih; Chen, Hang-Cheng] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, HC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan.	ezn2002@gmail.com		SEAK, CHEN-JUNE/0000-0003-0984-8385				Bolderman R, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.06.049; Ceriotti F, 2008, CLIN CHEM, V54, P559, DOI 10.1373/clinchem.2007.099648; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Domanovits H, 1999, MEDICINE, V78, P386, DOI 10.1097/00005792-199911000-00004; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Huang CC, 2007, AM J EMERG MED, V25, P164, DOI 10.1016/j.ajem.2006.06.010; KEATS AS, 1978, ANESTHESIOLOGY, V49, P233, DOI 10.1097/00000542-197810000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korzets Z, 2002, ISRAEL MED ASSOC J, V4, P781; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1995, INTENS CARE MED, V21, P770, DOI 10.1007/BF01704747; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Piffaretti G, 2008, VASC ENDOVASC SURG, V42, P375, DOI 10.1177/1538574408314445; Suzer O, 2002, EUR J RADIOL, V44, P59, DOI 10.1016/S0720-048X(01)00476-4; Tsai SH, 2007, INT J CLIN PRACT, V61, P62, DOI 10.1111/j.1742-1241.2006.01136.x	15	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98880	10.1371/journal.pone.0098880	http://dx.doi.org/10.1371/journal.pone.0098880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911965	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600018
J	Nada, O; Marian, A; Tran-Khanh, N; Buschmann, M; Podtetenev, M; Vidal, F; Costantino, S; Brunette, I				Nada, Ossama; Marian, Anca; Tran-Khanh, Nicolas; Buschmann, Michael; Podtetenev, Michel; Vidal, Francois; Costantino, Santiago; Brunette, Isabelle			Effect of Corneal Hydration on the Quality of the Femtosecond Laser Anterior Lamellar Cut	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; ENDOTHELIAL KERATOPLASTY; INTRALASE; THICKNESS; DONOR; MICROKERATOME; TRANSPARENCY; CREATION; LASIK; DISSECTION	The goal of this study was to assess the effect of corneal hydration on the quality of the femtosecond laser (FSL) anterior lamellar cut. The Visumax FSL was used to dissect an 8-mm-diameter corneal flap in 22 eye bank corneas showing various levels of hydration. The intended ablation depth was 220 mm in all eyes, which corresponded to the maximal depth available with this laser. After the cut, the achieved ablation depth was measured using optical coherence tomography images, flap separability was assessed by measuring the mean force generated to detach the flap, and stromal bed roughness was assessed by measuring the Haralick contrast level on the 1000 x scanning electron microscopy images of the ablated surfaces. The preoperative central corneal thickness ranged from 547 to 1104 mu m (mean +/- SEM: 833 +/- 30 mu m). A negative correlation was found between the level of corneal hydration and the ablation depth measured in the midperipheral cornea (r = -0.626, p = 0.003), the ablation being more superficial in more edematous corneas. The Haralick contrast also tended to increase as a function of corneal hydration ( r = 0.416, p = 0.061), suggesting that laser ablation in edematous corneas results in rougher stromal surfaces. These results support the hypothesis that the quality of the FSL lamellar cut decreases as the level of corneal hydration increases. Although FSL is still considered in the field as the tool of the future for corneal dissection, a better understanding of the limits of this tool will be needed before it can replace manual or automated stromal dissection techniques in hydrated corneas.	[Nada, Ossama; Marian, Anca; Podtetenev, Michel; Costantino, Santiago; Brunette, Isabelle] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Tran-Khanh, Nicolas; Buschmann, Michael] Ecole Polytech, Montreal, PQ H3C 3A7, Canada; [Tran-Khanh, Nicolas; Buschmann, Michael] Ecole Polytech, Grp Rech Sci & Technol Biomed, Montreal, PQ H3C 3A7, Canada; [Vidal, Francois] Inst Natl Rech Sci Energie Varennes, Ctr Energie Mat Telecommun, Varennes, PQ J3X 1S2, Canada; [Podtetenev, Michel; Costantino, Santiago; Brunette, Isabelle] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Podtetenev, Michel] Focus Vis Clin, Verdun, PQ, Canada; [Nada, Ossama] Ain Shams Univ, Cairo, Egypt	Universite de Montreal; Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal; University of Quebec; Universite de Montreal; Egyptian Knowledge Bank (EKB); Ain Shams University	Brunette, I (corresponding author), Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	i.brunett@videotron.ca	Costantino, Santiago/ABD-5472-2020; Vidal, François/A-3112-2010	Costantino, Santiago/0000-0002-2454-2635; Buschmann, Michael/0000-0002-2242-6198	Canadian Institutes of Health Research, Ottawa, ON, Canada; CNIB, Toronto, ON, Canada; FROUM, University of Montreal, Montreal, QC, Canada; FRQS Research in Vision Network, Montreal, QC, Canada	Canadian Institutes of Health Research, Ottawa, ON, Canada(Canadian Institutes of Health Research (CIHR)); CNIB, Toronto, ON, Canada; FROUM, University of Montreal, Montreal, QC, Canada; FRQS Research in Vision Network, Montreal, QC, Canada	This work was supported by: Canadian Institutes of Health Research, Ottawa, ON, Canada; CNIB, Toronto, ON, Canada; FROUM, University of Montreal, Montreal, QC, Canada; and FRQS Research in Vision Network, Montreal, QC, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn H, 2011, J CATARACT REFR SURG, V37, P349, DOI 10.1016/j.jcrs.2010.08.042; Bahar I, 2009, BRIT J OPHTHALMOL, V93, P73, DOI 10.1136/bjo.2008.148346; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Brunette I, 2011, INVEST OPHTH VIS SCI, V52, P206, DOI 10.1167/iovs.09-4101; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chan CC, 2010, CORNEA, V29, P290, DOI 10.1097/ICO.0b013e3181b77873; Cheng YYY, 2009, TRANSPLANTATION, V88, P1294, DOI 10.1097/TP.0b013e3181bc419c; Cheng YYY, 2009, CORNEA, V28, P73, DOI 10.1097/ICO.0b013e318183a379; Durrie DS, 2005, J CATARACT REFR SURG, V31, P120, DOI 10.1016/j.jcrs.2004.09.046; EBAA, 2011, EYE BANK STAT REP 20; Farid M, 2010, CURR OPIN OPHTHALMOL, V21, P288, DOI 10.1097/ICU.0b013e32833a8dbc; FARRELL RA, 1973, J PHYSIOL-LONDON, V233, P589, DOI 10.1113/jphysiol.1973.sp010325; GOLDMAN JN, 1968, INVEST OPHTH VISUAL, V7, P501; Hahn S, 2003, INVEST OPHTH VIS SCI, V44, P1508, DOI 10.1167/iovs.02-0641; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoffart L, 2007, J FR OPHTALMOL, V30, P689, DOI 10.1016/S0181-5512(07)91356-X; Javaloy J, 2007, J REFRACT SURG, V23, P178; Jones YJ, 2008, CORNEA, V27, P88, DOI 10.1097/ICO.0b013e31815771f5; Kim JY, 2011, JPN J OPHTHALMOL, V55, P423, DOI 10.1007/s10384-011-0042-2; Kim JH, 2008, J CATARACT REFR SURG, V34, P132, DOI 10.1016/j.jcrs.2007.08.036; Kim P, 2011, CURR OPIN OPHTHALMOL, V22, P238, DOI 10.1097/ICU.0b013e3283477c9c; Kopani KR, 2014, BRIT J OPHTHALMOL, V98, DOI 10.1136/bjophthalmol-2013-304546; Leonard DW, 1997, BIOPHYS J, V72, P1382, DOI 10.1016/S0006-3495(97)78784-8; Letko E, 2009, J REFRACT SURG, V25, P1039, DOI 10.3928/1081597X-20090617-13; Maier PC, 2010, KLIN MONATSBL AUGENH, V227, P453, DOI 10.1055/s-0029-1245351; Marian A, 2013, J CATARACT REFR SURG, V39, P118, DOI 10.1016/j.jcrs.2012.08.050; MCCAREY BE, 1977, INVEST OPHTH VIS SCI, V16, P743; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Meek KM, 2003, BIOPHYS J, V85, P2205, DOI 10.1016/S0006-3495(03)74646-3; Mehta JS, 2008, J CATARACT REFR SURG, V34, P1970, DOI 10.1016/j.jcrs.2008.07.028; Mehta JS, 2008, CORNEA, V27, P706, DOI 10.1097/QAI.0b013e31815ee267; Montes-Mico R, 2007, OPHTHALMOLOGY, V114, P62, DOI 10.1016/j.ophtha.2006.07.019; Nuzzo V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2811951; Prasad A, 2011, CORNEA, V30, P553, DOI 10.1097/ICO.0b013e3181fb880c; Proust H, 2011, AM J OPHTHALMOL, V151, P29, DOI 10.1016/j.ajo.2010.07.016; Salomao MQ, 2009, J CATARACT REFR SURG, V35, P1756, DOI 10.1016/j.jcrs.2009.05.032; Sarayba MA, 2007, CORNEA, V26, P446, DOI 10.1097/ICO.0b013e318033e7cc; Sarayba MA, 2007, J REFRACT SURG, V23, P58; Singh K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083185; Soong HK, 2005, OPHTHALMOLOGY, V112, P44, DOI 10.1016/j.ophtha.2004.06.037; Sutton G, 2008, J REFRACT SURG, V24, P802, DOI 10.3928/1081597X-20081001-06; Terry MA, 2005, CORNEA, V24, P453, DOI 10.1097/01.ico.0000151509.57189.6f; Yoo SH, 2011, AM J OPHTHALMOL, V151, P189, DOI 10.1016/j.ajo.2010.10.008; Zhou YH, 2011, J REFRACT SURG, V27, P408, DOI 10.3928/1081597X-20101029-01	44	2	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98852	10.1371/journal.pone.0098852	http://dx.doi.org/10.1371/journal.pone.0098852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911840	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000337165600017
J	Newman, LE; Zhou, CJ; Mudigonda, S; Mattheyses, AL; Paradies, E; Marobbio, CMT; Kahn, RA				Newman, Laura E.; Zhou, Cheng-jing; Mudigonda, Samatha; Mattheyses, Alexa L.; Paradies, Eleonora; Marobbio, Carlo Marya Thomas; Kahn, Richard A.			The ARL2 GTPase Is Required for Mitochondrial Morphology, Motility, and Maintenance of ATP Levels	PLOS ONE			English	Article							MEMBRANE ORGANIZATION; ARF FAMILY; COFACTOR-D; FUNCTIONAL-CHARACTERIZATION; S-ADENOSYLMETHIONINE; MITOFILIN COMPLEXES; ACTIVATING PROTEIN; STRUCTURAL BASIS; TRANSPORT; MUTANTS	ARF-like 2 (ARL2) is a member of the ARF family and RAS superfamily of regulatory GTPases, predicted to be present in the last eukaryotic common ancestor, and essential in a number of model genetic systems. Though best studied as a regulator of tubulin folding, we previously demonstrated that ARL2 partially localizes to mitochondria. Here, we show that ARL2 is essential to a number of mitochondrial functions, including mitochondrial morphology, motility, and maintenance of ATP levels. We compare phenotypes resulting from ARL2 depletion and expression of dominant negative mutants and use these to demonstrate that the mitochondrial roles of ARL2 are distinct from its roles in tubulin folding. Testing of current models for ARL2 actions at mitochondria failed to support them. Rather, we found that knockdown of the ARL2 GTPase activating protein (GAP) ELMOD2 phenocopies two of three phenotypes of ARL2 siRNA, making it a likely effector for these actions. These results add new layers of complexity to ARL2 signaling, highlighting the need to deconvolve these different cell functions. We hypothesize that ARL2 plays essential roles inside mitochondria along with other cellular functions, at least in part to provide coupling of regulation between these essential cell processes.	[Newman, Laura E.; Mudigonda, Samatha; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Zhou, Cheng-jing] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Mattheyses, Alexa L.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Paradies, Eleonora] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Marobbio, Carlo Marya Thomas] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy	Emory University; Emory University; Emory University; Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari Aldo Moro	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rkahn@emory.edu	MAROBBIO, Carlo/G-5775-2015; Paradies, Eleonora/K-4606-2014; Kahn, Richard/ABD-2666-2020	MAROBBIO, Carlo/0000-0002-2516-0321; Paradies, Eleonora/0000-0002-1668-7148; Kahn, Richard/0000-0002-0259-0601; Newman, Laura/0000-0001-5559-713X; Mattheyses, Alexa L/0000-0002-5119-7750	National Institutes of Health [GM090158]; American Heart Association predoctoral fellowship [14PRE18840040]; Microscopy Core of the Emory Neuroscience Core Facilities grant from National Institutes of Health [P30NS055077];  [5T32GM008367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); Microscopy Core of the Emory Neuroscience Core Facilities grant from National Institutes of Health; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (http://www.nih.gov/) GM090158 to RAK, American Heart Association predoctoral fellowship (http://www.heart.org/) 14PRE18840040 to LEN, Microscopy Core of the Emory Neuroscience Core Facilities grant P30NS055077 from National Institutes of Health (http://www.nih.gov/), L. Newman was supported by a training grant 5T32GM008367 while performing some of the work in this manuscript. As with the other funding sources, the funders had no role in the design or execution of the study, or the decision to publish or preparation of the manuscript.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Beghin A, 2008, CELL CYCLE, V7, P3074, DOI 10.4161/cc.7.19.6777; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Beltran-Parrazal L, 2006, AM J PHYSIOL-CELL PH, V291, pC1193, DOI 10.1152/ajpcell.00230.2006; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Bowzard JB, 2005, METHOD ENZYMOL, V404, P453, DOI 10.1016/S0076-6879(05)04040-1; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dong JH, 2007, GENE, V396, P116, DOI 10.1016/j.gene.2007.03.001; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Ivanova AA, 2014, J BIOL CHEM; Jaworek TJ, AM J HUM GE IN PRESS; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Fanarraga ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008846; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 1979, Methods Enzymol, V56, P279; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; STEARNS T, 1990, GENETICS, V124, P251; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tian GL, 2010, CYTOSKELETON, V67, P706, DOI 10.1002/cm.20480; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	75	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99270	10.1371/journal.pone.0099270	http://dx.doi.org/10.1371/journal.pone.0099270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911211	gold, Green Submitted, Green Published			2022-12-27	WOS:000337165600063
J	Bernin, D; Koch, V; Nyden, M; Topgaard, D				Bernin, Diana; Koch, Vanessa; Nyden, Magnus; Topgaard, Daniel			Multi-Scale Characterization of Lyotropic Liquid Crystals Using H-2 and Diffusion MRI with Spatial Resolution in Three Dimensions	PLOS ONE			English	Article							TENSOR IMAGING MATHEMATICS; INDUCED MULTILAMELLAR VESICLES; HOMOGENEOUS LENGTH-SCALE; LAMELLAR PHASE; DOMAIN-STRUCTURE; SELF-DIFFUSION; FIELD GRADIENT; NMR; SYSTEM; WATER	The ability of lyotropic liquid crystals to form intricate structures on a range of length scales can be utilized for the synthesis of structurally complex inorganic materials, as well as in devices for controlled drug delivery. Here we employ magnetic resonance imaging (MRI) for non-invasive characterization of nano-, micro-, and millimeter scale structures in liquid crystals. The structure is mirrored in the translational and rotational motion of the water, which we assess by measuring spatially resolved self-diffusion tensors and H-2 spectra. Our approach differs from previous works in that the MRI parameters are mapped with spatial resolution in all three dimensions, thus allowing for detailed studies of liquid crystals with complex millimeter-scale morphologies that are stable on the measurement time-scale of 10 hours. The H-2 data conveys information on the nanometer-scale structure of the liquid crystalline phase, while the combination of diffusion and H-2 data permits an estimate of the orientational distribution of micrometer-scale anisotropic domains. We study lamellar phases consisting of the nonionic surfactant C10E3 in (H2O)-H-2, and follow their structural equilibration after a temperature jump and the cessation of shear. Our experimental approach may be useful for detailed characterization of liquid crystalline materials with structures on multiple length scales, as well as for studying the mechanisms of phase transitions.	[Bernin, Diana] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Bernin, Diana] Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden; [Nyden, Magnus] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5001, Australia; [Koch, Vanessa; Topgaard, Daniel] Lund Univ, Dept Chem, Div Phys Chem, Lund, Sweden	Chalmers University of Technology; University of Gothenburg; University of South Australia; Lund University	Topgaard, D (corresponding author), Lund Univ, Dept Chem, Div Phys Chem, Lund, Sweden.	daniel.topgaard@fkem1.lu.se	Bernin, Diana/P-3643-2019; Nyden, Magnus/D-3359-2012	Bernin, Diana/0000-0002-9611-2263; Nyden, Magnus/0000-0002-3036-1152; Topgaard, Daniel/0000-0001-9373-6348	VINNOVA through the VINN Excellence Centre SuMo Biomaterials; Swedish Research Council VR [2009-6794, 2011-4334]	VINNOVA through the VINN Excellence Centre SuMo Biomaterials(Vinnova); Swedish Research Council VR(Swedish Research Council)	This work is funded by VINNOVA through the VINN Excellence Centre SuMo Biomaterials (Supramolecular Biomaterials - Structure dynamics and properties) and the Swedish Research Council VR (grant numbers 2009-6794 and 2011-4334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslund I, 2008, J PHYS CHEM B, V112, P2782, DOI 10.1021/jp076174l; Aslund I, 2011, J MAGN RESON, V209, P291, DOI 10.1016/j.jmr.2011.01.024; ATTARD GS, 1995, NATURE, V378, P366, DOI 10.1038/378366a0; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Briganti G, 1999, J PHYS CHEM B, V103, P825, DOI 10.1021/jp982967j; Brown JR, 2011, SOFT MATTER, V7, P10472, DOI 10.1039/c1sm06135f; Bulut S, 2010, SOFT MATTER, V6, P4520, DOI 10.1039/c0sm00085j; Callaghan P. T., 2011, TRANSLATIONAL DYNAMI; CALLAGHAN PT, 1983, J PHYS CHEM-US, V87, P1737, DOI 10.1021/j100233a019; CALLAGHAN PT, 1988, J PHYS E SCI INSTRUM, V21, P820, DOI 10.1088/0022-3735/21/8/017; Capitani D, 1999, J PHYS CHEM B, V103, P6088, DOI 10.1021/jp990143b; Capitani D, 2007, LANGMUIR, V23, P3036, DOI 10.1021/la062798r; Chen L, 2002, J MAGN RESON, V158, P164, DOI 10.1016/S1090-7807(02)00069-1; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Dvinskikh SV, 2001, LANGMUIR, V17, P6455, DOI 10.1021/la010693c; Evans D.F, 1999, COLLOIDAL DOMAIN PHY, V2nd; Fanfoni M, 1998, NUOVO CIMENTO D, V20, P1171, DOI 10.1007/BF03185527; Ferreira TM, 2013, ANNU REP NMR SPECTRO, V79, P73, DOI 10.1016/B978-0-12-408098-0.00003-3; Fischer E, 2000, EUROPHYS LETT, V50, P803, DOI 10.1209/epl/i2000-00552-9; Freund O, 2000, LIFE SCI, V67, P411, DOI 10.1016/S0024-3205(00)00640-8; Gauffre F, 1999, LANGMUIR, V15, P3738, DOI 10.1021/la981541t; Gotter M, 2005, FARADAY DISCUSS, V129, P327, DOI 10.1039/b405363j; Harris R. K., 1983, NUCL MAGNETIC RESONA; Hubbard PL, 2006, J PHYS CHEM B, V110, P20781, DOI 10.1021/jp0601872; Iwashita Y, 2006, NAT MATER, V5, P147, DOI 10.1038/nmat1580; Johnson WA, 1939, T AM I MIN MET ENG, V135, P416; Jonsson B., 2002, SURFACTANTS POLYM AQ; KHAN A, 1982, J PHYS CHEM-US, V86, P383, DOI 10.1021/j100392a020; KHAN A, 1982, J PHYS CHEM-US, V86, P4266, DOI 10.1021/j100218a034; Kindlmann G, 2004, P 6 JOINT EUR IEEE T, P1, DOI [DOI 10.2312/VISSYM/VISSYM04/147-154, 10.2312/VisSym/VisSym04/147-154]; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P101, DOI 10.1002/cmr.a.20048; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P123, DOI 10.1002/cmr.a.20049; Klinkenberg M, 1996, J MAGN RESON SER A, V119, P197, DOI 10.1006/jmra.1996.0073; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Le TD, 2001, LANGMUIR, V17, P999, DOI 10.1021/la001227a; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Levitt MH, 2008, SPIN DYNAMICS BASICS, VSecond; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Medronho B, 2008, LANGMUIR, V24, P6480, DOI 10.1021/la800326a; Medronho B, 2007, LANGMUIR, V23, P5270, DOI 10.1021/la063599a; Medronho B, 2010, LANGMUIR, V26, P1477, DOI 10.1021/la903682p; Medronho B, 2012, Z PHYS CHEM, V226, P1293, DOI 10.1524/zpch.2012.0313; Medronho B, 2011, SOFT MATTER, V7, P4938, DOI 10.1039/c0sm01323d; Nettesheim F, 2003, LANGMUIR, V19, P3603, DOI 10.1021/la026654y; Oliviero C, 2003, COLLOID SURFACE A, V228, P85, DOI 10.1016/S0927-7757(03)00356-X; PAKE GE, 1948, J CHEM PHYS, V16, P327, DOI 10.1063/1.1746878; Pommella A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.138301; Price W.S., 2009, NMR STUDIES TRANSLAT; Redkar M, 2007, J PHARM SCI-US, V96, P2436, DOI 10.1002/jps.20863; ROSEDALE JH, 1990, MACROMOLECULES, V23, P2329, DOI 10.1021/ma00210a032; Squires AM, 2013, LANGMUIR, V29, P1726, DOI 10.1021/la304726m; STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526; STRUIS RPWJ, 1987, J PHYS CHEM-US, V91, P1639, DOI 10.1021/j100290a069; Susumu M., 2007, INTRO DIFFUSION TENS; Szutkowski K, 2010, J PHYS CHEM B, V114, P165, DOI 10.1021/jp9072087; Topgaard D, 2002, J PHYS CHEM B, V106, P11887, DOI 10.1021/jp020130p; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; Westin C.F., 1997, GEOMETRICAL DIFFUSIO, P1742; Yethiraj A, 2005, LANGMUIR, V21, P3311, DOI 10.1021/la046962r; Zipfel J, 2001, EUROPHYS LETT, V53, P335, DOI 10.1209/epl/i2001-00158-3	65	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98752	10.1371/journal.pone.0098752	http://dx.doi.org/10.1371/journal.pone.0098752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905818	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000057
J	DeBarry, JD; Kissinger, JC				DeBarry, Jeremy D.; Kissinger, Jessica C.			A Survey of Innovation through Duplication in the Reduced Genomes of Twelve Parasites	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; SEGMENTAL DUPLICATIONS; TOXOPLASMA-GONDII; CRYPTOSPORIDIUM-PARVUM; GENE DUPLICATION; APICOMPLEXAN PARASITES; ORTHOLOG GROUPS; EVOLUTION; PLASMODIUM; SEQUENCE	We characterize the prevalence, distribution, divergence, and putative functions of detectable two-copy paralogs and segmental duplications in the Apicomplexa, a phylum of parasitic protists. Apicomplexans are mostly obligate intracellular parasites responsible for human and animal diseases (e. g. malaria and toxoplasmosis). Gene loss is a major force in the phylum. Genomes are small and protein-encoding gene repertoires are reduced. Despite this genomic streamlining, duplications and gene family amplifications are present. The potential for innovation introduced by duplications is of particular interest. We compared genomes of twelve apicomplexans across four lineages and used orthology and genome cartography to map distributions of duplications against genome architectures. Segmental duplications appear limited to five species. Where present, they correspond to regions enriched for multi-copy and species-specific genes, pointing toward roles in adaptation and innovation. We found a phylum-wide association of duplications with dynamic chromosome regions and syntenic breakpoints. Trends in the distribution of duplicated genes indicate that recent, species-specific duplicates are often tandem while most others have been dispersed by genome rearrangements. These trends show a relationship between genome architecture and gene duplication. Functional analysis reveals: proteases, which are vital to a parasitic lifecycle, to be prominent in putative recent duplications; a pair of paralogous genes in Toxoplasma gondii previously shown to produce the rate-limiting step in dopamine synthesis in mammalian cells, a possible link to the modification of host behavior; and phylum-wide differences in expression and subcellular localization, indicative of modes of divergence. We have uncovered trends in multiple modes of duplicate divergence including sequence, intron content, expression, subcellular localization, and functions of putative recent duplicates that highlight the role of duplications in the continuum of forces that have shaped these genomes.	[DeBarry, Jeremy D.; Kissinger, Jessica C.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [DeBarry, Jeremy D.; Kissinger, Jessica C.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Kissinger, Jessica C.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	DeBarry, JD (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	debarryj@gmail.com	Kissinger, Jessica C/E-9610-2010; Kissinger, Jessica/M-9920-2019	Kissinger, Jessica C/0000-0002-6413-1101; Kissinger, Jessica/0000-0002-6413-1101; DeBarry, Jeremy/0000-0001-5718-2675	National Institutes of Health [R01AI068908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant number R01AI068908 to J.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson TJC, 2009, TRENDS PARASITOL, V25, P336, DOI 10.1016/j.pt.2009.04.005; Aurrecoechea C, 2009, NUCLEIC ACIDS RES; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DeBarry J, 2011, MOL BIOL EVOLUTION, V28; Delwiche CF, 2004, BIOSCIENCE, V54, P991, DOI 10.1641/0006-3568(2004)054[0991:TGPGIE]2.0.CO;2; Durand PM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-282; Emes RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002295; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Guerzoni D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002381; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Kissinger JC, 2011, TRENDS PARASITOL, V27, P345, DOI 10.1016/j.pt.2011.03.006; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Kuo C-H, 2008, MOL BIOL EVOL; Kuo CH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-108; Li H, 2012, BBA-PROTEINS PROTEOM, V1824, P177, DOI 10.1016/j.bbapap.2011.06.002; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Nguyen HD, 2007, MOL BIOL EVOL, V24, P1093, DOI 10.1093/molbev/msm037; Oberstaller J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-516; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Saffo MB, 2010, P NATL ACAD SCI USA, V107, P16190, DOI 10.1073/pnas.1002335107; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sankoff D, 2001, CURR OPIN GENET DEV, V11, P681, DOI 10.1016/S0959-437X(00)00253-7; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Sun J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-49; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Templeton TJ, 2009, MOL BIOL EVOL; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108; Xu JH, 2012, MOL BIOL EVOL, V29, P861, DOI 10.1093/molbev/msr261; Yang ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/j.febslet.2011.01.017; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9; Zhu G, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-46; Zuther E, 1999, P NATL ACAD SCI USA, V96, P13387, DOI 10.1073/pnas.96.23.13387	67	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99213	10.1371/journal.pone.0099213	http://dx.doi.org/10.1371/journal.pone.0099213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919110	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000057
J	Masuda, T; Maruyama, H; Honda, A; Arai, F				Masuda, Taisuke; Maruyama, Hisataka; Honda, Ayae; Arai, Fumihito			Virus Enrichment for Single Virus Infection by Using 3D Insulator Based Dielectrophoresis	PLOS ONE			English	Article							DIFFRACTIVE-OPTICS FABRICATION; GRAY-SCALE LITHOGRAPHY; CONTINUOUS SEPARATION; MICROFLUIDIC DEVICES; CELLS; MANIPULATION; ELECTRODES; EFFICIENCY; PARTICLES; MASKS	We developed an active virus filter (AVF) that enables virus enrichment for single virus infection, by using insulator-based dielectrophoresis (iDEP). A 3D-constricted flow channel design enabled the production of an iDEP force in the microfluidic chip. iDEP using a chip with multiple active virus filters (AVFs) was more accurate and faster than using a chip with a single AVF, and improved the efficiency of virus trapping. We utilized maskless photolithography to achieve the precise 3D gray-scale exposure required for fabrication of constricted flow channel. Influenza virus (A PR/8) was enriched by a negative DEP force when sinusoidal wave was applied to the electrodes within an amplitude range of 20 Vp-p and a frequency of 10 MHz. AVF-mediated virus enrichment can be repeated simply by turning the current ON or OFF. Furthermore, the negative AVF can inhibit virus adhesion onto the glass substrate. We then trapped and transported one of the enriched viruses by using optical tweezers. This microfluidic chip facilitated the effective transport of a single virus from AVFs towards the cell-containing chamber without crossing an electrode. We successfully transported the virus to the cell chamber (v = 10 mu m/s) and brought it infected with a selected single H292 cell.	[Masuda, Taisuke; Maruyama, Hisataka; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Honda, Ayae] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan	Nagoya University; Hosei University	Masuda, T (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	masuda@mech.nagoya-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was partially supported by Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Akin D, 2004, NANO LETT, V4, P257, DOI 10.1021/nl034987p; Albrecht DR, 2004, BIOPHYS J, V87, P2131, DOI 10.1529/biophysj.104.039511; Aldaeus F, 2005, ELECTROPHORESIS, V26, P4252, DOI 10.1002/elps.200500068; Arai F, 2001, ELECTROPHORESIS, V22, P283, DOI 10.1002/1522-2683(200101)22:2<283::AID-ELPS283>3.0.CO;2-C; Demierre N, 2008, SENSOR ACTUAT B-CHEM, V132, P388, DOI 10.1016/j.snb.2007.09.078; Fiedler S, 1998, ANAL CHEM, V70, P1909, DOI 10.1021/ac971063b; Gadish N, 2006, ANAL CHEM, V78, P7870, DOI 10.1021/ac061170i; Honda A, 2008, J BIOTECHNOL, V133, P208, DOI 10.1016/j.jbiotec.2007.08.019; HUANG Y, 1991, MEAS SCI TECHNOL, V2, P1142, DOI 10.1088/0957-0233/2/12/005; Hughes MP, 1998, BBA-GEN SUBJECTS, V1425, P119, DOI 10.1016/S0304-4165(98)00058-0; Ino K, 2009, ELECTROPHORESIS, V30, P3406, DOI 10.1002/elps.200900244; Itoga K, 2008, ANAL CHEM, V80, P1323, DOI 10.1021/ac702208d; Lapizco-Encinas BH, 2005, J MICROBIOL METH, V62, P317, DOI 10.1016/j.mimet.2005.04.027; Li HB, 2002, SENSOR ACTUAT B-CHEM, V86, P215, DOI 10.1016/S0925-4005(02)00172-7; MARKX GH, 1995, BIOTECHNOL BIOENG, V45, P337, DOI 10.1002/bit.260450408; Markx GH, 1997, J PHYS D APPL PHYS, V30, P2470, DOI 10.1088/0022-3727/30/17/013; Maruyama H, 2011, MICROFLUID NANOFLUID, V10, P1109, DOI 10.1007/s10404-010-0739-4; MASUDA S, 1989, IEEE T IND APPL, V25, P732, DOI 10.1109/28.31255; Masuda T, 2011, PROC IEEE MICR ELECT, P1099, DOI 10.1109/MEMSYS.2011.5734621; Mittal N, 2007, LAB CHIP, V7, P1146, DOI 10.1039/b706342c; Morgan H, 2001, J PHYS D APPL PHYS, V34, P1553, DOI 10.1088/0022-3727/34/10/316; OSHEA DC, 1995, APPL OPTICS, V34, P7518, DOI 10.1364/AO.34.007518; PETHIG R, 1992, J PHYS D APPL PHYS, V25, P881, DOI 10.1088/0022-3727/25/5/022; Pethig R, 2010, BIOMICROFLUIDICS, V4; POHL HA, 1971, BIOPHYS J, V11, P711, DOI 10.1016/S0006-3495(71)86249-5; POHL HA, 1951, J APPL PHYS, V22, P869, DOI 10.1063/1.1700065; Pohl HA, 1978, DIELECTROPHRESIS; Regtmeier J, 2011, ELECTROPHORESIS, V32, P2253, DOI 10.1002/elps.201100055; Rosenthal A, 2006, LAB CHIP, V6, P508, DOI 10.1039/b600280n; Sabounchi P, 2008, BIOMED MICRODEVICES, V10, P661, DOI 10.1007/s10544-008-9177-4; Schnelle T, 1996, NATURWISSENSCHAFTEN, V83, P172, DOI 10.1007/BF01143058; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; SULESKI TJ, 1995, APPL OPTICS, V34, P7507, DOI 10.1364/AO.34.007507; Totsu K, 2006, SENSOR ACTUAT A-PHYS, V130, P387, DOI 10.1016/j.sna.2005.12.008; Ueda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067011; Waits CM, 2005, SENSOR ACTUAT A-PHYS, V119, P245, DOI 10.1016/j.sna.2004.03.024	36	22	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e94083	10.1371/journal.pone.0094083	http://dx.doi.org/10.1371/journal.pone.0094083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918921	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000002
J	Sugi, H; Chaen, S; Kobayashi, T; Abe, T; Kimura, K; Saeki, Y; Ohnuki, Y; Miyakawa, T; Tanokura, M; Sugiura, S				Sugi, Haruo; Chaen, Shigeru; Kobayashi, Takakazu; Abe, Takahiro; Kimura, Kazushige; Saeki, Yasutake; Ohnuki, Yoshiki; Miyakawa, Takuya; Tanokura, Masaru; Sugiura, Seiryo			Definite Differences between In Vitro Actin-Myosin Sliding and Muscle Contraction as Revealed Using Antibodies to Myosin Head	PLOS ONE			English	Article							ATP HYDROLYSIS; STEP-SIZE; FILAMENTS; MOVEMENT; MECHANISM; FIBERS; STROKE; SITE	Muscle contraction results from attachment-detachment cycles between myosin heads extending from myosin filaments and actin filaments. It is generally believed that a myosin head first attaches to actin, undergoes conformational changes to produce force and motion in muscle, and then detaches from actin. Despite extensive studies, the molecular mechanism of myosin head conformational changes still remains to be a matter for debate and speculation. The myosin head consists of catalytic (CAD), converter (CVD) and lever arm (LD) domains. To give information about the role of these domains in the myosin head performance, we have examined the effect of three site-directed antibodies to the myosin head on in vitro ATP-dependent actin-myosin sliding and Ca2+-activated contraction of muscle fibers. Antibody 1, attaching to junctional peptide between 50K and 20K heavy chain segments in the CAD, exhibited appreciable effects neither on in vitro actin-myosin sliding nor muscle fiber contraction. Since antibody 1 covers actin-binding sites of the CAD, one interpretation of this result is that rigor actin-myosin linkage is absent or at most a transient intermediate in physiological actin-myosin cycling. Antibody 2, attaching to reactive lysine residue in the CVD, showed a marked inhibitory effect on in vitro actin-myosin sliding without changing actin-activated myosin head (S1) ATPase activity, while it showed no appreciable effect on muscle contraction. Antibody 3, attaching to two peptides of regulatory light chains in the LD, had no significant effect on in vitro actin-myosin sliding, while it reduced force development in muscle fibers without changing MgATPase activity. The above definite differences in the effect of antibodies 2 and 3 between in vitro actin-myosin sliding and muscle contraction can be explained by difference in experimental conditions; in the former, myosin heads are randomly oriented on a glass surface, while in the latter myosin heads are regularly arranged within filament-lattice structures.	[Sugi, Haruo] Teikyo Univ, Sch Med, Dept Physiol, Tokyo 173, Japan; [Chaen, Shigeru] Nihon Univ, Coll Humanities & Sci, Dept Integrated Sci Phys & Biol, Tokyo, Japan; [Kobayashi, Takakazu; Abe, Takahiro; Kimura, Kazushige] Shibaura Inst Technol, Dept Elect Engn, Tokyo 108, Japan; [Saeki, Yasutake; Ohnuki, Yoshiki] Tsurumi Univ, Sch Dent, Dept Physiol, Yokohama, Kanagawa, Japan; [Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biochem, Tokyo, Japan; [Sugiura, Seiryo] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan	Teikyo University; Nihon University; Shibaura Institute of Technology; Tsurumi University; University of Tokyo; University of Tokyo	Sugi, H (corresponding author), Teikyo Univ, Sch Med, Dept Physiol, Tokyo 173, Japan.	sugi@kyf.biglobe.ne.jp		Tanokura, Masaru/0000-0001-5072-2480				Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; Brenner B, 1998, CURRENT METHODS MUSC, P33, DOI DOI 10.1093/ACPROF:OSO/9780198523970.003.0002; CHAEN S, 1986, J BIOL CHEM, V261, P3632; EDMAN KAP, 1988, J PHYSIOL-LONDON, V404, P301, DOI 10.1113/jphysiol.1988.sp017291; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; IWAMOTO H, 1990, J PHYSIOL-LONDON, V422, P185, DOI 10.1113/jphysiol.1990.sp017979; Kobayashi H, 2013, IUPS 2013 ABSTRACT B; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; KRAFT T, 1995, BIOPHYS J, V69, P1246, DOI 10.1016/S0006-3495(95)80018-4; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Minoda H, 2011, BIOCHEM BIOPH RES CO, V405, P651, DOI 10.1016/j.bbrc.2011.01.087; MORNET D, 1980, FEBS LETT, V117, P183, DOI 10.1016/0014-5793(80)80941-0; Muhlrad A, 2003, BIOPHYS J, V84, P1047, DOI 10.1016/S0006-3495(03)74921-2; PERRY SV, 1955, METHOD ENZYMOL, V2, P582, DOI 10.1016/S0076-6879(55)02258-1; Radocaj A, 2009, BIOPHYS J, V96, P1430, DOI 10.1016/j.bpj.2008.11.023; SAITO K, 1994, BIOPHYS J, V66, P769, DOI 10.1016/S0006-3495(94)80853-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Sugi H, 1997, P NATL ACAD SCI USA, V94, P4378, DOI 10.1073/pnas.94.9.4378; Sugi H, 2011, J MUSCLE RES CELL M, V32, P34; Sugi H, 2014, ABSTR BIOPH IN PRESS; Sugi H, 2008, P NATL ACAD SCI USA, V105, P17396, DOI 10.1073/pnas.0809581105; Sugi H, 2013, J PHYSIOL SCI, V63, pS35; SUTOH K, 1989, J MOL BIOL, V206, P357, DOI 10.1016/0022-2836(89)90485-3; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; YAMADA T, 1993, J PHYSIOL-LONDON, V466, P229	34	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e93272	10.1371/journal.pone.0093272	http://dx.doi.org/10.1371/journal.pone.0093272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918754	gold, Green Submitted, Green Published			2022-12-27	WOS:000338631000001
J	Alexander, NM; Harper, DM; Comes, JC; Smith, MS; Heutinck, MA; Handley, SM; Ahern, DA				Alexander, Natalie Marya; Harper, Diane Medved; Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin; Ahern, Debra Ann			Intent to Participate in Future Cervical Cancer Screenings Is Lower when Satisfaction with the Decision to Be Vaccinated Is Neutral	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; GUIDELINES; INCREASE; ERA	Background: HPV vaccination programs have adversely affected participation in future cervical cancer screening. The purpose of this study is to determine the influence of decision satisfaction with accepting/rejecting the HPV vaccine, as well as traditional clinical factors, on the intent to participate in future screening. Methods and Findings: From January 2011 through August 2012 women 18-26 years old presenting for health care in an urban college student health and wellness clinic in the US Midwest were asked to complete a descriptive and medical history survey including a six element decisional satisfaction survey scored on 5-point Likert scales, where the intent to participate in future cervical cancer screening was measured. Of the 568 women who completed the decisional satisfaction survey, 17% of those <21 years and 7% >= 21 years indicated no intent to participate in future cervical cancer screenings. Among women of current screening age, the univariate risk factors of race/ethnicity, contraceptive use, number of lifetime sexual partners, and receipt of HPV vaccine were not predictors of intent for future cervical cancer screening. Instead, only a history of a prior Pap test was a significant positive predictor and only a decisional satisfaction of 'neutral' (Likert score = 3) for any of the four decisional satisfaction elements was a significant negative predictor. For the decisional satisfaction element "best for me personally'', there was a 78% decreased likelihood of intending to participate in future screening if the satisfaction was neutral rather than firm (aOR = 0.22, 95% CI: 0.05-0.91) and a 26 fold increased likelihood if she had had a prior Pap test (aOR = 26, 95% CI: 5-133). Conclusions: HPV vaccination implementation programs must help women be the owner of their decision around HPV vaccination and understand the importance of future participation in cervical cancer screening.	[Alexander, Natalie Marya; Harper, Diane Medved; Ahern, Debra Ann] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64110 USA; [Harper, Diane Medved] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64110 USA; [Harper, Diane Medved] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; Kansas City Univ Med & Biosci, Dept Family Med, Kansas City, MO USA; [Harper, Diane Medved; Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin; Ahern, Debra Ann] Univ Missouri, Univ Missouri Kansas City Student Hlth & Wellness, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64110 USA.	diane.m.harper@gmail.com						Ahluwalia IB, 2007, J WOMENS HEALTH, V16, P935, DOI 10.1089/jwh.2007.CDC8; American College of Obstetricians and Gynecologists (ACOG), 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.0B013E318277C92A; [Anonymous], 2012, AHRQ PUBLICATION; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Bauch CT, 2010, LANCET INFECT DIS, V10, P133, DOI 10.1016/S1473-3099(10)70004-9; Beebe TJ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-19; Beer H, 2014, VACCINE, V32, P1828, DOI 10.1016/j.vaccine.2014.01.087; Blank PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045450; Brotherton JML, 2013, SS224 EUROGIN; Budd AC, 2010, SEX HEALTH, V7, P328, DOI 10.1071/SH09133; Camilloni L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-464; Cuzick J, 2013, CANCER EPIDEM BIOMAR; Engeland A, 1993, APMIS Suppl, V38, P1; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; Franco EL, 2009, PUBLIC HEALTH GENOM, V12, P352, DOI 10.1159/000214925; Goldie SJ, 2006, VACCINE, V24, P164, DOI 10.1016/j.vaccine.2006.05.114; Harper DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088493; Harper Diane M, 2010, J Vaccines Vaccin, V1; Harper DM, 2010, DISCOV MED, V10, P7; Harper Diane M, 2011, ISRN Obstet Gynecol, V2011, P457204, DOI 10.5402/2011/457204; Harper DM, 2010, LANCET INFECT DIS, V10, P594, DOI 10.1016/S1473-3099(10)70182-1; Harper DM, 1999, J FAM PRACTICE, V48, P531; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Hou SI, 2011, ASIAN PAC J CANCER P, V12, P3133; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Ogilvie GS, 2013, INT J CANCER, V133, P2934, DOI 10.1002/ijc.28324; Paiva AL, 2014, J AM COLL HEALTH, V62, P32, DOI 10.1080/07448481.2013.843534; Sancho-Garnier H, 2013, INT J CANCER, V133, P2681, DOI 10.1002/ijc.28283; Sasieni P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2968; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schmeink CE, 2011, REV MED VIROL, V21, P139, DOI 10.1002/rmv.686; Sforzo Gary A, 2013, Glob Adv Health Med, V2, P58, DOI 10.7453/gahmj.2013.040; StatSoft Inc, 2010, STATISTICA DAT AN SO; The National Committee for Quality Assurance (NCQA), HEALTHC EFF DAT INF; Tota J, 2010, SEX HEALTH, V7, P376, DOI 10.1071/SH10022; Vadaparampil ST, 2014, AM J PREV MED, V46, P80, DOI 10.1016/j.amepre.2013.07.009	37	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98665	10.1371/journal.pone.0098665	http://dx.doi.org/10.1371/journal.pone.0098665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914536	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700029
J	Delimont, D; Dufek, BM; Meehan, DT; Zallocchi, M; Gratton, MA; Phillips, G; Cosgrove, D				Delimont, Duane; Dufek, Brianna M.; Meehan, Daniel T.; Zallocchi, Marisa; Gratton, Michael Anne; Phillips, Grady; Cosgrove, Dominic			Laminin alpha 2-Mediated Focal Adhesion Kinase Activation Triggers Alport Glomerular Pathogenesis	PLOS ONE			English	Article							NF-KAPPA-B; BASEMENT-MEMBRANE; MOUSE MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; MATRIX METALLOPROTEINASES; MESANGIAL CELLS; RENAL-DISEASE; INTEGRIN; FAK; ALPHA-1-BETA-1	It has been known for some time that laminins containing alpha 1 and alpha 2 chains, which are normally restricted to the mesangial matrix, accumulate in the glomerular basement membranes (GBM) of Alport mice, dogs, and humans. We show that laminins containing the alpha 2 chain, but not those containing the alpha 1 chain activates focal adhesion kinase (FAK) on glomerular podocytes in vitro and in vivo. CD151-null mice, which have weakened podocyte adhesion to the GBM rendering these mice more susceptible to biomechanical strain in the glomerulus, also show progressive accumulation of alpha 2 laminins in the GBM, and podocyte FAK activation. Analysis of glomerular mRNA from both models demonstrates significant induction of MMP-9, MMP-10, MMP-12, MMPs linked to GBM destruction in Alport disease models, as well as the pro-inflammatory cytokine IL-6. SiRNA knockdown of FAK in cultured podocytes significantly reduced expression of MMP-9, MMP-10 and IL-6, but not MMP-12. Treatment of Alport mice with TAE226, a small molecule inhibitor of FAK activation, ameliorated fibrosis and glomerulosclerosis, significantly reduced proteinuria and blood urea nitrogen levels, and partially restored GBM ultrastructure. Glomerular expression of MMP-9, MMP-10 and MMP-12 mRNAs was significantly reduced in TAE226 treated animals. Collectively, this work identifies laminin alpha 2-mediated FAK activation in podocytes as an important early event in Alport glomerular pathogenesis and suggests that FAK inhibitors, if safe formulations can be developed, might be employed as a novel therapeutic approach for treating Alport renal disease in its early stages.	[Delimont, Duane; Dufek, Brianna M.; Meehan, Daniel T.; Zallocchi, Marisa; Cosgrove, Dominic] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; [Cosgrove, Dominic] Univ Nebraska Med Ctr, Dept Biochem, Omaha, NE USA; [Gratton, Michael Anne; Phillips, Grady] St Louis Univ, Dept Otolaryngol, St Louis, MO 63103 USA	Boys Town National Research Hospital; University of Nebraska System; University of Nebraska Medical Center; Saint Louis University	Cosgrove, D (corresponding author), Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA.	Dominic.cosgrove@boystown.org	Zallocchi, Marisa/HHS-7445-2022		 [NIH R01 DK055000];  [NIH R01 DC006442]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006442] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding provided by NIH R01 DK055000 to DC, NIH R01 DC006442 to MAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; Andrews KL, 2000, AM J PATHOL, V157, P303, DOI 10.1016/S0002-9440(10)64541-5; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Chen YJ, 2009, J CELL PHYSIOL, V221, P98, DOI 10.1002/jcp.21835; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; Cosgrove D, 2008, AM J PATHOL, V172, P761, DOI 10.2353/ajpath.2008.070473; Dennis J, 2010, AM J PATHOL, V177, P2527, DOI 10.2353/ajpath.2010.100017; Fischer E, 2000, NEPHROL DIAL TRANSPL, V15, P1956, DOI 10.1093/ndt/15.12.1956; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Hansen K, 2003, KIDNEY INT, V64, P110, DOI 10.1046/j.1523-1755.2003.00039.x; Horikoshi S, 1999, NEPHRON, V81, P284, DOI 10.1159/000045294; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Koepke ML, 2007, NEPHROL DIAL TRANSPL, V22, P1062, DOI 10.1093/ndt/gfl810; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Nagase H, 2001, SUBSTRATE SPECIFICIT, P39; Oh JH, 2009, GYNECOL ONCOL, V114, P509, DOI 10.1016/j.ygyno.2009.05.027; Rao VH, 2006, AM J PATHOL, V169, P32, DOI 10.2353/ajpath.2006.050896; Sampson NS, 2001, J BIOL CHEM, V276, P34182, DOI 10.1074/jbc.M102859200; SANCHEZLOPEZ R, 1993, J BIOL CHEM, V268, P7238; Sayers R, 1999, KIDNEY INT, V56, P1662, DOI 10.1046/j.1523-1755.1999.00744.x; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Van Slambrouck S, 2007, INT J ONCOL, V31, P1501; Zallocchi M, 2013, AM J PATHOL, V183, P1269, DOI 10.1016/j.ajpath.2013.06.015; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zeng ZZ, 2006, CANCER RES, V66, P8091, DOI 10.1158/0008-5472.CAN-05-4400	33	37	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99083	10.1371/journal.pone.0099083	http://dx.doi.org/10.1371/journal.pone.0099083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915008	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700060
J	Han, XZ; Hui, C				Han, Xiaozhuo; Hui, Cang			Niche Construction on Environmental Gradients: The Formation of Fitness Valley and Stratified Genotypic Distributions	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; EVOLUTIONARY CONSEQUENCES; POLYMORPHISM MAINTENANCE; METAPOPULATION DYNAMICS; EGG SIZE; PLANTS; POPULATION; STRATEGIES; SPECIATION; DIVERSITY	The process of niche construction can alter the trajectory of natural selection through organism-environment feedback. As such, the mechanism and impact of niche construction can be better investigated along environmental gradients. Here we investigate how the process of niche construction affects the distribution of genotypes and fitness landscape along an environmental gradient under three selection regimes, namely heterozygote superiority, genetic loci which dictates niche construction ability being either selectively neutral or non-neutral. Using a spatially explicit cellular automaton, we show that niche construction can stratify genetic diversity by forming band-like distributions consisting of different genotypic compositions and promote reproduction isolation by forming a divide with reduced average fitness along the gradients, termed a fitness valley. The band structure and the presence of a fitness valley depend on heterogeneous environments, resource-dependent fitness and the selection acting on the gene loci affecting the niche-constructing ability. Our work adds to the growing body of evidence on criticizing species distribution models which assume that the environment alone can determine species distributions. Based on the results, we argue that conservation planning should target preserving or restoring environmental gradients.	[Han, Xiaozhuo] Guangdong Univ Technol, Sch Appl Math, Guangzhou, Peoples R China; [Hui, Cang] Univ Stellenbosch, Dept Math Sci, Ctr Invas Biol, Matieland, South Africa; [Hui, Cang] African Inst Math Sci, Muizenberg, South Africa	Guangdong University of Technology; Stellenbosch University	Han, XZ (corresponding author), Guangdong Univ Technol, Sch Appl Math, Guangzhou, Peoples R China.	hanxzh03@163.com	Hui, Cang/A-1781-2008	Hui, Cang/0000-0002-3660-8160	National Natural Science Foundation of China [31100308]; National Research Foundation [76912, 81825]; University of Stellenbosch	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation; University of Stellenbosch	This work was supported by the National Natural Science Foundation of China (31100308). C.H. also received support from the National Research Foundation (Grants 76912 and 81825) and the University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo RBR, 1996, EVOLUTION, V50, P2338, DOI [10.2307/2410702, 10.1111/j.1558-5646.1996.tb03621.x]; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Berthouly-Salazar C, 2013, MOL ECOL, V22, P5793, DOI 10.1111/mec.12538; Berthouly-Salazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038145; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Bridle JR, 2001, J EVOLUTION BIOL, V14, P878, DOI 10.1046/j.1420-9101.2001.00344.x; BULLOCK J, 1994, TRENDS ECOL EVOL, V9, P299, DOI [10.1016/0169-5347(94)90037-X, 10.1016/0169-5347(94)90038-8]; Caplat P, 2014, BIOL INVASIONS, V16, P677, DOI 10.1007/s10530-013-0608-7; Corenblit D, 2009, GLOBAL ECOL BIOGEOGR, V18, P507, DOI 10.1111/j.1466-8238.2009.00461.x; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Coyne J.A., 2004, SPECIATION; Dassonville N, 2011, BIOL INVASIONS, V13, P1115, DOI 10.1007/s10530-011-9954-5; Davies SJ, 2013, AUSTRAL ECOL, V38, P851, DOI 10.1111/aec.12022; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Donaldson JE, 2014, GLOBAL CHANGE BIOL, V20, P1527, DOI 10.1111/gcb.12486; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Fogarty L, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911003311; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Gaertner M, 2014, DIVERS DISTRIB, V20, P733, DOI 10.1111/ddi.12182; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2014, TRENDS ECOL IN PRESS; Han XZ, 2009, APPL MATH COMPUT, V215, P449, DOI 10.1016/j.amc.2009.05.015; Han XZ, 2006, ECOL MODEL, V192, P160, DOI 10.1016/j.ecolmodel.2005.07.019; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Horak J, 2013, NATURWISSENSCHAFTEN, V100, P327, DOI 10.1007/s00114-013-1029-2; Hui C, 2006, ECOL COMPLEX, V3, P148, DOI 10.1016/j.ecocom.2005.12.003; Hui C, 2005, ECOL RES, V20, P115, DOI 10.1007/s11284-004-0020-y; Hui C, 2004, ECOL MODEL, V177, P107, DOI 10.1016/j.ecolmodel.2003.11.016; Hui C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3454; Hui C, 2012, ECOGRAPHY, V35, P1024, DOI 10.1111/j.1600-0587.2012.07697.x; In Meffe G. K., 1997, PRINCIPLES CONSERVAT, VSecond, P3; Izsak J, 2000, ECOL MODEL, V130, P151, DOI 10.1016/S0304-3800(00)00203-9; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kylafis G, 2008, ECOL LETT, V11, P1072, DOI 10.1111/j.1461-0248.2008.01220.x; Kylafis G, 2011, ECOL LETT, V14, P82, DOI 10.1111/j.1461-0248.2010.01551.x; Laland KN, 2006, EVOLUTION, V60, P1751; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lewontin R., 1972, EVOL BIOL, V6, P391; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MYERS N, 1997, PRINCIPLES CONSERVAT, P123; Odling-Smee F.J., 1988, P73; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Roura-Pascual N, 2009, GLOBAL CHANGE BIOL, V15, P2101, DOI 10.1111/j.1365-2486.2009.01907.x; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Schroder B, 2006, ECOL MODEL, V199, P505, DOI 10.1016/j.ecolmodel.2006.05.036; Silver M, 2006, THEOR POPUL BIOL, V70, P387, DOI 10.1016/j.tpb.2006.08.003; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Taylor T, 2004, Artificial Life IX, P375; Wcislo WT, 2009, BIOL REV, V84, P19, DOI 10.1111/j.1469-185X.2008.00059.x; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yue DX, 2004, ISR J PLANT SCI, V52, P235, DOI 10.1560/XBQW-L1WH-1Q3X-DJHR; Zhang F, 2013, EVOLUTION, V67, P548, DOI 10.1111/j.1558-5646.2012.01796.x; Zhang F, 2012, MATH BIOSCI, V240, P260, DOI 10.1016/j.mbs.2012.08.006	63	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99775	10.1371/journal.pone.0099775	http://dx.doi.org/10.1371/journal.pone.0099775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915290	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700134
J	Knight, JM; Moynihan, JA; Lyness, JM; Xia, YL; Tu, X; Messing, S; Hunter, BC; Huang, LS; Obi, RO; Gaisser, D; Liesveld, JL; Sahler, OJZ				Knight, Jennifer M.; Moynihan, Jan A.; Lyness, Jeffrey M.; Xia, Yinglin; Tu, Xin; Messing, Susan; Hunter, Bryan C.; Huang, Li-Shan; Obi, Rosemary O.; Gaisser, D'Arcy; Liesveld, Jane L.; Sahler, Olle Jane Z.			Peri-Transplant Psychosocial Factors and Neutrophil Recovery following Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							IMMUNE-SYSTEM; TRAIT ANXIETY; SURVIVAL; STRESS; LIFE; REDISTRIBUTION; RESPONSES; VALIDITY; OPTIMISM; SUPPORT	Objective: Multiple psychosocial factors appear to affect cancer progression in various populations; however, research investigating the relationship between psychosocial factors and outcomes following hematopoietic stem cell transplantation (HCT) is scarce. Subject to adverse immunological and psychological conditions, HCT patients may be especially vulnerable to psychosomatic health sequelae; therefore, we studied whether optimism and anxiety influence the pertinent clinical outcome of days to neutrophil engraftment (DTE). Method: 54 adults undergoing either autologous or allogeneic HCT completed self-report questionnaires measuring optimism and anxiety. We assessed the association between these psychosocial variables and DTE. Results: Greater optimism and less anxiety were associated with the favorable outcome of fewer DTE in autologous HCT recipients, though this relationship was no longer significant when reducing the sample size to only subjects who filled out their baseline survey by the time of engraftment. Conclusion: Our findings are suggestive that optimism and anxiety may be associated with time to neutrophil recovery in autologous, but not allogeneic, adult HCT recipients. Further investigation in larger, more homogeneous subjects with consistent baseline sampling is warranted.	[Knight, Jennifer M.; Moynihan, Jan A.; Lyness, Jeffrey M.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester Ctr Mind Body Res, Rochester, NY 14642 USA; [Xia, Yinglin; Tu, Xin; Messing, Susan; Huang, Li-Shan] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Hunter, Bryan C.] Nazareth Coll, Dept Mus Therapy, Rochester, NY USA; [Obi, Rosemary O.; Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Pediat, Div Hematol Oncol, Rochester, NY 14642 USA; [Gaisser, D'Arcy] Univ Rochester, Med Ctr, Dept Cardiol, Rochester, NY 14642 USA; [Liesveld, Jane L.; Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Med, Div Hematol Oncol, Rochester, NY 14642 USA; [Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Sahler, Olle Jane Z.] Univ Rochester, Med Ctr, Dept Med Humanities, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Knight, JM (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA.	jmknight@mcw.edu		Knight, Jennifer/0000-0002-9140-3109; Huang, Li-Shan/0000-0001-8297-2804	National Institutes of Health [5R24 AG031089-02, T32 073452, R21 AT000895]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT000895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R24AG031089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (5R24 AG031089-02, T32 073452, R21 AT000895). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsar FS, 2010, J CUTAN MED SURG, V14, P13, DOI 10.2310/7750.2010.09021; ANDRYKOWSKI MA, 1994, PSYCHOSOM MED, V56, P432, DOI 10.1097/00006842-199409000-00008; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Barker LA, 2005, BRIT J PHARMACOL, V145, P872, DOI 10.1038/sj.bjp.0706257; Bensinger W I, 2001, Rev Clin Exp Hematol, V5, P67, DOI 10.1046/j.1468-0734.2001.00033.x; Burke KL, 2000, CURR PSYCHOL, V19, P129, DOI 10.1007/s12144-000-1009-5; Cecilio CA, 1997, MEDIAT INFLAMM, V6, P46, DOI 10.1080/09629359791929; Chang G, 2004, PSYCHOSOMATICS, V45, P378, DOI 10.1176/appi.psy.45.5.378; Costanzo ES, 2013, BRAIN BEHAV IMMUN, V30, pS68, DOI 10.1016/j.bbi.2012.07.005; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Elsenbruch S, 2006, AM J GASTROENTEROL, V101, P2300, DOI 10.1111/j.1572-0241.2006.00837.x; Gregurek R, 1996, BONE MARROW TRANSPL, V18, P585; Hashizume H, 2005, BRIT J DERMATOL, V152, P1161, DOI 10.1111/j.1365-2133.2005.06449.x; Hochhausen N, 2007, J PSYCHOSOC ONCOL, V25, P87, DOI 10.1300/J077v25n01_05; Hoodin F, 2006, BONE MARROW TRANSPL, V38, P255, DOI 10.1038/sj.bmt.1705419; Hoodin F, 2003, PSYCHOSOMATICS, V44, P181, DOI 10.1176/appi.psy.44.3.181; JENKINS PL, 1994, PSYCHOSOMATICS, V35, P361, DOI 10.1016/S0033-3182(94)71757-6; Katsuura S, 2011, INT J PSYCHOPHYSIOL, V81, P38, DOI 10.1016/j.ijpsycho.2011.04.004; Kaufmann I, 2007, CLIN IMMUNOL, V125, P103, DOI 10.1016/j.clim.2007.07.004; Knight JM, 2013, PSYCHONEUROENDOCRINO, V38, P2383, DOI 10.1016/j.psyneuen.2013.06.016; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P389, DOI 10.1016/S1083-8791(03)00103-4; LEKANDER M, 1995, INT J BEHAV MED, V2, P1, DOI 10.1207/s15327558ijbm0201_1; Matzner P, 2013, NEUROIMMUNOMODULAT, V20, P194, DOI 10.1159/000348698; McGregor BA, 2013, BRAIN BEHAV IMMUN, V30, pS142, DOI 10.1016/j.bbi.2012.07.020; Mouthon MA, 1999, INT J RADIAT ONCOL, V43, P867, DOI 10.1016/S0360-3016(98)00477-5; Norkin M, 2012, SEMIN HEMATOL, V49, P104, DOI 10.1053/j.seminhematol.2011.10.004; Pasquini MC, 2012, CURRENT USE OUTCOME; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Saito T, 2003, BONE MARROW TRANSPL, V32, P601, DOI 10.1038/sj.bmt.1704205; Salome N, 2008, NEUROSCIENCE, V151, P1112, DOI 10.1016/j.neuroscience.2007.12.010; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Thaker PH, 2008, SEMIN CANCER BIOL, V18, P164, DOI 10.1016/j.semcancer.2007.12.005; Trabold B, 2007, SCAND CARDIOVASC J, V41, P59, DOI 10.1080/14017430601085948; Trigg ME, 2002, INT J HEMATOL, V76, P199, DOI 10.1007/BF03165245; Watson D, 1996, J PERS SOC PSYCHOL, V70, P567, DOI 10.1037/0022-3514.70.3.567	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99778	10.1371/journal.pone.0099778	http://dx.doi.org/10.1371/journal.pone.0099778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915544	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700136
J	Qi, HW; Nakka, P; Chen, C; Radhakrishnan, ML				Qi, Helena W.; Nakka, Priyanka; Chen, Connie; Radhakrishnan, Mala L.			The Effect of Macromolecular Crowding on the Electrostatic Component of Barnase-Barstar Binding: A Computational, Implicit Solvent-Based Study	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; NATIVE-STATE STABILITY; HUMAN TELOMERIC DNA; PROTEIN STABILITY; G-QUADRUPLEX; CELL; DYNAMICS; SURFACE; ENVIRONMENT; ASSOCIATION	Macromolecular crowding within the cell can impact both protein folding and binding. Earlier models of cellular crowding focused on the excluded volume, entropic effect of crowding agents, which generally favors compact protein states. Recently, other effects of crowding have been explored, including enthalpically-related crowder-protein interactions and changes in solvation properties. In this work, we explore the effects of macromolecular crowding on the electrostatic desolvation and solvent-screened interaction components of protein-protein binding. Our simple model enables us to focus exclusively on the electrostatic effects of water depletion on protein binding due to crowding, providing us with the ability to systematically analyze and quantify these potentially intuitive effects. We use the barnase-barstar complex as a model system and randomly placed, uncharged spheres within implicit solvent to model crowding in an aqueous environment. On average, we find that the desolvation free energy penalties incurred by partners upon binding are lowered in a crowded environment and solvent-screened interactions are amplified. At a constant crowder density ( fraction of total available volume occupied by crowders), this effect generally increases as the radius of model crowders decreases, but the strength and nature of this trend can depend on the water probe radius used to generate the molecular surface in the continuum model. In general, there is huge variation in desolvation penalties as a function of the random crowder positions. Results with explicit model crowders can be qualitatively similar to those using a lowered "effective'' solvent dielectric to account for crowding, although the "best'' effective dielectric constant will likely depend on multiple system properties. Taken together, this work systematically demonstrates, quantifies, and analyzes qualitative intuition-based insights into the effects of water depletion due to crowding on the electrostatic component of protein binding, and it provides an initial framework for future analyses.	[Qi, Helena W.; Nakka, Priyanka; Chen, Connie; Radhakrishnan, Mala L.] Wellesley Coll, Dept Chem, Wellesley, MA 02181 USA	Wellesley College	Radhakrishnan, ML (corresponding author), Wellesley Coll, Dept Chem, Wellesley, MA 02181 USA.	mradhakr@wellesley.edu	Radhakrishnan, Mala/X-1062-2019	Radhakrishnan, Mala/0000-0002-5434-3696	Wellesley College Staley Fellowship	Wellesley College Staley Fellowship	This work was funded by a Wellesley College Staley Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriata LA, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045006; Altman MD, 2006, THESIS; Batra J, 2009, BIOPHYS J, V97, P906, DOI 10.1016/j.bpj.2009.05.032; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Busby B, 2011, J MOL BIOL, V408, P321, DOI 10.1016/j.jmb.2011.01.053; Carrascal N, 2010, J PHYS CHEM B, V114, P5096, DOI 10.1021/jp910540z; Chen E, 2012, BIOCHEMISTRY-US, V51, P9836, DOI 10.1021/bi301324y; Chen Z, 2009, J AM CHEM SOC, V131, P10430, DOI 10.1021/ja9010749; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Christ CD, 2010, J COMPUT CHEM, V31, P1569, DOI 10.1002/jcc.21450; Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; de Ruiter A, 2011, CURR OPIN CHEM BIOL, V15, P547, DOI 10.1016/j.cbpa.2011.05.021; Despa F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228104; Despa F, 2004, PHYS REV LETT, V93; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Feig M, 2012, J PHYS CHEM B, V116, P599, DOI 10.1021/jp209302e; GERSTEIN M, 1995, J MOL BIOL, V249, P955, DOI 10.1006/jmbi.1995.0351; Ghosh S, 2013, LANGMUIR, V29, P7975, DOI 10.1021/la400840n; Giordano S, 2003, J ELECTROSTAT, V58, P59, DOI 10.1016/S0304-3886(02)00199-7; Green DF, 2005, PROTEINS, V60, P644, DOI 10.1002/prot.20540; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; Harada R, 2012, J AM CHEM SOC, V134, P4842, DOI 10.1021/ja211115q; Hassan SA, 2011, J PHYS CHEM B, V115, P14668, DOI 10.1021/jp208184e; Heddi B, 2011, J AM CHEM SOC, V133, P9824, DOI 10.1021/ja200786q; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Homouz D, 2009, J MOL BIOL, V391, P933, DOI 10.1016/j.jmb.2009.06.073; Homouz D, 2009, BIOPHYS J, V96, P671, DOI 10.1016/j.bpj.2008.10.014; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kim YC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3516589; Lee LP, 2001, PROTEIN SCI, V10, P362, DOI 10.1110/ps.40001; Lee LP, 2001, NAT STRUCT BIOL, V8, P73; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Li W, 2006, FEBS LETT, V580, P4905, DOI 10.1016/j.febslet.2006.08.007; Ma Q, 2012, PLOS ONE, V7; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Mikaelsson T, 2013, BIOPHYS J, V104, P694, DOI 10.1016/j.bpj.2012.12.020; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minkara MS, 2012, PROTEINS, V80, P573, DOI 10.1002/prot.23221; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Mittal J, 2010, BIOPHYS J, V98, P315, DOI 10.1016/j.bpj.2009.10.009; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Phillip Y, 2012, BIOPHYS J, V103, P1011, DOI 10.1016/j.bpj.2012.08.009; Phillip Y, 2009, BIOPHYS J, V97, P875, DOI 10.1016/j.bpj.2009.05.026; Predeus AV, 2012, J PHYS CHEM B, V116, P8610, DOI 10.1021/jp300129u; Qin SB, 2013, J CHEM THEORY COMPUT, V9, P4633, DOI 10.1021/ct4005195; Qin SB, 2009, BIOPHYS J, V97, P12, DOI 10.1016/j.bpj.2009.03.066; Radhakrishnan ML, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1252-5; Rincon V, 2011, BIOPHYS J, V100, P738, DOI 10.1016/j.bpj.2010.12.3714; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; Sanfelice D, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045002; Sasmal DK, 2013, LANGMUIR, V29, P2289, DOI 10.1021/la3043473; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Talley Kemper, 2008, PMC Biophys, V1, P2, DOI 10.1186/1757-5036-1-2; Tanizaki S, 2008, BIOPHYS J, V94, P747, DOI 10.1529/biophysj.107.116236; Tjong H, 2008, BIOPHYS J, V95, P2601, DOI 10.1529/biophysj.107.127746; Verma PK, 2011, BIOCHIMIE, V93, P1424, DOI 10.1016/j.biochi.2011.04.017; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wang YQ, 2010, J AM CHEM SOC, V132, P9392, DOI 10.1021/ja102296k; Wieczorek G, 2008, BIOPHYS J, V95, P5030, DOI 10.1529/biophysj.108.136291; Xue Y, 2007, J AM CHEM SOC, V129, P11185, DOI 10.1021/ja0730462; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	82	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98618	10.1371/journal.pone.0098618	http://dx.doi.org/10.1371/journal.pone.0098618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915485	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700027
J	Richard, AJ; Fuller, S; Fedorcenco, V; Beyl, R; Burris, TP; Mynatt, R; Ribnicky, DM; Stephens, JM				Richard, Allison J.; Fuller, Scott; Fedorcenco, Veaceslav; Beyl, Robbie; Burris, Thomas P.; Mynatt, Randall; Ribnicky, David M.; Stephens, Jacqueline M.			Artemisia scoparia Enhances Adipocyte Development and Endocrine Function In Vitro and Enhances Insulin Action In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; SKELETAL-MUSCLE; PPAR-GAMMA; METABOLIC SYNDROME; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; HEPATIC INSULIN; GENE-EXPRESSION	Background: Failure of adipocytes to expand during periods of energy excess can result in undesirable metabolic consequences such as ectopic fat accumulation and insulin resistance. Blinded screening studies have indicated that Artemisia scoparia (SCO) extracts can enhance adipocyte differentiation and lipid accumulation in cultured adipocytes. The present study tested the hypothesis that SCO treatment modulates fat cell development and function in vitro and insulin sensitivity in adipose tissue in vivo. Methods: In vitro experiments utilized a Gal4-PPAR gamma ligand binding domain (LBD) fusion protein-luciferase reporter assay to examine PPAR gamma activation. To investigate the ability of SCO to modulate adipogenesis and mature fat cell function in 3T3-L1 cells, neutral lipid accumulation, gene expression, and protein secretion were measured by Oil Red O staining, qRT-PCR, and immunoblotting, respectively. For the in vivo experiments, diet-induced obese (DIO) C57BL/6J mice were fed a high-fat diet (HFD) or HFD containing 1% w/w SCO for four weeks. Body weight and composition, food intake, and fasting glucose and insulin levels were measured. Phospho-activation and expression of insulin-sensitizing proteins in epididymal adipose tissue (eWAT) were measured by immunoblotting. Results: Ethanolic extracts of A. scoparia significantly activated the PPAR gamma LBD and enhanced lipid accumulation in differentiating 3T3-L1 cells. SCO increased the transcription of several PPAR gamma target genes in differentiating 3T3-L1 cells and rescued the negative effects of tumor necrosis factor alpha on production and secretion of adiponectin and monocyte chemoattractant protein-1 in fully differentiated fat cells. DIO mice treated with SCO had elevated adiponectin levels and increased phosphorylation of AMPK alpha in eWAT when compared to control mice. In SCO-treated mice, these changes were also associated with decreased fasting insulin and glucose levels. Conclusion: SCO has metabolically beneficial effects on adipocytes in vitro and adipose tissue in vivo, highlighting its potential as a metabolically favorable botanical supplement.	[Richard, Allison J.; Fuller, Scott; Fedorcenco, Veaceslav; Beyl, Robbie; Mynatt, Randall; Stephens, Jacqueline M.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Burris, Thomas P.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Ribnicky, David M.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Saint Louis University; Rutgers State University New Brunswick	Stephens, JM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	jsteph1@lsu.edu	Burris, Thomas P/B-3886-2016; Beyl, Robbie Albert/N-1951-2017; Mynatt, Randall L/N-1980-2017; Stephens, Jacqueline M/R-5217-2018; Fuller, Scott/GWM-5641-2022; Richard, Allison/N-1987-2017	Burris, Thomas P/0000-0003-2922-4449; Mynatt, Randall L/0000-0003-4399-0019; Fuller, Scott/0000-0002-2677-1677	NCAAM; ODS - NIH [2P50AT002776-06]; NIH [T32 AT004094]; COBRE [NIH 8 P20 GM103528]; NORC from the National Institutes of Health [NIH 2P30DK072476]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, U54GM104940] Funding Source: NIH RePORTER	NCAAM; ODS - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NORC from the National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research project was supported by an NCAAM and ODS funded NIH grant (2P50AT002776-06) awarded to the PBRC Botanical Research Center. AJR and SF were supported by an NIH T-32 postdoctoral training fellowship in botanicals granted to PBRC (T32 AT004094). This research project used PBRC Genomics Core facilities that are supported in part by COBRE (NIH 8 P20 GM103528) and NORC (NIH 2P30DK072476) center grants from the National Institutes of Health. Statistical analysis for this project was supported by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Busby SA, 2011, ACS CHEM BIOL, V6, P618, DOI 10.1021/cb100396s; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Frosig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062338; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hamza N, 2010, J ETHNOPHARMACOL, V128, P513, DOI 10.1016/j.jep.2010.01.004; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang JV, 2012, J LIPID RES, V53, P1738, DOI 10.1194/jlr.R024505; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107; Lim DW, 2013, MOLECULES, V18, P9241, DOI 10.3390/molecules18089241; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Obanda DN, 2012, DIABETES, V61, P597, DOI 10.2337/db11-0396; Ribnicky DM, 2006, PHYTOMEDICINE, V13, P550, DOI 10.1016/j.phymed.2005.09.007; Richard AJ, 2012, BBA-MOL BASIS DIS, V1822, P557, DOI 10.1016/j.bbadis.2011.12.005; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shibata T, 2013, J PHARMACOL SCI, V122, P93, DOI 10.1254/jphs.12270FP; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z; Wang ZQ, 2008, METABOLISM, V57, pS58, DOI 10.1016/j.metabol.2008.04.003; Wang ZQ, 2013, METABOLISM, V62, P1239, DOI 10.1016/j.metabol.2013.03.004; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Xing XH, 2009, J ETHNOPHARMACOL, V125, P410, DOI 10.1016/j.jep.2009.07.021; Yamamoto N, 2011, FOOD FUNCT, V2, P45, DOI 10.1039/c0fo00129e; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	47	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98897	10.1371/journal.pone.0098897	http://dx.doi.org/10.1371/journal.pone.0098897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915004	Green Published, gold			2022-12-27	WOS:000340947700042
J	Tamayo, T; Claessen, H; Ruckert, IM; Maier, W; Schunk, M; Meisinger, C; Mielck, A; Holle, R; Thorand, B; Narres, M; Moebus, S; Mahabadi, AA; Pundt, N; Krone, B; Slomiany, U; Erbel, R; Jockel, KH; Rathmann, W; Icks, A				Tamayo, Teresa; Claessen, Heiner; Rueckert, Ina-Maria; Maier, Werner; Schunk, Michaela; Meisinger, Christine; Mielck, Andreas; Holle, Rolf; Thorand, Barbara; Narres, Maria; Moebus, Susanne; Mahabadi, Amir-Abbas; Pundt, Noreen; Krone, Bastian; Slomiany, Uta; Erbel, Raimund; Joeckel, Karl-Heinz; Rathmann, Wolfgang; Icks, Andrea			Treatment Pattern of Type 2 Diabetes Differs in Two German Regions and with Patients' Socioeconomic Position	PLOS ONE			English	Article							HEINZ NIXDORF RECALL; EUROPEAN COUNTRIES; SOUTHERN GERMANY; HOUSEHOLD INCOME; PREVALENCE; HEALTH; CARE; INEQUALITIES; MANAGEMENT; MELLITUS	Background: Diabetes treatment may differ by region and patients' socioeconomic position. This may be particularly true for newer drugs. However, data are highly limited. Methods: We examined pooled individual data of two population-based German studies, KORA F4 (Cooperative Health Research in the Region of Augsburg, south), and the HNR (Heinz Nixdorf Recall study, west) both carried out 2006 to 2008. To ascertain the association between region and educational level with anti-hyperglycemic medication we fitted poisson regression models with robust error variance for any and newer anti-hyperglycemic medication, adjusting for age, sex, diabetes duration, BMI, cardiovascular disease, lifestyle, and insurance status. Results: The examined sample comprised 662 participants with self-reported type 2 diabetes (KORA F4: 83 women, 111 men; HNR: 183 women, 285 men). The probability to receive any anti-hyperglycemic drug as well as to be treated with newer anti-hyperglycemic drugs such as insulin analogues, thiazolidinediones, or glinides was significantly increased in southern compared to western Germany (prevalence ratio (PR); 95% CI: 1.12; 1.02-1.22, 1.52; 1.10-2.11 respectively). Individuals with lower educational level tended to receive anti-hyperglycemic drugs more likely than their better educated counterparts (PR; 95% CI univariable: 1.10; 0.99-1.22; fully adjusted: 1.10; 0.98-1.23). In contrast, lower education was associated with a lower estimated probability to receive newer drugs among those with any anti-hyperglycemic drugs (PR low vs. high education: 0.66; 0.48-0.91; fully adjusted: 0.68; 0.47-0.996). Conclusions: We found regional and individual social disparities in overall and newer anti-hyperglycemic medication which were not explained by other confounders. Further research is needed.	[Tamayo, Teresa; Claessen, Heiner; Narres, Maria; Rathmann, Wolfgang; Icks, Andrea] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Rueckert, Ina-Maria; Meisinger, Christine; Thorand, Barbara] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Maier, Werner; Schunk, Michaela; Mielck, Andreas; Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Thorand, Barbara] German Ctr Diabet Res DZD EV, Neuherberg, Germany; [Moebus, Susanne; Pundt, Noreen; Krone, Bastian; Slomiany, Uta; Joeckel, Karl-Heinz] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Mahabadi, Amir-Abbas; Erbel, Raimund] Univ Duisburg Essen, West German Heart Ctr, Dept Cardiol, Essen, Germany; [Icks, Andrea] Univ Dusseldorf, Dept Publ Hlth, Fac Med, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf	Icks, A (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	andrea.icks@ddz.uni-duesseldorf.de	Holle, Rolf/D-9333-2013; Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014; Mahabadi, Amir/ABE-6057-2020	Holle, Rolf/0000-0001-5395-2695; Thorand, Barbara/0000-0002-8416-6440; Moebus, Susanne/0000-0002-0072-5410; Maier, Werner/0000-0003-4356-7296; Schunk, Michaela/0000-0002-1200-1903; Meisinger, Christa/0000-0002-9026-6544	Competence Network Diabetes mellitus of the German Federal Ministry of Education and Research (BMBF) [01GI0816]; Heinz Nixdorf Foundation (Germany); German Ministry of Education and Science; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation from the German Diabetes Center; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	Competence Network Diabetes mellitus of the German Federal Ministry of Education and Research (BMBF); Heinz Nixdorf Foundation (Germany); German Ministry of Education and Science; Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; German Research Foundation from the German Diabetes Center; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	This work was supported by the Competence Network Diabetes mellitus of the German Federal Ministry of Education and Research (BMBF, grant 01GI0816). Andrea Icks is guarantor of this work. The authors thank the Heinz Nixdorf Foundation (Germany) for the generous support of the Heinz Nixdorf Recall Study (HNR). The study is also supported by the German Ministry of Education and Science. The KORA F4 research platform (KORA F4, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The KORA Diabetes Study was partly funded by a German Research Foundation project grant to W. R. from the German Diabetes Center. The German Diabetes Center is funded by the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westfalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Dorais Marc, 2008, Can J Clin Pharmacol, V15, pe15; Gude D, 2012, J PHARMACOL PHARMACO, V3, P127, DOI 10.4103/0976-500X.95507; Hagen B, 2012, 52012 DMP PROJ ZENTR; Icks A, 2006, AM J PUBLIC HEALTH, V96, P1656, DOI 10.2105/AJPH.2005.063339; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Koller D, 2013, INFECTION, V41, P121, DOI 10.1007/s15010-012-0302-1; Kraus L, 2001, ADDICTION, V96, P459, DOI 10.1046/j.1360-0443.2001.9634599.x; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Mielck A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-52; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; Nordin M, 2013, SOC SCI MED, V77, P106, DOI 10.1016/j.socscimed.2012.11.013; Oduncu FS, 2013, MED HEALTH CARE PHIL, V16, P237; Ozegowski S, 2014, HEALTH POLICY, V114, P54, DOI 10.1016/j.healthpol.2013.08.005; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Rabi DM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-11; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rosenthal T, 2012, ANNU REV MED, V63, P493, DOI 10.1146/annurev-med-050710-134438; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Stang A, 2005, EUR J EPIDEMIOL, V20, P489, DOI 10.1007/s10654-005-5529-z; Sundmacher L, 2011, GESUNDHEITSWESEN, V73, P229, DOI 10.1055/s-0030-1254154; Vonneilich N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-285; WAUGH N, 2010, HEALTH TECHNOL ASSES, V14, P1; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99773	10.1371/journal.pone.0099773	http://dx.doi.org/10.1371/journal.pone.0099773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915157	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700133
J	Ota, K; Kohda, M				Ota, Kazutaka; Kohda, Masanori			Maternal Food Provisioning in a Substrate-Brooding African Cichlid	PLOS ONE			English	Article							PARENTAL CARE; EGG SIZE; EVOLUTIONARY TRANSITIONS; MOUTHBROODING FEMALES; LIFE-HISTORY; FITNESS; FISHES; FEED	Fish demonstrate the greatest variety of parental care strategies within the animal kingdom. Fish parents seldom provision food for offspring, with some exceptions predominantly found in substrate-brooding Central American cichlids and mouth brooding African cichlids. Here, we provide the first evidence of food provisioning in a substrate-brooding African cichlid Neolamprologus mondabu. This fish is a maternal substrate-brooding cichlid endemic to Lake Tanganyika, and feeds on benthic animals using unique techniques-individuals typically feed on the surface of sandy substrates, but also expose prey by digging up substrates with vigorous wriggling of their body and fins. Young also feed on benthos on the substrate surface, but only using the first technique. We observed that feeding induced by digging accounted for 30% of total feeding bouts in adult females, demonstrating that digging is an important foraging tactic. However, parental females fed less frequently after digging than non-parental females, although both females stayed in pits created by digging for approximately 30 s. Instead, young gathered in the pit and fed intensively, suggesting that parental females provision food for young by means of digging. We tested this hypothesis by comparing the feeding frequency of young before and after digging that was simulated by hand, and observed that young doubled their feeding frequency after the simulated digging. This suggests that parental females engage in digging to uncover food items that are otherwise unavailable to young, and provision food for them at the expense of their own foraging. This behavior was similar to what has been observed in Central American cichlids.	[Ota, Kazutaka; Kohda, Masanori] Osaka City Univ, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 558, Japan	Osaka Metropolitan University	Ota, K (corresponding author), Osaka City Univ, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 558, Japan.	otkztk@gmail.com		Ota, Kazutaka/0000-0002-7097-7330	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Young Scientists (B) (to KO) and Grants-in-Aid for Overseas Scientific Research (to MK) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow G., 2002, CICHLID FISHES NATUR; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Friedman M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1733; GASHAGAZA M M, 1991, Physiology and Ecology Japan, V28, P29; Gashagaza M.M., 1986, AFR STUDY MONOGR, V6, P37; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; GROSS MR, 1985, AM ZOOL, V25, P807; HILDEMANN WH, 1959, AM NAT, V93, P27, DOI 10.1086/282054; Hori M., 1983, Physiology and Ecology Japan, V20, P129; Keenleyside M.H.A., 1991, PARENTAL CARE; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Klug H, 2010, EVOLUTION, V64, P823, DOI 10.1111/j.1558-5646.2009.00854.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mank JE, 2005, EVOLUTION, V59, P1570; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Monteith KM, 2012, J EVOLUTION BIOL, V25, P1815, DOI 10.1111/j.1420-9101.2012.02567.x; Nagoshi M., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P2663; Nagoshi M., 1983, AFR STUDY MONOGR, V3, P39; NOAKES DLG, 1973, BEHAVIOUR, V46, P221, DOI 10.1163/156853973X00021; Ota K, 2014, J ZOOL, V293, P63, DOI 10.1111/jzo.12125; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; REZNICK DN, 1990, J EVOLUTION BIOL, V3, P185, DOI 10.1046/j.1420-9101.1990.3030185.x; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Schurch R, 2005, BEHAVIOUR, V142, P265, DOI 10.1163/1568539053778274; Segers FHID, 2011, FUNCT ECOL, V25, P166, DOI 10.1111/j.1365-2435.2010.01790.x; SMITH C, 1994, ENVIRON BIOL FISH, V40, P99, DOI 10.1007/BF00002184; Sogard SM, 1997, B MAR SCI, V60, P1129; Taborsky B, 2004, ANIM BEHAV, V68, P1275, DOI 10.1016/j.anbehav.2004.03.005; Taborsky B, 2003, P ROY SOC B-BIOL SCI, V270, P713, DOI 10.1098/rspb.2002.2255; Takemon Y, 1998, ENVIRON BIOL FISH, V52, P261, DOI 10.1023/A:1007380431013; TRIVERS RL, 1974, AM ZOOL, V14, P249; WISENDEN BD, 1995, ANIM BEHAV, V49, P623; YANAGISAWA Y, 1990, ENVIRON BIOL FISH, V27, P43, DOI 10.1007/BF00004903; YANAGISAWA Y, 1991, ENVIRON BIOL FISH, V30, P353, DOI 10.1007/BF02028851; Zworykin DD, 1998, ETHOLOGY, V104, P771	38	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99094	10.1371/journal.pone.0099094	http://dx.doi.org/10.1371/journal.pone.0099094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911060	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600041
J	Xue, HL; Zhong, M; Xu, JH; Xu, LX				Xue, Huiliang; Zhong, Min; Xu, Jinhui; Xu, Laixiang			Geographic Distance Affects Dispersal of the Patchy Distributed Greater Long-Tailed Hamster (Tscherskia triton)	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; GENETIC DIVERSITY; MICROSATELLITE MARKERS; HABITAT FRAGMENTATION; POPULATION-STRUCTURE; DEPENDENT DISPERSAL; LANDSCAPE GENETICS; VOLE POPULATIONS; CLIMATE-CHANGE; SMALL MAMMALS	Dispersal is a fundamental process in ecology influencing the genetic structure and the viability of populations. Understanding how variable factors influence the dispersal of the population is becoming an important question in animal ecology. To date, geographic distance and geographic barriers are often considered as main factors impacting dispersal, but their effects are variable depending on different conditions. In general, geographic barriers affect more significantly than geographic distance on dispersal. In rapidly expanding populations, however, geographic barriers have less effect on dispersal than geographic distance. The effects of both geographic distance and geographic barriers in low-density populations with patchy distributions are poorly understood. By using a panel of 10 microsatellite loci we investigated the genetic structure of three patchy-distributed populations of the Greater long-tailed hamster (Tscherskia triton) from Raoyang, Guan and Shunyi counties of the North China Plain. The results showed that (i) high genetic diversity and differentiation exist in three geographic populations with patchy distributions; (ii) gene flow occurs among these three populations with physical barriers of Beijing city and Hutuo River, which potentially restricted the dispersal of the animal; (iii) the gene flow is negatively correlated with the geographic distance, while the genetic distance shows the positive correlation. Our results suggest that the effect of the physical barriers is conditional-dependent, including barrier capacity or individual potentially dispersal ability. Geographic distance also acts as an important factor affecting dispersal for the patchy distributed geographic populations. So, gene flow is effective, even at relatively long distances, in balancing the effect of geographic barrier in this study.	[Xue, Huiliang; Xu, Jinhui; Xu, Laixiang] Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China; [Zhong, Min] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Qufu Normal University; Auburn University System; Auburn University	Xu, LX (corresponding author), Qufu Normal Univ, Coll Life Sci, Qufu, Shandong, Peoples R China.	xulx@mail.qfnu.edu.cn			National Natural Science Foundation of China [31270417, 31300304]; Shandong Provincial Natural Science Foundation [ZR2010CL013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (31270417 and 31300304) and the Shandong Provincial Natural Science Foundation (ZR2010CL013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda F, 2013, J HERED, V104, P36, DOI 10.1093/jhered/ess071; An HS, 2013, MOL BIOL REP, V40, P3445, DOI 10.1007/s11033-012-2044-7; Andreassen HP, 2001, ECOLOGY, V82, P2911, DOI 10.2307/2679970; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; AYRES MP, 1994, ECOL MONOGR, V64, P465, DOI 10.2307/2937146; Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; Billot C, 2003, MAR ECOL PROG SER, V253, P111, DOI 10.3354/meps253111; Boonstra R, 1998, ECOLOGY, V79, P1479; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Casgrain P, 2001, DEV RELEASE R PACKAG; Chaves JA, 2012, J EVOLUTION BIOL, V25, P509, DOI 10.1111/j.1420-9101.2011.02447.x; Conradt L, 2001, OIKOS, V95, P416, DOI 10.1034/j.1600-0706.2001.950306.x; da Rocha LC, 2013, GENETICA, V141, P65, DOI 10.1007/s10709-013-9706-9; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DENNO RF, 1989, ECOL ENTOMOL, V14, P31, DOI 10.1111/j.1365-2311.1989.tb00751.x; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dong JP, 2010, J MAMMAL, V91, P200, DOI 10.1644/09-MAMM-A-098R1.1; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; GAINES MS, 1980, ANNU REV ECOL SYST, V11, P163, DOI 10.1146/annurev.es.11.110180.001115; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gunter LE, 2000, GLOBAL CHANGE BIOL, V6, P335, DOI 10.1046/j.1365-2486.2000.00313.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hedin M, 2013, MOL ECOL, V22, P508, DOI 10.1111/mec.12130; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Igawa T, 2013, HEREDITY, V110, P46, DOI 10.1038/hdy.2012.59; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Irene K, 2003, P ROYAL SOC B, V270, P417; Jensen H, 2013, MOL ECOL, V22, P1792, DOI 10.1111/mec.12226; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Kuussaari M, 1996, J ANIM ECOL, V65, P791, DOI 10.2307/5677; Leonardi S, 2012, J HERED, V103, P408, DOI 10.1093/jhered/ess004; Li Jing, 2010, Acta Entomologica Sinica, V53, P1135; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; Luo ZX, 2000, FAUNA SINICA MAMMALI, P63; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Magnus W, 2001, HEREDITY, V86, P703; Massot M, 2002, J ANIM ECOL, V71, P253, DOI 10.1046/j.1365-2656.2002.00592.x; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Nangong Zi-Yan, 2008, Acta Entomologica Sinica, V51, P417; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nei M, 1978, GENETICS, V89, P538; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Nielsen O, 1996, ARCTIC, V49, P383; Niemiller ML, 2013, EVOLUTION, V67, P1011, DOI 10.1111/evo.12017; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Parada R, 2012, MOL BIOL REP, V39, P5291, DOI 10.1007/s11033-011-1327-8; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Perez-Espona S, 2012, MOL ECOL, V21, P5969, DOI 10.1111/mec.12088; Piel AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058965; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Ronce Ophelie, 2001, P341; RYMAN N, 1983, AQUACULTURE, V33, P1, DOI 10.1016/0044-8486(83)90382-4; Schmitt T, 2004, MOL ECOL, V13, P21, DOI 10.1046/j.1365-294X.2004.02020.x; Serrano D, 2003, J ANIM ECOL, V72, P400, DOI 10.1046/j.1365-2656.2003.00707.x; Song MJ, 2005, CAN J ZOOL, V83, P773, DOI 10.1139/Z05-060; Wang YH, 2013, MAR GENOM, V9, P63, DOI 10.1016/j.margen.2012.06.003; WASER PM, 1994, BEHAV ECOL, V5, P135; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S., 1978, EVOLUTION GENETIC PO; Xie JY, 2006, INTEGR ZOOL, V1, P188, DOI 10.1111/j.1749-4877.2006.00035.x; Xu Lai-Xiang, 2002, Acta Zoologica Sinica, V48, P264; Xu LX, 2007, MOL ECOL NOTES, V7, P617, DOI 10.1111/j.1471-8286.2006.01651.x; Xu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054171; Zakharov EV, 2008, MOL ECOL, V17, P189, DOI 10.1111/j.1365-294X.2007.03488.x; Zhao Hui-Ting, 2008, Acta Zootaxonomica Sinica, V33, P89	81	6	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99540	10.1371/journal.pone.0099540	http://dx.doi.org/10.1371/journal.pone.0099540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911266	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600103
J	Damasceno, MV; Duarte, M; Pasqua, LA; Lima-Silva, AE; MacIntosh, BR; Bertuzzi, R				Damasceno, Mayara V.; Duarte, Marcos; Pasqua, Leonardo A.; Lima-Silva, Adriano E.; MacIntosh, Brian R.; Bertuzzi, Romulo			Static Stretching Alters Neuromuscular Function and Pacing Strategy, but Not Performance during a 3-Km Running Time-Trial	PLOS ONE			English	Article							VERTICAL JUMP PERFORMANCE; OXYGEN-UPTAKE; PERCEIVED EXERTION; SPRINT PERFORMANCE; HAMSTRING MUSCLES; FORCE PRODUCTION; BODY-COMPOSITION; ECONOMY; RUNNERS; STIFFNESS	Purpose: Previous studies report that static stretching (SS) impairs running economy. Assuming that pacing strategy relies on rate of energy use, this study aimed to determine whether SS would modify pacing strategy and performance in a 3-km running time-trial. Methods: Eleven recreational distance runners performed a) a constant-speed running test without previous SS and a maximal incremental treadmill test; b) an anthropometric assessment and a constant-speed running test with previous SS; c) a 3-km time-trial familiarization on an outdoor 400-m track; d and e) two 3-km time-trials, one with SS (experimental situation) and another without (control situation) previous static stretching. The order of the sessions d and e were randomized in a counterbalanced fashion. Sit-and-reach and drop jump tests were performed before the 3-km running time-trial in the control situation and before and after stretching exercises in the SS. Running economy, stride parameters, and electromyographic activity (EMG) of vastus medialis (VM), biceps femoris (BF) and gastrocnemius medialis (GA) were measured during the constant-speed tests. Results: The overall running time did not change with condition (SS 11:35 +/- 00:31 s; control 11:28 +/- 00:41 s, p=0.304), but the first 100 m was completed at a significantly lower velocity after SS. Surprisingly, SS did not modify the running economy, but the iEMG for the BF (+22.6%, p=0.031), stride duration (+2.1%, p=0.053) and range of motion (+11.1%, p = 0.0001) were significantly modified. Drop jump height decreased following SS (-9.2%, p=0.001). Conclusion: Static stretch impaired neuromuscular function, resulting in a slow start during a 3-km running time-trial, thus demonstrating the fundamental role of the neuromuscular system in the self-selected speed during the initial phase of the race.	[Damasceno, Mayara V.; Pasqua, Leonardo A.; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil; [Duarte, Marcos] Fed Univ ABC, Sao Paulo, Brazil; [Lima-Silva, Adriano E.] Univ Fed Pernambuco, Dept Phys Educ & Sports Sci, Sports Sci Res Grp, Vitoria De Santo Antao, PE, Brazil; [MacIntosh, Brian R.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Pernambuco; University of Calgary	Bertuzzi, R (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil.	bertuzzi@usp.br	Damasceno, Mayara/P-3468-2015; Lima-Silva, Adriano/Y-2404-2019; Lima-Silva, Adriano Eduardo/C-2800-2013; Duarte, Marcos/D-1854-2011; Bertuzzi, Romulo/E-7048-2012	Lima-Silva, Adriano/0000-0002-0613-5104; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Duarte, Marcos/0000-0002-0344-7460; 	Sao Paulo Research Foundation [FAPESP: 2011/10742-9, FAPESP: 2011/02769-4, 2010/13913-6]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation (FAPESP: 2011/10742-9). Mayara Vieira Damasceno and Leonardo Alves Pasqua were supported by a master scholarship from Sao Paulo Research Foundation (FAPESP: 2011/02769-4 and 2010/13913-6), www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Allison SJ, 2008, J SPORT SCI, V26, P1489, DOI 10.1080/02640410802392715; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Baltaci G, 2003, BRIT J SPORT MED, V37, P59, DOI 10.1136/bjsm.37.1.59; Baron B, 2009, EUR J APPL PHYSIOL, V105, P749, DOI 10.1007/s00421-008-0957-6; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Behm DG, 2007, EUR J APPL PHYSIOL, V101, P587, DOI 10.1007/s00421-007-0533-5; Bertuzzi R, 2013, J STRENGTH COND RES; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bradley PS, 2007, J STRENGTH COND RES, V21, P223, DOI 10.1519/00124278-200702000-00040; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Cornwell A, 2001, J HUM MOVEMENT STUD, V40, P307; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Faulkner J, 2008, PSYCHOPHYSIOLOGY, V45, P977, DOI 10.1111/j.1469-8986.2008.00712.x; Fletcher JR, 2009, J APPL PHYSIOL, V107, P1918, DOI 10.1152/japplphysiol.00307.2009; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Hayes PR, 2007, J STRENGTH COND RES, V21, P1227; Higashihara A, 2010, J SPORT SCI, V28, P1085, DOI 10.1080/02640414.2010.494308; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; Jones AM, 2008, SCAND J MED SCI SPOR, V18, P615, DOI 10.1111/j.1600-0838.2007.00725.x; Jones AM, 2002, INT J SPORTS MED, V23, P40, DOI 10.1055/s-2002-19271; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Lima-Silva AE, 2010, EUR J APPL PHYSIOL, V108, P1045, DOI 10.1007/s00421-009-1300-6; LOHMAN TG, 1981, HUM BIOL, V53, P181; Lusk G, 1928, SCI NUTR, P177; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Mikkola J, 2011, J SPORT SCI, V29, P1359, DOI 10.1080/02640414.2011.589467; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Nelson AG, 2005, J SPORT SCI, V23, P449, DOI 10.1080/02640410410001730205; Nummela AT, 2008, INT J SPORTS MED, V29, P738, DOI 10.1055/s-2007-989404; Nummela AT, 2006, EUR J APPL PHYSIOL, V97, P1, DOI 10.1007/s00421-006-0147-3; Ogura Y, 2007, J STRENGTH COND RES, V21, P788; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Ryan ED, 2009, J SPORT SCI, V27, P957, DOI 10.1080/02640410902998254; Lopes FAS, 2010, J STRENGTH COND RES, V24, P1650, DOI 10.1519/JSC.0b013e3181d32f7b; Sandals LE, 2006, INT J SPORTS MED, V27, P37, DOI 10.1055/s-2005-837468; Sayers AL, 2008, J STRENGTH COND RES, V22, P1416, DOI 10.1519/JSC.0b013e318181a450; Tucker R, 2006, INT J SPORT PHYSIOL, V1, P233, DOI 10.1123/ijspp.1.3.233; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Young W, 2001, RES Q EXERCISE SPORT, V72, P273, DOI 10.1080/02701367.2001.10608960; Young WB., 1995, J STRENGTH CONDITION, V9, P232, DOI DOI 10.1519/00124278-199511000-06005	44	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99238	10.1371/journal.pone.0099238	http://dx.doi.org/10.1371/journal.pone.0099238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905918	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000113
J	Zhao, JY; Yang, YHS; Xi, XQ; Zhang, CB; Sun, SC				Zhao, Jiyan; Yang, Yangheshan; Xi, Xinqiang; Zhang, Changbing; Sun, Shucun			Artificial Warming Facilitates Growth but Not Survival of Plateau Frog (Rana kukunoris) Tadpoles in Presence of Gape-Limited Predatory Beetles	PLOS ONE			English	Article							ESCAPE BEHAVIOR; TEMPERATURE; PLASTICITY; SIZE; LARVAE; SHAPE; METAMORPHOSIS; DRAGONFLIES; POPULATIONS; TEMPORARIA	Background: Global warming has been frequently demonstrated to increase growth rate in larval amphibians that have considerable phenotypic plasticity; this may lead to an increase in larval survival because large larvae are less likely to be captured by gape-limited predators. This study is to test whether warming could improve tadpole growth and thereby enhance the tadpole survival in plateau frog Rana kukunoris. Methodology: We conducted an experiment involving growing tadpoles under two contrasting temperatures, i.e. ambient temperature vs. warming by 3.8 degrees C, with and without their major predators - the gape-limited predaceous diving beetles Agabus sp. in eastern Tibetan Plateau, in a factorial arrangement. We recorded the survival and measured body fresh weight and morphological characteristics of the tadpoles. Principal Findings: Warming significantly increased body fresh weight in the presence of predators after three weeks of treatments. However, the predators imposed significant and similar effects on the survival of tadpoles under both ambient and elevated temperatures, with the effects mostly occurring in the first three weeks of the experiment. Changes in the body form, i.e. the greater whole length at a given fresh weight and the longer tail at a given body length, could have acted as mechanisms of defense and escape for the tadpoles. Conclusions/Significance: Warming did not increase tadpole survival with or without presence of predators. Moreover, an increased growth rate (due to warming in the presence of predators) was not a major factor contributing to the tadpole survival. We postulate that even if warming increases the tadpole growth rate in the plateau frog, it does not necessarily improve their survival in the presence of gape-limited predators.	[Zhao, Jiyan; Yang, Yangheshan; Sun, Shucun] Nanjing Univ, Dept Biol, Nanjing 210008, Jiangsu, Peoples R China; [Xi, Xinqiang; Sun, Shucun] Chinese Acad Sci, Chengdu Inst Biol, ECORES Lab, Chengdu, Peoples R China; [Zhang, Changbing] Sichuan Acad Grassland Sci, Chengdu, Peoples R China	Nanjing University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Sun, SC (corresponding author), Nanjing Univ, Dept Biol, Nanjing 210008, Jiangsu, Peoples R China.	shcs@nju.edu.cn			National Science Foundation of China [31325004]; 973 Program [2013CB956302]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This study was supported by National Science Foundation of China (31325004) and 973 Program (2013CB956302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Anderson MT, 2001, CAN J ZOOL, V79, P1834, DOI 10.1139/cjz-79-10-1834; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Benard MF, 2006, ECOLOGY, V87, P340, DOI 10.1890/05-0381; BLAUSTEIN AR, 1990, TRENDS ECOL EVOL, V5, P203, DOI 10.1016/0169-5347(90)90129-2; BRATTSTROM BH, 1963, ECOLOGY, V44, P238, DOI 10.2307/1932171; CALDWELL JP, 1980, OECOLOGIA, V46, P285, DOI 10.1007/BF00346253; CRONIN JT, 1986, HERPETOLOGICA, V42, P171; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Dittman DE, 1997, FUNCT ECOL, V11, P573, DOI 10.1046/j.1365-2435.1997.00127.x; Doherty PA, 1998, J EXP BIOL, V201, P2691; Edenhofer O., 2014, CONTRIBUTION WORKING; Falster D.S., 2006, USERS GUIDE SMATR ST; Gotthard K, 2000, J ANIM ECOL, V69, P896, DOI 10.1046/j.1365-2656.2000.00432.x; Heyer W.R., 1975, Biotopica, V7, P100; Hoff KV, 2000, AM ZOOL, V40, P62, DOI 10.1668/0003-1569(2000)040[0062:TLAMAT]2.0.CO;2; Jian-hong D, 2005, ZOOL RES, V26, P263; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Li P, 2010, DIVERSITY AMPHIBIANS, P34; Loman J, 2002, J ZOOL, V258, P115, DOI 10.1017/S0952836902001255; LONSDALE DJ, 1985, ECOLOGY, V66, P1397, DOI 10.2307/1938002; McCollum SA, 1996, EVOLUTION, V50, P583, DOI 10.1111/j.1558-5646.1996.tb03870.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Merila J, 2000, ECOGRAPHY, V23, P457, DOI 10.1034/j.1600-0587.2000.230408.x; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Qi Yin, 2007, Acta Zoologica Sinica, V53, P974; R Development Core Team, 2007, R LANG ENV STAT COMP; Reading CJ, 1999, OECOLOGIA, V121, P310, DOI 10.1007/s004420050933; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; RICHARDS SJ, 1990, COPEIA, P1041; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; SMITH DC, 1983, ECOLOGY, V64, P501, DOI 10.2307/1939970; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stahlberg F, 2001, J EVOLUTION BIOL, V14, P755, DOI 10.1046/j.1420-9101.2001.00333.x; TEJEDO M, 1993, HERPETOLOGICA, V49, P287; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Teplitsky C, 2005, J EVOLUTION BIOL, V18, P180, DOI 10.1111/j.1420-9101.2004.00790.x; THOMPSON DJ, 1978, J ANIM ECOL, V47, P757, DOI 10.2307/3669; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, 2011, J ANIM ECOL, V80, P79, DOI 10.1111/j.1365-2656.2010.01765.x; TRAVIS J, 1985, OIKOS, V45, P59, DOI 10.2307/3565222; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; WILBUR HM, 1987, ECOLOGY, V68, P1437, DOI 10.2307/1939227; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Zhang W, 2011, CHINESE INSECTS ILLU, P263	48	7	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98252	10.1371/journal.pone.0098252	http://dx.doi.org/10.1371/journal.pone.0098252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905846	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000025
J	Jahangirzadeh, A; Basser, H; Akib, S; Karami, H; Naji, S; Shamshirband, S				Jahangirzadeh, Afshin; Basser, Hossein; Akib, Shatirah; Karami, Hojat; Naji, Sareh; Shamshirband, Shahaboddin			Experimental and Numerical Investigation of the Effect of Different Shapes of Collars on the Reduction of Scour around a Single Bridge Pier	PLOS ONE			English	Article							LOCAL SCOUR; RIPRAP; SCALE; FIELD	The scour phenomenon around bridge piers causes great quantities of damages annually all over the world. Collars are considered as one of the substantial methods for reducing the depth and volume of scour around bridge piers. In this study, the experimental and numerical methods are used to investigate two different shapes of collars, i.e, rectangular and circular, in terms of reducing scour around a single bridge pier. The experiments were conducted in hydraulic laboratory at university of Malaya. The scour around the bridge pier and collars was simulated numerically using a three-dimensional, CFD model namely SSIIM 2.0, to verify the application of the model. The results indicated that although, both types of collars provides a considerable decrease in the depth of the scour, the rectangular collar, decreases scour depth around the pier by 79 percent, and has better performance compared to the circular collar. Furthermore, it was observed that using collars under the stream's bed, resulted in the most reduction in the scour depth around the pier. The results also show the SSIIM 2.0 model could simulate the scour phenomenon around a single bridge pier and collars with sufficient accuracy. Using the experimental and numerical results, two new equations were developed to predict the scour depth around a bridge pier exposed to circular and rectangular collars.	[Jahangirzadeh, Afshin; Basser, Hossein; Akib, Shatirah; Naji, Sareh] Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia; [Karami, Hojat] Semnan Univ, Dept Civil Engn, Semnan, Iran; [Shamshirband, Shahaboddin] Islamic Azad Univ, Dept Comp Sci, Chalous, Mazandaran, Iran	Universiti Malaya; Semnan University; Islamic Azad University	Akib, S (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur, Malaysia.	shatirahakib@yahoo.co.uk	Karami, Hojat/AAU-1618-2020; S.Band, Shahab/ABI-7388-2020; Akib, Shatirah/C-5165-2011; S.Band, Shahab/AAD-3311-2021	S.Band, Shahab/0000-0002-8963-731X; Akib, Shatirah/0000-0002-6538-0716; Basser, Hossein/0000-0001-8744-1869	High Impact Research Grant [UM.C/625/1/HIR/61];  [H-16001-00-D000061]	High Impact Research Grant; 	High Impact Research Grant, project number: UM.C/625/1/HIR/61, account number: H-16001-00-D000061: A Fundamental Research on Sustainable Scouring Countermeasure and Innovative Scouring Monitoring Systems with Smart Sensor Technologies. The funder (high impact research) has provided all expenses in project, also it will support all fees of publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akib S., 2014, WORLD ACAD SCI ENG T, V8, P56, DOI [10.5281/zenodo.1336432, DOI 10.5281/ZENODO.1336432]; Akib S, 2014, J HYDROL HYDROMECH, V62, P108, DOI 10.2478/johh-2014-0015; Akib S, 2011, BALT J ROAD BRIDGE E, V6, P107, DOI 10.3846/bjrbe.2011.15; Alabi P.D., 2006, THESIS U SASKATCHEWA; Bertoldi D, 1993, P NAT C HYDR ENG ASC, P121; Breusers H. N. C., 1991, SCOURING HYDRAULIC S; CHIEW YM, 1992, J HYDRAUL ENG-ASCE, V118, P1260, DOI 10.1061/(ASCE)0733-9429(1992)118:9(1260); CHIEW YM, 1987, J HYDRAUL RES, V25, P15, DOI 10.1080/00221688709499285; Christensen Z. M., 2009, REDUCTION LOCAL SCOU; DARGAHI B, 1990, J HYDRAUL ENG-ASCE, V116, P1197, DOI 10.1061/(ASCE)0733-9429(1990)116:10(1197); Dey S, 1997, INT J SEDIMENT RES, V12, P23; Duan JG, 2006, J HYDROL, V327, P426, DOI 10.1016/j.jhydrol.2005.11.055; Euler T, 2012, CATENA, V91, P35, DOI 10.1016/j.catena.2010.11.002; Ghodsian M, 2009, INT J SEDIMENT RES, V24, P145, DOI 10.1016/S1001-6279(09)60022-6; Jahangirzadeh A, 2014, NEUROCOMPUT IN PRESS; Karami H, 2012, WATER ENVIRON J, V28, P124, DOI DOI 10.1111/WEJ.12019; Kattell J, 1998, 9877 USDA FOREST SER; Kumar A, 2012, J HYDRO-ENVIRON RES, V6, P251, DOI 10.1016/j.jher.2012.05.006; Kumar V, 1999, J HYDRAUL ENG-ASCE, V125, P1302, DOI 10.1061/(ASCE)0733-9429(1999)125:12(1302); Lagasse PF, 1997, 396 NAT COOP HIGHW R; Link O, 2008, INT J SEDIMENT RES, V23, P258, DOI 10.1016/S1001-6279(08)60023-2; Melville B, 2008, P 4 INT C SCOUR ER T, P2838; Melville BW, 1999, J HYDRAUL ENG-ASCE, V125, P1221, DOI 10.1061/(ASCE)0733-9429(1999)125:11(1221); Melville BW, 1999, J HYDRAUL ENG-ASCE, V125, P59, DOI 10.1061/(ASCE)0733-9429(1999)125:1(59); MELVILLE BW, 1977, J HYDRAUL RES, V15, P373, DOI 10.1080/00221687709499641; Moncada-M AT, 2009, J HYDRAUL RES, V47, P119, DOI 10.3826/jhr.2009.3244; Muzzammil M, 2003, J HYDRAUL RES, V41, P285, DOI 10.1080/00221680309499973; Neill C. R., 1973, GUIDE BRIDGE HYDRAUL; Odgaard AJ, 1987, P NAT C HYDR ENG; Olsen N.R.B., 2009, 3 DIMENSIONAL NUMERI; PARKER G, 1998, COUNTERMEASURES PROT; PAROLA AC, 1993, J HYDRAUL ENG-ASCE, V119, P1080, DOI 10.1061/(ASCE)0733-9429(1993)119:10(1080); RAUDKIVI A. J., 1983, J HYDRAUL ENG-ASCE, V109, P339; SaniKhani H, 2008, P 4 NAT C CIV ENG TE; Schneible DE, 1951, THESIS STATE U IOWA; Sheppard DM, 2004, J HYDRAUL ENG, V130, P957, DOI 10.1061/(ASCE)0733-9429(2004)130:10(957); Shirhole A.M., 1991, TRANSPORTATION RES R; Tanaka S, 1967, P 12 IAHR C DELFT; Termini D, 2011, CATENA, V84, P125, DOI 10.1016/j.catena.2010.10.008; Thomas Z, 1967, P 12 IAHR C DELFT; van Rijn L.C., 1987, THESIS DELFT U TECHN; Zarrati AR, 2006, J HYDRAUL ENG, V132, P154, DOI 10.1061/(ASCE)0733-9429(2006)132:2(154); Zarrati AR, 2004, J HYDRAUL RES, V42, P97, DOI 10.1080/00221686.2004.9641188	43	18	18	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98592	10.1371/journal.pone.0098592	http://dx.doi.org/10.1371/journal.pone.0098592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919065	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000021
J	Jorgensen, CF; Powell, LA; Lusk, JJ; Bishop, AA; Fontaine, JJ				Jorgensen, Christopher F.; Powell, Larkin A.; Lusk, Jeffery J.; Bishop, Andrew A.; Fontaine, Joseph J.			Assessing Landscape Constraints on Species Abundance: Does the Neighborhood Limit Species Response to Local Habitat Conservation Programs?	PLOS ONE			English	Article							RING-NECKED PHEASANTS; BIRD POPULATIONS; BREEDING BIRDS; NEST PREDATORS; SPATIAL SCALE; AGRICULTURAL LANDSCAPES; PHASIANUS-COLCHICUS; RESERVE-PROGRAM; GRASSLAND BIRDS; LAND-USE	Landscapes in agricultural systems continue to undergo significant change, and the loss of biodiversity is an ever-increasing threat. Although habitat restoration is beneficial, management actions do not always result in the desired outcome. Managers must understand why management actions fail; yet, past studies have focused on assessing habitat attributes at a single spatial scale, and often fail to consider the importance of ecological mechanisms that act across spatial scales. We located survey sites across southern Nebraska, USA and conducted point counts to estimate Ring-necked Pheasant abundance, an economically important species to the region, while simultaneously quantifying landscape effects using a geographic information system. To identify suitable areas for allocating limited management resources, we assessed land cover relationships to our counts using a Bayesian binomial-Poisson hierarchical model to construct predictive Species Distribution Models of relative abundance. Our results indicated that landscape scale land cover variables severely constrained or, alternatively, facilitated the positive effects of local land management for Ring-necked Pheasants.	[Jorgensen, Christopher F.; Powell, Larkin A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Jorgensen, Christopher F.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE USA; [Lusk, Jeffery J.] Nebraska Game & Parks Commiss, Lincoln, NE USA; [Bishop, Andrew A.] US Fish & Wildlife Serv, Rainwater Basin Joint Venture, Grand Isl, NE USA; [Fontaine, Joseph J.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Jorgensen, CF (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.	jorgensen.chris@gmail.com	Fontaine, Joseph J/F-6557-2010	Fontaine, Joseph J/0000-0002-7639-9156	Federal Aid in Wildlife Restoration [W-89-R]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service; Wildlife Management Institute	Federal Aid in Wildlife Restoration; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	Funding for this project was received from Federal Aid in Wildlife Restoration projects W-89-R, administered by the Nebraska Game and Parks Commission. Any use of trade names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The Nebraska Cooperative Fish and Wildlife Research Unit is supported by a cooperative agreement among the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 1956, PHEASANTS N AM; Baxter WL, 1973, LIFE HIST ECOLOGY RI; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; BEST LB, 1995, AM MIDL NAT, V134, P1, DOI 10.2307/2426479; Best LB, 2001, J WILDLIFE MANAGE, V65, P442, DOI 10.2307/3803096; Blondel J., 1981, Studies in Avian Biology, P414; BOGENSCHUTZ TR, 1995, J WILDLIFE MANAGE, V59, P776, DOI 10.2307/3801956; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buckland S.T., 2001, pi; Caruana R, 2004, P 10 ACM SIGKDD INT; Chalfoun AD, 2002, ECOL APPL, V12, P858, DOI 10.1890/1051-0761(2002)012[0858:SNPIFP]2.0.CO;2; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; Clark WR, 1999, J WILDLIFE MANAGE, V63, P976, DOI 10.2307/3802812; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; COWARDIN LM, 1995, WILDLIFE SOC B, V23, P48; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Didier KA, 1999, WILDLIFE SOC B, V27, P409; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Drake JF, 2006, GAMEBIRD 2006 QUAIL, P302; Eggebo SL, 2003, WILDLIFE SOC B, V31, P779; Emmering QC, 2011, J ANIM ECOL, V80, P1305, DOI 10.1111/j.1365-2656.2011.01869.x; Errington PL, 1937, J WILDLIFE MANAGE, V1, P3; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Fletcher Jr RJ, 2010, PREDICTIVE MODELING, P91; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Franklin J, 2009, MAPPING SPECIES DIST; FRIED LOUIS A., 1940, JOUR WILDLIFE MANAGEMENT, V4, P27, DOI 10.2307/3796264; Garrettson PR, 2001, J WILDLIFE MANAGE, V65, P445; GATES JM, 1966, J WILDLIFE MANAGE, V30, P735, DOI 10.2307/3798280; Gelman A., 2007, DATA ANAL USING REGR; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gibeau ML, 1998, URSUS-SERIES, V10, P235; Giudice JH, 2007, J FIELD ORNITHOL, V78, P140, DOI 10.1111/j.1557-9263.2007.00097.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Heath RG, 1961, 2273 MICH DEP CONS G, V2273, P38; Henningsen JC, 2005, J WILDLIFE MANAGE, V69, P198, DOI 10.2193/0022-541X(2005)069&lt;0198:GBUORF&gt;2.0.CO;2; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; HILDEN OLAVL, 1965, ANN ZOOL FEN NICI, V2, P53; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hutto R.L., 1985, P455; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; JAMES FC, 1971, WILSON BULL, V83, P215; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kimball JW, 1949, J WILDLIFE MANAGE, V16, P429; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Kusak J, 1998, URSUS-SERIES, V10, P281; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Legendre P., 2012, NUMERICAL ECOLOGY; Leif AP, 2005, WILDLIFE SOC B, V33, P130, DOI 10.2193/0091-7648(2005)33[130:SEAHSO]2.0.CO;2; LEIF AP, 1994, J WILDLIFE MANAGE, V58, P501, DOI 10.2307/3809322; Leopold A., 1933, GAME MANAGEMENT; Liu C, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P4241; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luukkonen DR, 1997, J WILDLIFE MANAGE, V61, P1338, DOI 10.2307/3802135; LYON LJ, 1954, J WILDLIFE MANAGE, V18, P179, DOI 10.2307/3797712; MANKIN PC, 1992, AM MIDL NAT, V128, P281, DOI 10.2307/2426462; MARTIN TE, 1988, P NATL ACAD SCI USA, V85, P2196, DOI 10.1073/pnas.85.7.2196; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; McCoy TD, 1999, J WILDLIFE MANAGE, V63, P530, DOI 10.2307/3802639; MCGARIGAL K, 1995, PNWGTR351 US FOR SER; Miller DA, 2003, WILDLIFE SOC B, V31, P30; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Murray LD, 2008, CONDOR, V110, P747, DOI 10.1525/cond.2008.8610; Newburn D, 2005, CONSERV BIOL, V19, P1411, DOI 10.1111/j.1523-1739.2005.00199.x; Nielson RM, 2008, AUK, V125, P434, DOI 10.1525/auk.2008.07002; Patterson MP, 1996, AM MIDL NAT, V135, P153, DOI 10.2307/2426881; Perkins AL, 1997, J WILDLIFE MANAGE, V61, P634, DOI 10.2307/3802171; Peterjohn BG, 2003, AUK, V120, P14, DOI 10.1642/0004-8038(2003)120[0014:ALCTSH]2.0.CO;2; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Powell LA, 2012, ANIM BIODIV CONSERV, V35, P295; R Core Team, 2021, R LANGUAGE ENV STAT; Rahmig CJ, 2009, CONSERV BIOL, V23, P420, DOI 10.1111/j.1523-1739.2008.01118.x; Renfrew RB, 2003, AUK, V120, P371, DOI 10.1642/0004-8038(2003)120[0371:GPNPNP]2.0.CO;2; Ricklefs R. E., 1969, ANAL NESTING MORTALI, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; RILEY TZ, 1995, WILDLIFE SOC B, V23, P386; Riley TZ, 1998, J WILDLIFE MANAGE, V62, P36, DOI 10.2307/3802262; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; ROBERTSON PA, 1993, J APPL ECOL, V30, P465, DOI 10.2307/2404187; Robertson PA, 1996, WILDLIFE SOC B, V24, P98; Rodgers RD, 1999, WILDLIFE SOC B, V27, P654; Rohwer FC, 2004, TRANS N AM WILDL NAT, V69, P129; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Saab V, 1999, ECOL APPL, V9, P135, DOI 10.1890/1051-0761(1999)009[0135:IOSSTH]2.0.CO;2; SAUER JR, 2011, N AM BREEDING BIRD S; Schmitz RA, 1999, J WILDLIFE MANAGE, V63, P147, DOI 10.2307/3802495; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Smith SA, 1999, AM MIDL NAT, V141, P185, DOI 10.1674/0003-0031(1999)141[0185:HRHSAM]2.0.CO;2; SNYDER WD, 1984, J WILDLIFE MANAGE, V48, P878, DOI 10.2307/3801434; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; TAYLOR M W, 1978, Wildlife Society Bulletin, V6, P226; Thogmartin WE, 2006, CONDOR, V108, P25, DOI 10.1650/0010-5422(2006)108[0025:PRAORG]2.0.CO;2; Tuffery S., 2011, DATA MINING STAT DEC; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Ward EJ, 2008, ECOL MODEL, V211, P1, DOI 10.1016/j.ecolmodel.2007.10.030; WARNER RE, 1982, J WILDLIFE MANAGE, V46, P923, DOI 10.2307/3808225; WIENS JA, 1973, ECOLOGY, V54, P877, DOI 10.2307/1935683; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wrbka T, 2008, COMMUNITY ECOL, V9, P217, DOI 10.1556/ComEc.9.2008.2.11; Zinn HC, 1998, SOC NATUR RESOUR, V11, P649, DOI 10.1080/08941929809381109; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	115	8	10	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99339	10.1371/journal.pone.0099339	http://dx.doi.org/10.1371/journal.pone.0099339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918779	gold, Green Published			2022-12-27	WOS:000338631000079
J	Schuster, R; Martin, TG; Arcese, P				Schuster, Richard; Martin, Tara G.; Arcese, Peter			Bird Community Conservation and Carbon Offsets in Western North America	PLOS ONE			English	Article							BETA-DIVERSITY; PAYMENTS; LAND; FORESTS; COSTS; OPPORTUNITY; STRATEGIES; MANAGEMENT; EASEMENTS; ECOSYSTEM	Conservation initiatives to protect and restore valued species and communities in human-dominated landscapes face huge challenges linked to the cost of acquiring habitat. We ask how the sale of forest carbon offsets could reduce land acquisition costs, and how the alternate goals of maximizing alpha or beta-diversity in focal communities could affect the prioritization land parcels over a range of conservation targets. Maximizing total carbon storage and carbon sequestration potential reduced land acquisition costs by up to 48%. Maximizing beta rather than alpha-diversity within forest and savannah bird communities reduced acquisition costs by up to 15%, and when these solutions included potential carbon credit revenues, acquisition cost reductions up to 32% were achieved. However, the total cost of conservation networks increased exponentially as area targets increased in all scenarios. Our results indicate that carbon credit sales have the potential to enhance conservation outcomes in human-dominated landscapes by reducing the net acquisition costs of land conservation in old and maturing forests essential for the persistence of old forest plant and animal communities. Maximizing beta versus alpha-diversity may further reduce costs by reducing the total area required to meet conservation targets and enhancing landscape heterogeneity. Although the potential value of carbon credit sales declined as a fraction of total acquisition costs, even conservative scenarios using a carbon credit value of $12.5/T suggest reductions in acquisition cost of up to $235 M, indicating that carbon credit sales could substantially reduce the costs of conservation.	[Schuster, Richard; Martin, Tara G.; Arcese, Peter] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Martin, Tara G.] CSIRO Ecosyst Sci, Ecosci Precinct, Brisbane, Qld, Australia	University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schuster, R (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	mail@richard-schuster.com	Martin, Tara/M-1897-2016; Schuster, Richard/E-1619-2011	Martin, Tara/0000-0001-7165-9812; Schuster, Richard/0000-0003-3191-7869	Natural Sciences and Engineering Research Council Canada Discovery Grant; University of British Columbia	Natural Sciences and Engineering Research Council Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of British Columbia	The Natural Sciences and Engineering Research Council Canada Discovery Grant (PA, http://www.nserc-crsng.gc.ca/), W. and H. Hesse (RS, http://hess-eaward.sites.olt.ubc.ca/) and the University of British Columbia (RS, PA, http://ubc.ca/) kindly funded our work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; Anderson K, 2008, ECOL ECON, V68, P437, DOI 10.1016/j.ecolecon.2008.04.015; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 1991, SPECIAL REPORT SERIE; Arcese P, 2014, DIVERS DIST IN PRESS; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Armsworth PR, 2008, CONSERV LETT, V1, P182, DOI 10.1111/j.1755-263X.2008.00028.x; Arponen A, 2008, J APPL ECOL, V45, P1436, DOI 10.1111/j.1365-2664.2008.01513.x; Austin M.A., 2008, TAKING NATURES PULSE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bayon R, 2010, NATURE, V466, P184, DOI 10.1038/466184a; Bennett JR, 2013, CONSERV BIOL, V27, P417, DOI 10.1111/cobi.12015; Bennett JR, 2013, BIOL INVASIONS, V15, P707, DOI 10.1007/s10530-012-0320-z; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bivand RS, 2013, APPL SPATIAL DATA AN, DOI [10.1111/j.1541-0420.2009.012471.x, DOI 10.1111/J.1541-0420.2009.01247_1.X]; Bradshaw CJA, 2013, BIOL CONSERV, V161, P71, DOI 10.1016/j.biocon.2013.02.012; Bunn D, 2013, CALIF AGR, V67, P86, DOI 10.3733/ca.v067n02p86; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378; Climate Commission, 2013, CRIT DEC GLOB ACT BU; Convention on Biological Diversity, 2010, SECR CONV BIOL DIV M; Crossman ND, 2011, CONSERV BIOL, V25, P835, DOI 10.1111/j.1523-1739.2011.01649.x; Douglass LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023843; Drechsler M, 2007, BIOL CONSERV, V140, P174, DOI 10.1016/j.biocon.2007.08.013; Dunwiddie PW, 2011, NORTHWEST SCI, V85, P83, DOI 10.3955/046.085.0201; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Environmental Systems Research Institute (ESRI), 2012, ARCGIS 10 1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans MC, 2014, GLOB ENV CH IN PRESS; Fairbanks DHK, 2001, BIOL CONSERV, V98, P365, DOI 10.1016/S0006-3207(00)00179-8; Ferraro PJ, 2003, J POLICY ANAL MANAG, V22, P27, DOI 10.1002/pam.10094; Fishburn IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004996; Gonzales EK, 2008, ECOLOGY, V89, P3282, DOI 10.1890/08-0435.1; Gordon A, 2011, BIOL CONSERV, V144, P558, DOI 10.1016/j.biocon.2010.10.011; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Klimek S, 2008, BIOL CONSERV, V141, P2888, DOI 10.1016/j.biocon.2008.08.025; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Lea T., 2006, DAVIDSONIA, V17, P34; Lo AY, 2013, ECOL ECON, V87, P84, DOI 10.1016/j.ecolecon.2012.12.014; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh CJ, 2010, BIOL CONSERV, V143, P1364, DOI 10.1016/j.biocon.2010.03.010; Martin TG, 2011, BIOL CONSERV, V144, P459, DOI 10.1016/j.biocon.2010.09.033; McCune JL, 2013, BIOL CONSERV, V166, P293, DOI 10.1016/j.biocon.2013.08.004; Meidinger D, 1998, FIELD MANUAL DESCRIB; MES, 2008, TERR EC MAPP COAST D; Ministry of Environment BC, 2011, PROT CREAT FOR CARB; Mokany K, 2011, ECOL LETT, V14, P1043, DOI 10.1111/j.1461-0248.2011.01675.x; Moon K, 2011, J RURAL STUD, V27, P331, DOI 10.1016/j.jrurstud.2011.04.001; Mosseler A., 2003, Environmental Reviews, V11, pS1, DOI 10.1139/a03-018; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Newell RG, 2013, J ECON PERSPECT, V27, P123, DOI 10.1257/jep.27.1.123; Nickerson CJ, 2001, AM J AGR ECON, V83, P341, DOI 10.1111/0002-9092.00160; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Parker DP, 2004, NAT RESOUR J, V44, P483; PCT, 2013, PAC CARB TRUST CARB; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pellatt MG, 2012, ENVIRON MANAGE, V49, P802, DOI 10.1007/s00267-012-9815-8; Phelps J, 2012, NAT CLIM CHANGE, V2, P497, DOI [10.1038/NCLIMATE1462, 10.1038/nclimate1462]; Polasky S, 2001, LAND ECON, V77, P68, DOI 10.2307/3146981; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Rissman AR, 2013, ENVIRON CONSERV, V40, P222, DOI 10.1017/S0376892913000015; Rissman AR, 2011, CONSERV LETT, V4, P31, DOI 10.1111/j.1755-263X.2010.00136.x; Schilling BJ, 2013, J AGR RESOUR EC, V38; Schuster R, 2013, ECOGRAPHY, V36, P499, DOI 10.1111/j.1600-0587.2012.07681.x; Seely B, 2004, FOREST ECOL MANAG, V199, P283, DOI 10.1016/j.foreco.2004.05.048; Turner NJ, 2014, ANCIENT PATHWAYS ANC; Vellend M, 2008, BIOL CONSERV, V141, P2576, DOI 10.1016/j.biocon.2008.07.019; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wang Q, 2013, NATURE, V493, P273, DOI 10.1038/493273a; Wiersma YF, 2005, CONSERV BIOL, V19, P1262, DOI 10.1111/j.1523-1739.2005.00099.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	79	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99292	10.1371/journal.pone.0099292	http://dx.doi.org/10.1371/journal.pone.0099292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918621	Green Published, gold			2022-12-27	WOS:000338631000072
J	Du, F; Shi, HJ; Zhang, XC; Xu, XX				Du, Feng; Shi, Huijun; Zhang, Xingchang; Xu, Xuexuan			Responses of Reactive Oxygen Scavenging Enzymes, Proline and Malondialdehyde to Water Deficits among Six Secondary Successional Seral Species in Loess Plateau	PLOS ONE			English	Article							DROUGHT STRESS; MECHANISMS; OSMOTOLERANCE; SUPPRESSION; GENOTYPES; BETAINE	Drought can impact local vegetation dynamics in a long term. In order to predict the possible successional pathway of local community under drought, the responses of some drought resistance indices of six successional seral species in the semiarid Loss Hilly Region of China were illustrated and compared on three levels of soil water deficits along three growing months (7, 8 and 9). The results showed that: 1) the six species had significant differences in SOD, POD activities and MDA content. The rank correlations between SOD, POD activities and the successional niche positions of the six species were positive, and the correlation between MDA content and the niche positions was negative; 2) activities of SOD, CAT and POD, and content of proline and MDA had significant differences among the three months; 3) there existed significant interactions of SOD, CAT, POD activities and MDA content between months and species. With an exception, no interaction of proline was found. Proline in leaves had a general decline in reproductive month; 4) SOD, CAT, POD activities and proline content had negative correlations with MDA content. Among which, the correlation between SOD activity and MDA content was significant. The results implied that, in arid or semiarid region, the species at later successional stage tend to have strong drought resistance than those at early stage. Anti-drought indices can partially interpret the pathway of community succession in the drought impacted area. SOD activity is more distinct and important on the scope of protecting membrane damage through the scavenging of ROS on exposure to drought.	[Du, Feng; Shi, Huijun; Zhang, Xingchang; Xu, Xuexuan] Northwest Sci Tech Univ Agr & Forestry, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Du, Feng; Zhang, Xingchang; Xu, Xuexuan] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Du, Feng; Zhang, Xingchang] State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Du, F (corresponding author), Northwest Sci Tech Univ Agr & Forestry, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	dufeng@ms.iswc.ac.cn			National Natural Science Foundation of China [41271526, 41171421]; Northwest Agriculture and Forestry University [2109021121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest Agriculture and Forestry University	This research was supported jointly by the National Natural Science Foundation of China (41271526 and 41171421), basic scientific fund of Northwest Agriculture and Forestry University (2109021121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2006, ACTIVITIES ANTIOXIDA, P187; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Chutipaijit S, 2011, AUST J CROP SCI, V5, P1191; Chutipaijit S, 2009, PAK J BOT, V41, P2497; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Du F, 2005, J NATURAL RESOURCES, V20, P33; Du F, 2007, COLLOID SURFACE B, V58, P278, DOI 10.1016/j.colsurfb.2007.04.002; Elizamar CDS, 2013, RESPONSES ORG WATER; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gao JF, 2006, GUIDE BOT PHYSL EXPT; Grene Ruth, 2002, Arabidopsis Book, V1, pe0036, DOI 10.1199/tab.0036.1; HS Li, 2006, THEORY TECHNIQUES BO; Igarashi Y, 2000, PLANT CELL PHYSIOL, V41, P750, DOI 10.1093/pcp/41.6.750; Jiang M.Y., 1991, ACTA U AGR BOREALI O, V19, P88; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Ledger ME, 2011, GLOBAL CHANGE BIOL, V17, P2288, DOI 10.1111/j.1365-2486.2011.02420.x; Lemos JM, 2011, J AGR SCI TECHNOL B, V1, P22; LUDLOW MM, 1990, ADV AGRON, V43, P107; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Ning T., 2013, AGR SCI REV, V04, P100, DOI [10.4236/as.2013.45B019, DOI 10.4236/AS.2013.45B019]; Okuma E, 2004, SOIL SCI PLANT NUTR, V50, P1301, DOI 10.1080/00380768.2004.10408608; Okuma E, 2002, SOIL SCI PLANT NUTR, V48, P753, DOI 10.1080/00380768.2002.10409266; Ostle NJ, 2009, J ECOL, V97, P851, DOI 10.1111/j.1365-2745.2009.01547.x; Ozden M, 2009, SCI HORTIC-AMSTERDAM, V119, P163, DOI 10.1016/j.scienta.2008.07.031; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Shabala S, 2011, ADV BOT RES PLANT RE, V57, p[165, 505]; Shao HB, 2005, COLLOID SURFACE B, V42, P107, DOI 10.1016/j.colsurfb.2005.01.011; Shao HB, 2008, CR BIOL, V331, P433, DOI 10.1016/j.crvi.2008.03.011; Shao HB, 2007, COLLOID SURFACE B, V54, P143, DOI 10.1016/j.colsurfb.2006.09.004; Shipley B, 2010, PLANT TRAITS VEGETAT, P275; Sivakumar P, 2000, BIOCHEM BIOPH RES CO, V279, P512, DOI 10.1006/bbrc.2000.4005; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Tang Q., 2007, DPS DATA PROCESSING; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WU B-G, 1985, Acta Botanica Sinica, V27, P152; Yong T, 2006, COLLOID SURFACE B, V49, P60, DOI 10.1016/j.colsurtb.2006.02.014	44	15	22	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98872	10.1371/journal.pone.0098872	http://dx.doi.org/10.1371/journal.pone.0098872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914928	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700041
J	Honge, BL; Jespersen, S; Medina, C; Te, DD; da Silva, ZJ; Lewin, S; Ostergaard, L; Erikstrup, C; Wejse, C; Laursen, AL; Krarup, H				Honge, Bo Langhoff; Jespersen, Sanne; Medina, Candida; Te, David da Silva; da Silva, Zacarias Jose; Lewin, Sharon; Ostergaard, Lars; Erikstrup, Christian; Wejse, Christian; Laursen, Alex Lund; Krarup, Henrik		Bissau HIV Cohort Study Grp	Hepatitis B and Delta Virus Are Prevalent but Often Subclinical Co-Infections among HIV Infected Patients in Guinea-Bissau, West Africa: A Cross-Sectional Study	PLOS ONE			English	Article							CLINICAL-IMPLICATIONS; NATURAL-HISTORY; PREGNANT-WOMEN; DISEASE BURDEN; COTE-DIVOIRE; GENOTYPE-E; C VIRUS; HBV; EPIDEMIOLOGY; SEROPREVALENCE	Background: Co-infection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) may lead to accelerated hepatic disease progression with higher rates of liver cirrhosis and liver-related mortality compared with HBV mono-infection. Co or super-infection with hepatitis Delta virus (HDV) may worsen the liver disease and complicate treatment possibilities. Methods: In this cross-sectional study we included HIV-infected individuals who had a routine blood analysis performed at an HIV clinic in Bissau, Guinea-Bissau between the 28th of April and 30th of September 2011. All patients were interviewed, had a clinical exam performed and had a blood sample stored. The patients' samples were tested for HBV and HDV serology, and HBV/HDV viral loads were analyzed using in-house real-time PCR methods. Results: In total, 576 patients (417 HIV-1, 104 HIV-2 and 55 HIV-1/2) were included in this study. Ninety-four (16.3%) patients were HBsAg positive of whom 16 (17.0%) were HBeAg positive. In multivariable logistic regression analysis, CD4 cell count <200 cells/mu l and animist religion were significantly associated with HBsAg positivity. Due to scarcity of available plasma, virological analyses were not performed for eight patients. HBV DNA was detected in 42 of 86 samples (48.8%) positive for HBsAg and genotyping was performed in 26 patients; 25 of whom had genotype E and one genotype D. Among 9 patients on antiretroviral treatment (ART), one patient had the [L180M, M204V] mutation associated with lamivudine resistance. Among the HBsAg positive patients 25.0% were also positive for anti-HDV and 4/9 (44.4%) had detectable HDV RNA. Conclusion: HBV and HDV were frequent co-infections among HIV positive patients in Guinea-Bissau and chronic infection was associated with severe immunosuppression. Lamivudine was widely used among HBsAg positive patients with the risk of developing resistant HBV.	[Honge, Bo Langhoff; Jespersen, Sanne; da Silva, Zacarias Jose; Wejse, Christian] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Honge, Bo Langhoff; Jespersen, Sanne; Ostergaard, Lars; Wejse, Christian; Laursen, Alex Lund] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Medina, Candida; Te, David da Silva] Minist Hlth, Natl HIV Programme, Bissau, Guinea Bissau; [da Silva, Zacarias Jose] Natl Publ Hlth Lab, Bissau, Guinea Bissau; [Lewin, Sharon] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; [Wejse, Christian] Aarhus Univ, Sch Publ Hlth, Ctr Global Hlth, GloHAU, Aarhus, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	Aarhus University; Florey Institute of Neuroscience & Mental Health; Monash University; Burnet Institute; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital	Honge, BL (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	bohonge@gmail.com	Ostergaard, Lars/AAA-3020-2020; Wejse, Christian/C-8468-2014; Lewin, Sharon/Z-3297-2019	Ostergaard, Lars/0000-0003-2459-0511; Wejse, Christian/0000-0002-2534-2942; Fomsgaard, Anders/0000-0003-4304-0603; Laursen, Alex Lund/0000-0002-1206-156X; Erikstrup, Christian/0000-0001-6551-6647; Eugen-Olsen, Jesper/0000-0002-4630-4275; Sodemann, Morten/0000-0001-8992-2500; Ostergaard, Lars/0000-0002-7619-605X; Jespersen, Sanne/0000-0001-8493-2064	Bandim health project; 'Overlaege Johan Boserup og Lise Boserups Legat'; 'Aage og Johanne Louis-Hansens Fond'; 'Jacob og Olga Madsens Fond'; 'Aase og Ejnar Danielsens Fond'; Global Fund through the 'Secretariado National de Luta contra o Sida' in Guinea-Bissau; Ministry of foreign Affairs of Denmark (DANIDA); Aarhus University, Denmark; WAPHIR; IeDEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER; Lundbeck Foundation [R5-2006-359] Funding Source: researchfish	Bandim health project; 'Overlaege Johan Boserup og Lise Boserups Legat'; 'Aage og Johanne Louis-Hansens Fond'; 'Jacob og Olga Madsens Fond'; 'Aase og Ejnar Danielsens Fond'; Global Fund through the 'Secretariado National de Luta contra o Sida' in Guinea-Bissau; Ministry of foreign Affairs of Denmark (DANIDA); Aarhus University, Denmark; WAPHIR; IeDEA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Bandim health project, 'Overlaege Johan Boserup og Lise Boserups Legat', 'Aage og Johanne Louis-Hansens Fond', 'Jacob og Olga Madsens Fond' and 'Aase og Ejnar Danielsens Fond'. The Global Fund to Fight AIDS, TB and Malaria (Global Fund) supported the data collection during 2009-2013 through the 'Secretariado National de Luta contra o Sida' in Guinea-Bissau. The Ministry of foreign Affairs of Denmark (DANIDA) provided a travel grant for BLH. Aarhus University, Denmark supported a one year scholarship for BLH. Abbott provided serology reagents. WAPHIR and IeDEA supported data collection in Bissau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; BACHA A, 1990, J INFECT DIS, V161, P150, DOI 10.1093/infdis/161.1.150; Bado G, 2013, MED MALADIES INFECT, V43, P202, DOI 10.1016/j.medmal.2013.04.001; Bani-Sadr F, 2003, AM J MED, V114, P768, DOI 10.1016/S0002-9343(03)00156-6; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; BODSWORTH N, 1989, J INFECT DIS, V160, P577, DOI 10.1093/infdis/160.4.577; Borresen ML, 2010, J VIRAL HEPATITIS, V17, P162, DOI 10.1111/j.1365-2893.2009.01159.x; Boyd A, 2010, J VIRAL HEPATITIS, V17, P65, DOI 10.1111/j.1365-2893.2009.01153.x; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Diop-Ndiaye H, 2008, J MED VIROL, V80, P1332, DOI 10.1002/jmv.21236; Dumpis U, 2001, J HEPATOL, V35, P99, DOI 10.1016/S0168-8278(01)00064-2; Dupinay T, 2010, J MED VIROL, V82, P1515, DOI 10.1002/jmv.21865; Farci P, 2003, J HEPATOL, V39, pS212, DOI 10.1016/S0168-8278(03)00331-3; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Honge BL, 2013, J ACQ IMMUN DEF SYND, V65, P87; Honge BL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003499; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Krarup H, 2011, SCAND J GASTROENTERO, V46, P1484, DOI 10.3109/00365521.2011.619273; Krarup HB, 2008, SCAND J GASTROENTERO, V43, P334, DOI 10.1080/00365520701712198; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lunel-Fabiani F, 2013, J INFECTION, V67, P448, DOI 10.1016/j.jinf.2013.06.008; Mansour W, 2012, J MED VIROL, V84, P1186, DOI 10.1002/jmv.23336; Matthews GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061297; Mirandola S, 2011, J VIRAL HEPATITIS, V18, pE212, DOI 10.1111/j.1365-2893.2011.01435.x; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Onyekwere CA, 2012, INDIAN J GASTROENTER, V31, P34, DOI 10.1007/s12664-011-0158-9; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pastor R, 2009, WORLD J GASTROENTERO, V15, P753, DOI 10.3748/wjg.15.753; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Rouet F, 2004, J MED VIROL, V74, P34, DOI 10.1002/jmv.20143; Rowland-Jones SL, 2007, NAT IMMUNOL, V8, P329, DOI 10.1038/ni0407-329; Sagoe KWC, 2012, J MED VIROL, V84, P6, DOI 10.1002/jmv.22262; Soriano V, 2005, AIDS, V19, P221, DOI 10.1097/01.aids.0000192093.46506.e5; Stewart Balint, 2011, BMC Res Notes, V4, P561, DOI 10.1186/1756-0500-4-561; Suzuki S, 2003, J MED VIROL, V69, P459, DOI 10.1002/jmv.10331; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205	47	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99971	10.1371/journal.pone.0099971	http://dx.doi.org/10.1371/journal.pone.0099971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915064	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700141
J	Le Roux, C; Del Prete, S; Boutet-Mercey, S; Perreau, F; Balague, C; Roby, D; Fagard, M; Gaudin, V				Le Roux, Clementine; Del Prete, Stefania; Boutet-Mercey, Stephanie; Perreau, Francois; Balague, Claudine; Roby, Dominique; Fagard, Mathilde; Gaudin, Valerie			The hnRNP-Q Protein LIF2 Participates in the Plant Immune Response	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; BOTRYTIS-CINEREA; SCLEROTINIA-SCLEROTIORUM; DEFENSE RESPONSES; SIGNALING PATHWAYS; DISEASE RESISTANCE; III EFFECTOR; BINDING	Eukaryotes have evolved complex defense pathways to combat invading pathogens. Here, we investigated the role of the Arabidopsis thaliana heterogeneous nuclear ribonucleoprotein (hnRNP-Q) LIF2 in the plant innate immune response. We show that LIF2 loss-of-function in A. thaliana leads to changes in the basal expression of the salicylic acid (SA)- and jasmonic acid (JA)- dependent defense marker genes PR1 and PDF1.2, respectively. Whereas the expression of genes involved in SA and JA biosynthesis and signaling was also affected in the lif2-1 mutant, no change in SA and JA hormonal contents was detected. In addition, the composition of glucosinolates, a class of defense-related secondary metabolites, was altered in the lif2-1 mutant in the absence of pathogen challenge. The lif2-1 mutant exhibited reduced susceptibility to the hemi-biotrophic pathogen Pseudomonas syringae and the necrotrophic ascomycete Botrytis cinerea. Furthermore, the lif2-1 sid2-2 double mutant was less susceptible than the wild type to P. syringae infection, suggesting that the lif2 response to pathogens was independent of SA accumulation. Together, our data suggest that lif2-1 exhibits a basal primed defense state, resulting from complex deregulation of gene expression, which leads to increased resistance to pathogens with various infection strategies. Therefore, LIF2 may function as a suppressor of cell-autonomous immunity. Similar to its human homolog, NSAP1/SYNCRIP, a trans-acting factor involved in both cellular processes and the viral life cycle, LIF2 may regulate the conflicting aspects of development and defense programs, suggesting that a conserved evolutionary trade-off between growth and defense pathways exists in eukaryotes.	[Le Roux, Clementine; Del Prete, Stefania; Boutet-Mercey, Stephanie; Perreau, Francois; Fagard, Mathilde; Gaudin, Valerie] INRA AgroParisTech, UMR1318, Inst JP Bourgin, Ctr Versailles Grignon, Versailles, France; [Balague, Claudine; Roby, Dominique] INRA, Lab Interact Plantes Microorganismes, UMR441, F-31326 Castanet Tolosan, France; [Balague, Claudine; Roby, Dominique] CNRS, Lab Interact Plantes Microorganismes, UMR2594, Castanet Tolosan, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Gaudin, V (corresponding author), INRA AgroParisTech, UMR1318, Inst JP Bourgin, Ctr Versailles Grignon, Versailles, France.	valerie.gaudin@versailles.inra.fr	Del Prete, Stefania/AAS-4710-2020; Le Roux, Clementine/B-4761-2018	Del Prete, Stefania/0000-0002-1806-1819; Perreau, Francois/0000-0001-7873-9866; Gaudin, Valerie/0000-0002-1356-5567; Le Roux, Clementine/0000-0003-1689-6211	INRA CJS; European Commission [316965]; ANR from the French Research Ministry [ANR/08/BLAN-0200]; INRA	INRA CJS; European Commission(European CommissionEuropean Commission Joint Research Centre); ANR from the French Research Ministry(French National Research Agency (ANR)); INRA	CLR was supported by an INRA CJS PhD fellowship. SDP was supported by PhD fellowships provided by the European Commission Seventh Framework-People-2012-ITN project EpiTRAITS (Epigenetic regulation of economically important plant traits, no-316965). Furthermore, this work was supported by the ANR (ANR/08/BLAN-0200) from the French Research Ministry and by INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Alcazar R, 2011, CURR OPIN PLANT BIOL, V14, P378, DOI 10.1016/j.pbi.2011.04.001; Alvarez-Venegas R, 2007, EPIGENETICS-US, V2, P106, DOI 10.4161/epi.2.2.4404; Ambrosone A, 2012, PLANT SCI, V182, P12, DOI 10.1016/j.plantsci.2011.02.004; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Antico Christopher J, 2012, [Frontiers in Biology, 生物学前沿], V7, P48; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Chaouch S, 2010, PLANT PHYSIOL, V153, P1692, DOI 10.1104/pp.110.153957; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Choi KC, 2004, J VIROL, V78, P13153, DOI 10.1128/JVI.78.23.13153-13162.2004; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DeFraia CT, 2010, PLANT J, V64, P511, DOI 10.1111/j.1365-313X.2010.04345.x; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Denance N, 2013, PLANT J, V73, P225, DOI 10.1111/tpj.12027; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Guo XM, 2007, MOL PLANT MICROBE IN, V20, P1384, DOI 10.1094/MPMI-20-11-1384; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jeong BR, 2011, J BIOL CHEM, V286, P43272, DOI 10.1074/jbc.M111.290122; Jirage D, 2001, PLANT J, V26, P395, DOI 10.1046/j.1365-313X.2001.2641040.x; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; La Camera S, 2011, PLANT J, V68, P507, DOI 10.1111/j.1365-313X.2011.04706.x; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Lee DH, 2012, PLANT J, V72, P235, DOI 10.1111/j.1365-313X.2012.05063.x; Lee KC, 2006, ANAL BIOANAL CHEM, V386, P2225, DOI 10.1007/s00216-006-0882-7; Liu HM, 2009, VIROLOGY, V386, P249, DOI 10.1016/j.virol.2009.01.018; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Ludwig-Muller J, 1999, PLANTA, V208, P409, DOI 10.1007/s004250050576; Ma KW, 2011, PLANT PHYSIOL, V157, P535, DOI 10.1104/pp.111.182295; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; McCarty MF, 2006, INTEGR CANCER THER, V5, P252, DOI 10.1177/1534735406291499; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Morcx S, 2013, FUNGAL GENET BIOL, V52, P1, DOI 10.1016/j.fgb.2012.11.011; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Nakaminami K, 2012, BBA-GENE REGUL MECH, V1819, P149, DOI 10.1016/j.bbagrm.2011.07.015; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Palma K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001137; Park SM, 2011, NUCLEIC ACIDS RES, V39, P7791, DOI 10.1093/nar/gkr509; Perchepied L, 2010, MOL PLANT MICROBE IN, V23, P846, DOI 10.1094/MPMI-23-7-0846; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qi YP, 2010, MOL PLANT MICROBE IN, V23, P1573, DOI 10.1094/MPMI-05-10-0106; Ramirez V, 2011, PLANT PHYSIOL, V155, P1920, DOI 10.1104/pp.110.171843; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Staiger D, 2013, NEW PHYTOL, V197, P394, DOI 10.1111/nph.12022; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wang CZ, 2010, PLANT CELL PHYSIOL, V51, P1291, DOI 10.1093/pcp/pcq087; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Woloshen V, 2011, J PATHOG, V2011, DOI 10.4061/2011/278697; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang YL, 2005, CURR BIOL, V15, P1936, DOI 10.1016/j.cub.2005.09.038; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	92	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99343	10.1371/journal.pone.0099343	http://dx.doi.org/10.1371/journal.pone.0099343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914891	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700086
J	Liu, LJ; Zheng, HY; Jiang, F; Guo, W; Zhou, ST				Liu, Li-Jun; Zheng, Hong-Yuan; Jiang, Feng; Guo, Wei; Zhou, Shu-Tang			Comparative Transcriptional Analysis of Asexual and Sexual Morphs Reveals Possible Mechanisms in Reproductive Polyphenism of the Cotton Aphid	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM HEMIPTERA; PEA APHID; JUVENILE-HORMONE; RNA-SEQ; SEASONAL PHOTOPERIODISM; GENE-EXPRESSION; PARTHENOGENESIS; MEIOSIS; TITER; TOOL	Aphids, the destructive insect pests in the agriculture, horticulture and forestry, are capable of reproducing asexually and sexually upon environmental change. However, the molecular basis of aphid reproductive mode switch remains an enigma. Here we report a comparative analysis of differential gene expression profiling among parthenogenetic females, gynoparae and sexual females of the cotton aphid Aphis gossypii, using the RNA-seq approach with next-generation sequencing platforms, followed by RT-qPCR. At the cutoff criteria of fold change >= 2 and P<0.01, we identified 741 up- and 879 down-regulated genes in gynoparae versus parthenogenetic females, 2,101 up- and 2,210 down-regulated genes in sexual females compared to gynoparae, and 1,614 up- and 2,238 down-regulated genes in sexual females relative to parthenogenetic females. Gene ontology category and KEGG pathway analysis suggest the involvement of differentially expressed genes in multiple cellular signaling pathways into the reproductive mode transition, including phototransduction, cuticle composition, progesterone-mediated oocyte maturation and endocrine regulation. This study forms a basis for deciphering the molecular mechanisms underlying the shift from asexual to sexual reproduction in the cotton aphid. It also provides valuable resources for future studies on this host-alternating aphid species, and the insight into the understanding of reproductive mode plasticity in different aphid species.	[Liu, Li-Jun; Zheng, Hong-Yuan; Guo, Wei; Zhou, Shu-Tang] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Jiang, Feng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences	Zhou, ST (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	szhou@ioz.ac.cn	Guo, Wei/A-7089-2008; Jiang, Feng/AHC-5102-2022	Guo, Wei/0000-0001-9081-9754; Jiang, Feng/0000-0002-7407-7604	National Basic Research Program of China [2012CB114101]; One Hundred Talents Program of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China grant 2012CB114101 and the One Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CORBITT TS, 1985, ENTOMOL EXP APPL, V38, P131, DOI 10.1007/BF00361923; Cortes T, 2008, GENE, V408, P146, DOI 10.1016/j.gene.2007.10.030; DEKORT CAD, 1981, ANNU REV ENTOMOL, V26, P1, DOI 10.1146/annurev.en.26.010181.000245; Duncan EJ, 2013, DEV BIOL, V377, P262, DOI 10.1016/j.ydbio.2013.01.036; Gallot A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-76; Gallot A, 2010, INSECT BIOCHEM MOLEC, V40, P235, DOI 10.1016/j.ibmb.2009.12.001; HARDIE J, 1985, PHYSIOL ENTOMOL, V10, P297, DOI 10.1111/j.1365-3032.1985.tb00050.x; Henneberry TJ, 2000, SOUTHWEST ENTOMOL, V25, P161; Ishikawa A, 2012, INSECT MOL BIOL, V21, P49, DOI 10.1111/j.1365-2583.2011.01111.x; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Karlsson B, 2008, P ROY SOC B-BIOL SCI, V275, P2131, DOI 10.1098/rspb.2008.0404; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-456; Le Trionnaire G, 2008, BIOL CELL, V100, P441, DOI 10.1042/BC20070135; Le Trionnaire G, 2012, J INSECT PHYSIOL, V58, P1517, DOI 10.1016/j.jinsphys.2012.07.009; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MITTLER TE, 1976, J INSECT PHYSIOL, V22, P1717, DOI 10.1016/0022-1910(76)90065-2; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Riparbelli MG, 2005, DEV BIOL, V278, P220, DOI 10.1016/j.ydbio.2004.11.009; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 2010, CR BIOL, V333, P488, DOI 10.1016/j.crvi.2010.03.003; Srinivasan DG, 2010, INSECT MOL BIOL, V19, P229, DOI 10.1111/j.1365-2583.2009.00960.x; Stay B, 2007, ANNU REV ENTOMOL, V52, P277, DOI 10.1146/annurev.ento.51.110104.151050; Tagu D, 2005, INVERTEBR REPROD DEV, V48, P71, DOI 10.1080/07924259.2005.9652172; Uehara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024213; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	34	16	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99506	10.1371/journal.pone.0099506	http://dx.doi.org/10.1371/journal.pone.0099506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915491	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700108
J	Xiong, G; Zhang, B; Huang, MY; Zhou, HF; Chen, LZ; Feng, QS; Luo, X; Lin, HJ; Zeng, YX				Xiong, Geng; Zhang, Bo; Huang, Mu-yun; Zhou, Hufeng; Chen, Li-Zhen; Feng, Qi-Sheng; Luo, Xi; Lin, Hui-jia; Zeng, Yi-xin			Epstein-Barr Virus (EBV) Infection in Chinese Children: A Retrospective Study of Age-Specific Prevalence	PLOS ONE			English	Article								Background: Epstein-Barr Virus (EBV) is a globally prevalent herpesvirus associated with infectious mononucleosis and many malignancies. The survey on EBV prevalence appears to be important to study EBV-related diseases and determine when to administer prophylactic vaccine. The purpose of this retrospective study was to collect baseline information about the prevalence of EBV infection in Chinese children. Methodology/Principal Finding: We collected 1778 serum samples from healthy children aged 0 to 10, who were enrolled in conventional health and nutrition examinations without any EBV-related symptom in 2012 and 2013 in North China (n = 973) and South China (n = 805). We detected four EBV-specific antibodies, i.e., anti-VCA-IgG and IgM, anti-EBNA-IgG and anti-EA-IgG, by ELISA, representing all of the phases of EBV infection. The overall EBV seroprevalence in samples from North and South China were 80.78% and 79.38% respectively. The EBV seropositivity rates dropped slightly at age 2, and then increased gradually with age. The seroprevalence became stabilized at over 90% after age 8. In this study, the seroprevalence trends between North and South China showed no difference (P > 0.05), and the trends of average antibody concentrations were similar as well (P > 0.05). Conclusions/Significance: EBV seroprevalence became more than 50% before age 3 in Chinese children, and exceed 90% after age 8. This study can be helpful to study the relationship between EBV and EBV-associated diseases, and supportive to EBV vaccine development and implementation.	[Xiong, Geng; Huang, Mu-yun; Chen, Li-Zhen; Feng, Qi-Sheng; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Bo] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhou, Hufeng] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Zhou, Hufeng] Harvard Univ, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Luo, Xi] Guangzhou Women & Childrens Med Ctr, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China; [Lin, Hui-jia] Guangdong Women & Childrens Hosp, Neonatal Intens Care Unit, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Harvard University; Brigham & Women's Hospital; Harvard University	Xiong, G (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.	xionggeng@sysucc.org.cn; zengyix@mail.sysu.edu.cn	Zhou, Hufeng/M-1307-2014	Zhou, Hufeng/0000-0001-9382-5674				Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; Bagni R, 2012, J INFECT DIS, V205, P873, DOI 10.1093/infdis/jir871; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Balfour HH, 2013, J INFECT DIS, V207, P1787, DOI 10.1093/infdis/jit096; Bauer G, 2001, Clin Lab, V47, P223; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cohen JI, 2013, VACCINE, V31, pB194, DOI 10.1016/j.vaccine.2012.09.041; de The G, 1975, Bibl Haematol, P216; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921; Gao YN, 2002, ONCOGENE, V21, P825, DOI 10.1038/sj.onc.1205130; Hess RD, 2004, J CLIN MICROBIOL, V42, P3381, DOI 10.1128/JCM.42.8.3381-3387.2004; Hjalgrim H, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P929; Huang Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-55; Koidl C, 2011, WIEN KLIN WOCHENSCHR, V123, P230, DOI 10.1007/s00508-011-1561-z; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Macsween KF, 2003, LANCET INFECT DIS, V3, P131, DOI 10.1016/S1473-3099(03)00543-7; Morris MC, 2002, J MED VIROL, V67, P522, DOI 10.1002/jmv.10132; Murata T, 2014, REV MED VIROLOGY; PEARSON GR, 1988, J VIROL METHODS, V21, P97, DOI 10.1016/0166-0934(88)90056-0; Raab-Traub N, 1997, Oral Dis, V3 Suppl 1, pS164; Rea TD, 2002, AM J CLIN PATHOL, V117, P156; Robertson P, 2003, J MED VIROL, V70, P617, DOI 10.1002/jmv.10439; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Wang X, 1998, J VIROL, V72, P5552, DOI 10.1128/JVI.72.7.5552-5558.1998; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005; Zou Xiaonong, 1992, Chinese Medical Sciences Journal, V7, P201; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202	28	44	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99857	10.1371/journal.pone.0099857	http://dx.doi.org/10.1371/journal.pone.0099857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914816	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700139
J	Zhang, GH; Yuan, ZJ; Zhang, CX; Yin, KS; Tang, MJ; Guo, HW; Fu, JY; Xiao, Q				Zhang, Gui-Hua; Yuan, Zhi-Jun; Zhang, Chuan-Xi; Yin, Kun-Shan; Tang, Mei-Jun; Guo, Hua-Wei; Fu, Jian-Yu; Xiao, Qiang			Detecting Deep Divergence in Seventeen Populations of Tea Geometrid (Ectropis obliqua Prout) in China by COI mtDNA and Cross-Breeding	PLOS ONE			English	Article							DNA; LEPIDOPTERA; INSECT; ALEYRODIDAE; APHELINIDAE; HYMENOPTERA; RESISTANCE; HEMIPTERA; SEQUENCES; SOFTWARE	The tea geometrid (Ectropis obliqua Prout, Lepidoptera: Geometridae) is a dominant chewing insect endemic in most tea-growing areas in China. Recently some E. obliqua populations have been found to be resistant to the nucleopolyhedrovirus (EoNPV), a host-specific virus that has so far been found only in E. obliqua. Although the resistant populations are morphologically indistinguishable from susceptible populations, we conducted a nationwide collection and examined the genetic divergence in the COI region of the mtDNA in E. obliqua. Phylogenetic analyses of mtDNA in 17 populations revealed two divergent clades with genetic distance greater than 3.7% between clades and less than 0.7% within clades. Therefore, we suggest that E. obliqua falls into two distinct groups. Further inheritance analyses using reciprocal single-pair mating showed an abnormal F-1 generation with an unbalanced sex ratio and the inability to produce fertile eggs (or any eggs) through F1 self-crossing. These data revealed a potential cryptic species complex with deep divergence and reproductive isolation within E. obliqua. Uneven distribution of the groups suggests a possible geographic effect on the divergence. Future investigations will be conducted to examine whether EoNPV selection or other factors prompted the evolution of resistance.	[Zhang, Gui-Hua; Yuan, Zhi-Jun; Yin, Kun-Shan; Tang, Mei-Jun; Guo, Hua-Wei; Fu, Jian-Yu; Xiao, Qiang] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Fu, JY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China.	mybatigoal@mail.tricaas.com; xqtea@mail.tricaas.com	zhang, guihua/GVU-4494-2022; Zhang, Chuan-Xi/K-7978-2019	Zhang, Chuan-Xi/0000-0002-7784-1188	National Science and Technology Support Program Projects [2011BAD01B02]; Fundamental Research Funds of National Science and Technology [2013FY113200]; Key Innovation Team of Zhejiang Province [2011R09027-13]; National Natural Science Foundation of China [31100503]; public technology application research of Zhejiang Province [2013C32086]	National Science and Technology Support Program Projects; Fundamental Research Funds of National Science and Technology; Key Innovation Team of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); public technology application research of Zhejiang Province	This work was supported by the National Science and Technology Support Program Projects (2011BAD01B02), the Fundamental Research Funds of National Science and Technology (2013FY113200), the Key Innovation Team of Zhejiang Province (Grant No. 2011R09027-13), the National Natural Science Foundation of China (Grant No. 31100503) and the public technology application research of Zhejiang Province (2013C32086). The funders had no role in study design, samples collection and data analysis, decision to publish, or manuscript preparation.	Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Behere Gajanan T., 2007, BMC Evolutionary Biology, V7; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; Blair CP, 2005, EVOLUTION, V59, P304; Boykin LM, 2006, B ENTOMOL RES, V96, P457, DOI 10.1079/BER2006438; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Doak P, 2000, ECOLOGY, V81, P1828, DOI 10.1890/0012-9658(2000)081[1828:PCORDF]2.0.CO;2; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Hazarika LK, 2009, ANNU REV ENTOMOL, V54, P267, DOI 10.1146/annurev.ento.53.103106.093359; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Monti MM, 2005, B ENTOMOL RES, V95, P401, DOI 10.1079/BER2005371; Navajas M, 2001, B ENTOMOL RES, V91, P117; Ndo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058862; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Polaszek A, 2004, ZOOL SCR, V33, P403, DOI 10.1111/j.0300-3256.2004.00161.x; Prout LB, 1912, MACROLEPIDOPTERA WOR, V4, P1; PROUT LOUIS B., 1930, NOVITATES ZOOL [TRING], V35, P289; Qin Li, 2013, Acta Entomologica Sinica, V56, P186; Saha D, 2013, INT J TROP INSECT SC, V33, P46, DOI 10.1017/S1742758412000380; Scoble M, ONLINE LIST VALID AV; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Sourassou NF, 2012, EXP APPL ACAROL, V57, P15, DOI 10.1007/s10493-012-9534-0; Sperling FAH, 1999, INSECT MOL BIOL, V8, P97, DOI 10.1046/j.1365-2583.1999.810097.x; Warren W., 1894, Novitates Zoologicae, Vi, P366; Xi Yu, 2011, Journal of Tea Science, V31, P100; Ye GY, 2014, BIOL CONTROL, V68, P73, DOI 10.1016/j.biocontrol.2013.06.013; Yin Xian-Bing, 2007, Acta Entomologica Sinica, V50, P1263; Zhang HH, 2004, TEA PESTS NONPOLLUTI, P3	34	33	50	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99373	10.1371/journal.pone.0099373	http://dx.doi.org/10.1371/journal.pone.0099373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915522	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700091
J	Baboo, S; Bhushan, B; Jiang, HB; Grovenor, CRM; Pierre, P; Davis, BG; Cook, PR				Baboo, Sabyasachi; Bhushan, Bhaskar; Jiang, Haibo; Grovenor, Chris R. M.; Pierre, Philippe; Davis, Benjamin G.; Cook, Peter R.			Most Human Proteins Made in Both Nucleus and Cytoplasm Turn Over within Minutes	PLOS ONE			English	Article							TRANSLATION INITIATION; MASS-SPECTROMETRY; IN-VIVO; TRANSCRIPTION; DEGRADATION; CELLS; VISUALIZATION; MECHANISM; PEPTIDES; REVEALS	In bacteria, protein synthesis can be coupled to transcription, but in eukaryotes it is believed to occur solely in the cytoplasm. Using pulses as short as 5 s, we find that three analogues -L-azidohomoalanine, puromycin (detected after attaching fluors using 'click' chemistry or immuno-labeling), and amino acids tagged with 'heavy' N-15 and C-13 (detected using secondary ion mass spectrometry) -are incorporated into the nucleus and cytoplasm in a process sensitive to translational inhibitors. The nuclear incorporation represents a significant fraction of the total, and labels in both compartments have half-lives of less than a minute; results are consistent with most newly-made peptides being destroyed soon after they are made. As nascent RNA bearing a premature termination codon (detected by fluorescence in situ hybridization) is also eliminated by a mechanism sensitive to a translational inhibitor, the nuclear turnover of peptides is probably a by-product of proof-reading the RNA for stop codons (a process known as nonsense-mediated decay). We speculate that the apparently-wasteful turnover of this previously-hidden ('dark-matter') world of peptide is involved in regulating protein production.	[Baboo, Sabyasachi; Cook, Peter R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Bhushan, Bhaskar; Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Jiang, Haibo; Grovenor, Chris R. M.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13258 Marseille, France; [Pierre, Philippe] CNRS, Unites Mixtes Rech 7280, Marseille, France	University of Oxford; University of Oxford; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Cook, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	peter.cook@path.ox.ac.uk	Davis, Benjamin G/C-5281-2011; Jiang, Haibo/E-6623-2015	Davis, Benjamin G/0000-0002-5056-407X; Jiang, Haibo/0000-0002-2384-4826; Bhushan, Bhaskar/0000-0001-6136-8616; pierre, philippe/0000-0003-0863-8255; Cook, Peter/0000-0002-6639-188X; Baboo, Sabyasachi/0000-0002-4547-5160	Felix Scholarship Trust of Oxford University; Sir William Dunn School of Pathology; Rhodes Scholarship; China Scholarship Council; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/G026688/1, EP/E000614/1, EP/E036384/1, EP/I500200/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C510824/1, BB/E004350/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I500200/1, GR/T19797/01, EP/G026688/1, GR/T26542/01, EP/E000614/1, EP/E036384/1, EP/D023343/1, EP/D023335/1] Funding Source: researchfish	Felix Scholarship Trust of Oxford University; Sir William Dunn School of Pathology; Rhodes Scholarship; China Scholarship Council(China Scholarship Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	SB was supported by the Felix Scholarship Trust of Oxford University and The Sir William Dunn School of Pathology, BB is supported by a Rhodes Scholarship, and HJ by The China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; Apcher S, 2013, P NATL ACAD SCI USA, V110, P17951, DOI 10.1073/pnas.1309956110; Apcher S, 2012, CURR OPIN IMMUNOL, V24, P71, DOI 10.1016/j.coi.2012.01.007; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Boxer SG, 2009, ANNU REV BIOPHYS, V38, P53, DOI 10.1146/annurev.biophys.050708.133634; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Catic A, 2013, CELL, V155, P1380, DOI 10.1016/j.cell.2013.11.016; Dahlberg J, 2012, NUCLEUS-PHILA, V3, P320, DOI 10.4161/nucl.20754; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; GOIDL JA, 1978, TRENDS BIOCHEM SCI, V3, pN225; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; GREENBERG NA, 1979, J FOOD SCI, V44, P735, DOI 10.1111/j.1365-2621.1979.tb08487.x; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; HARRIS H, 1994, TRENDS BIOCHEM SCI, V19, P303, DOI 10.1016/0968-0004(94)90011-6; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Iborra FJ, 2004, J CELL SCI, V117, P899, DOI 10.1242/jcs.00933; Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kapranov Philipp, 2012, Frontiers in Genetics, V3, P60, DOI 10.3389/fgene.2012.00060; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; McMahon G, 2006, J AM SOC MASS SPECTR, V17, P1181, DOI 10.1016/j.jasms.2006.04.031; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Papantonis A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000419; REDMAN CM, 1966, P NATL ACAD SCI USA, V56, P608, DOI 10.1073/pnas.56.2.608; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SIUTAMANGANO P, 1981, J BIOL CHEM, V256, P2094; Szychowski J, 2010, J AM CHEM SOC, V132, P18351, DOI 10.1021/ja1083909; Tom Dieck Susanne, 2012, Curr Protoc Cell Biol, VChapter 7, DOI 10.1002/0471143030.cb0711s56; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; WHEATLEY DN, 1980, CELL BIOL INT REP, V4, P1081, DOI 10.1016/0309-1651(80)90045-4; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2013, P NATL ACAD SCI USA, V110, P17612, DOI 10.1073/pnas.1318259110	50	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99346	10.1371/journal.pone.0099346	http://dx.doi.org/10.1371/journal.pone.0099346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911415	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600075
J	Sinikumpu, SP; Huilaja, L; Jokelainen, J; Koiranen, M; Auvinen, J; Hagg, PM; Wikstrom, E; Timonen, M; Tasanen, K				Sinikumpu, Suvi-Paivikki; Huilaja, Laura; Jokelainen, Jari; Koiranen, Markku; Auvinen, Juha; Hagg, Paivi M.; Wikstrom, Erika; Timonen, Markku; Tasanen, Kaisa			High Prevalence of Skin Diseases and Need for Treatment in a Middle-Aged Population. A Northern Finland Birth Cohort 1966 Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ATOPIC-DERMATITIS; HAND ECZEMA; ANDROGENETIC ALOPECIA; MALIGNANT-MELANOMA; SOCIOECONOMIC-STATUS; SWEDISH POPULATION; RISK-FACTORS; STANDARD CLASSIFICATION; SEVERITY INDEX	To determine the overall prevalence of skin diseases a whole-body skin examination was performed for 1,932 members (46years of age) of the Northern Finland Birth Cohort (NFBC 1966), which is a comprehensive longitudinal research program (N = 12,058). A high prevalence of all skin diseases needing treatment was found (N = 1,158). Half of the cases of skin findings were evaluated to be serious enough to require diagnostic evaluation, treatment or follow-up either in a general health care, occupational health care or a secondary care setting. The remaining half were thought to be slight and selftreatment was advised. Males (70%) had more skin diseases needing treatment than females (52%) (P < 0.001). The most common skin finding was a benign skin tumor, which was found in every cohort member. Skin infections (44%), eczemas (27%) and sebaceous gland diseases (27%) were the most common skin diseases in the cohort. Moreover, skin infections and eczemas were more commonly seen in the group with low education compared to those with high education (P< 0.005). The results strengthen the postulate that skin diseases are common in an adult population.	[Sinikumpu, Suvi-Paivikki; Huilaja, Laura; Hagg, Paivi M.; Wikstrom, Erika; Tasanen, Kaisa] Univ Oulu, Dept Dermatol, Med Res Ctr, SF-90220 Oulu, Finland; [Sinikumpu, Suvi-Paivikki; Huilaja, Laura; Hagg, Paivi M.; Wikstrom, Erika; Tasanen, Kaisa] Oulu Univ Hosp, Oulu, Finland; [Jokelainen, Jari; Koiranen, Markku; Auvinen, Juha; Timonen, Markku] Univ Oulu, Fac Med, Inst Hlth Sci, SF-90220 Oulu, Finland; [Jokelainen, Jari] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Sinikumpu, SP (corresponding author), Univ Oulu, Dept Dermatol, Med Res Ctr, SF-90220 Oulu, Finland.	suvi-paivikki.sinikumpu@oulu.fi		Tasanen, Kaisa/0000-0001-8056-5949; Jokelainen, Jari/0000-0003-4629-0560	Oulu University Hospital; Northern Finland Cancer Association; Academy of Finland; University of Oulu	Oulu University Hospital; Northern Finland Cancer Association; Academy of Finland(Academy of Finland); University of Oulu	The authors are grateful to Oulu University Hospital, the Northern Finland Cancer Association, the Academy of Finland and the University of Oulu for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram K, 2010, ACTA DERM-VENEREOL, V90, P269, DOI 10.2340/00015555-0856; ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Augustin M, 2011, BRIT J DERMATOL, V165, P865, DOI 10.1111/j.1365-2133.2011.10436.x; AUGUSTSSON A, 1991, BRIT J DERMATOL, V124, P152, DOI 10.1111/j.1365-2133.1991.tb00424.x; BERG M, 1989, ACTA DERM-VENEREOL, V69, P419; Bergmann RL, 2000, CLIN EXP ALLERGY, V30, P1740, DOI 10.1046/j.1365-2222.2000.00927.x; Cash TF, 1999, BRIT J DERMATOL, V141, P398; Crawford GH, 2004, J AM ACAD DERMATOL, V51, P327, DOI 10.1016/j.jaad.2004.03.030; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; ELEWSKI B, 1995, J AM ACAD DERMATOL, V33, P816, DOI 10.1016/0190-9622(95)91838-8; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gibson GE, 1997, IRISH J MED SCI, V166, P72, DOI 10.1007/BF02944190; Goulden V, 1999, J AM ACAD DERMATOL, V41, P577, DOI 10.1016/S0190-9622(99)70300-2; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Herd RM, 1996, BRIT J DERMATOL, V135, P18; Isohanni I, 2001, SCAND J PUBLIC HEALT, V29, P87, DOI 10.1177/14034948010290020501; Johnson MT, 1978, SKIIN CONDITIONS REL; Julian CG, 1999, BRIT J DERMATOL, V141, P518; Karlsson P, 2000, ACTA DERM-VENEREOL, V80, P335; Krueger G, 2001, ARCH DERMATOL, V137, P280; Lacroix C, 2002, J EUR ACAD DERMATOL, V16, P139, DOI 10.1046/j.1468-3083.2002.00400.x; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Lowell BA, 2001, J AM ACAD DERMATOL, V45, P250, DOI 10.1067/mjd.2001.114598; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; Meding B, 2004, SCAND J WORK ENV HEA, V30, P334, DOI 10.5271/sjweh.804; Meding B, 2004, J INVEST DERMATOL, V122, P873, DOI 10.1111/j.0022-202X.2004.22406.x; MEDING B, 1990, CONTACT DERMATITIS, V22, P13, DOI 10.1111/j.1600-0536.1990.tb01499.x; Montnemery P, 2005, ACTA DERM-VENEREOL, V85, P429, DOI 10.1080/00015550510036658; Muto T, 2003, BRIT J DERMATOL, V148, P117, DOI 10.1046/j.1365-2133.2003.05092.x; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; OSTERLIND A, 1992, ACTA ONCOL, V31, P903, DOI 10.3109/02841869209089727; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Plunkett A, 1999, INT J DERMATOL, V38, P901, DOI 10.1046/j.1365-4362.1999.00856.x; REA JN, 1976, BRIT J PREV SOC MED, V30, P107; Remes ST, 1998, ALLERGY, V53, P682, DOI 10.1111/j.1398-9995.1998.tb03954.x; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Severi G, 2003, BRIT J DERMATOL, V149, P1207, DOI 10.1111/j.1365-2133.2003.05565.x; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; SUSITAIVAL P, 1994, SCAND J WORK ENV HEA, V20, P206, DOI 10.5271/sjweh.1407; SWERDLOW AJ, 1986, BRIT MED J, V292, P1555, DOI 10.1136/bmj.292.6535.1555; Thyssen JP, 2010, CONTACT DERMATITIS, V62, P75, DOI 10.1111/j.1600-0536.2009.01669.x; Wallenhammar LM, 2004, J INVEST DERMATOL, V122, P1381, DOI 10.1111/j.0022-202X.2004.22604.x; White GM, 1998, J AM ACAD DERMATOL, V39, pS34, DOI 10.1016/S0190-9622(98)70442-6; Wilkin J, 2002, J AM ACAD DERMATOL, V46, P584, DOI 10.1067/mjd.2002.120625; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Yi SM, 2012, BRIT J DERMATOL, V167, P306, DOI 10.1111/j.1365-2133.2012.10978.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	52	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99533	10.1371/journal.pone.0099533	http://dx.doi.org/10.1371/journal.pone.0099533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911008	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600100
J	Tang, C; Zhang, TS; Zhou, LF				Tang, Chao; Zhang, Tian-Song; Zhou, Liang-Fu			Risk Factors for Rebleeding of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis	PLOS ONE			English	Article							RUPTURED INTRACRANIAL ANEURYSMS; HETEROGENEITY; RERUPTURE; IMPACT	Background: Rebleeding is a serious complication of aneurysmal subarachnoid hemorrhaging. To date, there are conflicting data regarding the factors contributing to rebleeding and their significance. Methods: A systematic review of PubMed and Embase databases was conducted for studies pertaining to aneurysmal subarachnoid hemorrhage (aSAH) and rebleeding in order to assess the associated risk factors. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated from fourteen studies comprised of a total of 5693 patients that met the inclusion criteria. Results: Higher rebleeding rates were observed < 6 h after the initial aSAH (OR = 3.22, 95% CI = 1.46-7.12), and were associated with high systolic blood pressure (OR = 1.93, 95% CI = 1.31-2.83), poor Hunt-Hess grade (III-IV) (OR = 3.43, 95% CI = 2.33-5.05), intracerebral or intraventricular hematomas (OR = 1.65, 95% CI = 1.33-2.05), posterior circulation aneurysms (OR = 2.15, 95% CI = 1.32-3.49), and aneurysms >10 mm in size (OR = 1.70, 95% CI = 1.35-2.14). Conclusions: Aneurysmal rebleeding occurs more frequently within the first 6 hours after the initial aSAH. Risk factors associated with rebleeding include high systolic pressure, the presence of an intracerebral or intraventricular hematoma, poor Hunt-Hess grade (III-IV), aneurysms in the posterior circulation, and an aneurysm >10 mm in size.	[Tang, Chao; Zhou, Liang-Fu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhang, Tian-Song] Shanghai Jing An Dist Cent Hosp, Dept TCM, Shanghai, Peoples R China	Fudan University	Zhou, LF (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	lfzhouc@126.com	tang, chao/AAC-6376-2019	tang, chao/0000-0002-8722-7990				ANDO T, 1989, Neurological Research, V11, P245; Aoyagi N, 1996, ACTA NEUROCHIR, V138, P12, DOI 10.1007/BF01411717; Beck J, 2006, STROKE, V37, P2733, DOI 10.1161/01.STR.0000244762.51326.e7; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Cha KC, 2010, J KOREAN NEUROSURG S, V47, P119, DOI 10.3340/jkns.2010.47.2.119; De Marchis GM, 2014, J NEUROL NEUROSUR PS, V85, P56, DOI 10.1136/jnnp-2013-305051; Fujii Y, 1996, J NEUROSURG, V84, P35, DOI 10.3171/jns.1996.84.1.0035; Guo LM, 2011, WORLD NEUROSURG, V76, P292, DOI 10.1016/j.wneu.2011.03.025; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIJDRA A, 1987, J NEUROSURG, V67, P29, DOI 10.3171/jns.1987.67.1.0029; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; INAGAWA T, 1994, SURG NEUROL, V42, P130, DOI 10.1016/0090-3019(94)90373-5; INAGAWA T, 1987, SURG NEUROL, V28, P93, DOI 10.1016/0090-3019(87)90079-6; JUVELA S, 1989, SURG NEUROL, V32, P323, DOI 10.1016/0090-3019(89)90133-X; KASSELL NF, 1983, NEUROSURGERY, V13, P479, DOI 10.1227/00006123-198311000-00001; Kitsuta Y, 2006, PREHOSP DISASTER MED, V21, P190, DOI 10.1017/S1049023X00003666; Larsen CC, 2012, THROMB RES, V129, pE229, DOI 10.1016/j.thromres.2012.01.016; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Naggara O, 2011, AM J NEURORADIOL, V32, P437, DOI 10.3174/ajnr.A2425; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Narotam PK, 2008, J NEUROSURG, V109, P1065, DOI 10.3171/JNS.2008.109.12.1065; Ohkuma H, 2001, STROKE, V32, P1176, DOI 10.1161/01.STR.32.5.1176; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Pleizier CM, 2006, ACTA NEUROCHIR, V148, P1277, DOI 10.1007/s00701-006-0911-5; Sakaki T, 1999, J Stroke Cerebrovasc Dis, V8, P38, DOI 10.1016/S1052-3057(99)80038-X; STEIGER HJ, 1994, ACTA NEUROCHIR, V127, P21, DOI 10.1007/BF01808541; Tanno Y, 2007, J NEUROL SCI, V258, P11, DOI 10.1016/j.jns.2007.01.074; TORNER JC, 1981, NEUROSURGERY, V9, P506; Wells G.A., 2000, VIS COMMUN Q; Wu C, 2012, TURK NEUROSURG, V22, P675, DOI 10.5137/1019-5149.JTN.5054-11.1	31	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99536	10.1371/journal.pone.0099536	http://dx.doi.org/10.1371/journal.pone.0099536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911172	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600102
J	Williams-Bey, Y; Boularan, C; Vural, A; Huang, NN; Hwang, IY; Shan-Shi, C; Kehrl, JH				Williams-Bey, Yolanda; Boularan, Cedric; Vural, Ali; Huang, Ning-Na; Hwang, Il-Young; Shan-Shi, Chong; Kehrl, John H.			Omega-3 Free Fatty Acids Suppress Macrophage Inflammasome Activation by Inhibiting NF-kappa B Activation and Enhancing Autophagy	PLOS ONE			English	Article							RECEPTORS; SIGNALS; CELLS; GPR120	The omega-3 (omega 3) fatty acid docosahexaenoic acid (DHA) can suppress inflammation, specifically IL-1 beta production through poorly understood molecular mechanisms. Here, we show that DHA reduces macrophage IL-1 beta production by limiting inflammasome activation. Exposure to DHA reduced IL-1 beta production by ligands that stimulate the NLRP3, AIM2, and NAIP5/NLRC4 inflammasomes. The inhibition required Free Fatty Acid Receptor (FFAR) 4 (also known as GPR120), a G-protein coupled receptor (GPR) known to bind DHA. The exposure of cells to DHA recruited the adapter protein beta-arrestin1/2 to FFAR4, but not to a related lipid receptor. DHA treatment reduced the initial inflammasome priming step by suppressing the nuclear translocation of NF-kB. DHA also reduced IL-1 beta levels by enhancing autophagy in the cells. As a consequence macrophages derived from mice lacking the essential autophagy protein ATG7 were partially resistant to suppressive effects of DHA. Thus, DHA suppresses inflammasome activation by two distinct mechanisms, inhibiting the initial priming step and by augmenting autophagy, which limits inflammasome activity.	[Williams-Bey, Yolanda; Boularan, Cedric; Vural, Ali; Huang, Ning-Na; Hwang, Il-Young; Shan-Shi, Chong; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA.	jkehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health [National Institute of Allergy and Infectious Diseases]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Decuypere JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061020; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Luttrell LM, 2002, J CELL SCI, V115, P455; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shin S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/568671; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Yonezawa T, 2013, CURR MED CHEM, V20, P3855	18	148	155	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e97957	10.1371/journal.pone.0097957	http://dx.doi.org/10.1371/journal.pone.0097957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911523	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600126
J	Bennett, DL; Hamberg, LM; Wang, B; Hirsch, JA; Gonzalez, RG; Hunter, GJ				Bennett, Debbie L.; Hamberg, Leena M.; Wang, Bing; Hirsch, Joshua A.; Gonzalez, R. Gilberto; Hunter, George J.			Diagnostic Yield of Delayed Phase Imaging in CT Angiography of the Head and Neck: A Retrospective Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; INTERNAL CAROTID ARTERIES; MANAGEMENT; OCCLUSION	Purpose: To evaluate how often delayed images, obtained during neurovascular CTA, provide unique information relative to early phase imaging alone. Materials and Methods: Informed consent was waived by the institutional review body for this study. Neurovascular CTAs from January through June 2009 were searched to identify those with delayed phase imaging. Reports were reviewed to identify cases where delayed images provided potentially unique information. The studies with potentially unique information were re-interpreted to determine if the information was indeed unique. Results: 645 CTAs with delayed phase imaging were identified. There were 324 men and 310 women (median age 67 years; range 20-96 years). 59 studies (59/645: 9.1%) had findings on the delayed images. There were 13 cases with hemorrhage, with 4 showing progression on delayed views. Of the remaining 46 cases, 28 had occlusion of a vessel that did not reconstitute on the delayed images, 6 had occlusion of a vessel that did reconstitute on the delayed images, 7 had a string sign which was unchanged on the delayed views and 5 had no abnormal findings. Thus in 10 cases the findings were unique to the delayed images (10/645: 1.55%). Four showed active bleeding, three showed proximal occlusion with distal internal carotid filling from ophthalmic collaterals, two showed pial vessels filling distal to proximal MCA occlusion, and one showed retrograde vertebral artery filling due to subclavian steal. 95% confidence limits of the expected incidence of unique information from the delayed phase images are 0.6% - 2.5%. Conclusion: Obtaining delayed phase imaging for neurovascular CTA should be an active decision and not the default protocol. This avoids imaging with little, if any value. If delayed images had not been obtained in our cohort, no detriment in patient management would have occurred.	[Bennett, Debbie L.; Hirsch, Joshua A.; Gonzalez, R. Gilberto; Hunter, George J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hamberg, Leena M.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Wang, Bing] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center	Hunter, GJ (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	gjhunter@partners.org						Almandoz JED, 2010, RADIOL CLIN N AM, V48, P265, DOI 10.1016/j.rcl.2010.02.007; Bartlett ES, 2006, AM J NEURORADIOL, V27, P632; Berne JD, 2004, J TRAUMA, V57, P11, DOI 10.1097/01.TA.0000135499.70048.C7; Brott TG, 2011, STROKE, V42, pE464, DOI 10.1161/STR.0b013e3182112cc2; Chen Y, 2004, SKULL BASE-INTERD AP, V14, P185, DOI 10.1055/s-2004-860946; COUNTEE RW, 1979, J NEUROSURG, V50, P747, DOI 10.3171/jns.1979.50.6.0747; DeLaPaz RL, 2011, J AM COLL RADIOL, V8, P532, DOI 10.1016/j.jacr.2011.05.010; Fox AJ, 2012, AM J NEURORADIOL, V33, P792, DOI 10.3174/ajnr.A3099; Furtado AD, 2010, AM J NEURORADIOL, V31, P1290, DOI 10.3174/ajnr.A2075; Gandhi D, 2009, NEUROIMAG CLIN N AM, V19, P133, DOI 10.1016/j.nic.2009.02.002; Greiner C, 2004, ACTA NEUROCHIR, V146, P237, DOI 10.1007/s00701-004-0216-5; Halliburton SS, 2010, JACC-CARDIOVASC IMAG, V3, P536, DOI 10.1016/j.jcmg.2010.03.004; Han DK, 2010, J VASC SURG, V52, P746, DOI 10.1016/j.jvs.2010.04.028; Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83; Lev MH, 2012, AM J NEURORADIOL, V33, P790, DOI 10.3174/ajnr.A3098; Lev MH, 2003, AM J NEURORADIOL, V24, P1123; Li YQ, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-64; Niemela M, 2012, WORLD NEUROSURG, V78, P581, DOI 10.1016/j.wneu.2012.01.026; Pantazis G, 2006, SURG NEUROL, V66, P492, DOI 10.1016/j.surneu.2006.05.054; Perkins JA, 2005, INT J PEDIATR OTORHI, V69, P319, DOI 10.1016/j.ijporl.2004.10.008; Romero JM, 2012, EMERG RADIOL, V19, P195, DOI 10.1007/s10140-012-1020-9; SANDOK BA, 1971, ARCH NEUROL-CHICAGO, V24, P462, DOI 10.1001/archneur.1971.00480350096010; Sanelli PC, 2005, AM J ROENTGENOL, V184, P305, DOI 10.2214/ajr.184.1.01840305; Suzuki Y, 2005, NEUROL MED-CHIR, V45, P387, DOI 10.2176/nmc.45.387; Tholen ATR, 2010, RADIOLOGY, V256, P585, DOI 10.1148/radiol.10091157; Wyers MC, 2009, J VASC SURG, V49, P614, DOI 10.1016/j.jvs.2008.10.015	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99020	10.1371/journal.pone.0099020	http://dx.doi.org/10.1371/journal.pone.0099020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905932	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000092
J	Chavarria, NE; Hwang, SM; Cao, SY; Fu, X; Holman, M; Elbanna, D; Rodriguez, S; Arrington, D; Englert, M; Uthandi, S; Soll, D; Maupin-Furlow, JA				Chavarria, Nikita E.; Hwang, Sungmin; Cao, Shiyun; Fu, Xian; Holman, Mary; Elbanna, Dina; Rodriguez, Suzanne; Arrington, Deanna; Englert, Markus; Uthandi, Sivakumar; Soell, Dieter; Maupin-Furlow, Julie A.			Archaeal Tuc1/Ncs6 Homolog Required for Wobble Uridine tRNA Thiolation Is Associated with Ubiquitin-Proteasome, Translation, and RNA Processing System Homologs	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL MODIFICATION; HALOFERAX-VOLCANII; STATISTICAL-MODEL; PROTEINS; TRANSCRIPTION; BIOSYNTHESIS; THIOURIDINE; POSITION; DATABASE; EXOSOME	While cytoplasmic tRNA 2-thiolation protein 1 (Tuc1/Ncs6) and ubiquitin-related modifier-1 (Urm1) are important in the 2-thiolation of 5-methoxycarbonylmethyl-2-thiouridine (mcm(5)s(2)U) at wobble uridines of tRNAs in eukaryotes, the biocatalytic roles and properties of Ncs6/Tuc1 and its homologs are poorly understood. Here we present the first report of an Ncs6 homolog of archaea (NcsA of Haloferax volcanii) that is essential for maintaining cellular pools of thiolated tRNA(Lys) UUU and for growth at high temperature. When purified from Hfx. volcanii, NcsA was found to be modified at Lys204 by isopeptide linkage to polymeric chains of the ubiquitin-fold protein SAMP2. The ubiquitin-activating E1 enzyme homolog of archaea (UbaA) was required for this covalent modification. Non-covalent protein partners that specifically associated with NcsA were also identified including UbaA, SAMP2, proteasome activating nucleotidase (PAN)-A/1, translation elongation factor aEF-1 alpha and a beta-CASP ribonuclease homolog of the archaeal cleavage and polyadenylation specificity factor 1 family (aCPSF1). Together, our study reveals that NcsA is essential for growth at high temperature, required for formation of thiolated tRNA(Lys) UUU and intimately linked to homologs of ubiquitin-proteasome, translation and RNA processing systems.	[Chavarria, Nikita E.; Hwang, Sungmin; Cao, Shiyun; Fu, Xian; Holman, Mary; Elbanna, Dina; Rodriguez, Suzanne; Arrington, Deanna; Uthandi, Sivakumar; Maupin-Furlow, Julie A.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Maupin-Furlow, Julie A.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Englert, Markus; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Yale University; Yale University	Maupin-Furlow, JA (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Uthandi, Sivakumar/C-3277-2018; Maupin-Furlow, Julie/AAW-4035-2020	Uthandi, Sivakumar/0000-0002-7116-1317; Maupin-Furlow, Julie/0000-0001-6105-0923; Fu, Xian/0000-0001-9044-8850	NIGMS NIH HHS [R01 GM057498, R01GM22854, R01 GM022854] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R01GM057498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Aravind L, 1999, In Silico Biol, V1, P69; Auffinger P., 1998, MODIFICATION EDITING; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 1992, TRANSFER RNA PROTEIN; BORK P, 1994, PROTEINS, V20, P347, DOI 10.1002/prot.340200407; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Hepowit NL, 2012, MOL MICROBIOL, V86, P971, DOI 10.1111/mmi.12038; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Jager G, 2004, J BACTERIOL, V186, P750, DOI 10.1128/JB.186.3.750-757.2004; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Liu YC, 2012, J BIOL CHEM, V287, P36683, DOI 10.1074/jbc.M112.405688; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; Miranda HV, 2014, MOL CELL PROTEOMICS, V13, P220, DOI 10.1074/mcp.M113.029652; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Nakagawa H, 2013, PROTEINS, V81, P1232, DOI 10.1002/prot.24273; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nieuwlandt D. T., 1995, P161; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Perez-Fillol M, 1986, Microbiologia, V2, P73; Phung DK, 2013, NUCLEIC ACIDS RES, V41, P1091, DOI 10.1093/nar/gks1237; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Prunetti L, 2014, EXTREMOPHIL IN PRESS; Rawls KS, 2010, J BACTERIOL, V192, P6251, DOI 10.1128/JB.00827-10; Reuter CJ, 2004, J BACTERIOL, V186, P7763, DOI 10.1128/JB.186.22.7763-7772.2004; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Robinson JL, 2005, J BACTERIOL, V187, P923, DOI 10.1128/JB.187.3.923-929.2005; ROGERS KC, 1995, BIOCHIMIE, V77, P66, DOI 10.1016/0300-9084(96)88106-5; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Shigi N, 2012, J BIOL CHEM, V287, P17568, DOI 10.1074/jbc.M112.359844; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; Silva APG, 2011, STRUCTURE, V19, P622, DOI 10.1016/j.str.2011.03.002; Smith DM, 2009, HALOHANDBOOK VERSION, p7.2; Striebel F, 2014, BBA-MOL CELL RES, V1843, P103, DOI 10.1016/j.bbamcr.2013.03.022; Tomikawa C, 2013, FEBS LETT, V587, P3575, DOI 10.1016/j.febslet.2013.09.021; Vendeix FAP, 2012, J MOL BIOL, V416, P467, DOI 10.1016/j.jmb.2011.12.048; Wilson HL, 1999, J BACTERIOL, V181, P5814, DOI 10.1128/JB.181.18.5814-5824.1999	49	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99104	10.1371/journal.pone.0099104	http://dx.doi.org/10.1371/journal.pone.0099104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906001	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000103
J	Kondo, Y; Ninomiya, M; Kimura, O; Machida, K; Funayama, R; Nagashima, T; Kobayashi, K; Kakazu, E; Kato, T; Nakayama, K; Lai, MMC; Shimosegawa, T				Kondo, Yasuteru; Ninomiya, Masashi; Kimura, Osamu; Machida, Keigo; Funayama, Ryo; Nagashima, Takeshi; Kobayashi, Koju; Kakazu, Eiji; Kato, Takanobu; Nakayama, Keiko; Lai, Michael M. C.; Shimosegawa, Tooru			HCV Infection Enhances Th17 Commitment, Which Could Affect the Pathogenesis of Autoimmune Diseases	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; POLYMERASE-CHAIN-REACTION; IN-VIVO; MIXED CRYOGLOBULINEMIA; RHEUMATOID-ARTHRITIS; CELL-LINES; T-CELLS; PROTEIN; INTERFERON; RECEPTOR	Background: Various kinds of autoimmune diseases have been reported to have a significant relationship with persistent hepatitis c virus (HCV) infection and Th17 cells. Previously, our group reported that the existence of HCV in T lymphocytes could affect the development of CD4(+) helper T cells and their proliferation, in addition to the induction of immunoglobulin hyper-mutation. Methods: Therefore, we analyzed the relationship between persistent infection of HCV and the mechanism of Th17 cell induction ex vivo and in vitro. Results: The prevalence of autoimmune-related diseases in chronic hepatitis c patients (CH-C) was significantly higher than in other types of chronic hepatitis (hepatitis B and NASH). A significantly higher frequency of IL6 and TGF-beta double-high patients was detected in CH-C than in other liver diseases. Moreover, these double-high patients had significantly higher positivity of anti-nuclear antibody, cryoglobulinemia, and lymphotropic HCV and higher amounts of IL1-beta, IL21, IL23. In addition to the previously reported lymphotropic SB-HCV strain, we found a novel, genotype 1b lymphotropic HCV (Ly-HCV), by deep sequencing analysis. Lymphotropic-HCV replication could be detected in the lymphoid cells with various kinds of cytokine-conditions including IL1 beta, IL23, IL6 and TGF-beta in vitro. Infection by HCV could significantly enhance the development of Th17 cells. The HCV protein responsible for inducing the Th17 cells was HCV-Core protein, which could enhance the STAT-3 signaling and up-regulate the expression of ROR gamma t as a Th17 master gene. Conclusion: Infection by lymphotropic HCV might enhance the Th17 development and contribute to understanding the pathogenesis of autoimmune-related diseases.	[Kondo, Yasuteru; Ninomiya, Masashi; Kimura, Osamu; Kobayashi, Koju; Kakazu, Eiji; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Machida, Keigo; Lai, Michael M. C.] Univ So Calif, Keck Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90033 USA; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Cell Proliferat, Sendai, Miyagi 980, Japan; [Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo, Japan; [Lai, Michael M. C.] China Med Univ, Taichung, Taiwan	Tohoku University; University of Southern California; Tohoku University; National Institute of Infectious Diseases (NIID); China Medical University Taiwan	Kondo, Y (corresponding author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan.	yasuteru@ebony.plala.or.jp	Kondo, Yasuteru/A-6893-2010; Wang, Jing/B-2431-2014	Kondo, Yasuteru/0000-0001-5935-4346; Machida, Keigo/0000-0002-9721-8553	Ministry of Education, Culture, Sport, Science, and Technology of Japan [21790642, 23790761, 25460970]; Japan Society of Hepatology; National Institute on Alcohol Abuse and Alcoholism [R01 AA018857]; American Cancer Society [RSG-12-177-01]; Grants-in-Aid for Scientific Research [26670085] Funding Source: KAKEN; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R01AA018857] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of Hepatology; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Cancer Society(American Cancer Society); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by Grant-in Aid from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (Y.K. #21790642, #23790761 and #25460970), Grant from the Japan Society of Hepatology (Y.K), the National Institute on Alcohol Abuse and Alcoholism (K.M. #R01 AA018857) and the American Cancer Society (K. M. #RSG-12-177-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassiouny DA, 2011, CLIN EXP DERMATOL, V36, P292, DOI 10.1111/j.1365-2230.2010.03972.x; Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200; Chen XQ, 2010, J CLIN IMMUNOL, V30, P221, DOI 10.1007/s10875-009-9365-x; Dominguez-Villar M, 2007, J LEUKOCYTE BIOL, V82, P1301, DOI 10.1189/jlb.0507335; Ferri C, 2000, CURR OPIN RHEUMATOL, V12, P53, DOI 10.1097/00002281-200001000-00009; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Horie I, 2011, ENDOCRINOLOGY, V152, P4448, DOI 10.1210/en.2011-1356; Horie I, 2011, AUTOIMMUNITY, V44, P159, DOI 10.3109/08916931003777247; Hu Y, 2003, AM J CLIN PATHOL, V119, P95, DOI 10.1309/33TAJLB748KLMXVG; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Ito M, 2010, J INNATE IMMUN, V2, P607, DOI 10.1159/000317690; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Karavattathayyil SJ, 2000, AM J CLIN PATHOL, V113, P391, DOI 10.1309/REV9-FDTM-5NGC-HBWY; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kondo Y, 2011, HEPATOL RES; Kondo Y, 2013, HEPATOLOGY RES OFFIC; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kondo Yasuteru, 2012, Int J Microbiol, V2012, P647581, DOI 10.1155/2012/647581; Kondo Y, 2011, J GASTROENTEROL, V46, P232, DOI 10.1007/s00535-010-0297-2; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Machida K, 2006, J VIROL, V80, P866, DOI 10.1128/JVI.80.2.866-874.2006; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; MacParland SA, 2006, J GEN VIROL, V87, P3577, DOI 10.1099/vir.0.81868-0; Mariette X, 1999, LEUKEMIA LYMPHOMA, V33, P93, DOI 10.3109/10428199909093729; Mizukawa Y, 2000, J DERMATOL SCI, V22, P169, DOI 10.1016/S0923-1811(99)00083-3; Negro F, 1999, HEPATOLOGY, V29, P536, DOI 10.1002/hep.510290223; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Pan HF, 2012, MOL BIOL REP; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; Shiokawa M, 2010, BIOCHEM BIOPH RES CO, V399, P733, DOI 10.1016/j.bbrc.2010.07.145; Simula MP, 2007, ANN NY ACAD SCI, V1110, P121, DOI 10.1196/annals.1423.014; Stump KL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3329; Sung VMH, 2003, J VIROL, V77, P2134, DOI 10.1128/JVI.77.3.2134-2146.2003; TAKEUCHI K, 1990, NUCLEIC ACIDS RES, V18, P4626, DOI 10.1093/nar/18.15.4626; Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009; Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528; Yu CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029742; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018909; Zhou JH, 2009, J SURG RES, V157, P63, DOI 10.1016/j.jss.2008.08.027	41	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98521	10.1371/journal.pone.0098521	http://dx.doi.org/10.1371/journal.pone.0098521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905921	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000036
J	Qu, XK; Fang, WY; Gong, KZ; Ye, JD; Guan, SF; Li, RG; Xu, YJ; Shen, Y; Zhang, M; Liu, H; Xie, WH				Qu, Xinkai; Fang, Weiyi; Gong, Kaizheng; Ye, Jianding; Guan, Shaofeng; Li, Ruogu; Xu, Yingjia; Shen, Yan; Zhang, Min; Liu, Hua; Xie, Wenhui			Clinical Significance of A Single Multi-Slice CT Assessment in Patients with Coronary Chronic Total Occlusion Lesions Prior to Revascularization	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; MULTIDETECTOR COMPUTED-TOMOGRAPHY; MYOCARDIAL-INFARCTION; INTERVENTION; PERFUSION; RECANALIZATION; ANGIOGRAPHY; VIABILITY; OUTCOMES	Accurate assessment of coronary chronic total occlusion (CTO) lesion is essential to design an appropriate procedural strategy before revascularization. The present study aims to evaluate the significance of a single multislice computed tomography (MSCT) examination in patients with CTO lesion. We retrospectively analyzed the clinical data of 23 CTO lesions in twenty patients underwent computed tomography coronary angiography (CTCA) and SPECT. The CTCA was more powerful and sensitive to determine the CTO lesion length (100% v.s 47.8%) and to identify the length and location of calcification in occluded vessels compared with the coronary angiography (CAG). The LVEF measured by MSCT was comparable to that from the gated SPECT. Myocardial perfusion imaging showed that the location of the early defect region identified by MSCT was corresponded to the nuclide filling defect on the stressed (201)thallium-SPECT imaging. The late hyperenhancement on MSCT was presented as incomplete nuclide filling on the Tc-99m-MIBI imaging. The results suggested that a single MSCT examination in previous myocardial infarction without revascularization facilitates to provide some valuable information on the nature of the occluded lesion, myocardial perfusion and globe cardiac function, which would be helpful to design appropriate revascularization strategy in these subjects.	[Qu, Xinkai; Fang, Weiyi; Guan, Shaofeng; Li, Ruogu; Xu, Yingjia; Zhang, Min; Liu, Hua] Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Chest Hosp, Shanghai 200030, Peoples R China; [Gong, Kaizheng] Yangzhou Univ, Dept Cardiol, Clin Med Sch 2, Yangzhou, Jiangsu, Peoples R China; [Ye, Jianding; Shen, Yan] Shanghai Jiao Tong Univ, Dept Radiol, Shanghai Chest Hosp, Shanghai 200030, Peoples R China; [Xie, Wenhui] Shanghai Jiao Tong Univ, Dept Nucl Med, Shanghai Chest Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Yangzhou University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fang, WY (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Chest Hosp, Shanghai 200030, Peoples R China.	fwychest@163.com	韶峰, 关/GVS-2411-2022		Scientific Research Program of Shanghai Municipal Health Bureau [2010091]	Scientific Research Program of Shanghai Municipal Health Bureau	This study was partly supported Scientific Research Program of Shanghai Municipal Health Bureau (No. 2010091). The grant was 5000 dollars. And the funder's website is http://www.smhb.gov.cn/wsj/. The funders had no role in study design, data colloction and analysis, decision to publish, or preparation of the manuscript.	Choi JH, 2011, CIRC J, V75, P366, DOI 10.1253/circj.CJ-09-0940; Claessen BEPM, 2009, JACC-CARDIOVASC INTE, V2, P1128, DOI 10.1016/j.jcin.2009.08.024; Cury RC, 2008, RADIOLOGY, V248, P466, DOI 10.1148/radiol.2482071478; de Graaf FR, 2010, HEART LUNG CIRC, V19, P107, DOI 10.1016/j.hlc.2009.11.004; Ehara M, 2009, J INVASIVE CARDIOL, V21, P575; Francone M, 2006, EUR RADIOL, V16, P15, DOI 10.1007/s00330-005-2800-3; Gaemperli O, 2011, EUR HEART J, V32, P2100, DOI 10.1093/eurheartj/ehr057; Galassi AR, 2011, EUROINTERVENTION, V7, P472, DOI 10.4244/EIJV7I4A77; Grantham JA, 2010, CIRC-CARDIOVASC QUAL, V3, P284, DOI 10.1161/CIRCOUTCOMES.108.825760; Henneman MM, 2006, HEART, V92, P1779, DOI 10.1136/hrt.2006.087874; Henneman MM, 2008, AM J CARDIOL, V101, P144, DOI 10.1016/j.amjcard.2007.07.084; Hsu JT, 2011, INT J CARDIOL, V150, P135, DOI 10.1016/j.ijcard.2010.03.002; Kirschbaum SW, 2011, CIRC J, V75, P1678, DOI 10.1253/circj.CJ-10-1154; Lardo AC, 2006, CIRCULATION, V113, P394, DOI 10.1161/CIRCULATIONAHA.105.521450; Liew GYH, 2011, HEART LUNG CIRC, V20, P425, DOI 10.1016/j.hlc.2010.12.008; Maffei E, 2011, EUR RADIOL, V21, P944, DOI 10.1007/s00330-010-1996-z; Park HJ, 2012, CIRC J, V76, P868, DOI 10.1253/circj.CJ-11-1021; Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040; Schuleri KH, 2009, J AM COLL CARDIOL, V53, P1699, DOI 10.1016/j.jacc.2009.01.056; Soon Kean H, 2007, J Interv Cardiol, V20, P359, DOI 10.1111/j.1540-8183.2007.00275.x; Takimura H, 2012, J INVASIVE CARDIOL, V24, pE5; Toriyama T, 2007, EUR J CLIN INVEST, V37, P478, DOI 10.1111/j.1365-2362.2007.01815.x; van der Hoeven BL, 2012, NAT REV CARDIOL, V9, P333, DOI 10.1038/nrcardio.2012.14; Wu KC, 2003, CIRC RES, V93, P1146, DOI 10.1161/01.RES.0000103863.40055.E8; Yamaguchi Koji, 2007, J Med Invest, V54, P72, DOI 10.2152/jmi.54.72; Yamane M, 2012, REV ESP CARDIOL, V65, P265, DOI [10.1016/j.rec.2011.12.001, 10.1016/j.recesp.2011.10.026]	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98242	10.1371/journal.pone.0098242	http://dx.doi.org/10.1371/journal.pone.0098242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905494	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000022
J	Ruiz-Sanchez, E; Specht, CD				Ruiz-Sanchez, Eduardo; Specht, Chelsea D.			Ecological Speciation in Nolina parviflora (Asparagaceae): Lacking Spatial Connectivity along of the Trans-Mexican Volcanic Belt	PLOS ONE			English	Article							NICHE CONSERVATISM; LATITUDINAL VARIATION; GENE FLOW; CLIMATE; DIVERSIFICATION; MECHANISMS; SOFTWARE; HISTORY; MAXIMUM; MODELS	The hypothesis of ecological speciation states that as populations diverge in different niches, reproductive isolation evolves as a by-product of adaptation to these different environments. In this context, we used Nolina parviflora as a model to test if this species evolved via ecological speciation and to explore current and historical gene flow among its populations. Nolina parviflora is a montane species endemic to Mexico with its geographical distribution restricted largely to the Trans-Mexican Volcanic Belt. This mountain range is one of the most complex geological regions in Mexico, having undergone volcanism from the mid-Miocene to the present. Ecologically, the Trans-Mexican Volcanic Belt possesses different types of vegetation, including tropical dry forest; oak, pine, pine-oak, and pine-juniper forests; and xerophytic scrub - all of which maintain populations of N. parviflora. Using species distribution models, climatic analyses, spatial connectivity and morphological comparisons, we found significant differences in climatic and morphological variables between populations of N. parviflora in two distinct Trans-Mexican Volcanic Belt regions (east vs. west). This could mean that the geographically isolated populations diverged from one another via niche divergence, indicating ecological speciation. Spatial connectivity analysis revealed no connectivity between these regions under the present or last glacial maximum climate models, indicating a lack of gene flow between the populations of the two regions. The results imply that these populations may encompass more than a single species.	[Ruiz-Sanchez, Eduardo] Inst Ecol AC, Ctr Reg Bajio, Red Biodiversidad & Sistemat, Patzcuaro, Michoacan, Mexico; [Specht, Chelsea D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Specht, Chelsea D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Specht, Chelsea D.] Univ Calif Berkeley, Univ & Jepson Herbaria, Berkeley, CA 94720 USA	Instituto de Ecologia - Mexico; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ruiz-Sanchez, E (corresponding author), Inst Ecol AC, Ctr Reg Bajio, Red Biodiversidad & Sistemat, Patzcuaro, Michoacan, Mexico.	eduardo.ruiz@inecol.mx	Ruiz-Sanchez, Eduardo/P-3539-2019; Ruiz-Sanchez, Eduardo/L-8073-2013	Ruiz-Sanchez, Eduardo/0000-0002-7981-4490; Ruiz-Sanchez, Eduardo/0000-0002-7981-4490; Specht, Chelsea/0000-0001-7746-512X	UC Berkeley College of Natural Resources; University and Jepson Herbaria; UC-MEXUS; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	UC Berkeley College of Natural Resources; University and Jepson Herbaria; UC-MEXUS; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research funding was provided by UC Berkeley College of Natural Resources and the University and Jepson Herbaria. ERS was supported by a joint UC-MEXUS, Consejo Nacional de Ciencia y Tecnologia (CONACyT) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo DF, 2012, EVOL ECOL, V26, P991, DOI 10.1007/s10682-011-9528-0; [Anonymous], 2010, R LANG ENV STAT COMP; Avise J.C., 2000, PHYLOGEOGRAPHY; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Bryson RW, 2012, BIOL J LINN SOC, V105, P382, DOI 10.1111/j.1095-8312.2011.01798.x; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Correa-Metrio A, 2012, J QUATERNARY SCI, V27, P509, DOI 10.1002/jqs.2540; Correa-Metrio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081958; Coyne JA, 2004, SPECIATION; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrari L, 2012, TECTONOPHYSICS, V522, P122, DOI 10.1016/j.tecto.2011.09.018; Ferval M, 2013, S AFR J BOT; Ferval M, 2013, TURK J BOT, V37, P789, DOI 10.3906/bot-1209-51; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gomez-Tuena A, 2007, GEOL SOC AM SPEC PAP, V422, P129, DOI 10.1130/2007.2422(05); Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Hasumi H., 2004, K 1 COUPLED GCM MICR; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hua X, 2010, EVOLUTION, V64, P429, DOI 10.1111/j.1558-5646.2009.00836.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lomolino MV, 2006, BIOGEOGRAPHY; MANTEL N, 1967, CANCER RES, V27, P209; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Parra-Olea G, 2012, J BIOGEOGR, V39, P353, DOI 10.1111/j.1365-2699.2011.02593.x; Peterson AT, 2007, ECOL MODEL, V203, P527, DOI 10.1016/j.ecolmodel.2006.12.023; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Rousset F, 1997, GENETICS, V145, P1219; Ruiz-Sanchez E, 2012, ORG DIVERS EVOL, V26, P991; Ruiz-Sanchez E, 2014, ECOL EVOL, V4, P311, DOI 10.1002/ece3.938; Ruiz-Sanchez E, 2013, J BIOGEOGR, V40, P1336, DOI 10.1111/jbi.12073; *STATACORP, 2003, STAT STAT SOFTW; Svensson EI, 2012, ORG DIVERS EVOL, V12, P229, DOI 10.1007/s13127-012-0082-6; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Velo-Anton G, 2013, MOL ECOL, V22, P3261, DOI 10.1111/mec.12310; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	55	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98754	10.1371/journal.pone.0098754	http://dx.doi.org/10.1371/journal.pone.0098754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905911	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000058
J	Chen, X; Chen, J; Liu, XJ; Guo, ZH; Sun, XX; Zhang, J				Chen, Xue; Chen, Jing; Liu, Xinjuan; Guo, Zihao; Sun, Xiaoxin; Zhang, Jie			The Real-Time Dynamic Monitoring of microRNA Function in Cholangiocarcinoma	PLOS ONE			English	Article							CANCER; CELL; METASTASIS; INVASION; PROGRESS; NETWORK; PATHWAY; MIR-221; BREAST; GROWTH	Background: Although many studies have confirmed a relationship between microRNAs (miRNAs) and cholangiocarcinoma (CCA), the real-time dynamics of miRNA function have not been examined. Methods: miRNA reporter constructs were generated using a recombinant adeno-associated virus vector, which contained complementary sequences for six miRNAs (miR-200a, miR-200b, miR-21, miR-146a, miR-155, and miR-221), along with two independent expression cassettes encoding the fluorescent reporter genes Fluc and Gluc. The spatio-temporal function of each miRNA was monitored both in CCA and control tissues. Results: All miRNAs participated in CCA development, with distinct patterns of expression over time. The activity of miR-21 was significantly lower in female T3N0M0 CCA tissue relative to controls at three time points, yet was higher in two male T3N1M0 CCA tissues. The difference in miR-200b function between two male T3N1M0 CCA tissues and their corresponding controls peaked at 24 h, while function in a female T3N0M0 CCA was detected only at 72 h. The four remaining miRNAs (miR-200a, miR-146a, miR-155, and miR-221) displayed patient-specific activity patterns in both CCA and control tissues. Conclusion: Significant variability was observed in the temporal function of all six miRNAs, which may play an important role in the development of CCA.	[Chen, Xue; Sun, Xiaoxin; Zhang, Jie] Capital Med Univ, Beijing An Zhen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Chen, Jing] Capital Med Univ, Beijing Tong Ren Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Liu, Xinjuan; Guo, Zihao] Capital Med Univ, Beijing Chao Yang Hosp, Dept Gastroenterol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Zhang, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangjie4155@sina.com		Chen, Xue/0000-0002-8798-1790	Basic and Clinical Cooperation Foundation of Capital Medical University (China) [13JL77]	Basic and Clinical Cooperation Foundation of Capital Medical University (China)	This work was supported by the Basic and Clinical Cooperation Foundation of Capital Medical University No. 13JL77 (China). The funders had a role in the study design, experimental implementation, data collection, and decision to publish.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Chan KYK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028798; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066315; Chusorn P, 2013, TUMOR BIOL, V34, P1579, DOI 10.1007/s13277-013-0688-0; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Dong XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013479; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hinck L, 2014, CURR OPIN CELL BIOL, V26, P87, DOI 10.1016/j.ceb.2013.11.003; Huang K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-252; Huang Q, 2013, ASIAN PAC J CANCER P, V14, P829, DOI 10.7314/APJCP.2013.14.2.829; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Li L, 2014, HEPATOLOGY IN PRESS; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miska EA, 2008, NAT CELL BIOL, V10, P501, DOI 10.1038/ncb0508-501; NCCN, 2013, NCCN TNM HEP CANC 20; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Olaru AV, 2011, HEPATOLOGY, V54, P2089, DOI 10.1002/hep.24591; Peng F, 2013, BRIT J CANCER, V109, P3092, DOI 10.1038/bjc.2013.655; Razumilava N, 2014, LANCET IN PRESS; Ruvkun G, 2006, SCIENCE, V311, P36; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tian WH, 2013, METHODS MOL BIOL, V1039, P261, DOI 10.1007/978-1-62703-535-4_21; Tian WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029551; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	37	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99431	10.1371/journal.pone.0099431	http://dx.doi.org/10.1371/journal.pone.0099431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918778	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000085
J	Gupta, MR; Kolli, D; Molteni, C; Casola, A; Garofalo, RP				Gupta, Meera R.; Kolli, Deepthi; Molteni, Claudio; Casola, Antonella; Garofalo, Roberto P.			Paramyxovirus Infection Regulates T Cell Responses by BDCA-1(+) and BDCA-3(+) Myeloid Dendritic Cells	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMPORTANT RISK-FACTOR; NF-KAPPA-B; IMMUNE-RESPONSE; DIFFERENTIAL RESPONSE; RSV BRONCHIOLITIS; INTERFERON-ALPHA; CUTTING EDGE; ASTHMA	Respiratory syncytial virus (RSV) and human Metapneumovirus (hMPV), viruses belonging to the family Paramyxoviridae, are the most important causes of lower respiratory tract infection in young children. Infections with RSV and hMPV are clinically indistinguishable, and both RSV and hMPV infection have been associated with aberrant adaptive immune responses. Myeloid Dendritic cells (mDCs) play a pivotal role in shaping adaptive immune responses during infection; however, few studies have examined how interactions of RSV and hMPV with individual mDC subsets (BDCA-1(+) and BDCA-3(+) mDCs) affect the outcome of anti-viral responses. To determine whether RSV and hMPV induce virus-specific responses from each subset, we examined co-stimulatory molecules and cytokines expressed by BDCA-1(+) and BDCA-3(+) mDCs isolated from peripheral blood after infection with hMPV and RSV, and examined their ability to stimulate T cell proliferation and differentiation. Our data show that RSV and hMPV induce virus-specific and subset-specific patterns of co-stimulatory molecule and cytokine expression. RSV, but not hMPV, impaired the capacity of infected mDCs to stimulate T cell proliferation. Whereas hMPV-infected BDCA-1(+) and BDCA-3(+) mDCs induced expansion of Th17 cells, in response to RSV, BDCA-1+ mDCs induced expansion of Th1 cells and BDCA-3(+) mDCs induced expansion of Th2 cells and Tregs. These results demonstrate a virusspecific and subset-specific effect of RSV and hMPV infection on mDC function, suggesting that these viruses may induce different adaptive immune responses.	[Gupta, Meera R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Gupta, Meera R.; Kolli, Deepthi; Casola, Antonella; Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Kolli, Deepthi; Casola, Antonella; Garofalo, Roberto P.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Casola, Antonella; Garofalo, Roberto P.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Molteni, Claudio] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Gupta, MR (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	megupta@utmb.edu	Garofalo, Roberto P./ABL-2322-2022; Garofalo, Roberto P./AAF-7385-2022		National Center for Research Resources [UL1RR029876]; National Institutes of Health [NO1-HV-00245]; Universita degli Studi di Milano, Italy;  [KL2RR029875];  [AI062885];  [AI07924602]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029875, UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885, R01AI079246] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universita degli Studi di Milano, Italy; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project described was supported by award number KL2RR029875 (to Meera Gupta) and UL1RR029876 (to Allan Brasier) from the National Center for Research Resources and by award number AI062885 (to Roberto Garofalo/Allan Brasier) and AI07924602 (to Antonella Casola) and NO1-HV-00245 (to Alexander Kurosky/Roberto Garofalo) from the National Institutes of Health. Claudio Molteni was supported by a fellowship from Universita degli Studi di Milano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2005, J VIROL, V79, P5971, DOI 10.1128/JVI.79.10.5971-5978.2005; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bacher N, 2013, CANCER RES; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; Barnaba V, 2013, EUR J IMMUNOL, V43, P318, DOI 10.1002/eji.201243265; Benwell RK, 2010, CELL IMMUNOL, V264, P119, DOI 10.1016/j.cellimm.2010.05.008; Borderia AV, 2008, J IMMUNOL, V181, P6872, DOI 10.4049/jimmunol.181.10.6872; Braciale Thomas J, 2005, Proc Am Thorac Soc, V2, P141, DOI 10.1513/pats.200503-022AW; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; de Bree GJ, 2007, J INFECT DIS, V195, P1718, DOI 10.1086/517612; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Demedts IK, 2006, AM J RESP CELL MOL, V35, P387, DOI 10.1165/rcmb.2005-0382OC; Douville RN, 2006, J IMMUNOL, V176, P5848, DOI 10.4049/jimmunol.176.10.5848; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Garcia-Garcia ML, 2007, PEDIATR PULM, V42, P458, DOI 10.1002/ppul.20597; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Guerrero-Plata A, 2009, J IMMUNOL, V182, P3072, DOI 10.4049/jimmunol.0802262; Gupta MR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-71; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hayashi Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-29; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Johnson TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016458; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jyonouchi H, 2010, EUR J PEDIATR, V169, P1233, DOI 10.1007/s00431-010-1210-y; Kassianos AJ, 2012, EUR J IMMUNOL, V42, P1512, DOI 10.1002/eji.201142098; Kayserova J, 2012, SCAND J IMMUNOL, V75, P305, DOI 10.1111/j.1365-3083.2011.02649.x; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Larranaga CL, 2009, PEDIATR INFECT DIS J, V28, P867, DOI 10.1097/INF.0b013e3181a3ea71; Le Nouen C, 2009, VIROLOGY, V385, P169, DOI 10.1016/j.virol.2008.11.043; Le Nouen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015017; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Murtaza A, 1999, INT IMMUNOL, V11, P407, DOI 10.1093/intimm/11.3.407; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Ren JP, 2011, J GEN VIROL, V92, P2153, DOI 10.1099/vir.0.032987-0; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Rogge L, 1998, J IMMUNOL, V161, P6567; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Spears M, 2011, CLIN EXPT ALLERGY J, P1; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Sung RYT, 2001, EUR J PEDIATR, V160, P117, DOI 10.1007/s004310000676; Tan MC, 2007, VIROLOGY, V357, P1, DOI 10.1016/j.virol.2006.08.004; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410-1384SO; Williams JV, 2005, J INFECT DIS, V192, P1149, DOI 10.1086/444392; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wissinger EL, 2008, J IMMUNOL, V180, P2957, DOI 10.4049/jimmunol.180.5.2957; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zhao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046241; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778	84	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99227	10.1371/journal.pone.0099227	http://dx.doi.org/10.1371/journal.pone.0099227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918929	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000062
J	Mallon, JC; Anderson, JS				Mallon, Jordan C.; Anderson, Jason S.			The Functional and Palaeoecological Implications of Tooth Morphology and Wear for the Megaherbivorous Dinosaurs from the Dinosaur Park Formation (Upper Campanian) of Alberta, Canada	PLOS ONE			English	Article							JUDITH RIVER FORMATION; DENTAL MICROWEAR; PROVINCIAL-PARK; JAW MECHANICS; BRACHYLOPHOSAURUS-CANADENSIS; ORNITHISCHIA ANKYLOSAURIA; QUANTITATIVE-ANALYSIS; INTRACRANIAL JOINTS; FEEDING MECHANISMS; EVOLUTION	Megaherbivorous dinosaurs were exceptionally diverse on the Late Cretaceous island continent of Laramidia, and a growing body of evidence suggests that this diversity was facilitated by dietary niche partitioning. We test this hypothesis using the fossil megaherbivore assemblage from the Dinosaur Park Formation (upper Campanian) of Alberta as a model. Comparative tooth morphology and wear, including the first use of quantitative dental microwear analysis in the context of Cretaceous palaeosynecology, are used to infer the mechanical properties of the foods these dinosaurs consumed. The phylliform teeth of ankylosaurs were poorly adapted for habitually processing high-fibre plant matter. Nevertheless, ankylosaur diets were likely more varied than traditionally assumed: the relatively large, bladed teeth of nodosaurids would have been better adapted to processing a tougher, more fibrous diet than the smaller, cusp-like teeth of ankylosaurids. Ankylosaur microwear is characterized by a preponderance of pits and scratches, akin to modern mixed feeders, but offers no support for interspecific dietary differences. The shearing tooth batteries of ceratopsids are much better adapted to high-fibre herbivory, attested by their scratch-dominated microwear signature. There is tentative microwear evidence to suggest differences in the feeding habits of centrosaurines and chasmosaurines, but statistical support is not significant. The tooth batteries of hadrosaurids were capable of both shearing and crushing functions, suggestive of a broad dietary range. Their microwear signal overlaps broadly with that of ankylosaurs, and suggests possible dietary differences between hadrosaurines and lambeosaurines. Tooth wear evidence further indicates that all forms considered here exhibited some degree of masticatory propaliny. Our findings reveal that tooth morphology and wear exhibit different, but complimentary, dietary signals that combine to support the hypothesis of dietary niche partitioning. The inferred mechanical and dietary patterns appear constant over the 1.5 Myr timespan of the Dinosaur Park Formation megaherbivore chronofauna, despite continual species turnover.	[Mallon, Jordan C.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Mallon, JC (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.	jmallon@mus-nature.ca		Mallon, Jordan/0000-0002-8209-8827	NSERC Alexander Graham Bell Canada Graduate Scholarship; Alberta Innovates Technology Futures graduate student scholarship; Queen Elizabeth II Graduate Scholarship; Jurassic Foundation grant; NSERC Discovery grant	NSERC Alexander Graham Bell Canada Graduate Scholarship; Alberta Innovates Technology Futures graduate student scholarship; Queen Elizabeth II Graduate Scholarship; Jurassic Foundation grant; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding to JCM was provided by an NSERC Alexander Graham Bell Canada Graduate Scholarship, Alberta Innovates Technology Futures graduate student scholarship, Queen Elizabeth II Graduate Scholarship, and Jurassic Foundation grant. Funding to JSA was provided by an NSERC Discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1922, PALAEONTOL Z, V4, P87; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ager Derek V, 1963, PRINCIPLES PALEOECOL; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Archer D, 2002, J ZOOL, V257, P13, DOI 10.1017/S0952836902000614; ARCHIBALD JD, 1996, DINOSAUR EXTINCTION, P237; BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barrett PM, 2001, LIFE O PAST, P25; Barrett PM, 1998, THESIS U CAMBRIDGE C; Behrensmeyer Anna K., 1992, P15; BELAND P, 1978, CAN J EARTH SCI, V15, P1012, DOI 10.1139/e78-109; Brinkman DB, 1998, PALAIOS, V13, P160, DOI 10.2307/3515487; BRINKMAN DB, 1990, PALAEOGEOGR PALAEOCL, V78, P37, DOI 10.1016/0031-0182(90)90203-J; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Calvo Jorge O., 1994, Gaia, V10, P183; Carpenter K., 1990, P281, DOI 10.1017/CBO9780511608377.024; Carpenter Kenneth, 1997, P307; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Coe M.J., 1987, P225; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; Coombs W.P. Jr, 1990, P269, DOI 10.1017/CBO9780511608377.023; COSTA RL, 1981, J PALEONTOL, V55, P635; CROMPTON A W, 1970, Zoological Journal of the Linnean Society, V49, P21, DOI 10.1111/j.1096-3642.1970.tb00728.x; Currie Philip J., 1995, P111; Currie PJ, 1984, 3 S MES TERR EC, P52; Cuthbertson RS, 2012, ANAT REC, V295, P968, DOI 10.1002/ar.22458; Dodson P., 1983, Mosasaur, V1, P89; DODSON P, 1971, PALAEOGEOGR PALAEOCL, V10, P21, DOI 10.1016/0031-0182(71)90044-7; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; Dodson P., 1996, HORNED DINOSAURS NAT; Dodson P, 1997, ENCY DINOSAURS, P473; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dodson Peter, 1997, P393; EBERTH DA, 2001, GUIDEBOOK FIELD TRIP, P49; Eberth David A., 2010, P495; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Fiorillo A.R., 2011, PALAEONTOL ELECTRON, V14, P7; Fiorillo A. R, 1991, 5 S MES TERR ECOS BI, P23; Fiorillo Anthony R., 2008, P104; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Fraser D, 2011, J MORPHOL, V272, P1513, DOI 10.1002/jmor.11001; Fraser D, 2009, PALAIOS, V24, P818, DOI 10.2110/palo.2009.p09-064r; Freeman PW, 2000, EVOL ECOL RES, V2, P317; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Fujiwara S, 2009, J VERTEBR PALEONTOL, V29, P1136, DOI 10.1671/039.029.0406; Funston GF, 2014, CAN J EARTH SCI, V51, P156, DOI 10.1139/cjes-2013-0186; Galton P.M., 1986, P203; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; GORDON KD, 1984, AM J PHYS ANTHROPOL, V63, P77, DOI 10.1002/ajpa.1330630110; GORDON KD, 1984, J DENT RES, V63, P1043, DOI 10.1177/00220345840630080601; GORDON KD, 1984, ARCH ORAL BIOL, V29, P783, DOI 10.1016/0003-9969(84)90007-4; GORDON KD, 1982, AM J PHYS ANTHROPOL, V59, P195, DOI 10.1002/ajpa.1330590208; GORNIAK GC, 1982, J MORPHOL, V171, P321, DOI 10.1002/jmor.1051710307; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; GREAVES W S, 1974, Forma et Functio, V7, P363; GREAVES WS, 1978, J ZOOL, V184, P271, DOI 10.1111/j.1469-7998.1978.tb03282.x; GREAVES WS, 1980, AM NAT, V116, P432, DOI 10.1086/283636; GREAVES WS, 1973, J PALEONTOL, V47, P1000; Green JL, 2009, ZOOL J LINN SOC-LOND, V156, P201, DOI 10.1111/j.1096-3642.2008.00486.x; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Haas G., 1969, American Museum Novitates, VNo. 2399, P1; HAAS GEORG, 1955, AMER MUS NOVITATES, V1729, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hiiemae K.M., 1985, P262; Hiiemae KM, 1976, MASTICATION, P105; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hunt Rebecca K., 2010, P447; Hwang SH, 2005, J MORPHOL, V266, P208, DOI 10.1002/jmor.10372; JANIS C M, 1990, Memoirs of the Queensland Museum, V28, P349; JANIS CM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P76; Jernvall J., 2000, P269, DOI 10.1017/CBO9780511542626.019; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kaiser TM, 2010, J ZOOL, V281, P12, DOI 10.1111/j.1469-7998.2009.00674.x; Kay R.F., 1978, P173; Kay R.F., 1978, P309; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; King G.M., 1996, REPTILES HERBIVORY; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Kraeusel R., 1922, Palaeontologische Zeitschrift, V4, P80; KRASSILOV VA, 1981, PALAEOGEOGR PALAEOCL, V34, P207, DOI 10.1016/0031-0182(81)90065-1; Lambe L.M., 1920, GEOLOGICAL SURVEY CA, V120, P1, DOI [DOI 10.4095/101655, 10.4095/101655]; Lamprey H. F., 1963, East African Wildlife Journal, V1, P63; Landman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069771; Lehman T. M., 1997, DINOFEST INT, P223; Lehman Thomas M., 2001, P310; Losos Jonathan B., 1994, P60; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P.W., 2000, P282, DOI 10.1017/CBO9780511542626.020; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; LUCAS PW, 1995, PHILOS T R SOC B, V348, P363, DOI 10.1098/rstb.1995.0074; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Lull RS, 1908, AM J SCI, V25, P387; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mallon JC, J VERT PALE IN PRESS; Mallon JC, 2014, PALAEOGEOGR PALAEOCL, V394, P29, DOI 10.1016/j.palaeo.2013.11.014; Mallon JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067182; Mallon JC, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-14; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Manchester SR, 2010, INT J PLANT SCI, V171, P679, DOI 10.1086/653688; MCNAUGHTON SJ, 1986, ANNU REV ECOL SYST, V17, P39, DOI 10.1146/annurev.es.17.110186.000351; Merceron G, 2006, NATURWISSENSCHAFTEN, V93, P329, DOI 10.1007/s00114-006-0107-0; MILLS JRE, 1972, P ROY SOC MED, V65, P392, DOI 10.1177/003591577206500440; Morris W. J., 1970, Contr. Sci., VNo. 193, P1; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nopcsa F, 1900, DINOSAURIERRESTE SIE, V68, P555; Nopcsa F., 1928, GEOLOGICA HUNGARIA S, V1, P3; Norman D.B., 1984, Symposia of the Zoological Society of London, P521; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; OLSON EC, 1952, EVOLUTION, V6, P181, DOI 10.2307/2405622; OSTROM JH, 1966, EVOLUTION, V20, P290, DOI 10.1111/j.1558-5646.1966.tb03367.x; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P39; OSTROM JOHN H., 1964, POSTILLA [YALE PEABODY MUS], V88, P1; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Peng J-H, 2001, PROV MUS ALBERTA NAT, V25, P1, DOI DOI 10.5962/BHL.TITLE.115853; Penkalski P, 2013, CAN J EARTH SCI, V50, P171, DOI 10.1139/cjes-2012-0098; PREGILL G, 1984, J HERPETOL, V18, P186, DOI 10.2307/1563747; Reilly SM, 2001, COMP BIOCHEM PHYS A, V128, P397, DOI 10.1016/S1095-6433(00)00326-3; RENSBERGER JM, 1973, J PALEONTOL, V47, P515; Russell D.A., 1977, Natural Hist ser natn Mus Can, VNo. 4, P1; Russell L. S., 1940, University of Toronto Studies Geological Series, V43, P1; RUSSELL LORIS S., 1935, BULL NAT MUS CANADA, V77, P39; RYAN AS, 1979, AM J PHYS ANTHROPOL, V50, P155, DOI 10.1002/ajpa.1330500204; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Rybczynski N, 2001, LIFE O PAST, P299; Rybczynski N, 2008, PALAEONTOL ELECTRON, V11; Sampson Scott D., 2001, P263; Sampson SD, 1993, THESIS U TORONTO TOR; Sander P. M., 1997, ENCY DINOSAURS, P717; Sander PM., 2010, PLANTS MESOZOIC TIME, P331; Sanson G, 2006, AM J BOT, V93, P1531, DOI 10.3732/ajb.93.10.1531; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SINCLAIR ARE, 1975, J ANIM ECOL, V44, P497, DOI 10.2307/3608; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith J. M., 1959, School Science Review, V40, P289; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Sokal R.R., 2012, BIOMETRY; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Sternberg C. M., 1936, Journal of Paleontology Menasha, V10, P652; STRAIT SG, 1993, J HUM EVOL, V25, P471, DOI 10.1006/jhev.1993.1062; Strait Suzanne G., 1997, Evolutionary Anthropology, V5, P199, DOI 10.1002/(SICI)1520-6505(1997)5:6<199::AID-EVAN2>3.0.CO;2-8; TAIT JOHN, 1928, TRANS ROY SOC CANADA SECT V, V22, P13; Tanoue K, 2009, ANAT REC, V292, P1352, DOI 10.1002/ar.20979; Teaford M. F., 2007, EVOLUTION HOMININ DI, P106; Teaford Mark F., 1994, Evolutionary Anthropology, V3, P17, DOI 10.1002/evan.1360030107; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1167; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Thompson S, 2007, PALAEONTOL ELECTRON, V10; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Turner Derek, 2011, PALEONTOLOGY PHILOS; Tweet JS, 2008, PALAIOS, V23, P624, DOI 10.2110/palo.2007.p07-044r; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Varriale FJ, 2011, THESIS J HOPKINS U B; Varriale F, 2004, J VERTEBR PALEONTOL, V24, p124A; Versluys J., 1923, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V38, P1; Versluys J, 1922, PALAEONTOL Z, V4, P80; Versluys J., 1910, ZOOLOGISCHE JB ABTEI, V30, P175; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; von Kripp D, 1933, PALAEOBIOLOGICA, V5, P409; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; WEISHAMPEL D B, 1983, Acta Palaeontologica Polonica, V28, P271; Weishampel D.B., 1987, Occasional Paper of the Tyrrell Museum of Palaeontology, P167; Weishampel D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V167, P224; Weishampel David B., 2000, P123, DOI 10.1017/CBO9780511549717.006; WEISHAMPEL DB, 1984, ADV ANAT EMBRYOL CEL, V87, P1; Weishampel DB, 1989, GEOL SOC AM SPEC PAP, V238, P87, DOI DOI 10.1130/SPE238-P87; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; You Hailu, 2004, P478	196	48	51	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98605	10.1371/journal.pone.0098605	http://dx.doi.org/10.1371/journal.pone.0098605			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918431	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000023
J	Menghini, R; Campia, U; Tesauro, M; Marino, A; Rovella, V; Rodia, G; Schinzari, F; Tolusso, B; di Daniele, N; Federici, M; Zoli, A; Ferraccioli, G; Cardillo, C				Menghini, Rossella; Campia, Umberto; Tesauro, Manfredi; Marino, Arianna; Rovella, Valentina; Rodia, Giuseppe; Schinzari, Francesca; Tolusso, Barbara; di Daniele, Nicola; Federici, Massimo; Zoli, Angelo; Ferraccioli, Gianfranco; Cardillo, Carmine			Toll-Like Receptor 4 Mediates Endothelial Cell Activation Through NF-kappa B but Is Not Associated with Endothelial Dysfunction in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; REDUCES ATHEROSCLEROSIS; METALLOPROTEINASE 3; AMERICAN-COLLEGE; TISSUE INHIBITOR; APOLIPOPROTEIN-E; INNATE IMMUNITY; TLR4; MICE; DISEASE	Objective: To investigate the effects of TLR4 antagonism on human endothelial cells activation and cytokine expression, and whether the Asp299Gly TLR4 polymorphism is associated with better endothelial function in patients with rheumatoid arthritis (RA). Methods: Human aortic endothelial cells (HAECs) were treated with lipopolysaccharide (LPS), OxPAPC, and free fatty acids (FFA) at baseline and after incubation with the TLR4 antagonist eritoran (E5564). Cytokine expression was assessed by quantitative real-time PCR. In vivo endothelial function was assessed as brachial artery flow-mediated dilation (FMD) in RA patients with the wild type gene (aa) and with the Asp299Gly TLR4 polymorphic variant (ag). Results: In HAEC, TLR4 antagonism with eritoran inhibited LPS-induced mRNA expression of IL-6, IL-8, TNF alpha, CCL-2, VCAM and ICAM (P < 0.05 for all) and inhibited Ox-PAPC-induced mRNA expression of IL-8 (P < 0.05) and IL-6, albeit not to a statistically significant level (p = 0.07). In contrast, eritoran did not affect FFA-induced mRNA expression of IL-6 (P > 0.05). In 30 patients with RA (15 with the ag allele) undergoing measurement of FMD, no differences in FMD and plasma levels of IL6, IL-8, VCAM, and ICAM were found between the aa and the ag phenotype (P > 0.05 for all). Conclusions: TLR4 signaling in endothelial cells may be triggered by LPS and oxidized phospholipids, leading to endothelial activation and inflammation, which are inhibited by eritoran. Our in vivo investigation, however, does not support an association between the Asp299Gly TLR4 polymorphism and improved endothelium-dependent vasodilator function in patients with RA. Further study is needed to better understand the potential role of TLR4 on endothelial dysfunction in this and other patient populations.	[Menghini, Rossella; Tesauro, Manfredi; Marino, Arianna; Rovella, Valentina; Rodia, Giuseppe; di Daniele, Nicola; Federici, Massimo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Campia, Umberto] MedStar Heart Inst, Div Cardiol, Washington, DC 20010 USA; [Schinzari, Francesca; Cardillo, Carmine] Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, Rome, Italy; [Tolusso, Barbara; Zoli, Angelo; Ferraccioli, Gianfranco] Univ Cattolica Sacro Cuore, Sch Med, Dept Rheumatol, Rome, Italy; [Federici, Massimo] Policlin Tor Vergata, Ctr Atherosclerosis, Rome, Italy	University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Policlin Tor Vergata	Campia, U (corresponding author), MedStar Heart Inst, Div Cardiol, Washington, DC 20010 USA.	umberto.campia@medstar.net	schinzari, francesca/AAB-9982-2019; Tolusso, Barbara/K-8995-2018; Federici, Massimo/G-9940-2012; menghini, rossella/I-3485-2012; Rovella, Valentina/AAB-9727-2019	Tolusso, Barbara/0000-0002-9108-6609; Federici, Massimo/0000-0003-4989-5194; menghini, rossella/0000-0001-8397-2355; Rovella, Valentina/0000-0002-3311-486X; Cardillo, Carmine/0000-0001-5182-3005; Ferraccioli, Gianfranco/0000-0002-6884-4301	intramural grant of Tor Vergata University	intramural grant of Tor Vergata University	This work as supported by an intramural grant of Tor Vergata University to Dr. Menghini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barochia A, 2011, EXPERT OPIN DRUG MET, V7, P479, DOI 10.1517/17425255.2011.558190; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Chen L, 1997, J LIPID RES, V38, P546; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Dvoracek LA, 2010, ATHEROSCLEROSIS, V208, P50, DOI 10.1016/j.atherosclerosis.2009.06.013; He M, 2013, ARTERIOSCL THROM VAS, V33, P1384, DOI 10.1161/ATVBAHA.113.301490; Hollan I, 2013, AUTOIMMUNITY REV; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Lu ZY, 2013, J ENDOCRINOL, V216, P61, DOI 10.1530/JOE-12-0338; Lu ZY, 2012, ARTERIOSCL THROM VAS, V32, P1696, DOI 10.1161/ATVBAHA.112.251181; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Murdaca G, 2012, ATHEROSCLEROSIS, V224, P309, DOI 10.1016/j.atherosclerosis.2012.05.013; Netea MG, 2004, EUR J CLIN INVEST, V34, P94, DOI 10.1111/j.1365-2362.2004.01303.x; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Prevoo MLL, 1996, BRIT J RHEUMATOL, V35, P1101; Protogerou AD, 2011, ATHEROSCLEROSIS, V219, P734, DOI 10.1016/j.atherosclerosis.2011.09.015; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Rizza S, 2011, ATHEROSCLEROSIS, V215, P180, DOI 10.1016/j.atherosclerosis.2010.12.021; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sun RJ, 2012, CELL BIOL INT, V36, P475, DOI 10.1042/CBI20110535; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Zhang K, 2012, THROMB RES, V130, pE203, DOI 10.1016/j.thromres.2012.07.008	34	33	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99053	10.1371/journal.pone.0099053	http://dx.doi.org/10.1371/journal.pone.0099053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918924	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000044
J	Yang, Y; Fu, L; Zhang, JL; Hu, LH; Xu, MJ; Xu, J				Yang, Yong; Fu, Ling; Zhang, Jinlong; Hu, Linghan; Xu, Minjuan; Xu, Jun			Characterization of the Xiamenmycin Biosynthesis Gene Cluster in Streptomyces xiamenensis 318	PLOS ONE			English	Article							MEMBRANE-BOUND PRENYLTRANSFERASE; CHORISMATE PYRUVATE-LYASE; CHALCONE-ISOMERASE; ESCHERICHIA-COLI; LITHOSPERMUM-ERYTHRORHIZON; REACTION-MECHANISM; CLONING; 4-HYDROXYBENZOATE; PURIFICATION; ENZYME	Xiamenmycin (1) is a prenylated benzopyran derivative with anti-fibrotic activity. To investigate the genetic basis of xiamenmycin biosynthesis, we performed genome mining in the xiamenmycin-producing Streptomyces xiamenensis wildtype strain 318 to identify a candidate gene cluster. The complete gene cluster, consisting of five genes, was confirmed by a series of gene inactivations and heterologous expression. Based on bioinformatics analyses of each gene and feeding experiments, we found that the structure of an intermediate xiamenmycin B (3) accumulated in a ximA inactivation mutant, allowing us to propose a biosynthetic pathway. All five of the genes in the pathway were genetically and biochemically characterized. XimA was biochemically characterized as an ATP-dependent amide synthetase, catalyzing an amide bond formation in the presence of ATP as the final step in Xiamenmycin biosynthesis. The Km value of XimA was determined to be 474.38 mM for the substrate xiamenmycin B. These studies provide opportunities to use genetic and chemo-enzymatic methods to create new benzopyran derivatives as potential therapeutic agents.	[Yang, Yong; Fu, Ling; Zhang, Jinlong; Hu, Linghan; Xu, Jun] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Yang, Yong; Fu, Ling; Zhang, Jinlong; Hu, Linghan; Xu, Jun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Xu, Minjuan] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Shanghai 200030, Peoples R China; [Xu, Jun] Shanghai Jiao Tong Univ, Inst Oceanol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, MJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Shanghai 200030, Peoples R China.	minjuanxu@sjtu.edu.cn; xujunn@sjtu.edu.cn	zhang, jin/GXV-9154-2022		National Basic Research Program of China "973'' [2012CB721001]; NSFC [81273404]	National Basic Research Program of China "973''(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	The work was supported by the National Basic Research Program of China "973'' 2012CB721001 and NSFC 81273404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; BLACK PN, 1992, J BIOL CHEM, V267, P25513; BOLAND MJ, 1975, EUR J BIOCHEM, V50, P383, DOI 10.1111/j.1432-1033.1975.tb09814.x; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Chen YH, 2010, J BIOL CHEM, V285, P38853, DOI 10.1074/jbc.M110.147744; Gensheimer M, 2004, PROTEIN SCI, V13, P540, DOI 10.1110/ps.03395404; He YL, 2010, J MICROBIOL BIOTECHN, V20, P678, DOI 10.4014/jmb.0910.10031; Holden MJ, 2002, BBA-PROTEIN STRUCT M, V1594, P160, DOI 10.1016/S0167-4838(01)00302-8; Hur S, 2003, J AM CHEM SOC, V125, P1472, DOI 10.1021/ja0293047; Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266; Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200; Kawamura N., 2000, Jpn. Kokai Tokkyo Koho, Patent No. [JP 2000072766 A 20000307, 2000072766]; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; LAWRENCE J, 1974, J BACTERIOL, V118, P41, DOI 10.1128/JB.118.1.41-45.1974; LWaB Sontag, 1996, ANGEW CHEM INT EDIT, V1996, P3; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Muhlenweg A, 1998, PLANTA, V205, P407, DOI 10.1007/s004250050337; Ngaki MN, 2012, NATURE, V485, P530, DOI 10.1038/nature11009; NICHOLS BP, 1992, J BACTERIOL, V174, P5309, DOI 10.1128/JB.174.16.5309-5316.1992; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Peer WA, 2012, NAT CHEM BIOL, V8, P607, DOI 10.1038/nchembio.1006; Ruiz-Pernia JJ, 2007, J AM CHEM SOC, V129, P9117, DOI 10.1021/ja071720+; Sandmann A, 2007, ANGEW CHEM INT EDIT, V46, P2712, DOI 10.1002/anie.200603513; SCHREUDER HA, 1988, J MOL BIOL, V199, P637, DOI 10.1016/0022-2836(88)90307-5; SIEBERT M, 1992, FEBS LETT, V307, P347, DOI 10.1016/0014-5793(92)80710-X; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Smith L, 2008, CHEMBIOCHEM, V9, P2967, DOI 10.1002/cbic.200800585; Sultana A, 2004, EMBO J, V23, P1911, DOI 10.1038/sj.emboj.7600201; WU GH, 1993, J GEN MICROBIOL, V139, P1795, DOI 10.1099/00221287-139-8-1795; Xu J, 2009, INT J SYST EVOL MICR, V59, P472, DOI 10.1099/ijs.0.000497-0; Xu MJ, 2012, MAR DRUGS, V10, P639, DOI 10.3390/md10030639; Yazaki K, 2002, J BIOL CHEM, V277, P6240, DOI 10.1074/jbc.M106387200	36	16	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99537	10.1371/journal.pone.0099537	http://dx.doi.org/10.1371/journal.pone.0099537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919072	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000093
J	Aelterman, J; Naeyaert, M; Gutierrez, S; Luong, H; Goossens, B; Pizurica, A; Philips, W				Aelterman, Jan; Naeyaert, Maarten; Gutierrez, Shandra; Luong, Hiep; Goossens, Bart; Pizurica, Aleksandra; Philips, Wilfried			Automatic High-Bandwidth Calibration and Reconstruction of Arbitrarily Sampled Parallel MRI	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SENSE	Today, many MRI reconstruction techniques exist for undersampled MRI data. Regularization-based techniques inspired by compressed sensing allow for the reconstruction of undersampled data that would lead to an ill-posed reconstruction problem. Parallel imaging enables the reconstruction of MRI images from undersampled multi-coil data that leads to a well-posed reconstruction problem. Autocalibrating pMRI techniques encompass pMRI techniques where no explicit knowledge of the coil sensivities is required. A first purpose of this paper is to derive a novel autocalibration approach for pMRI that allows for the estimation and use of smooth, but high-bandwidth coil profiles instead of a compactly supported kernel. These high-bandwidth models adhere more accurately to the physics of an antenna system. The second purpose of this paper is to demonstrate the feasibility of a parameter-free reconstruction algorithm that combines autocalibrating pMRI and compressed sensing. Therefore, we present several techniques for automatic parameter estimation in MRI reconstruction. Experiments show that a higher reconstruction accuracy can be had using high-bandwidth coil models and that the automatic parameter choices yield an acceptable result.	[Aelterman, Jan; Luong, Hiep; Goossens, Bart; Pizurica, Aleksandra; Philips, Wilfried] Univ Ghent, IPI TELIN IMINDS, B-9000 Ghent, Belgium; [Naeyaert, Maarten] Univ Antwerp, BIO IMAGING Lab, B-2020 Antwerp, Belgium; [Gutierrez, Shandra] Univ Ghent, MEDISIP ELIS IMINDS, B-9000 Ghent, Belgium	Ghent University; IMEC; University of Antwerp; Ghent University; IMEC	Aelterman, J (corresponding author), Univ Ghent, IPI TELIN IMINDS, B-9000 Ghent, Belgium.	jaelterm@telin.ugent.be	Pizurica, Aleksandra/K-6866-2015; Pizurica, Aleksandra/AAG-4687-2021; Luong, Hiep Quang/AAA-7371-2020; Goossens, Bart/H-4772-2018	Pizurica, Aleksandra/0000-0002-9322-4999; Luong, Hiep Quang/0000-0002-6246-5538; Goossens, Bart/0000-0002-1666-5483; Aelterman, Jan/0000-0002-5543-2631	iMinds ICON project SuperMRI; University of Antwerp [BOF 26885 UA 2012]	iMinds ICON project SuperMRI; University of Antwerp	This work was funded by the iMinds ICON project SuperMRI (Speeded-up processing of magnetic resonance images) and a University of Antwerp Interdisciplinary PhD grant (ID) BOF 26885 UA 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelterman J, 2010, IEEE INT C IM PROC I; Aelterman J, 2011, SIGNAL PROCESS, V91, P2731, DOI 10.1016/j.sigpro.2011.04.033; Benedetto JJ, 2000, P SOC PHOTO-OPT INS, V4119, P130, DOI 10.1117/12.408588; Blaimer Martin, 2004, Top Magn Reson Imaging, V15, P223, DOI 10.1097/01.rmr.0000136558.09801.dd; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Buades A., 2005, P 2005 IEEE COMP VIS, VVolume 2, P60, DOI DOI 10.1109/CVPR.2005.38; Chaari L, 2010, MED IMAGE ANAL, V10; Chan RW, 2012, MAGN RESON MED, V67, P363, DOI 10.1002/mrm.23008; Chauffert N, 2013, ISBI 10 INT S BIOM I; Chen C., 2012, P 26 ANN C NEUR INF; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Fernandez-Granda C, 2009, P INT SOC MAG RESON; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Fortune S, 1986, S COMP GEOM; Goossens B, 2009, LNLA: 2009 INTERNATIONAL WORKSHOP ON LOCAL AND NON-LOCAL APPROXIMATION IN IMAGE PROCESSING, P112, DOI 10.1109/LNLA.2009.5278394; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hansen PC, 2001, ADV COMP BIOENG, V5, P119; Krupnik H, 1995, IEEE 18 CONV EE ISR; Larsson EG, 2003, J MAGN RESON, V163, P121, DOI 10.1016/S1090-7807(03)00132-0; Luong H, 2012, 4 INT WORKSH QUAL MU; Lustig M, 2007, TECHNICAL REPORT; Lustig M, 2011, P INT SOC MAG RES ME; Lustig M., 2009, P INT SOC MAGN RESON, V17, P379; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Lustig M, 2010, MAGN RESON MED, V64, P457, DOI 10.1002/mrm.22428; Marr D., 1982, VISION COMPUTATIONAL; Portilla J, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P37, DOI 10.1109/ICIP.2001.958418; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ramani S, 2012, IEEE T IMAGE PROCESS, V21, P3659, DOI 10.1109/TIP.2012.2195015; Roemer PB, 1990, MAGNETIC RESONANCE M, V2, P1522; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Sharif B, 2010, P INT SOC MAG RES ME; Sijbers J, 1998, IEEE T MED IMAGING, V17, P357, DOI 10.1109/42.712125; Sijbers J, 2004, MAGNET RESON MED, V51, P586, DOI 10.1002/mrm.10728; Tanase C, 2006, P ISMRM C SEATTL WAS; Uecker M, 2013, MAGN RESON IN PRESS; Van de Walle R, 2000, IEEE T MED IMAGING, V19, P1160, DOI 10.1109/42.897806; Ying L, 2007, MAGN RESON MED, V57, P1196, DOI 10.1002/mrm.21245	40	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98937	10.1371/journal.pone.0098937	http://dx.doi.org/10.1371/journal.pone.0098937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915203	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700044
J	Caron, V; Ede, FJ; Sunnucks, P				Caron, Valerie; Ede, Fiona J.; Sunnucks, Paul			Unravelling the Paradox of Loss of Genetic Variation during Invasion: Superclones May Explain the Success of a Clonal Invader	PLOS ONE			English	Article							OLIGOSPILUS FORSTER HYMENOPTERA; PARTHENOGENETIC SITOBION APHIDS; ADAPTIVE EVOLUTION; MOLECULAR EVIDENCE; REPRODUCTIVE MODE; RANGE EXPANSION; INSECT PEST; TENTHREDINIDAE; MICROSATELLITE; DISPERSAL	Clonality is a common characteristic of successful invasive species, but general principles underpinning the success of clonal invaders are not established. A number of mechanisms could contribute to invasion success including clones with broad tolerances and preferences, specialist clones and adaptation in situ. The majority of studies to date have been of plants and some invertebrate parthenogens, particularly aphids, and have not necessarily caught invasion at very early stages. Here we describe the early stages of an invasion by a Northern Hemisphere Hymenopteran model in three different land masses in the Southern Hemisphere. Nematus oligospilus Forster (Hymenoptera: Tenthredinidae), a sawfly feeding on willows (Salix spp.), was recently introduced to the Southern Hemisphere where it has become invasive and is strictly parthenogenetic. In this study, the number of N. oligospilus clones, their distribution in the landscape and on different willow hosts in South Africa, New Zealand and Australia were assessed using 25 microsatellite markers. Evidence is presented for the presence of two very common and widespread multilocus genotypes (MLGs) or 'superclones' dominating in the three countries. Rarer MLGs were closely related to the most widespread superclone; it is plausible that all N. oligospilus individuals were derived from a single clone. A few initial introductions to Australia and New Zealand seemed to have occurred. Our results point towards a separate introduction in Western Australia, potentially from South Africa. Rarer clones that were dominant locally putatively arose in situ, and might be locally favoured, or simply have not yet had time to spread. Data presented represent rare baseline data early in the invasion process for insights into the mechanisms that underlie the success of a global invader, and develop Nematus oligospilus as a valuable model to understand invasion genetics of clonal pests.	[Caron, Valerie; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Ede, Fiona J.] Dept Environm & Primary Ind, Biosci Res Div, Bundoora, Vic, Australia	Monash University	Caron, V (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	valerie.caron@monash.edu		Ede, Fiona/0000-0003-4553-7314; Sunnucks, Paul/0000-0002-8139-7059	Holsworth Endowment; Department of Primary Industries Nancy Millis Postgraduate Award; North East Catchment Management Agency; West Gippsland Catchment Management Agency; North Central Catchment Management Agency; Melbourne Water; Victorian Department of Primary Industries Nancy Millis Postgraduate Award	Holsworth Endowment; Department of Primary Industries Nancy Millis Postgraduate Award; North East Catchment Management Agency; West Gippsland Catchment Management Agency; North Central Catchment Management Agency; Melbourne Water; Victorian Department of Primary Industries Nancy Millis Postgraduate Award	This research was funded by Holsworth Endowment, the Department of Primary Industries Nancy Millis Postgraduate Award, North East Catchment Management Agency, West Gippsland Catchment Management Agency, North Central Catchment Management Agency, Melbourne Water and the Victorian Department of Primary Industries Nancy Millis Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2008, AQUAT BOT, V88, P113, DOI 10.1016/j.aquabot.2007.08.015; Benson R. B., 1950, Transactions of the Society for British Entomology, V10, P45; Berry Jocelyn A., 1997, New Zealand Entomologist, V20, P51; Bruzzese E., 2006, Plant Protection Quarterly, V21, P43; Budde KB, 2011, BIOL INVASIONS, V13, P45, DOI 10.1007/s10530-010-9785-9; Caron V, 2013, B ENTOMOL RES, V103, P74, DOI 10.1017/S0007485312000429; Caron V, 2014, AUSTRAL ENTOMOL, V53, P175, DOI 10.1111/aen.12067; Carr G., 1996, FLORA VICTORIA, P385; Carr GW, 2005, PROVISIONAL KEY NATU; Castaneda LE, 2010, J INSECT PHYSIOL, V56, P1058, DOI 10.1016/j.jinsphys.2010.02.019; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Colautti RI, 2005, MOL ECOL, V14, P1869, DOI 10.1111/j.1365-294X.2005.02565.x; Dapoto G., 1994, Bosque, V15, P27; Digweed SC, 2009, CAN ENTOMOL, V141, P201, DOI 10.4039/n09-003; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Figueroa CC, 2005, HEREDITY, V95, P24, DOI 10.1038/sj.hdy.6800662; Figueroa CC, 2004, J CHEM ECOL, V30, P2515, DOI 10.1007/s10886-004-7947-x; Fisher D, 2001, BULLETIN, V4500; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Hoffmann AA, 2008, P ROY SOC B-BIOL SCI, V275, P2473, DOI 10.1098/rspb.2008.0685; Koch F, 2000, P ENTOMOL SOC WASH, V102, P292; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Liston A. D., 1995, COMPENDIUM EUROPEAN; Marrs RA, 2008, BIOL INVASIONS, V10, P561, DOI 10.1007/s10530-007-9153-6; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Naumann ID, 2002, AUST J ENTOMOL, V41, P1, DOI 10.1046/j.1440-6055.2002.00260.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Perez JE, 2006, BIOL INVASIONS, V8, P1115, DOI 10.1007/s10530-005-8281-0; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Shannon C. E., 1949, MATH THEORY COMMUNIC; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Smith D.R, 1979, CATALOG HYMENOPTERA, V1, P3; Spencer R, 1997, HORTICULTURAL FLOR 1; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Sunnucks P, 1996, GENETICS, V144, P747; Sunnucks P, 1998, HEREDITY, V81, P638, DOI 10.1046/j.1365-2540.1998.00444.x; Urban AJ, 1995, AFR ENTOMOL, V3, P23; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Vorburger C, 2003, ECOL LETT, V6, P1091, DOI 10.1046/j.1461-0248.2003.00536.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Vorwerk S, 2006, GENOME, V49, P678, DOI 10.1139/G06-028; Weeks AR, 1998, EVOLUTION, V52, P1325, DOI [10.2307/2411302, 10.1111/j.1558-5646.1998.tb02014.x]; Weetman D, 2002, GENETICS, V162, P813; Wilson ACC, 1999, MOL ECOL, V8, P1655, DOI 10.1046/j.1365-294x.1999.00751.x; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x; Wilson ACC, 2006, GENET RES, V87, P175, DOI 10.1017/S0016672306008202; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x	64	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97744	10.1371/journal.pone.0097744	http://dx.doi.org/10.1371/journal.pone.0097744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914550	Green Published, gold			2022-12-27	WOS:000340947700011
J	Drye, LT; Spragg, D; Devanand, DP; Frangakis, C; Marano, C; Meinert, CL; Mintzer, JE; Munro, CA; Pelton, G; Pollock, BG; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Shade, DM; Weintraub, D; Yesavage, J; Lyketsos, CG				Drye, Lea T.; Spragg, David; Devanand, D. P.; Frangakis, Constantine; Marano, Christopher; Meinert, Curtis L.; Mintzer, Jacobo E.; Munro, Cynthia A.; Pelton, Gregory; Pollock, Bruce G.; Porsteinsson, Anton P.; Rabins, Peter V.; Rosenberg, Paul B.; Schneider, Lon S.; Shade, David M.; Weintraub, Daniel; Yesavage, Jerome; Lyketsos, Constantine G.		CitAD Res Grp	Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial	PLOS ONE			English	Article							ANTIDEPRESSANT USE; HEALTHY-SUBJECTS; CLINICAL-TRIAL; MORTALITY; POPULATION; AGE; DISPERSION; PEOPLE; GENDER; IMPACT	Background: A Food and Drug Administration (FDA) safety communication in August 2011 warned that citalopram was associated with a dose dependent risk of QT prolongation and recommended dose restriction in patients over the age of 60 but did not provide data for this age group. Methods: CitAD was a randomized, double-masked, placebo-controlled, multicenter clinical trial for agitation in Alzheimer's disease (AD). Participants were assigned to citalopram (target dose of 30 mg/day) or placebo in a 1:1 ratio. 186 people, 181 of whom were over the age of 60, having probable AD with clinically significant agitation were recruited from September 2009 to January 2013. After the FDA safety communication about citalopram, ECG was added to the required study procedures before enrollment and repeated at week 3 to monitor change in QTc interval. Forty-eight participants were enrolled after enhanced monitoring began. Results: Citalopram treatment was associated with a larger increase in QTc interval than placebo (difference in week 3 QTc adjusting for baseline QTc: 18.1 ms [95% CI: 6.1, 30.1]; p = 0.004). More participants in the citalopram group had an increase >= 30 ms from baseline to week 3 (7 in citalopram versus 1 in placebo; Fisher's exact p = 0.046), but only slightly more in the citalopram group met a gender-specific threshold for prolonged QTc (450 ms for males; 470 ms for females) at any point during follow-up (3 in citalopram versus 1 in placebo, Fisher's exact p = 0.611). One of the citalopram participants who developed prolonged QTc also displayed ventricular bigeminy. No participants in either group had a cardiovascular-related death. Conclusion: Citalopram at 30 mg/day was associated with improvement in agitation in patients with AD but was also associated with QT prolongation.	[Drye, Lea T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Drye, Lea T.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA; [Spragg, David] Johns Hopkins Univ Hosp, Electrophysiol Lab, Baltimore, MD 21287 USA; [Spragg, David; Rosenberg, Paul B.] Johns Hopkins Bayview Med Ctr, Baltimore, MD USA; [Devanand, D. P.] Columbia Univ, Coll Phys & Surg, Div Geriatr Psychiat, New York, NY USA; [Frangakis, Constantine] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Marano, Christopher] Johns Hopkins Univ, Sch Med, Div Geriatr Psychiat & Neuropsychiat, Johns Hopkins Bayview Med Ctr, Baltimore, MD USA; [Meinert, Curtis L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Meinert, Curtis L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Mintzer, Jacobo E.] Med Univ S Carolina, Ralph H Johnson VA Med Ctr, Clin Biotechnol Res Inst, Roper St Francis Healthcare,Dept Hlth Studies, Charleston, SC 29425 USA; [Munro, Cynthia A.] Johns Hopkins Bayview & Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Munro, Cynthia A.] Johns Hopkins Bayview & Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA; [Pelton, Gregory] Columbia Univ, New York State Psychiat Inst, Coll Phys & Surg, Div Geriatr Psychiat, New York, NY USA; [Pollock, Bruce G.] Univ Toronto, Campbell Family Mental Hlth Res Inst, Div Geriatr Psychiat, Toronto, ON, Canada; [Pollock, Bruce G.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porsteinsson, Anton P.] Univ Rochester, Sch Med & Dent, Alzheimers Dis Care Res & Educ Program AD CARE, Rochester, NY USA; [Rabins, Peter V.; Rosenberg, Paul B.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Rabins, Peter V.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Gerontol, Los Angeles, CA 90033 USA; [Shade, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Pulm Med, Baltimore, MD USA; [Shade, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shade, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA; [Weintraub, Daniel] Univ Penn, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Mental Illness Res Educ & Clin Ctr,Dept Psychiat, Perelman Sch Med,Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Univ Penn, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Mental Illness Res Educ & Clin Ctr,Dept Neurol, Perelman Sch Med,Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Yesavage, Jerome] Stanford Univ, Mental Illness Res Educ & Clin Ctr, Vet Affairs Palo Alto Hlth Care Syst, Aging Clin Res Ctr,Dept Psychiat,Sch Med, Palo Alto, CA 94304 USA; [Yesavage, Jerome] Stanford Univ, Sch Med, Dept Behav Sci, Palo Alto, CA 94304 USA; [Lyketsos, Constantine G.] Johns Hopkins Bayview & Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Memory & Alzheimers Treatment Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Columbia University; New York State Psychiatry Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Rochester; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Southern California; University of Southern California; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Drye, LT (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	ldrye@jhsph.edu	Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020	Weintraub, Daniel/0000-0003-0633-7168; Porsteinsson, Anton/0000-0002-0166-1738	National Institute on Aging; National Institute of Mental Health [R01AG031348]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031348, P50AG005142] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant funding: National Institute on Aging and National Institute of Mental Health, R01AG031348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; [Anonymous], 2012, FDA DRUG SAF COMM RE; [Anonymous], 1997, CPMP98696; Bergh S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1566; Bies RR, 2004, J CLIN PHARMACOL, V44, P1352, DOI 10.1177/0091270004269647; Castro VM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f288; Co-ordination Group for Mutual Recognition and Decentralised Procedures-Human, 2011, CMDH M HELD 17 18 19; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Drye LT, 2012, ALZHEIMERS DEMENT, V8, P121, DOI 10.1016/j.jalz.2011.01.007; European Medicines Agency, 2011, PHARM WORK PART PHVM; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P196; Food and Drug Administration, 2011, FDA DRUG SAF COMM AB; Food and Drug Administration, 2005, GUID IND E14 CLIN EV; Goldenberg I, 2006, J CARDIOVASC ELECTR, V17, P333, DOI 10.1111/j.1540-8167.2006.00408.x; Habib AS, 2008, ANESTH ANALG, V106, P1414, DOI 10.1213/ane.0b013e31816ba463; Harrigan EP, 2004, J CLIN PSYCHOPHARM, V24, P62, DOI 10.1097/01.jcp.0000104913.75206.62; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Mangoni AA, 2003, AGE AGEING, V32, P326, DOI 10.1093/ageing/32.3.326; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medicines and Healthcare Products Regulatory Agency (MHRA), 2011, DRUG SAFETY UPDATE, V5, pA1; Montanez A, 2004, ARCH INTERN MED, V164, P943, DOI 10.1001/archinte.164.9.943; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Reardon M, 1996, CLIN CARDIOL, V19, P949, DOI 10.1002/clc.4960191209; Sanofi-aventis, 2009, PAT INF UROXATRAL AL; Tran H, 2001, ANN NONINVAS ELECTRO, V6, P129, DOI 10.1111/j.1542-474X.2001.tb00097.x; Williams ES, 2012, AM HEART J, V164, P434, DOI 10.1016/j.ahj.2012.05.024; Wilton LV, 2001, J PSYCHOPHARMACOL, V15, P120, DOI 10.1177/026988110101500212; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; Zhang YY, 2011, EPIDEMIOLOGY, V22, P660, DOI 10.1097/EDE.0b013e318225768b; Zivin K, 2013, AM J PSYCHIAT	30	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98426	10.1371/journal.pone.0098426	http://dx.doi.org/10.1371/journal.pone.0098426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914549	Green Published, gold			2022-12-27	WOS:000340947700020
J	Phan, HT; Hause, B; Hause, G; Arcalis, E; Stoger, E; Maresch, D; Altmann, F; Joensuu, J; Conrad, U				Hoang Trong Phan; Hause, Bettina; Hause, Gerd; Arcalis, Elsa; Stoger, Eva; Maresch, Daniel; Altmann, Friedrich; Joensuu, Jussi; Conrad, Udo			Influence of Elastin-Like Polypeptide and Hydrophobin on Recombinant Hemagglutinin Accumulations in Transgenic Tobacco Plants	PLOS ONE			English	Article							PROTEIN BODY FORMATION; NEUTRALIZING ANTIBODIES; ENDOPLASMIC-RETICULUM; FUSION PROTEIN; IN-VITRO; PURIFICATION; EXPRESSION; VIRUS; BIOCOMPATIBILITY; INDUCTION	Fusion protein strategies are useful tools to enhance expression and to support the development of purification technologies. The capacity of fusion protein strategies to enhance expression was explored in tobacco leaves and seeds. C-terminal fusion of elastin-like polypeptides (ELP) to influenza hemagglutinin under the control of either the constitutive CaMV 35S or the seed-specific USP promoter resulted in increased accumulation in both leaves and seeds compared to the unfused hemagglutinin. The addition of a hydrophobin to the C-terminal end of hemagglutinin did not significantly increase the expression level. We show here that, depending on the target protein, both hydrophobin fusion and ELPylation combined with endoplasmic reticulum (ER) targeting induced protein bodies in leaves as well as in seeds. The N-glycosylation pattern indicated that KDEL sequence-mediated retention of leaf-derived hemagglutinins and hemagglutinin-hydrophobin fusions were not completely retained in the ER. In contrast, hemagglutinin-ELP from leaves contained only the oligomannose form, suggesting complete ER retention. In seeds, ER retention seems to be nearly complete for all three constructs. An easy and scalable purification method for ELPylated proteins using membrane-based inverse transition cycling could be applied to both leaf- and seed-expressed hemagglutinins.	[Hoang Trong Phan; Conrad, Udo] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany; [Hause, Bettina] Leibniz Inst Plant Biochem IPB, Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, Microscopy Unit, D-06108 Halle, Germany; [Arcalis, Elsa; Stoger, Eva] Univ Nat Resources & Appl Life Sci, Vienna, Austria; [Maresch, Daniel; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Hoang Trong Phan] Vietnam Acad Sci & Technol, Inst Biotechnol IBT, Dept Plant Cell Biotechnol, Hanoi, Vietnam; [Joensuu, Jussi] VTT Tech Res Ctr Finland, Espoo, Finland	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Vietnam Academy of Science & Technology (VAST); VTT Technical Research Center Finland	Conrad, U (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Mol Genet, Gatersleben, Germany.	conradu@ipk-gatersleben.de		Phan, Hoang Trong/0000-0001-7580-5776; Stoeger, Eva/0000-0002-7651-7992; Altmann, Friedrich/0000-0002-0112-7877; Arcalis, Elsa/0000-0001-9883-465X	Vietnam Ministry of Education and Training (MoET); BMBF (DLR), Germany	Vietnam Ministry of Education and Training (MoET); BMBF (DLR), Germany	This research was supported by the Vietnam Ministry of Education and Training (MoET) and by the BMBF (DLR), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcalis E, 2004, PLANT PHYSIOL, V136, P3457, DOI 10.1104/pp.104.050153; Christensen T, 2007, ANAL BIOCHEM, V360, P166, DOI 10.1016/j.ab.2006.09.020; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; Conrad U, 2011, PLANT BIOTECHNOL J, V9, P22, DOI 10.1111/j.1467-7652.2010.00523.x; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; Davoodi-Semiromi A, 2009, HUM VACCINES, V5, P488, DOI 10.4161/hv.8247; Duvenage L, 2013, J VIROL METHODS, V191, P55, DOI 10.1016/j.jviromet.2013.03.028; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Evangelista RL, 1998, BIOTECHNOL PROGR, V14, P607, DOI 10.1021/bp980047c; Fischer R, 2004, PLANT MADE PHARM TEC; Floss DM, 2012, ENCY SUSTAINABILITY, P8073; Floss DM, 2013, FUSION PROTEIN TECHN, P211; Floss DM, 2008, PLANT BIOTECHNOL J, V6, P379, DOI 10.1111/j.1467-7652.2008.00326.x; Floss DM, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P489, DOI 10.1007/978-3-642-01144-3_31; Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004; Floss DM, 2009, PLANT BIOTECHNOL J, V7, P899, DOI 10.1111/j.1467-7652.2009.00452.x; Floss DM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/274346; Gahrtz Manfred, 2009, V483, P289, DOI 10.1007/978-1-59745-407-0_17; Ge X, 2006, BIOTECHNOL BIOENG, V95, P424, DOI 10.1002/bit.21046; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40; Phan HT, 2013, CURR PHARM DESIGN, V19, P5601, DOI 10.2174/1381612811319310014; Phan HT, 2011, INT J MOL SCI, V12, P2808, DOI 10.3390/ijms12052808; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Isayenkov S, 2005, PLANT PHYSIOL, V139, P1401, DOI 10.1104/pp.105.069054; Joensuu JJ, 2009, TRANSGENIC RES, V18, P685, DOI 10.1007/s11248-009-9257-0; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; KEIL W, 1985, EMBO J, V4, P2711, DOI 10.1002/j.1460-2075.1985.tb03991.x; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Lin M, 2006, BIOCHEM J, V398, P577, DOI 10.1042/BJ20060544; Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; Patel J, 2007, TRANSGENIC RES, V16, P239, DOI 10.1007/s11248-006-9026-2; Phan HT, 2013, PLANT BIOTECHNOL J, V11, P582, DOI 10.1111/pbi.12049; Rincon AC, 2006, J BIOMED MATER RES A, V78A, P343, DOI 10.1002/jbm.a.30702; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Shoji Y, 2012, INFLUENZA OTHER RESP, V6, P204, DOI 10.1111/j.1750-2659.2011.00295.x; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Torrent Margarita, 2009, V483, P193, DOI 10.1007/978-1-59745-407-0_11; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306; Veit M, 2011, ADV VIROL, V2011, DOI 10.1155/2011/370606; WANDELT CI, 1992, PLANT J, V2, P181; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; [WHO] World Health Organization, INFL HUM AN INT HAI; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yusibov V, 2008, EXPERT REV VACCINES, V7, P1173, DOI 10.1586/14760584.7.8.1173; Zhang S, 2012, PROTEOMICS, V12, P1269, DOI 10.1002/pmic.201100474	57	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99347	10.1371/journal.pone.0099347	http://dx.doi.org/10.1371/journal.pone.0099347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914995	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700087
J	Yao, X; Jia, WQ; Si, HY; Guo, ZQ; Tian, YC; Liu, XJ; Cao, WX; Zhu, Y				Yao, Xia; Jia, Wenqing; Si, Haiyang; Guo, Ziqing; Tian, Yongchao; Liu, Xiaojun; Cao, Weixing; Zhu, Yan			Exploring Novel Bands and Key Index for Evaluating Leaf Equivalent Water Thickness in Wheat Using Hyperspectra Influenced by Nitrogen	PLOS ONE			English	Article							SPECTRAL REFLECTANCE; VEGETATION; MOISTURE; STRESS; GROWTH; MODEL; RISK; CORN	Leaf equivalent water thickness (LEWT) is an important indicator of crop water status. Effectively monitoring the water status of wheat under different nitrogen treatments is important for effective water management in precision agriculture. Trends in the variation of LEWT in wheat plants during plant growth were analyzed based on field experiments in which wheat plants under various water and nitrogen treatments in two consecutive growing seasons. Two-band spectral indices [ normalized difference spectral indices (NDSI), ratio spectral indices (RSI), different spectral indices (DSI)], and then three-band spectral indices were established based on the best two-band spectral index within the range of 350-2500 nm to reduce the noise caused by nitrogen and saturation. Then, optimal spectral indices were selected to construct models of LEWT monitoring in wheat. The results showed that the two-band spectral index NDSI(R-1204, R-1318) could be used for LEWT monitoring throughout the wheat growth season, but the model performed differently before and after anthesis. Therefore, further two-band spectral indices NDSIb(R-1445, R-487), NDSIa(R-1714, R-1395), and NDSI(R-1429, R-416), were constructed for the two developmental phases, with NDSI(R-1429, R-416) considered to be the best index. Finally, a three-band index (R-1429-R-416- R-1865)/(R-1429+R-416+R-1865), which was superior for monitoring LEWT and reducing the noise caused by nitrogen, was formed on the best two-band spectral index NDSI(R-1429, R-416) by adding the 1,865 nm wavelenght as the third band. This produced more uniformity and stable performance compared with the two-band spectral indices in the LEWT model. The results are of technical significance for monitoring the water status of wheat under different nitrogen treatments in precision agriculture.	[Yao, Xia; Jia, Wenqing; Si, Haiyang; Guo, Ziqing; Tian, Yongchao; Liu, Xiaojun; Cao, Weixing; Zhu, Yan] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhu, Y (corresponding author), Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Jiangsu Key Lab Informat Agr, Nanjing, Jiangsu, Peoples R China.	yanzhu@njau.edu.cn	Zhu, Yan/AAK-6927-2020	Zhu, Yan/0000-0002-8912-3888; Yao, Xia/0000-0002-1093-1736	National High-tech Research and Development Program of China (863 Program) [2013AA102404, 2011AA100703]; National Natural Science Foundation of China [31201130, 31201131]; Special Program for Agriculture Science and Technology from Ministry of Agriculture in China [201303109]; Science and Technology Support Plan of Jiangsu Province [BE2011351, BE2012302]; Jiangsu agriculture science and technology innovation fund [SCX(12)3272]; Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National High-tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Agriculture Science and Technology from Ministry of Agriculture in China; Science and Technology Support Plan of Jiangsu Province; Jiangsu agriculture science and technology innovation fund; Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National High-tech Research and Development Program of China (863 Program) (2013AA102404,2011AA100703), National Natural Science Foundation of China (31201130, 31201131), Special Program for Agriculture Science and Technology from Ministry of Agriculture in China (201303109), Science and Technology Support Plan of Jiangsu Province (BE2011351, BE2012302), Jiangsu agriculture science and technology innovation fund, SCX(12)3272, and Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Li, 2008, Scientia Agricultura Sinica, V41, P2499; CARTER GA, 1991, AM J BOT, V78, P916, DOI 10.2307/2445170; Ceccato P, 2001, REMOTE SENS ENVIRON, V77, P22, DOI 10.1016/S0034-4257(01)00191-2; Champagne CM, 2003, REMOTE SENS ENVIRON, V87, P148, DOI 10.1016/S0034-4257(03)00137-8; Chen HB, 2010, WATER SAVING IRRIGAT, V8, P69; Cheng T, 2011, REMOTE SENS ENVIRON, V115, P659, DOI 10.1016/j.rse.2010.11.001; Dong JingJing, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P587; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hou XJ, 2008, REMOTE SENSING INFOR, V2, P10; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; Jackson TJ, 2004, REMOTE SENS ENVIRON, V92, P475, DOI 10.1016/j.rse.2003.10.021; [刘良云 LIU Liangyun], 2007, [遥感学报, Journal of Remote Sensing], V11, P289; Liu XiaoJun, 2012, Scientia Agricultura Sinica, V45, P435; Maki M, 2004, REMOTE SENS ENVIRON, V90, P441, DOI 10.1016/j.rse.2004.02.002; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887, DOI 10.1080/01431169308954010; Pu RL, 2000, HYPERSPECTRAL REMOTE, P194; Schneider P, 2008, REMOTE SENS ENVIRON, V112, P1151, DOI 10.1016/j.rse.2007.07.010; Seelig HD, 2008, REMOTE SENS ENVIRON, V112, P445, DOI 10.1016/j.rse.2007.05.002; [沈艳 Shen Yan], 2005, [地理与地理信息科学, Geography and geo-information science], V21, P16; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Stow D, 2005, INT J REMOTE SENS, V26, P3867, DOI 10.1080/01431160500185342; Tian Yong-chao, 2010, Yingyong Shengtai Xuebao, V21, P966; Tian YongChao, 2005, Acta Phytoecologica Sinica, V29, P318; Tilling AK, 2007, FIELD CROP RES, V104, P77, DOI 10.1016/j.fcr.2007.03.023; VERASAN V, 1978, AGRON J, V70, P613, DOI 10.2134/agronj1978.00021962007000040021x; Verbesselt J, 2007, REMOTE SENS ENVIRON, V108, P357, DOI 10.1016/j.rse.2006.11.019; Wang JiHua, 2001, Scientia Agricultura Sinica, V34, P104; Wang P, 2010, REMOTE SENSING LAND, V3, P97; Wang W, 2012, FIELD CROP RES, V129, P90, DOI 10.1016/j.fcr.2012.01.014; Yao X, 2010, INT J APPL EARTH OBS, V12, P89, DOI 10.1016/j.jag.2009.11.008; Yilmaz MT, 2008, REMOTE SENS ENVIRON, V112, P2514, DOI 10.1016/j.rse.2007.11.014; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V85, P109, DOI 10.1016/S0034-4257(02)00197-9; [张佳华 ZHANG Jiahua], 2007, [应用基础与工程科学学报, Journal of Basic Science and Engineering], V15, P45; Zhang L, 2012, EUR J AGRON, V41, P103, DOI 10.1016/j.eja.2012.04.003; [赵全志 ZHAO Quanzhi], 2006, [干旱地区农业研究, Agricultural Research in the Arid Areas], V24, P61; Zhu Y, 2007, AUST J AGR RES, V58, P1077, DOI 10.1071/AR06413; Ziadi N, 2008, AGRON J, V100, P1264, DOI 10.2134/agronj2008.0016	38	21	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96352	10.1371/journal.pone.0096352	http://dx.doi.org/10.1371/journal.pone.0096352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914778	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700004
J	Beauchet, O; Allali, G; Montero-Odasso, M; Sejdic, E; Fantino, B; Annweiler, C				Beauchet, Olivier; Allali, Gilles; Montero-Odasso, Manuel; Sejdic, Ervin; Fantino, Bruno; Annweiler, Cedric			Motor Phenotype of Decline in Cognitive Performance among Community-Dwellers without Dementia: Population-Based Study and Meta-Analysis	PLOS ONE			English	Article							CLOCK DRAWING TEST; EXECUTIVE FUNCTION; ALZHEIMERS-DISEASE; GAIT VARIABILITY; WALKING SPEED; LOCOMOTOR FUNCTION; OLDER-ADULTS; FAST-PACE; GO TEST; IMPAIRMENT	Background: Decline in cognitive performance is associated with gait deterioration. Our objectives were: 1) to determine, from an original study in older community-dwellers without diagnosis of dementia, which gait parameters, among slower gait speed, higher stride time variability (STV) and Timed Up & Go test (TUG) delta time, were most strongly associated with lower performance in two cognitive domains (i.e., episodic memory and executive function); and 2) to quantitatively synthesize, with a systematic review and meta-analysis, the association between gait performance and cognitive decline (i.e., mild cognitive impairment (MCI) and dementia). Method: Based on a cross-sectional design, 934 older community-dwellers without dementia (mean +/- standard deviation, 70.3 +/- 4.9years; 52.1% female) were recruited. A score at 5 on the Short Mini-Mental State Examination defined low episodic memory performance. Low executive performance was defined by clock-drawing test errors. STV and gait speed were measured using GAITRite system. TUG delta time was calculated as the difference between the times needed to perform and to imagine the TUG. Then, a systematic Medline search was conducted in November 2013 using the Medical Subject Heading terms "Delirium,'' "Dementia,'' "Amnestic,'' "Cognitive disorders'' combined with "Gait'' OR "Gait disorders, Neurologic'' and "Variability.'' Findings: A total of 294 (31.5%) participants presented decline in cognitive performance. Higher STV, higher TUG delta time, and slower gait speed were associated with decline in episodic memory and executive performances (all P-values < 0.001). The highest magnitude of association was found for higher STV (effect size = -0.74 [95% Confidence Interval (CI): -1.05; -0.43], among participants combining of decline in episodic memory and in executive performances). Meta-analysis underscored that higher STV represented a gait biomarker in patients with MCI (effect size = 0.48 [95% CI: 0.30;0.65]) and dementia (effect size = 1.06 [95% CI: 0.40; 1.72]). Conclusion: Higher STV appears to be a motor phenotype of cognitive decline.	[Beauchet, Olivier; Fantino, Bruno; Annweiler, Cedric] Angers Univ Hosp, Dept Neurosci, Div Geriatr Med, Angers, France; [Allali, Gilles] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Allali, Gilles] Univ Geneva, Geneva, Switzerland; [Montero-Odasso, Manuel] Parkwood Hosp, Gait & Brain Lab, Lawson Hlth Res Inst, London, ON, Canada; [Sejdic, Ervin] Univ Pittsburgh, Dept Elect & Comp Engn, Swanson Sch Engn, Pittsburgh, PA USA; [Annweiler, Cedric] Univ Western Ontario, Robarts Res Inst, Dept Med Biophys, Schulich Sch Med & Dent, London, ON, Canada	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Geneva; University of Geneva; Western University (University of Western Ontario); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western University (University of Western Ontario)	Beauchet, O (corresponding author), Angers Univ Hosp, Dept Neurosci, Div Geriatr Med, Angers, France.	olbeauchet@chu-angers.fr	Allali, Gilles/D-1500-2009; Montero-Odasso, Manuel/G-3335-2011; Beauchet, Olivier/AAP-8108-2020	Allali, Gilles/0000-0002-4455-6719; Montero-Odasso, Manuel/0000-0002-5796-2361; Sejdic, Ervin/0000-0003-4987-8298; Annweiler, Cedric/0000-0002-7199-8109	NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allali G, 2012, EUR NEUROL, V67, P116, DOI 10.1159/000334394; Allali G, 2013, J GERONTO A IN PRESS; Allali G, 2008, DEMENT GERIATR COGN, V26, P364, DOI 10.1159/000162358; Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Annweiler C, 2010, J BONE MINER RES, V25, P1858, DOI 10.1002/jbmr.80; Bakker M, 2007, J NEURAL TRANSM, V114, P1323, DOI 10.1007/s00702-007-0783-8; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Beauchet O, 2011, NEUROLOGY, V76, P1617, DOI 10.1212/WNL.0b013e318219fb08; Beauchet O, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-12; Beauchet O, 2011, J AM GERIATR SOC, V59, P1973, DOI 10.1111/j.1532-5415.2011.03610_9.x; Beauchet O, 2010, J NEUROL SCI, V294, P102, DOI 10.1016/j.jns.2010.03.021; Beauchet Olivier, 2008, Neuropsychiatr Dis Treat, V4, P155; Beauchet O, 2009, GERONTOLOGY, V55, P702, DOI 10.1159/000235905; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Bridenbaugh SA, 2013, AGING CLIN EXP RES, V25, P283, DOI 10.1007/s40520-013-0046-5; Camicioli R, 1998, NEUROLOGY, V50, P1496, DOI 10.1212/WNL.50.5.1496; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Di Carlo A, 2000, J AM GERIATR SOC, V48, P775, DOI 10.1111/j.1532-5415.2000.tb04752.x; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Egger M., 2001, SYSTEMATIC REV HLTH; Gavrila D, 2009, ACTA NEUROL SCAND, V120, P300, DOI 10.1111/j.1600-0404.2009.01283.x; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Haubois G, 2013, EUR J NEUROL, V20, P588, DOI 10.1111/j.1468-1331.2012.03830.x; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Kearney FC, 2013, DEMENT GERIATR COGN, V36, P20, DOI 10.1159/000350031; Kluger A, 1997, J GERONTOL B-PSYCHOL, V52, pP28, DOI 10.1093/geronb/52B.1.P28; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; Lallart E, 2012, PSYCHIAT RES, V198, P366, DOI 10.1016/j.psychres.2011.12.013; Lan TY, 2003, J GERONTOL A-BIOL, V58, P721; LORD SR, 1994, J AM GERIATR SOC, V42, P1110, DOI 10.1111/j.1532-5415.1994.tb06218.x; Marquis S, 2002, ARCH NEUROL-CHICAGO, V59, P601, DOI 10.1001/archneur.59.4.601; Montero-Odasso M, 2004, J Nutr Health Aging, V8, P340; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Montero-Odasso M, 2012, ARCH PHYS MED REHAB, V93, P293, DOI 10.1016/j.apmr.2011.08.026; Muir SW, 2012, GAIT POSTURE, V35, P96, DOI 10.1016/j.gaitpost.2011.08.014; Nair AK, 2010, J NEUROPSYCH CLIN N, V22, P85, DOI 10.1176/appi.neuropsych.22.1.85; Nunes B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-42; Pinto E, 2009, DEMENT GERIATR COGN, V27, P201, DOI 10.1159/000203344; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rosano C, 2007, NEUROEPIDEMIOLOGY, V29, P193, DOI 10.1159/000111582; Scarmeas N, 2005, NEUROLOGY, V64, P1696, DOI 10.1212/01.WNL.0000162054.15428.E9; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scherder E, 2007, NEUROSCI BIOBEHAV R, V31, P485, DOI 10.1016/j.neubiorev.2006.11.007; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Shah A, 1997, AGE AGEING, V26, P217, DOI 10.1093/ageing/26.3.217; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; van Iersel MB, 2004, Z GERONTOL GERIATR, V37, P27, DOI 10.1007/s00391-004-0176-7; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Waite LM, 2005, J NEUROL SCI, V229, P89, DOI 10.1016/j.jns.2004.11.009; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Watson NL, 2010, J GERONTOL A-BIOL, V65, P1093, DOI 10.1093/gerona/glq111; Wittwer JE, 2010, GAIT POSTURE, V32, P113, DOI 10.1016/j.gaitpost.2010.04.001; Zimmerman ME, 2009, BRAIN RES, V1291, P73, DOI 10.1016/j.brainres.2009.07.043	63	53	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99318	10.1371/journal.pone.0099318	http://dx.doi.org/10.1371/journal.pone.0099318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911155	Green Published, gold, Green Accepted			2022-12-27	WOS:000337165600072
J	Esmaeelpour, M; Kajic, V; Zabihian, B; Othara, R; Ansari-Shahrezaei, S; Kellner, L; Krebs, I; Nemetz, S; Kraus, MF; Hornegger, J; Fujimoto, JG; Drexler, W; Binder, S				Esmaeelpour, Marieh; Kajic, Vedran; Zabihian, Behrooz; Othara, Richu; Ansari-Shahrezaei, Siamak; Kellner, Lukas; Krebs, Ilse; Nemetz, Susanne; Kraus, Martin F.; Hornegger, Joachim; Fujimoto, James G.; Drexler, Wolfgang; Binder, Susanne			Choroidal Haller's and Sattler's Layer Thickness Measurement Using 3-Dimensional 1060-nm Optical Coherence Tomography	PLOS ONE			English	Article							MACULAR DEGENERATION; NM; CHORIOCAPILLARIS; OCT; REPRODUCIBILITY; VISUALIZATION; SEGMENTATION; PENETRATION; CIRCULATION; EYES	Objectives: To examine the feasibility of automatically segmented choroidal vessels in three-dimensional (3D) 1060-nmOCT by testing repeatability in healthy and AMD eyes and by mapping Haller's and Sattler's layer thickness in healthy eyes Methods: Fifty-five eyes (from 45 healthy subjects and 10 with non-neovascular age-related macular degeneration (AMD) subjects) were imaged by 3D-1060- nmOCT over a 36 degrees x36 degrees field of view. Haller's and Sattler's layer were automatically segmented, mapped and averaged across the Early Treatment Diabetic Retinopathy Study grid. For ten AMD eyes and ten healthy eyes, imaging was repeated within the same session and on another day. Outcomes were the repeatability agreement of Haller's and Sattler's layer thicknesses in healthy and AMD eyes, the validation with ICGA and the statistical analysis of the effect of age and axial eye length ( AL) on both healthy choroidalsublayers. Conclusions: Automated Sattler's and Haller's thickness segmentation generates rapid 3D measurements with a repeatability correspondingto reported manual segmentation. Sublayers in healthy eyes thinnedsignificantly with increasing AL. In the presence of the thinned Sattler's layer in AMD, careful measurement interpretation is needed. Automatic choroidal vascular layer mapping may help to explain if pathological choroidal thinning affects medium and large choroidal vasculature in addition to choriocapillaris loss.	[Esmaeelpour, Marieh; Ansari-Shahrezaei, Siamak; Kellner, Lukas; Krebs, Ilse; Binder, Susanne] Rudolf Fdn Clin, Dept Ophthalmol, Ludwig Boltzmann Inst Retinol & Biomicroscop Lase, Vienna, Austria; [Esmaeelpour, Marieh; Kajic, Vedran; Zabihian, Behrooz; Othara, Richu; Drexler, Wolfgang] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Nemetz, Susanne] OptikNemetz, Vienna, Austria; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Bavaria, Germany; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Sch Adv Opt Technol SATO, D-91054 Erlangen, Bavaria, Germany; [Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Ludwig Boltzmann Institute; Medical University of Vienna; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Massachusetts Institute of Technology (MIT)	Esmaeelpour, M (corresponding author), Rudolf Fdn Clin, Dept Ophthalmol, Ludwig Boltzmann Inst Retinol & Biomicroscop Lase, Vienna, Austria.	marieh.esmaeelpour@meduniwien.ac.at	Hornegger, Joachim/H-2465-2017	Hornegger, Joachim/0000-0002-1834-8844; Drexler, Wolfgang/0000-0002-3557-6398	Medical University Vienna, Macular Vision Research Foundation (MVRF, USA); European Union [201880]; FAMOS [ICT 317744]; FWF-NFN [14294]; National Institutes of Health [NIH R01-EY011289-27]; Deutsche Forschungsgesellschaft [DFG-GSC80-SAOT]; German Research Foundation [DFG-GSC80-SAOT, DFG-HO-1791/11-1]; NATIONAL EYE INSTITUTE [R01EY011289] Funding Source: NIH RePORTER	Medical University Vienna, Macular Vision Research Foundation (MVRF, USA); European Union(European Commission); FAMOS; FWF-NFN(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by Medical University Vienna, Macular Vision Research Foundation (MVRF, USA), European Union project FUN OCT (FP7 HEALTH, contract no. 201880) and FAMOS (FP7 ICT 317744), FWF-NFN 'Photoacoustic imaging in biology and Medicine', Oesterreichische Nationalbank Jubilaumsfondsprojekt (14294), National Institutes of Health (NIH R01-EY011289-27), Deutsche Forschungsgesellschaft (DFG-GSC80-SAOT), CARL ZEISS Meditec Inc., Femtolasers GmbH and the Christian Doppler Society (Christian Doppler Laboratory ' Laser development and their application in medicine'). German Research Foundation DFG-GSC80-SAOT, DFG-HO-1791/11-1. Optik Nemetz provided support in the form of a salary for author SN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANSI, 2000, SAF US LAS SAF US OP; BILL A, 1983, INT OPHTHALMOL, V6, P101, DOI 10.1007/BF00127638; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Bruin DM, 2008, INVEST OPHTH VIS SCI, V49, P4545, DOI 10.1167/iovs.07-1553; Esmaeelpour M, 2010, INVEST OPHTH VIS SCI, V51, P5260, DOI 10.1167/iovs.10-5196; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; HAYREH SS, 1974, A GRAEF ARCH KLIN EX, V192, P165; Hayreh SS, 2004, INVEST OPHTH VIS SCI, V45, P749, DOI 10.1167/iovs.03-0469; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; Hogan MJ, 1971, SAUNDERS, P322; ICNIRP, 2000, REV GUID LIM EXP LAS; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V51, P2173; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Kajic V, 2013, BIOMED OPT EXPRESS, V4, P134, DOI 10.1364/BOE.4.000134; Kajic V, 2012, BIOMED OPT EXPRESS, V3, P86, DOI 10.1364/BOE.3.000086; Kim JH, 2013, EYE, V27, P809, DOI 10.1038/eye.2013.78; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Lee JY, 2013, INVEST OPHTH VIS SCI, V54, P7812, DOI 10.1167/iovs.13-12284; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; Motaghiannezam R, 2012, INVEST OPHTH VIS SCI, V53, P2337, DOI 10.1167/iovs.11-7823; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nishiyama Y, 2001, RETINA-J RET VIT DIS, V21, P237, DOI 10.1097/00006982-200106000-00007; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P1258, DOI 10.1167/iovs.11-8907; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2893, DOI 10.1167/iovs.12-11085; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Young M, 2014, RETINA-J RET VIT DIS, V34, P1308, DOI 10.1097/IAE.0000000000000081; ZHANG HR, 1994, PROG RETIN EYE RES, V13, P243, DOI 10.1016/1350-9462(94)90012-4; Zhang L, 2012, INVEST OPHTH VIS SCI, V53, P7510, DOI 10.1167/iovs.12-10311	36	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99690	10.1371/journal.pone.0099690	http://dx.doi.org/10.1371/journal.pone.0099690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911446	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600115
J	Furtner, J; Bender, B; Braun, C; Schittenhelm, J; Skardelly, M; Ernemann, U; Bisdas, S				Furtner, Julia; Bender, Benjamin; Braun, Christian; Schittenhelm, Jens; Skardelly, Marco; Ernemann, Ulrike; Bisdas, Sotirios			Prognostic Value of Blood Flow Measurements Using Arterial Spin Labeling in Gliomas	PLOS ONE			English	Article							GRADE GLIOMAS; PERFUSION; PREDICTION; SURVIVAL; BRAIN	The period of event-free survival (EFS) within the same histopathological glioma grades may have high variability, mainly without a known cause. The purpose of this study was to reveal the prognostic value of quantified tumor blood flow (TBF) values obtained by arterial spin labeling (ASL) for EFS in patients with histopathologically proven astrocytomas independent of WHO (World Health Organization) grade. Twenty-four patients with untreated gliomas underwent tumor perfusion quantification by means of pulsed ASL in 3T. The clinical history of the patients was retrospectively extracted from the local database. Six patients had to be excluded due to insufficent follow-up data for further evaluation or histopathologically verified oligodendroglioma tumor components. Receiver operating characteristic (ROC) curves were used to define an optimal cut-off value of maximum TBF (mTBF) values for subgrouping in low-perfused and high-perfused gliomas. KaplanMeier curves and Cox proportional hazard regression model were used to determine the prognostic value of mTBF for EFS. An optimal mTBF cut-off value of 182 ml/100 g/min (sensitivity =83%, specificity =100%) was determined. Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-perfused gliomas (p =0.0012) independent of the WHO glioma grade. Quantified mTBF values obtained by ASL offer a new and totally non-invasive marker to prognosticate the EFS, independently on histopathological tumor grading, in patients with gliomas.	[Furtner, Julia] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Furtner, Julia; Bender, Benjamin; Ernemann, Ulrike; Bisdas, Sotirios] Univ Tubingen, Dept Neuroradiol, Tubingen, Germany; [Braun, Christian] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Schittenhelm, Jens] Univ Tubingen, Dept Neuropathol, Tubingen, Germany; [Skardelly, Marco] Univ Tubingen, Dept Neurosurg, Tubingen, Germany	Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Bisdas, S (corresponding author), Univ Tubingen, Dept Neuroradiol, Tubingen, Germany.	sotirios.bisdas@uni-tuebingen.de	Bisdas, Sotirios/P-2549-2016; Skardelly, Marco/AAF-8680-2021	Bisdas, Sotirios/0000-0001-9930-5549; Bender, Benjamin/0000-0002-3205-4631; Furtner, Julia/0000-0001-8258-3681	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Bisdas S, 2009, AM J NEURORADIOL, V30, P681, DOI 10.3174/ajnr.A1465; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cao Y, 2006, INT J RADIAT ONCOL, V64, P876, DOI 10.1016/j.ijrobp.2005.09.001; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Golay X, 2006, NEUROIMAG CLIN N AM, V16, P259, DOI 10.1016/j.nic.2006.02.003; Hirai T, 2008, AM J NEURORADIOL, V29, P1505, DOI 10.3174/ajnr.A1121; Hirai T, 2011, AM J NEURORADIOL, V32, P2073, DOI 10.3174/ajnr.A2725; Jackson RJ, 2001, NEURO-ONCOLOGY, V3, P193, DOI 10.1093/neuonc/3.3.193; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; Kuo PH, 2010, RADIOLOGY, V3, P647; Law M, 2006, RADIOLOGY, V238, P658, DOI 10.1148/radiol.2382042180; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Lev MH, 2004, AM J NEURORADIOL, V25, P214; Mangla R, 2014, J NEURO-ONCOL, V116, P325, DOI 10.1007/s11060-013-1298-9; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Seeger A, 2013, ACAD RADIOL, p[12, 1557]; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; The WHO, 2020, CLASSIFICATION TUMOU; Walker C, 2003, CLIN CANCER RES, V9, P4841; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Weber MA, 2003, INVEST RADIOL, V38, P712, DOI 10.1097/01.rli.0000084890.57197.54; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506	29	23	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99616	10.1371/journal.pone.0099616	http://dx.doi.org/10.1371/journal.pone.0099616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911025	gold, Green Submitted, Green Published			2022-12-27	WOS:000337165600110
J	Noah, TL; Zhang, HT; Zhou, HB; Glista-Baker, E; Muller, L; Bauer, RN; Meyer, M; Murphy, PC; Jones, S; Letang, B; Robinette, C; Jaspers, I				Noah, Terry L.; Zhang, Hongtao; Zhou, Haibo; Glista-Baker, Ellen; Mueller, Loretta; Bauer, Rebecca N.; Meyer, Megan; Murphy, Paula C.; Jones, Shannon; Letang, Blanche; Robinette, Carole; Jaspers, Ilona			Effect of Broccoli Sprouts on Nasal Response to Live Attenuated Influenza Virus in Smokers: A Randomized, Double-Blind Study	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER CHEMOPREVENTION; CIGARETTE-SMOKING; RISK-FACTORS; H1N1 2009; SULFORAPHANE; INFECTION; EXPOSURE; EXPRESSION; NRF2	Background: Smokers have increased susceptibility and altered innate host defense responses to influenza virus infection. Broccoli sprouts are a source of the Nrf2 activating agentsulforaphane, and short term ingestion of broccoli sprout homogenates (BSH) has been shown to reduce nasal inflammatory responses to oxidant pollutants. Objectives: Assess the effects of BSH on nasal cytokines, virus replication, and Nrf2-dependent enzyme expression in smokers and nonsmokers. Methods: We conducted a randomized, double-blind, placebo-controlled trial comparing the effects of BSH on serially sampled nasal lavage fluid (NLF) cytokines, viral sequence quantity, and Nrf2-dependent enzyme expression in NLF cells and biopsied epithelium. Healthy young adult smokers and nonsmokers ingested BSH or placebo (alfalfa sprout homogenate) for 4 days, designated Days -1, 0, 1, 2. On Day 0 they received standard vaccine dose of live attenuated influenza virus (LAIV) intranasally. Nasal lavage fluids and nasal biopsies were collected serially to assess response to LAIV. Results: In area under curve analyses, post-LAIV IL-6 responses (P =0.03) and influenza sequences (P =0.01) were significantly reduced in NLF from BSH-treated smokers, whileNAD(P) H: quinoneoxidoreductasein NLF cells was significantly increased. In nonsmokers, a similar trend for reduction in virus quantity with BSH did not reach statistical significance. Conclusions: In smokers, short term ingestion of broccoli sprout homogenates appears to significantly reduce some virus-induced markers of inflammation, as well as reducing virus quantity. Nutritional antioxidant interventions have promise as a safe, low-cost strategy for reducing influenza risk among smokers and other at risk populations.	[Noah, Terry L.; Glista-Baker, Ellen; Jones, Shannon; Robinette, Carole; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27599 USA; [Noah, Terry L.; Murphy, Paula C.; Jaspers, Ilona] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Zhang, Hongtao; Zhou, Haibo] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Bauer, Rebecca N.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA; [Meyer, Megan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Letang, Blanche] Univ N Carolina, Biol & Biomed Sci Program, Chapel Hill, NC USA; [Mueller, Loretta] Univ Childrens Hosp Basel, Basel, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Basel	Noah, TL (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27599 USA.	terry_noah@med.unc.edu	Jaspers, Ilona/AAZ-5035-2020; ZHOU, Haibo/M-7373-2017		NIEHS NIH HHS [R01 ES013611, T32 ES007126, P30 ES010126] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013611, T32ES007126, P30ES010126] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Biswal Shyam, 2012, Proc Am Thorac Soc, V9, P47, DOI 10.1513/pats.201201-009MS; Cantin AM, 2012, CURR MOL MED, V12, P836; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Cohen HA, 2004, ARCH PEDIAT ADOL MED, V158, P217, DOI 10.1001/archpedi.158.3.217; Dinkova-Kostova AT, 2007, CANCER EPIDEM BIOMAR, V16, P847, DOI 10.1158/1055-9965.EPI-06-0934; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Gerhauser C, 2013, CURR OPIN CLIN NUTR, V16, P405, DOI 10.1097/MCO.0b013e328362014e; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Heber D, 2014, FOOD FUNCT, V5, P35, DOI 10.1039/c3fo60277j; Huttunen R, 2011, J INTERN MED, V269, P258, DOI 10.1111/j.1365-2796.2010.02332.x; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Jaspers I, 1999, J BIOL CHEM, V274, P31025, DOI 10.1074/jbc.274.43.31025; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; KARK JD, 1981, AM J PUBLIC HEALTH, V71, P530, DOI 10.2105/AJPH.71.5.530; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; LEBIUSH M, 1982, MIL MED, V147, P43, DOI 10.1093/milmed/147.1.43; Lenzi L, 2012, J BRAS PNEUMOL, V38, P57, DOI 10.1590/S1806-37132012000100009; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Macchia I, 1999, INT J IMMUNOPHARMACO, V21, P185, DOI 10.1016/S0192-0561(98)00080-0; Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15; Nantz MP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-161; Negishi H, 2013, J NUTR, V143, P1794, DOI 10.3945/jn.113.179036; Noah TL, 2012, AM J RESP CRIT CARE, V185, P179, DOI 10.1164/rccm.201103-0465OC; Noah TL, 2011, ENVIRON HEALTH PERSP, V119, P78, DOI 10.1289/ehp.1002258; Rager JE, 2013, AM J PHYSIOL-LUNG C, V305, pL432, DOI 10.1152/ajplung.00116.2013; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Ritz SA, 2007, AM J PHYSIOL-LUNG C, V292, pL33, DOI 10.1152/ajplung.00170.2006; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; Wilson KM, 2013, J PEDIATR-US, V162, P16, DOI 10.1016/j.jpeds.2012.06.043; Wong CM, 2013, INFLUENZA OTHER RESP, V7, P531, DOI 10.1111/j.1750-2659.2012.00411.x; Woolson RFC., 2002, STAT METHODS ANAL BI, Ved 2; Yageta Y, 2013, AM J RESP CELL MOL B	38	28	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98671	10.1371/journal.pone.0098671	http://dx.doi.org/10.1371/journal.pone.0098671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910991	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600009
J	Pritchard, AJ; Mir, AK; Dev, KK				Pritchard, Adam J.; Mir, Anis K.; Dev, Kumlesh K.			Fingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Cultures	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; IN-VITRO; SIGNALING PATHWAYS; TRANSGENIC MICE; FTY720; ACTIVATION	The family of sphingosine-1-phosphate receptors (S1PRs) is G-protein-coupled, comprised of subtypes S1PR1-S1PR5 and activated by the endogenous ligand S1P. The phosphorylated version of Fingolimod (pFTY720), an oral therapy for multiple sclerosis (MS), induces S1PR1 internalisation in T cells, subsequent insensitivity to S1P gradients and sequestering of these cells within lymphoid organs, thus limiting immune response. S1PRs are also expressed in neuronal and glial cells where pFTY720 is suggested to directly protect against lysolecithin-induced deficits in myelination state in organotypic cerebellar slices. Of note, the effect of pFTY720 on immune cells already migrated into the CNS, prior to treatment, has not been well established. We have previously found that organotypic slice cultures do contain immune cells, which, in principle, could also be regulated by pFTY720 to maintain levels of myelin. Here, a mouse organotypic cerebellar slice and splenocyte co-culture model was thus used to investigate the effects of pFTY720 on splenocyte-induced demyelination. Spleen cells isolated from myelin oligodendrocyte glycoprotein immunised mice (MOG-splenocytes) or from 2D2 transgenic mice (2D2splenocytes) both induced demyelination when co-cultured with mouse organotypic cerebellar slices, to a similar extent as lysolecithin. As expected, in vivo treatment of MOG-immunised mice with FTY720 inhibited demyelination induced by MOG-splenocytes. Importantly, in vitro treatment of MOG- and 2D2-splenocytes with pFTY720 also attenuated demyelination caused by these cells. In addition, while in vitro treatment of 2D2-splenocytes with pFTY720 did not alter cell phenotype, pFTY720 inhibited the release of the pro-inflammatory cytokines such as interferon gamma (IFN gamma) and interleukin 6 (IL6) from these cells. This work suggests that treatment of splenocytes by pFTY720 attenuates demyelination and reduces pro-inflammatory cytokine release, which likely contributes to enhanced myelination state induced by pFTY720 in organotypic cerebellar slices.	[Pritchard, Adam J.; Dev, Kumlesh K.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Mir, Anis K.] Novartis Pharma AG, Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammatory Dis, Basel, Switzerland	Trinity College Dublin; Novartis	Dev, KK (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland.	devk@tcd.ie		Dev, Kumlesh/0000-0003-4274-9119	Trinity College Dublin Ireland; Novartis Pharma Basel Switerland	Trinity College Dublin Ireland; Novartis Pharma Basel Switerland	This work was supported in part by research grants from Trinity College Dublin Ireland and Novartis Pharma Basel Switerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Note, however, that AKM is an employee of Novartis Pharma Basel and had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials under relevant material transfer agreements.	Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bin JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041237; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Buntinx M, 2002, J NEUROIMMUNOL, V124, P70, DOI 10.1016/S0165-5728(01)00495-7; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Fantini MC, 2007, NAT PROTOC, V2, P1789, DOI 10.1038/nprot.2007.258; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Healy LM, 2013, BRIT J PHARMACOL, V169, P1114, DOI 10.1111/bph.12207; Hu YH, 2011, MOL CELL NEUROSCI, V48, P72, DOI 10.1016/j.mcn.2011.06.007; Hwang SJ, 2010, LAB INVEST, V90, P9, DOI 10.1038/labinvest.2009.109; Idzko M, 2002, FASEB J, V16, P625, DOI 10.1096/fj.01-0625fje; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Jackson SJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-76; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim HJ, 2011, FASEB J, V25, P1509, DOI 10.1096/fj.10-173203; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Ling CY, 2008, J IMMUNOL, V180, P8393, DOI 10.4049/jimmunol.180.12.8393; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Noda H, 2013, J NEUROIMMUNOL, V256, P13, DOI 10.1016/j.jneuroim.2012.12.005; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okamoto H, 1999, BIOCHEM BIOPH RES CO, V260, P203, DOI 10.1006/bbrc.1999.0886; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Oz-Arslan D, 2006, J LEUKOCYTE BIOL, V80, P287, DOI 10.1189/jlb.1205751; Ozenci V, 1999, SCAND J IMMUNOL, V49, P554; PANITCH HS, 1987, LANCET, V1, P893; Poti F, 2013, ARTERIOSCL THROM VAS, V33, P1505, DOI 10.1161/ATVBAHA.113.301347; Pritchard AJ, 2013, FUTURE NEUROLOGY, V8, P487; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Schneider A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004970; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163; Sepulcre J, 2005, CYTOKINE, V32, P111, DOI 10.1016/j.cyto.2005.08.005; Sheridan GK, 2012, GLIA, V60, P382, DOI 10.1002/glia.22272; Shrestha R, 2014, NEUROPHARMACOLOGY, V76, P184, DOI 10.1016/j.neuropharm.2013.06.025; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Stelmasiak Z, 2000, MED SCI MONITOR, V6, P1108; Sun Y, 2011, AM J REPROD IMMUNOL, V66, P349, DOI 10.1111/j.1600-0897.2011.01010.x; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Wolf AM, 2009, J IMMUNOL, V183, P3751, DOI 10.4049/jimmunol.0901011; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yang Y, 2011, DEV BIOL, V350, P127, DOI 10.1016/j.ydbio.2010.11.028; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	59	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99444	10.1371/journal.pone.0099444	http://dx.doi.org/10.1371/journal.pone.0099444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911000	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600089
J	Brandstedt, J; Wangefjord, S; Nodin, B; Eberhard, J; Sundstrom, M; Manjer, J; Jirstrom, K				Brandstedt, Jenny; Wangefjord, Sakarias; Nodin, Bjorn; Eberhard, Jakob; Sundstrom, Magnus; Manjer, Jonas; Jirstrom, Karin			Associations of Anthropometric Factors with KRAS and BRAF Mutation Status of Primary Colorectal Cancer in Men and Women: A Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; ISLAND METHYLATOR PHENOTYPE; BETA-CATENIN ALTERATIONS; LIFE-STYLE FACTORS; KI-RAS MUTATIONS; COLON-CANCER; MICROSATELLITE INSTABILITY; PHYSICAL-ACTIVITY; CIGARETTE-SMOKING; TUMOR-DEVELOPMENT	Obesity is a well-established risk factor for colorectal cancer (CRC), and accumulating evidence suggests a differential influence of sex and anthropometric factors on the molecular carcinogenesis of the disease. The aim of the present study was to investigate the relationship between height, weight, bodyfat percentage, waist-and hip circumference, waist-hip ratio (WHR), body mass index (BMI) and CRC risk according to KRAS and BRAF mutation status of the tumours, with particular reference to potential sex differences. KRAS and BRAF mutations were analysed by pyrosequencing in tumours from 494 incident CRC cases in the Malmo Diet and Cancer Study. Hazard ratios of CRC risk according to anthropometric factors and mutation status were calculated using multivariate Cox regression models. While all anthropometric measures except height were associated with an increased risk of KRAS-mutated tumours, only BMI was associated with an increased risk of KRAS wild type tumours overall. High weight, hip, waist, WHR and BMI were associated with an increased risk of BRAF wild type tumours, but none of the anthropometric factors were associated with risk of BRAF-mutated CRC, neither in the overall nor in the sex-stratified analysis. In men, several anthropometric measures were associated with both KRAS-mutated and KRAS wild type tumours. In women, only a high WHR was significantly associated with an increased risk of KRA-Smutated CRC. A significant interaction was found between sex and BMI with respect to risk of KRAS-mutated tumours. In men, all anthropometric factors except height were associated with an increased risk of BRAF wild type tumours, whereas in women, only bodyfat percentage was associated with an increased risk of BRAF wild type tumours. The results from this prospective cohort study further support an influence of sex and lifestyle factors on different pathways of colorectal carcinogenesis, defined by KRAS and BRAF mutation status of the tumours.	[Brandstedt, Jenny; Wangefjord, Sakarias; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Brandstedt, Jenny; Wangefjord, Sakarias] Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Sundstrom, Magnus] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Manjer, Jonas] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Plast Surg, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Uppsala University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Brandstedt, J (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.	Jenny.brandstedt@med.lu.se			Knut and Alice Wallenberg Foundation; Swedish Cancer Society; Gunnar Nilsson Cancer Foundation, Region Skane; Research Funds of Skane University Hospital	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Foundation, Region Skane; Research Funds of Skane University Hospital	This study was supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Cancer Society, the Gunnar Nilsson Cancer Foundation, Region Skane and the Research Funds of Skane University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Bazan V, 2002, ANN ONCOL, V13, P1438, DOI 10.1093/annonc/mdf226; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bond CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047483; Brandstedt J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-293; Brandstedt J, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-23; Chen K, 2005, EUR J EPIDEMIOL, V20, P149, DOI 10.1007/s10654-004-2953-4; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Deng G, 2008, EUR J CANCER, V44, P1290, DOI 10.1016/j.ejca.2008.03.014; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P192, DOI 10.1093/jnci/86.3.192; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Hughes LAE, 2012, INT J EPIDEMIOL, V41, P1060, DOI 10.1093/ije/dys055; Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Kalady MF, 2012, DIS COLON RECTUM, V55, P128, DOI 10.1097/DCR.0b013e31823c08b3; KATZ MH, 1993, J GEN INTERN MED, V8, P702, DOI 10.1007/BF02598295; Kim GP, 2007, J CLIN ONCOL, V25, P767, DOI 10.1200/JCO.2006.05.8172; Kim IJ, 2006, CARCINOGENESIS, V27, P392, DOI 10.1093/carcin/bgi237; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; MacInnis RJ, 2006, INT J CANCER, V118, P1496, DOI 10.1002/ijc.21508; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nash GM, 2010, ANN SURG ONCOL, V17, P416, DOI 10.1245/s10434-009-0713-0; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Palmer RC, 2005, CANCER CAUSE CONTROL, V16, P55, DOI 10.1007/s10552-004-1253-3; Pancione Massimo, 2012, Patholog Res Int, V2012, P509348, DOI 10.1155/2012/509348; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Russo A, 2009, ONCOLOGY-BASEL, V77, P57, DOI 10.1159/000258497; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2010, CANCER CAUSE CONTROL, V21, P1237, DOI 10.1007/s10552-010-9551-4; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 2003, CANCER CAUSE CONTROL, V14, P75, DOI 10.1023/A:1022545017867; Slattery ML, 2001, MUTAT RES-FUND MOL M, V483, P73, DOI 10.1016/S0027-5107(01)00228-7; Steen B, 1987, Compr Gerontol A, V1, P102; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wangefjord S, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-17; Wangefjord S, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-10; Wangefjord Sakarias, 2011, Biol Sex Differ, V2, P10, DOI 10.1186/2042-6410-2-10; Yokota T, 2011, BRIT J CANCER, V104, P856, DOI 10.1038/bjc.2011.19; Zlobec I, 2010, INT J CANCER, V127, P2569, DOI 10.1002/ijc.25265	56	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98964	10.1371/journal.pone.0098964	http://dx.doi.org/10.1371/journal.pone.0098964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918610	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000036
J	Lerman, K; Hogg, T				Lerman, Kristina; Hogg, Tad			Leveraging Position Bias to Improve Peer Recommendation	PLOS ONE			English	Article							SOCIAL-INFLUENCE	With the advent of social media and peer production, the amount of new online content has grown dramatically. To identify interesting items in the vast stream of new content, providers must rely on peer recommendation to aggregate opinions of their many users. Due to human cognitive biases, the presentation order strongly affects how people allocate attention to the available content. Moreover, we can manipulate attention through the presentation order of items to change the way peer recommendation works. We experimentally evaluate this effect using Amazon Mechanical Turk. We find that different policies for ordering content can steer user attention so as to improve the outcomes of peer recommendation.	[Lerman, Kristina] USC Informat Sci Inst, Marina Del Rey, CA 90292 USA; [Hogg, Tad] Inst Mol Mfg, Palo Alto, CA USA	University of Southern California	Lerman, K (corresponding author), USC Informat Sci Inst, Marina Del Rey, CA 90292 USA.	lerman@isi.edu	Lerman, Kristina/P-5138-2019; Lerman, Kristina/F-4198-2010	Lerman, Kristina/0000-0002-5071-0575	AFOSR [FA9550-10-1-0569]; DARPA [W911NF-12-1-0034]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported in part by AFOSR (contract FA9550-10-1-0569) and by DARPA (contract W911NF-12-1-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUNCH NJ, 1984, J MARKETING RES, V21, P216, DOI 10.2307/3151704; Bohannon J, 2011, SCIENCE, V334, P307, DOI 10.1126/science.334.6054.307; BRANDTZAEG PB, 2007, INTETAIN 08, P1; Buscher G, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P21; Craswell N, 2008, PROC INTERNAT C WEB, P87, DOI 10.1145/1341531.1341545; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Hodas N.O., 2012, ASE IEEE INT C SOC C; Hogg T, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds5; Joachims T., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P154, DOI 10.1145/1076034.1076063; Kittur A, 2013, C COMPUTER SUPPORTED, P1301, DOI [DOI 10.1145/2441776.2441923, 10.1145/2441776.2441923]; Krumme C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033785; Lampe C., 2004, C HUMAN FACTORS COMP, P543, DOI [DOI 10.1145/985921.986080, DOI 10.1145/985692.985761]; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Payne SL, 1951, ART ASKING QUESTIONS; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Salganik MJ, 2008, SOC PSYCHOL QUART, V71, P338, DOI 10.1177/019027250807100404; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Surowiecki J., 2005, WISDOM CROWDS; Yue Y., 2010, P 19 INT C WORLD WID, P1011, DOI DOI 10.1145/1772690.1772793	21	44	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98914	10.1371/journal.pone.0098914	http://dx.doi.org/10.1371/journal.pone.0098914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919071	gold, Green Submitted, Green Published			2022-12-27	WOS:000338631000033
J	McCabe, RM; Grutsch, JF; Nutakki, SB; Braun, DP; Markman, M				McCabe, Ryan M.; Grutsch, James F.; Nutakki, Swetha B.; Braun, Donald P.; Markman, Maurie			Can Quality of Life Assessments Differentiate Heterogeneous Cancer Patients?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; EORTC QLQ-C30; LUNG-CANCER; HEALTH; ONCOLOGY; SCORES; OUTCOMES; INSTRUMENTS; VARIABLES; DISTRESS	Purpose: This research conducted a face validation study of patient responses to the application of an HRQOL assessment research tool in a comprehensive community cancer program setting across a heterogeneous cohort of cancer patients throughout the natural history of diagnosed malignant disease, many of whom would not be considered candidates for clinical research trial participation. Methods: Cancer registries at two regional cancer treatment centers identified 11072 cancer patients over a period of nine years. The EORTC QLQ-C30 was administered to patients at the time of their initial clinical presentation to these centers. To determine the significance of differences between patient subgroups, two analytic criteria were used. The Mann-Whitney test was used to determine statistical significance; clinical relevance defined a range of point differences that could be perceived by patients with different health states. Results: Univariate analyses were conducted across stratification variables for population, disease severity and demographic characteristics. The largest differences were associated with cancer diagnosis and recurrence of disease. Large differences were also found for site of origin, mortality and stage; minimal differences were observed for gender and age. Consistently sensitive QoL scales were appetite loss, fatigue and pain symptoms, and role (work-related), social and physical functions. Conclusions: 1) The EORTC QLQ-C30 collected meaningful patient health assessments in the context of non-research based clinical care, 2) patient assessment differences are manifested disparately across 15 QoL domains, and 3) in addition to indicating how a patient may feel at a point in time, QoL indicators may also reveal information about underlying biological responses to disease progression, treatments, and prospective survival.	[McCabe, Ryan M.; Grutsch, James F.; Nutakki, Swetha B.; Braun, Donald P.] Midwestern Reg Med Ctr, Canc Treatment Ctr Amer, Zion, IL USA; [Grutsch, James F.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol, Chicago, IL USA; [Markman, Maurie] Eastern Reg Med Ctr, Canc Treatment Ctr Amer, Philadelphia, PA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	McCabe, RM (corresponding author), Amer Coll Surg, Chicago, IL 60611 USA.	rmccabe@facs.org			Cancer Treatment Centers of America	Cancer Treatment Centers of America	The research program is funded by Cancer Treatment Centers of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bjordal K, 2000, EUR J CANCER, V36, P1796, DOI 10.1016/S0959-8049(00)00186-6; Bottomley A, 2002, ONCOLOGIST, V7, P120, DOI 10.1634/theoncologist.7-2-120; Bowling A, 2001, SOCIOLOGY HLTH ILLNE, V18, P395; Cella D, 2002, QUAL LIFE RES, V11, P207, DOI 10.1023/A:1015276414526; Cocks K, 2008, EUR J CANCER, V44, P1793, DOI 10.1016/j.ejca.2008.05.008; Cocks K, 2011, J CLIN ONCOL, V29, P89, DOI 10.1200/JCO.2010.28.0107; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Du-Quiton J, 2010, PSYCHO-ONCOLOGY, V19, P180, DOI 10.1002/pon.1539; Ferrans Carol Estwing, 2007, J Natl Cancer Inst Monogr, P22, DOI 10.1093/jncimonographs/lgm008; Gordon JS, 2008, HEMATOL ONCOL CLIN N, V22, P683, DOI 10.1016/j.hoc.2008.04.010; Grutsch JF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-193; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Halyard Michele Y, 2008, J Support Oncol, V6, P221; Hjermstad MJ, 1998, EUR J CANCER, V34, P1381, DOI 10.1016/S0959-8049(98)00136-1; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; King MT, 1996, QUAL LIFE RES, V5, P555, DOI 10.1007/BF00439229; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lis CG, 2009, PATIENT PREFER ADHER, V3, P287; Maringwa JT, 2011, SUPPORT CARE CANCER, V19, P1753, DOI 10.1007/s00520-010-1016-5; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Osoba D, 1997, QUAL LIFE RES, V6, P103; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pickard AS, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-4; Quinten C, 2011, JNCI-J NATL CANCER I, V103, P1851, DOI 10.1093/jnci/djr485; Rabkin JG, 2009, PSYCHO-ONCOLOGY, V18, P79, DOI 10.1002/pon.1386; Scott N., 2008, EORTC QLQ C30 REFERE; Sloan J. A., 2003, SOCRA SOURCE, V38, P23; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Tishelman C, 2007, J CLIN ONCOL, V25, P5381, DOI 10.1200/JCO.2006.08.7874; UNGER JM, 2014, J NATL CANC I; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P667, DOI 10.1016/j.ejca.2010.11.004; Velikova G, 1999, EUR J CANCER, V35, P1571, DOI 10.1016/S0959-8049(99)00193-8; Velikova G, 2010, EUR J CANCER, V46, P2381, DOI 10.1016/j.ejca.2010.04.030; Visser M, 2005, QUAL LIFE RES, V14, P2109, DOI 10.1007/s11136-004-2577-x; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99445	10.1371/journal.pone.0099445	http://dx.doi.org/10.1371/journal.pone.0099445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919068	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000087
J	Kelly, CM; van Oosterhout, JJ; Ngwalo, C; Stewart, RC; Benjamin, L; Robertson, KR; Khoo, S; Allain, TJ; Solomon, T				Kelly, Christine M.; van Oosterhout, Joep J.; Ngwalo, Chisomo; Stewart, Robert C.; Benjamin, Laura; Robertson, Kevin R.; Khoo, Saye; Allain, Theresa J.; Solomon, Tom			HIV Associated Neurocognitive Disorders (HAND) in Malawian Adults and Effect on Adherence to Combination Anti-Retroviral Therapy: A Cross Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEDICATION ADHERENCE; RISK-FACTORS; INFECTED PATIENTS; DEMENTIA; IMPAIRMENT; PERFORMANCE; INDIVIDUALS; PREVALENCE; DEPRESSION	Background: Little is known about the prevalence and burden of HIV associated neurocognitive disorder (HAND) among patients on combination antiretroviral therapy (cART) in sub-Saharan Africa. We estimated the prevalence of HAND in adult Malawians on cART and investigated the relationship between HAND and adherence to cART. Methods: HIV positive adults in Blantyre, Malawi underwent a full medical history, neurocognitive test battery, depression score, Karnofsky Performance Score and adherence assessment. The Frascati criteria were used to diagnose HAND and the Global Deficit Score (GDS) was also assessed. Blood was drawn for CD4 count and plasma nevirapine and efavirenz concentrations. HIV negative adults were recruited from the HIV testing clinic to provide normative scores for the neurocognitive battery. Results: One hundred and six HIV positive patients, with median (range) age 39 (18-71) years, 73% female and median (range) CD4 count 323.5 (68-1039) cells/mu l were studied. Symptomatic neurocognitive impairment was present in 15% (12% mild neurocognitive disorder [MND], 3% HIV associated dementia [HAD]). A further 55% fulfilled Frascati criteria for asymptomatic neurocognitive impairment (ANI); however factors other than neurocognitive impairment could have confounded this estimate. Neither the symptomatic (MND and HAD) nor asymptomatic (ANI) forms of HAND were associated with subtherapeutic nevirapine/efavirenz concentrations, adjusted odds ratio 1.44 (CI. 0.234, 8.798; p = 0.696) and aOR 0.577 (CI. 0.09, 3.605; p = 0.556) respectively. All patients with subtherapeutic nevirapine/efavirenz levels had a GDS of less than 0.6, consistent with normal neurocognition. Discussion/Conclusion: Fifteen percent of adult Malawians on cART had a diagnosis of MND or HAD. Subtherapeutic drug concentrations were found exclusively in patients with normal neurocognitive function suggesting HAND did not affect cART adherence. Further study of HAND requires more robust locally derived normative neurocognitive values and determination of the clinical relevance of ANI.	[Kelly, Christine M.; Benjamin, Laura; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Liverpool L69 3BX, Merseyside, England; [Kelly, Christine M.] Queen Elizabeth Cent Hosp, Coll Med, Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [van Oosterhout, Joep J.; Ngwalo, Chisomo; Allain, Theresa J.] Coll Med, Dept Med, Blantyre, Malawi; [Stewart, Robert C.] Coll Med, Dept Mental Hlth, Blantyre, Malawi; [Robertson, Kevin R.] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Khoo, Saye] Univ Liverpool, Inst Translat Med, HIV Pharmacol Grp, Liverpool L69 3BX, Merseyside, England; [van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Solomon, Tom] Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England	University of Liverpool; University of Malawi; University of Malawi; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill; University of Liverpool; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Liverpool L69 3BX, Merseyside, England.	tsolomon@liverpool.ac.uk		Solomon, Tom/0000-0001-7266-6547; Kelly, Christine/0000-0002-3239-7714; Benjamin, Laura/0000-0002-9685-1664	Liverpool Glasgow Wellcome Centre for Global Health Research [099934/Z/12/A]; Medical Research Council [G0901364] Funding Source: researchfish; MRC [G0901364] Funding Source: UKRI	Liverpool Glasgow Wellcome Centre for Global Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CMK is a Wellcome Trust Training Fellow supported by the Liverpool Glasgow Wellcome Centre for Global Health Research. Grant number 099934/Z/12/A, http://www.wellcome.ac.uk/Funding. TS is an MRC Senior Clinical Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abers MS, 2014, CNS DRUGS, V28, P131, DOI 10.1007/s40263-013-0132-4; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Braganca M, 2011, AIDS BEHAV, V15, P1879, DOI 10.1007/s10461-011-9973-3; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Else L, 2010, J CHROMATOGR B, V878, P1455, DOI 10.1016/j.jchromb.2010.03.036; Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd; Fabbiani M, 2013, HIV MED, V14, P136, DOI 10.1111/j.1468-1293.2012.01044.x; Garvey L, 2011, HIV CLIN TRIALS, V12, P333, DOI 10.1310/hct1206-333; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Haddow LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061826; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; Joska JA, 2011, AIDS PATIENT CARE ST, V25, P95, DOI 10.1089/apc.2010.0292; Karnofsky D. A., 1949, EVALUATION CHEMOTHER, P196; Kim DH, 2001, CAN J NEUROL SCI, V28, P228, DOI 10.1017/S0317167100001372; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Lawler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017233; Fernandes SM, 2012, INT PSYCHOGERIATR, V24, P1648, DOI 10.1017/S1041610212000944; McArthur JC, 2010, AIDS, V24, P1367, DOI 10.1097/QAD.0b013e3283391d56; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nakku J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-126; Nanzigu S, 2012, HIV MED, V13, P193, DOI 10.1111/j.1468-1293.2011.00952.x; Njamnshi AK, 2008, JAIDS-J ACQ IMM DEF, V49, P393, DOI 10.1097/QAI.0b013e318183a9df; Oshinaike OO, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/581531; Parsons TD, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-11; Patel VN, 2010, INT J STD AIDS, V21, P356, DOI 10.1258/ijsa.2010.009554; Robbins RN, 2011, AIDS PATIENT CARE ST, V25, P587, DOI 10.1089/apc.2011.0154; Robertson K, 2011, J NEUROVIROL, V17, P438, DOI 10.1007/s13365-011-0044-3; Robertson K, 2009, NEUROPSYCHOL REV, V19, P232, DOI 10.1007/s11065-009-9096-z; Robertson KR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-8; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Sacktor NC, 2005, AIDS, V19, P1367; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Selnes OA, 2002, JAIDS-J ACQ IMM DEF, V31, pS132, DOI 10.1097/00126334-200212153-00009; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Tozzi V, 2004, INT J STD AIDS, V15, P254, DOI 10.1258/095646204773557794; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8	44	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98962	10.1371/journal.pone.0098962	http://dx.doi.org/10.1371/journal.pone.0098962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915530	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700046
J	Niyompanich, S; Jaresitthikunchai, J; Srisanga, K; Roytrakul, S; Tungpradabkul, S				Niyompanich, Suthamat; Jaresitthikunchai, Janthima; Srisanga, Kitima; Roytrakul, Sittiruk; Tungpradabkul, Sumalee			Source-Identifying Biomarker Ions between Environmental and Clinical Burkholderia pseudomallei Using Whole-Cell Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS)	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; NORTHERN AUSTRALIA; IDENTIFICATION; MELIOIDOSIS; BACTERIA; INSIGHTS; DISCRIMINATION; CLASSIFICATION; EPIDEMIOLOGY; STRAINS	Burkholderia pseudomallei is the causative agent of melioidosis, which is an endemic disease in Northeast Thailand and Northern Australia. Environmental reservoirs, including wet soils and muddy water, serve as the major sources for contributing bacterial infection to both humans and animals. The whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (whole-cell MALDI-TOF MS) has recently been applied as a rapid, accurate, and high-throughput tool for clinical diagnosis and microbiological research. In this present study, we employed a whole-cell MALDI-TOF MS approach for assessing its potency in clustering a total of 11 different B. pseudomallei isolates (consisting of 5 environmental and 6 clinical isolates) with respect to their origins and to further investigate the source-identifying biomarker ions belonging to each bacterial group. The cluster analysis demonstrated that six out of eleven isolates were grouped correctly to their sources. Our results revealed a total of ten source-identifying biomarker ions, which exhibited statistically significant differences in peak intensity between average environmental and clinical mass spectra using ClinProTools software. Six out of ten mass ions were assigned as environmental-identifying biomarker ions (EIBIs), including, m/z 4,056, 4,214, 5,814, 7,545, 7,895, and 8,112, whereas the remaining four mass ions were defined as clinical-identifying biomarker ions (CIBIs) consisting of m/z 3,658, 6,322, 7,035, and 7,984. Hence, our findings represented, for the first time, the source-specific biomarkers of environmental and clinical B. pseudomallei.	[Niyompanich, Suthamat; Srisanga, Kitima; Tungpradabkul, Sumalee] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Jaresitthikunchai, Janthima; Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Tungpradabkul, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	sumalee.tan@mahidol.ac.th			Thailand Research Fund; RGJ (the Royal Golden Jubilee) [PHD/0341/2551]; Faculty of Science Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); RGJ (the Royal Golden Jubilee); Faculty of Science Mahidol University	This work was supported by the Thailand Research Fund and Faculty of Science Mahidol University. S. Niyompanich received the Ph. D. scholarship from RGJ (the Royal Golden Jubilee) No. PHD/0341/2551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 2013, J CLIN MICROBIOLOGY; Bartpho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037762; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chen YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09; Cheng AC, 2004, J CLIN MICROBIOL, V42, P5477, DOI 10.1128/JCM.42.12.5477-5483.2004; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; CURRIE B, 1994, EPIDEMIOL INFECT, V113, P307, DOI 10.1017/S0950268800051736; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; Demirev PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/jms.1474; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Donohue MJ, 2006, J MICROBIOL METH, V65, P380, DOI 10.1016/j.mimet.2005.08.005; Eddabra R, 2012, MICROBIOL RES, V167, P226, DOI 10.1016/j.micres.2011.09.002; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Giebel RA, 2008, WATER RES, V42, P931, DOI 10.1016/j.watres.2007.09.005; Haase A, 1997, J MED MICROBIOL, V46, P557, DOI 10.1099/00222615-46-7-557; HAASE A, 1995, J CLIN MICROBIOL, V33, P1687, DOI 10.1128/JCM.33.7.1687-1690.1995; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2000, EMERG INFECT DIS, V6, P56; Intelicato-Young J, 2013, J MICROBIOL METH, V92, P381, DOI 10.1016/j.mimet.2013.01.004; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229; Ketterlinus Ralf, 2005, Biotechniques, VSuppl, P37; Krasny L, 2013, INT J MASS SPECTROM, V353, P67, DOI 10.1016/j.ijms.2013.04.016; Leelayuwat C, 2000, ACTA TROP, V77, P229, DOI 10.1016/S0001-706X(00)00137-6; Liew SM, 2012, TROP BIOMED, V29, P160; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Niumsup P, 2002, J ANTIMICROB CHEMOTH, V50, P445, DOI 10.1093/jac/dkf165; Norton R, 1998, FEMS IMMUNOL MED MIC, V20, P37, DOI 10.1016/S0928-8244(97)00104-1; Rajakaruna L, 2009, INFECT GENET EVOL, V9, P507, DOI 10.1016/j.meegid.2009.01.012; Rattanavong S, 2011, APPL ENVIRON MICROB, V77, P532, DOI 10.1128/AEM.01822-10; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sandrin TR, 2013, MASS SPECTROM REV, V32, P188, DOI 10.1002/mas.21359; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sermswan RW, 2001, ACTA TROP, V80, P237, DOI 10.1016/S0001-706X(01)00176-0; Siegrist TJ, 2007, J MICROBIOL METH, V68, P554, DOI 10.1016/j.mimet.2006.10.012; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Tanigawa K, 2010, APPL ENVIRON MICROB, V76, P4055, DOI 10.1128/AEM.02698-09; Trakulsomboon Suwanna, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P756; Tungpradabkul S, 1999, MOL CELL PROBE, V13, P99, DOI 10.1006/mcpr.1999.0221; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Valentine N, 2005, APPL ENVIRON MICROB, V71, P58, DOI 10.1128/AEM.71.1.58-64.2005; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Vuddhakul V, 1999, AM J TROP MED HYG, V60, P458, DOI 10.4269/ajtmh.1999.60.458; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Winstanley C, 1998, J MED MICROBIOL, V47, P689, DOI 10.1099/00222615-47-8-689; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002	52	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99160	10.1371/journal.pone.0099160	http://dx.doi.org/10.1371/journal.pone.0099160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914956	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700068
J	Wang, XF; Wahl, R				Wang, Xiaofei; Wahl, Richard			Responses of the Insulin Signaling Pathways in the Brown Adipose Tissue of Rats following Cold Exposure	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER GLUT-4; IN-VIVO; F-18-FDG PET/CT; USA-FAT; ACCLIMATION; ADIPOCYTES; EXPRESSION; PKA; THERMOGENESIS; METABOLISM	The insulin signaling pathway is critical for the control of blood glucose levels. Brown adipose tissue (BAT) has also been implicated as important in glucose homeostasis. The effect of short-term cold exposure on this pathway in BAT has not been explored. We evaluated the effect of 4 hours of cold exposure on the insulin pathway in the BAT of rats. Whole genomic microarray chips were used to examine the transcripts of the pathway in BAT of rats exposed to 4 degrees C and 22 degrees C for 4 hours. The 4 most significantly altered pathways following 4 hours of cold exposure were the insulin signaling pathway, protein kinase A, PI3K/AKT and ERK/MAPK signaling. The insulin signaling pathway was the most affected. In the documented 142 genes of the insulin pathway, 42 transcripts (29.6%) responded significantly to this cold exposure with the least false discovery rate (Benjamini-Hochberg Multiple Testing: -log10 (p-value) = 7.18). Twenty-seven genes (64%) were up-regulated, including the insulin receptor (Insr), insulin substrates 1 and 2 (Irs1 and Irs2). Fifteen transcripts (36%) were down-regulated. Multiple transcripts of the primary target and secondary effector targets for the insulin signaling were also up-regulated, including those for carbohydrate metabolism. Using western blotting, we demonstrated that the cold induced higher Irs2, Irs1, and Akt-p protein levels in the BAT than in the BAT of controls maintained at room temperature, and higher Akt-p protein level in the muscle. Conclusion: this study demonstrated that 4 hours of cold exposure stimulated the insulin signaling pathway in the BAT and muscle of overnight fasted rats. This raises the possibility that acute cold stimulation may have potential to improve glucose clearance and insulin sensitivity.	[Wang, Xiaofei; Wahl, Richard] Johns Hopkins Univ, Sch Med, Div Nucl Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Wang, XF (corresponding author), Johns Hopkins Univ, Sch Med, Div Nucl Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	xfwang2002@yahoo.com; rwahl@jhmi.edu		WAHL, RICHARD L./0000-0002-7306-2590	Ruth L. Kirschstein-National Service Research Award from NIH [T32EB006351]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Ruth L. Kirschstein-National Service Research Award from NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Ruth L. Kirschstein-National Service Research Award from NIH (T32EB006351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CAMERON IL, 1964, J CELL BIOL, V23, P89, DOI 10.1083/jcb.23.1.89; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2003, J NUCL MED, V44, P170; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Dallner OS, 2006, ENDOCRINOLOGY, V147, P5730, DOI 10.1210/en.2006-0242; Farese RV, 2005, EXP BIOL MED, V230, P593; Gasparetti AL, 2005, PFLUG ARCH EUR J PHY, V449, P537, DOI 10.1007/s00424-004-1359-1; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HARDMAN MJ, 1970, J PHYSIOL-LONDON, V206, P263, DOI 10.1113/jphysiol.1970.sp009012; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; HIMMSHAGEN J, 1972, LIPIDS, V7, P310, DOI 10.1007/BF02532649; HIMMSHAGEN J, 1995, OBES RES, V3, P361, DOI 10.1002/j.1550-8528.1995.tb00162.x; LOPEZSORIANO FJ, 1988, BIOCHEM J, V252, P843, DOI 10.1042/bj2520843; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Mizuma H, 2010, J NUCL MED, V51, P1068, DOI 10.2967/jnumed.110.075184; OLICHONBERTHE C, 1992, MOL CELL ENDOCRINOL, V89, P11, DOI 10.1016/0303-7207(92)90205-K; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; SHIBATA H, 1989, AM J PHYSIOL, V257, pR96, DOI 10.1152/ajpregu.1989.257.1.R96; SHIMIZU Y, 1993, AM J PHYSIOL, V264, pE890, DOI 10.1152/ajpendo.1993.264.6.E890; SUTER ER, 1969, J ULTRA MOL STRUCT R, V26, P216, DOI 10.1016/S0022-5320(69)80003-1; Taha C, 1997, AM J PHYSIOL-ENDOC M, V273, pE68, DOI 10.1152/ajpendo.1997.273.1.E68; Tatsumi M, 2004, J NUCL MED, V45, P1189; Valladares A, 2000, J CELL PHYSIOL, V185, P324, DOI 10.1002/1097-4652(200012)185:3<324::AID-JCP2>3.0.CO;2-Q; VALLERAND AL, 1983, AM J PHYSIOL, V245, pE575, DOI 10.1152/ajpendo.1983.245.6.E575; VALLERAND AL, 1987, AM J PHYSIOL, V253, pE179, DOI 10.1152/ajpendo.1987.253.2.E179; VALLERAND AL, 1990, AM J PHYSIOL, V259, pR1043, DOI 10.1152/ajpregu.1990.259.5.R1043; Wang X, 2012, J VIS EXP, DOI [10.3791/e4060, DOI 10.3791/E4060]; Wu S, 2012, DIABETES, V61, P114, DOI 10.2337/db11-0956	34	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99772	10.1371/journal.pone.0099772	http://dx.doi.org/10.1371/journal.pone.0099772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915042	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700132
J	Lee, BG; Qiao, LP; Kinney, B; Feng, GS; Shao, JH				Lee, Bonggi; Qiao, Liping; Kinney, Brice; Feng, Gen-Sheng; Shao, Jianhua			Macrophage Depletion Disrupts Immune Balance and Energy Homeostasis	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; COLONY-STIMULATING FACTOR; CELL-LINEAGE-ABLATION; ADIPOSE-TISSUE; FOOD-INTAKE; STROMAL CELLS; ACTIVATION; OBESITY; INFLAMMATION; NEUTROPHILS	Increased macrophage infiltration in tissues including white adipose tissue and skeletal muscle has been recognized as a pro-inflammatory factor that impairs insulin sensitivity in obesity. However, the relationship between tissue macrophages and energy metabolism under non-obese physiological conditions is not clear. To study a homeostatic role of macrophages in energy homeostasis, we depleted tissue macrophages in adult mice through conditional expression of diphtheria toxin (DT) receptor and DT-induced apoptosis. Macrophage depletion robustly reduced body fat mass due to reduced energy intake. These phenotypes were reversed after macrophage recovery. As a potential mechanism, severe hypothalamic and systemic inflammation was induced by neutrophil (NE) infiltration in the absence of macrophages. In addition, macrophage depletion dramatically increased circulating granulocyte colony-stimulating factor (G-CSF) which is indispensable for NE production and tissue infiltration. Our in vitro study further revealed that macrophages directly suppress G-CSF gene expression. Therefore, our study indicates that macrophages may play a critical role in integrating immune balance and energy homeostasis under physiological conditions.	[Lee, Bonggi; Qiao, Liping; Kinney, Brice; Shao, Jianhua] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Shao, JH (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	jishao@ucsd.edu			NIH [DK080418, HD069634, DK095132, R01DK075916]; American Diabetes Association [1-13-BS-048]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075916, R01DK095132, R01DK080418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grants DK080418 (J.S.), HD069634 (J.S.), DK095132 (J.S.) and R01DK075916 (G. F.) from the NIH, as well as 1-13-BS-048 (G.F.) from the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2003, EXP TOXICOL PATHOL, V55, P21, DOI 10.1078/0940-2993-00297; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buchanan JB, 2007, NEUROENDOCRINOLOGY, V86, P183, DOI 10.1159/000108280; Butera PC, 2004, PHYSIOL BEHAV, V82, P777, DOI 10.1016/j.physbeh.2004.06.018; Chadzinska M, 2004, FOLIA BIOL-KRAKOW, V52, P225, DOI 10.3409/1734916044527557; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hierholzer C, 1998, J LEUKOCYTE BIOL, V63, P169, DOI 10.1002/jlb.63.2.169; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; PlataSalaman CR, 1996, PHYSIOL BEHAV, V60, P867, DOI 10.1016/S0031-9384(96)00148-5; RENNICK D, 1987, BLOOD, V69, P682; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; WATARI K, 1994, STEM CELLS, V12, P416, DOI 10.1002/stem.5530120409; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	39	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99575	10.1371/journal.pone.0099575	http://dx.doi.org/10.1371/journal.pone.0099575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911652	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600106
J	Rosenberger, A; Liphardt, AM; Bargmann, A; Muller, K; Beck, L; Mester, J; Zange, J				Rosenberger, Andre; Liphardt, Anna-Maria; Bargmann, Arne; Mueller, Klaus; Beck, Luis; Mester, Joachim; Zange, Jochen			EMG and Heart Rate Responses Decline within 5 Days of Daily Whole-Body Vibration Training with Squatting	PLOS ONE			English	Article							BED-REST; MUSCLE-ACTIVITY; OXYGEN-UPTAKE; EXERCISE; FREQUENCY; SYNCHRONIZATION; RECRUITMENT; AMPLITUDE; EXPOSURE; BENEFITS	In this study, we examined the acute effects of a 5-day daily whole-body vibration (WBV) training on electromyography (EMG) responses of the m. rectus femoris and m. gastrocnemius lateralis, heart rate (HR, continuously recorded), and blood lactate levels. The purpose of the study was to investigate the adaptation of muscle activity, heart rate and blood lactate levels during 5 days of daily training. Two groups of healthy male subjects performed either squat exercises with vibration at 20 Hz on a side alternating platform (SE+V, n = 20, age = 31.9 +/- 7.5 yrs., height = 178.8 +/- 6.2 cm, body mass = 79.2 +/- 11.4 kg) or squat exercises alone (SE, n = 21, age = 28.4 +/- 7.3 years, height = 178.9 +/- 7.4 cm, body mass = 77.2 +/- 9.7 kg). On training day 1, EMG amplitudes of the m. rectus femoris were significantly higher (P<0.05) during SE+V than during SE. However, this difference was no longer statistically significant on training days 3 and 5. The heart rate (HR) response was significantly higher (P<0.05) during SE+V than during SE on all training days, but showed a constant decline throughout the training days. On training day 1, blood lactate increased significantly more after SE+V than after SE (P<0.05). On the following training days, this difference became much smaller but remained significantly different. The specific physiological responses to WBV were largest on the initial training day and most of them declined during subsequent training days, showing a rapid neuromuscular and cardiovascular adaptation to the vibration stimulus.	[Rosenberger, Andre; Liphardt, Anna-Maria; Bargmann, Arne; Mueller, Klaus; Beck, Luis; Zange, Jochen] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Rosenberger, Andre; Liphardt, Anna-Maria; Mester, Joachim] German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany; [Bargmann, Arne; Zange, Jochen] Univ Cologne, Fac Med, D-50931 Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR); German Sport University Cologne; University of Cologne	Rosenberger, A (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany.	andre.rosenberger@dlr.de		Liphardt, Anna-Maria/0000-0003-0739-1959; Zange, Jochen/0000-0003-1822-0952				Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1794, DOI 10.1249/mss.0b013e3181238a0f; Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1642, DOI 10.1249/mss.0b013e318093f551; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695, DOI 10.1113/jphysiol.1976.sp011581; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Cardinale Marco, 2006, J Br Menopause Soc, V12, P12, DOI 10.1258/136218006775997261; Cardinale M, 2006, CLIN PHYSIOL FUNCT I, V26, P380, DOI 10.1111/j.1475-097X.2006.00706.x; Cochrane DJ, 2008, EUR J APPL PHYSIOL, V103, P441, DOI 10.1007/s00421-008-0736-4; Cochrane DJ, 2011, INT J SPORTS MED, V32, P75, DOI 10.1055/s-0030-1268010; Desmedt J E, 1983, Adv Neurol, V39, P671; Eckhardt H, 2011, J STRENGTH COND RES, V25, P1120, DOI 10.1519/JSC.0b013e3181d09e0e; EKLUND G, 1966, EXP NEUROL, V16, P80, DOI 10.1016/0014-4886(66)90088-4; Fratini A, 2009, J ELECTROMYOGR KINES, V19, P710, DOI 10.1016/j.jelekin.2008.04.005; Kerschan-Schindl K, 2001, CLIN PHYSIOL, V21, P377, DOI 10.1046/j.1365-2281.2001.00335.x; Kleine BU, 2001, J APPL PHYSIOL, V91, P1588, DOI 10.1152/jappl.2001.91.4.1588; Martin BJ, 1997, EUR J APPL PHYSIOL, V75, P504, DOI 10.1007/s004210050196; Mester J, 2006, J BIOMECH, V39, P1056, DOI 10.1016/j.jbiomech.2005.02.015; Mester J, 1999, J Sci Med Sport, V2, P211, DOI 10.1016/S1440-2440(99)80174-1; Mulder ER, 2009, J APPL PHYSIOL, V107, P1789, DOI 10.1152/japplphysiol.00230.2009; Pollock RD, 2012, J APPL PHYSIOL, V112, P388, DOI 10.1152/japplphysiol.01223.2010; Pollock RD, 2010, CLIN BIOMECH, V25, P840, DOI 10.1016/j.clinbiomech.2010.05.004; Randall JM, 1997, ERGONOMICS, V40, P879, DOI 10.1080/001401397187711; Rittweger J, 2003, CLIN PHYSIOL FUNCT I, V23, P81, DOI 10.1046/j.1475-097X.2003.00473.x; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rittweger J, 2001, EUR J APPL PHYSIOL, V86, P169, DOI 10.1007/s004210100511; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Ritzmann R, 2013, EUR J APPL PHYSIOL, V113, P1, DOI 10.1007/s00421-012-2402-0; Ritzmann R, 2010, EUR J APPL PHYSIOL, V110, P143, DOI 10.1007/s00421-010-1483-x; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Torvinen S, 2002, CLIN PHYSIOL FUNCT I, V22, P145, DOI 10.1046/j.1365-2281.2002.00410.x; VIITASALO JHT, 1977, EUR J APPL PHYSIOL, V37, P111, DOI 10.1007/BF00421697; Wakeling JM, 2002, J APPL PHYSIOL, V93, P1093, DOI 10.1152/japplphysiol.00142.2002; Zange J, 2009, EUR J APPL PHYSIOL, V105, P265, DOI 10.1007/s00421-008-0898-0; Zange J, 2009, EUR J APPL PHYSIOL, V105, P271, DOI 10.1007/s00421-008-0899-z	35	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99060	10.1371/journal.pone.0099060	http://dx.doi.org/10.1371/journal.pone.0099060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905721	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341869000100
J	Szwarc, MM; Kommagani, R; Jeong, JW; Wu, SP; Tsai, SY; Tsai, MJ; O'Malley, BW; DeMayo, FJ; Lydon, JP				Szwarc, Maria M.; Kommagani, Ramakrishna; Jeong, Jae-Wook; Wu, San-Pin; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.; DeMayo, Francesco J.; Lydon, John P.			Perturbing the Cellular Levels of Steroid Receptor Coactivator-2 Impairs Murine Endometrial Function	PLOS ONE			English	Article							MAMMARY-GLAND; EMBRYO IMPLANTATION; EXPRESSION; PROGESTERONE; ANDROGEN; MICE; PROLIFERATION; COREGULATORS; SRC-1; AIB1	As pleiotropic coregulators, members of the p160/steroid receptor coactivator (SRC) family control a broad spectrum of transcriptional responses that underpin a diverse array of physiological and pathophysiological processes. Because of their potent coregulator properties, strict controls on SRC expression levels are required to maintain normal tissue functionality. Accordingly, an unwarranted increase in the cellular levels of SRC members has been causally linked to the initiation and/or progression of a number of clinical disorders. Although knockout mouse models have underscored the critical non-redundant roles for each SRC member in vivo, there are surprisingly few mouse models that have been engineered to overexpress SRCs. This deficiency is significant since SRC involvement in many of these disorders is based on unscheduled increases in the levels (rather than the absence) of SRC expression. To address this deficiency, we used recent mouse technology that allows for the targeted expression of human SRC-2 in cells which express the progesterone receptor. Through cre-loxP recombination driven by the endogenous progesterone receptor promoter, a marked elevation in expression levels of human SRC-2 was achieved in endometrial cells that are positive for the progesterone receptor. As a result of this increase in coregulator expression, female mice are severely subfertile due to a dysfunctional uterus, which exhibits a hypersensitivity to estrogen exposure. Our findings strongly support the proposal from clinical observations that increased levels of SRC-2 are causal for a number of endometrial disorders which compromise fertility. Future studies will use this mouse model to decipher the molecular mechanisms that underpin the endometrial defect. We believe such mechanistic insight may provide new molecular descriptors for diagnosis, prognosis, and/or therapy in the clinical management of female infertility.	[Szwarc, Maria M.; Kommagani, Ramakrishna; Wu, San-Pin; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.; DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jeong, Jae-Wook] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA	Baylor College of Medicine; Michigan State University; Michigan State University College of Human Medicine	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	jlydon@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019; , San Pin Wu/AAF-8371-2020	DeMayo, Francesco/0000-0002-9480-7336; , San Pin Wu/0000-0001-9626-784X; Kommagani, Ramakrishna/0000-0003-0403-0971	National Institutes of Health [U19DK062434, HD-07857, U54 HD-07495, CA-077530]; Baylor College of Medicine Genetically Engineered Mouse Shared Resource [NH/NCI 5 P30 CA125123]; University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core - (Eunice Kennedy Shriver NICHD/NIH (SCCPIR)) [U54-HD28934]; Cancer Prevention Research Institute of Texas pre-doctoral training fellowship [CPRIT RP101499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042311, U54HD028934, R01HD008188, P50HD028934, R01HD007857, U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857, U01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, R29CA077530, R01CA077530] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Genetically Engineered Mouse Shared Resource; University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core - (Eunice Kennedy Shriver NICHD/NIH (SCCPIR)); Cancer Prevention Research Institute of Texas pre-doctoral training fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by National Institutes of Health grants: U19DK062434 to M.J.T., S.Y.T., B.W.O, and F.J.D. and HD-07857; U54 HD-07495; and CA-077530 to B.W.O.; F.J.D.; and J.P.L. respectively. These studies also were supported by the Baylor College of Medicine Genetically Engineered Mouse Shared Resource (NH/NCI 5 P30 CA125123) and the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core (supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) Grant U54-HD28934). M. M. S. is supported by Cancer Prevention Research Institute of Texas pre-doctoral training fellowship (CPRIT RP101499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Balmer NN, 2006, MODERN PATHOL, V19, P1593, DOI 10.1038/modpathol.3800696; Brinton LA, 2010, FERTIL STERIL, V94, P1787, DOI 10.1016/j.fertnstert.2009.10.012; Carretero J, 2013, ANN ANAT, V195, P253, DOI 10.1016/j.aanat.2013.01.009; Chen XA, 2010, MOL ENDOCRINOL, V24, P1917, DOI 10.1210/me.2010-0201; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; COULAM CB, 1983, OBSTET GYNECOL, V61, P403; Dasgupta S, 2014, ANNU REV MED, V65, P279, DOI 10.1146/annurev-med-051812-145316; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Fernandez-Valdivia R, 2008, ENDOCRINOLOGY, V149, P6236, DOI 10.1210/en.2008-0768; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; FOSSUM GT, 1989, J IN VITRO FERTIL EM, V6, P7, DOI 10.1007/BF01134574; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gregory CW, 2002, J CLIN ENDOCR METAB, V87, P2960, DOI 10.1210/jc.87.6.2960; Gregory CW, 2001, CANCER RES, V61, P4315; Ha Cole, 1933, P R SOC B, V114; Han SJ, 2012, NAT MED, V18, P1102, DOI 10.1038/nm.2826; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; He B, 2011, ENDOCRINOLOGY, V152, P1047, DOI 10.1210/en.2010-0732; Ismail PM, 2002, MOL ENDOCRINOL, V16, P2475, DOI 10.1210/me.2002-0169; Jeong JW, 2007, ENDOCRINOLOGY, V148, P4238, DOI 10.1210/en.2007-0122; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; Kefalopoulou Z, 2012, J NEURO-ONCOL, V106, P23, DOI 10.1007/s11060-011-0637-y; Kershah SM, 2004, GYNECOL ONCOL, V92, P304, DOI 10.1016/j.ygyno.2003.10.007; Kim JY, 2009, J CLIN ENDOCR METAB, V94, P1416, DOI 10.1210/jc.2008-1612; Kommagani R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003900; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; Markey CM, 2001, ENVIRON HEALTH PERSP, V109, P55, DOI 10.2307/3434921; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Park S, 2012, ENDOCRINOLOGY, V153, P3982, DOI 10.1210/en.2012-1044; PARR EL, 1987, BIOL REPROD, V36, P211, DOI 10.1095/biolreprod36.1.211; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Quezada S, 2006, FERTIL STERIL, V85, P1017, DOI 10.1016/j.fertnstert.2005.09.053; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; Sakaguchi H, 2007, J STEROID BIOCHEM, V104, P237, DOI 10.1016/j.jsbmb.2007.03.007; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Stashi E, 2014, CELL REP; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tien JCY, 2013, CANCER RES, V73, P3997, DOI 10.1158/0008-5472.CAN-12-3929; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Torres-Arzayus MI, 2010, CANCER RES, V70, P4102, DOI 10.1158/0008-5472.CAN-09-4080; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uchikawa J, 2003, CANCER, V98, P2207, DOI 10.1002/cncr.11760; Villavicencio A, 2006, GYNECOL ONCOL, V103, P307, DOI 10.1016/j.ygyno.2006.03.029; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Ye XC, 2005, P NATL ACAD SCI USA, V102, P9487, DOI 10.1073/pnas.0503577102; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076	66	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98664	10.1371/journal.pone.0098664	http://dx.doi.org/10.1371/journal.pone.0098664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905738	Green Submitted, gold, Green Published			2022-12-27	WOS:000341869000045
J	Xiao, DL; Huang, XH; Xue, Q; Zhang, LB				Xiao, DaLiao; Huang, Xiaohui; Xue, Qin; Zhang, Lubo			Antenatal Hypoxia Induces Programming of Reduced Arterial Blood Pressure Response in Female Rat Offspring: Role of Ovarian Function	PLOS ONE			English	Article							PRENATAL HYPOXIA; ADULT MALE; DEVELOPMENTAL ORIGINS; HEART SUSCEPTIBILITY; PROTEIN RESTRICTION; REPERFUSION INJURY; ANGIOTENSIN-II; IN-UTERO; FETAL; PREGNANCY	In utero exposure to adverse environmental factors increases the risk of cardiovascular disease in adulthood. The present study tested the hypothesis that antenatal hypoxia causes a gender-dependent programming of altered arterial blood pressure response (BP) in adult offspring. Time-dated pregnant rats were divided into normoxic and hypoxic (10.5% O-2 from days 15 to 21 of gestation) groups. The experiments were conducted in adult offspring. Antenatal hypoxia caused intrauterine growth restriction, and resulted in a gender-dependent increase Angiotensin II (Ang II)-induced BP response in male offspring, but significant decrease in BP response in female offspring. The baroreflex sensitivity was not significantly altered. Consistent with the reduced blood pressure response, antenatal hypoxia significantly decreased Ang II-induced arterial vasoconstriction in female offspring. Ovariectomy had no significant effect in control animals, but significantly increased Ang II-induced maximal BP response in prenatally hypoxic animals and eliminated the difference of BP response between the two groups. Estrogen replacement in ovariectomized animals significantly decreased the BP response to angiotensin II I only in control, but not in hypoxic animals. The result suggests complex programming mechanisms of antenatal hypoxia in regulation of ovary function. Hypoxia-mediated ovary dysfunction results in the phenotype of reduced vascular contractility and BP response in female adult offspring.	[Xiao, DaLiao; Huang, Xiaohui; Xue, Qin; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu	Xiao, DaLiao/AAY-1800-2020	Xiao, DaLiao/0000-0003-0147-2758; Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HD082779, HL083966, DA032510]; Regents of the University of California TRDRP [22XT-0022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083966, R01HL110125, R01HL118861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California TRDRP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health grants HD082779 (to L. Zhang), HL083966 (to L. Zhang) and DA032510 (to D. Xiao), and by the Regents of the University of California TRDRP grant 22XT-0022 (to D. Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-17; Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BARKER DJP, 1986, LANCET, V1, P1077; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Dias DPM, 2010, BRAZ J MED BIOL RES, V43, P969, DOI 10.1590/S0100-879X2010001000008; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; El-Seweidy MM, 2012, J PHARM PHARMACOL, V64, P108, DOI 10.1111/j.2042-7158.2011.01377.x; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; Hawkins P, 2000, AM J PHYSIOL-REG I, V279, pR340, DOI 10.1152/ajpregu.2000.279.1.R340; Hemmings DG, 2005, AM J PHYSIOL-HEART C, V289, pH674, DOI 10.1152/ajpheart.00191.2005; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; LAUNER LJ, 1993, BMJ-BRIT MED J, V307, P1451, DOI 10.1136/bmj.307.6917.1451; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Louey S., 2003, Archives of Physiology and Biochemistry, V111, P53, DOI 10.1076/apab.111.1.53.15137; Louey S, 2000, PEDIATR RES, V48, P808, DOI 10.1203/00006450-200012000-00018; Martin DS, 2008, AM J HYPERTENS, V21, P983, DOI 10.1038/ajh.2008.237; Matys T, 2000, J PHYSIOL PHARMACOL, V51, P161; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miner JA, 2011, AM J PHYSIOL-HEART C, V301, pH1716, DOI 10.1152/ajpheart.00405.2011; NEWBOLD RR, 1983, BIOL REPROD, V28, P735, DOI 10.1095/biolreprod28.3.735; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; OSullivan MJ, 1996, ACTA PAEDIATR, V85, P849, DOI 10.1111/j.1651-2227.1996.tb14166.x; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Pausova Z, 2003, KIDNEY INT, V64, P829, DOI 10.1046/j.1523-1755.2003.00172.x; Peyronnet J, 2002, PFLUG ARCH EUR J PHY, V443, P858, DOI 10.1007/s00424-001-0766-9; Ribeiro RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053226; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; Sathishkumar K, 2012, BRIT J NUTR, V107, P665, DOI 10.1017/S0007114511003448; Tong WN, 2011, AM J PHYSIOL-HEART C, V301, pH2113, DOI 10.1152/ajpheart.00356.2011; VAHAKANGAS K, 1985, TOXICOL LETT, V25, P75, DOI 10.1016/0378-4274(85)90103-1; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2013, HYPERTENSION, V61, P1246, DOI 10.1161/HYPERTENSIONAHA.113.01152; Xiao DL, 2009, HYPERTENSION, V53, P937, DOI 10.1161/HYPERTENSIONAHA.108.121830; Xiao DL, 2000, J SOC GYNECOL INVEST, V7, P279, DOI 10.1016/S1071-5576(00)00066-6; Xu X, 2008, INT J CARDIOL, V130, P196, DOI 10.1016/j.ijcard.2007.08.041; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Zemunik T, 2003, BRAZ J MED BIOL RES, V36, P871, DOI 10.1590/S0100-879X2003000700007	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98743	10.1371/journal.pone.0098743	http://dx.doi.org/10.1371/journal.pone.0098743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905716	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000056
J	Martin, SAL; Jameson, CH; Allan, SM; Lawrence, CB				Martin, Sarah A. L.; Jameson, Christine H.; Allan, Stuart M.; Lawrence, Catherine B.			Maternal High-Fat Diet Worsens Memory Deficits in the Triple-Transgenic (3xTgAD) Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							FEMALE MICE LEADS; EARLY-LIFE; INSULIN-RESISTANCE; INDUCED OBESITY; INCIDENT DEMENTIA; AMYLOID-BETA; RISK-FACTORS; BEHAVIOR; PREGNANCY; ACIDS	Alzheimer's disease (AD) is not normally diagnosed until later in life, although evidence suggests that the disease starts at a much earlier age. Risk factors for AD, such as diabetes, hypertension and obesity, are known to have their affects during mid-life, though events very early in life, including maternal over-nutrition, can predispose offspring to develop these conditions. This study tested whether over-nutrition during pregnancy and lactation affected the development of AD in offspring, using a transgenic AD mouse model. Female triple-transgenic AD dam mice (3xTgAD) were exposed to a high-fat (60% energy from fat) or control diet during pregnancy and lactation. After weaning (at 3 weeks of age), female offspring were placed on a control diet and monitored up until 12 months of age during which time behavioural tests were performed. A transient increase in body weight was observed in 4-week-old offspring 3xTgAD mice from dams fed a highfat diet. However, by 5 weeks of age the body weight of 3xTgAD mice from the maternal high-fat fed group was no different when compared to control-fed mice. A maternal high-fat diet led to a significant impairment in memory in 2-and 12monthold 3xTgAD offspring mice when compared to offspring from control fed dams. These effects of a maternal high-fat diet on memory were accompanied by a significant increase (50%) in the number of tau positive neurones in the hippocampus. These data demonstrate that a high-fat diet during pregnancy and lactation increases memory impairments in female 3xTgAD mice and suggest that early life events during development might influence the onset and progression of AD later in life.	[Martin, Sarah A. L.; Jameson, Christine H.; Allan, Stuart M.; Lawrence, Catherine B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lawrence, CB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	catherine.lawrence@manchester.ac.uk	Allan, Stuart/AAL-1245-2020	Allan, Stuart/0000-0001-9646-4456; Lawrence, Catherine/0000-0002-2372-2968	capacity-building award to Manchester's Centre for Integrative Mammalian Biology	capacity-building award to Manchester's Centre for Integrative Mammalian Biology	SALM and CHJ were Masters of Research students, supported by a capacity-building award to Manchester's Centre for Integrative Mammalian Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebakin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045179; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BARKER DJP, 1986, LANCET, V1, P1077; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Breteler MMB, 2001, EPIDEMIOLOGY, V12, P378; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Grant W B, 1999, J Alzheimers Dis, V1, P197; Grant W.B., 1997, ALZHEIMERS DIS REV, V2, P42; Gustafson D, 2008, EUR J PHARMACOL, V585, P163, DOI 10.1016/j.ejphar.2008.01.052; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Herring A, 2012, FASEB J, V26, P117, DOI 10.1096/fj.11-193193; Hiramatsu M, 1997, PHARMACOL BIOCHEM BE, V56, P73, DOI 10.1016/S0091-3057(96)00159-1; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Jones KL, 2013, BEHAV BRAIN RES, V238, P193, DOI 10.1016/j.bbr.2012.10.028; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kajantie E, 2008, HORM-INT J ENDOCRINO, V7, P101, DOI 10.1007/BF03401501; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; Knight EM, 2014, NEUROBIOL AGING, DOI 10.1016; Lahiri DK, 2008, BIOGERONTOLOGY, V9, P375, DOI 10.1007/s10522-008-9162-6; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; Leboucher A, 2013, DIABETES, V62, P1681, DOI 10.2337/db12-0866; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Liang C, 2009, BIRTH DEFECTS RES B, V86, P377, DOI 10.1002/bdrb.20206; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; McMillen IC, 2005, J PHYSIOL-LONDON, V565, P9, DOI 10.1113/jphysiol.2004.081992; Miller DB, 2008, METABOLISM, V57, pS44, DOI 10.1016/j.metabol.2008.07.011; Naef L, 2008, PSYCHOPHARMACOLOGY, V197, P83, DOI 10.1007/s00213-007-1008-4; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Panza F, 2004, PUBLIC HEALTH NUTR, V7, P959, DOI 10.1079/PHN2004561; Park SH, 2013, INT J MOL MED, V31, P577, DOI 10.3892/ijmm.2013.1233; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pedrini S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-40; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Phivilay A, 2009, NEUROSCIENCE, V159, P296, DOI 10.1016/j.neuroscience.2008.12.006; Polidori MC, 2012, J ALZHEIMERS DIS, V32, P521, DOI 10.3233/JAD-2012-120871; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Rahman A, 2005, FEBS LETT, V579, P6411, DOI 10.1016/j.febslet.2005.10.024; Raygada M, 1998, J NUTR, V128, P2505; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Rodriguez JS, 2012, INT J DEV NEUROSCI, V30, P75, DOI 10.1016/j.ijdevneu.2011.12.012; Ross MG, 2007, CURR ALZHEIMER RES, V4, P213, DOI 10.2174/156720507780362056; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wall PM, 2002, PSYCHOPHARMACOLOGY, V160, P233, DOI 10.1007/s00213-001-0979-9; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	60	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99226	10.1371/journal.pone.0099226	http://dx.doi.org/10.1371/journal.pone.0099226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918775	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000061
J	Takahashi, K; Raska, M; Horynova, MS; Hall, SD; Poulsen, K; Kilian, M; Hiki, Y; Yuzawa, Y; Moldoveanu, Z; Julian, BA; Renfrow, MB; Novak, J				Takahashi, Kazuo; Raska, Milan; Horynova, Milada Stuchlova; Hall, Stacy D.; Poulsen, Knud; Kilian, Mogens; Hiki, Yoshiyuki; Yuzawa, Yukio; Moldoveanu, Zina; Julian, Bruce A.; Renfrow, Matthew B.; Novak, Jan			Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; GALACTOSE-DEFICIENT IGA1; HUMAN SERUM IGA1; ABERRANTLY GLYCOSYLATED IGA1; CIRCULATING IMMUNE-COMPLEXES; RESONANCE MASS-SPECTROMETRY; BREAST-CANCER PATIENTS; N-GLYCOSYLATION; MESANGIAL CELLS; HINGE REGION	Patients with IgA nephropathy (IgAN) have elevated circulating levels of IgA1 with some O-glycans consisting of galactose (Gal)-deficient N-acetylgalactosamine (GalNAc) with or without N-acetylneuraminic acid (NeuAc). We have analyzed O-glycosylation heterogeneity of naturally asialo-IgA1 (Ale) myeloma protein that mimics Gal-deficient IgA1 (Gd-IgA1) of patients with IgAN, except that IgA1 O-glycans of IgAN patients are frequently sialylated. Specifically, serum IgA1 of healthy controls has more alpha 2,3-sialylated O-glycans (NeuAc attached to Gal) than alpha 2,6-sialylated O-glycans (NeuAc attached to GalNAc). As IgA1-producing cells from IgAN patients have an increased activity of alpha 2,6-sialyltransferase (ST6GalNAc), we hypothesize that such activity may promote premature sialylation of GalNAc and, thus, production of Gd-IgA1, as sialylation of GalNAc prevents subsequent Gal attachment. Distribution of NeuAc in IgA1 O-glycans may play an important role in the pathogenesis of IgAN. To better understand biological functions of NeuAc in IgA1, we established protocols for enzymatic sialylation leading to alpha 2,3- or alpha 2,6-sialylation of IgA1 O-glycans. Sialylation of Gal-deficient asialo-IgA1 (Ale) myeloma protein by an ST6GalNAc enzyme generated sialylated IgA1 that mimics the Gal-deficient IgA1 glycoforms in patients with IgAN, characterized by alpha 2,6-sialylated Gal-deficient GalNAc. In contrast, sialylation of the same myeloma protein by an alpha 2,3-sialyltransferase yielded IgA1 typical for healthy controls, characterized by alpha 2,3-sialylated Gal. The GalNAc-specific lectin from Helix aspersa (HAA) is used to measure levels of Gd-IgA1. We assessed HAA binding to IgA1 sialylated at Gal or GalNAc. As expected, alpha 2,6-sialylation of IgA1 markedly decreased reactivity with HAA. Notably, alpha 2,3-sialylation also decreased reactivity with HAA. Neuraminidase treatment recovered the original HAA reactivity in both instances. These results suggest that binding of a GalNAc-specific lectin is modulated by sialylation of GalNAc as well as Gal in the clustered IgA1 O-glycans. Thus, enzymatic sialylation offers a useful model to test the role of NeuAc in reactivities of the clustered O-glycans with lectins.	[Takahashi, Kazuo; Raska, Milan; Horynova, Milada Stuchlova; Hall, Stacy D.; Moldoveanu, Zina; Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Biomed FT ICR MS Lab, Birmingham, AL 35203 USA; [Takahashi, Kazuo; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 47011, Japan; [Raska, Milan; Horynova, Milada Stuchlova] Palacky Univ, Fac Med & Dent, Dept Immunol, CR-77147 Olomouc, Czech Republic; [Poulsen, Knud; Kilian, Mogens] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Hiki, Yoshiyuki] Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Fujita Health University; Palacky University Olomouc; Aarhus University; Fujita Health University	Renfrow, MB (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Biomed FT ICR MS Lab, Birmingham, AL 35203 USA.	renfrow@uab.edu; jannovak@uab.edu	Raska, Milan/E-9813-2013	Raska, Milan/0000-0002-8572-7246; Stuchlova Horynova, Milada/0000-0001-6375-4406; Kilian, Mogens/0000-0002-5861-0472; Renfrow, Matthew B./0000-0002-4193-7305	NIH [DK078244, GM098539, DK082753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, R56DK078244, R01DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24591219] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the NIH grants DK078244, GM098539, and DK082753, and by a gift from the IGA Nephropathy Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; BAENZIGER J, 1974, J BIOL CHEM, V249, P7270; Basset C, 1999, SCAND J IMMUNOL, V50, P572; Berger J, 1968, UROL NEPHROL PARIS, V74, P694; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583; COPPO R, 1993, CONTRIB NEPHROL, V104, P162; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; CZERKINSKY C, 1986, J CLIN INVEST, V77, P1931, DOI 10.1172/JCI112522; Ding JX, 2007, CLIN IMMUNOL, V125, P268, DOI 10.1016/j.clim.2007.08.009; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Hastings Margaret Colleen, 2013, Expert Opin Med Diagn, V7, P615, DOI 10.1517/17530059.2013.856878; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; Hiki Y, 2009, CLIN EXP NEPHROL, V13, P415, DOI 10.1007/s10157-009-0173-7; Horie A, 2003, AM J KIDNEY DIS, V42, P486, DOI 10.1016/S0272-6386(03)00743-1; Horynova M, 2012, PROTEIN EXPRES PURIF, V81, P175, DOI 10.1016/j.pep.2011.10.006; Horynova MS, 2013, CELL MOL LIFE SCI, V70, P829, DOI 10.1007/s00018-012-1082-6; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Julien S, 2005, BREAST CANCER RES TR, V90, P77, DOI 10.1007/s10549-004-3137-3; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kokubo T, 1998, J AM SOC NEPHROL, V9, P2048; LAI KN, 1994, NEPHRON, V66, P38, DOI 10.1159/000187763; Leung JCK, 2002, J CLIN LAB ANAL, V16, P11, DOI 10.1002/jcla.2035; Leung JCK, 1999, J LAB CLIN MED, V133, P152, DOI 10.1016/S0022-2143(99)90008-2; Leung JCK, 2001, KIDNEY INT, V59, P277, DOI 10.1046/j.1523-1755.2001.00489.x; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Maenuma K, 2009, J PROTEOME RES, V8, P3617, DOI 10.1021/pr800816w; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1989, IMMUNOL INVEST, V18, P313, DOI 10.3109/08820138909112245; MESTECKY J, 1986, MONOGR ALLERGY, V19, P277; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Mistry D, 2006, INT J BIOCHEM CELL B, V38, P1244, DOI 10.1016/j.biocel.2005.10.005; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; MOLDOVEANU Z, 1988, J IMMUNOL, V141, P208; MONTEIRO RC, 1985, KIDNEY INT, V28, P666, DOI 10.1038/ki.1985.181; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Moore JS, 2005, AIDS, V19, P381, DOI 10.1097/01.aids.0000161767.21405.68; Mungul A, 2004, INT J ONCOL, V25, P937; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; Novak J, 2013, CURR OPIN NEPHROL HY, V22, P287, DOI 10.1097/MNH.0b013e32835fef54; Odani H, 2000, BIOCHEM BIOPH RES CO, V271, P268, DOI 10.1006/bbrc.2000.2613; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; Raska M, 2007, J MOL BIOL, V369, P69, DOI 10.1016/j.jmb.2007.03.002; REINHOLDT J, 1990, INFECT IMMUN, V58, P1186, DOI 10.1128/IAI.58.5.1186-1194.1990; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Renfrow MB, 2005, J BIOL CHEM, V280, P19136, DOI 10.1074/jbc.M411368200; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sano T, 2002, NEPHROL DIAL TRANSPL, V17, P50, DOI 10.1093/ndt/17.1.50; SCHENA FP, 1989, CLIN EXP IMMUNOL, V77, P15; Schindlbeck C, 2005, HISTOCHEM CELL BIOL, V123, P631, DOI 10.1007/s00418-005-0781-6; SCHMITT FC, 1995, VIRCHOWS ARCH, V427, P251; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Takahashi K, 2012, J PROTEOME RES, V11, P692, DOI 10.1021/pr200608q; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Tarelli E, 2004, CARBOHYD RES, V339, P2329, DOI 10.1016/j.carres.2004.07.011; TOMANA M, 1988, GASTROENTEROLOGY, V94, P762, DOI 10.1016/0016-5085(88)90252-1; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; Troelsen LN, 2007, ARTHRITIS RHEUM, V56, P21, DOI 10.1002/art.22302; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Xu LX, 2005, KIDNEY INT, V68, P167, DOI 10.1111/j.1523-1755.2005.00390.x; Xue J, 2013, GLYCOCONJUGATE J, V30, P735, DOI 10.1007/s10719-013-9481-y	85	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99026	10.1371/journal.pone.0099026	http://dx.doi.org/10.1371/journal.pone.0099026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918438	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000041
J	Yeghiazaryan, M; Rutkowska-Wlodarczyk, I; Konopka, A; Wilczynski, GM; Melikyan, A; Korkotian, E; Kaczmarek, L; Figiel, I				Yeghiazaryan, Marine; Rutkowska-Wlodarczyk, Izabela; Konopka, Anna; Wilczynski, Grzegorz M.; Melikyan, Armenuhi; Korkotian, Eduard; Kaczmarek, Leszek; Figiel, Izabela			DP-b99 Modulates Matrix Metalloproteinase Activity and Neuronal Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACUTE ISCHEMIC-STROKE; SYNAPTIC PLASTICITY; STATUS EPILEPTICUS; MOUSE MODEL; MATRIX-METALLOPROTEINASE-9; EPILEPSY; MEMBRANE; CHELATOR; MMP-9	DP-b99 is a membrane-activated chelator of zinc and calcium ions, recently proposed as a therapeutic agent. Matrix metalloproteinases (MMPs) are zinc-dependent extracellularly operating proteases that might contribute to synaptic plasticity, learning and memory under physiological conditions. In excessive amounts these enzymes contribute to a number of neuronal pathologies ranging from the stroke to neurodegeneration and epileptogenesis. In the present study, we report that DP-b99 delays onset and severity of PTZ-induced seizures in mice, as well as displays neuroprotective effect on kainate excitotoxicity in hippocampal organotypic slices and furthermore blocks morphological reorganization of the dendritic spines evoked by a major neuronal MMP, MMP-9. Taken together, our findings suggest that DP-b99 may inhibit neuronal plasticity driven by MMPs, in particular MMP-9, and thus may be considered as a therapeutic agent under conditions of aberrant plasticity, such as those subserving epileptogenesis.	[Yeghiazaryan, Marine; Konopka, Anna; Wilczynski, Grzegorz M.] M Nencki Inst Expt Biol, Dept Neurophysiol, PL-02093 Warsaw, Poland; [Rutkowska-Wlodarczyk, Izabela; Kaczmarek, Leszek; Figiel, Izabela] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Melikyan, Armenuhi] D Pharm Ltd, Rehovot, Israel; [Korkotian, Eduard] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Weizmann Institute of Science	Figiel, I (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	i.figiel@nencki.gov.pl	Korkotian, Eduard/K-1744-2012; Kaczmarek, Leszek/B-6171-2008; Korkotian, Eduard/P-4559-2019; Kaczmarek, Leszek/AHA-0076-2022	Korkotian, Eduard/0000-0001-5515-3387; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Wilczynski, Grzegorz/0000-0001-6667-0291; Figiel, Izabela/0000-0001-5028-0168; Konopka, Anna/0000-0002-5487-6003	7FP EU; ERANET NEURON; National Science Centre Poland [N N301 665140]	7FP EU(European Commission); ERANET NEURON; National Science Centre Poland(National Science Centre, Poland)	This work has been supported by the 7FP EU grant Plasticise, ERANET NEURON grant TBI Epi, and grant no. N N301 665140 from National Science Centre Poland (IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Angel A, 2002, DRUG DEVELOP RES, P300; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Chaturvedi M, 2012, NEUROCHEM INT, V61, P1065, DOI 10.1016/j.neuint.2012.07.023; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Friedman J, 2010, INT J STROKE S2, V5, P142; Friedman J, 2010, INT J STROKE S2, V5, P141; Huntley GW, 2012, HIPPOCAMPUS, V22, P17, DOI 10.1002/hipo.20859; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Knapska E, 2013, J NEUROSCI, V33, P14591, DOI 10.1523/JNEUROSCI.5239-12.2013; Lees KR, 2013, STROKE, V44, P580, DOI 10.1161/STROKEAHA.111.000013; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Mioduszewska B, 2008, J NEUROSCI RES, V86, P61, DOI 10.1002/jnr.21469; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rosenberg G, 2005, BRIT J CLIN PHARMACO, V60, P7, DOI 10.1111/j.1365-2125.2005.02378.x; Rosenberg G, 2011, INT J STROKE, V6, P362, DOI 10.1111/j.1747-4949.2011.00608.x; Ruszczycki B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-213; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Vezzani A, 2000, P NATL ACAD SCI USA, V97, P11534, DOI 10.1073/pnas.190206797; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wiera G, 2013, HIPPOCAMPUS, V23, P529, DOI 10.1002/hipo.22112; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Zagulska-Szymczak S, 2001, NEUROCHEM INT, V38, P485, DOI 10.1016/S0197-0186(00)00101-7; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15	47	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99789	10.1371/journal.pone.0099789	http://dx.doi.org/10.1371/journal.pone.0099789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918931	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000110
J	Fernando, ME; Crowther, RG; Pappas, E; Lazzarini, PA; Cunningham, M; Sangla, KS; Buttner, P; Golledge, J				Fernando, Malindu Eranga; Crowther, Robert George; Pappas, Elise; Lazzarini, Peter Anthony; Cunningham, Margaret; Sangla, Kunwarjit Singh; Buttner, Petra; Golledge, Jonathan			Plantar Pressure in Diabetic Peripheral Neuropathy Patients with Active Foot Ulceration, Previous Ulceration and No History of Ulceration: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							BODY-MASS; DISEASE; QUALITY; RISK; EPIDEMIOLOGY; INSOLES; ULCERS; GAIT; LIFE	Aims: Elevated dynamic plantar pressures are a consistent finding in diabetes patients with peripheral neuropathy with implications for plantar foot ulceration. This meta-analysis aimed to compare the plantar pressures of diabetes patients that had peripheral neuropathy and those with neuropathy with active or previous foot ulcers. Methods: Published articles were identified from Medline via OVID, CINAHL, SCOPUS, INFORMIT, Cochrane Central EMBASE via OVID and Web of Science via ISI Web of Knowledge bibliographic databases. Observational studies reporting barefoot dynamic plantar pressure in adults with diabetic peripheral neuropathy, where at least one group had a history of plantar foot ulcers were included. Interventional studies, shod plantar pressure studies and studies not published in English were excluded. Overall mean peak plantar pressure (MPP) and pressure time integral (PTI) were primary outcomes. The six secondary outcomes were MPP and PTI at the rear foot, mid foot and fore foot. The protocol of the meta-analysis was published with PROPSERO, (registration number CRD42013004310). Results: Eight observational studies were included. Overall MPP and PTI were greater in diabetic peripheral neuropathy patients with foot ulceration compared to those without ulceration (standardised mean difference 0.551, 95% CI 0.290-0.811, p<0.001; and 0.762, 95% CI 0.303-1.221, p = 0.001, respectively). Sub-group analyses demonstrated no significant difference in MPP for those with neuropathy with active ulceration compared to those without ulcers. A significant difference in MPP was found for those with neuropathy with a past history of ulceration compared to those without ulcers; (0.467, 95% CI 0.181-0.753, p = 0.001). Statistical heterogeneity between studies was moderate. Conclusions: Plantar pressures appear to be significantly higher in patients with diabetic peripheral neuropathy with a history of foot ulceration compared to those with diabetic neuropathy without a history of ulceration. More homogenous data is needed to confirm these findings.	[Fernando, Malindu Eranga; Pappas, Elise; Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Vasc Biol Unit, Townsville, Qld 4811, Australia; [Fernando, Malindu Eranga; Crowther, Robert George] James Cook Univ, Inst Sports & Exercise Sci, Movement Anal Lab, Townsville, Qld 4811, Australia; [Sangla, Kunwarjit Singh] Townsville Hosp, Dept Internal Med, Townsville, Qld, Australia; [Lazzarini, Peter Anthony] Queensland Hlth, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Lazzarini, Peter Anthony] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld 4001, Australia; [Buttner, Petra] James Cook Univ, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Cunningham, Margaret] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland	James Cook University; James Cook University; Queensland Health; Queensland University of Technology (QUT); James Cook University; University of Stirling	Fernando, ME (corresponding author), James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Vasc Biol Unit, Townsville, Qld 4811, Australia.	malindu.fernando@my.jcu.edu.au	golledge, jonathan/I-2371-2013	Cunningham, Margaret/0000-0002-5850-9825; Lazzarini, Peter/0000-0002-8235-7964; golledge, jonathan/0000-0002-5779-8848	Queensland Government; National Health and Medical Research Council; Townsville Hospital Private Practice Fund; National Health and Medical Research Council, Australia [1019921]; Australian Postgraduate Award Scholarship at James Cook University	Queensland Government; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Townsville Hospital Private Practice Fund; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award Scholarship at James Cook University	Funding from the Queensland Government and National Health and Medical Research Council and The Townsville Hospital Private Practice Fund supported this work. JG holds a Practitioner Fellowships from the National Health and Medical Research Council, Australia (1019921). JG holds a Senior Clinical Research Fellowship from the Queensland Government. MF is currently supported by an Australian Postgraduate Award Scholarship at James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindas M, 2011, J FOOT ANKLE SURG, V50, P146, DOI 10.1053/j.jfas.2010.12.017; Armstrong D G, 1998, J Foot Ankle Surg, V37, P303; Armstrong D G, 1998, Ostomy Wound Manage, V44, P30; Bacarin TA, 2009, CLINICS, V64, P113, DOI 10.1590/S1807-59322009000200008; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; BOULTON AJM, 1983, DIABETES CARE, V6, P26, DOI 10.2337/diacare.6.1.26; Boulton AJM, 2004, DIABETOLOGIA, V47, P1343, DOI 10.1007/s00125-004-1463-y; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Brash PD, 1996, DIABETIC MED, V13, P973, DOI 10.1002/(SICI)1096-9136(199611)13:11<973::AID-DIA272>3.3.CO;2-X; Bus SA, 2009, CLIN BIOMECH, V24, P459, DOI 10.1016/j.clinbiomech.2009.02.004; CAVANAGH PR, 1991, DIABETES CARE, V14, P750, DOI 10.2337/diacare.14.8.750; Cavanagh PR, 1996, DIABETIC MED, V13, pS17, DOI 10.1002/dme.1996.13.s1.17; Cavanagh PR, 2000, DIABETES-METAB RES, V16, pS6, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR130>3.0.CO;2-Z; Chevalier TL, 2010, GAIT POSTURE, V31, P397, DOI 10.1016/j.gaitpost.2009.11.016; Clayton W., 2009, CLIN DIABETES, V27, P52, DOI [10.2337/diaclin.27.2.52, DOI 10.2337/DIACLIN.27.2.52]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coles S, 2008, NURS TIMES, V104, P42; Coles Sue, 2008, Nurs Times, V104, P42; Cook J, 2012, DIABETIC FOOT MED SU, P17; Cox PS, 2011, W INDIAN MED J, V60, P536; Crawford F, 2007, QJM-INT J MED, V100, P65; Critical Appraisal Skills Programme International, 2010, CRIT APPR SKILLS PRO; Fernando M, 2013, CLIN BIOMECH, V28, P831, DOI 10.1016/j.clinbiomech.2013.08.004; Ferreira Marcus Castro, 2004, Rev. Hosp. Clin., V59, P286, DOI 10.1590/S0041-87812004000500011; Garcia-Morales E, 2011, INT J LOW EXTR WOUND, V10, P6, DOI 10.1177/1534734611400257; Gonzalez R, 2010, DIABETES-METAB RES, V26, P115, DOI 10.1002/dmrr.1061; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Lavery LA, 2003, DIABETES CARE, V26, P1069, DOI 10.2337/diacare.26.4.1069; Lavery LA, 1998, ARCH INTERN MED, V158, P157, DOI 10.1001/archinte.158.2.157; Lazzarini PA, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-24; Longo B, 2013, PLAST RECONSTR SURG, V132, p735E, DOI 10.1097/PRS.0b013e3182a3bf05; Longo B, 2013, PLAST RECONSTR SURG, V132, P656, DOI 10.1097/PRS.0b013e31829acf84; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; MASSON EA, 1989, DIABETIC MED, V6, P426, DOI 10.1111/j.1464-5491.1989.tb01198.x; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; Melai T, 2011, GAIT POSTURE, V34, P379, DOI 10.1016/j.gaitpost.2011.06.005; Paton J, 2011, J DIABETES COMPLICAT, V25, P52, DOI 10.1016/j.jdiacomp.2009.09.002; Persaud R, 1996, BRIT MED J, V312, P125; Rich J, 2000, WOUNDS, V12, P82; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sauseng S, 1999, DIABETES NUTR METAB, V12, P189; Savelberg HHCM, 2009, CLIN BIOMECH, V24, P527, DOI 10.1016/j.clinbiomech.2009.05.001; Shen J, 2012, DIABETES TECHNOL THE, V14, P1053, DOI 10.1089/dia.2012.0146; Shenoy Anant M, 2012, Continuum (Minneap Minn), V18, P192, DOI 10.1212/01.CON.0000411562.03591.74; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Stess RM, 1997, DIABETES CARE, V20, P855, DOI 10.2337/diacare.20.5.855; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugimoto K, 2008, CURR PHARM DESIGN, V14, P953, DOI 10.2174/138161208784139774; van Deursen R, 2008, DIABETES-METAB RES, V24, pS96, DOI 10.1002/dmrr.827; van Schie C H M, 2005, Int J Low Extrem Wounds, V4, P160; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Viswanathan V, 2004, DIABETES CARE, V27, P474, DOI 10.2337/diacare.27.2.474; Wood WA, 2005, J AM PODIAT MED ASSN, V95, P469, DOI 10.7547/0950469	53	70	71	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99050	10.1371/journal.pone.0099050	http://dx.doi.org/10.1371/journal.pone.0099050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915443	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000340947700054
J	Shih, YH; Lin, DJ; Chang, KW; Hsia, SM; Ko, SY; Lee, SY; Hsue, SS; Wang, TH; Chen, YL; Shieh, TM				Shih, Yin-Hua; Lin, Dan-Jae; Chang, Kuo-Wei; Hsia, Shih-Min; Ko, Shun-Yao; Lee, Shyh-Yuan; Hsue, Shui-Sang; Wang, Tong-Hong; Chen, Yi-Ling; Shieh, Tzong-Ming			Evaluation Physical Characteristics and Comparison Antimicrobial and Anti-Inflammation Potentials of Dental Root Canal Sealers Containing Hinokitiol In Vitro	PLOS ONE			English	Article							ZINC OXIDE-EUGENOL; BETA-THUJAPLICIN; ENTEROCOCCUS-FAECALIS; ENDODONTIC SEALERS; ANTIBACTERIAL ACTIVITY; CALCIUM HYDROXIDE; MESSENGER-RNA; LYSYL OXIDASE; CANCER; CELLS	Hinokitiol displays potent antimicrobial activity. It has been used in toothpaste and oral-care gel to improve the oral lichen planus and reduce halitosis. The aim of this study was to evaluate the antimicrobial activity of 3 different dental root canal sealers with hinokitiol (sealers+H) and their physical and biological effects. AH Plus (epoxy amine resin-based, AH), Apexit Plus (calcium-hydroxide-based, AP), and Canals (zinc-oxide-eugenol-based, CA), were used in this study. The original AH and CA exhibited strong anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) activity, but AP did not. The setting time, working time, flowability, film thickness, and solubility of each sealer+0.2%H complied with ISO 6876:2001. CA+0.2%H exhibited high cytotoxicity, but the others sealers+0.2%H did not. Because hinokitiol combined with Zn2+ in CA creates a synergistic effect. The physical tests of AP+0.5%-1%H complied with ISO 6876:2001, improved antimicrobial activity, inhibited inflammation genes cyclooxygenase-2 (COX-2) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) mRNA in MG-63 cells and human gingival fibroblasts (HGF), and down-regulated lysyl oxidase (LOX) mRNA of HGF. In summary, AH and CA demonstrated strong antimicrobial activity, but AP did not. Application of hinokitiol increases AH anti-MRSA activity should less than 0.2% for keep well flowability. AP+0.5%-1% hinokitiol exhibited strong physical, antibacterial, and anti-inflammation potentials, and inhibited S. aureus abscess formation. Applying an appreciable proportion of hinokitiol to epoxy-amine-resin-based and calcium-hydroxide-based root canal sealers is warranted, but the enhanced cytotoxicity and synergistic effect must be considered.	[Shih, Yin-Hua] Natl Yang Ming Univ, Inst Oral Biol, Sch Dent, Taipei 112, Taiwan; [Lin, Dan-Jae; Chen, Yi-Ling; Shieh, Tzong-Ming] China Med Univ, Coll Hlth Care, Dept Dent Hyg, Taichung, Taiwan; [Chang, Kuo-Wei; Lee, Shyh-Yuan] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Chang, Kuo-Wei] Taipei Vet Gen Hosp, Dept Stomatol Oral & Maxillofacial Surg, Taipei, Taiwan; [Hsia, Shih-Min] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Ko, Shun-Yao] Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan; [Hsue, Shui-Sang] China Med Univ Hosp, Dept Oral Pathol, Taichung, Taiwan; [Wang, Tong-Hong] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Chang Jung Christian University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital	Shieh, TM (corresponding author), China Med Univ, Coll Hlth Care, Dept Dent Hyg, Taichung, Taiwan.	tmshieh@mail.cmu.edu.tw	Lee, Shyh-Yuan/F-8295-2012; Lin, Dan-Jae/D-6901-2013; Hsia, Shih-Min/AAL-2026-2020; Chen, Yi/HIR-2608-2022	Lee, Shyh-Yuan/0000-0002-9880-2372; Lin, Dan-Jae/0000-0001-8967-7090; 	National Science Council [NSC 99-2314-B-039-023-MY3]; China Medical University [CMU98-N1-30]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by research grants NSC 99-2314-B-039-023-MY3 from the National Science Council, CMU98-N1-30 from the China Medical University, and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049576; Anumula Lavanya, 2012, ISRN Dent, V2012, P989781, DOI 10.5402/2012/989781; Arima Y, 2003, J ANTIMICROB CHEMOTH, V51, P113, DOI 10.1093/jac/dkg037; Barret MC, 2001, INORG CHEM, V40, P4384, DOI 10.1021/ic0100368; Beerlage C, 2013, INFECT IMMUN, V81, P2562, DOI 10.1128/IAI.00302-13; Bernath M, 2003, INT ENDOD J, V36, P256, DOI 10.1046/j.1365-2591.2003.00662.x; Byeon SE, 2008, PLANTA MED, V74, P828, DOI 10.1055/s-2008-1074548; Chang PY, 2013, INT J ONCOL, V43, P1141, DOI 10.3892/ijo.2013.2050; CVEK M, 1974, ODONTOL REVY, V25, P239; Ema M, 2004, FOOD CHEM TOXICOL, V42, P465, DOI 10.1016/j.fct.2003.10.009; FONTANA R, 1990, ANTIMICROB AGENTS CH, V34, P314, DOI 10.1128/AAC.34.2.314; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; Higashi Y, 2009, J COSMET SCI, V60, P519; Huang FM, 2003, BIOMATERIALS, V24, P1869, DOI 10.1016/S0142-9612(02)00584-7; HUME WR, 1986, J AM DENT ASSOC, V113, P789, DOI 10.14219/jada.archive.1986.0256; Iha K, 2013, ORAL SURG ORAL MED O; Imai Norio, 2006, Journal of Toxicological Sciences, V31, P357, DOI 10.2131/jts.31.357; Inamori Y, 2000, BIOL PHARM BULL, V23, P995, DOI 10.1248/bpb.23.995; Jangra SL, 2012, J NANOSCI NANOTECHNO, V12, P7105, DOI 10.1166/jnn.2012.6574; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kayaoglu G, 2005, INT ENDOD J, V38, P483, DOI 10.1111/j.1365-2591.2005.00981.x; Krenn BM, 2009, J VIROL, V83, P58, DOI 10.1128/JVI.01543-08; Leonardo MR, 1999, ORAL SURG ORAL MED O, V88, P221, DOI 10.1016/S1079-2104(99)70119-8; Liguori PF, 2010, DALTON T, V39, P4205, DOI 10.1039/b922101h; Lin KH, 2013, BIOCHEM PHARMACOL, V85, P1478, DOI 10.1016/j.bcp.2013.02.027; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Nagao Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-348; Ng KT, 2011, J PERIODONTOL, V82, P136, DOI 10.1902/jop.2010.100100; Oblak EZ, 2012, ORG BIOMOL CHEM, V10, P8597, DOI 10.1039/c2ob26553b; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; SAEKI Y, 1989, Bulletin of Tokyo Dental College, V30, P129; Saha S, 2010, J Indian Soc Pedod Prev Dent, V28, P251, DOI 10.4103/0970-4388.76151; Saleh IM, 2004, INT ENDOD J, V37, P193, DOI 10.1111/j.0143-2885.2004.00785.x; Salz U, 2009, INT ENDOD J, V42, P1084, DOI 10.1111/j.1365-2591.2009.01635.x; Schwarze T, 2002, J ENDODONT, V28, P784, DOI 10.1097/00004770-200211000-00009; Senges C, 2011, J ENDODONT, V37, P1247, DOI 10.1016/j.joen.2011.05.034; Shantiaee Yazdan, 2010, Iran Endod J, V5, P1; Shieh TM, 2010, ORAL ONCOL, V46, pE47, DOI 10.1016/j.oraloncology.2010.04.009; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; Shih YH, 2013, MICROBIOL RES, V168, P254, DOI 10.1016/j.micres.2012.12.007; Shih YH, 2013, HEAD NECK-J SCI SPEC, V35, P250, DOI 10.1002/hed.22959; Silva LAB, 1997, J ENDODONT, V23, P86; Sonja Pezelj-Ribaric IB, 2001, ACTA STOMATOL CROAT, V35, P475; TRP F, 1997, HART END CLIN PRACT; Weiss EI, 1996, ENDOD DENT TRAUMATOL, V12, P179; Xu P, 2010, J ENDODONT, V36, P40, DOI 10.1016/j.joen.2009.09.002; YESILSOY C, 1988, ORAL SURG ORAL MED O, V65, P459, DOI 10.1016/0030-4220(88)90361-1	49	22	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e94941	10.1371/journal.pone.0094941	http://dx.doi.org/10.1371/journal.pone.0094941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915566	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700001
J	Chrostek, E; Marialva, MSP; Yamada, R; O'Neill, SL; Teixeira, L				Chrostek, Ewa; Marialva, Marta S. P.; Yamada, Ryuichi; O'Neill, Scott L.; Teixeira, Luis			High Anti-Viral Protection without Immune Upregulation after Interspecies Wolbachia Transfer	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-MELANOGASTER; MITOCHONDRIAL GENOTYPE; ENDOSYMBIONT WOLBACHIA; DENGUE VIRUS; EXPRESSION; SYMBIONT; DENSITY; ACTIVATION	Wolbachia, endosymbionts that reside naturally in up to 40-70% of all insect species, are some of the most prevalent intracellular bacteria. Both Wolbachia wAu, naturally associated with Drosophila simulans, and wMel, native to Drosophila melanogaster, have been previously described to protect their hosts against viral infections. wMel transferred to D. simulans was also shown to have a strong antiviral effect. Here we directly compare one of the most protective wMel variants and wAu in D. melanogaster in the same host genetic background. We conclude that wAu protects better against viral infections, it grows exponentially and significantly shortens the lifespan of D. melanogaster. However, there is no difference between wMel and wAu in the expression of selected antimicrobial peptides. Therefore, neither the difference in anti-viral effect nor the life-shortening could be attributed to the immune stimulation by exogenous Wolbachia. Overall, we prove that stable transinfection with a highly protective Wolbachia is not necessarily associated with general immune activation.	[Chrostek, Ewa; Marialva, Marta S. P.; Teixeira, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Yamada, Ryuichi] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [O'Neill, Scott L.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [O'Neill, Scott L.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Instituto Gulbenkian de Ciencia; Scripps Research Institute; University of Queensland; Monash University	Chrostek, E (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	e.chrostek@gmail.com	Teixeira, Luis/H-6106-2013; O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; Chrostek, Ewa/AAA-4218-2022	Teixeira, Luis/0000-0001-8326-6645; O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; Chrostek, Ewa/0000-0003-1825-372X; Yamada, Ryuichi/0000-0002-8344-5499	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/108327/2008, SFRH/BD/51625/2011]; Wellcome Trust [094664/Z/10/Z]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/108327/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt) grants PTDC/BIA-MIC/108327/2008 and the Wellcome Trust (http://www.wellcome.ac.uk) grant 094664/Z/10/Z. EC is supported by the PhD fellowship from Fundacao para a Ciencia e Tecnologia SFRH/BD/51625/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brun G, 1978, GENET BIOL DROSOPHIL, P625; Charlat S, 2004, EVOLUTION, V58, P1901, DOI 10.1111/j.0014-3820.2004.tb00478.x; Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1994, GENETICS, V136, P993; Ilinsky YY, 2007, RUSS J GENET+, V43, P748, DOI 10.1134/S102279540707006X; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; James AC, 2003, GENETICS, V164, P187; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kapun M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012421; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Poinsot D, 1998, GENETICS, V150, P227; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Richardson MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003129; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Siozios S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055390; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Teixeira L, 2012, BRIEF FUNCT GENOMICS, V11, P375, DOI 10.1093/bfgp/els043; Verspoor RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026318; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430; Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	50	44	45	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99025	10.1371/journal.pone.0099025	http://dx.doi.org/10.1371/journal.pone.0099025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911519	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600035
J	Dordevic, AL; Konstantopoulos, N; Cameron-Smith, D				Dordevic, Aimee L.; Konstantopoulos, Nicky; Cameron-Smith, David			3T3-L1 Preadipocytes Exhibit Heightened Monocyte-Chemoattractant Protein-1 Response to Acute Fatty Acid Exposure	PLOS ONE			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; ADIPOSE-TISSUE; TNF-ALPHA; ADIPOCYTE DIFFERENTIATION; INNATE IMMUNITY; KINASE-C; EXPRESSION	Preadipocytes contribute to the inflammatory responses within adipose tissue. Whilst fatty acids are known to elicit an inflammatory response within adipose tissue, the relative contribution of preadipocytes and mature adipocytes to this is yet to be determined. We aimed to examine the actions of common dietary fatty acids on the acute inflammatory and adipokine response in 3T3-L1 preadipocytes and differentiated mature adipocytes. Gene expression levels of key adipokines in 3T3-L1 preadipocytes and adipocytes were determined following incubation with palmitic acid, myristic acid or oleic acid and positive inflammatory control, lipopolysaccharide for 2 and 4 h. Inflammatory kinase signalling was assessed by analysis of nuclear factor-kappa B, p38-mitogen-activated protein kinase and c-jun amino-terminal kinase phosphorylation. Under basal conditions, intracellular monocyte chemoattractant protein-1 and interleukin-6 gene expression levels were increased in preadipocytes, whereas mature adipocytes expressed increased gene expression levels of leptin and adiponectin. Fatty acid exposure at 2 and 4 h increased both monocyte chemoattractant protein-1 and interleukin-6 gene expression levels in preadipocytes to greater levels than in mature adipocytes. There was an accompanying increase of inhibitor of kappa B-a degradation and nuclear factor-kB (p65) (Ser536) phosphorylation with fatty acid exposure in the preadipocytes only. The current study points to preadipocytes rather than the adipocytes as the contributors to both immune cell recruitment and inflammatory adipokine secretion with acute increases in fatty acids.	[Dordevic, Aimee L.; Cameron-Smith, David] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Dordevic, Aimee L.] Monash Univ, Dept Nutr & Dietet, Notting Hill, Vic, Australia; [Konstantopoulos, Nicky] Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia; [Cameron-Smith, David] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	Deakin University; Monash University; Deakin University; University of Auckland	Cameron-Smith, D (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia.	d.cameron-smith@auckland.ac.nz		Dordevic, Aimee/0000-0002-0405-3164; Cameron-Smith, David/0000-0002-0144-5816	Strategic Priorities grant	Strategic Priorities grant	Funding was received through a Strategic Priorities grant to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Annuzzi G, 2010, METABOLISM, V59, P567, DOI 10.1016/j.metabol.2009.08.020; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Chai WD, 2007, ENDOCRINOLOGY, V148, P1622, DOI 10.1210/en.2006-1068; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Gao D, 2012, INT J OBES LOND; Granados N, 2011, BRIT J NUTR, V105, P1226, DOI 10.1017/S0007114510004885; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Konstantopoulos N, 2007, ENDOCRINOLOGY, V148, P374, DOI 10.1210/en.2006-0446; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V368, P81, DOI 10.1016/j.bbrc.2008.01.035; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lamers D, 2012, MOL CELL ENDOCRINOL, V362, P194, DOI 10.1016/j.mce.2012.06.010; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Manning PJ, 2008, OBESITY, V16, P2046, DOI 10.1038/oby.2008.334; Masson CJ, 2011, J NUTR, V141, P816, DOI 10.3945/jn.110.136432; Melloni E, 2013, NUTRITION, V29, P332, DOI 10.1016/j.nut.2012.07.013; Meneses ME, 2011, MOL NUTR FOOD RES, V55, P1759, DOI 10.1002/mnfr.201100200; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Neacsu O, 2013, OBESITY, V21, P1843, DOI 10.1002/oby.20329; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; O'Hara A, 2012, MOL CELL ENDOCRINOL, V349, P239, DOI 10.1016/j.mce.2011.10.031; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Peairs AD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-122; Poulain-Godefroy O, 2007, BIOCHEM BIOPH RES CO, V356, P662, DOI 10.1016/j.bbrc.2007.03.053; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Shang Z, 2014, BIOSCI REP; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stehno-Bittel L, 2008, PHYS THER, V88, P1265, DOI 10.2522/ptj.20080034; Stuart AAV, 2012, J CLIN ENDOCR METAB, V97, P463, DOI 10.1210/jc.2011-1858; Tardif N, 2011, CLIN NUTR, V30, P799, DOI 10.1016/j.clnu.2011.05.009; Thompson GM, 2004, ANAL BIOCHEM, V330, P21, DOI 10.1016/j.ab.2004.03.061; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Voon PT, 2011, AM J CLIN NUTR, V94, P1451, DOI 10.3945/ajcn.111.020107; Wang BH, 2005, AM J PHYSIOL-ENDOC M, V288, pE731, DOI 10.1152/ajpendo.00475.2004; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	56	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99382	10.1371/journal.pone.0099382	http://dx.doi.org/10.1371/journal.pone.0099382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911931	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600078
J	Karampampa, K; Andersson, T; Drefahl, S; Ahlbom, A; Modig, K				Karampampa, Korinna; Andersson, Tomas; Drefahl, Sven; Ahlbom, Anders; Modig, Karin			Does Improved Survival Lead to a More Fragile Population: Time Trends in Second and Third Hospital Admissions among Men and Women above the Age of 60 in Sweden	PLOS ONE			English	Article							MORTALITY; EUROPE; DISEASES; HEALTH; OLD	Background:Life expectancy and time to first hospitalization have been prolonged, indicating that people live longer without needing hospital care. Life expectancy increased partially due to improved survival from severe diseases, which, however, could lead to a more fragile population. If so, time to a subsequent hospitalization could decrease. Alternatively, the overall trend of improved health could continue after the first hospitalization, prolonging also the time to subsequent hospitalizations. This study analyzes trends in subsequent hospitalizations among Swedish men and women above the age of 60, relating them to first hospitalization. It also looks at trends in the proportion of never hospitalized. Methods: Individuals were followed in national registers for hospital admissions and deaths between 1972 and 2010. The proportion of never hospitalized individuals at given ages and time points, and the annual change in the risks of first and subsequent hospitalizations, were calculated. Findings: An increase in the proportion of never hospitalized was seen over time. The risks of first as well as subsequent hospitalizations were reduced by almost 10% per decade for both men and women. Improvements were observed mainly for individuals below the ages of 90 and up to the year 2000. Conclusions: The reduction in annual risk of both first and subsequent hospitalizations up to 90 years of age speaks in favor of a postponement of the overall morbidity among the elderly and provides no support for the hypothesis that the population becomes more fragile due to increased survival from severe diseases.	[Karampampa, Korinna; Andersson, Tomas; Drefahl, Sven; Ahlbom, Anders; Modig, Karin] Karolinska Inst, Inst Environm Med, Epidemiol Unit, S-10401 Stockholm, Sweden; [Andersson, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Drefahl, Sven] Stockholm Univ, Dept Sociol, Demog Unit, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Stockholm University	Karampampa, K (corresponding author), Karolinska Inst, Inst Environm Med, Epidemiol Unit, S-10401 Stockholm, Sweden.	korinna.karampampa@ki.se	Modig, Karin/H-1542-2014	Drefahl, Sven/0000-0003-4533-7558; Modig, Karin/0000-0002-5151-4867	Swedish Research Council for Health; Working Life and Social Research (Forskningsradet for halsa, arbetsliv och valfard, FAS) [2011-0843]; Swedish Society of Medicine (Svenska Lakaresallskapet)	Swedish Research Council for Health; Working Life and Social Research (Forskningsradet for halsa, arbetsliv och valfard, FAS); Swedish Society of Medicine (Svenska Lakaresallskapet)	Funding was received from the Swedish Research Council for Health, Working Life and Social Research (Forskningsradet for halsa, arbetsliv och valfard, FAS) grant number: 2011-0843), and the Swedish Society of Medicine (Svenska Lakaresallskapet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CAUS DEATH REG; Bosetti C, 2013, ANN ONCOLOGY OFFICIA; Bronnum-Hansen H, 2009, AGE AGEING, V38, P47, DOI 10.1093/ageing/afn239; Cooper R, 2000, CIRCULATION, V102, P3137; Drefahl S, 2012, J INTERN MED, V272, P100, DOI 10.1111/j.1365-2796.2012.02518.x; Herberts P., 2011, ANN REPORT; Holosko MJ, 2009, SOC WORK PUBLIC HLTH, V24, P210, DOI 10.1080/19371910802595299; Karampampa K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003447; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kesteloot H, 2006, EUR HEART J, V27, P107, DOI 10.1093/eurheartj/ehi511; Larsson K, 2006, SCAND J PUBLIC HEALT, V34, P185, DOI 10.1080/14034950600677253; Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d; Modig K, 2013, INT J EPIDEMIOLOGY; Modig K, 2013, INT J EPIDEMIOL, V42, P914, DOI 10.1093/ije/dyt035; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; National Board of Health and Welfare [Socialstyrelsen], 2011, INP DIS SWED 1987 20; National Board of Health and Welfare [Socialstyrelsen], 2013, PAT REG; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rasmussen Lene Juel, 2011, Mech Ageing Dev, V132, P522, DOI 10.1016/j.mad.2011.07.004; Socialstyrelsen [National Board of Health and Welfare], 2012, PAT 2010 DRG PERSP; Statistics Sweden, 2013, LONG INT DAT HLTH IN; Statistics Sweden [Statistika Centralbyran], 2013, TOT POP REG; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128	23	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99034	10.1371/journal.pone.0099034	http://dx.doi.org/10.1371/journal.pone.0099034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911650	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600036
J	Lavigne, AC; Castells, M; Mermet, J; Kocanova, S; Dalvai, M; Bystricky, K				Lavigne, Anne-Claire; Castells, Magali; Mermet, Jerome; Kocanova, Silvia; Dalvai, Mathieu; Bystricky, Kerstin			Increased macroH2A1.1 Expression Correlates with Poor Survival of Triple-Negative Breast Cancer Patients	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE MACROH2A1; STEM-CELLS; MOLECULAR SUBTYPES; CLAUDIN-LOW; METASTASIS; SIGNATURE; GENES; LUNG; IDENTIFICATION	Purpose: Epithelial-Mesenchymal Transition (EMT) features appear to be key events in development and progression of breast cancer. Epigenetic modifications contribute to the establishment and maintenance of cancer subclasses, as well as to the EMT process. Whether histone variants contribute to these transformations is not known. We investigated the relative expression levels of histone macroH2A1 splice variants and correlated it with breast cancer status/prognosis/types. Methods: To detect differential expression of macroH2A1 variant mRNAs in breast cancer cells and tumor samples, we used the following databases: GEO, EMBL-EBI and publisher databases (may-august 2012). We extracted macroH2A1.1/macroH2A1 mRNA ratios and performed correlation studies on intrinsic molecular subclasses of breast cancer and on molecular characteristics of EMT. Associations between molecular and survival data were determined. Results: We found increased macroH2A1.1/macroH2A1 mRNA ratios to be associated with the claudin-low intrinsic subtype in breast cancer cell lines. At the molecular level this association translates into a positive correlation between macroH2A1 ratios and molecular characteristics of the EMT process. Moreover, untreated Triple Negative Breast Cancers presenting a high macroH2A1.1 mRNA ratio exhibit a poor outcome. Conclusion: These results provide first evidence that macroH2A1.1 could be exploited as an actor in the maintenance of a transient cellular state in EMT progress towards metastatic development of breast tumors.	[Lavigne, Anne-Claire; Castells, Magali; Mermet, Jerome; Kocanova, Silvia; Dalvai, Mathieu; Bystricky, Kerstin] Univ Toulouse, Lab Biol Mol Eucaryote, F-31062 Toulouse, France; [Lavigne, Anne-Claire; Castells, Magali; Mermet, Jerome; Kocanova, Silvia; Dalvai, Mathieu; Bystricky, Kerstin] CNRS, LBME, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lavigne, AC (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, F-31062 Toulouse, France.	lavigne@ibcg.biotoul.fr	Bystricky, Kerstin/AAA-3003-2020; Lavigne, Anne-Claire/O-8805-2015; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721; Mermet, Jerome/0000-0001-8623-7380	Institut National du Cancer [TRANSLA11-73]	Institut National du Cancer(Institut National du Cancer (INCA) France)	Funding provided by Institut National du Cancer - noTRANSLA11-73 -URL:http://www.e-cancer.fr/and Fondation pour la Recherche Medicale - URL: http://www.frm.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Barrero MJ, 2013, J BIOL CHEM; Barrero MJ, 2013, CELL REP; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carmody LC, 2012, J BIOMOL SCREEN, V17, P1204, DOI 10.1177/1087057112458317; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Dardenne E, 2012, NAT STRUCT MOL BIOL, V19, P1139, DOI 10.1038/nsmb.2390; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Germain AR, 2012, BIOORG MED CHEM LETT, V22, P3571, DOI 10.1016/j.bmcl.2012.01.035; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rody A, 2007, BREAST, V16, P235, DOI 10.1016/j.breast.2007.02.006; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, EUR J CANCER, V45, P405, DOI 10.1016/j.ejca.2008.10.016; Ruckhaberle E, 2010, EUR J CANCER, V46, P549, DOI 10.1016/j.ejca.2009.11.020; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; Stadler SC, 2012, SEMIN CANC BIOL; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Wang Y, 2012, EXP CELL RES; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warzecha CC, 2012, SEMIN CANC BIOL; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	63	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98930	10.1371/journal.pone.0098930	http://dx.doi.org/10.1371/journal.pone.0098930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911873	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600027
J	Li, LL; Zhou, HF; Yang, X; Zhao, L; Yu, XD				Li, Luanluan; Zhou, Huafei; Yang, Xin; Zhao, Li; Yu, Xiaodan			Relationships between 25-Hydroxyvitamin D and Nocturnal Enuresis in Five- to Seven-Year-Old Children	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; SLEEP FRAGMENTATION; D-RECEPTOR; MYOPATHY; EPIDEMIOLOGY; SOCIETY; DISEASE; SYSTEM; HEALTH	Background: Vitamin D has been recognized to contribute to various physiological processes. However, no study has investigated serum 25-hydroxyvitamin D [25(OH) D] concentrations in children with nocturnal enuresis (NE) in the English literature. Objective: In the present study, serum 25(OH) D concentrations were measured in five-to seven-year-old children with NE and compared with those in non-enuretic children to investigate whether there was any relationship between 25(OH) D and NE as the first time in the literature. Design: Two hundred forty-seven five-to seven-year-old children were recruited from Taizhou, Zhejiang Province, China. Serum 25(OH) D concentrations were measured, and the structured questionnaire was administered to the parents of all children. Low 25(OH) D was defined as serum 25(OH) D concentrations below 20 ng/ml. Results: The prevalence of NE was 7.3% in the group of children with 25(OH) D concentrations that exceeded 20 ng/ml; this prevalence was much lower than the 17.5% observed in the group of children with 25(OH) D concentrations below 20 ng/ml (p, 0.05). After adjusting for potential confounders, serum 25(OH) D (>= 20 ng/ml) was significantly associated with NE and represented a protective factor against NE (OR = 0.31, 95% CI = 0.092, 1.0, P,<0.05). A nonlinear relationship between 25(OH) D and NE was observed. The prevalence of NE decreased with increasing 25(OH) D concentrations above 19 ng/ml. Additionally, children exhibiting higher frequencies of bedwetting had lower 25(OH) D concentrations [5-7 times/week: 18.3 +/- 4.8; 2-4 times/week: 20.9 +/- 4.1; 0-1 times/week: 23.666.4 (ng/ml), P< 0.05)]. Conclusions: Low 25(OH) D was associated with an increased risk of NE in children aged five to seven years.	[Li, Luanluan; Yang, Xin; Zhao, Li; Yu, Xiaodan] Shanghai Jiao Tong Univ, Sch Med, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai Inst Pediat Res,Xinhua Hosp, Shanghai 200030, Peoples R China; [Zhou, Huafei] Taizhou Hosp Luqiao, Taizhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University	Yu, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai Inst Pediat Res,Xinhua Hosp, Shanghai 200030, Peoples R China.	xd_yu2003@126.com			Shanghai Committee of Science and Technology, China [114119a1600]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This study was funded by the Shanghai Committee of Science and Technology, China (No. 114119a1600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2012, CURR OPIN ALLERGY CL, V12, P13, DOI 10.1097/ACI.0b013e32834eccdb; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Butler RJ, 2004, CLIN PSYCHOL REV, V24, P909, DOI 10.1016/j.cpr.2004.07.001; Butler RJ, 2000, SCAND J UROL NEPHROL, V34, P270, DOI 10.1080/003655900750042022; Cohen-Zrubavel V, 2011, SLEEP, V34, P191, DOI 10.1093/sleep/34.2.191; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Glerup H, 2000, CALCIFIED TISSUE INT, V66, P419, DOI 10.1007/s002230010085; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Gumus B, 1999, ACTA PAEDIATR, V88, P1369, DOI 10.1080/080352599750030103; Gunes A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-357; Hjalmas K, 2004, J UROLOGY, V171, P2545, DOI 10.1097/01.ju.0000111504.85822.b2; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Kiddoo DA, 2006, AM J PHYSIOL-REG I, V290, pR1697, DOI 10.1152/ajpregu.00742.2005; Kong J, 2008, J AM SOC NEPHROL, V19, P2396, DOI 10.1681/ASN.2008010011; Krueger James M, 2011, Handb Clin Neurol, V98, P229, DOI 10.1016/B978-0-444-52006-7.00015-0; Leiberman A, 2006, INT J PEDIATR OTORHI, V70, P1675, DOI 10.1016/j.ijporl.2006.06.002; McCarty DE, 2012, J CLIN SLEEP MED, V8, P693, DOI 10.5664/jcsm.2266; McCarty DE, 2010, J CLIN SLEEP MED, V6, P605; Neveus T, 2008, PEDIATR NEPHROL, V23, P1201, DOI 10.1007/s00467-008-0859-1; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; NUNN JD, 1986, IMMUNOLOGY, V59, P479; Ozden Cuneyt, 2007, Int. braz j urol., V33, P216, DOI 10.1590/S1677-55382007000200013; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; PHILIP P, 1994, SLEEP, V17, P242; Prabhala A, 2000, ARCH INTERN MED, V160, P1199, DOI 10.1001/archinte.160.8.1199; Reid D, 2011, INT J PEDIATR OTORHI, V75, P261, DOI 10.1016/j.ijporl.2010.11.012; ROEHRS T, 1994, SLEEP, V17, P438, DOI 10.1093/sleep/17.5.438; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; RUSSELL JA, 1994, MUSCLE NERVE, V17, P578, DOI 10.1002/mus.880170603; Saintonge S, 2009, PEDIATRICS, V123, P797, DOI 10.1542/peds.2008-1195; Suzuki Y, 2009, J STEROID BIOCHEM, V113, P134, DOI 10.1016/j.jsbmb.2008.12.004; Umlauf Mary Grace, 2003, J Spec Pediatr Nurs, V8, P22, DOI 10.1111/j.1744-6155.2003.tb00180.x; van den Ouweland JMW, 2013, REV ENDOCR METAB DIS, V14, P159, DOI 10.1007/s11154-013-9241-0; Van der Schueren BJ, 2012, CURR OPIN LIPIDOL, V23, P17, DOI 10.1097/MOL.0b013e32834d7357; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200	42	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99316	10.1371/journal.pone.0099316	http://dx.doi.org/10.1371/journal.pone.0099316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911026	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600070
J	Ochiai-Shino, H; Kato, H; Sawada, T; Onodera, S; Saito, A; Takato, T; Shibahara, T; Muramatsu, T; Azuma, T				Ochiai-Shino, Hiromi; Kato, Hiroshi; Sawada, Takashi; Onodera, Shoko; Saito, Akiko; Takato, Tsuyoshi; Shibahara, Takahiko; Muramatsu, Takashi; Azuma, Toshifumi			A Novel Strategy for Enrichment and Isolation of Osteoprogenitor Cells from Induced Pluripotent Stem Cells Based on Surface Marker Combination	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; IN-VITRO; OSTERIX; TRANSCRIPTION; PROGENITORS; GENERATION; INHIBITION; DERIVATION	In this study, we developed a new method to stimulate osteogenic differentiation in tissue-nonspecific alkaline phosphatase (TNAP)-positive cells liberated from human induced pluripotent stem cells (hiPSCs)-derived embryoid bodies (EBs) with 14 days long TGF-beta/IGF-1/FGF-2 treatment. TNAP is a marker protein of osteolineage cells. We analyzed and isolated TNAP-positive and E-cadherin-negative nonepithelial cells by fluorescence-activated cell sorting. Treating the cells with a combination of transforming growth factor (TGF)-beta, insulin-like growth factor (IGF)-1, and fibroblast growth factor (FGF)-2 for 14 days greatly enhanced TNAP expression and maximized expression frequency up to 77.3%. The isolated cells expressed high levels of osterix, which is an exclusive osteogenic marker. Culturing these TNAP-positive cells in osteoblast differentiation medium (OBM) led to the expression of runt-related transcription factor 2, type I collagen, bone sialoprotein, and osteocalcin (OCN). These cells responded to treatment with activated vitamin D3 by upregulating OCN. Furthermore, in OBM they were capable of generating many mineralized nodules with strong expression of receptor activator of NF-kappaB ligand and sclerostin (SOST). Real-time RT-PCR showed a significant increase in the expression of osteocyte marker genes, including SOST, neuropeptide Y, and reelin. Scanning electron microscopy showed dendritic morphology. Examination of semi-thin toluidine blue-stained sections showed many interconnected dendrites. Thus, TNAP-positive cells cultured in OBM may eventually become terminally differentiated osteocyte-like cells. In conclusion, treating hiPSCs-derived cells with a combination of TGF-beta, IGF-1, and FGF-2 generated TNAP-positive cells at high frequency. These TNAP-positive cells had a high osteogenic potential and could terminally differentiate into osteocyte-like cells. The method described here may reveal new pathways of osteogenesis and provide a novel tool for regenerative medicine and drug development.	[Ochiai-Shino, Hiromi; Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Kato, Hiroshi; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Sawada, Takashi] Tokyo Dent Coll, Dept Ultrastruct Sci, Tokyo, Japan; [Takato, Tsuyoshi] Univ Tokyo, Fac Med, Grad Sch Med, Dept Oral & Maxillofacial Surg,Div Tissue Engn, Tokyo 113, Japan; [Muramatsu, Takashi] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College; University of Tokyo; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.	tazuma@tdc.ac.jp	Muramatsu, Takashi/AAW-2646-2020	Onodera, Shoko/0000-0003-0673-3400	JSPS KAKENHI [25861761]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25861761. The URL is "http://www.jsps.go.jp/j-grantsinaid/". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; Harkness L, 2011, BONE, V48, P231, DOI 10.1016/j.bone.2010.09.023; Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383; Li F, 2010, J CELL BIOCHEM, V109, P643, DOI 10.1002/jcb.22440; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Tashiro K, 2009, STEM CELLS, V27, P1802, DOI 10.1002/stem.108; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; Woll Nicole L., 2006, V330, P149; Woll NL, 2006, STEM CELLS DEV, V15, P865, DOI 10.1089/scd.2006.15.865; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	24	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99534	10.1371/journal.pone.0099534	http://dx.doi.org/10.1371/journal.pone.0099534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911063	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600101
J	Yoon, YK; Yang, KS; Lee, SE; Kim, HJ; Sohn, JW; Kim, MJ				Yoon, Young Kyung; Yang, Kyung Sook; Lee, Seung Eun; Kim, Hyun Jeong; Sohn, Jang Wook; Kim, Min Ja			Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ERTAPENEM USE; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANCE; IMPACT; IMIPENEM; CONSUMPTION; RATES	Objective: Antimicrobial stewardship programs have been proposed for reducing bacterial resistance in the hospital environment. The purpose of this study was to investigate the impact of a carbapenem-use stewardship program on the susceptibility of Acinetobacter baumannii to Group 2 carbapenems. Methods: A before and after intervention study was conducted at a university hospital from September 2008 to February 2013. Three study periods were defined: Phase I, pre-intervention (months 1-18); Phase II, a postintervention period during which ertapenem use was mandated but carbapenem use was not restricted (months 19-36); and Phase III, a postintervention period during which Group 2 carbapenem use was restricted (months 37-54). Results: During the study period, intervention resulted in diminished consumption of Group 2 carbapenems (antimicrobial use density (AUD): 21.3 +/- 6.0 in Phase I, 18.8 +/- 6.0 in Phase II, 16.1 +/- 4.4 in Phase III; P = 0.028) and increased consumption of ertapenem (AUD: 2.7 +/- 1.7 in Phase I, 7.2 +/- 4.5 in Phase II, 9.1 +/- 5.3 in Phase III; P<0.001). The use of autoregressive-error models showed that in contrast with ertapenem use, the use of Group 2 carbapenem during the previous one month was positively and significantly associated with a subsequent increase in the proportion of carbapenem-resistant A. baumannii (CRAB) (P = 0.031). Conclusions: Implementing a carbapenem-use stewardship program featuring the preferential use of ertapenem for treating appropriate indications of infection resulted in reduced use of Group 2 carbapenems and had a positive impact on the susceptibility of A. baumannii to carbapenems. This approach could be integrated into CRAB-control strategies in hospitals.	[Yoon, Young Kyung; Sohn, Jang Wook; Kim, Min Ja] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea; [Yoon, Young Kyung; Sohn, Jang Wook; Kim, Min Ja] Korea Univ, Coll Med, Inst Emerging Infect Dis, Seoul 136705, South Korea; [Yang, Kyung Sook] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Yoon, Young Kyung; Lee, Seung Eun; Kim, Hyun Jeong; Sohn, Jang Wook; Kim, Min Ja] Korea Univ, Anam Hosp, Infect Control Unit, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, MJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea.	macropha@korea.ac.kr	Kyung, Yoon Young/AAS-3428-2020	Yoon, Young Kyung/0000-0001-8435-935X; KIM, MIN JA/0000-0002-2125-7521	Merck Sharp Dohme	Merck Sharp Dohme(Merck & Company)	This study was financially supported by Merck Sharp & Dohme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beovic B, 2011, J CHEMOTHERAPY, V23, P216, DOI 10.1179/joc.2011.23.4.216; Cao J, 2013, J CLIN PHARMACOL, V53, P96, DOI 10.1177/0091270011435988; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; D'Agata EMC, 2000, INFECT CONT HOSP EP, V21, P588, DOI 10.1086/501808; Dortch MJ, 2011, SURG INFECT, V12, P15, DOI 10.1089/sur.2009.059; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Falagas ME, 2013, EXPERT REV ANTI-INFE, V11, P69, DOI [10.1586/eri.12.149, 10.1586/ERI.12.149]; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Goff DA, 2008, J INFECTION, V57, P123, DOI 10.1016/j.jinf.2008.06.001; Kim JY, 2008, J ANTIMICROB CHEMOTH, V62, P416, DOI 10.1093/jac/dkn164; Kuo HY, 2012, INT J ANTIMICROB AG, V39, P33, DOI 10.1016/j.ijantimicag.2011.08.016; Lee CM, 2013, DIAGN MICR INFEC DIS, V75, P94, DOI 10.1016/j.diagmicrobio.2012.09.018; Lee K, 2011, YONSEI MED J, V52, P879, DOI 10.3349/ymj.2011.52.6.879; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lee NY, 2011, DIAGN MICR INFEC DIS, V70, P150, DOI 10.1016/j.diagmicrobio.2010.12.008; Lima ALM, 2008, BRAZ J INFECT DIS, V12, P105, DOI 10.1590/S1413-86702008000200001; Lima ALLM, 2011, BRAZ J INFECT DIS, V15, P1, DOI [10.1016/S1413-8670(11)70131-3, 10.1590/S1413-86702011000100001]; Lima ALL, 2009, INFECT CONT HOSP EP, V30, P487, DOI 10.1086/596781; McDougall DAJ, 2013, J ANTIMICROB CHEMOTH, V68, P457, DOI 10.1093/jac/dks385; Nicolau DP, 2012, INT J ANTIMICROB AG, V39, P11, DOI 10.1016/j.ijantimicag.2011.08.018; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Sousa D, 2013, J ANTIMICROB CHEMOTH, V68, P1917, DOI 10.1093/jac/dkt091; Su CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037788; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Xu JC, 2013, INT J ENV RES PUB HE, V10, P1462, DOI 10.3390/ijerph10041462; Yoon YK, 2011, J MICROBIOL, V49, P363, DOI 10.1007/s12275-011-0491-9	27	14	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99101	10.1371/journal.pone.0099101	http://dx.doi.org/10.1371/journal.pone.0099101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911244	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600043
J	Cheah, KY; Howarth, GS; Bindon, KA; Kennedy, JA; Bastian, SEP				Cheah, Ker Y.; Howarth, Gordon S.; Bindon, Keren A.; Kennedy, James A.; Bastian, Susan E. P.			Low Molecular Weight Procyanidins from Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Caco-2 Human Colon Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PROANTHOCYANIDINS; ANTIOXIDANT; APOPTOSIS; ANGIOGENESIS; POLYPHENOLS; EXPRESSION; FRACTIONS; PATHWAYS; RECEPTOR	Objective: Grape seed procyanidins (PC) are flavan-3-ol oligomers and polymers known for their biological activity in the gut. Grape seed extract (GSE) have been reported to reduce intestinal injury in a rat model of mucositis. We sought to investigate effects of purified PC fractions differing in mean degree of polymerization (mDP) combined with 5-Fluorouracil (5-FU) chemotherapy on the viability of colon cancer cells (Caco-2). Design: SixPC fractions (F1-F6) were isolated from Cabernet Sauvignon seeds at two ripeness stages: pre-veraison unripe (immature) and ripe (mature), utilizing step gradient, low-pressure chromatography on a Sephadex LH-20 resin. Fractions were tested on Caco-2 cells, alone and in combination with 5-FU. Eluted fractions were characterized by phloroglucinolysis and gel permeation chromatography. Cell viability was determined by the 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide) (MTT) assay. Results: All isolated fractions significantly reduced Caco-2 cell viability compared to the control (P<0.05), but F2 and F3 (mDP 2-6) were the most active fractions (immature F2 = 32% mDP 2.4, F3 = 35% mDP 5.8 and mature F2 = 13% mDP 3.6 and F3 = 17% mDP 5.9; percentage of viable cells remaining) on Caco-2 cells. When combined with 5-FU, immature fractions F1-F3 enhanced the cell toxicity effects of 5-FU by 27-73% (P<0.05). Mature seed PC fractions (F1-F4) significantly enhanced the toxicity of 5-FU by 60-83% against Caco-2 cells (P<0.05). Moreover, some fractions alone were more potent at decreasing viability in Caco-2 cells (P<0.05; immature fractions = 65-68% and mature fractions = 83-87%) compared to 5-FU alone (37%). Conclusions: PCs of mDP 2-6 (immature F1-F3 and mature F1 and F4) not only enhanced the impact of 5-FU in killing Caco-2 cells, but also surpassed standard 5-FU chemotherapy as an anti-cancer agent. The bioactivity of PC is therefore attributed primarily to lower molecular weight PCs.	[Cheah, Ker Y.; Bastian, Susan E. P.] Sch Agr Food & Wine, Wine Sci & Business Grp, Glen Osmond, SA, Australia; [Cheah, Ker Y.; Howarth, Gordon S.] Children Youth & Womens Hlth Serv, Ctr Paediat & Adolescent Gastroenterol, Adelaide, SA, Australia; [Howarth, Gordon S.] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia; [Bindon, Keren A.; Kennedy, James A.] Australian Wine Res Inst, Adelaide, SA, Australia; [Kennedy, James A.] Calif State Univ Fresno, Dept Viticulture & Enol, Fresno, CA 93740 USA	University of Adelaide; Australian Wine Research Institute; California State University System; California State University Fresno	Bastian, SEP (corresponding author), Sch Agr Food & Wine, Wine Sci & Business Grp, Waite Campus,PMB 1, Glen Osmond, SA, Australia.	sue.bastian@adelaide.edu.au	Howarth, Gordon/AAM-8699-2020; Kennedy, James A/A-1636-2012	Howarth, Gordon/0000-0001-6979-6084; Kennedy, James A/0000-0002-5453-8469; Bastian, Susan/0000-0002-8790-2044	South Australian Health and Medical Research Institute Cancer Council	South Australian Health and Medical Research Institute Cancer Council	Professor Gordon Howarth is supported by a South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship. The current study was performed under the collaboration between Wine Science and Business Group, The University of Adelaide and Australian Wine Research Institute (AWRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis-Goretta L, 2008, J NUTR BIOCHEM, V19, P797, DOI 10.1016/j.jnutbio.2007.10.004; Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; Bindon KA, 2011, J AGR FOOD CHEM, V59, P2696, DOI 10.1021/jf1047207; Bindon KA, 2010, J AGR FOOD CHEM, V58, P2520, DOI 10.1021/jf9037453; Cheah KY, 2013, DIGEST DIS SCI, V58, P970, DOI 10.1007/s10620-012-2464-1; Cheah KY, 2009, CANCER BIOL THER, V8, P382, DOI 10.4161/cbt.8.4.7453; Cheah KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085184; Choi KC, 2011, BIOCHEM J, V433, P235, DOI 10.1042/BJ20100980; Choy YY, 2013, J AGR FOOD CHEM, V61, P121, DOI 10.1021/jf301939e; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Dinicola S, 2012, INT J MOL SCI, V13, P651, DOI 10.3390/ijms13010651; Dinicola S, 2010, BRIT J NUTR, V104, P824, DOI 10.1017/S0007114510001522; Du Y, 2007, J AGR FOOD CHEM, V55, P1695, DOI 10.1021/jf063071b; Engelbrecht AM, 2007, CANCER LETT, V258, P144, DOI 10.1016/j.canlet.2007.08.020; Faria A, 2006, J AGR FOOD CHEM, V54, P2392, DOI 10.1021/jf0526487; Huang SS, 2012, INT J MOL MED, V30, P1410, DOI 10.3892/ijmm.2012.1147; Huang SS, 2012, NUTR RES, V32, P530, DOI 10.1016/j.nutres.2012.05.012; Huynh-Delerme C, 2005, TOXICOL IN VITRO, V19, P439, DOI 10.1016/j.tiv.2004.08.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaur M, 2008, NUTR CANCER, V60, P2, DOI 10.1080/01635580802381295; Keefe DM, 2008, EXPERT OPIN EMERG DR, V13, P511, DOI 10.1517/14728214.13.3.511 ; Kennedy JA, 2003, J CHROMATOGR A, V995, P99, DOI 10.1016/S0021-9673(03)00420-5; Kern M, 2005, MOL NUTR FOOD RES, V49, P317, DOI 10.1002/mnfr.200400086; Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x; Nomoto H, 2004, NUTR CANCER, V49, P81, DOI 10.1207/s15327914nc4901_11; Park SY, 2011, J MED FOOD, V14, P9, DOI 10.1089/jmf.2010.1264; Pierini R, 2008, MOL NUTR FOOD RES, V52, P1399, DOI 10.1002/mnfr.200700513; Poncet-Legrand C, 2003, LANGMUIR, V19, P10563, DOI 10.1021/la034927z; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Spencer JPE, 2001, BIOCHEM BIOPH RES CO, V285, P588, DOI 10.1006/bbrc.2001.5211; Torres JL, 2002, J AGR FOOD CHEM, V50, P7548, DOI 10.1021/jf025868i; Ugartondo V, 2007, CHEM RES TOXICOL, V20, P1543, DOI 10.1021/tx700253y; Van Cutsem EJD, 2005, ANN ONCOL, V16, P16, DOI 10.1093/annonc/mdi808; Wang YH, 2011, INT IMMUNOPHARMACOL, V11, P1620, DOI 10.1016/j.intimp.2011.05.024	35	37	37	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98921	10.1371/journal.pone.0098921	http://dx.doi.org/10.1371/journal.pone.0098921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905821	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000079
J	Irvin, MR; Zhi, DG; Aslibekyan, S; Claas, SA; Absher, DM; Ordovas, JM; Tiwari, HK; Watkins, S; Arnett, DK				Irvin, Marguerite R.; Zhi, Degui; Aslibekyan, Stella; Claas, Steven A.; Absher, Devin M.; Ordovas, Jose M.; Tiwari, Hemant K.; Watkins, Steve; Arnett, Donna K.			Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ACTIVATED RECEPTOR-ALPHA; FATTY-ACID-COMPOSITION; MUSCLE-CELL MIGRATION; SERUM PLANT STEROLS; CHOLESTEROL ABSORPTION; ARTERY-DISEASE; FENOFIBRATE TREATMENT; ISCHEMIC-STROKE; PLASMA-LEVELS	Background: Increased postprandial lipid (PPL) response to dietary fat intake is a heritable risk factor for cardiovascular disease (CVD). Variability in postprandial lipids results from the complex interplay of dietary and genetic factors. We hypothesized that detailed lipid profiles (eg, sterols and fatty acids) may help elucidate specific genetic and dietary pathways contributing to the PPL response. Methods and Results: We used gas chromatography mass spectrometry to quantify the change in plasma concentration of 35 fatty acids and 11 sterols between fasting and 3.5 hours after the consumption of a high-fat meal (PPL challenge) among 40 participants from the GOLDN study. Correlations between sterols, fatty acids and clinical measures were calculated. Mixed linear regression was used to evaluate associations between lipidomic profiles and genomic markers including single nucleotide polymorphisms (SNPs) and methylation markers derived from the Affymetrix 6.0 array and the Illumina Methy1450 array, respectively. After the PPL challenge, fatty acids increased as well as sterols associated with cholesterol absorption, while sterols associated with cholesterol synthesis decreased. PPL saturated fatty acids strongly correlated with triglycerides, very low-density lipoprotein, and chylomicrons. Two SNPs (rs12247017 and rs12240292) in the sorbin and 5H3 domain containing 1 (SORBSI) gene were associated with b-Sitosterol after correction for multiple testing (P <= 4.5*10(-10)). SORBSI has been linked to obesity and insulin signaling. No other markers reached the genome-wide significance threshold, yet several other biologically relevant loci are highlighted (eg, PRIC285, a co-activator of PPARa). Conclusions: Integration of lipidomic and genomic data has the potential to identify new biomarkers of CVD risk.	[Irvin, Marguerite R.; Aslibekyan, Stella; Claas, Steven A.; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Zhi, Degui; Tiwari, Hemant K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Absher, Devin M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac, Madrid, Spain; [Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Watkins, Steve] Metabolon, Lipom Div, Res Triangle Pk, NC USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; HudsonAlpha Institute for Biotechnology; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Tufts University; United States Department of Agriculture (USDA); Metabolon	Irvin, MR (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	irvinr@uab.edu	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680; Claas, Steven/0000-0001-9789-8395	NIH HHS/United States [R01 HL091357/HL/NHLBI, R01 HL104135/HL/NHLBI]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091357, R01HL104135, U01HL072524] Funding Source: NIH RePORTER	NIH HHS/United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The full funding information for this manuscript in correct notation is as follows: R01 HL091357/HL/NHLBI NIH HHS/United States and R01 HL104135/HL/NHLBI NIH HHS/United States. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Aslibekyan S, 2012, NUTR METAB CARDIOVAS; Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Assmann G, 2006, NUTR METAB CARDIOVAS, V16, P13, DOI 10.1016/j.numecd.2005.04.001; Astrup A, 2011, AM J CLIN NUTR, V93, P684, DOI 10.3945/ajcn.110.004622; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Benno Peter, 2005, Microbial Ecology in Health and Disease, V17, P200, DOI 10.1080/08910600500519854; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Biong AS, 2004, BRIT J NUTR, V92, P791, DOI 10.1079/BJN20041257; Bourdeau ML, 2011, NEUROSCIENCE, V176, P173, DOI 10.1016/j.neuroscience.2010.11.051; Bouwens M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-262; Bouwens M, 2007, AM J CLIN NUTR, V86, P1515, DOI 10.1093/ajcn/86.5.1515; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Cuchel M, 1997, ARTERIOSCL THROM VAS, V17, P1910, DOI 10.1161/01.ATV.17.10.1910; Escurriol V, 2010, J LIPID RES, V51, P618, DOI 10.1194/jlr.P000471; Fassbender K, 2008, ATHEROSCLEROSIS, V196, P283, DOI 10.1016/j.atherosclerosis.2006.10.032; Flock MR, 2013, CURR OPIN CLIN NUTR, V16, P133, DOI 10.1097/MCO.0b013e328359e6ac; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633; Gylling H, 2009, METABOLISM, V58, P401, DOI 10.1016/j.metabol.2008.10.015; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Irvin MR, 2010, CIRC-CARDIOVASC GENE, V3, P462, DOI 10.1161/CIRCGENETICS.110.950667; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Kabagambe EK, 2009, ATHEROSCLEROSIS, V203, P633, DOI 10.1016/j.atherosclerosis.2008.08.005; Kent WJ, 2005, GENOME RES, V15, P737, DOI 10.1101/gr.3694705; KESANIEMI YA, 1987, J CLIN INVEST, V80, P578, DOI 10.1172/JCI113107; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kohler R, 2010, PFLUG ARCH EUR J PHY, V460, P343, DOI 10.1007/s00424-009-0768-6; Korani M, 2012, CLIN LAB, V58, P1283, DOI 10.7754/Clin.Lab.2012.120212; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Langsted A, 2011, J INTERN MED, V270, P65, DOI 10.1111/j.1365-2796.2010.02333.x; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Lopez-Alvarenga JC, 2010, METABOLISM, V59, P86, DOI 10.1016/j.metabol.2009.07.010; Lopez-Miranda J, 2007, BRIT J NUTR, V98, P458, DOI 10.1017/S000711450774268X; Lourenco VM, 2011, BIOINFORMATICS, V27, P815, DOI 10.1093/bioinformatics/btr006; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Matthan NR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005066; Matthan NR, 2010, J LIPID RES, V51, P202, DOI 10.1194/jlr.M900032-JLR200; Matthan NR, 2009, J LIPID RES, V50, P1927, DOI 10.1194/jlr.P900039-JLR200; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4; Miettinen TA, 2001, INT J CLIN PRACT, V55, P710; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; Moriwaki K, 2011, J BIOL CHEM, V286, P43123, DOI 10.1074/jbc.M111.262741; Nestel PJ, 2005, EUR J CLIN NUTR, V59, P1059, DOI 10.1038/sj.ejcn.1602211; Neurauter AA, 2007, ADV BIOCHEM ENG BIOT, V106, P41, DOI 10.1007/10_2007_072; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nolan DP, 2012, SAFETY AND SECURITY REVIEW FOR THE PROCESS INDUSTRIES: APPLICATION OF HAZOP, PHA, WHAT-IF AND SVA REVIEWS, 3RD EDITION, P5, DOI 10.1016/B978-1-4377-3518-5.00002-5; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; O'Connor BP, 2008, P NATL ACAD SCI USA, V105, P13015, DOI 10.1073/pnas.0803386105; O'Donnell-Megaro AM, 2011, J DAIRY SCI, V94, P59, DOI 10.3168/jds.2010-3571; Ostlund RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE911, DOI 10.1152/ajpendo.00328.2001; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Pevsner J, 2009, METHODS MOL BIOL, V537, P277, DOI 10.1007/978-1-59745-251-9_14; Pihlajamaki J, 2004, J LIPID RES, V45, P507, DOI 10.1194/jlr.M300368-JLR200; Pinedo S, 2007, J LIPID RES, V48, P139, DOI 10.1194/jlr.M600371-JLR200; Pruunsild P, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07796.x; Rajaratnam RA, 2000, J AM COLL CARDIOL, V35, P1185, DOI 10.1016/S0735-1097(00)00527-1; Rhee EP, 2012, CLIN CHEM, V58, P139, DOI 10.1373/clinchem.2011.169573; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Senti M, 2005, CIRC RES, V97, P1360, DOI 10.1161/01.RES.0000196557.93717.95; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Shen HQ, 2009, HUM GENET, V126, P567, DOI 10.1007/s00439-009-0700-3; Shentu TP, 2012, J LIPID RES, V53, P1348, DOI 10.1194/jlr.M027102; Silbernagel G, 2010, J LIPID RES, V51, P2384, DOI 10.1194/jlr.P002899; Simonen P, 2000, AM J CLIN NUTR, V72, P82; Smith JG, 2013, EUR J HEART FAIL, V15, P250, DOI 10.1093/eurjhf/hfs176; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Strandberg TE, 1996, DIABETES, V45, P755, DOI 10.2337/diabetes.45.6.755; Sudhop T, 2002, METABOLISM, V51, P1519, DOI 10.1053/meta.2002.36298; Surapureddi S, 2002, P NATL ACAD SCI USA, V99, P11836, DOI 10.1073/pnas.182426699; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tholstrup T, 2004, J AM COLL NUTR, V23, P169, DOI 10.1080/07315724.2004.10719358; Tiret L, 2000, EUR J CLIN INVEST, V30, P578; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; UITERWAAL CSPM, 1994, ANN INTERN MED, V121, P576, DOI 10.7326/0003-4819-121-8-199410150-00004; van Meijl LEC, 2008, NUTR RES REV, V21, P148, DOI 10.1017/S0954422408116997; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Weingartner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013467; Wilund KR, 2004, ARTERIOSCL THROM VAS, V24, P2326, DOI 10.1161/01.ATV.0000149140.00499.92; Windler E, 2009, ATHEROSCLEROSIS, V203, P284, DOI 10.1016/j.atherosclerosis.2008.06.014; Yang WS, 2003, OBES RES, V11, P586, DOI 10.1038/oby.2003.82	101	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99509	10.1371/journal.pone.0099509	http://dx.doi.org/10.1371/journal.pone.0099509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905834	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000123
J	Spaiser, V; Ranganathan, S; Mann, RP; Sumpter, DJT				Spaiser, Viktoria; Ranganathan, Shyam; Mann, Richard P.; Sumpter, David J. T.			The Dynamics of Democracy, Development and Cultural Values	PLOS ONE			English	Article							GROWTH; POSTMATERIALISM; MODERNIZATION	Over the past decades many countries have experienced rapid changes in their economies, their democratic institutions and the values of their citizens. Comprehensive data measuring these changes across very different countries has recently become openly available. Between country similarities suggest common underlying dynamics in how countries develop in terms of economy, democracy and cultural values. We apply a novel Bayesian dynamical systems approach to identify the model which best captures the complex, mainly non-linear dynamics that underlie these changes. We show that the level of Human Development Index (HDI) in a country drives first democracy and then higher emancipation of citizens. This change occurs once the countries pass a certain threshold in HDI. The data also suggests that there is a limit to the growth of wealth, set by higher emancipation. Having reached a high level of democracy and emancipation, societies tend towards equilibrium that does not support further economic growth. Our findings give strong empirical evidence against a popular political science theory, known as the Human Development Sequence. Contrary to this theory, we find that implementation of human-rights and democratisation precede increases in emancipative values.	[Spaiser, Viktoria; Mann, Richard P.; Sumpter, David J. T.] Inst Futures Studies, Stockholm, Sweden; [Ranganathan, Shyam; Mann, Richard P.; Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden	Uppsala University	Spaiser, V (corresponding author), Inst Futures Studies, Stockholm, Sweden.	viktoria.spaiser@iffs.se	Mann, Richard/N-9779-2014	Mann, Richard/0000-0003-0701-1274; Spaiser, Viktoria/0000-0002-5892-245X; Ranganathan, Shyam/0000-0002-1337-5173	European Research Council [IDCAB 220/104702003]; Riksbanken Jubileumsfond	European Research Council(European Research Council (ERC)European Commission); Riksbanken Jubileumsfond	This research was funded by European Research Council grant IDCAB 220/104702003 and the Riksbanken Jubileumsfond (http://www.rj.se/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahian MA, 2012, INT STUD QUART, V56, P827, DOI 10.1111/j.1468-2478.2012.00736.x; Alexander AC, 2012, INT POLIT SCI REV, V33, P41, DOI 10.1177/0192512111414682; Alexander AC, 2011, COMP POLIT, V43, P271, DOI 10.5129/001041511795274931; Barro RJ, 1999, J POLIT ECON, V107, pS158, DOI 10.1086/250107; Barro RJ, 1999, J ECON GROWTH, V1, P1; Barro RJ, 2010, 15902 NBER, DOI [10.1016/j.jdeveco.2012.10.001, DOI 10.1016/J.JDEVECO.2012.10.001]; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Bernardo JM, 1994, BAYESIAN THEORY; Boix C, 2003, WORLD POLIT, V55, P517, DOI 10.1353/wp.2003.0019; Boudon R, 2002, EUR SOCIOL REV, V18, P371, DOI 10.1093/esr/18.3.371; Brown NJ, 2011, DYNAMICS DEMOCRATISA; Cingranelli DL, 1999, J PEACE RES, V36, P511, DOI 10.1177/0022343399036005002; Cingranelli J, 2010, CIRI DATASET 2008; Costanza Robert., 2009, GDP NEED NEW MEASURE, V4; DESCHWEINITZ K, 1959, ECON DEV CULT CHANGE, V7, P385, DOI 10.1086/449812; Diamond L, 1992, REEXAMINING DEMOCRAC; DUCH RM, 1993, AM J POLIT SCI, V37, P747, DOI 10.2307/2111573; Durlauf SN, 2005, HANDB ECON, V22, P555; Edwards MS, 2009, J POLITICAL SCI, V37, P148; EHMAN LH, 1980, REV EDUC RES, V50, P99, DOI 10.3102/00346543050001099; England RW, 1998, ECOL ECON, V25, P89, DOI 10.1016/S0921-8009(97)00098-0; FRANKE RH, 1991, STRATEGIC MANAGE J, V12, P165, DOI 10.1002/smj.4250120912; FreedomHouse, 2010, FREED WORLD; FreedomHouse, 2008, FREED WORLD; Gelman A, 2004, J COMPUT GRAPH STAT, V13, P755, DOI 10.1198/106186004X11435; Geoffrey E, 2007, 75 AFR; Geoffrey E, 2006, 57 AFR; Glaeser EL, 2007, J ECON GROWTH, V12, P77, DOI 10.1007/s10887-007-9015-1; Glaeser EL, 2004, J ECON GROWTH, V9, P271, DOI 10.1023/B:JOEG.0000038933.16398.ed; Granato J, 1996, AM J POLIT SCI, V40, P607, DOI 10.2307/2111786; Guiso L, 2006, J ECON PERSPECT, V20, P23, DOI 10.1257/jep.20.2.23; Hadenius A, 2005, STUD COMP INT DEV, V39, P87, DOI 10.1007/BF02686166; Huntington S. P., 2006, POLITICAL ORDER CHAN; Huntington Samuel P., 1991, 3 WAVE DEMOCRATIZATI; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Inglehart R., 2005, MODERNIZATION CULTUR; Inglehart Ronald., 1997, MODERNIZATION POSTMO; Jaynes E., 2003, PROBABILITY THEORY L, DOI [10.1017/CBO9780511790423, DOI 10.1017/CBO9780511790423]; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kaufmann D, 2006, 3630 WORLD BANK POL; Krieckhaus J, 2004, BRIT J POLIT SCI, V34, P635, DOI 10.1017/S0007123404000225; Ley E, 2009, J APPL ECONOMET, V24, P651, DOI 10.1002/jae.1057; Lindenfors P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028270; LIPSET SM, 1959, AM POLIT SCI REV, V53, P69, DOI 10.2307/1951731; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Natoli R, 2011, SOC INDIC RES, V103, P33, DOI 10.1007/s11205-010-9695-3; Przeworski A, 1997, WORLD POLIT, V49, P155, DOI 10.1353/wp.1997.0004; Przeworski A., 2000, DEMOCRACY DEV POLITI, V3, DOI 10.1017/CBO9780511804946; Ranganathan S, 2014, PLOS ONE, V9; Reynolds B, 2009, GDP WHAT IS PROSPERI; Rindermann H, 2008, INTELLIGENCE, V36, P306, DOI 10.1016/j.intell.2007.09.003; RUSTOW DA, 1970, COMP POLIT, V2, P337, DOI 10.2307/421307; Sagar AD, 1998, ECOL ECON, V25, P249, DOI 10.1016/S0921-8009(97)00168-7; Shafiq MN, 2009, WORKING PAPER; Stebbins R., 2001, EXPLORATORY RES SOCI, DOI DOI 10.4135/9781412984249; Teorell J, 2006, STUD COMP INT DEV, V41, P95, DOI 10.1007/BF02686238; Teorell Jan., 2010, DETERMINANTS DEMOCRA; Tukey JW, 1977, EXPLORATORY DATA ANA; UNDP, 2011, HUM DEV REP 2011 TEC; UNDP, 2010, HUM DEV REP 2010; Weiss K, 2003, J SOCIOLOGY ED SOCIA, V23, P127; Welzel C, 2013, FREEDOM RISING: HUMAN EMPOWERMENT AND THE QUEST FOR EMANCIPATION, P1; Welzel C, 2003, EUR J POLIT RES, V42, P341, DOI 10.1111/1475-6765.00086; Welzel C, 2006, OXFORD HDB POLITICAL, P185; Welzel C, 2005, INT REV SOCIOL, V15, P81, DOI 10.1080/03906700500038579; Welzel C, 2006, STUD COMP INT DEV, V41, P74, DOI 10.1007/BF02686237; Wucherpfennig Julian, 2009, LIVING REV DEMOCRACY	68	24	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97856	10.1371/journal.pone.0097856	http://dx.doi.org/10.1371/journal.pone.0097856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905920	Green Published, gold			2022-12-27	WOS:000341869000014
J	Arndt, A; Hoffacker, P; Zellmer, K; Goecer, O; Recks, MS; Kuerten, S				Arndt, Andreas; Hoffacker, Peter; Zellmer, Konstantin; Goecer, Oktay; Recks, Mascha S.; Kuerten, Stefanie			Conventional Housing Conditions Attenuate the Development of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ANTIGEN-SPECIFIC T; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; CELL; MICROBIOTA; POLYSACCHARIDE; POPULATION; RESPONSES; DISEASE	Background: The etiology of multiple sclerosis (MS) has remained unclear, but a causative contribution of factors outside the central nervous system (CNS) is conceivable. It was recently suggested that gut bacteria trigger the activation of CNS-reactive T cells and the development of demyelinative disease. Methods: C57BL/6 (B6) mice were kept either under specific pathogen free or conventional housing conditions, immunized with the myelin basic protein (MBP)-proteolipid protein (PLP) fusion protein MP4 and the development of EAE was clinically monitored. The germinal center size of the Peyer's patches was determined by immunohistochemistry in addition to the level of total IgG secretion which was assessed by ELISPOT. ELISPOT assays were also used to measure MP4-specific T cell and B cell responses in the Peyer's patches and the spleen. Ear swelling assays were performed to determine the extent of delayed-type hypersensitivity reactions in specific pathogen free and conventionally housed mice. Results: In B6 mice that were actively immunized with MP4 and kept under conventional housing conditions clinical disease was significantly attenuated compared to specific pathogen free mice. Conventionally housed mice displayed increased levels of IgG secretion in the Peyer's patches, while the germinal center formation in the gut and the MP4-specific T(H)17 response in the spleen were diminished after immunization. Accordingly, these mice displayed an attenuated delayed type hypersensitivity (DTH) reaction in ear swelling assays. Conclusions: The data corroborate the notion that housing conditions play a substantial role in the induction of murine EAE and suggest that the presence of gut bacteria might be associated with a decreased immune response to antigens of lower affinity. This concept could be of importance for MS and calls for caution when considering the therapeutic approach to treat patients with antibiotics.	[Arndt, Andreas; Hoffacker, Peter; Zellmer, Konstantin; Goecer, Oktay; Recks, Mascha S.] Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; [Kuerten, Stefanie] Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Cologne; University of Wurzburg	Kuerten, S (corresponding author), Univ Wurzburg, Dept Anat & Cell Biol, D-97070 Wurzburg, Germany.	stefanie.kuerten@uni-wuerzburg.de			German Research Foundation (DFG) [KU 2760/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a research grant from the German Research Foundation (DFG), project KU 2760/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Berer K, 2012, ACTA NEUROPATHOL, V123, P639, DOI 10.1007/s00401-012-0949-9; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; HEMPEL K, 1985, INT ARCH ALLER A IMM, V76, P193, DOI 10.1159/000233691; Hundgeburth LC, 2013, CLIN IMMUNOL, V146, P155, DOI 10.1016/j.clim.2012.12.007; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kuerten S, 2008, CLIN IMMUNOL, V129, P256, DOI 10.1016/j.clim.2008.07.016; Kuerten S, 2006, J NEUROIMMUNOL, V177, P99, DOI 10.1016/j.jneuroim.2006.03.021; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; LIKE AA, 1991, DIABETES, V40, P259, DOI 10.2337/diabetes.40.2.259; Loh G, 2012, GUT MICROBES, V3, P544, DOI 10.4161/gmic.22156; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; SCHECHTER I, 1968, J EXP MED, V127, P237, DOI 10.1084/jem.127.2.237; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Shim JO, 2013, PEDIATR GASTROENTERO, V16, P17, DOI 10.5223/pghn.2013.16.1.17; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; Stys PK, 2012, NAT REV NEUROSCI, V13, P507, DOI 10.1038/nrn3275; Tigno-Aranjuez JT, 2009, J IMMUNOL, V183, P5654, DOI 10.4049/jimmunol.0900645; Tkach K, 2013, CURR OPIN IMMUNOL, V25, P120, DOI 10.1016/j.coi.2012.12.001; Vaghef-Mehrabany E, 2014, NUTRITION, V30, P430, DOI 10.1016/j.nut.2013.09.007; von Geldern G, 2012, NAT REV NEUROL, V8, P678, DOI 10.1038/nrneurol.2012.194; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Westall FC, 2006, J CLIN MICROBIOL, V44, P2099, DOI 10.1128/JCM.02532-05; Wong FS, 2008, ANN NY ACAD SCI, V1150, P123, DOI 10.1196/annals.1447.063	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99794	10.1371/journal.pone.0099794	http://dx.doi.org/10.1371/journal.pone.0099794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919069	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000111
J	Santana-Quintero, L; Dingerdissen, H; Thierry-Mieg, J; Mazumder, R; Simonyan, V				Santana-Quintero, Luis; Dingerdissen, Hayley; Thierry-Mieg, Jean; Mazumder, Raja; Simonyan, Vahan			HIVE-Hexagon: High-Performance, Parallelized Sequence Alignment for Next-Generation Sequencing Data Analysis	PLOS ONE			English	Article							SEARCH; SITES	Due to the size of Next-Generation Sequencing data, the computational challenge of sequence alignment has been vast. Inexact alignments can take up to 90% of total CPU time in bioinformatics pipelines. High-performance Integrated Virtual Environment (HIVE), a cloud-based environment optimized for storage and analysis of extra-large data, presents an algorithmic solution: the HIVE-hexagon DNA sequence aligner. HIVE-hexagon implements novel approaches to exploit both characteristics of sequence space and CPU, RAM and Input/Output (I/O) architecture to quickly compute accurate alignments. Key components of HIVE-hexagon include non-redundification and sorting of sequences; floating diagonals of linearized dynamic programming matrices; and consideration of cross-similarity to minimize computations.	[Santana-Quintero, Luis; Dingerdissen, Hayley; Simonyan, Vahan] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Dingerdissen, Hayley; Mazumder, Raja] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Thierry-Mieg, Jean] NIH, Natl Ctr Biotechnol Informat, US Natl Lib Med, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); George Washington University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Mazumder, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	mazumder@gwu.edu; Vahan.Simonyan@fda.hhs.gov	THIERRY-MIEG, Jean/F-1975-2017	THIERRY-MIEG, Jean/0000-0002-0396-6789; Mazumder, Raja/0000-0001-8823-9945	Food and Drug Administration Medical Countermeasures Initiative; Intramural Research Program of the NIH, National Library of Medicine	Food and Drug Administration Medical Countermeasures Initiative; Intramural Research Program of the NIH, National Library of Medicine	This research was supported in part by the Food and Drug Administration Medical Countermeasures Initiative and in part by Intramural Research Program of the NIH, National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bieganski P, 1994, GEN SUFFIX TREES BIO; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Burrows M., 1994, 124 DIG EQ CORP; CHAO KM, 1992, COMPUT APPL BIOSCI, V8, P481; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dingerdissen H, 2013, FEBS J, V280, P1542, DOI 10.1111/febs.12155; Dua S, 2013, DATA MINING FOR BIOINFORMATICS, P1; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Holmes I, 1998, J COMPUT BIOL, V5, P493, DOI 10.1089/cmb.1998.5.493; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Karagiannis Konstantinos, 2013, Genomics Proteomics & Bioinformatics, V11, P122, DOI 10.1016/j.gpb.2012.10.003; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pabinger S, 2013, BRIEF BIOINFORM; Phuc Vinh Nguyen Lam, 2013, Genomics Proteomics & Bioinformatics, V11, P96, DOI 10.1016/j.gpb.2012.11.003; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Shen S, 2008, BIOL MED PHYS BIOMED, P1; SMITH TF, 1981, J MOL EVOL, V18, P38, DOI 10.1007/BF01733210; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soares I, 2012, SCI WORLD J, DOI 10.1100/2012/450124; Sun WK, 2010, ALGORITHMS BIOINFORM; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Torri F, 2012, GENES-BASEL, V3, P545, DOI 10.3390/genes3030545; Valimaki N, 2007, BIOINFORMATICS, V23, P629, DOI 10.1093/bioinformatics/btl681; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang WX, 2011, SCI REP-UK, V1, DOI 10.1038/srep00055; WATERMAN MS, 1984, J THEOR BIOL, V108, P333, DOI 10.1016/S0022-5193(84)80037-5; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046	35	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99033	10.1371/journal.pone.0099033	http://dx.doi.org/10.1371/journal.pone.0099033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918764	Green Published, gold			2022-12-27	WOS:000338631000043
J	Wang, HZ; Liu, X; Lv, B; Yang, F; Hong, YZ				Wang, Huazhen; Liu, Xin; Lv, Bing; Yang, Fan; Hong, Yanzhu			Reliable Multi-Label Learning via Conformal Predictor and Random Forest for Syndrome Differentiation of Chronic Fatigue in Traditional Chinese Medicine	PLOS ONE			English	Article							CLASSIFICATION; DIAGNOSIS	Objective: Chronic Fatigue (CF) still remains unclear about its etiology, pathophysiology, nomenclature and diagnostic criteria in the medical community. Traditional Chinese medicine (TCM) adopts a unique diagnostic method, namely 'bian zheng lun zhi' or syndrome differentiation, to diagnose the CF with a set of syndrome factors, which can be regarded as the Multi-Label Learning (MLL) problem in the machine learning literature. To obtain an effective and reliable diagnostic tool, we use Conformal Predictor (CP), Random Forest (RF) and Problem Transformation method (PT) for the syndrome differentiation of CF. Methods and Materials: In this work, using PT method, CP-RF is extended to handle MLL problem. CP-RF applies RF to measure the confidence level (p-value) of each label being the true label, and then selects multiple labels whose p-values are larger than the pre-defined significance level as the region prediction. In this paper, we compare the proposed CP-RF with typical CP-NBC(Naive Bayes Classifier), CP-KNN(K-Nearest Neighbors) and ML-KNN on CF dataset, which consists of 736 cases. Specifically, 95 symptoms are used to identify CF, and four syndrome factors are employed in the syndrome differentiation, including 'spleen deficiency', 'heart deficiency', 'liver stagnation' and 'qi deficiency'. The Results: CP-RF demonstrates an outstanding performance beyond CP-NBC, CP-KNN and ML-KNN under the general metrics of subset accuracy, hamming loss, one-error, coverage, ranking loss and average precision. Furthermore, the performance of CP-RF remains steady at the large scale of confidence levels from 80% to 100%, which indicates its robustness to the threshold determination. In addition, the confidence evaluation provided by CP is valid and wellcalibrated. Conclusion: CP-RF not only offers outstanding performance but also provides valid confidence evaluation for the CF syndrome differentiation. It would be well applicable to TCM practitioners and facilitate the utilities of objective, effective and reliable computer-based diagnosis tool.	[Wang, Huazhen; Liu, Xin; Lv, Bing] Huaqiao Univ, Coll Comp Sci & Technol, Xiamen, Peoples R China; [Yang, Fan] Xiamen Univ, Sch Informat Sci & Engn, Xiamen, Peoples R China; [Hong, Yanzhu] Xiamen Univ, Dept Tradit Chinese Med, Xiamen, Peoples R China	Huaqiao University; Xiamen University; Xiamen University	Yang, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Xiamen, Peoples R China.	yang@xmu.edu.cn			National Natural Science Fundation of China [61202144, 61203282, 61300138]; Natural Science Foundation of Fujian Province China [2012J01274, 2012J05125]; Research Grant Council of Huaqiao University [09BS515]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province China(Natural Science Foundation of Fujian Province); Research Grant Council of Huaqiao University	The work is supported by National Natural Science Fundation of China under Grant No. 61202144, No. 61203282 and No. 61300138, Natural Science Foundation of Fujian Province China, under Grant No. 2012J01274 and No. 2012J05125, The Research Grant Council of Huaqiao University under Grant No. 09BS515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alraek T, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-87; Boutell MR, 2004, PATTERN RECOGN, V37, P1757, DOI 10.1016/j.patcog.2004.03.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen R, 2010, EVID-BASED COMPL ALT, V7, P3, DOI 10.1093/ecam/nen017; Chen RQ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-73; Dai J, 2012, EVID-BASED COMPL ALT, V2012, P1; Duan YX, 2010, J MATH MED, V23, P65; Elisseeff A, 2002, ADV NEUR IN, V14, P681; Fedorova V., 2012, P 29 INT C MACH LEAR; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gammerman, 2005, ALGORITHMIC LEARNING; [洪燕珠 HONG Yanzhu], 2009, [中医杂志, Journal of Traditional Chinese Medicine], V50, P1114; Jiang M, 2012, J ETHNOPHARMACOL, V140, P634, DOI 10.1016/j.jep.2012.01.033; Li FF, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-127; Li GZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/837245; Liu GP, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/135387; Liu GP, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-37; Lukman S, 2007, COMPUT METH PROG BIO, V88, P283, DOI 10.1016/j.cmpb.2007.09.008; Luo H, 2007, CHINA J TRADITIONAL, V22, P399; Madjarov G, 2012, PATTERN RECOGN, V45, P3084, DOI 10.1016/j.patcog.2012.03.004; McCrone P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040808; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Melluish T., 2001, PROC EUR C MACH LEAR, P360; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Pillai I, 2013, PATTERN RECOGN, V46, P2055, DOI 10.1016/j.patcog.2013.01.012; Prasko J, 2010, ACT NERV SUPER REDIV, V52, P104; Schapire RE, 2000, MACH LEARN, V39, P135, DOI 10.1023/A:1007649029923; Shafer G, 2008, J MACH LEARN RES, V9, P371; Song YM, 2011, CHINESE ARCH TRADITI, V8, P072; Song YN, 2013, EVID-BASED COMPL ALT, V2013, P1; Streich AP, 2008, LECT NOTES ARTIF INT, V5212, P390, DOI 10.1007/978-3-540-87481-2_26; Su SB, 2013, INT J INTEGR MED, V1, P1; Tsoumakas G., 2009, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Vanderlooy S, 2007, LECT NOTES ARTIF INT, V4571, P310, DOI 10.1007/978-3-540-73499-4_24; Vovk V, 2012, 12092673 ARXIV; Vovk V, 2006, THEOR COMPUT SCI, V364, P10, DOI 10.1016/j.tcs.2006.07.038; Vovk V, 2013, MACH LEARN, V92, P349, DOI 10.1007/s10994-013-5355-6; Wang H, 2009, J INFORM COMPUTATION, V6, P305; Wang HZ, 2009, COMPUT BIOL MED, V39, P425, DOI 10.1016/j.compbiomed.2009.02.002; Wang J, 2008, P 1 ACM INT C MULT I, P298, DOI DOI 10.1145/1460096.1460145; Wang J, 2012, EURASIP J ADV SIG PR, DOI [10.1186/1687-6180-2012-8, 10.1155/2012/268542]; Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036317; Wang YQ, 2011, INT J DATA MIN BIOIN, V5, P369, DOI 10.1504/IJDMB.2011.041554; Yang E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-55; Yang Y, 2001, P 24 ANN INT ACM SIG, P137, DOI DOI 10.1145/383952.383975; Zhang ML, 2014, IEEE T KNOWL DATA EN, V26, P1819, DOI 10.1109/TKDE.2013.39; Zhang ML, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, VOLS 1 AND 2, P718; Zhou WF, 2002, GIANJIN J TRADITIONA, V19, P1; Zhu Wen-feng, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P607	50	20	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99565	10.1371/journal.pone.0099565	http://dx.doi.org/10.1371/journal.pone.0099565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918430	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000095
J	Jin, SK; Cheng, TC; Jiang, L; Lin, P; Yang, Q; Xiao, Y; Kusakabe, T; Xia, QY				Jin, Shengkai; Cheng, Tingcai; Jiang, Liang; Lin, Ping; Yang, Qiong; Xiao, Yang; Kusakabe, Takahiro; Xia, Qingyou			Identification of a New Sprouty Protein Responsible for the Inhibition of the Bombyx mori Nucleopolyhedrovirus Reproduction	PLOS ONE			English	Article							POSTERIOR SILK GLAND; TYROSINE KINASE; SIGNALING PATHWAYS; DROSOPHILA-SPROUTY; ERK ACTIVATION; RAS ACTIVATION; GROWTH; GENES; FGF; PHOSPHORYLATION	The rat sarcoma-extracellular signal regulated kinase mitogen-activated protein kinases pathway, one of the most ancient signaling pathways, is crucial for the defense against Bombyx mori nucleopolyhedrovirus (BmNPV) infection. Sprouty (Spry) proteins can inhibit the activity of this pathway by receptor tyrosine kinases. We cloned and identified a new B. mori gene with a Spry domain similar to the Spry proteins of other organisms, such as fruitfly, mouse, human, chicken, Xenopus and zebrafish, and named it BmSpry. The gene expression analysis showed that BmSpry was transcribed in all of the examined tissues and in all developmental stages from embryo to adult. BmSpry also induced expression of BmNPV in the cells. Our results indicated: (1) the knock-down of BmSpry led to increased BmNPV replication and silkworm larvae mortality; (2) overexpression of BmSpry led to reduced BmNPV replication; and (3) BmSpry regulated the activation of ERK and inhibited BmNPV replication. These results showed that BmSpry plays a crucial role in the antiviral defense of the silkworm both in vitro and in vivo.	[Jin, Shengkai; Cheng, Tingcai; Jiang, Liang; Lin, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Yang, Qiong; Xiao, Yang] Guangdong Acad Agr Sci, Sericulture & Farm Prod Proc Res Inst, Guangzhou, Guangdong, Peoples R China; [Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 812, Japan	Southwest University - China; Guangdong Academy of Agricultural Sciences; Kyushu University	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Hi-Tech Research and Development Program of China [2011AA100306]; National Basic Research Program of China [2012CB114600]; Resistance Breeding Center of State Key Laboratory of Silkworm Genome Biology [2012B090600049]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Resistance Breeding Center of State Key Laboratory of Silkworm Genome Biology	This work was funded by the National Hi-Tech Research and Development Program of China (No. 2011AA100306, http://www.most.gov.cn/), the National Basic Research Program of China (No. 2012CB114600, http://www.most.gov.cn/), Resistance Breeding Center of State Key Laboratory of Silkworm Genome Biology (No. 2012B090600049, http://sklsgb.swu.edu.cn/cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BUDAY L, 1995, ONCOGENE, V11, P1327; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chambers D, 2000, MOL CELL NEUROSCI, V15, P22, DOI 10.1006/mcne.1999.0801; de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gao XR, 2004, J VIROL, V78, P11798, DOI 10.1128/JVI.78.21.11798-11806.2004; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gual P, 2001, ONCOGENE, V20, P156, DOI 10.1038/sj.onc.1204047; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Ikeda M, 1999, VIROLOGY, V258, P176, DOI 10.1006/viro.1999.9706; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041838; Jiang L, 2012, ARCH VIROL, V157, P1323, DOI 10.1007/s00705-012-1309-8; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Katsuma S, 1999, J GEN VIROL, V80, P783, DOI 10.1099/0022-1317-80-3-783; Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kramer S, 1999, DEVELOPMENT, V126, P2515; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Ma L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-182; Ma L, 2013, J PROTEOME RES, V12, P1924, DOI 10.1021/pr400005g; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Moriya K, 2010, INSECT MOL BIOL, V19, P291, DOI 10.1111/j.1365-2583.2009.00982.x; Mortensen AS, 2006, AQUAT TOXICOL, V79, P99, DOI 10.1016/j.aquatox.2006.05.009; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Panteva M, 2003, VIRUS RES, V92, P131, DOI 10.1016/S0168-1702(02)00356-8; Payungporn S, 2006, J VIROL METHODS, V131, P143, DOI 10.1016/j.jviromet.2005.08.004; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Reich A, 1999, DEVELOPMENT, V126, P4139; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Soejima K, 2001, J BIOCHEM-TOKYO, V130, P475, DOI 10.1093/oxfordjournals.jbchem.a003009; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tyler KL, 2001, TRENDS MICROBIOL, V9, P560, DOI 10.1016/S0966-842X(01)02103-5; UEKI K, 1994, J BIOL CHEM, V269, P15756; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zaremba A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-192; Zhang YZ, 2008, PROTEOMICS, V8, P4178, DOI 10.1002/pmic.200800133	73	27	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99200	10.1371/journal.pone.0099200	http://dx.doi.org/10.1371/journal.pone.0099200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915434	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700071
J	Kaneko, K; Yamaguchi, H; Saito, T; Yano, T; Oono, Y; Ikematsu, H; Nomura, S; Sato, A; Kojima, M; Esumi, H; Ochiai, A				Kaneko, Kazuhiro; Yamaguchi, Hiroshi; Saito, Takaaki; Yano, Tomonori; Oono, Yasuhiro; Ikematsu, Hiroaki; Nomura, Shogo; Sato, Akihiro; Kojima, Motohiro; Esumi, Hiroyasu; Ochiai, Atsushi			Hypoxia Imaging Endoscopy Equipped with Laser Light Source from Preclinical Live Animal Study to First-In-Human Subject Research	PLOS ONE			English	Article							TUMOR HYPOXIA; MALIGNANT-PROGRESSION; CANCER; FLOW	A goal in next-generation endoscopy is to develop functional imaging techniques to open up new opportunities for cancer diagnosis. Although spatial and temporal information on hypoxia is crucial for understanding cancer physiology and expected to be useful for cancer diagnosis, existing techniques using fluorescent indicators have limitations due to low spatial resolution and invasive administration. To overcome these problems, we developed an imaging technology based on hemoglobin oxygen saturation in both the tumor and surrounding mucosa using a laser endoscope system, and conducted the first human subject research for patients with aero-digestive tract cancer. The oxygen saturation map overlapped the images of cancerous lesions and indicated highly heterogeneous features of oxygen supply in the tumor. The hypoxic region of the tumor surface was found in both early cancer and cancer precursors. This technology illustrates a novel aspect of cancer biology as a potential biomarker and can be widely utilized in cancer diagnosis.	[Kaneko, Kazuhiro; Yano, Tomonori; Oono, Yasuhiro; Ikematsu, Hiroaki] Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba, Japan; [Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Div Sci & Technol Endoscopy & Surg, Kashiwa, Chiba, Japan; [Yamaguchi, Hiroshi; Saito, Takaaki] FUJIFILM Corp, Imaging Technol Ctr, Kaisei, Kanagawa, Japan; [Nomura, Shogo; Sato, Akihiro] Natl Canc Ctr, Clin Trial Sect, Kashiwa, Chiba, Japan; [Kojima, Motohiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Dept Pathol, Kashiwa, Chiba, Japan; [Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Fujifilm Corporation; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science	Kaneko, K (corresponding author), Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba, Japan.	kkaneko@east.ncc.go.jp; hiroshi.mm.yamaguchi@fujifilm.com	/AAM-6970-2020	/0000-0002-8387-0372; Nomura, Shogo/0000-0001-8734-6984	National Cancer Center Research and Development Fund [23-A-45, 23-A-15]; Ministry of Health, Labour and Welfare; Accelerating Regulatory Science Initiative [H-24]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Accelerating Regulatory Science Initiative	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-45) and (23-A-15) and the 3rd-term comprehensive 10-Year strategy for Cancer Control by the Ministry of Health, Labour and Welfare, and Accelerating Regulatory Science Initiative (H-24) [http://www.ncc.go.jp/en/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Benaron DA, 2004, ANESTHESIOLOGY, V100, P1469, DOI 10.1097/00000542-200406000-00019; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chitneni SK, 2011, J NUCL MED, V52, P165, DOI 10.2967/jnumed.110.075663; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada H, 2005, MOL IMAGING, V4, P182; Hockel M, 1996, CANCER RES, V56, P4509; Jordan BF, 2005, NEOPLASIA, V7, P475, DOI 10.1593/neo.04628; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Maxim PG, 2005, TECHNOL CANCER RES T, V4, P227, DOI 10.1177/153303460500400301; Moy AJ, 2011, MICROVASC RES, V82, P199, DOI 10.1016/j.mvr.2011.07.004; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Sutherland RM, 1998, ACTA ONCOL, V37, P567, DOI 10.1080/028418698430278; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/NMAT2509, 10.1038/nmat2509]	19	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99055	10.1371/journal.pone.0099055	http://dx.doi.org/10.1371/journal.pone.0099055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915532	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700055
J	Maekawa, N; Konnai, S; Ikebuchi, R; Okagawa, T; Adachi, M; Takagi, S; Kagawa, Y; Nakajima, C; Suzuki, Y; Murata, S; Ohashi, K				Maekawa, Naoya; Konnai, Satoru; Ikebuchi, Ryoyo; Okagawa, Tomohiro; Adachi, Mami; Takagi, Satoshi; Kagawa, Yumiko; Nakajima, Chie; Suzuki, Yasuhiko; Murata, Shiro; Ohashi, Kazuhiko			Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-gamma Production from Tumor-Infiltrating Cells by PD-L1 Blockade	PLOS ONE			English	Article							PROGRAMMED DEATH-1; UP-REGULATION; MOLECULAR-CLONING; B7-H1 EXPRESSION; CARCINOMA; MELANOMA; DOGS; ESTABLISHMENT; ANTIBODY; SAFETY	Programmed death 1 (PD-1), an immunoinhibitory receptor, and programmed death ligand 1 (PD-L1), its ligand, together induce the "exhausted'' status in antigen-specific lymphocytes and are thus involved in the immune evasion of tumor cells. In this study, canine PD-1 and PD-L1 were molecularly characterized, and their potential as therapeutic targets for canine tumors was discussed. The canine PD-1 and PD-L1 genes were conserved among canine breeds. Based on the sequence information obtained, the recombinant canine PD-1 and PD-L1 proteins were constructed; they were confirmed to bind each other. Antibovine PD-L1 monoclonal antibody effectively blocked the binding of recombinant PD-1 with PD-L1-expressing cells in a dose-dependent manner. Canine melanoma, mastocytoma, renal cell carcinoma, and other types of tumors examined expressed PD-L1, whereas some did not. Interestingly, anti-PD-L1 antibody treatment enhanced IFN-gamma production from tumor-infiltrating cells. These results showed that the canine PD-1/PD-L1 pathway is also associated with T-cell exhaustion in canine tumors and that its blockade with antibody could be a new therapeutic strategy for canine tumors. Further investigations are needed to confirm the ability of anti-PD-L1 antibody to reactivate canine antitumor immunity in vivo, and its therapeutic potential has to be further discussed.	[Maekawa, Naoya; Konnai, Satoru; Ikebuchi, Ryoyo; Okagawa, Tomohiro; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan; [Adachi, Mami; Takagi, Satoshi; Kagawa, Yumiko] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kagawa, Yumiko] North Lab, Sapporo, Hokkaido, Japan; [Nakajima, Chie; Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Ohashi, K (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido, Japan.	okazu@vetmed.hokudai.ac.jp	Okagawa, Tomohiro/AAX-1284-2021; Suzuki, Yasuhiko/F-6890-2012; Nakajima, Chie/A-5020-2012; Ikebuchi, Ryoyo/AAG-1138-2019	Ikebuchi, Ryoyo/0000-0003-0231-7733; TAKAGI, Satoshi/0000-0001-6653-5890; Satoru, Konnai/0000-0002-3230-7109	Japan Science and Technology Agency (JST); Akiyama Life Science Foundation of Japan	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Akiyama Life Science Foundation of Japan	This work was supported by a special grant for the Adaptable and Seamless Technology transfer Program (A-Step) through target driven R&D from the Japan Science and Technology Agency (JST) and Grants for Scientific Research from the Akiyama Life Science Foundation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Barroga EF, 1999, J VET MED SCI, V61, P361; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Bolton B, 1990, VET PATHOL, V27, P96; Boria PA, 2004, JAVMA-J AM VET MED A, V224, P388, DOI 10.2460/javma.2004.224.388; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chapon M, 2011, J INVEST DERMATOL, V131, P1300, DOI 10.1038/jid.2011.30; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; de Haij S, 2005, KIDNEY INT, V68, P2091, DOI 10.1111/j.1523-1755.2005.00665.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duncan B, 2003, J AM ANIM HOSP ASSOC, V39, P294; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Geng L, 2008, J CANCER RES CLIN, V134, P1021, DOI 10.1007/s00432-008-0364-8; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARVEY HJ, 1981, J AM VET MED ASSOC, V178, P580; Ikebuchi R, IMMUNOLOGY IN PRESS; Ikebuchi R, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-59; Ikebuchi R, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-103; Ikebuchi R, 2010, MICROBIOL IMMUNOL, V54, P291, DOI 10.1111/j.1348-0421.2010.00208.x; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Ishiguro T, 2001, J VET MED SCI, V63, P1031, DOI 10.1292/jvms.63.1031; KADOSAWA T, 1994, J VET MED SCI, V56, P1167, DOI 10.1292/jvms.56.1167; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Konnai S, 2013, COMP IMMUNOL MICROB, V36, P63, DOI 10.1016/j.cimid.2012.09.005; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohashi E, 2002, J VET MED SCI, V64, P169, DOI 10.1292/jvms.64.169; Ohashi E, 2001, J VET MED SCI, V63, P83, DOI 10.1292/jvms.63.83; Okagawa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-45; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Proulx DR, 2003, VET RADIOL ULTRASOUN, V44, P352, DOI 10.1111/j.1740-8261.2003.tb00468.x; Rassnick KM, 2001, J AM VET MED ASSOC, V218, P1444, DOI 10.2460/javma.2001.218.1444; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Shirai T, 2011, VET IMMUNOL IMMUNOP, V144, P462, DOI 10.1016/j.vetimm.2011.08.018; Spangler WL, 2006, VET PATHOL, V43, P136, DOI 10.1354/vp.43-2-136; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Takahashi T, 2001, INT ARCH ALLERGY IMM, V125, P228, DOI 10.1159/000053820; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Ye YF, 2009, J SURG ONCOL, V100, P500, DOI 10.1002/jso.21376; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347	52	68	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98415	10.1371/journal.pone.0098415	http://dx.doi.org/10.1371/journal.pone.0098415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915569	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700019
J	Lee, YK; Lee, KS; Kim, WM; Sohn, YS				Lee, Yeon Kyung; Lee, Kyeong-Seok; Kim, Won Mok; Sohn, Young-Soo			Detection of Amyloid-beta 42 Using a Waveguide-Coupled Bimetallic Surface Plasmon Resonance Sensor Chip in the Intensity Measurement Mode	PLOS ONE			English	Article							AMYLOID-BETA; OPTICAL BIOSENSORS; SENSITIVITY; BIOMARKERS; FILM; ENHANCEMENT	The waveguide-coupled bimetallic (WcBiM) surface plasmon resonance (SPR) chip had been utilized in the intensity interrogation detection mode to detect amyloid-beta 42 (A beta 42), a biomarker of the Alzheimer disease. The SPR reflectance curve of the WcBiM chip has the narrower full-width-at-half-maximum (FWHM) compared with the SPR reflectance curve of the conventional gold (Au) chip, resulting in the steeper gradient. For the enhancement of resolution, the light source was fixed at an angle where the slope of the reflectance curve is the steepest, and the change in the reflectance was monitored. For the detection of A beta 42, the antibody of A beta 42 (anti-A beta 42) was immobilized on the WcBiM SPR chip using the self-assembled monolayer. The SPR responses, the average changes in the reflectance to the A beta 42 at the concentrations of 100 pg/ml, 250 pg/ml, 500 pg/ml, 750 pg/ml, 1,000 pg/ml, and 2,000 pg/ml were 0.0111%, 0.0305%, 0.0867%, 0.1712%, 0.3021%, and 0.5577%, respectively, for the three replicates. From linear regression analysis, the calibration curve indicated that the SPR response had a linear relation with A beta 42 with the concentration in the range of 100 pg/ml to 2,000 pg/ml. A control experiment showed the anti-A beta 42-modified surface of the WcBiM chip had a high specificity to A beta 42. Thus, the enhanced resolution by utilizing the WcBiM SPR chip in the intensity interrogation detection mode aids the diagnosis of the Alzheimer disease by detecting the A beta 42 around the criteria concentration (500 pg/ml) without any labeling.	[Lee, Yeon Kyung; Sohn, Young-Soo] Catholic Univ Daegu, Dept Biomed Engn, Gyongsan, Gyeongbuk, South Korea; [Lee, Kyeong-Seok; Kim, Won Mok] Korea Inst Sci & Technol, Elect Mat Res Ctr, Seoul, South Korea	Catholic University of Daegu; Korea Institute of Science & Technology (KIST)	Sohn, YS (corresponding author), Catholic Univ Daegu, Dept Biomed Engn, Gyongsan, Gyeongbuk, South Korea.	sohnys@cu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2010028]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2010028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohunicky B, 2011, NANOTECHNOL SCI APPL, V4, P1, DOI 10.2147/NSA.S13465; Butterfield DA, 2004, NEUROBIOL AGING, V25, P563, DOI 10.1016/j.neurobiolaging.2003.12.027; Chen Y, 2011, APPL OPTICS, V50, P387, DOI 10.1364/AO.50.000387; Chien FC, 2004, BIOSENS BIOELECTRON, V20, P633, DOI 10.1016/j.bios.2004.03.014; Choi S, 2008, BIOSENS BIOELECTRON, V24, P893, DOI 10.1016/j.bios.2008.07.036; Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y; Englebienne P, 2003, SPECTROSC-INT J, V17, P255, DOI 10.1155/2003/372913; Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P266, DOI 10.1017/S1355617708080302; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hegnerova K, 2009, SENSOR ACTUAT B-CHEM, V139, P69, DOI 10.1016/j.snb.2008.09.006; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Kang DY, 2009, BIOSENS BIOELECTRON, V24, P1431, DOI 10.1016/j.bios.2008.08.018; Lame ME, 2011, ANAL BIOCHEM, V419, P133, DOI 10.1016/j.ab.2011.08.010; Lee KS, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/12/125302; Lee KS, 2010, SENSORS-BASEL, V10, P11390, DOI 10.3390/s101211390; Lee YK, 2013, J KOREAN PHYS SOC, V62, P475, DOI 10.3938/jkps.62.475; Li CT, 2012, BIOSENS BIOELECTRON, V36, P192, DOI 10.1016/j.bios.2012.04.016; Mascini M, 2008, BIOMARKERS, V13, P637, DOI [10.1080/13547500802645905, 10.1080/13547500802645905 ]; Mehta PD, 2007, J NEUROL SCI, V254, P22, DOI 10.1016/j.jns.2006.12.010; Moskovitz J, 2011, BIOCHEMISTRY-US, V50, P10687, DOI 10.1021/bi201426b; Oh ES, 2010, J ALZHEIMERS DIS, V21, P769, DOI 10.3233/JAD-2010-100456; Ong BH, 2006, SENSOR ACTUAT B-CHEM, V114, P1028, DOI 10.1016/j.snb.2005.07.064; Pejcic B, 2006, ANALYST, V131, P1079, DOI 10.1039/b603402k; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Ryu J, 2008, ANAL CHEM, V80, P2400, DOI 10.1021/ac7019514; Sharma AK, 2005, OPT COMMUN, V245, P159, DOI 10.1016/j.optcom.2004.10.013; Sharma AK, 2007, J APPL PHYS, V101, DOI 10.1063/1.2721779; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Tothill IE, 2009, SEMIN CELL DEV BIOL, V20, P55, DOI 10.1016/j.semcdb.2009.01.015; Ukraintseva S, 2006, STROKE, V37, P1155, DOI 10.1161/01.STR.0000217971.88034.e9; Viswanathan S, 2012, BIOSENS BIOELECTRON, V33, P179, DOI 10.1016/j.bios.2011.12.049; Wan YH, 2012, SENSOR ACTUAT B-CHEM, V162, P35, DOI 10.1016/j.snb.2011.12.019; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Yuk JS, 2011, BIOSENS BIOELECTRON, V26, P3213, DOI 10.1016/j.bios.2010.12.028; Zynio SA, 2002, SENSORS-BASEL, V2, P62, DOI 10.3390/s20200062	40	18	18	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98992	10.1371/journal.pone.0098992	http://dx.doi.org/10.1371/journal.pone.0098992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911167	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600032
J	Dall'Olio, GM; Bertranpetit, J; Wagner, A; Laayouni, H				Marco Dall'Olio, Giovanni; Bertranpetit, Jaume; Wagner, Andreas; Laayouni, Hafid			Human Genome Variation and the Concept of Genotype Networks	PLOS ONE			English	Article							ADAPTATION; INNOVATION; EVOLUTION; SEQUENCE; FEATURES; SPACE	Genotype networks are a concept used in systems biology to study sets of genotypes having the same phenotype, and the ability of these to bring forth novel phenotypes. In the past they have been applied to determine the genetic heterogeneity, and stability to mutations, of systems such as metabolic networks and RNA folds. Recently, they have been the base for reconciling the neutralist and selectionist views on evolution. Here, we adapted this concept to the study of population genetics data. Specifically, we applied genotype networks to the human 1000 genomes dataset, and analyzed networks composed of short haplotypes of Single Nucleotide Variants (SNV). The result is a scan of how properties related to genetic heterogeneity and stability to mutations are distributed along the human genome. We found that genes involved in acquired immunity, such as some HLA and MHC genes, tend to have the most heterogeneous and connected networks, and that coding regions tend to be more heterogeneous and stable to mutations than non-coding regions. We also found, using coalescent simulations, that regions under selection have more extended and connected networks. The application of the concept of genotype networks can provide a new opportunity to understand the evolutionary processes that shaped our genome. Learning how the genotype space of each region of our genome has been explored during the evolutionary history of the human species can lead to a better understanding on how selective pressures and neutral factors have shaped genetic diversity within populations and among individuals. Combined with the availability of larger datasets of sequencing data, genotype networks represent a new approach to the study of human genetic diversity that looks to the whole genome, and goes beyond the classical division between selection and neutrality methods.	[Marco Dall'Olio, Giovanni; Bertranpetit, Jaume; Laayouni, Hafid] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Catalonia, Spain; [Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA; [Laayouni, Hafid] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute; Autonomous University of Barcelona	Dall'Olio, GM (corresponding author), Kings Coll London, Div Canc Studies, London, England.	giovanni.dallolio@kcl.ac.uk	Laayouni, Hafid/AAA-9254-2019; Bertranpetit, Jaume/F-8550-2012	Laayouni, Hafid/0000-0003-1297-5078; Bertranpetit, Jaume/0000-0003-0100-0590; Dall'Olio, Giovanni Marco/0000-0001-9057-2480	Ministerio de Ciencia y Tecnologia (Spain) [BFU2010-19443]; Direccio General de Recerca, Generalitat de Catalunya [SGR 1101]; FPI [BES-2009-01773]; Swiss National Science Foundation; URPP Evolutionary Biology at the University of Zurich	Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); FPI(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); URPP Evolutionary Biology at the University of Zurich	This work was supported by grants BFU2010-19443 (subprogram BMC) awarded to JB by Ministerio de Ciencia y Tecnologia (Spain) and by the Direccio General de Recerca, Generalitat de Catalunya (Grup de Recerca Consolidat 2009 SGR 1101). GMD is supported by a FPI fellowship BES-2009-017731. AW would like to acknowledge support by the Swiss National Science Foundation and by the URPP Evolutionary Biology at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026324; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alves I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002837; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Cao HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069388; Csardi G, 2006, INTERJOURNAL; Dall'Olio GM, 2014, ARXIV14012016; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014172; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Greenbury SF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0249; Habegger L, 2012, BIOINFORMATICS, V28, P2267, DOI 10.1093/bioinformatics/bts368; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; Manrubia SC, 2010, ARBOR, V186, P1051, DOI 10.3989/arbor.2010.746n1253; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Nei M., 1987, MOL EVOLUTIONARY GEN; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732; Payne JL, 2014, ARTIF LIFE, V20, P111, DOI 10.1162/ARTL_a_00099; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Wagner A, 2011, ORIGINS OF EVOLUTIONARY INNOVATIONS: A THEORY OF TRANSFORMATIVE CHANGE IN LIVING SYSTEMS, P1, DOI 10.1093/acprof:oso/9780199692590.001.0001; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner A, 2012, P ROY SOC B-BIOL SCI, V279, P1249, DOI 10.1098/rspb.2011.2293; Wagner A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-231; Wagner A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-33; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	36	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99424	10.1371/journal.pone.0099424	http://dx.doi.org/10.1371/journal.pone.0099424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911413	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000337165600085
J	Li, MR; Xi, HL; Wang, QH; Hou, FQ; Huo, N; Zhang, XX; Li, F; Xu, XY				Li, Min-Ran; Xi, Hong-Li; Wang, Qin-Huan; Hou, Feng-Qin; Huo, Na; Zhang, Xia-Xia; Li, Fang; Xu, Xiao-Yuan			Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; SURFACE-ANTIGEN; ADEFOVIR DIPIVOXIL; LAMIVUDINE THERAPY; NATURAL-HISTORY; ENTECAVIR; REDUCTION; VIRUS; CCCDNA; ASSOCIATION	Background & Aims: About 350-400 million people are infected with hepatitis B virus (HBV) chronically and 1 million people die of hepatitis B virus (HBV)-related liver diseases. Nucleos(t)ide analogues (NAs) have been used for the treatment against HBV. However, few studies have investigated the long-term effects of different nucleos(t)ide analogues on levels of hepatitis B surface antigen (HBsAg) in patients with chronic hepatitis B (CHB). The aims of this study were to measure the magnitude of HBsAg reduction by long-term monotherapy with adefovir dipivoxil (ADV) and entecavir (ETV), to compare HBsAg reduction between the two drugs of different potency and to predict the expected time needed to achieve HBsAg loss. Methods: We retrospectively evaluated the kinetics of HBsAg in 67 patients with CHB who all exhibited persistent viral suppression. These patients were treated with ADV or ETV for at least 6 years. HBV genotype was determined at baseline. Liver biochemistry, HBV serological markers, serum HBV DNA and HBsAg titers were determined at baseline, half year and yearly from year 1 to 6. Results: Serum HBsAg titers after treatment with ADV or ETV were significantly lower than the baseline titers (P<0.05). HBsAg reduction rate of patients treated with ETV (0.11 log(10) IU/mL/year) was higher than that treated with ADV (0.10 log(10) IU/mL/year), and the calculated expected time to HBsAg loss for patients treated with ETV (approximate 24.99 years) was shorter than that with ADV (approximate 30.33 years), but there was no statistically significant difference between two groups (P>0.05). Conclusion: Serum HBsAg titers gradually decreased during long-term treatment with either ADV or ETV. It appears that the potency of ADV on HBsAg reduction is close to that of ETV, as long as patients have achieved persistent viral suppression.	[Li, Min-Ran; Xi, Hong-Li; Wang, Qin-Huan; Hou, Feng-Qin; Huo, Na; Zhang, Xia-Xia; Li, Fang; Xu, Xiao-Yuan] Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China	Peking University	Xu, XY (corresponding author), Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China.	yangpin@public3.bta.net.cn			12th Five-Year Plan [2012ZX10002 003-004-003, 2013 ZX10002004-001-003]; Beijing Municipal Science and Technology Commission of major projects [D121100003912003]	12th Five-Year Plan(Chinese Academy of Sciences); Beijing Municipal Science and Technology Commission of major projects	This study was supported by the 12th Five-Year Plan (No 2012ZX10002 003-004-003, NO 2013 ZX10002004-001-003) and Beijing Municipal Science and Technology Commission of major projects (No D121100003912003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KL, 2009, HEPATOLOGY, V49, pS166, DOI 10.1002/hep.22899; Boglione L, 2013, LIVER INT, V33, P580, DOI 10.1111/liv.12091; Chayama K, 1998, HEPATOLOGY, V27, P1711, DOI 10.1002/hep.510270634; Cheng PN, 2011, J MED VIROL, V83, P602, DOI 10.1002/jmv.22014; Feld JJ, 2009, HEPATOLOGY, V49, pS96, DOI 10.1002/hep.22977; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Ha NB, 2014, DIGEST DIS SCI, V59, P168, DOI 10.1007/s10620-013-2940-2; Hosaka T, 2013, J GASTROENTEROL, V48, P930, DOI 10.1007/s00535-012-0688-7; Jiang YF, 2012, ACTA GASTRO-ENT BELG, V75, P316; Kose S, 2010, HEPAT MON, V10, P289; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lee JM, 2011, HEPATOLOGY, V53, P1486, DOI 10.1002/hep.24221; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Seto WK, 2013, HEPATOLOGY, V58, P923, DOI 10.1002/hep.26376; SHERLOCK S, 2002, DIS LIVER BILIARY SY, P365; Su TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055916; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, ANTIVIR THER, V11, P909; Wong DKH, 2013, CLIN GASTROENTEROL H, V11, P1004, DOI 10.1016/j.cgh.2013.01.026; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Zhao SH, 2012, BRAZ J INFECT DIS, V16, P366, DOI 10.1016/j.bjid.2012.06.016; Zheng YY, 2013, J VIRAL HEPATITIS, V20, P273, DOI 10.1111/j.1365-2893.2012.01644.x; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	24	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98476	10.1371/journal.pone.0098476	http://dx.doi.org/10.1371/journal.pone.0098476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905586	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000033
J	Shi, PT; Zhang, J; Yang, B; Luo, JF				Shi, Peiteng; Zhang, Jiang; Yang, Bo; Luo, Jingfei			Hierarchicality of Trade Flow Networks Reveals Complexity of Products	PLOS ONE			English	Article							GLOBAL VALUE CHAINS; TRANSPORTATION NETWORKS; FOOD WEBS	With globalization, countries are more connected than before by trading flows, which amounts to at least 36 trillion dollars today. Interestingly, around 30-60 percents of exports consist of intermediate products in global. Therefore, the trade flow network of particular product with high added values can be regarded as value chains. The problem is weather we can discriminate between these products from their unique flow network structure? This paper applies the flow analysis method developed in ecology to 638 trading flow networks of different products. We claim that the allometric scaling exponent g can be used to characterize the degree of hierarchicality of a flow network, i.e., whether the trading products flow on long hierarchical chains. Then, it is pointed out that the flow networks of products with higher added values and complexity like machinary, transport equipment etc. have larger exponents, meaning that their trade flow networks are more hierarchical. As a result, without the extra data like global input-output table, we can identify the product categories with higher complexity, and the relative importance of a country in the global value chain by the trading network solely.	[Shi, Peiteng; Zhang, Jiang; Luo, Jingfei] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Yang, Bo] Minist Commerce Peoples Republ China, Beijing, Peoples R China	Beijing Normal University	Zhang, J (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhangjiang@bnu.edu.cn			National Natural Science Foundation of China [61004107]; Beijing Higher Education Young Elite Teacher Project [YETP0291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project	This work received funding from the National Natural Science Foundation of China under Grant No. 61004107, www.nsfc.gov.cn, and Beijing Higher Education Young Elite Teacher Project under Grant No.YETP0291, http://www.bjedu.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barigozzi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046104; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Cella G, 1984, OXFORD B ECON STAT, V46, P7384; Duan WQ, 2007, EUR PHYS J B, V59, P271, DOI 10.1140/epjb/e2007-00279-y; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Feenstra R. C, 2005, 11040 NAT BUR EC RES; Foti NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016431; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Gereffi G, 2005, REV INT POLIT ECON, V12, P78, DOI 10.1080/09692290500049805; Gibbon P, 2008, ECON SOC, V37, P315, DOI 10.1080/03085140802172656; Hausmann R, 2007, J ECON GROWTH, V12, P1, DOI 10.1007/s10887-006-9009-4; Herrada EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002757; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kali R, 2007, J INT BUS STUD, V38, P595, DOI 10.1057/palgrave.jibs.8400286; Kotha S, 2013, GLOB STRATEG J, V3, P41, DOI 10.1111/j.2042-5805.2012.01050.x; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Leontief W., 1966, INPUT OUTPUT EC; Mn Serrano, 2007, J ECON INTERACT COOR, V2, P111; Raa Tt, 2005, EC INPUT OUTPUT ANAL; Rainnie A, 2013, CAP CL, V37, P177, DOI 10.1177/0309816813481337; Smith D., 1985, REV J F BRAUDEL CTR, V18, P517; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; SNYDER D, 1979, AM J SOCIOL, V84, P1096, DOI 10.1086/226902; Song Y, 2006, CONSTR MANAG ECON, V24, P579, DOI 10.1080/01446190500435358; Tukker A, 2013, ECON SYST RES, V25, P1, DOI 10.1080/09535314.2012.761179; UNCTAD, 2013, GLOB VAL CHAINS DEV; Wei S.-J., 2010, 16426 NAT BUR EC RES; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072525; Zhang JA, 2010, J THEOR BIOL, V264, P760, DOI 10.1016/j.jtbi.2010.03.024; Zhu S, 2011, OECD SCI TECHNOLOGY	35	32	33	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98247	10.1371/journal.pone.0098247	http://dx.doi.org/10.1371/journal.pone.0098247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905753	Green Submitted, gold, Green Published			2022-12-27	WOS:000341869000024
J	Allareddy, V; Asad, R; Lee, MK; Nalliah, RP; Rampa, S; Speicher, DG; Rotta, AT; Allareddy, V				Allareddy, Veerajalandhar; Asad, Rahimullah; Lee, Min Kyeong; Nalliah, Romesh P.; Rampa, Sankeerth; Speicher, David G.; Rotta, Alexandre T.; Allareddy, Veerasathpurush			Hospital Based Emergency Department Visits Attributed to Child Physical Abuse in United States: Predictors of In-Hospital Mortality	PLOS ONE			English	Article							VICTIMIZATION; MALTREATMENT; INJURIES; TRAUMA	Objectives: To describe nationally representative outcomes of physical abuse injuries in children necessitating Emergency Department (ED) visits in United States. The impact of various injuries on mortality is examined. We hypothesize that physical abuse resulting in intracranial injuries are associated with worse outcome. Materials and Methods: We performed a retrospective analysis of the Nationwide Emergency Department Sample (NEDS), the largest all payer hospital based ED database, for the years 2008-2010. All ED visits and subsequent hospitalizations with a diagnosis of "Child physical abuse" (Battered baby or child syndrome) due to various injuries were identified using ICD-9-CM (International Classification of Diseases, 9th Revision, Clinical Modification) codes. In addition, we also examined the prevalence of sexual abuse in this cohort. A multivariable logistic regression model was used to examine the association between mortality and types of injuries after adjusting for a multitude of patient and hospital level factors. Results: Of the 16897 ED visits that were attributed to child physical abuse, 5182 (30.7%) required hospitalization. Hospitalized children were younger than those released treated and released from the ED (1.9 years vs. 6.4 years). Male or female partner of the child's parent/guardian accounted for >45% of perpetrators. Common injuries in hospitalized children include-any fractures (63.5%), intracranial injuries (32.3%) and crushing/internal injuries (9.1%). Death occurred in 246 patients (13 in ED and 233 following hospitalization). Amongst the 16897 ED visits, 1.3% also had sexual abuse. Multivariable analyses revealed each 1 year increase in age was associated with a lower odds of mortality (OR = 0.88, 95% CI = 0.81-0.96, p<0.0001). Females (OR = 2.39, 1.07-5.34, p = 0.03), those with intracranial injuries (OR = 65.24, 27.57-154.41, p<0.0001), or crushing/internal injury (OR = 4.98, 2.24-11.07, p<0.0001) had higher odds of mortality compared to their male counterparts. Conclusions: In this large cohort of physically abused children, younger age, females and intracranial or crushing/internal injuries were independent predictors of mortality. Identification of high risk cohorts in the ED may enable strengthening of existing screening programs and optimization of outcomes.	[Allareddy, Veerajalandhar; Asad, Rahimullah; Speicher, David G.; Rotta, Alexandre T.] Case Western Reserve Univ, Sch Med, Rainbow Babies & Childrens Hosp, Dept Pediat Crit Care, Cleveland, OH 44106 USA; [Lee, Min Kyeong; Nalliah, Romesh P.] Harvard Univ, Dept Dent Med, Boston, MA 02115 USA; [Rampa, Sankeerth] Texas A&M Univ, Dept Publ Hlth, College Stn, TX USA; [Allareddy, Veerasathpurush] Univ Iowa, Dept Dent, Iowa City, IA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Harvard University; Harvard School of Dental Medicine; Texas A&M University System; Texas A&M University College Station; University of Iowa	Allareddy, V (corresponding author), Case Western Reserve Univ, Sch Med, Rainbow Babies & Childrens Hosp, Dept Pediat Crit Care, Cleveland, OH 44106 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656; Rotta, Alexandre/0000-0002-4406-2276				Administration for Children & Families Child Maltreatment, 2010, ANN REPORT; Alexander R. C, 2001, CHILD ABUSE MED DIAG, P47; Benger JR, 2002, BRIT MED J, V324, P780, DOI 10.1136/bmj.324.7340.780; Bleeker G, 2005, NED TIJDSCHR GENEES, V149, P1620; Canty TG, 1999, J TRAUMA, V46, P234, DOI 10.1097/00005373-199902000-00005; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Child Maltreatment, 2011, CHILD MALTR 2011; Clark KD, 1997, PEDIATR EMERG CARE, V13, P259, DOI 10.1097/00006565-199708000-00005; Dubowitz H, 2007, LANCET, V369, P1891, DOI 10.1016/S0140-6736(07)60856-3; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Finkelhor D, 2005, CHILD MALTREATMENT, V10, P5, DOI 10.1177/1077559504271287; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gonzalez-Izquierdo A, 2010, ARCH DIS CHILD, V95, P918, DOI 10.1136/adc.2009.180216; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Kellogg N, 2005, EVALUATION SEXUAL AB, V116, P2506; KOLKO DJ, 1992, J INTERPERS VIOLENCE, V7, P244, DOI 10.1177/088626092007002009; Louwers ECFM, 2012, PEDIATRICS, V130, P457, DOI 10.1542/peds.2011-3527; Louwers ECFM, 2011, ARCH DIS CHILD, V96, P422, DOI 10.1136/adc.2010.202358; Louwers ECFM, 2010, ARCH DIS CHILD, V95, P214, DOI 10.1136/adc.2008.151654; McKenzie K, 2009, INJURY PREV, V15, P60, DOI 10.1136/ip.2008.019935; National Center on Child Abuse and Neglect, 1998, STUD NAT INC PREV CH; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Palazzi S, 2005, ARCH DIS CHILD, V90, P406, DOI 10.1136/adc.2003.040790; *PAN RES CHILD AB, 1993, UND CHILD AB NEGL; PEREZ CM, 1994, CHILD ABUSE NEGLECT, V18, P617, DOI 10.1016/0145-2134(94)90012-4; PLESS IB, 1987, CHILD ABUSE NEGLECT, V11, P193, DOI 10.1016/0145-2134(87)90058-5; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Schnitzer PG, 2011, CHILD ABUSE NEGLECT, V35, P3, DOI 10.1016/j.chiabu.2010.06.008; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Sedlak A. J., 2010, US DEP HLTH HUM SERV; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Sittig JS, 2013, AM J EMERG MED; Smeekens AEFN, 2011, ARCH DIS CHILD, V96, P330, DOI 10.1136/adc.2010.190801; The Agency for Healthcare Research and Quality (AHRQ), 2013, NEDS IS COMP DAT HEA; U.S. Department of Health and Human Services, 2006, CHILD MALTREATMENT; US Department of Health and Human Services Administration on Children Youth and Families, 2004, CHILD MALTREATMENT	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100110	10.1371/journal.pone.0100110	http://dx.doi.org/10.1371/journal.pone.0100110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919088	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000129
J	Buccigrossi, V; Laudiero, G; Russo, C; Miele, E; Sofia, M; Monini, M; Ruggeri, FM; Guarino, A				Buccigrossi, Vittoria; Laudiero, Gabriella; Russo, Carla; Miele, Erasmo; Sofia, Morena; Monini, Marina; Ruggeri, Franco Maria; Guarino, Alfredo			Chloride Secretion Induced by Rotavirus Is Oxidative Stress-Dependent and Inhibited by Saccharomyces boulardii in Human Enterocytes	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; ION-TRANSPORT; DISEASE; CHILDREN; DIARRHEA; METABOLITES; ARTICLE; PROTEIN; NSP4; VIVO	Rotavirus (RV) infection causes watery diarrhea via multiple mechanisms, primarily chloride secretion in intestinal epithelial cell. The chloride secretion largely depends on non-structural protein 4 (NSP4) enterotoxic activity in human enterocytes through mechanisms that have not been defined. Redox imbalance is a common event in cells infected by viruses, but the role of oxidative stress in RV infection is unknown. RV SA11 induced chloride secretion in association with an increase in reactive oxygen species (ROS) in Caco-2 cells. The ratio between reduced (GSH) and oxidized (GSSG) glutathione was decreased by RV. The same effects were observed when purified NSP4 was added to Caco-2 cells. N-acetylcysteine (NAC), a potent antioxidant, strongly inhibited the increase in ROS and GSH imbalance. These results suggest a link between oxidative stress and RV-induced diarrhea. Because Saccharomyces boulardii (Sb) has been effectively used to treat RV diarrhea, we tested its effects on RV-infected cells. Sb supernatant prevented RV-induced oxidative stress and strongly inhibited chloride secretion in Caco-2 cells. These results were confirmed in an organ culture model using human intestinal biopsies, demonstrating that chloride secretion induced by RV-NSP4 is oxidative stress-dependent and is inhibited by Sb, which produces soluble metabolites that prevent oxidative stress. The results of this study provide novel insights into RV-induced diarrhea and the efficacy of probiotics.	[Buccigrossi, Vittoria; Laudiero, Gabriella; Russo, Carla; Miele, Erasmo; Sofia, Morena; Guarino, Alfredo] Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy; [Monini, Marina; Ruggeri, Franco Maria] Ist Super Sanita, Viral Zoonoses Unit, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy	University of Naples Federico II; Istituto Superiore di Sanita (ISS)	Guarino, A (corresponding author), Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy.	alfguari@unina.it	MONINI, MARINA/C-9949-2015; Buccigrossi, Vittoria/AAA-1226-2020; Ruggeri, Franco M/B-5707-2013; Guarino, Alfredo/AAC-4812-2022	MONINI, MARINA/0000-0002-5874-2221; Guarino, Alfredo/0000-0003-0199-0336	Biocodex Laboratories, Gentilly, France	Biocodex Laboratories, Gentilly, France	This work was supported in part by Biocodex Laboratories, Gentilly, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agrawal L, 2011, NEUROBIOL DIS, P1; Albano F, 2007, EUR J PEDIATR, V166, P241, DOI 10.1007/s00431-006-0237-6; Allen S, 2001, METHODS CELL SCI, V22, P305; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Buccigrossi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029436; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Canani RB, 2003, GASTROENTEROLOGY, V124, P368, DOI 10.1053/gast.2003.50056; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Correa NBO, 2011, J PEDIATR GASTR NUTR, V53, P497, DOI 10.1097/MPG.0b013e31822b7ab0; De Marco G, 2009, J INFECT DIS, V200, P813, DOI 10.1086/605125; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Forster J, 2009, PEDIATRICS, V123, pe393, DOI 10.1542/peds.2008-2088; Gac M, 2010, VIROLOGY, V404, P293, DOI 10.1016/j.virol.2010.05.018; GRISHAM MB, 1990, INFLAMMATION, V14, P531, DOI 10.1007/BF00914274; Guarino A, 2012, J PEDIATR GASTR NUTR, V55, P621, DOI 10.1097/MPG.0b013e318272b5e2; Guarino A, 2009, CURR OPIN GASTROEN, V25, P18, DOI 10.1097/MOG.0b013e32831b4455; Hagbom M, 2012, CURR OPIN VIROL, V2, P408, DOI 10.1016/j.coviro.2012.05.006; Hosakote YM, 2009, AM J RESP CELL MOL, V41, P348, DOI 10.1165/rcmb.2008-0330OC; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Lorrot M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-31; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; NGUYEN TD, 1994, BIOCHEM PHARMACOL, V47, P403, DOI 10.1016/0006-2952(94)90032-9; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Piescik-Lech M, 2013, ALIMENT PHARM THER, V37, P289, DOI 10.1111/apt.12163; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Rooj AK, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-16; Schultheiss G, 2008, BRIT J PHARMACOL, V154, P991, DOI 10.1038/bjp.2008.162; Sodhi CP, 1996, INDIAN J MED RES, V104, P245; Szajewska H, 2007, ALIMENT PHARM THER, V25, P257, DOI 10.1111/j.1365-2036.2006.03202.x; TAMAI H, 1992, J CLIN INVEST, V89, P301, DOI 10.1172/JCI115576; Tanaka G, 2007, PEDIATR INFECT DIS J, V26, P1014, DOI 10.1097/INF.0b013e318125721c; Tsilingiri K, 2013, BENEF MICROBES, V4, P101, DOI 10.3920/BM2012.0046; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971	35	40	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99830	10.1371/journal.pone.0099830	http://dx.doi.org/10.1371/journal.pone.0099830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918938	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000116
J	Nakanishi, M; Wang, YJ; Wang, YT; Mitsukura, Y; Jung, TP				Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Mitsukura, Yasue; Jung, Tzyy-Ping			Generating Visual Flickers for Eliciting Robust Steady-State Visual Evoked Potentials at Flexible Frequencies Using Monitor Refresh Rate	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; CANONICAL CORRELATION-ANALYSIS; FEATURE-SELECTIVE ATTENTION; SSVEP; BCI; RESPONSES; TOOLBOX; DESIGN; PHASE; TIME	In the study of steady-state visual evoked potentials (SSVEPs), it remains a challenge to present visual flickers at flexible frequencies using monitor refresh rate. For example, in an SSVEP-based brain-computer interface (BCI), it is difficult to present a large number of visual flickers simultaneously on a monitor. This study aims to explore whether or how a newly proposed frequency approximation approach changes signal characteristics of SSVEPs. At 10 Hz and 12 Hz, the SSVEPs elicited using two refresh rates (75 Hz and 120 Hz) were measured separately to represent the approximation and constantperiod approaches. This study compared amplitude, signal-to-noise ratio (SNR), phase, latency, scalp distribution, and frequency detection accuracy of SSVEPs elicited using the two approaches. To further prove the efficacy of the approximation approach, this study implemented an eight-target BCI using frequencies from 8-15 Hz. The SSVEPs elicited by the two approaches were found comparable with regard to all parameters except amplitude and SNR of SSVEPs at 12 Hz. The BCI obtained an averaged information transfer rate (ITR) of 95.0 bits/min across 10 subjects with a maximum ITR of 120 bits/min on two subjects, the highest ITR reported in the SSVEP-based BCIs. This study clearly showed that the frequency approximation approach can elicit robust SSVEPs at flexible frequencies using monitor refresh rate and thereby can largely facilitate various SSVEP-related studies in neural engineering and visual neuroscience.	[Nakanishi, Masaki; Mitsukura, Yasue] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 223, Japan; [Nakanishi, Masaki; Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Wang, Yijun; Wang, Yu-Te; Jung, Tzyy-Ping] Univ Calif San Diego, Inst Engn Med, Ctr Adv Neurol Engn, La Jolla, CA 92093 USA	Keio University; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, YJ (corresponding author), Univ Calif San Diego, Inst Neural Computat, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA.	yijun@sccn.ucsd.edu	Mitsukura, Yasue/ABI-2277-2020; Mitsukura, Yasue/F-8149-2014; Mitsukura, Yasue/AAF-1449-2021; Nakanishi, Masaki/S-9251-2019; Wang, Yijun/F-3547-2012; Wang, Yijun/GXW-1763-2022	Mitsukura, Yasue/0000-0001-5575-8589; Mitsukura, Yasue/0000-0001-5575-8589; Jung, Tzyy-Ping/0000-0002-8377-2166	Swartz Foundation; Office of Naval Research [N00014-08-1215]; Army Research Office [W911NF-09-1-0510]; Army Research Laboratory [W911NF-10-2-0022]; DARPA [USDI D11PC20183]; Japan Society for the Promotion of Science	Swartz Foundation; Office of Naval Research(Office of Naval Research); Army Research Office; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research is supported in part by a gift fund from Swartz Foundation, Office of Naval Research (N00014-08-1215), Army Research Office (W911NF-09-1-0510), Army Research Laboratory (W911NF-10-2-0022), and DARPA (USDI D11PC20183). M. Nakanishi is also supported by Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; Bakardjian H, 2010, NEUROSCI LETT, V469, P34, DOI 10.1016/j.neulet.2009.11.039; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cao T, 2011, I IEEE EMBS C NEUR E, P465, DOI 10.1109/NER.2011.5910587; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diez PF, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-39; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gergondet P., 2011, 2011 IEEE International Conference on Robotics and Biomimetics (ROBIO), P192, DOI 10.1109/ROBIO.2011.6181284; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kluge T, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P425, DOI 10.1109/CNE.2007.369700; Lalor EC, 2005, EURASIP J APPL SIG P, V2005, P3156, DOI 10.1155/ASP.2005.3156; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin YP, 2013, IEEE ENG MED BIO, P1350, DOI 10.1109/EMBC.2013.6609759; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez-Gordo MA, 2010, NEURAL PROCESS LETT, V32, P1, DOI 10.1007/s11063-010-9139-8; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Nakanishi M, 2013, I IEEE EMBS C NEUR E, P1092, DOI 10.1109/NER.2013.6696127; Nan WY, 2011, I IEEE EMBS C NEUR E, P469, DOI 10.1109/NER.2011.5910588; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; Regan D., 1989, HUMAN BRAIN ELECTROP; Russo FD, 1999, VISION RES, V39, P2975, DOI DOI 10.1016/S0042-6989(99)00031-; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; SPEKREIJSE H, 1977, VISUAL EVOKED POTENT, P16; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2010, ELECTRON LETT, V46, P1057, DOI 10.1049/el.2010.0923; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YJ, 2005, 2005 FIRST INTERNATIONAL CONFERENCE ON NEURAL INTERFACE AND CONTROL PROCEEDINGS, P37; Wang YT, 2013, IEEE ENG MED BIO, P5271, DOI 10.1109/EMBC.2013.6610738; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	43	67	68	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99235	10.1371/journal.pone.0099235	http://dx.doi.org/10.1371/journal.pone.0099235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918435	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000065
J	Araya, RE; Jury, J; Bondar, C; Verdu, EF; Chirdo, FG				Araya, Romina E.; Jury, Jennifer; Bondar, Constanza; Verdu, Elena F.; Chirdo, Fernando G.			Intraluminal Administration of Poly I:C Causes an Enteropathy That Is Exacerbated by Administration of Oral Dietary Antigen	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DOUBLE-STRANDED-RNA; NONOBESE DIABETIC MICE; CELIAC-DISEASE; BACTERIAL DYSENTERY; GLUTEN SENSITIVITY; TRANSGLUTAMINASE 2; BARRIER FUNCTION; RESPONSES; GLIADIN	Systemic administration of polyinosinic: polycytidylic acid (poly I:C), mimics virally-induced activation of TLR3 signalling causing acute small intestine damage, but whether and how mucosal administration of poly I:C causes enteropathy is less clear. Our aim was to investigate the inflammatory pathways elicited after intraluminal administration of poly I:C and determine acute and delayed consequences of this locally induced immune activation. Intraluminal poly I:C induced rapid mucosal immune activation in C57BL/6 mice involving IFN beta and the CXCL10/CXCR3 axis, that may drive inflammation towards a Th1 profile. Intraluminal poly I:C also caused enteropathy and gut dysfunction in gliadin-sensitive NOD-DQ8 mice, and this was prolonged by concomitant oral administration of gliadin. Our results indicate that small intestine pathology can be induced in mice by intraluminal administration of poly I:C and that this is exacerbated by subsequent oral delivery of a relevant dietary antigen.	[Araya, Romina E.; Bondar, Constanza; Chirdo, Fernando G.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina; [Jury, Jennifer; Verdu, Elena F.] McMaster Univ, Farncombe Family Digest Hlth Inst, Div Gastroenterol, Hamilton, ON, Canada	National University of La Plata; McMaster University	Chirdo, FG (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina.	fchirdo@biol.unlp.edu.ar	Chirdo, Fernando/AAL-7928-2020	Araya, Romina Elizabeth/0000-0001-9787-2670; Chirdo, Fernando/0000-0002-7099-9142	CONICET [PIP 719]; CIHR [MOP-123282]; Canadian Association of Gastroenterology (CAG) - Latin American Student Research Opportunity	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology (CAG) - Latin American Student Research Opportunity	This work was supported by a grant to F.Ch. from CONICET PIP 719 and a CIHR grant to E. F. V. (MOP-123282). R. E. A. received a travel grant from Canadian Association of Gastroenterology (CAG) - Latin American Student Research Opportunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Bayardo M, 2012, CLIN EXP IMMUNOL, V168, P95, DOI 10.1111/j.1365-2249.2011.04545.x; Biagi F, 2004, J CLIN PATHOL, V57, P835, DOI 10.1136/jcp.2003.013607; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Bondar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089068; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; de Kauwe AL, 2009, J IMMUNOL, V182, P7440, DOI 10.4049/jimmunol.0900233; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Galipeau HJ, 2011, J IMMUNOLOGY; GARSIDE P, 1991, IMMUNOLOGY, V74, P279; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; Honda K, 2009, MUCOSAL IMMUNOL, V2, P187, DOI 10.1038/mi.2009.8; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kolodziej LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026352; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; McAllister CS, 2013, J IMMUNOL, V190, P418, DOI 10.4049/jimmunol.1202756; Nanayakkara M, 2013, AM J CLIN NUTR, V98, P1123, DOI 10.3945/ajcn.112.054544; Natividad JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006472; Ostvik AE, 2013, INFLAMM BOWEL DIS, V19, P265, DOI 10.1002/ibd.23034; Quaedackers JSLT, 2000, TRANSPLANT P, V32, P1307, DOI 10.1016/S0041-1345(00)01238-0; Rajagopalan G, 2003, DIABETES, V52, P342, DOI 10.2337/diabetes.52.2.342; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Suwanai H, 2010, P NATL ACAD SCI USA, V107, P9305, DOI 10.1073/pnas.1004492107; Troncone R, 2007, J PEDIATR GASTR NUTR, V44, P527, DOI 10.1097/MPG.0b013e31804ca0ec; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Verdu EF, 2007, CAN J GASTROENTEROL, V21, P453, DOI 10.1155/2007/169591; Verdu EF, 2012, AM J GASTROENTEROL, V107, P1752, DOI 10.1038/ajg.2012.291; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Zhou RB, 2007, P NATL ACAD SCI USA, V104, P7512, DOI 10.1073/pnas.0700822104; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	40	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99236	10.1371/journal.pone.0099236	http://dx.doi.org/10.1371/journal.pone.0099236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915573	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700073
J	Armstead, J; Morris, J; Denning, DW				Armstead, Joanne; Morris, Julie; Denning, David W.			Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; LUNG-FUNCTION; FUMIGATUS; SENSITIZATION; PREVALENCE; CLASSIFICATION; BRONCHITIS; FREQUENCY; DIAGNOSIS; CHILDREN	Aspergillus spp. can lead to allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitisation and Aspergillus bronchitis in CF. The relative frequencies of these entities have recently been ascertained in a large UK adult CF cohort. We have used this data to estimate the burden of aspergillosis and ABPA cases in adult CF patients in 30 countries reporting CF. National and international CF registry data was accessed and assessed for completeness and age distribution. Published proportions of ABPA (17.7%), Aspergillus sensitisation (14.6%) and Aspergillus bronchitis (30%) in CF were applied to those >18 years and compared with notified ABPA cases. Of the 76,201 estimated CF patients worldwide (not including India), 37,714 were >18 years. The proportion of adults to children varied from 63% in Norway to 20% in Brazil. ABPA caseload in adults is anticipated to be 6,675 cases of which only 2,221 cases (33%) are currently recorded, indicating substantial underdiagnosis. The ABPA diagnosis rate compared with estimated rates varies by country from 101% (France) to 14.5% (Greece), although genetic variation could account for genuine differences compared with the UK. Aspergillus bronchitis is not currently recognised or recorded in CF registries but there are an anticipated 10,988 adult cases. Aspergillus sensitisation, associated with increased bronchiectasis and reduced FEV1, affects an anticipated 5,506 patients without ABPA or Aspergillus bronchitis. Together ABPA and Aspergillus bronchitis are estimated to affect 17,989 adults, 47.7% of the adult CF population. ABPA also occurs in children and teenagers and 984 cases were documented in registries. Diagnosed ABPA rates by age were available for the ECFS registry, USA, UK, Ireland, Belgium and Netherlands. The rate was <1% under 4 years, and increased throughout childhood and adolescence, with marked variation between countries. Newly published diagnostic criteria and methods should facilitate better recognition of aspergillosis in CF, allowing better CF disease control.	[Denning, David W.] Univ Manchester, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England; Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Denning, DW (corresponding author), Univ Manchester, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England.	ddenning@manchester.ac.uk	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251	University Hospital of South Manchester	University Hospital of South Manchester	This work was funded by the University Hospital of South Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P671, DOI 10.1007/978-90-481-2408-4_39; Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; [Anonymous], 2011, IN FRENCH CYST FIBR; [Anonymous], 2011, CYSTIC FIBROSIS FDN; Av Norsk senter for cystisk fibrose Oslo universitetssykehus, 2011, CYST FIBR POP NORG P; Barton RC, 2008, DIAGN MICR INFEC DIS, V62, P287, DOI 10.1016/j.diagmicrobio.2008.06.018; Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007; BEAUMONT F, 1984, ALLERGY, V39, P183, DOI 10.1111/j.1398-9995.1984.tb02623.x; Belgische Mucoviscidose Register Registre Belge de la Mucoviscidose Scientific Institute of Public Health, 2010, BELG CYST FIBR REG S; Burgel PR, 2012, ANTIMICROB AGENTS CH, V56, P869, DOI 10.1128/AAC.05077-11; Carneiro Ana Cláudia Costa, 2008, J. bras. pneumol., V34, P900, DOI 10.1590/S1806-37132008001100003; Chakrabarti A, 2002, MYCOSES, V45, P295, DOI 10.1046/j.1439-0507.2002.00738.x; Chrdle A, 2012, ANN NY ACAD SCI, V1272, P73, DOI 10.1111/j.1749-6632.2012.06816.x; Cordero CV, 2008, REGISTRO EUROPEO FQ; Cystic Fibrosis Association of New Zealand, 2011, PORT CFNZ 2011 NAT D; Cystic Fibrosis Australia, 2012, CYST FIBR AUSTR 2011; Cystic Fibrosis Canada, 2013, CAN CYST FIBR REG 20; de Vrankrijker AMM, 2011, CLIN MICROBIOL INFEC, V17, P1381, DOI 10.1111/j.1469-0691.2010.03429.x; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Dutch Cystic Fibrosis Registry, 2012, ANN DAT REP 2011; ELDAHR JM, 1994, AM J RESP CRIT CARE, V150, P1513, DOI 10.1164/ajrccm.150.6.7952609; European Cystic Fibrosis Society, 2009, EUR CYST FIBR SOC PA; Fillaux J, 2012, SCAND J INFECT DIS, V44, P842, DOI 10.3109/00365548.2012.695454; Geller DE, 1999, CHEST, V116, P639, DOI 10.1378/chest.116.3.639; Greenberger PA, 2001, FRONTIERS BIOSCIENCE, V8, ps119; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Grupo Brasileiro De Estudos De Fibrose Cistica, 2010, REG BRAS FIBR CIST A; Hedayati MT, 2010, ENVIRON MONIT ASSESS, V168, P481, DOI 10.1007/s10661-009-1128-x; HENDERSON AH, 1968, THORAX, V23, P501, DOI 10.1136/thx.23.5.501; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; Hutcheson PS, 1996, CHEST, V110, P363, DOI 10.1378/chest.110.2.363; Kanthan SK, 2007, PEDIATR PULM, V42, P785, DOI 10.1002/ppul.20656; Kapoor V, 2006, J CYST FIBROS, V5, P43, DOI 10.1016/j.jcf.2005.10.002; KIRSTEN D, 1993, MED KLIN, V88, P353; Kopacz E, 2009, KONF V4 CF ZBORN PRE; MARCHANT JL, 1994, THORAX, V49, P1002, DOI 10.1136/thx.49.10.1002; Marshall B, 2013, US CYSTIC FIBROSIS F; Mastella G, 2000, EUR RESPIR J, V16, P464, DOI 10.1034/j.1399-3003.2000.016003464.x; MEARNS M, 1965, THORAX, V20, P385, DOI 10.1136/thx.20.5.385; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Milla CE, 1996, PEDIATR PULM, V21, P6, DOI 10.1002/(SICI)1099-0496(199601)21:1&lt;6::AID-PPUL1&gt;3.0.CO;2-R; Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Prasad R, 2010, INDIAN J CLIN BIOCHE, V25, P335, DOI 10.1007/s12291-010-0091-1; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sens B, 2011, QUALITATSSICHERUNG M; Shah JR, 1997, J ASSOC PHYSICIAN I, V19, P835; Shoseyov D, 2006, CHEST, V130, P222, DOI 10.1378/chest.130.1.222; SIMMONDS EJ, 1990, ARCH DIS CHILD, V65, P507, DOI 10.1136/adc.65.5.507; Skov M, 2005, RESP MED, V99, P887, DOI 10.1016/j.rmed.2004.11.018; Spagna F, 2010, FIBROSIS QUISTICA UR; State Social Security Institution Uruguay (BPS), 2012, FIBR QUIST UR SIT PE; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; The Cystic Fibrosis Registry of Ireland, 2011, ANN REPORT; Tudela Juan Luis Rodriguez, 2013, BURDEN SERIOUS FUNGA; UK CF Registry, 2013, ANN DAT REP 2011; Viviani L, 2012, EUROPEAN CYSTIC FIBR, P1; Wojnarowski C, 1997, AM J RESP CRIT CARE, V155, P1902, DOI 10.1164/ajrccm.155.6.9196093; Woodcock AA, 2006, ALLERGY, V61, P140, DOI 10.1111/j.1398-9995.2005.00941.x	61	75	75	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98502	10.1371/journal.pone.0098502	http://dx.doi.org/10.1371/journal.pone.0098502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914809	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700022
J	Avilov, S; Berardozzi, R; Gunewardene, MS; Adam, V; Hess, ST; Bourgeois, D				Avilov, Sergiy; Berardozzi, Romain; Gunewardene, Mudalige S.; Adam, Virgile; Hess, Samuel T.; Bourgeois, Dominique			In cellulo Evaluation of Phototransformation Quantum Yields in Fluorescent Proteins Used As Markers for Single-Molecule Localization Microscopy	PLOS ONE			English	Article							TO-RED PHOTOCONVERSION; SUPERRESOLUTION MICROSCOPY; CORRELATION SPECTROSCOPY; STRUCTURAL BASIS; DYNAMICS; PHOTOSTABILITY; FLUOROPHORES; CONVERSION; BLINKING; STATE	Single-molecule localization microscopy of biological samples requires a precise knowledge of the employed fluorescent labels. Photoactivation, photoblinking and photobleaching of phototransformable fluorescent proteins influence the data acquisition and data processing strategies to be used in (Fluorescence) Photoactivation Localization Microscopy ((F)-PALM), notably for reliable molecular counting. As these parameters might depend on the local environment, they should be measured in cellulo in biologically relevant experimental conditions. Here, we measured phototransformation quantum yields for Dendra2 fused to actin in fixed mammalian cells in typical (F)-PALM experiments. To this aim, we developed a data processing strategy based on the clustering optimization procedure proposed by Lee et al (PNAS 109, 17436-17441, 2012). Using simulations, we estimated the range of experimental parameters (molecular density, molecular orientation, background level, laser power, frametime) adequate for an accurate determination of the phototransformation yields. Under illumination at 561 nm in PBS buffer at pH 7.4, the photobleaching yield of Dendra2 fused to actin was measured to be (2.5 +/- 0.4) x 10(-5), whereas the blinking-off yield and thermally-activated blinking-on rate were measured to be (2.3 +/- 0.2) x 10(-5) and 11.7 +/- 0.5 s(-1), respectively. These phototransformation yields differed from those measured in polyvinyl alcohol (PVA) and were strongly affected by addition of the antifading agent 1,4-diazabicyclo[2.2.2] octane (DABCO). In the presence of DABCO, the photobleaching yield was reduced 2-fold, the blinking-off yield was decreased more than 3-fold, and the blinking-on rate was increased 2-fold. Therefore, DABCO largely improved Dendra2 photostability in fixed mammalian cells. These findings are consistent with redox-based bleaching and blinking mechanisms under (F)-PALM experimental conditions. Finally, the green-to-red photoconversion quantum yield of Dendra2 was estimated to be (1.4 +/- 0.6) x 10(-5) in cellulo under 405 nm illumination.	[Avilov, Sergiy; Berardozzi, Romain; Adam, Virgile; Bourgeois, Dominique] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Avilov, Sergiy; Berardozzi, Romain; Adam, Virgile; Bourgeois, Dominique] CNRS, IBS, Grenoble, France; [Avilov, Sergiy; Berardozzi, Romain; Adam, Virgile; Bourgeois, Dominique] CEA, DSV, IBS, Grenoble, France; [Gunewardene, Mudalige S.; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Maine System; University of Maine Orono	Hess, ST (corresponding author), Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA.	sam.hess@umit.maine.edu; dominique.bourgeois@ibs.fr	Adam, Virgile/B-9359-2009; , Bourgeois/AAI-2337-2020	Adam, Virgile/0000-0003-2209-7846; 	ANR [ANR-2011-BSV5-012-01 NOBLEACH]; U.S. National Institutes of Health [K25-AI65459, R15-GM094713]; U.S. National Science Foundation [CHE0722759]; Maine Technology Institute [MTAF 1106, MTAF 2061]; Maine Economic Improvement Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094713] Funding Source: NIH RePORTER	ANR(French National Research Agency (ANR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Maine Technology Institute; Maine Economic Improvement Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.B. acknowledges financial support by the ANR (ANR-2011-BSV5-012-01 NOBLEACH). S.T.H. and M.S.G. were supported by U.S. National Institutes of Health grants K25-AI65459 and R15-GM094713, U.S. National Science Foundation grant CHE0722759, Maine Technology Institute grants MTAF 1106 and MTAF 2061, and the Maine Economic Improvement Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2011, CHEM BIOL, V18, P1241, DOI 10.1016/j.chembiol.2011.08.007; Adam V, 2009, J AM CHEM SOC, V131, P18063, DOI 10.1021/ja907296v; Adam V, 2009, BIOCHEMISTRY-US, V48, P4905, DOI 10.1021/bi900383a; Altman RB, 2012, NAT METHODS, V9, P428, DOI 10.1038/nmeth.1988; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Baldini G, 2005, SCIENCE, V309, P1096, DOI 10.1126/science.1115001; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bogdanov AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053004; Bogdanov AM, 2009, NAT METHODS, V6, P859, DOI 10.1038/nmeth1209-859; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Coltharp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051725; DAVID CC, 2012, PHOTOCH PHOTOBIO SCI, V11, P358, DOI DOI 10.1039/C1PP05292F; Dean KM, 2011, BIOPHYS J, V101, P961, DOI 10.1016/j.bpj.2011.06.055; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Dittrich PS, 2005, BIOPHYS J, V89, P3446, DOI 10.1529/biophysj.105.061713; Duan CX, 2013, J AM CHEM SOC, V135, P15841, DOI 10.1021/ja406860e; Durisic N., 2014, NAT METHODS; Endesfelder U, 2011, MOLECULES, V16, P3106, DOI 10.3390/molecules16043106; Fourkas JT, 2001, OPT LETT, V26, P211, DOI 10.1364/OL.26.000211; Furstenberg A, 2013, PHYS CHEM CHEM PHYS, V15, P14919, DOI 10.1039/c3cp52289j; Ganguly S, 2011, BIOCHEM BIOPH RES CO, V405, P234, DOI 10.1016/j.bbrc.2011.01.016; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Gurskaya NG, 2006, NAT BIOTECHNOL; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Harms GS, 2001, BIOPHYS J, V80, P2396, DOI 10.1016/S0006-3495(01)76209-1; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoi HF, 2010, J MOL BIOL, V401, P776, DOI 10.1016/j.jmb.2010.06.056; JOHNSON GD, 1982, J IMMUNOL METHODS, V55, P231, DOI 10.1016/0022-1759(82)90035-7; Kao YT, 2012, P NATL ACAD SCI USA, V109, P3220, DOI 10.1073/pnas.1115311109; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lelimousin M, 2009, J AM CHEM SOC; Liu YX, 2006, J PHYS CHEM B, V110, P24138, DOI 10.1021/jp062164t; Makarov NS, 2014, J PHOTOCH PHOTOBIO A, V280, P5, DOI 10.1016/j.jphotochem.2014.02.001; Malkani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018586; McEvoy AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051314; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Moeyaert B, 2014, ACS NANO; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nanguneri S, 2014, MICROSC RES TECH; Ono M, 2001, J HISTOCHEM CYTOCHEM, V49, P305, DOI 10.1177/002215540104900304; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; Puchner EM, 2013, P NATL ACAD SCI USA, V110, P16015, DOI 10.1073/pnas.1309676110; Roy A, 2011, J AM CHEM SOC, V133, P18586, DOI 10.1021/ja2085355; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saha R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01580; Schenk A, 2004, BIOPHYS J, V86, P384, DOI 10.1016/S0006-3495(04)74114-4; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Tsutsui H, 2009, CHEM BIOL, V16, P1140, DOI 10.1016/j.chembiol.2009.10.010; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; van de Linde S, 2014, CHEM SOC REV, V43, P1076, DOI 10.1039/c3cs60195a; van de Linde S, 2012, ANNU REV PHYS CHEM, V63, P519, DOI 10.1146/annurev-physchem-032811-112012; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wolter S, 2011, OPT EXPRESS, V19, P7020, DOI 10.1364/OE.19.007020; Wong FHC, 2007, J AM CHEM SOC, V129, P10302, DOI 10.1021/ja0715905; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r; Zhao ZQW, 2014, P NATL ACAD SCI USA, V111, P681, DOI 10.1073/pnas.1318496111; Zondervan R, 2003, J PHYS CHEM A, V107, P6770, DOI 10.1021/jp034723r	73	24	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98362	10.1371/journal.pone.0098362	http://dx.doi.org/10.1371/journal.pone.0098362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915511	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700018
J	Odaka, H; Numakawa, T; Adachi, N; Ooshima, Y; Nakajima, S; Katanuma, Y; Inoue, T; Kunugi, H				Odaka, Haruki; Numakawa, Tadahiro; Adachi, Naoki; Ooshima, Yoshiko; Nakajima, Shingo; Katanuma, Yusuke; Inoue, Takafumi; Kunugi, Hiroshi			Cabergoline, Dopamine D2 Receptor Agonist, Prevents Neuronal Cell Death under Oxidative Stress via Reducing Excitotoxicity	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MITOCHONDRIAL DYSFUNCTION; GLUTAMATE TRANSPORTERS; GLUTATHIONE SYSTEM; INDUCED APOPTOSIS; STEM-CELLS; ACTIVATION; ERK; PROTEIN; KINASE	Several lines of evidence demonstrate that oxidative stress is involved in the pathogenesis of neurodegenerative diseases, including Parkinson's disease. Potent antioxidants may therefore be effective in the treatment of such diseases. Cabergoline, a dopamine D2 receptor agonist and antiparkinson drug, has been studied using several cell types including mesencephalic neurons, and is recognized as a potent radical scavenger. Here, we examined whether cabergoline exerts neuroprotective effects against oxidative stress through a receptor-mediated mechanism in cultured cortical neurons. We found that neuronal death induced by H2O2 exposure was inhibited by pretreatment with cabergoline, while this protective effect was eliminated in the presence of a dopamine D2 receptor inhibitor, spiperone. Activation of ERK1/2 by H2O2 was suppressed by cabergoline, and an ERK signaling pathway inhibitor, U0126, similarly protected cortical neurons from cell death. This suggested the ERK signaling pathway has a critical role in cabergoline-mediated neuroprotection. Furthermore, increased extracellular levels of glutamate induced by H2O2, which might contribute to ERK activation, were reduced by cabergoline, while inhibitors for NMDA receptor or L-type Ca2+ channel demonstrated a survival effect against H2O2. Interestingly, we found that cabergoline increased expression levels of glutamate transporters such as EAAC1. Taken together, these results suggest that cabergoline has a protective effect on cortical neurons via a receptor-mediated mechanism including repression of ERK1/2 activation and extracellular glutamate accumulation induced by H2O2.	[Odaka, Haruki; Numakawa, Tadahiro; Adachi, Naoki; Ooshima, Yoshiko; Nakajima, Shingo; Katanuma, Yusuke; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Odaka, Haruki; Katanuma, Yusuke; Inoue, Takafumi] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Numakawa, Tadahiro; Adachi, Naoki; Nakajima, Shingo; Kunugi, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Waseda University; Japan Science & Technology Agency (JST)	Numakawa, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan.	numakawa@ncnp.go.jp	Odaka, Haruki/AAQ-4448-2020; Inoue, Takafumi/AAM-9533-2020; Kunugi, Hiroshi/ABC-5260-2021	Odaka, Haruki/0000-0001-5632-2680; Inoue, Takafumi/0000-0002-2728-0060; Adachi, Naoki/0000-0002-4850-1467; Kunugi, Hiroshi/0000-0002-7209-3790	NCNP [24-11]; JST [08062571]; Takeda Science Foundation; JSPS KAKENHI [24300139]; JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [25640019]	NCNP; JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Intramural Research Grant (No. 24-11) for Neurological and Psychiatric Disorders of NCNP (http://www.ncnp.go.jp/) and CREST program "creation of a novel technology towards diagnosis and treatment based on understanding of molecular pathogenesis of psychiatric and neurological disorders'' (No. 08062571) of JST (http://www.sss.jst.go.jp/info/index.html) (T.N., N.A. and H.K.). This project was also supported by Takeda Science Foundation (http://www.takeda-sci.or.jp/) (T.N.), a grant from Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 24300139) (http://www.jsps.go. jp/english/index.html) (T.N.), and Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI Grant Number 25640019) (http://www.jsps.go.jp/english/ index.html) (T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Baas HKJ, 2001, EUR NEUROL, V46, P18, DOI 10.1159/000058049; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chau KY, 2009, J NEUROL SCI, V278, P44, DOI 10.1016/j.jns.2008.11.012; Chiba S, 2010, PSYCHOPHARMACOLOGY, V211, P291, DOI 10.1007/s00213-010-1894-8; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Curran MP, 2004, DRUGS, V64, P2125, DOI 10.2165/00003495-200464180-00015; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Feng Y, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/472932; Guillet B, 2002, NEUROCHEM INT, V40, P661, DOI 10.1016/S0197-0186(01)00110-3; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johri A, 2012, BBA-MOL BASIS DIS, V1822, P664, DOI 10.1016/j.bbadis.2011.11.014; Kalampokas T, 2013, GYNECOL ENDOCRINOL, V29, P98, DOI 10.3109/09513590.2012.730578; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kitamura Y, 2003, NEUROCHEM RES, V28, P1035, DOI 10.1023/A:1023207222944; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; Lombardi G, EUR J PHARM, V457, P95; Mailly F, 1999, J NEUROCHEM, V73, P1181, DOI 10.1046/j.1471-4159.1999.0731181.x; Miglio G, 2004, EUR J PHARMACOL, V489, P157, DOI 10.1016/j.ejphar.2004.03.006; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Pradeep H, 2012, FOLIA NEUROPATHOL, V50, P219, DOI 10.5114/fn.2012.30522; RESINK A, 1995, EUR J NEUROSCI, V7, P1700, DOI 10.1111/j.1460-9568.1995.tb00691.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Samanta S, 1998, J NEUROCHEM, V70, P2082; Sawada H, 1998, ANN NEUROL, V44, P110, DOI 10.1002/ana.410440117; Schinder AF, 1996, J NEUROSCI, V16, P6125; Scholz H, 2011, COCHRANE DB SYST REV, V16; Schroeter H, 2002, NEUROBIOL AGING, V23, P861, DOI 10.1016/S0197-4580(02)00075-1; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Tanaka K, 2001, NEUROCHEM RES, V26, P31, DOI 10.1023/A:1007672414239; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Wang AT, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-33; Wang W, 2003, J NEUROCYTOL, V32, P143, DOI 10.1023/B:NEUR.0000005599.10952.33; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Yang L, 2013, TOXICOL IN VITRO, V27, P908, DOI 10.1016/j.tiv.2013.01.001; Yoshioka M, 2002, NEUROSCI RES, V43, P259, DOI 10.1016/S0168-0102(02)00040-8; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	51	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99271	10.1371/journal.pone.0099271	http://dx.doi.org/10.1371/journal.pone.0099271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914776	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700076
J	Szczesny, SE; Edelstein, RS; Elliott, DM				Szczesny, Spencer E.; Edelstein, Rachel S.; Elliott, Dawn M.			DTAF Dye Concentrations Commonly Used to Measure Microscale Deformations in Biological Tissues Alter Tissue Mechanics	PLOS ONE			English	Article							COLLAGEN FIBRILS; TENDON COLLAGEN; SYNCHROTRON-RADIATION; ANNULUS FIBROSUS; STRAIN TRANSFER; IN-VITRO; STRESS; LEVEL; MULTISCALE; NANOSCALE	Identification of the deformation mechanisms and specific components underlying the mechanical function of biological tissues requires mechanical testing at multiple levels within the tissue hierarchical structure. Dichlorotriazinylaminofluorescein (DTAF) is a fluorescent dye that is used to visualize microscale deformations of the extracellular matrix in soft collagenous tissues. However, the DTAF concentrations commonly employed in previous multiscale experiments (>= 2000 mu g/ml) may alter tissue mechanics. The objective of this study was to determine whether DTAF affects tendon fascicle mechanics and if a concentration threshold exists below which any observed effects are negligible. This information is valuable for guiding the continued use of this fluorescent dye in future experiments and for interpreting the results of previous work. Incremental strain testing demonstrated that high DTAF concentrations >= 100 mu g/ml) increase the quasistatic modulus and yield strength of rat tail tendon fascicles while reducing their viscoelastic behavior. Subsequent multiscale testing and modeling suggests that these effects are due to a stiffening of the collagen fibrils and strengthening of the interfibrillar matrix. Despite these changes in tissue behavior, the fundamental deformation mechanisms underlying fascicle mechanics appear to remain intact, which suggests that conclusions from previous multiscale investigations of strain transfer are still valid. The effects of lower DTAF concentrations (<= 10 mu g/ml) on tendon mechanics were substantially smaller and potentially negligible; nevertheless, no concentration was found that did not at least slightly alter the tissue behavior. Therefore, future studies should either reduce DTAF concentrations as much as possible or use other dyes/techniques for measuring microscale deformations.	[Szczesny, Spencer E.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Edelstein, Rachel S.; Elliott, Dawn M.] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA	University of Pennsylvania; University of Delaware	Elliott, DM (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.	delliott@udel.edu	Elliott, Dawn/U-8375-2019; Szczesny, Spencer/AAL-9217-2021	Elliott, Dawn/0000-0003-4792-1029; Szczesny, Spencer/0000-0002-7691-949X	NIH COBRE grant [NIH/NCRR P20 RR016458]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016458] Funding Source: NIH RePORTER	NIH COBRE grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by an NIH COBRE grant (NIH/NCRR P20 RR016458) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8; BLAKESLEE D, 1976, J IMMUNOL METHODS, V13, P305, DOI 10.1016/0022-1759(76)90078-8; Bruehlmann SB, 2004, SPINE, V29, P2612, DOI 10.1097/01.brs.0000146465.05972.56; Buckley MR, 2010, J BIOMECH, V43, P796, DOI 10.1016/j.jbiomech.2009.10.012; Cheng VWT, 2007, J MATER SCI, V42, P8957, DOI 10.1007/s10853-007-1653-3; Clemmer J, 2010, J BIOMECH, V43, P2785, DOI 10.1016/j.jbiomech.2010.06.009; DAVISON PF, 1985, INVEST OPHTH VIS SCI, V26, P1202; Desrochers J, 2010, J BIOMECH, V43, P2141, DOI 10.1016/j.jbiomech.2010.03.045; Duncan NA, 2014, COMPUT METHOD BIOMEC, V17, P39, DOI 10.1080/10255842.2012.742075; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Granath K, 1973, CARBOHYDRATE RES, V2, P375, DOI DOI 10.1016/S0008-6215(00)81824-8; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Hagenau A, 2011, J STRUCT BIOL, V175, P339, DOI 10.1016/j.jsb.2011.05.016; Han WM, 2013, BIOPHYS J, V105, P807, DOI 10.1016/j.bpj.2013.06.023; Hansen P, 2009, CONNECT TISSUE RES, V50, P211, DOI 10.1080/03008200802610040; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Huyghe JM, 2012, BIOMECH MODEL MECHAN, V11, P161, DOI 10.1007/s10237-011-0300-8; Jayyosi C, 2014, ACTA BIOMATER, V10, P2591, DOI 10.1016/j.actbio.2014.02.031; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; Liao J, 2007, J BIOMECH ENG-T ASME, V129, P78, DOI 10.1115/1.2401186; Masic A, 2011, BIOMACROMOLECULES, V12, P3989, DOI 10.1021/bm201008b; Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047; MOSLER E, 1985, J MOL BIOL, V182, P589, DOI 10.1016/0022-2836(85)90244-X; NEMETSCHEK T, 1983, J MOL BIOL, V167, P461, DOI 10.1016/S0022-2836(83)80345-3; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; ROWE RWD, 1985, CONNECT TISSUE RES, V14, P9, DOI 10.3109/03008208509089839; Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3; Sasaki N, 1999, J BIOMECH, V32, P285, DOI 10.1016/S0021-9290(98)00174-2; Screen HRC, 2013, MED ENG PHYS, V35, P96, DOI 10.1016/j.medengphy.2012.04.004; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Smolin E. M., 1959, S TRIAZINES DERIVATI; Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Szczesny SE, 2014, ACTA BIOMATER, V10, P2582, DOI 10.1016/j.actbio.2014.01.032; Tanaka ML, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004412; Thorpe CT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1058; Thorpe CT, 2013, ACTA BIOMATER, V9, P7948, DOI 10.1016/j.actbio.2013.05.004; Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362; Upton ML, 2008, BIOPHYS J, V95, P2116, DOI 10.1529/biophysj.107.126938; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Wall ME, 2007, J BIOMECH, V40, P173, DOI 10.1016/j.jbiomech.2005.10.032; Wood ML, 1998, J ORTHOPAED RES, V16, P438, DOI 10.1002/jor.1100160407; Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008	48	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99588	10.1371/journal.pone.0099588	http://dx.doi.org/10.1371/journal.pone.0099588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915570	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700118
J	Wang, F; Zheng, PP; Yang, DY; Freeman, B; Fu, H; Chapman, S				Wang, Fan; Zheng, Pinpin; Yang, Dongyun; Freeman, Becky; Fu, Hua; Chapman, Simon			Chinese Tobacco Industry Promotional Activity on the Microblog Weibo	PLOS ONE			English	Article							MEDIA	Background: Although China ratified the WHO Framework Convention on Tobacco Control [FCTC] in 2005, the partial ban on tobacco advertising does not cover the internet. Weibo is one of the most important social media channels in China, using a format similar to its global counterpart, Twitter. The Weibo homepage is a platform to present products, brands and corporate culture. There is great potential for the tobacco industry to exploit Weibo to promote products. Methods: Seven tobacco industry Weibo accounts that each had more than 5000 fans were selected to examine the content of Weibos established by tobacco companies or their advertising agents. Results: Of the 12073 posts found on the seven accounts, 92.3% (11143) could be classified into six main themes: traditional culture, popular culture, social and business affairs, advertisement, public relations and tobacco culture. Posts under the theme of popular culture accounted for about half of total posts (49%), followed by 'advertisement' and 'tobacco culture' (both at 12%), 'traditional culture' and 'public relations' (both at 11%), and finally 'social and business affairs' (5%). 33% of posts included the words 'cigarette' or 'smoking' and 53% of posts included the tobacco brand name, indicating that tobacco companies carefully construct the topic and content of posts. Conclusions: Weibo is an important new online marketing tool for the Chinese tobacco industry. Tobacco industry use of Weibo to promote brands and normalize smoking subverts China's ratification of the WHO FCTC. Policy to control tobacco promotion needs reforming to address this widespread circumvention of China's tobacco advertising ban.	[Wang, Fan; Zheng, Pinpin; Fu, Hua] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Yang, Dongyun] Shanghai Univ Finance & Econ, Sch Stat & Management, Shanghai, Peoples R China; [Freeman, Becky; Chapman, Simon] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	Fudan University; Shanghai University of Finance & Economics; University of Sydney	Zheng, PP (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	zpinpin@shmu.edu.cn	Chapman, Simon/D-4114-2009		Shanghai Public Health Personnel Training Program [GWHW201203]	Shanghai Public Health Personnel Training Program	This study was partly supported by Shanghai Public Health Personnel Training Program (GWHW201203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2008, GUID IMPL ART 13 WHO; Chen M, NEW IDEA MARKETING S; China Internet labrary and Center for Internet and Society of Zhejiang University, RES REP CHIN WEIB DE; China Internet Network Information Center, 32 CHIN INT DEV STAT; Deng Q, ANAL TOBACCO WEIBO D; Feng W, WEIBO AROUSED ATTENT; Freeman B, 2009, TOB CONTROL, V18, P212, DOI 10.1136/tc.2008.027375; Freeman B, 2012, TOB CONTROL, V21, P139, DOI 10.1136/tobaccocontrol-2011-050193; Freeman B, 2010, TOB CONTROL, V19, pE1, DOI 10.1136/tc.2009.032847; He P, 2013, ENVIRON HEALTH PREV, V18, P85, DOI 10.1007/s12199-012-0288-4; Hefler M, 2013, TOB CONTROL, V22, P210, DOI 10.1136/tobaccocontrol-2012-050721; Henriksen L, 2012, TOB CONTROL, V21, P147, DOI 10.1136/tobaccocontrol-2011-050416; Penney K, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-17; Perez DA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-429; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rweibo Li J., RWEIBO PROVIDES INTE; Storey John, 2006, CULTURAL THEORY AND, P5; Wackowski OA, 2011, TOB CONTROL, V20, pE1, DOI 10.1136/tc.2010.037911; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Yang G, 2010, TOBACCO CONTROL FUTU; Zheng PP, 2014, TOB CONTROL, V23, P389, DOI 10.1136/tobaccocontrol-2012-050661	21	11	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99336	10.1371/journal.pone.0099336	http://dx.doi.org/10.1371/journal.pone.0099336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914739	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700085
J	Karbanova, J; Laco, J; Marzesco, AM; Janich, P; Vobornikova, M; Mokry, J; Fargeas, CA; Huttner, WB; Corbeil, D				Karbanova, Jana; Laco, Jan; Marzesco, Anne-Marie; Janich, Peggy; Vobornikova, Magda; Mokry, Jaroslav; Fargeas, Christine A.; Huttner, Wieland B.; Corbeil, Denis			Human PROMININ-1 (CD133) Is Detected in Both Neoplastic and Non-Neoplastic Salivary Gland Diseases and Released into Saliva in a Ubiquitinated Form	PLOS ONE			English	Article							STEM-CELL MARKER; CARCINOEMBRYONIC ANTIGEN CEA; APICAL PLASMA-MEMBRANE; BREAST-CANCER PATIENTS; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; HEMATOPOIETIC STEM; COLORECTAL-CANCER; PROGENITOR CELLS; MUCINS MUC1	Prominin-1 (CD133) is physiologically expressed at the apical membranes of secretory (serous and mucous) and duct cells of major salivary glands. We investigated its expression in various human salivary gland lesions using two distinct antiprominin- 1 monoclonal antibodies (80B258 and AC133) applied on paraffin-embedded sections and characterized its occurrence in saliva. The 80B258 epitope was extensively expressed in adenoid cystic carcinoma, in lesser extent in acinic cell carcinoma and pleomorphic adenoma, and rarely in mucoepidermoid carcinoma. The 80B258 immunoreactivity was predominately detected at the apical membrane of tumor cells showing acinar or intercalated duct cell differentiation, which lined duct-or cyst-like structures, and in luminal secretions. It was observed on the whole cell membrane in nonluminal structures present in the vicinity of thin-walled blood vessels and hemorrhagic areas in adenoid cystic carcinoma. Of note, AC133 labeled only a subset of 80B258-positive structures. In peritumoral salivary gland tissues as well as in obstructive sialadenitis, an up-regulation of prominin-1 (both 80B258 and AC133 immunoreactivities) was observed in intercalated duct cells. In most tissues, prominin-1 was partially co-expressed with two cancer markers: carcinoembryonic antigen (CEA) and mucin-1 (MUC1). Differential centrifugation of saliva followed by immunoblotting indicated that all three markers were released in association with small membrane vesicles. Immuno-isolated prominin-1-positive vesicles contained CEA and MUC1, but also exosome-related proteins CD63, flotillin-1, flotillin-2 and the adaptor protein syntenin-1. The latter protein was shown to interact with prominin-1 as demonstrated by its co-immunoisolation. A fraction of salivaassociated prominin-1 appeared to be ubiquitinated. Collectively, our findings bring new insights into the biochemistry and trafficking of prominin-1 as well as its immunohistochemical profile in certain types of salivary gland tumors and inflammatory diseases.	[Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Corbeil, Denis] Tech Univ Dresden, BIOTEC, Tissue Engn Labs, D-01062 Dresden, Germany; [Karbanova, Jana; Vobornikova, Magda; Mokry, Jaroslav] Charles Univ Prague, Fac Med, Dept Histol & Embryol, Prague, Czech Republic; [Karbanova, Jana; Laco, Jan; Vobornikova, Magda; Mokry, Jaroslav] Univ Hosp Hradec Kralove, Prague, Czech Republic; [Laco, Jan] Charles Univ Prague, Fac Med, Fingerland Dept Pathol, Prague, Czech Republic; [Marzesco, Anne-Marie; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; Max Planck Society	Karbanova, J (corresponding author), Tech Univ Dresden, BIOTEC, Tissue Engn Labs, D-01062 Dresden, Germany.	jana.karbanova@biotec.tu-dresden.de; corbeil@biotec.tu-dresden.de	Corbeil, Denis/AFL-1008-2022; Laco, Jan/L-9715-2017; Corbeil, Denis/A-6519-2010; Mokry, Jaroslav/B-5088-2017; Huttner, Wieland B./P-4080-2018; Corbeil, Denis/L-2340-2019	Laco, Jan/0000-0002-9602-7501; Mokry, Jaroslav/0000-0001-5769-9973; Corbeil, Denis/0000-0003-1181-3659; Karbanova, Jana/0000-0001-7687-0983; Janich, Peggy/0000-0003-1045-7365	Grant Agency of the Czech Republic [GACR 304/07/P307]; PRVOUK [P37/11, P37/6]; Deutsche Forschungsgemeinschaft [SFB655 A2, TRR83 TP6, SFB 655 B3, CO298/5-1]; Sachsisches Staatsministerium fur Wissenschaft und Kunst;  [LM2010004]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); PRVOUK; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sachsisches Staatsministerium fur Wissenschaft und Kunst; 	JK was supported by Grant Agency of the Czech Republic (GACR 304/07/P307). JL was supported by the programme PRVOUK P37/11 and the project LM2010004. JM and MV were supported by the programme PRVOUK P37/6. WBH was supported by Deutsche Forschungsgemeinschaft (SFB655 A2; TRR83 TP6) and DC (SFB 655 B3; TRR83 TP6; CO298/5-1). Sachsisches Staatsministerium fur Wissenschaft und Kunst supported JK, CAF and DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Hosseini F, 2009, MED ORAL PATOL ORAL, V14, pE521; Al Dhaybi R, 2010, MODERN PATHOL, V23, P376, DOI 10.1038/modpathol.2009.163; Alos L, 2005, AM J SURG PATHOL, V29, P806, DOI 10.1097/01.pas.0000155856.84553.c9; Angelov Angel, 1996, General and Diagnostic Pathology, V141, P229; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARANOV V, 1994, CANCER RES, V54, P3305; Barnes L., 2005, WHO CLASSIFICATION T; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Berckmans RJ, 2011, BLOOD, V117, P3172, DOI 10.1182/blood-2010-06-290460; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Bon GG, 1997, CLIN CHEM, V43, P585; BOSHELL M, 1992, BIOCHEM BIOPH RES CO, V185, P1, DOI 10.1016/S0006-291X(05)80946-5; Brooks MN, 2008, MOL MED REP, V1, P375; CASELITZ J, 1981, VIRCHOWS ARCH A, V394, P49, DOI 10.1007/BF00431664; CASELITZ J, 1981, J CANCER RES CLIN, V100, P205, DOI 10.1007/BF00403366; Chen KH, 2010, CHILD NERV SYST, V26, P1605, DOI 10.1007/s00381-010-1190-2; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2014, P NATL ACAD SCI USA, V111, pE1451, DOI 10.1073/pnas.1400195111; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Dai SM, 2005, CLIN CANCER RES, V11, P7554, DOI 10.1158/1078-0432.CCR-05-0810; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Ellis GLA., 2008, AFIP ATLAS TUMOR PAT, P301; Fan LN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-320; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Fargeas CA, 2013, ADV EXP MED BIOL, V777, P25, DOI 10.1007/978-1-4614-5894-4_2; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hamada T, 2004, J CLIN PATHOL, V57, P813, DOI 10.1136/jcp.2003.014043; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Handra-Luca A, 2005, AM J SURG PATHOL, V29, P881, DOI 10.1097/01.pas.0000159103.95360.e8; HAYES DF, 1985, J CLIN INVEST, V75, P1671, DOI 10.1172/JCI111875; He H, 2009, J CANCER RES CLIN, V135, P1315, DOI 10.1007/s00432-009-0572-x; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Huttner HB, 2012, EPILEPSY RES, V99, P101, DOI 10.1016/j.eplepsyres.2011.10.029; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Jaszai J, 2007, HISTOCHEM CELL BIOL, V128, P409, DOI 10.1007/s00418-007-0334-2; Julian J, 2002, BIOCHEM BIOPH RES CO, V293, P1183, DOI 10.1016/S0006-291X(02)00352-2; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Kojima M, 2008, CANCER SCI, V99, P1578, DOI 10.1111/j.1349-7006.2008.00849.x; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Liu B, 2002, J HISTOCHEM CYTOCHEM, V50, P811, DOI 10.1177/002215540205000607; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lonnroth C, 2012, INT J ONCOL, V41, P15, DOI 10.3892/ijo.2012.1460; Ma HI, 2011, J NEUROSURG, V114, P651, DOI 10.3171/2009.11.JNS091396; Mahomed F, 2011, ORAL ONCOL, V47, P797, DOI 10.1016/j.oraloncology.2011.06.008; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Mall AS, 2008, J CLIN PATHOL, V61, P1018, DOI 10.1136/jcp.2008.058057; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Marzesco AM, 2013, ADV EXP MED BIOL, V777, P41, DOI 10.1007/978-1-4614-5894-4_3; Marzesco AM, 2009, FEBS LETT, V583, P897, DOI 10.1016/j.febslet.2009.01.048; Missol-Kolka E, 2011, PROSTATE, V71, P254, DOI 10.1002/pros.21239; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; Okumura F, 2011, MOL CELL BIOCHEM, V352, P163, DOI 10.1007/s11010-011-0750-4; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; Rajesh S, 2011, J BIOL CHEM, V286, P39606, DOI 10.1074/jbc.M111.262402; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; SEKINE H, 1985, J CLIN ONCOL, V3, P1355, DOI 10.1200/JCO.1985.3.10.1355; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Soares AB, 2011, HISTOPATHOLOGY, V58, P377, DOI 10.1111/j.1365-2559.2011.03758.x; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Streckfus C, 2000, CANCER INVEST, V18, P101, DOI 10.3109/07357900009038240; Sussman LK, 2003, CANCER BIOL THER, V2, P255, DOI 10.4161/cbt.2.3.363; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VERSTIJNEN CPHJ, 1986, ANTICANCER RES, V6, P97; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang K, 1996, J CELL BIOCHEM, V60, P538, DOI 10.1002/(SICI)1097-4644(19960315)60:4<538::AID-JCB10>3.3.CO;2-A	94	23	24	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98927	10.1371/journal.pone.0098927	http://dx.doi.org/10.1371/journal.pone.0098927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911657	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600026
J	Knapp, JM; Aranda, G; Medina, A; Lutcavage, M				Knapp, Jessica M.; Aranda, Guillermo; Medina, Antonio; Lutcavage, Molly			Comparative Assessment of the Reproductive Status of Female Atlantic Bluefin Tuna from the Gulf of Mexico and the Mediterranean Sea	PLOS ONE			English	Article							THUNNUS-THYNNUS L.; MERLUCCIUS-MERLUCCIUS L.; POPULATION-STRUCTURE; THERMAL BIOLOGY; QUANTIFICATION; FECUNDITY; GROWTH; FISH; SIZE; MATURATION	Despite attention focused on the population status and rebuilding trajectory of Atlantic bluefin tuna (Thunnus thynnus), the reproduction and spawning biology remains poorly understood, especially in the NW Atlantic. At present, the eastern and western spawning populations are believed to exhibit different reproductive characteristics and, consequently, stock productivity. However, our study suggests that the two spawning populations, the Gulf of Mexico and the Mediterranean Sea, could show similar reproductive features and spawning strategies. Between 2007 and 2009, gonad samples from female Atlantic bluefin tuna were collected in the northern Gulf of Mexico (n = 147) and in the western Mediterranean Sea (n = 40). The histological and stereological analysis confirmed that sampled eastern and western bluefin tuna exhibit the same spawning duration (three months) but the spawning in the Gulf of Mexico begins one month earlier than in the Mediterranean Sea. Western bluefin tuna caught in the peak of the spawning season (May) showed a similar spawning frequency (60%) to the spawning peak observed in the Mediterranean Sea (June). Fecundity for the Gulf of Mexico fish (28.14 eggs: g(-1)) was lower but not significantly different than for fish sampled in the Mediterranean Sea (45: 56 eggs: g{1). Our study represents the first comparative histological analysis of the eastern and western spawning stocks whose findings, combined with new determinations of size/age at maturity and possible alternative spawning areas, might suggest basic life history attributes warrant further scientific and management attention.	[Knapp, Jessica M.; Lutcavage, Molly] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Aranda, Guillermo; Medina, Antonio] Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Campus Excelencia Int Mar CEI MAR, Cadiz, Spain; [Knapp, Jessica M.; Lutcavage, Molly] Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA	University System Of New Hampshire; University of New Hampshire; Universidad de Cadiz; University of Massachusetts System; University of Massachusetts Amherst	Knapp, JM (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	jessieknapp@gmail.com	Medina, Antonio/A-1624-2008; Aranda, Guillermo/X-7556-2018	Medina, Antonio/0000-0001-5609-3574; Aranda, Guillermo/0000-0002-9650-0856	NOAA [NA16FM2840]; Spanish Ministry of Science and Innovation [CTM2011-29525-C04-01]	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by NOAA grant # NA16FM2840 to M. Lutcavage and grant # CTM2011-29525-C04-01 from the Spanish Ministry of Science and Innovation to A. Medina. This is CEIMAR contribution # 39. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon L, 2010, J FISH BIOL, V77, P719, DOI 10.1111/j.1095-8649.2010.02713.x; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Aranda G, 2011, AQUACULTURE, V317, P255, DOI 10.1016/j.aquaculture.2011.04.030; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Baglin RE, 1976, ICCAT COL VOL SCI PA, V5, P279; Berkovich N, 2013, GEN COMP ENDOCR, V194, P10, DOI 10.1016/j.ygcen.2013.08.005; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Clay D, 1991, WORLD M STOCK ASS BL, P91; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Coward K, 2002, AQUAT LIVING RESOUR, V15, P259, DOI 10.1016/S0990-7440(02)01177-4; Davis TLO, 2001, FISH B-NOAA, V99, P381; Diaz GA, 2011, INT COMMISSION CONSE, V66.; Diaz Guillermo A., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V60, P1160; Dickhut RM, 2009, ENVIRON SCI TECHNOL, V43, P8522, DOI 10.1021/es901810e; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goldstein J, 2007, MAR BIOL, V151, P2063, DOI 10.1007/s00227-007-0638-8; Golet WJ, 2007, FISH B-NOAA, V105, P390; GUTIERREZ M, 1967, INVEST PESQ, V31, P265; Heinisch G, 2013, SEXUAL MATURIT UNPUB; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Itoh T, 2006, FISHERIES SCI, V72, P53, DOI 10.1111/j.1444-2906.2006.01116.x; Kjesbu OS, 2010, FISH RES, V104, P8, DOI 10.1016/j.fishres.2010.03.013; Kjesbu OS, 1998, J SEA RES, V40, P303, DOI 10.1016/S1385-1101(98)00029-X; Lutcavage M, 2012, PREDICTING POT UNPUB; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather FJ, 1995, NMFSSEFSC370 NOAA; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; Muhling BA, 2011, B MAR SCI, V87, P687, DOI 10.5343/bms.2010.1101; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Murua H, 2006, J FISH BIOL, V69, P1288, DOI 10.1111/j.1095-8649.2006.01169.x; Murua H, 1998, CAL COOP OCEAN FISH, V39, P196; Neville WC, 1942, TUNE FISHERY LONG IS; Paul Stacey D., 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1170; Pujolar JM, 2003, MAR BIOL, V143, P613, DOI 10.1007/s00227-003-1080-1; Rasband W., 2006, IMAGEJ; Restrepo VR, 2010, AQUAT LIVING RESOUR, V23, P335, DOI 10.1051/alr/2011004; Richards WJ, 1976, COL VOL SCI PAP ICCA, V5, P267; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; Rivas L. R., 1954, Bulletin of Marine Science of the Gulf and Caribbean, V4, P302; RODRIGUEZRODA J, 1967, INVEST PESQ, V31, P33; Rooker JR, 2008, MARINE ECOLOGY PROGR, V368; Rosenfeld H, 2012, GEN COMP ENDOCR, V175, P55, DOI 10.1016/j.ygcen.2011.09.013; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Sokal RR, 1998, BIOMETRY PRINCIPLES; Stauffer G, 1981, 1980 1981 EGG PRODUC; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; Wilson PC, 1967, INVENTORY US EXPLORA; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Witthames PR, 1995, NETH J SEA RES, V34, P45, DOI 10.1016/0077-7579(95)90013-6	61	30	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98233	10.1371/journal.pone.0098233	http://dx.doi.org/10.1371/journal.pone.0098233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911973	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600129
J	Long, R; Niruban, S; Heffernan, C; Cooper, R; Fisher, D; Ahmed, R; Egedahl, ML; Fur, R				Long, Richard; Niruban, Selvanayagam; Heffernan, Courtney; Cooper, Ryan; Fisher, Dina; Ahmed, Rabia; Egedahl, Mary Lou; Fur, Rhonda			A 10-Year Population Based Study of 'Opt-Out' HIV Testing of Tuberculosis Patients in Alberta, Canada: National Implications	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SAN-FRANCISCO; INFECTION; RECOMMENDATIONS; TRANSMISSION; COINFECTION; EXPERIENCES; INITIATION; SUPPORT; CARE	Introduction: Compliance with the recommendation that all tuberculosis (TB) patients be tested for human immunodeficiency virus (HIV) has not yet been achieved in Canada or globally. Methods:The experience of "opt-out" HIV testing of TB patients in the Province of Alberta, Canada is described over a 10-year period, 2003-2012. Testing rates are reported before and after the introduction of the "opt-out" approach. Risk factors for HIV seropositivity are described and demographic, clinical and laboratory characteristics of TB patients who were newly diagnosed versus previously diagnosed with HIV are compared. Genotypic clusters, defined as groups of two or more cases whose isolates of Mycobacterium tuberculosis had identical DNA fingerprints over the 10-year period or within 2 years of one another, were analyzed for their ability to predict HIV co-infection. Results: HIV testing rates were 26% before and 90% after the introduction of "opt-out" testing. During the "opt-out" testing years those <15 or >64 years of age at diagnosis were less likely to have been tested. In those tested the prevalence of HIV was 5.6%. In the age group 15-64 years, risk factors for HIV were: age (35-64 years), Canadian-born Aboriginal or foreign-born sub-Saharan African origin, and combined respiratory and non-respiratory disease. Compared to TB patients previously known to be HIV positive, TB patients newly discovered to be HIV positive had more advanced HIV disease (lower CD4 counts; higher viral loads) at diagnosis. Large duster size was associated with Aboriginal ancestry. Cluster size predicted HIV co-infection in Aboriginal peoples when clusters included all cases reported over 10 years but not when clusters included cases reported within 2 years of one another. Conclusion: "Opt-out" HIV testing of TB patients is effective and well received. Universal HIV testing of TB patients (>80% of patients tested) has immediate (patients) and longer-term (TB/HIV program planning) benefits.	[Long, Richard; Heffernan, Courtney; Cooper, Ryan; Ahmed, Rabia; Egedahl, Mary Lou] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Long, Richard; Niruban, Selvanayagam] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Fisher, Dina] Univ Calgary, Dept Med, Calgary, AB, Canada; [Fur, Rhonda] Alberta Hlth Serv, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Calgary; Alberta Health Services (AHS)	Long, R (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016					Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; [Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2013, ANN INTERN MED; [Anonymous], 2010, POL COLL TB HIV ACT; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Canadian Thoracic Society Tuberculosis Directors of Canada Department of National Health and Welfare in consultation with the provincial and territorial epidemiologists AIDS coordinators and HIV caregivers, 1992, CCDR, V18, P155; Centers for Disease Control, 1994, MMWR-MORBID MORTAL W, V50, P1; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P236; Centers for Disease Control (CDC), 1989, MMWR-MORBID MORTAL W, V38, P243; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Gardner A, 2012, INT J TUBERC LUNG D, V16, P1241, DOI 10.5588/ijtld.11.0628; Giordano TP, 2004, CLIN INFECT DIS, V38, P10, DOI 10.1086/380454; Horsburgh CR, 2000, CLIN INFECT DIS, V31, P633, DOI 10.1086/314007; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Jayaraman GC, 2003, CAN MED ASSOC J, V168, P679; Jensen M, 2012, INT J TUBERC LUNG D, V16, P43, DOI 10.5588/ijtld.11.0374; Kunimoto D, 2004, INT J TUBERC LUNG D, V8, P1213; Langlois-Klassen D, 2013, PLOS ONE, V7, DOI [10.1371/journal.pone.ee38431, DOI 10.1371/JOURNAL.PONE.EE38431]; Langlois-Klassen D, 2013, EMERG INFECT DIS, V19, P701, DOI 10.3201/eid1905.121578; Long R, 2013, CAN MED ASSOC J, V185, P587, DOI 10.1503/cmaj.113-2113; Long R, 2010, CAN J PUBLIC HEALTH, V101, P202, DOI 10.1007/BF03404374; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Menzies D, 2013, CAN RESPIR J SA, V20, p1A; Mohtashemi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008851; Person AK, 2010, AIDS PATIENT CARE ST, V24, P539, DOI 10.1089/apc.2010.0102; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Pope DS, 2010, AIDS CARE, V22, P238, DOI 10.1080/09540120903040594; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Shah S., 2010, Morbidity and Mortality Weekly Report, V59, P1509; Staples CT, 1999, CLIN INFECT DIS, V29, P150, DOI 10.1086/520144; Sturtevant D, 2009, CAN J PUBLIC HEALTH, V100, P116, DOI 10.1007/BF03405519; The Canadian Tuberculosis Committee of the Centre for Infectious Disease Prevention and Control Population and Public Health Branch Health Canada, 2002, CCDR, V28, P1; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WHO, 2009, GLOB TUB CONTR 2009; Word Health Organization, GLOB TUB REP 2012; World Health Organization, 2012, 20121 WHO HTM TB; Zencovich M, 2006, INT J STD AIDS, V17, P813, DOI 10.1258/095646206779307469	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98993	10.1371/journal.pone.0098993	http://dx.doi.org/10.1371/journal.pone.0098993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911262	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600033
J	Zhang, YH; Wu, YC; Zhang, Q; Su, DD; Zou, FS				Zhang, Yanhua; Wu, Yuchun; Zhang, Qiang; Su, Dongdong; Zou, Fasheng			Prevalence Patterns of Avian Plasmodium and Haemoproteus Parasites and the Influence of Host Relative Abundance in Southern China	PLOS ONE			English	Article							BLOOD PARASITES; MALARIA PARASITES; EVOLUTIONARY RELATIONSHIPS; HAEMOSPORIDIAN PARASITES; MIST NETS; DIVERSITY; BIRDS; ASSEMBLAGES; INFECTION; PHYLOGENY	Infectious diseases threaten the health and survival of wildlife populations. Consequently, relationships between host diversity, host abundance, and parasite infection are important aspects of disease ecology and conservation research. Here, we report on the prevalence patterns of avian Plasmodium and Haemoproteus infections and host relative abundance influence based on sampling 728 wild-caught birds representing 124 species at seven geographically widespread sites in southern China. The overall prevalence of two haemoprotozoan parasites, Plasmodium and Haemoproteus, was 29.5%, with 22.0% attributable to Haemoproteus and 7.8% to Plasmodium. Haemoproteus prevalence differed significantly among different avian host families, with the highest prevalence in Nectariniidae, Pycnonotidae and Muscicapidae, whereas Plasmodium prevalence varied significantly among host species. Seventy-nine mitochondrial lineages including 25 from Plasmodium and 54 from Haemoproteus were identified, 80% of which were described here for the first time. The phylogenetic relationships among these parasites indicated stronger host-species specificity for Haemoproteus than Plasmodium. Well-supported host-family (Timaliidae) specific clades were found in both Plasmodium and Haemoproteus. The Haemoproteus tree shows regional subclades, whereas the Plasmodium clades are "scattered'' among different geographical regions. Interestingly, there were statistically significant variations in the prevalence of Plasmodium and Haemoproteus among the geographical regions. Furthermore, the prevalence of Plasmodium and Haemoproteus were not significantly correlated with host relative abundance. Further efforts will focus on exploring the relationships between parasite prevalence and sex, age, and immune defense of the host.	[Zhang, Yanhua] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhang, Yanhua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Yuchun; Zhang, Qiang; Su, Dongdong; Zou, Fasheng] Guangdong Entomol Inst, South China Inst Endangered Anim, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zou, FS (corresponding author), Guangdong Entomol Inst, South China Inst Endangered Anim, Guangzhou, Guangdong, Peoples R China.	zoufs@gdei.gd.cn			National Natural Science Foundation of China [31172067, 31200327, 31201709]; Guangdong Natural Science Foundation [S2013010012976]; Wildlife survey in Nanling National Nature Reserve [RYCG12-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Wildlife survey in Nanling National Nature Reserve	This study was funded by National Natural Science Foundation of China (31172067, 31200327, 31201709), Guangdong Natural Science Foundation (S2013010012976) and Wildlife survey in Nanling National Nature Reserve (RYCG12-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Belo NO, 2012, PARASITOLOGY, V139, P1021, DOI 10.1017/S003118201200039X; BENNETT GF, 1993, SYST PARASITOL, V26, P171, DOI 10.1007/BF00009724; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; Brown CR, 2001, P ROY SOC B-BIOL SCI, V268, P1833, DOI 10.1098/rspb.2001.1749; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Cibois A, 2003, AUK, V120, P35, DOI 10.1642/0004-8038(2003)120[0035:MDPOBT]2.0.CO;2; Cornuault J, 2012, MOL ECOL, V21, P1438, DOI 10.1111/j.1365-294X.2012.05483.x; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dunn Erica H., 2004, Studies in Avian Biology, P1; Durrant KL, 2006, ORNITHOL MONOGR, P98; Fredensborg BL, 2006, MAR BIOL, V149, P275, DOI 10.1007/s00227-005-0184-1; Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2; Garamszegi LZ, 2006, ECOL LETT, V9, P933, DOI 10.1111/j.1461-0248.2006.00936.x; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Hellgren O, 2005, J ORNITHOL, V146, P55, DOI 10.1007/s10336-004-0055-4; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03227.x; Hellgren O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-381; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Jenkins T, 2012, EVOLUTION, V66, P740, DOI 10.1111/j.1558-5646.2011.01470.x; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Karr J.R., 1981, Studies in Avian Biology, P62; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kimura M, 2006, J PARASITOL, V92, P1043, DOI 10.1645/GE-639R.1; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Loiseau C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01126; Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; MACARTHUR RH, 1974, P NATL ACAD SCI USA, V71, P3230, DOI 10.1073/pnas.71.8.3230; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Perez-Tris J, 2005, PARASITOLOGY, V131, P15, DOI 10.1017/S003118200500733X; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Silva-Iturriza A, 2012, PARASITOL INT, V61, P650, DOI 10.1016/j.parint.2012.07.003; Slater LB, 2005, B HIST MED, V79, P261, DOI 10.1353/bhm.2005.0092; Srinivasan U, 2013, J APPL ECOL, V50, P920, DOI 10.1111/1365-2664.12123; Svensson-Coelho M, 2013, OMITHOLOGICAL MONOGR, V76, P1, DOI [10.1525/om.2013.76.1.1, DOI 10.1525/OM.2013.76.1.1]; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Tomas G, 2007, FUNCT ECOL, V21, P125, DOI 10.1111/j.1365-2435.2006.01214.x; Tracy CR, 2006, INTEGR COMP BIOL, V46, P1191, DOI 10.1093/icb/icl054; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2004, J WILDLIFE DIS, V40, P555, DOI 10.7589/0090-3558-40.3.555; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Zhang Qiang, 2010, Acta Zootaxonomica Sinica, V35, P135; Zou FS, 2012, ZOOL STUD, V51, P362	68	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99501	10.1371/journal.pone.0099501	http://dx.doi.org/10.1371/journal.pone.0099501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911323	Green Submitted, gold, Green Published			2022-12-27	WOS:000337165600094
J	Gumuscu, B; Erdogan, Z; Guler, MO; Tekinay, T				Gumuscu, Burcu; Erdogan, Zeynep; Guler, Mustafa O.; Tekinay, Turgay			Highly Sensitive Determination of 2,4,6-Trinitrotoluene and Related Byproducts Using a Diol Functionalized Column for High Performance Liquid Chromatography	PLOS ONE			English	Article							SELECTIVE SPECTROPHOTOMETRIC DETERMINATION; EPA METHOD 8330; COMPLETE SEPARATION; EXPLOSIVES; IDENTIFICATION; DEGRADATION; METABOLITES; VALIDATION; WATERS; ARRAY	In this work a new detection method for complete separation of 2,4,6-trinitrotoluene (TNT); 2,4-dinitrotoluene (2,4-DNT); 2,6-dinitrotoluene (2,6-DNT); 2-aminodinitrotoluene (2-ADNT) and 4-aminodinitrotoluene (4-ADNT) molecules in high-performance liquid-chromatography (HPLC) with UV sensor has been developed using dial column. This approach improves on cost, time, and sensitivity over the existing methods, providing a simple and effective alternative. Total analysis time was less than 13 minutes including column re-equilibration between runs, in which water and acetonitrile were used as gradient elution solvents. Under optimized conditions, the minimum resolution between 2,4-DNT and 2,6-DNT peaks was 2.06. The recovery rates for spiked environmental samples were between 95-98%. The detection limits for diol column ranged from 0.78 to 1.17 mu g/L for TNT and its byproducts. While the solvent consumption was 26.4 mL/min for two-phase EPA and 30 mL/min for EPA 8330 methods, it was only 8.8 mL/min for dial column. The resolution was improved up to 49% respect to two-phase EPA and EPA 8330 methods. When compared to C-18 and phenyl-3 columns, solvent usage was reduced up to 64% using diol column and resolution was enhanced approximately two-fold. The sensitivity of diol column was afforded by the hydroxyl groups on polyol layer, joining the formation of charge-transfer complexes with nitroaromatic compounds according to acceptor-donor interactions. Having compliance with current requirements, the proposed method demonstrates sensitive and robust separation.	[Gumuscu, Burcu; Erdogan, Zeynep; Guler, Mustafa O.; Tekinay, Turgay] Bilkent Univ, Inst Mat Sci & Nanotechnol, UNAM, Ankara, Turkey; [Gumuscu, Burcu] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tekinay, Turgay] Gazi Univ, Life Sci Applicat & Res Ctr, Ankara, Turkey; [Tekinay, Turgay] Gazi Univ, Fac Med, Dept Med Biol & Genet, Ankara, Turkey	Ihsan Dogramaci Bilkent University; University of Twente; Gazi University; Gazi University	Tekinay, T (corresponding author), Bilkent Univ, Inst Mat Sci & Nanotechnol, UNAM, Ankara, Turkey.	ttekinay@gazi.edu.tr	Guler, Mustafa/C-9453-2011; Gumuscu, Burcu/Q-6602-2018	Guler, Mustafa/0000-0003-1168-202X; Gumuscu, Burcu/0000-0003-4843-4724	Republic of Turkey, Ministry of Science Industry and Technology [STZ-00480-2009-2]	Republic of Turkey, Ministry of Science Industry and Technology(Ministry of Science, Industry & Technology - Turkey)	This work is supported by the Republic of Turkey, Ministry of Science Industry and Technology under the Project No. STZ-00480-2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FQ, 2009, J HAZARD MATER, V166, P757, DOI 10.1016/j.jhazmat.2008.11.116; Batlle R, 2002, J CHROMATOGR A, V963, P73, DOI 10.1016/S0021-9673(02)00136-X; Becanova J, 2010, INT J MASS SPECTROM, V291, P133, DOI 10.1016/j.ijms.2010.01.016; Borch T, 2004, J CHROMATOGR A, V1022, P83, DOI 10.1016/j.chroma.2003.09.067; Cenas N, 2001, BBA-GEN SUBJECTS, V1528, P31, DOI 10.1016/S0304-4165(01)00169-6; Craig HD, 2011, MAR TECHNOL SOC J, V45, P35, DOI 10.4031/MTSJ.45.6.10; DWIVEDY AK, 1967, J CHROMATOGR, V29, P120, DOI 10.1016/S0021-9673(00)92636-0; Environmental Protection Agency, 1989, HLTH ADV TNT CRIT ST; EPA, 2006, 8330 EPA; Esteve-Nunez A, 2001, MICROBIOL MOL BIOL R, V65, P335, DOI 10.1128/MMBR.65.3.335-352.2001; Gaurav, 2009, J HAZARD MATER, V172, P1652, DOI 10.1016/j.jhazmat.2009.08.039; Gumuscu B, 2013, INT BIODETER BIODEGR, V85, P35, DOI 10.1016/j.ibiod.2013.06.007; Holmgren E, 2012, J CHROM A, V1222, P109; ICH harmonised tripartite guidelines, 2005, ICH VAL AN PROC METH; Jiang Y, 2008, ANGEW CHEM, V120, P8663; Knackmuss HJ, 1996, BASIC KNOWLEDGE PERS, P1; Lang MJ, 1999, J CHROMATOGR A, V849, P381, DOI 10.1016/S0021-9673(99)00591-9; Lima Debora R. S., 2011, Reviews on Environmental Health, V26, P101, DOI 10.1515/REVEH.2011.014; Maeda T, 2006, J CHROMATOGR SCI, V44, P96, DOI 10.1093/chromsci/44.2.96; Monteil-Rivera F, 2004, J CHROMATOGR A, V1048, P213, DOI 10.1016/j.chroma.2004.07.054; Ozokwelu ED, 1997, KIRK OTHMER ENCY CHE; Preiss A, 2009, J CHROMATOGR A, V1216, P4968, DOI 10.1016/j.chroma.2009.04.055; Rahimi-Nasrabadi M, 2012, MICROCHIM ACTA, V177, P145, DOI 10.1007/s00604-012-0762-0; Schmidt AC, 2006, CHROMATOGRAPHIA, V63, P1, DOI 10.1365/s10337-005-0703-8; Shabir GA, 2003, J CHROMATOGR A, V987, P57, DOI 10.1016/S0021-9673(02)01536-4; Spain J.C., 2000, BIODEGRADATION NITRO; Sunahara GI, 2010, ECOTOXICOLOGY EXPLOS; Uzer A, 2004, ANAL CHIM ACTA, V505, P83, DOI 10.1016/S0003-2670(03)00674-3; Uzer AE, 2005, ANAL CHIM ACTA, V534, P307, DOI 10.1016/j.aca.2004.11.045; Vijayakumar C, 2010, CHEM COMMUN, V46, P874, DOI 10.1039/b921520d; Xu XM, 2014, SCI JUSTICE, V54, P3, DOI 10.1016/j.scijus.2013.08.003; YANG NC, 1964, J AM CHEM SOC, V86, P5022, DOI 10.1021/ja01076a070; Yildiz A, 1997, ENSTRUMENTAL ANALIZ	33	13	13	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99230	10.1371/journal.pone.0099230	http://dx.doi.org/10.1371/journal.pone.0099230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905826	Green Published, gold			2022-12-27	WOS:000341869000112
J	Skaaby, T; Husemoen, LLN; Jorgensen, T; Johansen, JD; Menne, T; Szecsi, PB; Stender, S; Bager, P; Thyssen, JP; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte N.; Jorgensen, Torben; Johansen, Jeanne D.; Menne, Torkil; Szecsi, Pal B.; Stender, Steen; Bager, Peter; Thyssen, Jacob P.; Linneberg, Allan			Associations of Filaggrin Gene Loss-of-Function Variants NE and Human Papillomavirus-Related Cancer and Pre-Cancer in Danish Adults	PLOS ONE			English	Article							ATOPIC-DERMATITIS; MUTATIONS; RISK; SKIN; SENSITIVITY; PROTEIN	Purpose: Filaggrin proteins are expressed in the skin, oral cavity, oesophagus, and cervical mucose. Loss-of-function mutations in the filaggrin gene (FLG) reduce filaggrin expression and cause an impaired skin barrier function. We hypothesized that FLG mutation carriers would be more susceptible to human papillomavirus (HPV) infection and thus a higher risk of HPV-related cancer and pre-cancer. We investigated the association of the FLG genotype with incidence of HPV-related cancer of cervix, vagina, vulva, penis, anus and head and neck, and pre-cancer of the cervix. Methods:W We included 13,376 persons from four population-based studies conducted in the same background population in Copenhagen, Denmark. Participants were genotyped for the most common FLG mutations in Europeans. Information on cancer was obtained from The Danish Cancer Registry until 11 July 2011. Results:There were 489 cases of prevalent and 97 cases of incident HPV-related cancer and pre-cancer (median follow-up 11.5 years). There was a statistically significant association between FLG genotype and incident HPV-related cancer and pre-cancer with a hazard ratio, HR =2.1 (95% confidence intervals, CI: 1.2, 3.7) for FLG mutation carriers vs. wild types. Conclusions: FLG loss-of-function mutations were associated with higher incidence of HPV-related cancers and pre-cancers that are potentially screening and vaccine preventable.	[Skaaby, Tea; Husemoen, Lise Lotte N.; Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Johansen, Jeanne D.; Menne, Torkil; Szecsi, Pal B.; Stender, Steen] Univ Copenhagen, Gentofte Hosp, Dept Clin Biochem, Hellerup, Denmark; [Bager, Peter] Natl Ctr Hlth Data & Dis Control, Dept Epidemiol Res, Copenhagen, Denmark; [Thyssen, Jacob P.] Univ Copenhagen, Gentofte Hosp, Natl Allergy Res Ctr, Dept Dermatoallergol, Hellerup, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018; Johansen, Jeanne/AAM-6382-2021; Thyssen, Jacob/ABD-8517-2020; Bager, Peter/R-3310-2019	Johansen, Jeanne/0000-0002-3537-8463; Bager, Peter/0000-0002-3577-8459; Szecsi, Pal/0000-0003-3446-0411; Skaaby, Tea/0000-0003-0031-5726; Jorgensen, Torben/0000-0001-9453-2830; Linneberg, Allan/0000-0002-0994-0184; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743				Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Carrillo-Infante C, 2007, INT J ONCOL, V30, P1521; CINTORINO M, 1988, ARCH GYNECOL OBSTET, V241, P235, DOI 10.1007/BF00931354; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Benedetto A, 2008, J INVEST DERMATOL, V128, P1594, DOI 10.1038/sj.jid.5701208; Ferlay J, 2013, IARC CANCERBASE; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gong JM, 2012, INT J GYNECOL CANCER, V22, P1564, DOI 10.1097/IGC.0b013e318272e7e7; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Husemoen LLN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084293; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; LARA C, 1994, ARCH GYNECOL OBSTET, V255, P73; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Meldgaard M, 2012, CLIN CHIM ACTA, V413, P1488, DOI 10.1016/j.cca.2012.06.014; Miajlovic H, 2010, J ALLERGY CLIN IMMUN, V126, P1184, DOI 10.1016/j.jaci.2010.09.015; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Skaaby S, 2011, INT J STD AIDS, V22, P214, DOI 10.1258/ijsa.2011.010372; Skaaby T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057647; Storm HH, 1997, DAN MED BULL, V44, P535; Thyssen JP, 2012, J ALLERGY CLIN IMMUN, V130, P1204, DOI 10.1016/j.jaci.2012.06.046; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; van Drongelen V, 2013, EXP DERMATOL, V22, P807, DOI 10.1111/exd.12271; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741	33	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99437	10.1371/journal.pone.0099437	http://dx.doi.org/10.1371/journal.pone.0099437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905740	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000122
J	Arends, S; Spoorenberg, A; Efde, M; Bos, R; Leijsma, MK; Bootsma, H; Veeger, NJGM; Brouwer, E; van der Veer, E				Arends, Suzanne; Spoorenberg, Anneke; Efde, Monique; Bos, Reinhard; Leijsma, Martha K.; Bootsma, Hendrika; Veeger, Nic J. G. M.; Brouwer, Elisabeth; van der Veer, Eveline			Higher Bone Turnover Is Related to Spinal Radiographic Damage and Low Bone Mineral Density in Ankylosing Spondylitis Patients with Active Disease: A Cross-Sectional Analysis	PLOS ONE			English	Article							ACTIVITY SCORE ASDAS; VERTEBRAL FRACTURES; BIOCHEMICAL MARKERS; BASE-LINE; PROGRESSION; SYNDESMOPHYTES; OSTEOPOROSIS; ASSOCIATION; CRITERIA; COHORT	Introduction: Ankylosing spondylitis (AS) is characterized by excessive bone formation and bone loss. Our aim was to investigate the association of bone turnover markers (BTM) with spinal radiographic damage and bone mineral density (BMD) in AS patients with active disease. Methods: 201 consecutive AS outpatients of the Groningen Leeuwarden AS (GLAS) cohort were included. Serum markers of bone resorption (C-telopeptides of type-I collagen, sCTX) and bone formation (procollagen type-I N-terminal peptide, PINP; bone-specific alkaline phosphatase, BALP) were measured. Z-scores were used to correct for the normal influence that age and gender have on bone turnover. Radiographs were scored by two independent readers according to modified Stoke AS Spinal Score (mSASSS). The presence of complete bridging (ankylosis of at least two vertebrae) was considered as measure of more advanced radiographic damage. Low BMD was defined as lumbar spine and/or hip BMD Z-score <= -1. Results: Of the 151 patients with complete data, 52 (34%) had >= 1 complete bridge, 49 (33%) had >= 1 syndesmophyte (nonbridging), and 50 (33%) had no syndesmophytes. 66 (44%) had low BMD. Patients with bridging had significantly higher sCTX and PINP Z-scores than patients without bridging (0.43 vs. -0.55 and 0.55 vs. 0.04, respectively). Patients with low BMD had significantly higher sCTX Z-score than patients with normal BMD (-0.08 vs. -0.61). After correcting for gender, symptom duration, and CRP, sCTX Z-score remained significantly related to the presence of low BMD alone (OR: 1.60), bridging alone (OR: 1.82), and bridging in combination with low BMD (OR: 2.26). Conclusions: This cross-sectional study in AS patients with active and relatively long-standing disease demonstrated that higher serum levels of sCTX, and to a lesser extent PINP, are associated with the presence of complete bridging. sCTX was also associated with low BMD. Longitudinal studies are needed to confirm that serum levels of sCTX can serve as objective marker for bone-related outcome in AS.	[Arends, Suzanne; Spoorenberg, Anneke; Leijsma, Martha K.; Bootsma, Hendrika; Veeger, Nic J. G. M.; Brouwer, Elisabeth; van der Veer, Eveline] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Arends, Suzanne; Efde, Monique; Bos, Reinhard] Med Ctr Leeuwarden, Leeuwarden, Netherlands	University of Groningen; Medical Center Leeuwarden	Arends, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	s.arends@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Bos, Reinhard/AAS-1726-2020; Arends, Suzanne/M-5436-2015; Veeger, Nic JGM/F-2966-2013; Brouwer, Elisabeth/A-3198-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Arends, Suzanne/0000-0002-4422-7640; Veeger, Nic JGM/0000-0002-1492-7937; Brouwer, Elisabeth/0000-0002-5652-4423; van der Veer, Eveline/0000-0002-4825-9981	Pfizer	Pfizer(Pfizer)	The GLAS cohort was supported by an unrestricted grant from Pfizer. Pfizer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes C, 1999, CLIN CHIM ACTA, V289, P99, DOI 10.1016/S0009-8981(99)00170-9; Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Arends S, 2011, OSTEOPOROSIS INT, V22, P1431, DOI 10.1007/s00198-010-1338-7; Arends S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3823; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Boonen A, 2009, J RHEUMATOL, V36, P1249, DOI 10.3899/jrheum.080831; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CALIN A, 1994, J RHEUMATOL, V21, P2281; El Maghraoui A, 2004, JOINT BONE SPINE, V71, P291, DOI 10.1016/j.jbspin.2003.06.002; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Geusens P, 2007, CURR OPIN RHEUMATOL, V19, P335, DOI 10.1097/BOR.0b013e328133f5b3; Ghozani I, 2009, BONE, V44, P772, DOI 10.1016/j.bone.2008.12.028; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Heiland GR, 2012, ANN RHEUM DIS, V71, P572, DOI 10.1136/annrheumdis-2011-200216; Karberg K, 2005, J RHEUMATOL, V32, P1290; Lange U, 2005, OSTEOPOROSIS INT, V16, P1999, DOI 10.1007/s00198-005-1990-5; Lee W, 2007, ANN RHEUM DIS, V66, P633, DOI 10.1136/ard.2006.060293; Lukas C, 2009, ANN RHEUM DIS, V68, P18, DOI 10.1136/ard.2008.094870; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Maksymowych WP, 2007, ARTHRITIS RHEUM-US, V56, P1846, DOI 10.1002/art.22589; Maksymowych WP, 2009, J RHEUMATOL, V36, P1785, DOI 10.3899/jrheum.090346; Mitra D, 1999, J RHEUMATOL, V26, P2201; Padi MC, 2008, YONSEI MED J, V49, P288, DOI 10.3349/ymj.2008.49.2.288; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Ramiro S, 2013, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-204055, DOI 10.1136/ANNRHEUMDIS-2013-20405]; Spoorenberg A, 2004, J RHEUMATOL, V31, P125; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vosse D, 2008, RHEUMATOLOGY, V47, P1219, DOI 10.1093/rheumatology/ken148; Vosse D, 2009, ANN RHEUM DIS, V68, P1839, DOI 10.1136/ard.2008.100503; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446	36	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99685	10.1371/journal.pone.0099685	http://dx.doi.org/10.1371/journal.pone.0099685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918782	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000103
J	Chen, JZ; Wang, JN; Zhu, WL				Chen, Jianzhong; Wang, Jinan; Zhu, Weiliang			Binding Modes of Three Inhibitors 8CA, F8A and I4A to A-FABP Studied Based on Molecular Dynamics Simulation	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SOLVATED INTERACTION ENERGY; BOUNDARY-ELEMENT METHOD; PARTICLE MESH EWALD; COMPUTATIONAL ANALYSIS; INSULIN-RESISTANCE; PK(A) VALUES; FORCE-FIELD; MM-PBSA; AP2	Adipocyte fatty-acid binding protein (A-FABP) is an important target of drug designs treating some diseases related to lipid-mediated biology. Molecular dynamics (MD) simulations coupled with solvated interaction energy method (SIE) were carried out to study the binding modes of three inhibitors 8CA, F8A and I4A to A-FABP. The rank of our predicted binding affinities is in accordance with experimental data. The results show that the substitution in the position 5 of N-benzyl and the seven-membered ring of N-benzyl-indole carboxylic acids strengthen the I4A binding, while the substitution in the position 2 of N-benzyl weakens the F8A binding. Computational alanine scanning and dynamics analyses were performed and the results suggest that the polar interactions of the positively charged residue R126 with the three inhibitors provide a significant contribution to inhibitor bindings. This polar interaction induces the disappearance of the correlated motion of the C terminus of A-FABP relative to the N terminus and favors the stability of the binding complex. This study is helpful for the rational design of potent inhibitors within the fields of metabolic disease, inflammation and atherosclerosis.	[Chen, Jianzhong] Shandong Jiaotong Univ, Sch Sci, Jinan, Peoples R China; [Wang, Jinan; Zhu, Weiliang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Discovery & Design Ctr, Shanghai, Peoples R China	Shandong Jiaotong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chen, JZ (corresponding author), Shandong Jiaotong Univ, Sch Sci, Jinan, Peoples R China.	chenjianzhong1970@163.com; wlzhu@mail.shcnc.ac.cn	Chen, Jianzhong/L-8899-2018	Chen, Jianzhong/0000-0003-1558-4398	National Natural Science Foundation of China [11104164, 11274206, 31200545]; National 863 Program [2012AA01A305]; Dr. Start-up Foundation of Shandong Jiaotong University; Natural Science Foundation of Shandong Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); Dr. Start-up Foundation of Shandong Jiaotong University; Natural Science Foundation of Shandong Jiaotong University	This work is supported by the National Natural Science Foundation of China (11104164, 11274206 and 31200545), the National 863 Program (Grant No. 2012AA01A305), Dr. Start-up Foundation of Shandong Jiaotong University, and Natural Science Foundation of Shandong Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay, 1995, J MED CHEM, V38, P4953, DOI 10.1021/jm00026a001; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Banaszak L, 1994, ADV PROTEIN CHEM, V45, P90; Barf T, 2009, BIOORG MED CHEM LETT, V19, P1745, DOI 10.1016/j.bmcl.2009.01.084; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; Cabre A, 2007, Atherosclerosis, V195, pe150; Case DA, 2012, AMBER 12; Chen JZ, 2013, J COMPUT AID MOL DES, V27, P965, DOI 10.1007/s10822-013-9693-z; Chen JZ, 2012, INT J MOL SCI, V13, P2176, DOI 10.3390/ijms13022176; Chen JZ, 2011, J MOL GRAPH MODEL, V30, P46, DOI 10.1016/j.jmgm.2011.06.003; COLEMAN TG, 1977, ANN BIOMED ENG, V5, P322, DOI 10.1007/BF02367312; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Hu GD, 2010, J COMPUT AID MOL DES, V24, P687, DOI 10.1007/s10822-010-9366-0; Huang XQ, 2008, J MED CHEM, V51, P6293, DOI 10.1021/jm800607u; Huang XQ, 2012, J PHYS CHEM B, V116, P3361, DOI 10.1021/jp2111605; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Ji CG, 2011, J AM CHEM SOC, V133, P17727, DOI 10.1021/ja206212a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Lehmann F, 2004, BIOORG MED CHEM LETT, V14, P4445, DOI 10.1016/j.bmcl.2004.06.057; Levy R, 2004, BIOPOLYMERS, V23, P1099; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Luo Q, 2013, AMINO ACIDS, V44, P1009, DOI 10.1007/s00726-012-1435-3; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; MELKI SA, 1993, J LIPID RES, V34, P1527; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Perdih A, 2009, J MOL MODEL, V15, P983, DOI 10.1007/s00894-009-0455-8; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; Ringom R, 2004, BIOORG MED CHEM LETT, V14, P4449, DOI 10.1016/j.bmcl.2004.06.058; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Verkhivker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040897; Vural B, 2008, CARDIOVASC PATHOL, V17, P392, DOI 10.1016/j.carpath.2008.02.006; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallace EM, 2006, J MED CHEM, V49, P441, DOI 10.1021/jm050834y; Wang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062745; Wang JN, 2010, J PHYS CHEM B, V114, P15172, DOI 10.1021/jp104508k; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang YT, 2009, J CHEM INF MODEL, V49, P2369, DOI 10.1021/ci9002238; Wu EL, 2008, CHEM-EUR J, V14, P8704, DOI 10.1002/chem.200800277; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; Zhu T, 2013, J CHEM THEORY COMPUT, V9, P2104, DOI 10.1021/ct300999w	60	31	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99862	10.1371/journal.pone.0099862	http://dx.doi.org/10.1371/journal.pone.0099862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918907	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000122
J	Liao, Y; Lu, W; Che, Q; Yang, TT; Qiu, HF; Zhang, HJ; He, XY; Wang, JY; Qiu, MT; Zou, YF; Gu, W; Wan, XP				Liao, Yun; Lu, Wen; Che, Qi; Yang, Tingting; Qiu, Haifeng; Zhang, Huijuan; He, Xiaoying; Wang, Jingyun; Qiu, Meiting; Zou, Yingfen; Gu, Wei; Wan, Xiaoping			SHARP1 Suppresses Angiogenesis of Endometrial Cancer by Decreasing Hypoxia-Inducible Factor-1 alpha Level	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTION FACTOR DEC2; TUMOR-GROWTH; PHASE-II; EXPRESSION; CARCINOMA; METASTASIS; CELLS; MECHANISMS; RECURRENT	Recent data support a role for SHARP1, a basic helix-loop-helix transcription repressor, in the regulation of malignant cell behavior in several human cancers. However, the expression and role of SHARP1 during the development of endometrial cancer (EC) remain unclear. Here we show that upregulation of SHARP1 suppressed tumor angiogenesis by decreasing hypoxia-inducible factor-1 alpha (HIF-1 alpha), inhibited cell viability and tumor growth in EC. Immunohistochemical staining showed that the expression of SHARP1 was negatively correlated with tumor stage, histological grade, myometrial invasion, lymph node metastasis, blood vessel permeation in the myometrium and HIF-1 alpha expression. Mechanistic studies showed that SHARP1 interacted with HIF-1 alpha physically, and the protein level of HIF-1 alpha and the mRNA level of its target genes (VEGFA, ANGPTL4 and CA9) were decreased by SHARP1 under hypoxia. Upregulation of SHARP1 in EC impeded hypoxia-induced angiogenesis by reducing VEGF secretion. Immunohistochemical analysis verified a correlation between decreased SHARP1 expression and increased microvessel density in EC tissues. Additionally, SHARP1 inhibited cell viability in EC cell lines. Overexpression of SHARP1 in vivo inhibited tumor growth and angiogenesis, and decreased HIF-1 alpha expression. In this study, we established SHARP1 as a novel tumor suppressor of EC and shed light on the mechanisms by how SHARP1 inhibited EC progression. Therefore, SHARP1 may be a valuable prognostic biomarker for EC progression and shows promise as a new potential target for antiangiogenic therapeutics in human EC.	[Liao, Yun; He, Xiaoying; Wang, Jingyun; Qiu, Meiting; Zou, Yingfen; Gu, Wei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Lu, Wen; Che, Qi; Yang, Tingting; Qiu, Haifeng; Wan, Xiaoping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhang, Huijuan] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Pathol, Shanghai 200030, Peoples R China; [Zhang, Huijuan] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Biobank, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gu, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	krisgu70@163.com; wanxp@sjtu.edu.cn	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022; zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		National Natural Science Foundation of China [81272885, 81172476, 81072139, 81072140]; Foundation Project of Shanghai Municipal Science and Technology Commission [13JC1404500]; Ph.D. Programs Foundation of the Ministry of Education of China [20120073110090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation Project of Shanghai Municipal Science and Technology Commission; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Natural Science Foundation of China (81272885, 81172476, 81072139, 81072140), the Foundation Project of Shanghai Municipal Science and Technology Commission (No. 13JC1404500) and the Ph.D. Programs Foundation of the Ministry of Education of China (No. 20120073110090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2011, J CLIN ONCOL, V29, P2259, DOI 10.1200/JCO.2010.32.6397; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Azmi S, 2002, MECH DEVELOP, V114, P181, DOI 10.1016/S0925-4773(02)00049-7; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Chen MC, 2013, BIOCHEM PHARMACOL, V85, P1278, DOI 10.1016/j.bcp.2013.02.009; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Fujimoto K, 2007, INT J MOL MED, V19, P925; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hill EK, 2012, DRUGS, V72, P705, DOI 10.2165/11631840-000000000-00000; Hirai M, 2001, GYNECOL ONCOL, V80, P181, DOI 10.1006/gyno.2000.6056; Jiang FZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-425; Kafousi M, 2012, PATHOL ONCOL RES, V18, P33, DOI 10.1007/s12253-011-9413-8; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Li YX, 2011, BREAST CANCER RES TR, V128, P667, DOI 10.1007/s10549-010-1083-9; Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Nordgren IK, 2011, CHEM SOC REV, V40, P4307, DOI 10.1039/c1cs15032d; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Ozbudak IH, 2008, GYNECOL ONCOL, V108, P603, DOI 10.1016/j.ygyno.2007.11.028; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Seeber LMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-307; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wright JD, 2007, ANTICANCER RES, V27, P3525; Wu YY, 2012, BIOMED RES-TOKYO, V33, P75, DOI 10.2220/biomedres.33.75; Xu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041862, 10.1371/journal.pone.0043769]; Yang TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067458; Yokoyama Y, 2000, GYNECOL ONCOL, V77, P413, DOI 10.1006/gyno.2000.5802; Yunokawa M, 2007, ONCOL REP, V17, P871	50	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99907	10.1371/journal.pone.0099907	http://dx.doi.org/10.1371/journal.pone.0099907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918449	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000125
J	Yeh, JJ; Wang, YC; Lin, CL; Chou, CYT; Yeh, TC; Wu, BT; Sung, FC; Kao, CH				Yeh, Jun-Jun; Wang, Yu-Chiao; Lin, Cheng-Li; Chou, Christine Yi-Ting; Yeh, Ting-Chun; Wu, Bing-Tsang; Sung, Fung-Chang; Kao, Chia-Hung			Nontuberculous Mycobacterial Infection Is Associated with Increased Respiratory Failure: A Nationwide Cohort Study	PLOS ONE			English	Article							THIN-SECTION CT; PULMONARY INFECTION; LUNG-DISEASE; CLINICAL CHARACTERISTICS; MEDICAL THERAPIES; AVIUM COMPLEX; EPIDEMIOLOGY	Background and Purpose: Population study on relationship between nontuberculous mycobacterial (NTM) infection and respiratory failure (RF) is limited. This study evaluated the RF risk, including acute respiratory failure (ARF), chronic respiratory failure (CRF) and ARF on CRF, in patients with NTM infection in Taiwan. Methods: We used the National Health Insurance Research Database of Taiwan to identify 3864 newly diagnosed NTM patients (NTM cohort) from 1999 to 2009, and 15456 non-NTM patients (non-NTM cohort), frequency matched by demographic status for comparison. Incidence and hazard of developing RF were measured by the end of 2010. Results: The incidence rate of RF was 4.31-fold higher in the NTM cohort than in the non-NTM cohort (44.0 vs. 10.2 per 1000 person-years), with an adjusted hazard ratio (HR) of 3.11 (95% CI: 2.73-3.54). The cumulative proportional incidence of RF was 10% higher in the NTM cohort than in the non-NTM cohort (P<0.0001). The RF risk was much greater within 6 months after the diagnosis of NTM infection with a HR of 7.45 (95% CI = 5.50-10.09). Age-specific comparison showed that the younger NTM patients had a higher HR of RF than the elderly NTM patients (HR: 4.42, 95% CI: 3.28-5.96 vs. HR: 2.52, 95% CI: 2.17-2.92). Comorbidity increased the risk of RF in both cohorts, particularly in those with chronic obstructive pulmonary disease. Conclusion: Our study suggests patients with NTM infection are at a high risk of RF. The risk appears much greater soon after patients diagnosed with NTM infection.	[Yeh, Jun-Jun; Chou, Christine Yi-Ting; Yeh, Ting-Chun; Wu, Bing-Tsang] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Cheng-Li; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Chou, Christine Yi-Ting] UCSD Med Ctr Hillcres, San Diego, CA USA; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	fcsung@mail.cmu.edu.tw; d10040@mail.cmuh.org.tw		Yeh, Jun-Jun/0000-0002-4368-7880	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence [MOHW103-TD-B-111-03];  [DMR-103-020];  [DMR-103-022]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence; ; 	The study was supported in part by the study projects (DMR-103-020 and DMR-103-022) in the authors' hospital and Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004), and Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kao CH and Sung FC have equal contribution for this study.	Andrejak C, 2013, THORAX, V68, P256, DOI 10.1136/thoraxjnl-2012-201772; Babalik A, 2012, TUBERK TORAK, V60, P20, DOI 10.5578/tt.2543; Behrendt CE, 2000, CHEST, V118, P1100, DOI 10.1378/chest.118.4.1100; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; Booth CM, 2011, CURR ONCOL, V18, P105; Booth CM, 2008, JAMA-J AM MED ASSOC, V300, P2177, DOI 10.1001/jama.300.18.2177; Carol J, 2001, ICD 9 C M, V2, P298; Ding LW, 2006, EPIDEMIOL INFECT, V134, P1060, DOI 10.1017/S0950268805005698; Erasmus JJ, 1999, RADIOGRAPHICS, V19, P1487, DOI 10.1148/radiographics.19.6.g99no101487; Franca SA, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.010; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Huang JH, 1999, CHEST, V115, P1033, DOI 10.1378/chest.115.4.1033; Huang WC, 2010, J MED MICROBIOL, V59, P1203, DOI 10.1099/jmm.0.020586-0; J Carol, 2001, ICD 9 C M, V3, P298; J Carol, 2001, ICD 9 C M, V1, P298; J Carol, 2001, ICD 9 C M, V2001, P298; Jeong YJ, 2004, RADIOLOGY, V231, P880, DOI 10.1148/radiol.2313030833; Kazumi Yuko, 2013, Kansenshogaku Zasshi, V87, P424; Kim TS, 2005, AM J ROENTGENOL, V184, P1247, DOI 10.2214/ajr.184.4.01841247; Koh WJ, 2002, KOREAN J RADIOL, V3, P145, DOI 10.3348/kjr.2002.3.3.145; Kohno S, 2013, RESPIRATION, V85, P27, DOI 10.1159/000335466; Kubo K, 1998, AM J RESP CRIT CARE, V158, P979, DOI 10.1164/ajrccm.158.3.9802042; Lee AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-558; Lee MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058214; Lewandowski K, 2003, CRIT CARE, V7, P288, DOI 10.1186/cc2352; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; MOORE EH, 1993, RADIOLOGY, V187, P777, DOI 10.1148/radiology.187.3.8497629; Orsini J, 2013, INTERDISCIP PERSPECT, V2013; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071109; Ringshausen FC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-231; Roussos C, 2003, EUR RESPIR J, V22, p3S, DOI 10.1183/09031936.03.00038503; Shaaban H, 2013, INT J STD AIDS; Shu CC, 2011, LUNG, V189, P467, DOI 10.1007/s00408-011-9321-4; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Sue DYLD, 2008, RESP FAILURE; Systrom DM, 2005, NEW ENGL J MED, V352, P1238, DOI 10.1056/NEJMcpc059003; WALLACE JM, 1988, WESTERN J MED, V149, P167; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Yamazaki Y, 2000, RESPIRATION, V67, P46, DOI 10.1159/000029462; Yeh JJ, 2014, LUNG; Zheng C, 2013, QJM-INT J MED, V106, P307, DOI 10.1093/qjmed/hct022	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99260	10.1371/journal.pone.0099260	http://dx.doi.org/10.1371/journal.pone.0099260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918925	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000068
J	Levinsson, A; Olin, AC; Modig, L; Dahgam, S; Bjorck, L; Rosengren, A; Nyberg, F				Levinsson, Anna; Olin, Anna-Carin; Modig, Lars; Dahgam, Santosh; Bjorck, Lena; Rosengren, Annika; Nyberg, Fredrik			Interaction Effects of Long-Term Air Pollution Exposure and Variants in the GSTP1, GSTT1 and GSTCD Genes on Risk of Acute Myocardial Infarction and Hypertension: A Case-Control Study	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CARDIOVASCULAR-DISEASE; PARTICULATE MATTER; OXIDATIVE STRESS; MORTALITY	Introducion: Experimental and epidemiological studies have reported associations between air pollution exposure, in particular related to vehicle exhaust, and cardiovascular disease. A potential pathophysiological pathway is pollution-induced pulmonary oxidative stress, with secondary systemic inflammation. Genetic polymorphisms in genes implicated in oxidative stress, such as GSTP1, GSTT1 and GSTCD, may contribute to determining individual susceptibility to air pollution as a promoter of coronary vulnerability. Aims: We aimed to investigate effects of long-term traffic-related air pollution exposure, as well as variants in GSTP1, GSTT1 and GSTCD, on risk of acute myocardial infarction (AMI) and hypertension. In addition, we studied whether air pollution effects were modified by the investigated genetic variants. Methods: Genotype data at 7 single nucleotide polymorphisms (SNPs) in the GSTP1 gene, and one in each of the GSTT1 and GSTCD genes, as well as air pollution exposure estimates, were available for 119 AMI cases and 1310 randomly selected population controls. Population control individuals with systolic blood pressure >= 140 mmHg, diastolic blood pressure >= 90 mmHg or on daily antihypertensive medication were defined as hypertensive (n = 468). Individual air pollution exposure levels were modeled as annual means of NO2 (marker of vehicle exhaust pollutants) using central monitoring data and dispersion models, linking to participants' home addresses. Results: Air pollution was significantly associated with risk of AMI: OR 1.78 (95%CI 1.04-3.03) per 10 mu g/m(3) of long-term NO2 exposure. Three GSTP1 SNPs were significantly associated with hypertension. The effect of air pollution on risk of AMI varied by genotype strata, although the suggested interaction was not significant. We saw no obvious interaction between genetic variants in the GST genes and air pollution exposure for hypertension. Conclusion: Air pollution exposure entails an increased risk of AMI, and this risk differed over genotype strata for variants in the GSTP1, GSTT1 and GSTCD genes, albeit not statistically-significantly.	[Levinsson, Anna; Olin, Anna-Carin; Dahgam, Santosh; Nyberg, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Modig, Lars] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden; [Bjorck, Lena; Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Nyberg, Fredrik] AstraZeneca R&D, Molndal, Sweden	University of Gothenburg; Umea University; University of Gothenburg; AstraZeneca	Levinsson, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden.	anna.levinsson@amm.gu.se	Olin, Anna-Carin/ABH-2627-2021	Nyberg, Fredrik/0000-0003-0892-5668; Rosengren, Annika/0000-0002-5409-6605	Vastra Gotaland County Council; Swedish Council for Working Life and Social Research; Swedish Research Council; Swedish Research Council for Environment and Spatial Planning; Swedish Heart and Lung Foundation; AstraZeneca R D Sweden	Vastra Gotaland County Council; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment and Spatial Planning; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AstraZeneca R D Sweden(AstraZeneca)	This research was supported by grants from the Vastra Gotaland County Council, the Swedish Council for Working Life and Social Research, the Swedish Research Council, the Swedish Research Council for Environment and Spatial Planning, the Swedish Heart and Lung Foundation, and AstraZeneca R & D Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, TOXICOL APPL PHARM; Bazo Ana Paula, 2011, Cardiovasc Pathol, V20, pe9, DOI 10.1016/j.carpath.2009.12.004; Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005; Bessa SS, 2009, EUR J INTERN MED, V20, P625, DOI 10.1016/j.ejim.2009.06.003; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2007, J EXPO SCI ENV EPID, V17, pS61, DOI 10.1038/sj.jes.7500628; Campen MJ, 2012, CURR OPIN PULM MED, V18, P155, DOI 10.1097/MCP.0b013e32834f210a; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Huttunen K, 2012, ENVIRON RES, V116, P44, DOI 10.1016/j.envres.2012.04.004; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Johansson CSG, 2006, EXPOSE EXPOSURE COMP; Kunzli N, 2011, PROG CARDIOVASC DIS, V53, P334, DOI 10.1016/j.pcad.2010.12.006; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Mordukhovich I, 2009, ENVIRON HEALTH PERSP, V117, P1767, DOI 10.1289/ehp.0900591; Nebert Daniel W., 2004, Human Genomics, V1, P460; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Probst-Hensch NM, 2008, ENV HLTH PERSPECT, V116; Raaschou-Nielsen O, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-60; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rosenlund M, 2006, EPIDEMIOLOGY, V17, P383, DOI 10.1097/01.ede.0000219722.25569.0f; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Schulz H, 2005, J AEROSOL MED, V18, P1, DOI 10.1089/jam.2005.18.1; Shrey K, 2011, ENVIRON TOXICOL PHAR, V31, P1, DOI 10.1016/j.etap.2010.09.002; Stephens JW, 2008, ATHEROSCLEROSIS, V200, P229, DOI 10.1016/j.atherosclerosis.2008.04.003; Wang J, 2010, MUTAGENESIS, V25, P365, DOI 10.1093/mutage/geq014; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426	28	31	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99043	10.1371/journal.pone.0099043	http://dx.doi.org/10.1371/journal.pone.0099043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915237	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700053
J	Schaftenaar, E; Verjans, GMGM; Getu, S; McIntyre, JA; Struthers, HE; Osterhaus, ADME; Peters, RPH				Schaftenaar, Erik; Verjans, Georges M. G. M.; Getu, Sarah; McIntyre, James A.; Struthers, Helen E.; Osterhaus, Albert D. M. E.; Peters, Remco P. H.			High Seroprevalence of Human Herpesviruses in HIV-Infected Individuals Attending Primary Healthcare Facilities in Rural South Africa	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; ZOSTER; PREVALENCE; CYTOMEGALOVIRUS; TRANSMISSION; REACTIVATION; POPULATION; PERSISTENT; ANTIBODIES; CHILDREN	Seroprevalence data of human herpesviruses (HHVs) are limited for sub-Saharan Africa. These are important to provide an indication of potential burden of HHV-related disease, in particular in human immunodeficiency virus (HIV)-infected individuals who are known to be at increased risk of these conditions in the Western world. In this cross-sectional study among 405 HIV-infected and antiretroviral therapy naive individuals in rural South Africa the seroprevalence of HHVs was: herpes simplex virus type 1 (HSV-1) (98%), herpes simplex virus type 2 (HSV-2) (87%), varicella zoster virus (VZV) (89%), and 100% for both Epstein-Barr virus (EBV) and cytomegalovirus (CMV). Independent factors associated with VZV seropositivity were low educational status and having children. Lack of in-house access to drinking water was independently associated with positive HSV-1 serostatus, whereas Shangaan ethnicity was associated with HSV-2 seropositivity. Increasing age was associated with higher IgG titres to both EBV and CMV, whereas CD4 cell count was negatively associated with EBV and CMV IgG titres. Moreover, IgG titres of HSV-1 and 2, VZV and CMV, and CMV and EBV were positively correlated. The high HHV seroprevalence emphasises the importance of awareness of these viral infections in HIV-infected individuals in South Africa.	[Schaftenaar, Erik; Verjans, Georges M. G. M.; Getu, Sarah; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Schaftenaar, Erik; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Schaftenaar, Erik; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Tzaneen, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Struthers, Helen E.] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Peters, Remco P. H.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Cape Town; University of Cape Town; Maastricht University	Peters, RPH (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.	rph.peters@gmail.com		Verjans, Georges/0000-0002-2465-2674; Peters, Remco Petrus Hendricus/0000-0003-2124-7275	Rotterdamse Stichting Blindenbelangen; Rotterdam global health initiative; US President's Emergency Plan for AIDS Relief (PEPFAR) program via the US Agency for International Development [674-A-00-08-00009-00]	Rotterdamse Stichting Blindenbelangen; Rotterdam global health initiative; US President's Emergency Plan for AIDS Relief (PEPFAR) program via the US Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was in part funded by the Rotterdamse Stichting Blindenbelangen and the Rotterdam global health initiative. Anova Health Institute receives a grant from the US President's Emergency Plan for AIDS Relief (PEPFAR) program via the US Agency for International Development under Cooperative Agreement No. 674-A-00-08-00009-00. The views expressed in this report do not necessarily reflect those of PEPFAR or USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Camarena V, 2010, CELL HOST MICROBE, V8, P320, DOI 10.1016/j.chom.2010.09.007; Chakraborty N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-147; Chakraborty R, 2003, CLIN INFECT DIS, V36, P922, DOI 10.1086/368207; Chatterjee K, 2010, J MED VIROL, V82, P2082, DOI 10.1002/jmv.21926; Compston LI, 2009, J MED VIROL, V81, P1860, DOI 10.1002/jmv.21614; Dollard SC, 2010, INT J CANCER, V127, P2395, DOI 10.1002/ijc.25235; Ghebrekidan H, 1999, J CLIN VIROL, V12, P53, DOI 10.1016/S0928-0197(98)00064-6; GLASER R, 1985, P SOC EXP BIOL MED, V179, P352; Haas A, 2010, EMBO MOL MED, V2, P231, DOI 10.1002/emmm.201000075; Heininger U, 2001, PEDIATR INFECT DIS J, V20, P775, DOI 10.1097/00006454-200108000-00011; Jansen K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-372; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Masuet-Aumatell C, 2013, TROP MED INT HEALTH, V18, P296, DOI 10.1111/tmi.12040; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Mmbaga Elia John, 2011, East Afr J Public Health, V8, P28; Munoz TAY, 1999, ARCH MED RES, V30, P60; Nichols RA, 2011, EPIDEMICS-NETH, V3, P12, DOI 10.1016/j.epidem.2010.11.003; Nyiro JU, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-155; Ogunjimi B, 2014, J MED VIROL, V86, P812, DOI 10.1002/jmv.23749; Otiti-Sengeri J, 2008, CURR OPIN HIV AIDS, V3, P432, DOI 10.1097/COH.0b013e328302cc3d; Patel P, 2012, SEX TRANSM DIS, V39, P154, DOI 10.1097/OLQ.0b013e318239d7fd; Pearce N, 2004, ENVIRON HEALTH PERSP, V112, P1047, DOI 10.1289/ehp.6927; Rabenau HF, 2010, SEX TRANSM DIS, V37, P454, DOI 10.1097/OLQ.0b013e3181cfcc2b; Silhol R, 2010, EPIDEMIOL INFECT, V138, P482, DOI 10.1017/S0950268809990896; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Smith MZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-100; STATISTICS SOUTH AFRICA, 2012, S AFR I KNOW HOM I U; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; Uribe-Salas F, 2009, T ROY SOC TROP MED H, V103, P151, DOI 10.1016/j.trstmh.2008.10.033; Wald Anna, 2004, Herpes, V11 Suppl 3, p130A; Weiss H, 2004, HERPES S, V11, p24A; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2005, INT WHO CLIN STAG HI; Wringe A, 2012, TROP MED INT HEALTH, V17, pe38, DOI 10.1111/j.1365-3156.2011.02925.x; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	41	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99243	10.1371/journal.pone.0099243	http://dx.doi.org/10.1371/journal.pone.0099243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914671	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700075
J	Shin, B; Oh, H; Park, SM; Han, HE; Ye, M; Song, WK; Park, WJ				Shin, Baehyun; Oh, Hyejin; Park, Sang Min; Han, Hye-Eun; Ye, Michael; Song, Woo Keun; Park, Woo Jin			Intracellular Cleavage of Amyloid beta by a Viral Protease NIa Prevents Amyloid beta-Mediated Cytotoxicity	PLOS ONE			English	Article							NEPRILYSIN GENE-TRANSFER; A-BETA; ALZHEIMERS-DISEASE; PLAQUE-FORMATION; SYNAPTIC PLASTICITY; MOUSE MODEL; PEPTIDE; PATHOLOGY; OLIGOMERS; BRAIN	Nuclear inclusion a (NIa) of turnip mosaic virus is a cytosolic protease that cleaves amyloid beta (A beta) when heterologously overexpressed. Lentivirus-mediated expression of NIa in the brains of APP(sw)/PS1 mice significantly reduces cerebral A beta levels and plaque depositions, and improves behavioral deficits. Here, the effects of NIa and neprilysin (NEP), a well-known A beta-cleaving protease, on oligomeric A beta-induced cell death were evaluated. NIa cleaved monomeric and oligomeric A beta at a similar rate, whereas NEP only cleaved monomeric A beta. Oligomeric A beta-induced cytotoxicity and mitochondrial dysfunction were significantly ameliorated by NIa, but not by NEP. Endocytosed fluorescently-labeled A beta localized to mitochondria, and this was significantly reduced by NIa, but not by NEP. These data suggest that NIa may exerts its protective roles by degrading Ab and thus preventing mitochondrial deposition of A beta.	[Shin, Baehyun; Park, Sang Min; Han, Hye-Eun; Ye, Michael; Park, Woo Jin] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Oh, Hyejin; Song, Woo Keun] Gwangju Inst Sci & Technol, Sch Life Sci, Bio Imaging & Cell Dynam Res Ctr, Kwangju, South Korea; [Shin, Baehyun; Oh, Hyejin] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Harvard University; Massachusetts General Hospital	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	woojinpark@me.com	Park, Sang Min/V-9194-2019		National Research Foundation of Korea [2009-0085747]; Global Research Laboratory Program - Korean Government (MEST) [M6-0605-00-0001]; Systems Biology Infrastructure Establishment Grant by GIST	National Research Foundation of Korea(National Research Foundation of Korea); Global Research Laboratory Program - Korean Government (MEST); Systems Biology Infrastructure Establishment Grant by GIST	This work was supported by a grant from the National Research Foundation of Korea (2009-0085747) and by the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean Government (MEST) and by a grant from the Systems Biology Infrastructure Establishment Grant provided by GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Glabe C, 2000, NAT MED, V6, P133, DOI 10.1038/72215; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Han HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015645; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jungbauer LM, 2009, J MOL RECOGNIT, V22, P403, DOI 10.1002/jmr.948; Kang H, 2001, J GEN VIROL, V82, P3115, DOI 10.1099/0022-1317-82-12-3115; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim TK, 2012, EXP MOL MED, V44, P740, DOI 10.3858/emm.2012.44.12.082; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Magrane J, 2006, EXP CELL RES, V312, P996, DOI 10.1016/j.yexcr.2005.12.009; Marr RA, 2003, J NEUROSCI, V23, P1992; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sellamuthu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022554; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011	44	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98650	10.1371/journal.pone.0098650	http://dx.doi.org/10.1371/journal.pone.0098650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915567	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700028
J	Wang, R; Munoz, EE; Zhu, SY; McGrath, BC; Cavener, DR				Wang, Rong; Munoz, Elyse E.; Zhu, Siying; McGrath, Barbara C.; Cavener, Douglas R.			Perk Gene Dosage Regulates Glucose Homeostasis by Modulating Pancreatic beta-Cell Functions	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; WOLCOTT-RALLISON-SYNDROME; INSULIN-SECRETION; EIF2-ALPHA KINASE; TRANSLATIONAL CONTROL; PROTEIN-SYNTHESIS; MICE; EIF2AK3; PROLIFERATION; EXPRESSION	Background: Insulin synthesis and cell proliferation are under tight regulation in pancreatic beta-cells to maintain glucose homeostasis. Dysfunction in either aspect leads to development of diabetes. PERK (EIF2AK3) loss of function mutations in humans and mice exhibit permanent neonatal diabetes that is characterized by insufficient beta-cell mass and reduced proinsulin trafficking and insulin secretion. Unexpectedly, we found that Perk heterozygous mice displayed lower blood glucose levels. Methodology: Longitudinal studies were conducted to assess serum glucose and insulin, intracellular insulin synthesis and storage, insulin secretion, and beta-cell proliferation in Perk heterozygous mice. In addition, modulation of Perk dosage specifically in beta-cells showed that the glucose homeostasis phenotype of Perk heterozygous mice is determined by reduced expression of PERK in the beta-cells. Principal Findings: We found that Perk heterozygous mice first exhibited enhanced insulin synthesis and secretion during neonatal and juvenile development followed by enhanced beta-cell proliferation and a substantial increase in beta-cell mass at the adult stage. These differences are not likely to entail the well-known function of PERK to regulate the ER stress response in cultured cells as several markers for ER stress were not differentially expressed in Perk heterozygous mice. Conclusions: In addition to the essential functions of PERK in beta-cells as revealed by severely diabetic phenotype in humans and mice completely deficient for PERK, reducing Perk gene expression by half showed that intermediate levels of PERK have a profound impact on beta-cell functions and glucose homeostasis. These results suggest that an optimal level of PERK expression is necessary to balance several parameters of beta-cell function and growth in order to achieve normoglycemia.	[Wang, Rong; Munoz, Elyse E.; Zhu, Siying; McGrath, Barbara C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu	Wang, Rong/M-4503-2019		National Institutes of Health [DK088140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole, by National Institutes of Health Grant DK088140 (to D.R.C.) www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Elghazi L, 2006, INT J BIOCHEM CELL B, V38, P157, DOI 10.1016/j.biocel.2005.08.017; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Greeley SAW, 2011, CURR DIABETES REP, V11, P519, DOI 10.1007/s11892-011-0234-7; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Kane C, 1996, NAT MED, V2, P1344, DOI 10.1038/nm1296-1344; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Owen CR, 2005, J NEUROCHEM, V94, P1235, DOI 10.1111/j.1471-4159.2005.03276.x; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Takane KK, 2012, DIABETES, V61, P418, DOI 10.2337/db11-0580; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Uchizono Y, 2007, DIABETES OBES METAB, V9, P56, DOI 10.1111/j.1463-1326.2007.00774.x; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	43	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99684	10.1371/journal.pone.0099684	http://dx.doi.org/10.1371/journal.pone.0099684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915520	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700126
J	Peng, C; Chen, JG; Tang, W; Liu, CL; Chen, XL				Peng, Can; Chen, Jungang; Tang, Wei; Liu, Chunlan; Chen, Xulin			Kaposi's Sarcoma-Associated Herpesvirus ORF6 Gene Is Essential in Viral Lytic Replication	PLOS ONE			English	Article							DNA-BINDING PROTEIN; EPSTEIN-BARR-VIRUS; OPEN READING FRAME; FUNCTIONAL INTERACTION; B-CELLS; EXPRESSION; INFECTION; LATENCY; GENOME; ICP8	Kaposi's sarcoma associated herpesvirus (KSHV) is associated with Kaposis's sarcoma (KS), primary effusion lymphoma and multicentric Castleman's disease. KSHV encodes at least 8 open reading frames (ORFs) that play important roles in its lytic DNA replication. Among which, ORF6 of KSHV encodes an ssDNA binding protein that has been proved to participate in origin-dependent DNA replication in transient assays. To define further the function of ORF6 in the virus life cycle, we constructed a recombinant virus genome with a large deletion within the ORF6 locus by using a bacterial artificial chromosome (BAC) system. Stable 293T cells carrying the BAC36 (wild type) and BAC Delta 6 genomes were generated. When monolayers of 293T-BAC36 and 293T-BAC Delta 6 cells were induced with 12-O-tetradecanoylphorbol-13-acetate (TPA) and sodium butyrate, infectious virus was detected from the 293T-BAC36 cell supernatants only and not from the 293T-BAC Delta 6 cell supernatants. DNA synthesis was defective in 293T-BAC Delta 6 cells. Expression of ORF6 in trans in BAC Delta 6-containing cells was able to rescue both defects. Our results provide genetic evidence that ORF6 is essential for KSHV lytic replication. The stable 293T cells carrying the BAC36 and BAC Delta 6 genomes could be used as tools to investigate the detailed functions of ORF6 in the lytic replication of KSHV.	[Peng, Can; Chen, Jungang; Tang, Wei; Liu, Chunlan; Chen, Xulin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Chen, XL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenxl@wh.iov.cn			National Natural Science Foundation of China [31070151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (grant 31070151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuCoin DP, 2004, VIROLOGY, V318, P542, DOI 10.1016/j.virol.2003.10.016; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Brulois KF, 2012, J VIROLOGY; Budt M, 2011, J VIROL, V85, P10415, DOI 10.1128/JVI.05071-11; BUSH M, 1991, J VIROL, V65, P1082, DOI 10.1128/JVI.65.3.1082-1089.1991; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Cohen JI, 2007, J VIROL, V81, P1586, DOI 10.1128/JVI.01220-06; DECAUSSIN G, 1995, J VIROL, V69, P7309, DOI 10.1128/JVI.69.11.7309-7314.1995; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Falkenberg M, 1998, J BIOL CHEM, V273, P32154, DOI 10.1074/jbc.273.48.32154; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; GAO M, 1991, J VIROL, V65, P2666, DOI 10.1128/JVI.65.5.2666-2675.1991; GAO M, 1989, J VIROL, V63, P5258, DOI 10.1128/JVI.63.12.5258-5267.1989; GODOWSKI PJ, 1986, P NATL ACAD SCI USA, V83, P256, DOI 10.1073/pnas.83.2.256; He H, 2001, ARCH VIR S, V17, P57; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; KINCHINGTON PR, 1988, J VIROL, V62, P802, DOI 10.1128/JVI.62.3.802-809.1988; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lu M, 2004, J VIROL, V78, P13637, DOI 10.1128/JVI.78.24.13637-13652.2004; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Majerciak V, 2007, J VIROL, V81, P1062, DOI 10.1128/JVI.01558-06; McNamee EE, 2000, J VIROL, V74, P10122, DOI 10.1128/JVI.74.21.10122-10131.2000; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Nicholas J, 1997, J VIROL, V71, P1963, DOI 10.1128/JVI.71.3.1963-1974.1997; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sathish N, 2010, VIROLOGY IN PRESS; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Tibbetts SA, 2006, VIROLOGY, V353, P210, DOI 10.1016/j.virol.2006.05.020; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Wang Y, 2004, J VIROL, V78, P8615, DOI 10.1128/JVI.78.16.8615-8629.2004; Wang Y, 2008, J VIROL, V82, P2867, DOI 10.1128/JVI.01319-07; Wang Y, 2011, J VIROL, V85, P1943, DOI 10.1128/JVI.02060-10; Wu FY, 2001, J VIROL, V75, P1487, DOI 10.1128/JVI.75.3.1487-1506.2001; Xu YY, 2006, J VIROL, V80, P9905, DOI 10.1128/JVI.01004-06; Yakushko Y, 2011, J VIROL, V85, P4612, DOI 10.1128/JVI.02068-10; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	47	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99542	10.1371/journal.pone.0099542	http://dx.doi.org/10.1371/journal.pone.0099542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911362	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600104
J	Sriurairatana, S; Boonyawiwat, V; Gangnonngiw, W; Laosutthipong, C; Hiranchan, J; Flegel, TW				Sriurairatana, Siriporn; Boonyawiwat, Visanu; Gangnonngiw, Warachin; Laosutthipong, Chaowanee; Hiranchan, Jindanan; Flegel, Timothy W.			White Feces Syndrome of Shrimp Arises from Transformation, Sloughing and Aggregation of Hepatopancreatic Microvilli into Vermiform Bodies Superficially Resembling Gregarines	PLOS ONE			English	Article							SURFACE-MORPHOLOGY; MARINE GREGARINES; N. SP.; LITOPENAEUS-VANNAMEI; MOLECULAR PHYLOGENY; SEPTATE GREGARINE; SELENIDIUM SPP.; APICOMPLEXA; EUGREGARINORIDA; PTEROSPORA	Accompanying acute hepatopancreatic necrosis disease (AHPND) in cultivated Asian shrimp has been an increasing prevalence of vermiform, gregarine-like bodies within the shrimp hepatopancreas (HP) and midgut. In high quantity they result in white fecal strings and a phenomenon called white feces syndrome (WFS). Light microscopy (LM) of squash mounts and stained smears from fresh HP tissue revealed that the vermiform bodies are almost transparent with widths and diameters proportional to the HP tubule lumens in which they occur. Despite vermiform appearance, they show no cellular structure. At high magnification (LM with 40-100x objectives), they appear to consist of a thin, outer membrane enclosing a complex of thicker, inter-folded membranes. Transmission electron microscopy (TEM) revealed that the outer non-laminar membrane of the vermiform bodies bore no resemblance to a plasma membrane or to the outer layer of any known gregarine, other protozoan or metazoan. Sub-cellular organelles such as mitochondria, nuclei, endoplasmic reticulum and ribosomes were absent. The internal membranes had a tubular sub-structure and occasionally enclosed whole B-cells, sloughed from the HP tubule epithelium. These internal membranes were shown to arise from transformed microvilli that peeled away from HP tubule epithelial cells and then aggregated in the tubule lumen. Stripped of microvilli, the originating cells underwent lysis. By contrast, B-cells remained intact or were sloughed independently and whole from the tubule epithelium. When sometimes engulfed by the aggregated, transformed microvilli (ATM) they could be misinterpreted as cyst-like structures by light microscopy, contributing to gregarine-like appearance. The cause of ATM is currently unknown, but formation by loss of microvilli and subsequent cell lysis indicate that their formation is a pathological process. If sufficiently severe, they may retard shrimp growth and may predispose shrimp to opportunistic pathogens. Thus, the cause of ATM and their relationship (if any) to AHPND should be determined.	[Sriurairatana, Siriporn; Laosutthipong, Chaowanee; Hiranchan, Jindanan; Flegel, Timothy W.] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10400, Thailand; [Boonyawiwat, Visanu] Kasetsart Univ, Fac Vet Med, Dept Farm Resources & Prod Med, Bangkok, Thailand; [Gangnonngiw, Warachin; Flegel, Timothy W.] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pratum Thani, Thailand; [Laosutthipong, Chaowanee; Hiranchan, Jindanan] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand	Mahidol University; Kasetsart University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Flegel, TW (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10400, Thailand.	sctwf@mahidol.ac.th		laosutthipong, chaowanee/0000-0001-5586-797X; Flegel, Timothy W./0000-0002-1913-213X	Surathani Shrimp Farmers Club; Frozen Food Association of Thailand; Charoen Pokphand Company Ltd.; Thai Commission for Higher Education; National Research Council of Thailand; Mahidol University	Surathani Shrimp Farmers Club; Frozen Food Association of Thailand; Charoen Pokphand Company Ltd.; Thai Commission for Higher Education; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Mahidol University	Partial funding for this work was obtained from the Surathani Shrimp Farmers Club, the Frozen Food Association of Thailand, Charoen Pokphand Company Ltd., the Thai Commission for Higher Education, the National Research Council of Thailand and Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell T.A., 1988, HDB NORMAL PENAEID S; Dilokkiet S, 2010, AQUABIZ, V36, P37; Ha NTH, 2010, AGR RURAL DEV SCI TE, V12, P45; Jimenez R, 2002, AQUAC RES, V33, P231, DOI 10.1046/j.1355-557x.2002.00647.x; Johnson P.T., 1980, HISTOLOGY BLUE CRAB; JONES TC, 1994, DIS AQUAT ORGAN, V19, P67, DOI 10.3354/dao019067; Landers SC, 2005, J EUKARYOT MICROBIOL, V52, P23, DOI 10.1111/j.1550-7408.2005.3277rrr.x; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; Leander BS, 2003, J PARASITOL, V89, P1191, DOI 10.1645/GE-3155; Lightner DV, 1996, HDB PATHOLOGY DIAGNO; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Poulpanich N, 2009, DIS AQUAT ORGAN, V86, P57, DOI 10.3354/dao02094; Rueckert S, 2008, ZOOL SCR, V37, P637, DOI 10.1111/j.1463-6409.2008.00346.x; Rueckert S, 2013, J EUKARYOT MICROBIOL, V60, P121, DOI 10.1111/jeu.12015; Rueckert S, 2009, J EUKARYOT MICROBIOL, V56, P428, DOI 10.1111/j.1550-7408.2009.00422.x; Tangprasittipap A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-139; Tangtrongpiros J, 2010, PUBL SEM VET MED AQ	18	51	54	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99170	10.1371/journal.pone.0099170	http://dx.doi.org/10.1371/journal.pone.0099170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911022	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600050
J	MacAulay, RK; Brouillette, RM; Foil, HC; Bruce-Keller, AJ; Keller, JN				MacAulay, Rebecca K.; Brouillette, Robert M.; Foil, Heather C.; Bruce-Keller, Annadora J.; Keller, Jeffrey N.			Longitudinal Study on Dual-Tasking Effects on Gait: Cognitive Change Predicts Gait Variance in the Elderly	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; OLDER-ADULTS; EXECUTIVE FUNCTION; FALLS; PERFORMANCE; IMPAIRMENT; ATTENTION; VARIABILITY; VALIDITY; DISEASE	Neuropsychological abilities have found to explain a large proportion of variance in objective measures of walking gait that predict both dementia and falling within the elderly. However, to this date there has been little research on the interplay between changes in these neuropsychological processes and walking gait overtime. To our knowledge, the present study is the first to investigate intra-individual changes in neurocognitive test performance and gait step time at two-time points across a one-year span. Neuropsychological test scores from 440 elderly individuals deemed cognitively normal at Year One were analyzed via repeated measures t-tests to assess for decline in cognitive performance at Year Two. 34 of these 440 individuals neuropsychological test performance significantly declined at Year Two; whereas the "non-decliners" displayed improved memory, working memory, attention/processing speed test performance. Neuropsychological test scores were also submitted to factor analysis at both time points for data reduction purposes and to assess the factor stability overtime. Results at Year One yielded a three-factor solution: Language/Memory, Executive Attention/Processing Speed, and Working Memory. Year Two's test scores also generated a three-factor solution (Working Memory, Language/Executive Attention/Processing Speed, and Memory). Notably, language measures loaded on Executive Attention/Processing Speed rather than on the Memory factor at Year Two. Hierarchal multiple regression revealed that both Executive Attention/Processing Speed and sex significantly predicted variance in dual task step time at both time points. Remarkably, in the "decliners", the magnitude of the contribution of the neuropsychological characteristics to gait variance significantly increased at Year Two. In summary, this study provides longitudinal evidence of the dynamic relationship between intra-individual cognitive change and its influence on dual task gait step time. These results also indicate that the failure to show improved test performance (particularly, on memory tests) with repeated administrations might prove to be useful of indicator of early cognitive decline.	[MacAulay, Rebecca K.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [MacAulay, Rebecca K.; Brouillette, Robert M.; Foil, Heather C.; Bruce-Keller, Annadora J.; Keller, Jeffrey N.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Keller, JN (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Jeffrey.keller@pbrc.edu	Keller, Jeffrey N/N-1975-2017; Bruce-Keller, Annadora/N-1954-2017	MacAulay, Rebecca/0000-0002-7985-998X; keller, jeffrey/0000-0002-9892-7423	Hibernia National Bank/Edward G Schlieder Chair; Institute for Dementia Research and Prevention	Hibernia National Bank/Edward G Schlieder Chair; Institute for Dementia Research and Prevention	The Hibernia National Bank/Edward G Schlieder Chair, and supporters of the Institute for Dementia Research and Prevention. The funders of this manuscript had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Allali G, 2007, GAIT POSTURE, V26, P572, DOI 10.1016/j.gaitpost.2006.12.011; Barak Y, 2006, PHYS THER, V86, P1501, DOI 10.2522/ptj.20050387; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2001, SCAND J PSYCHOL, V42, P277, DOI 10.1111/1467-9450.00237; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; Folstein MF, 2001, MIN STAT EX CLIN GUI; Goodglass H., 1983, BOSTON NAMING TEST; Grady CL, 2003, HIPPOCAMPUS, V13, P572, DOI 10.1002/hipo.10114; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hayden KM, 2011, ALZ DIS ASSOC DIS, V25, P128, DOI 10.1097/WAD.0b013e3181ffa76d; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Heun R, 2007, NEUROBIOL AGING, V28, P404, DOI 10.1016/j.neurobiolaging.2006.01.012; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Holtzer R, 2004, MEM COGNITION, V32, P1333, DOI 10.3758/BF03206324; Holtzer R, 2005, NEUROPSYCHOLOGY, V19, P18, DOI 10.1037/0894-4105.19.1.18; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P350; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Nutter-Upham KE, 2008, ARCH CLIN NEUROPSYCH, V23, P229, DOI 10.1016/j.acn.2008.01.005; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith EE., 2007, COGNITIVE PSYCHOL MI; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Voelcker-Rehage C, 2007, J GERONTOL B-PSYCHOL, V62, pP141, DOI 10.1093/geronb/62.3.P141; Wechsler, 1987, WECHSLER ADULT INTEL; Wechsler D., 1984, WMS R WECHSLER MEMOR; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	37	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99436	10.1371/journal.pone.0099436	http://dx.doi.org/10.1371/journal.pone.0099436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905590	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000121
J	Sichelstiel, A; Yadava, K; Trompette, A; Salami, O; Iwakura, Y; Nicod, LP; Marsland, BJ				Sichelstiel, Anke; Yadava, Koshika; Trompette, Aurelien; Salami, Olawale; Iwakura, Yoichiro; Nicod, Laurent P.; Marsland, Benjamin J.			Targeting IL-1 beta and IL-17A Driven Inflammation during Influenza-Induced Exacerbations of Chronic Lung Inflammation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; CIGARETTE-SMOKE; RESPIRATORY VIRUSES; COPD EXACERBATIONS; AIRWAY INFLAMMATION; NEUTROPHIL SURVIVAL; EMPHYSEMA; EXPRESSION; MICE	For patients with chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), exacerbations are life-threatening events causing acute respiratory distress that can even lead to hospitalization and death. Although a great deal of effort has been put into research of exacerbations and potential treatment options, the exact underlying mechanisms are yet to be deciphered and no therapy that effectively targets the excessive inflammation is available. In this study, we report that interleukin-1 beta (IL-1 beta) and interleukin-17A (IL-17A) are key mediators of neutrophilic inflammation in influenza-induced exacerbations of chronic lung inflammation. Using a mouse model of disease, our data shows a role for IL-1 beta in mediating lung dysfunction, and in driving neutrophilic inflammation during the whole phase of viral infection. We further report a role for IL-17A as a mediator of IL-1 beta induced neutrophilia at early time points during influenza-induced exacerbations. Blocking of IL-17A or IL-1 resulted in a significant abrogation of neutrophil recruitment to the airways in the initial phase of infection or at the peak of viral replication, respectively. Therefore, IL-17A and IL-1 beta are potential targets for therapeutic treatment of viral exacerbations of chronic lung inflammation	[Sichelstiel, Anke; Yadava, Koshika; Trompette, Aurelien; Salami, Olawale; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, CHUV, Serv Pneumol, Fac Biol & Med, Lausanne, Switzerland; [Sichelstiel, Anke] ETHZ, Zurich, Switzerland; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; ETH Zurich; Tokyo University of Science	Marsland, BJ (corresponding author), Univ Lausanne, CHUV, Serv Pneumol, Fac Biol & Med, Lausanne, Switzerland.	benjamin.marsland@chuv.ch	Salami, Olawale/AAR-7462-2020; Iwakura, Yoichiro/E-5457-2011; Nicod, Laurent/ABD-3360-2020	Salami, Olawale/0000-0001-9186-8160; Iwakura, Yoichiro/0000-0002-9934-5775; Nicod, Laurent P/0000-0002-0905-916X	ETH Project [01-08-2]; Velux Stiftung	ETH Project; Velux Stiftung	This work has been funded by ETH Project Grant 01-08-2 and the Velux Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Balbi B, 1997, EUR RESPIR J, V10, P846; Barnes PJ, 2010, SCIENCE, V330, P40, DOI 10.1126/science.1196017; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217; Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Daffern PJ, 1999, AM J RESP CELL MOL, V21, P259, DOI 10.1165/ajrcmb.21.2.3605; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Gaschler GJ, 2010, EUR RESPIR J, V36, P1131, DOI 10.1183/09031936.00113909; Gessner C, 2005, RESP MED, V99, P1229, DOI 10.1016/j.rmed.2005.02.041; Hacievliyagil SS, 2006, RESP MED, V100, P846, DOI 10.1016/j.rmed.2005.08.022; Han Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086166; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hoogendoorn M, 2011, EUR RESPIR J, V37, P508, DOI 10.1183/09031936.00043710; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hurst JR, 2005, EUR RESPIR J, V26, P846, DOI 10.1183/09031936.05.00043405; Kersul AL, 2011, ARCH BRONCONEUMOL, V47, P176, DOI 10.1016/j.arbres.2010.12.003; Ko FWS, 2007, CHEST, V132, P900, DOI 10.1378/chest.07-0530; Kythreotis Prokopis, 2009, BMC Pulm Med, V9, P11, DOI 10.1186/1471-2466-9-11; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Larsson L, 2004, INDOOR AIR, V14, P421, DOI 10.1111/j.1600-0668.2004.00290.x; Lucey EC, 2002, LAB INVEST, V82, P79, DOI 10.1038/labinvest.3780397; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Perttunen H, 2008, COPD, V5, P163, DOI 10.1080/15412550802092969; Potena Alfredo, 2007, Int J Chron Obstruct Pulmon Dis, V2, P477; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Suissa S., 2012, THORAX; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tan WC, 2003, AM J MED, V115, P272, DOI 10.1016/S0002-9343(03)00353-X; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030	59	31	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98440	10.1371/journal.pone.0098440	http://dx.doi.org/10.1371/journal.pone.0098440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918427	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000017
J	Smyth, TJ; Allen, I; Atkinson, A; Bruun, JT; Harmer, RA; Pingree, RD; Widdicombe, CE; Somerfield, PJ				Smyth, Tim J.; Allen, Icarus; Atkinson, Angus; Bruun, John T.; Harmer, Rachel A.; Pingree, Robin D.; Widdicombe, Claire E.; Somerfield, Paul J.			Ocean Net Heat Flux Influences Seasonal to Interannual Patterns of Plankton Abundance	PLOS ONE			English	Article							WESTERN ENGLISH-CHANNEL; SPRING PHYTOPLANKTON BLOOMS; TIME-SERIES; CONTINENTAL-SHELF; CRITICAL DEPTH; NORTH-SEA; VARIABILITY; STRATIFICATION; COMMUNITY; ZOOPLANKTON	Changes in the net heat flux (NHF) into the ocean have profound impacts on global climate. We analyse a long-term plankton time-series and show that the NHF is a critical indicator of ecosystem dynamics. We show that phytoplankton abundance and diversity patterns are tightly bounded by the switches between negative and positive NHF over an annual cycle. Zooplankton increase before the transition to positive NHF in the spring but are constrained by the negative NHF switch in autumn. By contrast bacterial diversity is decoupled from either NHF switch, but is inversely correlated (r = 20.920) with the magnitude of the NHF. We show that the NHF is a robust mechanistic tool for predicting climate change indicators such as spring phytoplankton bloom timing and length of the growing season.	[Smyth, Tim J.; Allen, Icarus; Atkinson, Angus; Bruun, John T.; Harmer, Rachel A.; Pingree, Robin D.; Widdicombe, Claire E.; Somerfield, Paul J.] Plymouth Marine Lab, Plymouth, Devon, England	Plymouth Marine Laboratory	Smyth, TJ (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	tjsm@pml.ac.uk	Bruun, John/AAZ-1375-2021; Smyth, Tim J/D-2008-2012; Bruun, John T/C-8849-2018; Widdicombe, Claire/AAC-7358-2022; Somerfield, Paul J/J-9189-2014	Bruun, John T/0000-0003-1307-6103; Somerfield, Paul J/0000-0002-7581-5621; Smyth, Tim/0000-0003-0659-1422	Natural Environmental Research Council National Capability Western Channel Observatory; INTERREG IVA France (Channel) - England programme (FEDER); EU FP7 projects Devotes (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status) [308392]; GreenSeas (Development of global plankton data base and model system for eco-climate early warning) [265294]; NERC [pml010004, NE/L003066/1, pml010010, NE/L003279/1, pml010009, pml010006] Funding Source: UKRI; Natural Environment Research Council [pml010004, NE/L003066/1, pml010009, NE/L003279/1, pml010006, pml010010] Funding Source: researchfish	Natural Environmental Research Council National Capability Western Channel Observatory; INTERREG IVA France (Channel) - England programme (FEDER); EU FP7 projects Devotes (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); GreenSeas (Development of global plankton data base and model system for eco-climate early warning); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is supported by the Natural Environmental Research Council funded National Capability Western Channel Observatory. It also contributes to the projects Marinexus and Charm2 funded in part by the INTERREG IVA France (Channel) - England programme (FEDER), and to the EU FP7 projects Devotes (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status, Grant Agreement number 308392) and GreenSeas (Development of global plankton data base and model system for eco-climate early warning, Grant Agreement number 265294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, EOS T AM GEOPHYS UNI, DOI DOI 10.1029/01EO00004; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Box G., 1970, TIME SERIES ANAL; Chiswell SM, 2011, MAR ECOL PROG SER, V443, P39, DOI 10.3354/meps09453; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Eloire D, 2010, J PLANKTON RES, V32, P657, DOI 10.1093/plankt/fbq009; Freund JA, 2012, MAR BIOL, V159, P2561, DOI 10.1007/s00227-012-2013-7; FUNG IY, 1984, REV GEOPHYS, V22, P177, DOI 10.1029/RG022i002p00177; Garcia-Soto C, 1998, J MAR BIOL ASSOC UK, V78, P17, DOI 10.1017/S002531540003993X; Garcia-Soto C, 2012, J MAR BIOL ASSOC UK, V92, P213, DOI 10.1017/S0025315410002134; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; GREGG MC, 1985, NATURE, V318, P140, DOI 10.1038/318140a0; Huisman J, 1999, LIMNOL OCEANOGR, V44, P1781, DOI 10.4319/lo.1999.44.7.1781; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Kiorboe T., 2008, MECH APPROACH PLANKT; Mackas DL, 2012, PROG OCEANOGR, V97, P31, DOI 10.1016/j.pocean.2011.11.005; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; Mann KH, 2006, DYNAMICS MARINE ECOS; Martin AP, 2005, BIOL LETT-UK, V1, P366, DOI 10.1098/rsbl.2005.0316; PINGREE RD, 1977, ESTUAR COAST MAR SCI, V5, P399, DOI 10.1016/0302-3524(77)90064-0; PINGREE RD, 1987, CONT SHELF RES, V7, P1181, DOI 10.1016/0278-4343(87)90084-7; PINGREE RD, 1989, DEEP-SEA RES, V36, P735, DOI 10.1016/0198-0149(89)90148-9; PINGREE RD, 1975, J MAR BIOL ASSOC UK, V55, P965, DOI 10.1017/S0025315400017859; PINGREE RD, 1976, J MAR BIOL ASSOC UK, V56, P845, DOI 10.1017/S0025315400020919; PINGREE RD, 1975, J MAR BIOL ASSOC UK, V55, P261, DOI 10.1017/S0025315400015939; Pingree RD, 1978, SPATIAL PATTERN PLAN; REED RK, 1977, J PHYS OCEANOGR, V7, P482, DOI 10.1175/1520-0485(1977)007<0482:OEIOTO>2.0.CO;2; REYNOLDS CS, 1993, HYDROBIOLOGIA, V249, P183, DOI 10.1007/BF00008853; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Sharples J, 2006, CONT SHELF RES, V26, P733, DOI 10.1016/j.csr.2006.01.011; Shumway RH, 2010, TIME SERIES ANAL ITS; Smyth TJ, 2010, J PLANKTON RES, V32, P585, DOI 10.1093/plankt/fbp128; Smyth TJ, 2002, APPL OPTICS, V41, P7679, DOI 10.1364/AO.41.007679; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293; THRONDSEN J, 1978, SARSIA, V63, P273, DOI 10.1080/00364827.1978.10411349; TOWNSEND DW, 1992, NATURE, V360, P59, DOI 10.1038/360059a0; *UNESCO, 1968, ZOOPL SAMPL; Widdicombe CE, 2010, J PLANKTON RES, V32, P643, DOI 10.1093/plankt/fbp127; Yu L, 2007, ENCY OCEAN SCI, P21	41	31	31	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98709	10.1371/journal.pone.0098709	http://dx.doi.org/10.1371/journal.pone.0098709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918906	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338631000026
J	Suarez-Pellicioni, M; Nunez-Pena, MI; Colome, A				Suarez-Pellicioni, Macarena; Isabel Nunez-Pena, Maria; Colome, Angels			Reactive Recruitment of Attentional Control in Math Anxiety: An ERP Study of Numeric Conflict Monitoring and Adaptation	PLOS ONE			English	Article							MATHEMATICS ANXIETY; ANTERIOR CINGULATE; COGNITIVE CONTROL; NEURAL ACTIVITY; PROCESSING EFFICIENCY; WORKING-MEMORY; TRAIT ANXIETY; RATING-SCALE; STROOP; PERFORMANCE	This study uses event-related brain potentials (ERPs) to investigate the electrophysiological correlates of numeric conflict monitoring in math-anxious individuals, by analyzing whether math anxiety is related to abnormal processing in early conflict detection (as shown by the N450 component) and/or in a later, response-related stage of processing (as shown by the conflict sustained potential; Conflict-SP). Conflict adaptation effects were also studied by analyzing the effect of the previous trial's congruence in current interference. To this end, 17 low math-anxious (LMA) and 17 high math-anxious (HMA) individuals were presented with a numerical Stroop task. Groups were extreme in math anxiety but did not differ in trait or state anxiety or in simple math ability. The interference effect of the current trial (incongruent-congruent) and the interference effect preceded by congruence and by incongruity were analyzed both for behavioral measures and for ERPs. A greater interference effect was found for response times in the HMA group than in the LMA one. Regarding ERPs, the LMA group showed a greater N450 component for the interference effect preceded by congruence than when preceded by incongruity, while the HMA group showed greater Conflict-SP amplitude for the interference effect preceded by congruence than when preceded by incongruity. Our study showed that the electrophysiological correlates of numeric interference in HMA individuals comprise the absence of a conflict adaptation effect in the first stage of conflict processing (N450) and an abnormal subsequent up-regulation of cognitive control in order to overcome the conflict (Conflict-SP). More concretely, our study shows that math anxiety is related to a reactive and compensatory recruitment of control resources that is implemented only when previously exposed to a stimuli presenting conflicting information.	[Suarez-Pellicioni, Macarena; Isabel Nunez-Pena, Maria; Colome, Angels] Univ Barcelona, Fac Psychol, Dept Behav Sci Methodol, Barcelona, Spain; [Suarez-Pellicioni, Macarena; Isabel Nunez-Pena, Maria] Univ Barcelona, Inst Res Brain Cognit & Behav IR3C, Barcelona, Spain; [Colome, Angels] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona	Nunez-Pena, MI (corresponding author), Univ Barcelona, Fac Psychol, Dept Behav Sci Methodol, Barcelona, Spain.	inunez@ub.edu	colome, angels/H-2522-2015; NÚÑEZ-PEÑA, MARIA ISABEL/B-3883-2011; Suárez Pellicioni, Macarena/H-5527-2015	colome, angels/0000-0002-2976-1853; NÚÑEZ-PEÑA, MARIA ISABEL/0000-0002-3677-859X; Suárez Pellicioni, Macarena/0000-0002-9056-9561	Spanish Ministry of Economy and Competitiveness [PSI2012-35703, BES-2010-036859]; Generalitat de Catalunya [SGR2009-11]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by grants PSI2012-35703 and BES-2010-036859 from the Spanish Ministry of Economy and Competitiveness and SGR2009-11 from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER L, 1989, MEAS EVAL COUNS DEV, V22, P143, DOI 10.1080/07481756.1989.12022923; Ansari TL, 2011, BIOL PSYCHOL, V86, P337, DOI 10.1016/j.biopsycho.2010.12.013; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Ashcraft M. H., 1998, DEV MATH SKILLS STUD, P175; Ashcraft MH., 2005, HDB MATH COGNITION, P315; Baddeley A. D, 1986, WORKING MEMORY; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Coderre E, 2011, BRAIN RES, V1413, P51, DOI 10.1016/j.brainres.2011.07.017; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Faust M. W., 1996, MATH COGNITION, V2, P25, DOI DOI 10.1080/135467996387534; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hochman S. H., 1967, PSYCHON SCI, V9, P475, DOI DOI 10.3758/BF03330904; HOCHMAN SH, 1969, PERCEPT MOTOR SKILL, V28, P115, DOI 10.2466/pms.1969.28.1.115; Hopko DR, 2002, COGNITIVE THER RES, V26, P157, DOI 10.1023/A:1014578218041; Hopko DR, 1998, J ANXIETY DISORD, V12, P343, DOI 10.1016/S0887-6185(98)00019-X; Nunez-Pena MI, 2013, LEARN INDIVID DIFFER, V24, P204, DOI 10.1016/j.lindif.2012.12.009; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lansbergen MM, 2007, J PSYCHOPHYSIOL, V21, P33, DOI 10.1027/0269-8803.21.1.33; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luck S.J., 2005, INTRO EVENT RELATED; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maloney EA, 2011, Q J EXP PSYCHOL, V64, P10, DOI 10.1080/17470218.2010.533278; Maloney EA, 2010, COGNITION, V114, P293, DOI 10.1016/j.cognition.2009.09.013; McNeely HE, 2003, J ABNORM PSYCHOL, V112, P679, DOI 10.1037/0021-843X.112.4.679; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Osinsky R, 2012, BIOL PSYCHOL, V89, P252, DOI 10.1016/j.biopsycho.2011.10.016; Osinsky R, 2010, COGN AFFECT BEHAV NE, V10, P372, DOI 10.3758/CABN.10.3.372; PALLAK MS, 1975, B PSYCHONOMIC SOC, V6, P248, DOI 10.3758/BF03336652; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Soltesz F, 2011, LEARN INDIVID DIFFER, V21, P662, DOI 10.1016/j.lindif.2010.10.004; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger CD., 2008, CUESTIONARIO ANSIEDA; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suarez-Pellicioni M, 2013, BIOL PSYCHOL, V94, P517, DOI 10.1016/j.biopsycho.2013.09.012; Suarez-Pellicioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081143; Szucs D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-35; Szucs D, 2009, NEUROIMAGE, V47, P1960, DOI 10.1016/j.neuroimage.2009.05.048; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Zhu XR, 2010, NEUROSCI LETT, V478, P1, DOI 10.1016/j.neulet.2010.04.036	60	32	32	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99579	10.1371/journal.pone.0099579	http://dx.doi.org/10.1371/journal.pone.0099579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918584	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000096
J	Babu, BK; Dinesh, P; Agrawal, PK; Sood, S; Chandrashekara, C; Bhatt, JC; Kumar, A				Babu, B. Kalyana; Dinesh, Pandey; Agrawal, Pawan K.; Sood, S.; Chandrashekara, C.; Bhatt, Jagadish C.; Kumar, Anil			Comparative Genomics and Association Mapping Approaches for Blast Resistant Genes in Finger Millet Using SSRs	PLOS ONE			English	Article							CALCIUM CONTENT; RICE BLAST; MARKERS; CORACANA; DIVERSITY; SOFTWARE; IDENTIFICATION; GENETICS	The major limiting factor for production and productivity of finger millet crop is blast disease caused by Magnaporthe grisea. Since, the genome sequence information available in finger millet crop is scarce, comparative genomics plays a very important role in identification of genes/QTLs linked to the blast resistance genes using SSR markers. In the present study, a total of 58 genic SSRs were developed for use in genetic analysis of a global collection of 190 finger millet genotypes. The 58 SSRs yielded ninety five scorable alleles and the polymorphism information content varied from 0.186 to 0.677 at an average of 0.385. The gene diversity was in the range of 0.208 to 0.726 with an average of 0.487. Association mapping for blast resistance was done using 104 SSR markers which identified four QTLs for finger blast and one QTL for neck blast resistance. The genomic marker RM262 and genic marker FMBLEST32 were linked to finger blast disease at a P value of 0.007 and explained phenotypic variance (R-2) of 10% and 8% respectively. The genomic marker UGEP81 was associated to finger blast at a P value of 0.009 and explained 7.5% of R-2. The QTLs for neck blast was associated with the genomic SSR marker UGEP18 at a P value of 0.01, which explained 11% of R-2. Three QTLs for blast resistance were found common by using both GLM and MLM approaches. The resistant alleles were found to be present mostly in the exotic genotypes. Among the genotypes of NW Himalayan region of India, VHC3997, VHC3996 and VHC3930 were found highly resistant, which may be effectively used as parents for developing blast resistant cultivars in the NW Himalayan region of India. The markers linked to the QTLs for blast resistance in the present study can be further used for cloning of the full length gene, fine mapping and their further use in the marker assisted breeding programmes for introgression of blast resistant alleles into locally adapted cultivars.	[Babu, B. Kalyana; Dinesh, Pandey; Kumar, Anil] Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India; [Babu, B. Kalyana; Agrawal, Pawan K.; Sood, S.; Chandrashekara, C.; Bhatt, Jagadish C.] Vivekananda Parvateeya Krishi Anusanthan Sansthan, Biotechnol Lab, Almora, Uttarakhand, India	Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan	Babu, BK (corresponding author), Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Mol Biol & Genet Engn, Pantnagar, Uttarakhand, India.	kalyan_biotek@yahoo.co.in; anilkumar.mbge@gmail.com	Sood, Salej/AAR-3504-2020; KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022					Arya L, 2009, J PLANT BIOCHEM BIOT, V18, P97, DOI 10.1007/BF03263303; Babu BK, 2007, GENET RESOUR CROP EV, V54, P399, DOI 10.1007/s10722-006-0002-8; Babu BK, 2014, MOL BIOL REP, V41, P3081, DOI 10.1007/s11033-014-3168-8; Babu BK, 2012, PLANT BREEDING, V131, P20, DOI 10.1111/j.1439-0523.2011.01919.x; Babu TK, 2013, EUR J PLANT PATHOL, V135, P299, DOI 10.1007/s10658-012-0086-2; Bharathi A, 2011, THESIS TAMIL NADU AG; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Carine AT, 2008, PLANT PHYSIOL, V146, P21; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Dida MM, 2008, TROPICAL PLANT BIOL, P31; Dje Y, 2000, THEOR APPL GENET, V100, P918, DOI 10.1007/s001220051371; Gowda BTS, 1986, SABRO J, V18, P119; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Koide Y, 2009, JARQ-JPN AGR RES Q, V43, P255, DOI 10.6090/jarq.43.255; Kumar A, 2012, MOL BIOL REP, V39, P4949, DOI 10.1007/s11033-011-1291-3; Li SG, 2000, PROG NAT SCI, V10, P44; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Mc Couch SR, 1988, THEOR APPL GENET, V76, P15; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Miyamoto M, 1996, MOL PLANT MICROBE IN, V9, P6, DOI 10.1094/MPMI-9-0-0006; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaraja A., 2007, Journal of Mycopathological Research, V45, P237; Nagaraja A., 2010, Crop Research (Hisar), V39, P120; Nirgude M, 2014, MOL BIOL REP, V41, P1189, DOI 10.1007/s11033-013-2825-7; nja MA, 2007, FINGER MILLET BLAST; Pan QH, 1998, PLANT BREEDING, V117, P27, DOI 10.1111/j.1439-0523.1998.tb01443.x; Panwar P, 2011, MOL BIOL REP, V38, P3427, DOI 10.1007/s11033-010-0452-0; Panwar P, 2010, J GENET, V89, P121, DOI 10.1007/s12041-010-0052-8; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard J, 2003, DOCUMENTATION STRUCT; RAO A N S, 1990, Mysore Journal of Agricultural Sciences, V24, P57; Reddy INBL, 2011, MOL BREEDING, V27, P315, DOI 10.1007/s11032-010-9433-1; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; rudin B, 2004, PGR NEWSL, V138, P50; Senthilvel S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-119; SOMASEKHARA YM, 1991, TROP AGR, V68, P231; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Srinivasachary MM, 2007, THEOR APPL GENET, V114, P21; Takan JP, 2012, MOL BIOTECHNOL, V50, P145, DOI 10.1007/s12033-011-9429-z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Udupa SM, 2001, MOL GENET GENOMICS, V265, P1097, DOI 10.1007/s004380100508; Varshney RK, 2000, PLANT MOL BIOL REP, V18, P5, DOI 10.1007/BF02825288; WANG GL, 1994, GENETICS, V136, P1421; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]; YU ZH, 1991, THEOR APPL GENET, V81, P471, DOI 10.1007/BF00219436	50	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99182	10.1371/journal.pone.0099182	http://dx.doi.org/10.1371/journal.pone.0099182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915067	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700069
J	Leslie, T; Martin, NJ; Jack-Roosberg, C; Odongo, G; Beausoleil, E; Tuck, J; Raviprakash, K; Kochel, TJ				Leslie, Teresa; Martin, Nicholas J.; Jack-Roosberg, Carol; Odongo, George; Beausoleil, Edwin; Tuck, Jennifer; Raviprakash, Kanakatte; Kochel, Tadeusz J.			Dengue Serosurvey in Sint Eustatius	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUS; ISLANDS; HEALTH	Four distinct serotypes of dengue viruses (DENV) are the cause of re-emerging dengue fever (DF) and dengue hemorrhagic fever (DHF). Dengue circulation in the Caribbean has gone from none or single serotype to multiple serotypes co-circulating with reports of continuing cycles of progressively more severe disease in the region. Few studies have investigated dengue on Sint Eustatius. Blood samples were collected to determine the prevalence of antibodies against dengue in the Sint Eustatius population. Greater than 90% of the serum samples (184 of 204) were positive for anti-flavivirus antibodies by enzyme linked immunosorbance assay (ELISA). Plaque reduction neutralization test (PRNT), specific for dengue viruses, showed that 171 of these 184 flavivirus antibody positive sera had a neutralization titer against one or more DENV serotypes. A majority of the sera (62%) had neutralizing antibody to all four dengue serotypes. Only 26 PRNT positive sera (15%) had monotypic dengue virus neutralizing antibody, most of which (20 of 26) were against DENV2. Evidence of infection with all four serotypes was observed across all age groups except in the youngest age group (10-19 years) which contained only DENV2 positive individuals. In a multiple logistic regression model, only the length of residence on the island was a predictor of a positive dengue PRNT50 result. To our knowledge this is the first dengue serosurveillance study conducted on Sint Eustatius since the 1970s. The lack of antibodies to the DEN1, 3, and 4 in the samples collected from participants under 20 years of age suggests that only DEN2 has circulated on island since the early 1990s. The high prevalence of antibodies against dengue (83.8%) and the observation that the length of time on the island was the strongest predictor of infection suggests dengue is endemic on Sint Eustatius and a public health concern that warrants further investigation.	[Leslie, Teresa] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Leslie, Teresa; Beausoleil, Edwin; Tuck, Jennifer] Eastern Caribbean Publ Hlth Fdn, Sint Eustatius, Netherlands; [Martin, Nicholas J.; Raviprakash, Kanakatte; Kochel, Tadeusz J.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD 20910 USA; [Jack-Roosberg, Carol] Sint Eustatius Publ Hlth Dept, Sint Eustatius, Netherlands; [Odongo, George] Queen Beatrix Med Ctr, Sint Eustatius, Netherlands	University System of Maryland; University of Maryland College Park; Naval Medical Research Center (NMRC)	Martin, NJ (corresponding author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD 20910 USA.	njmartin.reh@gmail.com			Military Infectious Diseases Research Program [S0353_12]	Military Infectious Diseases Research Program	This project was supported by a grant from the Military Infectious Diseases Research Program (S0353_12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CR, 1956, SCIENCE, V124, P224, DOI 10.1126/science.124.3214.224; ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brown T. U., 2004, Dengue Bulletin, V28, P7; GRIFFITHS BB, 1968, AM J TROP MED HYG, V17, P584, DOI 10.4269/ajtmh.1968.17.584; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Isturiz RE, 2000, INFECT DIS CLIN N AM, V14, P121, DOI 10.1016/S0891-5520(05)70221-X; Keating J, 2001, SOC SCI MED, V53, P1587, DOI 10.1016/S0277-9536(00)00443-3; Kesztyus B, 2005, DEN DUTCH CAR 15 EUR; KNUDSEN AB, 1983, MOSQ NEWS, V43, P269; Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a; NEFF JM, 1967, AM J EPIDEMIOL, V86, P162, DOI 10.1093/oxfordjournals.aje.a120722; Pan American Health Organization, 1965, EPIDEMIOLOGICAL NOTE, V37, P116; Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; RUSSELL PK, 1967, J IMMUNOL, V99, P285; van der KUYP E., 1949, DOCUMENTA NEERLAND ET INDONESICA MORBIS TROP, V1, P69; VANDERKUYP E, 1948, AM J TROP MED, V28, P747; VANDERSAR A, 1979, TROP GEOGR MED, V31, P229; WHO, 2013, 2 WHO	21	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e95002	10.1371/journal.pone.0095002	http://dx.doi.org/10.1371/journal.pone.0095002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914538	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700002
J	Marzal, M; Guerra-Giraldez, C; Paredes, A; Cangalaya, C; Rivera, A; Gonzalez, AE; Mahanty, S; Garcia, HH; Nash, TE				Marzal, Miguel; Guerra-Giraldez, Cristina; Paredes, Adriana; Cangalaya, Carla; Rivera, Andrea; Gonzalez, Armando E.; Mahanty, Siddhartha; Garcia, Hector H.; Nash, Theodore E.		Cysticercosis Working Grp Peru	Evans Blue Staining Reveals Vascular Leakage Associated with Focal Areas of Host-Parasite Interaction in Brains of Pigs Infected with Taenia solium	PLOS ONE			English	Article							PORCINE CYSTICERCOSIS; SCHISTOSOMA-MANSONI; INFLAMMATORY REACTION; HUMAN EOSINOPHILS; BARRIER; NEUROCYSTICERCOSIS; PERMEABILITY; DISEASE; MUSCLE; LARVAE	Cysticidal drug treatment of viable Taenia solium brain parenchymal cysts leads to an acute pericystic host inflammatory response and blood brain barrier breakdown (BBB), commonly resulting in seizures. Naturally infected pigs, untreated or treated one time with praziquantel were sacrificed at 48 hr and 120 hr following the injection of Evans blue (EB) to assess the effect of treatment on larval parasites and surrounding tissue. Examination of harvested non encapsulated muscle cysts unexpectedly revealed one or more small, focal round region(s) of Evans blue dye infiltration (REBI) on the surface of otherwise non dye-stained muscle cysts. Histopathological analysis of REBI revealed focal areas of eosinophil-rich inflammatory infiltrates that migrated from the capsule into the tegument and internal structures of the parasite. In addition some encapsulated brain cysts, in which the presence of REBI could not be directly assessed, showed histopathology identical to that of the REBI. Muscle cysts with REBI were more frequent in pigs that had received praziquantel (6.6% of 3736 cysts; n = 6 pigs) than in those that were untreated (0.2% of 3172 cysts; n = 2 pigs). Similar results were found in the brain, where 20.7% of 29 cysts showed histopathology identical to muscle REBI cysts in praziquantel-treated pigs compared to the 4.3% of 47 cysts in untreated pigs. Closer examination of REBI infiltrates showed that EB was taken up only by eosinophils, a major component of the cellular infiltrates, which likely explains persistence of EB in the REBI. REBI likely represent early damaging host responses to T. solium cysts and highlight the focal nature of this initial host response and the importance of eosinophils at sites of host-parasite interaction. These findings suggest new avenues for immunomodulation to reduce inflammatory side effects of anthelmintic therapy.	[Marzal, Miguel; Guerra-Giraldez, Cristina; Paredes, Adriana; Cangalaya, Carla; Rivera, Andrea; Mahanty, Siddhartha; Garcia, Hector H.; Nash, Theodore E.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Immunopathol Neurocysticercosis, Lima, Peru; [Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Fac Med Vet, Lima 14, Peru; [Mahanty, Siddhartha; Nash, Theodore E.] NIAID, NIH, Bethesda, MD 20892 USA; [Garcia, Hector H.] Inst Nacl Ciencias Neurol, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nash, TE (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Immunopathol Neurocysticercosis, Lima, Peru.	tnash@niaid.nih.gov	Guerra-Giraldez, Cristina/AAK-8596-2020; Mayta, Holger/ABA-4755-2020	Guerra-Giraldez, Cristina/0000-0002-9287-9838; Mayta, Holger/0000-0001-5306-628X; Verastegui, Manuela/0000-0002-7500-1353; Gonzalez, Armando/0000-0003-1909-1873; Gonzales-Gustavson, Eloy/0000-0001-7328-2983; Rivera Santillan, Andrea Mercedes/0000-0003-0093-3946; Cangalaya, Carla/0000-0002-3525-8445; Mahanty, Siddhartha/0000-0003-1068-0524; Orrego Solano, Miguel Angel/0000-0003-0036-427X	National Institutes of Allergy and Infectious Diseases; Fogarty International Center/NIH [D43 TW001140]; Wellcome Trust International Senior Research Fellowship in Public Health and Tropical Medicine; National Institutes of Health; FOGARTY INTERNATIONAL CENTER [D43TW001140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000846] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust International Senior Research Fellowship in Public Health and Tropical Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by intramural program of the National Institutes of Allergy and Infectious Diseases (www.niaid.nih.gov/), National Institutes of Health, and also with partial support from the Fogarty International Center/NIH (http://www.fic.nih.gov/; Training grant D43 TW001140). HHG is supported by a Wellcome Trust International Senior Research Fellowship in Public Health and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 1999, ADV DRUG DELIVER REV, V37, P253, DOI 10.1016/S0169-409X(98)00097-0; ALLEN TH, 1950, AM J PHYSIOL, V161, P473, DOI 10.1152/ajplegacy.1950.161.3.473; Alvarez JI, 2002, J COMP PATHOL, V127, P186, DOI 10.1053/jcpa.2002.0579; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; CHANDRASHEKAR R, 1990, INT J PARASITOL, V20, P725, DOI 10.1016/0020-7519(90)90005-8; DEALUJA AS, 1988, VET PARASITOL, V28, P65, DOI 10.1016/0304-4017(88)90019-2; DEALUJA AS, 1989, CLIN IMAG, V13, P292, DOI 10.1016/0899-7071(89)90062-4; Deckers N, 2008, INT J PARASITOL, V38, P1191, DOI 10.1016/j.ijpara.2008.01.005; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Evans CAW, 1997, AM J TROP MED HYG, V56, P33, DOI 10.4269/ajtmh.1997.56.33; Fang WR, 2013, NEUROCHEM INT, V62, P23, DOI 10.1016/j.neuint.2012.10.012; Garcia HH, 2011, CURR OPIN INFECT DIS, V24, P423, DOI 10.1097/QCO.0b013e32834a1b20; Gonzalez AE, 2012, AM J TROP MED HYG, V87, P292, DOI 10.4269/ajtmh.2012.11-0371; Guerra-Giraldez C, 2013, EXP PARASITOL, V134, P443, DOI 10.1016/j.exppara.2013.05.005; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; HANES MA, 1995, VET PATHOL, V32, P441, DOI 10.1177/030098589503200418; Ito A, 1998, PARASITE IMMUNOL, V20, P105, DOI 10.1046/j.1365-3024.1998.00108.x; ITO U, 1975, ACTA NEUROPATHOL, V34, P1; Jithendran K. P., 1998, Indian Journal of Experimental Biology, V36, P523; KASSIS AI, 1979, J IMMUNOL, V122, P398; Lampinen M, 2006, INT ARCH ALLERGY IMM, V140, P113, DOI 10.1159/000092412; Londono DP, 2002, VET PARASITOL, V109, P249, DOI 10.1016/S0304-4017(02)00290-X; Mahanty S, 2010, PROG NEUROBIOL, V91, P172, DOI 10.1016/j.pneurobio.2009.12.008; Matsumoto K, 2011, INT ARCH ALLERGY IMM, V155, P34, DOI 10.1159/000327263; MILHORAT TH, 1975, J NEUROSURG, V42, P315, DOI 10.3171/jns.1975.42.3.0315; Nash TE, 2003, ACTA TROP, V87, P61, DOI 10.1016/S0001-706X(03)00056-1; Nash T, 2012, PATHOG GLOB HEALTH, V106, P275, DOI 10.1179/2047773212Y.0000000026; Nash TE, 2011, NAT REV NEUROL, V7, P584, DOI 10.1038/nrneurol.2011.135; Nutten S, 1999, EUR J IMMUNOL, V29, P799, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;799::AID-IMMU799&gt;3.0.CO;2-1; Ooi WW, 2011, AM J TROP MED HYG, V85, P460, DOI 10.4269/ajtmh.2011.11-0221; Perez-Torres A, 2002, PARASITOL RES, V88, P150, DOI 10.1007/s00436-001-0510-6; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Robinson P, 1997, INFECT IMMUN, V65, P2925, DOI 10.1128/IAI.65.7.2925-2931.1997; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Sikasunge CS, 2008, VET PARASITOL, V158, P57, DOI 10.1016/j.vetpar.2008.08.014; Sikasunge CS, 2009, VET PARASITOL, V160, P242, DOI 10.1016/j.vetpar.2008.11.015; STEINWALL O, 1966, J NEUROPATH EXP NEUR, V25, P542, DOI 10.1097/00005072-196610000-00004; TAM ND, 1983, AUST J EXP BIOL MED, V61, P629, DOI 10.1038/icb.1983.59; THUMWOOD CM, 1989, BRIT J EXP PATHOL, V70, P293; TORRES A, 1992, PARASITOL RES, V78, P161, DOI 10.1007/BF00931659; WILLMS K, 1980, PARASITE IMMUNOL, V2, P261, DOI 10.1111/j.1365-3024.1980.tb00058.x; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	44	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97321	10.1371/journal.pone.0097321	http://dx.doi.org/10.1371/journal.pone.0097321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915533	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700010
J	Perkins, AD; Tanentzapf, G				Perkins, Alexander D.; Tanentzapf, Guy			An Ongoing Role for Structural Sarcomeric Components in Maintaining Drosophila melanogaster Muscle Function and Structure	PLOS ONE			English	Article							THIN FILAMENT LENGTH; INDIRECT FLIGHT-MUSCLE; MYOSIN HEAVY; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; STRIATED-MUSCLE; NEGATIVE GEOTAXIS; GENETIC-ANALYSIS; ACTIN-FILAMENTS; POINTED ENDS	Animal muscles must maintain their function while bearing substantial mechanical loads. How muscles withstand persistent mechanical strain is presently not well understood. The basic unit of muscle is the sarcomere, which is primarily composed of cytoskeletal proteins. We hypothesized that cytoskeletal protein turnover is required to maintain muscle function. Using the flight muscles of Drosophila melanogaster, we confirmed that the sarcomeric cytoskeleton undergoes turnover throughout adult life. To uncover which cytoskeletal components are required to maintain adult muscle function, we performed an RNAi-mediated knockdown screen targeting the entire fly cytoskeleton and associated proteins. Gene knockdown was restricted to adult flies and muscle function was analyzed with behavioural assays. Here we analyze the results of that screen and characterize the specific muscle maintenance role for several hits. The screen identified 46 genes required for muscle maintenance: 40 of which had no previously known role in this process. Bioinformatic analysis highlighted the structural sarcomeric proteins as a candidate group for further analysis. Detailed confocal and electron microscopic analysis showed that while muscle architecture was maintained after candidate gene knockdown, sarcomere length was disrupted. Specifically, we found that ongoing synthesis and turnover of the key sarcomere structural components Projectin, Myosin and Actin are required to maintain correct sarcomere length and thin filament length. Our results provide in vivo evidence of adult muscle protein turnover and uncover specific functional defects associated with reduced expression of a subset of cytoskeletal proteins in the adult animal.	[Perkins, Alexander D.; Tanentzapf, Guy] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Tanentzapf, G (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	tanentz@mail.ubc.ca	Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X; Perkins, Alexander/0000-0002-9817-2390	Natural Sciences and Engineering Research Council of Canada [356502]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	G.T. and A.D.P. gratefully acknowledge the support of the Natural Sciences and Engineering Research Council of Canada (Grant Number 356502; http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Barton B, 2007, J MUSCLE RES CELL M, V28, P219, DOI 10.1007/s10974-007-9120-y; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Beckett K, 2006, INT REV NEUROBIOL, V75, P55, DOI 10.1016/S0074-7742(06)75003-6; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burkart C, 2007, J MOL BIOL, V367, P953, DOI 10.1016/j.jmb.2007.01.059; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; CHUN MY, 1988, J CELL BIOL, V107, P2613, DOI 10.1083/jcb.107.6.2613; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Contompasis JL, 2010, J MOL BIOL, V395, P340, DOI 10.1016/j.jmb.2009.11.021; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Engel Andrew G, 2008, Handb Clin Neurol, V91, P103, DOI 10.1016/S0072-9752(07)01503-5; FERNANDES J, 1991, DEVELOPMENT, V113, P67; Fraterman S, 2007, MOL CELL PROTEOMICS, V6, P728, DOI 10.1074/mcp.M600345-MCP200; FYRBERG CC, 1992, P ROY SOC B-BIOL SCI, V249, P33, DOI 10.1098/rspb.1992.0080; FYRBERG E, 1989, CELL MOTIL CYTOSKEL, V14, P118, DOI 10.1002/cm.970140121; FYRBERG EA, 1990, ANNU REV CELL BIOL, V6, P559, DOI 10.1146/annurev.cb.06.110190.003015; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Ghosh SR, 2010, EUR J CELL BIOL, V89, P437, DOI 10.1016/j.ejcb.2009.11.027; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; KAR NC, 1979, CLIN CHIM ACTA, V94, P277, DOI 10.1016/0009-8981(79)90076-7; KARLIK CC, 1984, CELL, V38, P711, DOI 10.1016/0092-8674(84)90266-6; KRONERT WA, 1995, J MOL BIOL, V249, P111, DOI 10.1006/jmbi.1995.0283; Kucherenko MM, 2011, DEV BIOL, V352, P228, DOI 10.1016/j.ydbio.2011.01.013; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; LAGRANGE BM, 1976, DEV BIOL, V54, P214, DOI 10.1016/0012-1606(76)90300-6; Laviolette MJ, 2005, GENETICS, V170, P779, DOI 10.1534/genetics.104.035691; LAZARO RP, 1986, AM J CLIN PATHOL, V86, P378, DOI 10.1093/ajcp/86.3.378; Leal SM, 2002, J NEUROBIOL, V50, P245, DOI 10.1002/neu.10030; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Lopes KD, 2011, J CELL BIOL, V193, P785, DOI 10.1083/jcb.201010099; Maqbool T, 2007, J MUSCLE RES CELL M, V28, P397, DOI 10.1007/s10974-008-9133-1; Mardahl-Dumesnil M, 2001, J CELL BIOL, V155, P1043, DOI 10.1083/jcb.200108026; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miller MS, 2008, BIOPHYS J, V95, P2391, DOI [10.1529/biophysj.108.130005, 10.1529/hiophysj.108.130005]; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Nongthomba U, 2003, GENETICS, V164, P209; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; PAI AC, 1965, DEV BIOL, V11, P82, DOI 10.1016/0012-1606(65)90038-2; Perkins AD, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.2; Perkins AD, 2010, DEV BIOL, V338, P15, DOI 10.1016/j.ydbio.2009.10.034; Piazza N, 2011, PROG MOL BIOL TRANSL, V100, P155, DOI 10.1016/B978-0-12-384878-9.00005-4; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Rando TA, 2002, AM J PHYS MED REHAB, V81, pS175, DOI 10.1097/00002060-200211001-00018; Reedy MC, 2000, J CELL BIOL, V151, P1483, DOI 10.1083/jcb.151.7.1483; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Roper K, 2005, J CELL SCI, V118, P3937, DOI 10.1242/jcs.02517; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Salmikangas P, 2003, HUM MOL GENET, V12, P189, DOI 10.1093/hmg/ddg020; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; Schnorrer F, 2007, DEV CELL, V12, P751, DOI 10.1016/j.devcel.2007.02.017; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Seto JT, 2011, EXP GERONTOL, V46, P292, DOI 10.1016/j.exger.2010.11.006; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; Sparrow J, 2008, ADV EXP MED BIOL, V642, P192; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Spence HJ, 2002, BIOESSAYS, V24, P542, DOI 10.1002/bies.10098; Tanner BCW, 2011, AM J PHYSIOL-CELL PH, V301, pC383, DOI 10.1152/ajpcell.00016.2011; Thornhill P, 2008, BRAIN, V131, P1551, DOI 10.1093/brain/awn078; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Vigoreaux JO, 2006, MOL B INT U, P143, DOI 10.1007/0-387-32963-3_12; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; ZAK R, 1977, J BIOL CHEM, V252, P3430	83	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99362	10.1371/journal.pone.0099362	http://dx.doi.org/10.1371/journal.pone.0099362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915196	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700089
J	Powell, TY; Boonstra, TW; Martin, DM; Loo, CK; Breakspear, M				Powell, Tamara Y.; Boonstra, Tjeerd W.; Martin, Donel M.; Loo, Colleen K.; Breakspear, Michael			Modulation of Cortical Activity by Transcranial Direct Current Stimulation in Patients with Affective Disorder	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; NONINVASIVE BRAIN-STIMULATION; WORKING-MEMORY IMPROVEMENT; ANTERIOR CINGULATE; THETA-OSCILLATIONS; MAJOR DEPRESSION; EEG ALPHA; TDCS; EXCITABILITY; INHIBITION	Transcranial direct current stimulation (tDCS) has been shown to have antidepressant efficacy in patients experiencing a major depressive episode, but little is known about the underlying neurophysiology. The purpose of our study was to investigate the acute effects of tDCS on cortical activity using electroencephalography (EEG) in patients with an affective disorder. Eighteen patients diagnosed with an affective disorder and experiencing a depressive episode participated in a sham-controlled study of tDCS, each receiving a session of active (2 mA for 20 minutes) and sham tDCS to the left dorsolateral prefrontal cortex (DLPFC). The effects of tDCS on EEG activity were assessed after each session using event-related potentials (ERP) and measurement of spectral activity during a visual working memory (VWM) task. We observed task and intervention dependent effects on both ERPs and task-related alpha and theta activity, where active compared to sham stimulation resulted in a significant reduction in the N2 amplitude and reduced theta activity over frontal areas during memory retrieval. In summary a single session of anodal tDCS stimulation to the left DLPFC during a major depressive episode resulted in modulated brain activity evident in task-related EEG. Effects on the N2 and frontal theta activity likely reflect modulated activity in the medial frontal cortex and hence indicate that the after-effects of tDCS extend beyond the direct focal effects to the left DLPFC.	[Powell, Tamara Y.; Boonstra, Tjeerd W.; Martin, Donel M.; Loo, Colleen K.; Breakspear, Michael] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Powell, Tamara Y.; Boonstra, Tjeerd W.; Martin, Donel M.; Loo, Colleen K.; Breakspear, Michael] Black Dog Inst, Sydney, NSW, Australia; [Boonstra, Tjeerd W.] Vrije Univ Amsterdam, MOVE Res Inst, Amsterdam, Netherlands; [Loo, Colleen K.] St George Hosp, Kogarah, NSW, Australia; [Breakspear, Michael] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Breakspear, Michael] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	University of New South Wales Sydney; Black Dog Institute; Vrije Universiteit Amsterdam; St George Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Powell, TY (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	tamara.powell@qimrberghofer.edu.au	Breakspear, Michael/ABF-6302-2020; Breakspear, Michael/M-5859-2014; Boonstra, Tjeerd/C-5433-2011	Breakspear, Michael/0000-0003-4943-3969; Boonstra, Tjeerd/0000-0002-6969-7243; powell, tamara/0000-0003-2859-3103; Martin, Donel/0000-0002-8452-0390; Loo, Colleen/0000-0003-3267-0554	ARC Thinking Systems grant [TS0669860]; National Health and Medical Research Council (NHMRC) [510142]; BrainNRG collaborative award [JSMF22002082]; Netherlands Organisation for Scientific Research (NWO) [45110-030]	ARC Thinking Systems grant(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); BrainNRG collaborative award; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the ARC Thinking Systems grant (TS0669860); the National Health and Medical Research Council (NHMRC #510142); BrainNRG collaborative award (JSMF22002082), and the Netherlands Organisation for Scientific Research (NWO #45110-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Arul-Anandam AP, 2009, J AFFECT DISORDERS, V117, P137, DOI 10.1016/j.jad.2009.01.016; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Awh E, 2008, NAT NEUROSCI, V11, P5, DOI 10.1038/nn0108-5; Baskaran A, 2012, NEUROPHARMACOLOGY; Boonstra TW, 2013, INT J PSYCHOPHYSIOL, V89, P409, DOI 10.1016/j.ijpsycho.2013.04.001; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; da Silva MC, 2013, J PHYSIOL-PARIS, V107, P493, DOI 10.1016/j.jphysparis.2013.07.003; Dell'Osso B, 2012, EUR PSYCHIAT, V27, P513, DOI 10.1016/j.eurpsy.2011.02.008; Faria P, 2012, EPILEPSY BEHAV, V25, P417, DOI 10.1016/j.yebeh.2012.06.027; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Heimrath K, 2012, Front Psychiatry, V3, P56, DOI 10.3389/fpsyt.2012.00056; Hoy KE, 2013, NEUROPSYCHOLOGIA, V51, P1777, DOI 10.1016/j.neuropsychologia.2013.05.018; Jacobson L, 2012, CLIN NEUROPHYSIOL, V123, P979, DOI 10.1016/j.clinph.2011.09.016; Jensen MP, 2013, CLIN NEUROPHYSIOL, V124, P2016, DOI 10.1016/j.clinph.2013.04.009; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kalska H, 1999, Appl Neuropsychol, V6, P96, DOI 10.1207/s15324826an0602_5; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kochan NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023960; Krause CM, 2000, CLIN NEUROPHYSIOL, V111, P2071, DOI 10.1016/S1388-2457(00)00429-6; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Liu ZX, 2014, NEUROIMAGE, V85, P873, DOI 10.1016/j.neuroimage.2013.08.054; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Moran RJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00200; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2009, BIOL PSYCHIAT, V66, P503, DOI 10.1016/j.biopsych.2009.03.022; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palm U, 2009, WORLD J BIOL PSYCHIA, V10, P632, DOI 10.1080/15622970802480905; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Rose EJ, 2006, J AFFECT DISORDERS, V90, P149, DOI 10.1016/j.jad.2005.11.003; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Schestatsky P, 2013, JOVE-J VIS EXP, DOI 10.3791/50426; Segrave RA, 2010, J AFFECT DISORDERS, V127, P191, DOI 10.1016/j.jad.2010.05.022; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tsoneva Tsvetomira, 2011, Annu Int Conf IEEE Eng Med Biol Soc, V2011, P3828, DOI 10.1109/IEMBS.2011.6090952; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	65	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98503	10.1371/journal.pone.0098503	http://dx.doi.org/10.1371/journal.pone.0098503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914953	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700023
J	Willenbrock, S; Wagner, S; Reimann-Berg, N; Moulay, M; Hewicker-Trautwein, M; Nolte, I; Escobar, HM				Willenbrock, Saskia; Wagner, Siegfried; Reimann-Berg, Nicola; Moulay, Mohammed; Hewicker-Trautwein, Marion; Nolte, Ingo; Escobar, Hugo Murua			Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model	PLOS ONE			English	Article							MOBILITY GROUP A2; CARCINOMA CELL-LINE; HMGI-C; VIVO MODEL; TUMOR-DEVELOPMENT; PERIPHERAL-BLOOD; EXPRESSION; LET-7; MICRORNA; PROTEINS	The architectural transcription factor HMGA2 is abundantly expressed during embryonic development. In several malignant neoplasias including prostate cancer, high re-expression of HMGA2 is correlated with malignancy and poor prognosis. The let-7 miRNA family is described to regulate HMGA2 negatively. The balance of let-7 and HMGA2 is discussed to play a major role in tumour aetiology. To further analyse the role of HMGA2 in prostate cancer a stable and highly reproducible in vitro model system is precondition. Herein we established a canine CT1258-EGFP-HMGA2 prostate cancer cell line stably overexpressing HMGA2 linked to EGFP and in addition the reference cell line CT1258-EGFP expressing solely EGFP to exclude EGFP-induced effects. Both recombinant cell lines were characterised by fluorescence microscopy, flow cytometry and immunocytochemistry. The proliferative effect of ectopically overexpressed HMGA2 was determined via BrdU assays. Comparative karyotyping of the derived and the initial CT1258 cell lines was performed to analyse chromosome consistency. The impact of the ectopic HMGA2 expression on its regulator let-7a was analysed by quantitative real-time PCR. Fluorescence microscopy and immunocytochemistry detected successful expression of the EGFP-HMGA2 fusion protein exclusively accumulating in the nucleus. Gene expression analyses confirmed HMGA2 overexpression in CT1258-EGFP-HMGA2 in comparison to CT1258-EGFP and native cells. Significantly higher let-7a expression levels were found in CT1258-EGFP-HMGA2 and CT1258-EGFP. The BrdU assays detected an increased proliferation of CT1258-HMGA2-EGFP cells compared to CT1258-EGFP and native CT1258. The cytogenetic analyses of CT1258-EGFP and CT1258-EGFP-HMGA2 resulted in a comparable hyperdiploid karyotype as described for native CT1258 cells. To further investigate the impact of recombinant overexpressed HMGA2 on CT1258 cells, other selected targets described to underlie HMGA2 regulation were screened in addition. The new fluorescent CT1258-EGFP-HMGA2 cell line is a stable tool enabling in vitro and in vivo analyses of the HMGA2-mediated effects on cells and the development and pathogenesis of prostate cancer.	[Willenbrock, Saskia; Wagner, Siegfried; Reimann-Berg, Nicola; Moulay, Mohammed; Nolte, Ingo; Escobar, Hugo Murua] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Wagner, Siegfried] Leibniz Univ Hannover, Inst Biophys, Hannover, Germany; [Hewicker-Trautwein, Marion] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Escobar, Hugo Murua] Univ Rostock, Div Med Haematol Oncol & Palliat Med, D-18055 Rostock, Germany	University of Veterinary Medicine Hannover, Foundation; Leibniz University Hannover; University of Veterinary Medicine Hannover, Foundation; University of Rostock	Escobar, HM (corresponding author), Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany.	Hugo.Murua.Escobar@med.uni-rostock.de	Moulay, Mohammed/AAK-5699-2021	Moulay, Mohammed/0000-0002-3082-0101	Small Animal Clinic, University of Veterinary Medicine, Hannover	Small Animal Clinic, University of Veterinary Medicine, Hannover	No third party funds supported this study. The study was financed with the internal budget of the Small Animal Clinic, University of Veterinary Medicine, Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2003, BRIT J CANCER, V89, P2104, DOI 10.1038/sj.bjc.6601391; Aggarwal S, 2006, PROSTATE, V66, P903, DOI 10.1002/pros.20413; Anidjar M, 2001, PROSTATE, V46, P2; AUMULLER G, 1990, PROSTATE, V17, P31, DOI 10.1002/pros.2990170105; Battista S, 1999, CANCER RES, V59, P4793; Belge G, 2008, GENE CHROMOSOME CANC, V47, P56, DOI 10.1002/gcc.20505; BELL FW, 1991, J AM VET MED ASSOC, V199, P1623; BELL FW, 1995, J VET INTERN MED, V9, P149, DOI 10.1111/j.1939-1676.1995.tb03288.x; BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545; BULLERDIEK J, 1987, CANCER GENET CYTOGEN, V24, P205, DOI 10.1016/0165-4608(87)90100-2; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cattaruzzi G, 2007, NUCLEIC ACIDS RES, V35, P1751, DOI 10.1093/nar/gkl1106; Cleynen I, 2008, INT J ONCOL, V32, P289; Cornell KK, 2000, PROSTATE, V45, P173; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Fan TM, 2007, WITHROW MACEWENS SMA; Fork MAM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-240; Gioia G, 2011, VET IMMUNOL IMMUNOP, V142, P228, DOI 10.1016/j.vetimm.2011.05.020; Henriksen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-329; Hess JL, 1998, AM J CLIN PATHOL, V109, P251, DOI 10.1093/ajcp/109.3.251; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joetzke AE, 2010, VET COMP ONCOL, V8, P87, DOI 10.1111/j.1476-5829.2010.00207.x; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; KAIGHN ME, 1979, INVEST UROL, V17, P16; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Khanna C, 2009, CLIN CANCER RES, V15, P5671, DOI 10.1158/1078-0432.CCR-09-0719; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lai CL, 2008, PROSTATE, V68, P477, DOI 10.1002/pros.20720; Langelotz C, 2003, BRIT J CANCER, V88, P1406, DOI 10.1038/sj.bjc.6600935; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LeRoy BE, 2009, VET J, V180, P149, DOI 10.1016/j.tvjl.2008.07.012; Li Z, DEV CELL, V23, P1176; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MCENTEE M, 1987, PROSTATE, V11, P163, DOI 10.1002/pros.2990110207; Meyer B, 2007, LEUKEMIA LYMPHOMA, V48, P2008, DOI 10.1080/10428190701559116; Meyer B, 2007, MOL CARCINOGEN, V46, P503, DOI 10.1002/mc.20235; Miyazawa J, 2004, CANCER RES, V64, P2024, DOI 10.1158/0008-5472.CAN-03-1855; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Mueller F, 2007, ANTICANCER RES, V27, P155; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pegoraro S, 2013, ONCOTARGET, V4, P1293, DOI 10.18632/oncotarget.1136; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Qian ZR, 2009, MODERN PATHOL, V22, P431, DOI 10.1038/modpathol.2008.202; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Reimann N, 1996, CYTOGENET CELL GENET, V73, P140, DOI 10.1159/000134326; Reimann-Berg N, 2011, CYTOGENET GENOME RES, V132, P16, DOI 10.1159/000317077; Rogalla P, 1997, MOL CARCINOGEN, V19, P153, DOI 10.1002/(SICI)1098-2744(199707)19:3<153::AID-MC2>3.0.CO;2-F; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Roush SF, 2009, DEV BIOL, V334, P523, DOI 10.1016/j.ydbio.2009.07.012; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schubert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065064; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Sorenmo K U, 2003, Vet Comp Oncol, V1, P48, DOI 10.1046/j.1476-5829.2003.00007.x; Sterenczak KA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-284; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tallini G, 1999, ADV ANAT PATHOL, V6, P237, DOI 10.1097/00125480-199909000-00001; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; VELDSCHOLTE J, 1990, BIOCHIM BIOPHYS ACTA, V1052, P187, DOI 10.1016/0167-4889(90)90075-O; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Waters DJ, 1998, PROSTATE, V36, P64; Winkler S, 2005, J HERED, V96, P782, DOI 10.1093/jhered/esi085; Winkler S, 2007, CANCER GENET CYTOGEN, V177, P98, DOI 10.1016/j.cancergencyto.2007.06.008; Wisniewski JR, 2000, INT J MOL MED, V6, P409; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Wood LJ, 2000, CANCER RES, V60, P4256; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhu C, 2013, MOL CELL BIOCHEM, V379, P69, DOI 10.1007/s11010-013-1628-4; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	84	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98788	10.1371/journal.pone.0098788	http://dx.doi.org/10.1371/journal.pone.0098788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914948	Green Published, gold			2022-12-27	WOS:000340947700032
J	Wong, MC; Dobi, KC; Baylies, MK				Wong, Ming-Ching; Dobi, Krista C.; Baylies, Mary K.			Discrete Levels of Twist Activity Are Required to Direct Distinct Cell Functions during Gastrulation and Somatic Myogenesis	PLOS ONE			English	Article							DROSOPHILA MESODERM DEVELOPMENT; ADHERENS JUNCTIONS; SHAPE CHANGES; FGF-RECEPTOR; TRANSCRIPTION FACTORS; DEVELOPMENTAL CONTROL; DORSOVENTRAL PATTERN; REGULATORY NETWORKS; FOUNDER CELLS; ZYGOTIC GENE	Twist (Twi), a conserved basic helix-loop-helix transcriptional regulator, directs the epithelial-to-mesenchymal transition (EMT), and regulates changes in cell fate, cell polarity, cell division and cell migration in organisms from flies to humans. Analogous to its role in EMT, Twist has been implicated in metastasis in numerous cancer types, including breast, pancreatic and prostate. In the Drosophila embryo, Twist is essential for discrete events in gastrulation and mesodermal patterning. In this study, we derive a twi allelic series by examining the various cellular events required for gastrulation in Drosophila. By genetically manipulating the levels of Twi activity during gastrulation, we find that coordination of cell division is the most sensitive cellular event, whereas changes in cell shape are the least sensitive. Strikingly, we show that by increasing levels of Snail expression in a severe twi hypomorphic allelic background, but not a twi null background, we can reconstitute gastrulation and produce viable adult flies. Our results demonstrate that the level of Twi activity determines whether the cellular events of ventral furrow formation, EMT, cell division and mesodermal migration occur.	[Wong, Ming-Ching; Dobi, Krista C.; Baylies, Mary K.] Sloan Kettering Inst, Program Dev Biol, New York, NY 10065 USA; [Wong, Ming-Ching; Baylies, Mary K.] Cornell Med Sch, Weill Grad Sch, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Baylies, MK (corresponding author), Sloan Kettering Inst, Program Dev Biol, New York, NY 10065 USA.	m-baylies@ski.mskcc.org		Dobi, Krista C./0000-0001-6826-2195	National Institutes of General Medicine [GM 56980]; NIH [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056989, R01GM056980] Funding Source: NIH RePORTER	National Institutes of General Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding Support: National Institutes of General Medicine GM 56980 to MKB and NIH P30 CA008748 to Memorial Sloan Kettering Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artero R, 2003, DEVELOPMENT, V130, P6257, DOI 10.1242/dev.00843; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BATE M, 1991, DEVELOPMENT, V113, P79; BAYLIES MK, 1995, DEVELOPMENT, V121, P3829; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Bernard F, 2010, DEVELOPMENT, V137, P2633, DOI 10.1242/dev.053181; BODMER R, 1993, DEVELOPMENT, V118, P719; Bonn S, 2008, CURR OPIN GENET DEV, V18, P513, DOI 10.1016/j.gde.2008.09.005; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRAND AH, 1993, DEVELOPMENT, V118, P401; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gonzalez-Crespo S, INTERACTIONS DORSAL; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Knust E, 1996, BIOESSAYS, V18, P609, DOI 10.1002/bies.950180802; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; LEPTIN M, 1992, DEVELOPMENT, P23; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; Lin MH, 1997, DEV BIOL, V182, P240, DOI 10.1006/dbio.1996.8484; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Mathew SJ, 2011, MOL CELL BIOL, V31, P4978, DOI 10.1128/MCB.05542-11; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Nabel-Rosen H, 2005, CURR BIOL, V15, P295, DOI 10.1016/j.cub.2005.01.045; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Park KW, 2012, BMB REP, V45, P577, DOI 10.5483/BMBRep.2012.45.10.105; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Rembold M, CONSERVED ROLE SNAIL; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Shishido E, 1997, DEVELOPMENT, V124, P2119; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMPSON P, 1983, GENETICS, V105, P615; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Wilson R, 2005, DEVELOPMENT, V132, P491, DOI 10.1242/dev.01603; Wong MC, 2008, DEV BIOL, V317, P417, DOI 10.1016/j.ydbio.2008.02.020; Yagi Y, 1997, GENES CELLS, V2, P41, DOI 10.1046/j.1365-2443.1997.d01-282.x; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128	60	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99553	10.1371/journal.pone.0099553	http://dx.doi.org/10.1371/journal.pone.0099553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915423	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700116
J	DeBord, JD; Smith, DF; Anderton, CR; Heeren, RMA; Pasa-Tolic, L; Gomer, RH; Fernandez-Lima, FA				DeBord, John Daniel; Smith, Donald F.; Anderton, Christopher R.; Heeren, Ron M. A.; Pasa-Tolic, Ljiljana; Gomer, Richard H.; Fernandez-Lima, Francisco A.			Secondary Ion Mass Spectrometry Imaging of Dictyostelium discoideum Aggregation Streams	PLOS ONE			English	Article							TOF-SIMS; LIPID-COMPOSITION; PLASMA-MEMBRANES; ACCURACY; SURFACES; ENERGY; BEAMS	High resolution imaging mass spectrometry could become a valuable tool for cell and developmental biology, but both, high spatial and mass spectral resolution are needed to enable this. In this report, we employed Bi-3 bombardment time-off-light (Bi-3 ToF-SIMS) and C-60 bombardment Fourier transform ion cyclotron resonance secondary ion mass spectrometry (C-60 FTICR-SIMS) to image Dictyostelium discoideum aggregation streams. Nearly 300 lipid species were identified from the aggregation streams. High resolution mass spectrometry imaging (FTICR-SIMS) enabled the generation of multiple molecular ion maps at the nominal mass level and provided good coverage for fatty acyls, prenol lipids, and sterol lipids. The comparison of Bi-3 ToF-SIMS and C-60 FTICR-SIMS suggested that while the first provides fast, high spatial resolution molecular ion images, the chemical complexity of biological samples warrants the use of high resolution analyzers for accurate ion identification.	[DeBord, John Daniel; Fernandez-Lima, Francisco A.] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Smith, Donald F.; Heeren, Ron M. A.] FOM Inst AMOLF, Amsterdam, Netherlands; [Anderton, Christopher R.; Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	State University System of Florida; Florida International University; AMOLF; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Texas A&M University System; Texas A&M University College Station	Fernandez-Lima, FA (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	fernandf@fiu.edu	Heeren, Ron/ABA-4858-2020; Smith, Donald F/K-3939-2013	Heeren, Ron/0000-0002-6533-7179; Anderton, Christopher/0000-0002-6170-1033; Smith, Donald/0000-0003-3331-0526; Fernandez-Lima, Francisco/0000-0002-1283-4390; Gomer, Richard/0000-0003-2361-4307	NIGMS [R00GM106414, GM102280]; Department of Energy's Office of Biological and Environmental Research (DOE-BER); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM106414, R01GM102280] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy's Office of Biological and Environmental Research (DOE-BER)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIGMS grants R00GM106414 to FF-L and GM102280 to RHG. A portion of this research was performed at the W. R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research (DOE-BER) and located at Pacific Northwest National Laboratory (PNNL). This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of The Netherlands Organization for Scientific Research (NWO).	Benabdellah F, 2010, ANAL BIOANAL CHEM, V396, P151, DOI 10.1007/s00216-009-3031-2; Beu SC, 2011, J AM SOC MASS SPECTR, V22, P591, DOI 10.1007/s13361-010-0057-9; Bich C, 2013, ANAL CHEM, V85, P7745, DOI 10.1021/ac4009513; Birch GL, 2011, LIPIDOMIC PROFILING; Bouneau S, 2004, NUCL INSTRUM METH B, V225, P579, DOI 10.1016/j.nimb.2004.06.005; Brison J, 2010, J PHYS CHEM C, V114, P5565, DOI 10.1021/jp9066179; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brunelle A, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.022902; Cheng J, 2005, ANAL CHEM, V77, P3651, DOI 10.1021/ac048131w; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Delcorte A, 2013, J PHYS CHEM C, V117, P2740, DOI 10.1021/jp308411r; Della-Negra S, 2011, SURF INTERFACE ANAL, V43, P62, DOI 10.1002/sia.3416; Ellis S, 2013, ANAL BIOANAL CHEM, P1; Fernandez-Lima FA, 2013, SURF INTERFACE ANAL, V45, P294, DOI 10.1002/sia.4901; Fernandez-Lima FA, 2011, ANAL CHEM, V83, P8448, DOI 10.1021/ac201481r; Ferreri C, 2005, CHEMBIOCHEM, V6, P1722, DOI 10.1002/cbic.200500109; Fhaner CJ, 2012, ANAL CHEM, V84, P8917, DOI 10.1021/ac302154g; Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u; Fletcher JS, 2011, MASS SPECTROM REV, V30, P142, DOI 10.1002/mas.20275; Fletcher JS, 2008, ANAL CHEM, V80, P9058, DOI 10.1021/ac8015278; Fletcher JS, 2006, ANAL CHEM, V78, P1827, DOI 10.1021/ac051624w; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Gilmore IS, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4816935; Gormanns P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030576; Green FM, 2011, ANAL CHEM, V83, P3239, DOI 10.1021/ac200067s; HASE A, 1981, Journal of the Faculty of Science Hokkaido University Series V Botany, V12, P183; Jang W, 2011, EUKARYOT CELL, V10, P150, DOI 10.1128/EC.00219-10; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; LONG BH, 1974, J BIOL CHEM, V249, P521; Muramoto S, 2012, ANAL CHEM, V84, P365, DOI 10.1021/ac202713k; Novikov A, 2005, RAPID COMMUN MASS SP, V19, P1851, DOI 10.1002/rcm.1995; Ostrowski SG, 2005, ANAL CHEM, V77, P6190, DOI 10.1021/ac0508189; Paquet VE, 2013, EUKARYOT CELL, V12, P1326, DOI 10.1128/EC.00107-13; Petkovic M, 2001, ANAL BIOCHEM, V289, P202, DOI 10.1006/abio.2000.4926; Piehowski PD, 2008, ANAL CHEM, V80, P8662, DOI 10.1021/ac801591r; Rabbani S, 2011, ANAL CHEM, V83, P3793, DOI 10.1021/ac200288v; SINGH SB, 1991, TETRAHEDRON LETT, V32, P5279, DOI 10.1016/S0040-4039(00)92364-5; Smith DF, 2013, ANAL BIOANAL CHEM, V405, P6069, DOI 10.1007/s00216-013-7048-1; Smith DF, 2011, ANAL CHEM, V83, P9552, DOI 10.1021/ac2023348; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; TAKEDA N, 1987, CLIN CHEM, V33, P682; Touboul D, 2011, BIOCHIMIE, V93, P113, DOI 10.1016/j.biochi.2010.05.013; VanStipdonk MJ, 1996, RAPID COMMUN MASS SP, V10, P1987; WEEKS G, 1980, J LIPID RES, V21, P681; Wu CP, 2013, MASS SPECTROM REV, V32, P218, DOI 10.1002/mas.21360; YOSHIOKA S, 1985, J LIPID RES, V26, P1134	47	12	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99319	10.1371/journal.pone.0099319	http://dx.doi.org/10.1371/journal.pone.0099319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911189	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600073
J	Mohan, K; Purnapatra, SB; Mondal, PP				Mohan, Kavya; Purnapatra, Subhajit B.; Mondal, Partha Pratim			Three Dimensional Fluorescence Imaging Using Multiple Light-Sheet Microscopy	PLOS ONE			English	Article							LIVE CELLS; RESOLUTION; MULTILAYER; DYNAMICS; PROTEIN; BEAM	We developed a multiple light-sheet microscopy (MLSM) system capable of 3D fluorescence imaging. Employing spatial filter in the excitation arm of a SPIM system, we successfully generated multiple light-sheets. This improves upon the existing SPIM system and is capable of 3D volume imaging by simultaneously illuminating multiple planes in the sample. Theta detection geometry is employed for data acquisition from multiple specimen layers. This detection scheme inherits many advantages including, background reduction, cross-talk free fluorescence detection and high-resolution at long working distance. Using this technique, we generated 5 equi-intense light-sheets of thickness approximately 7: 5 mm with an inter-sheet separation of 15 mm. Moreover, the light-sheets generated by MLSM is found to be 2 times thinner than the state-of-art SPIM system. Imaging of fluorescently coated yeast cells of size 4 +/- 1 mm (encaged in Agarose gel-matrix) is achieved. Proposed imaging technique may accelerate the field of fluorescence microscopy, cell biology and biophotonics.	[Mohan, Kavya; Purnapatra, Subhajit B.; Mondal, Partha Pratim] Indian Inst Sci, Dept Instrumentat & Appl Phys, Bangalore 560012, Karnataka, India; [Mondal, Partha Pratim] Indian Inst Sci, Appl Photon Initiat, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Mondal, PP (corresponding author), Indian Inst Sci, Dept Instrumentat & Appl Phys, Bangalore 560012, Karnataka, India.	partha@iap.iisc.ernet.in			Department of Science & Technology, Indian National Science Academy, Board of Research in Nuclear Sciences ( Department of Atomic Energy) [2010/20/34/8/BRNS/2230]; Edmund Optics higher education grant; parent institute Indian Institute of Science	Department of Science & Technology, Indian National Science Academy, Board of Research in Nuclear Sciences ( Department of Atomic Energy); Edmund Optics higher education grant; parent institute Indian Institute of Science	Support for this study was received from Department of Science & Technology, Indian National Science Academy, Board of Research in Nuclear Sciences ( Department of Atomic Energy), 2010/20/34/8/BRNS/2230, Edmund Optics higher education grant, and parent institute Indian Institute of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Baumgart E, 2012, OPT EXPRESS, V20, P21805, DOI 10.1364/OE.20.021805; Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Carlton PM, 2010, P NATL ACAD SCI USA, V107, P16016, DOI 10.1073/pnas.1004037107; Dalgarno PA, 2010, OPT EXPRESS, V18, P877, DOI 10.1364/OE.18.000877; Demuro A, 2008, CELL CALCIUM, V43, P367, DOI 10.1016/j.ceca.2007.07.002; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Engelbrecht CJ, 2006, OPT LETT, V31, P1477, DOI 10.1364/OL.31.001477; Fahrbach FO, 2013, OPT EXPRESS, V21, P13824, DOI 10.1364/OE.21.013824; Fahrbach FO, 2010, NAT PHOTONICS, V4, P780, DOI [10.1038/nphoton.2010.204, 10.1038/NPHOTON.2010.204]; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kamp F, 1998, BIOPHYS J, V74, P290, DOI 10.1016/S0006-3495(98)77786-0; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kozak LP, 2012, NAT MED, V18, P1458, DOI 10.1038/nm.2956; Lehnert M, 2013, LANGMUIR, V29, P1732, DOI 10.1021/la303750p; Lindek S, 1999, OPT LETT, V24, P1505, DOI 10.1364/OL.24.001505; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Mondal PP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00149; Mondal PP, 2010, NANOSCALE, V2, P381, DOI 10.1039/b9nr00348g; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Prabhat P, 2004, IEEE T NANOBIOSCI, V3, P237, DOI 10.1109/TNB.2004.837899; Purnapatra SB, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816419; Purnapatra SB, 2013, AIP ADV, V3, DOI 10.1063/1.4807670; Purnapatra SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00692; Ramajo AP, 2006, CHEM PHYS, V323, P11, DOI 10.1016/j.chemphys.2005.08.033; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schonbrun J, 2003, P NATL ACAD SCI USA, V100, P12678, DOI 10.1073/pnas.1735417100; Silvestri L, 2012, OPT EXPRESS, V20, P20582, DOI 10.1364/OE.20.020582; STELZER EHK, 1994, OPT COMMUN, V111, P536, DOI 10.1016/0030-4018(94)90533-9; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Volk M, 2009, BIOPHYS J, V96, p322A, DOI 10.1016/j.bpj.2008.12.1619; Yang WJ, 2001, J COLLOID INTERF SCI, V234, P356, DOI 10.1006/jcis.2000.7325; Zanacchi FC, NATURE METHODS, V8, P1047	44	19	27	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e96551	10.1371/journal.pone.0096551	http://dx.doi.org/10.1371/journal.pone.0096551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911061	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000337165600122
J	Wu, JQ; Xu, JH; Zhang, ZF; Ren, JC; Li, YY; Wang, J; Cao, YL; Rong, F; Zhao, R; Huang, XL; Du, J				Wu, Junqing; Xu, Jianhua; Zhang, Zhaofeng; Ren, Jingcao; Li, Yuyan; Wang, Jian; Cao, Yunlei; Rong, Fen; Zhao, Rui; Huang, Xianliang; Du, Jing			Association of FTO Polymorphisms with Obesity and Metabolic Parameters in Han Chinese Adolescents	PLOS ONE			English	Article							BIRTH-WEIGHT; FAT MASS; GENE; VARIANTS; CHILDHOOD; CHILDREN; RISK	Background: Previous studies have suggested that fat mass-and obesity-associated (FTO) gene is associated with body mass index (BMI) and the risk of obesity. This study aims to assess the association of five FTO polymorphisms (rs9939609, rs8050136, rs1558902, rs3751812 and rs6499640) with obesity and relative parameters in Han Chinese adolescents. Methods: We examined a total of 401 adolescents, 223 normal weights (58.7% boys, 41.3% girls), 178 overweight (60.1% boys, 39.9% girls), aging from 14 to 18-years-old, recruited randomly from public schools in the central region of Wuxi, a southern city of China. DNA samples were genotyped for the five polymorphisms by Sequenom Plex MassARRAY. Association of the FTO polymorphisms with BMI, serum fasting plasm glucose (FPG), fasting insulin (FIns), triglyceride (TG) and cholesterol (TC) were investigated. Results: 1) Serum FPG, FIns, TG and TC were statistically significant higher than that in normal control group. 2) We found that BMI was higher in the rs9939609 TA+AA, rs8050136 AC+AA, rs1558902 TA+AA and rs3751812 GT+TT genotypes than in wild TT genotypes (rs9939609: P = 0.038; rs1558902: P = 0.038;), CC genotypes(rs8050136: P = 0.024) and GG genotypes (rs3751812: P = 0.024), which were not significant on adjusting for multiple testing. 3) In case-control studies, five polymorphisms were not significantly associated with overweight (p > 0.05), haplotype analyses showed non-haplotype is significantly associated with a higher risk of being overweight (p > 0.05). 4) There existed no significant statistical difference about FPG, FIns, TG and TC in genotype model for any SNP. Conclusions: Our study has conducted a genetic association study of the FTO polymorphisms with BMI, serum fasting plasm glucose (FPG), fasting insulin (FIns), triglyceride (TG) and cholesterol (TC). Our study found BMI of subjects with A allele of FTO rs9939609 is higher than that with T allele. Further studies on other polymorphisms from FTO and increasing the sample size are needed.	[Wu, Junqing; Li, Yuyan; Rong, Fen; Zhao, Rui] Shanghai Inst Planned Parenthood Res, WHO Collaborating Ctr Human Res, Shanghai, Peoples R China; [Wu, Junqing; Xu, Jianhua; Zhang, Zhaofeng; Li, Yuyan; Wang, Jian; Cao, Yunlei; Rong, Fen; Zhao, Rui; Huang, Xianliang; Du, Jing] Shanghai Inst Planned Parenthood Res, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China; [Xu, Jianhua; Zhang, Zhaofeng; Wang, Jian; Cao, Yunlei; Huang, Xianliang; Du, Jing] Fudan Univ, Shanghai Med Coll, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Ren, Jingcao] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang City, Henan, Peoples R China	Fudan University; Xinxiang Medical University	Wu, JQ (corresponding author), Shanghai Inst Planned Parenthood Res, WHO Collaborating Ctr Human Res, Shanghai, Peoples R China.	wujq1688@163.com; dujing42@126.com	Du, Jing/AAY-4092-2021	Du, Jing/0000-0002-6767-2763; Zhao, Rui/0000-0001-6445-3461	National Nature Science Foundation of China [81072364]; Knowledge Innovation Program in Chinese Academy of Sciences [KSCX2-EW-R-06]; Science and Technology Development Fund of Shanghai Municipal Commission of Health & Family Planning [2011GJ02]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program in Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Development Fund of Shanghai Municipal Commission of Health & Family Planning	This work was supported by National Nature Science Foundation of China (No. 81072364), the Knowledge Innovation Program in Chinese Academy of Sciences (No. KSCX2-EW-R-06) to YLW, and Science and Technology Development Fund of Shanghai Municipal Commission of Health & Family Planning (2011GJ02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bressler J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010521; [曹凌峰 CAO Ling-feng], 2010, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V5, P46; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Groop L, 2007, NAT GENET, V39, P706, DOI 10.1038/ng0607-706; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Ji Cheng-ye, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P103; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li Y, 2013, J HUM HYPERTENS, V27, P686, DOI 10.1038/jhh.2013.31; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Ma L, 2014, EUR J PEDIA IN PRESS; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Moore SC, 2012, OBESITY, V20, P1902, DOI 10.1038/oby.2011.238; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Olza J, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-123; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Ren JC, 2013, SAUDI MED J, V34, P623; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wang LN, 2013, OBES RES CLIN PRACT, V7, pE14, DOI 10.1016/j.orcp.2011.12.007; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu JQ, 2013, IRAN J PUBLIC HEALTH, V42, P480	29	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98984	10.1371/journal.pone.0098984	http://dx.doi.org/10.1371/journal.pone.0098984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911064	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600031
J	Bracale, R; Petroni, ML; Davinelli, S; Bracale, U; Scapagnini, G; Carruba, MO; Nisoli, E				Bracale, Renata; Petroni, Maria Letizia; Davinelli, Sergio; Bracale, Umberto; Scapagnini, Giovanni; Carruba, Michele O.; Nisoli, Enzo			Muscle Uncoupling Protein 3 Expression Is Unchanged by Chronic Ephedrine/Caffeine Treatment: Results of a Double Blind, Randomised Clinical Trial in Morbidly Obese Females	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; WEIGHT-LOSS; ENERGY-EXPENDITURE; BODY-COMPOSITION; SKELETAL-MUSCLE; MESSENGER-RNA; CAFFEINE; THERMOGENESIS; ADIPOCYTES; PLASMA	Ephedrine/caffeine combination (EC) has been shown to induce a small-to-moderate weight loss in obese patients. Several mechanisms have been proposed, among which an increased thermogenic capacity of skeletal muscle consequent to the EC-induced up-regulation of uncoupling protein 3 (UCP3) gene expression. We did a parallel group double-blind, placebo-controlled, 4-week trial to investigate this hypothesis. Thirteen morbidly obese women (25-52 years of age, body-mass index 48.0 +/- 4.0 kg/m(2), range 41.1-57.6) were randomly assigned to EC (200/20 mg, n = 6) or to placebo (n = 7) administered three times a day orally, before undergoing bariatric surgery. All individuals had an energy-deficit diet equal to about 70% of resting metabolic rate (RMR) diet (mean 5769 +/- 1105 kJ/day). The RMR analysed by intention to treat and the UCP3 (long and short isoform) mRNA levels in rectus abdominis were the primary outcomes. Body weight, plasma levels of adrenaline, noradrenaline, triglycerides, free fatty acids, glycerol, TSH, fT4, and fT3 were assessed, as well as fasting glucose, insulin and HOMA index, at baseline and at the end of treatments. Body weight loss was evident in both groups when compared to baseline values (overall -5.2 +/- 3.2%, p<0.0001) without significant differences between the treated groups. EC treatment increased the RMR (+9.2 +/- 6.8%, p = 0.020), differently from placebo which was linked to a reduction of RMR (-7.6 +/- 6.5%, p = 0.029). No significant differences were seen in other metabolic parameters. Notably, no changes of either UCP3 short or UCP3 long isoform mRNA levels were evident between EC and placebo group. Our study provides evidence that 4-week EC administration resulted in a pronounced thermogenic effect not related to muscle UCP3 gene expression and weight loss in morbidly obese females under controlled conditions.	[Bracale, Renata; Davinelli, Sergio; Scapagnini, Giovanni] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy; [Petroni, Maria Letizia] IRCCS Inst Auxol Italiano, Clin Nutr Lab, Oggebbio, Verbania, Italy; [Davinelli, Sergio; Scapagnini, Giovanni] Interuniv Consortium SannioTech, Benevento, Italy; [Bracale, Umberto] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Carruba, Michele O.; Nisoli, Enzo] Univ Milan, Dept Med Biotechnol & Translat Med, Ctr Study & Res Obes, Milan, Italy	University of Molise; IRCCS Istituto Auxologico Italiano; University of Naples Federico II; University of Milan	Nisoli, E (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Ctr Study & Res Obes, Milan, Italy.	enzo.nisoli@unimi.it	Nisoli, Enzo/D-6526-2014; Petroni, Maria Letizia/AAD-9430-2021; Davinelli, Sergio/U-1545-2017; Scapagnini, Giovanni/AAF-7491-2019	Nisoli, Enzo/0000-0002-6670-1630; Petroni, Maria Letizia/0000-0002-7040-6466; Davinelli, Sergio/0000-0003-2578-7199; Carruba, Michele/0000-0003-4589-387X; SCAPAGNINI, Giovanni/0000-0003-1592-5586; Bracale, Umberto/0000-0002-9868-0889; BRACALE, Renata/0000-0003-3650-7033				ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989; ASTRUP A, 1992, INT J OBESITY, V16, P269; ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S; Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207; BELLET S, 1969, METABOLIS, V18, P288, DOI 10.1016/0026-0495(69)90049-3; BERKOWITZ BA, 1971, EUR J PHARMACOL, V13, P193, DOI 10.1016/0014-2999(71)90150-6; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brunton L., 2011, GOODMAN GILMANS PHAR; BUEMANN B, 1994, INT J OBESITY, V18, P329; BUKOWIECKI L, 1982, INT J OBESITY, V6, P343; Casazza K, 2012, CLIN OBES, V2, P83, DOI 10.1111/j.1758-8111.2012.00052.x; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; De Matteis R, 2002, INT J OBESITY, V26, P1442, DOI 10.1038/sj.ijo.0802148; Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005; DULLOO AG, 1993, INT J OBESITY, V17, pS35; DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Forster CD, 1999, BIOMED CHROMATOGR, V13, P209, DOI 10.1002/(SICI)1099-0801(199905)13:3<209::AID-BMC820>3.0.CO;2-Z; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Greenway FL, 1999, OBES RES, V7, P523, DOI 10.1002/j.1550-8528.1999.tb00709.x; Hallas J, 2008, AM J EPIDEMIOL, V168, P966, DOI 10.1093/aje/kwn191; Ingerslev J, 1997, INT J OBESITY, V21, P666, DOI 10.1038/sj.ijo.0800457; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x; KRIEGER DR, 1990, T ASSOC AM PHYSICIAN, V103, P307; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Liu AG, 2013, OBESITY, V21, P1991, DOI 10.1002/oby.20416; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MILLER DS, 1974, P NUTR SOC, V33, pA28; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; Molnar D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433; Nabben M, 2011, BBA-BIOENERGETICS, V1807, P1095, DOI 10.1016/j.bbabio.2011.04.003; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; PASQUALI R, 1993, INT J OBESITY, V17, pS65; Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537; Solanes G, 1997, J BIOL CHEM, V272, P25433, DOI 10.1074/jbc.272.41.25433; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	43	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98244	10.1371/journal.pone.0098244	http://dx.doi.org/10.1371/journal.pone.0098244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905629	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000023
J	Du, MJ; Chen, XD; Zhou, XL; Wan, YJ; Lan, B; Zhang, CZ; Cao, YJ				Du, Ming-juan; Chen, Xiang-dong; Zhou, Xiao-li; Wan, Ya-juan; Lan, Bei; Zhang, Cui-zhu; Cao, Youjia			Estrogen Induces Vav1 Expression in Human Breast Cancer Cells	PLOS ONE			English	Article							SIGNAL TRANSDUCER VAV1; EXCHANGE FACTOR VAV1; CYCLE PROGRESSION; TRANSCRIPTION FACTOR; RECEPTOR INTERACTION; MECHANISMS; PROTEIN; IDENTIFICATION; APOPTOSIS; DISEASE	Vav1, a guanine nucleotide exchange factor (GEF) for Rho family GTPases, is a hematopoietic protein involved in a variety of cellular events. In recent years, aberrant expression of Vav1 has been reported in non-hematopoietic cancers including human breast cancer. It remains to be answered how Vav1 is expressed and what Vav1 does in its non-resident tissues. In this study, we aimed to explore the mechanism for Vav1 expression in breast cancer cells in correlation with estrogen-ER pathway. We not only verified the ectopic expression of Vav1 in human breast cancer cell lines, but also observed that Vav1 expression was induced by 17 beta-estradiol (E-2), a typical estrogen receptor (ER) ligand, in ER-positive cell lines. On the other hand, Tamoxifen, a selective estrogen receptor modulator (SERM), and ICI 182,780, an ER antagonist, suppressed the expression of Vav1. The estrogen receptor modulating Vav1 expression was identified to be alpha form, not beta. Furthermore, treatment of E-2 increased the transcription of vav1 gene by enhancing the promoter activity, though there was no recognizable estrogen response element (ERE). Nevertheless, two regions at the vav1 gene promoter were defined to be responsible for E-2-induced activation of vav1 promoter. Chromatin immunoprecipitation (ChIP) and co-immunoprecipitation (Co-IP) analyses suggested that ER alpha might access to the vav1 promoter via interacting with transcription factors, c-Myb and ELF-1. Consequently, the enhanced expression of Vav1 led to the elevation of Cyclin D1 and the progression of cell cycle. The present study implies that estrogen-ER modulates the transcription and expression of Vav1, which may contribute to the proliferation of cancerous cells.	[Du, Ming-juan; Chen, Xiang-dong; Zhou, Xiao-li; Wan, Ya-juan; Cao, Youjia] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Lan, Bei; Zhang, Cui-zhu; Cao, Youjia] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Cao, YJ (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn						BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Chan HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030397; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Gerloff A, 2011, ONCOL REP, V26, P1121, DOI 10.3892/or.2011.1409; Gjerstorff MF, 2006, INT J ONCOL, V28, P1327; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Huynh KT, 2012, EXPERT REV MOL DIAGN, V12, P371, DOI [10.1586/erm.12.26, 10.1586/ERM.12.26]; Ilan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029939; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan VC, 2009, CANCER RES, V69, P1243, DOI 10.1158/0008-5472.CAN-09-0029; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Lane Jane, 2008, Int Semin Surg Oncol, V5, P23, DOI 10.1186/1477-7800-5-23; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Li SY, 2013, J BIOL CHEM, V288, P3777, DOI 10.1074/jbc.M112.426221; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Parl FF, 2009, ANN NY ACAD SCI, V1155, P68, DOI 10.1111/j.1749-6632.2008.03676.x; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Petz LN, 2002, ENDOCRINOLOGY, V143, P4583, DOI 10.1210/en.2002-220369; Poelzl G, 2000, P NATL ACAD SCI USA, V97, P2836, DOI 10.1073/pnas.050580997; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Sebban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054321; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shigekawa Takashi, 2011, Hormones & Cancer, V2, P286, DOI 10.1007/s12672-011-0082-6; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Swaby RF, 2007, REV ENDOCR METAB DIS, V8, P229, DOI 10.1007/s11154-007-9034-4; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang X, 2009, JOVE-J VIS EXP, V32, pe1499, DOI DOI 10.3791/1499; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yin J, 2011, ACTA PHARMACOL SIN, V32, P99, DOI 10.1038/aps.2010.185; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200	49	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99052	10.1371/journal.pone.0099052	http://dx.doi.org/10.1371/journal.pone.0099052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905577	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000099
J	Wang, HJ; Xu, CY; Kong, XL; Li, XY; Kong, XN; Wang, Y; Ding, X; Yang, QF				Wang, Haiji; Xu, Chunyuan; Kong, Xiaoli; Li, Xiaoyan; Kong, Xiangnan; Wang, Yu; Ding, Xia; Yang, Qifeng			Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; CELLS; OVERCOME; RECEPTOR; SURVIVAL; CHEMORESISTANCE; SENSITIVITY; METASTASIS; ACTIVATION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis of cancer cells and is verified effective to various cancers. However, a variety of breast cancer cell lines are resistant to TRAIL and the mechanisms of resistance are largely unknown. In our present experiment, we successfully utilized breast cancer cell line MDA-MB-231 to establish TRAIL-resistant cell line. We found resistance to TRAIL could induce epithelial-mesenchymal transition (EMT) and enhance invasiveness. We further demonstrated PTEN was down-regulated in TRAIL-resistant cells. Silencing miR-221, PTEN expression was up-regulated, the process of EMT could be reversed, and the ability of migration and invasion were correspondingly weakened. We also demonstrated knockdown of miR-221 could reverse resistance to TRAIL partially by targeting PTEN. Our findings suggest that resistance to TRAIL could induce EMT and enhance invasiveness by suppressing PTEN via miR-221. Re-expression of miR-221 or targeting PTEN might serve as potential therapeutic approaches for the treatment of Trail-resistant breast cancer.	[Wang, Haiji; Xu, Chunyuan; Ding, Xia] Shandong Univ, Dept Oncol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Haiji] Qingdao Univ, Dept Oncol, Affiliated Hosp, Coll Med, Qingdao, Shandong, Peoples R China; [Wang, Haiji; Kong, Xiaoli; Li, Xiaoyan; Kong, Xiangnan; Yang, Qifeng] Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Xu, Chunyuan] Qingdao Municipal Hosp, Dept Oncol, Qingdao, Shandong, Peoples R China; [Wang, Yu] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Qingdao University; Shandong University; Qingdao Municipal Hospital; Shandong University	Yang, QF (corresponding author), Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022	Yang, Qifeng/0000-0003-0576-8513				Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bonavida Benjamin, 2011, Critical Reviews in Oncogenesis, V16, P211; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043; de Jong S, 2001, CANCER METAST REV, V20, P51, DOI 10.1023/A:1013112624971; Ding J, 2012, J BIOL CHEM, V287, P641, DOI 10.1074/jbc.M111.286526; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Germano S, 2009, CURR CANCER DRUG TAR, V9, P398, DOI 10.2174/156800909788166529; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Hotte SJ, 2008, CLIN CANCER RES, V14, P3450, DOI 10.1158/1078-0432.CCR-07-1416; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Lagadec C, 2008, ONCOGENE, V27, P1472, DOI 10.1038/sj.onc.1210749; Lai D, 2012, BIOSCIENCE REP, V32, P361, DOI 10.1042/BSR20110125; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Metwalli AR, 2010, CANCER BIOL THER, V10, P889, DOI 10.4161/cbt.10.9.13237; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Rahman M, 2009, ADV CANCER RES, V103, P43, DOI 10.1016/S0065-230X(09)03003-6; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Shin EC, 2002, EXP MOL MED, V34, P114, DOI 10.1038/emm.2002.17; Srivastava RK, 2010, MOL CANCER THER, V9, P3254, DOI 10.1158/1535-7163.MCT-10-0582; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Tanic N, 2012, CANCER BIOL THER, V13, P1165, DOI 10.4161/cbt.21346; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomek S, 2004, GYNECOL ONCOL, V94, P107, DOI 10.1016/j.ygyno.2004.04.012; Voelkel-Johnson C, 2002, CANCER GENE THER, V9, P164, DOI 10.1038/sj.cgt.7700420; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Ye X, 2013, BMB REPORTS; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203; Zhang A-Li, 2005, Ai Zheng, V24, P1301; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang XD, 1999, CANCER RES, V59, P2747; Zhuang H, 2012, J MOL MED BERL	44	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99067	10.1371/journal.pone.0099067	http://dx.doi.org/10.1371/journal.pone.0099067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905916	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000102
J	Perley, CC; Frahm, M; Click, EM; Dobos, KM; Ferrari, G; Stout, JE; Frothingham, R				Perley, Casey C.; Frahm, Marc; Click, Eva M.; Dobos, Karen M.; Ferrari, Guido; Stout, Jason E.; Frothingham, Richard			The Human Antibody Response to the Surface of Mycobacterium tuberculosis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PULMONARY TUBERCULOSIS; MEDIATED IMMUNITY; HUMORAL RESPONSE; INFECTION; ANTIGENS; PROFILES; CELLS; SURVIVAL; MODEL	Background: Vaccine-induced human antibodies to surface components of Haemophilus influenzae and Streptococcus pneumonia are correlated with protection. Monoclonal antibodies to surface components of Mycobacterium tuberculosis are also protective in animal models. We have characterized human antibodies that bind to the surface of live M. tuberculosis. Methods: Plasma from humans with latent tuberculosis (TB) infection (n = 23), active TB disease (n = 40), and uninfected controls (n = 9) were assayed by ELISA for reactivity to the live M. tuberculosis surface and to inactivated M. tuberculosis fractions (whole cell lysate, lipoarabinomannan, cell wall, and secreted proteins). Results: When compared to uninfected controls, patients with active TB disease had higher antibody titers to the surface of live M. tuberculosis (Delta = 0.72 log(10)), whole cell lysate (Delta = 0.82 log(10)), and secreted proteins (Delta = 0.62 log(10)), though there was substantial overlap between the two groups. Individuals with active disease had higher relative IgG avidity (Delta = 1.4 to 2.6) to all inactivated fractions. Surprisingly, the relative IgG avidity to the live M. tuberculosis surface was lower in the active disease group than in uninfected controls (Delta = -1.53, p = 0.004). Patients with active disease had higher IgG than IgM titers for all inactivated fractions (ratios, 2.8 to 10.1), but equal IgG and IgM titers to the live M. tuberculosis surface (ratio, 1.1). Higher antibody titers to the M. tuberculosis surface were observed in active disease patients who were BCG-vaccinated (Delta = 0.55 log(10), p = 0.008), foreign-born (Delta = 0.61 log10, p = 0.004), or HIV-seronegative (Delta = 0.60 log(10), p = 0.04). Higher relative IgG avidity scores to the M. tuberculosis surface were also observed in active disease patients who were BCG-vaccinated (Delta = 1.12, p<0.001) and foreign-born (Delta = 0.87, p = 0.01). Conclusions/Significance: Humans with active TB disease produce antibodies to the surface of M. tuberculosis with low avidity and with a low IgG/IgM ratio. Highly-avid IgG antibodies to the M. tuberculosis surface may be an appropriate target for future TB vaccines.	[Perley, Casey C.; Frahm, Marc; Frothingham, Richard] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Perley, Casey C.; Click, Eva M.; Ferrari, Guido; Frothingham, Richard] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Frahm, Marc; Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Stout, Jason E.; Frothingham, Richard] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Colorado State University; Duke University	Frothingham, R (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	richard.frothingham@duke.edu	Ferrari, Guido/Z-2137-2019; Dobos, Karen/D-1170-2017; Ferrari, Guido/A-6088-2015	Dobos, Karen/0000-0001-7115-8524; Ferrari, Guido/0000-0001-7747-3349; Stout, Jason/0000-0002-6698-8176	NIH (Southeast Regional Center of Excellence for Emerging Infections and Biodefense) [U54 AI057157]; Duke Center for Translational Research [P30 AI051445]; Regional Biocontainment Laboratory at Duke [UC6 AI058607]; National Science Foundation Graduate Research Fellowship [2011083676]; NIH (Tuberculosis Vaccine Testing and Research Materials) [HHSN266200400091C]; Duke NIH (Center for AIDS Research) [N01 AI040082, P30 AI064518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051445, UC6AI058607, U54AI057157, P30AI064518] Funding Source: NIH RePORTER	NIH (Southeast Regional Center of Excellence for Emerging Infections and Biodefense)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Duke Center for Translational Research; Regional Biocontainment Laboratory at Duke; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH (Tuberculosis Vaccine Testing and Research Materials); Duke NIH (Center for AIDS Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants U54 AI057157 (Southeast Regional Center of Excellence for Emerging Infections and Biodefense), P30 AI051445 (Duke Center for Translational Research), and UC6 AI058607 (Regional Biocontainment Laboratory at Duke), and by National Science Foundation Graduate Research Fellowship 2011083676 (C.C.P.). Mycobacterial antigen fractions from Colorado State University were produced under NIH Contract HHSN266200400091C (Tuberculosis Vaccine Testing and Research Materials) and distributed by the Biodefense and Emerging Infections Research Resources Repository. Specimen collection and storage for the TB-infected subjects was supported by the Duke NIH grants N01 AI040082 and P30 AI064518 (Center for AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Amor YB, 2005, SCAND J IMMUNOL, V61, P139, DOI 10.1111/j.0300-9475.2005.01557.x; ANDERSEN AB, 1986, J CLIN MICROBIOL, V23, P446, DOI 10.1128/JCM.23.3.446-451.1986; Arias-Bouda LMP, 2003, CLIN DIAGN LAB IMMUN, V10, P702, DOI 10.1128/CDLI.10.4.702-709.2003; Azzurri A, 2006, INT J IMMUNOPATH PH, V19, P199; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; BARDANA EJ, 1973, CLIN EXP IMMUNOL, V13, P65; Berry JD, 2011, N BIOTECHNOL; BOTHAMLEY GH, 1989, J INFECT DIS, V159, P549, DOI 10.1093/infdis/159.3.549; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chambers MA, 2004, FEMS IMMUNOL MED MIC, V41, P93, DOI 10.1016/j.femsim.2004.01.004; Connors M, 1997, NAT MED, V3, P533, DOI 10.1038/nm0597-533; DACOSTA CTKA, 1993, CLIN EXP IMMUNOL, V91, P25; DANIEL TM, 1985, CHEST, V88, P388, DOI 10.1378/chest.88.3.388; DAVID HL, 1992, INT J LEPROSY, V60, P208; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; Demkow U, 2007, J PHYSIOL PHARMACOL, V58, P117; Demkow U, 2006, J PHYSIOL PHARMACOL, V57, P63; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Greenaway C, 2005, INT J TUBERC LUNG D, V9, P1112; Hamasur B, 2004, CLIN EXP IMMUNOL, V138, P30, DOI 10.1111/j.1365-2249.2004.02593.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; HOBBS MV, 1991, J CELL BIOCHEM, V46, P312, DOI 10.1002/jcb.240460406; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; LEVETON C, 1989, INFECT IMMUN, V57, P390, DOI 10.1128/IAI.57.2.390-395.1989; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Rush JS, 2001, EUR J IMMUNOL, V31, P1150, DOI 10.1002/1521-4141(200104)31:4<1150::AID-IMMU1150>3.0.CO;2-V; Sanchez-Rodriguez C, 2002, INT J TUBERC LUNG D, V6, P706; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Silva VMC, 2003, INT J TUBERC LUNG D, V7, P478; Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Tjanlund A, 2006, INT IMMUNOL, V18, P807, DOI 10.1093/intimm/dxl017; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; World Health Organization, 2011, WHO REP 2011 GLOB CO; Yu X, 2012, CLIN VACCINE IMMUNOL, V19, P198, DOI 10.1128/CVI.05550-11	48	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98938	10.1371/journal.pone.0098938	http://dx.doi.org/10.1371/journal.pone.0098938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918450	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000035
J	Sibley, SD; Lauck, M; Bailey, AL; Hyeroba, D; Tumukunde, A; Weny, G; Chapman, CA; O'Connor, DH; Goldberg, TL; Friedrich, TC				Sibley, Samuel D.; Lauck, Michael; Bailey, Adam L.; Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin A.; O'Connor, David H.; Goldberg, Tony L.; Friedrich, Thomas C.			Discovery and Characterization of Distinct Simian Pegiviruses in Three Wild African Old World Monkey Species	PLOS ONE			English	Article							GB-VIRUS-C; HEPATITIS-G VIRUS; RNA SECONDARY STRUCTURES; C/HEPATITIS-G VIRUS; PHYLOGENETIC ANALYSIS; UNTRANSLATED REGION; SIGNAL PEPTIDES; NS5A PROTEIN; WEB SERVER; INFECTION	Within the Flaviviridae, the recently designated genus Pegivirus has expanded greatly due to new discoveries in bats, horses, and rodents. Here we report the discovery and characterization of three simian pegiviruses (SPgV) that resemble human pegivirus (HPgV) and infect red colobus monkeys (Procolobus tephrosceles), red-tailed guenons (Cercopithecus ascanius) and an olive baboon (Papio anubis). We have designated these viruses SPgV(krc), SPgV(krtg) and SPgV(kbab), reflecting their host species' common names, which include reference to their location of origin in Kibale National Park, Uganda. SPgV(krc) and SPgV(krtg) were detected in 47% (28/60) of red colobus and 42% (5/12) red-tailed guenons, respectively, while SPgV(kbab) infection was observed in 1 of 23 olive baboons tested. Infections were not associated with any apparent disease, despite the generally high viral loads observed for each variant. These viruses were monophyletic and equally divergent from HPgV and pegiviruses previously identified in chimpanzees (SPgV(cpz)). Overall, the high degree of conservation of genetic features among the novel SPgVs, HPgV and SPgV(cpz) suggests conservation of function among these closely related viruses. Our study describes the first primate pegiviruses detected in Old World monkeys, expanding the known genetic diversity and host range of pegiviruses and providing insight into the natural history of this genus.	[Sibley, Samuel D.; Goldberg, Tony L.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Lauck, Michael; Bailey, Adam L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin A.; Goldberg, Tony L.] Makerere Univ, Kampala, Uganda; [Chapman, Colin A.] Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Sch Environm, Montreal, PQ, Canada; [O'Connor, David H.; Goldberg, Tony L.; Friedrich, Thomas C.] Wisconsin Natl Primate Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Makerere University; McGill University	Friedrich, TC (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	thomasf@primate.wisc.edu	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; o'connor, david/0000-0003-2139-470X; Sibley, Samuel/0000-0002-6754-3187; Friedrich, Thomas/0000-0001-9831-6895	National Institutes of Health (NIH), NIH-NSF Ecology of Infectious Disease program [TW009237]; UK Economic and Social Research Council [P51OD011106, P51RR000167]; University of Wisconsin School of Medicine and Public Health Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID);  [R01 AI084787]; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084787, R01AI098420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061, T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIH-NSF Ecology of Infectious Disease program; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Wisconsin School of Medicine and Public Health Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) grants TW009237, as part of the joint NIH-NSF Ecology of Infectious Disease program, and R01 AI084787; the UK Economic and Social Research Council, through grants P51OD011106 and P51RR000167 to the Wisconsin National Primate Research Center; and by the University of Wisconsin School of Medicine and Public Health Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCL ACIDS RES; Adams NJ, 1998, J GEN VIROL, V79, P1871, DOI 10.1099/0022-1317-79-8-1871; Belyaev AS, 1998, J VIROL, V72, P868, DOI 10.1128/JVI.72.1.868-872.1998; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bhattarai N, 2013, J IMMUNOL, V190, P6351, DOI 10.4049/jimmunol.1300589; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Birkenmeyer LG, 1998, J MED VIROL, V56, P44, DOI 10.1002/(SICI)1096-9071(199809)56:1<44::AID-JMV8>3.0.CO;2-N; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bukh J, 1998, J INFECT DIS, V177, P855, DOI 10.1086/515255; Bukh J, 1997, VIROLOGY, V229, P429, DOI 10.1006/viro.1997.8461; Burbelo PD, 2012, J VIROL, V86, P6171, DOI 10.1128/JVI.00250-12; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Charrel RN, 1999, J GEN VIROL, V80, P2329, DOI 10.1099/0022-1317-80-9-2329; Cheng Y, 2000, J MED VIROL, V60, P28, DOI 10.1002/(SICI)1096-9071(200001)60:1<28::AID-JMV5>3.0.CO;2-S; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cuceanu NM, 2001, J GEN VIROL, V82, P713, DOI 10.1099/0022-1317-82-4-713; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438; Epstein JH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000972; Erker JC, 1998, J GEN VIROL, V79, P41, DOI 10.1099/0022-1317-79-1-41; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; George SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030653; Ghai RR, 2013, J GEN VIROL, V94, P2670, DOI 10.1099/vir.0.055509-0; Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407; Goldberg T. L., 2012, NEW DIRECTIONS CONSE, P452; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Goldberg TL, 2008, EMERG INFECT DIS, V14, P801, DOI 10.3201/eid1405.071686; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Hitzler W E, 2004, Clin Lab, V50, P25; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kapoor A, 2013, J VIROL, V87, P7185, DOI 10.1128/JVI.00324-13; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lauck M, 2013, J VIROL, V87, P8971, DOI 10.1128/JVI.00888-13; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056; Leary TP, 1996, J VIROL, V70, P9028, DOI 10.1128/JVI.70.12.9028-9030.1996; Leary TP, 1997, J GEN VIROL, V78, P2307, DOI 10.1099/0022-1317-78-9-2307; Lee YJ, 2001, BIOCHEM BIOPH RES CO, V286, P171, DOI 10.1006/bbrc.2001.5354; Lin C., 2006, HCV NS3 4A SERINE PR; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longdon B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002260; Lyons S, 2012, EMERG INFECT DIS, V18, P1976, DOI 10.3201/eid1812.120498; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohr EL, 2011, J GEN VIROL, V92, P91, DOI 10.1099/vir.0.026088-0; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Muerhoff AS, 2005, J GEN VIROL, V86, P1729, DOI 10.1099/vir.0.80854-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Parreira R, 2012, INFECT GENET EVOL, V12, P86, DOI 10.1016/j.meegid.2011.10.011; Pavesi A, 2001, J MOL EVOL, V53, P104, DOI 10.1007/s002390010198; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Pybus OG, 2013, NATURE, V498, P310, DOI 10.1038/498310b; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Ren H, 2005, WORLD J GASTROENTERO, V11, P970, DOI 10.3748/wjg.v11.i7.970; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Romano CM, 2008, J MOL EVOL, V66, P292, DOI 10.1007/s00239-008-9087-3; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; SCHLAUDER GG, 1995, J MED VIROL, V46, P81, DOI 10.1002/jmv.1890460117; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; Simons JN, 1996, J VIROL, V70, P6126, DOI 10.1128/JVI.70.9.6126-6135.1996; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Stapleton J. T., 2012, ASSIGNMENT HUMAN SIM; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Supapol WB, 2011, J MED VIROL, V83, P33, DOI 10.1002/jmv.21946; Takahashi K, 1997, HEPATOL RES, V8, P139, DOI 10.1016/S1386-6346(97)00063-6; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; Thurber MI, 2013, INT J PARASITOL, V43, P613, DOI 10.1016/j.ijpara.2013.03.002; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Welbourn S, 2006, HCV NS2 3 PROTEASE; Xia X, 2013, MOL BIOL EVOL, V38, pW7; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	98	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98569	10.1371/journal.pone.0098569	http://dx.doi.org/10.1371/journal.pone.0098569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918769	Green Published, gold			2022-12-27	WOS:000338631000019
J	Zoubrinetzky, R; Bielle, F; Valdois, S				Zoubrinetzky, Rachel; Bielle, Frederique; Valdois, Sylviane			New Insights on Developmental Dyslexia Subtypes: Heterogeneity of Mixed Reading Profiles	PLOS ONE			English	Article							VISUAL-ATTENTION SPAN; PHONOLOGICAL DYSLEXIA; DUAL-ROUTE; WORD RECOGNITION; SPEECH SOUNDS; FMRI EVIDENCE; DEFICIT; SURFACE; CHILDREN; ACQUISITION	We examined whether classifications based on reading performance are relevant to identify cognitively homogeneous subgroups of dyslexic children. Each of the 71 dyslexic participants was selected to have a mixed reading profile, i.e. poor irregular word and pseudo-word reading performance (accuracy and speed). Despite their homogeneous reading profile, the participants were found to split into four distinct cognitive subgroups, characterized by a single phonological disorder, a single visual attention span disorder, a double deficit or none of these disorders. The two subgroups characterized by single and contrasted cognitive disorders were found to exhibit a very similar reading pattern but more contrasted spelling performance (quantitative analysis). A qualitative analysis of the error types produced in reading and spelling provided some cues about the participants' underlying cognitive deficit. The overall findings disqualify subtyping based on reading profiles as a classification method to identify cognitively homogeneous subgroups of dyslexic children. They rather show an opaque relationship between the cognitive underpinnings of developmental dyslexia and their behavioral manifestations in reading and spelling. Future neuroimaging and genetic studies should take this issue into account since synthesizing over cognitively heterogeneous children would entail potential pitfalls.	[Zoubrinetzky, Rachel; Bielle, Frederique; Valdois, Sylviane] CHU Grenoble, Ctr Referent Diagnost Troubles Langage & Apprenti, Pole Couple Enfant, F-38043 Grenoble, France; [Zoubrinetzky, Rachel; Valdois, Sylviane] Univ Grenoble Alpes, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Zoubrinetzky, R (corresponding author), CHU Grenoble, Ctr Referent Diagnost Troubles Langage & Apprenti, Pole Couple Enfant, F-38043 Grenoble, France.	rachel.zoubri@gmail.com			ANR Blanc ORTHOLEARN [ANR-12-BSH2-0013-01]	ANR Blanc ORTHOLEARN(French National Research Agency (ANR))	This work was supported by ANR Blanc ORTHOLEARN: ANR-12-BSH2-0013-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ans B, 1998, PSYCHOL REV, V105, P678, DOI 10.1037/0033-295X.105.4.678-723; Baciu M., 2008, NEUROPSYCHOLOGY COGN, P22; Bogliotti C, 2008, J EXP CHILD PSYCHOL, V101, P137, DOI 10.1016/j.jecp.2008.03.006; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Bosse ML, 2003, CURR PSYCHOL LETT, V1, P10; Bosse ML, 2014, J RES READ IN PRESS; Bouvier-Chaverot M., 2012, REV NEUROPSYCHOL, V4, P24, DOI [10.3917/rne.041.0024, DOI 10.3917/RNE.041.0024]; Bowey JA, 2005, J EXP CHILD PSYCHOL, V92, P203, DOI 10.1016/j.jecp.2005.06.005; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Brunsdon R, 2005, COGN NEUROPSYCHOL, V22, P213, DOI 10.1080/02643290442000077; CAMPBELL R, 1985, Q J EXP PSYCHOL-A, V37, P435, DOI 10.1080/14640748508400944; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Castles A, 1996, COGN NEUROPSYCHOL, V13, P25, DOI 10.1080/026432996382051; Castles A, 2008, J RES READ; Castles A, 2006, FROM INKMARKS TO IDEAS: CURRENT ISSUES IN LEXICAL PROCESSING, P151; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Cunningham AE, 2002, J EXP CHILD PSYCHOL, V82, P185, DOI 10.1016/S0022-0965(02)00008-5; Cunningham AE, 2006, J EXP CHILD PSYCHOL, V95, P56, DOI 10.1016/j.jecp.2006.03.008; de Jong PF, 2007, SCI STUD READ, V11, P55, DOI 10.1207/s1532799xssr1101_4; Douklias SD, 2009, COGN NEUROPSYCHOL, V26, P705, DOI 10.1080/02643291003691106; Dubois M, 2007, COGN NEUROPSYCHOL, V24, P623, DOI 10.1080/02643290701617330; Dubois M, 2010, CORTEX, V46, P717, DOI 10.1016/j.cortex.2009.11.002; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; GOULANDRIS NK, 1991, COGNITIVE NEUROPSYCH, V8, P127, DOI 10.1080/02643299108253369; Griffiths YM, 2002, J EDUC PSYCHOL, V94, P34, DOI 10.1037//0022-0663.94.1.34; Hadzibeganovic T, 2010, CORTEX, V46, P1312, DOI 10.1016/j.cortex.2010.06.011; HANLEY JR, 1995, NEUROPSYCHOLOGIA, V33, P909, DOI 10.1016/0028-3932(95)00038-5; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; Heim S, 2008, ACTA NEUROBIOL EXP, V68, P73; Howard D, 1996, COGNITIVE NEUROPSYCH, V13, P887, DOI 10.1080/026432996381854; Hulme C, 2002, J EXP CHILD PSYCHOL, V82, P2, DOI 10.1006/jecp.2002.2670; Jacquier-Roux M., 2002, ODEDYS OUTIL DEPISTA; Jimenez JE, 2009, J EXP CHILD PSYCHOL, V103, P167, DOI 10.1016/j.jecp.2009.02.004; King WM, 2007, INT J LANG COMM DIS, V42, P77, DOI 10.1080/13682820600806680; Kyte CS, 2006, J EXP CHILD PSYCHOL, V93, P166, DOI 10.1016/j.jecp.2005.09.003; Lallier M, 2013, COGNITION, V126, P121, DOI 10.1016/j.cognition.2012.09.008; Lallier M, 2010, CORTEX, V46, P231, DOI 10.1016/j.cortex.2009.03.014; Lassus-Sangosse D, 2008, VISION RES, V48, P979, DOI 10.1016/j.visres.2008.01.025; LEFAVRAIS P, 1965, TEST ALOUETTE; Lete B, 2004, BEHAV RES METH INS C, V36, P156, DOI 10.3758/BF03195560; Lobier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058097; Lobier M, 2012, NEUROPSYCHOLOGIA, V50, P2195, DOI 10.1016/j.neuropsychologia.2012.05.023; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Manis FR, 1996, COGNITION, V58, P157, DOI 10.1016/0010-0277(95)00679-6; Manis Franck, 2008, SAGE HDB DYSLEXIA, P149, DOI DOI 10.4135/9780857020987.N8; Marshall J.C., 1984, DYSLEXIA GLOBAL ISSU, P45; Martinet C, 1999, ANN PSYCHOL, V99, P577; Mousty P., 1994, EVALUER TROUBLES LEC, P127; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Peterson RL, 2013, COGNITION, V126, P20, DOI 10.1016/j.cognition.2012.08.007; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; Peyrin C, 2011, BRAIN LANG, V118, P128, DOI 10.1016/j.bandl.2010.06.005; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Reilhac C, 2013, NEUROPSYCHOLOGIA, V51, P601, DOI 10.1016/j.neuropsychologia.2012.12.010; ROMANI C, 1994, BRAIN LANG, V47, P482; Serniclaes W, 2001, J SPEECH LANG HEAR R, V44, P384, DOI 10.1044/1092-4388(2001/032); Share DL, 1999, J EXP CHILD PSYCHOL, V72, P95, DOI 10.1006/jecp.1998.2481; Share DL, 2004, J EXP CHILD PSYCHOL, V87, P267, DOI 10.1016/j.jecp.2004.01.001; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; SNOWLING M, 1989, COGNITIVE NEUROPSYCH, V6, P379, DOI 10.1080/02643298908253289; Snowling M., 2000, DYSLEXIA; Sprenger-Charolles L, 2000, CAN J EXP PSYCHOL, V54, P87, DOI 10.1037/h0087332; Sprenger-Charolles L, 2011, SCI STUD READ, V15, P498, DOI 10.1080/10888438.2010.524463; Stanovich KE, 1997, DYSLEXIA: BIOLOGY, COGNITION AND INTERVENTION, P108; TEMPLE CM, 1983, BRIT J PSYCHOL, V74, P517, DOI 10.1111/j.2044-8295.1983.tb01883.x; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; Valdois S, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 1: A-G, P454; VALDOIS S, 1995, COGN NEUROPSYCHOL, V12, P31, DOI 10.1080/02643299508251991; Valdois S, 2014, CORTEX IN PRESS, DOI [10.1016/j.cortex. 2013.11.006, DOI 10.1016/J.CORTEX.2013.11.006]; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Valdois S, 2012, DYSLEXIA, V18, P77, DOI 10.1002/dys.1437; Valdois S, 2011, CORTEX, V47, P1197, DOI 10.1016/j.cortex.2011.05.011; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; WIMMER H, 1991, COGNITION, V40, P219, DOI 10.1016/0010-0277(91)90026-Z; Zabell Claire, 2002, Dyslexia, V8, P160, DOI 10.1002/dys.223; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2008, COGNITION, V107, P151, DOI 10.1016/j.cognition.2007.09.004	80	67	74	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99337	10.1371/journal.pone.0099337	http://dx.doi.org/10.1371/journal.pone.0099337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918441	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000077
J	Cho, Y; Kim, M				Cho, Yongrae; Kim, Minsung			Entropy and Gravity Concepts as New Methodological Indexes to Investigate Technological Convergence: Patent Network-Based Approach	PLOS ONE			English	Article							NANOTECHNOLOGY; INNOVATION; INDICATOR; DYNAMICS; INDUSTRY; TOOL	The volatility and uncertainty in the process of technological developments are growing faster than ever due to rapid technological innovations. Such phenomena result in integration among disparate technology fields. At this point, it is a critical research issue to understand the different roles and the propensity of each element technology for technological convergence. In particular, the network-based approach provides a holistic view in terms of technological linkage structures. Furthermore, the development of new indicators based on network visualization can reveal the dynamic patterns among disparate technologies in the process of technological convergence and provide insights for future technological developments. This research attempts to analyze and discover the patterns of the international patent classification codes of the United States Patent and Trademark Office's patent data in printed electronics, which is a representative technology in the technological convergence process. To this end, we apply the physical idea as a new methodological approach to interpret technological convergence. More specifically, the concepts of entropy and gravity are applied to measure the activities among patent citations and the binding forces among heterogeneous technologies during technological convergence. By applying the entropy and gravity indexes, we could distinguish the characteristic role of each technology in printed electronics. At the technological convergence stage, each technology exhibits idiosyncratic dynamics which tend to decrease technological differences and heterogeneity. Furthermore, through nonlinear regression analysis, we have found the decreasing patterns of disparity over a given total period in the evolution of technological convergence. This research has discovered the specific role of each element technology field and has consequently identified the coevolutionary patterns of technological convergence. These new findings on the evolutionary patterns of technological convergence provide some implications for engineering and technology foresight research, as well as for corporate strategy and technology policy.	[Cho, Yongrae] Sci & Technol Policy Inst STEPI, Div Vice President, Seoul, South Korea; [Cho, Yongrae] Hanyang Univ, Grad Sch Technol & Innovat Management, Seoul 133791, South Korea; [Kim, Minsung] Korea Adv Inst Sci & Technol, Grad Sch Innovat & Technol Management, Taejon 305701, South Korea	Science & Technology Policy Institute (STEPI), Republic of Korea; Hanyang University; Korea Advanced Institute of Science & Technology (KAIST)	Kim, M (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Innovat & Technol Management, Taejon 305701, South Korea.	ferrari@kaist.ac.kr			Science and Technology Policy Institute (STEPI) of Korean Government (Office of the Prime Minister)	Science and Technology Policy Institute (STEPI) of Korean Government (Office of the Prime Minister)	The publication fee was supported by Science and Technology Policy Institute (STEPI) of Korean Government (Office of the Prime Minister). The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Avila-Robinson A, 2013, TECHNOL FORECAST SOC, V80, P1071, DOI 10.1016/j.techfore.2012.07.012; Bauer JM, 2003, INT SER OPER RES MAN, V65, P209; Bekkers R, 2012, TECHNOL FORECAST SOC, V79, P1192, DOI 10.1016/j.techfore.2012.01.009; Bores C, 2003, TECHNOVATION, V23, P1, DOI 10.1016/S0166-4972(01)00094-3; Curran CS, 2011, TECHNOL FORECAST SOC, V78, P256, DOI 10.1016/j.techfore.2010.06.021; Curran CS, 2010, TECHNOL FORECAST SOC, V77, P385, DOI 10.1016/j.techfore.2009.10.002; Das R, 2012, PRINTED ORGANIC FLEX; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; European Commission, 2010, FOC REP 2010 PRINT E; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Glanzel W, 2012, SCIENTOMETRICS, V93, P113, DOI 10.1007/s11192-012-0639-3; GRUPP H, 1990, SCIENTOMETRICS, V18, P219, DOI 10.1007/BF02017763; Hacklin F, 2008, CONTRIB MANAG SCI, P1, DOI 10.1007/978-3-7908-1990-8; Hacklin F, 2010, INT J TECHNOL MANAGE, V49, P220, DOI 10.1504/IJTM.2010.029419; Hacklin F, 2009, TECHNOL FORECAST SOC, V76, P723, DOI 10.1016/j.techfore.2009.03.003; Hadas S, 2012, PLOS ONE, V7; Hullmann A, 2003, SCIENTOMETRICS, V58, P507, DOI 10.1023/B:SCIE.0000006877.45467.a7; Islam N, 2009, TECHNOL FORECAST SOC, V76, P128, DOI 10.1016/j.techfore.2008.03.021; Kodama Fumio, 1995, EMERGING PATTERNS IN; Lloyd M., 2011, SMARTPHONE PATENT WA; Miyazaki K, 2007, TECHNOVATION, V27, P661, DOI 10.1016/j.technovation.2007.05.009; Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501; Morillo F, 2001, SCIENTOMETRICS, V51, P203, DOI 10.1023/A:1010529114941; No HJ, 2010, TECHNOL FORECAST SOC, V77, P63, DOI 10.1016/j.techfore.2009.06.006; Perelaer J, 2010, J MATER CHEM, V20, P8446, DOI 10.1039/c0jm00264j; PORTER AL, 1985, SCIENTOMETRICS, V8, P161, DOI 10.1007/BF02016934; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; ROSENBERG N, 1963, J ECON HIST, V23, P414, DOI 10.1017/S0022050700109155; Scott J, 2003, SOCIAL NETWORK ANAL; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Takeda Y, 2009, SCIENTOMETRICS, V80, P23, DOI 10.1007/s11192-007-1897-3; Tinbergen J., 1962, ANAL WORLD TRADE FLO; Tinnemann P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014059; Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569; Wasserman S., 2006, SOCIAL NETWORK ANAL	35	13	16	10	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98009	10.1371/journal.pone.0098009	http://dx.doi.org/10.1371/journal.pone.0098009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24914959	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700014
J	Hirdes, JP; Poss, JW; Mitchell, L; Korngut, L; Heckman, G				Hirdes, John P.; Poss, Jeffrey W.; Mitchell, Lori; Korngut, Lawrence; Heckman, George			Use of the interRAI CHESS Scale to Predict Mortality among Persons with Neurological Conditions in Three Care Settings	PLOS ONE			English	Article							MINIMUM DATA SET; NURSING-HOME; HEALTH; FRAILTY; INFORMATION; SURVIVAL; ASSESSMENTS; RESIDENTS; VALIDITY; DISEASE	Background: Persons with certain neurological conditions have higher mortality rates than the population without neurological conditions, but the risk factors for increased mortality within diagnostic groups are less well understood. The interRAI CHESS scale has been shown to be a strong predictor of mortality in the overall population of persons receiving health care in community and institutional settings. This study examines the performance of CHESS as a predictor of mortality among persons with 11 different neurological conditions. Methods: Survival analyses were done with interRAI assessments linked to mortality data among persons in home care (n = 359,940), complex continuing care hospitals/units (n = 88,721), and nursing homes (n = 185,309) in seven Canadian provinces/territories. Results: CHESS was a significant predictor of mortality in all 3 care settings for the 11 neurological diagnostic groups considered after adjusting for age and sex. The distribution of CHESS scores varied between diagnostic groups and within diagnostic groups in different care settings. Conclusions: CHESS is a valid predictor of mortality in neurological populations in community and institutional care. It may prove useful for several clinical, administrative, policy-development, evaluation and research purposes. Because it is routinely gathered as part of normal clinical practice in jurisdictions (like Canada) that have implemented interRAI assessment instruments, CHESS can be derived without additional need for data collection.	[Hirdes, John P.; Poss, Jeffrey W.; Heckman, George] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Mitchell, Lori] Winnipeg Reg Hlth Author, Winnipeg, MB, Canada; [Korngut, Lawrence] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	University of Waterloo; University of Calgary	Hirdes, JP (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada.	hirdes@uwaterloo.ca		Heckman, George/0000-0003-3847-3287	Public Health Agency of Canada [6271-15-2010/3970773]; Ontario Ministry of Health and Long Term Care	Public Health Agency of Canada; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	Funding for the study was provided by the Public Health Agency of Canada, Project #6271-15-2010/3970773. Funding was also provided for the Ontario Home Care Research and Knowledge Exchange Chair (to JPH) through the Ontario Ministry of Health and Long Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JJ, 2010, AGE AGEING, V39, P755, DOI 10.1093/ageing/afq121; Bernabei R, 2009, INT GERONTOLOGY HAZZ, P69; Caesar-Chavannes CR, 2013, CHRON DIS INJ CAN, V33, P188; Carpenter GI, 2013, USING INTERRAI ASSES, P93; Czira ME, 2014, ACTA NEUROL SCAND, V130, P283, DOI 10.1111/ane.12220; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Gambassi G, 1998, MED CARE, V36, P167, DOI 10.1097/00005650-199802000-00006; Gray LC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-71; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-27; Hirdes JP, 2012, PALLIAT SUPPORT CARE, V10, P155, DOI 10.1017/S1478951511000824; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Hjaltadottir I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-86; Kaufmann P, 2005, NEUROLOGY, V64, P38, DOI 10.1212/01.WNL.0000148648.38313.64; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Lee JSW, 2009, EUR J PUBLIC HEALTH, V19, P308, DOI 10.1093/eurpub/ckp006; Lutomski JE, 2013, J AM GERIATR SOC, V61, P1625, DOI 10.1111/jgs.12430; Mitnitski AB, 2002, MECH AGEING DEV, V123, P1457, DOI 10.1016/S0047-6374(02)00082-9; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; Poss J W, 2008, Healthc Manage Forum, V21, P33; Pritchard C, 2013, PUBLIC HEALTH, V127, P357, DOI 10.1016/j.puhe.2012.12.018; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Sabia S, 2014, J GERONTOL A-BIOL, V69, P354, DOI 10.1093/gerona/glt114; Scotton WJ, 2012, AMYOTROPH LATERAL SC, V13, P502, DOI 10.3109/17482968.2012.679281; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tjam EY, 2012, INT J CARDIOL, V155, P75, DOI 10.1016/j.ijcard.2011.01.031; World Health Organization, 2007, GLOB BURD NEUR DIS E, P27	30	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99066	10.1371/journal.pone.0099066	http://dx.doi.org/10.1371/journal.pone.0099066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24914546	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700056
J	Sato, Y; Ando, S; Takahashi, H				Sato, Yukiyo; Ando, Sugihiro; Takahashi, Hideki			Role of Intron-Mediated Enhancement on Accumulation of an Arabidopsis NB-LRR Class R-protein that Confers Resistance to Cucumber mosaic virus	PLOS ONE			English	Article							EXON-JUNCTION COMPLEX; FLAX RUST RESISTANCE; OPEN READING FRAMES; DISEASE-RESISTANCE; GENE-EXPRESSION; HYPERSENSITIVE RESPONSE; DEFENSE RESPONSES; CELL-DEATH; MESSENGER-RNAS; SALICYLIC-ACID	The accumulation of RCY1 protein, which is encoded by RESISTANCE TO CMV(Y) (RCY1), a CC-NB-LRR class R-gene, is tightly correlated with the strength of the resistance to a yellow strain of Cucumber mosaic virus [CMV(Y)] in Arabidopsis thaliana. In order to enhance resistance to CMV by overexpression of RCY1, A. thaliana was transformed with intron-less RCY1 cDNA construct under the control of strong CaMV35S promoter. Remarkably, a relative amount of RCY1 protein accumulation in the transformants was much lower than that in plants expressing genomic RCY1 under the control of its native promoter. To identify a regulatory element of RCY1 that could cause such differential levels of RCY1 accumulation, a series of RCY1 cDNA and genomic RCY1 constructs were transiently expressed in Nicotiana benthamiana leaves by the Agrobacterium-mediated infiltration method. Comparative analysis of the level of RCY1 accumulation in the leaf tissues transiently expressing each construct indicated that the intron located in the RCY1-coding region of genomic RCY1, but not the native RCY1 genomic promoter or the 5'- and 3'-untranslated regions of RCY1, was indispensable for high level RCY1 accumulation. The increased levels of RCY1 accelerated plant disease defense reactions. Interestingly, such intron-mediated enhancement of RCY1 accumulation depended neither on the abundance of the RCY1 transcript nor on the RCY1 specific-intron sequence. Taken together, intron-mediated RCY1 expression seems to play a key role in the expression of complete resistance to CMV(Y) by maintaining RCY1 accumulation at high levels.	[Sato, Yukiyo; Ando, Sugihiro; Takahashi, Hideki] Tohoku Univ, Grad Sch Agr Sci, Dept Appl Plant Sci, Sendai, Miyagi 980, Japan	Tohoku University	Takahashi, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Appl Plant Sci, Sendai, Miyagi 980, Japan.	takahash@bios.tohoku.ac.jp	Ando, Sugihiro/T-5720-2019	Sato, Yukiyo/0000-0003-4514-8482	Ministry of Education, Culture, Sports, Science and Technology, Japan [22380028, 24658037]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a grant-in-aid for Scientific Research (B) (22380028) and Challenging Exploratory Research (24658037) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PA, 1997, PLANT CELL, V9, P641, DOI 10.1105/tpc.9.4.641; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Bechtold N, 1998, METH MOL B, V82, P259; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Borhan MH, 2004, MOL PLANT MICROBE IN, V17, P711, DOI 10.1094/MPMI.2004.17.7.711; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Cooley MB, 2000, PLANT CELL, V12, P663, DOI 10.1105/tpc.12.5.663; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DEAN C, 1989, PLANT CELL, V1, P201, DOI 10.1105/tpc.1.2.201; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Farrell R. E. Jr., 2007, Regulation of gene expression in plants: the role of transcript structure and processing, P1, DOI 10.1007/978-0-387-35640-2_1; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Green MR, 2012, MOL CLONING LAB MANU, V1; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hakata M, 2010, BREEDING SCI, V60, P575, DOI 10.1270/jsbbs.60.575; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hondo D, 2007, MOL PLANT MICROBE IN, V20, P72, DOI 10.1094/MPMI-20-0072; Ishihara T, 2008, PLANT BIOLOGY, V10, P451, DOI 10.1111/j.1438-8677.2008.00050.x; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; LAWRENCE GJ, 1995, PLANT CELL, V7, P1195, DOI 10.1105/tpc.7.8.1195; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mes JJ, 2000, PLANT J, V23, P183, DOI 10.1046/j.1365-313x.2000.00765.x; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mohr TJ, 2010, MOL PLANT MICROBE IN, V23, P1303, DOI 10.1094/MPMI-01-10-0022; Mufarrege EF, 2011, J EXP BOT, V62, P5025, DOI 10.1093/jxb/err202; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Park NI, 2007, PLANTA, V225, P625, DOI 10.1007/s00425-006-0385-y; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Rethmeier N, 1997, PLANT J, V12, P895, DOI 10.1046/j.1365-313X.1997.12040895.x; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Rose AB, 1997, PLANT J, V11, P455, DOI 10.1046/j.1365-313X.1997.11030455.x; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Sekine KT, 2008, MOL PLANT MICROBE IN, V21, P1398, DOI 10.1094/MPMI-21-11-1398; Sekine KT, 2006, PLANT MOL BIOL, V62, P669, DOI 10.1007/s11103-006-9048-4; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; Takahashi H, 2002, PLANT J, V32, P655, DOI 10.1046/j.1365-313X.2002.01453.x; TAKAHASHI H, 1994, PLANT J, V6, P369, DOI 10.1046/j.1365-313X.1994.06030369.x; TAKAHASHI H, 1993, MOL PLANT MICROBE IN, V6, P182, DOI 10.1094/MPMI-6-182; Takahashi H, 2014, PLANT CELL REP, V33, P99, DOI 10.1007/s00299-013-1515-1; Takahashi H, 2012, PHYSIOL MOL PLANT P, V79, P40, DOI 10.1016/j.pmpp.2012.03.003; Takahashi H, 2012, MOL PLANT MICROBE IN, V25, P1171, DOI 10.1094/MPMI-04-12-0076-R; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tomaru K., 1960, B HATANO TOB EXP STN, V46, P143; XU Y, 1994, PLANT PHYSIOL, V106, P459, DOI 10.1104/pp.106.2.617; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474	67	12	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99041	10.1371/journal.pone.0099041	http://dx.doi.org/10.1371/journal.pone.0099041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915153	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700052
J	Weber, U; Rodriguez, E; Martignetti, J; Mlodzik, M				Weber, Ursula; Rodriguez, Estefania; Martignetti, John; Mlodzik, Marek			Luna, a Drosophila KLF6/KLF7, Is Maternally Required for Synchronized Nuclear and Centrosome Cycles in the Preblastoderm Embryo	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-6; CELL-CYCLE; ACTIVATION; CENTRIOLES; MITOSIS; GENOME; GENES; EYE	Kruppel like factors (KLFs) are conserved transcription factors that have been implicated in many developmental processes including differentiation, organ patterning, or regulation of stem cell pluripotency. We report the generation and analysis of loss-of-function mutants of Drosophila Klf6/7, the luna gene. We demonstrate that luna mutants are associated with very early embryonic defects prior to cellularization at the syncytial stage and cause DNA separation defects during the rapid mitotic cycles resulting in un-coupled DNA and centrosome cycles. These defects manifest themselves, both in animals that are maternally homozygous and heterozygous mutant. Surprisingly, luna is only required during the syncytial stages and not later in development, suggesting that the DNA segregation defect is linked to centrosomes, since centrosomes are dispensable for later cell divisions.	[Weber, Ursula; Mlodzik, Marek] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Weber, Ursula; Mlodzik, Marek] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Rodriguez, Estefania; Martignetti, John] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mlodzik, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	marek.mlodzik@mssm.edu			National Institutes of Health [EY13256, CA122332]; NATIONAL CANCER INSTITUTE [R01CA122332] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant EY13256 to MM and CA122332 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2007, PLOS GENET, V3, P2163, DOI 10.1371/journal.pgen.0030200; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; CHOU TB, 1993, DEVELOPMENT, V119, P1359; D'Astolfo DS, 2008, CELL DEATH DIFFER, V15, P613, DOI 10.1038/sj.cdd.4402299; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Foe Victoria E., 1993, P149; Jenny A, 2008, BIOTECHNIQUES, V44, P335, DOI 10.2144/000112720; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Megraw TL, 1999, DEVELOPMENT, V126, P2829; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; Racca AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022438; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; Reynolds-Kenneally J, 2005, DEV BIOL, V285, P38, DOI 10.1016/j.ydbio.2005.05.038; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; Seetharam A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-276; SIMPSON P, 1983, GENETICS, V105, P615; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Telley IA, 2013, NAT PROTOC, V8, P310, DOI 10.1038/nprot.2013.003; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Van Doren M, 1998, CURR BIOL, V8, P243; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; Zhao XA, 2010, DEV BIOL, V344, P79, DOI 10.1016/j.ydbio.2010.04.018	38	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96933	10.1371/journal.pone.0096933	http://dx.doi.org/10.1371/journal.pone.0096933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915236	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700008
J	Windhager, S; Schaschl, H; Schaefer, K; Mitteroecker, P; Huber, S; Wallner, B; Fieder, M				Windhager, Sonja; Schaschl, Helmut; Schaefer, Katrin; Mitteroecker, Philipp; Huber, Susanne; Wallner, Bernard; Fieder, Martin			Variation at Genes Influencing Facial Morphology Are Not Associated with Developmental Imprecision in Human Faces	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HETEROZYGOSITY-FITNESS CORRELATIONS; FLUCTUATING ASYMMETRY; INSTABILITY; POPULATION; ROTTERDAM; GENOTYPE; SYMMETRY; DESIGN; UPDATE	Facial asymmetries are commonly used as a proxy for human developmental imprecision resulting from inbreeding, and thus reduced genetic heterozygosity. Several environmental factors influence human facial asymmetry (e. g., health care, parasites), but the generalizability of findings on genetic stressors has been limited in humans by sample characteristics (island populations, endogamy) and indirect genetic assessment (inference from pedigrees). In a sample of 3215 adult humans from the Rotterdam Study, we therefore studied the relationship of facial asymmetry, estimated from nine midfacial landmarks, with genetic variation at 102 single nucleotide polymorphism (SNP) loci recently associated with facial shape variation. We further tested whether the degree of individual heterozygosity is negatively correlated with facial asymmetry. An ANOVA tree regression did not identify any SNP relating to either fluctuating asymmetry or total asymmetry. In a general linear model, only age and sex-but neither heterozygosity nor any SNP previously reported to covary with facial shape-was significantly related to total or fluctuating asymmetry of the midface. Our study does not corroborate the common assumption in evolutionary and behavioral biology that morphological asymmetries reflect heterozygosity. Our results, however, may be affected by a relatively small degree of inbreeding, a relatively stable environment, and an advanced age in the Rotterdam sample. Further large-scale genetic studies, including gene expression studies, are necessary to validate the genetic and developmental origin of morphological asymmetries.	[Windhager, Sonja; Schaschl, Helmut; Schaefer, Katrin; Huber, Susanne; Wallner, Bernard; Fieder, Martin] Univ Vienna, Dept Anthropol, Vienna, Austria; [Windhager, Sonja] Konrad Lorenz Inst Evolut & Cognit Res, Altenberg, Austria; [Mitteroecker, Philipp] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Cognit Sci Platform, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna; University of Vienna	Windhager, S (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	sonja.windhager@univie.ac.at	Wallner, Bernard/B-1089-2009; Schaefer, Katrin/G-8632-2011; Windhager, Sonja/K-7618-2013; Mitteroecker, Philipp/A-1591-2012	Schaefer, Katrin/0000-0002-0173-3092; Windhager, Sonja/0000-0003-1809-8678; Schaschl, Helmut/0000-0003-2826-8773; Mitteroecker, Philipp/0000-0002-5308-3837	Konrad Lorenz Institute for Evolution and Cognition Research; University of Vienna [IP 547011]	Konrad Lorenz Institute for Evolution and Cognition Research; University of Vienna	This work was supported by a fellowship of the Konrad Lorenz Institute for Evolution and Cognition Research to SW, and by the University of Vienna (Emerging Field "Comparative Human Life History: A Multilevel Approach'' to KS, Back-to-Research Grant to SH, Focus of Excellence "Biometrics of EvoDevo'' to PM, and Investitionsprojekt IP 547011 to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Asher JH, 1996, HUM MUTAT, V7, P30, DOI 10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Bookstein FL, EVOL BIOL IN PRESS, P1; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coleman Sydney R, 2006, Aesthet Surg J, V26, pS4, DOI 10.1016/j.asj.2005.09.012; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; DeWoody YD, 2005, J HERED, V96, P85, DOI 10.1093/jhered/esi017; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; FRYDENBERG O, 1963, HEREDITAS, V50, P89; Gordon JRS, 2012, NEW ENGL J MED, V366, pE25, DOI 10.1056/NEJMicm1104059; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; HERSHKOVITZ I, 1992, AM J HUM BIOL, V4, P83, DOI 10.1002/ajhb.1310040111; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hope D, 2013, ECON HUM BIOL, V11, P236, DOI 10.1016/j.ehb.2011.06.006; Ikram MA, 2011, EUR J EPIDEMIOL, V26, P811, DOI 10.1007/s10654-011-9624-z; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; LIVSHITS G, 1991, HUM BIOL, V63, P441; Livshits G, 1994, DEV INSTABILITY ITS, P157; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Miller JM, 2014, MOL ECOL, V23, P1899, DOI 10.1111/mec.12707; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; MITTON JB, 1997, SELECTION NATURAL PO; Otremski I, 1993, Anthropol Anz, V51, P233; Ozener B, 2010, AM J HUM BIOL, V22, P557, DOI 10.1002/ajhb.21046; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Penke L, 2009, EVOL HUM BEHAV, V30, P429, DOI 10.1016/j.evolhumbehav.2009.06.001; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Polak M., 2003, CAUSES CONSEQUENCES; R Core Team, 2021, R LANGUAGE ENV STAT; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Schaefer K, 2006, AM J PHYS ANTHROPOL, V129, P132, DOI 10.1002/ajpa.20224; Sommer A, 2003, AM J MED GENET A, V123A, P91, DOI 10.1002/ajmg.a.20501; SUTTON PRN, 1968, ANGLE ORTHOD, V38, P82; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; Vogt G, 2008, J EXP BIOL, V211, P510, DOI 10.1242/jeb.008755; Warner DR, 2007, BBA-MOL CELL RES, V1773, P814, DOI 10.1016/j.bbamcr.2007.03.016	46	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99009	10.1371/journal.pone.0099009	http://dx.doi.org/10.1371/journal.pone.0099009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914781	Green Published, gold			2022-12-27	WOS:000340947700049
J	Yuyama, I; Higuchi, T				Yuyama, Ikuko; Higuchi, Tomihiko			Comparing the Effects of Symbiotic Algae (Symbiodinium) Clades C1 and D on Early Growth Stages of Acropora tenuis	PLOS ONE			English	Article							REEF-BUILDING CORALS; GENE-EXPRESSION; HEAT-STRESS; IDENTIFICATION; ENDOSYMBIONTS; FLEXIBILITY; SPECIFICITY; DIVERSITY; JUVENILES; LARVAE	Reef-building corals switch endosymbiotic algae of the genus Symbiodinium during their early growth stages and during bleaching events. Clade C Symbiodinium algae are dominant in corals, although other clades - including A and D - have also been commonly detected in juvenile Acroporid corals. Previous studies have been reported that only molecular data of Symbiodinium clade were identified within field corals. In this study, we inoculated aposymbiotic juvenile polyps with cultures of clades C1 and D Symbiodinium algae, and investigated the different effect of these two clades of Symbiodinium on juvenile polyps. Our results showed that clade C1 algae did not grow, while clade D algae grew rapidly during the first 2 months after inoculation. Polyps associated with clade C1 algae exhibited bright green fluorescence across the body and tentacles after inoculation. The growth rate of polyp skeletons was lower in polyps associated with clade C1 algae than those associated with clade D algae. On the other hand, antioxidant activity (catalase) of corals was not significantly different between corals with clade C1 and clade D algae. Our results suggested that clade D Symbiodinium algae easily form symbiotic relationships with corals and that these algae could contribute to coral growth in early symbiosis stages.	[Yuyama, Ikuko; Higuchi, Tomihiko] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan	Shizuoka University	Yuyama, I (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka, Japan.	Ikuko_yy@hotmail.com	Higuchi, Tomihiko/AAW-6006-2020; Higuchi, Tomihiko/D-7118-2019	Higuchi, Tomihiko/0000-0001-7324-5752; Higuchi, Tomihiko/0000-0001-7324-5752	MEXT, Japan [20121002]; Fujiwara Natural History Foundation [2415]; Kurita Water and Environment Foundation [13A055]; Grants-in-Aid for Scientific Research [14J40135] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fujiwara Natural History Foundation; Kurita Water and Environment Foundation(Kurita Water and Environment Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research for the project titled "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses" (No. 20121002), from the MEXT, Japan. Additional support was received from the Fujiwara Natural History Foundation (2415) and Kurita Water and Environment Foundation (13A055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BEERS RF, 1952, J BIOL CHEM, V195, P133; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; D'Angelo C, 2012, CORAL REEFS, V31, P1045, DOI 10.1007/s00338-012-0926-8; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Higuchi T., 2009, P 11 INT COR REEF S, P926; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Kenkel CD, 2011, P ROY SOC B-BIOL SCI, V278, P2691, DOI 10.1098/rspb.2010.2344; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Smith GJ, 1999, MAR BIOL, V134, P405, DOI 10.1007/s002270050557; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yakovleva I, 2004, COMP BIOCHEM PHYS B, V139, P721, DOI 10.1016/j.cbpc.2004.08.016; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857; Yamashita H, 2012, CORAL REEFS, V16, P129, DOI DOI 10.1007/S00338-012-0980-2; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004	31	36	36	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98999	10.1371/journal.pone.0098999	http://dx.doi.org/10.1371/journal.pone.0098999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914677	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700048
J	Hayashi, K; Ogiyama, Y; Yokomi, K; Nakagawa, T; Kaino, T; Kawamukai, M				Hayashi, Kazuhiro; Ogiyama, Yuki; Yokomi, Kazumasa; Nakagawa, Tsuyoshi; Kaino, Tomohiro; Kawamukai, Makoto			Functional Conservation of Coenzyme Q Biosynthetic Genes among Yeasts, Plants, and Humans	PLOS ONE			English	Article							POLYPRENYL DIPHOSPHATE TRANSFERASE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; UBIQUINONE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CHAIN-LENGTH; PROTEIN; SYNTHASE; ANTIOXIDANT	Coenzyme Q (CoQ) is an essential factor for aerobic growth and oxidative phosphorylation in the electron transport system. The biosynthetic pathway for CoQ has been proposed mainly from biochemical and genetic analyses of Escherichia coli and Saccharomyces cerevisiae; however, the biosynthetic pathway in higher eukaryotes has been explored in only a limited number of studies. We previously reported the roles of several genes involved in CoQ synthesis in the fission yeast Schizosaccharomyces pombe. Here, we expand these findings by identifying ten genes (dps1, dlp1, ppt1, and coq3-9) that are required for CoQ synthesis. CoQ10-deficient S. pombe coq deletion strains were generated and characterized. All mutant fission yeast strains were sensitive to oxidative stress, produced a large amount of sulfide, required an antioxidant to grow on minimal medium, and did not survive at the stationary phase. To compare the biosynthetic pathway of CoQ in fission yeast with that in higher eukaryotes, the ability of CoQ biosynthetic genes from humans and plants (Arabidopsis thaliana) to functionally complement the S. pombe coq deletion strains was determined. With the exception of COQ9, expression of all other human and plant COQ genes recovered CoQ10 production by the fission yeast coq deletion strains, although the addition of a mitochondrial targeting sequence was required for human COQ3 and COQ7, as well as A. thaliana COQ6. In summary, this study describes the functional conservation of CoQ biosynthetic genes between yeasts, humans, and plants.	[Hayashi, Kazuhiro; Ogiyama, Yuki; Yokomi, Kazumasa; Kaino, Tomohiro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Interdisciplinary Ctr Sci Res, Matsue, Shimane, Japan	Shimane University; Shimane University	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimanen-u.ac.jp	Kawamukai, Makoto/AET-1038-2022	Kawamukai, Makoto/0000-0003-2929-8798	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380056]; Japanese Coenzyme Q association	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Coenzyme Q association	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (# 24380056) and by Japanese Coenzyme Q association (http://www.coenzymeq-jp.com/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Ducluzeau AL, 2012, PLANT J, V69, P366, DOI 10.1111/j.1365-313X.2011.04796.x; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; Garcia-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Jonassen T, 2000, J BIOL CHEM, V275, P12381, DOI 10.1074/jbc.275.17.12381; Jun L, 2004, PLANT CELL PHYSIOL, V45, P1882, DOI 10.1093/pcp/pch211; Kainou T, 2001, J BIOL CHEM, V276, P7876, DOI 10.1074/jbc.M007472200; Kawamukai M, 2002, J BIOSCI BIOENG, V94, P511, DOI 10.1016/S1389-1723(02)80188-8; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Matsuo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059887; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Miki R, 2008, FEBS J, V275, P5309, DOI 10.1111/j.1742-4658.2008.06661.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nishida T, 2013, J MOL STRUCT, V1048, P375, DOI 10.1016/j.molstruc.2013.05.066; Okada K, 2004, PLANT MOL BIOL, V55, P567, DOI 10.1007/s11103-004-1298-4; Okada K, 1998, FEBS LETT, V431, P241, DOI 10.1016/S0014-5793(98)00753-4; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2003, BIOFACTORS, V18, P229, DOI 10.1002/biof.5520180225; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Suzuki K, 1997, J BIOCHEM, V121, P496; Tay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055041; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zhang M, 2008, FEBS J, V275, P3653, DOI 10.1111/j.1742-4658.2008.06510.x; Zhang M, 2008, BIOFACTORS, V32, P91, DOI 10.1002/biof.5520320111	50	43	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99038	10.1371/journal.pone.0099038	http://dx.doi.org/10.1371/journal.pone.0099038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911838	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600037
J	Hutchinson, JN; Raj, T; Fagerness, J; Stahl, E; Viloria, FT; Gimelbrant, A; Seddon, J; Daly, M; Chess, A; Plenge, R				Hutchinson, John N.; Raj, Towfique; Fagerness, Jes; Stahl, Eli; Viloria, Fernando T.; Gimelbrant, Alexander; Seddon, Johanna; Daly, Mark; Chess, Andrew; Plenge, Robert			Allele-Specific Methylation Occurs at Genetic Variants Associated with Complex Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; SUSCEPTIBILITY LOCI; COMMON VARIANTS; METAANALYSIS; EXPRESSION; RISK; TWIN; AGE; POLYMORPHISM	We hypothesize that the phenomenon of allele-specific methylation (ASM) may underlie the phenotypic effects of multiple variants identified by Genome-Wide Association studies (GWAS). We evaluate ASM in a human population and document its genome-wide patterns in an initial screen at up to 380,678 sites within the genome, or up to 5% of the total genomic CpGs. We show that while substantial inter-individual variation exists, 5% of assessed sites show evidence of ASM in at least six samples; the majority of these events (81%) are under genetic influence. Many of these cis-regulated ASM variants are also eQTLs in peripheral blood mononuclear cells and monocytes and/or in high linkage-disequilibrium with variants linked to complex disease. Finally, focusing on autoimmune phenotypes, we extend this initial screen to confirm the association of cis-regulated ASM with multiple complex disease-associated variants in an independent population using next-generation bisulfite sequencing. These four variants are implicated in complex phenotypes such as ulcerative colitis and AIDS progression disease (rs10491434), Celiac disease (rs2762051), Crohn's disease, IgA nephropathy and early-onset inflammatory bowel disease (rs713875) and height (rs6569648). Our results suggest cis-regulated ASM may provide a mechanistic link between the non-coding genetic changes and phenotypic variation observed in these diseases and further suggests a route to integrating DNA methylation status with GWAS results.	[Hutchinson, John N.; Stahl, Eli; Plenge, Robert] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Hutchinson, John N.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Raj, Towfique; Viloria, Fernando T.] Broad Inst, Cambridge, MA USA; [Raj, Towfique] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Fagerness, Jes; Daly, Mark] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Gimelbrant, Alexander] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Gimelbrant, Alexander] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Seddon, Johanna] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA; [Seddon, Johanna] Tufts Med Ctr, Ophthalm Epidemiol & Genet Serv, Boston, MA USA; [Chess, Andrew] Mt Sinai Sch Med, Friedman Brain Inst, Dept Genet & Genom Sci, Fishberg Dept Neurosci,Dept Dev & Regenerat Biol, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Tufts University; Tufts Medical Center; Icahn School of Medicine at Mount Sinai	Hutchinson, JN (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	jhutchin@hsph.harvard.edu	Hutchinson, John/AAA-1976-2020; Daly, Mark J/B-2453-2017; Raj, Towfique/ABD-7620-2021	Hutchinson, John/0000-0002-7804-7576; Daly, Mark J/0000-0002-0949-8752; Gimelbrant, Alexander/0000-0001-6986-0285	NIH [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Burroughs Wellcome Fund; National Institutes of Health, Bethesda, MD [R01-EY11309]; Massachusetts Lions Eye Research Fund, Inc.; Research to Prevent Blindness, Inc., New York, NY; American Macular Degeneration Foundation, Northampton, MA;  [RC2-GM093080]; NATIONAL EYE INSTITUTE [R01EY011309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059648, R01AR056768, R01AR057108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080, U01GM092691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund, Inc.; Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); American Macular Degeneration Foundation, Northampton, MA; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RMP was supported by grants from the NIH (R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. The PhenoGenetic Project of Brigham and Women's Hospital was supported by RC2-GM093080. JS was supported in part by Grants R01-EY11309 from the National Institutes of Health, Bethesda, MD; Massachusetts Lions Eye Research Fund, Inc.; Unrestricted grant from Research to Prevent Blindness, Inc., New York, NY; the American Macular Degeneration Foundation, Northampton, MA; donations to the Macular Degeneration Research Fund of the Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Consortium TIS, 2009, NATURE, V460, P748; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hellman A, 2007, SCIENCE, V147; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; JABLON S, 1967, AM J HUM GENET, V19, P133; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang MY, 2008, CANCER-AM CANCER SOC, V112, P1699, DOI 10.1002/cncr.23335; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Limou S, 2012, CURR HIV RES, V10, P143, DOI 10.2174/157016212799937209; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, AM J HUM GENET, V92, P517; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Stepanow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017711; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tycko B, 2010, AM J HUM GENET, V86, P109, DOI 10.1016/j.ajhg.2010.01.021; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zeller T, PLOS ONE, V5; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	49	30	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98464	10.1371/journal.pone.0098464	http://dx.doi.org/10.1371/journal.pone.0098464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911414	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600006
J	Lonsdorf, EV; Markham, AC; Heintz, MR; Anderson, KE; Ciuk, DJ; Goodall, J; Murray, CM				Lonsdorf, Elizabeth V.; Markham, A. Catherine; Heintz, Matthew R.; Anderson, Karen E.; Ciuk, David J.; Goodall, Jane; Murray, Carson M.			Sex Differences in Wild Chimpanzee Behavior Emerge during Infancy	PLOS ONE			English	Article							PAN-TROGLODYTES; LIFE-HISTORY; REPRODUCTIVE SUCCESS; GENDER DIFFERENCES; BIASED INVESTMENT; DOMINANCE RANK; SOCIALIZATION; PATTERNS; MILK	The role of biological and social influences on sex differences in human child development is a persistent topic of discussion and debate. Given their many similarities to humans, chimpanzees are an important study species for understanding the biological and evolutionary roots of sex differences in human development. In this study, we present the most detailed analyses of wild chimpanzee infant development to date, encompassing data from 40 infants from the long-term study of chimpanzees at Gombe National Park, Tanzania. Our goal was to characterize age-related changes, from birth to five years of age, in the percent of observation time spent performing behaviors that represent important benchmarks in nutritional, motor, and social development, and to determine whether and in which behaviors sex differences occur. Sex differences were found for indicators of social behavior, motor development and spatial independence with males being more physically precocious and peaking in play earlier than females. These results demonstrate early sex differentiation that may reflect adult reproductive strategies. Our findings also resemble those found in humans, which suggests that biologically based sex differences may have been present in the common ancestor and operated independently from the influences of modern sex-biased parental behavior and gender socialization.	[Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA; [Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Biol Fdn Behav Program, Lancaster, PA 17604 USA; [Lonsdorf, Elizabeth V.; Heintz, Matthew R.; Anderson, Karen E.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL USA; [Markham, A. Catherine; Murray, Carson M.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Heintz, Matthew R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Ciuk, David J.] Franklin & Marshall Coll, Dept Govt, Lancaster, PA 17604 USA; [Goodall, Jane] Jane Goodall Inst, Vienna, VA USA	Franklin & Marshall College; Franklin & Marshall College; George Washington University; University of Chicago; Franklin & Marshall College	Lonsdorf, EV (corresponding author), Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA.	Elizabeth.lonsdorf@fandm.edu		Ciuk, David/0000-0002-5366-683X	Leo S. Guthman Foundation; National Geographic Society; National Institutes of Health [5R00HD057992]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD057992] Funding Source: NIH RePORTER	Leo S. Guthman Foundation; National Geographic Society(National Geographic Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Leo S. Guthman Foundation, the National Geographic Society, and the National Institutes of Health (5R00HD057992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2001, DEV PSYCHOBIOL, V38, P252, DOI 10.1002/dev.1019; BERMAN PW, 1977, CHILD DEV, V48, P711, DOI 10.1111/j.1467-8624.1977.tb01225.x; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Brent L, 1997, BEHAVIOUR, V134, P1189, DOI 10.1163/156853997X00124; Brown GR, 2000, PRIMATES, V41, P63, DOI 10.1007/BF02557462; Campbell DW, 1999, INFANT CHILD DEV, V8, P1, DOI 10.1002/(SICI)1522-7219(199903)8:1<1::AID-ICD186>3.0.CO;2-O; Clark C. B., 1977, P235; Connellan J, 2000, INFANT BEHAV DEV, V23, P113, DOI 10.1016/S0163-6383(00)00032-1; Edwards C.P., 1993, JUVENILE PRIMATES LI, P327; Forster S, 2005, BEHAVIOUR, V142, P869, DOI 10.1163/1568539055010138; Garza C, 2006, ACTA PAEDIATR, V95, P66, DOI 10.1080/08035320500495530; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; Gilby IC, 2006, ANIM BEHAV, V72, P169, DOI 10.1016/j.anbehav.2006.01.013; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; GOLDBERG S, 1982, CHILD DEV, V53, P1544, DOI 10.1111/j.1467-8624.1982.tb03477.x; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goodall J, 1967, PRIMATE ETHOLOGY, P287; Hasegawa T, 1990, CHIMPANZEES MAHALE, P100; Haviland J. J., 1981, GENDER NONVERBAL BEH, P183, DOI [10.1007/978-1-4612-5953-4_10, DOI 10.1007/978-1-4612-5953-4_10]; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hiraiwa-Hasegawa M., 1990, P257; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lonsdorf EV, 2014, ANIM BEHAV, V88, P79, DOI 10.1016/j.anbehav.2013.11.015; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; MACCOBY EE, 1988, DEV PSYCHOL, V24, P755, DOI 10.1037/0012-1649.24.6.755; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; McGrew W.C., 1979, Perspectives on Human Evolution, V5, P441; McIntyre MH, 2009, ANNU REV ANTHROPOL, V38, P83, DOI 10.1146/annurev-anthro-091908-164338; Meredith S. L., 2013, BUILDING BABIES PRIM, P411; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; Nicholson NA, 1977, PRIMATE BIOSOCIAL DE, P592; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; OWENS NW, 1975, ANIM BEHAV, V23, P387, DOI 10.1016/0003-3472(75)90087-1; Plooij FX., 1984, BEHAV DEV FREE LIVIN; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1990, BEHAVIOUR, V115, P203, DOI 10.1163/156853990X00581; Pusey AE, 2005, INT J PRIMATOL, V26, P3, DOI 10.1007/s10764-005-0721-2; PUSEY AE, 1983, ANIM BEHAV, V31, P363, DOI 10.1016/S0003-3472(83)80055-4; Roney James R., 2003, P171; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; Smith TM, 2013, P NATL ACAD SCI USA, V110, P2787, DOI 10.1073/pnas.1218746110; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; van Lawick-Goodall J., 1968, Animal Behaviour Monographs, V1, P161; VANDERIJTPLOOIJ HHC, 1987, BEHAVIOUR, V101, P1, DOI 10.1163/156853987X00378; Whiting B. B., 1988, CHILDREN DIFFERENT W; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Witt SD, 1997, ADOLESCENCE, V32, P253; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wrangham R W, 1980, J Reprod Fertil Suppl, VSuppl 28, P13; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zihlman A, 2004, P NATL ACAD SCI USA, V101, P10541, DOI 10.1073/pnas.0402635101	55	53	53	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99099	10.1371/journal.pone.0099099	http://dx.doi.org/10.1371/journal.pone.0099099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911160	Green Published, gold			2022-12-27	WOS:000337165600042
J	Tegethoff, M; Stalujanis, E; Belardi, A; Meinlschmidt, G				Tegethoff, Marion; Stalujanis, Esther; Belardi, Angelo; Meinlschmidt, Gunther			School Mental Health Services: Signpost for Out-of-School Service Utilization in Adolescents with Mental Disorders? A Nationally Representative United States Cohort	PLOS ONE			English	Article							COMORBIDITY SURVEY REPLICATION; SUPPLEMENT NCS-A; SELF-REPORTED USE; DSM-IV DISORDERS; PSYCHOSOCIAL IMPAIRMENT; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; REGISTRATION DATA; CARE UTILIZATION; CHILDREN	Background: School mental health services are important contact points for children and adolescents with mental disorders, but their ability to provide comprehensive treatment is limited. The main objective was to estimate in mentally disordered adolescents of a nationally representative United States cohort the role of school mental health services as guide to mental health care in different out-of-school service sectors. Methods: Analyses are based on weighted data (N=6483) from the United States National Comorbidity Survey Replication Adolescent Supplement (participants' age: 13-18 years). Lifetime DSM-IV mental disorders were assessed using the fully structured WHO CIDI interview, complemented by parent report. Adolescents and parents provided information on mental health service use across multiple sectors, based on the Service Assessment for Children and Adolescents. Results: School mental health service use predicted subsequent out-of-school service utilization for mental disorders i) in the medical specialty sector, in adolescents with affective (hazard ratio (HR) = 3.01, confidence interval (CI) = 1.77-5.12), anxiety (HR = 3.87, CI = 1.97-7.64), behavior (HR = 2.49, CI = 1.62-3.82), substance use (HR = 4.12, CI = 1.87-9.04), and eating (HR = 10.72, CI = 2.31-49.70) disorders, and any mental disorder (HR = 2.97, CI = 1.94-4.54), and ii) in other service sectors, in adolescents with anxiety (HR = 3.15, CI = 2.17-4.56), behavior (HR = 1.99, CI = 1.29-3.06), and substance use (HR = 2.48, CI = 1.57-3.94) disorders, and any mental disorder (HR = 2.33, CI = 1.54-3.53), but iii) not in the mental health specialty sector. Conclusions: Our findings indicate that in the United States, school mental health services may serve as guide to out-of-school service utilization for mental disorders especially in the medical specialty sector across various mental disorders, thereby highlighting the relevance of school mental health services in the trajectory of mental care. In light of the missing link between school mental health services and mental health specialty services, the promotion of a stronger collaboration between these sectors should be considered regarding the potential to improve and guarantee adequate mental care at early life stages.	[Tegethoff, Marion; Stalujanis, Esther; Belardi, Angelo] Univ Basel, Dept Psychol, Div Clin Psychol & Psychiat, Basel, Switzerland; [Meinlschmidt, Gunther] Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland; [Meinlschmidt, Gunther] Ruhr Univ Bochum, Fac Med, Bochum, Germany	University of Basel; University of Basel; Ruhr University Bochum	Tegethoff, M (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Psychiat, Basel, Switzerland.	marion.tegethoff@unibas.ch	Meinlschmidt, Gunther/AAD-3618-2019; Belardi, Angelo/H-4364-2019	Meinlschmidt, Gunther/0000-0002-3488-193X; Belardi, Angelo/0000-0002-6421-4767	Swiss National Science Foundation (SNSF) [PZ00P1_137023, 100014_135328]; United States Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health [U01-MH60220]; United States Department of Health and Human Services, National Institutes of Health, National Institute of Drug Abuse [R01-DA12058-05]; United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; Robert Wood Johnson Foundation [044780]; John W. Alden Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH060220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012058] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); United States Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health; United States Department of Health and Human Services, National Institutes of Health, National Institute of Drug Abuse; United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); John W. Alden Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was financed by the Swiss National Science Foundation (SNSF, to MT, project no. PZ00P1_137023). GM received SNSF funding under project no. 100014_135328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Comorbidity Survey Replication Adolescent Supplement (NCS-A) was funded by: United States Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (U01-MH60220); United States Department of Health and Human Services, National Institutes of Health, National Institute of Drug Abuse (R01-DA12058-05); United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration; Robert Wood Johnson Foundation (Grant 044780); John W. Alden Trust.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], AM J HLTH ED, V32, P179; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Brauner CB, 2006, PUBLIC HEALTH REP, V121, P303, DOI 10.1177/003335490612100314; Burns B. J., 1997, J CHILD FAM STUD, V6, P89, DOI DOI 10.1023/A:1025024808146; BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147; Cantwell DP, 1997, J AM ACAD CHILD PSY, V36, P610, DOI 10.1097/00004583-199705000-00011; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Costello EJ, 2005, J AM ACAD CHILD PSY, V44, P972, DOI 10.1097/01.chi.0000172552.41596.6f; COSTELLO EJ, 1990, ACTA PSYCHIAT SCAND, V81, P523, DOI 10.1111/j.1600-0447.1990.tb05492.x; Cunningham PJ, 1996, HEALTH SERV RES, V31, P409; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Essau CA, 2000, J ADOLESCENT RES, V15, P470, DOI 10.1177/0743558400154003; Essau CA, 2000, J ANXIETY DISORD, V14, P263, DOI 10.1016/S0887-6185(99)00039-0; Farmer EM., 1994, J CHILD FAM STUD, V3, P307, DOI [10.1007/BF02234688, DOI 10.1007/BF02234688]; Farmer EMZ, 2003, PSYCHIATR SERV, V54, P60, DOI 10.1176/appi.ps.54.1.60; Farmer EMZ, 1999, COMMUNITY MENT HLT J, V35, P31, DOI 10.1023/A:1018743908617; Foy Jane Meschan, 2010, Pediatrics, V125 Suppl 3, pS69, DOI 10.1542/peds.2010-0788C; Grills AE, 2002, CLIN CHILD FAM PSYCH, V5, P57, DOI 10.1023/A:1014573708569; Guevara JP, 2003, PEDIATRICS, V112, pE440, DOI 10.1542/peds.112.6.e440; Gundgaard J, 2008, EUR J PUBLIC HEALTH, V18, P189, DOI 10.1093/eurpub/ckm103; Heneghan A, 2008, J DEV BEHAV PEDIATR, V29, P262, DOI 10.1097/DBP.0b013e31817dbd97; Hogan MF, 2003, PSYCHIAT SERVICES, V54; HOLM S, 1979, SCAND J STAT, V6, P65; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Jimerson S.R., 2007, HDB INT SCH PSYCHOL; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Kessler RC, 2012, PSYCHOL MED, V42, P1997, DOI 10.1017/S0033291712000025; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kessler RC, 2009, INT J METH PSYCH RES, V18, P69, DOI 10.1002/mpr.279; Kessler RC, 2009, J AM ACAD CHILD PSY, V48, P386, DOI 10.1097/CHI.0b013e31819a1cbc; Kessler RC, 2009, J AM ACAD CHILD PSY, V48, P380, DOI 10.1097/CHI.0b013e3181999705; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Killeen TK, 2004, DRUG ALCOHOL DEPEN, V73, P141, DOI 10.1016/j.drugalcdep.2003.09.006; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; MARINO S, 1995, PSYCHOL MED, V25, P1135, DOI 10.1017/S0033291700033110; Merikangas KR, 2009, J AM ACAD CHILD PSY, V48, P367, DOI 10.1097/CHI.0b013e31819996f1; Merikangas KR, 2011, J AM ACAD CHILD PSY, V50, P32, DOI 10.1016/j.jaac.2010.10.006; Newson RB, 2010, STATA J, V10, P568, DOI 10.1177/1536867X1101000403; OFFORD DR, 1987, ARCH GEN PSYCHIAT, V44, P832; Olfson M, 2002, AM J PSYCHIAT, V159, P1914, DOI 10.1176/appi.ajp.159.11.1914; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reijneveld SA, 2001, INT J EPIDEMIOL, V30, P1407, DOI 10.1093/ije/30.6.1407; Reijneveld SA, 2000, J CLIN EPIDEMIOL, V53, P267, DOI 10.1016/S0895-4356(99)00138-9; Remschmidt Helmut, 2005, World Psychiatry, V4, P147; Roberts RE, 1998, AM J PSYCHIAT, V155, P715; Sawyer MG, 2002, J AM ACAD CHILD PSY, V41, P530, DOI 10.1097/00004583-200205000-00010; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stiffman AR, 2000, J AM ACAD CHILD PSY, V39, P1032, DOI 10.1097/00004583-200008000-00019; Verhulst FC, 1997, J AM ACAD CHILD PSY, V36, P901, DOI 10.1097/00004583-199707000-00011; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Wang PS, 2000, J GEN INTERN MED, V15, P284, DOI 10.1046/j.1525-1497.2000.9908044.x; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wang PS, 2002, AM J PUBLIC HEALTH, V92, P92, DOI 10.2105/AJPH.92.1.92; Wang PS, 2006, AM J PSYCHIAT, V163, P1187, DOI 10.1176/appi.ajp.163.7.1187; Watkins MW, 2001, SCHOOL PSYCHOL INT, V22, P64, DOI 10.1177/01430343010221005; Weisz JR, 2006, AM PSYCHOL, V61, P671, DOI 10.1037/0003-066X.61.7.671; Wells KB, 2001, BIOL PSYCHIAT, V49, P1111, DOI 10.1016/S0006-3223(01)01113-1; Willett JB, 2004, SAGE HDB QUANTITATIV; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wood Patricia A, 2005, Ment Health Serv Res, V7, P185, DOI 10.1007/s11020-005-5787-0; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55; Zahner GEP, 1997, AM J PUBLIC HEALTH, V87, P1440, DOI 10.2105/AJPH.87.9.1440; Zito JM, 2000, JAMA-J AM MED ASSOC, V283, P1025, DOI 10.1001/jama.283.8.1025	68	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99675	10.1371/journal.pone.0099675	http://dx.doi.org/10.1371/journal.pone.0099675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911241	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000337165600113
J	Lee, YH; Hsu, CY; Chu, CW; Liu, PH; Hsia, CY; Huang, YH; Su, CW; Chiou, YY; Lin, HC; Huo, TI				Lee, Yun-Hsuan; Hsu, Chia-Yang; Chu, Chen-Wei; Liu, Po-Hong; Hsia, Cheng-Yuan; Huang, Yi-Hsiang; Su, Chien-Wei; Chiou, Yi-You; Lin, Han-Chieh; Huo, Teh-Ia			A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; LIVER RESECTION; HEPATIC RESECTION; RISK-FACTORS; CLASS-B; MANAGEMENT; SURVIVAL; THERAPY; MODEL; RECURRENCE	Background/Aim: Majority of patients with hepatocellular carcinoma (HCC) belonged to Child-Turcotte-Pugh (CTP) class A. We aimed to identify a new class of patients with very well-preserved liver function and analyze its impact on outcome prediction, tumor staging and treatment allocation. Methods: A total of 2654 HCC patients were retrospectively analyzed. The prognostic ability was compared by the Akaike information criterion (AIC). Results: The CTP class 0 was defined by fulfilling all criteria of albumin >= 4 g/dL, bilirubin <= 0.8 mg/dL, prothrombin time prolongation <0 seconds, no ascites and encephalopathy. A total of 23% of patients of CTP class A were reclassified as CTP class 0. Patients with CTP class 0 had a higher serum sodium level, lower serum creatinine, alanine aminotransferase, afetoprotein levels, shorter prothrombin time, better general well-being, smaller tumor burden with more solitary nodules, lower rates of vascular invasion, ascites formation, hepatic encephalopathy, more frequently treated with curative interventions and better Barcelona Clinic Liver Cancer (BCLC) stages (all p<0.001). In the Cox proportional hazards model, the adjusted hazard ratios for CTP class A, B and C were 1.739, 3.120 and 5.107, respectively, compared to class 0 (all p<0.001). Reassigning patients with CTP class 0, A, B, B and C to stage 0, A, B, C and D, respectively, provided the lowest AIC score among all BCLC-based models. Conclusions: The proposal of CTP class 0 independently predicted better survival in HCC patients. Modification of tumor staging systems according to the modified CTP classification further enhances their prognostic ability.	[Lee, Yun-Hsuan; Hsu, Chia-Yang; Chu, Chen-Wei; Liu, Po-Hong; Hsia, Cheng-Yuan; Su, Chien-Wei; Chiou, Yi-You; Lin, Han-Chieh; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Hsu, Chia-Yang; Liu, Po-Hong; Huang, Yi-Hsiang; Su, Chien-Wei; Lin, Han-Chieh; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lee, Yun-Hsuan; Chu, Chen-Wei] Taipei Vet Gen Hosp, Dept Med, Yuanshan Branch, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; University of California System; University of California Los Angeles	Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/G-8459-2015; Su, Chien-Wei/AHC-8307-2022; Liu, Po-Hong/HGB-9015-2022; Su, Chien-Wei/C-1521-2012	Liu, Po-Hong/0000-0001-6205-3704; Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425				Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cabibbo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070016; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chen X, 2012, BRIT J SURG, V99, P1701, DOI 10.1002/bjs.8951; Child CG, 1964, LIVER PORTAL HYPERTE, P50; FEINSTEIN AR, 1972, CLIN PHARMACOL THER, V13, P609; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; GRANT BF, 1988, SEMIN LIVER DIS, V8, P12, DOI 10.1055/s-2008-1040525; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Harada N, 2012, ANN TRANSPL, V17, P11; Hosmer DW, 1997, STAT MED, V16, P965; Hsu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089373; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Hsu KF, 2012, EUR J RADIOL, V81, P466, DOI 10.1016/j.ejrad.2010.12.058; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Ikeda K, 2011, LIVER INT, V31, P692, DOI 10.1111/j.1478-3231.2011.02480.x; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Komorizono Y, 2003, CANCER-AM CANCER SOC, V97, P1253, DOI 10.1002/cncr.11168; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Lee YH, 2014, J CLIN GAST IN PRESS; Lee YH, 2012, DIGEST LIVER DIS, V44, P868, DOI 10.1016/j.dld.2012.04.018; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Manghisi G, 1998, HEPATOLOGY, V28, P751; Nagasue N, 1999, ANN SURG, V229, P84, DOI 10.1097/00000658-199901000-00011; Okuwaki Y, 2009, AM J GASTROENTEROL, V104, P2747, DOI 10.1038/ajg.2009.414; Pompili M, 2013, J HEPATOL, V59, P89, DOI 10.1016/j.jhep.2013.03.009; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Silva MF, 2013, EJSO-EUR J SURG ONC, V39, P386, DOI 10.1016/j.ejso.2012.12.011; Song PP, 2012, LIVER INT, V32, P1053, DOI 10.1111/j.1478-3231.2012.02792.x; Takahashi S, 2007, DIGEST DIS, V25, P303, DOI 10.1159/000106909; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99115	10.1371/journal.pone.0099115	http://dx.doi.org/10.1371/journal.pone.0099115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906132	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000104
J	Nardella, A; Rocchi, L; Conte, A; Bologna, M; Suppa, A; Berardelli, A				Nardella, Andrea; Rocchi, Lorenzo; Conte, Antonella; Bologna, Matteo; Suppa, Antonio; Berardelli, Alfredo			Inferior Parietal Lobule Encodes Visual Temporal Resolution Processes Contributing to the Critical Flicker Frequency Threshold in Humans	PLOS ONE			English	Article							THETA-BURST-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; PHOSPHENE THRESHOLDS; EVOKED-POTENTIALS; FUSION THRESHOLD; PREFRONTAL CORTEX; MOTOR CORTEX; BLOOD-FLOW; MOTION; BRAIN	The measurement of the Critical Flicker Frequency threshold is used to study the visual temporal resolution in healthy subjects and in pathological conditions. To better understand the role played by different cortical areas in the Critical Flicker Frequency threshold perception we used continuous Theta Burst Stimulation (cTBS), an inhibitory plasticity-inducing protocol based on repetitive transcranial magnetic stimulation. The Critical Flicker Frequency threshold was measured in twelve healthy subjects before and after cTBS applied over different cortical areas in separate sessions. cTBS over the left inferior parietal lobule altered the Critical Flicker Frequency threshold, whereas cTBS over the left mediotemporal cortex, primary visual cortex and right inferior parietal lobule left the Critical Flicker Frequency threshold unchanged. No statistical difference was found when the red or blue lights were used. Our findings show that left inferior parietal lobule is causally involved in the conscious perception of Critical Flicker Frequency and that Critical Flicker Frequency threshold can be modulated by plasticity-inducing protocols.	[Nardella, Andrea; Conte, Antonella; Bologna, Matteo; Suppa, Antonio; Berardelli, Alfredo] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Rocchi, Lorenzo; Conte, Antonella; Berardelli, Alfredo] Univ Rome, Dept Neurol & Psychiat, Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Berardelli, A (corresponding author), IRCCS Neuromed, Pozzilli, Isernia, Italy.	alfredo.berardelli@uniroma1.it	Suppa, Antonio/K-4803-2016; Conte, Antonella/J-4508-2012; Rocchi, Lorenzo/K-7983-2016; Bologna, Matteo/K-7886-2016	Suppa, Antonio/0000-0001-9903-5550; Rocchi, Lorenzo/0000-0003-3979-156X; Bologna, Matteo/0000-0003-0165-0833; Conte, Antonella/0000-0002-6338-2961; BERARDELLI, Alfredo/0000-0003-3598-3142				Aglioti SM, 2003, NEUROLOGY, V60, P782, DOI 10.1212/01.WNL.0000046528.24693.5B; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Battelli L, 2003, BRAIN, V126, P2164, DOI 10.1093/brain/awg221; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; BECKERS G, 1992, P ROY SOC B-BIOL SCI, V249, P173, DOI 10.1098/rspb.1992.0100; Bernardi Luciana, 2007, Arq. Bras. Oftalmol., V70, P91, DOI 10.1590/S0004-27492007000100017; Bestmann S, 2008, TRENDS COGN SCI, V12, P81, DOI 10.1016/j.tics.2007.12.002; BLACK S, 1975, NEW ZEAL MED J, V81, P244; Bolognini N, 2009, EXP BRAIN RES, V195, P509, DOI 10.1007/s00221-009-1820-7; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bosco G, 2008, J NEUROSCI, V28, P12071, DOI 10.1523/JNEUROSCI.2869-08.2008; Bowles KE, 2012, ADV EXP MED BIOL, V723, P503, DOI 10.1007/978-1-4614-0631-0_63; Bradley D, 2012, J NEUROL, V259, P77, DOI 10.1007/s00415-011-6125-7; Brighina F, 2003, EUR J NEUROSCI, V17, P2469, DOI 10.1046/j.1460-9568.2003.02679.x; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; Connolly D, 2007, OPTOMETRY VISION SCI, V84, P529, DOI 10.1097/OPX.0b013e318073c65b; Conte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032979; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Curran S, 2004, INT J GERIATR PSYCH, V19, P575, DOI 10.1002/gps.1134; Curran S, 2000, HUM PSYCHOPHARM CLIN, V15, P103, DOI 10.1002/(SICI)1099-1077(200003)15:2<103::AID-HUP149>3.0.CO;2-7; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Fiesta MP, 2008, J NEUROSCI METH, V174, P103, DOI 10.1016/j.jneumeth.2008.06.020; Fiorio M, 2003, ANN NEUROL, V53, P630, DOI 10.1002/ana.10525; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gregori B, 2011, J NEUROL SCI, V300, P130, DOI 10.1016/j.jns.2010.09.002; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hagenbeek RE, 2002, HUM BRAIN MAPP, V17, P244, DOI 10.1002/hbm.10067; Hecht S, 1933, P NATL ACAD SCI USA, V19, P522, DOI 10.1073/pnas.19.5.522; Herwig U, 2001, PSYCHIAT RES-NEUROIM, V108, P123, DOI 10.1016/S0925-4927(01)00121-4; Hong KS, 2000, J NEUROL SCI, V181, P50, DOI 10.1016/S0022-510X(00)00412-3; Hotson JR, 1999, NEUROPSYCHOLOGIA, V37, P169; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iezzi E, 2010, EUR J NEUROSCI, V31, P585, DOI 10.1111/j.1460-9568.2010.07090.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Kagi G, 2013, MOVEMENT DISORD, V28, P356, DOI 10.1002/mds.25305; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2010, CLIN NEUROPHYSIOL, V121, P376, DOI 10.1016/j.clinph.2009.12.002; Koivisto M, 2010, NEUROIMAGE, V51, P828, DOI 10.1016/j.neuroimage.2010.02.042; KOOI KA, 1958, NEUROLOGY, V8, P764, DOI 10.1212/WNL.8.10.764; Kowacs PA, 2005, CEPHALALGIA, V25, P339, DOI 10.1111/j.1468-2982.2004.00861.x; Krolak-Salmon P, 2003, ANN NEUROL, V53, P73, DOI 10.1002/ana.10403; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Leopold DA, 2012, ANNU REV NEUROSCI, V35, P91, DOI 10.1146/annurev-neuro-062111-150356; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lyskov E, 1998, INT J PSYCHOPHYSIOL, V28, P285, DOI 10.1016/S0167-8760(97)00074-3; MECACCI L, 1987, INT J PSYCHOPHYSIOL, V4, P325, DOI 10.1016/0167-8760(87)90045-6; Midena E, 1989, Metab Pediatr Syst Ophthalmol (1985), V12, P28; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nicholls M E, 1996, Laterality, V1, P97; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Petukhov IV, 2007, B EXP BIOL MED+, V144, P267, DOI 10.1007/s10517-007-0306-5; Puzzo I, 2013, BRAIN RES, V1541, P33, DOI 10.1016/j.brainres.2013.10.016; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; REBAI M, 1986, PERCEPTION, V15, P589, DOI 10.1068/p150589; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Romero-Gomez M, 2007, HEPATOLOGY, V45, P879, DOI 10.1002/hep.21586; Sack AT, 2006, NEUROIMAGE, V29, P1326, DOI 10.1016/j.neuroimage.2005.08.027; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Seitz AR, 2005, HUM PSYCHOPHARM CLIN, V20, P55, DOI 10.1002/hup.661; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; SIMONSON E, 1952, PHYSIOL REV, V32, P349, DOI 10.1152/physrev.1952.32.3.349; Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012; Talairach J., 1988, COPLANAR STEREOTAXIC; Teo JTH, 2007, CLIN NEUROPHYSIOL, V118, P1649, DOI 10.1016/j.clinph.2007.04.010; Thickbroom GW, 1998, ELECTROMYOGR MOTOR C, V109, P79, DOI 10.1016/S0924-980X(98)00006-X; Toman J, 1941, J NEUROPHYSIOL, V4, P51, DOI 10.1152/jn.1941.4.1.51; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; TYLER CW, 1989, J OPT SOC AM A, V6, P481, DOI 10.1364/JOSAA.6.000481; Walker AE, 1944, ARCH NEURO PSYCHIATR, V52, P117, DOI 10.1001/archneurpsyc.1944.02290320032004; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038	82	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98948	10.1371/journal.pone.0098948	http://dx.doi.org/10.1371/journal.pone.0098948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905987	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000081
J	Garmendia-Torres, C; Skupin, A; Michael, SA; Ruusuvuori, P; Kuwada, NJ; Falconnet, D; Cary, GA; Hansen, C; Wiggins, PA; Dudley, AM				Garmendia-Torres, Cecilia; Skupin, Alexander; Michael, Sean A.; Ruusuvuori, Pekka; Kuwada, Nathan J.; Falconnet, Didier; Cary, Gregory A.; Hansen, Carl; Wiggins, Paul A.; Dudley, Aimee M.			Unidirectional P-Body Transport during the Yeast Cell Cycle	PLOS ONE			English	Article							CYTOPLASMIC PROCESSING BODIES; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; BUDDING YEAST; PROTEIN LOCALIZATION; SYSTEMS BIOLOGY; GENE DELETION; GRANULES; BUD; IDENTIFICATION	P-bodies belong to a large family of RNA granules that are associated with post-transcriptional gene regulation, conserved from yeast to mammals, and influence biological processes ranging from germ cell development to neuronal plasticity. RNA granules can also transport RNAs to specific locations. Germ granules transport maternal RNAs to the embryo, and neuronal granules transport RNAs long distances to the synaptic dendrites. Here we combine microfluidic-based fluorescent microscopy of single cells and automated image analysis to follow p-body dynamics during cell division in yeast. Our results demonstrate that these highly dynamic granules undergo a unidirectional transport from the mother to the daughter cell during mitosis as well as a constrained "hovering'' near the bud site half an hour before the bud is observable. Both behaviors are dependent on the Myo4p/She2p RNA transport machinery. Furthermore, single cell analysis of cell size suggests that PBs play an important role in daughter cell growth under nutrient limiting conditions.	[Garmendia-Torres, Cecilia] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Skupin, Alexander] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Skupin, Alexander] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Michael, Sean A.; Cary, Gregory A.] Inst Syst Biol, Seattle, WA USA; [Ruusuvuori, Pekka] Tampere Univ Technol, Pori, Finland; [Ruusuvuori, Pekka] Univ Tampere, BioMediTech, Tampere, Finland; [Kuwada, Nathan J.; Wiggins, Paul A.] Univ Washington, Seattle, WA 98195 USA; [Falconnet, Didier; Hansen, Carl] Univ British Columbia, Dept Phys & Astron, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Cary, Gregory A.; Dudley, Aimee M.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Dudley, Aimee M.] Pacific Northwest Diabet Res Inst, Washington, DC USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Luxembourg; University of California System; University of California San Diego; Institute for Systems Biology (ISB); Tampere University; Tampere University; University of Washington; University of Washington Seattle; University of British Columbia; University of Washington; University of Washington Seattle	Dudley, AM (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	aimee.dudley@gmail.com	Ruusuvuori, Pekka/C-9229-2016	Wiggins, Paul/0000-0002-8316-4339; Cary, Gregory/0000-0003-3573-5229; Dudley, Aimee/0000-0003-3644-0625; SKUPIN, Alexander/0000-0002-8955-8304	University of Luxembourg - Institute for Systems Biology Strategic Partnership; U.S. National Institutes of Health (Center for Systems Biology) [P50 GM076547]; Academy of Finland [140052]; Div Of Molecular and Cellular Bioscience [1151043] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	University of Luxembourg - Institute for Systems Biology Strategic Partnership; U.S. National Institutes of Health (Center for Systems Biology)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by the University of Luxembourg - Institute for Systems Biology Strategic Partnership, the U.S. National Institutes of Health (Center for Systems Biology, P50 GM076547) and the Academy of Finland (project #140052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dehlinger D, 2013, BIOTECHNOL BIOENG, V110, P838, DOI 10.1002/bit.24757; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Falconnet D, 2011, LAB CHIP, V11, P466, DOI [10.1039/c0lc00228c, 10.1039/c01c00228c]; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Fukunaga K., 2013, INTRO STAT PATTERN R; Gaillard H, 2008, MOL BIOL CELL, V19, P4980, DOI 10.1091/mbc.E08-02-0193; Hansen CL, 2004, P NATL ACAD SCI USA, V101, P14431, DOI 10.1073/pnas.0405847101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwaki A, 2012, BIOCHEM J, V446, P225, DOI 10.1042/BJ20120583; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; Rose MD., 1990, METHODS YEAST GENETI; Ruusuvuori P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-248; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Voronina E., 2011, COLD SPRING HARB PER, V3; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477	49	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99428	10.1371/journal.pone.0099428	http://dx.doi.org/10.1371/journal.pone.0099428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918601	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000084
J	Karlen, W; Gan, H; Chiu, M; Dunsmuir, D; Zhou, GH; Dumont, GA; Ansermino, JM				Karlen, Walter; Gan, Heng; Chiu, Michelle; Dunsmuir, Dustin; Zhou, Guohai; Dumont, Guy A.; Ansermino, J. Mark			Improving the Accuracy and Efficiency of Respiratory Rate Measurements in Children Using Mobile Devices	PLOS ONE			English	Article								The recommended method for measuring respiratory rate (RR) is counting breaths for 60 s using a timer. This method is not efficient in a busy clinical setting. There is an urgent need for a robust, low-cost method that can help front-line health care workers to measure RR quickly and accurately. Our aim was to develop a more efficient RR assessment method. RR was estimated by measuring the median time interval between breaths obtained from tapping on the touch screen of a mobile device. The estimation was continuously validated by measuring consistency (% deviation from the median) of each interval. Data from 30 subjects estimating RR from 10 standard videos with a mobile phone application were collected. A sensitivity analysis and an optimization experiment were performed to verify that a RR could be obtained in less than 60 s; that the accuracy improves when more taps are included into the calculation; and that accuracy improves when inconsistent taps are excluded. The sensitivity analysis showed that excluding inconsistent tapping and increasing the number of tap intervals improved the RR estimation. Efficiency (time to complete measurement) was significantly improved compared to traditional methods that require counting for 60 s. There was a trade-off between accuracy and efficiency. The most balanced optimization result provided a mean efficiency of 9.9 s and a normalized root mean square error of 5.6%, corresponding to 2.2 breaths/min at a respiratory rate of 40 breaths/min. The obtained 6-fold increase in mean efficiency combined with a clinically acceptable error makes this approach a viable solution for further clinical testing. The sensitivity analysis illustrating the trade-off between accuracy and efficiency will be a useful tool to define a target product profile for any novel RR estimation device.	[Karlen, Walter; Dumont, Guy A.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Gan, Heng; Dunsmuir, Dustin; Ansermino, J. Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Chiu, Michelle] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada; [Zhou, Guohai] Univ British Columbia, Dept Stat, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Karlen, W (corresponding author), Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada.	walter.karlen@ieee.org	Karlen, Walter/C-6290-2008; Karlen, Walter/AAN-9397-2020	Karlen, Walter/0000-0001-8643-3074; Karlen, Walter/0000-0001-8643-3074; Dumont, Guy/0000-0003-2048-4391; Ansermino, J Mark/0000-0001-8427-2035; Zhou, Guohai/0000-0002-8826-403X; Dunsmuir, Dustin/0000-0001-9717-3685; Gan, Heng/0000-0003-2894-9114	Swiss National Science Foundation; Grand Challenges Canada Rising Stars in Global Health grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grand Challenges Canada Rising Stars in Global Health grant	WK is supported by the Swiss National Science Foundation (www.snf.ch) and a Grand Challenges Canada Rising Stars in Global Health grant (www.grandchallenges.ca). The research was conducted using internal University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, RRate on Google Play website, Patent No. [US 4625292, 4625292]; Centre for Clinical Practice, 2007, AC ILL PAT HOSP REC; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; FENNER A, 1973, PEDIATR RES, V7, P174, DOI 10.1203/00006450-197304000-00020; Folke M, 2003, MED BIOL ENG COMPUT, V41, P377, DOI 10.1007/BF02348078; International Data Corporation (IDC), 2003, TECHNICAL REPORT; Karlen W, 2013, IEEE T BIO-MED ENG, V60, P1946, DOI 10.1109/TBME.2013.2246160; Lovett PB, 2005, ANN EMERG MED, V45, P68, DOI 10.1016/j.annemergmed.2004.06.016; Petersen CL, 2013, ACM SIGPLAN NOTICES, V48, P357, DOI [10.1145/2500365.2500615, 10.1145/2544174.2500615]; Philip J, 1982, P 17 ANN AAMI M SAN; Philip J, 1981, P 16 ANN AAMI M WASH; Strange B, 2013, TECHNICAL REPORT; Synovate Uganda, 2011, ARI TIMER RES REPORT; Vital Wave Consulting, 2009, MHEALTH DEV OPP MOB; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; World Health Organization, 1990, TECHNICAL REPORT; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	17	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99266	10.1371/journal.pone.0099266	http://dx.doi.org/10.1371/journal.pone.0099266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919062	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000069
J	Li, JJ; Zhang, HM; Shen, ZY; Zhou, YJ; Fang, NY; Wang, L; Wang, B; Wang, JW; Tang, ZZ				Li, Jianjun; Zhang, Hongman; Shen, Zhiyong; Zhou, Yuejiao; Fang, Ningye; Wang, Lu; Wang, Bin; Wang, Jiangwei; Tang, Zhenzhu			Screening for Acute HIV Infections and Estimating HIV Incidence among Female Sex Workers from Low-Grade Venues in Guangxi, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ENZYME-IMMUNOASSAY; SUBTYPE CRF01-AE; YUNNAN PROVINCE; RISK BEHAVIORS; KAIYUAN CITY; SEROCONVERSION; TRANSMISSION; SYPHILIS; PREVALENCE	Background: Guangxi has become one of the provinces with the most severe HIV-1 epidemic in China, where heterosexual contact is the dominant transmission route. However, data of acute HIV infections and HIV incidence among female sex workers (FSWs) from low-grade venues are scant. Methods: A cross-sectional survey was performed among FSWs from low-grade venues in Guangxi. HIV antibody screening was performed by rapid testing (RT). HIV antibody-negative specimens were screened by pooled nucleic acid amplification testing (NAAT) for acute HIV infections. HIV antibody-positive specimens were further analyzed by Western blot (WB), followed by an HIV-1 BED capture enzyme immunoassay (BED-CEIA) to identify the recent infections. HIV-1 incidence was estimated by the data of pooled NAAT and BED-CEIA, respectively. Results: A total of 7936 FSWs were recruited and answered the questionnaires. We successfully collected the blood samples from 6469 (81.5%) participants, of which 139 (2.1%) were HIV antibody-positive and 6330 (97.9%) were HIV antibodynegative by RT. With pooled NAAT, 7 cases were found to be HIV RNA positive, representing an additional 5.0% of HIVinfected persons and an estimated HIV incidence of 1.45 (95% CI: 1.17-1.76) per 100 person years. There were 137 positive and 2 indeterminate by WB, of which 124 (90.5%) positive specimens were subjected to BED-CEIA testing identifying 28 recent infections. The HIV incidence determined by BED-CEIA testing was 1.04 (95% CI: 0.65-1.43) per 100 person years. The overall prevalence of HIV among FSWs from low-grade venues in Guangxi was 2.2% (95% CI: 1.9-2.6). Conclusions: We found that the addition of HIV RNA screening to routine HIV antibody testing significantly improved the detection of HIV infection among FSWs from low-grade venues in Guangxi. Our findings also provided the useful baseline data of HIV incidence among this population for targeting local HIV prevention, intervention, monitoring and treatment.	[Li, Jianjun; Zhang, Hongman; Fang, Ningye; Wang, Lu; Wang, Bin; Wang, Jiangwei] Guangxi Ctr Dis Control & Prevent, Inst HIV AIDS Prevent & Control, Guangxi Cent Lab HIV AIDS Confirmat, Nanning, Peoples R China; [Shen, Zhiyong; Zhou, Yuejiao] Guangxi Ctr Dis Control & Prevent, Inst HIV AIDS Prevent & Control, Nanning, Peoples R China; [Tang, Zhenzhu] Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China		Tang, ZZ (corresponding author), Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China.	tangzhzh@163.com			Fund of National Natural Science [81360442]; project of Guangxi science and technology development plan [12980031-4]	Fund of National Natural Science(National Natural Science Foundation of China (NSFC)); project of Guangxi science and technology development plan	This work was supported by Fund of National Natural Science (81360442) and project of Guangxi science and technology development plan (12980031-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHIN J AIDS STD; Brookmeyer R, 1999, BIOMETRICS, V55, P608, DOI 10.1111/j.0006-341X.1999.00608.x; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Center for Disease Control and Prevention Office of the Global AIDS Coordinator, 2006, INT REC US BED CAPT; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P731; Chinese Center for Disease Control and Prevention, 2009, NAT GUID DET HIV AID; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Li L, 2013, J MED VIROL, V85, P388, DOI 10.1002/jmv.23360; Lu F, 2009, SE ASIAN J TROP MED, V40, P263; Morandi PA, 1998, J CLIN MICROBIOL, V36, P1534, DOI 10.1128/JCM.36.6.1534-1538.1998; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Wang BX, 2012, J INFECT DIS, V206, P907, DOI 10.1093/infdis/jis466; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wang Y, 2013, S CHINA J PREV MED, V39, P6; Wu ZY, 2010, JAIDS-J ACQ IMM DEF, V53, pS1, DOI 10.1097/QAI.0b013e3181c7d379; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055413, 10.1371/journal.pone.0059050]; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Xu JJ, 2010, INT J INFECT DIS, V14, pE608, DOI 10.1016/j.ijid.2009.09.004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou YJ, 2013, AIDS CARE, V25, P1433, DOI 10.1080/09540121.2013.772282; Zhu BY, 2012, JPN J INFECT DIS, V65, P75	36	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99522	10.1371/journal.pone.0099522	http://dx.doi.org/10.1371/journal.pone.0099522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918933	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000092
J	Muller, B; Anders, M; Reinstein, J				Mueller, Barbara; Anders, Maria; Reinstein, Jochen			In Vitro Analysis of Human Immunodeficiency Virus Particle Dissociation: Gag Proteolytic Processing Influences Dissociation Kinetics	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; TYPE-1 GAG; HIV-1 PARTICLES; ENERGY-TRANSFER; CAPSID PROTEIN; MATURATION; INFECTIVITY; MICROSCOPY; MUTATIONS; MEMBRANE	Human immunodeficiency virus particles undergo a step of proteolytic maturation, in which the main structural polyprotein Gag is cleaved into its mature subunits matrix (MA), capsid (CA), nucleocapsid (NC) and p6. Gag proteolytic processing is accompanied by a dramatic structural rearrangement within the virion, which is necessary for virus infectivity and has been proposed to proceed through a sequence of dissociation and reformation of the capsid lattice. Morphological maturation appears to be tightly regulated, with sequential cleavage events and two small spacer peptides within Gag playing important roles by regulating the disassembly of the immature capsid layer and formation of the mature capsid lattice. In order to measure the influence of individual Gag domains on lattice stability, we established Forster's resonance energy transfer (FRET) reporter virions and employed rapid kinetic FRET and light scatter measurements. This approach allowed us to measure dissociation properties of HIV-1 particles assembled in eukaryotic cells containing Gag proteins in different states of proteolytic processing. While the complex dissociation behavior of the particles prevented an assignment of kinetic rate constants to individual dissociation steps, our analyses revealed characteristic differences in the dissociation properties of the MA layer dependent on the presence of additional domains. The most striking effect observed here was a pronounced stabilization of the MA-CA layer mediated by the presence of the 14 amino acid long spacer peptide SP1 at the CA C-terminus, underlining the crucial role of this peptide for the resolution of the immature particle architecture.	[Mueller, Barbara; Anders, Maria] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany; [Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg 1, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Muller, B (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany.	Barbara_Mueller@med.uni-heidelberg.de	Muller, Barbara/AAC-4483-2020		University Hospital Heidelberg; Max-Planck-Society; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitaet Heidelberg	University Hospital Heidelberg; Max-Planck-Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitaet Heidelberg	This work was supported by core funding from the University Hospital Heidelberg (BM, MA) and the Max-Planck-Society (JR). BM and JR are investigators of the CellNetworks Cluster of Excellence (EXC81). The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitaet Heidelberg within the funding programme 'Open Access Publishing'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-69; Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Adamson C.S., 2012, MOL BIOL INT, V2012; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Gluschankof P, 1997, VIROLOGY, V230, P125, DOI 10.1006/viro.1997.8453; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hogue IB, 2009, J VIROL, V83, P7322, DOI 10.1128/JVI.02545-08; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Keller PW, 2013, J VIROL, V87, P13655, DOI 10.1128/JVI.01408-13; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; KONVALINKA J, 1995, EUR J BIOCHEM, V228, P191, DOI 10.1111/j.1432-1033.1995.tb20249.x; KRAUSSLICH HG, 1995, J VIROL, V69, P3407; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; PARK J, 1993, VIROLOGY, V194, P843, DOI 10.1006/viro.1993.1328; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Perrin-Tricaud C, 1999, VIROLOGY, V255, P20, DOI 10.1006/viro.1998.9573; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; REICIN AS, 1995, J VIROL, V69, P642, DOI 10.1128/JVI.69.2.642-650.1995; ROSE JR, 1995, J VIROL, V69, P2751; Salzwedel K, 2007, AIDS REV, V9, P162; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sundquist W.I., 2012, COLD SPRING HARB PER, V2; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Zhou J, 2005, J BIOL CHEM, V280, P42149, DOI 10.1074/jbc.M508951200	40	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99504	10.1371/journal.pone.0099504	http://dx.doi.org/10.1371/journal.pone.0099504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915417	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700107
J	Feng, Q; Zhu, ML; Wei, KC; Bian, LM				Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming			Cell-Mediated Degradation Regulates Human Mesenchymal Stem Cell Chondrogenesis and Hypertrophy in MMP-Sensitive Hyaluronic Acid Hydrogels	PLOS ONE			English	Article							IN-VITRO; EXTRACELLULAR-MATRIX; II COLLAGEN; FATE; MINERALIZATION; CONDENSATION; DISRUPTION; INDUCTION; INVASION; CULTURES	Photocrosslinked methacrylated hyaluronic acid (MeHA) hydrogels support chondrogenesis of encapsulated human mesenchymal stem cells (hMSCs). However, the covalent crosslinks formed via chain polymerization in these hydrogels are hydrolytically non-degradable and restrict cartilage matrix spatial distribution and cell spreading. Meanwhile, cells are known to remodel their surrounding extracellular matrix (ECM) by secreting catabolic enzymes, such as MMPs. Hydrogels that are created with bifunctional crosslinkers containing MMP degradable peptide sequences have been shown to influence hMSC differentiations. However, crosslinks formed in the MMP-degradable hydrogels of these previous studies are also prone to hydrolysis, thereby confounding the effect of MMP-mediated degradation. The objective of this study is to develop a MMP-sensitive but hydrolytically stable hydrogel scaffold and investigate the effect of MMP-mediated hydrogel degradation on the chondrogenesis of the encapsulated hMSCs. Hyaluronic acid macromers were modified with maleimide groups and crosslinked with MMP-cleavable peptides or control crosslinkers containing dual thiol groups. The chondrogenesis of the hMSCs encapsulated in the hydrolytically stable MMP-sensitive HA hydrogels were compared with that of the MMP-insensitive HA hydrogels. It was found that hMSCs encapsulated in the MMP-sensitive hydrogels switched to a more spreaded morphology while cells in the MMP-insensitive hydrogels remained in round shape. Furthermore, hMSCs in the MMP-sensitive hydrogels expressed higher level of chondrogenic marker genes but lower level of hypertrophic genes compared to cells in the MMP-insensitive hydrogels. As a result, more cartilage specific matrix molecules but less calcification was observed in the MMP-degradable hydrogels than in the MMP-insensitive hydrogels. Findings from this study demonstrate that cell-mediated scaffold degradation regulates the chondrogenesis and hypertrophy of hMSCs encapsulated in HA hydrogels.	[Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming] Chinese Univ Hong Kong, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming] Chinese Univ Hong Kong, Dept Mech & Automat Engn, Hong Kong, Hong Kong, Peoples R China; [Feng, Qian; Zhu, Meiling; Wei, Kongchang; Bian, Liming] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Hong Kong, Hong Kong, Peoples R China; [Bian, Liming] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Bian, LM (corresponding author), Chinese Univ Hong Kong, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	lbian@mae.cuhk.edu.hk	Bian, Liming/A-7183-2011; Bian, Liming/AAQ-5504-2020; Wei, Phenihus/M-5422-2013; Bian, Liming/AAV-3801-2021; Wei, Kongchang/K-2096-2013	Bian, Liming/0000-0003-4739-0918; Wei, Phenihus/0000-0002-6555-2768; Wei, Kongchang/0000-0002-6555-2768; Feng, Qian/0000-0003-3196-0840	Research Grants Council of Hong Kong [439913]; Faculty of Engineering in the Chinese University of Hong Kong; Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong [BME-8115043]; Lui Che Woo Foundation; National Natural Science Foundation of China [31300796]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Faculty of Engineering in the Chinese University of Hong Kong; Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong(Chinese University of Hong Kong); Lui Che Woo Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by an Early Career Scheme grant from the Research Grants Council of Hong Kong (Project No. 439913). This work is supported by a direct grant from the Faculty of Engineering in the Chinese University of Hong Kong. This research is also supported by project BME-8115043 of the Shun Hing Institute of Advanced Engineering, the Chinese University of Hong Kong. This research project was made possible by equipment/resources donated by Lui Che Woo Foundation. Project 31300796 is supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052; Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033; BOSKEY AL, 1991, CRIT REV ORAL BIOL M, V2, P369, DOI 10.1177/10454411910020030501; CHEN CC, 1984, CALCIFIED TISSUE INT, V36, P285, DOI 10.1007/BF02405332; DeLise AM, 2002, J CELL BIOCHEM, V87, P342, DOI 10.1002/jcb.10308; Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jubeck B, 2008, ARTHRITIS RHEUM-US, V58, P2809, DOI 10.1002/art.23762; Jubeck B, 2009, ARTHRITIS RHEUM-US, V60, P2741, DOI 10.1002/art.24773; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035; Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884; Lim YB, 2003, J CELL BIOCHEM, V88, P713, DOI 10.1002/jcb.10389; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156; McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794; Mello MA, 2006, J ORTHOP RES, V24, P2095, DOI 10.1002/jor.20233; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V333, P1011, DOI 10.1016/j.bbrc.2005.06.010; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870; Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115	39	40	41	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99587	10.1371/journal.pone.0099587	http://dx.doi.org/10.1371/journal.pone.0099587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911871	Green Submitted, gold, Green Published			2022-12-27	WOS:000337165600107
J	Nubling, GS; Levin, J; Bader, B; Lorenzl, S; Hillmer, A; Hogen, T; Kamp, F; Giese, A				Nuebling, Georg Sebastian; Levin, Johannes; Bader, Benedikt; Lorenzl, Stefan; Hillmer, Andreas; Hoegen, Tobias; Kamp, Frits; Giese, Armin			Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers	PLOS ONE			English	Article							PARKINSONS-DISEASE; NEURONAL DYSFUNCTION; INCLUSION FORMATION; METAL-IONS; PROTEIN; IRON; BRAIN; VESICLES; NEURODEGENERATION; COAGGREGATION	Background: In several neurodegenerative diseases, hyperphosphorylation at position Ser129 is found in fibrillar deposits of alpha-synuclein (asyn), implying a pathophysiological role of asyn phosphorylation in neurodegeneration. However, recent animal models applying asyn phosphorylation mimics demonstrated a protective effect of phosphorylation. Since metal-ion induced asyn oligomers were identified as a potential neurotoxic aggregate species with membrane pore-forming abilities, the current study was undertaken to determine effects of asyn phosphorylation on oligomer membrane binding. Methods: We investigated the influence of S129 phosphorylation on interactions of metal-ion induced asyn oligomers with small unilamellar lipid vesicles (SUV) composed of POPC and DPPC applying the phosphorylation mimic asyn129E. Confocal single-particle fluorescence techniques were used to monitor membrane binding at the single-particle level. Results: Binding of asyn129E monomers to gel-state membranes (DPPC-SUV) is slightly reduced compared to wild-type asyn, while no interactions with membranes in the liquid-crystalline state (POPC-SUV) are seen for both asyn and asyn129E. Conversely, metal-ion induced oligomer formation is markedly increased in asyn129E. Surprisingly, membrane binding to POPC-SUV is nearly absent in Fe3+ induced asyn129E oligomers and markedly reduced in Al3+ induced oligomers. Conclusion: The protective effect of pseudophosphorylation seen in animal models may be due to impeded oligomer membrane binding. Phosphorylation at Ser129 may thus have a protective effect against neurotoxic asyn oligomers by preventing oligomer membrane binding and disruption of the cellular electrophysiological equilibrium. Importantly, these findings put a new complexion on experimental pharmaceutical interventions against POLO-2 kinase.	[Nuebling, Georg Sebastian; Levin, Johannes; Bader, Benedikt; Lorenzl, Stefan; Hoegen, Tobias] Univ Munich, Dept Neurol, Klinikum Univ Munchen, D-80539 Munich, Germany; [Nuebling, Georg Sebastian; Hillmer, Andreas; Giese, Armin] Univ Munich, Ctr Neuropathol & Prion Res, D-80539 Munich, Germany; [Nuebling, Georg Sebastian; Lorenzl, Stefan] Univ Munich, Dept Palliat Med, Klinikum Univ Munchen, D-80539 Munich, Germany; [Lorenzl, Stefan] Paracelsus Med Univ, Inst Nursing Sci & Practice, Endowed Professorship Interdisciplinary Res Palli, Salzburg, Austria; [Kamp, Frits] Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich; University of Munich; Paracelsus Private Medical University; University of Munich	Nubling, GS (corresponding author), Univ Munich, Dept Neurol, Klinikum Univ Munchen, D-80539 Munich, Germany.	georg.nuebling@med.uni-muenchen.de	Giese, Armin/F-3271-2010; Levin, Johannes/E-4052-2010	Giese, Armin/0000-0002-8238-4102; Levin, Johannes/0000-0001-5092-4306; Nubling, Georg/0000-0003-4492-7302				Aubele DL, 2013, CHEMMEDCHEM, V8, P1295, DOI 10.1002/cmdc.201300166; Bader B, 2011, BIOCHEM BIOPH RES CO, V411, P190, DOI 10.1016/j.bbrc.2011.06.135; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bieschke J, 2000, P NATL ACAD SCI USA, V97, P5468, DOI 10.1073/pnas.97.10.5468; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Castellani RJ, 2000, ACTA NEUROPATHOL, V100, P111, DOI 10.1007/s004010050001; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fiske M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/392180; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giese A, 2005, BIOCHEM BIOPH RES CO, V333, P1202, DOI 10.1016/j.bbrc.2005.06.025; Giese A, 2000, ARCH VIROL, P161; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hogen T, 2012, BIOPHYS J, V102, P1646, DOI 10.1016/j.bpj.2012.01.059; Huls S, 2011, J NEUROCHEM, V117, P868, DOI 10.1111/j.1471-4159.2011.07254.x; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Levin J, 2011, J PARKINSON DIS, V1, P205, DOI 10.3233/JPD-2011-11040; Li W, 1998, NEUROCHEM; Logroscino G, 2008, AM J EPIDEMIOL, V168, P1381, DOI 10.1093/aje/kwn273; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nubling G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-35; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Schmidt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042545; Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Stockl M, 2012, MOL BIOSYST, V8, P338, DOI 10.1039/c1mb05293d; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174	44	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98906	10.1371/journal.pone.0098906	http://dx.doi.org/10.1371/journal.pone.0098906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911099	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600021
J	Wang, SL; Shi, XH; Yang, Z; Zhang, YM; Shen, LR; Lei, ZY; Zhang, ZQ; Cao, C; Fan, DL				Wang, Shao-liang; Shi, Xiao-hua; Yang, Zhi; Zhang, Yi-ming; Shen, Li-ru; Lei, Ze-yuan; Zhang, Zhi-qing; Cao, Cong; Fan, Dong-li			Osteopontin (OPN) Is an Important Protein to Mediate Improvements in the Biocompatibility of C Ion-Implanted Silicone Rubber	PLOS ONE			English	Article							PLASMA-SURFACE MODIFICATION; IN-VITRO; HORSERADISH-PEROXIDASE; BREAST IMPLANTS; TITANIUM-ALLOY; CANCER-CELLS; FUNCTIONALIZATION; ADHESION; BIOMATERIALS; ACTIVATION	Medical device implants are drawing increasing amounts of interest from modern medical practitioners. However, this attention is not evenly spread across all such devices; most of these implantable devices can cause adverse reactions such as inflammation, fibrosis, thrombosis, and infection. In this work, the biocompatibility of silicone rubber (SR) was improved through carbon (C) ion implantation. Scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), and X-ray diffraction (XRD) results confirmed that these newly generated carbon-implanted silicone rubbers (C-SRs) had large, irregular peaks and deep valleys on their surfaces. The water contact angle of the SR surface decreased significantly after C ion implantation. C ion implantation also changed the surface charge distribution, silicone oxygen rate, and chemical-element distribution of SR to favor cell attachment. The dermal fibroblasts cultured on the surface C-SR grew faster and showed more typical fibroblastic shapes. The expression levels of major adhesion proteins, including talin-1, zyxin, and vinculin, were significantly higher in dermal fibroblasts cultured on C-SR coated plates than in dermal fibroblasts cultured on SR. Those same dermal fibroblasts on C-SRs showed more pronounced adhesion and migration abilities. Osteopontin (OPN), a critical extracellular matrix (ECM) protein, was up-regulated and secreted from dermal fibroblasts cultured on C-SR. Matrix metalloproteinase-9 (MMP-9) activity was also increased. These cells were highly mobile and were able to adhere to surfaces, but these abilities were inhibited by the monoclonal antibody against OPN, or by shRNA-mediated MMP-9 knockdown. Together, these results suggest that C ion implantation significantly improves SR biocompatibility, and that OPN is important to promote cell adhesion to the C-SR surface.	[Wang, Shao-liang; Shi, Xiao-hua; Yang, Zhi; Zhang, Yi-ming; Lei, Ze-yuan; Fan, Dong-li] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing, Peoples R China; [Shen, Li-ru] Southwestern Inst Phys, Chengdu, Sichuan, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Army Medical University; Southwestern Institute of Physics - China; Soochow University - China	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; fdltmmu@sina.com			National Natural Science Foundation of China [81071574]; Third Military Medical University [2012XZH05]; research start-up funds of Soochow University [Q321506612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University; research start-up funds of Soochow University	This work was funded by a grant from National Natural Science Foundation of China (81071574) (http://www.nsfc.gov.cn/publish/portal0/default.htm), a grant for Transformation of Scientific and Technological Achievements from Third Military Medical University (2012XZH05) (http://www.tmmu.edu.cn/), and the research start-up funds of Soochow University to Cong Cao (Q321506612)(http://www.suda.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Beck H, 2010, AM J CARDIOL, V106, P810, DOI 10.1016/j.amjcard.2010.04.043; Berry MG, 2012, J PLAST RECONSTR AES, V65, P697, DOI 10.1016/j.bjps.2012.02.019; Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009; Borschel C, 2009, SMALL, V5, P2576, DOI 10.1002/smll.200900562; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Cao C, 2006, BIOCHEM J, V400, P225, DOI 10.1042/BJ20060816; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Cooper L, 2005, GENOME BIOL, V6; Cordeiro AL, 2009, LANGMUIR, V25, P1509, DOI 10.1021/la803054s; Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010; Gan BK, 2008, J BIOMED MATER RES A, V85A, P605, DOI 10.1002/jbm.a.31612; Hunter C, 2012, J SURG RES, V176, P348, DOI 10.1016/j.jss.2011.07.054; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Jun K, 2009, J VAC SCI TECHNOL B, V27, P3043, DOI 10.1116/1.3259919; Jung DH, 2007, PLAST RECONSTR SURG, V120, P1997, DOI 10.1097/01.prs.0000287323.71630.e6; Kondyurin A, 2008, ACTA BIOMATER, V4, P1218, DOI 10.1016/j.actbio.2008.04.017; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; Legrand AP, 2005, J MATER SCI-MATER M, V16, P477, DOI 10.1007/s10856-005-6989-0; Li WQ, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-175; Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016; Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013; Matsuoka M, 2009, BIO-MED MATER ENG, V19, P155, DOI 10.3233/BME-2009-0575; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Miyauchi T, 2010, BIOMATERIALS, V31, P3827, DOI 10.1016/j.biomaterials.2010.01.133; Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293; Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus; Ren TB, 2008, J BIOMED MATER RES A, V86A, P209, DOI 10.1002/jbm.a.31508; Roth J, 2008, LANGMUIR, V24, P12603, DOI 10.1021/la801970s; Rullo OJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4150; Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010; Seyhan H, 2011, J PLAST RECONSTR AES, V64, pE60, DOI 10.1016/j.bjps.2010.08.016; Thein-Han WW, 2009, ACTA BIOMATER, V5, P2668, DOI 10.1016/j.actbio.2009.04.029; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Tuboltsev V, 2009, SMALL, V5, P2687, DOI 10.1002/smll.200901424; Wang HY, 2012, ACS APPL MATER INTER, V4, P4380, DOI 10.1021/am301033t; Wu GS, 2012, SURF COAT TECH, V206, P3186, DOI 10.1016/j.surfcoat.2012.01.001; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Zeplin PH, 2010, PLAST RECONSTR SURG, V126, P266, DOI 10.1097/PRS.0b013e3181dbc313; Zhang RH, 2011, ANAT REC, V294, P406, DOI 10.1002/ar.21324; Zhang YM, 2009, AESTHET PLAST SURG, V33, P760, DOI 10.1007/s00266-009-9363-7; Zhang YM, 2012, MATER LETT, V66, P203, DOI 10.1016/j.matlet.2011.08.060; Zhao Y, 2013, ACS APPL MATER INTER, V5, P1510, DOI 10.1021/am302961h; Zou CY, 2013, CELL BIOCHEM BIOPHYS, V65, P455, DOI 10.1007/s12013-012-9449-8	51	14	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98320	10.1371/journal.pone.0098320	http://dx.doi.org/10.1371/journal.pone.0098320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911051	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600002
J	Wang, YL; Jeong, Y; Jhiang, SM; Yu, LB; Menq, CH				Wang, Yuliang; Jeong, Younkoo; Jhiang, Sissy M.; Yu, Lianbo; Menq, Chia-Hsiang			Quantitative Characterization of Cell Behaviors through Cell Cycle Progression via Automated Cell Tracking	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; MICROSCOPY; MIGRATION; MOTILITY; SEGMENTATION; DIFFUSION	Cell behaviors are reflections of intracellular tension dynamics and play important roles in many cellular processes. In this study, temporal variations in cell geometry and cell motion through cell cycle progression were quantitatively characterized via automated cell tracking for MCF-10A non-transformed breast cells, MCF-7 non-invasive breast cancer cells, and MDA-MB-231 highly metastatic breast cancer cells. A new cell segmentation method, which combines the threshold method and our modified edge based active contour method, was applied to optimize cell boundary detection for all cells in the field-of-view. An automated cell-tracking program was implemented to conduct live cell tracking over 40 hours for the three cell lines. The cell boundary and location information was measured and aligned with cell cycle progression with constructed cell lineage trees. Cell behaviors were studied in terms of cell geometry and cell motion. For cell geometry, cell area and cell axis ratio were investigated. For cell motion, instantaneous migration speed, cell motion type, as well as cell motion range were analyzed. We applied a cell-based approach that allows us to examine and compare temporal variations of cell behavior along with cell cycle progression at a single cell level. Cell body geometry along with distribution of peripheral protrusion structures appears to be associated with cell motion features. Migration speed together with motion type and motion ranges are required to distinguish the three cell-lines examined. We found that cells dividing or overlapping vertically are unique features of cell malignancy for both MCF-7 and MDA-MB-231 cells, whereas abrupt changes in cell body geometry and cell motion during mitosis are unique to highly metastatic MDA-MB-231 cells. Taken together, our live cell tracking system serves as an invaluable tool to identify cell behaviors that are unique to malignant and/or highly metastatic breast cancer cells.	[Wang, Yuliang; Jeong, Younkoo; Menq, Chia-Hsiang] Ohio State Univ, Dept Mech & Aerosp Engn, Precis Measurement & Control Lab, Columbus, OH 43210 USA; [Wang, Yuliang; Jhiang, Sissy M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jhiang, Sissy M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Menq, CH (corresponding author), Ohio State Univ, Dept Mech & Aerosp Engn, Precis Measurement & Control Lab, Columbus, OH 43210 USA.	menq.1@osu.edu	Menq, Chia-Hsiang/AAT-9302-2021; yu, lianbo/B-3472-2010		National Science Foundation [CMMI-1067962]; National Institutes of Health/National Cancer Institute developmental research program [P50CA168505]; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P50CA168505, P01CA124570, P30CA016058] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Cancer Institute developmental research program; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Science Foundation CMMI-1067962 (to CMH) and National Institutes of Health/National Cancer Institute P50CA168505 developmental research program (to CMH). YW is a recipient of Pelotonia postdoctoral fellowship from the Ohio State University Comprehensive Cancer Center. The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARMSTRONG PB, 1985, CANCER METAST REV, V4, P59, DOI 10.1007/BF00047737; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Bunyak F, 2006, I S BIOMED IMAGING, P1040; Chakravorty R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083251; Cheng JR, 2009, IEEE T BIO-MED ENG, V56, P741, DOI 10.1109/TBME.2008.2008635; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goodman JAN, 1995, INTRO FOURIER OPTICS, P220; Guo LL, 2009, OPHTHALMIC RES, V42, P213, DOI 10.1159/000232971; Henrickson SE, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.112pt2; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Mendoz E, 2011, CELL MOL BIOENG, V4, P411, DOI 10.1007/s12195-011-0193-8; Palaniappan K., 2004, IEEE CVPR WORKSH ART, V1, P25; Pathak A, 2013, INTEGR BIOL, V5, P1067; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rajah TT, 1998, IN VITRO CELL DEV-AN, V34, P626, DOI 10.1007/s11626-996-0009-7; Rapoport DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027315; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Scherf N, 2012, EXP HEMATOL, V40, P119, DOI 10.1016/j.exphem.2011.10.009; Selinummi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007497; Silletti S, 1997, Pathol Oncol Res, V3, P230, DOI 10.1007/BF02899927; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Weiger MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058859; Zimmer C, 2002, IEEE T MED IMAGING, V21, P1212, DOI 10.1109/TMI.2002.806292	35	11	11	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98762	10.1371/journal.pone.0098762	http://dx.doi.org/10.1371/journal.pone.0098762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911281	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600013
J	Nakaoka, S; Ishizaki, T; Urushihara, H; Satoh, T; Ikeda, S; Yamamoto, M; Nakayama, T				Nakaoka, Sachiko; Ishizaki, Tatsuro; Urushihara, Hisashi; Satoh, Toshihiko; Ikeda, Shunya; Yamamoto, Mitsutoshi; Nakayama, Takeo			Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010	PLOS ONE			English	Article							DOPAMINE AGONISTS; DISEASE; IMPACT; PREVALENCE; MANAGEMENT; CISAPRIDE; PRESCRIPTION; VALVULOPATHY; DATABASE; COHORT	Objective: Therapeutic options for Parkinson's disease mainly consist of L-dopa and dopamine agonists. However, in Japan, the product labeling of the ergot dopamine agonists, cabergoline and pergolide, was revised in April 2007 due to the risk of developing cardiac valvulopathy. Here, we describe the prescribing trends of anti-Parkinson drugs from 2005 through 2010 in Japan, and examined whether these trends changed after the drug safety measures in 2007. Methods and Patients: We used medical claim data from January 2005 to December 2010 for Parkinson's disease patients older than 30 years who were prescribed anti-Parkinson drugs. We calculated the proportion of patients prescribed each drug for each year, and compared the proportions of first-line drugs prescribed before and after April 2007. We also examined the prescription variations of cabergoline/pergolide users one year before or after April 2007. Results: L-dopa was the most frequently prescribed drug for Parkinson's disease (2005, 58%; 2010, 51%). The proportion of patients prescribed ergot dopamine agonists markedly decreased and non-ergot dopamine agonists increased after 2007. Among first-line drugs, the proportion of non-ergot agents increased after April 2007. Among 54 cabergoline/pergolide users, 24 (44%) discontinued these drugs, nine of whom switched to non-ergot agents. Conclusion: L-dopa was the mainstay of Parkinson's disease treatment between 2005 and 2010 in Japan. There was a decrease in ergot agents and an increase in non-ergot agents prescribed after the regulatory actions in 2007.	[Nakaoka, Sachiko; Ishizaki, Tatsuro; Nakayama, Takeo] Kyoto Univ Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Ishizaki, Tatsuro] Tokyo Metropolitan Inst Gerontol, Human Care Res Team, Tokyo, Japan; [Urushihara, Hisashi] Keio Univ, Div Drug Dev & Regulatory Sci, Fac Pharm, Tokyo, Japan; [Satoh, Toshihiko] Aoyama Gakuin Univ, Sch Social Informat, Tokyo, Kanagawa 150, Japan; [Ikeda, Shunya] Int Univ Hlth & Welf, Sch Pharm, Dept Pharmaceut Sci, Otawara, Tochigi, Japan; [Yamamoto, Mitsutoshi] Takamatsu Neurol Clin, Kagawa, Japan	Kyoto University; Tokyo Metropolitan Institute of Gerontology; Keio University; Aoyama Gakuin University; International University of Health & Welfare	Nakayama, T (corresponding author), Kyoto Univ Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan.	nakayama.takeo.4a@kyoto-u.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022	Urushihara, Hisashi/0000-0001-6913-9930; Nakayama, Takeo/0000-0002-7918-6252				ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Askmark H, 2003, PARKINSONISM RELAT D, V9, P271, DOI 10.1016/S1353-8020(02)00117-7; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; European Pharmaceutical Market Research Association, AN CLASS; Hallas J, 2005, PHARMACOEPIDEM DR S, V14, P455, DOI 10.1002/pds.1063; Higashi Takahiro, 2012, Glob J Health Sci, V4, P197, DOI 10.5539/gjhs.v4n6p197; Hollingworth SA, 2011, PHARMACOEPIDEM DR S, V20, P450, DOI 10.1002/pds.2114; Hubner-Liebermann B, 2005, INT J SOC PSYCHIATR, V51, P83, DOI 10.1177/0020764005050337; Japanese Society of Neurology, 2011, GUID TREATM PARK DIS; Jones JK, 2001, JAMA-J AM MED ASSOC, V286, P1607, DOI 10.1001/jama.286.13.1607; Katada H, 2014, CLIN RHEUMA IN PRESS; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kirigaya D, 2011, INTERNAL MED, V50, P2793, DOI 10.2169/internalmedicine.50.5266; Kohro T, 2013, INT HEART J, V54, P93, DOI 10.1536/ihj.54.93; Lee D, 2007, TXB PHARMACOEPIDEMIO, P399; Leoni O, 2002, PHARMACOEPIDEM DR S, V11, P149, DOI 10.1002/pds.682; Ministor of Health Labour and Welfare, 2007, REV PRECAUTIONS; Ministry of Health Labour and Welfare, 2011, HLTH INS; Miyasaki JM, 2002, NEUROLOGY, V58, P11, DOI 10.1212/WNL.58.1.11; Miziuno Yoshikuni, 2002, Rinsho Shinkeigaku, V42, P421; Nakaoka S, 2011, INTERNAL MED, V50, P687, DOI 10.2169/internalmedicine.50.4344; Nakayama T, 2012, YAKUGAKU ZASSHI, V132, P549, DOI 10.1248/yakushi.132.549; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; Nemeroff CB, 2007, ARCH GEN PSYCHIAT, V64, P466, DOI 10.1001/archpsyc.64.4.466; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Ogino S, 2011, PROG NEURO-PSYCHOPH, V35, P78, DOI 10.1016/j.pnpbp.2010.08.030; Ooba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066116; Ooba N, 2011, DRUG SAFETY, V34, P329, DOI 10.2165/11588230-000000000-00000; Osaki Y, 2011, ACTA NEUROL SCAND, V124, P182, DOI 10.1111/j.1600-0404.2010.01442.x; Rosa MM, 2010, MOVEMENT DISORD, V25, P1053, DOI 10.1002/mds.23038; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Shatin D, 2005, PHARMACOEPIDEM DR S, V14, P149, DOI 10.1002/pds.961; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Steiger M, 2009, J NEURAL TRANSM, V116, P179, DOI 10.1007/s00702-008-0179-4; Swarztrauber K, 2006, NEUROLOGY, V66, P1425, DOI 10.1212/01.wnl.0000210433.49727.40; Taniguchi A, 2008, CLIN NEUROL, V48, P106; Trifiro G, 2008, PARKINSONISM RELAT D, V14, P420, DOI 10.1016/j.parkreldis.2007.10.010; U.S. Department of Health and Human Services Food and Drug Administration, 2011, GUID IND MED GUID DI; Urushihara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028483; Wada M, 2013, INT J GEN MED, V6, P597, DOI 10.2147/IJGM.S44190; Weatherby LB, 2001, PHARMACOEPIDEM DR S, V10, P211, DOI 10.1002/pds.592; Yamamoto M, 2006, NEUROLOGY, V67, P1225, DOI 10.1212/01.wnl.0000238508.68593.1d; Yamanaka H, 2014, MOD RHEUMATOL, V24, P33, DOI 10.3109/14397595.2013.854059; Yamashiro K, 2008, MOVEMENT DISORD, V23, P935, DOI 10.1002/mds.22036; Yamawaki M, 2009, NEUROEPIDEMIOLOGY, V32, P263, DOI 10.1159/000201565	45	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99021	10.1371/journal.pone.0099021	http://dx.doi.org/10.1371/journal.pone.0099021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906013	gold, Green Published			2022-12-27	WOS:000341869000093
J	Vedder, MM; Marquez, M; de Bekker-Grob, EW; Calle, ML; Dyrskjot, L; Kogevinas, M; Segersten, U; Malmstrom, PU; Algaba, F; Beukers, W; Orntoft, TF; Zwarthoff, E; Real, FX; Malats, N; Steyerberg, EW				Vedder, Moniek M.; Marquez, Mirari; de Bekker-Grob, Esther W.; Calle, Malu L.; Dyrskjot, Lars; Kogevinas, Manoils; Segersten, Ulrika; Malmstrom, Per-Uno; Algaba, Ferran; Beukers, Willemien; Orntoft, Torben F.; Zwarthoff, Ellen; Real, Francisco X.; Malats, Nuria; Steyerberg, Ewout W.			Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours	PLOS ONE			English	Article							UROTHELIAL CARCINOMA; SCORING MODEL; TABLES; CLASSIFICATION; IMPUTATION; NEOPLASMS; VALUES	Objective: We aimed to determine the validity of two risk scores for patients with non-muscle invasive bladder cancer in different European settings, in patients with primary tumours. Methods: We included 1,892 patients with primary stage Ta or T1 non-muscle invasive bladder cancer who underwent a transurethral resection in Spain (n = 973), the Netherlands (n = 639), or Denmark (n = 280). We evaluated recurrence-free survival and progression-free survival according to the European Organisation for Research and Treatment of Cancer (EORTC) and the Spanish Urological Club for Oncological Treatment (CUETO) risk scores for each patient and used the concordance index (c-index) to indicate discriminative ability. Results: The 3 cohorts were comparable according to age and sex, but patients from Denmark had a larger proportion of patients with the high stage and grade at diagnosis (p < 0.01). At least one recurrence occurred in 839 (44%) patients and 258 (14%) patients had a progression during a median follow-up of 74 months. Patients from Denmark had the highest 10-year recurrence and progression rates (75% and 24%, respectively), whereas patients from Spain had the lowest rates (34% and 10%, respectively). The EORTC and CUETO risk scores both predicted progression better than recurrence with c-indices ranging from 0.72 to 0.82 while for recurrence, those ranged from 0.55 to 0.61. Conclusion: The EORTC and CUETO risk scores can reasonably predict progression, while prediction of recurrence is more difficult. New prognostic markers are needed to better predict recurrence of tumours in primary non-muscle invasive bladder cancer patients.	[Vedder, Moniek M.; de Bekker-Grob, Esther W.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Marquez, Mirari; Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Calle, Malu L.] Univ Vic, Dept Syst Biol, Barcelona, Spain; [Dyrskjot, Lars; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Kogevinas, Manoils] Municipal Inst Med Res, Ctr Res Environm Epidemiol, Barcelona, Spain; [Segersten, Ulrika; Malmstrom, Per-Uno] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Algaba, Ferran] Autonomous Univ Barcelona, Dept Pathol, Fundacio Puigvert, Barcelona, Spain; [Beukers, Willemien; Zwarthoff, Ellen] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain; [Real, Francisco X.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Erasmus University Rotterdam; Erasmus MC; Centro Nacional de Investigaciones Oncologicas (CNIO); Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Aarhus University; Uppsala University; Autonomous University of Barcelona; Fundacio Puigvert; Erasmus University Rotterdam; Erasmus MC; Centro Nacional de Investigaciones Oncologicas (CNIO); Pompeu Fabra University	Steyerberg, EW (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	e.steyerberg@erasmusmc.nl	Arribas, Francisco X Real/H-5275-2015; Malats, Nuria/H-7041-2015; Calle, M.Luz/D-2704-2015; Kogevinas, Manolis/C-3918-2017	Arribas, Francisco X Real/0000-0001-9501-498X; Malats, Nuria/0000-0003-2538-3784; Calle, M.Luz/0000-0001-9334-415X; Kogevinas, Manolis/0000-0002-9605-0461; Dyrskjot, Lars/0000-0001-7061-9851; malmstrom, per-uno/0000-0001-8572-9957	European Community [201663]; The Danish Cancer Society [R72-A4591] Funding Source: researchfish	European Community(European Commission); The Danish Cancer Society(Danish Cancer Society)	This research received funding from the European Community's Seventh Framework program FP7/2007-2011 under grant agreement 201663 (Uromol project, http://www.uromol.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler G, 2007, STAT METHODS MED RES, V16, P277, DOI 10.1177/0962280206074466; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Buethe DD, 2011, NAT REV UROL, V8, P480, DOI 10.1038/nrurol.2011.118; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fahmy N, 2013, CUAJ-CAN UROL ASSOC, V7, pE740, DOI 10.5489/cuaj.1213; Ferlay J, 2010, IARC CANCERBASE; Fernandez-Gomez J, 2011, EUR UROL, V60, P423, DOI 10.1016/j.eururo.2011.05.033; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Fristrup N, 2012, AM J PATHOL, V180, P1824, DOI 10.1016/j.ajpath.2012.01.023; Gonul II, 2007, UROL INT, V78, P338, DOI 10.1159/000100839; Harrel F.E., 2001, REGRESSION MODELING; Hernandez V, 2011, WORLD J UROL, V29, P409, DOI 10.1007/s00345-010-0635-2; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Kompier LC, 2009, J PATHOL, V218, P104, DOI 10.1002/path.2507; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; Porta N, 2012, STAT MED, V31, P287, DOI 10.1002/sim.4433; Rosevear HM, 2011, J UROLOGY, V185, P67, DOI 10.1016/j.juro.2010.08.083; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Shariat SF, 2010, UROL ONCOL-SEMIN ORI, V28, P389, DOI 10.1016/j.urolonc.2010.02.011; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; van Rhijn BWG, 2012, UROL ONCOL-SEMIN ORI, V30, P518, DOI 10.1016/j.urolonc.2012.04.002; van Rhijn BWG, 2010, EUR UROL, V58, P433, DOI 10.1016/j.eururo.2010.05.043; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Vickers A, 2010, EUR UROL, V57, P571, DOI 10.1016/j.eururo.2009.12.026; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Xylinas E, 2013, BRIT J CANCER, V109, P1460, DOI 10.1038/bjc.2013.372	28	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96849	10.1371/journal.pone.0096849	http://dx.doi.org/10.1371/journal.pone.0096849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905984	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000341869000003
J	Wang, HH; Reitz, SR; Xiang, JC; Smagghe, G; Lei, ZR				Wang, Haihong; Reitz, Stuart R.; Xiang, Juncheng; Smagghe, Guy; Lei, Zhongren			Does Temperature-Mediated Reproductive Success Drive the Direction of Species Displacement in Two Invasive Species of Leafminer Fly?	PLOS ONE			English	Article							LIRIOMYZA-SATIVAE DIPTERA; TRIFOLII BURGESS DIPTERA; INTRASPECIFIC COMPETITION; CLIMATE-CHANGE; L-BRYONIAE; AGROMYZIDAE; DROSOPHILA; HUIDOBRENSIS; COEXISTENCE; ADAPTATION	Liriomyza sativae and L. trifolii (Diptera: Agromyzidae) are two highly invasive species of leafmining flies, which have become established as pests of horticultural crops throughout the world. In certain regions where both species have been introduced, L. sativae has displaced L. trifolii, whereas the opposite has occurred in other regions. These opposing outcomes suggest that neither species is an inherently superior competitor. The regions where these displacements have been observed (southern China, Japan and western USA) are climatically different. We determined whether temperature differentially affects the reproductive success of these species and therefore if climatic differences could affect the outcome of interspecific interactions where these species are sympatric. The results of life table parameters indicate that both species can develop successfully at all tested temperatures (20, 25, 31, 33 degrees C). L. sativae had consistently higher fecundities at all temperatures, but L. trifolii developed to reproductive age faster. Age-stage specific survival rates were higher for L. sativae at low temperatures, but these were higher for L. trifolii at higher temperatures. We then compared the net reproductive rates (R-0) for both species in pure and mixed cultures maintained at the same four constant temperatures. Both species had significantly lower net reproductive rates in mixed species cultures compared with their respective pure species cultures, indicating that both species are subject to intense interspecific competition. Net reproductive rates were significantly greater for L. sativae than for L. trifolii in mixed species groups at the lower temperatures, whereas the opposite occurred at the higher temperature. Therefore, interactions between the species are temperature dependent and small differences could shift the competitive balance between the species. These temperature mediated effects may contribute to the current ongoing displacement of L. sativae by the more recent invader L. trifolii in warm climatic areas of China.	[Wang, Haihong; Xiang, Juncheng; Lei, Zhongren] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Reitz, Stuart R.] Oregon State Univ, Dept Crop & Soil Sci, Ontario, OR USA; [Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Oregon State University; Ghent University	Lei, ZR (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zrlei@ippcaas.cn	Reitz, Stuart/AAC-4467-2019; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313	China Agriculture Research System [CARS-25-B-07]; National Natural Science Foundation of China [31201526]; Beijing Municipal Natural Science Foundation [6122026]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported in part by the China Agriculture Research System (CARS-25-B-07), the National Natural Science Foundation of China (31201526), and Beijing Municipal Natural Science Foundation (6122026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, APPL ENTOMOL ZOOL, V36, P277, DOI 10.1303/aez.2001.277; Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; CARRACEDO MC, 1986, GENETICA, V69, P97, DOI 10.1007/BF00115128; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2009, TWOSEX MSCHART COMPU; DEBACH P, 1966, ANNU REV ENTOMOL, V11, P183, DOI 10.1146/annurev.en.11.010166.001151; DESTASO J, 1994, T AM FISH SOC, V123, P289, DOI 10.1577/1548-8659(1994)123<0289:IOWTOI>2.3.CO;2; Efron B., 1994, INTRO BOOTSTRAP; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Lanzoni A, 2002, ENVIRON ENTOMOL, V31, P797, DOI 10.1603/0046-225X-31.5.797; Lei ZR, 1997, ANN AGR SCI CHINA YO, P495; Lei ZR, 2005, BIOL MANAGEMENT INVA, P177; Minkenberg OPJM, 1998, B OEPP, V18, P173; ORENGO DJ, 1994, Z ZOOL SYST EVOL, V32, P44; PARRELLA MP, 1983, ENVIRON ENTOMOL, V12, P1412, DOI 10.1093/ee/12.5.1412; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; PARRELLA MP, 1988, PAN-PAC ENTOMOL, V64, P17; PETITT FL, 1992, ENVIRON ENTOMOL, V21, P136, DOI 10.1093/ee/21.1.136; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Reitz SR, 2002, ENTOMOL EXP APPL, V102, P101, DOI 10.1023/A:1015861716270; Reitz SR, 2013, INSECTICIDES DEV SAF; Scheffer SJ, 2005, ANN ENTOMOL SOC AM, V98, P181, DOI 10.1603/0013-8746(2005)098[0181:MPOVPL]2.0.CO;2; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; Spencer KA, 1973, SERIES ENTOMOLOGICA, V9; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Tantowijoyo W, 2010, ENTOMOL EXP APPL, V135, P141, DOI 10.1111/j.1570-7458.2010.00984.x; Tokumaru S, 2005, APPL ENTOMOL ZOOL, V40, P551, DOI 10.1303/aez.2005.551; Tokumaru S, 2003, JPN J APPL ENTOMOL Z, V47, P143, DOI 10.1303/jjaez.2003.143; Tokumaru S, 2007, APPL ENTOMOL ZOOL, V42, P317, DOI 10.1303/aez.2007.317; TRUMBLE JT, 1983, ENVIRON ENTOMOL, V12, P810, DOI 10.1093/ee/12.3.810; Wang SY, 2014, MITOCHONDR DNA, V25, P104, DOI 10.3109/19401736.2013.786706; Wang SY, 2011, MOL BIOL REP, V38, P687, DOI 10.1007/s11033-010-0155-6; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; [相君成 Xiang Juncheng], 2012, [生态学报, Acta Ecologica Sinica], V32, P1616	41	19	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98761	10.1371/journal.pone.0098761	http://dx.doi.org/10.1371/journal.pone.0098761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906119	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000060
J	Korb, S; With, S; Niedenthal, P; Kaiser, S; Grandjean, D				Korb, Sebastian; With, Stephane; Niedenthal, Paula; Kaiser, Susanne; Grandjean, Didier			The Perception and Mimicry of Facial Movements Predict Judgments of Smile Authenticity	PLOS ONE			English	Article							ELECTROMYOGRAPHIC ACTIVITY; EMOTIONAL EXPRESSION; ZYGOMATICUS-MAJOR; RECOGNITION; IMITATION; DYNAMICS; FACES; SENSITIVITY; ENJOYMENT; FEEDBACK	The mechanisms through which people perceive different types of smiles and judge their authenticity remain unclear. Here, 19 different types of smiles were created based on the Facial Action Coding System (FACS), using highly controlled, dynamic avatar faces. Participants observed short videos of smiles while their facial mimicry was measured with electromyography (EMG) over four facial muscles. Smile authenticity was judged after each trial. Avatar attractiveness was judged once in response to each avatar's neutral face. Results suggest that, in contrast to most earlier work using static pictures as stimuli, participants relied less on the Duchenne marker (the presence of crow's feet wrinkles around the eyes) in their judgments of authenticity. Furthermore, mimicry of smiles occurred in the Zygomaticus Major, Orbicularis Oculi, and Corrugator muscles. Consistent with theories of embodied cognition, activity in these muscles predicted authenticity judgments, suggesting that facial mimicry influences the perception of smiles. However, no significant mediation effect of facial mimicry was found. Avatar attractiveness did not predict authenticity judgments or mimicry patterns.	[Korb, Sebastian; Niedenthal, Paula] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [With, Stephane; Kaiser, Susanne; Grandjean, Didier] Univ Geneva, Dept Psychol, Geneva, Switzerland; [Grandjean, Didier] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Wisconsin System; University of Wisconsin Madison; University of Geneva; University of Geneva	Korb, S (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.		Korb, Sebastian/A-6294-2016	Korb, Sebastian/0000-0002-3517-3783; Grandjean, Didier/0000-0001-6125-4520	Early Postdoc Mobility scholarship; Swiss National Science Foundation [PBGEP1-139870]; Swiss Science Foundation; National Science Foundation [BCS-1251101]; Division Of Behavioral and Cognitive Sci [1251101] Funding Source: National Science Foundation	Early Postdoc Mobility scholarship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Sebastian Korb was supported by an Early Postdoc Mobility scholarship by the Swiss National Science Foundation (PBGEP1-139870). Didier Grandjean was partially supported by the Swiss Science Foundation. Paula Niedenthal was supported by a grant # BCS-1251101 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019; ADELMANN PK, 1989, ANNU REV PSYCHOL, V40, P249, DOI 10.1146/annurev.ps.40.020189.001341; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Ambadar Z, 2009, J NONVERBAL BEHAV, V33, P17, DOI 10.1007/s10919-008-0059-5; Arsalidou M, 2011, BRAIN TOPOGR, V24, P149, DOI 10.1007/s10548-011-0171-4; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; BUCK R, 1980, J PERS SOC PSYCHOL, V38, P811, DOI 10.1037/0022-3514.38.5.811; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Dyck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003628; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; EKMAN P, 1993, PSYCHOL SCI, V4, P342, DOI 10.1111/j.1467-9280.1993.tb00576.x; Ekman P., 1997, WHAT FACE REVEALS; Ekman P., 2002, FACIAL ACTION CODING; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gosselin P, 2002, J NONVERBAL BEHAV, V26, P83, DOI 10.1023/A:1015613504532; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Heller AS, 2011, NEUROIMAGE; Hennenlotter A, 2009, CEREB CORTEX, V19, P537, DOI 10.1093/cercor/bhn104; HESS U, 1992, INT J PSYCHOPHYSIOL, V12, P251, DOI 10.1016/0167-8760(92)90064-I; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; HESS U, 1994, EUR J SOC PSYCHOL, V24, P367, DOI 10.1002/ejsp.2420240306; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Indersmitten T, 2003, J NEUROSCI, V23, P3820; James William, 1950, PRINCIPLES PSYCHOL, V1; Johnston L, 2010, BRIT J SOC PSYCHOL, V49, P107, DOI 10.1348/014466609X412476; Koerth-Baker M., 2013, NY TIMES; Korb S, 2012, SOC NEUROSCI-UK, V7, P510, DOI 10.1080/17470919.2012.667573; Korb S, 2010, BIOL PSYCHOL, V85, P347, DOI 10.1016/j.biopsycho.2010.07.012; Krumhuber E, 2005, J NONVERBAL BEHAV, V29, P3, DOI 10.1007/s10919-004-0887-x; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Krumhuber EG, 2012, EMOTION, V12, P351, DOI 10.1037/a0026632; Krumhuber EG, 2009, EMOTION, V9, P807, DOI 10.1037/a0017844; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Likowski K, 2008, INT J PSYCHOL, V43, P376; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Likowski KU, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00214; Likowski KU, 2011, EMOTION, V11, P457, DOI 10.1037/a0023162; Lipps T, 1903, ARCH GESAMTE PSYCHOL, V1, P185; Maringer M, 2011, EMOTION, V11, P181, DOI 10.1037/a0022596; McIntosh DN, 1996, MOTIV EMOTION, V20, P121, DOI 10.1007/BF02253868; McLellan TL, 2012, NEUROSCI LETT, V531, P149, DOI 10.1016/j.neulet.2012.10.039; McLellan T, 2010, COGNITION EMOTION, V24, P1277, DOI 10.1080/02699930903306181; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1989, DEV PSYCHOL, V25, P954, DOI 10.1037/0012-1649.25.6.954; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; Mojzisch A, 2006, SOC NEUROSCI-UK, V1, P184, DOI 10.1080/17470910600985621; Murphy NA, 2010, PSYCHOL AGING, V25, P811, DOI 10.1037/a0019888; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Otta E, 1996, PERCEPT MOTOR SKILL, V82, P1111, DOI 10.2466/pms.1996.82.3c.1111; Roesch EB, 2011, J NONVERBAL BEHAV, V35, P1, DOI 10.1007/s10919-010-0095-9; Ross ED, 2013, CORTEX, V49, P1280, DOI 10.1016/j.cortex.2012.05.002; Rychlowska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090876; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Scherer KR, 2000, PERS SOC PSYCHOL B, V26, P327, DOI 10.1177/0146167200265006; Schilbach L, 2008, SOC NEUROSCI-UK, V3, P37, DOI 10.1080/17470910701563228; Schmidt KL, 2006, J NONVERBAL BEHAV, V30, P37, DOI 10.1007/s10919-005-0003-x; Smith A, 1790, THEORY MORAL SEMTIME; Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Thibault P, WRINKLES EYES UNPUB; Thibault P, 2009, J EXP CHILD PSYCHOL, V102, P360, DOI 10.1016/j.jecp.2008.08.005; Tomkins S, 1992, AFFECT IMAGERY CONSC; Van Boxtel A, 1998, PSYCHOPHYSIOLOGY, V35, P690, DOI 10.1017/S0048577298970317; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; WEISS F, 1987, MOTIV EMOTION, V11, P67, DOI 10.1007/BF00992214; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, pS106; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Weyers P, 2009, PSYCHOPHYSIOLOGY, V46, P328, DOI 10.1111/j.1469-8986.2008.00771.x; Yonas A, 1985, NEONATE COGNITION BL, P113	95	67	68	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99194	10.1371/journal.pone.0099194	http://dx.doi.org/10.1371/journal.pone.0099194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24918939	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000056
J	Ranji, P; Rauthan, M; Pitot, C; Pilon, M				Ranji, Parmida; Rauthan, Manish; Pitot, Christophe; Pilon, Marc			Loss of HMG-CoA Reductase in C-elegans Causes Defects in Protein Prenylation and Muscle Mitochondria	PLOS ONE			English	Article							GERM-CELL MIGRATION; CAENORHABDITIS-ELEGANS; MEVALONATE PATHWAY; UPR; ACTIVATION	HMG-CoA reductase is the rate-limiting enzyme in the mevalonate pathway and the target of cholesterol-lowering statins. We characterized the C elegans hmgr-1(tm4368) mutant, which lacks HMG-CoA reductase, and show that its phenotypes recapitulate that of statin treatment, though in a more severe form. Specifically, the hmgr-1(tm4368) mutant has defects in growth, reproduction and protein prenylation, is rescued by exogenous mevalonate, exhibits constitutive activation of the UPRer and requires less mevalonate to be healthy when the UPRmt is activated by a constitutively active form of ATFS-1. We also show that different amounts of mevalonate are required for different physiological processes, with reproduction requiring the highest levels. Finally, we provide evidence that the mevalonate pathway is required for the activation of he UPRmt.	[Ranji, Parmida; Rauthan, Manish; Pitot, Christophe; Pilon, Marc] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg	Pilon, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	marc.pilon@cmb.gu.se	Pilon, Marc/B-9955-2008; Pilon, Marc/AAY-4082-2020	Pilon, Marc/0000-0003-3919-2882; Pilon, Marc/0000-0003-3919-2882; Ranji, Parmida/0000-0003-4502-1000	National Institute of Health Office of Research Infrasctructure Program [P400D010440]; Swedish Research Council; Cancerfonden; Carl Trygger Stiftelse; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of Health Office of Research Infrasctructure Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Carl Trygger Stiftelse; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institute of Health Office of Research Infrasctructure Program (P400D010440). This work was funded by the Swedish Research Council, Cancerfonden and Carl Trygger Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd TT, 2011, EXPERT OPIN DRUG SAF, V10, P373, DOI 10.1517/14740338.2011.540568; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Patel TN, 2007, EUR HEART J, V28, P664, DOI 10.1093/eurheartj/ehl445; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Rauthan M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-243; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Westwood FR, 2008, TOXICOL PATHOL, V36, P345, DOI 10.1177/0192623307311412; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612	27	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100033	10.1371/journal.pone.0100033	http://dx.doi.org/10.1371/journal.pone.0100033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918786	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000127
J	Tucker, AC; Escalante-Semerena, JC				Tucker, Alex C.; Escalante-Semerena, Jorge C.			Determinants within the C-Terminal Domain of Streptomyces lividans Acetyl-CoA Synthetase that Block Acetylation of Its Active Site Lysine In Vitro by the Protein Acetyltransferase (Pat) Enzyme	PLOS ONE			English	Article							COENZYME-A; RHODOPSEUDOMONAS-PALUSTRIS; SALMONELLA-ENTERICA; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; IDENTIFICATION; VECTORS; DEACETYLASE; ACTIVATION; EXPRESSION	Reversible lysine acetylation (RLA) is a widespread regulatory mechanism that modulates the function of proteins involved in diverse cellular processes. A strong case has been made for RLA control exerted by homologues of the Salmonella enterica protein acetyltransferase (SePat) enzyme on the broadly distributed AMP-forming CoA ligase (a.k.a. acyl-CoA synthetases) family of metabolic enzymes, with acetyl-CoA synthetase (Acs) being the paradigm in the field. Here we investigate why the Acs homologue in Streptomyces lividans (S/Acs) is poorly acetylated in vitro by the S. lividans protein acetyltransferase (S/Pat) enzyme. Chimeras of S. enterica Acs (SeAcs) and S. lividans Acs (S/Acs) constructed during the course of this work were acetylated by S/PatA in vitro, retained most of their activity, and were under RLA control in a heterologous host. We identified SeAcs residues N- and C-terminal to the target lysine that when introduced into SlAcs, rendered the latter under RLA control. These results lend further support to the idea that Pat enzymes interact with extensive surfaces of their substrates. Finally, we suggest that acetylation of SlAcs depends on factors or conditions other than those present in our in vitro system. We also discuss possible explanations why SlAcs is not controlled by RLA as defined in other bacterial species.	[Tucker, Alex C.; Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	jcescala@uga.edu			United States Public Health Service; National Institutes of Health [R01 GM062203]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062203, T32GM007215] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by United States Public Health Service, National Institutes of Health grant R01 GM062203. The funders had no role in the design, data collection and analysis, decision to publish or preparation of the manuscript. A	BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Crosby HA, 2012, J BIOL CHEM, V287, P41392, DOI 10.1074/jbc.M112.417360; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Elion E. A., 2007, CURRENT PROTOCOLS MO; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Mikulik K, 2012, BIOCHEM CELL BIOL, V90, P179, DOI [10.1139/O11-086, 10.1139/o11-086]; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; SASSE J, 1991, CURRENT PROTOCOLS MO; Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Tucker AC, 2010, J BACTERIOL, V192, P6200, DOI 10.1128/JB.00874-10; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t	39	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99817	10.1371/journal.pone.0099817	http://dx.doi.org/10.1371/journal.pone.0099817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918787	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000115
J	Andersen, CL; Lindegaard, H; Vestergaard, H; Siersma, VD; Hasselbalch, HC; Olivarius, ND; Bjerrum, OW; Junker, P				Andersen, Christen Lykkegaard; Lindegaard, Hanne; Vestergaard, Hanne; Siersma, Volkert Dirk; Hasselbalch, Hans Carl; Olivarius, Niels de Fine; Bjerrum, Ole Weis; Junker, Peter			Risk of Lymphoma and Solid Cancer among Patients with Rheumatoid Arthritis in a Primary Care Setting	PLOS ONE			English	Article							MALIGNANT-LYMPHOMAS; THERAPY; EOSINOPHILIA; INFLAMMATION; AUTOIMMUNE; DISORDERS; LEUKEMIA; UPDATE; HEALTH; COHORT	Background: Several studies have demonstrated an association between rheumatoid arthritis (RA) and lymphoproliferative malignancies, but pathogenic mechanisms remain unclear. We investigated 1) the risk of lymphoproliferative malignancies and solid tumors in adults with RA identified in primary care and 2) the possible mediating role of blood eosinophilia in the clonal evolution of cancer in these patients. Methods: From the Copenhagen Primary Care Differential Count (CopDiff) Database, we identified 356,196 individuals with at least one differential cell count (DIFF) encompassing the eosinophil count between 2000-2007. From these, one DIFF was randomly chosen (the index DIFF). By linking to the Danish National Patient Register, we categorized the selected individuals according to known longstanding (>= 3 years) or recent onset (<3 years) RA prior to the index DIFF. In addition, the cohort was stratified according to management in primary or secondary care. From the Danish Cancer Registry we ascertained malignancies within four years following the index DIFF. Using multivariable logistic regression, odds ratios (OR) were calculated and adjusted for sex, age, year, month, eosinophilia, comorbid conditions and C-reactive protein (CRP). Results: 921 patients had recent onset RA and 2,578 had longer disease duration. Seventy three percent of RA patients were managed in primary care. After adjustment for sex, age, year, and month, neither recent onset nor long-standing RA was associated with incident lymphoproliferative malignancies or solid cancers. These risk estimates did not change when eosinophilia, CRP, and comorbidities were included in the models. Conclusions: In this large cohort of patients with RA of short or long duration recruited from a primary care resource, RA was not associated with an increased risk of lymphoproliferative or solid cancers during 4 years of follow-up, when the models were adjusted for confounders. Blood eosinophilia could not be identified as a mediator of cancer development in the present setting.	[Andersen, Christen Lykkegaard; Hasselbalch, Hans Carl] Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark; [Andersen, Christen Lykkegaard; Siersma, Volkert Dirk; Olivarius, Niels de Fine] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Andersen, Christen Lykkegaard; Siersma, Volkert Dirk; Olivarius, Niels de Fine] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark; [Lindegaard, Hanne; Junker, Peter] Odense Univ Hosp, Dept Rheumatol, DK-5000 Odense, Denmark; [Vestergaard, Hanne] Odense Univ Hosp, Dept Hematol, DK-5000 Odense, Denmark; [Bjerrum, Ole Weis] Copenhagen Univ Hosp, Dept Hematol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Andersen, CL (corresponding author), Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark.	christenla@gmail.com	de Fine Olivarius, Niels/K-6832-2015; Bjerrum, Ole Weis/AAF-9999-2019; Lindegaard, Hanne Merete/AAV-5437-2020; Siersma, Volkert D/G-6867-2016; Hasselbalch, Hans/H-2217-2017	de Fine Olivarius, Niels/0000-0001-6465-3615; Lindegaard, Hanne Merete/0000-0002-5675-3859; Siersma, Volkert D/0000-0003-1941-2681; Hasselbalch, Hans/0000-0003-3936-8032; Lykkegaard Andersen, Christen Bertel/0000-0001-7753-6768	Danish Cancer Society; Eva & Henry Frankels' memorial foundation; Axel Muusfeldts memorial foundation	Danish Cancer Society(Danish Cancer Society); Eva & Henry Frankels' memorial foundation; Axel Muusfeldts memorial foundation	Christen Lykkegaard Andersen wishes to thank The Danish Cancer Society, which has granted a three-year scholarship (2010-2013). The authors would also like to express their gratitude to Eva & Henry Frankels' memorial foundation and Axel Muusfeldts memorial foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo L, 2008, SEMIN ARTHRITIS RHEU, V37, P388, DOI 10.1016/j.semarthrit.2007.08.006; Andersen CL, 2013, AM J HEMATOL, V88, P843, DOI 10.1002/ajh.23515; Askling Johan, 2007, Curr Rheumatol Rep, V9, P421, DOI 10.1007/s11926-007-0067-1; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Baecklund E, 2014, SEMIN CANCER BIOL, V24, P61, DOI 10.1016/j.semcancer.2013.12.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Chakravarty EF, 2005, J RHEUMATOL, V32, P2130; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YJ, 2011, ARTHRITIS RHEUM-US, V63, P352, DOI 10.1002/art.30134; Cools J, 2005, HAEMATOLOGICA, V90, P582; Cush JJ, 2012, RHEUM DIS CLIN N AM, V38, P761, DOI 10.1016/j.rdc.2012.09.006; Ekstrom K, 2003, ARTHRITIS RHEUM-US, V48, P963, DOI 10.1002/art.10939; Smedby KE, 2006, CANCER EPIDEM BIOMAR, V15, P2069, DOI 10.1158/1055-9965.EPI-06-0300; Franklin J, 2006, ANN RHEUM DIS, V65, P617, DOI 10.1136/ard.2005.044784; Geborek P, 2005, ANN RHEUM DIS, V64, P699, DOI 10.1136/ard.2004.030528; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gotlib J, 2014, AM J HEMATOL, V89, P325, DOI 10.1002/ajh.23664; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hemminki K, 2013, BRIT J HAEMATOL, V161, P677, DOI 10.1111/bjh.12330; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Kargili AE, 2004, RHEUMATOL INT, V24, P321, DOI 10.1007/s00296-004-0469-6; Khurana R, 2008, J RHEUMATOL, V35, P1704; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mercer LK, 2013, RHEUMATOLOGY, V52, P91, DOI 10.1093/rheumatology/kes350; Morton LM, 2005, CANCER EPIDEM BIOMAR, V14, P925, DOI 10.1158/1055-9965.EPI-04-0693; PANUSH RS, 1971, ANN INTERN MED, V75, P199, DOI 10.7326/0003-4819-75-2-199; Pedersen M, 2004, EUR J EPIDEMIOL, V19, P1097, DOI 10.1007/s10654-004-1025-0; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; Simonsson M, 1999, SCAND J RHEUMATOL, V28, P340; Tefferi A, 2006, BRIT J HAEMATOL, V133, P468, DOI 10.1111/j.1365-2141.2006.06038.x; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P1433, DOI 10.1002/art.22579; Woodward M., 2005, EPIDEMIOLOGY STUDY D, P278	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99388	10.1371/journal.pone.0099388	http://dx.doi.org/10.1371/journal.pone.0099388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914777	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700094
J	Bang, C; Weidenbach, K; Gutsmann, T; Heine, H; Schmitz, RA				Bang, Corinna; Weidenbach, Katrin; Gutsmann, Thomas; Heine, Holger; Schmitz, Ruth A.			The Intestinal Archaea Methanosphaera stadtmanae and Methanobrevibacter smithii Activate Human Dendritic Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; METHANOGENIC BACTERIA; BREATH-METHANE; DIVERSITY; PEPTIDES; INNATE; HEALTH; MEMBER; DNA	The methanoarchaea Methanosphaera stadtmanae and Methanobrevibacter smithii are known to be part of the indigenous human gut microbiota. Although the immunomodulatory effects of bacterial gut commensals have been studied extensively in the last decade, the impact of methanoarchaea in human's health and disease was rarely examined. Consequently, we studied and report here on the effects of M. stadtmanae and M. smithii on human immune cells. Whereas exposure to M. stadtmanae leads to substantial release of proinflammatory cytokines in monocyte-derived dendritic cells (moDCs), only weak activation was detected after incubation with M. smithii. Phagocytosis of M. stadtmanae by moDCs was demonstrated by confocal microscopy as well as transmission electronic microscopy (TEM) and shown to be crucial for cellular activation by using specific inhibitors. Both strains, albeit to different extents, initiate a maturation program in moDCs as revealed by up-regulation of the cell-surface receptors CD86 and CD197 suggesting additional activation of adaptive immune responses. Furthermore, M. stadtmanae and M. smithii were capable to alter the gene expression of antimicrobial peptides in moDCs to different extents. Taken together, our findings strongly argue that the archaeal gut inhabitants M. stadtmanae and M . smithii are specifically recognized by the human innate immune system. Moreover, both strains are capable of inducing an inflammatory cytokine response to different extents arguing that they might have diverse immunomodulatory functions. that the impact of intestinal methanoarchaea on pathological conditions involving the gut microbiota has been underestimated until now.	[Bang, Corinna; Weidenbach, Katrin; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Gutsmann, Thomas] Res Ctr Borstel, Div Biophys, Borstel, Germany; [Heine, Holger] Airway Res Ctr North, Res Ctr Borstel, Div Innate Immun, Borstel, Germany	University of Kiel; Forschungszentrum Borstel; Forschungszentrum Borstel	Schmitz, RA (corresponding author), Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Heine, Holger/H-4552-2012; Gutsmann, Thomas/E-6100-2011	Heine, Holger/0000-0001-8128-5068; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829; Bang, Corinna/0000-0001-6814-6151	German research foundation (DFG) [SCHM1051/11-1]	German research foundation (DFG)(German Research Foundation (DFG))	This work was support by German research foundation (DFG) (SCHM1051/11-1) (www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bang C, 2012, ANTIMICROB AGENTS CH, V56, P4123, DOI 10.1128/AAC.00661-12; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988; BELAY N, 1990, J CLIN MICROBIOL, V28, P1666, DOI 10.1128/JCM.28.7.1666-1668.1990; Blais-Lecours P, 2011, PLOS ONE, V6; Blais-Lecours P, 2014, PLOS ONE, V9; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Cavicchioli R, 2003, BIOESSAYS, V25, P1119, DOI 10.1002/bies.10354; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; CHEN CY, 1994, J IMMUNOL, V152, P4929; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; DEMACARIO EC, 1982, J IMMUNOL, V129, P1670; DEMACARIO EC, 1983, P NATL ACAD SCI-BIOL, V80, P6346; DEMACARIO EC, 1984, J IMMUNOL, V132, P883; Dridi B, 2011, ANAEROBE, P1; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Eckburg PB, 2003, INFECT IMMUN, V71, P591, DOI 10.1128/IAI.71.2.591-596.2003; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gutsmann T, 2005, J ENDOTOXIN RES, V11, P167, DOI 10.1179/096805105X37330; HAINES A, 1977, LANCET, V2, P481; HART D N J, 1990, International Reviews of Immunology, V6, P127, DOI 10.3109/08830189009056624; Heine H, 2007, J ENDOTOXIN RES, V13, P126, DOI 10.1177/0968051907079122; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; Konig H, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P1; KONIG H, 1988, CAN J MICROBIOL, V34, P395, DOI 10.1139/m88-071; KONIG H, 1982, ZBL BAKT MIK HYG I C, V3, P179; Levitt MD, 2006, CLIN GASTROENTEROL H, V4, P123, DOI 10.1016/j.cgh.2005.11.006; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1984, APPL ENVIRON MICROB, V48, P449, DOI 10.1128/AEM.48.2.449-450.1984; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; PIQUE JM, 1984, GASTROENTEROLOGY, V87, P601; Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79; Turpin J, 1986, J Clin Apher, V3, P111, DOI 10.1002/jca.2920030207; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200	53	81	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99411	10.1371/journal.pone.0099411	http://dx.doi.org/10.1371/journal.pone.0099411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915454	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700099
J	Finkelstein, EA; Chay, J; Bajpai, S				Finkelstein, Eric A.; Chay, Junxing; Bajpai, Shailendra			The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; CORONARY-HEART-DISEASE; WEIGHT-LOSS; HEALTH; PRODUCTIVITY; PREVENTION; OBESITY; RISK; HYPERTENSION; INDIVIDUALS	Objectives: The goal of this study is: (1) to estimate the current direct out-of-pocket (OOP) and indirect non-communicable diseases (NCD) burden on Indonesian households and (2) to project NCD prevalence and burden in 2020 focusing specifically on hypertension, diabetes, heart problems and stroke. Methods: This study relies on econometric analyses based on four waves of the Indonesian Family Life Survey (IFLS). Results: In aggregate, of the NCDs studied, heart problems exert the greatest economic burden on households, costing Int$1.56 billion in OOP and indirect burden in 2010. This was followed by hypertension (Int$1.36 billion), diabetes (Int$0.81 billion) and stroke (Int$0.29 billion). The OOP and indirect burden of these conditions is estimated to be Int$4.02 billion. Diabetes and stroke are expected to have the largest proportional increases in burden by 2020; 56.0% for diabetes and 56.9% for stroke to total Int$1.27 billion and Int$0.45 billion respectively. The burden of heart problems in 2020 is expected to increase by 34.4% to total Int$2.09 billion and hypertension burden will increase by 46.1% to Int$1.99 billion. In 2020, these conditions are expected to impose an economic burden of Int$5.80 billion. Conclusion: In conclusion, this study demonstrates the significant burden of 4 primary NCDs on Indonesian households. In addition to the indirect burden, hypertension, diabetes, heart problems and stroke account for 8% of the nation's OOP healthcare expenditure, and due to rising disease prevalence and an aging population, this figure is expected to increase to 12% by 2020 without a significant health intervention.	[Finkelstein, Eric A.; Chay, Junxing] Duke NUS Grad Med Sch, Hlth Serv & Syst Res Program, Singapore, Singapore; [Finkelstein, Eric A.] Duke Univ, Global Hlth Inst, Durham, NC USA; [Bajpai, Shailendra] Sanofi Aventis, Med Affairs, Singapore, Singapore	National University of Singapore; Duke University; Sanofi-Aventis	Finkelstein, EA (corresponding author), Duke NUS Grad Med Sch, Hlth Serv & Syst Res Program, Singapore, Singapore.	eric.finkelstein@duke-nus.edu.sg		Chay, Junxing/0000-0002-3291-4523	Sanofi-Aventis Singapore Pte. Ltd	Sanofi-Aventis Singapore Pte. Ltd	These findings are the result of work supported by Sanofi-Aventis Singapore Pte. Ltd. The views expressed in this paper are those of the authors, and no official endorsement by Sanofi-Aventis is intended or should be inferred. Publication of the study results was not contingent upon sponsor's approval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Bilger M, 2013, MED CARE, V51, P471, DOI 10.1097/MLR.0b013e318286e437; Chang Hoo-Sun, 2012, J Prev Med Public Health, V45, P291, DOI 10.3961/jpmph.2012.45.5.291; Chapman RH, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-11; Clegg A, 2003, INT J OBESITY, V27, P1167, DOI 10.1038/sj.ijo.0802394; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Finkelstein EA, 2010, J OCCUP ENVIRON MED, V52, P971, DOI 10.1097/JOM.0b013e3181f274d2; Fox KM, 2008, CURR MED RES OPIN, V24, P3323, DOI [10.1185/03007990802520045, 10.1185/03007990802520045 ]; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Gulliford M, 2013, EUR J HEALTH ECON, P1; HATZIANDREU EI, 1988, AM J PUBLIC HEALTH, V78, P1417, DOI 10.2105/AJPH.78.11.1417; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; International Diabetes Federation, 2009, IDF DIAB ATL; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Leartsakulpanitch Jittrakul, 2007, Journal of the Medical Association of Thailand, V90, P1925; Lightwood J, 2009, AM J PUBLIC HEALTH, V99, P2230, DOI 10.2105/AJPH.2008.152595; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Liu JLY, 2002, HEART, V88, P597, DOI 10.1136/heart.88.6.597; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; Ma Y, 2010, EUR J NEUROL, V17, P1270, DOI 10.1111/j.1468-1331.2010.03007.x; McManus RJ, 2005, BMJ-BRIT MED J, V331, P493, DOI 10.1136/bmj.38558.393669.E0; Ministry of Health and National Institute of Health Research and Development, 2008, NAT REP BAS HLTH RES; Muller-Nordhorn J, 2008, CLIN RES CARDIOL, V97, P152, DOI 10.1007/s00392-007-0602-0; National Heart Lung and Blood Institute, 2003, 7 JNC NAT HEART LUNG; National Institute for Health and Clinical Excellence, 2007, GUID MAN; Organization WH, 2016, GLOBAL STATUS REPORT; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Rice D P, 1981, Vital Health Stat 3, P1; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P1954, DOI 10.2105/AJPH.57.11.1954; Shaw LJ, 2006, CIRCULATION, V114, P894, DOI 10.1161/CIRCULATIONAHA.105.609990; Sullivan PW, 2007, VALUE HEALTH, V10, P443, DOI 10.1111/j.1524-4733.2007.00199.x; Sutrisna B, 2009, MEDIA MEDIKA INDONES, V43, P247; Thabrany H., 2012, INDONESIA HEAVEN CIG; WHO, 2006, BMI CLASS; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2003, MAK CHOC HLTH WHO GU; World Health Organization, WHO HLTH EXP SER; Zheng H, 2010, APPL HEALTH ECON HEA, V8, P179, DOI 10.2165/11530520-000000000-00000	44	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99572	10.1371/journal.pone.0099572	http://dx.doi.org/10.1371/journal.pone.0099572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9SD	24915510	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700117
J	Zdzalik, D; Vagbo, CB; Kirpekar, F; Davydova, E; Puscian, A; Maciejewska, AM; Krokan, HE; Klungland, A; Tudek, B; van den Born, E; Falnes, PO				Zdzalik, Daria; Vagbo, Cathrine B.; Kirpekar, Finn; Davydova, Erna; Puscian, Alicja; Maciejewska, Agnieszka M.; Krokan, Hans E.; Klungland, Arne; Tudek, Barbara; van den Born, Erwin; Falnes, Pal O.			Protozoan ALKBH8 Oxygenases Display both DNA Repair and tRNA Modification Activities	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; OBESITY-ASSOCIATED FTO; ESCHERICHIA-COLI; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; WOBBLE POSITION; ENZYME ALKB; PROTEINS; BACTERIAL; LESIONS	The ALKBH family of Fe(II) and 2-oxoglutarate dependent oxygenases comprises enzymes that display sequence homology to AlkB from E. coli, a DNA repair enzyme that uses an oxidative mechanism to dealkylate methyl and etheno adducts on the nucleobases. Humans have nine different ALKBH proteins, ALKBH1-8 and FTO. Mammalian and plant ALKBH8 are tRNA hydroxylases targeting 5-methoxycarbonylmethyl-modified uridine (mcm(5)U) at the wobble position of tRNA(Gly(UCC)). In contrast, the genomes of some bacteria encode a protein with strong sequence homology to ALKBH8, and robust DNA repair activity was previously demonstrated for one such protein. To further explore this apparent functional duality of the ALKBH8 proteins, we have here enzymatically characterized a panel of such proteins, originating from bacteria, protozoa and mimivirus. All the enzymes showed DNA repair activity in vitro, but, interestingly, two protozoan ALKBH8s also catalyzed wobble uridine modification of tRNA, thus displaying a dual in vitro activity. Also, we found the modification status of tRNA(Gly(UCC)) to be unaltered in an ALKBH8 deficient mutant of Agrobacterium tumefaciens, indicating that bacterial ALKBH8s have a function different from that of their eukaryotic counterparts. The present study provides new insights on the function and evolution of the ALKBH8 family of proteins.	[Zdzalik, Daria; Davydova, Erna; van den Born, Erwin; Falnes, Pal O.] Univ Oslo, Dept Biosci, Oslo, Norway; [Zdzalik, Daria; Puscian, Alicja; Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Warsaw, Poland; [Vagbo, Cathrine B.; Krokan, Hans E.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Kirpekar, Finn] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Puscian, Alicja] Polish Acad Sci, M Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland; [Maciejewska, Agnieszka M.; Tudek, Barbara] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Klungland, Arne] Oslo Univ Hosp, Clin Diagnost & Intervent, Rikshosp, Oslo, Norway; [Klungland, Arne] Oslo Univ Hosp, Inst Med Microbiol, Rikshosp, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; University of Warsaw; Norwegian University of Science & Technology (NTNU); University of Southern Denmark; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Falnes, PO (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	pal.falnes@ibv.uio.no	Zdżalik-Bielecka, Daria P/N-6785-2015; Maciejewska, Agnieszka M/B-2287-2012; Vågbø, Cathrine Broberg/N-3226-2017; Puscian, Alicja/AAQ-7575-2021; Falnes, Pål Ø./AAA-4581-2020; Klungland, Arne/X-1233-2019	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Puscian, Alicja/0000-0002-7029-1275; Zdzalik-Bielecka, Daria/0000-0003-3096-8293; Davydova, Erna/0000-0001-7072-4539; Kirpekar, Finn/0000-0003-1901-2266; Maciejewska, Agnieszka M./0000-0002-1268-2606; Falnes, Pal/0000-0001-8114-6025; Klungland, Arne/0000-0001-7274-3661	Research Council of Norway; Norwegian Cancer Society; Polish-Norwegian Research Programme [PNRF-143-A1-1/07]; Iceland, Liechtenstein and Norway - European Economic Area Financial Mechanism; Norwegian Financial Mechanism	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Polish-Norwegian Research Programme; Iceland, Liechtenstein and Norway - European Economic Area Financial Mechanism; Norwegian Financial Mechanism	This work was supported by the Research Council of Norway; the Norwegian Cancer Society; the Polish-Norwegian Research Programme (PNRF-143-A1-1/07) and by Iceland, Liechtenstein and Norway by means of co-financing from the European Economic Area Financial Mechanism and the Norwegian Financial Mechanism as part of the Scholarship and Training Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; ARAVIND L, 2001, GENOME BIOL, V2; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dinglay S, 2000, GENE DEV, V14, P2097; DOSANJH MK, 1994, P NATL ACAD SCI USA, V91, P1024, DOI 10.1073/pnas.91.3.1024; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Falnes PO, 2003, RES MICROBIOL, V154, P531, DOI 10.1016/S0923-2508(03)00150-5; Frick LE, 2007, P NATL ACAD SCI USA, V104, P755, DOI 10.1073/pnas.0607377104; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim MY, 2007, CHEM RES TOXICOL, V20, P1075, DOI 10.1021/tx700167v; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Leihne V, 2011, NUCLEIC ACIDS RES, V39, P7688, DOI 10.1093/nar/gkr406; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Maciejewska AM, 2013, J BIOL CHEM, V288, P432, DOI 10.1074/jbc.M112.353342; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; van den Born E, 2008, NUCLEIC ACIDS RES, V36, P5451, DOI 10.1093/nar/gkn519; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; van den Born E, 2009, NUCLEIC ACIDS RES, V37, P7124, DOI 10.1093/nar/gkp774; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	57	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98729	10.1371/journal.pone.0098729	http://dx.doi.org/10.1371/journal.pone.0098729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914785	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700031
J	Awan, TH; Chauhan, BS; Cruz, PCS				Awan, Tahir Hussain; Chauhan, Bhagirath Singh; Cruz, Pompe C. Sta.			Physiological and Morphological Responses of Ischaemum rugosum Salisb. (Wrinkled Grass) to Different Nitrogen Rates and Rice Seeding Rates	PLOS ONE			English	Article							GROWTH; FERTILIZATION; COMPETITION; MANAGEMENT; LIGHT; RATIO	Ischaemum rugosum is a competitive weed in direct-seeded rice systems. Developing integrated weed management strategies that promote the suppression of weeds by crop density, cultivar selection, and nutrition requires better understanding of the extent to which rice interferes with the growth of this weed and how it responds to resource limitation due to rice interference. The growth of I. rugosum was studied when grown with four rice seeding rates (0, 50, and 100 kg ha(-1)) and four nitrogen (N) rates (0, 50, 100, and 150 kg ha(-1)). Compared to the weed plants grown alone, weed tiller number was reduced by 63-80%, leaf number by 68-77%, leaf area by 69-77%, leaf biomass by 72-84%, and inflorescence biomass by 81-93% at the rice seeding rates of-5-100 kg ha(-1). All these parameters increased with increasing rates of N from 0 to 150 kg ha(-1). At weed maturity, I. rugosum plants were 100% taller than rice at 0 kg N ha(-1), whereas, with added N, the weeds were only 50% taller than rice. Weed biomass increased by 82-160%, whereas rice biomass increased by 92-229%, with the application of 50-150 kg N ha(-1). Added N favored rice biomass production more than it did the weed. Rice interference reduced the height and biomass of I. rugosum, but did not suppress its growth completely. I. rugosum showed the ability to reduce the effects of rice interference by increasing leaf area, leaf weight ratio, and specific leaf area, and by decreasing the root-shoot weight ratio in comparison to the weed plants grown alone. The results suggest that rice crop interference alone may reduce I. rugosum growth but may not provide complete control of this weed. The need for integrated weed management practices to effectively control this weed species is highlighted.	[Awan, Tahir Hussain; Chauhan, Bhagirath Singh] Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines; [Cruz, Pompe C. Sta.] Univ Philippines, Coll Agr, Crop Sci Cluster, Dept Agron, Los Banos, Philippines	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Awan, TH (corresponding author), Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines.	t.awan@irri.org	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668				AMPONGNYARKO K, 1993, WEED RES, V33, P269, DOI 10.1111/j.1365-3180.1993.tb01941.x; Andersson TN, 1999, WEED SCI, V47, P47, DOI 10.1017/S0043174500090640; Baki Haji Bakar, 2003, Weed Biology and Management, V3, P8, DOI 10.1046/j.1445-6664.2003.00075.x; Blackshaw RE, 2003, WEED SCI, V51, P532, DOI 10.1614/0043-1745(2003)051[0532:DROWST]2.0.CO;2; Bonifas KD, 2005, WEED SCI, V53, P670, DOI 10.1614/WS-05-002R.1; Buhler DD, 2000, WEED SCI, V48, P274, DOI 10.1614/0043-1745(2000)048[0274:TAPCTA]2.0.CO;2; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Chauhan BS, 2012, ADV AGRON, V117, P315, DOI 10.1016/B978-0-12-394278-4.00007-6; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2013, CROP PROT, V54, P142, DOI 10.1016/j.cropro.2013.08.005; Evans SP, 2003, WEED SCI, V51, P408, DOI 10.1614/0043-1745(2003)051[0408:NAITCP]2.0.CO;2; Gibson KD, 2004, WEED SCI, V52, P271, DOI 10.1614/WS-03-103R; Gibson KD, 2001, WEED RES, V41, P59, DOI 10.1046/j.1365-3180.2001.00223.x; Holm L. G., 1977, WORLDS WORST WEEDS D; Itoh K., 1991, LIFE CYCLES RICE FIE, P55; Jornsgard B, 1996, WEED RES, V36, P461, DOI 10.1111/j.1365-3180.1996.tb01675.x; Knops JMH, 2000, AM MIDL NAT, V144, P265, DOI 10.1674/0003-0031(2000)144[0265:SLAAAN]2.0.CO;2; Liebman M., 1990, Sustainable agriculture in temperate zones., P111; Lubigan RT, 1989, INT RICE RES NEWSL, V14, P49; Mahajan G, 2013, FIELD CROP RES, V144, P89, DOI 10.1016/j.fcr.2013.01.008; Marenco Ricardo A., 1998, Revista Brasileira de Fisiologia Vegetal, V10, P107; Mishra J. S., 2001, Indian Journal of Plant Physiology, V6, P386; Phuong LT, 2005, J AGRON CROP SCI, V191, P185, DOI 10.1111/j.1439-037X.2005.00151.x; Ponce RG, 1998, WEED RES, V38, P453, DOI 10.1046/j.1365-3180.1998.00116.x; Reynolds HL, 1996, PLANT SOIL, V185, P75, DOI 10.1007/BF02257566; Shafagh-Kolvanagh J, 2008, J FOOD AGRIC ENVIRON, V6, P368; TERASHIMA I, 1988, PLANT CELL PHYSIOL, V29, P143; Valverde BE, 2007, WEED TECHNOL, V21, P310, DOI 10.1614/WT-06-097.1; Vourlitis GL, 2013, WEED SCI, V61, P117, DOI 10.1614/WS-D-11-00220.1; Zhao D., 2006, THESIS WAGENINGEN U	30	20	21	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98255	10.1371/journal.pone.0098255	http://dx.doi.org/10.1371/journal.pone.0098255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910995	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600130
J	Tang, JH; Ma, LL; Yu, TX; Zheng, J; Zhang, HJ; Liang, H; Shao, P				Tang, Jian-Hua; Ma, Li-Li; Yu, Tian-Xia; Zheng, Juan; Zhang, Hui-Juan; Liang, Hui; Shao, Peng			RETRACTED: Insulin-Like Growth Factor-1 as a Prognostic Marker in Patients with Acute Ischemic Stroke (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							IGF-I; BINDING PROTEIN-3; SERUM-LEVELS; INSULIN-LIKE-GROWTH-FACTOR-1; CLASSIFICATION; RECEPTORS; ESTROGEN; CELLS	Objective: Insulin-like growth factor-1 (IGF-1) has been associated with cardiovascular risk factors and atherosclerosis. The aim of the present study was to evaluate the prognostic value of IGF-1 levels in patients with acute ischemic stroke (AIS). Methods: All patients with first-ever AIS from August 1, 2012 to August 31, 2013 were recruited to participate in the study. Clinical data were collected. The National Institutes of Health Stroke Scale (NIHSS) score was assessed on admission blinded to serum IGF-1 levels. For the assessment of functional outcome at 90 days Modified Rankin Scale (mRS) was used. On admission, serum IGF-1 levels were determined by chemiluminescence immunoassay. The influence of IGF-1 levels on functional outcome and death was assessed by multivariate logistic regression analysis. Results: Patients with an unfavorable outcomes and non-survivors had significantly decreased serum IGF-1 levels on admission (P < 0.0001 for both). IGF-1 was an independent prognostic marker of functional outcome and death [odds ratio 0.89 (0.84-0.93) and 0.90 (0.84-0.95), respectively, P < 0.0001 for both, adjusted for age, NIHSS score and other predictors] in patients with ischemic stroke. Serum IGF-1 levels <= 130 ng/mL was as an value indicator for unfavorable functional outcome (OR 3.31, 95% CI: 1.87-5.62; P < 0.0001), after adjusting for other significant confounders. Conclusions: We reported a significant association between low serum IGF-1 levels and unfavorable functional outcome and death.	[Tang, Jian-Hua; Ma, Li-Li; Yu, Tian-Xia; Zheng, Juan; Zhang, Hui-Juan; Liang, Hui; Shao, Peng] Yantaishan Hosp, Dept Neurol, Yantai, Shandong, Peoples R China		Shao, P (corresponding author), Yantaishan Hosp, Dept Neurol, Yantai, Shandong, Peoples R China.	jonjeneuro55@163.com						Aberg D, 2011, J CLIN ENDOCR METAB, V96, pE1055, DOI 10.1210/jc.2010-2802; Aberg ND, 2013, EUR J ENDOCRINOL, V169, P759, DOI 10.1530/EJE-13-0486; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aimaretti G, 2008, J ENDOCRINOL INVEST, V31, P445, DOI 10.1007/BF03346389; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BAR RS, 1984, BIOCHEM BIOPH RES CO, V124, P203, DOI 10.1016/0006-291X(84)90937-9; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; Beresewicz M, 2010, INT J DEV NEUROSCI, V28, P91, DOI 10.1016/j.ijdevneu.2009.09.002; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; De Smedt A, 2011, STROKE, V42, P2180, DOI 10.1161/STROKEAHA.110.600783; Denti L, 2004, AM J MED, V117, P312, DOI 10.1016/j.amjmed.2004.02.049; Dong X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094845; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Granada ML, 2008, CLIN ENDOCRINOL, V68, P942, DOI 10.1111/j.1365-2265.2007.03120.x; HOCHBERG Z, 1992, ENDOCRINOLOGY, V131, P430, DOI 10.1210/en.131.1.430; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Johnsen SP, 2005, J CLIN ENDOCR METAB, V90, P5937, DOI 10.1210/jc.2004-2088; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Mehta S, 2012, BRIT J DIABETES VASC, V12, P17; PFEIFLE B, 1983, J ENDOCRINOL, V96, P251, DOI 10.1677/joe.0.0960251; Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Sohrabji F, 2013, J NEUROENDOCRINOL, V25, P1173, DOI 10.1111/jne.12059; Yeap BB, 2013, CLIN ENDOCRINOL, V78, P752, DOI 10.1111/cen.12052; Zemva J, 2011, CURR DIABETES REV, V7, P356, DOI 10.2174/157339911797415594	32	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99186	10.1371/journal.pone.0099186	http://dx.doi.org/10.1371/journal.pone.0099186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911265	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600053
J	Hirst, JA; Howick, J; Aronson, JK; Roberts, N; Perera, R; Koshiaris, C; Heneghan, C				Hirst, Jennifer A.; Howick, Jeremy; Aronson, Jeffrey K.; Roberts, Nia; Perera, Rafael; Koshiaris, Constantinos; Heneghan, Carl			The Need for Randomization in Animal Trials: An Overview of Systematic Reviews	PLOS ONE			English	Review							FOCAL CEREBRAL-ISCHEMIA; EXPERIMENTAL STROKE; STRATIFIED METAANALYSIS; METHODOLOGICAL QUALITY; EMPIRICAL-EVIDENCE; EFFICACY; MODELS; BIAS; INTERVENTIONS; FLUORIDE	Background and Objectives: Randomization, allocation concealment, and blind outcome assessment have been shown to reduce bias in human studies. Authors from the Collaborative Approach to Meta Analysis and Review of Animal Data from Experimental Studies (CAMARADES) collaboration recently found that these features protect against bias in animal stroke studies. We extended the scope the work from CAMARADES to include investigations of treatments for any condition. Methods: We conducted an overview of systematic reviews. We searched Medline and Embase for systematic reviews of animal studies testing any intervention (against any control) and we included any disease area and outcome. We included reviews comparing randomized versus not randomized (but otherwise controlled), concealed versus unconcealed treatment allocation, or blinded versus unblinded outcome assessment. Results: Thirty-one systematic reviews met our inclusion criteria: 20 investigated treatments for experimental stroke, 4 reviews investigated treatments for spinal cord diseases, while 1 review each investigated treatments for bone cancer, intracerebral hemorrhage, glioma, multiple sclerosis, Parkinson's disease, and treatments used in emergency medicine. In our sample 29% of studies reported randomization, 15% of studies reported allocation concealment, and 35% of studies reported blinded outcome assessment. We pooled the results in a meta-analysis, and in our primary analysis found that failure to randomize significantly increased effect sizes, whereas allocation concealment and blinding did not. In our secondary analyses we found that randomization, allocation concealment, and blinding reduced effect sizes, especially where outcomes were subjective. Conclusions: Our study demonstrates the need for randomization, allocation concealment, and blind outcome assessment in animal research across a wide range of outcomes and disease areas. Since human studies are often justified based on results from animal studies, our results suggest that unduly biased animal studies should not be allowed to constitute part of the rationale for human trials.	[Hirst, Jennifer A.; Howick, Jeremy; Aronson, Jeffrey K.; Perera, Rafael; Heneghan, Carl] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Roberts, Nia] Univ Oxford, Bodleian Lib, Oxford, England	University of Oxford; University of Oxford	Hirst, JA (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	jennifer.hirst@phc.ox.ac.uk; jeremy.howick@phc.ox.ac.uk	Koshiaris, Constantinos/R-1263-2019; Howick, Jeremy/ADP-7644-2022; Roberts, Nia W/F-9842-2010	Roberts, Nia W/0000-0002-1142-6440; Howick, Jeremy/0000-0003-0280-7206; Hirst, Jennifer/0000-0002-8416-2159; Perera, Rafael/0000-0003-2418-2091	National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	Jeremy Howick was funded by a National Institute for Health Research (NIHR) non-clinical fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Banwell V, 2009, J STROKE CEREBROVASC, V18, P269, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.009; Batchelor PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071317; Batchelor PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072659; Bath PMW, 2009, INT J STROKE, V4, P471, DOI 10.1111/j.1747-4949.2009.00386.x; Bath PMW, 2009, BRIT J PHARMACOL, V157, P1157, DOI 10.1111/j.1476-5381.2009.00196.x; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Breuer K, 2000, APPL ANIM BEHAV SCI, V66, P273, DOI 10.1016/S0168-1591(99)00097-0; Chalmers I., 2007, TREATING INDIVIDUALS; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Currie GL, 2013, PAIN, V154, P917, DOI 10.1016/j.pain.2013.02.033; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egan KJ, 2014, NEUROREHABIL NEURAL; FARLEY SM, 1989, J CLIN EPIDEMIOL, V42, P1067, DOI 10.1016/0895-4356(89)90048-6; Frantzias J, 2011, ANN NEUROL, V69, P389, DOI 10.1002/ana.22243; Gibson CL, 2006, J CEREBR BLOOD F MET, V26, P1103, DOI 10.1038/sj.jcbfm.9600270; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hirst TC, 2013, BRIT J CANCER, V108, P64, DOI 10.1038/bjc.2012.504; Horn J, 2001, STROKE, V32, P2433, DOI 10.1161/hs1001.096009; Howick JH., 2011, PHILOS EVIDENCE BASE; International Committee of Medical Journal Editors, 2009, BIOMEDICAL J UNPUB; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kimmelman J, 2012, NAT BIOTECHNOL, V30, P488, DOI 10.1038/nbt.2261; KNEKT P, 1994, AM J EPIDEMIOL, V139, P1180, DOI 10.1093/oxfordjournals.aje.a116964; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; LYNCH JJ, 1974, PSYCHOPHYSIOLOGY, V11, P472, DOI 10.1111/j.1469-8986.1974.tb00575.x; Macleod Malcolm, 2010, Pract Neurol, V10, P312, DOI 10.1136/jnnp.2010.230524; Macleod M, 2010, NEUROMETHODS, V47, P7, DOI 10.1007/978-1-60761-750-1_2; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2005, J CEREBR BLOOD F MET, V25, P713, DOI 10.1038/sj.jcbfm.9600064; Macleod MR, 2005, J PINEAL RES, V38, P35, DOI 10.1111/j.1600-079X.2004.00172.x; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Medical Research Council, 2013, MRC CLIN TRIALS; Newton J E, 1993, Integr Physiol Behav Sci, V28, P280, DOI 10.1007/BF02691245; Odgaard-Jensen J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub3; Pedder H, 2014, STROKE, V45, P563, DOI 10.1161/STROKEAHA.113.003128; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; Rooke EDM, 2011, PARKINSONISM RELAT D, V17, P313, DOI 10.1016/j.parkreldis.2011.02.010; SABRE, 2012, SABRE RES UK; Sackett D. L., 1997, EVIDENCE BASED MED P; SACKETT DL, 1969, AM J EPIDEMIOL, V89, P125, DOI 10.1093/oxfordjournals.aje.a120921; SACKETT DL, 1986, CHEST, V89, pS2, DOI 10.1378/chest.89.2_Supplement.2S; Savovic J, 2012, ANN INTERNAL MED; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sena E, 2007, STROKE, V38, P388, DOI 10.1161/01.STR.0000254462.75851.22; Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Simera I, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2471; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; Vesterinen HM, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-33; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Vesterinen HV, 2011, J CEREBR BLOOD F MET, V31, P1064, DOI 10.1038/jcbfm.2010.217; Vilar J, 2003, NEED LARGE SIMPLE RA; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Wheble PCR, 2008, CEREBROVASC DIS, V25, P5, DOI 10.1159/000111493; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	69	135	139	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98856	10.1371/journal.pone.0098856	http://dx.doi.org/10.1371/journal.pone.0098856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906117	Green Published, gold			2022-12-27	WOS:000341869000071
J	Taegtmeyer, AB; Haschke, M; Tchambaz, L; Buylaert, M; Tschopl, M; Beuers, U; Drewe, J; Krahenbuhl, S				Taegtmeyer, Anne B.; Haschke, Manuel; Tchambaz, Lydia; Buylaert, Mirabel; Tschoepl, Martin; Beuers, Ulrich; Drewe, Juergen; Kraehenbuehl, Stephan			A Study of the Relationship between Serum Bile Acids and Propranolol Pharmacokinetics and Pharmacodynamics in Patients with Liver Cirrhosis and in Healthy Controls	PLOS ONE			English	Article							SYSTEMIC BLOOD-SERUM; SALT EXPORT PUMP; PORTAL-HYPERTENSION; EXPRESSION CLONING; DOSE ADJUSTMENT; DISEASE; METABOLISM; IDENTIFICATION; PHARMACOLOGY; MODEL	The main objectives of the study were to determine the exposure and bioavailability of oral propranolol and to investigate their associations with serum bile acid concentration in patients with liver cirrhosis and in healthy controls. A further objective was to study the pharmacodynamics of propranolol. An open-label crossover study was performed to determine the pharmacokinetics and pharmacodynamics of propranolol after oral (40 mg) and intravenous (1 mg) administration as well as the concentration of total and individual fasting serum bile acids in 15 patients with liver cirrhosis and 5 healthy controls. After intravenous propranolol, patients showed a 1.8-fold increase in the area under the plasma concentration-time curve (AUC(0-infinity)), a 1.8-fold increase in volume of distribution and a 3-fold increase in the elimination half-life (mean +/- SEM: 641 +/- 100 vs. 205 +/- 43 minutes) compared to controls. After oral application, AUC(0-infinity) and elimination half-life of propranolol were increased 6- and 4-fold, respectively, and bioavailability 3-fold (83 +/- 8 vs. 27 +/- 9.2%). Maximal effects on blood pressure and heart rate occurred during the first 4 and first 2 hours, respectively, after intravenous and oral application in both patients and controls. Total serum bile acid concentrations were higher in patients than controls (42 +/- 11 vs. 2.7 +/- 0.3 mmol/L) and were linearly correlated with the serum chenodeoxycholic acid concentration. There was a linear correlation between the SBA concentration and propranolol oral AUC(0-infinity) in subjects not receiving interacting drugs (r(2) = 0.73, n = 18). The bioavailability of and exposure to oral propranolol are increased in patients with cirrhosis. Fasting serum bile acid concentration may be helpful in predicting the exposure to oral propranolol in these patients.	[Taegtmeyer, Anne B.; Haschke, Manuel; Tchambaz, Lydia; Buylaert, Mirabel; Tschoepl, Martin; Drewe, Juergen; Kraehenbuehl, Stephan] Univ Basel, Div Clin Pharmacol & Toxicol, Basel, Switzerland; [Taegtmeyer, Anne B.; Haschke, Manuel; Tchambaz, Lydia; Buylaert, Mirabel; Tschoepl, Martin; Drewe, Juergen; Kraehenbuehl, Stephan] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Haschke, Manuel; Drewe, Juergen; Kraehenbuehl, Stephan] Univ Basel, Dept Biomed, Basel, Switzerland; [Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Basel; University of Basel; University of Basel; University of Amsterdam; Academic Medical Center Amsterdam	Krahenbuhl, S (corresponding author), Univ Basel, Div Clin Pharmacol & Toxicol, Basel, Switzerland.	stephan.kraehenbuehl@usb.ch	Haschke, Manuel M/L-9386-2014; Drewe, Juergen/ABF-8204-2021; Krähenbühl, Stephan/Z-4744-2019	Haschke, Manuel M/0000-0003-1846-8640; Drewe, Juergen/0000-0001-5178-7825; 	Department of Clinical Pharmacology and Toxicology, University Hospital Basel; Swiss National Science Foundation [SNF 31003A-132992]; Department of Internal Medicine, University Hospital Basel ('Astra-Fonds')	Department of Clinical Pharmacology and Toxicology, University Hospital Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Department of Internal Medicine, University Hospital Basel ('Astra-Fonds')	The study was supported by internal funds from the Department of Clinical Pharmacology and Toxicology, University Hospital Basel, a grant from the Swiss National Science Foundation to SK (SNF 31003A-132992; http://www.snf.ch/) and an unrestricted award from the Department of Internal Medicine, University Hospital Basel ('Astra-Fonds'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin A, 1998, CLIN PHARMACOL THER, V64, P8, DOI 10.1016/S0009-9236(98)90017-0; AHLBERG J, 1977, GASTROENTEROLOGY, V73, P1377; Akrimax Pharmaceuticals LLC Cranford NJ USA, 2010, PROD LAB IND PROPR H; ANGELIN B, 1982, J CLIN INVEST, V70, P724, DOI 10.1172/JCI110668; ARTHUR MJP, 1985, GUT, V26, P14, DOI 10.1136/gut.26.1.14; AstraZeneca AG, 2010, PRODUCT INFORM INDER; Banares R, 2002, HEPATOLOGY, V36, P1367, DOI 10.1053/jhep.2002.36947; BRANCH R A, 1976, Clinical Pharmacokinetics, V1, P264; BRANCH RA, 1976, BRIT J CLIN PHARMACO, V3, P243, DOI 10.1111/j.1365-2125.1976.tb00599.x; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Child CG, 1964, LIVER PORTAL HYPERTE, P50; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145; Delco F, 2005, DRUG SAFETY, V28, P529, DOI 10.2165/00002018-200528060-00005; Franz CC, 2013, EUR J CLIN PHARMACOL, V69, P1565, DOI 10.1007/s00228-013-1502-z; Franz CC, 2012, EUR J CLIN PHARMACOL, V68, P179, DOI 10.1007/s00228-011-1105-5; Frye RF, 2006, CLIN PHARMACOL THER, V80, P235, DOI 10.1016/j.clpt.2006.05.006; Garcia-Tsao G, 2009, AM J GASTROENTEROL, V104, P1802, DOI 10.1038/ajg.2009.191; GEORGE J, 1995, HEPATOLOGY, V21, P120, DOI 10.1002/hep.1840210121; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gonzalez-Abraldes J, 2001, GASTROENTEROLOGY, V121, P382, DOI 10.1053/gast.2001.26288; Granfors MT, 2004, CLIN PHARMACOL THER, V76, P598, DOI 10.1016/j.clpt.2004.08.018; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KRAHENBUHL S, 1993, EUR J CLIN PHARMACOL, V45, P247; KRAHENBUHL S, 1994, HEPATOLOGY, V19, P471, DOI 10.1016/0270-9139(94)90027-2; McGinnity DF, 2000, DRUG METAB DISPOS, V28, P1327; MIESCHER G, 1983, EUR J CLIN INVEST, V13, P439, DOI 10.1111/j.1365-2362.1983.tb00126.x; Miyajima H, 2001, J GASTROEN HEPATOL, V16, P647, DOI 10.1046/j.1440-1746.2001.02493.x; MORGAN DJ, 1995, CLIN PHARMACOKINET, V29, P370, DOI 10.2165/00003088-199529050-00005; Mottet C, 1998, HEPATOLOGY, V27, P920, DOI 10.1002/hep.510270405; NIES AS, 1975, CIRCULATION, V52, P6, DOI 10.1161/01.CIR.52.1.6; OHKUBO H, 1984, GASTROENTEROLOGY, V86, P514; PENTIKAINEN PJ, 1989, J CLIN PHARMACOL, V29, P272, DOI 10.1002/j.1552-4604.1989.tb03327.x; PENTIKAINEN PJ, 1980, EUR J CLIN PHARMACOL, V17, P275, DOI 10.1007/BF00625801; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Schlatter C, 2009, DRUG SAFETY, V32, P561, DOI 10.2165/00002018-200932070-00003; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Vyas Kaushal, 2002, Indian J Gastroenterol, V21, P176; WATSON RGP, 1987, BRIT J CLIN PHARMACO, V24, P527, DOI 10.1111/j.1365-2125.1987.tb03207.x; YOSHIMOTO K, 1995, BRIT J CLIN PHARMACO, V39, P421, DOI 10.1111/j.1365-2125.1995.tb04472.x; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	42	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97885	10.1371/journal.pone.0097885	http://dx.doi.org/10.1371/journal.pone.0097885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906133	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000016
J	Biswas, S; Haselier, C; Mataruga, A; Thumann, G; Walter, P; Muller, F				Biswas, Sonia; Haselier, Christine; Mataruga, Anja; Thumann, Gabriele; Walter, Peter; Mueller, Frank			Pharmacological Analysis of Intrinsic Neuronal Oscillations in rd10 Retina	PLOS ONE			English	Article							CONE BIPOLAR CELLS; DEGENERATING MOUSE RETINA; INNER PLEXIFORM LAYER; GLUTAMATE-RECEPTOR; LIGHT RESPONSES; GANGLION-CELLS; AII AMACRINE; MAMMALIAN RETINA; ROD PATHWAYS; ION CHANNELS	In the widely used mouse model of retinal degeneration, rd1, the loss of photoreceptors leads to rhythmic electrical activity of around 10-16 Hz in the remaining retinal network. Recent studies suggest that this oscillation is formed within the electrically coupled network of AII amacrine cells and ON-bipolar cells. A second mouse model, rd10, displays a delayed onset and slower progression of degeneration, making this mouse strain a better model for human retinitis pigmentosa. In rd10, oscillations occur at a frequency of 3-7 Hz, raising the question whether oscillations have the same origin in the two mouse models. As rd10 is increasingly being used as a model to develop experimental therapies, it is important to understand the mechanisms underlying the spontaneous rhythmic activity. To study the properties of oscillations in rd10 retina we combined multi electrode recordings with pharmacological manipulation of the retinal network. Oscillations were abolished by blockers for ionotropic glutamate receptors and gap junctions. Frequency and amplitude of oscillations were modulated strongly by blockers of inhibitory receptors and to a lesser extent by blockers of HCN channels. In summary, although we found certain differences in the pharmacological modulation of rhythmic activity in rd10 compared to rd1, the overall pattern looked similar. This suggests that the generation of rhythmic activity may underlie similar mechanisms in rd1 and rd10 retina.	[Biswas, Sonia; Mataruga, Anja; Mueller, Frank] Forschungszentrum Julich, Inst Complex Syst, Cellular Biophys, ICS 4, D-52425 Julich, Germany; [Haselier, Christine; Thumann, Gabriele; Walter, Peter] Rhein Westfal TH Aachen, Dept Ophthalmol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Muller, F (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Cellular Biophys, ICS 4, D-52425 Julich, Germany.	f.mueller@fz-juelich.de	Walter, Peter/L-5982-2018; Mueller, Frank/I-7196-2013	Walter, Peter/0000-0001-8745-6593; Mueller, Frank/0000-0001-7264-1227	Deutsche Forschungsgemeinschaft [TH 603/15-1, WA 1472/6-1, MU 3036/3-1, MU 3036/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grants TH 603/15-1 to GT, WA 1472/6-1 to PW, MU 3036/3-1 and MU 3036/2-1 to FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; ENZ R, 1995, VISUAL NEUROSCI, V12, P501, DOI 10.1017/S0952523800008403; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; Goo YS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035003; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Jae SA, 2013, KOREAN J PHYSIOL PHA, V17, P229, DOI 10.4196/kjpp.2013.17.3.229; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kaur T, 2012, J PHYSIOL-LONDON, V590, P179, DOI 10.1113/jphysiol.2011.218974; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1983, VISION RES, V23, P301, DOI 10.1016/0042-6989(83)90078-0; Krizaj D, 2010, VISION RES, V50, P2460, DOI 10.1016/j.visres.2010.08.034; Lin YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-7; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Morgans CW, 2010, BIOESSAYS, V32, P609, DOI 10.1002/bies.200900198; MULLER F, 1992, VISUAL NEUROSCI, V9, P415, DOI 10.1017/S0952523800010828; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nakamura M, 2010, MOL VIS, V16, P425; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Petit-Jacquea J, 2005, J NEUROPHYSIOL, V94, P1770, DOI 10.1152/jn.00279.2005; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Toychiev AH, 2013, J NEUROSCI, V33, P13972, DOI 10.1523/JNEUROSCI.2399-13.2013; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Varela C, 2003, VISION RES, V43, P879, DOI 10.1016/S0042-6989(02)00493-5; Veruki ML, 2009, J NEUROPHYSIOL, V101, P2339, DOI 10.1152/jn.00112.2009; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Ye JH, 2008, IEEE ENG MED BIO, P2465, DOI 10.1109/IEMBS.2008.4649699	61	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99075	10.1371/journal.pone.0099075	http://dx.doi.org/10.1371/journal.pone.0099075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918437	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000047
J	Delatorre, E; Mir, D; Bello, G				Delatorre, Edson; Mir, Daiana; Bello, Gonzalo			Spatiotemporal Dynamics of the HIV-1 Subtype G Epidemic in West and Central Africa	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; HUMAN-IMMUNODEFICIENCY-VIRUS; NORTH-CENTRAL NIGERIA; NAIVE PREGNANT-WOMEN; SUB-SAHARAN AFRICA; NON-B SUBTYPES; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HIGH PREVALENCE; BURKINA-FASO	The human immunodeficiency virus type 1 (HIV-1) subtype G is the second most prevalent HIV-1 clade in West Africa, accounting for nearly 30% of infections in the region. There is no information about the spatiotemporal dynamics of dissemination of this HIV-1 clade in Africa. To this end, we analyzed a total of 305 HIV-1 subtype G pol sequences isolated from 11 different countries from West and Central Africa over a period of 20 years (1992 to 2011). Evolutionary, phylogeographic and demographic parameters were jointly estimated from sequence data using a Bayesian coalescent-based method. Our analyses indicate that subtype G most probably emerged in Central Africa in 1968 (1956-1976). From Central Africa, the virus was disseminated to West and West Central Africa at multiple times from the middle 1970s onwards. Two subtype G strains probably introduced into Nigeria and Togo between the middle and the late 1970s were disseminated locally and to neighboring countries, leading to the origin of two major western African clades (G(WA-I) and G(WA-II)). Subtype G clades circulating in western and central African regions displayed an initial phase of exponential growth followed by a decline in growth rate since the early/middle 1990s; but the mean epidemic growth rate of G(WA-I) (0.75 year(-1)) and G(WA-II) (0.95 year(-1)) clades was about two times higher than that estimated for central African lineages (0.47 year(-1)). Notably, the overall evolutionary and demographic history of G(WA-I) and G(WA-II) clades was very similar to that estimated for the CRF06_cpx clade circulating in the same region. These results support the notion that the spatiotemporal dissemination dynamics of major HIV-1 clades circulating in western Africa have probably been shaped by the same ecological factors.	[Delatorre, Edson; Mir, Daiana; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Delatorre, Edson/J-8330-2015; , daiana/J-5515-2019; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Delatorre, Edson/0000-0002-5746-0820; , daiana/0000-0002-3172-4867; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	FAPERJ [E-26/111.758/2012]; CNPq [472896/2012-1]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Public Health Service grants E-26/111.758/2012 from the FAPERJ and 472896/2012-1 from the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Ajoge HO, 2012, AIDS RES HUM RETROV, V28, P115, DOI [10.1089/aid.2011.0115, 10.1089/AID.2011.0115]; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Archer J, 2007, AIDS, V21, P1693, DOI 10.1097/QAD.0b013e32825eabd0; Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bobkova M, 2013, AIDS REV, V15, P204; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Caron M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-64; Chamberland A, 2012, SEX TRANSM INFECT, V88, P179, DOI 10.1136/sextrans-2011-050209; Chaplin B, 2011, AIDS RES HUM RETROV, V27, P71, DOI 10.1089/aid.2010.0050; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Delatorre E, 2013, AIDS, V27, P1313, DOI 10.1097/QAD.0b013e32835f1df4; Delgado E, 2008, JAIDS-J ACQ IMM DEF, V48, P599, DOI 10.1097/QAI.0b013e3181806c0e; Derache A, 2008, J ANTIMICROB CHEMOTH, V62, P456, DOI 10.1093/jac/dkn234; Diop-Ndiaye H, 2010, AIDS RES HUM RETROV, V26, P1133, DOI 10.1089/aid.2009.0295; Djoko CF, 2010, AIDS RES HUM RETROV, V26, P1027, DOI 10.1089/aid.2010.0046; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gisselquist David, 2004, SAHARA J, V1, P114; Gnisci D, 2009, W AFRICAN STUDIES RE, P67; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Kalish ML, 2004, EMERG INFECT DIS, V10, P1227; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Maiga AI, 2012, AIDS RES HUM RETROVI; Mamadou S, 2002, AIDS RES HUM RETROV, V18, P723, DOI 10.1089/088922202760072357; Marechal V, 2006, AIDS RES HUM RETROV, V22, P1036, DOI 10.1089/aid.2006.22.1036; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Minin VN, 2008, J MATH BIOL, V56, P391, DOI 10.1007/s00285-007-0120-8; Nii-Trebi NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071972; Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770; Ouedraogo-Traore R, 2003, AIDS, V17, P441, DOI 10.1097/00002030-200302140-00019; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Pandrea I, 2002, AIDS RES HUM RETROV, V18, P1103, DOI 10.1089/088922202320567842; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Rambaut A, 2007, TRACER V1 6; Rambaut A., 2014, FIGTREE V14 TREE FIG; Salama P, 2001, AIDS, V15, pS4, DOI 10.1097/00002030-200104003-00002; Sankale JL, 2007, AIDS RES HUM RETROV, V23, P1020, DOI 10.1089/aid.2006.0304; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904; Tebit DM, 2009, J MED VIROL, V81, P1691, DOI 10.1002/jmv.21600; Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217; Toni TD, 2007, AIDS RES HUM RETROV, V23, P1155, DOI 10.1089/aid.2007.0072; Vergne L, 2006, ANTIVIR THER, V11, P575; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yaotse DA, 2009, INFECT GENET EVOL, V9, P646, DOI 10.1016/j.meegid.2009.04.002; Yusim K, 2001, PHILOS T R SOC B, V356, P855, DOI 10.1098/rstb.2001.0859; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25	80	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98908	10.1371/journal.pone.0098908	http://dx.doi.org/10.1371/journal.pone.0098908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918930	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000032
J	Laszlo, Z; Solyom, K; Prazsmari, H; Barta, Z; Tothmeresz, B				Laszlo, Zoltan; Solyom, Katalin; Prazsmari, Hunor; Barta, Zoltan; Tothmeresz, Bela			Predation on Rose Galls: Parasitoids and Predators Determine Gall Size through Directional Selection	PLOS ONE			English	Article							OPTIMAL CLUTCH SIZE; VARIABLE SELECTION; BIRD PREDATION; TROPHIC LEVELS; HYMENOPTERA; WASP; INSECTS; OAK	Both predators and parasitoids can have significant effects on species' life history traits, such as longevity or clutch size. In the case of gall inducers, sporadically there is evidence to suggest that both vertebrate predation and insect parasitoid attack may shape the optimal gall size. While the effects of parasitoids have been studied in detail, the influence of vertebrate predation is less well-investigated. To better understand this aspect of gall size evolution, we studied vertebrate predation on galls of Diplolepis rosae on rose (Rosa canina) shrubs. We measured predation frequency, predation incidence, and predation rate in a large-scale observational field study, as well as an experimental field study. Our combined results suggest that, similarly to parasitoids, vertebrate predation makes a considerable contribution to mortality of gall inducer larvae. On the other hand, its influence on gall size is in direct contrast to the effect of parasitoids, as frequency of vertebrate predation increases with gall size. This suggests that the balance between predation and parasitoid attack shapes the optimal size of D. rosae galls.	[Laszlo, Zoltan; Prazsmari, Hunor] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, R-3400 Cluj Napoca, Romania; [Solyom, Katalin] Univ Debrecen, Dept Ecol, Debrecen, Hungary; [Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, MTA DE Lendulet Behav Ecol Res Grp, Debrecen, Hungary; [Tothmeresz, Bela] Univ Debrecen, MTA DE Biodivers & Ecosyst Serv Res Grp, Debrecen, Hungary	Babes Bolyai University from Cluj; University of Debrecen; MTA-DE Biodiversity & Ecosystem Services Research Group; University of Debrecen	Laszlo, Z (corresponding author), Univ Babes Bolyai, Hungarian Dept Biol & Ecol, R-3400 Cluj Napoca, Romania.	laszlozoltan@gmail.com	Laszlo, Zoltan/F-8651-2011	Laszlo, Zoltan/0000-0001-5064-4785; Barta, Zoltan/0000-0002-7121-9865; Tothmeresz, Bela/0000-0002-4766-7668	Romanian Ministry of Education; CNCS - UEFISCDI [PN-II-RU-PD-2012-3-0065 (45/30.04.2013)]; Hungarian Research Fund [OTKA K75696];  [TA MOP 4.2.1./B-09/1/KONV-2010-0007];  [TAMOP-4.2.2/B-10/1-2010-0024]	Romanian Ministry of Education(Ministry of Education and Research - Romania); CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ; 	The work of ZL was supported by a grant of the Romanian Ministry of Education, CNCS - UEFISCDI, project number PN-II-RU-PD-2012-3-0065 (45/30.04.2013). The work of BT was supported by the TA MOP 4.2.1./B-09/1/KONV-2010-0007, and TAMOP-4.2.2/B-10/1-2010-0024 projects. ZB was supported by a Hungarian Research Fund grant (OTKA K75696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson W. G., 1997, EVOLUTIONARY ECOLOGY; Abrahamson WG, 1997, MONOGR POPUL BIOL, P26; [Anonymous], FORAGING THEORY; Askew R. R., 1961, Transactions of the Society for British Entomology, V14, P237; Bailey JK, 2003, OIKOS, V101, P127, DOI 10.1034/j.1600-0706.2003.12185.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; CONFER JL, 1985, J FIELD ORNITHOL, V56, P56; Crawley MJ, 2013, R BOOK, P557; Floyd T, 1996, ECOLOGY, V77, P1544, DOI 10.2307/2265550; Freese G, 1996, OECOLOGIA, V108, P293, DOI 10.1007/BF00334654; HAILS RS, 1992, J ANIM ECOL, V61, P567, DOI 10.2307/5612; Ito M, 2004, J FOREST RES-JPN, V9, P355, DOI 10.1007/s10310-004-0091-1; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; KATO K, 1993, RES POPUL ECOL, V35, P1, DOI 10.1007/BF02515640; Kohnen A, 2011, BIOL J LINN SOC, V102, P369, DOI 10.1111/j.1095-8312.2010.01582.x; Laszlo Z, 2006, ACTA ZOOL ACAD SCI H, V52, P373; Laszlo Z, 2013, B ENTOMOL RES, V103, P326, DOI 10.1017/S0007485312000764; Laszlo Z, 2008, ENTOMOL FENNICA, V19, P168, DOI 10.33338/ef.84432; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; MCGINLEY MA, 1989, EVOL ECOL, V3, P150, DOI 10.1007/BF02270917; Nordlander G., 1973, Entomologisk Tidskrift, V94, P148; Orrock JL, 2010, ETHOLOGY, V116, P338, DOI 10.1111/j.1439-0310.2010.01740.x; Pearson D.E., 1999, Northwestern Naturalist, V80, P26, DOI 10.2307/3536631; PRICE PW, 1986, ECOLOGY, V67, P1593, DOI 10.2307/1939090; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; SCHLICHTER L, 1978, CAN FIELD NAT, V92, P71; Schonrogge K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053959; SCHRODER D., 1967, Technical Bulletin. Commonwealth Institute of Biological Control, P93; Shealer DA, 1999, AM MIDL NAT, V142, P102, DOI 10.1674/0003-0031(1999)142[0102:FPOEGS]2.0.CO;2; STILLE B, 1984, OECOLOGIA, V63, P364, DOI 10.1007/BF00390666; STILLE B, 1985, GENETICA, V67, P145, DOI 10.1007/BF02424421; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Strong AM, 2000, OECOLOGIA, V125, P370, DOI 10.1007/s004420000467; TSCHARNTKE T, 1992, ECOLOGY, V73, P1689, DOI 10.2307/1940020; Van Hezewijk BH, 2003, ECOL ENTOMOL, V28, P593, DOI 10.1046/j.1365-2311.2003.00553.x; WEIS AE, 1992, EVOLUTION, V46, P1674, DOI [10.1111/j.1558-5646.1992.tb01161.x, 10.2307/2410023]; WEIS AE, 1994, EVOLUTION, V48, P734, DOI 10.1111/j.1558-5646.1994.tb01357.x; WEIS AE, 1983, ECOLOGY, V64, P688, DOI 10.2307/1937190	39	7	9	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99806	10.1371/journal.pone.0099806	http://dx.doi.org/10.1371/journal.pone.0099806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918448	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000113
J	Mary, N; Barasc, H; Ferchaud, S; Billon, Y; Meslier, F; Robelin, D; Calgaro, A; Loustau-Dudez, AM; Bonnet, N; Yerle, M; Acloque, H; Ducos, A; Pinton, A				Mary, Nicolas; Barasc, Harmonie; Ferchaud, Stephane; Billon, Yvon; Meslier, Frederic; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain			Meiotic Recombination Analyses of Individual Chromosomes in Male Domestic Pigs (Sus scrofa domestica)	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX LENGTH; CROSSOVER INTERFERENCE; HUMAN GENOME; LINKAGE MAP; CROSSING-OVER; HOT-SPOTS; MOUSE; MLH1; ANEUPLOIDY; FREQUENCY	For the first time in the domestic pig, meiotic recombination along the 18 porcine autosomes was directly studied by immunolocalization of MLH1 protein. In total, 7,848 synaptonemal complexes from 436 spermatocytes were analyzed, and 13,969 recombination sites were mapped. Individual chromosomes for 113 of the 436 cells (representing 2,034 synaptonemal complexes) were identified by immunostaining and fluorescence in situ hybridization (FISH). The average total length of autosomal synaptonemal complexes per cell was 190.3 mu m, with 32.0 recombination sites (crossovers), on average, per cell. The number of crossovers and the lengths of the autosomal synaptonemal complexes showed significant intra- (i.e. between cells) and inter-individual variations. The distributions of recombination sites within each chromosomal category were similar: crossovers in metacentric and submetacentric chromosomes were concentrated in the telomeric regions of the p- and q-arms, whereas two hotspots were located near the centromere and in the telomeric region of acrocentrics. Lack of MLH1 foci was mainly observed in the smaller chromosomes, particularly chromosome 18 (SSC18) and the sex chromosomes. All autosomes displayed positive interference, with a large variability between the chromosomes.	[Mary, Nicolas; Barasc, Harmonie; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Mary, Nicolas; Barasc, Harmonie; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain] Univ Toulouse INPT ENSAT, Genet Physiol & Syst Elevage UMR1388, Castanet Tolosan, France; [Mary, Nicolas; Barasc, Harmonie; Robelin, David; Calgaro, Anne; Loustau-Dudez, Anne-Marie; Bonnet, Nathalie; Yerle, Martine; Acloque, Herve; Ducos, Alain; Pinton, Alain] Univ Toulouse INPT ENVT, Genet Physiol & Syst Elevage UMR1388, Toulouse, France; [Ferchaud, Stephane; Billon, Yvon; Meslier, Frederic] UE1372 GenESI Genet Expt & Syst Innovants, Surgeres, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Mary, N (corresponding author), INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France.	n.mary@envt.fr	Barasc, Harmonie/AAS-9519-2020; MARY, Nicolas/AAT-9071-2020; Ducos, Alain/AAQ-3673-2020; Pinton, Alain/AAQ-1648-2020	Barasc, Harmonie/0000-0002-1644-4701; MARY, Nicolas/0000-0002-7304-5555; Ducos, Alain/0000-0002-2741-9579; Pinton, Alain/0000-0002-0809-7180; Acloque, Herve/0000-0003-4761-1055				Anderson LK, 1999, GENETICS, V151, P1569; Baier B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004125; Barasc H, 2014, THERIOGENOLOGY, V81, P368, DOI 10.1016/j.theriogenology.2013.10.006; Basheva EA, 2008, CHROMOSOME RES, V16, P709, DOI 10.1007/s10577-008-1221-y; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bidau CJ, 2001, HEREDITY, V87, P305, DOI 10.1046/j.1365-2540.2001.00877.x; Borodin P M, 2008, Tsitologiia, V50, P62; Borodin PM, 2009, ANIM GENET, V40, P235, DOI 10.1111/j.1365-2052.2008.01808.x; Borodin PM, 2008, GENETICS, V178, P621, DOI 10.1534/genetics.107.079665; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 2002, GENETICS, V160, P1123; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Codina-Pascual M, 2005, HUM REPROD, V20, P2133, DOI 10.1093/humrep/dei023; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; de Massy B, 2013, ANNU REV GENET, V47, P563, DOI 10.1146/annurev-genet-110711-155423; Drouaud J, 2007, PLOS GENET, V3, P1096, DOI 10.1371/journal.pgen.0030106; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Ducos A, 1998, J HERED, V89, P136, DOI 10.1093/jhered/89.2.136; EGOZCUE J, 1983, HUM GENET, V65, P185, DOI 10.1007/BF00286660; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Ford CE, 1980, P 1 INT C STAND BAND; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Garcia-Cruz R, 2011, CHROMOSOMA; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hall H, 2006, CURR OPIN GENET DEV, V16, P323, DOI 10.1016/j.gde.2006.04.011; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HULTEN M, 1974, HEREDITAS, V76, P55; Hulten MA, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-10; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lian J, 2008, HUM MOL GENET, V17, P2583, DOI 10.1093/hmg/ddn158; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Massip K, 2010, CHROMOSOME RES, V18, P925, DOI 10.1007/s10577-010-9162-7; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mikawa S, 1999, ANIM GENET, V30, P407, DOI 10.1046/j.1365-2052.1999.00493.x; Mompart F, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-30; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Pan ZZ, 2012, AM J MED GENET A, V158A, P581, DOI 10.1002/ajmg.a.35222; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Pinton A, 2011, CYTOGENET GENOME RES, V133, P202, DOI 10.1159/000321794; Pita M, 2008, J ZOOL SYST EVOL RES, V46, P186, DOI 10.1111/j.1439-0469.2008.00466.x; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Rogel-Gaillard C, 1997, CYTOGENET CELL GENET, V79, P79, DOI 10.1159/000134687; SCHWARZACHER T, 1984, CHROMOSOMA, V91, P12, DOI 10.1007/BF00286480; Shi QH, 2002, AM J HUM GENET, V71, P254, DOI 10.1086/341559; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Sun F, 2006, HUM REPROD, V21, P2335, DOI 10.1093/humrep/del190; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tempest HG, 2011, SYST BIOL REPROD MED, V57, P93, DOI 10.3109/19396368.2010.504879; Templado C, 2013, MOL HUM REPROD, V19, P634, DOI 10.1093/molehr/gat039; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Villagomez DAF, 2009, CYTOGENET GENOME RES, V126, P110, DOI 10.1159/000245911; VILLAGOMEZ DAF, 1993, HEREDITAS, V118, P87, DOI 10.1111/j.1601-5223.1993.t01-3-00087.x; Vingborg RKK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-134; Vozdova M, 2013, CYTOGENET GENOME RES, V140, P36, DOI 10.1159/000350444; Vranis NM, 2010, GENES-BASEL, V1, P505, DOI 10.3390/genes1030505; Wessa P., 2013, FREE STAT SOFTWARE; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831; Yang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019255	73	23	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99123	10.1371/journal.pone.0099123	http://dx.doi.org/10.1371/journal.pone.0099123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919066	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000051
J	Portnoy, DS; Hollenbeck, CM; Vidal, RR; Gold, JR				Portnoy, David S.; Hollenbeck, Christopher M.; Vidal, R. Rodrigo; Gold, John R.			A Comparison of Neutral and Immune Genetic Variation in Atlantic Salmon, Salmo salar L. in Chilean Aquaculture Facilities	PLOS ONE			English	Article							MICROSATELLITE MARKERS; WILD; POPULATION; ANEMIA; LOCI; DISEASE; VARIABILITY; SELECTION; STRAINS; TRAIT	Genetic diversity was assessed in samples of cultured Atlantic salmon, Salmo salar L., obtained from facilities in Chile between 2005 and 2010, a period of time during which the infectious pathogens Infectious Salmon Anemia (ISA) virus, Caligus rogercresseyi (sea lice), and Piscirickettsia salmonis (salmon rickettsial syndrome) were common. Two panels of microsatellite markers were utilized: one with microsatellites with no known gene associations (neutral) and one featuring microsatellites linked to putative immune-related genes (immune-related). Allelic richness and gene diversity across samples were significantly greater in neutral loci as compared to immune-related loci. Both diversity measures were homogeneous among samples for immune-related loci and heterogeneous among samples for neutral loci. Immune-related loci were identified as F-ST outliers in pairwise comparisons of samples at a 10-fold higher frequency than neutral loci. These results indicate that neutral and immune-related portions of the Atlantic salmon genome may have differed in response to the gauntlet of pathogens and that monitoring of specific, well characterized immune-related loci as well as neutral loci in cultured species could be useful when disease control and prevention is a goal.	[Portnoy, David S.; Gold, John R.] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX 78412 USA; [Portnoy, David S.; Hollenbeck, Christopher M.; Gold, John R.] Texas A&M Univ, Marine Genom Lab, Harte Res Inst, Corpus Christi, TX USA; [Vidal, R. Rodrigo] Univ Santiago Chile, Dept Biol, Lab Mol Ecol Genom & Evolutionary Studies, Santiago, Chile	Texas A&M University System; Texas A&M University System; Universidad de Santiago de Chile	Portnoy, DS (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX 78412 USA.	david.portnoy@tamucc.edu			Departamento de Investigaciones Cientificas y Tecnologicas (DICYT-USACH); CORFO-INNOVA Chile [12IDL2-16192]; Visiting Scholar Program of the Fulbright Program in Chile; Texas AgriLife [H-6703]	Departamento de Investigaciones Cientificas y Tecnologicas (DICYT-USACH); CORFO-INNOVA Chile; Visiting Scholar Program of the Fulbright Program in Chile; Texas AgriLife	Work was supported in part by Departamento de Investigaciones Cientificas y Tecnologicas (DICYT-USACH), CORFO-INNOVA Chile 12IDL2-16192, in part by the Visiting Scholar Program of the Fulbright Program in Chile (for JRG), and in part by Texas AgriLife under Project H-6703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1986, P57; Alvial A., 2012, RECOVERY CHILEAN SAL; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Asche F, 2009, MAR RESOUR ECON, V24, P405, DOI 10.1086/mre.24.4.42629664; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bruno DW, 2004, AQUACULTURE, V235, P13, DOI 10.1016/j.aquaculture.2003.11.035; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Consuegra S, 2007, EVOL ECOL, V21, P229, DOI 10.1007/s10682-006-9001-7; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; CVITANICH JD, 1991, J FISH DIS, V14, P121, DOI 10.1111/j.1365-2761.1991.tb00584.x; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Diaz-Rosales P, 2012, MAR BIOTECHNOL, V14, P515, DOI 10.1007/s10126-012-9465-0; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DOYLE RW, 1983, AQUACULTURE, V33, P167, DOI 10.1016/0044-8486(83)90398-8; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Finnegan AK, 2013, HEREDITY, V111, P34, DOI 10.1038/hdy.2013.17; Fraser DJ, 2010, ECOL APPL, V20, P935, DOI 10.1890/09-0694.1; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Guo FC, 2009, VET PARASITOL, V163, P207, DOI 10.1016/j.vetpar.2009.06.016; Halwart M., 2007, CAGE AQUACULTURE REG, V498, P42; Hamilton-West C, 2012, PREV VET MED, V104, P341, DOI 10.1016/j.prevetmed.2011.12.002; Karlsson S, 2008, MOL ECOL RESOUR, V8, P393, DOI 10.1111/j.1471-8286.2007.01969.x; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Kozak M, 2010, COMMUN BIOMET CROP S, V5, P69; Le Corre V, 2003, GENETICS, V164, P1205; LEWONTIN RC, 1973, GENETICS, V74, P175; Li JY, 2011, MAR BIOTECHNOL, V13, P232, DOI 10.1007/s10126-010-9284-0; Li Q, 2004, AQUACULTURE, V235, P207, DOI 10.1016/j.aquaculture.2003.12.018; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; MCCONNELL SK, 1995, CAN J FISH AQUAT SCI, V52, P1863, DOI 10.1139/f95-779; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Moen T, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-53; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; NYLUND A, 1994, DIS AQUAT ORGAN, V19, P95, DOI 10.3354/dao019095; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Paterson S, 2004, MOL ECOL NOTES, V4, P160, DOI 10.1111/j.1471-8286.2004.00598.x; R Core Team, 2018, R LANG ENV STAT COMP; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rengmark AH, 2006, AQUACULTURE, V253, P229, DOI 10.1016/j.aquaculture.2005.09.022; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SLETTAN A, 1995, ANIM GENET, V26, P281, DOI 10.1111/j.1365-2052.1995.tb03262.x; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Tonteri A, 2008, MOL ECOL RESOUR, V8, P1486, DOI 10.1111/j.1755-0998.2008.02317.x; Tonteri A, 2010, MOL ECOL, V19, P1273, DOI 10.1111/j.1365-294X.2010.04573.x; Vasemagi A, 2005, MOL ECOL NOTES, V5, P282, DOI 10.1111/j.1471-8286.2005.00902.x; Wren JD, 2000, AM J HUM GENET, V67, P345, DOI 10.1086/303013; ZACHARIAE COC, 1993, ACTA DERM-VENEREOL, P1	57	2	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99358	10.1371/journal.pone.0099358	http://dx.doi.org/10.1371/journal.pone.0099358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918941	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000080
J	Chen, XL; Yang, K; Zhang, WH; Chen, XZ; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG; Hu, JK				Chen, Xiao-Long; Yang, Kun; Zhang, Wei-Han; Chen, Xin-Zu; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang; Hu, Jian-Kun			Metastasis, Risk Factors and Prognostic Significance of Splenic Hilar Lymph Nodes in Gastric Adenocarcinoma	PLOS ONE			English	Article							SPLEEN PRESERVATION; TOTAL GASTRECTOMY; CANCER; SPLENECTOMY; CARCINOMA; CHEMOTHERAPY; DISSECTION; SURVIVAL; IMPACT	Background: The metastatic rate and risk factors of splenic hilar (No. 10) lymph nodes (LNs) in gastric adenocarcinoma were still variable and uncertain, and the prognostic significance of No. 10 LNs was also controversial. The aim of this retrospective study was to analyze the metastatic rate, risk factors and prognostic significance of No. 10 LNs in gastric adenocarcinoma. Methods: From August 2007 to December 2011, 205 patients who were diagnosed with primary gastric adenocarcinoma and underwent total or proximal gastrectomy plus No. 10 LNs dissection in West China Hospital were enrolled. Clinicopathological features and survival outcomes were retrospectively analyzed. Results: Mean numbers of harvested LNs and metastatic LNs were 34.8 +/- 12.6 (15-73) and 8.7 +/- 10.8 (0-67), respectively. The proportion of cases with positive No. 10 LNs was 8.8% (18/205). In all 204 dissected No. 10 LNs, 47 LNs (23.0%) were metastatic. In 52.2% (107/205) patients, the dissected splenic hilar tissues were histologically determined as only fat tissues but without LNs structure. Histological evidence of LNs structure was found in 98 (47.8%) patients with 18.4% (18/98) metastatic No. 10 LNs. In multivariate logistic regression analysis, metastasis of No. 10 LNs was significantly correlated with No. 4sa LNs (p = 0.010) and pN stage (p = 0.012). Regarding survival analysis, 199 (97.1%) patients were followed up (0.6-74.8 months). In all patients with R0 resection, metastatic No. 10 LNs caused significantly worse prognosis both in Kaplan-Meier (p = 0.006) and Cox regression analysis (p = 0.031). Conclusions: Although the metastatic rate of No. 10 LNs was 8.8%, dissection of No. 10 LNs might be meaningful due to the poor prognosis of positive cases. And attentions should be also paid to its correlated factors including pN stage and No. 4sa LNs.	[Chen, Xiao-Long; Yang, Kun; Zhang, Wei-Han; Chen, Xin-Zu; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang; Hu, Jian-Kun] Sichuan Univ, West China Hosp, Dept Gastrointestinal, Chengdu, Sicuhan, Peoples R China	Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal, Chengdu, Sicuhan, Peoples R China.	hujkwch@126.com	Chen, Xin-Zu/K-2988-2019; Chen, Xin-Zu/G-6579-2014; Yang, Kun/A-4293-2010; Zhang, Wei-Han/AAS-3536-2021	, Zongguang/0000-0002-7616-1199				Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Aoyagi K, 2010, WORLD J HEPATOL, V2, P81, DOI 10.4254/wjh.v2.i2.81; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chen XZ, 2008, WORLD J GASTROENTERO, V14, P2715, DOI 10.3748/wjg.14.2715; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chikara K, 2001, HEPATO-GASTROENTEROL, V48, P908; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Degiuli M, 1997, EUR J SURG ONCOL, V23, P310, DOI 10.1016/S0748-7983(97)90696-X; Fatouros M, 2005, ANTICANCER RES, V25, P3023; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Ikeguchi M, 2004, AM SURGEON, V70, P645; Ishikawa S, 2009, WORLD J SURG, V33, P1687, DOI 10.1007/s00268-009-0083-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kunisaki C, 2007, J GASTROINTEST SURG, V11, P1039, DOI 10.1007/s11605-007-0186-z; MAEHARA Y, 1991, CANCER, V67, P3006, DOI 10.1002/1097-0142(19910615)67:12<3006::AID-CNCR2820671213>3.0.CO;2-V; Monig SP, 2001, J SURG ONCOL, V76, P89; Nashimoto A, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/301530; OKAJIMA K, 1995, WORLD J SURG, V19, P537, DOI 10.1007/BF00294715; Okinaga K, 2006, J EXP CLIN CANC RES, V25, P339; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Shin SH, 2009, ANN SURG ONCOL, V16, P1304, DOI 10.1245/s10434-009-0389-5; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Wen L, 2012, HEPATO-GASTROENTEROL, V59, P633, DOI 10.5754/hge11834; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Zhang Cheng-hai, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P589; Zhu GL, 2012, J SURG ONCOL, V105, P786, DOI 10.1002/jso.22149	30	12	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99650	10.1371/journal.pone.0099650	http://dx.doi.org/10.1371/journal.pone.0099650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915065	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700123
J	Wang, J; Zhou, M; Wang, XB; Yang, XL; Wang, MH; Zhang, CX; Zhou, SZ; Tang, N				Wang, Ji; Zhou, Min; Wang, Xiaobin; Yang, Xiaoling; Wang, Maohua; Zhang, Chunxiang; Zhou, Shuzhi; Tang, Ni			Impact of Ketamine on Learning and Memory Function, Neuronal Apoptosis and Its Potential Association with miR-214 and PTEN in Adolescent Rats	PLOS ONE			English	Article							ANESTHESIA; NEURODEGENERATION; NEUROTOXICITY; ANTAGONIST; PROPOFOL; CANCER; MODEL; PAIN; AGE	Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is used as a general pediatric anesthetic and antidepressive drug. Recent studies suggest that ketamine enhances neuronal apoptosis in developing rats. The goal of this study is to explore whether ketamine could result in learning and memory impairment and neurodegeneration in adolescent rats, and if so, whether the effects of ketamine are associated with miR-214 and PTEN expression. Fifty-day-old SD rats were randomly divided into three groups receiving ketamine at 30, or 80 mg/kg, i.p. or saline for seven consecutive days. Twenty-four hours after the last treatment, learning and memory function were tested by the Morris water maze. The rats were then decapitated, and the brains were isolated for detection of neuronal apoptosis and protein PTEN expression by TUNEL and immunohistochemistry respectively. Expression levels of the miR-214 and PTEN in the hippocampus were measured by qRT-PCR and western blot analysis respectively. Ketamine administered to the adolescent rats at a dose of 80 mg/kg rather than the lower dose of 30 mg/kg caused learning and memory impairment, increased the number of apoptotic cells in the hippocampal CA(1) region, cerebral cortex and subcortical region, decreased the miR-214 levels and increased PTEN protein expression in hippocampus. The results suggest that ketamine at a dose of 80 mg/kg in the adolescent rats is able to induce the learning and memory impairment and neurodegeneration, in which the down-regulation of miR-214 and high expression of PTEN protein may be involved.	[Wang, Ji; Zhou, Min; Wang, Xiaobin; Yang, Xiaoling; Wang, Maohua; Zhou, Shuzhi; Tang, Ni] Luzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Luzhou, Sichuan, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA	Southwest Medical University; Rush University	Wang, XB (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Luzhou, Sichuan, Peoples R China.	wangxiaobin67@163.com	Wang, Maohua/GNW-6319-2022	Wang, Maohua/0000-0003-2252-2291	National Natural Science Foundation of China [8127147]; International Cooperation, Department of Science & Technology of Sichuan Province [2011HH0031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation, Department of Science & Technology of Sichuan Province	This project was supported by the Projects of the National Natural Science Foundation of China (Grant No. 8127147) and International Cooperation, Department of Science & Technology of Sichuan Province (Grant No. 2011HH0031) to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Becker A, 2004, PROG NEURO-PSYCHOPH, V28, P1267, DOI 10.1016/j.pnpbp.2004.06.019; Campbell LL, 2011, TOXICOLOGY, V283, P1, DOI 10.1016/j.tox.2011.01.014; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; EVANS AM, 1986, BIOL REPROD, V34, P322, DOI 10.1095/biolreprod34.2.322; Gama CS, 2012, SCHIZOPHR RES, V141, P162, DOI 10.1016/j.schres.2012.08.002; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Gomes LMRS, 2011, PAIN PHYSICIAN, V14, P83; Hayashi H, 2002, PAEDIATR ANAESTH, V12, P770, DOI 10.1046/j.1460-9592.2002.00883.x; Huang LN, 2012, BRAIN RES, V1476, P164, DOI 10.1016/j.brainres.2012.07.059; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Kitagishi Y, 2013, INT J MOL MED, V31, P511, DOI 10.3892/ijmm.2013.1235; Kohrs R, 1998, ANESTH ANALG, V87, P1186, DOI 10.1097/00000539-199811000-00039; Kos T, 2006, EUR NEUROPSYCHOPHARM, V16, P297, DOI 10.1016/j.euroneuro.2005.10.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2013, INT J MOL MED, V32, P439, DOI 10.3892/ijmm.2013.1411; Lin C, 2005, PEDIATR ANESTH, V15, P91, DOI 10.1111/j.1460-9592.2005.01475.x; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Schmid RL, 1999, PAIN, V82, P111, DOI 10.1016/S0304-3959(99)00044-5; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Shi YJ, 2012, J CELL SCI, V125, P4687, DOI 10.1242/jcs.093765; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Straiko MMW, 2009, ANESTHESIOLOGY, V110, P862, DOI 10.1097/ALN.0b013e31819b5eab; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Vutskits Laszlo, 2007, Ideggyogy Sz, V60, P109; Wang J, 2011, ANESTHESIOLOGY, V115, P812, DOI 10.1097/ALN.0b013e31822f16ae; Wang XB, 2012, J ECT, V28, P128, DOI 10.1097/YCT.0b013e31824d1d02; Wang XB, 2011, PSYCHIAT RES, V185, P248, DOI 10.1016/j.psychres.2010.04.046; WATERMAN AE, 1978, BRIT J ANAESTH, V50, P885, DOI 10.1093/bja/50.9.885; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086149; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010; Zou XJ, 2009, TOXICOL SCI, V108, P149, DOI 10.1093/toxsci/kfn270	39	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99855	10.1371/journal.pone.0099855	http://dx.doi.org/10.1371/journal.pone.0099855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914689	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700138
J	Wang, XJ; Jin, X; Dun, BQ; Kong, N; Jia, SR; Tang, QL; Wang, ZX				Wang, Xu-Jing; Jin, Xi; Dun, Bao-Qing; Kong, Ning; Jia, Shi-Rong; Tang, Qiao-Ling; Wang, Zhi-Xing			Gene-Splitting Technology: A Novel Approach for the Containment of Transgene Flow in Nicotiana tabacum	PLOS ONE			English	Article							INTEIN; CHLOROPLAST; STRATEGIES; RESISTANCE; PLASTIDS; SUBUNIT	The potential impact of transgene escape on the environment and food safety is a major concern to the scientists and public. This work aimed to assess the effect of intein-mediated gene splitting on containment of transgene flow. Two fusion genes, EPSPSn-In and Ic-EPSPSc, were constructed and integrated into N. tabacum, using Agrobacterium tumefaciens-mediated transformation. EPSPSn-In encodes the first 295 aa of the herbicide resistance gene 5-enolpyruvyl shikimate-3-phosphate synthase (EPSPS) fused with the first 123 aa of the Ssp DnaE intein (In), whereas Ic-EPSPSc encodes the 36 C-terminal aa of the Ssp DnaE intein (Ic) fused to the rest of EPSPS C terminus peptide sequences. Both EPSPSn-In and Ic-EPSPSc constructs were introduced into the same N. tabacum genome by genetic crossing. Hybrids displayed resistance to the herbicide N-(phosphonomethyl)-glycine (glyphosate). Western blot analysis of protein extracts from hybrid plants identified full-length EPSPS. Furthermore, all hybrid seeds germinated and grew normally on glyphosate selective medium. The 6-8 leaf hybrid plants showed tolerance of 2000 ppm glyphosate in field spraying. These results indicated that functional EPSPS protein was reassembled in vivo by intein-mediated trans-splicing in 100% of plants. In order to evaluate the effect of the gene splitting technique for containment of transgene flow, backcrossing experiments were carried out between hybrids, in which the foreign genes EPSPSn-In and Ic-EPSPSc were inserted into different chromosomes, and non-transgenic plants NC89. Among the 2812 backcrossing progeny, about 25% (664 plantlets) displayed glyphosate resistance. These data indicated that transgene flow could be reduced by 75%. Overall, our findings provide a new and highly effective approach for biological containment of transgene flow.	[Wang, Xu-Jing; Jin, Xi; Kong, Ning; Jia, Shi-Rong; Tang, Qiao-Ling; Wang, Zhi-Xing] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Dun, Bao-Qing] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wang, ZX (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	wangcotton@126.com	Jia, Shirong/L-8788-2019		Major Project of China on New Varieties of GMO Cultivation [2013ZX08010-003]; National Natural Science Foundation of China [31100408]	Major Project of China on New Varieties of GMO Cultivation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Project of China on New Varieties of GMO Cultivation (2013ZX08010-003) and the National Natural Science Foundation of China (31100408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad H, 2005, PLANTA, V222, P372, DOI 10.1007/s00425-005-1540-6; Benitez EP, 2010, CROP SCI, V50, P185, DOI 10.2135/cropsci2009.02.0108; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; Chin HG, 2003, P NATL ACAD SCI USA, V100, P4510, DOI 10.1073/pnas.0736538100; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1272, DOI 10.1104/pp.107.106062; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Elleuche S, 2010, APPL MICROBIOL BIOT, V87, P479, DOI 10.1007/s00253-010-2628-x; Gidoni D, 2008, IN VITRO CELL DEV-PL, V44, P457, DOI 10.1007/s11627-008-9140-3; Gils M, 2012, METHODS MOL BIOL, V847, P123, DOI 10.1007/978-1-61779-558-9_11; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Huesken Alexandra, 2010, Environmental Biosafety Research, V9, P67, DOI 10.1051/ebr/2010009; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; James C, 2013, CHINA BIOTECH, V33, P1; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kempken F, 2010, BIOTECH AGR FOREST, V64, P253, DOI 10.1007/978-3-642-02391-0_14; Khan MS, 2005, TRENDS BIOTECHNOL, V23, P217, DOI 10.1016/j.tibtech.2005.03.006; Leflon M, 2010, PLANT BREEDING, V129, P13, DOI 10.1111/j.1439-0523.2009.01645.x; Moon HS, 2010, TRENDS BIOTECHNOL, V28, P3, DOI 10.1016/j.tibtech.2009.09.008; Munsch M, 2008, MAYDICA, V53, P261; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Rieben S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029730; Ruf S, 2007, P NATL ACAD SCI USA, V104, P6998, DOI 10.1073/pnas.0700008104; Svab Z, 2007, P NATL ACAD SCI USA, V104, P7003, DOI 10.1073/pnas.0700063104; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Yang JJ, 2003, P NATL ACAD SCI USA, V100, P3513, DOI 10.1073/pnas.0635899100; Yoshida H, 2007, PLANT BIOTECHNOL J, V5, P835, DOI 10.1111/j.1467-7652.2007.00291.x; [朱玉 Zhu Yu], 2003, [分子植物育种, Molecular Plant Breeding], V1, P435	29	7	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99651	10.1371/journal.pone.0099651	http://dx.doi.org/10.1371/journal.pone.0099651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915192	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700124
J	Panngom, K; Lee, SH; Park, DH; Sim, GB; Kim, YH; Uhm, HS; Park, G; Choi, EH				Panngom, Kamonporn; Lee, Sang Hark; Park, Dae Hoon; Sim, Geon Bo; Kim, Yong Hee; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha			Non-Thermal Plasma Treatment Diminishes Fungal Viability and Up-Regulates Resistance Genes in a Plant Host	PLOS ONE			English	Article							PATHOGENESIS-RELATED GENE; PROGRAMMED CELL-DEATH; NITRIC-OXIDE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; NADPH OXIDASES; APOPTOSIS; TOMATO; GROWTH; WILT	Reactive oxygen and nitrogen species can have either harmful or beneficial effects on biological systems depending on the dose administered and the species of organism exposed, suggesting that application of reactive species can possibly produce contradictory effects in disease control, pathogen inactivation and activation of host resistance. A novel technology known as atmospheric-pressure non-thermal plasma represents a means of generating various reactive species that adversely affect pathogens (inactivation) while simultaneously up-regulating host defense genes. The anti-microbial efficacy of this technology was tested on the plant fungal pathogen Fusarium oxysporum f.sp. lycopersici and its susceptible host plant species Solanum lycopercicum. Germination of fungal spores suspended in saline was decreased over time after exposed to argon (Ar) plasma for 10 min. Although the majority of treated spores exhibited necrotic death, apoptosis was also observed along with the up-regulation of apoptosis related genes. Increases in the levels of peroxynitrite and nitrite in saline following plasma treatment may have been responsible for the observed spore death. In addition, increased transcription of pathogenesis related (PR) genes was observed in the roots of the susceptible tomato cultivar (S. lycopercicum) after exposure to the same Ar plasma dose used in fungal inactivation. These data suggest that atmospheric-pressure non-thermal plasma can be efficiently used to control plant fungal diseases by inactivating fungal pathogens and up-regulating mechanisms of host resistance.	[Panngom, Kamonporn; Sim, Geon Bo; Kim, Yong Hee; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea; [Lee, Sang Hark] Kwangwoon Univ, Plasma Display Panel Res Ctr, Seoul, South Korea; [Panngom, Kamonporn; Sim, Geon Bo; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Dept Plasma Biosci & Display, Seoul, South Korea; [Park, Dae Hoon; Uhm, Han Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Dept Elect & Biol Phys, Seoul, South Korea	Kwangwoon University; Kwangwoon University; Kwangwoon University; Kwangwoon University	Park, G (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea.	gyungp@kw.ac.kr; ehchoi@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022; Panngom, Kamonporn/HHN-3668-2022	Choi, Eun Ha/0000-0001-5385-1878; Park, Gyungsoon/0000-0003-1592-3847	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2010-0027963, NRF-2013R1A1A3011245]; Rural Development Administration, Republic of Korea [PJ009891]	National Research Foundation of Korea (NRF) - Korean government (MSIP)(National Research Foundation of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2010-0027963, NRF-2013R1A1A3011245) and also by the Rural Development Administration, Republic of Korea (PJ009891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Baidya S, 2011, APPL ENVIRON MICROB, V77, P5524, DOI 10.1128/AEM.00638-11; Basaran P, 2008, FOOD MICROBIOL, V25, P626, DOI 10.1016/j.fm.2007.12.005; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Filaire E, 2012, JOINT BONE SPINE, V79, P341, DOI 10.1016/j.jbspin.2012.03.007; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Ianoul A, 2002, ANAL CHEM, V74, P1458, DOI 10.1021/ac010863q; Ito S, 2007, FEBS LETT, V581, P3217, DOI 10.1016/j.febslet.2007.06.010; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Kavroulakis N, 2006, ANN BOT-LONDON, V98, P555, DOI 10.1093/aob/mcl149; Kayano Y, 2013, FUNGAL GENET BIOL, V56, P87, DOI 10.1016/j.fgb.2013.05.001; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Larkin RP, 1998, PLANT DIS, V82, P1022, DOI 10.1094/PDIS.1998.82.9.1022; Li D, 2012, AM J MED SCI, V344, P486, DOI 10.1097/MAJ.0b013e3182579dc6; Liu P, 2010, MYCOLOGIA, V102, P311, DOI 10.3852/09-176; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nejad P, 2000, BIOL CONTROL, V18, P208, DOI 10.1006/bcon.2000.0837; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Oehmigen K, 2011, PLASMA PROCESS POLYM, V8, P904, DOI 10.1002/ppap.201000099; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Papapostolou I, 2010, FUNGAL BIOL-UK, V114, P387, DOI 10.1016/j.funbio.2010.01.010; Park G, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3684632; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Rieger L, 2004, WATER SCI TECHNOL, V50, P143, DOI 10.2166/wst.2004.0682; Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231; Schlicht M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00351; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Shi M, 2012, MICROBIOL-SGM, V158, P166, DOI 10.1099/mic.0.052670-0; Taheri P., 2012, J BOT, DOI [10.1155/2012/137037, DOI 10.1155/2012/137037]; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010; Weller R, 2001, J APPL MICROBIOL, V90, P648, DOI 10.1046/j.1365-2672.2001.01291.x; Won DongChan, 2013, Korean Journal of Breeding Science, V45, P153, DOI 10.9787/KJBS.2013.45.2.153	53	76	78	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99300	10.1371/journal.pone.0099300	http://dx.doi.org/10.1371/journal.pone.0099300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911947	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600068
J	Vindstad, OPL; Schultze, S; Jepsen, JU; Biuw, M; Kapari, L; Sverdrup-Thygeson, A; Ims, RA				Vindstad, Ole Petter Laksforsmo; Schultze, Sabrina; Jepsen, Jane Uhd; Biuw, Martin; Kapari, Lauri; Sverdrup-Thygeson, Anne; Ims, Rolf Anker			Numerical Responses of Saproxylic Beetles to Rapid Increases in Dead Wood Availability following Geometrid Moth Outbreaks in Sub-Arctic Mountain Birch Forest	PLOS ONE			English	Article							BOREAL FORESTS; NATIONAL-PARK; CONSERVATION; COLEOPTERA; SPRUCE; RETENTION; DYNAMICS; LEPIDOPTERA; RESOURCES; DIVERSITY	Saproxylic insects play an important part in decomposing dead wood in healthy forest ecosystems, but little is known about their role in the aftermath of large-scale forest mortality caused by pest insect outbreaks. We used window traps to study short-term changes in the abundance and community structure of saproxylic beetles following extensive mortality of mountain birch in sub-arctic northern Norway caused by an outbreak of geometrid moths. Three to five years after the outbreak, the proportion of obligate saproxylic individuals in the beetle community was roughly 10% higher in forest damaged by the outbreak than in undamaged forest. This was mainly due to two early-successional saproxylic beetle species. Facultative saproxylic beetles showed no consistent differences between damaged and undamaged forest. These findings would suggest a weak numerical response of the saproxylic beetle community to the dead wood left by the outbreak. We suggest that species-specific preferences for certain wood decay stages may limit the number of saproxylic species that respond numerically to an outbreak at a particular time, and that increases in responding species may be constrained by limitations to the amount of dead wood that can be exploited within a given timeframe (i.e. satiation effects). Low diversity of beetle species or slow development of larvae in our cold sub-arctic study region may also limit numerical responses. Our study suggests that saproxylic beetles, owing to weak numerical responses, may so far have played a minor role in decomposing the vast quantities of dead wood left by the moth outbreak.	[Vindstad, Ole Petter Laksforsmo; Kapari, Lauri; Ims, Rolf Anker] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Schultze, Sabrina] Univ Luneburg, Dept Ecol, D-21335 Luneburg, Germany; [Jepsen, Jane Uhd; Biuw, Martin] Norwegian Inst Nat Res, Fram Ctr, Tromso, Norway; [Sverdrup-Thygeson, Anne] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway	UiT The Arctic University of Tromso; Leuphana University Luneburg; Norwegian Institute Nature Research; Norwegian University of Life Sciences	Vindstad, OPL (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	ole.p.vindstad@uit.no	Vindstad, Ole Petter laksforsmo/P-5821-2019; Sverdrup-Thygeson, Anne/I-2902-2017; Sverdrup-Thygeson, Anne/AAW-7779-2021; Biuw, Martin/AAF-9895-2021	Vindstad, Ole Petter laksforsmo/0000-0003-2483-2568; Sverdrup-Thygeson, Anne/0000-0002-3122-2250; Biuw, Martin/0000-0001-8051-3399; Jepsen, Jane Uhd/0000-0003-1517-1569	University of Tromso; research council of Norway; Norwegian Institute of Nature Research; Nordic Centre of Excellence - How to preserve the tundra under a warming climate (NCoE-Tundra) - Norden Top-Level Initiative "Effect studies and adaptation to climate change''	University of Tromso; research council of Norway(Research Council of Norway); Norwegian Institute of Nature Research; Nordic Centre of Excellence - How to preserve the tundra under a warming climate (NCoE-Tundra) - Norden Top-Level Initiative "Effect studies and adaptation to climate change''	This study was funded by the University of Tromso and the research council of Norway, with additional support from the Norwegian Institute of Nature Research and the Nordic Centre of Excellence - How to preserve the tundra under a warming climate (NCoE-Tundra) funded by the Norden Top-Level Initiative "Effect studies and adaptation to climate change''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa P., 2012, INSECT OUTBREAKS REV; Bell JL, 1997, AM MIDL NAT, V137, P239, DOI 10.2307/2426843; Bergman KO, 2012, FOREST ECOL MANAG, V265, P133, DOI 10.1016/j.foreco.2011.10.030; Bohme J, 2005, KAFAR MITTELEUROPAS; Bouget C, 2004, BIOL CONSERV, V118, P281, DOI 10.1016/j.biocon.2003.09.009; Boulanger Y, 2007, ENVIRON ENTOMOL, V36, P128, DOI 10.1603/0046-225X-36.1.128; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Buckland P.I., 2006, IGBP PAGES WORLD DAT; Bylund Helena, 1999, Ecological Bulletins, V47, P54; Dahlberg A, 2004, VEDLEVANDE ARTERS KR; Drever MC, 2009, ECOLOGY, V90, P1095, DOI 10.1890/08-0575.1; Ehnstr?m B, 2002, INSEKTSGNAG BARK; Eschtruth AK, 2006, CAN J FOREST RES, V36, P1435, DOI 10.1139/X06-050; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Gibb H, 2006, ECOGRAPHY, V29, P191, DOI 10.1111/j.2006.0906-7590.04372.x; Greenacre M., 2010, BIPLOTS PRACTICE; Grimbacher PS, 2009, OECOLOGIA, V161, P591, DOI 10.1007/s00442-009-1399-5; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Hammond HEJ, 2004, CAN J FOREST RES, V34, P1, DOI 10.1139/X03-192; Haney JC, 1999, FOREST ECOL MANAG, V120, P203, DOI 10.1016/S0378-1127(98)00545-3; Hogstad O, 2005, IBIS, V147, P77, DOI [10.1111/j.1474-919X.2004.00338.x, 10.1111/j.1474-919x.2004.00338]; Hyvurinen, 2006, THESIS U JOENSUU, V2006, P1; Jepsen JU, 2013, ECOSYSTEMS, V16, P561, DOI 10.1007/s10021-012-9629-9; Jepsen JU, 2009, P ROY SOC B-BIOL SCI, V276, P4119, DOI 10.1098/rspb.2009.1148; Jogeir N., 2012, BIODIVERSITY DEAD WO; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Kaila L, 1997, BIODIVERS CONSERV, V6, P1, DOI 10.1023/A:1018399401248; Kalas J. A., 2010, NORWEGIAN RED LIST S; Karlsen S, 2013, OECOLOGIA, P1; Kaukonen M, 2013, ECOLOGY, V94, P267, DOI 10.1890/12-0917.1; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lehnert LW, 2013, J NAT CONSERV, V21, P97, DOI 10.1016/j.jnc.2012.11.003; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Lindhe A, 2005, BIODIVERS CONSERV, V14, P3033, DOI 10.1007/s10531-004-0314-y; Makinen H, 2006, ECOL APPL, V16, P1865, DOI 10.1890/1051-0761(2006)016[1865:PTDOSP]2.0.CO;2; Marcello GJ, 2008, J ANIM ECOL, V77, P41, DOI 10.1111/j.1365-2656.2007.01310.x; Martikainen P, 2004, BIOL CONSERV, V120, P171, DOI 10.1016/j.biocon.2004.02.009; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; Menke N, 2006, UNTERSUCHUNGEN STRUK; Muller J, 2008, BIODIVERS CONSERV, V17, P2979, DOI 10.1007/s10531-008-9409-1; Muller J, 2010, BIOL CONSERV, V143, P2559, DOI 10.1016/j.biocon.2010.06.024; Muller MM, 2002, FOREST ECOL MANAG, V166, P165, DOI 10.1016/S0378-1127(01)00671-5; MUONA J, 1994, ANN ZOOL FENN, V31, P109; Price P.W., 2011, INSECT ECOLOGY BEHAV; Reeve JD, 1997, OECOLOGIA, V112, P48, DOI 10.1007/s004420050282; Ruohomaki K, 2000, POPUL ECOL, V42, P211, DOI 10.1007/PL00012000; Saint-Germain M, 2004, ENVIRON ENTOMOL, V33, P1703, DOI 10.1603/0046-225X-33.6.1703; Schowalter T. D., 1992, TROPICAL ECOSYSTEMS, P373; Speight M.C., 1989, SAPROXYLIC INVERTEBR; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; Sverdrup-Thygeson A, 2014, BIODIVERS CONSERV, V23, P513, DOI 10.1007/s10531-014-0628-3; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Tenow O., 1972, Zoologiska Bidr Upps, V2, P1; Ulyshen MD, 2013, INSECT CONSERV DIVER, V6, P393, DOI 10.1111/j.1752-4598.2012.00220.x; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Vandegrift KJ, 2009, J ANIM ECOL, V78, P202, DOI 10.1111/j.1365-2656.2008.01456.x; Wermelinger Beat, 2002, Forest Snow and Landscape Research, V77, P133; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2012, ECOLOGICAL CONSEQUEN, P197; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; ZHONG H, 1989, CAN J FOREST RES, V19, P943, DOI 10.1139/x89-145	66	9	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99624	10.1371/journal.pone.0099624	http://dx.doi.org/10.1371/journal.pone.0099624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911056	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000337165600111
J	He, DM; Ruan, HH				He, Dongmei; Ruan, Honghua			Long Term Effect of Land Reclamation from Lake on Chemical Composition of Soil Organic Matter and Its Mineralization	PLOS ONE			English	Article							COMMON ARABLE TOPSOILS; CARBON MINERALIZATION; HUMIC SUBSTANCES; SPECTROSCOPIC CHARACTERIZATION; MICROBIAL BIOMASS; FOREST FLOOR; FULVIC-ACIDS; DYNAMICS; LABILE; TEMPERATURE	Since the late 1950s, land reclamation from lakes has been a common human disturbance to ecosystems in China. It has greatly diminished the lake area, and altered natural ecological succession. However, little is known about its impact on the carbon (C) cycle. We conducted an experiment to examine the variations of chemical properties of dissolved organic matter (DOM) and C mineralization under four land uses, i.e. coniferous forest (CF), evergreen broadleaf forest (EBF), bamboo forest (BF) and cropland (CL) in a reclaimed land area from Taihu Lake. Soils and lake sediments (LS) were incubated for 360 days in the laboratory and the CO2 evolution from each soil during the incubation was fit to a double exponential model. The DOM was analyzed at the beginning and end of the incubation using UV and fluorescence spectroscopy to understand the relationships between DOM chemistry and C mineralization. The C mineralization in our study was influenced by the land use with different vegetation and management. The greatest cumulative CO2-C emission was observed in BF soil at 0-10 cm depth. The active C pool in EBF at 10-25 cm had longer (62 days) mean residence time (MRT). LS showed the highest cumulative CO2-C and shortest MRT comparing with the terrestrial soils. The carbohydrates in DOM were positively correlated with CO2-C evolution and negatively correlated to phenols in the forest soils. Cropland was consistently an outlier in relationships between DOM chemistry and CO2-evolution, highlighting the unique effects that this land use on soil C cycling, which may be attributed the tillage practices. Our results suggest that C mineralization is closely related to the chemical composition of DOM and sensitive to its variation. Conversion of an aquatic ecosystem into a terrestrial ecosystem may alter the chemical structure of DOM, and then influences soil C mineralization.	[Ruan, Honghua] Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; Nanjing Forestry Univ, Key Lab Forestry & Ecol Engn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Ruan, HH (corresponding author), Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	hhruan@njfu.edu.cn			MOST of China (973 Program) [2012CB416904]; National Science Foundation of China [31170417]; PAPD; Collaborative Innovation plan of Jiangsu higher education, Doctorate Fellowship Foundation of Nanjing Forestry University	MOST of China (973 Program); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); PAPD; Collaborative Innovation plan of Jiangsu higher education, Doctorate Fellowship Foundation of Nanjing Forestry University	This study was supported by the MOST of China (973 Program No. 2012CB416904), the National Science Foundation of China (No. 31170417) and partially supported by PAPD and Collaborative Innovation plan of Jiangsu higher education, Doctorate Fellowship Foundation of Nanjing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi J, 2007, CHEMOSPHERE, V69, P1040, DOI 10.1016/j.chemosphere.2007.04.036; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Boddy E, 2007, SOIL BIOL BIOCHEM, V39, P827, DOI 10.1016/j.soilbio.2006.09.030; Bu XL, 2011, EUR J SOIL BIOL, V47, P102, DOI 10.1016/j.ejsobi.2010.11.009; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Caravaca F, 2002, SOIL TILL RES, V68, P23, DOI 10.1016/S0167-1987(02)00080-6; Chantigny M.H., 2007, SOIL SAMPLING METHOD, P617; Chantigny MH, 2003, GEODERMA, V113, P357, DOI 10.1016/S0016-7061(02)00370-1; Chen J, 2003, CHEMOSPHERE, V50, P639, DOI 10.1016/S0045-6535(02)00616-1; Chen J, 2002, CHEMOSPHERE, V48, P59, DOI 10.1016/S0045-6535(02)00041-3; Cookson WR, 2008, SOIL BIOL BIOCHEM, V40, P763, DOI 10.1016/j.soilbio.2007.10.011; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Corvasce M, 2006, CHEMOSPHERE, V62, P1583, DOI 10.1016/j.chemosphere.2005.07.065; Don A, 2005, SOIL BIOL BIOCHEM, V37, P2171, DOI 10.1016/j.soilbio.2005.03.019; Embacher A, 2007, GEODERMA, V139, P11, DOI 10.1016/j.geoderma.2006.12.002; Embacher A, 2008, GEODERMA, V148, P63, DOI 10.1016/j.geoderma.2008.09.006; EWALD M, 1988, GEODERMA, V43, P11, DOI 10.1016/0016-7061(88)90051-1; Faikd HA, 2000, THESIS ZHEJIANG U CH; Fuentes M, 2006, ORG GEOCHEM, V37, P1949, DOI 10.1016/j.orggeochem.2006.07.024; Ge Q., 2000, ACTA GEOGRAPHICA SIN, V55, P698; Glatzel S, 2003, GEODERMA, V113, P397, DOI 10.1016/S0016-7061(02)00372-5; Nguyen HVM, 2011, CHEMOSPHERE, V85, P782, DOI 10.1016/j.chemosphere.2011.06.068; Hansson K, 2010, SOIL BIOL BIOCHEM, V42, P178, DOI 10.1016/j.soilbio.2009.10.013; Hur J, 2011, CHEMOSPHERE, V85, P1360, DOI 10.1016/j.chemosphere.2011.08.001; Hur J, 2009, CHEMOSPHERE, V75, P483, DOI 10.1016/j.chemosphere.2008.12.056; Jacinthe PA, 2004, SOIL TILL RES, V77, P111, DOI 10.1016/j.still.2003.11.004; Juarez S, 2011, GEODERMA, V167-68, P247, DOI 10.1016/j.geoderma.2011.09.007; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kalbitz K, 2003, SOIL BIOL BIOCHEM, V35, P1129, DOI 10.1016/S0038-0717(03)00165-2; Kalbitz K, 1999, BIOGEOCHEMISTRY, V47, P219, DOI 10.1007/BF00994924; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Kalbitz K, 2001, J PLANT NUTR SOIL SC, V164, P259, DOI 10.1002/1522-2624(200106)164:3<259::AID-JPLN259>3.0.CO;2-T; Kalbitz K, 2007, BIOGEOCHEMISTRY, V86, P301, DOI 10.1007/s10533-007-9161-8; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Khomutova TE, 2000, PLANT SOIL, V219, P13, DOI 10.1023/A:1004793515494; Kiikkila O, 2006, SOIL BIOL BIOCHEM, V38, P737, DOI 10.1016/j.soilbio.2005.06.024; Kowalczuk P, 2009, MAR CHEM, V113, P182, DOI 10.1016/j.marchem.2009.01.015; Lal R, 2002, ENVIRON POLLUT, V116, P353, DOI 10.1016/S0269-7491(01)00211-1; Leinweber P, 2008, SOIL BIOL BIOCHEM, V40, P1496, DOI 10.1016/j.soilbio.2008.01.003; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Majcher EH, 2000, SOIL SCI SOC AM J, V64, P157, DOI 10.2136/sssaj2000.641157x; Marinari S, 2010, SOIL TILL RES, V106, P211, DOI 10.1016/j.still.2009.12.010; Marschner B, 2003, GEODERMA, V113, P211, DOI 10.1016/S0016-7061(02)00362-2; Marschner B, 2002, SOIL BIOL BIOCHEM, V34, P459, DOI 10.1016/S0038-0717(01)00203-6; Martin D, 2010, AGR ECOSYST ENVIRON, V138, P64, DOI 10.1016/j.agee.2010.04.001; Matilainen A, 2011, CHEMOSPHERE, V83, P1431, DOI 10.1016/j.chemosphere.2011.01.018; Mora JL, 2007, SCI TOTAL ENVIRON, V378, P143, DOI 10.1016/j.scitotenv.2007.01.040; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Rey A, 2006, GLOBAL CHANGE BIOL, V12, P1894, DOI 10.1111/j.1365-2486.2006.01230.x; Rodriguez AR, 2004, GEODERMA, V121, P205, DOI 10.1016/j.geoderma.2003.11.009; Rovira P, 2007, SOIL BIOL BIOCHEM, V39, P202, DOI 10.1016/j.soilbio.2006.07.021; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Simonsson M, 2005, GEODERMA, V124, P157, DOI 10.1016/j.geoderma.2004.04.010; Sondergaard M, 2007, J APPL ECOL, V44, P1089, DOI 10.1111/j.1365-2664.2007.01426.x; Teixeira Mariana Carolina, 2011, Acta Limnol. Bras., V23, P333; Tian L, 2010, APPL SOIL ECOL, V46, P426, DOI 10.1016/j.apsoil.2010.09.007; Tobiasova E, 2011, SOIL TILL RES, V114, P183, DOI 10.1016/j.still.2011.05.003; Traversa A, 2008, FOREST ECOL MANAG, V256, P2018, DOI 10.1016/j.foreco.2008.07.038; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang LY, 2009, J ENVIRON SCI, V21, P581, DOI 10.1016/S1001-0742(08)62311-6; Wang XW, 2010, J ENVIRON SCI-CHINA, V22, P1057, DOI 10.1016/S1001-0742(09)60217-5; Wang Y, 2010, SOIL SCI, V175, P624, DOI 10.1097/SS.0b013e3181fe2ee4; Wieder WR, 2008, BIOGEOCHEMISTRY, V88, P127, DOI 10.1007/s10533-008-9200-0; Yang Li-xia, 2006, Journal of Forestry Research (Harbin), V17, P39, DOI 10.1007/s11676-006-0009-1; Yin HB, 2008, PEDOSPHERE, V18, P564, DOI 10.1016/S1002-0160(08)60050-8; You BS, 2007, J ENVIRON SCI, V19, P1055, DOI 10.1016/S1001-0742(07)60172-7; Zhang LY, 2005, MODERN FOOD SCI TECH, V22, P247; Zhao MX, 2008, EUR J SOIL BIOL, V44, P158, DOI 10.1016/j.ejsobi.2007.09.007; Zhou Y, 2009, THESIS NANJING FORES; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0; Zsolnay A, 2003, GEODERMA, V113, P187, DOI 10.1016/S0016-7061(02)00361-0	71	6	11	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99251	10.1371/journal.pone.0099251	http://dx.doi.org/10.1371/journal.pone.0099251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905998	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000114
J	Kim, HW; Kim, SH; Kim, YO; Jin, DC; Song, HC; Choi, EJ; Kim, YL; Kim, YS; Kang, SW; Kim, NH; Yang, CW; Kim, YK				Kim, Hyung Wook; Kim, Su-Hyun; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Kim, Yong-Lim; Kim, Yon-Su; Kang, Shin-Wook; Kim, Nam-Ho; Yang, Chul Woo; Kim, Yong Kyun			Comparison of the Impact of High-Flux Dialysis on Mortality in Hemodialysis Patients with and without Residual Renal Function	PLOS ONE			English	Article							DIALYZER MEMBRANE-CHARACTERISTICS; MAINTENANCE HEMODIALYSIS; CLINICAL-OUTCOMES; PERMEABILITY; REUSE; BETA(2)-MICROGLOBULIN; SURVIVAL; HEMO; RISK	Background: The effect of flux membranes on mortality in hemodialysis (HD) patients is controversial. Residual renal function (RRF) has shown to not only be as a predictor of mortality but also a contributor to beta 2-microglobulin clearance in HD patients. Our study aimed to determine the interaction of residual renal function with dialyzer membrane flux on mortality in HD patients. Methods: HD Patients were included from the Clinical Research Center registry for End Stage Renal Disease, a prospective observational cohort study in Korea. Cox proportional hazards regression models were used to study the association between use of high-flux dialysis membranes and all-cause mortality with RRF and without RRF. The primary outcome was all-cause mortality. Results: This study included 893 patients with 24 h-residual urine volume >= 100 ml (569 and 324 dialyzed using low-flux and high-flux dialysis membranes, respectively) and 913 patients with 24 h-residual urine volume < 100 ml (570 and 343 dialyzed using low-flux and high-flux dialysis membranes, respectively). After a median follow-up period of 31 months, mortality was not significantly different between the high and low-flux groups in patients with 24 h-residual urine volume >= 100 ml (HR 0.86, 95% CI, 0.38-1.95, P = 0.723). In patients with 24 h-residual urine volume < 100 ml, HD using high-flux dialysis membrane was associated with decreased mortality compared to HD using low-flux dialysis membrane in multivariate analysis (HR 0.40, 95% CI, 0.21-0.78, P = 0.007). Conclusions: Our data showed that HD using high-flux dialysis membranes had a survival benefit in patients with 24 h-residual urine volume < 100 ml, but not in patients with 24 h-residual urine volume >= 100 ml. These findings suggest that high-flux dialysis rather than low-flux dialysis might be considered in HD patients without RRF.	[Kim, Hyung Wook; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Yang, Chul Woo; Kim, Yong Kyun] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Su-Hyun] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kim, Yon-Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Kim, Hyung Wook] St Vincents Hosp, Suwon, South Korea; [Kim, Yong Kyun] Catholic Univ Korea, MRC Cell Death Dis Res Ctr, Seoul, South Korea	Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chonnam National University; Catholic University of Korea	Kim, YK (corresponding author), Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea.	drkimyk@catholic.ac.kr			Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauveau P, 2005, AM J KIDNEY DIS, V45, P565, DOI 10.1053/j.ajkd.2004.11.014; Cheung AK, 1999, J AM SOC NEPHROL, V10, P117; Cheung AK, 2003, J AM SOC NEPHROL, V14, P3251, DOI 10.1097/01.ASN.0000096373.13406.94; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; DIRAIMONDO CR, 1989, AM J KIDNEY DIS, V13, P390, DOI 10.1016/S0272-6386(89)80022-8; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; HORNBERGER JC, 1992, J AM SOC NEPHROL, V3, P1227; Krane V, 2007, AM J KIDNEY DIS, V49, P267, DOI 10.1053/j.ajkd.2006.11.026; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Matos JPS, 2000, AM J KIDNEY DIS, V35, P839, DOI 10.1016/S0272-6386(00)70253-8; MCCARTHY JT, 1994, J LAB CLIN MED, V123, P495; Peritoneal Dialysis Adequacy 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS91, DOI DOI 10.1053/J.AJKD.2006.05.016; Port FK, 2001, AM J KIDNEY DIS, V37, P276, DOI 10.1053/ajkd.2001.21290; Shemin D, 2001, AM J KIDNEY DIS, V38, P85, DOI 10.1053/ajkd.2001.25198; Tattersall J, 2010, NEPHROL DIAL TRANSPL, V25, P1230, DOI 10.1093/ndt/gfp626; van der Wal WM, 2011, NEPHROL DIAL TRANSPL, V26, P2978, DOI 10.1093/ndt/gfq856; Vilar E, 2009, NEPHROL DIAL TRANSPL, V24, P2502, DOI 10.1093/ndt/gfp071; Ward RA, 2004, SEMIN DIALYSIS, V17, P489, DOI 10.1111/j.0894-0959.2004.17617.x; Ward RA, 2011, SEMIN DIALYSIS, V24, P65, DOI 10.1111/j.1525-139X.2010.00807.x; Yoshino M, 2006, J AM SOC NEPHROL, V17, P3510, DOI 10.1681/ASN.2006020156	20	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97184	10.1371/journal.pone.0097184	http://dx.doi.org/10.1371/journal.pone.0097184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906205	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000005
J	Nakaya, T; Honjo, K; Hanibuchi, T; Ikeda, A; Iso, H; Inoue, M; Sawada, N; Tsugane, S				Nakaya, Tomoki; Honjo, Kaori; Hanibuchi, Tomoya; Ikeda, Ai; Iso, Hiroyasu; Inoue, Manami; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Ctr-Based Prospe	Associations of All-Cause Mortality with Census-Based Neighbourhood Deprivation and Population Density in Japan: A Multilevel Survival Analysis	PLOS ONE			English	Article							AREA-BASED DEPRIVATION; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC POSITION; HEALTH INEQUALITIES; OLDER-PEOPLE; ENVIRONMENT; BRITAIN; INCOME; URBAN; INDEX	Background: Despite evidence that neighbourhood conditions affect residents' health, no prospective studies of the association between neighbourhood socio-demographic factors and all-cause mortality have been conducted in non-Western societies. Thus, we examined the effects of areal deprivation and population density on all-cause mortality in Japan. Methods: We employed census and survival data from the Japan Public Health Center-based Prospective Study, Cohort I (n = 37,455), consisting of middle-aged residents (40 to 59 years at the baseline in 1990) living in four public health centre districts. Data spanned between 1990 and 2010. A multilevel parametric proportional-hazard regression model was applied to estimate the hazard ratios (HRs) of all-cause mortality by two census-based areal variables -areal deprivation index and population density-as well as individualistic variables such as socioeconomic status and various risk factors. Results: We found that areal deprivation and population density had moderate associations with all-cause mortality at the neighbourhood level based on the survival data with 21 years of follow-ups. Even when controlling for individualistic socioeconomic status and behavioural factors, the HRs of the two areal factors (using quartile categorical variables) significantly predicted mortality. Further, this analysis indicated an interaction effect of the two factors: areal deprivation prominently affects the health of residents in neighbourhoods with high population density. Conclusions: We confirmed that neighbourhood socio-demographic factors are significant predictors of all-cause death in Japanese non-metropolitan settings. Although further study is needed to clarify the cause-effect relationship of this association, the present findings suggest that health promotion policies should consider health disparities between neighbourhoods and possibly direct interventions towards reducing mortality in densely populated and highly deprived neighbourhoods.	[Nakaya, Tomoki] Ritsumeikan Univ, Dept Geog, Kita Ku, Kyoto, Japan; [Nakaya, Tomoki] Ritsumeikan Univ, Inst Disaster Mitigat Urban Cultural Heritage, Kita Ku, Kyoto, Japan; [Honjo, Kaori] Osaka Univ, Global Collaborat Ctr, Suita, Osaka, Japan; [Hanibuchi, Tomoya] Chukyo Univ, Sch Int Liberal Studies, Toyota, Aichi, Japan; [Ikeda, Ai; Inoue, Manami; Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Chuo Ku, Tokyo 104, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	Ritsumeikan University; Ritsumeikan University; Osaka University; Chukyo University; National Cancer Center - Japan; Osaka University; University of Tokyo	Nakaya, T (corresponding author), Ritsumeikan Univ, Dept Geog, Kita Ku, Kyoto, Japan.	nakaya@lt.ritsumei.ac.jp	Tsugane, Shoichiro/A-2424-2015	Tsugane, Shoichiro/0000-0003-4105-2774; Iso, Hiroyasu/0000-0002-9241-7289; Nakaya, Tomoki/0000-0002-3827-1012	Ministry of Health, Labour and Welfare of Japan [23-A-31[toku], 26-A-2]; Ministry of Education, Culture, Sports, Science and Technology for the Osaka University Program for the Support of Networking among Present and Future Women Researchers; JSPS KAKENHI Grant [24300323, 20590793]; Grants-in-Aid for Scientific Research [25704018] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology for the Osaka University Program for the Support of Networking among Present and Future Women Researchers; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for National Cancer Center Research and Development Fund (23-A-31[toku] and 26-A-2) (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010), the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology for the Osaka University Program for the Support of Networking among Present and Future Women Researchers. This work was also supported by JSPS KAKENHI Grant (Number 24300323 and 20590793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007; Barnett S, 2001, J EPIDEMIOL COMMUN H, V55, P44, DOI 10.1136/jech.55.1.44; Carstairs V., 1991, DEPRIVATION HLTH SCO; Chaix B, 2006, INT J EPIDEMIOL, V35, P633, DOI 10.1093/ije/dyl009; Dorling D., 2007, POVERTY WEALTH BRITA; Fujino Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-398; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Fukuda Y, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-65; Fukuda Y, 2005, INT J EPIDEMIOL, V34, P100, DOI 10.1093/ije/dyh283; Fukuda Y, 2004, HEALTH PROMOT INT, V19, P177, DOI 10.1093/heapro/dah205; Fukuda Y, 2007, PUBLIC HEALTH, V121, P163, DOI 10.1016/j.puhe.2006.10.015; Gordon D, 1995, J EPIDEMIOL COMMUN H, V49, pS39, DOI 10.1136/jech.49.Suppl_2.S39; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Hanibuchi T, 2012, HEALTH PLACE, V18, P229, DOI 10.1016/j.healthplace.2011.09.015; Haynes R, 1999, HEALTH PLACE, V5, P301, DOI 10.1016/S1353-8292(99)00020-9; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; Inoue S, 2011, J EPIDEMIOL, V21, P481, DOI 10.2188/jea.JE20110044; Ito S, 2008, EUR J PUBLIC HEALTH, V18, P466, DOI 10.1093/eurpub/ckn052; Kawachi I., 2003, NEIGHBORHOODS HLTH; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; Meijer M, 2012, HEALTH PLACE, V18, P391, DOI 10.1016/j.healthplace.2011.12.001; Ministry of Health, 2013, HLTH JAP 21 2 CAMP; Nakaya T, 2005, SOC SCI MED, V60, P2865, DOI 10.1016/j.socscimed.2004.11.007; Nakaya T., 2011, P I STAT MATH, V59, P239; Nishiwaki Y, 2013, J ATHEROSCLER THROMB, V20, P296, DOI 10.5551/jat.15347; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Pampalon R, 2010, HEALTH PLACE, V16, P416, DOI 10.1016/j.healthplace.2009.11.012; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Riva M, 2007, J EPIDEMIOL COMMUN H, V61, P853, DOI 10.1136/jech.2006.050740; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Senior M, 2000, SOC SCI MED, V51, P289, DOI 10.1016/S0277-9536(99)00454-2; Senior M., 2002, CENSUS DATA SYSTEM, P123; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Smith SJ, 2005, T I BRIT GEOGR, V30, P173, DOI 10.1111/j.1475-5661.2005.00159.x; Tabuchi T, 2012, SOC SCI MED, V75, P1015, DOI 10.1016/j.socscimed.2012.04.030; Takano T., 2005, JMAJ - Japan Medical Association Journal, V48, P458; Tanaka K, 2010, J CROSS-CULT GERONTO, V25, P199, DOI 10.1007/s10823-010-9118-6; Townsend PP., 1988, HLTH DEPRIVATION INE; Tsugane S, 2001, J Epidemiol, V11, pS24; Watanabe S, 2001, J Epidemiol, V11, pS3; White C, 2005, Health Stat Q, P18; Yen IH, 1999, AM J EPIDEMIOL, V149, P898	45	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97802	10.1371/journal.pone.0097802	http://dx.doi.org/10.1371/journal.pone.0097802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905731	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000012
J	Nelson, JA; Bugbee, B				Nelson, Jacob A.; Bugbee, Bruce			Economic Analysis of Greenhouse Lighting: Light Emitting Diodes vs. High Intensity Discharge Fixtures	PLOS ONE			English	Article							FAR-RED LIGHT; BLUE-LIGHT; LETTUCE GROWTH; PLANTS; PHOTOSYNTHESIS; SUPPLEMENTATION; PRODUCTIVITY; RADIATION; SPECTRUM	Lighting technologies for plant growth are improving rapidly, providing numerous options for supplemental lighting in greenhouses. Here we report the photosynthetic (400-700 nm) photon efficiency and photon distribution pattern of two double-ended HPS fixtures, five mogul-base HPS fixtures, ten LED fixtures, three ceramic metal halide fixtures, and two fluorescent fixtures. The two most efficient LED and the two most efficient double-ended HPS fixtures had nearly identical efficiencies at 1.66 to 1.70 micromoles per joule. These four fixtures represent a dramatic improvement over the 1.02 micromoles per joule efficiency of the mogul-base HPS fixtures that are in common use. The best ceramic metal halide and fluorescent fixtures had efficiencies of 1.46 and 0.95 micromoles per joule, respectively. We also calculated the initial capital cost of fixtures per photon delivered and determined that LED fixtures cost five to ten times more than HPS fixtures. The five-year electric plus fixture cost per mole of photons is thus 2.3 times higher for LED fixtures, due to high capital costs. Compared to electric costs, our analysis indicates that the long-term maintenance costs are small for both technologies. If widely spaced benches are a necessary part of a production system, the unique ability of LED fixtures to efficiently focus photons on specific areas can be used to improve the photon capture by plant canopies. Our analysis demonstrates, however, that the cost per photon delivered is higher in these systems, regardless of fixture category. The lowest lighting system costs are realized when an efficient fixture is coupled with effective canopy photon capture.	[Nelson, Jacob A.; Bugbee, Bruce] Utah State Univ, Crop Physiol Lab, Dept Plant Soils & Climate, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Bugbee, B (corresponding author), Utah State Univ, Crop Physiol Lab, Dept Plant Soils & Climate, Logan, UT 84322 USA.	bruce.bugbee@usu.edu		Nelson, Jacob/0000-0002-4663-2420				Blonquist M, 2013, ANAL SPECTRAL COSINE; Both AJ, 2000, ACTA HORT ISHS, P183; Bourget CM, 2008, HORTSCIENCE, V43, P1944, DOI 10.21273/HORTSCI.43.7.1944; Ciolkosz DE, 2001, APPL ENG AGRIC, V17, P875; Cope KR, 2014, PHOTOCHEM PHOTOBIOL, V90, P574, DOI 10.1111/php.12233; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; Craig DS, 2013, J AM SOC HORTIC SCI, V138, P167, DOI 10.21273/JASHS.138.3.167; Dougher TAO, 2004, J AM SOC HORTIC SCI, V129, P467, DOI 10.21273/JASHS.129.4.0467; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P199, DOI 10.1562/0031-8655(2001)073&lt;0199:DITROW&gt;2.0.CO;2; Ferentinos KP, 2005, ENG APPL ARTIF INTEL, V18, P473, DOI 10.1016/j.engappai.2004.11.005; Frantz JM, 2000, J AM SOC HORTIC SCI, V125, P694, DOI 10.21273/JASHS.125.6.694; Gomez C, 2013, HORTTECHNOLOGY, V23, P93, DOI 10.21273/HORTTECH.23.1.93; IESNA Testing Procedures Committee, 2008, IES APPR METH EL PHO; INADA K, 1976, PLANT CELL PHYSIOL, V17, P355; Johkan M, 2012, ENVIRON EXP BOT, V75, P128, DOI 10.1016/j.envexpbot.2011.08.010; Kim HH, 2004, HORTSCIENCE, V39, P1617, DOI 10.21273/HORTSCI.39.7.1617; Massa GD, 2008, HORTSCIENCE, V43, P1951, DOI 10.21273/HORTSCI.43.7.1951; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; MORROW RC, 1988, PLANT PHYSIOL, V88, P1110, DOI 10.1104/pp.88.4.1110; Morrow RC, 2008, HORTSCIENCE, V43, P1947, DOI 10.21273/HORTSCI.43.7.1947; Nelson J. A., 2013, SPECTRAL CHARACTERIS; Yang ZC, 2012, SCI HORTIC-AMSTERDAM, V136, P81, DOI 10.1016/j.scienta.2011.12.023; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380	23	169	174	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99010	10.1371/journal.pone.0099010	http://dx.doi.org/10.1371/journal.pone.0099010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905835	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000091
J	Bai, XS; Zhang, EK; Ye, H; Nandakumar, V; Wang, Z; Chen, LH; Tang, CN; Li, JH; Li, HJ; Zhang, W; Han, W; Lou, F; Zhang, DD; Sun, H; Dong, HC; Zhang, GC; Liu, ZY; Dong, ZS; Guo, BS; Yan, H; Yan, CW; Wang, L; Su, ZY; Li, YY; Jones, L; Huang, XF; Chen, SY; Gao, JL				Bai, Xusheng; Zhang, Enke; Ye, Hua; Nandakumar, Vijayalakshmi; Wang, Zhuo; Chen, Lihong; Tang, Chuanning; Li, Jianhui; Li, Huijin; Zhang, Wei; Han, Wei; Lou, Feng; Zhang, Dandan; Sun, Hong; Dong, Haichao; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; Yan, He; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang; Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi; Gao, Jinglong			PIK3CA and TP53 Gene Mutations in Human Breast Cancer Tumors Frequently Detected by Ion Torrent DNA Sequencing	PLOS ONE			English	Article							KINASE INHIBITORS; OVARIAN-CANCER; PREVENTION; EXPRESSION; LAPATINIB; HER2; P53; REDUCTION; EFFICACY; RECEPTOR	Breast cancer is the most common malignancy and the leading cause of cancer deaths in women worldwide. While specific genetic mutations have been linked to 5-10% of breast cancer cases, other environmental and epigenetic factors influence the development and progression of the cancer. Since unique mutations patterns have been observed in individual cancer samples, identification and characterization of the distinctive breast cancer molecular profile is needed to develop more effective target therapies. Until recently, identifying genetic cancer mutations via personalized DNA sequencing was impractical and expensive. The recent technological advancements in next-generation DNA sequencing, such as the semiconductor-based Ion Torrent sequencing platform, has made DNA sequencing cost and time effective with more reliable results. Using the Ion Torrent Ampliseq Cancer Panel, we sequenced 737 loci from 45 cancer-related genes to identify genetic mutations in 105 human breast cancer samples. The sequencing analysis revealed missense mutations in PIK3CA, and TP53 genes in the breast cancer samples of various histologic types. Thus, this study demonstrates the necessity of sequencing individual human cancers in order to develop personalized drugs or combination therapies to effectively target individual, breast cancer-specific mutations.	[Bai, Xusheng; Zhang, Enke; Wang, Zhuo; Chen, Lihong; Li, Jianhui; Li, Huijin; Zhang, Wei; Han, Wei; Gao, Jinglong] Peoples Hosp Shan Xi Prov, Cent Lab, Xian, Peoples R China; [Ye, Hua; Tang, Chuanning; Lou, Feng; Zhang, Dandan; Sun, Hong; Dong, Haichao; Zhang, Guangchun; Liu, Zhiyuan; Dong, Zhishou; Guo, Baishuai; Yan, He; Yan, Chaowei; Wang, Lu; Su, Ziyi; Li, Yangyang] San Valley Biotechnol Inc, Beijing, Peoples R China; [Jones, Lindsey; Huang, Xue F.; Chen, Si-Yi] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Chen, SY (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	siyichen@usc.edu; gaojinglong126@126.com			National Natural Science Foundation of China; Wu Jieping Foundation; National Institute of Health [R01 CA90427, R01 AI084811]; NATIONAL CANCER INSTITUTE [R01CA090427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084811] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wu Jieping Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the grants from National Natural Science Foundation of China, the Wu Jieping Foundation, and the National Institute of Health (R01 CA90427 & R01 AI084811 to SY Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsner J, 2000, CLIN CANCER RES, V6, P3923; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Blackburn GL, 2007, AM J CLIN NUTR, V86, p878S, DOI 10.1093/ajcn/86.3.878S; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2627, DOI 10.1002/cncr.22656; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; EASTON DF, 1995, AM J HUM GENET, V56, P265; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Fabian CJ, 2007, INT J CLIN PRACT, V61, P2051, DOI 10.1111/j.1742-1241.2007.01587.x; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Ferlay J, 2013, IARC CANCERBASE; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kang S, 2005, CELL CYCLE, V4, P578, DOI 10.4161/cc.4.4.1593; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Lazzeroni M, 2013, HEMATOL ONCOL CLIN N, V27, P657, DOI 10.1016/j.hoc.2013.05.009; Levin B, 2012, MOL MED, V18, P1327, DOI 10.2119/molmed.2012.00280; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Montemurro F, 2007, EXPERT OPIN BIOL TH, V7, P257, DOI 10.1517/14712598.7.2.257; Nakopoulou LL, 1996, J PATHOL, V179, P31, DOI 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; Obiorah I, 2011, MATURITAS, V70, P315, DOI 10.1016/j.maturitas.2011.09.006; Perez-Tenorio G, 2007, CLIN CANCER RES, V13, P3577, DOI 10.1158/1078-0432.CCR-06-1609; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Roukos DH, 2012, ANN SURG ONCOL, V19, P3646, DOI 10.1245/s10434-012-2542-9; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Toi M, 2009, BRIT J CANCER, V101, P1676, DOI 10.1038/sj.bjc.6605343; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Xia WL, 2007, CANCER RES, V67, P1170, DOI 10.1158/0008-5472.CAN-06-2101; Xu Bing-He, 2011, Chin J Cancer, V30, P327; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	39	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99306	10.1371/journal.pone.0099306	http://dx.doi.org/10.1371/journal.pone.0099306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918944	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000074
J	He, JS; Yang, L; Han, XY; Zheng, GF; Zheng, WY; Wei, GQ; Wu, WJ; Ye, XJ; Shi, JM; Xie, WZ; Li, L; Zhang, J; Huang, WJ; Zhao, Y; Huang, H; Zhang, XJ; Fu, JP; Cai, Z				He, Jingsong; Yang, Li; Han, Xiaoyan; Zheng, Gaofeng; Zheng, Weiyan; Wei, Guoqing; Wu, Wenjun; Ye, Xiujin; Shi, Jimin; Xie, Wanzhuo; Li, Li; Zhang, Jie; Huang, Weijia; Zhao, Yi; Huang, He; Zhang, Xuejin; Fu, Jiaping; Cai, Zhen			The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; INDUCTION TREATMENT PRIOR; HERPES-ZOSTER EVENTS; COMPLETE RESPONSE; AUTOLOGOUS TRANSPLANTATION; PERIPHERAL NEUROPATHY; PLUS DEXAMETHASONE; TREATED PATIENTS; SINGLE-CENTER; APEX TRIAL	Introduction: Bortezomib has significantly improved multiple myeloma (MM) response rates, but strategies for choosing bortezomib-based regimens for initial MM therapy are not standardized. Here, we describe four bortezomib-based therapies in Chinese MM patients to determine the optimal chemotherapeutic approach. Methods: Newly diagnosed symptomatic MM patients at three hematological centers between February 1, 2006 and May 31, 2013 were treated with therapies including bortezomib plus dexamethasone (PD) or combinations of PD with either adriamycin (PAD), cyclophosphamide (PCD) or thalidomide (PTD) for every 28 days. Results: The overall response rate of all the 215 eligible patients was 90.2%. The ORR for PCD, PAD, PTD and PD were 97.4%, 93.2%, 85.3% and 77.8% while the effects with VGPR or better were 63.7%, 62.7%, 44.2% and 37.8%, respectively. The effect of ORR, VGPR and CR/nCR for the PCD regimen was better than the PD protocol. Median PFS for all patients was 29.0 months with significant differences observed among treatment groups. Median OS of all the patients was not reached, but three-drug combinations were superior to PD alone. Frequently observed toxicities were neutropenia, thrombocytopenia, fatigue, infection, herpes zoster, and peripheral neuropathy. The incidence of peripheral neuropathy (PN) in PTD group was significantly higher than other three groups, especially grade 2-3 PN. Treatment with anti-viral agent acyclovir significantly reduced the incidence of herpes zoster. Conclusions: Our experience indicated that bortezomib-based regimens were effective and well-tolerated in the Chinese population studied; three-drug combinations PCD, PAD were superior to PD, especially with respect to PCD.	[He, Jingsong; Yang, Li; Han, Xiaoyan; Zheng, Gaofeng; Zheng, Weiyan; Wei, Guoqing; Wu, Wenjun; Ye, Xiujin; Shi, Jimin; Xie, Wanzhuo; Li, Li; Zhang, Jie; Huang, Weijia; Zhao, Yi; Huang, He; Cai, Zhen] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [He, Jingsong; Yang, Li; Han, Xiaoyan; Zheng, Gaofeng; Zheng, Weiyan; Wei, Guoqing; Wu, Wenjun; Ye, Xiujin; Shi, Jimin; Xie, Wanzhuo; Li, Li; Zhang, Jie; Huang, Weijia; Zhao, Yi; Huang, He; Cai, Zhen] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Multiple Myeloma Treatment Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Xuejin] Red Cross Hosp Hangzhou, Dept Hematol, Hangzhou, Zhejiang, Peoples R China; [Fu, Jiaping] Shaoxing Peoples Hosp, Dept Hematol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cai, Z (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	caiz@zju.edu.cn	han, xiao/HDN-9782-2022		Major International (region) Co-elaboration Research Project of Chinese National Natural Science Foundation [81120108018]; National Natural Science Foundation of China [91029740, 81071936, 30900533]; Key project of the Ministry of Health of China; Scientific Research Program for Public Interests from the Health Ministry of China [201002024]	Major International (region) Co-elaboration Research Project of Chinese National Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key project of the Ministry of Health of China; Scientific Research Program for Public Interests from the Health Ministry of China	This work was supported by Major International (region) Co-elaboration Research Project of Chinese National Natural Science Foundation (Project No. 81120108018); National Natural Science Foundation of China (Project No. 91029740, 81071936, 30900533); Key project of the Ministry of Health of China (Project 2010-2012); Scientific Research Program for Public Interests from the Health Ministry of China (Project No. 201002024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2011, JPN J CLIN ONCOL, V41, P876, DOI 10.1093/jjco/hyr063; Badros A, 2007, CANCER-AM CANCER SOC, V110, P1042, DOI 10.1002/cncr.22921; Barlogie B, 2008, CANCER-AM CANCER SOC, V113, P355, DOI 10.1002/cncr.23546; Blade J, 2008, ANN ONCOL, V19, P117, DOI 10.1093/annonc/mdn437; Cavo M, 2005, BLOOD, V106, P35, DOI 10.1182/blood-2005-02-0522; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Chanan-Khan A, 2008, J CLIN ONCOL, V26, P4784, DOI 10.1200/JCO.2007.14.9641; Chaudhry V, 2008, J PERIPHER NERV SYST, V13, P275, DOI 10.1111/j.1529-8027.2008.00193.x; de la Rubia J, 2011, EXPERT REV HEMATOL, V4, P381, DOI [10.1586/ehm.11.38, 10.1586/EHM.11.38]; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2006, HAEMATOLOGICA, V91, P1498; Harousseau JL, 2010, BLOOD, V116, P3743, DOI 10.1182/blood-2010-03-275800; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Harousseau JL, 2009, BLOOD, V114, P3139, DOI 10.1182/blood-2009-03-201053; Jagannath S, 2009, BRIT J HAEMATOL, V146, P619, DOI 10.1111/j.1365-2141.2009.07803.x; Lahuerta JJ, 2008, J CLIN ONCOL, V26, P5775, DOI 10.1200/JCO.2008.17.9721; Kim SJ, 2008, CLIN LYMPHOMA MYELOM, V8, P237, DOI 10.3816/CLM.2008.n.031; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; Mohty B, 2010, HAEMATOL-HEMATOL J, V95, P311, DOI 10.3324/haematol.2009.012674; Niesvizky R, 2008, BRIT J HAEMATOL, V143, P46, DOI 10.1111/j.1365-2141.2008.07303.x; Ohguchi H, 2009, INT J HEMATOL, V89, P342, DOI 10.1007/s12185-009-0279-4; Palumbo A, 2008, ANN ONCOL, V19, P1160, DOI 10.1093/annonc/mdn018; Palumbo A, 2010, J CLIN ONCOL, V28, P800, DOI 10.1200/JCO.2009.22.7561; Rajkumar SV, 2012, HEMATOL-AM SOC HEMAT, P354, DOI 10.1182/asheducation-2012.1.354; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Reeder CB, 2010, BLOOD, V115, P3416, DOI 10.1182/blood-2010-02-271676; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Rosinol L, 2007, J CLIN ONCOL, V25, P4452, DOI 10.1200/JCO.2007.12.3323; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Tao ZF, 2007, CHINESE MED J-PEKING, V120, P1655, DOI 10.1097/00029330-200710010-00002; Tong Y, 2007, AM J HEMATOL, V82, P403, DOI 10.1002/ajh.20838; van de Velde HJK, 2007, HAEMATOLOGICA, V92, P1399, DOI 10.3324/haematol.11534; Vickrey E, 2009, CANCER-AM CANCER SOC, V115, P229, DOI 10.1002/cncr.24006; Wang LD, 2012, HEMATOL ONCOL, V30, P57, DOI 10.1002/hon.1007; Zheng WY, 2009, LEUKEMIA RES, V33, P1615, DOI 10.1016/j.leukres.2009.04.006	37	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99174	10.1371/journal.pone.0099174	http://dx.doi.org/10.1371/journal.pone.0099174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918626	Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000054
J	Dies, H; Toppozini, L; Rheinstadter, MC				Dies, Hannah; Toppozini, Laura; Rheinstaedter, Maikel C.			The Interaction between Amyloid-beta Peptides and Anionic Lipid Membranes Containing Cholesterol and Melatonin	PLOS ONE			English	Article							X-RAY-DIFFRACTION; LIQUID-ORDERED STATE; ALZHEIMERS-DISEASE; PHOSPHOLIPID-MEMBRANES; PROTEIN INTERACTIONS; PHASE DMPC; BILAYERS; FLUID; DOMAINS; MODEL	One of the hallmarks of Alzheimer's disease is the formation of senile plaques, primarily consisting of amyloid-beta (A beta) peptides. Peptide-membrane and peptide-lipid interactions are thought to be crucial in this process. We studied the interaction of A beta(1-42) and A beta(25-35) peptides with anionic lipid membranes made of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphoserine (DMPS) using X-ray diffraction. We compare the experimentally determined electron densities in the gel state of the membranes with density calculations from peptide structures reported in the Protein Data Bank in order to determine the position of the peptide in the bilayers. The full length peptide A beta(1-42) was found to embed in the hydrocarbon core of the anionic lipid bilayers. Two populations were found for the A beta(25-35) peptide: (1) membrane-bound states in the hydrophilic head group region of the bilayers, where the peptides align parallel to the membranes, and (2) an embedded state in the bilayer center. Aging plays an important role in the development of Alzheimer's, in particular with respect to changes in cholesterol and melatonin levels in the brain tissue. Immiscible cholesterol plaques were created by addition of 30 mol% cholesterol to the anionic membranes. The A beta(25-35) peptides were found to strongly interact with the lipid bilayers, displacing further cholesterol molecules into the plaques, effectively lowering the cholesterol concentration in the membranes and increasing the total fraction of cholesterol plaques. Addition of 30 mol% melatonin molecules to the anionic membranes drastically reduced the population of the membrane-embedded A beta state. These results present experimental evidence for an interaction between A beta peptides, melatonin and cholesterol in lipid membranes.	[Dies, Hannah; Toppozini, Laura; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University	Rheinstadter, MC (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Bacon, Hannah/AAQ-9604-2021	Rheinstadter, Maikel C/0000-0002-0558-7475; Bacon, Hannah/0000-0002-2772-141X	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation; NSERC Undergraduate Research Awards (USRA); NSERC Graduate Scholarship (CGS); Early Researcher Award of the Province of Ontario	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation; NSERC Undergraduate Research Awards (USRA); NSERC Graduate Scholarship (CGS); Early Researcher Award of the Province of Ontario	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. H. D. is the recipient of an NSERC Undergraduate Research Awards (USRA), L. T. is the recipient of an NSERC Graduate Scholarship (CGS), M. C. R. is the recipient of an Early Researcher Award of the Province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, CHEM PHYS LIPIDS, V107, P93, DOI 10.1016/S0009-3084(00)00154-7; Ahyayauch H, 2012, BIOPHYS J, V103, P453, DOI 10.1016/j.bpj.2012.06.043; Apajalahti T, 2009, FARADAY DISCUSS, V2010; Armstrong CL, 2014, SOFT MATTER, V10, P2600, DOI 10.1039/c3sm51757h; Armstrong CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066162; Armstrong CL, 2012, EUR BIOPHYS J BIOPHY, V41, P901, DOI 10.1007/s00249-012-0826-4; Armstrong CL, 2011, PROTEIN PEPTIDE LETT, V18, P344; Barrett MA, 2013, SOFT MATTER, V9, P9342, DOI 10.1039/c3sm50700a; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Buchsteiner A, 2012, SOFT MATTER, V8, P424, DOI 10.1039/c1sm06823g; Buchsteiner A, 2010, BBA-BIOMEMBRANES, V1798, P1969, DOI 10.1016/j.bbamem.2010.06.024; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Casuso I, 2010, BIOPHYS J, V99, pL47, DOI 10.1016/j.bpj.2010.07.028; Chaudhuri A, 2011, BBA-BIOMEMBRANES, V1808, P19, DOI 10.1016/j.bbamem.2010.10.013; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; D'Ursi AM, 2004, J MED CHEM, V47, P4231, DOI 10.1021/jm040773o; Dai J, 2010, J PHYS CHEM B, V114, P840, DOI 10.1021/jp909061h; Dante S, 2002, BIOPHYS J, V83, P2610, DOI 10.1016/S0006-3495(02)75271-5; Dante S, 2011, BBA-BIOMEMBRANES, V1808, P2646, DOI 10.1016/j.bbamem.2011.07.024; Dante S, 2006, EUR BIOPHYS J BIOPHY, V35, P523, DOI 10.1007/s00249-006-0062-x; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; de Lima VR, 2010, J PINEAL RES, V49, P169, DOI 10.1111/j.1600-079X.2010.00782.x; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; Ding H, 2012, BIOPHYS J, V103, P1500, DOI 10.1016/j.bpj.2012.08.051; Drolle E., 2013, BIOCHIM BIOPHYS ACTA, V1828; Drolle E, 2012, BIOPHYS J, V103, pL27, DOI 10.1016/j.bpj.2012.06.053; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Fonseca ACRG, 2010, EXP NEUROL, V223, P282, DOI 10.1016/j.expneurol.2009.09.013; Fragneto G, 2007, CR PHYS, V8, P865, DOI 10.1016/j.crhy.2007.09.003; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Hall A, 2010, J PHYS CHEM B, V114, P7797, DOI 10.1021/jp912175d; Hane F, 2011, J ALZHEIMERS DIS, V26, P485, DOI 10.3233/JAD-2011-102112; Hristova K, 1998, BIOPHYS J, V74, P2419, DOI 10.1016/S0006-3495(98)77950-0; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; KING GI, 1971, PHYS LETT A, VA 35, P259, DOI 10.1016/0375-9601(71)90371-9; Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lenne PF, 2009, SOFT MATTER, V5, P2841, DOI 10.1039/b822956b; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maltseva E, 2004, CHEMPHYSCHEM, V5, P1185, DOI 10.1002/cphc.200400045; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; Mason RP, 2003, BBA-BIOMEMBRANES, V1610, P198, DOI 10.1016/S0005-2736(03)00018-X; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Meinhardt S, 2013, P NATL ACAD SCI USA, V110, P4476, DOI 10.1073/pnas.1221075110; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Mouritsen OG, 2010, BBA-BIOMEMBRANES, V1798, P1286, DOI 10.1016/j.bbamem.2010.02.017; NAGLE JF, 1989, BIOPHYS J, V55, P309, DOI 10.1016/S0006-3495(89)82806-1; Nagle JF, 1996, BIOPHYS J, V70, P1419, DOI 10.1016/S0006-3495(96)79701-1; Nagle JF, 2013, FARADAY DISCUSS, V161, P11, DOI 10.1039/c2fd20121f; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Novakova E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051911; Pabst G, 2010, CHEM PHYS LIPIDS, V163, P460, DOI 10.1016/j.chemphyslip.2010.03.010; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Pappolla MA, 1997, J NEUROSCI, V17, P1683; Pappolla MA, 2000, J NEURAL TRANSM, V107, P203, DOI 10.1007/s007020050018; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Poojari C, 2012, BIOCH BIOPHYSICA ACT; Poojari C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078399; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Raguz M, 2011, BBA-BIOMEMBRANES, V1808, P1072, DOI 10.1016/j.bbamem.2010.12.019; Rapaport H, 2001, BIOPHYS J, V81, P2729, DOI 10.1016/S0006-3495(01)75915-2; Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x; Rheinstadter MC, 2013, CURR OPIN COLLOID IN, V18, P440, DOI 10.1016/j.cocis.2013.07.001; Rheinstadter MC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128104; Saija A, 2002, EUR J PHARM BIOPHARM, V53, P209, DOI 10.1016/S0939-6411(01)00239-9; Sani MA, 2011, FEBS LETT, V585, P749, DOI 10.1016/j.febslet.2011.02.011; Sasahara K, 2013, PHYS CHEM CHEM PHYS, V15, P8929, DOI 10.1039/c3cp44517h; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Sodt AJ, 2014, J AM CHEM SOC, V136, P725, DOI 10.1021/ja4105667; Solomonov I, 2005, BIOPHYS J, V88, P1809, DOI 10.1529/biophysj.104.044834; Solomonov I, 2009, EUR PHYS J E, V30, P215, DOI 10.1140/epje/i2009-10498-2; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Thakur G, 2009, COLLOID SURFACE B, V74, P436, DOI 10.1016/j.colsurfb.2009.07.043; Toppozini L, 2012, SOFT MATTER, V8, P11839, DOI 10.1039/c2sm26546j; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; Tsai HHG, 2010, PROTEINS, V78, P1909, DOI 10.1002/prot.22705; Tulenko TN, 1998, J LIPID RES, V39, P947; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vance DE, 2000, BBA-MOL CELL BIOL L, V1529, P1, DOI 10.1016/S1388-1981(00)00133-5; Wang JZ, 2006, ACTA PHARMACOL SIN, V27, P41, DOI 10.1111/j.1745-7254.2006.00260.x; Watkins EB, 2011, P NATL ACAD SCI USA, V108, P6975, DOI 10.1073/pnas.1014579108; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wood WG, 2003, BBA-BIOMEMBRANES, V1610, P281, DOI 10.1016/S0005-2736(03)00025-7; WORCESTER DL, 1976, J MOL BIOL, V100, P359, DOI 10.1016/S0022-2836(76)80068-X; Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x; Ziblat R, 2011, ANGEW CHEM INT EDIT, V50, P3620, DOI 10.1002/anie.201004470; Ziblat R, 2012, BIOPHYS J, V103, P255, DOI 10.1016/j.bpj.2012.05.025; Ziblat R, 2010, J AM CHEM SOC, V132, P9920, DOI 10.1021/ja103975g	106	57	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99124	10.1371/journal.pone.0099124	http://dx.doi.org/10.1371/journal.pone.0099124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915524	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700064
J	Matallana-Surget, S; Derock, J; Leroy, B; Badri, H; Deschoenmaeker, F; Wattiez, R				Matallana-Surget, Sabine; Derock, Jeremy; Leroy, Baptiste; Badri, Hanene; Deschoenmaeker, Frederic; Wattiez, Ruddy			Proteome-Wide Analysis and Diel Proteomic Profiling of the Cyanobacterium Arthrospira platensis PCC 8005	PLOS ONE			English	Article							CIRCADIAN CLOCK; SHOTGUN PROTEOMICS; EXPRESSION; PROTEINS; BINDING; GENOME; GENES; CYCLE; IDENTIFICATION; ADAPTATION	The filamentous cyanobacterium Arthrospira platensis has a long history of use as a food supply and it has been used by the European Space Agency in the MELiSSA project, an artificial microecosystem which supports life during long-term manned space missions. This study assesses progress in the field of cyanobacterial shotgun proteomics and light/dark diurnal cycles by focusing on Arthrospira platensis. Several fractionation workflows including gel-free and gel-based protein/peptide fractionation procedures were used and combined with LC-MS/MS analysis, enabling the overall identification of 1306 proteins, which represents 21% coverage of the theoretical proteome. A total of 30 proteins were found to be significantly differentially regulated under light/dark growth transition. Interestingly, most of the proteins showing differential abundance were related to photosynthesis, the Calvin cycle and translation processes. A novel aspect and major achievement of this work is the successful improvement of the cyanobacterial proteome coverage using a 3D LC-MS/MS approach, based on an immobilized metal affinity chromatography, a suitable tool that enabled us to eliminate the most abundant protein, the allophycocyanin. We also demonstrated that cell growth follows a light/dark cycle in A. platensis. This preliminary proteomic study has highlighted new characteristics of the Arthrospira platensis proteome in terms of diurnal regulation.	[Matallana-Surget, Sabine; Derock, Jeremy; Leroy, Baptiste; Badri, Hanene; Deschoenmaeker, Frederic; Wattiez, Ruddy] Univ Mons, Interdisciplinary Mass Spectrometry Ctr CISMa, Dept Prote & Microbiol, B-7000 Mons, Belgium; [Badri, Hanene] Belgian Nucl Res Ctr SCK CEN, Inst Environm Hlth & Safety, Expert Grp Mol & Cellular Biol, Microbiol Unit, Mol, Belgium	University of Mons; Belgian Nuclear Research Centre (SCK-CEN)	Wattiez, R (corresponding author), Univ Mons, Interdisciplinary Mass Spectrometry Ctr CISMa, Dept Prote & Microbiol, B-7000 Mons, Belgium.	ruddy.wattiez@umh.ac.be	Surget, Sabine Matallana/AAM-1004-2020	Surget, Sabine Matallana/0000-0002-6023-3215; wattiez, ruddy/0000-0003-2071-4310; Leroy, Baptiste/0000-0001-7166-4478	European Space Agency (ESA-PRODEX); Belgian Federal Office; FNRS [2877824]	European Space Agency (ESA-PRODEX)(European Space Agency); Belgian Federal Office; FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the European Space Agency (ESA-PRODEX) and the Belgian Federal Office. This work was also partially financed by the FNRS under grant "grand equipement'' no. 2877824. Frederic Deschoenmaeker is an F.R.I.A. PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Asato Y, 2003, CELL MOL LIFE SCI, V60, P663, DOI 10.1007/s00018-003-2079-y; Axmann IM, 2009, J BACTERIOL, V191, P5342, DOI 10.1128/JB.00419-09; Barber J, 2003, PHOTOCH PHOTOBIO SCI, V2, P536, DOI 10.1039/b300063j; Barrios-Llerena Martin E., 2006, Briefings in Functional Genomics & Proteomics, V5, P121, DOI 10.1093/bfgp/ell021; Belay A., 2020, J AM NUTRACEUTICAL A, V5, P27; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; BINDER BJ, 1995, APPL ENVIRON MICROB, V61, P708, DOI 10.1128/AEM.61.2.708-717.1995; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Cogne G, 2003, BIOTECHNOL BIOENG, V81, P588, DOI 10.1002/bit.10504; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Doolittle W F, 1979, Adv Microb Physiol, V20, P1; Ekman M, 2006, MOL PLANT MICROBE IN, V19, P1251, DOI 10.1094/MPMI-19-1251; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Gan CS, 2005, PROTEOMICS, V5, P2468, DOI 10.1002/pmic.200401266; Hendrickx L, 2006, RES MICROBIOL, V157, P77, DOI 10.1016/j.resmic.2005.06.014; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Holtzendorff J, 2001, J BACTERIOL, V183, P915, DOI 10.1128/JB.183.3.915-920.2001; Hongsthong A, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-33; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Janssen PJ, 2010, J BACTERIOL, V192, P2465, DOI 10.1128/JB.00116-10; Johnson CH, 1996, MOL MICROBIOL, V21, P5, DOI 10.1046/j.1365-2958.1996.00613.x; Kim YO, 2006, PLANT CELL PHYSIOL, V47, P793, DOI 10.1093/pcp/pcj047; Koksharova OA, 2007, MICROBIOL-SGM, V153, P2505, DOI 10.1099/mic.0.2007/007039-0; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Mastroleo F, 2009, J PROTEOME RES, V8, P2530, DOI 10.1021/pr900007d; Matallana-Surget S, 2010, EXPERT REV PROTEOMIC, V7, P5, DOI [10.1586/epr.09.101, 10.1586/EPR.09.101]; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; MERGENHAGEN D, 1987, EUR J CELL BIOL, V43, P203; Mullineaux CW, 2009, J BACTERIOL, V191, P5333, DOI 10.1128/JB.00719-09; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Sergeyenko TV, 2000, FEMS MICROBIOL LETT, V193, P213, DOI 10.1016/S0378-1097(00)00482-1; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Tan XM, 2011, J BACTERIOL, V193, P2675, DOI 10.1128/JB.01454-10; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vonshak A., 1997, SPIRULINA PLATENSIS, P43; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang DN, 2013, INT J MOL SCI, V14, P9018, DOI 10.3390/ijms14059018; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; Zhang LF, 2009, J PROTEOME RES, V8, P2892, DOI 10.1021/pr900024w	49	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99076	10.1371/journal.pone.0099076	http://dx.doi.org/10.1371/journal.pone.0099076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914774	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700058
J	Su, ML; Chang, TM; Chiang, CH; Chang, HC; Hou, MF; Li, WS; Hung, WC				Su, Mei-Lin; Chang, Tsung-Ming; Chiang, Chi-Hsiang; Chang, Han-Chen; Hou, Ming-Feng; Li, Wen-Shan; Hung, Wen-Chun			Inhibition of Chemokine (C-C Motif) Receptor 7 Sialylation Suppresses CCL19-Stimulated Proliferation, Invasion and Anti-Anoikis	PLOS ONE			English	Article							CYCLIN D1 DEGRADATION; HUMAN BREAST-CANCER; UP-REGULATES CCR7; PROTEIN GLYCOSYLATION; DENDRITIC CELLS; SIALIC ACIDS; PHOSPHORYLATION; EXPRESSION; SURFACE; METASTASIS	Chemokine (C-C motif) receptor 7 (CCR7) is involved in lymph-node homing of naive and regulatory T cells and lymphatic metastasis of cancer cells. Sialic acids comprise a group of monosaccharide units that are added to the terminal position of the oligosaccharide chain of glycoproteins by sialyation. Recent studies suggest that aberrant sialylation of receptor proteins contributes to proliferation, motility, and drug resistance of cancer cells. In this study, we addressed whether CCR7 is a sialylated receptor protein and tried to elucidate the effect of sialylation in the regulation of signal transduction and biological function of CCR7. Our results demonstrated that alpha-2, 3-sialyltransferase which catalyze sialylation reaction in vivo was overexpressed in breast tumor tissues and cell lines. Lectin blot analysis clearly demonstrated that CCR7 receptor was sialyated in breast cancer cells. Chemokine (C-C motif) ligand 19 (CCL19), the cognate ligand for CCR7, induced the activation of extracellular signal-regulated kinase (ERK) and AKT signaling and increased the expression of cell cycle regulatory proteins and proliferation of breast cancer cells. When cells were pre-treated with a sialyltransferase inhibitor AL10 or sialidase, CCL19-induced cell growth was significantly suppressed. CCL19 also increased invasion and prevented anoikis by up-regulating pro-survival proteins Bcl-2 and Bcl-xL. Inhibition of sialylation by AL10 totally abolished these effects. Finally, we showed that AL10 inhibited tumorigenicity of breast cancer in experimental animals. Taken together, we demonstrate for the first time that CCR7 receptor is a sialylated protein and sialylation is important for the paracrine stimulation by its endogenous ligand CCL19. In addition, inhibition of aberrant sialylation of CCR7 suppresses proliferation and invasion and triggers anoikis in breast cancer cells. Targeting of sialylation enzymes may be a novel strategy for breast cancer treatment.	[Su, Mei-Lin; Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chang, Tsung-Ming; Chiang, Chi-Hsiang; Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Coll Med, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Dept Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Han-Chen; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei, Taiwan	National Sun Yat Sen University; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan	Li, WS (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.	wenshan@chem.sinica.edu.tw; hung1228@nhri.org.tw	Hung, Wen-Chun/F-4846-2011; Chiang, Chih-Po/AAZ-5092-2020; Li, Wen-Shan/F-1972-2015	Chiang, Chih-Po/0000-0002-5399-3902; Li, Wen-Shan/0000-0002-8359-4582; Hou, Ming-Feng/0000-0001-6030-9702	Excellence for Cancer Research Center Grant, the Ministry of Health and Welfare [MOHW103-TD-B-111-05]; National Science Council, Taiwan, Republic of China [NSC-102-2321-B-400-003]	Excellence for Cancer Research Center Grant, the Ministry of Health and Welfare; National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the grants: (1) MOHW103-TD-B-111-05 from Excellence for Cancer Research Center Grant, the Ministry of Health and Welfare and (2) NSC-102-2321-B-400-003 from National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Chiang CH, 2010, J CELL PHYSIOL, V223, P492, DOI 10.1002/jcp.22068; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Crespo HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00491; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Feng Q, 2007, ONCOGENE, V26, P5098, DOI 10.1038/sj.onc.1210309; Fodero LR, 2001, J NEUROCHEM, V79, P1022, DOI 10.1046/j.1471-4159.2001.00640.x; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hsu MC, 2008, MODERN PATHOL, V21, P609, DOI [10.1038/modpathol.2008.23, 10.1038/mpath.2008.23]; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kilker RL, 2004, J STEROID BIOCHEM, V92, P63, DOI 10.1016/j.jsbmb.2004.05.005; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; MAGUIRE TM, 1994, NEUROBIOL AGING, V15, P99, DOI 10.1016/0197-4580(94)90149-X; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Picco G, 2010, GLYCOBIOLOGY, V20, P1241, DOI 10.1093/glycob/cwq085; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Schneider F, 2001, CANCER RES, V61, P4605; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Vaites LP, 2011, MOL CELL BIOL, V31, P4513, DOI 10.1128/MCB.05733-11; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	43	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98823	10.1371/journal.pone.0098823	http://dx.doi.org/10.1371/journal.pone.0098823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915301	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700035
J	Wang, HQ; Yang, J; Zhang, XW; Yan, LN; Yang, JY				Wang, Haiqing; Yang, Jian; Zhang, Xiaowu; Yan, Lunan; Yang, Jiayin			Liver Resection in Hepatitis B-Related Hepatocellular Carcinoma: Clinical Outcomes and Safety in Overweight and Obese Patients	PLOS ONE			English	Article							BODY-MASS-INDEX; PERIOPERATIVE OUTCOMES; RESOURCE UTILIZATION; CHINESE ADULTS; COMPLICATIONS; SURGERY; HEPATECTOMY; CIRRHOSIS; IMPACT; CANCER	Objective and Background: Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory. The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular carcinoma in a large sample. Methods: In a retrospective cohort with 1543 hepatitis B-related hepatocellular carcinoma patients, the subjects were stratified into four groups according to their body mass index(BMI): obesity(BMI >= 28), overweight(BMI: 24.0-27.9), normal weight(BMI: 18.5-23.9) and underweight(BMI<18.5). The Dindo-Clavien classification system was used for grading complications. Clinical characteristics and operative outcomes were compared among the four groups. Risk factors for postoperative complications were evaluated by multivariate analysis. Results: According to the category criteria of the Working Group on Obesity in China (WGOC) criteria, 73(4.7%) obese, 412(26.7%) overweight, 982(63.6%) normal weight and 76(4.9%) underweight patients were included in our cohort. Overweight and obese patients had more preoperative comorbidities such as hypertension(P<0.001). Mortality, total complications and complications classified by Clavien system were similar among the four groups except that the underweight patients had fewer total complications. However, postoperative wound complication was more common in overweight and obese patients(6.3% vs 2.5%, P<0.001,11.0% vs 2.5%, P = 0.001). Multivariate analysis revealed that BMI was not an independently significant factor for postoperative complications. Conclusions: Liver resection for obese and overweight patients is safe and BMI itself is not a risk factor for mortality and morbidity.	[Wang, Haiqing; Yang, Jian; Zhang, Xiaowu; Yan, Lunan; Yang, Jiayin] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China	Sichuan University	Yang, JY (corresponding author), Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu 610064, Peoples R China.	yangjygyz@163.com			National Science and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Science and Technology Major Project of China	This work was supported by National Science and Technology Major Project of China, No. 2012ZX10002-016 and No. 2012ZX10002-017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzan S, 2010, WORLD J SURG, V34, P2960, DOI 10.1007/s00268-010-0756-1; Bower M, 2013, AM J SURG, V205, P685, DOI 10.1016/j.amjsurg.2012.07.034; Breitenstein S, 2010, ANN SURG, V252, P726, DOI 10.1097/SLA.0b013e3181fb8c1a; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cucchetti A, 2011, BRIT J SURG, V98, P1147, DOI 10.1002/bjs.7516; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Dindo D, 2003, LANCET, V361, P2032, DOI 10.1016/S0140-6736(03)13640-9; Gedaly R, 2009, ANN SURG, V249, P414, DOI 10.1097/SLA.0b013e31819a032d; Hawn MT, 2005, ANN SURG, V241, P821, DOI 10.1097/01.sla.0000161044.20857.24; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Itoh S, 2012, J SURG RES, V178, P640, DOI 10.1016/j.jss.2012.05.063; Mathur AK, 2010, J GASTROINTEST SURG, V14, P1285, DOI 10.1007/s11605-010-1232-9; Mathur AK, 2010, J GASTROINTEST SURG, V14, P849, DOI 10.1007/s11605-010-1163-5; Mullen JT, 2008, ANN SURG ONCOL, V15, P2164, DOI 10.1245/s10434-008-9990-2; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Okamura Y, 2012, J HEPATO-BIL-PAN SCI, V19, P449, DOI 10.1007/s00534-011-0461-y; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Saunders JK, 2012, ARCH SURG-CHICAGO, V147, P331, DOI 10.1001/archsurg.2011.1404; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Vigano L, 2011, HPB, V13, P103, DOI 10.1111/j.1477-2574.2010.00252.x; Wen TF, 2007, HEPATOL RES, V37, P346, DOI 10.1111/j.1872-034X.2007.00061.x; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	30	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99281	10.1371/journal.pone.0099281	http://dx.doi.org/10.1371/journal.pone.0099281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914932	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700077
J	Zhang, YC; Zhang, J; Song, TT; Li, JY; Tian, J; Jin, KN; Yao, YC				Zhang, Yanchen; Zhang, Jie; Song, Tingting; Li, Jinyan; Tian, Ji; Jin, Kaina; Yao, Yuncong			Low Medium pH Value Enhances Anthocyanin Accumulation in Malus Crabapple Leaves	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; FLAVONOID BIOSYNTHESIS; RED COLORATION; COLORFUL MODEL; FLOWER COLOR; APPLE FRUIT; EXPRESSION; PETUNIA; GENE; PROTEIN	Anthocyanin is a critical factor involved in coloration of plant tissues, but the mechanism how medium pH values affect anthocyanin accumulation in woody plants is unknown. We analyzed anthocyanin composition and the expression of elements encoding anthocyanin and flavonols biosynthesis underlying different medium pH values by using three different leave color type cultivars. HPLC analysis demonstrated that high medium pH values treatment induced a dramatic decrease in the concentration of cyaniding in crabapple leaves. Conversely, the high medium pH values induced up-regulation of the content of flavones and flavonols, suggesting that low pH treatment-induced anthocyanin accumulation. Quantitative real time PCR experiment showed the expression level of anthocyanidin synthase (McANS) and uridine diphosphate glucose flavonoid 3-O-glucosyltransferase (McUFGT) was up-regulated by low pH values treatment, and high medium pH value treatment up-regulate the transcription level of flavonol synthase (McFLS). Meanwhile, several MYB TFs have been suggested in the regulation of pH responses. These results strongly indicate that the low pH treatment-induced anthocyanin accumulation is mediated by the variation of mRNA transcription of the anthocyanin biosynthetic genes.	[Zhang, Yanchen; Zhang, Jie; Song, Tingting; Li, Jinyan; Tian, Ji; Jin, Kaina; Yao, Yuncong] Beijing Agr Univ, Plant Sci & Technol Coll, Beijing 100094, Peoples R China; [Zhang, Jie; Song, Tingting; Tian, Ji; Yao, Yuncong] Beijing Agr Univ, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture	Yao, YC (corresponding author), Beijing Agr Univ, Plant Sci & Technol Coll, Beijing 100094, Peoples R China.	yaoyc_20@126.com			Beijing Municipal Education Commission [PXM2012_014207_000036]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR20110515]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [IDHT20140509]; National Natural Science Foundation of China [31301762]	Beijing Municipal Education Commission(Beijing Municipal Commission of Education); Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the science and technology project of Beijing Municipal Education Commission (PXM2012_014207_000036) and the Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR20110515), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (IDHT20140509) and the National Natural Science Foundation of China (31301762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowska A, 2003, FOOD CHEM, V81, P349, DOI 10.1016/S0308-8146(02)00429-6; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; CARRENO J, 1995, FOOD RES INT, V28, P373, DOI 10.1016/0963-9969(95)00008-A; DEVLAMING P, 1983, THEOR APPL GENET, V66, P271, DOI 10.1007/BF00251158; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2013, PLANT BIOTECHNOL J, V11, P408, DOI 10.1111/pbi.12017; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Fraser LG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-28; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Gutha LR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-187; Henry-Kirk RA, 2012, J EXP BOT, V63, P5437, DOI 10.1093/jxb/ers193; Honda T, 2002, HETEROCYCLES, V56, P633, DOI 10.3987/REV-01-SR(K)2; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Palapol Y, 2009, PLANTA, V229, P1323, DOI 10.1007/s00425-009-0917-3; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Shen HX, 2012, ACTA PHYSIOL PLANT, V34, P1353, DOI 10.1007/s11738-012-0932-z; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Telias A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-93; Tian J, 2011, SCI HORTIC-AMSTERDAM, V129, P449, DOI 10.1016/j.scienta.2011.04.015; Wadl PA, 2010, EUPHYTICA, V176, P99, DOI 10.1007/s10681-010-0219-7; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu XL, 2005, J AGR FOOD CHEM, V53, P3101, DOI 10.1021/jf0478861; YOSHIDA K, 1995, NATURE, V373, P291, DOI 10.1038/373291a0; Zhou XR, 2008, NEW PHYTOL, V178, P532, DOI 10.1111/j.1469-8137.2008.02384.x	27	26	30	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97904	10.1371/journal.pone.0097904	http://dx.doi.org/10.1371/journal.pone.0097904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914811	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700013
J	Dourado, M; Wong, E; Hackos, DH				Dourado, Michelle; Wong, Evera; Hackos, David H.			Pannexin-1 Is Blocked by Its C-Terminus through a Delocalized Non-Specific Interaction Surface	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; FIND-ME SIGNAL; ATP RELEASE; INFLAMMASOME ACTIVATION; P2X(7) RECEPTOR; 1 CHANNELS; FAMILY; HEMICHANNELS; MEMBRANE; INACTIVATION	The Pannexin-1 (Panx1) channel is known to become activated under a variety of physiological conditions resulting in the release of medium-sized molecules such as ATP and amino acids from the cell. The detailed molecular mechanism of activation of the channel resulting in the opening of the Pannexin pore is poorly understood. The best-studied gating mechanism is caspase-3/7-mediated cleavage and truncation of the c-terminus. In the absence of caspase-cleavage, the cterminal peptide maintains the channel in the closed state, possibly by directly plugging the pore from the intracellular side. We sought to understand in detail the part of the c-terminus necessary for this interaction by alanine-scanning and truncation mutagenesis of the c-terminal gating peptide. These experiments demonstrate that no single amino acid sidechain is necessary for this interaction. In fact, replacing blocks of 10-12 amino acids in different parts of the c-terminal peptide with alanines fails to disrupt the ability of the c-terminus to keep the channel closed. Surprisingly, even replacing the entire c-terminal gating peptide with a scrambled peptide of the same length maintains the interaction in some cases. Further analysis revealed that the interaction surface, while delocalized, is located within the amino-terminal two-thirds of the c-terminal peptide. Such a delocalized and potentially low-affinity interaction surface is allowed due to the high effective concentration of the c-terminal peptide near the inner vestibule of the pore and likely explains why this region is poorly conserved between species. This type of weak interaction with a tethered gating peptide may be required to maintain high-sensitivity to caspase-dependent activation.	[Dourado, Michelle; Wong, Evera; Hackos, David H.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Roche Holding; Genentech	Hackos, DH (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	davidhh@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This research has been supported by Genentech, Inc., a for-profit pharmaceutical company. The funder provided support in the form of salaries for authors (DHH, EW, MD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Ma WH, 2012, PFLUG ARCH EUR J PHY, V463, P585, DOI 10.1007/s00424-012-1077-z; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Wang HB, 2013, PROTEIN CELL, V4, P259, DOI 10.1007/s13238-013-2114-1; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	34	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99596	10.1371/journal.pone.0099596	http://dx.doi.org/10.1371/journal.pone.0099596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911976	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600108
J	Micale, G; Pulvirenti, A; Giugno, R; Ferro, A				Micale, Giovanni; Pulvirenti, Alfredo; Giugno, Rosalba; Ferro, Alfredo			GASOLINE: a Greedy And Stochastic algorithm for Optimal Local multiple alignment of Interaction NEtworks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; CONSERVED PATHWAYS; DATABASE; YEAST; TOOL	The analysis of structure and dynamics of biological networks plays a central role in understanding the intrinsic complexity of biological systems. Biological networks have been considered a suitable formalism to extend evolutionary and comparative biology. In this paper we present GASOLINE, an algorithm for multiple local network alignment based on statistical iterative sampling in connection to a greedy strategy. GASOLINE overcomes the limits of current approaches by producing biologically significant alignments within a feasible running time, even for very large input instances. The method has been extensively tested on a database of real and synthetic biological networks. A comprehensive comparison with state-of-the art algorithms clearly shows that GASOLINE yields the best results in terms of both reliability of alignments and running time on real biological networks and results comparable in terms of quality of alignments on synthetic networks. GASOLINE has been developed in Java, and is available, along with all the computed alignments, at the following URL: http://ferrolab.dmi.unict.it/gasoline/gasoline.html.	[Micale, Giovanni] Univ Pisa, Dept Comp Sci, Pisa, Italy; [Pulvirenti, Alfredo; Giugno, Rosalba; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy	University of Pisa; University of Catania	Giugno, R (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	apulvirenti@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Micale, Giovanni/AAT-2092-2021	Pulvirenti, Alfredo/0000-0002-9764-0295; Micale, Giovanni/0000-0002-4953-026X; Giugno, Rosalba/0000-0001-9843-7638	Programma Operativo Fondo Europeo per lo Sviluppo Regionale (PO-FESR); Linea di intervento [CUP G23F11000840004]	Programma Operativo Fondo Europeo per lo Sviluppo Regionale (PO-FESR); Linea di intervento	This work has been partially founded by Programma Operativo Fondo Europeo per lo Sviluppo Regionale (PO-FESR) 2007-2013), Linea di intervento 4.1.1.2. Grant number: CUP G23F11000840004. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banks E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r138; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; Bonnici V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S13; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Dost B, 2007, LECT NOTES COMPUT SC, V4453, P1; Ferro A, 2007, BIOINFORMATICS, V23, P910, DOI 10.1093/bioinformatics/btm032; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Giugno R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076911; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Jiawei H., 2001, DATA MINING CONCEPTS, P5; Kalaev M, 2009, J COMPUT BIOL, V16, P989, DOI 10.1089/cmb.2009.0136; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Osman A, 2004, METH MOL B, V270, P403; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Qian XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008070; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Sahraeian SME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067995; Sahraeian SME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041474; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	36	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98750	10.1371/journal.pone.0098750	http://dx.doi.org/10.1371/journal.pone.0098750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911103	gold, Green Submitted, Green Published			2022-12-27	WOS:000337165600011
J	Gregory, AJ; Beck, JL				Gregory, Andrew J.; Beck, Jeffrey L.			Spatial Heterogeneity in Response of Male Greater Sage-Grouse Lek Attendance to Energy Development	PLOS ONE			English	Article							WINTER HABITAT SELECTION; REGRESSION	Landscape modification due to rapidly expanding energy development, in particular oil and gas, in the westernUSA, have prompted concerns over how such developments may impact wildlife. One species of conservation concern across much of the Intermountain West is the greater sage-grouse (Centrocercusurophasianus). Sage-grouse have been petitioned for listing under provisions of the Endangered Species Act 7 times and the state of Wyoming alone represents 64% of the extant sage-grouse population in the eastern portion of their range. Consequently, the relationship between sage-grouse populations and oil and gas development in Wyoming is an important component to managing the long-term viability of this species. We used 814 leks from the Wyoming Game and Fish Department's lek survey database and well pad data from the Wyoming Oil and Gas Conservation Commission to evaluate changes in sage-grouse lek counts as a function of oil and gas development since 1991. From 1991-2011 we found that oil and gas well-pad density increased 3.6-fold across the state and was associated with a 24% decline in the number of male sage-grouse. Using a spatial and temporally structured analysis via Geographically Weighted Regression, we found a 1-to-4 year time lag between development density and lek decline. Sage-grouse also responded to development densities at multiple spatial neighborhoods surrounding leks, including broad scales of 10 km. However, sage-grouse lek counts do not always decline as a result of oil and gas development. We found similar development densities resulting in different sage-grouse lek count responses, suggesting that development density alone is insufficient to predict the impacts that oil and gas development have on sage-grouse. Finally, our analysis suggests a maximum development density of 1 well-pad within 2 km of leks to avoid measurable impacts within 1 year, and <6 well-pads within 10 km of leks to avoid delayed impacts.	[Gregory, Andrew J.] Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA; [Beck, Jeffrey L.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA	University System of Ohio; Bowling Green State University; University of Wyoming	Gregory, AJ (corresponding author), Bowling Green State Univ, Sch Earth Environm & Soc, Bowling Green, OH 43403 USA.	agregor@bgsu.edu		Gregory, Andrew/0000-0003-1905-3236	Northern Arizona University; Gordon and Betty Moore Foundation; University of Wyoming	Northern Arizona University; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Wyoming	The Wyoming Game and Fish Department provided funding for our study. Support for A. Gregory was provided by Northern Arizona University and a grant from the Gordon and Betty Moore Foundation. Support for J. Beck was provided by the University of Wyoming. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; American Gas Association, 2013, STAT PROF NAT GAS; American Wind Energy Association, 2013, STAT FACT SHEETS; Charlton M., 2003, GWR 3 SOFTWARE GEOGR; Charlton M., 2009, GEOGRAPHICALLY WEIGH; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cleveland WS, 1996, TECHNICAL REPORT; Connelly JW, 2011, STUD AVIAN BIOL, P53; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Doherty K. E., 2008, THESIS U MONTANA MIS; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; Ellis EC, 2008, ANTHROPOGENICBIOMES; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fedy BC, 2011, J WILDLIFE MANAGE, V75, P1022, DOI 10.1002/jwmg.155; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gamo R.S., 2013, WILDL PROF, V7, P56; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Hagen C.A., 2010, T 75 N AM WILDL NAT, V75, P96; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hess JE, 2012, J WILDLIFE MANAGE, V76, P1625, DOI 10.1002/jwmg.417; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hornaday W.T., 1916, NEW YORK ZOOLOGICAL, V5, P179; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; International Energy Agency, 2008, WORLD EN OUTL 2008; JENNI DA, 1978, J WILDLIFE MANAGE, V42, P46, DOI 10.2307/3800688; Johnson DH, 2011, STUD AVIAN BIOL, P407; Long J.S., 2006, REGRESSION MODELS CA; Noss R. F., 1994, SAVING NATURES LEGAC; R Core Team, 2012, R LANG ENV STAT COMP; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Schwarz CJ, 2001, J AGR BIOL ENVIR ST, V6, P195, DOI 10.1198/108571101750524706; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V75, P13909; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433	41	29	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97132	10.1371/journal.pone.0097132	http://dx.doi.org/10.1371/journal.pone.0097132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918922	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000008
J	Ueda, S; Kumagai, G; Otaki, Y; Yamaguchi, S; Kohshima, S				Ueda, Sayoko; Kumagai, Gaku; Otaki, Yusuke; Yamaguchi, Shinya; Kohshima, Shiro			A Comparison of Facial Color Pattern and Gazing Behavior in Canid Species Suggests Gaze Communication in Gray Wolves (Canis lupus)	PLOS ONE			English	Article							PIGMENTATION GENES; UNIQUE MORPHOLOGY; VISION; EYE	As facial color pattern around the eyes has been suggested to serve various adaptive functions related to the gaze signal, we compared the patterns among 25 canid species, focusing on the gaze signal, to estimate the function of facial color pattern in these species. The facial color patterns of the studied species could be categorized into the following three types based on contrast indices relating to the gaze signal: A-type (both pupil position in the eye outline and eye position in the face are clear), B-type (only the eye position is clear), and C-type (both the pupil and eye position are unclear). A-type faces with light-colored irises were observed in most studied species of the wolf-like clade and some of the red fox-like clade. A-type faces tended to be observed in species living in family groups all year-round, whereas B-type faces tended to be seen in solo/pair-living species. The duration of gazing behavior during which the facial gaze-signal is displayed to the other individual was longest in gray wolves with typical A-type faces, of intermediate length in fennec foxes with typical B-type faces, and shortest in bush dogs with typical C-type faces. These results suggest that the facial color pattern of canid species is related to their gaze communication and that canids with A-type faces, especially gray wolves, use the gaze signal in conspecific communication.	[Ueda, Sayoko] Tokyo Inst Technol, Tokyo 152, Japan; [Kumagai, Gaku] Tokyo Zool Pk Soc, Tama Zool Pk, Tokyo, Japan; [Otaki, Yusuke; Yamaguchi, Shinya] Yokohama Zool Gardens, Yokohama, Kanagawa, Japan; [Ueda, Sayoko; Kohshima, Shiro] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan	Tokyo Institute of Technology; Kyoto University	Ueda, S (corresponding author), Tokyo Inst Technol, Tokyo 152, Japan.	sykueda.ookami@gmail.com			21st century COE program [K11]; Global COE program [K03]; JSPS core-to-core program of Japan Society for the Promotion of Science	21st century COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS core-to-core program of Japan Society for the Promotion of Science	This research was partly supported by 21st century COE program (Grant No. K11), Global COE program (Grant No. K03) and JSPS core-to-core program (A. Advanced Research Networks) of Japan Society for the Promotion of Science (www.jsps.go.jp). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Angerbjorn A., 2004, CANIDS FOXES WOLVES, P117; Asa C., 2004, CANIDS FOXES WOLVES, P205; Bauer EA, 1994, WILD DOGS WOLVES COY; Chaplin G, 2004, AM J PHYS ANTHROPOL, V125, P292, DOI 10.1002/ajpa.10263; Clark Howard O. Jr., 2009, Mammalian Species, P1, DOI 10.1644/832.1; Corbett L., 2004, CANIDS FOXES WOLVES, P223; Cott H.B., 1940, ADAPTIVE COLORATION; Fox M., 1971, BEHAV WOLVES DOGS RE; GOODMANN PA, 2002, WOLF ETHOGRAM ETHOLO, V3; IKEDA H, 1991, Japanese Journal of Ecology (Tokyo), V41, P263; Imaizumi T, 1993, WILD DOGS YASEI NO I; Imaizumi T, 1995, ENCY HUNTING ANIMALS; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; KLEIMAN DG, 1973, ANIM BEHAV, V21, P637, DOI 10.1016/S0003-3472(73)80088-0; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Leboeuf D, 1996, WOLF GHOST HUNTER; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Macdonald D.W., 2004, CANIDS FOXES WOLVES, P129; Mech L. D., 2004, CANIDS FOXES WOLVES, P124; Mech L.D., 1991, WAY WOLF; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miller PE, 1995, J AM VET MED ASSOC, V207, P1623; Obee B, 1994, WOLF WILD HUNTER N A; QUEVEDO WC, 1985, J HUM EVOL, V14, P43, DOI 10.1016/S0047-2484(85)80094-4; Range F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016888; Robbins RL, 2000, BEHAVIOUR, V137, P1271, DOI 10.1163/156853900501926; SCHENKEL R, 1967, AM ZOOL, V7, P319; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Tighem KV, 1999, PREDATORS WILD DOGS; Vienot F, 1999, COLOR RES APPL, V24, P243, DOI 10.1002/(SICI)1520-6378(199908)24:4<243::AID-COL5>3.0.CO;2-3; WOODROFFE R, 2004, CANIDS FOXES WOLVES, P174; Zimen E, 1990, WOLF VERHALTEN OKOLO; Zuercher G.L., 2004, CANIDS FOXES WOLVES, P76	38	13	14	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98217	10.1371/journal.pone.0098217	http://dx.doi.org/10.1371/journal.pone.0098217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918751	Green Published, gold			2022-12-27	WOS:000338631000013
J	Chew, M; Rahim, AA; Ross, OB				Chew, Melvin; Rahim, Azman Abdul; Ross, Othman bin Haji			Tinggianthura alba: A New Genus and Species of Anthuridae (Isopoda, Cymothoida, Anthuroidea) from Pulau Tinggi, Johor, Malaysia with an Updated Key to the Genera of Anthuridae	PLOS ONE			English	Article							TIOMAN ARCHIPELAGO; CRUSTACEA	A new anthurid isopod from dead coral rubble and stones in the intertidal area of Pulau Tinggi, Johor, Malaysia, is described. It is placed in a new genus and species, Tinggianthura alba. Tinggianthura is characterized by: (1) subtriangular carpus shape of pereopods 4-7, (2) pereopod 1 propodus palm without prominent tooth or steps and (3) maxillipedal palp 2-articled.	[Chew, Melvin; Rahim, Azman Abdul; Ross, Othman bin Haji] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Dept Marine Sci, Bangi 43600, Selangor, Malaysia; [Rahim, Azman Abdul; Ross, Othman bin Haji] Univ Kebangsaan Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr EKOMAR, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Rahim, AA (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Dept Marine Sci, Bangi 43600, Selangor, Malaysia.	abarahim@gmail.com	Rahim, Azman Abdul/AAJ-8832-2020	Rahim, Azman Abdul/0000-0002-8964-6638	Universiti Kebangsaan Malaysia [DIP-2012-020, GUP-2012-057]	Universiti Kebangsaan Malaysia	This work was supported by Universiti Kebangsaan Malaysia, grant numbers: DIP-2012-020 and GUP-2012-057 (www.ukm.my). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt A, 2003, INVERTEBR SYST, V17, P893, DOI 10.1071/IS02032; Muller Hans-Georg, 1993, Mitteilungen aus dem Zoologischen Museum in Berlin, V69, P19; MULLER HG, 1992, REV SUISSE ZOOL, V99, P369, DOI 10.5962/bhl.part.79835; MULLER HG, 1992, CAH BIOL MAR, V33, P179; MULLER HG, 1992, ZOOL ANZ, V228, P156; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negoescu Ileana, 1997, Travaux du Museum National d'Histoire Naturelle "Grigore Antipa", V38, P177; Poore GCB, 2009, ZOOKEYS, P171, DOI 10.3897/zookeys.18.198; Poore GCB, 2001, CRUSTACEAN ISS, V13, P63	9	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99072	10.1371/journal.pone.0099072	http://dx.doi.org/10.1371/journal.pone.0099072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914642	gold, Green Published			2022-12-27	WOS:000340947700057
J	Hsieh, TY; Nillegoda, NB; Tyedmers, J; Bukau, B; Mogk, A; Kramer, G				Hsieh, Tzung-yang; Nillegoda, Nadinath B.; Tyedmers, Jens; Bukau, Bernd; Mogk, Axel; Kramer, Guenter			Monitoring Protein Misfolding by Site-Specific Labeling of Proteins In Vivo	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBE	Incorporating fluorescent amino acids by suppression of the TAG amber codon is a useful tool for site-specific labeling of proteins and visualizing their localization in living cells. Here we use a plasmid encoded orthogonal tRNA/aminoacyl-tRNA synthetase pair to site-specifically label firefly luciferase with the environmentally sensitive fluorescent amino acid, 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (ANAP) and explore the detectability of conformational changes in labeled luciferase in the yeast cytoplasm. We find that ANAP labeling efficiency is greatly increased in [PSI+] cells and show that analysis of the ANAP fluorescence emission by confocal imaging allows for tracking the thermal unfolding and aggregation of luciferase in vivo. Furthermore we demonstrate that flow cytometry can be used to study conformational changes in luciferase and chaperone-mediated refolding in quantitative terms and at the level of single cells. This experimental setup for the first time allows for the direct analysis of the folding state of a protein in living cells and may serve as valuable new tool for examining mechanisms of protein folding, misfolding and aggregation.	[Hsieh, Tzung-yang; Nillegoda, Nadinath B.; Tyedmers, Jens; Bukau, Bernd; Mogk, Axel; Kramer, Guenter] Univ Heidelberg ZMBH, Deutsch Krebsforschungszentrum DKFZ, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kramer, G (corresponding author), Univ Heidelberg ZMBH, Deutsch Krebsforschungszentrum DKFZ, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany.	g.kramer@zmbh.uni-heidelberg.de		Nillegoda, Nadinath/0000-0002-9980-3991; Kramer, Gunter/0000-0001-7552-8393; Bukau, Bernd/0000-0003-0521-7199	Deutsche Forschungsgemeinschaft (DFG) [SFB638]; Alexander von Humboldt Stiftung; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	This work was supported by the SFB638 of the Deutsche Forschungsgemeinschaft (DFG) to G.K. and B.B., a postdoc fellowship of the Alexander von Humboldt Stiftung to N.B.N. and a PhD scholarship of the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) to T.Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Chatterjee A, 2013, J AM CHEM SOC, V135, P12540, DOI 10.1021/ja4059553; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Dobson Christopher M., 1998, EMBO (European Molecular Biology Organization) Journal, V17, P5251, DOI 10.1093/emboj/17.18.5251; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025	18	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99395	10.1371/journal.pone.0099395	http://dx.doi.org/10.1371/journal.pone.0099395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915041	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700096
J	Neugebauer, JM; Collins, KH; Hawkins, DA				Neugebauer, Jennifer M.; Collins, Kelsey H.; Hawkins, David A.			Ground Reaction Force Estimates from ActiGraph GT3X+Hip Accelerations	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; CUT-POINTS; WALKING; ACCELEROMETRY; CALIBRATION; ASYMMETRY; EXERCISE; VALIDITY	Simple methods to quantify ground reaction forces (GRFs) outside a laboratory setting are needed to understand daily loading sustained by the body. Here, we present methods to estimate peak vertical GRF (pGRFvert) and peak braking GRF (pGRFbrake) in adults using raw hip activity monitor (AM) acceleration data. The purpose of this study was to develop a statistically based model to estimate pGRFvert and pGRFbrake during walking and running from ActiGraph GT3X+ AM acceleration data. 19 males and 20 females (age 21.2 +/- 1.3 years, height 1.73 +/- 0.12 m, mass 67.6 +/- 11.5 kg) wore an ActiGraph GT3X+ AM over their right hip. Six walking and six running trials (0.95-2.19 and 2.20-4.10 m/s, respectively) were completed. Average of the peak vertical and anterior/posterior AM acceleration (ACCvert and ACCbrake, respectively) and pGRFvert and pGRFbrake during the stance phase of gait were determined. Thirty randomly selected subjects served as the training dataset to develop generalized equations to predict pGRFvert and pGRFbrake. Using a holdout approach, the remaining 9 subjects were used to test the accuracy of the models. Generalized equations to predict pGRFvert and pGRFbrake included ACCvert and ACCbrake, respectively, mass, type of locomotion (walk or run), and type of locomotion acceleration interaction. The average absolute percent differences between actual and predicted pGRFvert and pGRFbrake were 8.3% and 17.8%, respectively, when the models were applied to the test dataset. Repeated measures generalized regression equations were developed to predict pGRFvert and pGRFbrake from ActiGraph GT3X+ AM acceleration for young adults walking and running. These equations provide a means to estimate GRFs without a force plate.	[Neugebauer, Jennifer M.; Hawkins, David A.] Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA; [Collins, Kelsey H.; Hawkins, David A.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hawkins, DA (corresponding author), Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA.	dahawkins@ucdavis.edu		Neugebauer, Jennifer/0000-0001-8886-7976	College of Biological Sciences at the University of California-Davis; University of California T32 Pre-Doctoral Clinical Research Training Program; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024146]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	College of Biological Sciences at the University of California-Davis; University of California T32 Pre-Doctoral Clinical Research Training Program; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by the College of Biological Sciences at the University of California-Davis along with a small gift from Actigraph. This work was partially supported by funding from the University of California T32 Pre-Doctoral Clinical Research Training Program. Statistical advice was made possible by Grant Number UL1 RR024146 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph Support, 2013, WHAT AR COUNTS ACTIG; Ahola R, 2010, J BIOMECH, V43, P1960, DOI 10.1016/j.jbiomech.2010.03.021; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; BASSEY EJ, 1995, BONE, V16, P469; Bassey EJ, 1998, J BONE MINER RES, V13, P1805, DOI 10.1359/jbmr.1998.13.12.1805; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Brooks AG, 2005, MED SCI SPORT EXER, V37, P1216, DOI 10.1249/01.mss.0000170074.19649.0e; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Christiansen CL, 2011, ARCH PHYS MED REHAB, V92, P1624, DOI 10.1016/j.apmr.2011.05.010; Colby E, 2013, J PHARMACOKINET PHAR, V40, P243, DOI 10.1007/s10928-013-9313-5; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Crouter SE, 2013, J PHYS ACT HEALTH, V10, P504, DOI 10.1123/jpah.10.4.504; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Diggle PJ, 1994, ANAL LONGITUDINAL DA, P379; Divert C, 2005, INT J SPORTS MED, V26, P593, DOI 10.1055/s-2004-821327; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garcia A. W., 2004, MEASURE PHYS ED EXER, V8, P119, DOI DOI 10.1207/S15327841MPEE0803_1; Hall KS, 2013, MED SCI SPORT EXER, V45, P574, DOI 10.1249/MSS.0b013e318276c73c; Jamsa T, 2006, CLIN BIOMECH, V21, P1, DOI 10.1016/j.clinbiomech.2005.10.003; Janz KF, 2003, PEDIATR EXERC SCI, V15, P34, DOI 10.1123/pes.15.1.34; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kohrt WM, 1997, J BONE MINER RES, V12, P1253, DOI 10.1359/jbmr.1997.12.8.1253; Laughton CA, 2003, J APPL BIOMECH, V19, P153, DOI 10.1123/jab.19.2.153; Little C, 2013, J SPORT SCI, V31, P1312, DOI 10.1080/02640414.2013.779739; Long X, 2009, IEEE ENG MED BIO, P6107, DOI 10.1109/IEMBS.2009.5334925; Loprinzi PD, 2012, RES Q EXERCISE SPORT, V83, P422; Mercer JA, 2003, MED SCI SPORT EXER, V35, P307, DOI 10.1249/01.MSS.0000048837.81430.E7; Neugebauer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048182; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Peterson CL, 2011, GAIT POSTURE, V33, P562, DOI 10.1016/j.gaitpost.2011.01.010; Rowlands AV, 2012, J BIOMECH, V45, P448, DOI 10.1016/j.jbiomech.2011.12.006; Zifchock RA, 2006, J BIOMECH, V39, P2792, DOI 10.1016/j.jbiomech.2005.10.003	35	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99023	10.1371/journal.pone.0099023	http://dx.doi.org/10.1371/journal.pone.0099023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914946	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700050
J	Woo, J; Park, H; Sung, SH; Moon, BI; Suh, H; Lim, W				Woo, Joohyun; Park, Heejung; Sung, Sun Hee; Moon, Byung-In; Suh, Hyunsuk; Lim, Woosung			Prognostic Value of Human Apurinic/Apyrimidinic Endonuclease 1 (APE1) Expression in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DNA-DAMAGING AGENTS; REPAIR; LOCALIZATION; HAP1; TRANSCRIPTION; APE1/REF-1; HAP1/REF-1; RESISTANCE; APE/REF-1	Human apurinic/apyrimidinic endonuclease 1 (APE1) is an essential protein for DNA base excision repair (BER) and redox regulation. The ability of cancer cells to recognize DNA damage and initiate DNA repair is an important mechanism for therapeutic resistance. Several recent studies have suggested that APE1 expression levels and/or subcellular dysregulation may be used to indicate the sensitivity of tumors to radiotherapy or chemotherapy. In this study, we assessed the prognostic significance of APE1 and differences in APE1 expression levels according to breast cancer molecular subtypes. We analyzed formalin-fixed, paraffin-embedded tumor tissue sections from 243 cases diagnosed as invasive breast cancer at Ewha Womans University Medical Center between January 2003 and December 2008. Immunohistochemistry was performed and the nuclear level of APE1 was scored by taking into account the percentage of positive cells. Medical records were reviewed to investigate clinicopathologic characteristics. We found that nuclear APE1 high-level expression (proportion >= 50%) in breast cancer showed a tendency towards unfavorable prognosis regarding disease-free survival (p = 0.093). However, there was no significant difference in overall survival between low and high-level expression groups (p = 0.294). Interestingly, within the Ki-67 low-level expression group, APE1 low-level expression was significantly associated with poor overall survival (p = 0.007). A significant positive correlation was observed between APE1 nuclear expression and estrogen receptor status (75.7% vs. 59.7%, p = 0.022). Also, the luminal A subtype was the most commonly observed breast cancer subtype in the APE1 high-level expression group (61.6% vs. 45.2%, p = 0.000). This study suggests that APE1 expression may be associated with breast cancer prognosis. In particular, its role as a prognostic factor would be significant for breast cancers with a low Ki-67 proliferation index. It is proposed that nuclear APE1 may be a novel target in breast cancer with a low proliferation rate to obtain better outcome.	[Woo, Joohyun; Moon, Byung-In; Lim, Woosung] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Surg, Seoul, South Korea; [Park, Heejung; Sung, Sun Hee] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Pathol, Seoul, South Korea; [Suh, Hyunsuk] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Plast Surg, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Lim, W (corresponding author), Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Surg, Seoul, South Korea.	limw@ewha.ac.kr			Ewha Womans University Research Grant	Ewha Womans University Research Grant	This work was supported by a 2010 Ewha Womans University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attar A, 2010, BRIT J CANCER, V102, P704, DOI 10.1038/sj.bjc.6605541; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; Kakolyris S, 1998, BRIT J CANCER, V77, P1169, DOI 10.1038/bjc.1998.194; Kakolyris S, 1999, J PATHOL, V189, P351, DOI 10.1002/(SICI)1096-9896(199911)189:3<351::AID-PATH435>3.0.CO;2-1; Koukourakis MI, 2001, INT J RADIAT ONCOL, V50, P27, DOI 10.1016/S0360-3016(00)01561-3; Li M, 2013, HUMAN APURINIC APYRI, V1; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Moore DH, 2000, CLIN CANCER RES, V6, P602; Poletto M, 2012, BIOCHEM BIOPH RES CO, V424, P34, DOI 10.1016/j.bbrc.2012.06.039; Puglisi F, 2002, ONCOL REP, V9, P11; REMMELE W, 1987, PATHOLOGE, V8, P138; Robertson KA, 2001, CANCER RES, V61, P2220; ROBSON CN, 1992, NUCLEIC ACIDS RES, V20, P4417, DOI 10.1093/nar/20.17.4417; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Schultz-Norton JR, 2006, MOL ENDOCRINOL, V20, P1982, DOI 10.1210/me.2006-0006; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wang D, 2004, MOL CANCER THER, V3, P679; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23	25	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99528	10.1371/journal.pone.0099528	http://dx.doi.org/10.1371/journal.pone.0099528			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914806	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700112
J	Wu, JS; Kao, EF; Lee, CN				Wu, Jain-Shing; Kao, E-Fong; Lee, Chung-Nan			Discovering Hidden Connections among Diseases, Genes and Drugs Based on Microarray Expression Profiles with Negative-Term Filtering	PLOS ONE			English	Article							THYMIDINE PHOSPHORYLASE; GEFITINIB; INHIBITOR; APOPTOSIS; CANCER; DIFFERENTIATION; COMBINATION; PREDICTION; LYMPHOMA; TOOL	Microarrays based on gene expression profiles (GEPs) can be tailored specifically for a variety of topics to provide a precise and efficient means with which to discover hidden information. This study proposes a novel means of employing existing GEPs to reveal hidden relationships among diseases, genes, and drugs within a rich biomedical database, PubMed. Unlike the co-occurrence method, which considers only the appearance of keywords, the proposed method also takes into account negative relationships and non-relationships among keywords, the importance of which has been demonstrated in previous studies. Three scenarios were conducted to verify the efficacy of the proposed method. In Scenario 1, disease and drug GEPs (disease: lymphoma cancer, lymph node cancer, and drug: cyclophosphamide) were used to obtain lists of disease-and drug-related genes. Fifteen hidden connections were identified between the diseases and the drug. In Scenario 2, we adopted different diseases and drug GEPs (disease: AML-ALL dataset and drug: Gefitinib) to obtain lists of important diseases and drug-related genes. In this case, ten hidden connections were identified. In Scenario 3, we obtained a list of disease-related genes from the disease-related GEP (liver cancer) and the drug (Capecitabine) on the PharmGKB website, resulting in twenty-two hidden connections. Experimental results demonstrate the efficacy of the proposed method in uncovering hidden connections among diseases, genes, and drugs. Following implementation of the weight function in the proposed method, a large number of the documents obtained in each of the scenarios were judged to be related: 834 of 4028 documents, 789 of 1216 documents, and 1928 of 3791 documents in Scenarios 1, 2, and 3, respectively. The negative-term filtering scheme also uncovered a large number of negative relationships as well as non-relationships among these connections: 97 of 834, 38 of 789, and 202 of 1928 in Scenarios 1, 2, and 3, respectively.	[Wu, Jain-Shing; Lee, Chung-Nan] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung 80424, Taiwan; [Kao, E-Fong; Lee, Chung-Nan] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	National Sun Yat Sen University; Kaohsiung Medical University	Lee, CN (corresponding author), Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung 80424, Taiwan.	cnlee@mail.cse.nsysu.edu.tw	Wu, JainShing/AAG-1828-2019	Wu, JainShing/0000-0002-4856-7423; Kao, E-Fong/0000-0003-4051-9651				Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Buyko Ekaterina, 2009, BIONLP 09 SHARED TAS; BYRNE JA, 1993, HUM GENET, V91, P275; Chang GC, 2008, EUR J PHARMACOL, V600, P37, DOI 10.1016/j.ejphar.2008.10.024; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Ezaki Takahiro, 2005, Int J Clin Oncol, V10, P171, DOI 10.1007/s10147-005-0488-7; Foster FM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2328; Frijters R, 2008, NUCLEIC ACIDS RES, V36, pW406, DOI 10.1093/nar/gkn215; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Jari Bjorne<spacing Tapio, 2011, P BIONLP SHAR TASK 2, P183; JS Wu, 2010, CIIS LAB TECH REP 20; Kancherla RR, 2001, CANCER, V91, P463, DOI 10.1002/1097-0142(20010201)91:3<463::AID-CNCR1023>3.0.CO;2-R; Ko JC, 2011, BIOCHEM PHARMACOL, V81, P680, DOI 10.1016/j.bcp.2010.12.008; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Li J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000450; Markaverich BM, 2010, J STEROID BIOCHEM, V122, P219, DOI 10.1016/j.jsbmb.2010.06.006; McDonald R., 2005, P HUM LANG TECHN C C, P523, DOI [10.3115/1220575.1220641, DOI 10.3115/1220575.1220641]; Minagawa Y, 2001, Hum Cell, V14, P237; Nasukawa T, 2003, P 2 INT C KNOWL CAPT, P23; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; Sanchez-Graillet O, 2007, BIOINFORMATICS, V23, pI424, DOI 10.1093/bioinformatics/btm184; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shrader M, 2007, CANCER RES, V67, P1430, DOI 10.1158/0008-5472.CAN-06-1224; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Spasser MA, 1997, J AM SOC INFORM SCI, V48, P707, DOI 10.1002/(SICI)1097-4571(199708)48:8<707::AID-ASI4>3.3.CO;2-B; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Swanson D. R., 2001, B AM SOC INFORM SCI, V27, P12; SWANSON DR, 1986, LIBR QUART, V56, P103, DOI 10.1086/601720; Tomiuk S, 2001, Brief Bioinform, V2, P329, DOI 10.1093/bib/2.4.329; Xiao YS, 2004, J CANCER RES CLIN, V130, P546, DOI 10.1007/s00432-004-0565-8; Yu X, 2011, DNA CELL BIOL, V30, P777, DOI 10.1089/dna.2011.1223; Zhang X, 2010, CANCER SCI, V101, P2163, DOI 10.1111/j.1349-7006.2010.01664.x	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98826	10.1371/journal.pone.0098826	http://dx.doi.org/10.1371/journal.pone.0098826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915461	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700036
J	Yamada-Fowler, N; Fredrikson, M; Soderkvist, P				Yamada-Fowler, Naomi; Fredrikson, Mats; Soderkvist, Peter			Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADENOSINE RECEPTORS; RISK-FACTORS; CANCER-RISK; COFFEE; LOCI; MAPT; POLYMORPHISM; REPLICATION; CONSUMPTION	A complex interplay between genetic and environmental factors is thought to be involved in the etiology of Parkinson's disease (PD). A recent genome-wide association and interaction study (GWAIS) identified GRIN2A, which encodes an NMDA-glutamate-receptor subunit involved in brain's excitatory neurotransmission, as a PD genetic modifier in inverse association with caffeine intake. Here in, we attempted to replicate the reported association of a single nucleotide polymorphism, GRIN2A_rs4998386, and its interaction with caffeine intake with PD in patient-control study in an ethnically homogenous population in southeastern Sweden, as consistent and independent genetic association studies are the gold standard for the validation of genome-wide association studies. All the subjects (193 sporadic PD patients and 377 controls) were genotyped, and the caffeine intake data was obtained by questionnaire. We observed an association between rs4998386 and PD with odds ratio (OR) of 0.61, 95% confidence intervals (CI) of 0.39-0.96, p = 0.03, under a model excluding rare TT allele. There was also a strong significance in joint effects of gene and caffeine on PD risk (TC heavy caffeine vs. CC light caffeine: OR = 0.38, 95% CI = [0.20-0.70], p = 0.002) and gene-caffeine interaction (OR = 0.998, 95% CI = [0.991-0.999], p<0.001). Overall, our results are in support of the findings of the GWAIS and provided additional evidence indicating PD protective effects of coffee drinking/caffeine intake as well as the interaction with glutamate receptor genotypes.	[Yamada-Fowler, Naomi; Soderkvist, Peter] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Occupat & Environm Med, Linkoping, Sweden	Linkoping University; Linkoping University	Yamada-Fowler, N (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden.	naomi.yamada@liu.se			Foundation for Parkinson's Research at Linkoping University, Sweden (Stiftelsen for Parkinsonforskning) [20110525]	Foundation for Parkinson's Research at Linkoping University, Sweden (Stiftelsen for Parkinsonforskning)	This study was funded by the Foundation for Parkinson's Research at Linkoping University, Sweden (Stiftelsen for Parkinsonforskning, 20110525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gelber RP, 2011, J ALZHEIMERS DIS, V23, P607, DOI 10.3233/JAD-2010-101428; Hallstrom H, 2006, OSTEOPOROSIS INT, V17, P1055, DOI 10.1007/s00198-006-0109-y; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Itokawa M, 2003, NEUROSCI LETT, V345, P53, DOI 10.1016/S0304-3940(03)00501-9; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Larsson SC, 2006, INT J CANCER, V119, P2186, DOI 10.1002/ijc.22105; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Turic D, 2004, MOL PSYCHIATR, V9, P169, DOI 10.1038/sj.mp.4001387; Winkler S, 2007, EUR J HUM GENET, V15, P1163, DOI 10.1038/sj.ejhg.5201901; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	21	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99294	10.1371/journal.pone.0099294	http://dx.doi.org/10.1371/journal.pone.0099294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915238	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700080
J	Kitazoe, Y; Tanaka, M				Kitazoe, Yasuhiro; Tanaka, Masashi			Evolution of Mitochondrial Power in Vertebrate Metazoans	PLOS ONE			English	Article							RESPIRATORY COMPLEX I; CYTOCHROME-C-OXIDASE; MULTIDIMENSIONAL VECTOR-SPACE; MEMBRANE-PROTEINS; PHYLOGENY; LONGEVITY; CYSTEINE; GENOME; ENERGETICS; THREONINE	Background: Basal metabolic rate (BMR) has a very strong body-mass (M) dependence in an individual animal group, and BMR per unit mass (msBMR) converges on a markedly narrow range even across major taxonomic groups. However, it is here a basic question in metazoan biology how much BMR per unit mitochondrion (mtBMR) changes, and then whether mtBMR can be related to the original molecular mechanism of action of mt-encoded membrane proteins (MMPs) playing a central role in cellular energy production. Methodology/Principal Findings: Analyzing variations of amino-acid compositions of MMPs across 13 metazoan animal groups, incorporating 2022 sequences, we found a strong inverse correlation between Ser/Thr composition (STC) and hydrophobicity (HYD). A majority of animal groups showed an evolutionary pathway of a gradual increase in HYD and decrease in STC, whereas only the deuterostome lineage revealed a rapid decrease in HYD and increase in STC. The strongest correlations appeared in 5 large subunits (ND4, ND5, ND2, CO1, and CO3) undergoing dynamic conformational changes for the proton-pumping function. The pathway of the majority groups is well understood as reflecting natural selection to reduce mtBMR, since simply raising HYD in MMPs (surrounded by the lipid bilayer) weakens their mobility and strengthens their stability. On the other hand, the marked decrease in HYD of the deuterostome elevates mtBMR, but is accompanied with their instability heightening a turnover rate of mitochondria and then cells. Interestingly, cooperative networks of interhelical hydrogen-bonds between motifs involving Ser and Thr residues can enhance MMP stability. Conclusion/Significance: This stability enhancement lowers turnover rates of mitochondria/cells and may prolong even longevity, and was indeed founded by strong positive correlations of STC with both mtBMR and longevity. The lowest HYD and highest STC in Aves and Mammals are congruent with their very high mtBMR and long longevity.	[Kitazoe, Yasuhiro] Kochi Med Sch, Ctr Med Informat Sci, Nankoku, Kochi, Japan; [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longev & Hlth, Tokyo, Japan	Kochi University; Tokyo Metropolitan Institute of Gerontology	Kitazoe, Y (corresponding author), Kochi Med Sch, Ctr Med Informat Sci, Nankoku, Kochi, Japan.	kitazoeyasuhiro@yahoo.co.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-22240072, B-21390459, C-21590411]; Ministry of Health, Labor, and Welfare of Japan [23-016, 23-116, 24-005]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (A-22240072 B-21390459 and C-21590411 to M.T.) by Grants-in-Aid for Research on Intractable Diseases (Mitochondrial Disorders) from the Ministry of Health, Labor, and Welfare of Japan (23-016, 23-116 and 24-005 to M.T.) and by grants for scientific research from the Takeda Science Foundation (to M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; COWAN R, 1990, Peptide Research, V3, P75; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Jobson RW, 2010, MITOCHONDRION, V10, P540, DOI 10.1016/j.mito.2010.05.013; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kitazoe Y, 2005, MOL BIOL EVOL, V22, P704, DOI 10.1093/molbev/msi051; Kitazoe Y, 2001, MOL BIOL EVOL, V18, P812, DOI 10.1093/oxfordjournals.molbev.a003863; Kitazoe Y, 2011, GENOME BIOL EVOL, V3, P1233, DOI 10.1093/gbe/evr079; Kitazoe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003343; Lane N., 2005, POWER SEX SUICIDE MI; Lane N, 2011, BIOESSAYS, V33, P860, DOI 10.1002/bies.201100051; Lane N, 2011, SCIENCE, V334, P184, DOI 10.1126/science.1214012; Lane N, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-35; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; Maina JN, 2000, J EXP BIOL, V203, P3045; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x; Moosmann B, 2011, EXP GERONTOL, V46, P164, DOI 10.1016/j.exger.2010.08.034; Mourier A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001129; Owen RJ, 2014, NATURE, V505, P169; Porter RK, 2001, CELL MOL LIFE SCI, V58, P815, DOI 10.1007/PL00000902; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindeldecker M, 2011, MECH AGEING DEV, V132, P171, DOI 10.1016/j.mad.2011.03.002; Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110; Suarez RK, 1999, J EXP ZOOL, V284, P1, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;1::AID-JEZ1&gt;3.0.CO;2-P; Suarez RK, 1998, J EXP BIOL, V201, P1065; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Yamashita T, 2012, J AM CHEM SOC, V134, P1147, DOI 10.1021/ja209176e	42	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98188	10.1371/journal.pone.0098188	http://dx.doi.org/10.1371/journal.pone.0098188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911874	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600128
J	Mulukutla, BC; Yongky, A; Daoutidis, P; Hu, WS				Mulukutla, Bhanu Chandra; Yongky, Andrew; Daoutidis, Prodromos; Hu, Wei-Shou			Bistability in Glycolysis Pathway as a Physiological Switch in Energy Metabolism	PLOS ONE			English	Article							PYRUVATE-KINASE; CANCER-CELLS; TUMOR-GROWTH; FRUCTOSE 2,6-BISPHOSPHATE; SKELETAL-MUSCLE; STEM-CELLS; RAT; PHOSPHOFRUCTOKINASE; INHIBITION; EXPRESSION	The flux of glycolysis is tightly controlled by feed-back and feed-forward allosteric regulations to maintain the body's glucose homeostasis and to respond to cell's growth and energetic needs. Using a mathematical model based on reported mechanisms for the allosteric regulations of the enzymes, we demonstrate that glycolysis exhibits multiple steady state behavior segregating glucose metabolism into high flux and low flux states. Two regulatory loops centering on phosphofructokinase and on pyruvate kinase each gives rise to the bistable behavior, and together impose more complex flux control. Steady state multiplicity endows glycolysis with a robust switch to transit between the two flux states. Under physiological glucose concentrations the glycolysis flux does not move between the states easily without an external stimulus such as hormonal, signaling or oncogenic cues. Distinct combination of isozymes in glycolysis gives different cell types the versatility in their response to different biosynthetic and energetic needs. Insights from the switch behavior of glycolysis may reveal new means of metabolic intervention in the treatment of cancer and other metabolic disorders through suppression of glycolysis.	[Mulukutla, Bhanu Chandra; Yongky, Andrew; Daoutidis, Prodromos; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hu, WS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@cems.umn.edu						ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BOSCA L, 1982, BIOCHEM BIOPH RES CO, V106, P486, DOI 10.1016/0006-291X(82)91136-6; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chesney J, 2006, CURR OPIN CLIN NUTR, V9, P535, DOI 10.1097/01.mco.0000241661.15514.fb; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Desai S, 2013, ONCOTARGET; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; KITAJIMA S, 1984, J BIOL CHEM, V259, P6896; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KRETSCHMER M, 1984, BIOCHEM BIOPH RES CO, V124, P793, DOI 10.1016/0006-291X(84)91027-1; KRETSCHMER M, 1985, BIOCHEM BIOPH RES CO, V131, P899, DOI 10.1016/0006-291X(85)91324-5; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; KURATA N, 1972, BIOCHEM BIOPH RES CO, V48, P473, DOI 10.1016/0006-291X(72)90371-3; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Moreno-Sanchez R, 2012, J CELL BIOCHEM, V113, P1692, DOI 10.1002/jcb.24039; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Park Y, 2010, J BIOTECHNOL, V150, P131, DOI 10.1016/j.jbiotec.2010.08.001; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1477, DOI 10.1021/bi00548a034; Schutt A., 2013, CANC METABOLISM, V1, P10; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tominaga N, 1997, ARCH BIOCHEM BIOPHYS, V347, P275, DOI 10.1006/abbi.1997.0346; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu CD, 2006, ADV ENZYME REGUL, V46, P72, DOI 10.1016/j.advenzreg.2006.01.010; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; YANEY GC, 1995, DIABETES, V44, P1285, DOI 10.2337/diabetes.44.11.1285; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	61	39	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98756	10.1371/journal.pone.0098756	http://dx.doi.org/10.1371/journal.pone.0098756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911170	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600012
J	Pinz, S; Unser, S; Rascle, A				Pinz, Sophia; Unser, Samy; Rascle, Anne			The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; TYROSINE KINASE INHIBITOR; PROSTATE-CANCER CELLS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; JAK/STAT PATHWAY; TRANSACTIVATION DOMAIN; JAK-STAT5 PATHWAY; LEUKEMIA-CELLS	Signal transducer and activator of transcription STAT5 is an essential mediator of cytokine, growth factor and hormone signaling. While its activity is tightly regulated in normal cells, its constitutive activation directly contributes to oncogenesis and is associated to a number of hematological and solid tumor cancers. We previously showed that deacetylase inhibitors can inhibit STAT5 transcriptional activity. We now investigated whether the dietary chemopreventive agent sulforaphane, known for its activity as deacetylase inhibitor, might also inhibit STAT5 activity and thus could act as a chemopreventive agent in STAT5-associated cancers. We describe here sulforaphane (SFN) as a novel STAT5 inhibitor. We showed that SFN, like the deacetylase inhibitor trichostatin A (TSA), can inhibit expression of STAT5 target genes in the B cell line Ba/F3, as well as in its transformed counterpart Ba/F3-1* 6 and in the human leukemic cell line K562 both of which express a constitutively active form of STAT5. Similarly to TSA, SFN does not alter STAT5 initial activation by phosphorylation or binding to the promoter of specific target genes, in favor of a downstream transcriptional inhibitory effect. Chromatin immunoprecipitation assays revealed that, in contrast to TSA however, SFN only partially impaired the recruitment of RNA polymerase II at STAT5 target genes and did not alter histone H3 and H4 acetylation, suggesting an inhibitory mechanism distinct from that of TSA. Altogether, our data revealed that the natural compound sulforaphane can inhibit STAT5 downstream activity, and as such represents an attractive cancer chemoprotective agent targeting the STAT5 signaling pathway.	[Pinz, Sophia; Unser, Samy; Rascle, Anne] Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany	University of Regensburg	Rascle, A (corresponding author), Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany.	anne.rascle@klinik.uni-regensburg.de	Rascle, Anne/AAC-1904-2019	Rascle, Anne/0000-0001-7464-8545; /0000-0001-8613-0655	Deutsche Forschungsgemeinschaft [RA 2010/2-1]; Deutsche Krebshilfe [109750]; institutional research funds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); institutional research funds	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. RA 2010/2-1 to AR), the Deutsche Krebshilfe (Grant No. 109750 to AR) and institutional research funds (Foerderlinie C to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Al-Shami A, 1999, J BIOL CHEM, V274, P5333, DOI 10.1074/jbc.274.9.5333; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Butturini E, 2013, FREE RADIC BIOL MED; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; Cho SD, 2005, NUTR CANCER, V52, P213, DOI 10.1207/s15327914nc5202_11; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; DEGROOT RP, 1991, NUCLEIC ACIDS RES, V19, P775, DOI 10.1093/nar/19.4.775; Frazier-Jessen MR, 2002, FEBS LETT, V513, P203, DOI 10.1016/S0014-5793(02)02295-0; Fuda NJ, 2013, EMBO J, V32, P1796, DOI 10.1038/emboj.2013.138; Fujihara M, 1998, J IMMUNOL, V161, P3659; Go VLW, 2004, J NUTR, V134, p3513S, DOI 10.1093/jn/134.12.3513S; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Hanan EJ, 2012, J MED CHEM, V55, P10090, DOI 10.1021/jm3012239; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Jeong WS, 2004, PHARM RES-DORDR, V21, P649, DOI 10.1023/B:PHAM.0000022412.69380.d7; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Keum YS, 2011, ANN NY ACAD SCI, V1229, P184, DOI 10.1111/j.1749-6632.2011.06092.x; Kim BH, 2013, BIOCHEM PHARMACOL, V86, P950, DOI 10.1016/j.bcp.2013.08.009; KITABAYASHI I, 1993, J BIOL CHEM, V268, P14482; Kong ANT, 2001, MUTAT RES-FUND MOL M, V480, P231, DOI 10.1016/S0027-5107(01)00182-8; Kosan Christian, 2013, JAKSTAT, V2, pe26102, DOI 10.4161/jkst.26102; Kraus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037207; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Liu CB, 1999, J BIOL CHEM, V274, P6342, DOI 10.1074/jbc.274.10.6342; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nelson EA, 2011, ONCOTARGET, V2, P518; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; PHINNEY DG, 1994, ONCOGENE, V9, P2353; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V309, P709, DOI 10.1016/j.bbrc.2003.08.055; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; U.S. National Institutes of Health. ClinicalTrials.gov, SEARCH SULF; Ullrich A, 2004, ANN ONCOL, V15, P249, DOI 10.1093/annonc/mdh935; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Ward AC, 2000, BLOOD, V95, P19; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; World Health Organization, 2012, CANC FACT SHEET; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	99	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99391	10.1371/journal.pone.0099391	http://dx.doi.org/10.1371/journal.pone.0099391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910998	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600079
J	Wang, JM; Du, J; Jin, Q				Wang, Jianmin; Du, Jiang; Jin, Qi			Class I ADP-Ribosylation Factors Are Involved in Enterovirus 71 Replication	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; NUCLEOTIDE EXCHANGE FACTORS; CELLULAR-PROTEIN SECRETION; BREFELDIN-A; ENDOPLASMIC-RETICULUM; POLIOVIRUS INFECTION; MEMBRANE ASSOCIATION; 3A PROTEINS; ARF FAMILY; RNA	Enterovirus 71 is one of the major causative agents of hand, foot, and mouth disease in infants and children. Replication of enterovirus 71 depends on host cellular factors. The viral replication complex is formed in novel, cytoplasmic, vesicular compartments. It has not been elucidated which cellular pathways are hijacked by the virus to create these vesicles. Here, we investigated whether proteins associated with the cellular secretory pathway were involved in enterovirus 71 replication. We used a loss-of-function assay, based on small interfering RNA. We showed that enterovirus 71 RNA replication was dependent on the activity of Class I ADP-ribosylation factors. Simultaneous depletion of ADP-ribosylation factors 1 and 3, but not three others, inhibited viral replication in cells. We also demonstrated with various techniques that the brefeldin-A-sensitive guanidine nucleotide exchange factor, GBF1, was critically important for enterovirus 71 replication. Our results suggested that enterovirus 71 replication depended on GBF1-mediated activation of Class I ADP-ribosylation factors. These results revealed a connection between enterovirus 71 replication and the cellular secretory pathway; this pathway may represent a novel target for antiviral therapies.	[Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [31300154]; National Science and Technology Major Project of China [2011ZX10004-001, 2013ZX10004-101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China	This work was supported by the National Natural Science Foundation of China (No. 31300154) and National Science and Technology Major Project of China (Project No. 2011ZX10004-001 and No. 2013ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BIENZ K, 1994, ARCH VIROL, P147; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; Cuconati A, 1998, J VIROL, V72, P6456, DOI 10.1128/JVI.72.8.6456-6464.1998; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DOEDENS J, 1994, ARCH VIROL, P159; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Gazina EV, 2002, J VIROL, V76, P11113, DOI 10.1128/JVI.76.21.11113-11122.2002; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hyodo K, 2013, J VIROL, V87, P163, DOI 10.1128/JVI.02383-12; IRURZUN A, 1992, VIROLOGY, V191, P166, DOI 10.1016/0042-6822(92)90178-R; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579; Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; MAYNELL LA, 1992, J VIROL, V66, P1985, DOI 10.1128/JVI.66.4.1985-1994.1992; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popoff V, 2011, J BIOL CHEM, V286, P35634, DOI 10.1074/jbc.M111.261800; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; Wessels E, 2005, J VIROL, V79, P5163, DOI 10.1128/JVI.79.8.5163-5173.2005; Wessels E, 2006, J VIROL, V80, P11852, DOI 10.1128/JVI.01225-06; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Zhang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032135	45	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99768	10.1371/journal.pone.0099768	http://dx.doi.org/10.1371/journal.pone.0099768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911624	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600116
J	Tan, XY; Yang, WL; Guo, J; Zhang, Y; Wu, CW; Sapkota, R; Kushwaha, SP; Gong, SG; Sun, XG; Liu, JM				Tan, Xiaoyue; Yang, Wenlan; Guo, Jian; Zhang, Yan; Wu, Changwei; Sapkota, Rikesh; Kushwaha, Shailendra Prasad; Gong, Sugang; Sun, Xingguo; Liu, Jinming			Usefulness of Decrease in Oxygen Uptake Efficiency to Identify Gas Exchange Abnormality in Patients with Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIORESPIRATORY FUNCTIONAL RESERVE; TIDAL CARBON-DIOXIDE; VENTILATORY EFFICIENCY; PROGNOSTIC VALUE; EXERCISE; CAPACITY; SLOPE; THRESHOLD; PLATEAU	Background: Decline in oxygen uptake efficiency (OUE), especially during exercise, is found in patients with chronic heart failure. In this study we aimed to test the validity and usefulness of OUE in evaluating gas exchange abnormality of patients with idiopathic pulmonary arterial hypertension (IPAH). Methods: We retrospectively investigated the cardiopulmonary exercise test (CPET) with gas exchange measurements in 32 patients with confirmed IPAH. All patients also had resting hemodynamic measurements and pulmonary function test (PFT). Sixteen healthy subjects, matched by age, sex, and body size were used as controls, also had CPET and PFT measurements. Results: In IPAH patients, the magnitude of absolute and percentage of predicted (%pred) oxygen uptake efficiency slope (OUES) and oxygen uptake efficiency plateau (OUEP), as well as several other CPET parameters, were strikingly worse than healthy subjects (P<0.0001). Pattern of changes in OUE in patients is similar to that in controls, In IPAH patients, OUE values at rest, warming up, anaerobic threshold and peak exercise were all significantly lower than in normal (P<0.0001). OUEP%pred, better than OUES%pred, correlated significantly with New York Heart Association (NYHA) functional Class (r = -0.724, P<0.005), Total Pulmonary Vascular Resistance (TPVR) (r = -0.694, P<0.005), diffusing capacity for carbon monoxide (DLCO) (r = 0.577, P<0.05), and the lowest ventilation versus CO2 output ratio during exercise (Lowest(V) over dotE/(V) over dotCO(2)) (r = -0.902, P<0.0001). In addition, the coefficient of variation (COV) of OUEP was lower (20.9%) markedly than OUES (34.3%) (P<0.0001). Conclusions: In patients with IPAH, OUES and OUEP are both significantly lower than the healthy subjects. OUEP is a better physiological parameter than OUES in evaluating the gas exchange abnormality of patients with IPAH.	[Tan, Xiaoyue; Yang, Wenlan; Guo, Jian; Zhang, Yan; Wu, Changwei; Liu, Jinming] Tongji Univ, Shanghai Pulm Hosp, Dept Pulm Funct Test, Shanghai 200092, Peoples R China; [Zhang, Yan] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Zhejiang Prov Hosp Tradit Chinese Med, Div Resp, Hangzhou, Zhejiang, Peoples R China; [Sapkota, Rikesh; Kushwaha, Shailendra Prasad; Gong, Sugang; Liu, Jinming] Tongji Univ, Shanghai Pulm Hosp, Dept Pulm Circulat, Shanghai 200092, Peoples R China; [Sun, Xingguo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Heart Lung Funct Testing Ctr,Fuwai Hosp, Beijing 100730, Peoples R China; [Sun, Xingguo] Peking Union Med Coll, Beijing 100021, Peoples R China	Tongji University; Zhejiang Chinese Medical University; Tongji University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, XG (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Heart Lung Funct Testing Ctr,Fuwai Hosp, Beijing 100730, Peoples R China.	xgsun@labiomed.org; jinmingliu2013@163.com			Chinese Academy of Medical Sciences [2012-YJR02]; National Center for Cardiovascular Diseases; Chinese Medicine Association [08020420120]; science and technology commission of shanghai municipality [11411951302, 114119a3000]	Chinese Academy of Medical Sciences; National Center for Cardiovascular Diseases; Chinese Medicine Association; science and technology commission of shanghai municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This retrospective CPET data reanalysis is partially supported by Chinese Academy of Medical Sciences (No. 2012-YJR02), Key Project Starting Grant from National Center for Cardiovascular Diseases. CPET data collected at Shanghai Pulmonary Hospital were partially supported from Chinese Medicine Association (No. 08020420120) and science and technology commission of shanghai municipality (NO. 11411951302 and 114119a3000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena R, 2008, AM HEART J, V156, P982, DOI 10.1016/j.ahj.2008.06.024; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; Arena R, 2007, INT J CARDIOL, V117, P103, DOI 10.1016/j.ijcard.2006.04.058; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Baba R, 1999, EUR J APPL PHYSIOL O, V80, P397, DOI 10.1007/s004210050610; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; Guazzi M, 2005, J AM COLL CARDIOL, V46, P1883, DOI 10.1016/j.jacc.2005.07.051; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Itoh H, 1990, CIRCULATION, V81, pII31; Mortara A, 1997, CIRCULATION, V96, P3450; Mu K, 1990, SUMMARY CHINESE PULM, V2, P83; Oudiz RJ, 2007, EUR J HEART FAIL, V9, P917, DOI 10.1016/j.ejheart.2007.06.013; Oudiz RJ, 2010, AM J CARDIOL, V105, P1186, DOI 10.1016/j.amjcard.2009.12.024; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Reindl I, 1998, AM HEART J, V136, P778, DOI 10.1016/S0002-8703(98)70121-8; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SHIMIZU M, 1991, AM HEART J, V122, P509, DOI 10.1016/0002-8703(91)91009-C; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Sun X., 2012, ABST APPL ANAL, V2012, P1, DOI DOI 10.1371/J0URNAL.PGEN.1002674; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Sun XG, 2013, MED PHILOS, V4, P22; Sun XG, 2012, CHEST, V141, P1284, DOI 10.1378/chest.11-1270; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; Ting H, 2001, CHEST, V119, P824, DOI 10.1378/chest.119.3.824; Van Laethem C, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.032; Wasserman K, 2011, PRINCIPLES EXERCISE, P568; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637; 孙兴国, 2013, [中国循环杂志, Chinese Circulation Journal], V28, P88	35	16	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98889	10.1371/journal.pone.0098889	http://dx.doi.org/10.1371/journal.pone.0098889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905576	gold, Green Submitted, Green Published			2022-12-27	WOS:000341869000077
J	Ben Haddou, T; Beni, S; Hosztafi, S; Malfacini, D; Calo, G; Schmidhammer, H; Spetea, M				Ben Haddou, Tanila; Beni, Szabolcs; Hosztafi, Sandor; Malfacini, Davide; Calo, Girolamo; Schmidhammer, Helmut; Spetea, Mariana			Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity	PLOS ONE			English	Article							IN-VITRO; DERIVATIVES; 6-AMINO	Morphine and structurally related derivatives are highly effective analgesics, and the mainstay in the medical management of moderate to severe pain. Pharmacological actions of opioid analgesics are primarily mediated through agonism at the m opioid peptide (MOP) receptor, a G protein-coupled receptor. Position 17 in morphine has been one of the most manipulated sites on the scaffold and intensive research has focused on replacements of the 17-methyl group with other substituents. Structural variations at the N-17 of the morphinan skeleton led to a diversity of molecules appraised as valuable and potential therapeutics and important research probes. Discovery of therapeutically useful morphine-like drugs has also targeted the C-6 hydroxyl group, with oxymorphone as one of the clinically relevant opioid analgesics, where a carbonyl instead of a hydroxyl group is present at position 6. Herein, we describe the effect of N-substituent variation in morphine and oxymorphone on in vitro and in vivo biological properties and the emerging structure-activity relationships. We show that the presence of a N-phenethyl group in position 17 is highly favorable in terms of improved affinity and selectivity at the MOP receptor, potent agonism and antinociceptive efficacy. The N-phenethyl derivatives of morphine and oxymorphone were very potent in stimulating G protein coupling and intracellular calcium release through the MOP receptor. In vivo, they were highly effective against acute thermal nociception in mice with marked increased antinociceptive potency compared to the lead molecules. It was also demonstrated that a carbonyl group at position 6 is preferable to a hydroxyl function in these N-phenethyl derivatives, enhancing MOP receptor affinity and agonist potency in vitro and in vivo. These results expand the understanding of the impact of different moieties at the morphinan nitrogen on ligand-receptor interaction, molecular mode of action and signaling, and may be instrumental to the development of new opioid therapeutics.	[Ben Haddou, Tanila; Schmidhammer, Helmut; Spetea, Mariana] Univ Innsbruck, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Ben Haddou, Tanila; Schmidhammer, Helmut; Spetea, Mariana] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Beni, Szabolcs; Hosztafi, Sandor] Semmelweis Univ, Dept Pharmaceut Chem, H-1085 Budapest, Hungary; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Dept Med Sci, Pharmacol Sect, I-44100 Ferrara, Italy; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Italian Inst Neurosci, I-44100 Ferrara, Italy	University of Innsbruck; University of Innsbruck; Semmelweis University; University of Ferrara; University of Ferrara	Spetea, M (corresponding author), Univ Innsbruck, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria.	Mariana.Spetea@uibk.ac.at		Spetea, Mariana/0000-0002-2379-5358; Schmidhammer, Helmut/0000-0001-8752-5050; Malfacini, Davide/0000-0003-4562-9550	Austrian Science Fund (FWF) [TRP 19-B18]; University of Ferrara (FAR grant); Janos Bolyai Research Scholarship; Austrian Exchange Service (Osterreichischer Austauschdienst GmbH, OeAD) fellowship;  [OTKA PD109373]; Austrian Science Fund (FWF) [TRP 19] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Ferrara (FAR grant); Janos Bolyai Research Scholarship(Hungarian Academy of Sciences); Austrian Exchange Service (Osterreichischer Austauschdienst GmbH, OeAD) fellowship; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): TRP 19-B18 (MS), Hungarian Research Grant: OTKA PD109373 (SB), and the University of Ferrara (FAR grant to GC). S. Beni thanks the Hungarian Academy of Sciences for the financial support under the Janos Bolyai Research Scholarship and for the Austrian Exchange Service (Osterreichischer Austauschdienst GmbH, OeAD) fellowship (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2003, OPIOID RECEPTORS ANT, P371; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; BENYHE S, 1994, LIFE SCI, V55, P969, DOI 10.1016/0024-3205(94)00631-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camarda Valeria, 2013, Methods Mol Biol, V937, P293; CLARK RL, 1953, J AM CHEM SOC, V75, P4963, DOI 10.1021/ja01116a024; Furst S, 2008, ACTA PHYSIOL HUNG, V95, P3, DOI 10.1556/APhysiol.95.2008.1.1; Goodman AJ, 2007, CHEMMEDCHEM, V2, P1552, DOI 10.1002/cmdc.200700143; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hart ER, 1944, J PHARMACOL EXP THER, V82, P339; HOSZTAFI S, 1992, SYNTHETIC COMMUN, V22, P2527, DOI 10.1080/00397919208021649; Houde R.W., 1956, FED PROC, V15, P440; Jacobson AE, 1998, BIOL EVALUATION COMP, VXXII; KNOLL J, 1975, NEUROPHARMACOLOGY, V14, P921, DOI 10.1016/0028-3908(75)90046-5; KUTTER E, 1970, J MED CHEM, V13, P801, DOI 10.1021/jm00299a003; LASAGNA L, 1954, J PHARMACOL EXP THER, V112, P356; Lewis JW, 2011, TOP CURR CHEM, V299, P93, DOI 10.1007/128_2010_89; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; LOEW GH, 1978, J MED CHEM, V21, P101, DOI 10.1021/jm00199a018; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marcus DA, 2009, CURR CLIN PRACT, P1, DOI 10.1007/978-1-60327-465-4; May EL, 1998, MED CHEM RES, V8, P311; Mayyas F, 2010, J PAIN SYMPTOM MANAG, V39, P296, DOI 10.1016/j.jpainsymman.2009.07.010; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Schmidhammer H, 2013, CURR PHARM DESIGN, V19, P7391; Schmidhammer H, 2011, TOP CURR CHEM, V299, P63, DOI 10.1007/128_2010_77; SEKI I, 1964, Yakugaku Zasshi, V84, P280; Sevarino Kevin A., 2009, P227, DOI 10.1007/978-1-59745-197-0_12; SMALL LF, 1958, J ORG CHEM, V23, P1387, DOI 10.1021/jo01103a615; Spetea M, 2004, EUR J PHARMACOL, V483, P301, DOI 10.1016/j.ejphar.2003.10.049; Spetea M, 2012, CURR MED CHEM, V19, P2442, DOI 10.2174/092986712800269308; Spetea M, 2013, CURR PHARM DESIGN, V19, P7415; Spetea M, 2011, J MED CHEM, V54, P980, DOI 10.1021/jm101211p; Spetea M, 2010, EUR J PHARM SCI, V41, P125, DOI 10.1016/j.ejps.2010.05.018; Toll L, 1998, NIDA Res Monogr, V178, P440; Unna K, 1943, J PHARMACOL EXP THER, V79, P27; WEISS U, 1965, J MED CHEM, V8, P123, DOI 10.1021/jm00325a028; WINTER CA, 1957, ARCH INT PHARMACOD T, V110, P186; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	39	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99231	10.1371/journal.pone.0099231	http://dx.doi.org/10.1371/journal.pone.0099231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919067	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338631000063
J	Marrachelli, VG; Monleon, D; Rentero, P; Mansego, ML; Morales, JM; Galan, I; Segura, R; Martinez, F; Martin-Escudero, JC; Briongos, L; Marin, P; Lliso, G; Chaves, FJ; Redon, J				Marrachelli, Vannina G.; Monleon, Daniel; Rentero, Pilar; Mansego, Maria L.; Manuel Morales, Jose; Galan, Inma; Segura, Remedios; Martinez, Fernando; Carlos Martin-Escudero, Juan; Briongos, Laisa; Marin, Pablo; Lliso, Gloria; Javier Chaves, Felipe; Redon, Josep			Genomic and Metabolomic Profile Associated to Microalbuminuria	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HYPERTENSION; INSULIN; DISEASE; POLYMORPHISM; HEALTH; SERUM	To identify factors related with the risk to develop microalbuminuria using combined genomic and metabolomic values from a general population study. One thousand five hundred and two subjects, Caucasian, more than 18 years, representative of the general population, were included. Blood pressure measurement and albumin/creatinine ratio were measured in a urine sample. Using SNPlex, 1251 SNPs potentially associated to urinary albumin excretion (UAE) were analyzed. Serum metabolomic profile was assessed by H-1 NMR spectra using a Brucker Advance DRX 600 spectrometer. From the total population, 1217 (mean age 54 +/- 19, 50.6% men, ACR>30 mg/g in 81 subjects) with high genotyping call rate were analysed. A characteristic metabolomic profile, which included products from mitochondrial and extra mitochondrial metabolism as well as branched amino acids and their derivative signals, were observed in microalbuminuric as compare to normoalbuminuric subjects. The comparison of the metabolomic profile between subjects with different UAE status for each of the genotypes associated to microalbuminuria revealed two SNPs, the rs10492025_TT of RPH3A gene and the rs4359_CC of ACE gene, with minimal or no statistically significant differences. Subjects with and without microalbuminuria, who shared the same genotype and metabolomic profile, differed in age. Microalbuminurics with the CC genotype of the rs4359 polymorphism and with the TT genotype of the rs10492025 polymorphism were seven years older and seventeen years younger, respectively as compared to the whole microalbuminuric subjects. With the same metabolomic environment, characteristic of subjects with microalbuminuria, the TT genotype of the rs10492025 polymorphism seems to increase and the CC genotype of the rs4359 polymorphism seems to reduce risk to develop microalbuminuria.	[Marrachelli, Vannina G.; Monleon, Daniel; Manuel Morales, Jose; Segura, Remedios] INCLIVA, Hlth Res Inst, Metabol & Mol Image Lab, Valencia, Spain; [Rentero, Pilar; Galan, Inma; Marin, Pablo; Javier Chaves, Felipe] INCLIVA, Hlth Res Inst, Genotyping & Genet Diag Unit, Valencia, Spain; [Mansego, Maria L.] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Mansego, Maria L.; Martinez, Fernando; Lliso, Gloria; Redon, Josep] Hlth Inst Carlos III, CIBERObn, Madrid, Spain; [Martinez, Fernando; Briongos, Laisa; Redon, Josep] Univ Valencia, Hosp Clin, Hypertens Unit, Valencia, Spain; [Carlos Martin-Escudero, Juan] Hosp Rio Hortega, Valladolid, Spain; [Javier Chaves, Felipe] Hlth Inst Carlos III, CIBERDem, Madrid, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Valencia; Hospital del Rio Hortega; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Monleon, D (corresponding author), INCLIVA, Hlth Res Inst, Metabol & Mol Image Lab, Valencia, Spain.	daniel.monleon@uv.es	REDON, JOSEP/E-1719-2019; Monleon, Daniel/GNP-4083-2022; Monleon, Daniel/A-5078-2010; Chaves-Martinez, Felipe Javier/ABC-3294-2021; marrachelli, vannina G/L-6041-2014; MartÃnez, Fernando/AAO-5879-2021; tatay, jose manuel morales/L-7972-2014; Redon, Josep/L-5997-2019; Rentero-Garrido, Pilar/AAC-1788-2019; MANSEGO, MARIA/A-5687-2011	Monleon, Daniel/0000-0002-4803-1573; Monleon, Daniel/0000-0002-4803-1573; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; marrachelli, vannina G/0000-0002-4097-3312; MartÃnez, Fernando/0000-0001-8562-4477; tatay, jose manuel morales/0000-0002-4404-6735; Redon, Josep/0000-0001-8777-6773; Marin-Garcia, Pablo/0000-0003-3988-2365; MANSEGO, MARIA/0000-0001-8914-7890; Segura, Remedios/0000-0001-7923-4448; Lliso-Ribera, Gloria/0000-0002-8569-5133; Rentero-Garrido, Pilar/0000-0002-6158-0104; Martin-Escudero, Juan Carlos/0000-0002-6209-6509	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, European Commission, 7th Framework Programme [2011.2.4.2-2];  [PS09/02014];  [SAF2011-23029];  [PI 12/02615]	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, European Commission, 7th Framework Programme; ; ; 	The study has been funded by the Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, 2011.2.4.2-2 European Commission, 7th Framework Programme; and the grants PS09/02014, SAF2011-23029 and PI 12/02615. The funders had no role in the study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Atkins RC, 2004, KIDNEY INT, V66, pS22, DOI 10.1111/j.1523-1755.2004.09206.x; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Bodi V, 2012, J AM COLL CARDIOL, V59, P1629, DOI 10.1016/j.jacc.2011.09.083; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feldt-Rasmussen B, 2000, DIABETES METAB, V26, P64; Gavin JR, 1999, DIABETES CARE, V22, pS5; Giner V, 2004, J INTERN MED, V255, P588, DOI 10.1046/j.1365-2796.2003.01280.x; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; IWASAKI Y, 1980, GASTROENTEROLOGY, V78, P677; Lee JD, 2008, MICROSC MICROANAL, V14, P507, DOI 10.1017/S1431927608080628; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liang MY, 2011, KIDNEY INT, V80, P15, DOI 10.1038/ki.2011.84; Lorente-Galdos B, 2012, INT J DATA MIN BIOIN, V6, P324, DOI 10.1504/IJDMB.2012.049249; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Martinez F, 2010, J HYPERTENS, V28, P213, DOI 10.1097/HJH.0b013e328333afb3; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Monleon D, 2010, CANCER RES, V70, P8426, DOI 10.1158/0008-5472.CAN-10-1498; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; NICHOLSON JK, 1984, LANCET, V2, P751; Pedrinelli R, 2002, J HUM HYPERTENS, V16, P79, DOI 10.1038/sj.jhh.1001316; Pontremoli R, 2000, KIDNEY INT, V57, P561, DOI 10.1046/j.1523-1755.2000.t01-1-00876.x; Rastaldi MP, 2003, AM J PATHOL, V163, P889, DOI 10.1016/S0002-9440(10)63449-9; Redon J, 2000, HYPERTENSION, V35, P490, DOI 10.1161/01.HYP.35.1.490; Redon J, 2006, CURR HYPERTENS REP, V8, P171, DOI 10.1007/s11906-006-0015-x; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Stuveling EM, 2004, HYPERTENSION, V43, P791, DOI 10.1161/01.HYP.0000120125.08867.42; Toto Robert D, 2004, J Clin Hypertens (Greenwich), V6, P2, DOI 10.1111/j.1524-6175.2004.4064.x; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683	33	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98227	10.1371/journal.pone.0098227	http://dx.doi.org/10.1371/journal.pone.0098227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918908	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000014
J	Sato, T; Manabe, K; Hamada, N				Sato, Tatsuhiko; Manabe, Kentaro; Hamada, Nobuyuki			Microdosimetric Analysis Confirms Similar Biological Effectiveness of External Exposure to Gamma-Rays and Internal Exposure to Cs-137, Cs-134, and I-131	PLOS ONE			English	Article							FUKUSHIMA NUCLEAR ACCIDENT; CYTOPLASMIC IRRADIATION; SAFETY REGULATIONS; RADIATION; MODEL; RADIONUCLIDES; PARTICLE; INDUCTION; ELECTRON; PHITS	The risk of internal exposure to Cs-137, Cs-134, and I-131 is of great public concern after the accident at the Fukushima-Daiichi nuclear power plant. The relative biological effectiveness (RBE, defined herein as effectiveness of internal exposure relative to the external exposure to gamma-rays) is occasionally believed to be much greater than unity due to insufficient discussions on the difference of their microdosimetric profiles. We therefore performed a Monte Carlo particle transport simulation in ideally aligned cell systems to calculate the probability densities of absorbed doses in subcellular and intranuclear scales for internal exposures to electrons emitted from Cs-137, Cs-134, and I-131, as well as the external exposure to 662 keV photons. The RBE due to the inhomogeneous radioactive isotope (RI) distribution in subcellular structures and the high ionization density around the particle trajectories was then derived from the calculated microdosimetric probability density. The RBE for the bystander effect was also estimated from the probability density, considering its non-linear dose response. The RBE due to the high ionization density and that for the bystander effect were very close to 1, because the microdosimetric probability densities were nearly identical between the internal exposures and the external exposure from the 662 keV photons. On the other hand, the RBE due to the RI inhomogeneity largely depended on the intranuclear RI concentration and cell size, but their maximum possible RBE was only 1.04 even under conservative assumptions. Thus, it can be concluded from the microdosimetric viewpoint that the risk from internal exposures to Cs-137, Cs-134, and I-131 should be nearly equivalent to that of external exposure to gamma-rays at the same absorbed dose level, as suggested in the current recommendations of the International Commission on Radiological Protection.	[Sato, Tatsuhiko; Manabe, Kentaro] Japan Atom Energy Agcy, Res Grp Radiat Protect, Tokai, Ibaraki, Japan; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Komae, Tokyo 201, Japan	Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Sato, T (corresponding author), Japan Atom Energy Agcy, Res Grp Radiat Protect, Shirakata Shirane 2-4, Tokai, Ibaraki, Japan.	sato.tatsuhiko@jaea.go.jp	Sato, Tatsuhiko/G-5964-2012	Sato, Tatsuhiko/0000-0001-9902-7083; Hamada, Nobuyuki/0000-0003-2518-6131	Japan Atomic Energy Agency	Japan Atomic Energy Agency(Japan Atomic Energy Agency)	This work was supported by Japan Atomic Energy Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, 36 ICRU M; [Anonymous], 1986, 40 ICRU, DOI DOI 10.1093/JICRU_OS21.1.30; Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; *CERRIE, 2004, REP COMM EX RAD RISK; EAPEN J, 1971, Journal of Radiation Research, V12, P51, DOI 10.1269/jrr.12.51; Fakir H, 2009, RADIAT RES, V171, P320, DOI 10.1667/RR1293.1; GODDU SM, 1994, J NUCL MED, V35, P303; Goddu SM, 1996, ACTA ONCOL, V35, P909, DOI 10.3109/02841869609104045; Hamada N, 2008, BIOL SCI SPACE, V22, P46, DOI DOI 10.2187/BSS.22.46; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Harrison JD, 2003, INT J RADIAT BIOL, V79, P1, DOI 10.1080/0955300021000038671; Harrison JD, 2002, RADIAT PROT DOSIM, V98, P299, DOI 10.1093/oxfordjournals.rpd.a006722; International Commission on Radiological Protection, 2008, ICRP PUBL; International Commission on Radiological Protection, 2013, ICRP PUBL, V123; International Commission on Radiological Protection, 2009, ICRP PUBL, V110; International Commission on Radiological Protection, 2007, ICRP PUBL; International Commission on Radiological Protection, 2003, ICRP PUBL, V92; International Committee on Radiological Protection, 1991, ICRP PUBL; Leggett RW, 2010, RADIAT RES, V174, P496, DOI 10.1667/RR2243.1; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; McMahon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054526; Morgan WF, 2015, CANCER LETT, V356, P17, DOI 10.1016/j.canlet.2013.09.009; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Roomans G, 1971, J CELL SCI, V21, P119; Sato T, 2006, RADIAT PROT DOSIM, V122, P41, DOI 10.1093/rpd/ncl407; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Sato T, 2012, RADIAT RES, V178, P341, DOI 10.1667/RR2842.1; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Stewart RD, 2006, RADIAT RES, V165, P460, DOI 10.1667/RR3520.1; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Zhou HN, 2009, J RADIAT RES, V50, pA59, DOI 10.1269/jrr.08120S	36	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99831	10.1371/journal.pone.0099831	http://dx.doi.org/10.1371/journal.pone.0099831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919099	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000117
J	Ye, K; Felimban, R; Traianedes, K; Moulton, SE; Wallace, GG; Chung, J; Quigley, A; Choong, PFM; Myers, DE				Ye, Ken; Felimban, Raed; Traianedes, Kathy; Moulton, Simon E.; Wallace, Gordon G.; Chung, Johnson; Quigley, Anita; Choong, Peter F. M.; Myers, Damian E.			Chondrogenesis of Infrapatellar Fat Pad Derived Adipose Stem Cells in 3D Printed Chitosan Scaffold	PLOS ONE			English	Article							AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE DEFECTS; MICROFRACTURE TECHNIQUE; OSTEOCHONDRAL DEFECTS; KNEE-JOINT; TISSUE; DIFFERENTIATION; COLLAGEN; MATRIX; REGENERATION	Infrapatellar fat pad adipose stem cells (IPFP-ASCs) have been shown to harbor chondrogenic potential. When combined with 3D polymeric structures, the stem cells provide a source of stem cells to engineer 3D tissues for cartilage repair. In this study, we have shown human IPFP-ASCs seeded onto 3D printed chitosan scaffolds can undergo chondrogenesis using TGF beta 3 and BMP6. By week 4, a pearlescent, cartilage-like matrix had formed that penetrated the top layers of the chitosan scaffold forming a 'cap' on the scaffold. Chondrocytic morphology showed typical cells encased in extracellular matrix which stained positively with toluidine blue. Immunohistochemistry demonstrated positive staining for collagen type II and cartilage proteoglycans, as well as collagen type I. Real time PCR analysis showed up-regulation of collagen type II, aggrecan and SOX9 genes when IPFP-ASCs were stimulated by TGF beta 3 and BMP6. Thus, IPFP-ASCs can successfully undergo chondrogenesis using TGF beta 3 and BMP6 and the cartilage-like tissue that forms on the surface of 3D-printed chitosan scaffold may prove useful as an osteochondral graft.	[Ye, Ken; Felimban, Raed; Choong, Peter F. M.; Myers, Damian E.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [Ye, Ken; Felimban, Raed; Choong, Peter F. M.; Myers, Damian E.] St Vincents Hosp, Dept Orthopaed, Fitzroy, Vic 3065, Australia; [Traianedes, Kathy; Quigley, Anita] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Traianedes, Kathy; Quigley, Anita] Univ Melbourne, St Vincents Hosp, Dept Clin Neurosci, Fitzroy, Vic 3065, Australia; [Moulton, Simon E.; Wallace, Gordon G.; Chung, Johnson] Univ Wollongong, ARC Ctr Excellence Elect Sci ACES, Intelligent Polymer Res Inst, North Wollongong, NSW, Australia	St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Wollongong	Myers, DE (corresponding author), Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.	damianem@unimelb.edu.au	FELIMBAN, RAED/AAX-4537-2020; Wallace, Gordon G/H-1123-2011; Choong, Peter/F-1109-2014; Chung, Johnson/F-9854-2011; Myers, Damian E/L-5302-2013; Moulton, Simon/AAS-1452-2021	Wallace, Gordon G/0000-0002-0381-7273; Choong, Peter/0000-0002-3522-7374; Chung, Johnson/0000-0003-2449-3607; Moulton, Simon/0000-0002-8320-3852; Quigley, Anita/0000-0002-4060-2079; Myers, Damian/0000-0002-7569-9907; FELIMBAN, RAED/0000-0002-0853-2162; Choong, Peter/0000-0001-7333-7665	Australian Orthopaedics Association Research Foundation (AOA Research Foundation); Australian Research Council (ARC); National Health and Medical Research Council (NHMRC) Postgraduate Scholarship [APP1017633]	Australian Orthopaedics Association Research Foundation (AOA Research Foundation); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded through the Australian Orthopaedics Association Research Foundation (AOA Research Foundation), Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) Postgraduate Scholarship for author K Ye (APP1017633). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015; Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895; Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012; Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckley CT, 2010, J BIOMECH, V43, P920, DOI 10.1016/j.jbiomech.2009.11.005; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Felimban R, 2014, TISSUE ENG A; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Gobbi A, 2009, AM J SPORT MED, V37, P1083, DOI 10.1177/0363546509331419; Goessler UR, 2006, OTOLARYNG HEAD NECK, V134, P510, DOI 10.1016/j.otohns.2005.10.026; Goessler UR, 2004, INT J MOL MED, V14, P1015; Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004; Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122; Khan WS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2448; Lee KH, 2001, HUM GENE THER, V12, P1805, DOI 10.1089/104303401750476294; Lee SY, 2008, BIOCHEM BIOPH RES CO, V376, P148, DOI 10.1016/j.bbrc.2008.08.138; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; MeridaVelasco JA, 1997, ANAT REC, V248, P269, DOI 10.1002/(SICI)1097-0185(199706)248:2<269::AID-AR14>3.0.CO;2-N; Mithoefer K, 2005, J BONE JOINT SURG AM, V87A, P1911, DOI 10.2106/JBJS.D.02846; Mithoefer K, 2006, AM J SPORT MED, V34, P1413, DOI 10.1177/0363546506288240; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402; Ogawa R, 2010, CURR STEM CELL RES T, V5, P129, DOI 10.2174/157488810791268627; Steadman J Richard, 2003, J Knee Surg, V16, P83; Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056; Zaslav K, 2009, AM J SPORT MED, V37, P42, DOI 10.1177/0363546508322897; Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	81	85	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99410	10.1371/journal.pone.0099410	http://dx.doi.org/10.1371/journal.pone.0099410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918443	Green Published, Green Accepted, gold			2022-12-27	WOS:000338631000083
J	Zabala, J; Diaz, B; Salona-Bordas, MI				Zabala, Jabi; Diaz, Beatriz; Salona-Bordas, Marta I.			Seasonal Blowfly Distribution and Abundance in Fragmented Landscapes. Is It Useful in Forensic Inference about Where a Corpse Has Been Decaying?	PLOS ONE			English	Article							DIPTERA CALLIPHORIDAE; ARTHROPOD SUCCESSION; INSECT SUCCESSION; CARRION; FLIES; URBAN; DECOMPOSITION; ENTOMOLOGY; OCCUPANCY; GRADIENT	Blowflies are insects of forensic interest as they may indicate characteristics of the environment where a body has been laying prior to the discovery. In order to estimate changes in community related to landscape and to assess if blowfly species can be used as indicators of the landscape where a corpse has been decaying, we studied the blowfly community and how it is affected by landscape in a 7,000 km(2) region during a whole year. Using baited traps deployed monthly we collected 28,507 individuals of 10 calliphorid species, 7 of them well represented and distributed in the study area. Multiple Analysis of Variance found changes in abundance between seasons in the 7 analyzed species, and changes related to land use in 4 of them (Calliphora vomitoria, Lucilia ampullacea, L. caesar and L. illustris). Generalised Linear Model analyses of abundance of these species compared with landscape descriptors at different scales found only a clear significant relationship between summer abundance of C. vomitoria and distance to urban areas and degree of urbanisation. This relationship explained more deviance when considering the landscape composition at larger geographical scales (up to 2,500 m around sampling site). For the other species, no clear relationship between land uses and abundance was found, and therefore observed changes in their abundance patterns could be the result of other variables, probably small changes in temperature. Our results suggest that blowfly community composition cannot be used to infer in what kind of landscape a corpse has decayed, at least in highly fragmented habitats, the only exception being the summer abundance of C. vomitoria.	[Zabala, Jabi; Diaz, Beatriz; Salona-Bordas, Marta I.] Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Bilbao, Spain; [Zabala, Jabi] Sebero Otxoa, Arrigorriaga 48480, Biscay, Spain; [Diaz, Beatriz] Aranzadi Sci Soc, Dept Entomol, San Sebastian, Guipuzcoa, Spain	University of Basque Country	Salona-Bordas, MI (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Bilbao, Spain.	m.salona@ehu.es	Zabala, Jabi/B-8157-2009	Zabala, Jabi/0000-0002-1425-1594; SalonaBordas, Marta/0000-0002-6873-7784	Basque Government; University of the Basque Country	Basque Government(Basque Government); University of the Basque Country	Field work and technicians assistance was supported by a research project funded by the Basque Government and the University of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GS, 1996, J FORENSIC SCI, V41, P617; [Anonymous], 1991, BLOWFLIES DIPTERA CA; Arnaldos MI, 2004, INT J LEGAL MED, V118, P197, DOI 10.1007/s00414-004-0446-3; Arnaldos MI, 2006, CIENCIA FORENSE, V8, P63; Baz A, 2007, ANN SOC ENTOMOL FR, V43, P289, DOI 10.1080/00379271.2007.10697524; Bordas Marta Ines Salona, 2009, Boletin de la Asociacion Espanola de Entomologia, V33, P63; BRAACK LEO, 1986, ONDERSTEPOORT J VET, V53, P13; Brundage A, 2011, FORENSIC SCI INT, V212, P115, DOI 10.1016/j.forsciint.2011.05.023; Castillo Miralbes M, 2002, MONOGRAFIAS SOC ENTO, V6, P96; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Crawley M.J., 2007, R BOOK; Garcia-Rojo Ana Marie, 2004, Boletin de la SEA, V34, P263; Goff M L, 1993, Forensic Sci Rev, V5, P81; Gonzalez Mora D., 1990, Eos-Revista Espanola de Entomologia, V65, P39; Gonzalez Mora D, 1988, EOS, V64, P91; Grassberger M, 2004, J MED ENTOMOL, V41, P511, DOI 10.1603/0022-2585-41.3.511; Hwang C, 2005, MED VET ENTOMOL, V19, P379, DOI 10.1111/j.1365-2915.2005.00583.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kavazos CRJ, 2012, LANDSCAPE URBAN PLAN, V106, P183, DOI 10.1016/j.landurbplan.2012.03.002; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Martinez-Sanchez A, 2000, MED VET ENTOMOL, V14, P56, DOI 10.1046/j.1365-2915.2000.00205.x; Moneo Pellitero J, 2007, B SOC ENTOMOLOGICA A, V40, P479; NUORTEVA PEKKA, 1963, ANN ENTOMOL FENNICA, V29, P1; PERIS S V, 1991, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Biologica, V87, P187; Castro CPE, 2011, ANN SOC ENTOMOL FR, V47, P128; R Core Team, 2021, R LANGUAGE ENV STAT; Schoenly KG, 2006, AM BIOL TEACH, V68, P402, DOI 10.1662/0002-7685(2006)68[402:RDAITS]2.0.CO;2; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Smith K. G. V., 1986, A manual of forensic entomology.; Turner B, 1999, FORENSIC SCI INT, V101, P113, DOI 10.1016/S0379-0738(99)00018-3; Zabala J, 2005, EUR J WILDLIFE RES, V51, P157, DOI 10.1007/s10344-005-0094-z; Zabala J, 2006, ORNIS FENNICA, V83, P97; Zumpt F., 1956, pUnpaginated; Zuur Alain F., 2009, P1	34	31	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99668	10.1371/journal.pone.0099668	http://dx.doi.org/10.1371/journal.pone.0099668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918607	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000102
J	Zhou, XH; Bi, B; Zheng, LQ; Li, Z; Yang, HM; Song, HJ; Sun, YX				Zhou, Xinghu; Bi, Bo; Zheng, Liqiang; Li, Zhao; Yang, Hongmei; Song, Hongjie; Sun, Yingxian			The Prevalence and Risk Factors for Depression Symptoms in a Rural Chinese Sample Population	PLOS ONE			English	Article							MAJOR DEPRESSION; MENTAL-DISORDERS; UNITED-STATES; EPIDEMIOLOGY; ADULTS; EUROPE; PHQ-9; DIET; CITY	Background: It is essential to understand how we can prevent and treat the epidemic of depression. Several studies have reported the prevalence of depressive symptoms in the urban population in China, but there is a lack of information regarding the prevalence of depression in rural populations. Objective: To understand the prevalence of depression in a rural Chinese population and to analyze the risk factors for depression. Methods: This study used a cross-sectional approach. A total of 11,473 subjects were surveyed and completed the Patient Health Questionnaire-9 (PHQ-9) and the World Health Organization Quality of Life Brief scales. Living conditions, per capita income, marital status, and information about dietary health and chronic disease status were assessed. Results: The prevalence of depressive symptoms in the population was 5.9%. The prevalence in women (8.1%) was higher compared with men (3.5%) and also increased with age. The per capita income level, amount of sleep obtained per day, education level, weekly consumption of meat and beans or bean products, salt intake, and chronic disease status were associated with depressive symptoms. The quality of life of individuals with a score less than 10 points on the PHQ-9 was significantly better compared with individuals with a score greater than 10. Conclusion: The prevalence of depressive symptoms among rural population is higher than some southern cities in China. Dietary patterns may be an important risk factor linked to this disorder in the Chinese rural population.	[Zhou, Xinghu; Li, Zhao; Yang, Hongmei; Song, Hongjie; Sun, Yingxian] China Med Univ, Hosp 1, Dept Cardiol, Shenyang, Liaoning Provin, Peoples R China; [Bi, Bo] China Med Univ, Hosp 1, Dept Psychol, Shenyang, Liaoning Provin, Peoples R China; [Zheng, Liqiang] China Med Univ, Shenjing Hosp, Dept Clin Epidemiol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University	Sun, YX (corresponding author), China Med Univ, Hosp 1, Dept Cardiol, Shenyang, Liaoning Provin, Peoples R China.	yxsun@mail.cmu.edu.cn			"Twelfth Five-Year'' project funds (National Science and Technology Support Program of China) [2012BAJ18B02]	"Twelfth Five-Year'' project funds (National Science and Technology Support Program of China)	This study was supported by grants from the "Twelfth Five-Year'' project funds (National Science and Technology Support Program of China, grant #2012BAJ18B02) that Pro Yingxian Sun responsible for enable the project completion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Amoran O, 2007, AUST J RURAL HEALTH, V15, P211, DOI 10.1111/j.1440-1584.2006.00794.x; Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Bhattacharyya M, 2013, PUBLIC HEALTH NUTR, P1; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Colin A, 2003, ENCEPHALE, V29, P49; Compton WM, 2006, AM J PSYCHIAT, V163, P2141, DOI 10.1176/appi.ajp.163.12.2141; Cooper J, 2001, BRIT J PSYCHIAT, V179, P85; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Dunn A L, 1991, Exerc Sport Sci Rev, V19, P41; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Eaton SB, 2010, AM J CLIN NUTR, V91, P295, DOI 10.3945/ajcn.2009.29058; Jeste ND, 2006, J AFFECT DISORDERS, V90, P37, DOI 10.1016/j.jad.2005.10.007; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lee S, 2009, PSYCHOL MED, V39, P735, DOI 10.1017/S0033291708004091; Li YM, 2012, INT J GERIATR PSYCH, V27, P31, DOI 10.1002/gps.2685; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Lu J, 2008, J AFFECT DISORDERS, V111, P221, DOI 10.1016/j.jad.2008.02.018; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Norberg MM, 2008, J ANXIETY DISORD, V22, P1516, DOI 10.1016/j.janxdis.2008.03.005; Pakriev S, 1998, ACTA PSYCHIAT SCAND, V97, P169, DOI 10.1111/j.1600-0447.1998.tb09983.x; Pan A, 2008, J AFFECT DISORDERS, V105, P167, DOI 10.1016/j.jad.2007.05.003; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Probst JC, 2006, FAM MED, V38, P653; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Sugawara N., 2012, ANN GEN PSYCHIATR, V11; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Van der Wurff FB, 2004, ETHNIC HEALTH, V9, pS57; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wilhelm K, 2003, J AFFECT DISORDERS, V75, P155, DOI 10.1016/S0165-0327(02)00040-X; Wu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033857; Yu J, 2012, INT J GERIATR PSYCH, V27, P305, DOI 10.1002/gps.2721	37	66	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99692	10.1371/journal.pone.0099692	http://dx.doi.org/10.1371/journal.pone.0099692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919087	gold, Green Submitted, Green Published			2022-12-27	WOS:000338631000105
J	Zotta, T; Ricciardi, A; Ianniello, RG; Parente, E; Reale, A; Rossi, F; Iacumin, L; Comi, G; Coppola, R				Zotta, Teresa; Ricciardi, Annamaria; Ianniello, Rocco G.; Parente, Eugenio; Reale, Anna; Rossi, Franca; Iacumin, Lucilla; Comi, Giuseppe; Coppola, Raffaele			Assessment of Aerobic and Respiratory Growth in the Lactobacillus casei Group	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; SUPEROXIDE-DISMUTASE; MANGANESE CATALASE; PYRUVATE OXIDASE; PLANTARUM WCFS1; CLONING; METABOLISM; EXPRESSION; BACTERIA; HEME	One hundred eighty four strains belonging to the species Lactobacillus casei, L. paracasei and L. rhamnosus were screened for their ability to grow under aerobic conditions, in media containing heme and menaquinone and/or compounds generating reactive oxygen species (ROS), in order to identify respiratory and oxygen-tolerant phenotypes. Most strains were able to cope with aerobic conditions and for many strains aerobic growth and heme or heme/menaquinone supplementation increased biomass production compared to anaerobic cultivation. Only four L. casei strains showed a catalase-like activity under anaerobic, aerobic and respiratory conditions and were able to survive in presence of H2O2 (1 mM). Almost all L. casei and L. paracasei strains tolerated menadione (0.2 mM) and most tolerated pyrogallol (50 mM), while L. rhamnosus was usually resistant only to the latter compound. This is the first study in which an extensive screening of oxygen and oxidative stress tolerance of members of the L. casei group has been carried out. Results allowed the selection of strains showing the typical traits of aerobic and respiratory metabolism (increased pH and biomass under aerobic or respiratory conditions) and unique oxidative stress response properties. Aerobic growth and respiration may confer technological and physiological advantages in the L. casei group and oxygen-tolerant phenotypes could be exploited in several food industry applications.	[Zotta, Teresa; Ricciardi, Annamaria; Parente, Eugenio; Reale, Anna; Coppola, Raffaele] CNR, Ist Sci Alimentaz, Avellino, Italy; [Ricciardi, Annamaria; Ianniello, Rocco G.; Parente, Eugenio] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, I-85100 Potenza, Italy; [Rossi, Franca; Coppola, Raffaele] Univ Molise, Dipartimento Agr Ambiente & Alimenti, Campobasso, Italy; [Iacumin, Lucilla; Comi, Giuseppe] Univ Udine, Dipartimento Sci Alimenti, I-33100 Udine, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Basilicata; University of Molise; University of Udine	Zotta, T (corresponding author), CNR, Ist Sci Alimentaz, Avellino, Italy.	teresa.zotta@isa.cnr.it	Reale, Anna/AAX-7486-2020; Iacumin, Lucilla/ABD-7559-2021; Comi, Giuseppe/GYE-0141-2022; Rossi, Franca/X-8036-2018; Coppola, Raffaele/A-3291-2012; Parente, Eugenio/B-3809-2014	Iacumin, Lucilla/0000-0003-2967-8109; Rossi, Franca/0000-0002-7443-1538; Parente, Eugenio/0000-0002-5716-2348; COPPOLA, RAFFAELE/0000-0003-1849-6801; Reale, Anna/0000-0001-5576-257X; Ricciardi, Annamaria/0000-0002-6146-8331; Zotta, Teresa/0000-0001-8228-6804	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy; Project FIRB 2010 "Futuro in Ricerca'' [RBFR107VML]	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy(Ministry of Education, Universities and Research (MIUR)); Project FIRB 2010 "Futuro in Ricerca''	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, Project FIRB 2010 "Futuro in Ricerca'', n. RBFR107VML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2004, APPL ENVIRON MICROB, V70, P603, DOI 10.1128/AEM.70.1.603-606.2004; An HR, 2011, J AGR FOOD CHEM, V59, P3851, DOI 10.1021/jf200251k; An HR, 2010, MOL BIOTECHNOL, V45, P155, DOI 10.1007/s12033-010-9254-9; Andrus JM, 2003, ARCH BIOCHEM BIOPHYS, V420, P103, DOI 10.1016/j.abb.2003.09.007; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; BARANYI J., 1996, DMFIT MANUAL VERSION; Baureder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036725; Beulens JWJ, 2013, BRIT J NUTR, V110, P1357, DOI 10.1017/S0007114513001013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; De Vendittis A, 2010, MOL BIOSYST, V6, P1973, DOI 10.1039/c003557b; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Frolkova P, 2012, FOLIA MICROBIOL, V57, P439, DOI 10.1007/s12223-012-0115-8; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Guidone A, 2013, WORLD J MICROB BIOT, V29, P1713, DOI 10.1007/s11274-013-1334-0; Hertzberger RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057235; Igarashi T, 1996, J BIOL CHEM, V271, P29521, DOI 10.1074/jbc.271.47.29521; Kang TS, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-10; KNAUF HJ, 1992, APPL ENVIRON MICROB, V58, P832, DOI 10.1128/AEM.58.3.832-839.1992; KONO Y, 1983, J BACTERIOL, V155, P742, DOI 10.1128/JB.155.2.742-746.1983; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Nagpal R, 2012, FEMS MICROBIOL LETT, V334, P1, DOI 10.1111/j.1574-6968.2012.02593.x; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ricciardi A, 2014, ANN MICROBIOL, V64, P1861, DOI 10.1007/s13213-014-0819-x; RISSE B, 1992, PROTEIN SCI, V1, P1699, DOI 10.1002/pro.5560011218; Rochat T, 2006, APPL ENVIRON MICROB, V72, P5143, DOI 10.1128/AEM.00482-06; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; SANDERS JW, 1995, J BACTERIOL, V177, P5254, DOI 10.1128/jb.177.18.5254-5260.1995; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; Serata M, 2012, MICROBIOL-SGM, V158, P953, DOI 10.1099/mic.0.053942-0; Settanni L, 2010, FOOD MICROBIOL, V27, P691, DOI 10.1016/j.fm.2010.05.023; Singh S, 2009, LWT-FOOD SCI TECHNOL, V42, P448, DOI 10.1016/j.lwt.2008.05.019; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Strus M, 2009, J PHYSIOL PHARMACOL, V60, P49; Tindall BJ, 2008, INT J SYST EVOL MICR, V58, P1764, DOI 10.1099/ijs.0.2008/005330-0; Toh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075073; Wang GH, 2011, J IND MICROBIOL BIOT, V38, P985, DOI 10.1007/s10295-010-0871-x; Watanabe M, 2012, APPL ENVIRON MICROB, V78, P4062, DOI 10.1128/AEM.00287-12; Watanabe M, 2012, MICROBIOL-SGM, V158, P293, DOI 10.1099/mic.0.051250-0; Zotta T, 2014, J APPL MICROBIOL, V116, P632, DOI 10.1111/jam.12398; Zotta T, 2013, J APPL MICROBIOL, V115, P848, DOI 10.1111/jam.12285; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	47	55	56	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99189	10.1371/journal.pone.0099189	http://dx.doi.org/10.1371/journal.pone.0099189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918811	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000055
J	Goodson, JM; Kantarci, A; Hartman, ML; Denis, GV; Stephens, D; Hasturk, H; Yaskell, T; Vargas, J; Wang, XS; Cugini, M; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K; Welty, F				Goodson, J. Max; Kantarci, Alpdogan; Hartman, Mor-Li; Denis, Gerald V.; Stephens, Danielle; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Wang, Xiaoshan; Cugini, Maryann; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem; Welty, Francine			Metabolic Disease Risk in Children by Salivary Biomarker Analysis	PLOS ONE			English	Article							REACTIVE PROTEIN-LEVELS; PLASMA-INSULIN; CHRONIC PERIODONTITIS; NONDIABETIC SUBJECTS; DIABETIC-PATIENTS; WHOLE SALIVA; INFLAMMATION; OBESITY; GLUCOSE; ADOLESCENTS	Objective: The study of obesity-related metabolic syndrome or Type 2 diabetes (T2D) in children is particularly difficult because of fear of needles. We tested a non-invasive approach to study inflammatory parameters in an at-risk population of children to provide proof-of-principle for future investigations of vulnerable subjects. Design and Methods: We evaluated metabolic differences in 744, 11-year old children selected from underweight, normal healthy weight, overweight and obese categories by analyzing fasting saliva samples for 20 biomarkers. Saliva supernatants were obtained following centrifugation and used for analyses. Results: Salivary C-reactive protein (CRP) was 6 times higher, salivary insulin and leptin were 3 times higher, and adiponectin was 30% lower in obese children compared to healthy normal weight children (all P<0.0001). Categorical analysis suggested that there might be three types of obesity in children. Distinctly inflammatory characteristics appeared in 76% of obese children while in 13%, salivary insulin was high but not associated with inflammatory mediators. The remaining 11% of obese children had high insulin and reduced adiponectin. Forty percent of the non-obese children were found in groups which, based on biomarker characteristics, may be at risk for becoming obese. Conclusions: Significantly altered levels of salivary biomarkers in obese children from a high-risk population, suggest the potential for developing non-invasive screening procedures to identify T2D-vulnerable individuals and a means to test preventative strategies.	[Goodson, J. Max; Kantarci, Alpdogan; Hartman, Mor-Li; Stephens, Danielle; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Wang, Xiaoshan; Cugini, Maryann; Soparkar, Pramod] Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA; [Denis, Gerald V.] Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA; [Barake, Roula; Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha; Ariga, Jitendra] Minist Hlth, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait; [Welty, Francine] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Forsyth Institute; Boston University; Kuwait University; Harvard University; Beth Israel Deaconess Medical Center	Goodson, JM (corresponding author), Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA.	mgoodson@forsyth.org		Denis, Gerald/0000-0001-9886-0401; Barake, Roula/0000-0002-9461-2897	Dasman Diabetes Institute in Kuwait; NATIONAL CANCER INSTITUTE [U01CA182898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090455] Funding Source: NIH RePORTER	Dasman Diabetes Institute in Kuwait; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the Dasman Diabetes Institute in Kuwait. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; Arellano-Garcia MT, 2008, ORAL DIS, V14, P705, DOI 10.1111/j.1601-0825.2008.01488.x; Aydin S, 2007, J BIOCHEM MOL BIOL, V40, P29; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Browne RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059498; CDC, 2012, CHILD TEEN BMI CALC; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Farb MG, 2011, J AM COLL CARDIOL, V58, P232, DOI 10.1016/j.jacc.2011.01.051; Floriano PN, 2009, CLIN CHEM, V55, P1530, DOI 10.1373/clinchem.2008.117713; Gornowicz A, 2012, ANN AGR ENV MED, V19, P711; Groschl M, 2009, BIOESSAYS, V31, P843, DOI 10.1002/bies.200900013; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Gupta MA, 2013, CLIN DERMATOL, V31, P1, DOI 10.1016/j.clindermatol.2011.11.018; Hettmansperger TP, 2012, ROBUST NONPARAMETRIC; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Janket SJ, 2008, ORAL SURG ORAL MED O, V105, P173, DOI 10.1016/j.tripleo.2007.06.027; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Kamaryt J, 1989, Cesk Pediatr, V44, P517; Kang EH, 2011, CLIN EXP RHEUMATOL, V29, P970; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; KNIP M, 1993, AM J CLIN NUTR, V57, P490, DOI 10.1093/ajcn/57.4.490; Lee JY, 2007, ORAL DIS, V13, P550, DOI 10.1111/j.1601-0825.2006.01332.x; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; MARCHETTI P, 1990, DIABETES METAB, V16, P16; MARCHETTI P, 1986, DIABETOLOGIA, V29, P695, DOI 10.1007/BF00870278; Naidoo T, 2012, CARDIOVASC J AFR, V23, P501, DOI 10.5830/CVJA-2012-058; Nielsen AA, 2005, SCAND J GASTROENTERO, V40, P1444, DOI 10.1080/00365520510023774; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ozcaka O, 2011, J PERIODONTAL RES, V46, P592, DOI 10.1111/j.1600-0765.2011.01377.x; PASIC J, 1988, DIABETES CARE, V11, P489, DOI 10.2337/diacare.11.6.489; Rai Balwant, 2008, J Oral Sci, V50, P53, DOI 10.2334/josnusd.50.53; Rathnayake N, 2013, J CLIN PERIODONTOL, V40, P140, DOI 10.1111/jcpe.12038; Renaldi Olly, 2009, Acta Med Indones, V41, P20; Rosa JS, 2011, J CLIN RES PEDIATR E, V3, P115, DOI 10.4274/jcrpe.v3i3.23; Scheicher ME, 2007, EUR RESPIR J, V29, P489, DOI 10.1183/09031936.00060205; Sexton WM, 2011, J CLIN PERIODONTOL, V38, P434, DOI 10.1111/j.1600-051X.2011.01706.x; Shea S, 2003, OBES RES, V11, P95, DOI 10.1038/oby.2003.15; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Surdacka A, 2011, ARCH ORAL BIOL, V56, P428, DOI 10.1016/j.archoralbio.2010.11.005; Suriano K, 2010, J PEDIAT; Teles RP, 2009, J PERIODONTAL RES, V44, P411, DOI 10.1111/j.1600-0765.2008.01119.x; TENOVUO J, 1986, J DENT RES, V65, P62, DOI 10.1177/00220345860650011101; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	44	78	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98799	10.1371/journal.pone.0098799	http://dx.doi.org/10.1371/journal.pone.0098799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915044	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700033
J	Gorvel, L; Textoris, J; Banchereau, R; Ben Amara, A; Tantibhedhyangkul, W; von Bargen, K; Ka, MB; Capo, C; Ghigo, E; Gorvel, JP; Mege, JL				Gorvel, Laurent; Textoris, Julien; Banchereau, Romain; Ben Amara, Amira; Tantibhedhyangkul, Wiwit; von Bargen, Kristin; Ka, Mignane B.; Capo, Christian; Ghigo, Eric; Gorvel, Jean-Pierre; Mege, Jean-Louis			Intracellular Bacteria Interfere with Dendritic Cell Functions: Role of the Type I Interferon Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; ORIENTIA-TSUTSUGAMUSHI; GENE-EXPRESSION; SCRUB TYPHUS; ENDOPLASMIC-RETICULUM; TROPHERYMA-WHIPPLEI; COXIELLA-BURNETII; HUMAN MACROPHAGES; DC-SIGN; BRUCELLA	Dendritic cells (DCs) orchestrate host defenses against microorganisms. In infectious diseases due to intracellular bacteria, the inefficiency of the immune system to eradicate microorganisms has been attributed to the hijacking of DC functions. In this study, we selected intracellular bacterial pathogens with distinct lifestyles and explored the responses of monocyte-derived DCs (moDCs). Using lipopolysaccharide as a control, we found that Orientia tsutsugamushi, the causative agent of scrub typhus that survives in the cytosol of target cells, induced moDC maturation, as assessed by decreased endocytosis activity, the ability to induce lymphocyte proliferation and the membrane expression of phenotypic markers. In contrast, Coxiella burnetii, the agent of Q fever, and Brucella abortus, the agent of brucellosis, both of which reside in vacuolar compartments, only partly induced the maturation of moDCs, as demonstrated by a phenotypic analysis. To analyze the mechanisms used by C. burnetii and B. abortus to alter moDC activation, we performed microarray and found that C. burnetii and B. abortus induced a specific signature consisting of TLR4, TLR3, STAT1 and interferon response genes. These genes were down-modulated in response to C. burnetii and B. abortus but up-modulated in moDCs activated by lipopolysaccharide and O. tsutsugamushi. This transcriptional alteration was associated with the defective interferon-beta production. This study demonstrates that intracellular bacteria specifically affect moDC responses and emphasizes how C. burnetii and B. abortus interfere with moDC activation and the antimicrobial immune response. We believe that comparing infection by several bacterial species may be useful for defining new pathways and biomarkers and for developing new treatment strategies.	[Gorvel, Laurent; Textoris, Julien; Ben Amara, Amira; Tantibhedhyangkul, Wiwit; Ka, Mignane B.; Capo, Christian; Ghigo, Eric; Mege, Jean-Louis] Aix Marseille Univ, INSERM U1095, IRD198, CNRS,UMR 7278, Marseille, France; [Banchereau, Romain] Baylor Inst Immunol Res, Dallas, TX USA; [von Bargen, Kristin; Gorvel, Jean-Pierre] Aix Marseille Univ, CNRS, INSERM, UM2,U1104,UMR7280,CIML, Marseille, France; [Tantibhedhyangkul, Wiwit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Baylor Scott & White Health; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Mahidol University	Mege, JL (corresponding author), Aix Marseille Univ, INSERM U1095, IRD198, CNRS,UMR 7278, Marseille, France.	jean-louis.mege@univ-amu.fr	GORVEL, Laurent/AAB-1749-2020; Eric, Ghigo/N-9427-2016; Textoris, Julien/H-3317-2019; MEGE, JEAN-LOUIS/O-6063-2016; Gorvel, Jean-Pierre/O-1332-2018	GORVEL, Laurent/0000-0001-7526-261X; Textoris, Julien/0000-0002-3821-9337; Gorvel, Jean-Pierre/0000-0002-2829-9804; tantibhedhyangkul, wiwit/0000-0003-0943-9012				Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Andres S, 2011, FEMS IMMUNOL MED MIC, V61, P168, DOI 10.1111/j.1574-695X.2010.00761.x; Balboa L, 2010, IMMUNOL CELL BIOL, V88, P716, DOI 10.1038/icb.2010.22; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Ben Amara A, 2013, J IMMUNOL, V191, P5501, DOI 10.4049/jimmunol.1300988; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Choi JH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001981; Miraglia MC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-47; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; de Bagues MPJ, 2005, INFECT IMMUN, V73, P3178, DOI 10.1128/IAI.73.5.3178-3183.2005; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Dimitrakopoulos O, 2013, MICROBES INFECT, V15, P450, DOI 10.1016/j.micinf.2013.04.007; Edelson BT, 2012, ADV IMMUNOL, V113, P33, DOI 10.1016/B978-0-12-394590-7.00006-3; Feau S, 2005, BLOOD, V105, P697, DOI 10.1182/blood-2004-03-1059; Ge Y, 2011, MICROBES INFECT, V13, P638, DOI 10.1016/j.micinf.2011.03.003; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gorvel L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.11; Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Martirosyan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055117; Ojcius DM, 1998, J IMMUNOL, V160, P1297; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Paris DH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001466; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Tam MA, 2004, TRENDS IMMUNOL, V25, P335, DOI 10.1016/j.it.2004.05.004; Tantibhedhyangkul W, 2013, MICROB PATHOGENESIS, V55, P55, DOI 10.1016/j.micpath.2012.10.001; Tantibhedhyangkul W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001028; Textoris J, 2012, RECENT RES DEV IMMUN, V8, P49; Wang YH, 2009, AUTOPHAGY, V5, P540, DOI 10.4161/auto.5.4.8167; Wei L, 2012, CURR MICROBIOL, V65, P133, DOI 10.1007/s00284-012-0136-1; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zenk SF, 2009, J IMMUNOL, V183, P2697, DOI 10.4049/jimmunol.0900937	48	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99420	10.1371/journal.pone.0099420	http://dx.doi.org/10.1371/journal.pone.0099420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915541	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700100
J	Clemens, A; Noack, H; Brueckmann, M; Lip, GYH				Clemens, Andreas; Noack, Herbert; Brueckmann, Martina; Lip, Gregory Y. H.			Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria	PLOS ONE			English	Article							FACTOR XA INHIBITOR; ATRIAL-FIBRILLATION; WARFARIN; PHARMACODYNAMICS; PHARMACOKINETICS; DABIGATRAN; APIXABAN; EDOXABAN; SAFETY; EFFICACY	Background: A number of novel oral anticoagulants (direct thrombin inhibitors or factor Xa inhibitors) are in clinical use for various indications. The dosing regimens differ between twice-daily and once-daily dosing for the prevention of stroke in patients with atrial fibrillation. With the availability of the results from four phase 3 studies (> 70,000 patients), we explored whether twice-daily or once-daily dosing provides better risk-benefit balance among novel oral anticoagulants. Methods: We conducted a strict, stepwise, fixed-effects meta-analysis with predefined heterogeneity quality criteria to generate the most appropriate common estimates for twice-daily (BID) or once-daily (QD) dosing regimens. An indirect comparison of these dosing regimens with fixed-effects meta-analysis common estimates (where available), or individual compound results, was done respectively. Results: Comparing indirectly BID vs QD dosing regimens resulted in hazard ratios (HR [95% confidence interval]) for stroke and systemic embolism of 0.75 (0.58-0.96) for dabigatran 150 mg BID, and 0.91 (0.73-1.13) for apixaban BID vs the QD dosing regimen. For ischemic stroke, the HR of BID vs QD was 0.85 (0.69-1.05). For intracranial hemorrhage, BID vs rivaroxaban QD was 0.57 (0.37-0.88) and, vs edoxaban QD, 0.81 (0.54-1.22). Due to heterogeneity, common estimates for major bleeding QD or BID were not justified, therefore indirect comparison of regimens were not possible. All non-vitamin K antagonist oral anticoagulants reduced all-cause mortality vs warfarin with a HR of 0.90 (0.86-0.96) without differences between regimen. Conclusions: Based on the available phase 3 study evidence, the twice-daily dosing regimen of non-vitamin K antagonist oral anticoagulants appears to offer a more balanced risk-benefit profile with respect to stroke prevention and intracranial hemorrhage.	[Clemens, Andreas] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Clemens, Andreas] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biostat & Data Management, Ingelheim, Germany; [Noack, Herbert; Brueckmann, Martina] Boehringer Ingelheim Pharma GmbH & Co KG, Corp Div Med, Global Therapeut Area Cardiovasc, Ingelheim, Germany; [Brueckmann, Martina] Heidelberg Univ, Fac Med Mannheim, Mannheim, Germany; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	Johannes Gutenberg University of Mainz; Boehringer Ingelheim; Boehringer Ingelheim; Ruprecht Karls University Heidelberg; University of Birmingham	Clemens, A (corresponding author), Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany.	andreas.clemens66@gmail.com		Noack, Herbert/0000-0002-3194-2039	Federal Ministry of Education and Research [BMBF 01EO1003]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany is supported by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Clemens A, 2012, CURR MED RES OPIN, V28, P195, DOI 10.1185/03007995.2011.654109; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Francis KM, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.365.365; Frost C, 2013, BRIT J CLIN PHARMACO, V76, P776, DOI 10.1111/bcp.12106; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jackson D, 2006, STAT MED, V25, P2688, DOI 10.1002/sim.2481; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Mueck W, 2008, THROMB HAEMOSTASIS, V100, P453, DOI 10.1160/07-12-0714; Mueck W, 2014, CLIN PHARMACOKINET, V53, P1, DOI 10.1007/s40262-013-0100-7; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; RD Lopes, 2010, AM HEART J, V159, P1162; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Song X, 2012, AM J CARDIOVASC DRUG, V12, P245, DOI 10.2165/11632540-000000000-00000; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758	25	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99276	10.1371/journal.pone.0099276	http://dx.doi.org/10.1371/journal.pone.0099276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911432	Green Published, gold			2022-12-27	WOS:000337165600065
J	Lamothe, M; Roy, JS; Bouffard, J; Gagne, M; Bouyer, LJ; Mercier, C				Lamothe, Melanie; Roy, Jean-Sebastien; Bouffard, Jason; Gagne, Martin; Bouyer, Laurent J.; Mercier, Catherine			Effect of Tonic Pain on Motor Acquisition and Retention while Learning to Reach in a Force Field	PLOS ONE			English	Article							NECK-SHOULDER PAIN; MUSCLE PAIN; EVOKED-POTENTIALS; ELBOW-FLEXION; SHORT-TERM; LIMB PAIN; CORTEX; EXCITABILITY; MODULATION; STIMULATION	Most patients receiving intensive rehabilitation to improve their upper limb function experience pain. Despite this, the impact of pain on the ability to learn a specific motor task is still unknown. The aim of this study was to determine whether the presence of experimental tonic pain interferes with the acquisition and retention stages of motor learning associated with training in a reaching task. Twenty-nine healthy subjects were randomized to either a Control or Pain Group (receiving topical capsaicin cream on the upper arm during training on Day 1). On two consecutive days, subjects made ballistic movements towards two targets (NEAR/FAR) using a robotized exoskeleton. On Day 1, the task was performed without (baseline) and with a force field (adaptation). The adaptation task was repeated on Day 2. Task performance was assessed using index distance from the target at the end of the reaching movement. Motor planning was assessed using initial angle of deviation of index trajectory from a straight line to the target. Results show that tonic pain did not affect baseline reaching. Both groups improved task performance across time (p<0.001), but the Pain group showed a larger final error (under-compensation) than the Control group for the FAR target (p = 0.030) during both acquisition and retention. Moreover, a Group x Time interaction (p = 0.028) was observed on initial angle of deviation, suggesting that subjects with Pain made larger adjustments in the feedforward component of the movement over time. Interestingly, behaviour of the Pain group was very stable from the end of Day 1 (with pain) to the beginning of Day 2 (pain-free), indicating that the differences observed could not solely be explained by the impact of pain on immediate performance. This suggests that if people learn to move differently in the presence of pain, they might maintain this altered strategy over time.	[Lamothe, Melanie; Roy, Jean-Sebastien; Bouffard, Jason; Gagne, Martin; Bouyer, Laurent J.; Mercier, Catherine] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Lamothe, Melanie; Roy, Jean-Sebastien; Bouffard, Jason; Bouyer, Laurent J.; Mercier, Catherine] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ G1K 7P4, Canada	Laval University	Mercier, C (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada.	catherine.mercier@rea.ulaval.ca	Bouffard, Jason/AFM-1347-2022; Bouyer, Laurent/L-6471-2019; Bouyer, Laurent J/A-9255-2010	Bouffard, Jason/0000-0003-1083-5899; Bouyer, Laurent/0000-0003-2034-4516; Bouyer, Laurent J/0000-0003-2034-4516; Roy, Jean-Sebastien/0000-0003-2853-9940; Mercier, Catherine/0000-0002-2037-6916	Canadian Institutes of Health Research (CIHR) [MOP-125869]; Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS); CIRRIS; Fonds de la recherche Quebec - Sante (FRQS); FRQS; Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST); CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS); CIRRIS; Fonds de la recherche Quebec - Sante (FRQS); FRQS; Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR)[MOP-125869] and by a seed grant from the Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS). ML was supported by a studentship from the CIRRIS. JSR was supported by a salary award from the Fonds de la recherche Quebec - Sante (FRQS). JB was supported by studentships from the FRQS, CIHR and Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST). CM was supported by salary awards from the CIHR and FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004214; Arendt-Nielsen L, 2008, CLIN J PAIN, V24, P291, DOI 10.1097/AJP.0b013e31815b608f; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bement MKH, 2009, NEUROSCI LETT, V452, P209, DOI 10.1016/j.neulet.2009.01.038; Bock O, 2011, HUM MOVEMENT SCI, V30, P415, DOI 10.1016/j.humov.2010.10.007; Boudreau S, 2007, PAIN, V132, P169, DOI 10.1016/j.pain.2007.07.019; Cheong J Y, 2003, Electromyogr Clin Neurophysiol, V43, P203; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; de Xivry JJO, 2011, CEREB CORTEX, V21, P1475, DOI 10.1093/cercor/bhq192; Del Santo F, 2007, BRAIN RES, V1128, P91, DOI 10.1016/j.brainres.2006.09.039; Diederichsen LP, 2009, EXP BRAIN RES, V194, P329, DOI 10.1007/s00221-008-1701-5; Dillingham TR, 2001, AM J PHYS MED REHAB, V80, P563, DOI 10.1097/00002060-200108000-00003; Dube JA, 2011, CLIN NEUROPHYSIOL, V122, P2318, DOI 10.1016/j.clinph.2011.03.026; Ervilha UF, 2004, EUR J APPL PHYSIOL, V92, P168, DOI 10.1007/s00421-004-1083-8; Ervilha UF, 2004, EXP BRAIN RES, V156, P174, DOI 10.1007/s00221-003-1781-1; Eva-Maj M, 2013, EUR J APPL PHYSIOL, V113, P2487, DOI 10.1007/s00421-013-2683-y; Fadiga L, 2004, NEUROSCI LETT, V361, P250, DOI 10.1016/j.neulet.2003.12.016; Farina S, 2003, NEUROL RES, V25, P130, DOI 10.1179/016164103101201283; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; Fierro B, 2010, EXP BRAIN RES, V203, P31, DOI 10.1007/s00221-010-2206-6; Franklin DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001336; Graven-Nielsen Thomas, 2008, Curr Rheumatol Rep, V10, P475; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hug F., 2014, J NEUROPHYSIOL; Ingham D, 2011, EUR J PAIN, V15, P1028, DOI 10.1016/j.ejpain.2011.04.006; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Jonsson AC, 2006, J NEUROL NEUROSUR PS, V77, P590, DOI 10.1136/jnnp.2005.079145; Kaneko K, 1998, ELECTROMYOGR MOTOR C, V109, P364, DOI 10.1016/S0924-980X(98)00031-9; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Kofler M, 2001, CLIN NEUROPHYSIOL, V112, P1053, DOI 10.1016/S1388-2457(01)00540-5; Kofler M, 1998, NEUROSCI LETT, V246, P97, DOI 10.1016/S0304-3940(98)00243-2; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Kothari M, 2012, EUR J ORAL SCI, V120, P46, DOI 10.1111/j.1600-0722.2011.00894.x; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; Lundstrom E, 2009, EUR J NEUROL, V16, P188, DOI 10.1111/j.1468-1331.2008.02378.x; Madeleine P, 1999, EUR J APPL PHYSIOL, V79, P127, DOI 10.1007/s004210050486; Madeleine P, 2008, EXP BRAIN RES, V185, P689, DOI 10.1007/s00221-007-1199-2; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Melendez-Calderon A, 2011, IEEE T NEUR SYS REH, V19, P298, DOI 10.1109/TNSRE.2011.2125990; Mercier C, 2011, PHYSIOTHER CAN, V63, P305, DOI 10.3138/ptc.2010-08p; Orban de Xivry JJ, 2011, CORTICOSPINAL REORGA; Richardson AG, 2006, J NEUROSCI, V26, P12466, DOI 10.1523/JNEUROSCI.1139-06.2006; Roosink M, 2011, ARCH PHYS MED REHAB, V92, P1139, DOI 10.1016/j.apmr.2011.02.016; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; UNCINI A, 1991, ELECTROEN CLIN NEURO, V81, P344, DOI 10.1016/0168-5597(91)90023-Q; Urban PP, 2004, MUSCLE NERVE, V29, P663, DOI 10.1002/mus.20011; Valeriani M, 1999, CLIN NEUROPHYSIOL, V110, P1475, DOI 10.1016/S1388-2457(99)00075-9; Wassinger CA, 2013, J ORTHOP SPORT PHYS, V43, P199, DOI 10.2519/jospt.2013.4276; Weerakkody NS, 2008, J PHYSIOL-LONDON, V586, P3183, DOI 10.1113/jphysiol.2008.152942; Weerakkody NS, 2003, SOMATOSENS MOT RES, V20, P27, DOI 10.1080/0899022031000083816	54	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99159	10.1371/journal.pone.0099159	http://dx.doi.org/10.1371/journal.pone.0099159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911814	Green Submitted, gold, Green Published			2022-12-27	WOS:000337165600047
J	Alhilali, LM; Reynolds, AR; Fakhran, S				Alhilali, Lea M.; Reynolds, Arich R.; Fakhran, Saeed			Value of Prominent Flow Voids without Cord Edema in the Detection of Spinal Arteriovenous Fistulae	PLOS ONE			English	Article							ENHANCED MR-ANGIOGRAPHY; VASCULAR MALFORMATIONS; MYELOPATHY	Purpose: To determine the prevalence of spinal dural arteriovenous fistulae (SDAVF) in patients presenting with prominent vascular flow voids on imaging without other imaging findings suggestive of SDAVF. Methods: We retrospectively identified patients from January 1, 2005 to March 1, 2012 who underwent spinal angiography for suspected SDAVF with prominent vascular flow voids on prior imaging. We excluded patients with other major spinal pathology or other imaging findings of SDAVF including cord hyperintensity, enhancement, or expansion. We calculated the proportion of patients with positive findings for SDAVF on angiography and evaluated the prevalence of SDAVF for this finding alone and in correlation with clinical findings. Results: 18 patients underwent spinal angiography for prominent flow voids on imaging without other spinal pathology or imaging findings of SDAVF. Three had a SDAVF detected on angiography. The prevalence of SDAVF in this population was low, only 17% (95% CI 6-39%). All of the patients with positive angiography findings had myelopathy, increasing the prevalence to 100% if the additional clinical finding of myelopathy was present. Conclusions: Prominent flow voids without other imaging findings suggestive of SDAVF is poorly predictive of the presence of a SDAVF, unless myelopathy is present clinically.	[Alhilali, Lea M.; Reynolds, Arich R.; Fakhran, Saeed] Univ Pittsburgh Med Ctr, Dept Radiol, Pittsburgh, PA 15221 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alhilali, LM (corresponding author), Univ Pittsburgh Med Ctr, Dept Radiol, Pittsburgh, PA 15221 USA.	alhilalilm@upmc.edu						Aghakhani N, 2008, STROKE, V39, P2756, DOI 10.1161/STROKEAHA.108.517037; Anson J A, 1992, Clin Neurosurg, V39, P388; Bowen B C, 2000, Magn Reson Imaging Clin N Am, V8, P597; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Donghai W, 2013, SPINE PHILA PA 1976; GULLIVER D, 1988, Australasian Radiology, V32, P57, DOI 10.1111/j.1440-1673.1988.tb02692.x; Hacein-Bey L, 2014, CLIN NEUROL NEUROSUR; Hall C, 1991, PRACTICAL STAT MED R, P404; Hartman J, 2012, NEUROLOGY, V79, P15, DOI 10.1212/WNL.0b013e3182582f1f; Hetts SW, 2012, J NEUROSURG-SPINE, V16, P433, DOI 10.3171/2012.1.SPINE11643; Hurst RW, 2000, AM J NEURORADIOL, V21, P781; Jellema K, 2006, BRAIN, V129, P3150, DOI 10.1093/brain/awl220; Jellema K, 2006, J NEUROL, V253, P159, DOI 10.1007/s00415-005-0936-3; Krings T, 2009, AM J NEURORADIOL, V30, P639, DOI 10.3174/ajnr.A1485; Marcus J, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0335-7; MASARYK TJ, 1987, RADIOLOGY, V164, P845, DOI 10.1148/radiology.164.3.3615886; Mascalchi M, 2001, RADIOLOGY, V219, P346, DOI 10.1148/radiology.219.2.r01ap26346; Mull M, 2007, AM J NEURORADIOL, V28, P1249, DOI 10.3174/ajnr.A0612; Muralidharan R, 2013, SPINE, V38, P1188, DOI 10.1097/BRS.0b013e31828b2e10; Muralidharan R, 2011, SPINE, V36, pE1641, DOI 10.1097/BRS.0b013e31821352dd; ROSENBLUM DS, 1991, ARCH PHYS MED REHAB, V72, P233; Saraf-Lavi E, 2002, AM J NEURORADIOL, V23, P858; Sato K, 2012, J NEUROSURG-SPINE, V16, P441, DOI 10.3171/2012.2.SPINE11500; SYMON L, 1984, J NEUROSURG, V60, P238, DOI 10.3171/jns.1984.60.2.0238; Toossi S, 2012, NEUROLOGY, V79, P25, DOI 10.1212/WNL.0b013e3182582f07; van Rooij WJ, 2012, AM J NEURORADIOL, V33, P1888, DOI 10.3174/ajnr.A3082	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99004	10.1371/journal.pone.0099004	http://dx.doi.org/10.1371/journal.pone.0099004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905497	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000341869000088
J	Chevret, P; Robinson, TJ; Perez, J; Veyrunes, F; Britton-Davidian, J				Chevret, Pascale; Robinson, Terence J.; Perez, Julie; Veyrunes, Frederic; Britton-Davidian, Janice			A Phylogeographic Survey of the Pygmy Mouse Mus minutoides in South Africa: Taxonomic and Karyotypic Inference from Cytochrome b Sequences of Museum Specimens	PLOS ONE			English	Article							SUBGENUS NANNOMYS RODENTIA; MOLECULAR PHYLOGENY; GENUS MUS; MITOCHONDRIAL; MICE; MURINAE; SYSTEMATICS; DIVERSITY; GENES	The African pygmy mice (Mus, subgenus Nannomys) are a group of small-sized rodents that occur widely throughout sub-Saharan Africa. Chromosomal diversity within this group is extensive and numerous studies have shown the karyotype to be a useful taxonomic marker. This is pertinent to Mus minutoides populations in South Africa where two different cytotypes (2n = 34, 2n = 18) and a modification of the sex determination system (due to the presence of a Y chromosome in some females) have been recorded. This chromosomal diversity is mirrored by mitochondrial DNA sequences that unambiguously discriminate among the various pygmy mouse species and, importantly, the different M. minutoides cytotypes. However, the geographic delimitation and taxonomy of pygmy mice populations in South Africa is poorly understood. To address this, tissue samples of M. minutoides were taken and analysed from specimens housed in six South African museum collections. Partial cytochrome b sequences (400 pb) were successfully amplified from 44% of the 154 samples processed. Two species were identified: M. indutus and M. minutoides. The sequences of the M. indutus samples provided two unexpected features: i) nuclear copies of the cytochrome b gene were detected in many specimens, and ii) the range of this species was found to extend considerably further south than is presently understood. The phylogenetic analysis of the M. minutoides samples revealed two well-supported clades: a Southern clade which included the two chromosomal groups previously identified in South Africa, and an Eastern clade that extended from Eastern Africa into South Africa. Congruent molecular phylogenetic and chromosomal datasets permitted the tentative chromosomal assignments of museum specimens within the different clades as well as the correction of misidentified museum specimens.	[Chevret, Pascale] Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa; [Perez, Julie; Veyrunes, Frederic; Britton-Davidian, Janice] Univ Montpellier 2, UMR CNRS 5554, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Stellenbosch University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Chevret, P (corresponding author), Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	pascale.chevret@univ-lyon1.fr	Chevret, Pascale/B-7299-2009; Robinson, Terence J./K-7342-2017	Veyrunes, Frederic/0000-0002-1706-9915; Robinson, Terence J./0000-0002-4298-4891	University of Stellenbosch; ANR [10-JCJC-1605]	University of Stellenbosch; ANR(French National Research Agency (ANR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders: Ellerman Fellowship from the University of Stellenbosch (http:/www.sun.ac.za) to JBD and TJR; and ANR (http:/www.agence-nationale-recherche.fr/) grant "SEXYMUS" (No 10-JCJC-1605) to FV.	Britton-Davidian J, 2012, ACTA OECOL, V42, P41, DOI 10.1016/j.actao.2012.01.001; Castiglia R, 2002, CHROMOSOME RES, V10, P399, DOI 10.1023/A:1016853719616; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; den Tex RJ, 2010, GENETICA, V138, P979, DOI 10.1007/s10709-010-9481-9; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Happold DCD, 2013, MAMMALS AFRICA, V3, P473; Kouassi SK, 2008, MAMMALIA, V72, P237, DOI 10.1515/MAMM.2008.035; Lamb J, 2014, MAMM BIOL, V79, P24, DOI 10.1016/j.mambio.2013.08.010; Macholan M, 2001, ZOOL ANZ, V240, P7, DOI 10.1078/0044-5231-00002; Martinkova N, 2006, MOL ECOL NOTES, V6, P1014, DOI 10.1111/j.1471-8286.2006.01482.x; Mboumba JF, 2011, J ZOOL SYST EVOL RES, V49, P77, DOI 10.1111/j.1439-0469.2010.00579.x; McDonough MM, 2013, ZOOKEYS, P35, DOI 10.3897/zookeys.359.6247; Meester JAJ, 1986, TRANSVAAL MUSEUM MON, V5; Monadjem A, 2008, IUCN 2013 IUCN RED L; Montgelard C, 2002, MOL PHYLOGENET EVOL, V22, P220, DOI 10.1006/mpev.2001.1056; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Pages M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031123; Qu HY, 2008, J GENET GENOMICS, V35, P485, DOI 10.1016/S1673-8527(08)60066-1; Rambaut A, 2009, TRACER; ROBERTS AUSTIN, 1926, ANN TRANSVAAL MUS, V11, P245; Rodriguez F, 2007, J HERED, V98, P243, DOI 10.1093/jhered/esm013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Skinner J. D., 1990, MAMMALS SO AFRICAN S; Smit HA, 2008, J MAMMAL, V89, P1257, DOI 10.1644/07-MAMM-A-254.1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomas O, 1910, ANN MAG NAT HIST, V8, P83; Vermeiren L, 1983, ANN MUSEE R AFRIQUE, V237, P137; Veyrunes F, 2005, MOL PHYLOGENET EVOL, V36, P358, DOI 10.1016/j.ympev.2005.02.011; Veyrunes F, 2004, CHROMOSOME RES, V12, P369, DOI 10.1023/B:CHRO.0000034098.09885.e6; Veyrunes F, 2013, SEX DEV, V7, P244, DOI 10.1159/000351223; Veyrunes F, 2009, CHROMOSOME RES UNPUB; Veyrunes F, 2010, CHROMOSOME RES, V18, P563, DOI 10.1007/s10577-010-9144-9; Veyrunes F, 2010, P ROY SOC B-BIOL SCI, V277, P1049, DOI 10.1098/rspb.2009.1925	35	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98499	10.1371/journal.pone.0098499	http://dx.doi.org/10.1371/journal.pone.0098499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905736	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000034
J	Hudson, CM; Bent, ZW; Meagher, RJ; Williams, KP				Hudson, Corey M.; Bent, Zachary W.; Meagher, Robert J.; Williams, Kelly P.			Resistance Determinants and Mobile Genetic Elements of an NDM-1-Encoding Klebsiella pneumoniae Strain	PLOS ONE			English	Article							QUINOLONE RESISTANCE; ESCHERICHIA-COLI; ENTEROBACTER-AEROGENES; BETA-LACTAMASE; EVOLUTION; PLASMIDS; IDENTIFICATION; DISSEMINATION; ORGANIZATION; ACQUISITION	Multidrug-resistant Enterobacteriaceae are emerging as a serious infectious disease challenge. These strains can accumulate many antibiotic resistance genes though horizontal transfer of genetic elements, those for beta-lactamases being of particular concern. Some beta-lactamases are active on a broad spectrum of beta-lactams including the last-resort carbapenems. The gene for the broad-spectrum and carbapenem-active metallo-beta-lactamase NDM-1 is rapidly spreading. We present the complete genome of Klebsiella pneumoniae ATCC BAA-2146, the first U.S. isolate found to encode NDM-1, and describe its repertoire of antibiotic-resistance genes and mutations, including genes for eight beta-lactamases and 15 additional antibiotic-resistance enzymes. To elucidate the evolution of this rich repertoire, the mobile elements of the genome were characterized, including four plasmids with varying degrees of conservation and mosaicism and eleven chromosomal genomic islands. One island was identified by a novel phylogenomic approach, that further indicated the cps-lps polysaccharide synthesis locus, where operon translocation and fusion was noted. Unique plasmid segments and mosaic junctions were identified. Plasmid-borne bla(CTX-M-15) was transposed recently to the chromosome by ISEcp1. None of the eleven full copies of IS26, the most frequent IS element in the genome, had the expected 8-bp direct repeat of the integration target sequence, suggesting that each copy underwent homologous recombination subsequent to its last transposition event. Comparative analysis likewise indicates IS26 as a frequent recombinational junction between plasmid ancestors, and also indicates a resolvase site. In one novel use of high-throughput sequencing, homologously recombinant subpopulations of the bacterial culture were detected. In a second novel use, circular transposition intermediates were detected for the novel insertion sequence ISKpn21 of the ISNCY family, suggesting that it uses the two-step transposition mechanism of IS3. Robust genome-based phylogeny showed that a unified Klebsiella cluster contains Enterobacter aerogenes and Raoultella, suggesting the latter genus should be abandoned.	[Hudson, Corey M.; Bent, Zachary W.; Williams, Kelly P.] Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94550 USA; [Meagher, Robert J.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Williams, KP (corresponding author), Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94550 USA.	kpwilli@sandia.gov	Hudson, Corey M./I-1283-2019	Hudson, Corey M./0000-0003-4796-538X; Meagher, Robert/0000-0002-6262-2126	Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development) program [165683]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development) program; U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development, grant number 165683) program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI S, 1995, INFECT IMMUN, V63, P903; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Brisse S, 1999, ANTIMICROB AGENTS CH, V43, P2051, DOI 10.1128/AAC.43.8.2051; Broberg CA, 2013, GENOME ANNOUNC, V1; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chen ZL, 2011, CLIN INFECT DIS, V52, P692, DOI 10.1093/cid/ciq231; CLEARY JM, 1982, J BACTERIOL, V150, P1467, DOI 10.1128/JB.150.3.1467-1471.1982; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Doyon JP, 2010, LECT N BIOINFORMAT, V6398, P93, DOI 10.1007/978-3-642-16181-0_9; Duvernay C, 2011, MICROBIOL-SGM, V157, P496, DOI 10.1099/mic.0.043885-0; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jensen SO, 2004, CAN J MICROBIOL, V50, P299, DOI 10.1139/W04-010; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068988; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P639, DOI 10.1128/AAC.01051-08; Leski T, 2012, INT J ANTIMICROB AG, V40, P282, DOI 10.1016/j.ijantimicag.2012.05.019; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mantri Y, 2004, NUCLEIC ACIDS RES, V32, pD55, DOI 10.1093/nar/gkh059; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Osborn AM, 1997, FEMS MICROBIOL REV, V19, P239, DOI 10.1111/j.1574-6976.1997.tb00300.x; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6065, DOI 10.1128/AAC.00117-12; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Partridge SR, 2002, ANTIMICROB AGENTS CH, V46, P1288, DOI 10.1128/AAC.46.5.1288-1294.2002; Pasquali F, 2005, J ANTIMICROB CHEMOTH, V55, P562, DOI 10.1093/jac/dkh553; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1087, DOI 10.1128/AAC.05620-11; Ramirez MS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00121; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Sabate M, 2002, ANTIMICROB AGENTS CH, V46, P2656, DOI 10.1128/AAC.46.8.2656-2661.2002; Sampei G, 2010, PLASMID, V64, P92, DOI 10.1016/j.plasmid.2010.05.005; Seo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-679; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Shu HY, 2009, MICROBIOL-SGM, V155, P4170, DOI 10.1099/mic.0.029017-0; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tian SF, 2011, ENFERM INFEC MICR CL, V29, P731, DOI 10.1016/j.eimc.2011.07.011; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; TOLMASKY ME, 1993, PLASMID, V29, P31, DOI 10.1006/plas.1993.1004; Ton-Hoang B, 1999, MOL MICROBIOL, V32, P617, DOI 10.1046/j.1365-2958.1999.01379.x; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Warner DM, 2013, ANTIMICROB AGENTS CH, V57, P1935, DOI 10.1128/AAC.02445-12; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Yang HY, 2013, INT J ANTIMICROB AG, V42, P173, DOI 10.1016/j.ijantimicag.2013.04.026; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	70	90	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99209	10.1371/journal.pone.0099209	http://dx.doi.org/10.1371/journal.pone.0099209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905728	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000111
J	Pelletier, A; Delanaud, S; de Seze, R; Bach, V; Libert, JP; Loos, N				Pelletier, Amandine; Delanaud, Stephane; de Seze, Rene; Bach, Veronique; Libert, Jean-Pierre; Loos, Nathalie			Does Exposure to a Radiofrequency Electromagnetic Field Modify Thermal Preference in Juvenile Rats?	PLOS ONE			English	Article							PHONE BASE STATIONS; BEHAVIORAL THERMOREGULATION; HYPOTHALAMIC TEMPERATURE; AMBIENT-TEMPERATURE; BODY-TEMPERATURE; SLEEP; MECHANISMS; ANTENNAS; TAIL	Some studies have shown that people living near a mobile phone base station may report sleep disturbances and discomfort. Using a rat model, we have previously shown that chronic exposure to a low-intensity radiofrequency electromagnetic field (RF-EMF) was associated with paradoxical sleep (PS) fragmentation and greater vasomotor tone in the tail. Here, we sought to establish whether sleep disturbances might result from the disturbance of thermoregulatory processes by a RF-EMF. We recorded thermal preference and sleep stage distribution in 18 young male Wistar rats. Nine animals were exposed to a low-intensity RF-EMF (900 MHz, 1 V.m(-1)) for five weeks and nine served as non-exposed controls. Thermal preference was assessed in an experimental chamber comprising three interconnected compartments, in which the air temperatures (T-a) were set to 24 degrees C, 28 degrees C and 31 degrees C. Sleep and tail skin temperature were also recorded. Our results indicated that relative to control group, exposure to RF-EMF at 31 degrees C was associated with a significantly lower tail skin temperature (-1.6 degrees C) which confirmed previous data. During the light period, the exposed group preferred to sleep at T-a=31 degrees C and the controls preferred T-a=28 degrees C. The mean sleep duration in exposed group was significantly greater (by 15.5%) than in control group (due in turn to a significantly greater amount of slow wave sleep (SWS, +14.6%). Similarly, frequency of SWS was greater in exposed group (by 4.9 episodes.h(-1)). The PS did not differ significantly between the two groups. During the dark period, there were no significant intergroup differences. We conclude that RF-EMF exposure induced a shift in thermal preference towards higher temperatures. The shift in preferred temperature might result from a cold thermal sensation. The change in sleep stage distribution may involve signals from thermoreceptors in the skin. Modulation of SWS may be a protective adaptation in response to RF-EMF exposure.	[Pelletier, Amandine; Delanaud, Stephane; Bach, Veronique; Libert, Jean-Pierre; Loos, Nathalie] Jules Verne Univ Picardy, Fac Med, PeriTox Lab, UMR I INERIS 01, Amiens, France; [de Seze, Rene] Natl Inst Ind Environm & Risks INERIS, Expt Toxicol Unit, PeriTox Lab, UMR I INERIS 01, Verneuil En Halatte, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de l'Environnement Industriel et des Risques (INERIS)	Pelletier, A (corresponding author), Jules Verne Univ Picardy, Fac Med, PeriTox Lab, UMR I INERIS 01, Amiens, France.	amandine.pelletier@u-picardie.fr	de Seze, Rene/R-1894-2018; stepahne, delanaud/AAD-2762-2022; Pelletier, Amandine/AAE-7724-2022; Bach, Veronique/AAD-5958-2022; Libert, Jean-Pierre/AAD-5970-2022	de Seze, Rene/0000-0002-7978-798X; Bach, Veronique/0000-0002-0684-0305	French Ministry of Ecology as part of the Pole applicatif en Toxicologie et Ecotoxicologie program	French Ministry of Ecology as part of the Pole applicatif en Toxicologie et Ecotoxicologie program	This study was funded by a Post-Grenelle grant from the French Ministry of Ecology, as part of the Pole applicatif en Toxicologie et Ecotoxicologie program coordinated by the French National Institute of Environment and Industrial Risks (INERIS) (www.developpement-durable.gouv.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rassoul G, 2007, NEUROTOXICOLOGY, V28, P434, DOI 10.1016/j.neuro.2006.07.012; ADAIR E R, 1980, Bioelectromagnetics, V1, P1, DOI 10.1002/bem.2250010102; ADAIR ER, 1984, BIOELECTROMAGNETICS, V5, P13, DOI 10.1002/bem.2250050103; ADAIR ER, 1983, BEHAV NEUROSCI, V97, P49; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Bohr H, 2000, PHYS REV E, V61, P4310, DOI 10.1103/PhysRevE.61.4310; Bohr H, 2000, BIOELECTROMAGNETICS, V21, P68, DOI 10.1002/(SICI)1521-186X(200001)21:1<68::AID-BEM10>3.0.CO;2-9; Bolomey JC, 2004, IEEE T ANTENN PROPAG, V52, P593, DOI 10.1109/TAP.2004.823999; CARLISLE HJ, 1966, J COMP PHYSIOL PSYCH, V61, P388, DOI 10.1037/h0023260; CORBIT JD, 1969, SCIENCE, V166, P256, DOI 10.1126/science.166.3902.256; Durney CH, 1986, USAFSAMTR8573 BROOKS; HELLSTROM B, 1975, CAN J PHYSIOL PHARM, V53, P207, DOI 10.1139/y75-030; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Kumar D, 2009, PHYSIOL BEHAV, V98, P186, DOI 10.1016/j.physbeh.2009.05.008; McGinty D, 2001, ARCH ITAL BIOL, V139, P63; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Opp MR, 1997, PHYSIOL BEHAV, V63, P67, DOI 10.1016/S0031-9384(97)00390-9; Parmeggiani P., 1980, PHYSL SLEEP, P97; PARMEGGIANI PL, 1980, EXPERIENTIA, V36, P6, DOI 10.1007/BF02003941; PARMEGGIANI PL, 1977, ELECTROEN CLIN NEURO, V42, P372, DOI 10.1016/0013-4694(77)90173-0; PARMEGGIANI PL, 1970, ARCH ITAL BIOL, V108, P369; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pelletier A, 2013, ENVIRON SCI POLLUT R, V20, P2735, DOI 10.1007/s11356-012-1266-5; RAND RP, 1965, CAN J PHYSIOL PHARM, V43, P257, DOI 10.1139/y65-025; Ray B, 2004, BEHAV BRAIN RES, V154, P519, DOI 10.1016/j.bbr.2004.03.021; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; SAKAGUCHI S, 1979, AM J PHYSIOL, V237, pR80, DOI 10.1152/ajpregu.1979.237.1.R80; Santini R, 2003, PATHOL BIOL, V51, P412, DOI 10.1016/S0369-8114(03)00020-8; SATINOFF E, 1964, AM J PHYSIOL, V206, P1389, DOI 10.1152/ajplegacy.1964.206.6.1389; STERN S, 1979, SCIENCE, V206, P1198, DOI 10.1126/science.505008; Szymusiak R, 2001, ARCH ITAL BIOL, V139, P77; Vyazovskiy V, 2007, BRAIN RES BULL, V74, P37, DOI 10.1016/j.brainresbull.2007.05.001; WEISS B, 1961, SCIENCE, V133, P1338, DOI 10.1126/science.133.3461.1338	33	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99007	10.1371/journal.pone.0099007	http://dx.doi.org/10.1371/journal.pone.0099007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905635	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000089
J	Yashima, K; Sasaki, A				Yashima, Kenta; Sasaki, Akira			Epidemic Process over the Commute Network in a Metropolitan Area	PLOS ONE			English	Article							PANDEMIC INFLUENZA; DISEASE; STRATEGIES; SPREAD; MODEL	An understanding of epidemiological dynamics is important for prevention and control of epidemic outbreaks. However, previous studies tend to focus only on specific areas, indicating that application to another area or intervention strategy requires a similar time-consuming simulation. Here, we study the epidemic dynamics of the disease-spread over a commute network, using the Tokyo metropolitan area as an example, in an attempt to elucidate the general properties of epidemic spread over a commute network that could be used for a prediction in any metropolitan area. The model is formulated on the basis of a metapopulation network in which local populations are interconnected by actual commuter flows in the Tokyo metropolitan area and the spread of infection is simulated by an individual-based model. We find that the probability of a global epidemic as well as the final epidemic sizes in both global and local populations, the timing of the epidemic peak, and the time at which the epidemic reaches a local population are mainly determined by the joint distribution of the local population sizes connected by the commuter flows, but are insensitive to geographical or topological structure of the network. Moreover, there is a strong relation between the population size and the time that the epidemic reaches this local population and we are able to determine the reason for this relation as well as its dependence on the commute network structure and epidemic parameters. This study shows that the model based on the connection between the population size classes is sufficient to predict both global and local epidemic dynamics in metropolitan area. Moreover, the clear relation of the time taken by the epidemic to reach each local population can be used as a novel measure for intervention; this enables efficient intervention strategies in each local population prior to the actual arrival.	[Yashima, Kenta; Sasaki, Akira] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst Sokendai Hayama, Hayama, Kanagawa, Japan; [Sasaki, Akira] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Sasaki, Akira] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Yashima, Kenta] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo 101, Japan	Graduate University for Advanced Studies - Japan; International Institute for Applied Systems Analysis (IIASA); Japan Science & Technology Agency (JST); Meiji University	Yashima, K (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst Sokendai Hayama, Hayama, Kanagawa, Japan.	yashima_kenta@soken.ac.jp			MEXT [21370009]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported by MEXT Grant-in-Aid for Scientific Research (B) 21370009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 2007, TECHNICAL REPORT; Balcan D, 2012, J THEOR BIOL, V293, P87, DOI 10.1016/j.jtbi.2011.10.010; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; ELLNER S. P., 2011, DYNAMIC MODELS BIOL; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Murray, 2002, MATH BIOL I INTRO IN; Ohkusa Yasushi, 2007, Journal of Infection and Chemotherapy, V13, P380, DOI 10.1007/s10156-007-0556-1; Ohkusa Y, 2009, JPN J INFECT DIS, V62, P98; Saito MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072866; Yasuda H, 2009, EUROSURVEILLANCE, V14, P12; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0	25	13	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98518	10.1371/journal.pone.0098518	http://dx.doi.org/10.1371/journal.pone.0098518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905831	Green Accepted, Green Published, gold			2022-12-27	WOS:000341869000035
J	Zhou, YJ; Zhang, Y; Guo, Y; Zhang, YY; Xu, M; He, B				Zhou, Yujiao; Zhang, Yuan; Guo, Yang; Zhang, Youyi; Xu, Ming; He, Bei			beta 2-Adrenoceptor Involved in Smoking-Induced Airway Mucus Hypersecretion through beta-Arrestin-Dependent Signaling	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; EPITHELIAL-CELLS; GENE-EXPRESSION; ACTIVATION; BLOCKERS; EXACERBATIONS; INFLAMMATION; INHIBITION; RECEPTORS	Progression of chronic obstructive pulmonary disease is associated with small airway obstruction by accumulation of inflammatory mucous exudates. However, the mechanism of mucin hypersecretion after exposure to cigarette smoke (CS) is still not clear. In this study, we explored the contribution of beta(2)-adrenoceptor (beta(2)-AR) signaling to CS extract (CSE)-induced mucus hypersecretion in vitro and examined the effect of a beta-blocker on airway mucin hypersecretion in vivo. NCI-H292 epithelial cell line was used to determine the contribution of beta(2)-AR signaling to CSE-induced MUC5AC production by treatment with beta(2)-AR antagonists propranolol and ICI118551 and beta(2)-AR-targeted small interfering RNA. The effect of propranolol on airway mucus hypersecretion was examined in a rat model exposed to CS. MUC5AC expression was assayed by real-time PCR, immunohistochemistry and ELISA. beta(2)-AR and its downstream signaling were detected by western blot analysis. We found that pretreating NCI-H292 cells with propranolol, ICI118551 for 30 min or beta(2)AR-targeted siRNA for 48 h reduced MUC5AC mRNA and protein levels stimulated by CSE. However, inhibiting the classical beta(2)AR-cAMP-PKA pathway didn't attenuate CSE-induced MUC5AC production, while silencing beta-arretin2 expression significantly decreased ERK and p38MAPK phosphorylation, thus reduced the CSE-stimulated MUC5AC production. In vivo, we found that administration of propranolol (25 mg kg(-1) d(-1)) for 28 days significantly attenuated the airway goblet cell metaplasia, mucus hypersecretion and MUC5AC expression of rats exposed to CS. From the study, beta(2)-AR-beta-arrestin2-ERK1/2 signaling was required for CS-induced airway MUC5AC expression. Chronic propranolol administration ameliorated airway mucus hypersecretion and MUC5AC expression in smoking rats. The exploration of these mechanisms may contribute to the optimization of beta(2)-AR target therapy in chronic obstructive pulmonary disease.	[Zhou, Yujiao; Zhang, Yuan; Zhang, Youyi; Xu, Ming; He, Bei] Peking Univ, Hosp 3, Dept Resp Med, Beijing 100871, Peoples R China; [Zhou, Yujiao; Zhang, Yuan; Zhang, Youyi; Xu, Ming; He, Bei] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Zhou, Yujiao; Zhang, Yuan; Zhang, Youyi; Xu, Ming; He, Bei] Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China; [Guo, Yang] Changji Renmin Hosp, Dept Resp Med, Changji, Xinjiang, Peoples R China	Peking University; Peking University	He, B (corresponding author), Peking Univ, Hosp 3, Dept Resp Med, Beijing 100871, Peoples R China.	xuminghi@bjmu.edu.cn; puh3_hb@bjmu.edu.cn			National Natural Science Foundation of China [81270097, 30910103902, 81121061]; Beijing Natural Science Foundation [7112745]; Ph.D. Programs Foundation of Ministry of Education of China [20090001110093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by a grant from the National Natural Science Foundation of China (No. 81270097; 30910103902; 81121061), the Beijing Natural Science Foundation (No. 7112745) and Ph.D. Programs Foundation of Ministry of Education of China (No. 20090001110093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Chakravorty I, 2011, INT J CHRONIC OBSTR, V6, P693, DOI 10.2147/COPD.S22896; Chen YH, 2009, CYTOKINE, V45, P117, DOI 10.1016/j.cyto.2008.11.009; Choi WI, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-172; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Dicpinigaitis PV, 2003, CHEST, V123, P685, DOI 10.1378/chest.123.3.685; Foresi A, 2010, RESPIRATION, V80, P177, DOI 10.1159/000318583; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Guo Y, 2014, IHALATION T IN PRESS; Guo Y, 2014, INHAL TOXICOL, V26, P271, DOI 10.3109/08958378.2014.885098; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ikeda T, 2012, BRIT J PHARMACOL, V166, P1804, DOI 10.1111/j.1476-5381.2012.01881.x; JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136; Kargin F, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-8; Kim ST, 2011, AM J RHINOL ALLERGY, V25, P303, DOI 10.2500/ajra.2011.25.3627; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGraw DW, 2000, AM J PHYSIOL-LUNG C, V279, pL379, DOI 10.1152/ajplung.2000.279.2.L379; Mebratu YA, 2011, AM J RESP CRIT CARE, V183, P1531, DOI 10.1164/rccm.201011-1930OC; Minor DS, 2013, J CLIN HYPERTENS, V15, P925, DOI 10.1111/jch.12204; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nyunoya T, 2013, AM J RESP CELL MOL B; Oldenburger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031574; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Qian L, 2009, GLIA, V57, P1600, DOI 10.1002/glia.20873; Quint JK, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6650; Rogers DF, 2001, RESP PHYSIOL, V125, P129, DOI 10.1016/S0034-5687(00)00209-7; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Sarir H, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-12; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Song Jeong-Sup, 2005, Korean Journal of Internal Medicine, V20, P275; Song KS, 2013, ACTA PHYSIOL, V208, P245, DOI 10.1111/apha.12104; Stefan MS, 2012, THORAX, V67, P977, DOI 10.1136/thoraxjnl-2012-201945; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	50	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97788	10.1371/journal.pone.0097788	http://dx.doi.org/10.1371/journal.pone.0097788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905583	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000011
J	Chianese, C; Gunning, AC; Giachini, C; Daguin, F; Balercia, G; Ars, E; Lo Giacco, D; Ruiz-Castane, E; Forti, G; Krausz, C				Chianese, Chiara; Gunning, Adam C.; Giachini, Claudia; Daguin, Fabrice; Balercia, Giancarlo; Ars, Elisabet; Lo Giacco, Deborah; Ruiz-Castane, Eduard; Forti, Gianni; Krausz, Csilla			X Chromosome-Linked CNVs in Male Infertility: Discovery of Overall Duplication Load and Recurrent, Patient-Specific Gains with Potential Clinical Relevance	PLOS ONE			English	Article							PSEUDOAUTOSOMAL REGION; DNA-REPLICATION; Y-CHROMOSOME; DIAGNOSIS; GENES; CELLS	Introduction: Spermatogenesis is a highly complex process involving several thousand genes, only a minority of which have been studied in infertile men. In a previous study, we identified a number of Copy Number Variants (CNVs) by high-resolution array-Comparative Genomic Hybridization (a-CGH) analysis of the X chromosome, including 16 patient-specific X chromosome-linked gains. Of these, five gains (DUP1A, DUP5, DUP20, DUP26 and DUP40) were selected for further analysis to evaluate their clinical significance. Materials and Methods: The copy number state of the five selected loci was analyzed by quantitative-PCR on a total of 276 idiopathic infertile patients and 327 controls in a conventional case-control setting (199 subjects belonged to the previous a-CGH study). For one interesting locus (intersecting DUP1A) additional 338 subjects were analyzed. Results and Discussion: All gains were confirmed as patient-specific and the difference in duplication load between patients and controls is significant (p = 1.65 x 10(-4)). Two of the CNVs are private variants, whereas 3 are found recurrently in patients and none of the controls. These CNVs include, or are in close proximity to, genes with testis-specific expression. DUP1A, mapping to the PAR1, is found at the highest frequency (1.4%) that was significantly different from controls (0%) (p = 0.047 after Bonferroni correction). Two mechanisms are proposed by which DUP1A may cause spermatogenic failure: i) by affecting the correct regulation of a gene with potential role in spermatogenesis; ii) by disturbing recombination between PAR1 regions during meiosis. This study allowed the identification of novel spermatogenesis candidate genes linked to the 5 CNVs and the discovery of the first recurrent, X-linked gain with potential clinical relevance.	[Chianese, Chiara; Gunning, Adam C.; Giachini, Claudia; Daguin, Fabrice; Forti, Gianni; Krausz, Csilla] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Chianese, Chiara; Gunning, Adam C.; Giachini, Claudia; Daguin, Fabrice; Forti, Gianni; Krausz, Csilla] Ctr Excellence DeNothe, Florence, Italy; [Balercia, Giancarlo] Polytech Univ Marche, Umberto I Hosp, Dept Clin & Mol Sci, Div Endocrinol, Ancona, Italy; [Chianese, Chiara; Ars, Elisabet; Lo Giacco, Deborah] Univ Autonoma Barcelona, Fundacio Puigvert, Mol Biol Lab, E-08193 Barcelona, Spain; [Lo Giacco, Deborah; Ruiz-Castane, Eduard; Krausz, Csilla] Univ Autonoma Barcelona, Fundacio Puigvert, Androl Serv, E-08193 Barcelona, Spain	University of Florence; Marche Polytechnic University; Autonomous University of Barcelona; Fundacio Puigvert; Autonomous University of Barcelona; Fundacio Puigvert	Krausz, C (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy.	c.krausz@dfc.unifi.it	Ars, Elisabet/AAM-8454-2021	Ars, Elisabet/0000-0002-4118-4358; Krausz, Csilla Gabriella/0000-0001-6748-8918	Tuscan Regional Health Research Program; Spanish Ministry of Health [FIS-11/02254]; PRIN; European Commission - Reproductive Biology Early Research Training (REPROTRAIN) [289880]	Tuscan Regional Health Research Program; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Commission - Reproductive Biology Early Research Training (REPROTRAIN)	This work was supported by the Tuscan Regional Health Research Program; Spanish Ministry of Health (grant FIS-11/02254); PRIN 2009; European Commission - Reproductive Biology Early Research Training (REPROTRAIN, Project Number: 289880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chalmel F, 2012, HUM REPROD, V27, P3233, DOI 10.1093/humrep/des301; CHANDLEY AC, 1971, CYTOGENETICS, V10, P295, DOI 10.1159/000130149; Eward KL, 2004, J CELL SCI, V117, P5875, DOI 10.1242/jcs.01503; Filatov DA, 2004, MOL BIOL EVOL, V21, P410, DOI 10.1093/molbev/msh032; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Krausz C, 2014, ANDROLOGY-US, V2, P5, DOI 10.1111/j.2047-2927.2013.00173.x; Krausz C, 2011, J ENDOCRINOL INVEST, V34, P376, DOI [10.1007/BF03347463, 10.3275/7612]; Krausz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044887; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Lopes AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003349; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Prakash SK, 1999, GENOMICS, V59, P77, DOI 10.1006/geno.1999.5844; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	22	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97746	10.1371/journal.pone.0097746	http://dx.doi.org/10.1371/journal.pone.0097746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914684	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700012
J	Di-Poi, C; Lacasse, J; Rogers, SM; Aubin-Horth, N				Di-Poi, Carole; Lacasse, Jennyfer; Rogers, Sean M.; Aubin-Horth, Nadia			Extensive Behavioural Divergence following Colonisation of the Freshwater Environment in Threespine Sticklebacks	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACK; ANTIPREDATOR BEHAVIOR; POPULATIONS; EVOLUTION; BOLDNESS; TEMPERAMENT; INFORMATION; AGGRESSION	Colonisation of novel environments means facing new ecological challenges often resulting in the evolution of striking divergence in phenotypes. However, little is known about behavioural divergence following colonisation, despite the predicted importance of the role of behavioural phenotype-environment associations in adaptive divergence. We studied the threespine stickleback (Gasterosteus aculeatus), a model system for postglacial colonisation of freshwater habitats largely differing in ecological conditions from the ones faced by the descendants of the marine ancestor. We found that common-environment reared freshwater juveniles were less social, more active and more aggressive than their marine counterparts. This behavioural divergence could represent the result of natural selection that acted on individuals following freshwater colonisation, with predation as a key selection agent. Alternatively, the behavioural profile of freshwater juveniles could represent the characteristics of individuals that preferentially invaded freshwater after the glacial retreat, drawn from the standing variation present in the marine population.	[Di-Poi, Carole; Lacasse, Jennyfer; Aubin-Horth, Nadia] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Di-Poi, Carole; Lacasse, Jennyfer; Aubin-Horth, Nadia] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada; [Rogers, Sean M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Laval University; Laval University; University of Calgary	Aubin-Horth, N (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	Nadia.Aubin-Horth@bio.ulaval.ca	Di Poi, Carole/H-6493-2017	Di Poi, Carole/0000-0001-7846-5287	Government of Canada Post-Doctoral Research Fellowship; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures New Faculty Award	Government of Canada Post-Doctoral Research Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures New Faculty Award	Funding was provided to C. Di-Poi by the Government of Canada Post-Doctoral Research Fellowship, to N. Aubin-Horth and S. Rogers through Natural Sciences and Engineering Research Council of Canada Discovery grants and an Alberta Innovates Technology Futures New Faculty Award to S. Rogers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin-Horth N, 2012, HORM BEHAV, V61, P140, DOI 10.1016/j.yhbeh.2011.11.008; BAKKER TCM, 1988, ANIM BEHAV, V36, P1556, DOI 10.1016/S0003-3472(88)80233-1; Barrett RDH, 2011, P ROY SOC B-BIOL SCI, V278, P233, DOI 10.1098/rspb.2010.0923; Barrett RDH, 2009, BIOL LETTERS, V5, P788, DOI 10.1098/rsbl.2009.0416; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell MA, 1994, EVOLUTIONARY BIOL TH, P571; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braithwaite VA, 2003, J FISH BIOL, V63, P74, DOI 10.1111/j.1095-8649.2003.00218.x; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brydges NM, 2008, J ANIM ECOL, V77, P229, DOI 10.1111/j.1365-2656.2007.01343.x; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cooper WJ, 2010, PLOS ONE, V5, pA38, DOI 10.1371/journal.pone.0009551; Cresko WA, 2007, GENETICA, V129, P105, DOI 10.1007/s10709-006-0036-z; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dzieweczynski TL, 2011, J FISH BIOL, V79, P776, DOI 10.1111/j.1095-8649.2011.03064.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; GILES N, 1984, ANIM BEHAV, V32, P264, DOI 10.1016/S0003-3472(84)80346-2; GODIN JGJ, 1988, NATURE, V333, P69, DOI 10.1038/333069a0; Grant PR, 2011, HOW AND WHY SPECIES, P218; Greenwood AK, 2011, HEREDITY, V107, P155, DOI 10.1038/hdy.2011.1; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Herczeg G, 2011, J EVOLUTION BIOL, V24, P2434, DOI 10.1111/j.1420-9101.2011.02371.x; Herczeg G, 2012, EVOL ECOL, V26, P109, DOI 10.1007/s10682-011-9491-9; Huizinga M, 2009, J EVOLUTION BIOL, V22, P1860, DOI 10.1111/j.1420-9101.2009.01799.x; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Lacasse J, 2012, CURR ZOOL, V58, P53, DOI 10.1093/czoolo/58.1.53; Laskowski KL, 2013, ECOL LETT, V16, P746, DOI 10.1111/ele.12105; Losos JB., 2009, LIZARDS EVOLUTIONARY, P528; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; MAGURRAN AE, 1992, P ROY SOC B-BIOL SCI, V248, P117, DOI 10.1098/rspb.1992.0050; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Nomakuchi S, 2009, BEHAV ECOL, V20, P340, DOI 10.1093/beheco/arp001; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pitcher T. J, 1993, BEHAV TELEOST FISHES; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rogers SM, 2002, EVOLUTION, V56, P2322; Saimoto RK, 1993, THESIS U BRIT COLUMB, P97; Schluter D, 2000, OXFORD SERIES ECOLOG, V296; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; SNYDER RJ, 1989, CAN J ZOOL, V67, P2448, DOI 10.1139/z89-345; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Wark AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018316	49	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98980	10.1371/journal.pone.0098980	http://dx.doi.org/10.1371/journal.pone.0098980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914554	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700047
J	Souza, TAJ; Noll, FB; Bicudo, HEMD; Madi-Ravazzi, L				Jorge Souza, Tiago Alves; Noll, Fernando Barbosa; Melara de Campos Bicudo, Hermione Elly; Madi-Ravazzi, Lilian			Scanning Electron Microscopy of Male Terminalia and Its Application to Species Recognition and Phylogenetic Reconstruction in the Drosophila saltans Group	PLOS ONE			English	Article							ESTERASE PATTERNS; MOLECULAR EVOLUTION; DIPTERA; NUCLEAR	The Drosophila saltans group consists of five subgroups and 21 species, most of which have been identified only by morphological aspects of the male terminalia revealed by drawings using a camera lucida and a bright-field microscope. However, several species in the group, mainly those included in the saltans subgroup, are difficult to differentiate using only these characteristics. In this study, we used scanning electron microscopy (SEM) to analyze 19 structures of the male terminalia in 10 species from the five saltans subgroups. Among these structures, nine could be identified only through SEM analysis. We aimed to find other characteristics useful for morphological recognition of these species and to use these characteristics for phylogenetic reconstruction. These morphological differences enabled us to effectively distinguish among sibling species. These findings confirmed the monophyly of this group as previously determined in evolutionary studies based on other markers. The single most parsimonious tree (CI = 87 and RI = 90) indicated that the cordata subgroup is the most basal lineage and the saltans subgroup is the most apical lineage, as shown in earlier studies based on morphological data. However, our findings differed somewhat from these studies with respect to the phylogenetic relationships of species in the saltans group indicating that this group is still a puzzle that remains to be deciphered.	[Jorge Souza, Tiago Alves] Univ Sao Paulo, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Noll, Fernando Barbosa] Sao Paulo State Univ, UNESP IBILCE, Dept Bot & Zool, Sao Jose Do Rio Preto, SP, Brazil; [Melara de Campos Bicudo, Hermione Elly; Madi-Ravazzi, Lilian] Sao Paulo State Univ, UNESP IBILCE, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista	Madi-Ravazzi, L (corresponding author), Sao Paulo State Univ, UNESP IBILCE, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil.	lilian@ibilce.unesp.br	de Souza, Tiago Alves Jorge/I-8236-2019; Madi-Ravazzi, Lilian/H-2587-2013; FERNANDO, NOLL B/A-3606-2008; NOLL, FERNANDO BARBOSA/N-1206-2019	de Souza, Tiago Alves Jorge/0000-0001-9308-4773; Madi-Ravazzi, Lilian/0000-0002-6250-0794; FERNANDO, NOLL B/0000-0003-0207-1067; NOLL, FERNANDO BARBOSA/0000-0003-0207-1067	FAPESP (Foundation for supporting research of the Sao Paulo State) [07/07180-3]	FAPESP (Foundation for supporting research of the Sao Paulo State)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Foundation for supporting research of the Sao Paulo State, Process number: 07/07180-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachli G., 2004, FAUNA ENTOMOL SCAD, V39; Bernardo AA, 2009, GENETICA, V137, P111, DOI 10.1007/s10709-009-9357-z; BICUDO H E M C, 1978, Revista Brasileira de Genetica, V1, P11; Bicudo HEMC., 1979, REV BRAS GENET, V2, P247; BICUDO HEMD, 1973, GENETICA, V44, P313; BICUDO HEMD, 1973, GENETICA, V44, P520; Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428; CLARK JB, 1995, MOL BIOL EVOL, V12, P902; de Castro JP, 2004, J MOL EVOL, V59, P31, DOI 10.1007/s00239-004-2601-3; de Castro JP, 2004, MOL PHYLOGENET EVOL, V32, P383, DOI 10.1016/j.ympev.2004.01.005; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Goloboff P.A., 2003, TREE ANAL USING NEW; GRIMALDI DA, 1990, B AM MUS NAT HIST, P1; Jamjoom Manal B., 2006, World Journal of Zoology, V1, P64; LEITE ACR, 1995, MEM I OSWALDO CRUZ, V90, P475, DOI 10.1590/S0074-02761995000400008; MAGALHAES LE, 1962, U TEX PUBL, V6205, P135; Magalhaes LE, 1957, BRAZ J BIOL, V16, P273; MOURAO CELSO ABBADE, 1967, PAP AVULS PEP ZOOL SAP PAULO, V20, P123; Nascimento AP, 2006, GENETICA, V126, P265, DOI 10.1007/s10709-005-8459-5; Nascimento AP, 2002, GENETICA, V114, P41, DOI 10.1023/A:1014672502359; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; O'Grady PM, 1998, MOL BIOL EVOL, V15, P656, DOI 10.1093/oxfordjournals.molbev.a025969; O'Grady PM, 2002, MOL PHYLOGENET EVOL, V22, P442, DOI 10.1006/mpev.2001.1053; Rodriguez-Trelles F, 1999, MOL PHYLOGENET EVOL, V13, P110, DOI 10.1006/mpev.1999.0631; Silva JC, 2000, MOL BIOL EVOL, V17, P1542, DOI 10.1093/oxfordjournals.molbev.a026253; THROCKMORTON LH, 1962, U TEX PUBL, V6205, P489; Torres FR, 2006, BIOTA NEOTROP, V8, P47; VILELA C R, 1983, Revista Brasileira de Entomologia, V27, P1; Wieczorek K, 2012, ZOOMORPHOLOGY, V131, P303, DOI 10.1007/s00435-012-0163-2; Yassin A, 2008, MOL ECOL RESOUR, V8, P491, DOI 10.1111/j.1471-8286.2007.02020.x; Yassin Amir, 2009, Zoological Research, V30, P225, DOI 10.3724/SP.J.1141.2009.03225	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e97156	10.1371/journal.pone.0097156	http://dx.doi.org/10.1371/journal.pone.0097156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915442	Green Submitted, gold, Green Published			2022-12-27	WOS:000340947700009
J	Mandel, JR; McAssey, EV; Nambeesan, S; Garcia-Navarro, E; Burke, JM				Mandel, Jennifer R.; McAssey, Edward V.; Nambeesan, Savithri; Garcia-Navarro, Elena; Burke, John M.			Molecular Evolution of Candidate Genes for Crop-Related Traits in Sunflower (Helianthus annuus L.)	PLOS ONE			English	Article							CULTIVATED SUNFLOWER; SEED-GERMINATION; ARTIFICIAL SELECTION; GIBBERELLIC-ACID; PHYTOCHROME B; DOMESTICATION; ARABIDOPSIS; TOMATO; WILD; POLYMORPHISMS	Evolutionary analyses aimed at detecting the molecular signature of selection during crop domestication and/or improvement can be used to identify genes or genomic regions of likely agronomic importance. Here, we describe the DNA sequence-based characterization of a pool of candidate genes for crop-related traits in sunflower. These genes, which were identified based on homology to genes of known effect in other study systems, were initially sequenced from a panel of improved lines. All genes that exhibited a paucity of sequence diversity, consistent with the possible effects of selection during the evolution of cultivated sunflower, were then sequenced from a panel of wild sunflower accessions an outgroup. These data enabled formal tests for the effects of selection in shaping sequence diversity at these loci. When selection was detected, we further sequenced these genes from a panel of primitive landraces, thereby allowing us to investigate the likely timing of selection (i.e., domestication vs. improvement). We ultimately identified seven genes that exhibited the signature of positive selection during either domestication or improvement. Genetic mapping of a subset of these genes revealed co-localization between candidates for genes involved in the determination of flowering time, seed germination, plant growth/development, and branching and QTL that were previously identified for these traits in cultivated x wild sunflower mapping populations.	[Mandel, Jennifer R.; McAssey, Edward V.; Nambeesan, Savithri; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Garcia-Navarro, Elena] CSIC, Inst Agr Sostenible, Cordoba, Spain	University System of Georgia; University of Georgia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Burke, JM (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmburke@uga.edu	Burke, John M/A-3502-2013	Burke, John M/0000-0002-1412-5539; Mandel, Jennifer/0000-0003-3539-2991	USDA National Institute of Food and Agriculture [2008-35300-19263]; NSF Plant Genome Research Program [DBI-0820451]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by funding from the USDA National Institute of Food and Agriculture (2008-35300-19263) and the NSF Plant Genome Research Program (DBI-0820451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baack EJ, 2008, MOL ECOL, V17, P666, DOI 10.1111/j.1365-294X.2007.03596.x; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bachlava E, 2010, THEOR APPL GENET, V120, P829, DOI 10.1007/s00122-009-1212-1; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Blackman BK, 2013, J EXP BOT, V64, P421, DOI 10.1093/jxb/ers359; Blackman BK, 2011, MOL ECOL, V20, P3503, DOI 10.1111/j.1365-294X.2011.05166.x; Blackman BK, 2011, GENETICS, V187, P271, DOI 10.1534/genetics.110.121327; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Brunick R, 2007, THESIS; Burke JM, 2002, GENETICS, V161, P1257; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Casal JJ, 1998, SEED SCI RES, V8, P317, DOI 10.1017/S0960258500004256; Chakrabarti M, 2013, P NATL ACAD SCI USA, V110, P17125, DOI 10.1073/pnas.1307313110; Chapman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071941; Chapman MA, 2012, THEOR APPL GENET, V125, P897, DOI 10.1007/s00122-012-1881-z; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; DOEBLEY J, 1995, GENETICS, V141, P333; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle J. J., 1987, PHYTOCHEM B, P11; Fick GN., 1997, SUNFLOWER TECHNOLOGY, P395, DOI DOI 10.2134/AGR0NM0N-0GR35.C8; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; GOYNE PJ, 1989, AGRON J, V81, P826, DOI 10.2134/agronj1989.00021962008100050025x; GOYNE PJ, 1987, AGRON J, V79, P704, DOI 10.2134/agronj1987.00021962007900040025x; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; HAMMER K, 1984, Kulturpflanze, V32, P11; HEISER C. B. JUN., 1951, Proceedings of the American Philosophical Society, V95, P432; HEISER CB, 1954, AM MIDL NAT, V51, P287, DOI 10.2307/2422222; HEISER CB, 1945, MISS BOT GARDEN B, V3, P163; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; HUDSON RR, 1987, GENETICS, V116, P153; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kimura M., 1983, NEUTRAL THEORY MOL E; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; LEWONTIN RC, 1973, GENETICS, V74, P175; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Mandel J, 2011, THEOR APPL GENET, V123, P693, DOI 10.1007/s00122-011-1619-3; Mandel JR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003378; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Neff MM, 2012, DEV CELL, V22, P687, DOI 10.1016/j.devcel.2012.04.003; Nesbitt TC, 2001, PLANT PHYSIOL, V127, P575, DOI [10.1104/pp.010087, 10.1104/pp.127.2.575]; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Putt E.D., 1997, SUNFLOWER TECHNOLOGY, V2nd ed., P1, DOI [10.2134/agronmonogr35, DOI 10.2134/AGRONMONOGR35.C1]; Renaut S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2833; Rogers C., 1982, SUNFLOWER SPECIES US; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Soleri Daniela, 1993, Journal of Ethnobiology, V13, P203; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wills DM, 2007, GENETICS, V176, P2589, DOI 10.1534/genetics.107.075333; Wills DM, 2010, J HERED, V101, P727, DOI 10.1093/jhered/esq089; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Zhang N, 2012, THEOR APPL GENET, V125, P273, DOI 10.1007/s00122-012-1832-8	62	7	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99620	10.1371/journal.pone.0099620	http://dx.doi.org/10.1371/journal.pone.0099620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914686	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700120
J	Wang, Y; Shen, J; Xiong, XX; Xu, YH; Zhang, H; Huang, CJ; Tian, Y; Jiao, CY; Wang, XH; Li, XC				Wang, Yun; Shen, Jian; Xiong, Xuanxuan; Xu, Yonghua; Zhang, Hai; Huang, Changjun; Tian, Yuan; Jiao, Chengyu; Wang, Xuehao; Li, Xiangcheng			Remote Ischemic Preconditioning Protects against Liver Ischemia-Reperfusion Injury via Heme Oxygenase-1-Induced Autophagy	PLOS ONE			English	Article							HEPATIC ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; INDUCED CYTOTOXICITY; OXIDATIVE STRESS; RAT HEPATOCYTES; MICE; CELLS; MODEL; GENE; ACTIVATION	Background: Growing evidence has linked autophagy to a protective role of preconditioning in liver ischemia/reperfusion (IR). Heme oxygenase-1 (HO-1) is essential in limiting inflammation and preventing the apoptotic response to IR. We previously demonstrated that HO-1 is up-regulated in liver graft after remote ischemic preconditioning (RIPC). The aim of this study was to confirm that RIPC protects against IR via HO-1-mediated autophagy. Methods: RIPC was performed with regional ischemia of limbs before liver ischemia, and HO-1 activity was inhibited preoperation. Autophagy was assessed by the expression of light chain 3-II (LC3-II). The HO-1/extracellular signal-related kinase (ERK)/p38/mitogen-activated protein kinase (MAPK) pathway was detected in an autophagy model and mineral oil-induced IR in vitro. Results: In liver IR, the expression of LC3-II peaked 12-24 h after IR, and the ultrastructure revealed abundant autophagosomes in hepatocytes after IR. Autophagy was inhibited when HO-1 was inactivated, which we believe resulted in the aggravation of liver IR injury (IRI) in vivo. Hemin-induced autophagy also protected rat hepatocytes from IRI in vitro, which was abrogated by HO-1 siRNA. Phosphorylation of p38-MAPK and ERK1/2 was up-regulated in hemin-pretreated liver cells and down-regulated after treatment with HO-1 siRNA. Conclusions: RIPC may protect the liver from IRI by induction of HO-1/p38-MAPK-dependent autophagy.	[Huang, Changjun; Tian, Yuan; Jiao, Chengyu; Wang, Xuehao; Li, Xiangcheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Minist Publ Hlth,Key Lab Living Donor Liver Trans, Nanjing, Jiangsu, Peoples R China; [Wang, Yun] Southeast Univ Xuzhou, Tumor Res Inst, Southeast Univ Med Sch Xuzhou, Affiliated Hosp,Xuzhou City Cent Hosp, Xuzhou, Jiangsu, Peoples R China; [Shen, Jian] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Xiong, Xuanxuan] Southeast Univ Med Sch Xuzhou, Affiliated Hosp, Xuzhou City Cent Hosp, Dept Gastroenterol 2, Xuzhou, Jiangsu, Peoples R China; [Xu, Yonghua] Yancheng First Peoples Hosp, Dept Gen Surg, Yancheng, Jiangsu, Peoples R China; [Zhang, Hai] Jiangsu Univ, Affiliated Hosp 1, Dept Gen Surg, Zhenjiang, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Southeast University - China; Jiangsu University	Li, XC (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat Ctr, Minist Publ Hlth,Key Lab Living Donor Liver Trans, Nanjing, Jiangsu, Peoples R China.	drxcli@njmu.edu.cn	huang, changjun/F-9012-2019; li, xiang/GWM-6319-2022	huang, changjun/0000-0002-5211-9367; 	National Natural Science Foundation of China [81170415, 81302108]; Nanjing Medical University [2012NJMU087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	The study was supported by grants from the National Natural Science Foundation of China (81170415) from Dr. Xiangcheng Li, and from the National Natural Science Foundation of China (81302108) from Dr. Jian Shen, and from Nanjing Medical University (2012NJMU087). Dr. Xiangcheng Li had a role in study design, data collection and analysis, decision to publish, and Dr. Jian Shen also had role in study design, data collection and analysis, decision to publish.	Abu-Amara M, 2011, LIVER TRANSPLANT, V17, P70, DOI 10.1002/lt.22204; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cardinal J, 2009, HEPATOLOGY, V50, P565, DOI 10.1002/hep.23021; Choi BM, 2003, HEPATOLOGY, V37, P810, DOI 10.1053/jhep.2003.50114; David A, 2010, NEPHRON EXP NEPHROL, V115, pe33; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Devey L, 2009, TRANSPLANTATION, V88, P308, DOI 10.1097/TP.0b013e3181ae3067; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Esposti DD, 2010, AUTOPHAGY, V6, P172, DOI 10.4161/auto.6.1.10699; Kim HS, 2008, NITRIC OXIDE-BIOL CH, V18, P256, DOI 10.1016/j.niox.2008.02.002; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187; Lai IR, 2006, TRANSPLANTATION, V81, P1311, DOI 10.1097/01.tp.0000203555.14546.63; Meldrum KK, 2003, CIRC RES, V92, P293, DOI 10.1161/01.RES.0000057754.35180.99; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Tapuria N, 2009, HPB, V11, P108, DOI 10.1111/j.1477-2574.2009.00006.x; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wang HQ, 2010, BRAIN RES, V1360, P159, DOI 10.1016/j.brainres.2010.08.100; Wang JH, 2012, AUTOPHAGY, V8, P140, DOI 10.4161/auto.8.1.18391; Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005; Yang YC, 2011, FREE RADICAL BIO MED, V51, P2073, DOI 10.1016/j.freeradbiomed.2011.09.007; Yao P, 2007, J HEPATOL, V47, P253, DOI 10.1016/j.jhep.2007.02.008; Yun N, 2012, J PHYSIOL SCI, V62, P199, DOI 10.1007/s12576-012-0199-6; Yun N, 2010, ANTIOXID REDOX SIGN, V13, P1503, DOI 10.1089/ars.2009.2873; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang WJ, 2013, BIOCHEM BIOPH RES CO, V434, P492, DOI 10.1016/j.bbrc.2013.03.101	34	57	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98834	10.1371/journal.pone.0098834	http://dx.doi.org/10.1371/journal.pone.0098834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914543	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700038
J	Williams, DL; Mann, BK				Williams, David L.; Mann, Brenda K.			Efficacy of a Crosslinked Hyaluronic Acid-Based Hydrogel as a Tear Film Supplement: A Masked Controlled Study	PLOS ONE			English	Article							CANINE KERATOCONJUNCTIVITIS SICCA; OPHTHALMIC APPLICATIONS; EYE DROPS; GEL; MODEL	Keratoconjunctivitis sicca (KCS), or dry eye, is a significant medical problem in both humans and dogs. Treating KCS often requires the daily application of more than one type of eye drop in order to both stimulate tear prodcution and provide a tear supplement to increase hydration and lubrication. A previous study demonstrated the potential for a crosslinked hyaluronic acid-based hydrogel (xCMHA-S) to reduce the clinical signs associated with KCS in dogs while using a reduced dosing regimen of only twice-daily administration. The present study extended those results by comparing the use of the xCMHA-S to a standard HA-containing tear supplement in a masked, randomized clinical study in dogs with a clinical diagnosis of KCS. The xCMHA-S was found to significantly improve ocular surface health (conjunctival hyperaemia, ocular irritation, and ocular discharge) to a greater degree than the alternative tear supplement (P = 0.0003). Further, owners reported the xCMHA-S treatment as being more highly effective than the alternative tear supplement (P = 0.0024). These results further demonstrate the efficacy of the xCMHA-S in reducing the clinical signs associated with KCS, thereby improving patient health and owner happiness.	[Williams, David L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Mann, Brenda K.] SentrX Anim Care Inc, Salt Lake City, UT USA; [Mann, Brenda K.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	University of Cambridge; Utah System of Higher Education; University of Utah	Williams, DL (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	dlw33@cam.ac.uk						Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1; Bron AJ, 1998, EUR J OPHTHALMOL, V8, P81, DOI 10.1177/112067219800800206; Festing Michael F W, 2002, ILAR J, V43, P244; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; Guillaumie F, 2010, J BIOMED MATER RES A, V92A, P1421, DOI 10.1002/jbm.a.32481; Hamano T, 1996, JPN J OPHTHALMOL, V40, P62; Higashide T, 2008, CLIN OPHTHALMOL, V2, P21; KASWAN RL, 1989, ARCH OPHTHALMOL-CHIC, V107, P1210, DOI 10.1001/archopht.1989.01070020276038; KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235; Nakamura S, 2004, CORNEA, V23, P390, DOI 10.1097/00003226-200405000-00015; NEWCOMBE RG, 1987, BRIT J OPHTHALMOL, V71, P645, DOI 10.1136/bjo.71.9.645; Rah MJ, 2011, OPTOMETRY, V82, P38, DOI 10.1016/j.optm.2010.08.003; Smith JA, 2007, OCUL SURF, V5, P93; Stonecipher K, 2005, CURR MED RES OPIN, V21, P1057, DOI 10.1185/030079905X50615; Williams David, 2012, Vet Res Forum, V3, P229; Williams DL, 2008, VET CLIN N AM-SMALL, V38, P251, DOI 10.1016/j.cvsm.2007.12.002; Williams DL, 2013, INT J BIOMATER, V2013, DOI 10.1155/2013/460437; Yang GH, 2010, VET OPHTHALMOL, V13, P144, DOI 10.1111/j.1463-5224.2010.00771.x; Yang GF, 2011, INT J GYNECOL CANCER, V21, P486, DOI 10.1097/IGC.0b013e31820fa168	19	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99766	10.1371/journal.pone.0099766	http://dx.doi.org/10.1371/journal.pone.0099766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914681	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700129
J	Biscaro, C; Giupponi, C				Biscaro, Claudio; Giupponi, Carlo			Co-Authorship and Bibliographic Coupling Network Effects on Citations	PLOS ONE			English	Article							VULNERABILITY ASSESSMENT; COLLABORATION; PRODUCTIVITY; INNOVATION; SCIENCE; GROWTH; MODEL	This paper analyzes the effects of the co-authorship and bibliographic coupling networks on the citations received by scientific articles. It expands prior research that limited its focus on the position of co-authors and incorporates the effects of the use of knowledge sources within articles: references. By creating a network on the basis of shared references, we propose a way to understand whether an article bridges among extant strands of literature and infer the size of its research community and its embeddedness. Thus, we map onto the article - our unit of analysis - the metrics of authors' position in the co-authorship network and of the use of knowledge on which the scientific article is grounded. Specifically, we adopt centrality measures - degree, betweenneess, and closeness centrality - in the co-authorship network and degree, betweenness centrality and clustering coefficient in the bibliographic coupling and show their influence on the citations received in first two years after the year of publication. Findings show that authors' degree positively impacts citations. Also closeness centrality has a positive effect manifested only when the giant component is relevant. Author's betweenness centrality has instead a negative effect that persists until the giant component - largest component of the network in which all nodes can be linked by a path - is relevant. Moreover, articles that draw on fragmented strands of literature tend to be cited more, whereas the size of the scientific research community and the embeddedness of the article in a cohesive cluster of literature have no effect.	[Biscaro, Claudio; Giupponi, Carlo] Ca Foscari Univ Venice, Dept Econ, Venice, Italy; [Biscaro, Claudio] Ca Foscari Univ Venice, Dept Management, Venice, Italy; [Biscaro, Claudio] Johannes Kepler Univ Linz, Inst Org & Globale Managementstudien, A-4040 Linz, Austria	Universita Ca Foscari Venezia; Universita Ca Foscari Venezia; Johannes Kepler University Linz	Biscaro, C (corresponding author), Ca Foscari Univ Venice, Dept Econ, Venice, Italy.	claudio.biscaro@jku.at	Giupponi, Carlo/E-5895-2012; Biscaro, Claudio/W-4501-2017	Giupponi, Carlo/0000-0001-5358-9208; Biscaro, Claudio/0000-0003-2928-1945	KULTURisk Project [FP7-ENV.2010.1.3.2-1-265280]	KULTURisk Project	The authors gratefully acknowledge the financial support of the KULTURisk Project (FP7-ENV.2010.1.3.2-1-265280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Blei DM, 2007, ANN APPL STAT, V1, P17, DOI 10.1214/07-AOAS114; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Catmull E., 2008, PIXAR FOSTERS COLLEC; Chang J, 2010, ANN APPL STAT, V4, P124, DOI 10.1214/09-AOAS309; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dekas KH, 2013, ACAD MANAGE PERSPECT, V27, P219, DOI 10.5465/amp.2011.0097; Dorta-Gonzalez P, 2013, J INFORMETR, V7, P593, DOI 10.1016/j.joi.2013.03.005; Frigotto ML, 2011, SCIENTOMETRICS, V89, P397, DOI 10.1007/s11192-011-0431-9; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; Hargadon A, 1997, ADMIN SCI QUART, V42, P716, DOI 10.2307/2393655; Heinze T, 2007, SCIENTOMETRICS, V70, P811, DOI 10.1007/s11192-007-0313-3; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Janssen M. A., 2007, Ecology and Society, V12, P9; Janssen MA, 2006, GLOBAL ENVIRON CHANG, V16, P240, DOI 10.1016/j.gloenvcha.2006.04.001; JE Davidson, 1995, NATURE INSIGHT, P465; Jose AM, 1996, WATER AIR SOIL POLL, V92, P191; Kaplan S, 2012, IDENTIFYING BREAKTHR; KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Maske KL, 2003, ECON INQ, V41, P555, DOI 10.1093/ei/cbg027; Mazloumian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018975; Moretti E., 2012, NEW GEOGRAPHY JOBS; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Perry-Smith JE, 2006, ACAD MANAGE J, V49, P85, DOI 10.2307/20159747; Polanyi M, 2000, MINERVA, V38, P1, DOI 10.1023/A:1026591624255; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Schilling MA, 2005, CREATIVITY RES J, V17, P131, DOI 10.1207/s15326934crj1702&3_2; SIMON HA, 1973, AM SCI, V61, P394; Simonton DK, 1999, PSYCHOL INQ, V10, P309; Strzepek KM, 1996, CLIMATE RES, V6, P89, DOI 10.3354/cr006089; Sun XL, 2013, ADV MATER RES-SWITZ, V616-618, P3, DOI [10.4028/www.scientific.net/AMR.616-618.3, 10.1038/srep01069]; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Uddin S, 2012, SCIENTOMETRICS, V90, P687, DOI 10.1007/s11192-011-0511-x; Wallace ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033339; Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128; Yin LC, 2006, INFORM PROCESS MANAG, V42, P1599, DOI 10.1016/j.ipm.2006.03.021	45	68	68	6	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99502	10.1371/journal.pone.0099502	http://dx.doi.org/10.1371/journal.pone.0099502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911416	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600095
J	Nielsen, JR; Kristensen, K; Lewy, P; Bastardie, F				Nielsen, J. Rasmus; Kristensen, Kasper; Lewy, Peter; Bastardie, Francois			A Statistical Model for Estimation of Fish Density Including Correlation in Size, Space, Time and between Species from Research Survey Data	PLOS ONE			English	Article							GADUS-MORHUA L.; BALTIC COD; RECRUITMENT; ABUNDANCE; DYNAMICS; PATTERNS; STOCK	Trawl survey data with high spatial and seasonal coverage were analysed using a variant of the Log Gaussian Cox Process (LGCP) statistical model to estimate unbiased relative fish densities. The model estimates correlations between observations according to time, space, and fish size and includes zero observations and over-dispersion. The model utilises the fact the correlation between numbers of fish caught increases when the distance in space and time between the fish decreases, and the correlation between size groups in a haul increases when the difference in size decreases. Here the model is extended in two ways. Instead of assuming a natural scale size correlation, the model is further developed to allow for a transformed length scale. Furthermore, in the present application, the spatial-and size-dependent correlation between species was included. For cod (Gadus morhua) and whiting (Merlangius merlangus), a common structured size correlation was fitted, and a separable structure between the time and space-size correlation was found for each species, whereas more complex structures were required to describe the correlation between species (and space-size). The within-species time correlation is strong, whereas the correlations between the species are weaker over time but strong within the year.	[Nielsen, J. Rasmus; Kristensen, Kasper; Lewy, Peter; Bastardie, Francois] Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, Charlottenlund, Denmark	Technical University of Denmark	Nielsen, JR (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, Charlottenlund, Denmark.	rn@aqua.dtu.dk	Nielsen, J. Rasmus/AAG-2647-2021	Nielsen, J. Rasmus/0000-0002-2833-3873; Kristensen, Kasper/0000-0003-3425-3762; Bastardie, Francois/0000-0002-2669-6179	International Femern Belt Science Provision Project (Femern Baelt A/S, DK); Danish Strategic Research Council Project IMAGE (MAFIA); EU	International Femern Belt Science Provision Project (Femern Baelt A/S, DK); Danish Strategic Research Council Project IMAGE (MAFIA); EU(European Commission)	This study was funded by the International Femern Belt Science Provision Project (Femern Baelt A/S, DK). Smaller parts of the study have been supported by the Danish Strategic Research Council Project IMAGE (MAFIA) and the EU FP7 SOCIOEC Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastardie F, 2014, CAN J FISH AQUAT SCI, V71, P366, DOI 10.1139/cjfas-2013-0126; Bastardie F, 2010, FISH RES, V101, P188, DOI 10.1016/j.fishres.2009.10.009; Bastardie F, 2010, ICES J MAR SCI, V67, P71, DOI 10.1093/icesjms/fsp228; Bromley PJ, 1997, ICES J MAR SCI, V54, P846, DOI 10.1006/jmsc.1996.0211; Cressie N., 2011, STAT SPATIO TEMPORAL; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Eero M, 2012, CONSERV LETT, P1; ENGAS A, 1989, J CONSEIL, V45, P269; Hrafnkelsson B, 2004, CAN J FISH AQUAT SCI, V61, P1135, DOI 10.1139/F04-049; ICES, 2012, 2012ACOM10 ICES WGBF; ICES, 2012, 2012SSGESST02 ICES W; Jansen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038758; Koster FW, 2001, CAN J FISH AQUAT SCI, V58, P1516, DOI 10.1139/cjfas-58-8-1516; Kristensen K, 2009, THESIS U COPENHAGEN; Kristensen K, 2006, CAN J FISH AQUAT SCI, V63, P2531, DOI 10.1139/F06-135; Kristensen K, 2014, CAN J FISH AQUAT SCI, V71, P326, DOI 10.1139/cjfas-2013-0151; Lewy P, 2004, CAN J FISH AQUAT SCI, V61, P636, DOI 10.1139/F04-034; Lewy P, 2009, CAN J FISH AQUAT SCI, V66, P1809, DOI 10.1139/F09-114; Lundgren B, 2008, ICES J MAR SCI, V65, P581, DOI 10.1093/icesjms/fsn031; Marchal P, 2001, ICES J MAR SCI, V58, P298, DOI 10.1006/jmsc.2000.1011; Neuenfeldt S, 2000, ICES J MAR SCI, V57, P300, DOI 10.1006/jmsc.2000.0647; Nielsen J.R., 2009, WORLD FISH, V58, P8; Nielsen JR, 1999, ICES J MAR SCI, V56, P627, DOI 10.1006/jmsc.1999.0515; Nielsen JR, 2001, A4JF2001 DG FISH EUR; Nilsson LAF, 2003, AQUAT LIV RES, V16; O'Neill MF, 2003, FISH RES, V60, P471, DOI 10.1016/S0165-7836(02)00101-7; Rivoirard J., 2008, GEOSTATISTICS ESTIMA; RUE H., 2005, GAUSSIAN MARKOV RAND; Sparholt Henrik, 1994, Dana, V10, P131; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Stelzenmuller V, 2005, MAR BIOL RES, V1, P375, DOI 10.1080/17451000500361009; Uzars D, 2000, ICES J MAR SCI, V57, P324, DOI 10.1006/jmsc.1999.0527	32	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99151	10.1371/journal.pone.0099151	http://dx.doi.org/10.1371/journal.pone.0099151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911631	Green Published, gold			2022-12-27	WOS:000337165600046
J	Menichetti, G; Remondini, D; Panzarasa, P; Mondragon, RJ; Bianconi, G				Menichetti, Giulia; Remondini, Daniel; Panzarasa, Pietro; Mondragon, Raul J.; Bianconi, Ginestra			Weighted Multiplex Networks	PLOS ONE			English	Article							COMPLEX; ORGANIZATION; MULTISCALE; FEATURES	One of the most important challenges in network science is to quantify the information encoded in complex network structures. Disentangling randomness from organizational principles is even more demanding when networks have a multiplex nature. Multiplex networks are multilayer systems of N nodes that can be linked in multiple interacting and co-evolving layers. In these networks, relevant information might not be captured if the single layers were analyzed separately. Here we demonstrate that such partial analysis of layers fails to capture significant correlations between weights and topology of complex multiplex networks. To this end, we study two weighted multiplex co-authorship and citation networks involving the authors included in the American Physical Society. We show that in these networks weights are strongly correlated with multiplex structure, and provide empirical evidence in favor of the advantage of studying weighted measures of multiplex networks, such as multistrength and the inverse multiparticipation ratio. Finally, we introduce a theoretical framework based on the entropy of multiplex ensembles to quantify the information stored in multiplex networks that would remain undetected if the single layers were analyzed in isolation.	[Menichetti, Giulia; Remondini, Daniel] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Menichetti, Giulia; Remondini, Daniel] Univ Bologna, INFN Sez Bologna, Bologna, Italy; [Panzarasa, Pietro] Queen Mary Univ London, Sch Business & Management, London, England; [Mondragon, Raul J.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Bianconi, Ginestra] Queen Mary Univ London, Sch Math Sci, London, England	University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Bianconi, G (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	ginestra.bianconi@gmail.com	Bianconi, Ginestra/AAE-4114-2020; Bianconi, Ginestra/I-5742-2018; Remondini, Daniel/ABA-9971-2020	Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Menichetti, Giulia/0000-0001-5201-6774; Remondini, Daniel/0000-0003-3185-7456	Italian Ministry of Education and Research through the Flagship InterOmics [PB05]; European Methods for Integrated analysis of multiple Omics datasets (MIMOmics) projects [305280]	Italian Ministry of Education and Research through the Flagship InterOmics; European Methods for Integrated analysis of multiple Omics datasets (MIMOmics) projects	DR and GM acknowledge support by the Italian Ministry of Education and Research through the Flagship (PB05) InterOmics and the European Methods for Integrated analysis of multiple Omics datasets (MIMOmics) (305280) projects. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy M, 2003, PHYSICA A, V319, P633, DOI 10.1016/S0378-4371(02)01382-1; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Donges JF, 2011, EUR PHYS J B, V84, P635, DOI 10.1140/epjb/e2011-10795-8; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Halu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078293; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Karsai M, 2013, ARXIV13035966; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Morris RG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128703; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Radicchi F, 2008, PNAS, V105, P17266; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Sagarra O, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062806; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107	34	134	134	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97857	10.1371/journal.pone.0097857	http://dx.doi.org/10.1371/journal.pone.0097857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906003	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000015
J	Chao, J; Huo, TI; Cheng, HY; Tsai, JC; Liao, JW; Lee, MS; Qin, XM; Hsieh, MT; Pao, LH; Peng, WH				Chao, Jung; Huo, Teh-Ia; Cheng, Hao-Yuan; Tsai, Jen-Chieh; Liao, Jiunn-Wang; Lee, Meng-Shiou; Qin, Xue-Mei; Hsieh, Ming-Tsuen; Pao, Li-Heng; Peng, Wen-Huang			Gallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; TYPE-2 DIABETES-MELLITUS; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; METABOLIC-RESPONSES; INSULIN-RESISTANCE; HEPATIC STEATOSIS; NMR-SPECTROSCOPY; OXIDATIVE STRESS; BLOOD-PLASMA	Gallic acid (GA), a naturally abundant plant phenolic compound in vegetables and fruits, has been shown to have potent anti-oxidative and anti-obesity activity. However, the effects of GA on nonalcoholic fatty liver disease (NAFLD) are poorly understood. In this study, we investigated the beneficial effects of GA administration on nutritional hepatosteatosis model by a more "holistic view" approach, namely H-1 NMR-based metabolomics, in order to prove efficacy and to obtain information that might lead to a better understanding of the mode of action of GA. Male C57BL/6 mice were placed for 16 weeks on either a normal chow diet, a high fat diet (HFD, 60%), or a high fat diet supplemented with GA (50 and 100 mg/kg/day, orally). Liver histopathology and serum biochemical examinations indicated that the daily administration of GA protects against hepatic steatosis, obesity, hypercholesterolemia, and insulin resistance among the HFD-induced NAFLD mice. In addition, partial least squares discriminant analysis scores plots demonstrated that the cluster of HFD fed mice is clearly separated from the normal group mice plots, indicating that the metabolic characteristics of these two groups are distinctively different. Specifically, the GA-treated mice are located closer to the normal group of mice, indicating that the HFD-induced disturbances to the metabolic profile were partially reversed by GA treatment. Our results show that the hepatoprotective effect of GA occurs in part through a reversing of the HFD caused disturbances to a range of metabolic pathways, including lipid metabolism, glucose metabolism (glycolysis and gluconeogenesis), amino acids metabolism, choline metabolism and gut-microbiota-associated metabolism. Taken together, this study suggested that a H-1 NMR-based metabolomics approach is a useful platform for natural product functional evaluation. The selected metabolites are potentially useful as preventive action biomarkers and could also be used to help our further understanding of the effect of GA in hepatosteatosis mice.	[Chao, Jung; Huo, Teh-Ia] Natl Yang Ming Univ, Coll Med, Inst Pharmacol, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Taiwan Univ Hosp, Dept Oncol & Internal Med, Taipei, Taiwan; [Cheng, Hao-Yuan] Chung Jen Coll Nursing Hlth Sci & Management, Dept Nursing, Chiayi, Taiwan; [Tsai, Jen-Chieh] Asia Univ, Coll Hlth Sci, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Jen-Chieh] Jen Teh Jr Coll Med Nursing & Management, Miaoli, Taiwan; [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan; [Lee, Meng-Shiou; Hsieh, Ming-Tsuen; Peng, Wen-Huang] China Med Univ, Coll Pharm, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung, Taiwan; [Qin, Xue-Mei] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Peoples R China; [Pao, Li-Heng] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Pao, Li-Heng] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Asia University Taiwan; National Chung Hsing University; China Medical University Taiwan; Shanxi University; Chang Gung University of Science & Technology; National Defense Medical Center	Pao, LH (corresponding author), Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan.	paolh@ndmctsgh.edu.tw; whpeng@mail.cmu.edu.tw		Liao, Jiunn-Wang/0000-0001-7374-1203; Lee, Meng-Shiou/0000-0003-3470-4121	National Science Council, Taiwan [NSC100-2320-B-039-013, NSC101-2320-B-039-032-MY2]; Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan [CCMP102-RD-014]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan	This study is supported in part by the National Science Council, Taiwan (NSC100-2320-B-039-013, NSC101-2320-B-039-032-MY2) and Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan (CCMP102-RD-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bialonska D, 2010, INT J FOOD MICROBIOL, V140, P175, DOI 10.1016/j.ijfoodmicro.2010.03.038; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Brand HS, 1998, AMINO ACIDS, V15, P373, DOI 10.1007/BF01320901; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; Center for Drug Evaluation and Research, 2005, GUID IND EST MAX SAF; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Commission E, 2002, OP SCI COMM FOOD UPP; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eriksson L JE, 2006, MULTI MEGAVARIATE 1, P307; GROOTVELD M, 1993, FEBS LETT, V322, P266, DOI 10.1016/0014-5793(93)81584-M; Gupte AA, 2009, DIABETES, V58, P567, DOI 10.2337/db08-1070; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hsiang CY, 2013, FOOD CHEM, V136, P426, DOI 10.1016/j.foodchem.2012.08.009; Hsu CL, 2007, BRIT J NUTR, V98, P727, DOI 10.1017/S000711450774686X; INOUE M, 1995, BIOL PHARM BULL, V18, P1526; Jang A, 2008, CHEM-BIOL INTERACT, V174, P109, DOI 10.1016/j.cbi.2008.05.018; Kim HK, 2011, TRENDS BIOTECHNOL, V29, P267, DOI 10.1016/j.tibtech.2011.02.001; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Klein MS, 2011, METABOLOMICS, V7, P237, DOI 10.1007/s11306-010-0243-6; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; KROES BH, 1992, PLANTA MED, V58, P499, DOI 10.1055/s-2006-961535; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z; LEE WM, 1987, HEPATOLOGY, V7, P906, DOI 10.1002/hep.1840070519; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Li HK, 2009, PHYTOTHER RES, V23, P1332, DOI 10.1002/ptr.2590; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Llorach R, 2012, J AGR FOOD CHEM, V60, P8797, DOI 10.1021/jf301142b; Ma J, 2003, J NAT PROD, V66, P983, DOI 10.1021/np020576x; Maheshwari DT, 2011, FOOD CHEM TOXICOL, V49, P2422, DOI 10.1016/j.fct.2011.06.061; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; McLoughlin GA, 2009, J PROTEOME RES, V8, P1943, DOI 10.1021/pr800892u; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; Miyazaki T, 2012, AMINO ACIDS; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Niho N, 2001, FOOD CHEM TOXICOL, V39, P1063, DOI 10.1016/S0278-6915(01)00054-0; Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602; Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508; Poeze M, 2008, CLIN NUTR, V27, P523, DOI 10.1016/j.clnu.2008.04.006; Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360; Rajalakshmi K, 2001, FOOD CHEM TOXICOL, V39, P919, DOI 10.1016/S0278-6915(01)00022-9; Rezzi S, 2007, J PROTEOME RES, V6, P513, DOI 10.1021/pr060522z; Ringeissen S, 2003, BIOMARKERS, V8, P240, DOI 10.1080/1354750031000149124; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sheng XY, 2011, AM J PHYSIOL-ENDOC M, V300, pE886, DOI 10.1152/ajpendo.00332.2010; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Tian Y, 2012, J PROTEOME RES, V11, P1397, DOI 10.1021/pr2011507; Timbrell JA, 1996, ADV EXP MED BIOL, V403, P125; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; Wang SH, 2011, J AGR FOOD CHEM, V59, P3686, DOI 10.1021/jf1048386; Wang X, 2012, MOL CELL PROTEOMICS; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Wang YL, 2006, J PROTEOME RES, V5, P1535, DOI 10.1021/pr0504182; WATERFIELD CJ, 1991, ARCH TOXICOL, V65, P548, DOI 10.1007/BF01973715; Xu W, 2012, J PROTEOME RES; Xuan JK, 2011, J PROTEOME RES, V10, P5433, DOI 10.1021/pr2006796; Yang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016641; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang LM, 2011, J PROTEOME RES, V10, P614, DOI 10.1021/pr100792q; Zhao XJ, 2012, J PROTEOME RES, V11, P4712, DOI 10.1021/pr300533a	77	129	138	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e96969	10.1371/journal.pone.0096969	http://dx.doi.org/10.1371/journal.pone.0096969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918580	Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000006
J	Kidgell, JT; de Nys, R; Hu, Y; Paul, NA; Roberts, DA				Kidgell, Joel T.; de Nys, Rocky; Hu, Yi; Paul, Nicholas A.; Roberts, David A.			Bioremediation of a Complex Industrial Effluent by Biosorbents Derived from Freshwater Macroalgae	PLOS ONE			English	Article							METAL-IONS; WASTE-WATER; BIOSORPTION; ALGAE; ADSORPTION; CAPACITY; SORPTION; BIOMASS; PH; EXCHANGE	Biosorption with macroalgae is a promising technology for the bioremediation of industrial effluents. However, the vast majority of research has been conducted on simple mock effluents with little data available on the performance of biosorbents in complex effluents. Here we evaluate the efficacy of dried biomass, biochar, and Fe-treated biomass and biochar to remediate 21 elements from a real-world industrial effluent from a coal-fired power station. The biosorbents were produced from the freshwater macroalga Oedogonium sp. (Chlorophyta) that is native to the industrial site from which the effluent was sourced, and which has been intensively cultivated to provide a feed stock for biosorbents. The effect of pH and exposure time on sorption was also assessed. These biosorbents showed specificity for different suites of elements, primarily differentiated by ionic charge. Overall, biochar and Fe-biochar were more successful biosorbents than their biomass counterparts. Fe-biochar adsorbed metalloids (As, Mo, and Se) at rates independent of effluent pH, while untreated biochar removed metals (Al, Cd, Ni and Zn) at rates dependent on pH. This study demonstrates that the biomass of Oedogonium is an effective substrate for the production of biosorbents to remediate both metals and metalloids from a complex industrial effluent.	[Kidgell, Joel T.; de Nys, Rocky; Paul, Nicholas A.; Roberts, David A.] James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; [Kidgell, Joel T.; de Nys, Rocky; Paul, Nicholas A.; Roberts, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Hu, Yi] James Cook Univ, Adv Analyt Ctr, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Roberts, DA (corresponding author), James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	david.roberts1@jcu.edu.au	Roberts, David A/D-9322-2012; Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012	Roberts, David A/0000-0003-0261-691X; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535; Kidgell, Joel/0000-0002-1551-6769	Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme; Australian Renewable Energy Agency (ARENA)	Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Renewable Energy Agency (ARENA)(Australian Renewable Energy Agency (ARENA))	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage with the co-operation of Stanwell Energy Corporation. This project is supported by the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme, and the Australian Renewable Energy Agency (ARENA). Stanwell Energy Corporation provided effluents for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; Bird MI, 2011, BIORESOURCE TECHNOL, V102, P1886, DOI 10.1016/j.biortech.2010.07.106; BRADY JM, 1995, ENZYME MICROB TECH, V17, P791, DOI 10.1016/0141-0229(95)00142-R; Chen C, 2007, CHEMOSPHERE, V69, P1610, DOI 10.1016/j.chemosphere.2007.05.043; CRIST RH, 1994, ENVIRON SCI TECHNOL, V28, P1859, DOI 10.1021/es00060a016; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Entwistle TJ, 2007, ALGAE AUSTR BATRACHO; Esmaeili A, 2010, NAT PROD RES, V24, P341, DOI 10.1080/14786410903064915; Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2; Farrell M, 2013, J HAZARD MATER, V250, P29, DOI 10.1016/j.jhazmat.2013.01.073; Figueira MM, 1997, BIOTECHNOL BIOENG, V54, P344; Figueira MM, 2000, ENVIRON SCI TECHNOL, V34, P4320, DOI 10.1021/es001027l; Frankenberger W. T. Jr., 2004, Irrigation and Drainage Systems, V18, P19, DOI 10.1023/B:IRRI.0000019422.68706.59; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; GARNHAM GW, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P289; Jankowski J, 2006, FUEL, V85, P243, DOI 10.1016/j.fuel.2005.05.028; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Karthikeyan S, 2007, BIORESOURCE TECHNOL, V98, P452, DOI 10.1016/j.biortech.2006.01.010; Kogej A, 2001, WORLD J MICROB BIOT, V17, P677, DOI 10.1023/A:1012901224684; Lalvani SB, 2004, SELEMIUM REMOVAL AGR; Latva S, 2003, ANAL CHIM ACTA, V478, P229, DOI 10.1016/S0003-2670(02)01524-6; Lawton RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090223; Lee HS, 2004, MINER ENG, V17, P487, DOI 10.1016/j.mineng.2004.01.002; MANCEAU A, 1994, J COLLOID INTERF SCI, V168, P87, DOI 10.1006/jcis.1994.1396; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; Mehta SK, 2000, EUR J PROTISTOL, V36, P443, DOI 10.1016/S0932-4739(00)80050-4; Oman J, 2002, WASTE MANAGE, V22, P617, DOI 10.1016/S0956-053X(01)00038-1; Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032; PETERSON HG, 1984, CAN J FISH AQUAT SCI, V41, P974, DOI 10.1139/f84-111; PIRSZEL J, 1995, J IND MICROBIOL, V14, P319, DOI 10.1007/BF01569945; Quinn GP, 2003, EXPT DESIGN DATA ANA; Roberts DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081631; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Schijf J, 2010, ENVIRON SCI TECHNOL, V44, P1644, DOI 10.1021/es9029667; Schneegurt MA, 2001, ENVIRON SCI TECHNOL, V35, P3786, DOI 10.1021/es010766e; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; SIGG L, 1994, EURO CH ENV, V5, P153; Stumm W., 2012, AQUATIC CHEM CHEM EQ; TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821, DOI 10.1128/AEM.47.4.821-824.1984; Vieira DM, 2007, ELECTRON J BIOTECHN, V10, P368, DOI 10.2225/vol10-issue3-fulltext-3; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2; Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062; Yang T, 2012, ENVIRON SCI TECHNOL, V46, P2251, DOI 10.1021/es204034z; Zamil SS, 2009, BIORESOURCE TECHNOL, V100, P1895, DOI 10.1016/j.biortech.2008.10.014; Zhang N, 2008, WATER RES, V42, P3809, DOI 10.1016/j.watres.2008.07.025	47	23	23	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e94706	10.1371/journal.pone.0094706	http://dx.doi.org/10.1371/journal.pone.0094706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919058	gold, Green Published, Green Accepted			2022-12-27	WOS:000338631000003
J	Kolokoltsova, OA; Grant, AM; Huang, C; Smith, JK; Poussard, AL; Tian, B; Brasier, AR; Peters, CJ; Tseng, CTK; de la Torre, JC; Paessler, S				Kolokoltsova, Olga A.; Grant, Ashley M.; Huang, Cheng; Smith, Jennifer K.; Poussard, Allison L.; Tian, Bing; Brasier, Allan R.; Peters, Clarence J.; Tseng, Chien-Te Kent; de la Torre, Juan C.; Paessler, Slobodan			RIG-I Enhanced Interferon Independent Apoptosis upon Junin Virus Infection	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; LYMPHATIC TISSUE; RHESUS MACAQUES; GUINEA-PIGS; CELLS; REPLICATION; VACCINE; STRAIN; ARENAVIRUS; PHOSPHATIDYLSERINE	Junin virus (JUNV) is the etiological agent of Argentine hemorrhagic fever (AHF), a human disease with a high case-fatality rate. It is widely accepted that arenaviral infections, including JUNV infections, are generally non-cytopathic. In contrast, here we demonstrated apoptosis induction in human lung epithelial carcinoma (A549), human hepatocarcinoma and Vero cells upon infection with the attenuated Candid#1 strain of, JUNV as determined by phosphatidylserine (PS) translocation, Caspase 3 (CASP3) activation, Poly (ADP-ribose) polymerase (PARP) cleavage and/or chromosomal DNA fragmentation. Moreover, as determined by DNA fragmentation, we found that the pathogenic Romero strain of JUNV was less cytopathic than Candid#1 in human hepatocarcinoma and Vero, but more apoptotic in A549 and Vero E6 cells. Additionally, we found that JUNV-induced apoptosis was enhanced by RIG-I signaling. Consistent with the previously reported role of RIG-I like helicase (RLH) signaling in initiating programmed cell death, we showed that cell death or DNA fragmentation of Candid#1-infected A549 cells was decreased upon siRNA or shRNA silencing of components of RIG-I pathway in spite of increased virus production. Similarly, we observed decreased DNA fragmentation in JUNV-infected human hepatocarcinoma cells deficient for RIG-I when compared with that of RIG-I-competent cells. In addition, DNA fragmentation detected upon Candid#1 infection of type I interferon (IFN)-deficient Vero cells suggested a type I IFN-independent mechanism of apoptosis induction in response to JUNV. Our work demonstrated for the first time apoptosis induction in various cells of mammalian origin in response to JUNV infection and partial mechanism of this cell death.	[Kolokoltsova, Olga A.; Grant, Ashley M.; Huang, Cheng; Smith, Jennifer K.; Poussard, Allison L.; Peters, Clarence J.; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Tian, Bing; Brasier, Allan R.] UTMB, Galveston, TX USA; [Peters, Clarence J.; Tseng, Chien-Te Kent] UTMB, Dept Microbiol & Immunol, Galveston, TX USA; [de la Torre, Juan C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Scripps Research Institute	Paessler, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	slpaessl@utmb.edu	Huang, Cheng/R-6619-2017	Huang, Cheng/0000-0001-5402-353X; Brasier, Allan/0000-0002-5012-4090	Public Health Service [R01AI093445]; Sealy Center for Vaccine Development and McLaughlin Predoctoral Fellowships; Vale Asche/McLaughlin Foundation; W.M. Keck Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093445] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sealy Center for Vaccine Development and McLaughlin Predoctoral Fellowships; Vale Asche/McLaughlin Foundation; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01AI093445 to S.P. and J.C.D.L.T. Olga Kolokoltsova was supported by the Sealy Center for Vaccine Development and McLaughlin Predoctoral Fellowships. Ashley Grant was supported by a training fellowship from the Vale Asche/McLaughlin Foundation and from the W.M. Keck Foundation to the Gulf Coast Consortia through the Keck Center for Virus Imaging, University of Texas Medical Branch, Galveston, TX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 1997, J GEN VIROL, V78, P1605, DOI 10.1099/0022-1317-78-7-1605; Albarino CG, J VIROL; AMBROSIO M, 1990, ACTA VIROL, V34, P58; Animal and Plant Health Inspection Service CDC, SEL AG TOX LIST; Olsen S J, 2000, MMWR CDC Surveill Summ, V49, P1; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bossi Philippe, 2004, Euro Surveill, V9, pE11, DOI 10.2807/esm.09.12.00504-en; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; CARBALLAL G, 1981, J INFECT DIS, V143, P7, DOI 10.1093/infdis/143.1.7; Charrel RN, 2010, VET MICROBIOL, V140, P213, DOI 10.1016/j.vetmic.2009.08.027; Charrel RN, 2008, CURR OPIN MICROBIOL, V11, P362, DOI 10.1016/j.mib.2008.06.001; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; CONTIGIANI M, 1993, ACTA VIROL, V37, P41; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Goni SE, 2010, VIRUS GENES, V40, P320, DOI 10.1007/s11262-010-0450-2; ENRIA DA, 1994, ANTIVIR RES, V23, P23, DOI 10.1016/0166-3542(94)90030-2; ENRIA DA, 1987, ANTIVIR RES, V7, P353, DOI 10.1016/0166-3542(87)90017-9; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferrer PE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002083; Fields BN, 2013, FIELDS VIROLOGY; Gallardo F, 1970, MED S1, V1, P77; Garcia JB, 2000, VIROLOGY, V272, P127, DOI 10.1006/viro.2000.0345; Ghiringhelli PD, 1997, AM J TROP MED HYG, V56, P216, DOI 10.4269/ajtmh.1997.56.216; Goni SE, 2006, VIRUS GENES, V32, P37, DOI 10.1007/s11262-005-5843-2; GONZALEZ PH, 1980, ARCH PATHOL LAB MED, V104, P250; GREENMAN DL, 1987, J TOXICOL ENV HEALTH, V22, P113, DOI 10.1002/jmv.1890220203; Groseth A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001137; Harrison LH, 1999, CLIN INFECT DIS, V28, P1091, DOI 10.1086/514749; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Huang C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001659; KENYON RH, 1992, INTERVIROLOGY, V33, P23; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Kolokoltsova OA, 2010, J VIROL, V84, P13063, DOI 10.1128/JVI.01389-10; LAGUENS M, 1983, INFECT IMMUN, V41, P1279, DOI 10.1128/IAI.41.3.1279-1283.1983; LAGUENS RM, 1986, MED MICROBIOL IMMUN, V175, P187, DOI 10.1007/BF02122447; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Licata JM, 2003, INT REV IMMUNOL, V22, P451, DOI 10.1080/08830180305217; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; MAIZTEGUI J, 1986, MED MICROBIOL IMMUN, V175, P149, DOI 10.1007/BF02122437; Maiztegui JI, 1998, J INFECT DIS, V177, P277, DOI 10.1086/514211; MAIZTEGUI JI, 1975, B WORLD HEALTH ORGAN, V52, P567; Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736; MCKEE KT, 1985, J INFECT DIS, V152, P218, DOI 10.1093/infdis/152.1.218; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Muller S, 2007, J GEN VIROL, V88, P1568, DOI 10.1099/vir.0.82529-0; NIAID, 2013, BIOD EM INF DIS; Park SH, 2006, MOL CELLS, V21, P21; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Rahman ZSM, 2011, IMMUNOL RES, V51, P125, DOI 10.1007/s12026-011-8248-4; RUGGIERO HA, 1986, PRESSE MED, V15, P2239; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; US Department of Health and Human Services, 2009, BIOSAFETY MICROBIOLO, V5th; Vince JE, 2010, EMBO J, V29, P1627, DOI 10.1038/emboj.2010.79; Wolff S, 2013, J VIROL, V87, P224, DOI 10.1128/JVI.01929-12; Yun NE, 2008, AM J TROP MED HYG, V79, P275, DOI 10.4269/ajtmh.2008.79.275	64	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99610	10.1371/journal.pone.0099610	http://dx.doi.org/10.1371/journal.pone.0099610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918927	Green Submitted, Green Published, gold			2022-12-27	WOS:000338631000098
J	Peake, PW; Pianta, TJ; Succar, L; Fernando, M; Pugh, DJ; McNamara, K; Endre, ZH				Peake, Philip W.; Pianta, Timothy J.; Succar, Lena; Fernando, Mangalee; Pugh, Debbie J.; McNamara, Kathleen; Endre, Zoltan H.			A Comparison of the Ability of Levels of Urinary Biomarker Proteins and Exosomal mRNA to Predict Outcomes after Renal Transplantation	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; ACUTE CELLULAR REJECTION; CYSTATIN C; REAL-TIME; DISEASE; EXOSOMES/MICROVESICLES; DYSFUNCTION; RECIPIENTS; ROLES	Background: mRNA for biomarkers of kidney injury extracted from urinary exosomes may reflect or predict levels of the corresponding protein after transplantation and clinical outcomes. Methods: Urinary exosomes were isolated from patients following renal transplantation, from healthy controls, and patients with CKD. Expression of exosomal mRNA for the injury biomarkers neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1), and cystatin C was compared with the concentrations of corresponding urinary proteins, 18S RNA and serum creatinine. Results: All biomarker protein concentrations increased after transplantation, and urinary NGAL and IL-18 at 24 and 168 h correlated with the day 7 creatinine reduction ratio (CRR). Exosomal18S RNA increased after transplantation, but exosomal mRNA for NGAL, IL-18 and cystatin C did not correlate with the day 7 CRR, or urinary biomarker concentrations at any time after transplantation. Exosomal NGAL mRNA was lower 4 h after transplantation than in control exosomes. In contrast, exosomal mRNA for cystatin C was unchanged after transplantation and in CKD, although urinary cystatin C temporarily increased following transplantation. Urinary KIM-1 increased after transplantation, but exosomal mRNA for KIM-1 remained undetectable. In CKD 18S RNA was raised, and exosomal mRNA for NGAL, IL-18 and cystatin C was detected in all patients. While urinary NGAL was greater in CKD than control subjects, exosomal NGAL mRNA was unchanged. Exosomal IL-18 mRNA was increased in CKD, but not IL-18 protein. Conclusions: After renal transplantation, urinary NGAL and IL-18 levels reflect the day 7 CRR. However, while mRNA for these biomarkers is present in exosomes, their levels do not reflect or predict urinary biomarker levels or the CRR. This likely reflects the fact that packaging of mRNA in exosomes is selective, and is not necessarily representative of mRNA in the parent cells responsible for biomarker production.	[Peake, Philip W.; Pianta, Timothy J.; Succar, Lena; Fernando, Mangalee; Pugh, Debbie J.; McNamara, Kathleen; Endre, Zoltan H.] Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia; [Peake, Philip W.; Pianta, Timothy J.; Succar, Lena; Fernando, Mangalee; Endre, Zoltan H.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney	Peake, PW (corresponding author), Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia.	p.peake@unsw.edu.au	Endre, Zoltan/A-3331-2009	Endre, Zoltan/0000-0002-4782-8695; Pianta, Timothy/0000-0002-9196-4889	Kidney Health Australia; Jacquot Research Entry Scholarship; University of New South Wales Australian Postgraduate Award; NHMRC Infrastructure Funding	Kidney Health Australia; Jacquot Research Entry Scholarship; University of New South Wales Australian Postgraduate Award; NHMRC Infrastructure Funding	This research was supported by a grant from Kidney Health Australia. Timothy Pianta is the recipient of a Jacquot Research Entry Scholarship and a University of New South Wales Australian Postgraduate Award. Lena Succar is supported by NHMRC Infrastructure Funding, and Zoltan Endre has received research and travel support from Alere and Abbott Corporations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar N, 2011, NEPHRON CLIN PRACT, V118, pC173, DOI 10.1159/000321381; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Endre ZH, 2013, PEDIATR NEPHROL, V28, P207, DOI 10.1007/s00467-012-2171-3; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Ferguson MA, 2012, CLIN CHEM, V58, P680, DOI 10.1373/clinchem.2011.167494; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Makris K, 2012, CLIN CHEM LAB MED, V50, P1519, DOI 10.1515/cclm-2012-0227; Martensson J, 2012, BRIT J ANAESTH, V109, P843, DOI 10.1093/bja/aes357; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Moon PG, 2011, MASS SPECTROM REV, V30, P1185, DOI 10.1002/mas.20319; Nejat M, 2012, NEPHROL DIAL TRANSPL, V27, P96, DOI 10.1093/ndt/gfr222; Nogare AL, 2012, TRANSPL P, V44, P2297, DOI 10.1016/j.transproceed.2012.07.047; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; van Ham SM, 2010, KIDNEY INT, V78, P1033, DOI 10.1038/ki.2010.274; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599	33	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98644	10.1371/journal.pone.0098644	http://dx.doi.org/10.1371/journal.pone.0098644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918752	gold, Green Published			2022-12-27	WOS:000338631000025
J	Barleon, L; Wahl, J; Morfeld, P; Deters, C; Lichtmess, A; Haas-Braahler, S; Muller, U; Breitstadt, R; Pfeiffer, N				Barleon, Lorenz; Wahl, Jochen; Morfeld, Peter; Deters, Claudia; Lichtmess, Andrea; Haas-Braehler, Sibylle; Mueller, Uta; Breitstadt, Rolf; Pfeiffer, Norbert			The Evonik-Mainz-Eye-Care-Study (EMECS): Design and Execution of the Screening Investigation	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; COST-EFFECTIVENESS; DIABETIC-RETINOPATHY; VISUAL IMPAIRMENT; POPULATION; PREVALENCE; WORLDWIDE; WORK	Purpose: To determine if screening for major ophthalmological diseases is feasible within the frame of routine occupational medicine examinations in a large working population. Methods: 13037 employees of Evonik Industries aged 40 to 65 years were invited to be screened for major ophthalmological diseases (glaucoma, age related macular degeneration and diabetic retinopathy between June 2007 and March 2008 within an extended setting of occupational medicine. Ophthalmological examinations consisted of visual acuity, objective refraction, pachymetry, tonometry, perimetry (frequency doubling technology), confocal scanning laser ophthalmoscopy and digital fundus photography. Participants responded to a questionnaire addressing history of ocular and general diseases and social history. Results: 4183 participants (961 female and 3222 male) were examined at 13 different sites. Response rates for eligible persons at those sites ranged from 17.9 to 60.5% but were in part limited by availability of examination slots. Average age of participants was 48.4 +/- 5.4 years (mean +/- SD). 4147 out of 4183 subjects (99.1%) had a visual acuity >= 0.5 in the better eye and 3665 out of 4183 (87.6%) subjects had a visual acuity >= 0.8 in the better eye. 1629 participants (38.9%) had previously not been seen by an ophthalmologist at all or not within the last three years. Conclusion: This article describes the study design and basic characteristics of study participants within a large occupational medicine based screening study for ophthalmological diseases. Response rates exceeded expectations and were limiting examination capacity. Meaningful data could be obtained for almost all participants. We reached participants who previously had not received ophthalmic care. Thus, ophthalmological screening appears to be feasible within the frame of routine occupational medicine examinations.	[Barleon, Lorenz; Wahl, Jochen; Deters, Claudia; Lichtmess, Andrea; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany; [Morfeld, Peter] Univ Cologne, Inst Occupat Med Environm Med & Prevent Res, D-50931 Cologne, Germany; [Morfeld, Peter] Inst Occupat Epidemiol & Risk Assessment Evonik I, Essen, Germany; [Haas-Braehler, Sibylle] Evonik Ind, Occupat Hlth, Hanau, Germany; [Mueller, Uta; Breitstadt, Rolf] Evonik Ind, Occupat Hlth, Essen, Germany	Johannes Gutenberg University of Mainz; University of Cologne; Evonik Industries; Evonik Industries; Evonik Industries	Barleon, L (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	L.Barleon@diak-ka.de	Pfeiffer, Norbert/AAO-7586-2020		Evonik Industries	Evonik Industries	This investigation was sponsored by a grant from Evonik Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler W, 2010, KLIN MONATSBL AUGENH, V227, P905, DOI 10.1055/s-0029-1245425; [Anonymous], 1991, Ophthalmology, V98, P786; Antony K, 2007, GMS HLTH TECHNOL ASS, V3, P1; Antony K, 2007, GMS HLTH TECHNOL ASS, V3, P57; BAVC, 2002, INF FUHR BUND CHEM E; Boivin J F, 1996, J Med Screen, V3, P154; Buch H, 2001, OPHTHALMOLOGY, V108, P2347, DOI 10.1016/S0161-6420(01)00823-5; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Costa G, 2007, ERGONOMICS, V50, P1914, DOI 10.1080/00140130701676054; de Voogd S, 2005, OPHTHALMOLOGY, V112, P1487, DOI 10.1016/j.ophtha.2005.04.018; DGUV, 2010, DTSCH GES UNF BER GR; DGUV, 2007, DTSCH GES UNF GUID O; FAA, 2006, FED AV ADM GUID AV M; GFK-Marktforschung, 2010, HITL VORS AP UMSCH 1; GOTTLIEB LK, 1983, SURV OPHTHALMOL, V28, P206, DOI 10.1016/0039-6257(83)90098-X; Hernandez R, 2008, J GLAUCOMA, V17, P159, DOI 10.1097/IJG.0b013e31814b9693; Hernandez RA, 2008, INT J TECHNOL ASSESS, V24, P203, DOI 10.1017/S0266462308080288; HSE, 2000, HLTH SAF GUID 6 HSG6; HSE, 2003, WORK DISPL SCREEN EQ; Le Blanc R, 1989, Surv Ophthalmol, V33 Suppl, P445, DOI 10.1016/0039-6257(89)90082-9; Le Blanc R, 1989, SURV OPHTHALMOL S, P449; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Meyer C, 2006, IST GLAUKOMSCREENING; Mowatt G, 2008, INVEST OPHTH VIS SCI, V49, P5373, DOI 10.1167/iovs.07-1501; Peto T, 2012, CURR DIABETES REP, V12, P338, DOI 10.1007/s11892-012-0285-4; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schmier JK, 2007, PHARMACOECONOMICS, V25, P287, DOI 10.2165/00019053-200725040-00003; SHARIT J, 1994, ERGONOMICS, V37, P559, DOI 10.1080/00140139408963674; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; StataCorp, 2009, STAT REL 11 STAT SOF; Sundling V, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-17; Tuomi K, 2001, OCCUP MED-OXFORD, V51, P318, DOI 10.1093/occmed/51.5.318; Vaahtoranta-Lehtonen H, 2007, ACTA OPHTHALMOL SCAN, V85, P508, DOI 10.1111/j.1600-0420.2007.00947.x; Wagner G, 1974, SEHVERMOGEN FARBTUCH; Yamauchi Y, 2012, JPN J OPHTHALMOL, V56, P577, DOI 10.1007/s10384-012-0184-x	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98538	10.1371/journal.pone.0098538	http://dx.doi.org/10.1371/journal.pone.0098538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915063	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700024
J	Bruckner, S; Kammer, T				Brueckner, Sabrina; Kammer, Thomas			Is Theta Burst Stimulation Applied to Visual Cortex Able to Modulate Peripheral Visual Acuity?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LOW-FREQUENCY; MOTOR; EXCITABILITY; PSYCHOPHYSICS; SUPPRESSION; DEPRESSION; PLASTICITY; PHOSPHENES; ANISOTROPY	Repetitive transcranial magnetic stimulation is usually applied to visual cortex to explore the effects on cortical excitability. Most researchers therefore concentrate on changes of phosphene threshold, rarely on consequences for visual performance. Thus, we investigated peripheral visual acuity in the four quadrants of the visual field using Landolt C optotypes before and after repetitive stimulation of the visual cortex. We applied continuous and intermittend theta burst stimulation with various stimulation intensities (60%, 80%, 100%, 120% of individual phosphene threshold) as well as monophasic and biphasic 1 Hz stimulation, respectively. As an important result, no serious adverse effects were observed. In particular, no seizure was induced, even with theta burst stimulation applied with 120% of individual phosphene threshold. In only one case stimulation was ceased because the subject reported intolerable pain. Baseline visual acuity decreased over sessions, indicating a continuous training effect. Unexpectedly, none of the applied transcranial magnetic stimulation protocols had an effect on performance: no change in visual acuity was found in any of the four quadrants of the visual field. Binocular viewing as well as the use of peripheral instead of foveal presentation of the stimuli might have contributed to this result. Furthermore, intraindividual variability could have masked the TMS-induced effects on visual acuity.	[Brueckner, Sabrina; Kammer, Thomas] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany	Ulm University	Bruckner, S (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	sabrina.brueckner@uni-ulm.de	Kammer, Thomas/K-2168-2012	Kammer, Thomas/0000-0002-2769-5645; Lorenz, Sabrina/0000-0001-5798-4838				Agostino R, 2008, EUR J NEUROSCI, V28, P822, DOI 10.1111/j.1460-9568.2008.06373.x; Antal A, 2002, NEUROREPORT, V13, P2229, DOI 10.1097/00001756-200212030-00013; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Bower JD, 2012, ATTEN PERCEPT PSYCHO, V74, P942, DOI 10.3758/s13414-012-0283-2; Brighina F, 2002, EXP BRAIN RES, V145, P177, DOI 10.1007/s00221-002-1096-7; Bruckner S, 2013, NEUROSCIENCE, V233, P64, DOI 10.1016/j.neuroscience.2012.12.033; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Darrien JH, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-13; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Epstein CM, 1996, J CLIN NEUROPHYSIOL, V13, P242, DOI 10.1097/00004691-199605000-00008; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Harpaz Y, 2009, CORTEX, V45, P1097, DOI 10.1016/j.cortex.2009.01.002; Huang YZ, 2010, J PHYSIOL-LONDON, V588, P3683, DOI 10.1113/jphysiol.2010.191361; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Kamke MR, 2012, J NEUROSCI, V32, P7001, DOI 10.1523/JNEUROSCI.1028-12.2012; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2005, EXP BRAIN RES, V160, P118, DOI 10.1007/s00221-004-1991-1; Kammer T, 2005, EXP BRAIN RES, V160, P129, DOI 10.1007/s00221-004-1992-0; Kammer T, 2002, EXP BRAIN RES, V145, P407, DOI 10.1007/s00221-002-1160-3; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kastner S, 1998, EXP BRAIN RES, V118, P19, DOI 10.1007/s002210050251; Knoch D, 2005, CEREB CORTEX, V15, P885, DOI 10.1093/cercor/bhh196; Kondo M, 2008, JPN PSYCHOL RES, V50, P93, DOI 10.1111/j.1468-5884.2008.00365.x; Kraft A, 2010, EXP BRAIN RES, V207, P283, DOI 10.1007/s00221-010-2453-6; Low FN, 1943, AM J PHYSIOL, V140, P0083, DOI 10.1152/ajplegacy.1943.140.1.83; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; Nyffeler T, 2008, EUR J NEUROSCI, V27, P1809, DOI 10.1111/j.1460-9568.2008.06154.x; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Nyffeler T, 2009, STROKE, V40, P2791, DOI 10.1161/STROKEAHA.109.552323; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Oberman LM, 2009, BRAIN STIMUL, V2, P246, DOI 10.1016/j.brs.2009.03.003; Palomares M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020779; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Saint-Amour D, 2005, EUR J NEUROSCI, V21, P1107, DOI 10.1111/j.1460-9568.2005.03914.x; Salminen-Vaparanta N, 2012, HUM BRAIN MAPP, V33, P652, DOI 10.1002/hbm.21237; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Tashiro K, 2007, NEUROREPORT, V18, P229, DOI 10.1097/WNR.0b013e3280113977; Thielscher A, 2010, CEREB CORTEX, V20, P328, DOI 10.1093/cercor/bhp102; To MPS, 2011, VISION RES, V51, P1686, DOI 10.1016/j.visres.2011.05.010; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Westheimer G, 2001, VISION RES, V41, P47, DOI 10.1016/S0042-6989(00)00245-5; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zafar N, 2008, CLIN NEUROPHYSIOL, V119, P1393, DOI 10.1016/j.clinph.2008.02.006	52	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99429	10.1371/journal.pone.0099429	http://dx.doi.org/10.1371/journal.pone.0099429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914682	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700102
J	Markowicz, S; Matalinska, J; Kurzepa, K; Bochynska, M; Biernacka, M; Samluk, A; Dudek, D; Skurzak, H; Yoshikawa, M; Lipkowski, AW				Markowicz, Sergiusz; Matalinska, Joanna; Kurzepa, Katarzyna; Bochynska, Marta; Biernacka, Marzena; Samluk, Anna; Dudek, Dorota; Skurzak, Henryk; Yoshikawa, Masaaki; Lipkowski, Andrzej W.			Anticancer Properties of Peptide Fragments of Hair Proteins	PLOS ONE			English	Article							KERATIN; CELLS; GENE; SKIN; SUPERINFECTION; CYTOTOXICITY; SENSITIVITY; EXPRESSION; DEFENSINS; TISSUE	The primary function of hair and fur covering mammalian skin is to provide mechanical and thermal protection for the body. The proteins that constitute hair are extremely resistant to degradation by environmental factors. However, even durable materials can be slowly broken down by mechanical stresses, biodegradation mediated by endogenous enzymes in the skin or host microbes. We hypothesised that the biodegradation products of hair may possess bioprotective properties, which supplement their physical protective properties. Although evolutionary processes have led to a reduction in the amount of hair on the human body, it is possible that the bioprotective properties of hair biodegradation products have persisted. The human skin is exposed to various environmental carcinogenic factors. Therefore, we hypothesised that the potential bioprotective mechanisms of hair degradation products affect melanoma growth. We used pepsin to partially digest hair enzymatically, and this process produced a water-soluble lysate containing a mixture of peptides, including fragments of keratin and keratin-associated proteins. We found out that the mixtures of soluble peptides obtained from human hair inhibited the proliferation of human melanoma cells in vitro. Moreover, the hair-derived peptide mixtures also inhibited the proliferation of B lymphoma cells and urinary bladder cancer cells. Normal human cells varied in their susceptibility to the effects of the lysate; the hair-derived peptide mixtures modulated the proliferation of normal human fibroblasts but did not inhibit the proliferation of human mesenchymal cells derived from umbilical cord stromal cells. These results suggest that hair-derived peptides may represent a new class of anti-proliferative factors derived from basically structural proteins. Identification of active regulatory compounds and recognition of the mechanism of their action might pave the way to elaboration of new anticancer drugs.	[Matalinska, Joanna; Bochynska, Marta; Lipkowski, Andrzej W.] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Markowicz, Sergiusz; Biernacka, Marzena; Samluk, Anna; Dudek, Dorota; Skurzak, Henryk] Maria Sklodowska Curie Mem Inst & Oncol Ctr, Warsaw, Poland; [Kurzepa, Katarzyna] Ind Chem Res Inst, PL-01793 Warsaw, Poland; [Yoshikawa, Masaaki] Res Inst Prod Dev, Sakyo Ku, Kyoto, Japan; [Lipkowski, Andrzej W.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Industrial Chemistry Research Institute; Tufts University	Lipkowski, AW (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.	andrzej@lipkowski.org	; Kurzepa, Katarzyna/W-5796-2018	Markowicz, Sergiusz/0000-0003-1280-6514; Kurzepa, Katarzyna/0000-0001-9822-0922; Matalinska, Joanna/0000-0003-0837-7171	Polish Research Grant [2011/01/B/ST5/07818]; Regional Cluster Grant for Peptide Sciences in Mazovia, Poland	Polish Research Grant; Regional Cluster Grant for Peptide Sciences in Mazovia, Poland	This work was partially supported by the Polish Research Grant 2011/01/B/ST5/07818 and Regional Cluster Grant for Peptide Sciences in Mazovia, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER W, 1994, INT J CANCER, V59, P717, DOI 10.1002/ijc.2910590522; Bhutia SK, 2008, TRENDS BIOTECHNOL, V26, P210, DOI 10.1016/j.tibtech.2008.01.002; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Chen YQ, 2010, PEPTIDES, V31, P1504, DOI 10.1016/j.peptides.2010.05.010; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gewartowski K, 2006, ACTA BIOCHIM POL, V53, P179; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harris F, 2013, MED RES REV, V33, P190, DOI 10.1002/med.20252; Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Jorritsma A, 2009, IMMUNOTHERAPY-UK, V1, P679, DOI [10.2217/imt.09.20, 10.2217/IMT.09.20]; Jurga M, 2009, TISSUE ENG PART C-ME, V15, P365, DOI 10.1089/ten.tec.2008.0485; KLEIN G, 1972, INT J CANCER, V10, P44, DOI 10.1002/ijc.2910100108; Krishnan B, 2013, PROSTATE, V73, P60, DOI 10.1002/pros.22540; Kulik J, 2001, MELANOMA RES, V11, P65, DOI 10.1097/00008390-200102000-00008; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Lipkowski AW, 2009, POLIMERY-W, V54, P386, DOI 10.14314/polimery.2009.386; Markowicz S, 2012, MED ONCOL, V29, P2966, DOI 10.1007/s12032-012-0168-1; Matalinska J, 2013, FOLIA NEUROPATHOL, V51, P132, DOI 10.5114/fn.2013.35956; NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221; NYORMOI O, 1973, INT J CANCER, V12, P396, DOI 10.1002/ijc.2910120211; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Pojda Z, 2008, BLOOD, V112, P1189, DOI 10.1182/blood.V112.11.3465.3465; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Rogers MA, 1998, J BIOL CHEM, V273, P26683, DOI 10.1074/jbc.273.41.26683; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Rogers MA, 2000, J INVEST DERMATOL, V114, P464, DOI 10.1046/j.1523-1747.2000.00910.x; Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999; Sage J, 2014, MATRIX BIOL, V33, P41, DOI 10.1016/j.matbio.2013.07.002; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, PIGM CELL MELANOMA R, V22, P154, DOI 10.1111/j.1755-148X.2008.00540.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; STEINERT PM, 1985, CELL, V42, P411, DOI 10.1016/0092-8674(85)90098-4; Szenajch J, 2003, CLIN CHEM, V49, P1450, DOI 10.1373/49.9.1450	38	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e98073	10.1371/journal.pone.0098073	http://dx.doi.org/10.1371/journal.pone.0098073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915193	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700016
J	Pan, LN; Zhu, W; Li, Y; Xu, XL; Guo, LJ; Lu, Q; Wang, J				Pan, Lin-na; Zhu, Wei; Li, Yang; Xu, Xu-lin; Guo, Lian-jun; Lu, Qing; Wang, Jian			Astrocytic Toll-Like Receptor 3 Is Associated with Ischemic Preconditioning-Induced Protection against Brain Ischemia in Rodents	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NF-KAPPA-B; HEMORRHAGIC BRAIN; IN-VITRO; NEUROPROTECTION; INFLAMMATION; INJURY; MECHANISMS; STROKE; TLR3	Background: Cerebral ischemic preconditioning (IPC) protects brain against ischemic injury. Activation of Toll-like receptor 3 (TLR3) signaling can induce neuroprotective mediators, but whether astrocytic TLR3 signaling is involved in IPC-induced ischemic tolerance is not known. Methods: IPC was modeled in mice with three brief episodes of bilateral carotid occlusion. In vitro, IPC was modeled in astrocytes by 1-h oxygen-glucose deprivation (OGD). Injury and components of the TLR3 signaling pathway were measured after a subsequent protracted ischemic event. A neutralizing antibody against TLR3 was used to evaluate the role of TLR3 signaling in ischemic tolerance. Results: IPC in vivo reduced brain damage from permanent middle cerebral artery occlusion in mice and increased expression of TLR3 in cortical astrocytes. IPC also reduced damage in isolated astrocytes after 12-h OGD. In astrocytes, IPC or 12-h OGD alone increased TLR3 expression, and 12-h OGD alone increased expression of phosphorylated NF kappa B (pNF kappa B). However, IPC or 12-h OGD alone did not alter the expression of Toll/interleukin receptor domain-containing adaptorinducing IFN beta (TRIF) or phosphorylated interferon regulatory factor 3 (pIRF3). Exposure to IPC before OGD increased TRIF and pIRF3 expression but decreased pNF kappa B expression. Analysis of cytokines showed that 12-h OGD alone increased IFNb and IL-6 secretion; 12-h OGD preceded by IPC further increased IFNb secretion but decreased IL-6 secretion. Preconditioning with TLR3 ligand Poly I:C increased pIRF3 expression and protected astrocytes against ischemic injury; however, cells treated with a neutralizing antibody against TLR3 lacked the IPC- and Poly I:C-induced ischemic protection and augmentation of IFN beta. Conclusions: The results suggest that IPC-induced ischemic tolerance is mediated by astrocytic TLR3 signaling. This reprogramming of TLR3 signaling by IPC in astrocytes may play an important role in suppression of the post-ischemic inflammatory response and thereby protect against ischemic damage. The mechanism may be via activation of the TLR3/ TRIF/IRF3 signaling pathway.	[Pan, Lin-na; Li, Yang; Xu, Xu-lin; Guo, Lian-jun; Lu, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Hubei, Peoples R China; [Pan, Lin-na] Second Hosp Nanchang, Dept Med Neurol, Nanchang, Jiangxi, Peoples R China; [Zhu, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Emergency Internal Med, Wuhan 430074, Hubei, Peoples R China; [Zhu, Wei; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Xu, Xu-lin; Guo, Lian-jun; Lu, Qing] Key Lab Drug Target Res & Pharmacodynam Evaluat, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Nanchang University; Huazhong University of Science & Technology; Johns Hopkins University	Lu, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Hubei, Peoples R China.	qinglu@mail.hust.edu.cn	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	National Natural Science Foundation of China [81001432, 81173038, 81001425]; National Institutes of Health [K01AG031926, R01AT007317, R01NS078026]; National Center for Complementary & Integrative Health [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031926] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Natural Science Foundation of China http://www.nsfc.gov.cn/ (No. 81001432 reveived by QL, No. 81173038 reveive by LJG, No. 81001425 received by XLX), and the National Institutes of Health http://www.nih.gov/ (K01AG031926, R01AT007317, R01NS078026 reveived by JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Borysiewicz E, 2013, J NEUROIMMUNOL, V255, P54, DOI 10.1016/j.jneuroim.2012.11.002; Bowen KK, 2006, NEUROCHEM INT, V49, P127, DOI 10.1016/j.neuint.2006.02.011; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cho S, 2005, J CEREBR BLOOD F MET, V25, P493, DOI 10.1038/sj.jcbfm.9600058; Gabryel B, 2001, NEUROTOX RES, V3, P205, DOI 10.1007/BF03033192; Gesuete R, 2012, J NEUROCHEM, V123, P75, DOI 10.1111/j.1471-4159.2012.07946.x; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hecker M, 2013, MOL NEUROBIOL; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Kilic U, 2008, NEUROBIOL DIS, V31, P33, DOI 10.1016/j.nbd.2008.03.002; Koyama Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-51; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu HP, 2002, NEUROSCI LETT, V327, P146, DOI 10.1016/S0304-3940(02)00371-3; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu Q, 2011, NITRIC OXIDE-BIOL CH, V24, P132, DOI 10.1016/j.niox.2011.01.007; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2008, CURR OPIN PHARMACOL, V8, P8, DOI 10.1016/j.coph.2007.09.009; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Packard AEB, 2012, J CEREBR BLOOD F MET, V32, P242, DOI 10.1038/jcbfm.2011.160; Pan LN, 2012, ACTA PHARMACOL SIN, V33, P1246, DOI 10.1038/aps.2012.122; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Vannet BMRAV, 2007, ANGLE ORTHOD, V77, P716, DOI 10.2319/052706-212.1; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Shpargel Karl B, 2008, Cleve Clin J Med, V75 Suppl 2, pS77; Sparapani M, 1997, GLIA, V20, P203, DOI 10.1002/(SICI)1098-1136(199707)20:3<203::AID-GLIA4>3.0.CO;2-8; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Vartanian KB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-140; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1029, DOI 10.1097/01.WCB.0000080703.47016.B6; Wang J, 2008, NEUROSCIENCE, V155, P1133, DOI 10.1016/j.neuroscience.2008.07.004; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22; Zan L, 2014, NEUROSCIENCE, V262, P118, DOI 10.1016/j.neuroscience.2013.12.060; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	50	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99526	10.1371/journal.pone.0099526	http://dx.doi.org/10.1371/journal.pone.0099526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914679	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700111
J	Rios, RS; Salgado-Luarte, C; Gianoli, E				Rios, Rodrigo S.; Salgado-Luarte, Cristian; Gianoli, Ernesto			Species Divergence and Phylogenetic Variation of Ecophysiological Traits in Lianas and Trees	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; NATURAL-SELECTION; EMERGING PATTERNS; TROPICAL FORESTS; GLOBAL ANALYSIS; LIFE-HISTORY; LEAF TRAITS; EVOLUTION; RATES; GROWTH	The climbing habit is an evolutionary key innovation in plants because it is associated with enhanced clade diversification. We tested whether patterns of species divergence and variation of three ecophysiological traits that are fundamental for plant adaptation to light environments (maximum photosynthetic rate [A(max)], dark respiration rate [R-d], and specific leaf area [SLA]) are consistent with this key innovation. Using data reported from four tropical forests and three temperate forests, we compared phylogenetic distance among species as well as the evolutionary rate, phylogenetic distance and phylogenetic signal of those traits in lianas and trees. Estimates of evolutionary rates showed that R-d evolved faster in lianas, while SLA evolved faster in trees. The mean phylogenetic distance was 1.2 times greater among liana species than among tree species. Likewise, estimates of phylogenetic distance indicated that lianas were less related than by chance alone (phylogenetic evenness across 63 species), and trees were more related than expected by chance (phylogenetic clustering across 71 species). Lianas showed evenness for R-d, while trees showed phylogenetic clustering for this trait. In contrast, for SLA, lianas exhibited phylogenetic clustering and trees showed phylogenetic evenness. Lianas and trees showed patterns of ecophysiological trait variation among species that were independent of phylogenetic relatedness. We found support for the expected pattern of greater species divergence in lianas, but did not find consistent patterns regarding ecophysiological trait evolution and divergence. R-d followed the species-level pattern, i.e., greater divergence/evolution in lianas compared to trees, while the opposite occurred for SLA and no pattern was detected for A(max). R-d may have driven lianas' divergence across forest environments, and might contribute to diversification in climber clades.	[Rios, Rodrigo S.; Salgado-Luarte, Cristian; Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile; [Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile	Universidad de La Serena; Universidad de Concepcion	Gianoli, E (corresponding author), Univ La Serena, Dept Biol, La Serena, Chile.	egianoli@userena.cl	Rios, Rodrigo S./C-5098-2015; Gianoli, Ernesto/A-7984-2015	Rios, Rodrigo S./0000-0003-3068-0118; Gianoli, Ernesto/0000-0003-4246-8640	FONDECYT [1100585]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by the FONDECYT grant 1100585 (http://www.conicyt.cl/fondecyt/). FONDECYT is the Chilean Agency of Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Ackerly DD, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P391; Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cai ZQ, 2009, OECOLOGIA, V161, P25, DOI 10.1007/s00442-009-1355-4; Cornelissen JHC, 1997, OECOLOGIA, V111, P460, DOI 10.1007/s004420050259; Dodd ME, 1999, EVOLUTION, V53, P732, DOI [10.2307/2640713, 10.1111/j.1558-5646.1999.tb05367.x]; Duran SM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0301; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; EWERS FW, 1991, OECOLOGIA, V88, P233, DOI 10.1007/BF00320816; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gallagher RV, 2012, J BIOGEOGR, V39, P1757, DOI 10.1111/j.1365-2699.2012.02773.x; GARTNER BL, 1990, AM J BOT, V77, P742, DOI 10.2307/2444366; Gastauer M, 2013, ECOL INFORM, V15, P85, DOI 10.1016/j.ecoinf.2013.03.005; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Gentry A.H., 1991, BIOL VINES, P3; Gentry AH, 1991, BIOL VINES, P393, DOI DOI 10.1017/CBO9780511897658.017; Gianoli E, 2004, P ROY SOC B-BIOL SCI, V271, P2011, DOI 10.1098/rspb.2004.2827; Gianoli E, 2014, ECOLOGY LIA IN PRESS; Gianoli E, 2013, OECOLOGIA, V173, P13, DOI 10.1007/s00442-013-2590-2; Gianoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038831; Gianoli E, 2010, J VEG SCI, V21, P66, DOI 10.1111/j.1654-1103.2009.01124.x; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Heard Stephen B., 1995, Historical Biology, V10, P151; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; Jacobsen AL, 2012, AM J BOT, V99, P1583, DOI 10.3732/ajb.1200140; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kooyman RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080685; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lambers H., 1998, PLANT PHYSL ECOLOGY, P299, DOI 10.1007/978-1-4757-2855-2; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Magnuson-Ford K, 2012, AM NAT, V180, P225, DOI 10.1086/666649; Mooers AO, 1999, AM NAT, V154, P249, DOI 10.1086/303226; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; O'Meara BC, 2006, EVOLUTION, V60, P922; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pearcy RW, 2007, FUNCTIONAL PLANT ECO, P213, DOI DOI 10.1201/9781420007626.CH7; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Revell LJ, 2013, SYST BIOL, V62, P339, DOI 10.1093/sysbio/sys084; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Riveros M., 1995, ECOLOGIA BOSQUES NAT, P235; Saldana A, 2007, EVOL ECOL, V21, P651, DOI 10.1007/s10682-006-9143-7; Salgado-Luarte C, 2012, AM NAT, V180, pE42, DOI 10.1086/666612; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; van der Heijden GM, 2013, BIOTROPICA, V45, P682, DOI 10.1111/btp.12060; van der Sande MT, 2013, OECOLOGIA, V172, P961, DOI 10.1007/s00442-012-2563-x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wyka TP, 2013, ANN BOT-LONDON, V112, P1667, DOI 10.1093/aob/mct236; Zheng L, 2009, FUNCT ECOL, V23, P1059, DOI 10.1111/j.1365-2435.2009.01596.x; Zhu SD, 2009, PLANT ECOL, V204, P295, DOI 10.1007/s11258-009-9592-5	75	8	8	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99871	10.1371/journal.pone.0099871	http://dx.doi.org/10.1371/journal.pone.0099871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914958	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700140
J	Du, J; Cui, CH; Park, SC; Kim, JK; Yu, HS; Jin, FX; Sun, CK; Kim, SC; Im, WT				Du, Juan; Cui, Chang-Hao; Park, Sung Chul; Kim, Jin-Kwang; Yu, Hong-Shan; Jin, Feng-Xie; Sun, Changkai; Kim, Sun-Chang; Im, Wan-Taek			Identification and Characterization of a Ginsenoside-Transforming beta-Glucosidase from Pseudonocardia sp Gsoil 1536 and Its Application for Enhanced Production of Minor Ginsenoside Rg(2)(S)	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; PANAX-GINSENG; COMPOUND K; ENZYMATIC BIOTRANSFORMATION; SIMULTANEOUS QUANTIFICATION; RARE GINSENOSIDES; PA14 DOMAIN; RED GINSENG; SP NOV.; GLYCOSIDE	The ginsenoside Rg(2)(S), which is one of the pharmaceutical components of ginseng, is known to have neuroprotective, antiinflammation, and anti-diabetic effects. However, the usage of ginsenoside Rg2(S) is restricted owing to the small amounts found in white and red ginseng. To enhance the production of ginsenoside Rg2(S) as a 100 gram unit with high specificity, yield, and purity, an enzymatic bioconversion method was developed to adopt the recombinant glycoside hydrolase (BglPC28), which is a ginsenoside-transforming recombinant beta-glucosidase from Pseudonocardia sp. strain Gsoil 1536. The gene, termed bglPC28, encoding beta-glucosidase (BglPC28) belonging to the glycoside hydrolase family 3 was cloned. bglPC28 consists of 2,232 bp (743 amino acid residues) with a predicted molecular mass of 78,975 Da. This enzyme was overexpressed in Escherichia coli BL21(DE3) using a GST-fused pGEX 4T-1 vector system. The optimum conditions of the recombinant BglPC28 were pH 7.0 and 37 degrees C. BglPC28 can effectively transform the ginsenoside Re to Rg2(S); the Km values of PNPG and Re were 6.36 +/- 1.10 and 1.42 +/- 0.13 mM, respectively, and the V-max values were 40.0 +/- 2.55 and 5.62 +/- 0.21 mmol min(-1) mg(-)1 of protein, respectively. A scaled-up biotransformation reaction was performed in a 10 L jar fermenter at pH 7.0 and 30 degrees C for 12 hours with a concentration of 20 mg/ml of ginsenoside Re from American ginseng roots. Finally, 113 g of Rg2(S) was produced from 150 g of Re with 84.0 +/- 1.1% chromatographic purity. These results suggest that this enzymatic method could be usefully exploited in the preparation of ginsenoside Rg(2)(S) in the cosmetics, functional food, and pharmaceutical industries.	[Du, Juan; Kim, Jin-Kwang; Kim, Sun-Chang] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Taejon 305701, South Korea; [Du, Juan; Yu, Hong-Shan; Jin, Feng-Xie] Dalian Polytech Univ, Coll Biotechnol, Dalian, Peoples R China; [Cui, Chang-Hao; Kim, Sun-Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Sung Chul; Kim, Sun-Chang] Intelligent Synthet Biol Ctr, Taejon, South Korea; [Sun, Changkai] Dalian Med Univ, Inst Brain Disorders, Dalian, Peoples R China; [Im, Wan-Taek] Hankyoung Natl Univ, Dept Biotechnol, Chungang No, Anseong Si, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Dalian Polytechnic University; Korea Advanced Institute of Science & Technology (KAIST); Dalian Medical University	Im, WT (corresponding author), Hankyoung Natl Univ, Dept Biotechnol, Chungang No, Anseong Si, South Korea.	wandra@hknu.ac.kr	Cui, Changhao/ABC-8055-2021; SUN, CHANG/GXM-3680-2022; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011		Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology of Republic of Korea [2011-0031967]; China Major Projects [2012ZX09503001-003]	Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); China Major Projects	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031967) of Republic of Korea and by the China Major Projects No. 2012ZX09503001-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2012, APPL MICROBIOL BIOT, V94, P673, DOI 10.1007/s00253-011-3614-7; An DS, 2011, INT J SYST EVOL MICR, V61, P2606, DOI 10.1099/ijs.0.028431-0; An DS, 2010, APPL ENVIRON MICROB, V76, P5827, DOI 10.1128/AEM.00106-10; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bae EA, 2005, BIOL PHARM BULL, V28, P1903, DOI 10.1248/bpb.28.1903; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Chi H, 2005, BIOTECHNOL LETT, V27, P765, DOI 10.1007/s10529-005-5632-y; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Cho YS, 2013, KOREAN J PHYSIOL PHA, V17, P133, DOI 10.4196/kjpp.2013.17.2.133; Choi SH, 2011, J GINSENG RES, V35, P191, DOI 10.5142/jgr.2011.35.2.191; Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Cleland W W, 1979, Methods Enzymol, V63, P103; Cui CH, 2013, APPL ENVIRON MICROB, V79, P5788, DOI 10.1128/AEM.01150-13; Cui CH, 2013, APPL MICROBIOL BIOT, V97, P649, DOI 10.1007/s00253-012-4324-5; Cui CH, 2011, J MICROBIOL, V49, P393, DOI 10.1007/s12275-011-1176-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ha SE, 2010, N-S ARCH PHARMACOL, V382, P89, DOI 10.1007/s00210-010-0522-9; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Hofseth LJ, 2007, J NUTR, V137, p183S, DOI 10.1093/jn/137.1.183S; Hong H, 2012, J GINSENG RES, V36, P418, DOI 10.5142/jgr.2012.36.4.418; In G, 2012, J GINSENG RES, V36, P205, DOI 10.5142/jgr.2012.36.2.205; Jeong SJ, 2007, INT J TOXICOL, V26, P151, DOI 10.1080/10915810701226370; Jin XF, 2012, J MICROBIOL BIOTECHN, V22, P343, DOI 10.4014/jmb.1107.07066; Kang S, 2012, J GINSENG RES, V36, P354, DOI 10.5142/jgr.2012.36.4.354; Kim JK, 2013, FOOD CHEM, V141, P1369, DOI 10.1016/j.foodchem.2013.04.012; Kim JK, 2012, J BIOTECHNOL, V161, P294, DOI 10.1016/j.jbiotec.2012.06.021; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Kim SN, 2007, J PHARMACEUT BIOMED, V45, P164, DOI 10.1016/j.jpba.2007.05.001; Kim YJ, 2013, J AGR FOOD CHEM, V61, P9185, DOI 10.1021/jf402774d; Kimura M., 1983, NEUTRAL THEORY MOL E; Ko SR, 2003, PLANTA MED, V69, P285, DOI 10.1055/s-2003-38476; Korea Food & Drug Administration (KFDA), PROD REC HLTH FUNCT; Lee F.C., 1992, FACTS GINSENG ELIXIR; Lee GW, 2012, BIOTECHNOL LETT, V34, P1679, DOI 10.1007/s10529-012-0949-9; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Lee JH, 2011, J GINSENG RES, V35, P375, DOI 10.5142/jgr.2011.35.3.375; Leung K.W., 2010, BIOMED CENTRAL, V5, P20; Li N, 2007, J ETHNOPHARMACOL, V111, P458, DOI 10.1016/j.jep.2006.12.015; Liu QM, 2013, ANTON LEEUW INT J G, V103, P747, DOI 10.1007/s10482-012-9856-2; Lu Jie, 2001, Zhongguo Zhongyao Zazhi, V26, P556; Noh KH, 2009, BIOL PHARM BULL, V32, P1830, DOI 10.1248/bpb.32.1830; Noh KH, 2009, BIOSCI BIOTECH BIOCH, V73, P316, DOI 10.1271/bbb.80525; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Park HJ, 2012, J GINSENG RES, V36, P225, DOI 10.5142/jgr.2012.36.3.225; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Quan LH, 2012, J IND MICROBIOL BIOT, V39, P1557, DOI 10.1007/s10295-012-1158-1; Quan LH, 2012, BIOTECHNOL LETT, V34, P913, DOI 10.1007/s10529-012-0849-z; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Quan LH, 2012, APPL MICROBIOL BIOT, V94, P377, DOI 10.1007/s00253-011-3861-7; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; Ruan CC, 2009, MOLECULES, V14, P2043, DOI 10.3390/molecules14062043; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SUN LQ, 2004, ASIAN J DRUG METABOL, V4, P261; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian JW, 2009, PHYTOTHER RES, V23, P486, DOI 10.1002/ptr.2653; Wang L, 2012, J MICROBIOL BIOTECHN, V22, P311, DOI 10.4014/jmb.1106.06041; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Yuan HD, 2012, CHEM-BIOL INTERACT, V195, P35, DOI 10.1016/j.cbi.2011.10.006; Yuan HD, 2011, METABOLISM, V60, P43, DOI 10.1016/j.metabol.2009.12.024; Zhang GZ, 2008, J ETHNOPHARMACOL, V115, P441, DOI 10.1016/j.jep.2007.10.026; Zmudka MW, 2013, PROTEIN SCI, V22, P883, DOI 10.1002/pro.2204	65	31	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e96914	10.1371/journal.pone.0096914	http://dx.doi.org/10.1371/journal.pone.0096914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911166	Green Submitted, gold, Green Published			2022-12-27	WOS:000337165600123
J	Hellewell, AL; Foresti, O; Gover, N; Porter, MY; Hewitt, EW				Hellewell, Andrew L.; Foresti, Ombretta; Gover, Nicola; Porter, Morwenna Y.; Hewitt, Eric W.			Analysis of Familial Hemophagocytic Lymphohistiocytosis Type 4 (FHL-4) Mutant Proteins Reveals that S-Acylation Is Required for the Function of Syntaxin 11 in Natural Killer Cells	PLOS ONE			English	Article							N-TERMINAL PEPTIDE; MUTATIONS; BINDING; SNARE; PALMITOYLATION; MUNC18-1; SNAP-23; GOLGI; CYTOTOXICITY; DISSECTION	Natural killer (NK) cell secretory lysosome exocytosis and cytotoxicity are impaired in familial hemophagocytic lymphohistiocytosis type 4 (FHL-4), a disorder caused by mutations in the gene encoding the SNARE protein syntaxin 11. We show that syntaxin 11 binds to SNAP23 in NK cells and that this interaction is reduced by FHL-4 truncation and frameshift mutation proteins that delete all or part of the SNARE domain of syntaxin 11. In contrast the FHL-4 mutant proteins bound to the Sec-1/Munc18-like (SM) protein Munc18-2. We demonstrate that the C-terminal cysteine rich region of syntaxin 11, which is deleted in the FHL-4 mutants, is S-acylated. This posttranslational modification is required for the membrane association of syntaxin 11 and for its polarization to the immunological synapse in NK cells conjugated to target cells. Moreover, we show that Munc18-2 is recruited by syntaxin 11 to intracellular membranes in resting NK cells and to the immunological synapse in activated NK cells. This recruitment of Munc18-2 is abolished by deletion of the C-terminal cysteine rich region of syntaxin 11. These results suggest a pivotal role for S-acylation in the function of syntaxin 11 in NK cells.	[Hewitt, Eric W.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Hewitt, EW (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	e.w.hewitt@leeds.ac.uk	Foresti, Ombretta/M-3930-2019; Foresti, Ombretta/J-8165-2015	Foresti, Ombretta/0000-0002-6878-0395; Foresti, Ombretta/0000-0002-6878-0395; Hewitt, Eric/0000-0002-6238-6303	Wellcome Trust [089410/Z/09/Z]; BBSRC [BB/526502/1]	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust (089410/Z/09/Z) and BBSRC (BB/526502/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson LN, 2007, J IMMUNOL, V179, P3397, DOI 10.4049/jimmunol.179.6.3397; Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cetica V, 2010, J MED GENET, V47, P595, DOI 10.1136/jmg.2009.075341; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; D'Orlando O, 2013, EUR J IMMUNOL, V43, P194, DOI 10.1002/eji.201142343; Dabrazhynetskaya A, 2012, J CELL MOL MED, V16, P129, DOI 10.1111/j.1582-4934.2011.01280.x; Danielian S, 2010, J CLIN IMMUNOL, V30, P330, DOI 10.1007/s10875-009-9350-4; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Dugan GE, 2008, J VIROL, V82, P3271, DOI 10.1128/JVI.01705-07; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Hackmann Y, 2013, P NATL ACAD SCI USA, V110, pE4482, DOI 10.1073/pnas.1313474110; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; He YH, 2009, J LIPID RES, V50, P398, DOI 10.1194/jlr.M800360-JLR200; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Macartney CA, 2011, PEDIATR BLOOD CANCER, V56, P654, DOI 10.1002/pbc.22676; Marsh RA, 2010, PEDIATR BLOOD CANCER, V55, P134, DOI 10.1002/pbc.22499; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Meeths M, 2010, BLOOD, V116, P2635, DOI 10.1182/blood-2010-05-282541; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Muller ML, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00515; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; Prekeris R, 2000, EUR J CELL BIOL, V79, P771, DOI 10.1078/0171-9335-00109; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Sakurai C, 2012, MOL BIOL CELL, V23, P4849, DOI 10.1091/mbc.E12-01-0069; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Topham NJ, 2009, IMMUNOLOGY, V128, P7, DOI 10.1111/j.1365-2567.2009.03123.x; Valdez AC, 1999, J CELL SCI, V112, P845; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Xie LX, 2009, INFLAMM RES, V58, P407, DOI 10.1007/s00011-009-0006-x; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; Zhang ST, 2008, BRIT J HAEMATOL, V142, P469, DOI 10.1111/j.1365-2141.2008.07191.x; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	52	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98900	10.1371/journal.pone.0098900	http://dx.doi.org/10.1371/journal.pone.0098900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910990	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600019
J	Hoffmann, B; Proust, H; Belcram, K; Labrune, C; Boyer, FD; Rameau, C; Bonhomme, S				Hoffmann, Beate; Proust, Helene; Belcram, Katia; Labrune, Cecile; Boyer, Francois-Didier; Rameau, Catherine; Bonhomme, Sandrine			Strigolactones Inhibit Caulonema Elongation and Cell Division in the Moss Physcomitrella patens	PLOS ONE			English	Article							PLANT HORMONES; ARABIDOPSIS-THALIANA; RESISTANT MUTANTS; SEED-GERMINATION; ROOT-SYSTEM; TIP GROWTH; RICE; PERCEPTION; MOLECULES; RESPONSES	In vascular plants, strigolactones (SLs) are known for their hormonal role and for their role as signal molecules in the rhizosphere. SLs are also produced by the moss Physcomitrella patens, in which they act as signaling factors for controlling filament extension and possibly interaction with neighboring individuals. To gain a better understanding of SL action at the cellular level, we investigated the effect of exogenously added molecules (SLs or analogs) in moss growth media. We used the previously characterized Ppccd8 mutant that is deficient in SL synthesis and showed that SLs affect moss protonema extension by reducing caulonema cell elongation and mainly cell division rate, both in light and dark conditions. Based on this effect, we set up bioassays to examine chemical structure requirements for SL activity in moss. The results suggest that compounds GR24, GR5, and 5-deoxystrigol are active in moss (as in pea), while other analogs that are highly active in the control of pea branching show little activity in moss. Interestingly, the karrikinolide KAR1, which shares molecular features with SLs, did not have any effect on filament growth, even though the moss genome contains several genes homologous to KAI2 (encoding the KAR1 receptor) and no canonical homologue to D14 (encoding the SL receptor). Further studies should investigate whether SL signaling pathways have been conserved during land plant evolution.	[Hoffmann, Beate; Proust, Helene; Belcram, Katia; Labrune, Cecile; Boyer, Francois-Didier; Rameau, Catherine; Bonhomme, Sandrine] Inst Natl Rech Agron AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France; [Boyer, Francois-Didier] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Bonhomme, S (corresponding author), Inst Natl Rech Agron AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France.	Sandrine.Bonhomme@versailles.inra.fr	Bonhomme, Sandrine/AAF-5961-2021		Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT); Agence Nationale de la Recherche [ANR-12-BSV6-004-01]	Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT); Agence Nationale de la Recherche(French National Research Agency (ANR))	H.P. was supported by a PhD fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT). The authors are grateful to the Agence Nationale de la Recherche (contract ANR-12-BSV6-004-01) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Akiyama K, 2010, PLANT CELL PHYSIOL, V51, P1104, DOI 10.1093/pcp/pcq058; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Arite T, 2012, J PLANT GROWTH REGUL, V31, P165, DOI 10.1007/s00344-011-9228-6; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Bonhomme Sandrine, 2013, Methods Mol Biol, V959, P21, DOI 10.1007/978-1-62703-221-6_2; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Boyer FD, 2014, MOL PLANT, V7, P675, DOI 10.1093/mp/sst163; Boyer FD, 2012, PLANT PHYSIOL, V159, P1524, DOI 10.1104/pp.112.195826; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; Chen VX, 2010, CHEM-EUR J, V16, P13941, DOI 10.1002/chem.201002817; Cohen M, 2013, MOL PLANT, V6, P141, DOI 10.1093/mp/sss134; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Cove D, 2006, ANNU REV PLANT BIOL, V57, P497, DOI 10.1146/annurev.arplant.57.032905.105338; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; de Saint Germain A, 2013, PLANT PHYSIOL, V163, P1012, DOI 10.1104/pp.113.220541; Delaux PM, 2012, NEW PHYTOL, V195, P857, DOI 10.1111/j.1469-8137.2012.04209.x; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Fukui K, 2011, BIOORG MED CHEM LETT, V21, P4905, DOI 10.1016/j.bmcl.2011.06.019; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Guo YX, 2013, P NATL ACAD SCI USA, V110, P8284, DOI 10.1073/pnas.1306265110; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hu ZY, 2010, PLANT CELL PHYSIOL, V51, P1136, DOI 10.1093/pcp/pcq075; JENKINS GI, 1986, PLANT CELL ENVIRON, V9, P637, DOI 10.1111/j.1365-3040.1986.tb01621.x; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Ligrone R, 2012, ANN BOT-LONDON, V109, P851, DOI 10.1093/aob/mcs017; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Nelson DC, 2009, PLANT PHYSIOL, V149, P863, DOI 10.1104/pp.108.131516; Prandi C, 2013, MOL PLANT, V6, P113, DOI 10.1093/mp/sss133; Proust H, 2011, DEVELOPMENT, V138, P1531, DOI 10.1242/dev.058495; Rasmussen A, 2013, PLANTA, V238, P615, DOI 10.1007/s00425-013-1911-3; Rasmussen A, 2013, MOL PLANT, V6, P100, DOI 10.1093/mp/sss110; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Schaefer DG, 2001, PLANT PHYSIOL, V127, P1430, DOI 10.1104/pp.010786; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang Y, 2013, DEV CELL, V27, P681, DOI 10.1016/j.devcel.2013.11.010; Waters MT, 2013, MOL PLANT, V6, P63, DOI 10.1093/mp/sss127; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Waters MT, 2011, PLANT SIGNAL BEHAV, V6, P1418, DOI 10.4161/psb.6.9.17303; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zwanenburg B, 2013, BIOORG MED CHEM LETT, V23, P5182, DOI 10.1016/j.bmcl.2013.07.004; Zwanenburg B, 2013, MOL PLANT, V6, P38, DOI 10.1093/mp/sss141; Zwanenburg B, 2009, PEST MANAG SCI, V65, P478, DOI 10.1002/ps.1706	56	30	31	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99206	10.1371/journal.pone.0099206	http://dx.doi.org/10.1371/journal.pone.0099206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911649	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600056
J	Jin, JO; Zhang, W; Du, JY; Wong, KW; Oda, T; Yu, Q				Jin, Jun-O; Zhang, Wei; Du, Jiang-Yuan; Wong, Ka-Wing; Oda, Tatsuya; Yu, Qing			Fucoidan Can Function as an Adjuvant In Vivo to Enhance Dendritic Cell Maturation and Function and Promote Antigen-Specific T Cell Immune Responses	PLOS ONE			English	Article							A SCAVENGER RECEPTOR; LANGERHANS CELLS; VIRUS-INFECTION; CANCER; CTL; MACROPHAGES; CYTOTOXICITY; STIMULATION; VACCINES	Fucoidan, a sulfated polysaccharide purified from brown algae, has a variety of immune-modulation effects, including promoting antigen uptake and enhancing anti-viral and anti-tumor effects. However, the effect of fucoidan in vivo, especially its adjuvant effect on in vivo anti-tumor immune responses, was not fully investigated. In this study, we investigated the effect of fucoidan on the function of spleen dendritic cells (DCs) and its adjuvant effect in vivo. Systemic administration of fucoidan induced up-regulation of CD40, CD80 and CD86 expression and production of IL-6, IL-12 and TNF-alpha in spleen cDCs. Fucoidan also promoted the generation of IFN-gamma-producing Th1 and Tc1 cells in an IL-12-dependent manner. When used as an adjuvant in vivo with ovalbumin (OVA) antigen, fucoidan promoted OVA-specific antibody production and primed IFN-gamma production in OVA-specific T cells. Moreover, fucoidan enhanced OVA-induced up-regulation of MHC class I and II on spleen cDCs and strongly prompted the proliferation of OVA-specific CD4 and CD8 T cells. Finally, OVA immunization with fucoidan as adjuvant protected mice from the challenge with B16-OVA tumor cells. Taken together, these results suggest that fucoidan can function as an adjuvant to induce Th1 immune response and CTL activation, which may be useful in tumor vaccine development.	[Jin, Jun-O; Zhang, Wei; Du, Jiang-Yuan; Wong, Ka-Wing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Oda, Tatsuya] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 852, Japan; [Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA	Fudan University; Nagasaki University; Harvard University; Forsyth Institute	Jin, JO (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China.	Junojin1@gmail.com	yu, qing/HGC-4611-2022; Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111	Shanghai Public Health Clinical Center in Fudan University [RCJJP17]; NIH [R01 DE023838]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023838] Funding Source: NIH RePORTER	Shanghai Public Health Clinical Center in Fudan University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the Shanghai Public Health Clinical Center in Fudan University (RCJJP17) and NIH grant R01 DE023838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Cao T, 2007, EUR J IMMUNOL, V37, P2657, DOI 10.1002/eji.200636499; Cerundolo V, 2004, NAT IMMUNOL, V5, P7, DOI 10.1038/ni0104-7; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Hu YL, 2010, BIOCHEM BIOPH RES CO, V392, P329, DOI 10.1016/j.bbrc.2010.01.018; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kawashima T, 2012, INT J MOL MED, V29, P447, DOI 10.3892/ijmm.2011.854; Kim MH, 2008, IMMUNOL LETT, V115, P138, DOI 10.1016/j.imlet.2007.10.016; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851; Lasarte JJ, 2007, J IMMUNOL, V178, P748, DOI 10.4049/jimmunol.178.2.748; Miconnet I, 2001, J IMMUNOL, V166, P4612, DOI 10.4049/jimmunol.166.7.4612; Mori N, 2012, WORLD J GASTROENTERO, V18, P2225, DOI 10.3748/wjg.v18.i18.2225; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Perret R, 2013, CANCER RES, V73, P6597, DOI 10.1158/0008-5472.CAN-13-0875; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Takeda K, 2012, INT J ONCOL, V40, P251, DOI 10.3892/ijo.2011.1168; Thelen T, 2010, J IMMUNOL, V185, P4328, DOI 10.4049/jimmunol.1000989; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Yang M, 2008, INT IMMUNOPHARMACOL, V8, P1754, DOI 10.1016/j.intimp.2008.08.007	34	62	66	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99396	10.1371/journal.pone.0099396	http://dx.doi.org/10.1371/journal.pone.0099396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911024	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600080
J	Jing, SL; Zhang, L; Ma, YH; Liu, BF; Zhao, Y; Yu, HJ; Zhou, X; Qin, R; Zhu, LL; He, GC				Jing, Shengli; Zhang, Lei; Ma, Yinhua; Liu, Bingfang; Zhao, Yan; Yu, Hangjin; Zhou, Xi; Qin, Rui; Zhu, Lili; He, Guangcun			Genome-Wide Mapping of Virulence in Brown Planthopper Identifies Loci That Break Down Host Plant Resistance	PLOS ONE			English	Article							NILAPARVATA-LUGENS HOMOPTERA; GENETIC-LINKAGE MAP; RICE; COEVOLUTION; BIOTYPES; DELPHACIDAE; POPULATIONS; MARKERS; POTATO; IRRI	Insects and plants have coexisted for over 350 million years and their interactions have affected ecosystems and agricultural practices worldwide. Variation in herbivorous insects' virulence to circumvent host resistance has been extensively documented. However, despite decades of investigation, the genetic foundations of virulence are currently unknown. The brown planthopper (Nilaparvata lugens) is the most destructive rice (Oryza sativa) pest in the world. The identification of the resistance gene Bph1 and its introduction in commercial rice varieties prompted the emergence of a new virulent brown planthopper biotype that was able to break the resistance conferred by Bph1. In this study, we aimed to construct a high density linkage map for the brown planthopper and identify the loci responsible for its virulence in order to determine their genetic architecture. Based on genotyping data for hundreds of molecular markers in three mapping populations, we constructed the most comprehensive linkage map available for this species, covering 96.6% of its genome. Fifteen chromosomes were anchored with 124 gene-specific markers. Using genome-wide scanning and interval mapping, the Qhp7 locus that governs preference for Bph1 plants was mapped to a 0.1 cM region of chromosome 7. In addition, two major QTLs that govern the rate of insect growth on resistant rice plants were identified on chromosomes 5 (Qgr5) and 14 (Qgr14). This is the first study to successfully locate virulence in the genome of this important agricultural insect by marker-based genetic mapping. Our results show that the virulence which overcomes the resistance conferred by Bph1 is controlled by a few major genes and that the components of virulence originate from independent genetic characters. The isolation of these loci will enable the elucidation of the molecular mechanisms underpinning the rice-brown planthopper interaction and facilitate the development of durable approaches for controlling this most destructive agricultural insect.	[Jing, Shengli; Ma, Yinhua; Liu, Bingfang; Zhao, Yan; Yu, Hangjin; Zhou, Xi; Zhu, Lili; He, Guangcun] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Zhang, Lei; Qin, Rui] South Cent Univ Nationalities, Coll Life Sci, Engn Res Ctr Protect & Utilizat Biol Resources Mi, Wuhan, Peoples R China	Wuhan University; South Central Minzu University	He, GC (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	gche@whu.edu.cn		He, Guangcun/0000-0001-6395-4774	National Natural Science Foundation of China [31230060]; China Postdoctoral Science Foundation [2012M521463]; Science and Technology Project of Zhejiang Province [2012C22041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Project of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31230060), the China Postdoctoral Science Foundation (Grant No. 2012M521463) and the Science and Technology Project of Zhejiang Province (Grant No. 2012C22041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MC, 2012, MOL ECOL RESOUR, V12, P570, DOI 10.1111/j.1755-0998.2012.03133.x; ATHWAL DS, 1971, CROP SCI, V11, P747, DOI 10.2135/cropsci1971.0011183X001100050043x; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; BUHL A, 2006, SPSS 14 PEARSON STUD; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Cheng XY, 2013, PLANT J, V76, P687, DOI 10.1111/tpj.12328; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CHURCHILL GA, 1994, GENETICS, V138, P963; CLARIDGE MF, 1982, ENTOMOL EXP APPL, V32, P213, DOI 10.1111/j.1570-7458.1982.tb03208.x; CLARIDGE MF, 1980, ENTOMOL EXP APPL, V27, P23, DOI 10.1007/BF00377236; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; DENHOLLANDER J, 1981, ENTOMOL EXP APPL, V29, P76, DOI 10.1007/BF00300752; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Fishman L, 2001, GENETICS, V159, P1701; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fujita D., 2009, PLANTHOPPERS NEW THR, P389; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Han YC, 2008, ELECTROPHORESIS, V29, P1355, DOI 10.1002/elps.200700558; HE GC, 2013, GENETICS GENOMICS RI, P177; Jairin J, 2013, DNA RES, V20, P17, DOI 10.1093/dnares/dss030; Jena KK, 2010, RICE, V3, P161, DOI 10.1007/s12284-010-9050-y; Jing S, 2012, B ENTOMOL RES, V102, P113, DOI 10.1017/S0007485311000435; Jing SL, 2012, INT J MOL SCI, V13, P9527, DOI 10.3390/ijms13089527; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katiyar SK, 2000, GENOME, V43, P322, DOI 10.1139/gen-43-2-322; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Manenti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000331; Myint KKM, 2009, APPL ENTOMOL ZOOL, V44, P149, DOI 10.1303/aez.2009.149; Occhipinti A, 2013, J PLANT INTERACT, V8, P188, DOI 10.1080/17429145.2013.816881; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; PATHAK MD, 1969, NATURE, V223, P502, DOI 10.1038/223502a0; Pauquet J, 2004, MAP BASED CLONING VA, P325; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Ratcliffe RH, 2000, J ECON ENTOMOL, V93, P1319, DOI 10.1603/0022-0493-93.4.1319; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Roderick George K., 1994, P551; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; SOGAWA K, 1981, APPL ENTOMOL ZOOL, V16, P193, DOI 10.1303/aez.16.193; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SOGAWA K, 1981, APPL ENTOMOL ZOOL, V16, P129, DOI 10.1303/aez.16.129; Sun JT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13401; Tanaka K, 1999, ENTOMOL EXP APPL, V90, P279, DOI 10.1023/A:1026456230292; Tang M, 2010, APPL ENVIRON MICROB, V76, P1740, DOI 10.1128/AEM.02240-09; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W, 2009, MAPQTL 6 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	63	21	24	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98911	10.1371/journal.pone.0098911	http://dx.doi.org/10.1371/journal.pone.0098911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911169	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600022
J	Lv, CY; Chen, ML; Xu, M; Xu, GP; Zhang, Y; He, SM; Xue, MJ; Gao, J; Yu, MX; Gao, X; Zhu, TY				Lv, Chaoyang; Chen, Minling; Xu, Ming; Xu, Guiping; Zhang, Yao; He, Shunmei; Xue, Mengjuan; Gao, Jian; Yu, Mingxiang; Gao, Xin; Zhu, Tongyu			Influencing Factors of New-Onset Diabetes after a Renal Transplant and Their Effects on Complications and Survival Rate	PLOS ONE			English	Article							KIDNEY-PANCREAS TRANSPLANTATION; ENERGY PHOSPHATE-METABOLISM; GLUCOSE-METABOLISM; RISK-FACTORS; INSULIN SENSITIVITY; MELLITUS; CYCLOSPORINE; RECIPIENTS; DISEASE; IMPACT	Objective: To discuss the onset of and relevant risk factors for new-onset diabetes after a transplant (NODAT) in patients who survive more than 1 year after undergoing a renal transplant and the influence of these risk factors on complications and long-term survival. Method: A total of 428 patients who underwent a renal transplant between January 1993 and December 2008 and were not diabetic before surgery were studied. The prevalence rate of and relevant risk factors for postoperative NODAT were analyzed on the basis of fasting plasma glucose (FPG) levels, and differences in postoperative complications and survival rates between patients with and without NODAT were compared. Results: The patients in this study were followed up for a mean of 5.65 +/- 3.68 years. In total, 87 patients (20.3%) developed NODAT. Patients who converted from treatment with CSA to FK506 had increased prevalence rates of NODAT (P<0.05). Multi-factor analysis indicated that preoperative FPG level (odds ratio [OR] = 1.48), age (OR = 1.10), body mass index (OR = 1.05), hepatitis C virus infection (OR = 2.72), and cadaveric donor kidney (OR = 1.18) were independent risk factors for NODAT (All P,0.05). Compared with the N-NODAT group, the NODAT group had higher prevalence rates (P< 0.05) of postoperative infection, hypertension, and dyslipidemia; in addition, the survival rate and survival time of the 2 groups did not significantly differ. Conclusion: Among the patients who survived more than 1 year after a renal transplant, the prevalence rate of NODAT was 20.32%. Preoperative FPG level, age, body mass index, hepatitis C virus infection, and cadaveric donor kidney were independent risk factors for NODAT. Patients who converted from treatment with CSA to FK506 after a renal transplant had aggravated impairments in glycometabolism. Patients with NODAT were also more vulnerable to postoperative complications such as infection, hypertension, and hyperlipidemia.	[Lv, Chaoyang; Chen, Minling; Xu, Guiping; Zhang, Yao; He, Shunmei; Xue, Mengjuan; Yu, Mingxiang; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Xu, Ming; Zhu, Tongyu] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai Key Lab Organ Transplantat, Shanghai 200433, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Evidence Base Med Ctr, Shanghai 200433, Peoples R China; [Chen, Minling] Fujian Univ Tradit Chinese Med, Peoples Hosp Fujian Prov, Peoples Hosp, Dept Endocrinol & Metab, Fuzhou, Peoples R China; [Xu, Guiping] Fujian Med Univ, Fujian Prov Hosp, Dept Cadres Ward, Fuzhou, Fujian, Peoples R China	Fudan University; Fudan University; Fudan University; Fujian University of Traditional Chinese Medicine; Fujian Medical University; Fujian Provincial Hospital	Yu, MX (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	yu.mingxiang@zs-hospital.sh.cn; gao.xin@zs-hospital.sh.cn		Gao, Xin/0000-0003-1864-7796				Abu Elmagd MM, 2008, EXP CLIN TRANSPLANT, V6, P42; Aktas A, 2014, SEMIN NUCL MED, V44, P129, DOI 10.1053/j.semnuclmed.2013.10.005; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Baid-Agrawal S, 2009, AM J TRANSPLANT, V9, P2777, DOI 10.1111/j.1600-6143.2009.02843.x; Bergrem HA, 2010, NEPHROL DIAL TRANSPL, V25, P985, DOI 10.1093/ndt/gfp566; Borda B, 2012, ACTA PHYSIOL HUNG, V99, P206, DOI 10.1556/APhysiol.99.2012.2.14; Brzezinska B, 2013, ENDOKRYNOL POL, V64, P21; Cighetti G, 2009, FREE RADICAL BIO MED, V47, P307, DOI 10.1016/j.freeradbiomed.2009.05.007; Cotovio P, 2013, TRANSPL P, V45, P1079, DOI 10.1016/j.transproceed.2013.03.009; D'Addio Francesca, 2012, G Ital Nefrol, V29, P44; Davidson J, 2003, TRANSPLANTATION, V75, pSS3, DOI 10.1097/01.TP.0000069952.49242.3E; Davidson JA, 2004, DIABETES CARE, V27, P805, DOI 10.2337/diacare.27.3.805; Del Carro U, 2007, DIABETES CARE, V30, P3063, DOI 10.2337/dc07-0206; Ducloux D, 2005, TRANSPLANTATION, V79, P438, DOI 10.1097/01.TP.0000151799.98612.EB; Fernandez LA, 1999, TRANSPLANTATION, V68, P1532, DOI 10.1097/00007890-199911270-00017; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Fiorina P, 2004, DIABETES, V53, P2291, DOI 10.2337/diabetes.53.9.2291; Fiorina P, 2007, DIABETES CARE, V30, P597, DOI 10.2337/dc06-1324; Fiorina P, 2012, ACTA DIABETOL, V49, pS133, DOI 10.1007/s00592-012-0369-2; Fiorina P, 2012, DIABETES CARE, V35, P367, DOI 10.2337/dc11-1697; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; Hagen M, 2003, NEPHROL DIAL TRANSPL, V18, P2154, DOI 10.1093/ndt/gfg338; Hanto DW, 2008, AM J TRANSPLANT, V8, P1765, DOI 10.1111/j.1600-6143.2008.02348.x; Hecking M, 2013, NEPHROL DIAL TRANSPL, V28, P1; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Huang JF, 2007, LIVER TRANSPLANT, V13, P193, DOI 10.1002/lt.21081; Huang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-867; Hur KY, 2007, DIABETES CARE, V30, P609, DOI 10.2337/dc06-1277; Knight SR, 2010, TRANSPLANTATION, V89, P1, DOI 10.1097/TP.0b013e3181c518cc; Kuo HT, 2010, TRANSPLANTATION, V89, P434, DOI 10.1097/TP.0b013e3181c47a91; Luan FL, 2008, AM J TRANSPLANT, V8, P1871, DOI 10.1111/j.1600-6143.2008.02328.x; Luan FL, 2011, TRANSPLANTATION, V91, P334, DOI 10.1097/TP.0b013e318203c25f; Luan FL, 2010, CLIN TRANSPLANT, V24, P778, DOI 10.1111/j.1399-0012.2009.01194.x; Maffi P, 2007, DIABETES CARE, V30, P1150, DOI 10.2337/dc06-1794; Maldonado F, 2009, TRANSPL P, V41, P2664, DOI 10.1016/j.transproceed.2009.06.133; Marin M, 2005, TRANSPL P, V37, P1851, DOI 10.1016/j.transproceed.2005.03.140; Mathew JT, 2003, NEPHROL DIAL TRANSPL, V18, P164, DOI 10.1093/ndt/18.1.164; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Neetha S, 2008, J INDIAN SOC PERIODO, V12, P41; Neumayer HH, 1996, NEPHROL DIAL TRANSPL, V11, P165; Orsenigo E, 2005, TRANSPL P, V37, P3570, DOI 10.1016/j.transproceed.2005.09.059; Orsenigo E, 2004, TRANSPL P, V36, P1072, DOI 10.1016/j.transproceed.2004.04.056; Orsenigo E, 2004, TRANSPL P, V36, P568; Ozbay LA, 2011, BRIT J PHARMACOL, V162, P136, DOI 10.1111/j.1476-5381.2010.01018.x; Paroni R, 2005, AMINO ACIDS, V28, P389, DOI 10.1007/s00726-005-0191-z; Perseghin G, 2005, J AM COLL CARDIOL, V46, P1085, DOI 10.1016/j.jacc.2005.05.075; Polastri L, 2002, ACTA DIABETOL, V39, P229, DOI 10.1007/s005920200039; Porrini E, 2006, AM J KIDNEY DIS, V48, P134, DOI 10.1053/j.ajkd.2006.04.078; Salonia A, 2011, TRANSPLANTATION, V92, P802, DOI 10.1097/TP.0b013e31822c6eb8; Sezer S, 2012, TRANSPL P, V44, P2893, DOI 10.1016/j.transproceed.2012.09.111; TAMURA K, 1995, TRANSPLANTATION, V59, P1606, DOI 10.1097/00007890-199506150-00018; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Valderhaug TG, 2011, DIABETOLOGIA, V54, P1341, DOI 10.1007/s00125-011-2105-9; van Duijnhoven EM, 2001, J AM SOC NEPHROL, V12, P583, DOI 10.1681/ASN.V123583; Wiesbauer F, 2010, TRANSPLANTATION, V89, P612, DOI 10.1097/TP.0b013e3181c6ffa4; Wilkinson A, 2005, CLIN TRANSPLANT, V19, P291, DOI 10.1111/j.1399-0012.2005.00359.x; Wyzgal J, 2007, ANN TRANSPL, V12, P26; Xu Y, 2011, DIABETES RES CLIN PR, V92, P11, DOI 10.1016/j.diabres.2010.12.006; Zelle DM, 2010, AM J TRANSPLANT, V10, P106, DOI 10.1111/j.1600-6143.2009.02876.x	60	22	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99406	10.1371/journal.pone.0099406	http://dx.doi.org/10.1371/journal.pone.0099406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911157	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600082
J	Mikova, R; Vrkoslav, V; Hanus, R; Hakova, E; Habova, Z; Dolezal, A; Plavka, R; Coufal, P; Cvacka, J				Mikova, Radka; Vrkoslav, Vladimir; Hanus, Robert; Hakova, Eva; Habova, Zuzana; Dolezal, Antonin; Plavka, Richard; Coufal, Pavel; Cvacka, Josef			Newborn Boys and Girls Differ in the Lipid Composition of Vernix Caseosa	PLOS ONE			English	Article							TOF MASS-SPECTROMETRY; SEBACEOUS GLAND; FATTY-ACIDS; WAX ESTERS; POTENTIAL ROLE; MATRIX; CHROMATOGRAPHY; POLYPEPTIDES; ORGANIZATION; SEPARATION	Vernix caseosa protects the skin of a human fetus during the last trimester of pregnancy and of a newborn after the delivery. Besides its cellular and proteinaceous components, an important constituent and functional agent is a complex lipid fraction, implicated in a multitude of salubrious effects of vernix caseosa. Little is known about how the chemical composition of vernix caseosa lipids is affected by various biological characteristics of the baby, such as the gestational age, birth weight, and, last but not least, the gender of the newborn. This study reports on the chemical variability of lipids contained in the vernix caseosa of twenty newborn girls and boys and shows that the quantitative patterns of the lipids are sex-specific. The specificity of lipids was investigated at the level of fatty acids in the total lipid extracts and intact lipids of several neutral lipid classes. Hydrocarbons, wax esters, cholesteryl esters, diol diesters and triacylglycerols were isolated using optimized semipreparative thin-layer chromatography, and the molecular species within each class were characterized using matrix-assisted laser desorption/ionization mass spectrometry. Statistical evaluation revealed significant quantitative sex-related differences in the lipid composition of vernix caseosa among the newborns, pronounced in the two lipid classes associated with the activity of sebaceous glands. Higher proportions of wax esters and triacylglycerols with longer hydrocarbon chains were observed in newborn girls.	[Mikova, Radka; Vrkoslav, Vladimir; Hanus, Robert; Hakova, Eva; Cvacka, Josef] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic; [Mikova, Radka; Hakova, Eva; Coufal, Pavel] Charles Univ Prague, Dept Analyt Chem, Fac Sci, CR-12840 Prague, Czech Republic; [Mikova, Radka] Charles Univ Prague, Internal Dept 3, Gen Fac Hosp, Prague, Czech Republic; [Mikova, Radka; Habova, Zuzana; Dolezal, Antonin; Plavka, Richard] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Habova, Zuzana; Dolezal, Antonin; Plavka, Richard] Charles Univ Prague, Dept Obstet & Gynaecol, Gen Fac Hosp, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; General University Hospital Prague	Cvacka, J (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.	cvacka@uochb.cas.cz	Doležal, Antonín/I-3126-2017; Hanus, Robert/D-4765-2013; Coufal, Pavel/L-8303-2017; Mikova, Radka/C-2554-2017; Harazim, Eva/G-8865-2014; Vrkoslav, Vladimir/B-2146-2012; Cvačka, Josef/A-6126-2014; Plavka, Richard/K-2222-2017	Doležal, Antonín/0000-0002-6231-1117; Hanus, Robert/0000-0002-7054-1975; Coufal, Pavel/0000-0001-6520-2891; Mikova, Radka/0000-0001-9688-1030; Cvačka, Josef/0000-0002-3590-9009; Plavka, Richard/0000-0003-2579-2393	Czech Science Foundation [206/12/0750]; Academy of Sciences of the Czech Republic [RVO 61388963]; Charles University in Prague [MSM 0021620857, 5302-28002PVK]	Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Charles University in Prague	Funding for this project was provided by Czech Science Foundation (Project No. 206/12/0750), Academy of Sciences of the Czech Republic (Project RVO 61388963), Charles University in Prague (Project SW), research projects MSM 0021620857 and 5302-28002PVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2003, PEDIATR RES, V53, P558, DOI 10.1203/01.PDR.0000055777.25933.98; ANSARI MNA, 1970, LIPIDS, V5, P279, DOI 10.1007/BF02532480; Asbury GR, 1999, J AM SOC MASS SPECTR, V10, P983, DOI 10.1016/S1044-0305(99)00063-X; Astigarraga E, 2008, ANAL CHEM, V80, P9105, DOI 10.1021/ac801662n; Bautista MIB, 2000, PEDIATR DERMATOL, V17, P253, DOI 10.1046/j.1525-1470.2000.01770.x; CARROLL KK, 1961, J LIPID RES, V2, P135; Fuchs B, 2010, PROG LIPID RES, V49, P450, DOI 10.1016/j.plipres.2010.07.001; Fuchs B, 2009, EUR J LIPID SCI TECH, V111, P83, DOI 10.1002/ejlt.200800223; Hanley K, 1996, J CLIN INVEST, V97, P2576, DOI 10.1172/JCI118706; Hauff S, 2010, J CHROMATOGR A, V1217, P8270, DOI 10.1016/j.chroma.2010.10.088; Hidaka H, 2007, ANN CLIN LAB SCI, V37, P213; Hoath S. B., 2006, International Journal of Cosmetic Science, V28, P319, DOI 10.1111/j.1467-2494.2006.00338.x; KARKKAINEN J, 1965, J INVEST DERMATOL, V44, P333, DOI 10.1038/jid.1965.58; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; NAZZAROPORRO M, 1979, J INVEST DERMATOL, V73, P112, DOI 10.1111/1523-1747.ep12532793; NICOLAIDES N, 1970, Journal of Chromatographic Science, V8, P717; NICOLAIDES N, 1976, LIPIDS, V11, P781, DOI 10.1007/BF02533404; Nopper AJ, 1996, J PEDIATR-US, V128, P660, DOI 10.1016/S0022-3476(96)80132-6; POCHI PE, 1974, J INVEST DERMATOL, V62, P191, DOI 10.1111/1523-1747.ep12676783; Rissmann R, 2008, BBA-BIOMEMBRANES, V1778, P2350, DOI 10.1016/j.bbamem.2008.06.017; Rissmann R, 2006, J INVEST DERMATOL, V126, P1823, DOI 10.1038/sj.jid.5700305; Rissmann R, 2009, INT J PHARMACEUT, V372, P59, DOI 10.1016/j.ijpharm.2009.01.013; Rissmann R, 2009, CHEM PHYS LIPIDS, V158, P32, DOI 10.1016/j.chemphyslip.2008.10.001; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Schiller J, 2007, FRONT BIOSCI-LANDMRK, V12, P2568, DOI 10.2741/2255; Singh Gurcharan, 2008, Indian J Dermatol, V53, P54, DOI 10.4103/0019-5154.41645; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; STEWART ME, 1982, J INVEST DERMATOL, V78, P291, DOI 10.1111/1523-1747.ep12507228; STEWART ME, 1981, LIPIDS, V16, P355, DOI 10.1007/BF02534962; Stransky K, 1996, FETT-LIPID, V98, P65; Stubiger G, 2007, ANAL CHEM, V79, P3206, DOI 10.1021/ac062236c; Tansirikongkol A, 2007, J COSMET SCI, V58, P651; Tansirikongkol A, 2007, PEDIATR RES, V62, P49, DOI 10.1203/PDR.0b013e318067b442; Tollin M, 2005, CELL MOL LIFE SCI, V62, P2390, DOI 10.1007/s00018-005-5260-7; Visscher Marty O, 2005, J Perinatol, V25, P440, DOI 10.1038/sj.jp.7211305; Vrkoslav V, 2009, J MASS SPECTROM, V44, P101, DOI 10.1002/jms.1476; Yoshio H, 2003, PEDIATR RES, V53, P211, DOI 10.1203/01.PDR.0000047471.47777.B0; Youssef W, 2001, SKIN RES TECHNOL, V7, P10, DOI 10.1034/j.1600-0846.2001.007001010.x; Zouboulis CC, 2008, EXP DERMATOL, V17, P542, DOI 10.1111/j.1600-0625.2008.00725.x; Zschornig O, 2005, J LIPID RES, V46, P803, DOI 10.1194/jlr.M400265-JLR200	40	16	17	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99173	10.1371/journal.pone.0099173	http://dx.doi.org/10.1371/journal.pone.0099173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911066	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600051
J	Moghim, N; Corne, DW				Moghim, Negin; Corne, David W.			Predicting Epileptic Seizures in Advance	PLOS ONE			English	Article							ACCUMULATED ENERGY; REAL-TIME; OSCILLATIONS; ALGORITHMS; DYNAMICS; LONG	Epilepsy is the second most common neurological disorder, affecting 0.6-0.8% of the world's population. In this neurological disorder, abnormal activity of the brain causes seizures, the nature of which tend to be sudden. Antiepileptic Drugs (AEDs) are used as long-term therapeutic solutions that control the condition. Of those treated with AEDs, 35% become resistant to medication. The unpredictable nature of seizures poses risks for the individual with epilepsy. It is clearly desirable to find more effective ways of preventing seizures for such patients. The automatic detection of oncoming seizures, before their actual onset, can facilitate timely intervention and hence minimize these risks. In addition, advance prediction of seizures can enrich our understanding of the epileptic brain. In this study, drawing on the body of work behind automatic seizure detection and prediction from digitised Invasive Electroencephalography (EEG) data, a prediction algorithm, ASPPR (Advance Seizure Prediction via Pre-ictal Relabeling), is described. ASPPR facilitates the learning of predictive models targeted at recognizing patterns in EEG activity that are in a specific time window in advance of a seizure. It then exploits advanced machine learning coupled with the design and selection of appropriate features from EEG signals. Results, from evaluating ASPPR independently on 21 different patients, suggest that seizures for many patients can be predicted up to 20 minutes in advance of their onset. Compared to benchmark performance represented by a mean S1-Score (harmonic mean of Sensitivity and Specificity) of 90.6% for predicting seizure onset between 0 and 5 minutes in advance, ASPPR achieves mean S1-Scores of: 96.30% for prediction between 1 and 6 minutes in advance, 96.13% for prediction between 8 and 13 minutes in advance, 94.5% for prediction between 14 and 19 minutes in advance, and 94.2% for prediction between 20 and 25 minutes in advance.	[Moghim, Negin; Corne, David W.] Heriot Watt Univ, Edinburgh, Midlothian, Scotland	Heriot Watt University	Moghim, N (corresponding author), Heriot Watt Univ, Edinburgh, Midlothian, Scotland.	neg.moghim@gmail.com			SICSA prize studentship [09/200903/2013]; Department of Computer Science, Heriot-Watt University [09/2009-03/2013]	SICSA prize studentship; Department of Computer Science, Heriot-Watt University	This project was supported by a SICSA prize studentship (http://www.sicsa.ac.uk/) for the timespan of 09/200903/2013. This study was also part-supported by the Department of Computer Science, Heriot-Watt University (http://www.macs.hw.ac.uk/departments/computerscience.htm) for the timespan of 09/2009-03/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1999, EPILEPSIA, V40, P1484, DOI 10.1111/j.1528-1157.1999.tb02030.x; Baumgartner C, 1998, PREICTAL SPECT TEMPO; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaovalitwongse W, 2005, EPILEPSY RES, V64, P93, DOI 10.1016/j.eplepsyres.2005.03.009; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa RP, 2008, LECT NOTES ARTIF INT, V5178, P281, DOI 10.1007/978-3-540-85565-1_35; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Daubechies I, 1998, J FOURIER ANAL APPL; De Clercq W, 2003, LANCET, V361, P971, DOI 10.1016/S0140-6736(03)12780-8; EEGLAB, 2011, EEGLAP OP SOURC MATL; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Gigola S, 2004, J NEUROSCI METH, V138, P107, DOI 10.1016/j.jneumeth.2004.03.016; Grassberger P, 1983, PHYS REV LETT; Grassberger P, 1991, INT J BIFURCAT CHAOS, V1, P521, DOI 10.1142/S0218127491000403; Hand D., 2001, ADAP COMP MACH LEARN; Harrison MAF, 2005, CLIN NEUROPHYSIOL, V116, P527, DOI 10.1016/j.clinph.2004.08.022; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; IASEMIDIS L D, 1990, Brain Topography, V2, P187, DOI 10.1007/BF01140588; Iasemidis LD, 2005, CLIN NEUROPHYSIOL, V116, P532, DOI 10.1016/j.clinph.2004.10.013; Kaiser D, 2013, SEMIN PEDIATR NEUROL, V20, P242, DOI 10.1016/j.spen.2013.10.005; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Kerem DH, 2005, MED BIOL ENG COMPUT, V43, P230, DOI 10.1007/BF02345960; Knerr S, 1990, SINGLE LAYER LEARNIN, P41, DOI [10.1007/978-3-642-76153-9_5, DOI 10.1007/978-3-642-76153-9_5]; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Kononenko I., 1994, Machine Learning: ECML-94. European Conference on Machine Learning. Proceedings, P171; Kressel UHG, 1999, PAIRWISE CLASSIFICAT; Le Van Quyen M, 2001, J CLIN NEUROPHYSIOL, V18, P191, DOI 10.1097/00004691-200105000-00001; Le Van Quyen M, 1999, NEUROREPORT, V10, P2149; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Mormann F, 2006, CURR OPIN NEUROL, V19, P187, DOI 10.1097/01.wco.0000218237.52593.bc; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Ott E., 2002, CHAOS DYNAMICAL SYST, V2nd, DOI DOI 10.1017/CBO9780511803260; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; PRANDONI P., 2008, SIGNAL PROCESSING CO, DOI [10.1201/9781439808009, DOI 10.1201/9781439808009]; Ren LK, 2011, ANN NEUROL, V69, P201, DOI 10.1002/ana.22158; REYNOLDS EH, 1983, LANCET, V2, P952; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9, DOI 10.1007/BF00335153; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Salant Y, 1998, MED BIOL ENG COMPUT, V36, P549, DOI 10.1007/BF02524422; Schuster H.G., 2006, DETERMINISTIC CHAOS, V4th ed; SIEGEL A, 1982, EPILEPSIA, V23, P47, DOI 10.1111/j.1528-1157.1982.tb05052.x; Stein AG, 2000, EPILEPSY RES, V39, P103, DOI 10.1016/S0920-1211(99)00107-2; Teixeira CA, 2011, J NEUROSCI METH, V200, P257, DOI 10.1016/j.jneumeth.2011.07.002; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Uniklinik-freiburg.de, 2013, SECT EP; Van Quyen ML, 2003, EPILEPSIA, V44, P30; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; VIGLIONE S S, 1975, Electroencephalography and Clinical Neurophysiology, V39, P435; Winterhalder M, 2006, EPILEPSY RES, V72, P80, DOI 10.1016/j.eplepsyres.2006.06.012	59	63	63	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99334	10.1371/journal.pone.0099334	http://dx.doi.org/10.1371/journal.pone.0099334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911316	gold, Green Published			2022-12-27	WOS:000337165600074
J	Sun, YF; Yu, H; Zhou, JJ; Pickett, JA; Wu, KM				Sun, Yufeng; Yu, Hao; Zhou, Jing-Jiang; Pickett, John A.; Wu, Kongming			Plant Volatile Analogues Strengthen Attractiveness to Insect	PLOS ONE			English	Article							BT COTTON; ATTRACTANT	Green leaf bug Apolygus lucorum (Meyer-Dur) is one of the major pests in agriculture. Management of A. lucorum was largely achieved by using pesticides. However, the increasing population of A. lucorum since growing Bt cotton widely and the increased awareness of ecoenvironment and agricultural product safety makes their population-control very challenging. Therefore this study was conducted to explore a novel ecological approach, synthetic plant volatile analogues, to manage the pest. Here, plant volatile analogues were first designed and synthesized by combining the bioactive components of bionone and benzaldehyde. The stabilities of beta-ionone, benzaldehyde and analogue 3 g were tested. The electroantennogram (EAG) responses of A. lucorum adult antennae to the analogues were recorded. And the behavior assay and filed experiment were also conducted. In this study, thirteen analogues were acquired. The analogue 3 g was demonstrated to be more stable than beta-ionone and benzaldehyde in the environment. Many of the analogues elicited EAG responses, and the EAG response values to 3 g remained unchanged during seven-day period. 3 g was also demonstrated to be attractive to A. lucorum adults in the laboratory behavior experiment and in the field. Its attractiveness persisted longer than beta-ionone and benzaldehyde. This indicated that 3 g can strengthen attractiveness to insect and has potential as an attractant. Our results suggest that synthetic plant volatile analogues can strengthen attractiveness to insect. This is the first published study about synthetic plant volatile analogues that have the potential to be used in pest control. Our results will support a new ecological approach to pest control and it will be helpful to ecoenvironment and agricultural product safety.	[Sun, Yufeng; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Yu, Hao] Henan Inst Sci & Technol, Dept Entomol, Xinxiang, Peoples R China; [Zhou, Jing-Jiang; Pickett, John A.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Institute of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			National Natural Science Foundation of China [31321004]; Chinese Ministry of Agriculture [201103012]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BB/J020281/1] Funding Source: researchfish; BBSRC [BB/J020281/1, BBS/E/C/00005194] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the National Natural Science Funds (No. 31321004) from National Natural Science Foundation of China and the Special Fund for Agro-scientific Research in the Public Interest (201103012) from the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin EA, 2000, HORTSCIENCE, V35, P1013, DOI 10.21273/HORTSCI.35.6.1013; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; BLUM MS, 1969, COMP BIOCHEM PHYSIOL, V29, P461, DOI 10.1016/0010-406X(69)91766-6; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Chen W, 2012, THESIS HUAZHONG AGR; Cruz-Lopez L, 2006, J CHEM ECOL, V32, P351, DOI 10.1007/s10886-005-9006-7; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; HEDIN PA, 1971, PHYTOCHEMISTRY, V10, P3316, DOI 10.1016/S0031-9422(00)97414-4; James DG, 2005, J CHEM ECOL, V31, P481, DOI 10.1007/s10886-005-2020-y; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kolosova N, 2001, PLANT CELL, V13, P2333, DOI 10.1105/tpc.13.10.2333; Lee BH, 2001, CROP PROT, V20, P317, DOI 10.1016/S0261-2194(00)00158-7; Liu F, 2011, THESIS BEIJING U TEC; LOUGHRIN JH, 1990, PHYTOCHEMISTRY, V29, P2473, DOI 10.1016/0031-9422(90)85169-G; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Martel JW, 2005, AGR FOREST ENTOMOL, V7, P71, DOI 10.1111/j.1461-9555.2005.00247.x; Murai T, 2000, J CHEM ECOL, V26, P2557, DOI 10.1023/A:1005536713025; OBATA T, 1981, JPN J APPL ENTOMOL Z, V25, P47, DOI 10.1303/jjaez.25.47; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pickett JA, 1998, BIOCHEMIST, V20, P8, DOI DOI 10.1016/J.PHYT0CHEM.2011.04.011; Price P.W., 2011, INSECT ECOLOGY BEHAV; Roelofs W.L., 1984, Springer Series in Experimental Entomology, V1984, P131; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Simpson M, 2011, J APPL ECOL, V48, P580, DOI 10.1111/j.1365-2664.2010.01946.x; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Tian WH, 2012, THESIS SHANXI NORMAL; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P285; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; Underwood BA, 2005, PLANT PHYSIOL, V138, P255, DOI 10.1104/pp.104.051144; Wang SF, 2005, J AGR FOOD CHEM, V53, P6240, DOI 10.1021/jf0502202; Xiao C, 2000, ACTA AGR JIANGXI, V12, P27	36	8	8	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99142	10.1371/journal.pone.0099142	http://dx.doi.org/10.1371/journal.pone.0099142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911460	Green Accepted, gold, Green Published			2022-12-27	WOS:000337165600045
J	Tarumi, W; Itoh, MT; Suzuki, N				Tarumi, Wataru; Itoh, Masanori T.; Suzuki, Nao			Effects of 5 alpha- Dihydrotestosterone and 17 beta- Estradiol on the Mouse Ovarian Follicle Development and Oocyte Maturation	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; GRANULOSA-CELLS; IN-VITRO; ER-BETA; MEIOTIC RESUMPTION; GROWTH; RAT; PROGESTERONE; EXPRESSION; DIFFERENTIATION	We have previously reported that androstenedione induces abnormalities of follicle development and oocyte maturation in the mouse ovary. In granulosa cells of the ovarian follicle, androstenedione is aromatized to 17 beta-estradiol (E-2). To determine whether the androgen or estrogen acts directly on the follicle to induce the above-mentioned abnormalities, we compared the effects of a non-aromatizable androgen, 5 alpha-dihydrotestosterone (DHT), with those of E-2 on murine follicular development and oocyte maturation in a single follicle culture system. The high dose (10(-6) M) of DHT prompted normal follicular development, and there was no effect on oocyte meiotic maturation after stimulation with human chorionic gonadotropin (hCG) and epidermal growth factor (EGF). In contrast, culture with the high dose (10(-6) M) of E-2 delayed follicular growth and also suppressed proliferation of granulosa cells and antrum formation. Furthermore, culture with E-2 delayed or inhibited oocyte meiotic maturation, such as chromosome alignment on the metaphase plate and extrusion of the first polar body, after addition of hCG and EGF. In conclusion, these findings demonstrate that E-2, but not DHT, induces abnormalities of follicular development, which leads to delay or inhibition of oocyte meiotic maturation.	[Tarumi, Wataru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Itoh, Masanori T.] Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Dept Biol, Chiba, Japan	Saint Marianna University; Tokyo Medical & Dental University (TMDU)	Tarumi, W (corresponding author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan.	wt02022569@marianna-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22591839]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( no. 22591839 to M.T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2001, REPRODUCTION, V121, P647, DOI 10.1530/rep.0.1210647; AZZOLIN GC, 1983, P SOC EXP BIOL MED, V172, P70; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Beker-van Woudenberg AR, 2004, BIOL REPROD, V70, P1465, DOI 10.1095/biolreprod.103.025684; BENDELL JJ, 1991, ENDOCRINOLOGY, V128, P2663, DOI 10.1210/endo-128-5-2663; Borman SM, 2004, BIOL REPROD, V71, P366, DOI 10.1095/biolreprod.103.023390; Britt KL, 2002, J ENDOCRINOL, V175, P269, DOI 10.1677/joe.0.1750269; Can A, 2005, MOL HUM REPROD, V11, P389, DOI 10.1093/molehr/gah179; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Crisosto N, 2009, ENDOCRINE, V36, P339, DOI 10.1007/s12020-009-9227-6; Cui XS, 2006, THERIOGENOLOGY, V66, P267, DOI 10.1016/j.theriogenology.2005.11.011; DORRINGTON JH, 1975, ENDOCRINOLOGY, V97, P1328, DOI 10.1210/endo-97-5-1328; Drummond AE, 2002, MOL CELL ENDOCRINOL, V191, P27, DOI 10.1016/S0303-7207(02)00052-7; Dupont S, 2000, DEVELOPMENT, V127, P4277; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798; FORTUNE JE, 1977, ENDOCRINOLOGY, V100, P1341, DOI 10.1210/endo-100-5-1341; Gava N, 2004, ENDOCRINOLOGY, V145, P3487, DOI 10.1210/en.2004-0212; Gill A, 2004, MOL ENDOCRINOL, V18, P97, DOI 10.1210/me.2003-0326; Hewitt Sylvia Curtis, 2002, Rev Endocr Metab Disord, V3, P193, DOI 10.1023/A:1020068224909; Hofbauer LC, 1999, EUR J ENDOCRINOL, V141, P195, DOI 10.1530/eje.0.1410195; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Lund TD, 2006, J NEUROSCI, V26, P1448, DOI 10.1523/JNEUROSCI.3777-05.2006; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Okutsu Y, 2010, FERTIL STERIL, V93, P927, DOI 10.1016/j.fertnstert.2008.10.064; Orisaka M, 2009, ENDOCRINOLOGY, V150, P2740, DOI 10.1210/en.2008-1536; Otala M, 2004, FERTIL STERIL, V82, P1077, DOI 10.1016/j.fertnstert.2004.06.032; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Rosenfeld CS, 2001, MOL REPROD DEV, V59, P336, DOI 10.1002/mrd.1039; Shimada M, 2004, J MOL ENDOCRINOL, V33, P209, DOI 10.1677/jme.0.0330209; Siqueira LC, 2012, THERIOGENOLOGY, V77, P1779, DOI 10.1016/j.theriogenology.2011.12.022; Sotomayor-Zarate R, 2008, BIOL REPROD, V78, P673, DOI 10.1095/biolreprod.107.063974; Tarumi W, 2012, FERTIL STERIL, V97, P469, DOI 10.1016/j.fertnstert.2011.11.040; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Yang MY, 2006, BIOL REPROD, V75, P924, DOI 10.1095/biolreprod.106.051813; ZAVA DT, 1978, ENDOCRINOLOGY, V103, P624, DOI 10.1210/endo-103-2-624	42	32	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99423	10.1371/journal.pone.0099423	http://dx.doi.org/10.1371/journal.pone.0099423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911314	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600084
J	Yu, CS; Cheng, CW; Su, WC; Chang, KC; Huang, SW; Hwang, JK; Lu, CH				Yu, Chin-Sheng; Cheng, Chih-Wen; Su, Wen-Chi; Chang, Kuei-Chung; Huang, Shao-Wei; Hwang, Jenn-Kang; Lu, Chih-Hao			CELLO2GO: A Web Server for Protein subCELlular LOcalization Prediction with Functional Gene Ontology Annotation	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; GENOMICS; NETWORKS; TERMS; TOOL; GO	CELLO2GO (http://cello.life.nctu.edu.tw/cello2go/) is a publicly available, web-based system for screening various properties of a targeted protein and its subcellular localization. Herein, we describe how this platform is used to obtain a brief or detailed gene ontology (GO)-type categories, including subcellular localization(s), for the queried proteins by combining the CELLO localization-predicting and BLAST homology-searching approaches. Given a query protein sequence, CELLO2GO uses BLAST to search for homologous sequences that are GO annotated in an in-house database derived from the UniProt KnowledgeBase database. At the same time, CELLO attempts predict at least one subcellular localization on the basis of the species in which the protein is found. When homologs for the query sequence have been identified, the number of terms found for each of their GO categories, i.e., cellular compartment, molecular function, and biological process, are summed and presented as pie charts representing possible functional annotations for the queried protein. Although the experimental subcellular localization of a protein may not be known, and thus not annotated, CELLO can confidentially suggest a subcellular localization. CELLO2GO should be a useful tool for research involving complex subcellular systems because it combines CELLO and BLAST into one platform and its output is easily manipulated such that the user-specific questions may be readily addressed.	[Yu, Chin-Sheng; Cheng, Chih-Wen; Su, Wen-Chi; Chang, Kuei-Chung] Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Masters Program Biomed Informat & Biomed Engn, Taichung 40724, Taiwan; [Huang, Shao-Wei] Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan; [Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Hwang, Jenn-Kang] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan; [Lu, Chih-Hao] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	Feng Chia University; Feng Chia University; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan	Lu, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chlu@mail.cmu.edu.tw		Chang, Shu-chuan/0000-0002-7087-0744	National Science Council of Taiwan [NSC-101-2113-M-035-002]; Academic Summit Program of National Science Council of Taiwan [NSC-103-2745-B-009-001]; "Center for Bioinformatics Research of Aiming for the Top University Program" of National Chiao Tung University and Ministry of Education of Taiwan; China Medical University of Taiwan [CMU99-N2-02-2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academic Summit Program of National Science Council of Taiwan; "Center for Bioinformatics Research of Aiming for the Top University Program" of National Chiao Tung University and Ministry of Education of Taiwan; China Medical University of Taiwan(China Medical University)	This work was supported by grant in part from the National Science Council of Taiwan [NSC-101-2113-M-035-002 to CSY], the Academic Summit Program of National Science Council of Taiwan [NSC-103-2745-B-009-001 to JKH], the "Center for Bioinformatics Research of Aiming for the Top University Program" of National Chiao Tung University and Ministry of Education of Taiwan, and China Medical University of Taiwan [CMU99-N2-02-2 to CHL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Chawley P, 2014, GENOMICS, V103, P83, DOI 10.1016/j.ygeno.2013.12.002; Chi SM, 2012, BIOINFORMATICS, V28, P1028, DOI 10.1093/bioinformatics/bts062; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-503; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI DOI 10.1093/nar/gkh066; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619; Luo HW, 2012, APPL ENVIRON MICROB, V78, P6550, DOI 10.1128/AEM.01406-12; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mooney C, 2011, BIOINFORMATICS, V27, P2812, DOI 10.1093/bioinformatics/btr494; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nair R, 2003, NUCLEIC ACIDS RES, V31, P3337, DOI 10.1093/nar/gkg514; Nair R, 2002, PROTEIN SCI, V11, P2836, DOI 10.1110/ps.0207402; Paramasivam N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00218; Park S, 2009, J PROTEOME RES, V8, P3367, DOI 10.1021/pr900018z; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	33	330	338	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99368	10.1371/journal.pone.0099368	http://dx.doi.org/10.1371/journal.pone.0099368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911789	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600077
J	Zhao, X; Cui, HX; Chen, WJ; Wang, Y; Cui, B; Sun, CJ; Meng, ZG; Liu, GQ				Zhao, Xiang; Cui, Haixin; Chen, Wenjie; Wang, Yan; Cui, Bo; Sun, Changjiao; Meng, Zhigang; Liu, Guoqiang			Morphology, Structure and Function Characterization of PEI Modified Magnetic Nanoparticles Gene Delivery System	PLOS ONE			English	Article							DNA NANOPARTICLES; MAGNETOFECTION; THERAPEUTICS	Modified magnetic nanoparticles are used as non-viral gene carriers in biological applications. To achieve successful gene delivery, it is critical that nanoparticles effectually assemble with nucleic acids. However, relatively little work has been conducted on the assemble mechanisms between nanoparticles and DNA, and its effects on transfection efficiency. Using biophysical and biochemical characterization, along with Atomic force microscopy (AFM) and Transmission electron microscopy (TEM), we investigate the morphologies, assembling structures and gene delivering abilities of the PEI modified magnetic nanoparticles (MNPs) gene delivery system. In this gene delivery system, MNP/DNA complexes are formed via binding of DNA onto the surface of MNPs. MNPs are favorable to not only increase DNA concentration but also prevent DNA degradation. Magnetofection experiments showed that MNPs has low cytotoxicity and introduces highly stable transfection in mammalian somatic cells. In addition, different binding ratios between MNPs and DNA result in various morphologies of MNP/DNA complexes and have an influence on transfection efficiency. Dose-response profile indicated that transfection efficiency positively correlate with MNP/DNA ratio. Furthermore, intracellular tracking demonstrate that MNPs move though the cell membranes, deliver and release exogenous DNA into the nucleus.	[Zhao, Xiang; Cui, Haixin; Chen, Wenjie; Wang, Yan; Cui, Bo; Sun, Changjiao; Liu, Guoqiang] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Zhao, Xiang; Cui, Haixin] Chinese Acad Agr Sci, Nano Biol Res Ctr, Beijing 100193, Peoples R China; [Meng, Zhigang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	cuihaixin@caas.cn		CHEN, WenJie/0000-0001-9512-9664; Meng, ZhiGang/0000-0001-8959-5685	Genetically Modified Organisms Breeding Major Projects [2009ZX08010-006B]	Genetically Modified Organisms Breeding Major Projects	The authors thank the Genetically Modified Organisms Breeding Major Projects (No. 2009ZX08010-006B) for the financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Barreto JA, 2011, ADV MATER, V23, pH18, DOI 10.1002/adma.201100140; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Gu JL, 2011, SCI CHINA LIFE SCI, V54, P793, DOI 10.1007/s11427-011-4215-5; Gu W, 2010, EUR CELLS MAT S, V20, P294; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135; Honig D, 2010, BIOMACROMOLECULES, V11, P1802, DOI 10.1021/bm1002569; Krotz F, 2003, MOL THER, V7, P700, DOI 10.1016/S1525-0016(03)00065-0; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]; MacDonald C, 2010, NANOMEDICINE-UK, V5, P65, DOI 10.2217/NNM.09.97; Mykhaylyk O, 2007, NAT PROTOC, V2, P2391, DOI 10.1038/nprot.2007.352; Namgung R, 2010, BIOMATERIALS, V31, P4204, DOI 10.1016/j.biomaterials.2010.01.123; Park IK, 2008, BIOMATERIALS, V29, P724, DOI 10.1016/j.biomaterials.2007.10.018; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Plank C, 2011, ADV DRUG DELIVER REV, V63, P1300, DOI 10.1016/j.addr.2011.08.002; Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4; Qi LF, 2012, BIOMACROMOLECULES, V13, P2723, DOI 10.1021/bm3006903; Rackstraw BJ, 2001, LANGMUIR, V17, P3185, DOI 10.1021/la001456x; Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101; Schillinger U, 2005, J MAGN MAGN MATER, V293, P501, DOI 10.1016/j.jmmm.2005.01.032; Singh R, 2009, TRENDS BIOTECHNOL, V27, P220, DOI 10.1016/j.tibtech.2009.01.003; Thanh NTK, 2010, NANO TODAY, V5, P213, DOI 10.1016/j.nantod.2010.05.003; Thurn KT, 2011, NANOMED-NANOTECHNOL, V7, P123, DOI 10.1016/j.nano.2010.09.004; Vijayanathan V, 2004, NUCLEIC ACIDS RES, V32, P127, DOI 10.1093/nar/gkg936; Vijayanathan V, 2002, BIOCHEMISTRY-US, V41, P14085, DOI 10.1021/bi0203987; Volcke C, 2006, J BIOTECHNOL, V125, P11, DOI 10.1016/j.jbiotec.2006.02.010; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159	33	16	17	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98919	10.1371/journal.pone.0098919	http://dx.doi.org/10.1371/journal.pone.0098919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911360	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600024
J	Nagar, H; Jung, SB; Kwon, SK; Park, JB; Shong, M; Song, HJ; Jeon, BH; Irani, K; Kim, CS				Nagar, Harsha; Jung, Saet-byel; Kwon, Sun Kwan; Park, Jung-Bum; Shong, Minho; Song, Hee-Jung; Jeon, Byeong Hwa; Irani, Kaikobad; Kim, Cuk-Seong			CRIF1 Deficiency Induces p66shc-Mediated Oxidative Stress and Endothelial Activation	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL DYSFUNCTION; LIFE-SPAN; PHOSPHORYLATION; P66(SHC); PROTEIN; P66SHC; SHC; DELETION; ASSOCIATION	Mitochondrial dysfunction has been implicated in the pathophysiology of various cardiovascular diseases. CRIF1 is a protein present in the mitochondria associated with large mitoribosomal subunits, and CRIF1 knockdown induces mitochondrial dysfunction and promotes ROS production. p66shc is a redox enzyme implicated in mitochondrial ROS generation and translation of oxidative signals and, therefore, is a key factor for oxidative stress in endothelial cells. In this study, we investigated whether mitochondrial dysfunction induced by CRIF1 knockdown induces p66shc stimulation and plays any role in mitochondrial dysfunction-induced endothelial activation. Knockdown of CRIF1 decreased the expression of mitochondrial oxidative phosphorylation (OXPHOS) complexes I, III and IV, leading to increased mitochondrial ROS (mtROS) and hyperpolarization of the mitochondrial membrane potential. Knockdown of CRIF1 also stimulated phosphorylation of p66shc and increased cytosolic ROS in endothelial cells. Furthermore, the expression of vascular cell adhesion molecule-1 and endoplasmic reticulum stress proteins were increased upon CRIF1 knockdown in endothelial cells. However, p66shc knockdown blunted the alteration in mitochondrial dynamics and ROS production in CRIF1 knockdown endothelial cells. In addition, p66shc knockdown reduced the CRIF1 knockdown-induced increases in adhesion between monocytes and endothelial cells. Taken together, these results suggest that CRIF1 knockdown partially induces endothelial activation via increased ROS production and phosphorylation of p66shc.	[Nagar, Harsha; Kwon, Sun Kwan; Park, Jung-Bum; Jeon, Byeong Hwa; Kim, Cuk-Seong] Chungnam Natl Univ, Sch Med, Dept Physiol, Taejon, South Korea; [Jung, Saet-byel; Shong, Minho] Chungnam Natl Univ Hosp, Dept Endocrinol, Taejon, South Korea; [Song, Hee-Jung] Chungnam Natl Univ Hosp, Dept Neurol, Taejon, South Korea; [Irani, Kaikobad] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA	Chungnam National University; Chungnam National University; Chungnam National University Hospital; Chungnam National University; Chungnam National University Hospital; University of Iowa	Kim, CS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Physiol, Taejon, South Korea.	cskim@cnu.ac.kr	Jeon, Byeong Hwa/D-4160-2012; /H-7803-2012	Jeon, Byeong Hwa/0000-0002-3347-2739; Song, Hee-Jung/0000-0001-9572-4105; Kim, Cuk-Seong/0000-0001-7647-6089; Irani, Kaikobad/0000-0001-9194-7387; shong, minho/0000-0002-0247-7115; Nagar, Harsha/0000-0002-2879-0118	National Research Foundation of Korea (NRF) - Korean government (MEST) [2011-0023858]; Chungnam National University; Chungnam National University Hospital	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Chungnam National University; Chungnam National University Hospital	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0023858), Chungnam National University and Chungnam National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Camici GG, 2008, J APPL PHYSIOL, V105, P1628, DOI 10.1152/japplphysiol.90579.2008; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; De Marchi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/564961; Fink BD, 2005, AM J PHYSIOL-ENDOC M, V288, pE71, DOI 10.1152/ajpendo.00332.2004; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kao AW, 1997, ENDOCRINOLOGY, V138, P2474, DOI 10.1210/en.138.6.2474; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Martin-Padura I, 2008, ENDOTHELIUM-J ENDOTH, V15, P276, DOI 10.1080/10623320802487791; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pinton P, 2008, CELL CYCLE, V7, P304, DOI 10.4161/cc.7.3.5360; Rimessi A, 2007, CELL STRESS CHAPERON, V12, P291, DOI 10.1379/CSC-211.1; Robinson BH, 1998, J INHERIT METAB DIS, V21, P598, DOI 10.1023/A:1005427323835; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Ryu MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003356; Ryu MJ, 2013, MOL CELLS, V35, P134, DOI 10.1007/s10059-012-2257-1; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Skulachev VP, 2000, IUBMB LIFE, V49, P177; Thorburn DR, 2004, NAT GENET, V36, P13, DOI 10.1038/ng0104-13; Trinei M, 2009, AGING-US, V1, P503, DOI 10.18632/aging.100057; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Yang CPH, 2000, CANCER RES, V60, P5171; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98670	10.1371/journal.pone.0098670	http://dx.doi.org/10.1371/journal.pone.0098670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906005	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000048
J	Curtis, TH; McCandless, CT; Carlson, JK; Skomal, GB; Kohler, NE; Natanson, LJ; Burgess, GH; Hoey, JJ; Pratt, HL				Curtis, Tobey H.; McCandless, Camilla T.; Carlson, John K.; Skomal, Gregory B.; Kohler, Nancy E.; Natanson, Lisa J.; Burgess, George H.; Hoey, John J.; Pratt, Harold L., Jr.			Seasonal Distribution and Historic Trends in Abundance of White Sharks, Carcharodon carcharias, in the Western North Atlantic Ocean	PLOS ONE			English	Article							NEW-SOUTH-WALES; MIGRATION PATTERNS; HARBOR PORPOISE; POPULATIONS; MOVEMENTS; PREDATION; BEHAVIOR; HABITAT; CATCH; BEACHES	Despite recent advances in field research on white sharks (Carcharodon carcharias) in several regions around the world, opportunistic capture and sighting records remain the primary source of information on this species in the northwest Atlantic Ocean (NWA). Previous studies using limited datasets have suggested a precipitous decline in the abundance of white sharks from this region, but considerable uncertainty in these studies warrants additional investigation. This study builds upon previously published data combined with recent unpublished records and presents a synthesis of 649 confirmed white shark records from the NWA compiled over a 210-year period (1800-2010), resulting in the largest white shark dataset yet compiled from this region. These comprehensive records were used to update our understanding of their seasonal distribution, relative abundance trends, habitat use, and fisheries interactions. All life stages were present in continental shelf waters year-round, but median latitude of white shark occurrence varied seasonally. White sharks primarily occurred between Massachusetts and New Jersey during summer and off Florida during winter, with broad distribution along the coast during spring and fall. The majority of fishing gear interactions occurred with rod and reel, longline,and gillnet gears. Historic abundance trends from multiple sources support a significant decline in white shark abundance in the 1970s and 1980s, but there have been apparent increases in abundance since the 1990s when a variety of conservation measures were implemented. Though the white shark's inherent vulnerability to exploitation warrants continued protections, our results suggest a more optimistic outlook for the recovery of this iconic predator in the Atlantic.	[Curtis, Tobey H.] NOAA, Natl Marine Fisheries Serv, Greater Atlantic Reg Fisheries Off, Gloucester, MA 01930 USA; [McCandless, Camilla T.; Kohler, Nancy E.; Natanson, Lisa J.; Hoey, John J.; Pratt, Harold L., Jr.] NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Narragansett, RI USA; [Carlson, John K.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Panama City, FL USA; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA; [Burgess, George H.] Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32611 USA; [Pratt, Harold L., Jr.] Mote Marine Lab, Summerland Key, FL USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Division of Marine Fisheries; State University System of Florida; University of Florida; Mote Marine Laboratory & Aquarium	Curtis, TH (corresponding author), NOAA, Natl Marine Fisheries Serv, Greater Atlantic Reg Fisheries Off, Gloucester, MA 01930 USA.	Tobey.Curtis@noaa.gov	Pratt, Harold/AAK-9544-2020	Curtis, Tobey/0000-0003-0164-7335				Adam Peter J., 2004, Mammalian Species, P1, DOI 10.1644/747; Adams DH, 1994, MAR FISH REV, V56, P24; [Anonymous], 1996, GREAT WHITE SHARKS B; ARNOLD PW, 1972, J FISH RES BOARD CAN, V29, P1213, DOI 10.1139/f72-179; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; BRODIE P, 1983, CAN J FISH AQUAT SCI, V40, P267, DOI 10.1139/f83-040; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce Barry D., 2012, P225; Burgess GH, 2005, FISHERIES, V30, P30; CAREY FG, 1982, COPEIA, P254; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; CLARK EUGENIE, 1965, BULL MAR SCI, V15, P13; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Clua Eric, 2012, P343; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; Conn P. B., 2010, SE DAT ASS REV 21 AS; Conn PB, 2010, CAN J FISH AQUAT SCI, V67, P108, DOI 10.1139/F09-175; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; COSEWIC, 2006, COSEWIC ASS STAT REP; Curtis TH, 2006, CALIF FISH GAME, V92, P113; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Duffy Clinton A.J., 2012, P301; Ellis R, 1991, GREAT WHITE SHARK; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Ezcurra JM., 2012, OXYGEN CONSUMPTION R, P17; Fergusson IK, 1996, GREAT WHITE SHARKS, P321, DOI 10.1016/B978-012415031-7/50031-8; Francis Malcolm P., 2012, P319; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Garrison LP, 2007, NOAANMFSSEFSC553; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Gubili Chrysoula, 2012, P357; Hale L. F., 2011, NMFSSEFSC611 NOAA; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hoey JJ, 2005, SE DAT ASS REV DAT W; IUCN, 2012, IUCN RED LIST THREAT; KLIMLEY AP, 1992, COPEIA, P680; Klimley AP, 1985, S CAL ACAD SCI MEM, V9, P15; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Kohler N. E., 1996, NMFSNE110 NOAA; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Long DJ, 1996, GREAT WHITE SHARKS, P293, DOI 10.1016/B978-012415031-7/50028-8; Lowe Christopher G., 2012, P169; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Maunder MN, 2001, CAN J FISH AQUAT SCI, V58, P795, DOI 10.1139/cjfas-58-4-795; McCandless CT, 2010, SE DAT ASS REV 21 DA; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Mollet HF, 1996, GREAT WHITE SHARKS, P91, DOI 10.1016/B978-012415031-7/50011-2; Mollomo Paul, 1998, Northeastern Naturalist, V5, P207, DOI 10.2307/3858620; Morgan A, 2009, MAR FISH REV, V71, P23; National Marine Fisheries Service, 1993, FISH MAN PLAN SHARKS; National Marine Fisheries Service, 1997, FRAM SEAS ADJ MAN ME; Pratt HL, 1996, GREAT WHITE SHARKS, P131, DOI 10.1016/B978-012415031-7/50014-8; PRATT HL, 1982, FISH B-NOAA, V80, P153; R Development Core Team, 2012, R LANG ENV STAT COMP; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; REID DD, 1992, AUST J MAR FRESH RES, V43, P283; RIVAS L R, 1982, Florida Scientist, V45, P40; Santana-Morales Omar, 2012, P187; Shepherd GR, 2006, FISH B-NOAA, V104, P559; Skomal Gregory B., 2012, P405; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Smith-Vaniz WF, 1999, AM SOC ICHTHVOLOGIST, V4; Springer S., 1960, Fishery Bulletin United States, V61, P1; SPRINGER STEWART, 1939, COPEIA, V1939, P114, DOI 10.2307/1435964; STRONG WR, 1992, AUST J MAR FRESH RES, V43, P13; Taylor JKD, 2013, MAR MAMMAL SCI, V29, P204, DOI 10.1111/j.1748-7692.2011.00542.x; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Turnbull SD, 2012, NORTHEAST NAT, V19, P705, DOI 10.1656/045.019.0416; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Wintner SP, 1999, FISH B-NOAA, V97, P153; Wood-Lafond SA, 2009, THESIS U MASSACHUSET	81	64	64	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99240	10.1371/journal.pone.0099240	http://dx.doi.org/10.1371/journal.pone.0099240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918579	gold, Green Published			2022-12-27	WOS:000338631000066
J	Dirks-Hofmeister, ME; Singh, R; Leufken, CM; Inlow, JK; Moerschbacher, BM				Dirks-Hofmeister, Mareike E.; Singh, Ratna; Leufken, Christine M.; Inlow, Jennifer K.; Moerschbacher, Bruno M.			Structural Diversity in the Dandelion (Taraxacum officinale) Polyphenol Oxidase Family Results in Different Responses to Model Substrates	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; PLANT CATECHOL OXIDASE; CRYSTAL-STRUCTURE; AUREUSIDIN SYNTHASE; MULTIGENE FAMILY; TYROSINASE; PROTEIN; EXPRESSION; PURIFICATION; CLONING	Polyphenol oxidases (PPOs) are ubiquitous type-3 copper enzymes that catalyze the oxygen-dependent conversion of o-diphenols to the corresponding quinones. In most plants, PPOs are present as multiple isoenzymes that probably serve distinct functions, although the precise relationship between sequence, structure and function has not been addressed in detail. We therefore compared the characteristics and activities of recombinant dandelion PPOs to gain insight into the structure-function relationships within the plant PPO family. Phylogenetic analysis resolved the 11 isoenzymes of dandelion into two evolutionary groups. More detailed in silico and in vitro analyses of four representative PPOs covering both phylogenetic groups were performed. Molecular modeling and docking predicted differences in enzyme-substrate interactions, providing a structure-based explanation for grouping. One amino acid side chain positioned at the entrance to the active site (position H-B2+1) potentially acts as a "selector'' for substrate binding. In vitro activity measurements with the recombinant, purified enzymes also revealed group-specific differences in kinetic parameters when the selected PPOs were presented with five model substrates. The combination of our enzyme kinetic measurements and the in silico docking studies therefore indicate that the physiological functions of individual PPOs might be defined by their specific interactions with different natural substrates.	[Dirks-Hofmeister, Mareike E.; Singh, Ratna; Leufken, Christine M.; Moerschbacher, Bruno M.] Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany; [Inlow, Jennifer K.] Indiana State Univ, Dept Chem & Phys, Terre Haute, IN 47809 USA	University of Munster; Indiana State University	Dirks-Hofmeister, ME (corresponding author), Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany.	mareike.dirks-hofmeister@uni-muenster.de	Singh, Ratna/AAM-7340-2021; Moerschbacher, Bruno M/C-2012-2017	Singh, Ratna/0000-0003-0487-2861; Dirks-Hofmeister, Mareike E./0000-0002-9634-6932	doctorate scholarship program of the Deutsche Bundesstiftung Umwelt (DBU); internal funds of the University	doctorate scholarship program of the Deutsche Bundesstiftung Umwelt (DBU); internal funds of the University	The work was funded in part by the doctorate scholarship program of the Deutsche Bundesstiftung Umwelt (DBU) and partly by internal funds of the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chazarra S, 2001, J AGR FOOD CHEM, V49, P4870, DOI 10.1021/jf0100301; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chopra G, 2010, PROTEINS, V78, P2668, DOI 10.1002/prot.22781; Constabel CP, 1998, PHYTOCHEMISTRY, V47, P507, DOI 10.1016/S0031-9422(97)00539-6; Dirks-Hofmeister ME, 2012, PLANT MOL BIOL, V80, P203, DOI 10.1007/s11103-012-9943-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1972; Eicken C, 1999, CURR OPIN STRUC BIOL, V9, P677, DOI 10.1016/S0959-440X(99)00029-9; Elumalai P, 2011, INT J BIOL MACROMOL, V49, P134, DOI 10.1016/j.ijbiomac.2011.03.017; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Espin JC, 1999, J AGR FOOD CHEM, V47, P3518, DOI 10.1021/jf981275p; Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Gerdemann C, 2002, J INORG BIOCHEM, V89, P155, DOI 10.1016/S0162-0134(01)00399-3; GOLBECK JH, 1981, PLANT PHYSIOL, V67, P977, DOI 10.1104/pp.67.5.977; Kanade SR, 2007, FEBS J, V274, P4177, DOI 10.1111/j.1742-4658.2007.05944.x; Kanade SR, 2006, BIOCHEM J, V395, P551, DOI 10.1042/BJ20051509; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marri C, 2003, PHYTOCHEMISTRY, V63, P745, DOI 10.1016/S0031-9422(03)00353-4; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; MOORE BM, 1990, J BIOL CHEM, V265, P4982; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Munoz JL, 2006, ANAL BIOCHEM, V351, P128, DOI 10.1016/j.ab.2006.01.011; Nakayama T, 2000, SCIENCE, V290, P1163, DOI 10.1126/science.290.5494.1163; NEWMAN SM, 1993, PLANT MOL BIOL, V21, P1035, DOI 10.1007/BF00023601; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Raj SN, 2006, FUNCT PLANT BIOL, V33, P563, DOI 10.1071/FP06003; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Shetty SM, 2011, PHYTOCHEMISTRY, V72, P2275, DOI 10.1016/j.phytochem.2011.08.028; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sullivan ML, 2004, PLANT PHYSIOL, V136, P3234, DOI 10.1104/pp.104.047449; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tepper AWJW, 2005, J AM CHEM SOC, V127, P567, DOI 10.1021/ja0454687; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Thipyapong P, 2004, PLANT SCI, V167, P693, DOI 10.1016/j.plantsci.2004.04.008; Thipyapong P, 1997, PLANT PHYSIOL, V115, P409, DOI 10.1104/pp.115.2.409; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Virador VM, 2010, J AGR FOOD CHEM, V58, P1189, DOI 10.1021/jf902939q; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Walker JRL, 1998, BIOTECHNOL GENET ENG, V15, P457, DOI 10.1080/02648725.1998.10647966; Wang JH, 2004, PLANTA, V220, P87, DOI 10.1007/s00425-004-1327-1	58	23	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99759	10.1371/journal.pone.0099759	http://dx.doi.org/10.1371/journal.pone.0099759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918587	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000108
J	Swinnen, KRR; Reijniers, J; Breno, M; Leirs, H				Swinnen, Kristijn R. R.; Reijniers, Jonas; Breno, Matteo; Leirs, Herwig			A Novel Method to Reduce Time Investment When Processing Videos from Camera Trap Studies	PLOS ONE			English	Article							ACTIVITY PATTERNS; HABITAT USE; RHINOCEROS-SONDAICUS; IMAGE-ANALYSIS; NATIONAL-PARK; FOREST; POPULATION; ECOLOGY; DENSITY; MAMMALS	Camera traps have proven very useful in ecological, conservation and behavioral research. Camera traps non-invasively record presence and behavior of animals in their natural environment. Since the introduction of digital cameras, large amounts of data can be stored. Unfortunately, processing protocols did not evolve as fast as the technical capabilities of the cameras. We used camera traps to record videos of Eurasian beavers (Castor fiber). However, a large number of recordings did not contain the target species, but instead empty recordings or other species (together non-target recordings), making the removal of these recordings unacceptably time consuming. In this paper we propose a method to partially eliminate non-target recordings without having to watch the recordings, in order to reduce workload. Discrimination between recordings of target species and non-target recordings was based on detecting variation (changes in pixel values from frame to frame) in the recordings. Because of the size of the target species, we supposed that recordings with the target species contain on average much more movements than non-target recordings. Two different filter methods were tested and compared. We show that a partial discrimination can be made between target and non-target recordings based on variation in pixel values and that environmental conditions and filter methods influence the amount of non-target recordings that can be identified and discarded. By allowing a loss of 5% to 20% of recordings containing the target species, in ideal circumstances, 53% to 76% of non-target recordings can be identified and discarded. We conclude that adding an extra processing step in the camera trap protocol can result in large time savings. Since we are convinced that the use of camera traps will become increasingly important in the future, this filter method can benefit many researchers, using it in different contexts across the globe, on both videos and photographs.	[Swinnen, Kristijn R. R.; Reijniers, Jonas; Breno, Matteo; Leirs, Herwig] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	University of Antwerp	Leirs, H (corresponding author), Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium.	herwig.leirs@uantwerpen.be	Leirs, Herwig/B-8197-2008; breno, matteo/ABH-4494-2020	Leirs, Herwig/0000-0002-7612-5024; breno, matteo/0000-0003-1559-8730; Swinnen, Kristijn/0000-0002-1910-9247	Ph.D. grant of the Agency for Innovation by Science and Technology (IWT)	Ph.D. grant of the Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Research was funded by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addink EA, 2010, REMOTE SENS ENVIRON, V114, P674, DOI 10.1016/j.rse.2009.11.015; Ariefiandy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058800; Bridges AS, 2004, WILDLIFE BIOL, V10, P277, DOI 10.2981/wlb.2004.033; Can OE, 2009, ORYX, V43, P427, DOI 10.1017/S0030605308000628; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fegraus EH, 2011, ECOL INFORM, V6, P345, DOI 10.1016/j.ecoinf.2011.06.003; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Hariyadi AR, 2010, PACHYDERM, P93; Hariyadi ARS, 2011, PACHYDERM, P90; Harris G., 2010, B ECOL SOC AM, V91, P352, DOI DOI 10.1890/0012-9623-91.3.352; Head JS, 2012, J TROP ECOL, V28, P571, DOI 10.1017/S0266467412000612; Jacomo ATDA, 2004, J ZOOL, V262, P99; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 2008, ANIM CONSERV, V11, P182, DOI 10.1111/j.1469-1795.2008.00179.x; Macdonald DW, 2001, NEW ENCY MAMMALS, P590; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Matlab, 2012, VERS R2012B 8 0 0 78; O'Brien TG, 2010, ANIM CONSERV, V13, P335, DOI 10.1111/j.1469-1795.2010.00357.x; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Brien TG, 2008, BIRD CONSERV INT, V18, pS144, DOI 10.1017/S0959270908000348; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Olson ER, 2012, ORYX, V46, P593, DOI 10.1017/S0030605312000488; Pennekamp F, 2013, METHODS ECOL EVOL, V4, P483, DOI 10.1111/2041-210X.12036; Prasad S, 2010, ECOL RES, V25, P225, DOI 10.1007/s11284-009-0650-1; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; RStudio, 2012, RSTUDIO INT DEV ENV; Scheibe KM, 2008, EUR J WILDLIFE RES, V54, P53, DOI 10.1007/s10344-007-0108-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seki SI, 2010, J FOREST RES-JPN, V15, P307, DOI 10.1007/s10310-010-0186-9; Sharpe F, 2003, ANIM BEHAV, V66, P1059, DOI 10.1006/anbe.2003.2274; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Srbek-Araujo AC, 2005, J TROP ECOL, V21, P121, DOI 10.1017/S0266467404001956; Staller EL, 2005, J WILDLIFE MANAGE, V69, P124, DOI 10.2193/0022-541X(2005)069&lt;0124:IPANBN&gt;2.0.CO;2; Sundaresan S.R., 2011, B ECOL SOC AM, V92, P188, DOI DOI 10.1890/0012-9623-92.2.188; Swann DE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P27, DOI 10.1007/978-4-431-99495-4_3; Tan CL, 2013, PRIMATES, V54, P1, DOI 10.1007/s10329-012-0318-2; Tobler MW, 2008, ANIM CONSERV, V11, P187, DOI 10.1111/j.1469-1795.2008.00181.x; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Vogt P, 2007, ECOL INDIC, V7, P481, DOI 10.1016/j.ecolind.2006.11.001; Yu XY, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-52	52	43	47	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98881	10.1371/journal.pone.0098881	http://dx.doi.org/10.1371/journal.pone.0098881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918777	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000031
J	Walsh, MG; Haseeb, MA				Walsh, Michael G.; Haseeb, M. A.			Small-Area Estimation of the Probability of Toxocariasis in New York City Based on Sociodemographic Neighborhood Composition	PLOS ONE			English	Article							CANIS INFECTION; UNITED-STATES; RISK-FACTORS; CHILDREN; POVERTY; AMERICA	Toxocariasis is increasingly recognized as an important neglected infection of poverty (NIP) in developed countries, and may constitute the most important NIP in the United States (US) given its association with chronic sequelae such as asthma and poor cognitive development. Its potential public health burden notwithstanding, toxocariasis surveillance is minimal throughout the US and so the true burden of disease remains uncertain in many areas. The Third National Health and Nutrition Examination Survey conducted a representative serologic survey of toxocariasis to estimate the prevalence of infection in diverse US subpopulations across different regions of the country. Using the NHANES III surveillance data, the current study applied the predicted probabilities of toxocariasis to the sociodemographic composition of New York census tracts to estimate the local probability of infection across the city. The predicted probability of toxocariasis ranged from 6% among US-born Latino women with a university education to 57% among immigrant men with less than a high school education. The predicted probability of toxocariasis exhibited marked spatial variation across the city, with particularly high infection probabilities in large sections of Queens, and smaller, more concentrated areas of Brooklyn and northern Manhattan. This investigation is the first attempt at small-area estimation of the probability surface of toxocariasis in a major US city. While this study does not define toxocariasis risk directly, it does provide a much needed tool to aid the development of toxocariasis surveillance in New York City.	[Walsh, Michael G.; Haseeb, M. A.] Suny Downstate Med Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA; [Haseeb, M. A.] Suny Downstate Med Ctr, Coll Med, Dept Cell Biol, Brooklyn, NY 11203 USA; [Haseeb, M. A.] Suny Downstate Med Ctr, Coll Med, Dept Pathol & Med, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Walsh, MG (corresponding author), Suny Downstate Med Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA.	thegowda@gmail.com		Walsh, Michael/0000-0002-6441-3635				Bureau USC, AM FACFINDER SEARCH; Congdon P, 2011, INT J PUBLIC HEALTH, V56, P15, DOI 10.1007/s00038-010-0143-6; Geography UCB, TIGER PROD; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256; MARMOR M, 1987, AM J PUBLIC HEALTH, V77, P554, DOI 10.2105/AJPH.77.5.554; Nelson S, 1996, NEUROTOXICOL TERATOL, V18, P167, DOI 10.1016/0892-0362(95)02018-7; Walsh MG, 2012, INT J PARASITOL, V42, P1159, DOI 10.1016/j.ijpara.2012.10.002; Walsh MG, 2011, INT J PARASITOL, V41, P243, DOI 10.1016/j.ijpara.2010.09.006; Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552	10	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99303	10.1371/journal.pone.0099303	http://dx.doi.org/10.1371/journal.pone.0099303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918785	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000073
J	Ekback, M; Tedner, M; Devenney, I; Oldaeus, G; Norrman, G; Stromberg, L; Falth-Magnusson, K				Ekback, Marie; Tedner, Michaela; Devenney, Irene; Oldaeus, Goran; Norrman, Gunilla; Stromberg, Leif; Falth-Magnusson, Karin			Severe Eczema in Infancy Can Predict Asthma Development. A Prospective Study to the Age of 10 Years	PLOS ONE			English	Article							ATOPIC-DERMATITIS; ALLERGIC DISEASES; YOUNG-CHILDREN; PRESCHOOL-CHILDREN; NATURAL COURSE; RISK-FACTORS; FOLLOW-UP; SENSITIZATION; ASSOCIATION; CHILDHOOD	Background: Children with atopic eczema in infancy often develop allergic rhinoconjunctivitis and asthma, but the term "atopic march'' has been questioned as the relations between atopic disorders seem more complicated than one condition progressing into another. Objective: In this prospective multicenter study we followed children with eczema from infancy to the age of 10 years focusing on sensitization to allergens, severity of eczema and development of allergic airway symptoms at 4.5 and 10 years of age. Methods: On inclusion, 123 children were examined. Hanifin-Rajka criteria and SCORAD index were used to describe the eczema. Episodes of wheezing were registered, skin prick tests and IgE tests were conducted and questionnaires were filled out. Procedures were repeated at 4.5 and 10 years of age with additional examinations for ARC and asthma. Results: 94 out of 123 completed the entire study. High SCORAD points on inclusion were correlated with the risk of developing ARC, (B = 9.86, P = 0.01) and asthma, (B = 10.17, P = 0.01). For infants with eczema and wheezing at the first visit, the OR for developing asthma was 4.05(P = 0.01). ARC at 4.5 years of age resulted in an OR of 11.28(P = 0.00) for asthma development at 10 years. Conclusion: This study indicates that infant eczema with high SCORAD points is associated with an increased risk of asthma at 10 years of age. Children with eczema and wheezing episodes during infancy are more likely to develop asthma than are infants with eczema alone. Eczema in infancy combined with early onset of ARC seems to indicate a more severe allergic disease, which often leads to asthma development. The progression from eczema in infancy to ARC at an early age and asthma later in childhood shown in this study supports the relevance of the term "atopic march'', at least in more severe allergic disease.	[Ekback, Marie; Devenney, Irene; Falth-Magnusson, Karin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Ekback, Marie; Devenney, Irene; Falth-Magnusson, Karin] Cty Council Ostergotland, Dept Pediat, Linkoping, Sweden; [Tedner, Michaela] Pediat Clin, Stockholm, Sweden; [Oldaeus, Goran] Cty Hosp Ryhov, Pediat Clin, Jonkoping, Sweden; [Norrman, Gunilla] Pediat Clin, Hudiksvall, Sweden; [Stromberg, Leif] Cty Council Ostergotland, Dept Pediat Norrkoping, Norrkoping, Sweden	Linkoping University; City Council Ostergotland; City Council Ostergotland	Devenney, I (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden.	irene.devenney@lio.se			Health Research Council in the South-East of Sweden (FORSS); Swedish Asthma and Allergy Association's Research Foundation; Lion's Club in the South-East of Sweden; GlaxoSmithKline; Konsul Th C Bergh's Foundation for Scientific Research	Health Research Council in the South-East of Sweden (FORSS); Swedish Asthma and Allergy Association's Research Foundation; Lion's Club in the South-East of Sweden; GlaxoSmithKline(GlaxoSmithKline); Konsul Th C Bergh's Foundation for Scientific Research	Financial support was given by the Health Research Council in the South-East of Sweden (FORSS), the Swedish Asthma and Allergy Association's Research Foundation, and grants were received from Lion's Club in the South-East of Sweden, GlaxoSmithKline and Konsul Th C Bergh's Foundation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2010, PHYSICIAN SPORTSMED, V38, P81, DOI 10.3810/psm.2010.12.1829; [Anonymous], 1 ASTHM TODDL TERM D; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Ballardini N, J ALLERGY C IN PRESS; Bergmann RL, 1998, CLIN EXP ALLERGY, V28, P965; Burgess JA, 2009, J ASTHMA, V46, P429, DOI 10.1080/02770900902846356; Burke W, 2003, AM J PREV MED, V24, P160, DOI 10.1016/S0749-3797(02)00589-5; Carlsten C, 2013, ANN ALLERG ASTHMA IM, V110, P24, DOI 10.1016/j.anai.2012.10.005; DALEN G, 1979, ACTA PAEDIATR SCAND, V68, P103, DOI 10.1111/j.1651-2227.1979.tb04968.x; Devenney I, 2001, ANN ALLERG ASTHMA IM, V87, P386, DOI 10.1016/S1081-1206(10)62919-5; Devenney I, 2006, ACTA PAEDIATR, V95, P1133, DOI 10.1080/08035250500516672; Dharmage SC, 2013, ALLERGY, V14; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Duncan JM, 2008, CURR OPIN ALLERGY CL, V8, P398, DOI 10.1097/ACI.0b013e32830d82ed; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Frank PI, 2008, BRIT MED J, V336, P1423, DOI 10.1136/bmj.39568.623750.BE; Gaffin JM, 2011, CLIN PEDIATR, V50, P133, DOI 10.1177/0009922810384720; Govaere E, 2009, PEDIAT ALLERG IMM-UK, V20, P448, DOI 10.1111/j.1399-3038.2008.00805.x; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Gustafsson D, 2003, PEDIAT ALLERG IMM-UK, V14, P448, DOI 10.1046/j.0905-6157.2003.00093.x; Gustafsson D, 2000, ALLERGY, V55, P240, DOI 10.1034/j.1398-9995.2000.00391.x; Halken S, 2004, PEDIAT ALLERG IMM-UK, V15, P9, DOI 10.1111/j.1399-3038.2004.0148b.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Host A, 2000, ALLERGY, V55, P600, DOI 10.1034/j.1398-9995.2000.00122.x; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Jenkins C, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2734; Just J, 2013, ANN ALLERG ASTHMA IM, V111, P256, DOI 10.1016/j.anai.2013.07.002; Ker J, 2009, ANN ALLERG ASTHMA IM, V103, P282, DOI 10.1016/S1081-1206(10)60526-1; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Nissen SP, 2013, PEDIAT ALLERG IMM-UK, V24, P549, DOI 10.1111/pai.12108; Ostblom E, 2008, CLIN EXP ALLERGY, V38, P1325, DOI 10.1111/j.1365-2222.2008.03010.x; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Peroni DG, 2003, CLIN EXP ALLERGY, V33, P1349, DOI 10.1046/j.1365-2222.2003.01766.x; Ricci G, 2006, J AM ACAD DERMATOL, V55, P765, DOI 10.1016/j.jaad.2006.04.064; Saunes M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-168; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Scadding GK, 2007, CLIN EXP ALLERGY, V37, P485, DOI 10.1111/j.1365-2222.2007.02675.x; Schmitt J, 2007, J ALLERGY CLIN IMMUN, V120, P1389, DOI 10.1016/j.jaci.2007.08.011; Schram ME, 2012, ALLERGY, V67, P99, DOI 10.1111/j.1398-9995.2011.02719.x; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; SILVERMAN M, 1972, ARCH DIS CHILD, V47, P882, DOI 10.1136/adc.47.256.882; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Strachan DP, 1998, THORAX, V53, P117, DOI 10.1136/thx.53.2.117; Tomicic S, 2009, PEDIAT ALLERG IMM-UK, V20, P35, DOI 10.1111/j.1399-3038.2008.00738.x; Van Bever Hugo P S, 2009, Allergy Asthma Clin Immunol, V5, P6, DOI 10.1186/1710-1492-5-6; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; von Kobyletzki LB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-11	51	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99609	10.1371/journal.pone.0099609	http://dx.doi.org/10.1371/journal.pone.0099609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914552	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700119
J	Matic, MG; Coric, VM; Savic-Radojevic, AR; Bulat, PV; Pljesa-Ercegovac, MS; Dragicevic, DP; Djukic, TI; Simic, TP; Pekmezovic, TD				Matic, Marija G.; Coric, Vesna M.; Savic-Radojevic, Ana R.; Bulat, Petar V.; Pljesa-Ercegovac, Marija S.; Dragicevic, Dejan P.; Djukic, Tatjana I.; Simic, Tatjana P.; Pekmezovic, Tatjana D.			Does Occupational Exposure to Solvents and Pesticides in Association with Glutathione S-Transferase A1, M1, P1, and T1 Polymorphisms Increase the Risk of Bladder Cancer? The Belgrade Case-Control Study	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; GENETIC SUSCEPTIBILITY; GSTM1; GSTT1; IDENTIFICATION; METABOLISM; NAT2	Objective: We investigated the role of the glutathione S-transferase A1, M1, P1 and T1 gene polymorphisms and potential effect modification by occupational exposure to different chemicals in Serbian bladder cancer male patients. Patients and Methods: A hospital-based case-control study of bladder cancer in men comprised 143 histologically confirmed cases and 114 age-matched male controls. Deletion polymorphism of glutathione S-transferase M1 and T1 was identified by polymerase chain reaction method. Single nucleotide polymorphism of glutathione S-transferase A1 and P1 was identified by restriction fragment length polymorphism method. As a measure of effect size, odds ratio (OR) with corresponding 95% confidence interval (95% CI) was calculated. Results: The glutathione S-transferase A1, T1 and P1 genotypes did not contribute independently toward the risk of bladder cancer, while the glutathione S-transferase M1-null genotype was overrepresented among cases (OR = 2.1, 95% CI = 1.1-4.2, p = 0.032). The most pronounced effect regarding occupational exposure to solvents and glutathione S-transferase genotype on bladder cancer risk was observed for the low activity glutathione S-transferase A1 genotype (OR = 9.2, 95% CI = 2.4-34.7, p = 0.001). The glutathione S-transferase M1-null genotype also enhanced the risk of bladder cancer among subjects exposed to solvents (OR = 6,5, 95% CI = 2.1-19.7, p = 0.001). The risk of bladder cancer development was 5.3-fold elevated among glutathione S-transferase T1-active patients exposed to solvents in comparison with glutathione Stransferase T1-active unexposed patients (95% CI = 1.9-15.1, p = 0.002). Moreover, men with glutathione S-transferase T1-active genotype exposed to pesticides exhibited 4.5 times higher risk in comparison with unexposed glutathione Stransferase T1-active subjects (95% CI = 0.9-22.5, p = 0.067). Conclusion: Null or low-activity genotypes of the glutathione S-transferase A1, T1, and P1 did not contribute independently towards the risk of bladder cancer in males. However, in association with occupational exposure, low activity glutathione Stransferase A1 and glutathione S-transferase M1-null as well as glutathione S-transferase T1-active genotypes increase individual susceptibility to bladder cancer.	[Matic, Marija G.; Coric, Vesna M.; Savic-Radojevic, Ana R.; Pljesa-Ercegovac, Marija S.; Djukic, Tatjana I.; Simic, Tatjana P.] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Bulat, Petar V.] Inst Occupat Hlth, Belgrade, Serbia; [Dragicevic, Dejan P.] Clin Ctr Serbia, Urol Clin, Belgrade, Serbia; [Pekmezovic, Tatjana D.] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Matic, Marija G.; Coric, Vesna M.; Savic-Radojevic, Ana R.; Bulat, Petar V.; Pljesa-Ercegovac, Marija S.; Dragicevic, Dejan P.; Djukic, Tatjana I.; Simic, Tatjana P.; Pekmezovic, Tatjana D.] Univ Belgrade, Fac Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade	Pekmezovic, TD (corresponding author), Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia.	pekmezovic@sezampro.rs	Pljesa-Ercegovac, Marija/AFS-8309-2022	Bulat, Petar/0000-0002-4311-8960; Simic, Tatjana/0000-0001-8683-5129; Coric, Vesna/0000-0003-0227-821X; Djukic, Tatjana/0000-0003-1959-5115	Ministry of Education and Science of the Republic of Serbia [175052, 175087]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of the Republic of Serbia (Grants number: 175052 and 175087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman SZ, 1996, CANCER LETT, V107, P229, DOI 10.1016/0304-3835(96)04832-X; American Cancer Society, 2012, BLADD CANC 2012; Band PR, 2005, J OCCUP ENVIRON MED, V47, P854, DOI 10.1097/01.jom.0000169094.77036.1d; BONASSI S, 1989, INT J CANCER, V44, P648, DOI 10.1002/ijc.2910440415; Buzio L, 2003, OCCUP ENVIRON MED, V60, P789, DOI 10.1136/oem.60.10.789; Clapp R, 2005, ENV OCCUPATIONAL CAU; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; CORDIER S, 1993, INT J EPIDEMIOL, V22, P403, DOI 10.1093/ije/22.3.403; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Falck GCM, 1999, MUTAT RES-GEN TOX EN, V441, P225, DOI 10.1016/S1383-5718(99)00051-0; Guengerich P, 2005, GLUTATHIONE TRANSFER, P9; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Heuser VD, 2007, TOXICOLOGY, V232, P235, DOI 10.1016/j.tox.2007.01.011; Hirvonen Ari, 2005, Toxicol Appl Pharmacol, V207, P329, DOI 10.1016/j.taap.2004.11.030; Honaker MT, 2013, J BIOL CHEM, V288, P18599, DOI 10.1074/jbc.M112.445767; IARC Monographs Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V99, P1; International Agency for Research on Cancer, 2010, IARC MONOGRAPHS EVAL, P43; Karami S, 2008, CARCINOGENESIS, V29, P1567, DOI 10.1093/carcin/bgn153; Kim JJ, 2012, CURR UROL REP, V13, P147, DOI 10.1007/s11934-012-0238-0; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; LAVECCHIA C, 1990, INT J EPIDEMIOL, V19, P264, DOI 10.1093/ije/19.2.264; Lohi J, 2008, AM J IND MED, V51, P668, DOI 10.1002/ajim.20606; Lynge E, 1997, CANCER CAUSE CONTROL, V8, P406, DOI 10.1023/A:1018461406120; Miller DR, 2006, CANCER-AM CANCER SOC, V107, P1570, DOI 10.1002/cncr.22124; Moore LE, 2010, CANCER RES, V70, P6527, DOI 10.1158/0008-5472.CAN-09-4167; Olfert SM, 2006, SOUTH MED J, V99, P1256, DOI 10.1097/01.smj.0000247266.10393.72; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; RISCH HA, 1988, BRIT J IND MED, V45, P361; Rossi AM, 1999, PHARMACOGENETICS, V9, P445; Ruder AM, 2013, OCCUP ENVIRON MED, V70, P73, DOI 10.1136/oemed-2011-100588; Savic-Radojevic A, 2007, EUR UROL, V52, P470, DOI 10.1016/j.eururo.2007.01.046; Scarpato R, 1996, ENVIRON MOL MUTAGEN, V27, P263, DOI 10.1002/(SICI)1098-2280(1996)27:4<263::AID-EM3>3.0.CO;2-E; SCHULTE PA, 1987, OCCUP MED, V2, P85; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simic T, 2005, UROLOGY, V65, P1035, DOI 10.1016/j.urology.2005.01.005; Simic T, 2009, NAT REV UROL, V6, P281, DOI 10.1038/nrurol.2009.49; Thier R, 2002, TOXICOL LETT, V127, P321, DOI 10.1016/S0378-4274(01)00515-X; VIEL JF, 1995, OCCUP ENVIRON MED, V52, P587, DOI 10.1136/oem.52.9.587; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Zahm SH, 1997, J OCCUP ENVIRON MED, V39, P1055, DOI 10.1097/00043764-199711000-00006	43	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99448	10.1371/journal.pone.0099448	http://dx.doi.org/10.1371/journal.pone.0099448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914957	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700104
J	Ramirez, AG; Munoz, E; Holden, AEC; Adeigbe, RT; Suarez, L				Ramirez, Amelie G.; Munoz, Edgar; Holden, Alan E. C.; Adeigbe, Rebecca T.; Suarez, Lucina			Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995-2010: An Update	PLOS ONE			English	Article							UNITED-STATES; SURVIVAL; TRENDS	Background: A previous study showed Hepatocellular Carcinoma (HCC) rates to be higher among Latinos in Texas and highest among South Texas Latinos compared to other non-Hispanic whites (NHW) and other Latinos in the United States (U.S.). We used more recent data to assess trends in HCC among Texas Latinos and to reassess the elevated HCC incidence rate in Texas Latinos. Methods: We used data from the U.S. SEER Program and the Texas Cancer Registry to calculate annual and 3-year moving average age-specific and age-adjusted HCC incidence rates, annual percent changes (APCs), and their corresponding 95% confidence intervals for Latinos and NHW in the U.S., Texas and South Texas. Results: Texas Latino male and female incidence rates were 3.1 and 4.0 times higher than their NHW counterparts in SEER regions. Latino males and females in South Texas had the highest rates of HCC incidence overall; rate ratios were 3.6 and 4.2 among South Texas Latino males and females compared to SEER NHW counterparts. There are statistically significant increases in HCC incidence rates in all groups (Texas and South Texas Latinos and NHW groups) and across all age groups. The elevated HCC rates in Texas Latinos are consistent over the 1995-2010 period. Conclusions: The incidence of HCC among Latinos in South Texas remains higher than elsewhere in the U.S. and warrants closer investigation of potential risk factors related to prevailing conditions unique to the population including higher obesity and diabetes rates, environmental, cultural and socioeconomic factors and possibly genetic predisposition.	[Ramirez, Amelie G.; Munoz, Edgar; Holden, Alan E. C.; Adeigbe, Rebecca T.; Suarez, Lucina] Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA; [Ramirez, Amelie G.; Holden, Alan E. C.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Ramirez, AG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Hlth Promot Res, San Antonio, TX 78229 USA.	ramirezag@uthscsa.edu	Munoz, Edgar/L-1857-2019	Munoz, Edgar/0000-0002-1555-8408	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center [P30CA054174]; Redes En AcciA3n: The National Latino Cancer Research Network [U01 CA114657-05]; NATIONAL CANCER INSTITUTE [P30CA054174, U01CA114657] Funding Source: NIH RePORTER	Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center; Redes En AcciA3n: The National Latino Cancer Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge the Cancer Center Support Group of the Cancer Therapy and Research Center at the University of Texas Health Science at Center San Antonio, an NCI-designated Cancer Center (grant # P30CA054174) and Redes En AcciA3n: The National Latino Cancer Research Network (U01 CA114657-05) for support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Fritz A, 2000, INT CLASSIFICATION D; Hu DJ, 2013, HEPATOLOGY, V58, P856, DOI 10.1002/hep.26286; Institute for Health Promotion Research, 2007, S TEX HLTH STAT REV; Mendez-Sanchez N, 2007, ANN HEPATOL, V6, P279; NAACCR: North American Association of Central Cancer Registries, 2008, GUID ENH LAT LAT ID; National Cancer Institute DCCPS Surveillance Research Program Surveillance Systems Branch, 2012, SURV EP END RES SEER; Ramirez AG, 2013, S TEXAS HLTH STATUS, P7, DOI [10.1007/978-3-319-00233-0_2, DOI 10.1007/978-3-319-00233-0_2]; Ramirez AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035573; REED TE, 1974, SCIENCE, V185, P283, DOI 10.1126/science.185.4147.283; Saunders D, 2010, ALIMENT PHARM THER, V31, P1051, DOI 10.1111/j.1365-2036.2010.04271.x; Texas Department of State Health Services Texas Cancer Registry, SEER STAT DAT 1995 2; U. S. Census Bureau, 2008, US CENS BUR 2008 201; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160	16	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99365	10.1371/journal.pone.0099365	http://dx.doi.org/10.1371/journal.pone.0099365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915432	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700090
J	Saunders, NR; Noor, NM; Dziegielewska, KM; Wheaton, BJ; Liddelow, SA; Steer, DL; Ek, CJ; Habgood, MD; Wakefield, MJ; Lindsay, H; Truettner, J; Miller, RD; Smith, AI; Dietrich, WD				Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Steer, David L.; Ek, C. Joakim; Habgood, Mark D.; Wakefield, Matthew J.; Lindsay, Helen; Truettner, Jessie; Miller, Robert D.; Smith, A. Ian; Dietrich, W. Dalton			Age-Dependent Transcriptome and Proteome Following Transection of Neonatal Spinal Cord of Monodelphis domestica (South American Grey Short-Tailed Opossum)	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; AXONAL REGENERATION; UBIQUITIN LIGASE; DIFFERENTIAL EXPRESSION; INFLAMMATORY RESPONSE; THERAPEUTIC HYPOTHERMIA; GALECTIN-1 EXPRESSION	This study describes a combined transcriptome and proteome analysis of Monodelphis domestica response to spinal cord injury at two different postnatal ages. Previously we showed that complete transection at postnatal day 7 (P7) is followed by profuse axon growth across the lesion with near-normal locomotion and swimming when adult. In contrast, at P28 there is no axon growth across the lesion, the animals exhibit weight-bearing locomotion, but cannot use hind limbs when swimming. Here we examined changes in gene and protein expression in the segment of spinal cord rostral to the lesion at 24 h after transection at P7 and at P28. Following injury at P7 only forty genes changed (all increased expression); most were immune/inflammatory genes. Following injury at P28 many more genes changed their expression and the magnitude of change for some genes was strikingly greater. Again many were associated with the immune/inflammation response. In functional groups known to be inhibitory to regeneration in adult cords the expression changes were generally muted, in some cases opposite to that required to account for neurite inhibition. For example myelin basic protein expression was reduced following injury at P28 both at the gene and protein levels. Only four genes from families with extracellular matrix functions thought to influence neurite outgrowth in adult injured cords showed substantial changes in expression following injury at P28: Olfactomedin 4 (Olfm4, 480 fold compared to controls), matrix metallopeptidase (Mmp1, 104 fold), papilin (Papln, 152 fold) and integrin alpha 4 (Itga4, 57 fold). These data provide a resource for investigation of a priori hypotheses in future studies of mechanisms of spinal cord regeneration in immature animals compared to lack of regeneration at more mature stages.	[Saunders, Norman R.; Noor, Natassya M.; Dziegielewska, Katarzyna M.; Wheaton, Benjamin J.; Liddelow, Shane A.; Habgood, Mark D.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Steer, David L.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Ek, C. Joakim] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden; [Wakefield, Matthew J.; Lindsay, Helen] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wakefield, Matthew J.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Lindsay, Helen] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Truettner, Jessie; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Miller, Robert D.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	University of Melbourne; Stanford University; Monash University; University of Gothenburg; Walter & Eliza Hall Institute; University of Melbourne; University of Zurich; University of Miami; University of New Mexico	Saunders, NR (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia.	n.saunders@unimelb.edu.au	Wakefield, Matthew J/A-7795-2008; Wheaton, Ben/AAC-7037-2021; Wakefield, Matthew/X-7593-2019; Liddelow, Shane/ABE-6456-2020	Wakefield, Matthew J/0000-0001-6624-4698; Wakefield, Matthew/0000-0001-6624-4698; Liddelow, Shane/0000-0002-0840-1437; Miller, Robert/0000-0002-8479-8819; Lindsay, Helen/0000-0001-8614-1661; Saunders, Norman/0000-0001-6660-7639; Wheaton, Benjamin/0000-0003-0619-4777	Victoria Neurotrauma Initiative	Victoria Neurotrauma Initiative	This project was supported by the Victoria Neurotrauma Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akbik F, 2011, EXPT NEUROLOGY; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Anders A, 2011, HTSEQ ANAL HIGH THRO; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Biancheri R, 2013, EUR J HUM GENET, V21, P34, DOI 10.1038/ejhg.2012.93; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cajal S, 1928, DEGENERATION REGENER; Catania A, 2008, TRENDS NEUROSCI, V31, P353, DOI 10.1016/j.tins.2008.04.002; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Chen KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072567; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Dulhunty A, 2009, J PHYSIOL-LONDON, V587, P3135, DOI 10.1113/jphysiol.2009.171959; Dziegielewska KM, 2000, J COMP NEUROL, V423, P373, DOI 10.1002/1096-9861(20000731)423:3<373::AID-CNE2>3.0.CO;2-D; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Eva R, 2012, INT REV NEUROBIOL, V106, P75, DOI 10.1016/B978-0-12-407178-0.00004-1; Farlow DN, 2000, J CELL BIOCHEM, V80, P171; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gris P, 2003, MOL CELL NEUROSCI, V24, P555, DOI 10.1016/S1044-7431(03)00211-2; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hollis ER, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00005; Hu WH, 2002, J NEUROCHEM, V81, P36, DOI 10.1046/j.1471-4159.2002.00788.x; Hurtado A, 2012, EXP NEUROL, V233, P606, DOI 10.1016/j.expneurol.2010.11.015; Iketani M, 2013, DEV NEUROBIOL, V73, P230, DOI 10.1002/dneu.22058; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; KRAUS DB, 1987, LAB ANIM SCI, V37, P478; Kubota F, 2008, INT J DEV BIOL, V52, P397, DOI 10.1387/ijdb.072424fk; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Kurihara D, 2010, NEUROSCI RES, V66, P265, DOI 10.1016/j.neures.2009.11.008; Lane MA, 2007, EUR J NEUROSCI, V25, P1725, DOI 10.1111/j.1460-9568.2007.05439.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li C, 2011, NEUROSCIENCE, V197, P121, DOI 10.1016/j.neuroscience.2011.08.031; Lin AW, 2003, J NEUROBIOL, V56, P328, DOI 10.1002/neu.10239; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGraw J, 2005, EXP NEUROL, V195, P103, DOI 10.1016/j.expneurol.2005.04.004; McGraw J, 2004, NEUROSCIENCE, V128, P713, DOI 10.1016/j.neuroscience.2004.06.075; McKerracher L, 2012, INT REV NEUROBIOL, V105, P117, DOI 10.1016/B978-0-12-398309-1.00007-X; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller RD, 2010, SEMIN IMMUNOL, V22, P3, DOI 10.1016/j.smim.2009.11.005; Mladinic M, 2005, CELL MOL NEUROBIOL, V25, P407, DOI 10.1007/s10571-005-3150-z; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Noor NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027465; Parra ZE, 2009, J IMMUNOL, V182, P154, DOI 10.4049/jimmunol.182.1.154; Pei XH, 2011, CANCER RES, V71, P2969, DOI 10.1158/0008-5472.CAN-10-4300; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Ponyeam W, 2012, CELL SIGNAL, V24, P290, DOI 10.1016/j.cellsig.2011.08.020; Reddy SJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E4; Redies C, 2008, DEV DYNAM, V237, P2496, DOI 10.1002/dvdy.21650; Saunders NR, 1998, J NEUROSCI, V18, P339; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; SAUNDERS NR, 1992, P ROY SOC B-BIOL SCI, V250, P171, DOI 10.1098/rspb.1992.0146; Seale SM, 2012, PHARMACOL BIOCHEM BE, V101, P77, DOI 10.1016/j.pbb.2011.12.006; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Sharp KG, 2012, EXP NEUROL, V233, P625, DOI 10.1016/j.expneurol.2010.12.020; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tello J.F., 1911, TRAB LAB INVEST BIOL, V9, P123; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; van den Berg R, 2012, ADV EXP MED BIOL, V970, P173, DOI 10.1007/978-3-7091-0932-8_8; Veeravalli KK, 2012, J NEUROTRAUM, V29, P2251, DOI 10.1089/neu.2012.2460; Veeravalli KK, 2009, NEUROBIOL DIS, V36, P200, DOI 10.1016/j.nbd.2009.07.012; Verhaagen Joost, 2012, Handb Clin Neurol, V109, P595, DOI 10.1016/B978-0-444-52137-8.00037-1; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045931; Wang XM, 1998, J COMP NEUROL, V398, P83; Wheaton BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071181; Wheaton BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026826; Xiao Lin, 2005, Shengli Xuebao, V57, P705; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yau TO, 2002, DEV BIOL, V252, P287, DOI 10.1006/dbio.2002.0849; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6; Zhu H, 2012, EXP BIOL MED, V237, P143, DOI 10.1258/ebm.2011.011152	121	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99080	10.1371/journal.pone.0099080	http://dx.doi.org/10.1371/journal.pone.0099080			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914927	Green Published, gold			2022-12-27	WOS:000340947700059
J	Shahzad, K; Bionaz, M; Trevisi, E; Bertoni, G; Rodriguez-Zas, SL; Loor, JJ				Shahzad, Khuram; Bionaz, Massimo; Trevisi, Erminio; Bertoni, Giuseppe; Rodriguez-Zas, Sandra L.; Loor, Juan J.			Integrative Analyses of Hepatic Differentially Expressed Genes and Blood Biomarkers during the Peripartal Period between Dairy Cows Overfed or Restricted-Fed Energy Prepartum	PLOS ONE			English	Article							FEED RESTRICTION; LIPID-METABOLISM; INFLAMMATORY CONDITIONS; ENDOPLASMIC-RETICULUM; FAT MOBILIZATION; EARLY LACTATION; LIVER-FUNCTION; PERFORMANCE; ADAPTATIONS; STEATOSIS	Using published dairy cattle liver transcriptomics dataset along with novel blood biomarkers of liver function, metabolism, and inflammation we have attempted an integrative systems biology approach applying the classical functional enrichment analysis using DAVID, a newly-developed Dynamic Impact Approach (DIA), and an upstream gene network analysis using Ingenuity Pathway Analysis (IPA). Transcriptome data was generated from experiments evaluating the impact of prepartal plane of energy intake [overfed (OF) or restricted (RE)] on liver of dairy cows during the peripartal period. Blood biomarkers uncovered that RE vs. OF led to greater prepartal liver distress accompanied by a low-grade inflammation and larger proteolysis (i.e., higher haptoglobin, bilirubin, and creatinine). Post-partum the greater bilirubinaemia and lipid accumulation in OF vs. RE indicated a large degree of liver distress. The re-analysis of microarray data revealed that expression of.4,000 genes was affected by diet x time. The bioinformatics analysis indicated that RE vs. OF cows had a liver with a greater lipid and amino acid catabolic capacity both pre-and post-partum while OF vs. RE cows had a greater activation of pathways/functions related to triglyceride synthesis. Furthermore, RE vs. OF cows had a larger (or higher capacity to cope with) ER stress likely associated with greater protein synthesis/processing, and a higher activation of inflammatory-related functions. Liver in OF vs. RE cows had a larger cell proliferation and cell-to-cell communication likely as a response to the greater lipid accumulation. Analysis of upstream regulators indicated a pivotal role of several lipid-related transcription factors (e.g., PPARs, SREBPs, and NFE2L2) in priming the liver of RE cows to better face the early postpartal metabolic and inflammatory challenges. An all-encompassing dynamic model was proposed based on the findings.	[Shahzad, Khuram; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Shahzad, Khuram; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Shahzad, Khuram; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Illinois Informat Inst, Urbana, IL USA; [Bionaz, Massimo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Trevisi, Erminio; Bertoni, Giuseppe] Univ Cattolica Sacro Cuore, Ist Zootecn, I-20123 Milan, Italy; [Trevisi, Erminio; Bertoni, Giuseppe] Univ Cattolica Sacro Cuore, Ctr Ric Nutrigenom, I-20123 Milan, Italy; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Oregon State University; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; University of Illinois System; University of Illinois Urbana-Champaign	Bionaz, M (corresponding author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.	massimo.bionaz@oregonstate.edu; jloor@illinois.edu	Shahzad, Khuram/AAC-8884-2019; Bionaz, Massimo/I-4222-2018; Loor, Juan J./H-3760-2012	Bionaz, Massimo/0000-0002-0674-1892; Loor, Juan J./0000-0003-1586-4365; TREVISI, Erminio/0000-0003-1644-1911; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Shahzad, Dr Khuram/0000-0002-2333-1684				Akbar H, 2013, J DAIRY SCI, V96, P2201, DOI 10.3168/jds.2012-6036; Anderson DEJ, 2012, BIOCHEM BIOPH RES CO, V427, P159, DOI 10.1016/j.bbrc.2012.09.034; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Apte UM, 2004, TOXICOL PATHOL, V32, P567, DOI 10.1080/01926230490508812; BAIRD GD, 1981, FED PROC, V40, P2530; Bell AW, 2000, P NUTR SOC, V59, P119, DOI 10.1017/S0029665100000148; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BIONAZ M, 2013, PPAR RES, DOI DOI 10.1155/2013/684159; Bionaz M, 2012, GENE REGUL SYST BIO, V6, P109, DOI 10.4137/GRSB.S9852; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Braun JP, 2003, VET CLIN PATH, V32, P162, DOI 10.1111/j.1939-165X.2003.tb00332.x; DALE H, 1979, NORD VET MED, V31, P97; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; Dann HM, 2006, J DAIRY SCI, V89, P3563, DOI 10.3168/jds.S0022-0302(06)72396-7; DELGIUDICE GD, 1992, CAN J ZOOL, V70, P974, DOI 10.1139/z92-139; Donkin SS, 2012, ROLE LIVER METABOLIS, P97; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Etzler ME, 2009, ESSENTIALS GLYCOBIOL; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; Federico A, 2010, WORLD J GASTROENTERO, V16, P4762, DOI 10.3748/wjg.v16.i38.4762; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; Grala TM, 2013, PHYSL GENOMICS; Grum DE, 1996, J DAIRY SCI, V79, P1836, DOI 10.3168/jds.S0022-0302(96)76552-9; Hebbring SJ, 2007, HUM MOL GENET, V16, P463, DOI 10.1093/hmg/ddl468; Hornick JL, 1998, J ANIM SCI, V76, P260; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu YD, 2009, DRUG METAB DISPOS, V37, P841, DOI 10.1124/dmd.108.024059; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; JONES SJ, 1990, J ANIM SCI, V68, P2707; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kurzawski M, 2012, ENVIRON TOXICOL PHAR, V34, P87, DOI 10.1016/j.etap.2012.03.001; Kusunoki M, 2003, DIABETES, V52, pA341; Ling PR, 2004, AM J PHYSIOL-REG I, V287, pR801, DOI 10.1152/ajpregu.00715.2003; LOBLEY GE, 1992, J ANIM SCI, V70, P3264; Loor JJ, 2010, ANIMAL, V4, P1110, DOI 10.1017/S1751731110000960; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2006, PHYSIOL GENOMICS, V27, P29, DOI 10.1152/physiolgenomics.00036.2006; Loor JJ, 2011, J MAMMARY GLAND BIOL, V16, P305, DOI 10.1007/s10911-011-9232-2; Lu Y, 2006, BIOCHEM BIOPH RES CO, V344, P221, DOI 10.1016/j.bbrc.2006.03.111; Madero M, 2011, CURR OPIN NEPHROL HY, V20, P622, DOI 10.1097/MNH.0b013e32834ba210; Mandard S, 2013, PPAR RES, V2013, DOI 10.1155/2013/613864; McCarthy SD, 2010, PHYSIOL GENOMICS, V42A, P188, DOI 10.1152/physiolgenomics.00118.2010; METZ S, 1983, J CLIN INVEST, V71, P1191, DOI 10.1172/JCI110868; MULLER MJ, 1981, J NUTR, V111, P1370; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Overton TR, 1998, J ANIM SCI, V76, P2938; Petit HV, 2007, J DAIRY SCI, V90, P4780, DOI 10.3168/jds.2007-0066; Prinsen BHCMT, 2003, J LIPID RES, V44, P1341, DOI 10.1194/jlr.M300023-JLR200; Rajman M, 2006, COMP BIOCHEM PHYS A, V145, P363, DOI 10.1016/j.cbpa.2006.07.004; Remppis S, 2011, ASIAN AUSTRAL J ANIM, V24, P540, DOI 10.5713/ajas.2011.10134; Sahoo A, 2009, J ANIM SCI, V87, P2664, DOI 10.2527/jas.2008-0906; Spears JW, 2011, J ANIM SCI, V89, P2502, DOI 10.2527/jas.2010-3265; Sullivan TM, 2009, THERIOGENOLOGY, V72, P1202, DOI 10.1016/j.theriogenology.2009.07.016; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; Trevisi E, 2009, J ANIM SCI, V87, P3020, DOI 10.2527/jas.2008-1178; TUCKER WB, 1991, J ANIM SCI, V69, P1205; Valenti L, 2013, DIABETES; Varady KA, 2009, NUTRITION, V25, P486, DOI 10.1016/j.nut.2008.10.017; Viana LD, 2013, ONCOLOGY-BASEL, V84, P81, DOI 10.1159/000343436; Weber C, 2013, J DAIRY SCI, V96, P5670, DOI 10.3168/jds.2012-6277	67	30	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99757	10.1371/journal.pone.0099757	http://dx.doi.org/10.1371/journal.pone.0099757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914544	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700128
J	Sun, JC; Xu, T; Zuo, Q; Wang, RB; Qi, AQ; Cao, WL; Sun, AJ; Sun, XJ; Xu, JJ				Sun, Jing-chuan; Xu, Tao; Zuo, Qiao; Wang, Ruo-bing; Qi, Ai-qing; Cao, Wen-luo; Sun, Ai-jun; Sun, Xue-jun; Xu, Jiajun			Hydrogen-Rich Saline Promotes Survival of Retinal Ganglion Cells in a Rat Model of Optic Nerve Crush	PLOS ONE			English	Article							REDUCING OXIDATIVE STRESS; PUPILLARY LIGHT REFLEX; ISCHEMIA/REPERFUSION INJURY; PARKINSONS-DISEASE; FREE-RADICALS; PROTECTS; GLUTAMATE; MICE; MICROGLIA; APOPTOSIS	Objective: To investigate the effect of molecular hydrogen (H-2) in a rat model subjected to optic nerve crush (ONC). Methods: We tested the hypothesis that after optic nerve crush (ONC), retinal ganglion cell (RGC) could be protected by H-2. Rats in different groups received saline or hydrogen-rich saline every day for 14 days after ONC. Retinas from animals in each group underwent measurements of hematoxylin and eosin (H&E) staining, cholera toxin beta (CTB) tracing, gamma synuclein staining, and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) staining 2 weeks post operation. Flash visual evoked potentials (FVEP) and pupillary light reflex (PLR) were then tested to evaluate the function of optic nerve. The malondialdehyde (MDA) level in retina was evaluated. Results: H&E, gamma synuclein staining and CTB tracing showed that the survival rate of RGCs in hydrogen saline-treated group was significantly higher than that in saline-treated group. Apoptosis of RGCs assessed by TUNEL staining were less observed in hydrogen saline-treated group. The MDA level in retina of H-2 group was much lower than that in placebo group. Furthermore, animals treated with hydrogen saline showed better function of optic nerve in assessments of FVEP and PLR. Conclusion: These results demonstrated that H-2 protects RGCs and helps preserve the visual function after ONC and had a neuroprotective effect in a rat model subjected to ONC.	[Sun, Jing-chuan; Xu, Tao; Zuo, Qiao; Qi, Ai-qing; Cao, Wen-luo; Sun, Ai-jun; Xu, Jiajun] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Sun, Jing-chuan; Xu, Tao; Zuo, Qiao] Second Mil Med Univ, Grad Management Unit, Shanghai, Peoples R China; [Wang, Ruo-bing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Sun, Xue-jun] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Naval Medical University	Xu, JJ (corresponding author), Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China.	xujiajun1963@126.com	Piccione, Giuseppe/P-3394-2015; sun, xuejun/A-5561-2010	Piccione, Giuseppe/0000-0002-4736-1087; sun, xuejun/0000-0003-2387-5531	National Basic Research Program of China (973 Program) [2005CB724302]; Creativity and Innovation Training Program of Second Military Medical University [MS2010035]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Creativity and Innovation Training Program of Second Military Medical University	This work was supported by The National Basic Research Program of China (973 Program 2005CB724302) and the Creativity and Innovation Training Program of Second Military Medical University (MS2010035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Cai JM, 2009, BRAIN RES, V1256, P129, DOI 10.1016/j.brainres.2008.11.048; CHAN KMC, 1995, EUR J NEUROSCI, V7, P2053, DOI 10.1111/j.1460-9568.1995.tb00628.x; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen J, 2004, PHARMAZIE, V59, P155; Clutton S, 1997, BRIT MED BULL, V53, P662; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEMEDIUK P, 1989, J NEUROSCI RES, V23, P95, DOI 10.1002/jnr.490230113; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Grozdanic S, 2003, CURR EYE RES, V26, P371, DOI 10.1076/ceyr.26.5.371.15439; Huang Y, 2011, BRAIN RES, V1378, P125, DOI 10.1016/j.brainres.2010.12.071; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kanski JJ, 2003, CLIN OPHTHALMOLOGY; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kreutz MR, 1999, RESTOR NEUROL NEUROS, V14, P127; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Li YP, 2011, CYTOTECHNOLOGY, V63, P119, DOI 10.1007/s10616-010-9317-6; Lin Y, 2011, NEUROSCI LETT, V487, P12, DOI 10.1016/j.neulet.2010.09.064; Matteucci A, 2005, EXP BRAIN RES, V167, P641, DOI 10.1007/s00221-005-0068-0; Oharazawa H, 2009, INVEST OPHTH VIS SCI; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Qian LR, 2010, FREE RADICAL RES, V44, P275, DOI 10.3109/10715760903468758; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Shingu C, 2010, J ANESTH, V24, P569, DOI 10.1007/s00540-010-0942-1; Surgucheva I, 2008, MOL VIS, V14, P1540; Terasaki Y, 2011, AM J PHYSIOL-LUNG C, V301, pL415, DOI 10.1152/ajplung.00008.2011; Vorwerk CK, 2004, BRAIN RES BULL, V62, P485, DOI 10.1016/S0361-9230(03)00075-3; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wang F, 2011, J SURG RES, V167, pE339, DOI 10.1016/j.jss.2010.11.005; Wang RB, 2010, J NEUROTRAUM, V27, P763, DOI 10.1089/neu.2009.1005; Wei LH, 2012, EXP EYE RES, V94, P117, DOI 10.1016/j.exer.2011.11.016; Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959; Wilhelm H, 2003, J NEURO-OPHTHALMOL, V23, P42, DOI 10.1097/00041327-200303000-00010; Zhao LQ, 2011, INT J BIOL SCI, V7, P297, DOI 10.7150/ijbs.7.297; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603	46	143	151	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99299	10.1371/journal.pone.0099299	http://dx.doi.org/10.1371/journal.pone.0099299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915536	gold, Green Published			2022-12-27	WOS:000340947700082
J	Hernandez, AV; Guarnizo, M; Miranda, Y; Pasupuleti, V; Deshpande, A; Paico, S; Lenti, H; Ganoza, S; Montalvo, L; Thota, P; Lazaro, H				Hernandez, Adrian V.; Guarnizo, Mirella; Miranda, Yony; Pasupuleti, Vinay; Deshpande, Abhishek; Paico, Socorro; Lenti, Hosten; Ganoza, Silvia; Montalvo, Laritza; Thota, Priyaleela; Lazaro, Herbert			Association between Insulin Resistance and Breast Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GROWTH-FACTOR-I; C-PEPTIDE LEVELS; CANCER-RISK; METABOLIC SYNDROME; SERUM-INSULIN; POSTMENOPAUSAL WOMEN; IGF-I; GLUCOSE; HYPERINSULINEMIA; WEIGHT	Objective: This study was undertaken to evaluate the association between components defining insulin resistance and breast cancer in women. Study Design We conducted a systematic review of four databases (PubMed-Medline, EMBASE, Web of Science, and Scopus) for observational studies evaluating components defining insulin resistance in women with and without breast cancer. A meta-analysis of the association between insulin resistance components and breast cancer was performed using random effects models. Results: Twenty-two studies (n=33,405)were selected. Fasting insulin levels were not different between women with and without breast cancer (standardized mean difference, SMD -0.03, 95%CI -0.32 to 0.27; p = 0.9). Similarly, non-fasting/ fasting C-peptide levels were not different between the two groups (mean difference, MD 0.07, -0.21 to 0.34; p = 0.6). Using individual odds ratios (ORs) adjusted at least for age, there was no higher risk of breast cancer when upper quartiles were compared with the lowest quartile (Q1) of fasting insulin levels (OR (Q2 vs. Q1) 0.96, 0.71 to 1.28; OR (Q3 vs. Q1) 1.22, 0.91 to 1.64; OR (Q4 vs. Q1) 0.98, 0.70 to 1.38). Likewise, there were no differences for quartiles of non-fasting/fasting C-peptide levels (OR (Q2) (vs. Q1) 1.12, 0.91 to 1.37; OR (Q3 vs. Q1) 1.20, 0.91 to 1.59; OR (Q4 vs. Q1) 1.40, 1.03 to 1.92). Homeostatic model assessment (HOMAIR) levels in breast cancer patients were significantly higher than in people without breast cancer ( MD 0.22, 0.13 to 0.31, p < 0.00001). Conclusions: Higher levels of fasting insulin or non-fasting/fasting C-peptide are not associated with breast cancer in women. HOMA-IR levels are slightly higher in women with breast cancer.	[Hernandez, Adrian V.; Guarnizo, Mirella; Miranda, Yony; Paico, Socorro; Lenti, Hosten; Ganoza, Silvia; Montalvo, Laritza; Lazaro, Herbert] Inst Med Metab, Inst Med Mujer, Lima, Peru; [Hernandez, Adrian V.] Univ Peruana Ciencias Aplicadas UPC, Postgrad Sch, Lima, Peru; [Hernandez, Adrian V.] Univ Peruana Ciencias Aplicadas UPC, Sch Med, Lima, Peru; [Hernandez, Adrian V.] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Hlth Outcomes & Clin Epidemiol Sect, Cleveland, OH 44106 USA; [Pasupuleti, Vinay; Deshpande, Abhishek; Thota, Priyaleela] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Deshpande, Abhishek] Cleveland Clin, Dept Med, Inst Med, Cleveland, OH 44106 USA	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana de Ciencias Aplicadas (UPC); Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Hernandez, AV (corresponding author), Inst Med Metab, Inst Med Mujer, Lima, Peru.	adrianhernandezdiaz@gmail.com	Hernandez, Adrian V./ABD-4616-2021; Pasupuleti, Vinay/G-1316-2013	Hernandez, Adrian V./0000-0002-9999-4003; 	Instituto Medico de la Mujer, Lima, Peru	Instituto Medico de la Mujer, Lima, Peru	This study was funded by the Instituto Medico de la Mujer, Lima, Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi M, 2010, METAB SYNDR RELAT D, V8, P411, DOI 10.1089/met.2009.0112; American Cancer Society, 2014, ACS CANC FACTS FIG; Autier P, 2013, CANCER CAUSE CONTROL, V24, P873, DOI 10.1007/s10552-013-0164-6; BRUNING PF, 1992, INT J CANCER, V52, P511, DOI 10.1002/ijc.2910520402; Capasso I, 2010, CANCER BIOL THER, V10, P1240, DOI 10.4161/cbt.10.12.13473; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Cust AE, 2009, BREAST CANCER RES TR, V113, P567, DOI 10.1007/s10549-008-9958-8; Del Giudice ME, 1998, BREAST CANCER RES TR, V47, P111, DOI 10.1023/A:1005831013718; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eliassen AH, 2007, CANCER EPIDEM BIOMAR, V16, P161, DOI 10.1158/1055-9965.EPI-06-0693; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Fair AM, 2007, CANCER DETECT PREV, V31, P214, DOI 10.1016/j.cdp.2007.04.003; Falk RT, 2006, BREAST CANCER RES TR, V98, P157, DOI 10.1007/s10549-005-9144-1; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Friedenreich CM, 2012, ENDOCR-RELAT CANCER, V19, P785, DOI 10.1530/ERC-12-0211; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Garmendia ML, 2007, ANN EPIDEMIOL, V17, P403, DOI 10.1016/j.annepidem.2007.01.037; Gnagnarella P, 2008, AM J CLIN NUTR, V87, P1793, DOI 10.1093/ajcn/87.6.1793; Gonullu G, 2005, CYTOKINE, V31, P264, DOI 10.1016/j.cyto.2005.05.003; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Jernstrom H, 1999, J WOMEN HEALTH GEN-B, V8, P1265, DOI 10.1089/jwh.1.1999.8.1265; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Kaaks R, 2001, Gynecol Obstet Fertil, V29, P185; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Keinan-Boker L, 2003, INT J CANCER, V106, P90, DOI 10.1002/ijc.11193; Lawlor DA, 2004, CANCER CAUSE CONTROL, V15, P267, DOI 10.1023/B:CACO.0000024225.14618.a8; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Mink PJ, 2002, AM J EPIDEMIOL, V156, P349, DOI 10.1093/aje/kwf050; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Riserus U, 2007, DIABETES CARE, V30, P2928, DOI 10.2337/dc07-0360; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Schairer C, 2004, INT J CANCER, V108, P773, DOI 10.1002/ijc.11624; Sieri S, 2012, INT J CANCER, V130, P921, DOI 10.1002/ijc.26071; Tehard B, 2004, INT J CANCER, V111, P264, DOI 10.1002/ijc.20213; Toniolo P, 2000, INT J CANCER, V88, P828, DOI 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8; Tran TT, 1996, CANCER EPIDEM BIOMAR, V5, P1013; Tsugane S, 2010, CANCER SCI, V101, P1073, DOI 10.1111/j.1349-7006.2010.01521.x; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Verheus M, 2006, INT J CANCER, V119, P659, DOI 10.1002/ijc.21861; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yam D, 1996, CANCER LETT, V104, P129, DOI 10.1016/0304-3835(96)04211-5	45	59	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99317	10.1371/journal.pone.0099317	http://dx.doi.org/10.1371/journal.pone.0099317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911052	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600071
J	Pepin, J; Abou Chakra, CN; Pepin, E; Nault, V; Valiquette, L				Pepin, Jacques; Abou Chakra, Claire Nour; Pepin, Eric; Nault, Vincent; Valiquette, Louis			Evolution of the Global Burden of Viral Infections from Unsafe Medical Injections, 2000-2010	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE WORKERS; OCCUPATIONAL-EXPOSURE; HIV-INFECTION; RISK-FACTORS; HUMAN-PAPILLOMAVIRUS; UGANDAN ADULTS; DRUG-USERS; E-ANTIGEN; TRANSMISSION	Background: In 2000, the World Health Organization estimated that, in developing and transitional countries, unsafe injections accounted for respectively 5%, 32% and 40% of new infections with HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV). Safe injection campaigns were organized worldwide. The present study sought to measure the progress in reducing the transmission of these viruses through unsafe injections over the subsequent decade. Methods: A mass action model was updated, to recalculate the number of injection-related HIV, HCV and HBV infections acquired in 2000 and provide estimates for 2010. Data about the annual number of unsafe injections were updated. HIV prevalence in various regions in 2000 and 2010 were calculated from UNAIDS data. The ratio of HIV prevalence in healthcare settings compared to the general population was estimated from a literature review. Improved regional estimates of the prevalence of HCV seropositivity, HBsAg and HBeAg antigenemia were used for 2000 and 2010. For HIV and HCV, revised estimates of the probability of transmission per episode of unsafe injection were used, with low and high values allowing sensitivity analyses. Results: Despite a 13% population growth, there was a reduction of respectively 87% and 83% in the absolute numbers of HIV and HCV infections transmitted through injections. For HBV, the reduction was more marked (91%) due to the additional impact of vaccination. While injections-related cases had accounted for 4.6%-9.1% of newly acquired HIV infections in 2000, this proportion decreased to 0.7%-1.3% in 2010, when unsafe injections caused between 16,939 and 33,877 HIV infections, between 157,592 and 315,120 HCV infections, and 1,679,745 HBV infections. Conslusion: From 2000 to 2010, substantial progress was made in reducing the burden of HIV, HCV and HBV infections transmitted through injections. In some regions, their elimination might become a reasonable public health goal.	[Pepin, Jacques; Abou Chakra, Claire Nour; Pepin, Eric; Nault, Vincent; Valiquette, Louis] Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Pepin, J (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada.	jacques.pepin@usherbrooke.ca			Safe Injection Global Network	Safe Injection Global Network	This work was supported by the Safe Injection Global Network which had no role in study design, data collection and analysis, preparation of the manuscript and decision to publish. The views expressed in this article are those of the authors only.	[Anonymous], DEM HLTH SURV; Avert, S AFR HIV AIDS STAT; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Banura C, 2008, J INFECT DIS, V197, P555, DOI 10.1086/526792; Bebell LM, 2010, AIDS, V24, P1945, DOI 10.1097/QAD.0b013e32833bb732; Bell David M., 1997, American Journal of Medicine, V102, P9, DOI 10.1016/S0002-9343(97)89441-7; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Chang LW, 2002, J ACQ IMMUN DEF SYND, V29, P511, DOI 10.1097/00042560-200204150-00012; Croce F, 2007, TROP MED INT HEALTH, V12, P1011, DOI 10.1111/j.1365-3156.2007.01880.x; Francesconi P, 2001, AIDS, V15, P2445, DOI 10.1097/00002030-200112070-00013; Gerberding JL, 2003, NEW ENGL J MED, V348, P826, DOI 10.1056/NEJMcp020892; GERBERDING JL, 1995, NEW ENGL J MED, V332, P444, DOI 10.1056/NEJM199502163320707; Gisselquist D, 2006, INFECT CONT HOSP EP, V27, P944, DOI 10.1086/506408; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hauri AM., 2004, COMP QUANTIFICATION; Horwood C, 2011, TROP MED INT HEALTH, V16, P42, DOI 10.1111/j.1365-3156.2010.02672.x; Hudgens MG, 2002, AM J EPIDEMIOL, V155, P159, DOI 10.1093/aje/155.2.159; Hudgens MG, 2001, J ROY STAT SOC C-APP, V50, P1, DOI 10.1111/1467-9876.00216; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; IPPOLITO G, 1993, ARCH INTERN MED, V153, P1451, DOI 10.1001/archinte.153.12.1451; Ivers Louise C, 2007, AIDS Res Ther, V4, P28, DOI 10.1186/1742-6405-4-28; Jagger J, 2002, JAMA-J AM MED ASSOC, V288, P1469, DOI 10.1001/jama.288.12.1469; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; La Ruche G, 1998, INT J CANCER, V76, P480, DOI 10.1002/(SICI)1097-0215(19980518)76:4&lt;480::AID-IJC6&gt;3.0.CO;2-N; Njobvu P, 1998, J RHEUMATOL, V25, P1553; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Ott JJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-131; Pepin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080948; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Reid S, 2009, INT J STD AIDS, V20, P295, DOI 10.1258/ijsa.2008.008441; Schmid GP, 2004, LANCET, V363, P482, DOI 10.1016/S0140-6736(04)15497-4; Shisana O, 2008, AIDS CARE, V20, P755, DOI 10.1080/09540120701771705; Solomon SS, 2004, INT J STD AIDS, V15, P658, DOI 10.1258/0956462041944402; Tharyan P, 2003, AIDS CARE, V15, P197, DOI 10.1080/0954012031000068344; TOKARS JI, 1993, ANN INTERN MED, V118, P913, DOI 10.7326/0003-4819-118-12-199306150-00001; UNAIDS, 2010, UNAIDS REP GLOB AIDS; United Nations Department of Economic and Social Affairs, WORLD POP PROSP 2010; Van Geertruyden JP, 2006, J INFECT DIS, V194, P917, DOI 10.1086/507310; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; WERNER BG, 1982, ANN INTERN MED, V97, P367, DOI 10.7326/0003-4819-97-3-367; World Health Organization, IMM SURV ASS MON; Yazdanpanah Y, 2005, CLIN INFECT DIS, V41, P1423, DOI 10.1086/497131	45	73	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99677	10.1371/journal.pone.0099677	http://dx.doi.org/10.1371/journal.pone.0099677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911341	Green Published, gold, Green Submitted			2022-12-27	WOS:000337165600114
J	Ruther, NN; Tettamanti, M; Cappa, SF; Bellebaum, C				Ruether, Norma Naima; Tettamanti, Marco; Cappa, Stefano F.; Bellebaum, Christian			Observed Manipulation Enhances Left Fronto-Parietal Activations in the Processing of Unfamiliar Tools	PLOS ONE			English	Article							PREMOTOR CORTEX; NEURAL REPRESENTATIONS; GRASPABLE OBJECTS; ACTION KNOWLEDGE; RECOGNITION; PERCEPTION; EXPERIENCE; MEMORY; BRAIN	Tools represent a special class of objects, as functional details of tools can afford certain actions. In addition, information gained via prior experience with tools can be accessed on a semantic level, providing a basis for meaningful object interactions. Conceptual representations of tools also encompass knowledge about tool manipulation which can be acquired via direct (active manipulation) or indirect (observation of others manipulating objects) motor experience. The present study aimed to explore the impact of observation of manipulation on the neural processing of previously unfamiliar, manipulable objects. Brain activity was assessed by means of functional magnetic resonance imaging while participants accomplished a visual matching task involving pictures of the novel objects before and after they received object-related training. Three training session in which subjects observed an experimenter manipulating one set of objects and visually explored another set of objects were used to make subjects familiar with the tools and to allow the formation of new tool representations. A control object set was not part of the training. Training-related brain activation increases were found for observed manipulation objects compared to not trained objects in a left-hemispheric network consisting of inferior frontal gyrus (iFG) pars opercularis and triangularis and supramarginal/angular gyrus. This illustrates that direct manipulation experience is not required to elicit tool-associated activation changes in the action system. While the iFG activation might indicate a close relationship between the areas involved in tool representation and those involved in observational knowledge acquisition, the parietal activation is discussed in terms of non-semantic effects of object affordances and handtool spatial relationships.	[Ruether, Norma Naima] Ruhr Univ Bochum, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany; [Ruether, Norma Naima] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Tettamanti, Marco] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Tettamanti, Marco; Cappa, Stefano F.] Ist Sci San Raffaele, Dept Nucl Med, I-20132 Milan, Italy; [Cappa, Stefano F.] Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; [Bellebaum, Christian] Univ Dusseldorf, Inst Expt Psychol, Dusseldorf, Germany	Ruhr University Bochum; Ruhr University Bochum; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Heinrich Heine University Dusseldorf	Ruther, NN (corresponding author), Ruhr Univ Bochum, Dept Neuropsychol, Inst Cognit Neurosci, Univ Str 150, Bochum, Germany.	naima.ruether@rub.de	Tettamanti, Marco/K-1510-2016; Cappa, Stefano/B-1874-2014	Tettamanti, Marco/0000-0003-3039-1500; Cappa, Stefano/0000-0003-1003-3925	German Research Foundation(Deutsche Forschungsgemeinschaft, DFG) [SFB 874/TP B6]	German Research Foundation(Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The authors thank the German Research Foundation for supporting this work (Deutsche Forschungsgemeinschaft, DFG; SFB 874/TP B6 to C. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Bellebaum C, 2013, CORTEX, V49, P1110, DOI 10.1016/j.cortex.2012.03.023; Buxbaum LJ, 2010, ANN NY ACAD SCI, V1191, P201, DOI 10.1111/j.1749-6632.2010.05447.x; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Creem-Regehr SH, 2007, J INT NEUROPSYCH SOC, V13, P1009, DOI 10.1017/S1355617707071093; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Cross ES, 2012, NEUROPSYCHOLOGIA, V50, P3207, DOI 10.1016/j.neuropsychologia.2012.09.028; DERENZI E, 1988, BRAIN, V111, P1173, DOI 10.1093/brain/111.5.1173; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibson J.J., 1977, PERCEIVING ACTING KN, V1, P67, DOI [DOI 10.2307/1421838, 10.4324/9781315740218]; Goldenberg G, 1998, NEUROPSYCHOLOGIA, V36, P581, DOI 10.1016/S0028-3932(97)00165-6; Goldenberg G, 2009, BRAIN, V132, P1645, DOI 10.1093/brain/awp080; Goldenberg G, 2013, WIRES COGN SCI, V4, P453, DOI 10.1002/wcs.1241; Goldenberg G, 2009, NEUROPSYCHOLOGIA, V47, P1449, DOI 10.1016/j.neuropsychologia.2008.07.014; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Hodges JR, 1999, P NATL ACAD SCI USA, V96, P9444, DOI 10.1073/pnas.96.16.9444; Jacquet PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039629; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Kiefer M, 2007, J COGNITIVE NEUROSCI, V19, P525, DOI 10.1162/jocn.2007.19.3.525; LEHMKUHL G, 1981, CORTEX, V17, P153, DOI 10.1016/S0010-9452(81)80017-2; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 1998, MEM CALIF ACAD SCI, P69; Martin A, 2001, HDB FUNCTIONAL NEURO, P153; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; Proverbio AM, 2012, BIOL PSYCHOL, V91, P1, DOI 10.1016/j.biopsycho.2012.04.003; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROTHI LJG, 1991, COGN NEUROPSYCHOL, V8, P443, DOI 10.1080/02643299108253382; Rothi LJG, 1997, BRAIN DAM B, P29; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SIRIGU A, 1991, BRAIN, V114, P2555, DOI 10.1093/brain/114.6.2555; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Symes E, 2007, ACTA PSYCHOL, V124, P238, DOI 10.1016/j.actpsy.2006.03.005; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Valenstein E., 2003, CLIN NEUROPSYCHOLOGY, P215; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	56	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99401	10.1371/journal.pone.0099401	http://dx.doi.org/10.1371/journal.pone.0099401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911053	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600081
J	Liberio, MD; Bastos, IMD; Pires, OR; Fontes, W; Santana, JM; Castro, MS				Liberio, Michelle da Silva; Bastos, Izabela M. D.; Pires Junior, Osmindo R.; Fontes, Wagner; Santana, Jaime M.; Castro, Mariana S.			The Crude Skin Secretion of the Pepper Frog Leptodactylus labyrinthicus Is Rich in Metallo and Serine Peptidases	PLOS ONE			English	Article							BOTHROPS PROTEASE-A; ANTIMICROBIAL PEPTIDES; MOLECULAR-CLONING; AMPHIBIAN SKIN; TRYPSIN-INHIBITOR; IV; PURIFICATION; ENZYMES; XENOPUS; AMINOPEPTIDASE	Peptidases are ubiquitous enzymes involved in diverse biological processes. Fragments from bioactive peptides have been found in skin secretions from frogs, and their presence suggests processing by peptidases. Thus, the aim of this work was to characterize the peptidase activity present in the skin secretion of Leptodactylus labyrinthicus. Zymography revealed the presence of three bands of gelatinase activity of approximately 60 kDa, 66 kDa, and 80 kDa, which the first two were calcium-dependent. These three bands were inhibited either by ethylenediaminetetraacetic acid (EDTA) and phenathroline; thus, they were characterized as metallopeptidases. Furthermore, the proteolytic enzymes identified were active only at pH 6.0-10.0, and their activity increased in the presence of CHAPS or NaCl. Experiments with fluorogenic substrates incubated with skin secretions identified aminopeptidase activity, with cleavage after leucine, proline, and alanine residues. This activity was directly proportional to the protein concentration, and it was inhibited in the presence of metallo and serine peptidase inhibitors. Besides, the optimal pH for substrate cleavage was determined to be 7.0-8.0. The results of the in gel activity assay showed that all substrates were hydrolyzed by a 45 kDa peptidase. Gly-Pro-AMC was also cleaved by a peptidase greater than 97 kDa. The data suggest the presence of dipeptidyl peptidases (DPPs) and metallopeptidases; however, further research is necessary. In conclusion, our work will help to elucidate the implication of these enzymatic activities in the processing of the bioactive peptides present in frog venom, expanding the knowledge of amphibian biology.	[Liberio, Michelle da Silva; Pires Junior, Osmindo R.; Castro, Mariana S.] Univ Brasilia, Toxinol Lab, Dept Physiol Sci, Inst Biol, Brasilia, DF, Brazil; [Liberio, Michelle da Silva; Fontes, Wagner; Castro, Mariana S.] Univ Brasilia, Dept Cell Biol, Inst Biol, Brazilian Ctr Prot Res, Brasilia, DF, Brazil; [Bastos, Izabela M. D.; Santana, Jaime M.] Univ Brasilia, Inst Biol, Lab Host Pathogen Interact, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Castro, MS (corresponding author), Univ Brasilia, Toxinol Lab, Dept Physiol Sci, Inst Biol, Brasilia, DF, Brazil.	mscastro@unb.br	Santana, Jaime/H-5319-2013; Fontes, Wagner/A-1771-2008; Pires, O.r./ABC-8410-2020; Rodrigues Pires Junior, Osmindo/Q-8384-2016	Fontes, Wagner/0000-0001-5140-8573; S. Castro, Mariana/0000-0001-5143-152X; Bastos, Izabela/0000-0002-2785-4255; Rodrigues Pires Junior, Osmindo/0000-0002-9875-9407	Brazilian National Council for Scientific and Technological Development (CNPq) [563972/2010-6, 302925/2012-0]; Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES); Funding Authority for Studies and Projects (FINEP); Foundation for Research Support of the Federal District (FAPDF) [193.000.414/2008, 193.000.461/2011]; University of Brasilia Foundation (FUB/UnB)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Funding Authority for Studies and Projects (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Foundation for Research Support of the Federal District (FAPDF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); University of Brasilia Foundation (FUB/UnB)	This study was supported by the Brazilian National Council for Scientific and Technological Development (CNPq, grant numbers 563972/2010-6 and 302925/2012-0), the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES), the Funding Authority for Studies and Projects (FINEP), the Foundation for Research Support of the Federal District (FAPDF, grant numbers 193.000.414/2008 and 193.000.461/2011) and the University of Brasilia Foundation (FUB/UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2002, BBA-PROTEINS PROTEOM, V1601, P55, DOI 10.1016/S1570-9639(02)00432-6; Almeida FM, 2002, TOXICON, V40, P1041, DOI 10.1016/S0041-0101(02)00084-3; Leite JMA, 2010, J EXP ZOOL PART A, V313A, P1, DOI 10.1002/jez.551; BARRA D, 1995, TRENDS BIOTECHNOL, V13, P205, DOI 10.1016/S0167-7799(00)88947-7; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; Bastos IMD, 2010, MICROBES INFECT, V12, P457, DOI 10.1016/j.micinf.2010.02.007; Berthonneau J, 2000, EXP PARASITOL, V95, P158, DOI 10.1006/expr.2000.4524; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Buckley SJ, 2004, INT J BIOCHEM CELL B, V36, P1281, DOI 10.1016/j.biocel.2003.02.001; Cadavid-Restrepo G, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-46; Calderon LD, 2011, AMINO ACIDS, V40, P29, DOI 10.1007/s00726-010-0622-3; Charpentier S, 1998, J BIOL CHEM, V273, P14690, DOI 10.1074/jbc.273.24.14690; Chen TB, 2003, PEPTIDES, V24, P873, DOI 10.1016/S0196-9781(03)00165-7; Clamagirand C, 2002, COMP BIOCHEM PHYS B, V132, P751, DOI 10.1016/S1096-4959(02)00093-3; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2006, PROTEIN PEPTIDE LETT, V13, P411, DOI 10.2174/092986606775974410; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Daly JW, 2004, TOXICON, V44, P805, DOI 10.1016/j.toxicon.2004.08.016; DARBY NJ, 1988, BIOCHEM BIOPH RES CO, V153, P1193, DOI 10.1016/S0006-291X(88)81354-8; Dionisio G, 2001, PROTEOLYTIC ENZYMES, P77; Dourado FS, 2007, TOXICON, V50, P572, DOI 10.1016/j.toxicon.2007.04.027; Doyle J, 2003, EUR J BIOCHEM, V270, P1141, DOI 10.1046/j.1432-1033.2003.03462.x; Erspamer Vittorio, 1994, P178; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Gilmartin L, 1999, NEUROSCI RES, V34, P1, DOI 10.1016/S0168-0102(99)00025-5; GIOVANNINI MG, 1987, BIOCHEM J, V243, P113, DOI 10.1042/bj2430113; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P6; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; KELLEHER PJ, 1984, ANAL BIOCHEM, V136, P470, DOI 10.1016/0003-2697(84)90246-X; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; King JD, 2005, COMP BIOCHEM PHYS C, V141, P393, DOI 10.1016/j.cbpc.2005.09.002; Kruger NJ, 2002, PROTEIN PROTOCOLS HD, P747; Leme AFP, 2008, J THROMB HAEMOST, V6, P1363, DOI 10.1111/j.1538-7836.2008.02995.x; Liberio MS, 2011, AMINO ACIDS, V40, P51, DOI 10.1007/s00726-009-0384-y; Maes MB, 2007, CLIN CHIM ACTA, V380, P31, DOI 10.1016/j.cca.2007.01.024; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Menezes MC, 2006, TOXICON, V47, P304, DOI 10.1016/j.toxicon.2005.11.007; Merchant M, 2010, VET IMMUNOL IMMUNOP, V136, P28, DOI 10.1016/j.vetimm.2010.01.005; Motta FN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030431; Murayama N, 2003, BBA-PROTEINS PROTEOM, V1652, P1, DOI 10.1016/j.bbapap.2003.08.001; Nascimento ACC, 2004, PROTEIN J, V23, P501, DOI 10.1007/s10930-004-7877-z; Nascimento A, 2007, TOXICON, V50, P1095, DOI 10.1016/j.toxicon.2007.07.014; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Pukala TL, 2006, NAT PROD REP, V23, P368, DOI 10.1039/b512118n; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RESNICK NM, 1991, CELL, V66, P541, DOI 10.1016/0092-8674(81)90017-9; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Rollins-Smith LA, 2005, REGUL PEPTIDES, V124, P173, DOI 10.1016/j.regpep.2004.07.013; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Sah H, 2006, BIOTECHNOL LETT, V28, P567, DOI 10.1007/s10529-006-0016-5; Schroder JM, 1999, BIOCHEM PHARMACOL, V57, P121, DOI 10.1016/S0006-2952(98)00226-3; Sentandreu MA, 2001, MEAT SCI, V57, P93, DOI 10.1016/S0309-1740(00)00082-6; Shinnar AE, 2003, BIOORG CHEM, V31, P425, DOI 10.1016/S0045-2068(03)00080-4; Sitaram N, 1999, BBA-BIOMEMBRANES, V1462, P29, DOI 10.1016/S0005-2736(99)00199-6; Souza AP, 2001, BIOMATERIALS, V22, P2025, DOI 10.1016/S0142-9612(00)00388-4; STLEGER RJ, 1993, J GEN MICROBIOL, V139, P237, DOI 10.1099/00221287-139-2-237; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Wang M, 2012, PEPTIDES, V33, P245, DOI 10.1016/j.peptides.2012.01.003; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x	65	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96893	10.1371/journal.pone.0096893	http://dx.doi.org/10.1371/journal.pone.0096893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906116	gold, Green Published, Green Submitted			2022-12-27	WOS:000341869000004
J	Meshcheryakova, A; Tamandl, D; Bajna, E; Stift, J; Mittlboeck, M; Svoboda, M; Heiden, D; Stremitzer, S; Jensen-Jarolim, E; Grunberger, T; Bergmann, M; Mechtcheriakova, D				Meshcheryakova, Anastasia; Tamandl, Dietmar; Bajna, Erika; Stift, Judith; Mittlboeck, Martina; Svoboda, Martin; Heiden, Denise; Stremitzer, Stefan; Jensen-Jarolim, Erika; Gruenberger, Thomas; Bergmann, Michael; Mechtcheriakova, Diana			B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							IMMUNE CELLS; DENDRITIC CELLS; LIVER METASTASES; T-CELLS; RITUXIMAB; CD20; CHEMOTHERAPY; CARCINOMA; SURVIVAL; DRIVEN	Remarkably limited information is available about biological mechanisms that determine the disease entity of metastatic colorectal cancer in the liver (CRCLM) with no good clinical parameters to estimate prognosis. For the last few years, understanding the relationship between tumor characteristics and local immune response has gained increasing attention. Given the multifaceted roles of B-cell-driven responses, we aimed to elucidate the immunological imprint of B lymphocytes at the metastatic site, the interrelation with macrophages, and their prognostic relevance. Here we present novel algorithm allowing to assess a link between the local patient-specific immunological capacity and clinical outcome. The microscopy-based imaging platform was used for automated scanning of large-scale tissue sections and subsequent qualitative and quantitative analyses of immune cell subtypes using lineage markers and single-cell recognition strategy. Results indicate massive infiltration of CD45-positive leukocytes confined to the metastatic border. We report for the first time the accumulation of CD20-positive B lymphocytes at the tumor - liver interface comprising the major population within the large CD45-positive aggregates. Strikingly, functionally active, activation-induced cytidine deaminase (AID)-positive ectopic lymphoid structures were found to be assembled within the metastatic margin. Furthermore, the CD20-based data set revealed a strong prognostic power: patients with high CD20 content and/or ectopic follicles had significantly lower risk for disease recurrence as revealed by univariate analysis (p<0.001 for both) and in models adjusted for clinicopathological variables (p<0.001 and p = 0.01, respectively), and showed prolonged overall survival. In contrast, CD68 staining-derived data set did not show an association with clinical outcome. Taken together, we nominate the magnitude of B lymphocytes, including those organized in ectopic follicles, as novel prognostic marker which is superior to clinicopathological parameters. Findings emphasize anti-tumoral role of B cell-driven mechanism(s) and thus indicate a new way of thinking about potential treatment strategies for CRCLM patients.	[Meshcheryakova, Anastasia; Bajna, Erika; Svoboda, Martin; Heiden, Denise; Jensen-Jarolim, Erika; Mechtcheriakova, Diana] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Tamandl, Dietmar; Stremitzer, Stefan; Gruenberger, Thomas; Bergmann, Michael] Med Univ Vienna, Dept Surg, Vienna, Austria; [Stift, Judith] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Mittlboeck, Martina] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Jensen-Jarolim, Erika] Vet Univ Vienna, Med Univ Vienna, Messerli Res Inst, A-1030 Vienna, Austria; [Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Tamandl, D (corresponding author), Med Univ Vienna, Dept Surg, Vienna, Austria.	dietmar.tamandl@meduniwien.ac.at; diana.mechtcheriakova@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022; Gruenberger, Thomas/ABA-1661-2020; Jensen-Jarolim, Erika/C-5120-2018	Gruenberger, Thomas/0000-0002-2671-0540; Jensen-Jarolim, Erika/0000-0003-4019-5765; Bergmann, Michael/0000-0001-8529-1166; Mittlboeck, Martina/0000-0003-1097-4047; Meshcheryakova, Anastasia/0000-0003-4359-9546; Stift, Judith/0000-0001-5334-9343; Mechtcheriakova, Diana/0000-0002-8737-3592	Austrian Science Fund (FWF) [P 23228, P 22441] Funding Source: researchfish; Austrian Science Fund FWF [P 23228, P 22441] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aguilar LK, 2011, J CELL BIOCHEM, V112, P1969, DOI 10.1002/jcb.23126; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bogusz AM, 2012, CLIN CANCER RES, V18, P6122, DOI 10.1158/1078-0432.CCR-12-0397; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2012, MOL ONCOL, V6, P242, DOI 10.1016/j.molonc.2012.01.002; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Halama N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24116; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Halama N, 2010, ANAL QUANT CYTOL, V32, P333; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Keim S, 2012, ONCOIMMUNOLOGY, V1, P593, DOI 10.4161/onci.20179; Lahrmann B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028048; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Leandro MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3908; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032639; Mankai A, 2008, CANCER RES, V68, P7512, DOI 10.1158/0008-5472.CAN-07-6446; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Mechtcheriakova D, 2012, CANCER IMMUNOL IMMUN, V61, P1591, DOI 10.1007/s00262-012-1255-z; Mechtcheriakova D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025611; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Morita S, 2011, CARCINOGENESIS, V32, P1706, DOI 10.1093/carcin/bgr194; Naito Y, 1998, CANCER RES, V58, P3491; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Remark R, 2013, CLIN CANCER RES, V19, P4079, DOI 10.1158/1078-0432.CCR-12-3847; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sasaki M, 2014, J CLIN PATHOL, V67, P470, DOI 10.1136/jclinpath-2013-201917; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; Stremitzer S, 2012, BRIT J SURG, V99, P1575, DOI 10.1002/bjs.8909; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Winiarska M, 2012, J BIOL CHEM, V287, P31983, DOI 10.1074/jbc.M112.374751; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312	62	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99008	10.1371/journal.pone.0099008	http://dx.doi.org/10.1371/journal.pone.0099008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905750	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000090
J	Orlandi, JG; Stetter, O; Soriano, J; Geisel, T; Battaglia, D				Orlandi, Javier G.; Stetter, Olav; Soriano, Jordi; Geisel, Theo; Battaglia, Demian			Transfer Entropy Reconstruction and Labeling of Neuronal Connections from Simulated Calcium Imaging	PLOS ONE			English	Article							IN-VIVO; FUNCTIONAL CONNECTIVITY; INFORMATION-TRANSFER; CORTICAL CULTURES; NETWORK ACTIVITY; BRAIN NETWORKS; DYNAMICS; ORGANIZATION; EXCITATION/INHIBITION; SYNCHRONIZATION	Neuronal dynamics are fundamentally constrained by the underlying structural network architecture, yet much of the details of this synaptic connectivity are still unknown even in neuronal cultures in vitro. Here we extend a previous approach based on information theory, the Generalized Transfer Entropy, to the reconstruction of connectivity of simulated neuronal networks of both excitatory and inhibitory neurons. We show that, due to the model-free nature of the developed measure, both kinds of connections can be reliably inferred if the average firing rate between synchronous burst events exceeds a small minimum frequency. Furthermore, we suggest, based on systematic simulations, that even lower spontaneous inter-burst rates could be raised to meet the requirements of our reconstruction algorithm by applying a weak spatially homogeneous stimulation to the entire network. By combining multiple recordings of the same in silico network before and after pharmacologically blocking inhibitory synaptic transmission, we show then how it becomes possible to infer with high confidence the excitatory or inhibitory nature of each individual neuron.	[Orlandi, Javier G.; Soriano, Jordi] Univ Barcelona, Dept Estruct & Consituents Mat, Barcelona, Spain; [Stetter, Olav; Geisel, Theo; Battaglia, Demian] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Stetter, Olav; Geisel, Theo] Univ Gottingen, Dept Phys, D-37073 Gottingen, Germany; [Stetter, Olav; Geisel, Theo; Battaglia, Demian] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Battaglia, Demian] Aix Marseille Univ, Inserm UMR1106, Inst Neurosci Syst, Marseille, France	University of Barcelona; Max Planck Society; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Battaglia, D (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	demian.battaglia@univ-amu.fr	Orlandi, Javier/AFD-9072-2022; Battaglia, Demian/C-1281-2017; Soriano, Jordi/B-4756-2016; Orlandi, Javier G./B-1314-2009	Battaglia, Demian/0000-0003-2021-7920; Soriano, Jordi/0000-0003-2676-815X; Orlandi, Javier G./0000-0001-5683-1717	Ministerio de Ciencia e Innovacion (Spain) [FIS2009-07523, FIS2010-21924-C02-02, FIS2011-28820-C02-01]; Generalitat de Catalunya [2009-SGR-00014]; German Ministry for Education and Science (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Goettingen [01GQ0430]; FP7 Marie Curie career development fellowship [IEF 330792]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); German Ministry for Education and Science (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Goettingen(Federal Ministry of Education & Research (BMBF)); FP7 Marie Curie career development fellowship	JO and JS received financial support from Ministerio de Ciencia e Innovacion (Spain) under projects FIS2009-07523, and FIS2010-21924-C02-02, FIS2011-28820-C02-01 and from the Generalitat de Catalunya under project 2009-SGR-00014. OS, TG and DB were supported by the German Ministry for Education and Science (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Goettingen (Grant No. 01GQ0430). OS and DB acknowledge in addition, respectively, the Minerva Foundation (Muenchen, Germany) and funding from the FP7 Marie Curie career development fellowship IEF 330792 (DynViB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2013, NATURE, V499, P272, DOI 10.1038/499272a; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Bansal S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-405; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chicurel M, 2000, NATURE, V406, P822, DOI 10.1038/35022659; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Cohen O, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18008; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Durand DM, 2001, P IEEE, V89, P1065, DOI 10.1109/5.939821; Eckmann JP, 2007, PHYS REP, V449, P54, DOI 10.1016/j.physrep.2007.02.014; Eckmann JP, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00132; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Jacobi S, 2009, EUR J NEUROSCI, V30, P998, DOI 10.1111/j.1460-9568.2009.06891.x; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kandel E, 1967, ELECTROPHYSIOLOGICAL, P385; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kobayashi R, 2013, J COMPUT NEUROSCI, V35, P109, DOI 10.1007/s10827-013-0443-y; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Linaro D, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00043; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Madhavan Radhika, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1593; MAEDA E, 1995, J NEUROSCI, V15, P6834; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Marissal T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2318; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Nicoll RA, 1998, SCIENCE, V281, P360, DOI 10.1126/science.281.5375.360; Orlandi JG, 2013, NAT PHYS, V9, P582, DOI [10.1038/NPHYS2686, 10.1038/nphys2686]; Pajevic S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000271; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; Schmeltzer C, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012116; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; SEGAL M, 1992, J PHYSIOL-LONDON, V448, P655, DOI 10.1113/jphysiol.1992.sp019063; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Tibau E, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00199; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16; Wang Z, 2013, NEURON, V78, P1116, DOI 10.1016/j.neuron.2013.04.023; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	88	47	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98842	10.1371/journal.pone.0098842	http://dx.doi.org/10.1371/journal.pone.0098842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905689	Green Submitted, Green Published, gold			2022-12-27	WOS:000341869000067
J	Wang, YD; Wu, H; Wu, XL; Bian, ZQ; Gao, Q				Wang, Yidong; Wu, Hong; Wu, Xiaoling; Bian, Zhuoqiong; Gao, Qing			Interleukin 17A Promotes Gastric Cancer Invasiveness via NF-kappa B Mediated Matrix Metalloproteinases 2 and 9 Expression	PLOS ONE			English	Article							CUTTING EDGE; IL-17; CELL; ANGIOGENESIS; RECRUITMENT; INHIBITION; RECEPTOR	Interleukin 17A (IL-17A), as a pro-inflammatory cytokine, is involved in pathology of inflammatory diseases and tumor microenvironment. The aim of this study is to investigate the effect of IL-17A on the invasiveness of gastric cancer (GC). In the study, we found that IL-17A could promote the migration and invasion of GC cells. Furthermore, after treated with IL-17A, the expressions and activities of matrix metalloproteinase 2 (MMP-2) and MMP-9 were upregulated, while the expressions of TIMP-1 and TIMP-2 were downregulated. Moreover, the nuclear/overall fractions of p65 and p50 were dramatically elevated by IL-17A. Pretreatment with helenalin, a nuclear factor-kappa B (NF-kappa B) inhibitor, was proved to abolish the promoting effect of IL-17A on the invasion ability of GC cells and upregulation of MMP-2 and MMP-9. In conclusion, our findings illustrated that IL-17A could promote the invasion of GC cells by activating NF-kappa B pathway, and subsequently upregulating the expression of MMP-2 and MMP-9. These results may lead to the identification of new diagnostic markers and therapeutic targets of GC.	[Wang, Yidong; Wu, Xiaoling; Gao, Qing] Xi An Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Wu, Hong] XIAN XD GRP Hosp, Dept Gen Surg, Xian, Shaanxi, Peoples R China; [Bian, Zhuoqiong] Fifth Hosp Xian City, Dept Rheumatol 5, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; China XD Group	Gao, Q (corresponding author), Xi An Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China.	dqinggao@163.com			National Natural Science Foundation of China [81070536]; Youth Scientific Funds of The Central Hospital of Taian [2011ZRQNO35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Scientific Funds of The Central Hospital of Taian	The project was supported by National Natural Science Foundation of China (No. 81070536) and Youth Scientific Funds of The Central Hospital of Taian (2011ZRQNO35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Chen JG, 2011, INT J BIOL SCI, V7, P53, DOI 10.7150/ijbs.7.53; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Gao C, 2009, CELL MOL NEUROBIOL, V29, P1161, DOI 10.1007/s10571-009-9409-z; Holck S, 2003, FEMS IMMUNOL MED MIC, V36, P175, DOI 10.1016/S0928-8244(03)00028-2; Hus I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078091; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lavu H, 2013, J SURG RES, V185, P516, DOI 10.1016/j.jss.2012.09.034; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Lu L, 2013, J IMMUNOTHER, V36, P451, DOI 10.1097/CJI.0b013e3182a802cf; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tan B, 2013, TUMOUR BIOL; Zambon CF, 2002, CYTOKINE, V18, P242, DOI 10.1006/cyto.2002.0891; Zhao L, 2010, CANCER BIOL THER, V9, P42, DOI 10.4161/cbt.9.1.10282; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	29	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96678	10.1371/journal.pone.0096678	http://dx.doi.org/10.1371/journal.pone.0096678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905806	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000001
J	Chen, R; Shi, YH; Amiduo, R; Tuokan, T; Suzuk, L				Chen, Rui; Shi, Yonghua; Amiduo, Reshalaity; Tuokan, Talaf; Suzuk, Lalai			Expression and Prognostic Value of Aquaporin 1, 3 in Cervical Carcinoma in Women of Uygur Ethnicity from Xinjiang, China	PLOS ONE			English	Article							CELL-MIGRATION; ANGIOGENESIS	Background: Overexpression of several aquaporins has been reported in different types of human cancer but the role of aquaporins in carcinogenesis has not yet been clearly defined. There is few report concerning role of aquaporins in human cervical carcinogenesis so far. Here, we determined the expression and prognostic value of aquaporin 1, 3 in cervical carcinoma in Chinese women of Uygur ethnicity. Methods and Results: Real-time PCR analyses demonstrated aquaporin 1, 3 mRNA were differentially expressed in cervical carcinoma, CIN 2-3 and mild cervicitis. Immunofluorescent and immunohistochemical analyses demonstrated aquaporin 1 was predominantly localized to stromal endothelial cells in cervical lesions. Aquaporin 3 was localized to the membrane of normal squamous epithelium, CIN and carcinoma cells. Aquaporin 1 and 3 were upregulated in cervical cancer compared to mild cervicitis and CIN2-3 (P<0.05); Tumor expression of aquaporin 1, 3 significantly increased in advanced stage disease, and patients with deeper tumor infiltration, lymph node metastases or larger tumor volume (P<0.05). Multivariate analysis demonstrated that aquaporin 1, 3 were not independent prognostic factors in cervical carcinoma. Conclusion: Aquaporins may participate in the initiation and progression of cervical carcinoma by promoting tumor growth, invasion or lymph node metastasis. Further study is required to determine whether aquaporins have potential as prognostic factors in cervical cancer.	[Chen, Rui] Xinjiang Med Univ, Affiliated Hosp 3, Dept Gynecol, Urumqi, Xinjiang, Peoples R China; [Shi, Yonghua; Amiduo, Reshalaity; Tuokan, Talaf; Suzuk, Lalai] Xinjiang Med Univ, Basic Med Coll, Dept Pathol, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Shi, YH (corresponding author), Xinjiang Med Univ, Basic Med Coll, Dept Pathol, Urumqi, Xinjiang, Peoples R China.	z5826711@126.com			National Natural Science Foundation of China [81060216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (Grant Number: 81060216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056735; Freeman SJ, 2012, RADIOGRAPHICS, V32, P1805, DOI 10.1148/rg.326125519; Hayashi Y, 2007, NEOPLASIA, V9, P777, DOI 10.1593/neo.07454; Hwang Insang, 2012, Chonnam Med J, V48, P174, DOI 10.4068/cmj.2012.48.3.174; Ishimoto S, 2012, INT J ONCOL, V41, P67, DOI [10.3892/ijo.2012.1445, 10.3892/ijo.2011.1445]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji C, 2008, CANCER CHEMOTH PHARM, V62, P857, DOI 10.1007/s00280-007-0674-6; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kao SCH, 2012, CANCER-AM CANCER SOC, V118, P2952, DOI 10.1002/cncr.26497; Kusayama M, 2011, CANCER SCI, V102, P1128, DOI 10.1111/j.1349-7006.2011.01927.x; Loreto C, 2010, CURR NEUROPHARMACOL, V8, P105, DOI 10.2174/157015910791233196; Otterbach F, 2010, BREAST CANCER RES TR, V120, P67, DOI 10.1007/s10549-009-0370-9; Pan H, 2008, INT J GYNECOL OBSTET, V101, P239, DOI 10.1016/j.ijgo.2007.12.006; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Peng YH, 2003, ZHONGHUA FU CHAN KE, V38, P764; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Shen LZ, 2010, BIOMED PHARMACOTHER, V64, P313, DOI 10.1016/j.biopha.2009.12.003; Shi YH, 2012, J PRACTICAL ONCOLOGY, V27, P18; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang JH, 2011, HISTOL HISTOPATHOL, V26, P1197, DOI 10.14670/HH-26.1197	22	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98576	10.1371/journal.pone.0098576	http://dx.doi.org/10.1371/journal.pone.0098576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918928	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000020
J	Chou, JP; Ramirez, CM; Ryba, DM; Koduri, MP; Effros, RB				Chou, Jennifer P.; Ramirez, Christina M.; Ryba, Danielle M.; Koduri, Megha P.; Effros, Rita B.			Prostaglandin E-2 Promotes Features of Replicative Senescence in Chronically Activated Human CD8+T Cells	PLOS ONE			English	Article							IN-VITRO SENESCENCE; T-CELL; HIV-1 INFECTION; EXPRESSION; PROLIFERATION; LYMPHOCYTES; RECEPTOR; DIFFERENTIATION; NONPROGRESSORS; COSTIMULATION	Prostaglandin E-2 (PGE(2)), a pleiotropic immunomodulatory molecule, and its free radical catalyzed isoform, iso-PGE(2), are frequently elevated in the context of cancer and chronic infection. Previous studies have documented the effects of PGE(2) on the various CD4+ T cell functions, but little is known about its impact on cytotoxic CD8+ T lymphocytes, the immune cells responsible for eliminating virally infected and tumor cells. Here we provide the first demonstration of the dramatic effects of PGE(2) on the progression of human CD8+ T cells toward replicative senescence, a terminal dysfunctional state associated multiple pathologies during aging and chronic HIV-1 infection. Our data show that exposure of chronically activated CD8+ T cells to physiological levels of PGE2 and iso-PGE(2) promotes accelerated acquisition of markers of senescence, including loss of CD28 expression, increased expression of p16 cell cycle inhibitor, reduced telomerase activity, telomere shortening and diminished production of key cytotoxic and survival cytokines. Moreover, the CD8+ T cells also produced higher levels of reactive oxygen species, suggesting that the resultant oxidative stress may have further enhanced telomere loss. Interestingly, we observed that even chronic activation per se resulted in increased CD8+ T cell production of PGE(2), mediated by higher COX-2 activity, thus inducing a negative feedback loop that further inhibits effector function. Collectively, our data suggest that the elevated levels of PGE(2) and iso-PGE(2), seen in various cancers and HIV-1 infection, may accelerate progression of CD8+ T cells towards replicative senescence in vivo. Inhibition of COX-2 activity may, therefore, provide a strategy to counteract this effect.	[Chou, Jennifer P.; Ryba, Danielle M.; Koduri, Megha P.; Effros, Rita B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Effros, Rita B.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Ramirez, Christina M.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Effros, RB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	reffros@mednet.ucla.edu	Ramirez, Christina/AAT-5088-2021	Ramirez, Christina/0000-0002-8435-0416	 [R01AG032422 (Effros)];  [U01 AI35040 (Detels)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI035043] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	R01AG032422 (Effros), U01 AI35040 (Detels). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMAN GP, 1994, CELL IMMUNOL, V158, P182, DOI 10.1006/cimm.1994.1266; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bluestone JA, 1997, J IMMUNOL, V158, P1989; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brose SA, 2011, J LIPID RES, V52, P850, DOI 10.1194/jlr.D013441; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chou JP, 2013, CURR PHARM DESIGN, V19, P1680; DOSREIS GA, 1986, CELL IMMUNOL, V101, P213, DOI 10.1016/0008-8749(86)90199-1; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Effros RB, 2003, EXP GERONTOL, V38, P1243, DOI 10.1016/j.exger.2003.09.004; Fabricius D, 2010, J IMMUNOL, V184, P677, DOI 10.4049/jimmunol.0902028; Fitzgerald DW, 2012, CANCER PREV RES, V5, P34, DOI 10.1158/1940-6207.CAPR-11-0496; HAMMARSTROM S, 1983, ANNU REV BIOCHEM, V52, P355, DOI 10.1146/annurev.bi.52.070183.002035; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jin X, 1998, EUR J IMMUNOL, V28, P3564, DOI 10.1002/(SICI)1521-4141(199811)28:11<3564::AID-IMMU3564>3.3.CO;2-A; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kong Y, 2011, J AGING RES, V2011, DOI [10.4061/2011/963172, DOI 10.4061/2011/963172]; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lv GC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-207; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Parish ST, 2010, J CLIN IMMUNOL, V30, P798, DOI 10.1007/s10875-010-9449-7; PERILLO NL, 1993, MECH AGEING DEV, V67, P173, DOI 10.1016/0047-6374(93)90121-7; Pettersen FO, 2011, J VIROL, V85, P6557, DOI 10.1128/JVI.00073-11; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; Saldanha SN, 2003, ANAL BIOCHEM, V315, P1, DOI 10.1016/S0003-2697(02)00663-2; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Sarr D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-45; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Tosato M, 2007, CLIN INTERV AGING, V2, P401; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	36	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99432	10.1371/journal.pone.0099432	http://dx.doi.org/10.1371/journal.pone.0099432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918932	gold, Green Submitted, Green Published			2022-12-27	WOS:000338631000086
J	Dattilo, W; Fagundes, R; Gurka, CAQ; Silva, MSA; Vieira, MCL; Izzo, TJ; Diaz-Castelazo, C; Del-Claro, K; Rico-Gray, V				Dattilo, Wesley; Fagundes, Roberth; Gurka, Carlos A. Q.; Silva, Mara S. A.; Vieira, Marisa C. L.; Izzo, Thiago J.; Diaz-Castelazo, Cecilia; Del-Claro, Kleber; Rico-Gray, Victor			Individual-Based Ant-Plant Networks: Diurnal-Nocturnal Structure and Species-Area Relationship	PLOS ONE			English	Article							EXTRAFLORAL NECTAR SECRETION; ANIMAL MUTUALISTIC NETWORKS; ITACOLOMI STATE-PARK; TROPICAL RAIN-FOREST; ECOLOGICAL NETWORKS; TEMPORAL VARIATION; FORBIDDEN LINKS; PROTECTION; HERBIVORY; NESTEDNESS	Despite the importance and increasing knowledge of ecological networks, sampling effort and intrapopulation variation has been widely overlooked. Using continuous daily sampling of ants visiting three plant species in the Brazilian Neotropical savanna, we evaluated for the first time the topological structure over 24 h and species-area relationships (based on the number of extrafloral nectaries available) in individual-based ant-plant networks. We observed that diurnal and nocturnal ant-plant networks exhibited the same pattern of interactions: a nested and non-modular pattern and an average level of network specialization. Despite the high similarity in the ants' composition between the two collection periods, ant species found in the central core of highly interacting species totally changed between diurnal and nocturnal sampling for all plant species. In other words, this "night-turnover'' suggests that the ecological dynamics of these ant-plant interactions can be temporally partitioned (day and night) at a small spatial scale. Thus, it is possible that in some cases processes shaping mutualistic networks formed by protective ants and plants may be underestimated by diurnal sampling alone. Moreover, we did not observe any effect of the number of extrafloral nectaries on ant richness and their foraging on such plants in any of the studied ant-plant networks. We hypothesize that competitively superior ants could monopolize individual plants and allow the coexistence of only a few other ant species, however, other alternative hypotheses are also discussed. Thus, sampling period and species-area relationship produces basic information that increases our confidence in how individual-based ant-plant networks are structured, and the need to consider nocturnal records in ant-plant network sampling design so as to decrease inappropriate inferences.	[Dattilo, Wesley; Rico-Gray, Victor] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Fagundes, Roberth; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, Lab Ecol Comportamental & Interacoes, BR-38400 Uberlandia, MG, Brazil; [Fagundes, Roberth] Univ Fed Ouro Preto, Ouro Preto, Brazil; [Gurka, Carlos A. Q.; Silva, Mara S. A.; Vieira, Marisa C. L.; Izzo, Thiago J.] Univ Fed Mato Grosso, Cuiaba, Brazil; [Diaz-Castelazo, Cecilia] Inst Ecol AC, Red Interacc Multitrof, Xalapa, Veracruz, Mexico	Universidad Veracruzana; Universidade Federal de Uberlandia; Universidade Federal de Ouro Preto; Universidade Federal de Mato Grosso; Instituto de Ecologia - Mexico	Dattilo, W (corresponding author), Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico.	wdattilo@hotmail.com	Del-Claro, K/C-5570-2013; Del-Claro, Kleber/N-3700-2019; , WD/A-6371-2012; Díaz Castelazo, Cecilia/Q-8973-2018; Izzo, Thiago/K-7405-2012	Del-Claro, K/0000-0001-8886-9568; , WD/0000-0002-4758-4379; Díaz Castelazo, Cecilia/0000-0002-0185-6607; Izzo, Thiago/0000-0002-4613-3787	CNPq [237339/2012-9]; CONACYT [489746]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Servio P. Ribeiro has provided useful information on species-area relationships. The authors also wish to thank Lucas Kaminski and DeniseLange for support in the identification of Qualea grandiflora and to Gustavo Araujo for his help in the fieldwork. WD was supported by the CNPq (no. 237339/2012-9) and CONACYT (no. 489746). MCLV was supported by CNPq. RF, CAQG and MSAS were supported by CAPES. KDC has a researcher fellowship from CNPq.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Alves-Silva E, 2013, NATURWISSENSCHAFTEN, V100, P525, DOI 10.1007/s00114-013-1048-z; [Anonymous], [No title captured]; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Baldock KCR, 2011, ECOLOGY, V92, P687, DOI 10.1890/10-1110.1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Campos RI, 2006, ECOGRAPHY, V29, P442, DOI 10.1111/j.2006.0906-7590.04520.x; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; Chamberlain SA, 2009, FUNCT ECOL, V23, P196, DOI 10.1111/j.1365-2435.2008.01472.x; Chamberlain SA, 2010, OECOLOGIA, V164, P741, DOI 10.1007/s00442-010-1673-6; COSTA FMCB, 1992, ECOL ENTOMOL, V17, P363, DOI 10.1111/j.1365-2311.1992.tb01071.x; Marquitti FMD, 2014, ECOGRAPHY, V37, P221, DOI 10.1111/j.1600-0587.2013.00506.x; Dattilo W, 2014, AM J PRIMATOL, V76, P670, DOI 10.1002/ajp.22261; Dattilo W, 2014, ECOLOGY, V95, P475, DOI 10.1890/12-1647.1; Dattilo W, 2014, J TROP ECOL, V30, P165, DOI 10.1017/S0266467413000813; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dattilo Wesley, 2012, Network Biology, V2, P127; Dattilo W, 2013, ECOL ENTOMOL, V38, P374, DOI 10.1111/een.12029; Dattilo W, 2013, ARTHROPOD-PLANT INTE, V7, P455, DOI 10.1007/s11829-013-9256-1; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; de la Fuente MAS, 1999, OECOLOGIA, V118, P192, DOI 10.1007/s004420050718; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Devoto M, 2011, ECOL ENTOMOL, V36, P25, DOI 10.1111/j.1365-2311.2010.01247.x; Diaz-Castelazo C, 2004, ECOSCIENCE, V11, P472, DOI 10.1080/11956860.2004.11682857; Diaz-Castelazo C, 2013, ANN BOT-LONDON, V111, P1285, DOI 10.1093/aob/mct071; Djieto-Lordon C, 2004, ACTA OECOL, V26, P109, DOI 10.1016/j.actao.2004.03.007; Dutra VF, 2008, ACTA BOT BRAS, V22, P547, DOI 10.1590/S0102-33062008000200021; Falcao JCF, 2014, J PLANT INTERACT, V9, P137, DOI 10.1080/17429145.2013.782513; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Gomez JM, 2012, P ROY SOC B-BIOL SCI, V279, P1754, DOI 10.1098/rspb.2011.2244; Fujaco MAG, 2010, REM-REV ESC MINAS, V63, P695, DOI 10.1590/S0370-44672010000400016; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Holldobler B., 1990, pi; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Koptur S, 1998, AM J BOT, V85, P736, DOI 10.2307/2446544; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Livingston GF, 2010, ECOL RES, V25, P1129, DOI 10.1007/s11284-010-0738-7; MAC ARTHUR ROBERT H., 1967; Milliken W, 1998, BIOTROPICA, V30, P530, DOI 10.1111/j.1744-7429.1998.tb00093.x; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Oliveira PS, 1999, FUNCT ECOL, V13, P623, DOI 10.1046/j.1365-2435.1999.00360.x; OLIVEIRA PS, 1991, ANT - PLANT INTERACTIONS, P198; Powell S, 2011, J ANIM ECOL, V80, P352, DOI 10.1111/j.1365-2656.2010.01779.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; Rico-Gray Victor, 2006, Acta Zool. Mex, V22, P23; Rios RS, 2008, OECOLOGIA, V156, P577, DOI 10.1007/s00442-008-1024-z; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Santos GMM, 2014, ECOL ENTOMO IN PRESS; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; SCHUPP EW, 1991, ANT - PLANT INTERACTIONS, P175; SILVESTRE R., 2001, REV BRAS ENTOMOL, V44, P71; Strauss SY, 2009, ECOLOGY, V90, P419, DOI 10.1890/07-1533.1; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Villamil N, 2013, ANN BOT-LONDON, V112, P701, DOI 10.1093/aob/mct005; Zardo DC, 2010, REV UNIARA, V13, P105, DOI DOI 10.25061/2527-2675/REBRAM/2010.V13I2.143.	78	50	53	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99838	10.1371/journal.pone.0099838	http://dx.doi.org/10.1371/journal.pone.0099838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918750	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000121
J	Nedergaard, MK; Kristoffersen, K; Michaelsen, SR; Madsen, J; Poulsen, HS; Stockhausen, MT; Lassen, U; Kjaer, A				Nedergaard, Mette K.; Kristoffersen, Karina; Michaelsen, Signe R.; Madsen, Jacob; Poulsen, Hans S.; Stockhausen, Marie-Therese; Lassen, Ulrik; Kjaer, Andreas			The Use of Longitudinal F-18-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; UPTAKE KINETICS; BRAIN-TUMORS; IN-VITRO; GLIOMA; GRADE; BEVACIZUMAB; MANAGEMENT; MODEL	Objectives: Brain tumor imaging is challenging. Although F-18-FET PET is widely used in the clinic, the value of 18F-FET MicroPET to evaluate brain tumors in xenograft has not been assessed to date. The aim of this study therefore was to evaluate the performance of in vivo F-18-FET MicroPET in detecting a treatment response in xenografts. In addition, the correlations between the F-18-FET tumor accumulation and the gene expression of Ki67 and the amino acid transporters LAT1 and LAT2 were investigated. Furthermore, Ki67, LAT1 and LAT2 gene expression in xenograft and archival patient tumors was compared. Methods: Human GBM cells were injected orthotopically in nude mice and F-18-FET uptake was followed by weekly MicroPET/CT. When tumor take was observed, mice were treated with CPT-11 or saline weekly. After two weeks of treatment the brain tumors were isolated and quantitative polymerase chain reaction were performed on the xenograft tumors and in parallel on archival patient tumor specimens. Results:The relative tumor-to-brain (T/B) ratio of SUV, was significantly lower after one week (123 +/- 6%, n = 7 vs. 147 +/- 6%, n = 7; p = 0.018) and after two weeks (142 +/- 8%, n = 5 vs. 204 +/- 27%, n = 4; p = 0.047) in the CPT-11 group compared with the control group. Strong negative correlations between SUVmax T/B ratio and LAT1 (r = 0.62, p = 0.04) and LAT2 (r = 0.67, p = 0.02) were observed. In addition, a strong positive correlation between LAT1 and Ki67 was detected in xenografts. Furthermore, a 1.6 fold higher expression of LAT1 and a 23 fold higher expression of LAT2 were observed in patient specimens compared to xenografts. Conclusions: F-18-FET MicroPET can be used to detect a treatment response to CPT-11 in GBM xenografts. The strong negative correlation between SUVmax T/B ratio and LAT1/LAT2 indicates an export transport function. We suggest that (FFET)-F-18 PET may be used for detection of early treatment response in patients.	[Nedergaard, Mette K.; Madsen, Jacob; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette K.; Madsen, Jacob; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Nedergaard, Mette K.; Madsen, Jacob; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Kristoffersen, Karina; Michaelsen, Signe R.; Poulsen, Hans S.; Stockhausen, Marie-Therese] Rigshosp, Finsen Ctr, Dept Radiat Biol, DK-2100 Copenhagen, Denmark; [Lassen, Ulrik] Rigshosp, Finsen Ctr, Dept Oncol, Phase Unit 1, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nedergaard, MK (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.	Mette.kjoelhede.nedergaard@regionh.dk	Michaelsen, Signe/ABB-1451-2020; Lassen, Ulrik/AAH-2799-2021; Kjaer, Andreas/E-8932-2015	Michaelsen, Signe/0000-0001-9047-6384; Lassen, Ulrik/0000-0002-3865-4574; Kjaer, Andreas/0000-0002-2706-5547	Danish Cancer Society; Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Svend Andersen Foundation; John and Birthe Meyer Foundation; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish National Advanced Technology Foundation; AP Moller Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Svend Andersen Foundation; John and Birthe Meyer Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding from The Danish Cancer Society; Danish National Advanced Technology Foundation, AP Moller Foundation, The Lundbeck Foundation, Novo Nordisk Foundation, Svend Andersen Foundation, The John and Birthe Meyer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; El Ali HH, 2012, DIAGNOSTICS, V2, P42, DOI 10.3390/diagnostics2040042; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Galldiks N, 2012, CASE REP ONCOL, V5, P490, DOI 10.1159/000342480; Galldiks N, 2013, EUR J NUCL MED MOL I, V40, P22, DOI 10.1007/s00259-012-2251-4; Galldiks N, 2012, J NUCL MED, V53, P1048, DOI 10.2967/jnumed.111.098590; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Haining Z, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-4; Heinzel A, 2013, J NUCL MED, V54, P1217, DOI 10.2967/jnumed.113.120089; Heiss P, 1999, J NUCL MED, V40, P1367; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Jeong SY, 2012, NUCL MED BIOL, V39, P977, DOI 10.1016/j.nucmedbio.2012.02.009; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; Kristoffersen K, 2013, CANCER BIOL THER, V14, P625, DOI 10.4161/cbt.24595; Kuroda J, 2010, CLIN CANCER RES, V16, P521, DOI 10.1158/1078-0432.CCR-09-2393; Lahoutte T, 2004, J NUCL MED, V45, P1591; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Langen KJ, 2003, NUCL MED BIOL, V30, P501, DOI 10.1016/S0969-8051(03)00023-4; Menichetti L, 2011, APPL RADIAT ISOTOPES, V69, P1717, DOI 10.1016/j.apradiso.2011.02.037; Nihashi T, 2013, AM J ROENTGENOL, V200, pW654, DOI 10.2214/AJR.12.9168; OLIVERO WC, 1995, J NEUROL NEUROSUR PS, V58, P250, DOI 10.1136/jnnp.58.2.250; Popperl G, 2007, EUR J NUCL MED MOL I, V34, P1933, DOI 10.1007/s00259-007-0534-y; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Sai KKS, 2013, J NUCL MED, V54, P1120, DOI 10.2967/jnumed.112.113217; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Verreault M, 2012, J CONTROL RELEASE, V158, P34, DOI 10.1016/j.jconrel.2011.09.095; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang HE, 2005, NUCL MED BIOL, V32, P367, DOI 10.1016/j.nucmedbio.2005.01.005; Wang LM, 2011, NUCL MED BIOL, V38, P53, DOI 10.1016/j.nucmedbio.2010.07.005; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wester HJ, 1999, J NUCL MED, V40, P205; Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069	35	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100009	10.1371/journal.pone.0100009	http://dx.doi.org/10.1371/journal.pone.0100009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918622	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000126
J	Nwosu, BU; Maranda, L				Nwosu, Benjamin Udoka; Maranda, Louise			The Effects of Vitamin D Supplementation on Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Children and Adolescents with Vitamin D Deficiency and Either Type 1 or Type 2 Diabetes Mellitus	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NUTRITION EXAMINATION SURVEY; PLACEBO-CONTROLLED TRIAL; INSULIN-RESISTANCE; ALANINE AMINOTRANSFERASE; SERUM 25-HYDROXYVITAMIN-D; CARDIOVASCULAR-DISEASE; GLUCOSE-HOMEOSTASIS; NATIONAL-HEALTH; BIRTH-COHORT	Background: The effects of vitamin D supplementation on mild hepatic dysfunction and glycemic control are unclear in children and adolescents with either type 1 (T1D) or type 2 diabetes (T2D). Hypothesis: Vitamin D supplementation will improve hepatic dysfunction and glycemic control. Aim: To determine the effect of vitamin D supplementation on alanine transaminase (ALT), hemoglobin A1c (HbA1c), and serum 25-hydroxyvitamin D [25(OH)D] concentration. Subjects and Methods: A retrospective study of 131 subjects with either T1D (n = 88:46 females, 42 males), or T2D (n = 43:26 females, 17 males) of ages 3-18 years between 2007-2013. All subjects had (1) a diagnosis of diabetes for >12 mo, (2) received vitamin D supplementation for the management of vitamin D deficiency (3) had baseline and subsequent simultaneous measurements of HbA1c, ALT, and 25(OH)D. Vitamin D deficiency was defined as 25(OH)D concentration of <50 nmol/L (20 ng/mL). Results: At baseline, vitamin D deficiency occurred in 72.1% of patients with T2D and in 37.5% of T1D patients (p<0.001). Patients with T2D had significantly higher values for BMI SDS (p<0.001), alanine transaminase (ALT) (p = 0.001), but lower 25(OH)D (p<0.001), and no difference in HbA1c (p = 0.94), and total daily dose (TDD) of insulin per kg body weight (p = 0.48) as compared to T1D patients. After 3 months of vitamin D supplementation, there was a significant increase in 25(OH)D in both T2D (p = 0.015), and T1D patients (p<0.001); significant reduction in BMI SDS (p = 0.015) and ALT (p = 0.012) in T2D, but not in T1D. There was a clinically-significant decrease in HbA1c in T2D from 8.5 +/- 2.9% at baseline to 7.7 +/- 2.5 at 3 mo, but not in T1D, 8.5 +/- 1.2 to 8.53 +/- 1.1%. Conclusions: Vitamin D supplementation in subjects with T2D was associated with statistically significant decreases in BMI SDS, ALT, and a clinically-significant decrease in HbA1c.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01605 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01605 USA.	Benjamin.Nwosu@umassmemorial.org			Department of Pediatrics; Faculty Diversity Scholars Program, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Department of Pediatrics; Faculty Diversity Scholars Program, University of Massachusetts Medical School, Worcester, MA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by a grant to Benjamin U. Nwosu from the Department of Pediatrics, and the Faculty Diversity Scholars Program, University of Massachusetts Medical School, Worcester, MA. He is also a member of the UMass Diabetes and Endocrine Research Center (DK32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2009, ANN MED, V41, P265, DOI 10.1080/07853890802552437; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Baynes KCR, 1997, DIABETOLOGIA, V40, P344, DOI 10.1007/s001250050685; Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Christakos S, 1979, BIOCHEM BIOPH RES CO, V89, P56; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Di Cesar DJ, 2006, DIABETES CARE, V29, P174, DOI 10.2337/diacare.29.1.174; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Greer RM, 2013, PEDIATR DIABETES, V14, P31, DOI 10.1111/j.1399-5448.2012.00890.x; Grineva EN, 2013, AGING-US, V5, P575; Hahn S, 2006, EXP CLIN ENDOCR DIAB, V114, P577, DOI 10.1055/s-2006-948308; Heinemann L, 2010, Int J Clin Pract Suppl, P29, DOI 10.1111/j.1742-1241.2009.02276.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Jorde R, 2009, EUR J NUTR, V48, P349, DOI 10.1007/s00394-009-0020-3; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Kostoglou-Athanassiou I, 2013, THER ADV ENDOCRINOL, V4, P122, DOI 10.1177/2042018813501189; Kuczmarski R J, 2000, Adv Data, P1; Liangpunsakul S, 2011, DIGEST DIS SCI, V56, P2124, DOI 10.1007/s10620-011-1707-x; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Manco M, 2010, HEPATOLOGY, V51, P2229, DOI 10.1002/hep.23724; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Nadeau KJ, 2005, J PEDIATR GASTR NUTR, V41, P94, DOI 10.1097/01.MPG.0000164698.03164.E5; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Nikooyeh B, 2011, AM J CLIN NUTR, V93, P764, DOI 10.3945/ajcn.110.007336; NORMAN AW, 1980, SCIENCE, V209, P823, DOI 10.1126/science.6250216; Nwosu BU, 2012, J PEDIATR ENDOCR MET, V25, P181, DOI 10.1515/jpem-2011-0403; Ortega RM, 2009, INT J VITAM NUTR RES, V79, P71, DOI 10.1024/0300-9831.79.2.71; Ostergard M, 2011, EUR J CLIN NUTR, V65, P657, DOI 10.1038/ejcn.2010.285; Perez-Ferre N, 2012, ENDOCR PRACT, V18, P676, DOI 10.4158/EP12025.OR; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Ryu OH, 2013, ENDOCR J; Schwimmer JB, 2003, J PEDIATR-US, V143, P500, DOI 10.1067/S0022-3476(03)00325-1; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shab-Bidar S, 2012, DIABETES-METAB RES, V28, P424, DOI 10.1002/dmrr.2290; Strobel F, 2013, HORM METAB RES; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Sun X, 2008, INT J OBESITY, V32, P1305, DOI 10.1038/ijo.2008.59; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Tamborlane WV, 2005, PEDIATR DIABETES, V6, P13; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1; Zelber-Sagi S, 2013, LIVER INT, V33, P1406, DOI 10.1111/liv.12200; Zemel MB, 2008, NUTR REV, V66, pS139, DOI 10.1111/j.1753-4887.2008.00099.x; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	63	32	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99646	10.1371/journal.pone.0099646	http://dx.doi.org/10.1371/journal.pone.0099646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918447	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000101
J	Omland, T; Lie, KA; Akre, H; Sandlie, LE; Jebsen, P; Sandvik, L; Nymoen, DA; Bzhalava, D; Dillner, J; Brondbo, K				Omland, Turid; Lie, Kathrine A.; Akre, Harriet; Sandlie, Lars Erik; Jebsen, Peter; Sandvik, Leiv; Nymoen, Dag Andre; Bzhalava, Davit; Dillner, Joakim; Brondbo, Kjell			Recurrent Respiratory Papillomatosis: HPV Genotypes and Risk of High-Grade Laryngeal Neoplasia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; SQUAMOUS-CELL CARCINOMAS; JUVENILE-ONSET; MALIGNANT-TRANSFORMATION; DNA; CONDYLOMATA; INFECTION; TYPE-11; CANCER; IDENTIFICATION	Patients with recurrent respiratory papillomatosis (RRP) in Norway treated between 1987 and 2009 were recruited to this cohort study. They were followed from disease onset and data recorded until January 2012. Here, we describe the distribution of human papillomavirus (HPV) genotypes, the prevalence of multiple HPV infections, and the risk of high-grade laryngeal neoplasia and respiratory tract invasive carcinoma in a large cohort of patients with RRP. We also examined whether HPV genotype, gender, age or clinical course are risk factors for this development. Clinical records and histological specimens were reviewed. Using formalin-fixed paraffin-embedded biopsies, HPV genotyping were performed by quantitative polymerase chain reaction assays identifying 15 HPV types. HPV-negative specimens were analyzed by metagenomic sequencing. Paraffin blocks were available in 224/238 patients. The DNA quality was approved in 221/224 cases. HPV DNA was detected in 207/221 patients and all were HPV 6 or HPV 11 positive, comprising HPV 6 in 133/207, HPV 11 in 40/207 cases and HPV 6/11 in 15/207 cases. Co-infection with one or two high-risk HPV types together with HPV 6 or HPV 11 was present in 19/207 patients. Metagenomic sequencing of 14 HPV-negative specimens revealed HPV 8 in one case. In total, 39/221 patients developed high-grade laryngeal neoplasia. 8/221 patients developed carcinoma of the respiratory tract (six patients with laryngeal carcinoma and two patients with lung carcinoma). High-grade laryngeal neoplasias were found more frequently in HPV-negative versus HPV-positive patients, (RR = 2.35, 95% CI 1.1, 4.99), as well as respiratory tract carcinomas (RR = 48, 95% CI 10.72, 214.91). In summary, the majority of RRP were associated with HPV 6 and/or 11. HPV-negative RRP biopsies occurred more frequently in adult-onset patients, and were associated with an increased risk of laryngeal neoplasia and carcinoma in the respiratory tract.	[Omland, Turid; Akre, Harriet; Brondbo, Kjell] Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway; [Omland, Turid; Akre, Harriet; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Oslo, Norway; [Lie, Kathrine A.; Sandlie, Lars Erik; Jebsen, Peter; Nymoen, Dag Andre] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Dept Biostat, Oslo, Norway; [Sandvik, Leiv] Univ Oslo, Fac Dent, Oslo, Norway; [Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; [Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Biostat, Stockholm, Sweden; [Bzhalava, Davit; Dillner, Joakim] Karolinska Hosp, Dept Clin Microbiol & Pathol, S-10401 Stockholm, Sweden	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Omland, T (corresponding author), Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway.	tuomland@ous-hf.no		Bzhalava, Davit/0000-0002-7646-7892	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aubin F, 2008, CLIN INFECT DIS, V47, P610, DOI 10.1086/590560; Blumin JH, 2009, ANN OTO RHINOL LARYN, V118, P481, DOI 10.1177/000348940911800704; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; Buchinsky FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002263; Bzhalava D DJ, 2013, J DATA MINING GENOMI, V4; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; DOYLE DJ, 1994, ARCH OTOLARYNGOL, V120, P1273; Draganov P, 2006, INT J PEDIATR OTORHI, V70, P469, DOI 10.1016/j.ijporl.2005.07.018; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Friis S, 1997, J INFECT DIS, V175, P743, DOI 10.1086/513966; GAYLIS B, 1991, AM J OTOLARYNG, V12, P104, DOI 10.1016/0196-0709(91)90045-H; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Go C, 2003, ANN OTO RHINOL LARYN, V112, P298, DOI 10.1177/000348940311200402; Grce M, 2000, ANTICANCER RES, V20, P2097; Hall JE, 2011, OTOLARYNG HEAD NECK, V144, P252, DOI 10.1177/0194599810391626; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Hobbs Christopher G L, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P88, DOI 10.1097/00020840-200404000-00006; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; KASHIMA H, 1993, ANN OTO RHINOL LARYN, V102, P580, DOI 10.1177/000348949310200802; KASHIMA H, 1988, LARYNGOSCOPE, V98, P619; KASHIMA HK, 1992, LARYNGOSCOPE, V102, P9; Kjaer S K, 1989, IARC Sci Publ, P113; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; Koskinen WJ, 2007, J CANCER RES CLIN, V133, P673, DOI 10.1007/s00432-007-0219-8; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lacey CJ, 2006, VACCINE S3, V24, pS3; LACK EE, 1980, LANCET, V2, P592; Lee LA, 2008, LARYNGOSCOPE, V118, P50, DOI 10.1097/MLG.0b013e318155a288; LIE ES, 1994, ACTA OTO-LARYNGOL, V114, P209, DOI 10.3109/00016489409126044; Lin HW, 2010, AM J OTOLARYNG, V31, P291, DOI 10.1016/j.amjoto.2009.02.019; LINDEBERG H, 1989, ACTA OTO-LARYNGOL, V107, P141, DOI 10.3109/00016488909127491; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Omland T, 2012, LARYNGOSCOPE, V122, P1595, DOI 10.1002/lary.23327; Penaloza-Plascencia M, 2000, ARCH OTOLARYNGOL, V126, P1119, DOI 10.1001/archotol.126.9.1119; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; Sanchez GI, 2012, HEAD NECK; Silverberg MJ, 2003, OBSTET GYNECOL, V101, P645, DOI 10.1016/S0029-7844(02)03081-8; Skerlev M, 2002, CLIN DERMATOL, V20, P173, DOI 10.1016/S0738-081X(02)00210-9; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SOLOMON D, 1985, LARYNGOSCOPE, V95, P900; Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3; Vandepapeliere P, 2005, J INFECT DIS, V192, P2099, DOI 10.1086/498164; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walboomers JMM, 1997, J PATHOL, V181, P253, DOI 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f; World Health Organization Classification of Tumours, 2005, WHO CLASS TUM PATH G	59	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99114	10.1371/journal.pone.0099114	http://dx.doi.org/10.1371/journal.pone.0099114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918765	Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000049
J	Shackleton, R; Shackleton, C; Shackleton, S; Gambiza, J				Shackleton, R.; Shackleton, C.; Shackleton, S.; Gambiza, J.			Deagrarianisation and Forest Revegetation in a Biodiversity Hotspot on the Wild Coast, South Africa (vol 8, e76939, 2013)	PLOS ONE			English	Correction													Shackleton, Ross/AAE-7865-2020; Gambiza, James/GPX-8046-2022; Shackleton, Ross/AAA-8469-2020; Shackleton, Charlie M/F-4177-2014; Shackleton, Charlie/GLV-1260-2022	Shackleton, Ross/0000-0001-5628-4506; Shackleton, Charlie/0000-0002-8489-6136; Shackleton, Sheona/0000-0002-6133-9070				Shackleton R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076939	1	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e100463	10.1371/journal.pone.0100463	http://dx.doi.org/10.1371/journal.pone.0100463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918942	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000134
J	Zhou, LM; Zheng, W; Luo, MJ; Feng, J; Jin, ZC; Wang, Y; Zhang, DL; Tang, QX; He, Y				Zhou, Limin; Zheng, Wei; Luo, Majing; Feng, Jing; Jin, Zhichun; Wang, Yan; Zhang, Dunlan; Tang, Qiongxiu; He, Yan			dbCerEx: A Web-Based Database for the Analysis of Cervical Cancer Transcriptomes	PLOS ONE			English	Article							CELL-CYCLE; EXPRESSION; GENES	Background: Cervical cancers are ranked the second-most hazardous ailments among women worldwide. In the past two decades, microarray technologies have been applied to study genes involved in malignancy progress. However, in most of the published microarray studies, only a few genes were reported leaving rather a large amount of data unused. Also, RNA-Seq data has become more standard for transcriptome analysis and is widely applied in cancer studies. There is a growing demand for a tool to help the experimental researchers who are keen to explore cervical cancer gene therapy, but lack computer expertise to access and analyze the high throughput gene expression data. Description: The dbCerEx database is designed to retrieve and process gene expression data from cervical cancer samples. It includes the genome wide expression profiles of cervical cancer samples, as well as a web utility to cluster genes with similar expression patterns. This feature will help researchers conduct further research to uncover novel gene functions. Conclusion: The dbCerEx database is freely available for non-commercial use at http://128.135.207.10/dbCerEx/, and will be updated and integrated with more features as needed.	[Zhou, Limin; Jin, Zhichun; Wang, Yan; Zhang, Dunlan; Tang, Qiongxiu] Hubei Maternal & Child Hlth Hosp, Wuhan, Hubei, Peoples R China; [Zheng, Wei] Yichang Humanwell Pharmaceut Co, Yichang, Hubei, Peoples R China; [He, Yan] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Luo, Majing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Feng, Jing] Wuhan Univ, Int Sch Software, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Wuhan University; Wuhan University	He, Y (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China.	heyan@mail.hzau.edu.cn	Zhou, Li/GSE-4531-2022		National Natural Science Founds of China [31202013]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120146120007]; Fundamental Research Funds for the Central Universities [2011QC075]	National Natural Science Founds of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the National Natural Science Founds of China (Program No. 31202013), Specialized Research Fund for the Doctoral Program of Higher Education of China (Program No 20120146120007), Fundamental Research Funds for the Central Universities (Program No. 2011QC075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Imadome K, 2010, CANCER BIOL THER, V10, P1019, DOI 10.4161/cbt.10.10.13249; Iwakawa M, 2007, CANCER BIOL THER, V6, P905, DOI 10.4161/cbt.6.6.4098; Kloth JN, 2008, J PATHOL, V215, P222, DOI 10.1002/path.2347; Mine KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2693; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rajkumar T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-365; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Team R, 2008, R LANG ENV STAT COMP; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	20	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99834	10.1371/journal.pone.0099834	http://dx.doi.org/10.1371/journal.pone.0099834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24918550	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000120
J	Chen, J; Rashid, T; Feng, GL				Chen, Jian; Rashid, Tahir; Feng, Guolei			A Comparative Study between Solenopsis invicta and Solenopsis richteri on Tolerance to Heat and Desiccation Stresses	PLOS ONE			English	Article							FIRE ANT HYMENOPTERA; FORMICIDAE POPULATIONS; WATER RELATIONS; PHYSIOLOGY; FORAGERS	Solenopsis invicta and Solenopsis richteri are two very closely related invasive ant species; however, S. invicta is a much more successful invader. Physiological tolerance to abiotic stress has been hypothesized to be important to the success of an invasive species. In this study, we tested the hypothesis that S. invicta is more tolerant to heat and desiccation stress than S. richteri. The data strongly support our hypothesis. S. invicta was found to be significantly less vulnerable than S. richteri to both heat and desiccation stress. Despite S. richteri having significantly higher body water content, S. invicta was less sensitive to desiccation stress due to its significantly lower water loss rate (higher desiccation resistance). After the cuticular lipid was removed, S. invicta still had a significantly lower water loss rate than S. richteri, indicating that cuticular lipids were not the only factors accounting for difference in the desiccation resistance between these two species. Since multiple biological and/or ecological traits can contribute to the invasion success of a particular species, whether the observed difference in tolerance to heat and desiccation stresses is indeed associated with the variation in invasion success between these two species can only be confirmed by further extensive comparative study.	[Chen, Jian] ARS, Biol Control Pests Res Unit, USDA, Stoneville, MS 38776 USA; [Rashid, Tahir; Feng, Guolei] Alcorn State Univ, Extens Res Demonstrat Farm & Technol Transfer Ctr, Mound Bayou, MS USA	United States Department of Agriculture (USDA); Alcorn State University	Chen, J (corresponding author), ARS, Biol Control Pests Res Unit, USDA, Stoneville, MS 38776 USA.	jian.chen@ars.usda.gov						Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Bennett VA, 2005, J EXP BIOL, V208, P4467, DOI 10.1242/jeb.01892; Boyles JG, 2009, J THERM BIOL, V34, P81, DOI 10.1016/j.jtherbio.2008.10.005; BUREN W F, 1972, Journal of the Georgia Entomological Society, V7, P1; Callcott A.M., 2002, P 2002 IMP FIR ANT C, P91; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; DUNCAN FD, 1994, J EXP ZOOL, V270, P350, DOI 10.1002/jez.1402700404; Edney E.B., 1977, WATER BALANCE LAND A, P17; Finke M.D., 2008, ENCY ENTOMOLOGY, V2nd, P2687; FRANCKE OF, 1985, SOUTHWEST NAT, V30, P59, DOI 10.2307/3670657; Hadley N. F, 1994, WATER RELATIONS TERR; Holldobler B., 1990, pi; Holmstrup Martin, 2010, P166, DOI 10.1017/CBO9780511675997.008; HOOD WG, 1990, PHYSIOL ENTOMOL, V15, P23, DOI 10.1111/j.1365-3032.1990.tb00489.x; James SS, 2002, ENVIRON ENTOMOL, V31, P127, DOI 10.1603/0046-225X-31.1.127; Johnson RA, 2000, PHYSIOL ENTOMOL, V25, P48, DOI 10.1046/j.1365-3032.2000.00170.x; JOUVENAZ DP, 1990, WESTV STUD, P620; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Oliver JB, 2009, J ENTOMOL SCI, V44, P149, DOI 10.18474/0749-8004-44.2.149; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; Porter SD, 1997, ENVIRON ENTOMOL, V26, P373, DOI 10.1093/ee/26.2.373; PORTER SD, 1992, J ECON ENTOMOL, V85, P1155; Quinlan MC, 1999, PHYSIOL ENTOMOL, V24, P293, DOI 10.1046/j.1365-3032.1999.00140.x; Ross KG, 2005, MOL ECOL, V14, P3419, DOI 10.1111/j.1365-294X.2005.02661.x; Schilman PE, 2007, PHYSIOL ENTOMOL, V32, P1, DOI 10.1111/j.1365-3032.2006.00533.x; Streett DA, 2006, FLA ENTOMOL, V89, P91, DOI 10.1653/0015-4040(2006)89[91:SOIFAH]2.0.CO;2; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Tschinkel W.R., 2006, FIRE ANTS, P747; Valles SM, 2003, INSECT SOC, V50, P199, DOI 10.1007/s00040-003-0662-8; VANDERMEER RK, 1989, J CHEM ECOL, V15, P1757, DOI 10.1007/BF01012263; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9; Yoder JA, 2006, J INSECT PHYSIOL, V52, P202, DOI 10.1016/j.jinsphys.2005.10.005	36	8	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96842	10.1371/journal.pone.0096842	http://dx.doi.org/10.1371/journal.pone.0096842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915009	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700006
J	Cho, S; Shi, K; Seffernick, JL; Dodge, AG; Wackett, LP; Aihara, H				Cho, Seunghee; Shi, Ke; Seffernick, Jennifer L.; Dodge, Anthony G.; Wackett, Lawrence P.; Aihara, Hideki			Cyanuric Acid Hydrolase from Azorhizobium caulinodans ORS 571: Crystal Structure and Insights into a New Class of Ser-Lys Dyad Proteins	PLOS ONE			English	Article							SEQUENCE; MODEL; DIFFRACTION; ENZYME; SYSTEM; FAMILY; SUITE	Cyanuric acid hydrolase (CAH) catalyzes the hydrolytic ring-opening of cyanuric acid (2,4,6-trihydroxy-1,3,5-triazine), an intermediate in s-triazine bacterial degradation and a by-product from disinfection with trichloroisocyanuric acid. In the present study, an X-ray crystal structure of the CAH-barbituric acid inhibitor complex from Azorhizobium caulinodans ORS 571 has been determined at 2.7 angstrom resolution. The CAH protein fold consists of three structurally homologous domains forming a beta-barrel-like structure with external alpha-helices that result in a three-fold symmetry, a dominant feature of the structure and active site that mirrors the three-fold symmetrical shape of the substrate cyanuric acid. The active site structure of CAH is similar to that of the recently determined AtzD with three pairs of active site Ser-Lys dyads. In order to determine the role of each Ser-Lys dyad in catalysis, a mutational study using a highly sensitive, enzyme-coupled assay was conducted. The 10(9)-fold loss of activity by the S226A mutant was at least ten times lower than that of the S79A and S333A mutants. In addition, bioinformatics analysis revealed the Ser226/Lys156 dyad as the only absolutely conserved dyad in the CAH/barbiturase family. These data suggest that Lys156 activates the Ser226 nucleophile which can then attack the substrate carbonyl. Our combination of structural, mutational, and bioinformatics analyses differentiates this study and provides experimental data for mechanistic insights into this unique protein family.	[Cho, Seunghee; Shi, Ke; Seffernick, Jennifer L.; Wackett, Lawrence P.; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Seffernick, Jennifer L.; Dodge, Anthony G.; Wackett, Lawrence P.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Wackett, Lawrence P.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.	wacke003@umn.edu; aihar001@umn.edu		, Ke/0000-0003-4175-3714	BioTechnology Institute; National Center for Food Safety and Defense; Lonza; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095558] Funding Source: NIH RePORTER	BioTechnology Institute(Ankara University); National Center for Food Safety and Defense; Lonza; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the BioTechnology Institute, a grant from the National Center for Food Safety and Defense, and a grant from Lonza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Burman JD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-30; Cho S, 2013, ACTA CRYSTALLOGR F, V69, P880, DOI 10.1107/S1744309113017077; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; Dodge AG, 2013, J BACTERIOL, V195, P5233, DOI 10.1128/JB.00965-13; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fruchey I, 2003, APPL ENVIRON MICROB, V69, P3653, DOI 10.1128/AEM.69.6.3653-3657.2003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huthmacher K., 2000, ULLMANNS ENCY IND CH, DOI [10.1002/14356007.a08_191, DOI 10.1002/14356007.A08_191]; JUTZI K, 1982, BIOCHEM J, V208, P679, DOI 10.1042/bj2080679; Karns JS, 1999, APPL ENVIRON MICROB, V65, P3512; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Knapik AA, 2012, ACTA CRYSTALLOGR F, V68, P1294, DOI 10.1107/S1744309112041796; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Oelschlaeger P, 2005, PROTEIN SCI, V14, P765, DOI 10.1110/ps.041093405; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Soong CL, 2001, BIOCHEM BIOPH RES CO, V286, P222, DOI 10.1006/bbrc.2001.5356; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	32	9	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99349	10.1371/journal.pone.0099349	http://dx.doi.org/10.1371/journal.pone.0099349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24915109	Green Submitted, Green Published, gold			2022-12-27	WOS:000340947700088
J	Shivarov, V; Ivanova, M; Naumova, E				Shivarov, Velizar; Ivanova, Milena; Naumova, Elissaveta			Rapid Detection of DNMT3A R882 Mutations in Hematologic Malignancies Using a Novel Bead-Based Suspension Assay with BNA(NC) Probes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; LOCKED NUCLEIC-ACID; POOR-PROGNOSIS; RISK STRATIFICATION; SOMATIC MUTATIONS; MULTIPLEX ASSAY; IDENTIFICATION; METHYLATION; TECHNOLOGY; IMPACT	Mutations in the human DNA methyl transferase 3A (DNMT3A) gene are recurrently identified in several hematologic malignancies such as Philadelphia chromosome-negative myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), MPN/MDS overlap syndromes and acute myeloid leukemia (AML). They have been shown to confer worse prognosis in some of these entities. Notably, about 2/3 of these mutations are missense mutations in codon R882 of the gene. We aimed at the development and validation of a novel easily applicable in routine practice method for quantitative detection of the DNMT3A p. R882C/H/R/S mutations bead-based suspension assay. Initial testing on plasmid constructs showed excellent performance of BNA(NC)-modified probes with an optimal hybridization temperature of 66 degrees C. The method appeared to be quantitative and showed sensitivity of 2.5% for different mutant alleles, making it significantly superior to direct sequencing. The assay was further validated on plasmid standards at different ratios between wild type and mutant alleles and on clinical samples from 120 patients with known or suspected myeloid malignancies. This is the first report on the quantitative detection of DNMT3A R882 mutations using bead-based suspension assay with BNA(NC)-modified probes. Our data showed that it could be successfully implemented in the diagnostic work-up for patients with myeloid malignancies, as it is rapid, easy and reliable in terms of specificity and sensitivity.	[Shivarov, Velizar] Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia, Bulgaria; [Ivanova, Milena; Naumova, Elissaveta] Med Univ, Alexandrovska Univ Hosp, Dept Clin Immunol, Sofia, Bulgaria	Medical University Sofia	Shivarov, V (corresponding author), Natl Hematol Hosp, Lab Hematopathol & Immunol, Sofia, Bulgaria.	vshivarov@abv.bg	Shivarov, Velizar/B-4553-2008; Ivanova, MIlena/AAY-9725-2021; Naumova, Elissaveta/AFT-1332-2022	Shivarov, Velizar/0000-0001-5362-7999; 	National Science Fund, Bulgaria [5/16.12.2009, ID_09_157]	National Science Fund, Bulgaria(National Science Fund of Bulgaria)	This work was supported financially by Project ID_09_157 (Contract 5/16.12.2009) from the National Science Fund, Bulgaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-405; Bisling KE, 2014, LEUKEMIA LYMPHOMA, V55, P711, DOI 10.3109/10428194.2013.811580; Brewin JN, 2013, LEUKEMIA LYMPHOMA, V54, P1336, DOI 10.3109/10428194.2012.736986; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gaidzik VI, 2013, BLOOD, V121, P4769, DOI 10.1182/blood-2012-10-461624; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Hafez M, 2010, J MOL DIAGN, V12, P629, DOI 10.2353/jmoldx.2010.090219; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Hou HA, 2014, LEUKEMIA, V28, P50, DOI 10.1038/leu.2013.236; Itzykson R, 2013, BEST PRACT RES CL HA, V26, P355, DOI 10.1016/j.beha.2014.01.001; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; Ivanova MI, 2011, LEUKEMIA RES, V35, P1120, DOI 10.1016/j.leukres.2011.04.012; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Kihara R, 2014, LEUKEMIA IN PRESS; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Koshkin AA, 1998, J AM CHEM SOC, V120, P13252, DOI 10.1021/ja9822862; Laosinchai-Wolf W, 2011, J CLIN PATHOL, V64, P30, DOI 10.1136/jcp.2010.081539; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026906; Luthra R, 2013, HAEMATOLOGI IN PRESS; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Paradis FW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-54; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Rahman SMA, 2008, J AM CHEM SOC, V130, P4886, DOI 10.1021/ja710342q; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Shackelford Rodney E, 2013, Methods Mol Biol, V999, P93, DOI 10.1007/978-1-62703-357-2_6; Shivarov V, 2013, LEUKEMIA RES, V37, P1445, DOI 10.1016/j.leukres.2013.07.032; Shivarov V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076944; Shivarov V, 2013, LEUKEMIA LYMPHOMA, V54, P1343, DOI 10.3109/10428194.2012.745526; Shivarov V, 2011, LEUKEMIA LYMPHOMA, V52, P2023, DOI 10.3109/10428194.2011.584995; Singh RR, 2012, J MOL DIAGN, V14, P336, DOI 10.1016/j.jmoldx.2012.02.009; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Wallace J, 2003, LEUKEMIA, V17, P1411, DOI 10.1038/sj.leu.2402986; Wertheim GBW, 2014, J MOL DIAGN, V16, P207, DOI 10.1016/j.jmoldx.2013.10.010; Wu SY, 2010, CLIN CHEM LAB MED, V48, P1103, DOI 10.1515/CCLM.2010.227; Xu J, 2014, P NATL ACAD IN PRESS; Yamamoto T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/707323	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99769	10.1371/journal.pone.0099769	http://dx.doi.org/10.1371/journal.pone.0099769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914952	Green Published, gold, Green Submitted			2022-12-27	WOS:000340947700131
J	Skinner, C; Patfield, S; Stanker, LH; Fratamico, P; He, XH				Skinner, Craig; Patfield, Stephanie; Stanker, Larry H.; Fratamico, Pina; He, Xiaohua			New High-Affinity Monoclonal Antibodies against Shiga Toxin 1 Facilitate the Detection of Hybrid Stx1/Stx2 In Vivo	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI; ENCODING BACTERIOPHAGES; B-SUBUNIT; VARIANTS; MICE; ASSOCIATION; STRAINS; DISEASE; STEC	Background: Shiga toxin-producing E. coli (STEC) are a group of common and potentially deadly intestinal pathogens expressing Shiga toxin (Stx) as a primary virulence factor. Of the two types of Stx, Stx2 is responsible for more severe symptoms during infection, while Stx1 is almost identical to the Shiga toxin from Shigella dysenteriae, a ubiquitous pathogen in developing countries. Although antibodies against Stx1 have been reported, few have reached the affinity needed for assembling highly sensitive immunoassays. Sensitive and affordable immunoassays for Stx1 and Stx2 could help improve detection of STEC in livestock, food, the environment, and in clinical samples resulting in improved food safety and human health. Method and Findings: Three new monoclonal antibodies (mAbs) against the B subunit of Stx1 were generated using recombinant toxoid Stx1E167Q and hybridoma technology. These new mAbs recognize all subtypes of Stx1, but do not cross-react with any subtype of Stx2. In addition, they exhibited the ability to neutralize Stx1 toxicity in Vero cell assays. An optimized sandwich ELISA using of a pair of these mAbs had a limit of detection of 8.7 pg/mL, which is superior to any existing assay of this kind. Using one of these Stx1 mAbs in concert with Stx2 mAbs, the presence of hybrid Stx1/Stx2 toxin in the culture media of STEC strains that express both Stx1 and Stx2 was demonstrated. Conclusions: These new mAbs provide a mix of availability, utility, versatility, and most importantly, increased sensitivity for detection of Stx1. There are numerous potential applications for these mAbs, including low-cost detection assays and therapeutic use. Analysis of hybrid Stx1/2 could provide new insights on the structure, activity, and cellular targets of Shiga toxins.	[Skinner, Craig; Patfield, Stephanie; Stanker, Larry H.; He, Xiaohua] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Fratamico, Pina] USDA ARS, Eastern Reg Res Ctr, Wyndmoor, PA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	He, XH (corresponding author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.	xiaohua.he@ars.usda.gov			USDA-ARS National Program [NP108]; CRIS project [5325-42000-048-00D]	USDA-ARS National Program; CRIS project	This research was supported by USDA-ARS National Program NP108, CRIS project 5325-42000-048-00D. The U.S. Department of Agriculture is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Beutin L, 2007, J APPL MICROBIOL, V102, P630, DOI 10.1111/j.1365-2672.2006.03139.x; Burk C, 2003, J CLIN MICROBIOL, V41, P2106, DOI 10.1128/JCM.41.5.2106-2112.2003; CANTEY JR, 1985, J INFECT DIS, V151, P766, DOI 10.1093/infdis/151.5.766; Cheng LW, 2013, TOXINS, V5, P1845, DOI 10.3390/toxins5101845; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Friedrich AW, 2003, J CLIN MICROBIOL, V41, P2448, DOI 10.1128/JCM.41.6.2448-2453.2003; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gaston MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069823; He X, 2012, J IMMUNOL METHODS; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; HEAD SC, 1991, J BIOL CHEM, V266, P3617; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175, DOI 10.1016/S0749-0720(15)30142-0; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Nassar FJ, 2013, FOODBORNE PATHOG DIS, V10, P805, DOI 10.1089/fpd.2013.1510; Ojha SC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/412370; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2001, RES MICROBIOL, V152, P687, DOI 10.1016/S0923-2508(01)01249-9; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059760; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	34	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99854	10.1371/journal.pone.0099854	http://dx.doi.org/10.1371/journal.pone.0099854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24914553	gold, Green Published, Green Submitted			2022-12-27	WOS:000340947700137
J	Acosta, JR; Goldsbury, C; Winnick, C; Badrock, AP; Fraser, ST; Laird, AS; Hall, TE; Don, EK; Fifita, JA; Blair, IP; Nicholson, GA; Cole, NJ				Acosta, Jamie Rae; Goldsbury, Claire; Winnick, Claire; Badrock, Andrew P.; Fraser, Stuart T.; Laird, Angela S.; Hall, Thomas E.; Don, Emily K.; Fifita, Jennifer A.; Blair, Ian P.; Nicholson, Garth A.; Cole, Nicholas J.			Mutant Human FUS Is Ubiquitously Mislocalized and Generates Persistent Stress Granules in Primary Cultured Transgenic Zebrafish Cells	PLOS ONE			English	Article							SARCOMA FUS; MUTATIONS; PROTEINS; FUS/TLS; GENE	FUS mutations can occur in familial amyotrophic lateral sclerosis (fALS), a neurodegenerative disease with cytoplasmic FUS inclusion bodies in motor neurons. To investigate FUS pathology, we generated transgenic zebrafish expressing GFP-tagged wild-type or fALS (R521C) human FUS. Cell cultures were made from these zebrafish and the subcellular localization of human FUS and the generation of stress granule (SG) inclusions examined in different cell types, including differentiated motor neurons. We demonstrate that mutant FUS is mislocalized from the nucleus to the cytosol to a similar extent in motor neurons and all other cell types. Both wild-type and R521C FUS localized to SGs in zebrafish cells, demonstrating an intrinsic ability of human FUS to accumulate in SGs irrespective of the presence of disease-associated mutations or specific cell type. However, elevation in relative cytosolic to nuclear FUS by the R521C mutation led to a significant increase in SG assembly and persistence within a sub population of vulnerable cells, although these cells were not selectively motor neurons.	[Acosta, Jamie Rae; Goldsbury, Claire; Laird, Angela S.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Acosta, Jamie Rae; Goldsbury, Claire; Winnick, Claire; Badrock, Andrew P.; Fraser, Stuart T.; Don, Emily K.; Cole, Nicholas J.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Acosta, Jamie Rae; Goldsbury, Claire; Winnick, Claire; Badrock, Andrew P.; Cole, Nicholas J.] Univ Sydney, Discipline Anat & Histol, Sydney, NSW 2006, Australia; [Fraser, Stuart T.] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Laird, Angela S.; Fifita, Jennifer A.; Blair, Ian P.; Nicholson, Garth A.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia; [Winnick, Claire; Badrock, Andrew P.; Don, Emily K.; Fifita, Jennifer A.; Blair, Ian P.; Nicholson, Garth A.; Cole, Nicholas J.] Macquarie Univ, Australian Sch Adv Med, Motorneurone Dis Res Ctr, Sydney, NSW 2109, Australia; [Hall, Thomas E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; ANZAC Research Institute; Macquarie University; University of Queensland	Goldsbury, C (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	claire.goldsbury@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016; cole, nicholas/M-7010-2016; Hall, Thomas/J-2125-2014	Hall, Thomas/0000-0002-7718-7614; Fifita, Jennifer/0000-0002-0814-0118; Goldsbury, Claire/0000-0003-0647-1789; Laird, Angela/0000-0002-6860-9192; Nicholson, Garth/0000-0001-9694-066X; Cole, Nicholas/0000-0003-1006-2662; Don, Emily/0000-0001-5371-0135; Fraser, Stuart/0000-0003-3795-9461; Blair, Ian/0000-0003-3083-0075	National Health and Medical Research Council (NHMRC), Australia; Rebecca Cooper Medical Research Foundation; MND Research Institute of Australia The Snow Foundation	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation; MND Research Institute of Australia The Snow Foundation	Funding provided by The National Health and Medical Research Council (NHMRC), Australia, The Rebecca Cooper Medical Research Foundation and The MND Research Institute of Australia The Snow Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Armstrong GAB, 2013, HUM MOL GENET, V22, P4282, DOI 10.1093/hmg/ddt278; Belzil VV, 2009, NEUROLOGY, V73, P1176, DOI 10.1212/WNL.0b013e3181bbfeef; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Drepper C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.017; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Huang C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002011; Hyman AH, 2011, NATURE, V480, P34, DOI 10.1038/480034a; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Kawamata H, 2011, METHODS MOL BIOL, V793, P3, DOI 10.1007/978-1-61779-328-8_1; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Ticozzi N, 2009, NEUROLOGY, V73, P1180, DOI 10.1212/WNL.0b013e3181bbff05; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012	32	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e90572	10.1371/journal.pone.0090572	http://dx.doi.org/10.1371/journal.pone.0090572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24912067	Green Published, gold			2022-12-27	WOS:000337165600119
J	Gur, I; Fujiwara, K; Hasegawa, K; Yoshikawa, K				Gur, Ibrahim; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki			Necdin Promotes Ubiquitin-Dependent Degradation of PIAS1 SUMO E3 Ligase	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; NEURONAL GROWTH SUPPRESSOR; MAGE GENE FAMILY; NUCLEAR-MATRIX; POSTEMBRYONIC NEUROGENESIS; TRANSCRIPTION FACTOR; PROTEIN INHIBITOR; ACTIVATED STAT1; SMC5-6 COMPLEX; MOUSE-BRAIN	Necdin, a pleiotropic protein that promotes differentiation and survival of mammalian neurons, is a member of MAGE (melanoma antigen) family proteins that share a highly conserved MAGE homology domain. Several MAGE proteins interact with ubiquitin E3 ligases and modulate their activities. However, it remains unknown whether MAGE family proteins interact with SUMO (small ubiquitin-like modifier) E3 ligases such as PIAS (protein inhibitor of activated STAT) family, Nsmce2/Mms21 and Cbx4/Pc2. In the present study, we examined whether necdin interacts with these SUMO E3 ligases. Coimmunoprecipitation analysis revealed that necdin, MAGED1, MAGEF1 and MAGEL2 bound to PIAS1 but not to Nsmce2 or Cbx4. These SUMO E3 ligases bound to MAGEA1 but failed to interact with necdin-like 2/MAGEG1. Necdin bound to PIAS1 central domains that are highly conserved among PIAS family proteins and suppressed PIAS1-dependent sumoylation of the substrates STAT1 and PML (promyelocytic leukemia protein). Remarkably, necdin promoted degradation of PIAS1 via the ubiquitin-proteasome pathway. In transfected HEK293A cells, amino-and carboxyl-terminally truncated mutants of PIAS1 bound to necdin but failed to undergo necdin-dependent ubiquitination. Both PIAS1 and necdin were associated with the nuclear matrix, where the PIAS1 terminal deletion mutants failed to localize, implying that the nuclear matrix is indispensable for necdin-dependent ubiquitination of PIAS1. Our data suggest that necdin suppresses PIAS1 both by inhibiting SUMO E3 ligase activity and by promoting ubiquitin- dependent degradation.	[Gur, Ibrahim; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan	Osaka University	Yoshikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan.	yoshikaw@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science [24300134]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research B2 (24300134) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bischof JM, 2003, DEV DYNAM, V228, P475, DOI 10.1002/dvdy.10398; Chibuk TK, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-22; Chomez P, 2001, CANCER RES, V61, P5544; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Depaux A, 2007, ONCOGENE, V26, P6665, DOI 10.1038/sj.onc.1210486; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Francois S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043335; Fujiwara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030948; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; Hasegawa K, 2012, J NEUROSCI, V32, P5562, DOI 10.1523/JNEUROSCI.0142-12.2012; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang ZY, 2013, J NEUROSCI, V33, P10362, DOI 10.1523/JNEUROSCI.5682-12.2013; Hudson JJR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017270; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2001, J BIOL CHEM, V276, P36624, DOI 10.1074/jbc.M101085200; Lopez-Sanchez N, 2007, PHYSIOL GENOMICS, V30, P156, DOI 10.1152/physiolgenomics.00249.2006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Minamide R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084460; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Nakada Y, 1998, GENE, V213, P65, DOI 10.1016/S0378-1119(98)00206-6; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Nishimura I, 2008, NEUROSCIENCE, V154, P572, DOI 10.1016/j.neuroscience.2008.03.075; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pold M, 1999, GENOMICS, V59, P161, DOI 10.1006/geno.1999.5870; Rabellino A, 2012, CANCER RES, V72, P2275, DOI 10.1158/0008-5472.CAN-11-3159; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Sudharsan R, 2012, J CELL SCI, V125, P5819, DOI 10.1242/jcs.110825; Takazaki R, 2002, EXP CELL RES, V277, P220, DOI 10.1006/excr.2002.5558; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.333; Zhao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048240; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	71	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99503	10.1371/journal.pone.0099503	http://dx.doi.org/10.1371/journal.pone.0099503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911587	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600096
J	Ribeiro-Pereira, C; Moraes, JA; Souza, MD; Laurindo, FR; Arruda, MA; Barja-Fidalgo, C				Ribeiro-Pereira, Cristiane; Moraes, Joao Alfredo; Souza, Mariele de Jesus; Laurindo, Francisco R.; Arruda, Maria Augusta; Barja-Fidalgo, Christina			RedoxModulation of FAK Controls Melanoma Survival - Role of NOX4	PLOS ONE			English	Article							FOCAL ADHESION KINASE; OXIDASE REGULATES GROWTH; CELL-CYCLE PROGRESSION; PROSTATE-CANCER CELLS; OXIDATIVE STRESS; ESSENTIAL MEDIATORS; ANOIKIS RESISTANCE; HYDROGEN-PEROXIDE; REDOX REGULATION; FREE-RADICALS	Studies have demonstrated that reactive oxygen species (ROS) generated by NADPH oxidase are essential for melanoma proliferation and survival. However, the mechanisms by which NADPH oxidase regulates these effects are still unclear. In this work, we investigate the role of NADPH oxidase-derived ROS in the signaling events that coordinate melanoma cell survival. Using the highly metastatic human melanoma cell line MV3, we observed that pharmacological NADPH oxidase inhibition reduced melanoma viability and induced dramatic cellular shape changes. These effects were accompanied by actin cytoskeleton rearrangement, diminished FAK(Y397) phosphorylation, and decrease of FAK-actin and FAK-cSrc association, indicating disassembly of focal adhesion processes, a phenomenon that often results in anoikis. Accordingly, NADPH oxidase inhibition also enhanced hypodiploid DNA content, and caspase-3 activation, suggesting activation of the apoptotic machinery. NOX4 is likely to be involved in these effects, since silencing of NOX4 significantly inhibited basal ROS production, reduced FAK(Y397) phosphorylation and decreased tumor cell viability. Altogether, the results suggest that intracellular ROS generated by the NADPH oxidase, most likely NOX4, transmits cell survival signals on melanoma cells through the FAK pathway, maintaining adhesion contacts and cell viability.	[Ribeiro-Pereira, Cristiane; Moraes, Joao Alfredo; Souza, Mariele de Jesus; Arruda, Maria Augusta; Barja-Fidalgo, Christina] Univ Estado Rio de Janeiro, IBRAG, Dept Cell Biol, Lab Cellular & Mol Pharmacol, BR-20550011 Rio De Janeiro, RJ, Brazil; [Laurindo, Francisco R.] Univ Sao Paulo, Inst Coracao, Lab Vasc Biol, Sao Paulo, Brazil; [Arruda, Maria Augusta] Fiocruz MS, Farmanguinhos, BR-21045900 Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Barja-Fidalgo, C (corresponding author), Univ Estado Rio de Janeiro, IBRAG, Dept Cell Biol, Lab Cellular & Mol Pharmacol, BR-20550011 Rio De Janeiro, RJ, Brazil.	barja-fidalgo@uerj.br	Moraes, João Alfredo A/E-3557-2017; Laurindo, Francisco R/J-6575-2015	Moraes, João Alfredo A/0000-0002-8563-6432; Arruda, Maria Augusta/0000-0002-0828-9430	CNPq; CAPES; FAPERJ; Sub-reitoria de Pos-Graduacao e Pesquisa [SR-2/UERJ]; Women In Science National Fellowship	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Sub-reitoria de Pos-Graduacao e Pesquisa; Women In Science National Fellowship	This work was supported by CNPq (www.cnpq.br), CAPES (www.capes.gov.br), FAPERJ (www.faperj.br) and Sub-reitoria de Pos-Graduacao e Pesquisa (SR-2/UERJ-www.sr2.uerj.br). M.A. Arruda is a L'Oreal-UNESCO-ABC For Women In Science National Fellowship - 2008 awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2011, AGING DIS, V2, P219; Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Beausejour M, 2012, APOPTOSIS, V17, P566, DOI 10.1007/s10495-012-0713-6; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chiarugi P, 2005, FREE RADICAL RES, V39, P353, DOI 10.1080/10715760400027987; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Cooper KL, 2009, FREE RADICAL BIO MED, V47, P381, DOI 10.1016/j.freeradbiomed.2009.04.034; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; de Vries E, 2012, BRIT J DERMATOL, V167, P53, DOI 10.1111/j.1365-2133.2012.11087.x; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; DOOLEY DC, 1982, EXP HEMATOL, V10, P591; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Du J, 2012, MOL CARCINOGENESIS; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hess AR, 2006, CELL CYCLE, V5, P478, DOI 10.4161/cc.5.5.2518; Hsieh CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023945; Klees RF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/87246; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Liu F, 2012, J INVEST DERMATOL, P1; Liu GY, 2008, CELL BIOL INT, V32, P663, DOI 10.1016/j.cellbi.2008.01.292; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Poljsak B, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/135206; Qin Y, 2008, CELL BIOL INT, V32, P224, DOI 10.1016/j.cellbi.2007.08.028; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; VANDELOOSDRECHT AA, 1991, J IMMUNOL METHODS, V141, P15, DOI 10.1016/0022-1759(91)90205-T; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; Weaver JR, 2013, MOL CELL ENDOCRINOL, V369, P35, DOI 10.1016/j.mce.2013.01.011; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Woodhead A D, 1999, J Epidemiol, V9, pS102; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Young C, 2009, OCCUP MED-OXFORD, V59, P82, DOI 10.1093/occmed/kqn170; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005; Zhou XX, 2011, J PHARMACOL EXP THER, V339, P218, DOI 10.1124/jpet.111.182352	65	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99481	10.1371/journal.pone.0099481	http://dx.doi.org/10.1371/journal.pone.0099481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911159	gold, Green Published, Green Submitted			2022-12-27	WOS:000337165600092
J	Sikkema, WKA; Strikwerda, A; Sharma, M; Assi, K; Salh, B; Cox, ME; Mills, J				Sikkema, William K. A.; Strikwerda, Arend; Sharma, Manju; Assi, Kiran; Salh, Baljinder; Cox, Michael E.; Mills, Julia			Regulation of Mitotic Cytoskeleton Dynamics and Cytokinesis by Integrin-Linked Kinase in Retinoblastoma Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; SPINDLE ORGANIZATION; GENOMIC INSTABILITY; CYCLE PROGRESSION; PROLIFERATION; CENTROSOME; ILK; OSTEOSARCOMA; GLIOBLASTOMA	During cell division integrin-linked kinase (ILK) has been shown to regulate microtubule dynamics and centrosome clustering, processes involved in cell cycle progression, and malignant transformation. In this study, we examine the effects of downregulating ILK on mitotic function in human retinoblastoma cell lines. These retinal cancer cells, caused by the loss of function of two gene alleles (Rb1) that encode the retinoblastoma tumour suppressor, have elevated expression of ILK. Here we show that inhibition of ILK activity results in a concentration-dependent increase in nuclear area and multinucleated cells. Moreover, inhibition of ILK activity and expression increased the accumulation of multinucleated cells over time. In these cells, aberrant cytokinesis and karyokinesis correlate with altered mitotic spindle organization, decreased levels of cortical F-actin and centrosome de-clustering. Centrosome de-clustering, induced by ILK siRNA, was rescued in FLAG-ILK expressing Y79 cells as compared to those expressing FLAG-tag alone. Inhibition of ILK increased the proportion of cells exhibiting mitotic spindles and caused a significant G2/M arrest as early as 24 hours after exposure to QLT-0267. Live cell analysis indicate ILK downregulation causes an increase in multipolar anaphases and failed cytokinesis (bipolar and multipolar) of viable cells. These studies extend those indicating a critical function for ILK in mitotic cytoskeletal organization and describe a novel role for ILK in cytokinesis of Rb deficient cells.	[Sikkema, William K. A.; Strikwerda, Arend; Mills, Julia] Trinity Western Univ, Dept Biol, Langley, BC, Canada; [Sharma, Manju; Cox, Michael E.] Vancouver Coastal Hlth Res Inst, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Assi, Kiran; Salh, Baljinder] Univ British Columbia, Div Gastroenterol, Vancouver, BC V5Z 1M9, Canada; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Trinity Western University; Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University	Mills, J (corresponding author), Trinity Western Univ, Dept Biol, Langley, BC, Canada.	julia.mills@twu.ca			Murdock College Research Program for Life Sciences; Murdock General Science Grant; Murdock Trust	Murdock College Research Program for Life Sciences; Murdock General Science Grant; Murdock Trust	The authors gratefully acknowledge the award from the Murdock College Research Program for Life Sciences that made this research possible. A Murdock General Science Grant as a match to the CFI Leaders Opportunity Fund Grant enabled the purchase of the Olympus DSU spinning disk confocal used in this study. The Molecular and Cell Biology laboratory and Cell Culture laboratory in which these studies took place were made possible by a grant from Murdock Trust as a match to the Industry Canada Knowledge Infrastructure Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2012, NAT CELL BIOL; Assi K, 2008, GUT, V57, P931, DOI 10.1136/gut.2007.142778; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Chen Z, 2011, GRAEF ARCH CLIN EXP, V249, P1399, DOI 10.1007/s00417-010-1607-3; Dobreva I, 2008, J PROTEOME RES, V7, P1740, DOI 10.1021/pr700852r; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fielding AB, 2008, CELL CYCLE, V7, P1899, DOI 10.4161/cc.7.13.6204; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fielding A, 2009, CANCER METAST REV, V28, P99, DOI 10.1007/s10555-008-9177-0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Galimberti F, 2011, CLIN CANCER RES, V17, P1218, DOI 10.1158/1078-0432.CCR-10-1178; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gkretsi V, 2007, HEPATOLOGY, V45, P1025, DOI 10.1002/hep.21540; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HOWARD MA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1025, DOI 10.1001/archopht.1989.01070020087037; Huang CY, 2011, BIOCHEM PHARMACOL, V81, P577, DOI 10.1016/j.bcp.2010.12.005; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053702; MacPherson D, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-9; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mills J, 2006, J NEUROSCI, V26, P830, DOI 10.1523/JNEUROSCI.1852-05.2006; Mills J, 2003, J NEUROSCI, V23, P1638; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Seigel GM, 2005, MOL VIS, V11, P729; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Zhu J, 2005, ANTICANCER RES, V25, P1919	37	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98838	10.1371/journal.pone.0098838	http://dx.doi.org/10.1371/journal.pone.0098838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911651	Green Published, Green Submitted, gold			2022-12-27	WOS:000337165600016
J	Xing, K; Hoffmann, AA; Ma, CS				Xing, Kun; Hoffmann, Ary A.; Ma, Chun-Sen			Does Thermal Variability Experienced at the Egg Stage Influence Life History Traits across Life Cycle Stages in a Small Invertebrate?	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA LEPIDOPTERA; MYZUS-PERSICAE HEMIPTERA; DIAMONDBACK MOTH; INCUBATION-TEMPERATURE; HATCHLING PHENOTYPES; CONSTANT; SURVIVAL; INSECT; GROWTH; PERFORMANCE	Although effects of thermal stability on eggs have often been considered in vertebrates, there is little data thermal stability in insect eggs even though these eggs are often exposed in nature to widely fluctuating ambient conditions. The modularity of development in invertebrates might lead to compensation across life cycle stages but this remains to be tested particularly within the context of realistic temperature fluctuations encountered in nature. We simulated natural temperate fluctuations on eggs of the worldwide cruciferous insect pest, the diamondback moth (DBM), Plutella xylostella (L.), while maintaining the same mean temperature (25 degrees C +/- 0 degrees C, 25 +/- 4 degrees C, 25 +/- 6 degrees C, 25 +/- 8 degrees C, 25 +/- 10 degrees C, 25 +/- 12 degrees C) and assessed egg development, survival and life history traits across developmental stages. Moderate fluctuations (25 +/- 4 degrees C, 25 +/- 6 degrees C) did not influence performance compared to the constant temperature treatment, and none of the treatments influenced egg survival. However the wide fluctuating temperatures (25 +/- 10 degrees C, 25 +/- 2 degrees C) slowed development time and led to an increase in pre-pupal mass, although these changes did not translate into any effects on longevity or fecundity at the adult stage. These findings indicate that environmental effects can extend across developmental stages despite the modularity of moth development but also highlight that there are few fitness consequences of the most variable thermal conditions likely to be experienced by Plutella xylostella.	[Xing, Kun; Ma, Chun-Sen] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Climate Change Biol Res Grp, Beijing 100193, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Dept Zool, Inst Bio21, Parkville, Vic 3052, Australia; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Inst Bio21, Parkville, Vic 3052, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Melbourne; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Climate Change Biol Res Grp, Beijing 100193, Peoples R China.	machunsen@caas.cn	Hoffmann, Ary/C-2961-2011; Ma, Chun-Sen/K-5414-2019; Hoffmann, Ary/R-2972-2019	Ma, Chun-Sen/0000-0002-3253-6921; Hoffmann, Ary/0000-0001-9497-7645	Ministry of Agriculture (MOA), PR China [201103021]	Ministry of Agriculture (MOA), PR China	This research was financially supported by a research grant (201103021) from the Ministry of Agriculture (MOA), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha SJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P597, DOI 10.1086/652245; Andrews RM, 2012, BIOL J LINN SOC, V106, P851, DOI 10.1111/j.1095-8312.2012.01901.x; Angilletta MJ, 2009, BIO HABIT, P35; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Boardman L, 2013, J INSECT PHYSIOL, V59, P781, DOI 10.1016/j.jinsphys.2013.05.005; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Chen Fei-Zhou, 2003, Acta Ecologica Sinica, V23, P688; Chen TX, 2007, PLATEAU METEOR, V1, P17; Chen Yi-xin, 2011, Fujian Nongye Xuebao, V26, P611; Davis JA, 2006, ENVIRON ENTOMOL, V35, P1461, DOI 10.1603/0046-225X(2006)35[1461:EOHAFT]2.0.CO;2; Dmitriew C, 2005, OECOLOGIA, V142, P150, DOI 10.1007/s00442-004-1712-2; Du WG, 2009, J THERM BIOL, V34, P250, DOI 10.1016/j.jtherbio.2009.03.002; Escobar A, 2012, INSECT SCI, V19, P657, DOI 10.1111/j.1744-7917.2011.01470.x; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; GHARIB B, 1983, FEBS LETT, V160, P119, DOI 10.1016/0014-5793(83)80949-1; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; Hassan MW, 2011, J ECON ENTOMOL, V104, P1436, DOI 10.1603/EC11046; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Liu SS, 1999, B ENTOMOL RES, V89, P53, DOI 10.1017/S0007485399000073; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Macqueen DJ, 2008, BIOL LETTERS, V4, P294, DOI 10.1098/rsbl.2007.0620; Makowski K, 2008, ATMOS CHEM PHYS, V8, P6483, DOI 10.5194/acp-8-6483-2008; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Micheli-Campbell MA, 2012, J ZOOL, V288, P143, DOI 10.1111/j.1469-7998.2012.00934.x; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Petavy G, 2004, EVOL ECOL RES, V6, P873; PITTS GC, 1986, GROWTH, V50, P419; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; QAYYUM A, 1987, J AUST ENTOMOL SOC, V26, P295; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Salvucci ME, 2000, J THERM BIOL, V25, P353, DOI 10.1016/S0306-4565(99)00107-2; Sarfraz RM, 2011, ENTOMOL SCI, V14, P20, DOI 10.1111/j.1479-8298.2010.00413.x; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Stevens MM, 1998, AQUAT INSECT, V20, P181, DOI 10.1076/aqin.20.3.181.4470; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Umeya K, 1973, JPN J APPL ENTOMOL Z, P112; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Xing Kun, 2013, Yingyong Shengtai Xuebao, V24, P1769; YANG YL, 1995, OECOLOGIA, V104, P225, DOI 10.1007/BF00328587; Yengkokpam S, 2013, AQUAC NUTR, V19, P297; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zhao F, 2014, J ANIM ECOL, V83, P769, DOI 10.1111/1365-2656.12196	51	24	29	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99500	10.1371/journal.pone.0099500	http://dx.doi.org/10.1371/journal.pone.0099500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911213	Green Published, gold			2022-12-27	WOS:000337165600093
J	Bhat, S; Boynton, TO; Pham, D; Shimkets, LJ				Bhat, Swapna; Boynton, Tye O.; Pham, Dan; Shimkets, Lawrence J.			Fatty Acids from Membrane Lipids Become Incorporated into Lipid Bodies during Myxococcus xanthus Differentiation	PLOS ONE			English	Article							DEVELOPMENTAL GENE-EXPRESSION; ADVENTUROUS GLIDING MOTILITY; FRUITING BODY DEVELOPMENT; GUANOSINE PENTAPHOSPHATE; COMBINATORIAL REGULATION; CELL-INTERACTIONS; ISOVALERYL-COA; C-FACTOR; PROTEIN; IDENTIFICATION	Myxococcus xanthus responds to amino acid limitation by producing fruiting bodies containing dormant spores. During development, cells produce triacylglycerides in lipid bodies that become consumed during spore maturation. As the cells are starved to induce development, the production of triglycerides represents a counterintuitive metabolic switch. In this paper, lipid bodies were quantified in wild-type strain DK1622 and 33 developmental mutants at the cellular level by measuring the cross sectional area of the cell stained with the lipophilic dye Nile red. We provide five lines of evidence that triacylglycerides are derived from membrane phospholipids as cells shorten in length and then differentiate into myxospores. First, in wild type cells, lipid bodies appear early in development and their size increases concurrent with an 87% decline in membrane surface area. Second, developmental mutants blocked at different stages of shortening and differentiation accumulated lipid bodies proportionate with their cell length with a Pearson's correlation coefficient of 0.76. Third, peripheral rods, developing cells that do not produce lipid bodies, fail to shorten. Fourth, genes for fatty acid synthesis are down-regulated while genes for fatty acid degradation are up regulated. Finally, direct movement of fatty acids from membrane lipids in growing cells to lipid bodies in developing cells was observed by pulse labeling cells with palmitate. Recycling of lipids released by Programmed Cell Death appears not to be necessary for lipid body production as a fadL mutant was defective in fatty acid uptake but proficient in lipid body production. The lipid body regulon involves many developmental genes that are not specifically involved in fatty acid synthesis or degradation. MazF RNA interferase and its target, enhancer-binding protein NIa6, appear to negatively regulate cell shortening and TAG accumulation whereas most cell-cell signals activate these processes.	[Bhat, Swapna; Boynton, Tye O.; Pham, Dan; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Shimkets, LJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	shimkets@uga.edu			National Science Foundation [MCB 0742976]; National Institute of General Medical Sciences of the National Institutes of Health [1RO1GM095826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095826] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in this publication was supported by the National Science Foundation under award number MCB 0742976 and by the National Institute of General Medical Sciences of the National Institutes of Health under award number 1RO1GM095826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Bhat S, 2014, MBIO, V5, DOI 10.1128/mBio.00939-13; Bode HB, 2006, J BACTERIOL, V188, P5632, DOI 10.1128/JB.00438-06; Bode HB, 2009, CHEMBIOCHEM, V10, P128, DOI 10.1002/cbic.200800219; Bonner PJ, 2006, MOL MICROBIOL, V61, P1283, DOI 10.1111/j.1365-2958.2006.05298.x; Bonner PJ, 2006, J BACTERIOL, V188, P4585, DOI 10.1128/JB.00237-06; Boynton TO, 2013, MOL MICROBIOL, V87, P1267, DOI 10.1111/mmi.12165; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Caberoy NB, 2003, J BACTERIOL, V185, P6083, DOI 10.1128/JB.185.20.6083-6094.2003; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; CHENG Y, 1989, J BACTERIOL, V171, P3727, DOI 10.1128/jb.171.7.3727-3731.1989; Dickschat JS, 2005, ORG BIOMOL CHEM, V3, P2824, DOI 10.1039/b504889c; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; Giglio KM, 2011, P NATL ACAD SCI USA, V108, pE431, DOI 10.1073/pnas.1105876108; GILL RE, 1988, J BACTERIOL, V170, P5289, DOI 10.1128/jb.170.11.5289-5297.1988; GILL RE, 1988, J BACTERIOL, V170, P5279, DOI 10.1128/jb.170.11.5279-5288.1988; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gronewold TMA, 2007, J BACTERIOL, V189, P1836, DOI 10.1128/JB.01618-06; Gronewold TMA, 2002, J BACTERIOL, V184, P1172, DOI 10.1128/jb.184.4.1172-1179.2002; Gronewold TMA, 2001, MOL MICROBIOL, V40, P744, DOI 10.1046/j.1365-2958.2001.02428.x; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; Harris BZ, 1998, GENE DEV, V12, P1022, DOI 10.1101/gad.12.7.1022; HARTZELL P, 1991, J BACTERIOL, V173, P7615, DOI 10.1128/jb.173.23.7615-7624.1991; Hoiczyk E, 2009, MOL MICROBIOL, V74, P497, DOI 10.1111/j.1365-2958.2009.06879.x; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kearns DB, 1998, P NATL ACAD SCI USA, V95, P11957, DOI 10.1073/pnas.95.20.11957; KIM SK, 1991, J BACTERIOL, V173, P1722, DOI 10.1128/jb.173.5.1722-1728.1991; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; KUSPA A, 1992, J BACTERIOL, V174, P7360, DOI 10.1128/jb.174.22.7360-7369.1992; KUSPA A, 1989, J BACTERIOL, V171, P2762, DOI 10.1128/jb.171.5.2762-2772.1989; KUSPA A, 1986, DEV BIOL, V117, P267, DOI 10.1016/0012-1606(86)90369-6; Lee B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028968; LI SF, 1992, GENE DEV, V6, P401, DOI 10.1101/gad.6.3.401; LI SF, 1993, J BACTERIOL, V175, P3648, DOI 10.1128/jb.175.11.3648-3652.1993; Li YY, 2013, ANGEW CHEM INT EDIT, V52, P1304, DOI 10.1002/anie.201207984; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; MANOIL C, 1980, J BACTERIOL, V141, P305, DOI 10.1128/JB.141.1.305-315.1980; MANOIL C, 1980, J BACTERIOL, V141, P297, DOI 10.1128/JB.141.1.297-304.1980; Mittal S, 2009, J BACTERIOL, V191, P2753, DOI 10.1128/JB.01818-08; Moraleda-Munoz A, 2007, J BACTERIOL, V189, P3072, DOI 10.1128/JB.01772-06; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; NUNN WD, 1978, P NATL ACAD SCI USA, V75, P3377, DOI 10.1073/pnas.75.7.3377; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; ORNDORFF PE, 1980, J BACTERIOL, V141, P914, DOI 10.1128/JB.141.2.914-927.1980; Ossa F, 2007, J BACTERIOL, V189, P8474, DOI 10.1128/JB.00894-07; PLAMANN L, 1995, J BACTERIOL, V177, P2014, DOI 10.1128/jb.177.8.2014-2020.1995; PLAMANN L, 1994, J BACTERIOL, V176, P2013, DOI 10.1128/jb.176.7.2013-2020.1994; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Shi WY, 2000, FEMS MICROBIOL LETT, V192, P211, DOI 10.1016/S0378-1097(00)00434-1; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; SHIMKETS L, 1975, J BACTERIOL, V121, P711, DOI 10.1128/JB.121.2.711-720.1975; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; SINGER M, 1995, GENE DEV, V9, P1633, DOI 10.1101/gad.9.13.1633; SogaardAndersen L, 1996, GENE DEV, V10, P740, DOI 10.1101/gad.10.6.740; Sun H, 2001, J BACTERIOL, V183, P6733, DOI 10.1128/JB.183.23.6733-6739.2001; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; THONYMEYER L, 1993, J BACTERIOL, V175, P7450; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Viswanathan P, 2007, P NATL ACAD SCI USA, V104, P7969, DOI 10.1073/pnas.0701569104; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; VOELZ H, 1962, J BACTERIOL, V84, P943, DOI 10.1128/JB.84.5.943-952.1962; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; White DJ, 2000, MOL MICROBIOL, V36, P662, DOI 10.1046/j.1365-2958.2000.01887.x; WITKIN SS, 1970, J BACTERIOL, V103, P641, DOI 10.1128/JB.103.3.641-649.1970; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang ZM, 2000, J BACTERIOL, V182, P5793, DOI 10.1128/JB.182.20.5793-5798.2000; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	79	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99622	10.1371/journal.pone.0099622	http://dx.doi.org/10.1371/journal.pone.0099622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906161	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000126
J	Liu, DY; Ma, CX; Hong, WG; Huang, L; Liu, M; Liu, H; Zeng, HP; Deng, DJ; Xin, HG; Song, J; Xu, CH; Sun, XW; Hou, XL; Wang, XW; Zheng, HK				Liu, Dongyuan; Ma, Chouxian; Hong, Weiguo; Huang, Long; Liu, Min; Liu, Hui; Zeng, Huaping; Deng, Dejing; Xin, Huaigen; Song, Jun; Xu, Chunhua; Sun, Xiaowen; Hou, Xilin; Wang, Xiaowu; Zheng, Hongkun			Construction and Analysis of High-Density Linkage Map Using High-Throughput Sequencing Data	PLOS ONE			English	Article							GENETIC-RECOMBINATION MAP; GENOME SEQUENCE; PROVIDES INSIGHTS; SNP DISCOVERY; PHYSICAL MAP; EVOLUTION; MARKERS; GENOTYPE; LOCI; L.	Linkage maps enable the study of important biological questions. The construction of high-density linkage maps appears more feasible since the advent of next-generation sequencing (NGS), which eases SNP discovery and high-throughput genotyping of large population. However, the marker number explosion and genotyping errors from NGS data challenge the computational efficiency and linkage map quality of linkage study methods. Here we report the HighMap method for constructing high-density linkage maps from NGS data. HighMap employs an iterative ordering and error correction strategy based on a k-nearest neighbor algorithm and a Monte Carlo multipoint maximum likelihood algorithm. Simulation study shows HighMap can create a linkage map with three times as many markers as ordering-only methods while offering more accurate marker orders and stable genetic distances. Using HighMap, we constructed a common carp linkage map with 10,004 markers. The singleton rate was less than one-ninth of that generated by JoinMap4.1. Its total map distance was 5,908 cM, consistent with reports on low-density maps. HighMap is an efficient method for constructing high-density, high-quality linkage maps from high-throughput population NGS data. It will facilitate genome assembling, comparative genomic analysis, and QTL studies. HighMap is available at http://highmap.biomarker.com.cn/.	[Liu, Dongyuan; Ma, Chouxian; Hong, Weiguo; Huang, Long; Liu, Min; Liu, Hui; Zeng, Huaping; Deng, Dejing; Xin, Huaigen; Song, Jun; Xu, Chunhua; Wang, Xiaowu; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China; [Hou, Xilin] Nanjing Agr Univ, Minist Agr, Key Lab Biol & Germplasm Enhancement Hort Crops E, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaowu] CAAS, IVF, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences	Wang, XW (corresponding author), Biomarker Technol Corp, Beijing, Peoples R China.	wangxw@mail.caas.net.cn; zhenghk@biomarker.com.cn	Wang, Xiaowu/L-2579-2019; Hong, Weiguo/ABD-4294-2020		National Program on Key Basic Research Projects [the 973 Program] [2012CB113906, 2012CB113900]; National High Technology Research and Development Program of China [the 863 Program] [2012AA100101]	National Program on Key Basic Research Projects [the 973 Program]; National High Technology Research and Development Program of China [the 863 Program]	This work was supported by a National Program on Key Basic Research Projects [the 973 Program: 2012CB113906 and 2012CB113900]; a National High Technology Research and Development Program of China [the 863 Program, No. 2012AA100101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Chen W, 2013, GENOME RES, V23, P142, DOI 10.1101/gr.142455.112; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Le SQ, 2011, GENOME RES, V21, P952, DOI 10.1101/gr.113084.110; MacLeod A, 2005, NUCLEIC ACIDS RES, V33, P6688, DOI 10.1093/nar/gki980; Margarido GRA, 2007, HEREDITAS, V144, P78, DOI 10.1111/j.2007.0018-0661.02000.x; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Munoz M, 2012, ANIM GENET, V43, P620, DOI 10.1111/j.1365-2052.2011.02301.x; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Sun ZD, 2007, THEOR APPL GENET, V114, P1305, DOI 10.1007/s00122-006-0483-z; Tong C, 2010, TREE GENET GENOMES, V6, P12; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Wu RL, 2002, THEOR POPUL BIOL, V61, P349, DOI 10.1006/tpbi.2002.1577; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2256; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9	41	282	295	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98855	10.1371/journal.pone.0098855	http://dx.doi.org/10.1371/journal.pone.0098855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905985	Green Published, Green Submitted, gold			2022-12-27	WOS:000341869000070
J	Rechsteiner, MP; Floros, X; Boehm, BO; Marselli, L; Marchetti, P; Stoffel, M; Moch, H; Spinas, GA				Rechsteiner, Markus P.; Floros, Xenofon; Boehm, Bernhard O.; Marselli, Lorella; Marchetti, Piero; Stoffel, Markus; Moch, Holger; Spinas, Giatgen A.			Automated Assessment of beta-Cell Area and Density per Islet and Patient Using TMEM27 and BACE2 Immunofluorescence Staining in Human Pancreatic beta-Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; MASS; APOPTOSIS	In this study we aimed to establish an unbiased automatic quantification pipeline to assess islet specific features such as beta-cell area and density per islet based on immunofluorescence stainings. To determine these parameters, the in vivo protein expression levels of TMEM27 and BACE2 in pancreatic islets of 32 patients with type 2 diabetes (T2D) and in 28 non-diabetic individuals (ND) were used as input for the automated pipeline. The output of the automated pipeline was first compared to a previously developed manual area scoring system which takes into account the intensity of the staining as well as the percentage of cells which are stained within an islet. The median TMEM27 and BACE2 area scores of all islets investigated per patient correlated significantly with the manual scoring and with the median area score of insulin. Furthermore, the median area scores of TMEM27, BACE2 and insulin calculated from all T2D were significantly lower compared to the one of all ND. TMEM27, BACE2, and insulin area scores correlated as well in each individual tissue specimen. Moreover, islet size determined by costaining of glucagon and either TMEM27 or BACE2 and beta-cell density based either on TMEM27 or BACE2 positive cells correlated significantly. Finally, the TMEM27 area score showed a positive correlation with BMI in ND and an inverse pattern in T2D. In summary, automated quantification outperforms manual scoring by reducing time and individual bias. The simultaneous changes of TMEM27, BACE2, and insulin in the majority of the beta-cells suggest that these proteins reflect the total number of functional insulin producing beta-cells. Additionally, beta-cell subpopulations may be identified which are positive for TMEM27, BACE2 or insulin only. Thus, the cumulative assessment of all three markers may provide further information about the real beta-cell number per islet.	[Rechsteiner, Markus P.; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Floros, Xenofon] ETH, Dept Comp Sci, Zurich, Switzerland; [Boehm, Bernhard O.] Ulm Univ Med Ctr, Div Endocrinol Diabet & Metab, Ulm, Germany; [Marselli, Lorella; Marchetti, Piero] Univ Pisa, Islet Cell Lab, Dept Clin & Expt Med, Pisa, Italy; [Stoffel, Markus] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Spinas, Giatgen A.] Univ Zurich Hosp, Div Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; University of Pisa; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Rechsteiner, MP (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	markus.rechsteiner@usz.ch	Boehm, Bernhard Otto/F-8750-2015; Marchetti, Piero/J-7439-2013	Marchetti, Piero/0000-0003-4907-0635; Marselli, Lorella/0000-0002-6698-2962; Stoffel, Markus/0000-0003-1304-5817	Hoffmann La Roche Ltd. [34310037]	Hoffmann La Roche Ltd.(Hoffmann-La Roche)	The project was funded by Hoffmann La Roche Ltd. (Project-Nr. 34310037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2012, DIABETOLOGIA, V55, P2316, DOI 10.1007/s00125-012-2609-y; Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Altirriba J, 2010, DIABETOLOGIA, V53, P1406, DOI 10.1007/s00125-010-1728-6; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Brom M, 2014, DIABETOLOGIA, V57, P950, DOI 10.1007/s00125-014-3166-3; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Floros X, 2009, LECT NOTES COMPUT SC, V5762, P633, DOI 10.1007/978-3-642-04271-3_77; Fuchs TJ, 2008, LECT NOTES COMPUT SC, V5242, P1, DOI 10.1007/978-3-540-85990-1_1; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Puri S, 2012, CELL, V150, P1103, DOI 10.1016/j.cell.2012.08.021; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vats D, 2012, DIABETOLOGIA, V55, P2407, DOI 10.1007/s00125-012-2605-2	19	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98932	10.1371/journal.pone.0098932	http://dx.doi.org/10.1371/journal.pone.0098932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905913	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000341869000080
J	Zhong, YQW; Shangguan, ZP				Zhong, Yangquanwei; Shangguan, Zhouping			Water Consumption Characteristics and Water Use Efficiency of Winter Wheat under Long-Term Nitrogen Fertilization Regimes in Northwest China	PLOS ONE			English	Article							RAINFALL-USE EFFICIENCY; LOESS PLATEAU; YIELD RELATIONS; SOIL FERTILITY; DRYLAND WHEAT; PEARL-MILLET; GRAIN-YIELD; MANAGEMENT; MAIZE; IRRIGATION	Water shortage and nitrogen (N) deficiency are the key factors limiting agricultural production in arid and semi-arid regions, and increasing agricultural productivity under rain-fed conditions often requires N management strategies. A field experiment on winter wheat (Triticum aestivum L.) was begun in 2004 to investigate effects of long-term N fertilization in the traditional pattern used for wheat in China. Using data collected over three consecutive years, commencing five years after the experiment began, the effects of N fertilization on wheat yield, evapotranspiration (ET) and water use efficiency (WUE, i.e. the ratio of grain yield to total ET in the crop growing season) were examined. In 2010, 2011 and 2012, N increased the yield of wheat cultivar Zhengmai No. 9023 by up to 61.1, 117.9 and 34.7%, respectively, and correspondingly in cultivar Changhan No. 58 by 58.4, 100.8 and 51.7%. N-applied treatments increased water consumption in different layers of 0-200 cm of soil and thus ET was significantly higher in N-applied than in non-N treatments. WUE was in the range of 1.0-2.09 kg/m(3) for 2010, 2011 and 2012. N fertilization significantly increased WUE in 2010 and 2011, but not in 2012. The results indicated the following: (1) in this dryland farming system, increased N fertilization could raise wheat yield, and the drought-tolerant Changhan No. 58 showed a yield advantage in drought environments with high N fertilizer rates; (2) N application affected water consumption in different soil layers, and promoted wheat absorbing deeper soil water and so increased utilization of soil water; and (3) comprehensive consideration of yield and WUE of wheat indicated that the N rate of 270 kg/ha for Changhan No. 58 was better to avoid the risk of reduced production reduction due to lack of precipitation; however, under conditions of better soil moisture, the N rate of 180 kg/ha was more economic.	[Zhong, Yangquanwei; Shangguan, Zhouping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Shangguan, ZP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn	mahsum, masot/ABC-4546-2020		National Natural Science Foundation of China [41390463, 61273329]; CAS [KZCX2-YW-JC408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	The study was sponsored by the National Natural Science Foundation of China (41390463, 61273329) and the Important Direction Project of Innovation of CAS (KZCX2-YW-JC408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Basso B, 2010, EUR J AGRON, V33, P132, DOI 10.1016/j.eja.2010.04.004; Borlaug N, 2009, FOOD SECUR, V1, P1, DOI 10.1007/s12571-009-0012-4; Dawe D, 2000, FIELD CROP RES, V66, P175, DOI 10.1016/S0378-4290(00)00075-7; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hai L, 2010, SOIL BIOL BIOCHEM, V42, P253, DOI 10.1016/j.soilbio.2009.10.023; Halvorson AD, 2004, AGRON J, V96, P1196, DOI 10.2134/agronj2004.1196; HAMBLIN A, 1987, AUST J AGR RES, V38, P513, DOI 10.1071/AR9870513; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; HOWELL TA, 1995, T ASAE, V38, P745, DOI 10.13031/2013.27888; Huifang H, 2012, MAYDICA, V56; Hunsaker DJ, 2000, AGR FOREST METEOROL, V104, P85, DOI 10.1016/S0168-1923(00)00157-X; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; JOHNSON WENDELL C., 1964, AGRONJ, V56, P29; JUPP AP, 1987, NEW PHYTOL, V105, P393, DOI 10.1111/j.1469-8137.1987.tb00876.x; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kirda C, 2005, FIELD CROP RES, V93, P132, DOI 10.1016/j.fcr.2004.09.015; Li SX, 2009, ADV AGRON, V102, P223, DOI 10.1016/S0065-2113(09)01007-4; Li Y.S., 1982, J AGRONOMY SHAANXI P, V2, P1; Malhi SS, 2011, NUTR CYCL AGROECOSYS, V90, P227, DOI 10.1007/s10705-011-9424-6; MCINTYRE BD, 1995, FIELD CROP RES, V43, P67, DOI 10.1016/0378-4290(95)00035-O; Morell FJ, 2011, SOIL TILL RES, V117, P76, DOI 10.1016/j.still.2011.09.002; MUSICK JT, 1994, AGRON J, V86, P980, DOI 10.2134/agronj1994.00021962008600060010x; Perry C, 2009, AGR WATER MANAGE, V96, P1517, DOI 10.1016/j.agwat.2009.05.005; PIMENTEL D, 1973, SCIENCE, V182, P443, DOI 10.1126/science.182.4111.443; Qiu GY, 2008, AGR FOREST METEOROL, V148, P1848, DOI 10.1016/j.agrformet.2008.06.010; Rahman MA, 2005, FIELD CROP RES, V91, P71, DOI 10.1016/j.fcr.2004.06.010; Regmi AP, 2002, SOIL SCI SOC AM J, V66, P857, DOI 10.2136/sssaj2002.0857; Rockstrom J, 1997, PLANT SOIL, V195, P311, DOI 10.1023/A:1004233303066; Schindler DW, 2009, SCIENCE, V324, P721, DOI 10.1126/science.324_721b; Schneider AD, 1997, T ASAE, V40, P137, DOI 10.13031/2013.21258; Shan L., 1983, NEWSLETTERS PLANT PH, V5, P7; Shangguan ZP, 2002, INT J SUST DEV WORLD, V9, P341, DOI 10.1080/13504500209470129; Shangguan ZP, 2000, J PLANT PHYSIOL, V156, P46, DOI 10.1016/S0176-1617(00)80271-0; Shen JY, 2012, PLANT SOIL ENVIRON, V58, P161, DOI 10.17221/404/2011-PSE; Sheng HD, 1985, ACTA U AGR BOREALI O, V13, P73; Timsina J, 2001, FIELD CROP RES, V72, P143, DOI 10.1016/S0378-4290(01)00171-X; Turner NC, 2005, AUST J AGR RES, V56, P1123, DOI 10.1071/AR05076; Turner NC, 2004, J EXP BOT, V55, P2413, DOI 10.1093/jxb/erh154; Unger PW, 1972, DRYLAND WINTER WHEAT, P11; Zand-Parsa S, 2006, AGR WATER MANAGE, V81, P227, DOI 10.1016/j.agwat.2005.03.010; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang HP, 1999, AGR WATER MANAGE, V38, P195, DOI 10.1016/S0378-3774(98)00069-9; Zhang JH, 1998, FIELD CROP RES, V59, P91, DOI 10.1016/S0378-4290(98)00104-X; Zhang XC, 2007, CHINESE J ECOAGRICUL, V15; Zhou JB, 2011, FIELD CROP RES, V122, P157, DOI 10.1016/j.fcr.2011.03.009; Zhou XB, 2011, PLANT SOIL ENVIRON, V57, P115, DOI 10.17221/130/2010-PSE	50	64	68	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98850	10.1371/journal.pone.0098850	http://dx.doi.org/10.1371/journal.pone.0098850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905909	Green Published, gold, Green Submitted			2022-12-27	WOS:000341869000069
J	Hinamoto, N; Maeshima, Y; Saito, D; Yamasaki, H; Tanabe, K; Nasu, T; Watatani, H; Ujike, H; Kinomura, M; Sugiyama, H; Sonoda, H; Sato, Y; Makino, H				Hinamoto, Norikazu; Maeshima, Yohei; Saito, Daisuke; Yamasaki, Hiroko; Tanabe, Katsuyuki; Nasu, Tatsuyo; Watatani, Hiroyuki; Ujike, Haruyo; Kinomura, Masaru; Sugiyama, Hitoshi; Sonoda, Hikaru; Sato, Yasufumi; Makino, Hirofumi			Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEGATIVE FEEDBACK REGULATOR; BASEMENT-MEMBRANE GLOMERULONEPHRITIS; GLOMERULAR CAPILLARY REPAIR; TYPE-2 DIABETIC MICE; REMNANT KIDNEY MODEL; IMPAIRED ANGIOGENESIS; HEMODIALYSIS-PATIENTS; EXPRESSION; VEGF	Vasohibin-1 (VASH-1) is a negative feedback regulator of angiogenesis, and a small vasohibin-binding protein (SVBP) serves as its secretory chaperone and contributes to its antiangiogenic effects. In the present study, we aimed to define the clinical significance of VASH-1 and SVBP in patients with chronic kidney disease (CKD). We recruited 67 Japanese hospitalized patients with renal disorders with (n = 45) or without (n = 22) renal biopsy samples and 10 Japanese healthy controls. We evaluated the correlations between the plasma and urinary levels of VASH-1/VASH-1-SVBP complex/SVBP and the clinicopathological parameters. The plasma levels of VASH-1 were inversely correlated with age and systolic and diastolic blood pressure and positively correlated with crescent formation. Increased plasma and urinary levels of VASH-1 and VASH-1-SVBP complex were significantly correlated with worse renal outcomes. These results demonstrate an association between elevated urinary and plasma levels of VASH-1 and progressive decline of the renal function, thus suggesting a potential role for VASH-1 in predicting a worse renal prognosis in patients with renal disease, including CKD.	[Hinamoto, Norikazu; Maeshima, Yohei; Saito, Daisuke; Yamasaki, Hiroko; Tanabe, Katsuyuki; Nasu, Tatsuyo; Watatani, Hiroyuki; Ujike, Haruyo; Kinomura, Masaru; Sugiyama, Hitoshi; Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama 7008530, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Chron Kidney Dis & Peritoneal Dialysis, Okayama 7008530, Japan; [Sonoda, Hikaru] Shionogi, Discovery Res Labs, Osaka, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi 980, Japan	Okayama University; Okayama University; Okayama University; Shionogi & Company Limited; Tohoku University	Maeshima, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan.	ymaeshim@md.okayama-u.ac.jp	Sato, Yasufumi/AAF-3367-2019; Tanabe, Katsuyuki/J-1341-2019; Sugiyama, Hitoshi/B-2252-2011	Tanabe, Katsuyuki/0000-0003-4767-5892; Sugiyama, Hitoshi/0000-0002-4127-6471	JSPS KAKENHI [20590958, 23591193]; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	A portion of this study was supported by JSPS KAKENHI Grant Number (20590958, 23591193, YM) and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University (2010-2013, YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Futrakul N, 2008, CLIN HEMORHEOL MICRO, V38, P201; Guo QY, 2009, NEPHROL DIAL TRANSPL, V24, P3468, DOI 10.1093/ndt/gfp315; Hara A, 2006, KIDNEY INT, V69, P1986, DOI 10.1038/sj.ki.5000439; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Hirokoshi K, 2007, NEPHRON CLIN PRACT, V106, pC43, DOI 10.1159/000101483; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Kang DH, 2001, AM J KIDNEY DIS, V37, P601, DOI 10.1053/ajkd.2001.22087; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kim W, 2006, NY TIMES BK REV, P1; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Li DJ, 2010, CANCER SCI, V101, P448, DOI 10.1111/j.1349-7006.2009.01388.x; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Mallamaci F, 2008, J HYPERTENS, V26, P1875, DOI 10.1097/HJH.0b013e328307c3d2; Masuda Y, 2001, AM J PATHOL, V159, P599, DOI 10.1016/S0002-9440(10)61731-2; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; Miyazaki Y, 2012, CLIN CANCER RES, V18, P4145, DOI 10.1158/1078-0432.CCR-12-0073; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740; Rizkalla B, 2005, J HYPERTENS, V23, P153, DOI 10.1097/00004872-200501000-00026; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Shimizu A, 2004, J AM SOC NEPHROL, V15, P2655, DOI 10.1097/01.ASN.0000141038.28733.F2; Shulman K, 1996, J AM SOC NEPHROL, V7, P661; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Tamaki K, 2010, CANCER SCI, V101, P1051, DOI 10.1111/j.1349-7006.2009.01483.x; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Wang G, 2009, AM J HYPERTENS, V22, P300, DOI 10.1038/ajh.2008.360; Wang QZ, 2012, MED ONCOL, V29, P2727, DOI 10.1007/s12032-011-0106-7; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Watanabe T, 2012, TRANSPL P, V44, P1155, DOI 10.1016/j.transproceed.2012.02.022; Woolf AS, 2001, PEDIATR NEPHROL, V16, P177, DOI 10.1007/s004670000509; Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176; Yoshinaga K, 2008, CANCER SCI, V99, P914, DOI 10.1111/j.1349-7006.2008.00777.x; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Yuan HT, 2002, KIDNEY INT, V61, P2078, DOI 10.1046/j.1523-1755.2002.00381.x	50	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e96932	10.1371/journal.pone.0096932	http://dx.doi.org/10.1371/journal.pone.0096932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	25255225	gold, Green Submitted, Green Published			2022-12-27	WOS:000340947700007
J	Lee, YH; Su, SB; Huang, CC; Sheu, HM; Tsai, JC; Lin, CH; Wang, YJ; Wang, BJ				Lee, Yu-Hsuan; Su, Shih-Bin; Huang, Chien-Cheng; Sheu, Hamm-Ming; Tsai, Jui-Chen; Lin, Chia-Ho; Wang, Ying-Jan; Wang, Bour-Jr			N-Acetylcysteine Attenuates Hexavalent Chromium-Induced Hypersensitivity through Inhibition of Cell Death, ROS-Related Signaling and Cytokine Expression	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; ARSENIC TRIOXIDE; REDOX REGULATION; SKIN-DISEASE; CANCER-CELLS; FACTOR-ALPHA; TNF-ALPHA	Chromium hypersensitivity (chromium-induced allergic contact dermatitis) is an important issue in occupational skin disease. Hexavalent chromium (Cr(VI)) can activate the Akt, Nuclear factor kappa B (NF-kappa B), and Mitogen-activated protein kinase (MAPK) pathways and induce cell death, via the effects of reactive oxygen species (ROS). Recently, cell death stimuli have been proposed to regulate the release of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1). However, the exact effects of ROS on the signaling molecules and cytotoxicity involved in Cr(VI)-induced hypersensitivity have not yet been fully demonstrated. N-acetylcysteine (NAC) could increase glutathione levels in the skin and act as an antioxidant. In this study, we investigated the effects of NAC on attenuating the Cr(VI)-triggered ROS signaling in both normal keratinocyte cells (HaCaT cells) and a guinea pig (GP) model. The results showed the induction of apoptosis, autophagy and ROS were observed after different concentrations of Cr(VI) treatment. HaCaT cells pretreated with NAC exhibited a decrease in apoptosis and autophagy, which could affect cell viability. In addition, Cr (VI) activated the Akt, NF-kappa B and MAPK pathways thereby increasing IL-1 alpha and TNF-alpha production. However, all of these stimulation phenomena could be inhibited by NAC in both of in vitro and in vivo studies. These novel findings indicate that NAC may prevent the development of chromium hypersensitivity by inhibiting of ROS-induced cell death and cytokine expression.	[Lee, Yu-Hsuan; Wang, Ying-Jan; Wang, Bour-Jr] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Sheu, Hamm-Ming] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Tsai, Jui-Chen] Natl Cheng Kung Univ, Inst Clin Pharm, Tainan 70101, Taiwan; [Lin, Chia-Ho] Chi Mei Med Ctr, Dept Surg, Div Urol, Liouying, Taiwan; [Lin, Chia-Ho] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Ying-Jan] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wang, Bour-Jr] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci & Inst Cosmet Sci, Tainan, Taiwan	National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Asia University Taiwan; Chia Nan University of Pharmacy & Science	Wang, YJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	yjwang@mail.ncku.edu.tw; pochih.wang@msa.hinet.net	Lee, Yu-Hsuan/AAT-3856-2021	Lee, Yu-Hsuan/0000-0001-7660-3770; Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Beveridge, Ross/0000-0001-6489-6676; Wu, Ruey-Meei/0000-0002-4947-5467; Lin, Chin-Hsien/0000-0001-8566-7573	Chi Mei Medical Center, Tainan, Taiwan [CMNCKU10110]; National Science Council, Taiwan [NSC-102-2314-B006-034]	Chi Mei Medical Center, Tainan, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Chi Mei Medical Center, Tainan, Taiwan (CMNCKU10110) and the National Science Council, Taiwan (NSC-102-2314-B006-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bonnet MC, 2013, EUR J DERMATOL; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Faurschou A, 2008, EXP DERMATOL, V17, P992, DOI 10.1111/j.1600-0625.2008.00740.x; Freitas M, 2010, J BIOL INORG CHEM, V15, P1275, DOI 10.1007/s00775-010-0685-3; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Harris J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00083; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Pena-Sanoja MJ, 2013, INVEST CLIN, V54, P325; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kanzawa T, 2003, CANCER RES, V63, P2103; Khan MI, 2012, BIOMATERIALS, V33, P1477, DOI 10.1016/j.biomaterials.2011.10.080; Khatami A, 2013, INT J DERMATOL, V52, P1513, DOI 10.1111/j.1365-4632.2012.05623.x; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; LOPEZTORRES M, 1994, J INVEST DERMATOL, V102, P476, DOI 10.1111/1523-1747.ep12373032; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luczak MW, 2013, FREE RADICAL BIO MED, V65, P262, DOI 10.1016/j.freeradbiomed.2013.06.028; Martin BD, 1998, CHEM RES TOXICOL, V11, P1402, DOI 10.1021/tx9801559; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; McCall MR, 1999, FREE RADICAL BIO MED, V26, P1034, DOI 10.1016/S0891-5849(98)00302-5; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paglin S, 2001, CANCER RES, V61, P439; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; Polak L, 1983, CHROMIUM METABOLISM; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Robert LR, 2001, FISHERS CONTACT DERM; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shelnutt SR, 2007, CRIT REV TOXICOL, V37, P375, DOI 10.1080/10408440701266582; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Son YO, 2013, TOXICOL APPL PHARM, V271, P239, DOI 10.1016/j.taap.2013.04.036; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; VANHOOGSTRATEN IMW, 1992, INT ARCH ALLERGY IMM, V97, P258, DOI 10.1159/000236131; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Wang BJ, 2010, TOXICOL LETT, V198, P216, DOI 10.1016/j.toxlet.2010.06.024; Wang BJ, 2010, EXP DERMATOL, V19, pE191, DOI 10.1111/j.1600-0625.2009.01045.x; Winyard P G, 1997, Adv Pharmacol, V38, P403; Xie Y, 2014, CELL PHYSIOL BIOCHEM, V33, P705, DOI 10.1159/000358646; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	58	135	139	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108317	10.1371/journal.pone.0108317	http://dx.doi.org/10.1371/journal.pone.0108317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248126	Green Published, Green Submitted, gold			2022-12-27	WOS:000342351800081
J	Lee, HK; Song, HE; Lee, HB; Kim, CS; Koketsu, M; Ngan, LTM; Ahn, YJ				Lee, Hyun-Kyung; Song, Ha Eun; Lee, Haeng-Byung; Kim, Cheol-Soo; Koketsu, Mamoru; Luong Thi My Ngan; Ahn, Young-Joon			Growth Inhibitory, Bactericidal, and Morphostructural Effects of Dehydrocostus Lactone from Magnolia sieboldii Leaves on Antibiotic-Susceptible and -Resistant Strains of Helicobacter pylori	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; IN-VITRO; MEDICINAL-PLANTS; UREASE; OMEPRAZOLE; PHYTOCHEMICALS; CLARITHROMYCIN; METRONIDAZOLE; THERAPY; PH	Helicobacter pylori is associated with various diseases of the upper gastrointestinal tract, such as gastric inflammation and duodenal and gastric ulcers. The aim of the study was to assess anti-H. pylori effects of the sesquiterpene lactone dehydrocostus lactone (DCL) from Magnolia sieboldii leaves, compared to commercial pure DCL, two previously known sesquiterpene lactones (costunolide and parthenolide), (-)-epigallocatechin gallate, and four antibiotics. The antibacterial activity of natural DCL toward antibiotic-susceptible H. pylori ATCC 700392 and H. pylori ATCC 700824 strains (MIC, 4.9 and 4.4 mg/L) was similar to that of commercial DCL and was more effective than costunolide, parthenolide, and EGCG. The activity of DCL was slightly lower than that of metronidazole (MIC, 1.10 and 1.07 mg/L). The antibacterial activity of DCL was virtually identical toward susceptible and resistant strains, even though resistance to amoxicillin (MIC, 11.1 mg/L for PED 503G strain), clarithromycin (49.8 mg/L for PED 3582GA strain), metronidazole (21.6 mg/L for H. pylori ATCC 43504 strain; 71.1 mg/L for 221 strain), or tetracycline (14.2 mg/L for B strain) was observed. This finding indicates that DCL and the antibiotics do not share a common mode of action. The bactericidal activity of DCL toward H. pylori ATCC 43504 was not affected by pH values examined (4.0-7.0). DCL caused considerable conversion to coccoid form (94 versus 49% at 8 and 4 mg/L of DCL for 48 h). The Western blot analysis revealed that urease subunits (UreA and UreB) of H. pylori ATCC 43504 were not affected by 10 mM of DCL, whereas UreA monomer band completely disappeared at 0.1 mM of (-)-epigallocatechin gallate. Global efforts to reduce the level of antibiotics justify further studies on M. sieboldii leaf-derived materials containing DCL as potential antibacterial products or a lead molecule for the prevention or eradication of drug-resistant H. pylori.	[Lee, Hyun-Kyung; Lee, Haeng-Byung] Seoul Natl Univ, Coll Agr & Life Sci, Interdisciplinary Program Agr Biotechnol, Seoul, South Korea; [Song, Ha Eun; Ahn, Young-Joon] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Cheol-Soo] Halla Bot Garden, Jeju City, Jeju, South Korea; [Koketsu, Mamoru] Gifu Univ, Dept Chem & Biomol Sci, Gifu, Japan; [Luong Thi My Ngan] Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh City, Vietnam	Seoul National University (SNU); Seoul National University (SNU); Gifu University; Vietnam National University Hanoi; Vietnam National University Hochiminh City	Ngan, LTM (corresponding author), Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh City, Vietnam.	ltmngan@hcmus.edu.vn; yjahn@snu.ac.kr	Cho, Eunyoung/AAV-4469-2020; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Luong, Ngan/0000-0003-0500-007X	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	This work was carried out with the support by the Brain Korea 21 PLUS through the National Research Foundation of Korea funded by the Ministry of Education of the Korean Government to Y.-J. Ahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsson I, 1999, J ANTIMICROB CHEMOTH, V44, P629, DOI 10.1093/jac/44.5.629; Buhling A, 2001, ALIMENT PHARM THER, V15, P1445, DOI 10.1046/j.1365-2036.2001.01033.x; Chaturvedi D., 2011, SESQUITERPENE LACTON, P313; Cho SH, 2003, J APPL MICROBIOL, V95, P7, DOI 10.1046/j.1365-2672.2003.01998.x; Cole SP, 1999, J INFECT DIS, V180, P1713, DOI 10.1086/315079; Cole SP, 1997, INFECT IMMUN, V65, P843, DOI 10.1128/IAI.65.2.843-846.1997; De Leo M, 2006, PHYTOCHEMISTRY, V67, P2623, DOI 10.1016/j.phytochem.2006.07.017; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Fabry W, 1996, CHEMOTHERAPY, V42, P315, DOI 10.1159/000239460; Francesco Vincenzo De, 2011, World J Gastrointest Pathophysiol, V2, P35, DOI 10.4291/wjgp.v2.i3.35; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Funatogawa K, 2004, MICROBIOL IMMUNOL, V48, P251, DOI 10.1111/j.1348-0421.2004.tb03521.x; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Haristoy X, 2005, PLANTA MED, V71, P326, DOI 10.1055/s-2005-864098; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Icatlo FC, 1998, J BIOL CHEM, V273, P18130, DOI 10.1074/jbc.273.29.18130; ITOH T, 1987, MICROBIOL IMMUNOL, V31, P603, DOI 10.1111/j.1348-0421.1987.tb03121.x; Kim KW, 2007, MICRON, V38, P626, DOI 10.1016/j.micron.2006.09.006; Kusters JG, 1997, INFECT IMMUN, V65, P3672, DOI 10.1128/IAI.65.9.3672-3679.1997; Lee Hyun-Kyung, 2004, Journal of Applied Biological Chemistry, V47, P91; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Lin YT, 2005, APPL ENVIRON MICROB, V71, P8558, DOI 10.1128/AEM.71.12.8558-8564.2005; Luong TMN, 2012, J AGR FOOD CHEM, V60, P9062, DOI 10.1021/jf3035034; Mabe K, 1999, ANTIMICROB AGENTS CH, V43, P1788, DOI 10.1128/AAC.43.7.1788; MALANOSKI GJ, 1993, EUR J CLIN MICROBIOL, V12, P131, DOI 10.1007/BF01967591; Marshall BJ, 2005, MED CLIN N AM, V89, P313, DOI 10.1016/j.mcna.2004.09.001; Matsubara S, 2003, BIOCHEM BIOPH RES CO, V310, P715, DOI 10.1016/j.bbrc.2003.09.066; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Nakao M, 1998, HELICOBACTER, V3, P21, DOI 10.1046/j.1523-5378.1998.08024.x; Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247; Ohno T, 2003, HELICOBACTER, V8, P207, DOI 10.1046/j.1523-5378.2003.00146.x; Park BS, 2006, J ETHNOPHARMACOL, V105, P255, DOI 10.1016/j.jep.2005.11.005; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rimbara E, 2011, NAT REV GASTRO HEPAT, V8, P79, DOI 10.1038/nrgastro.2010.210; Saito N, 2003, J INFECTION, V46, P49, DOI 10.1053/jinf.2002.1047; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sekiguchi H, 2008, J CLIN BIOCHEM NUTR, V43, P109, DOI 10.3164/jcbn.2008054; SHIBATA K, 1995, ANTIMICROB AGENTS CH, V39, P1295, DOI 10.1128/AAC.39.6.1295; Sjostrom JE, 1996, J MED MICROBIOL, V44, P425; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Taylor David N., 1995, P551; Wang YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep147; Watt IM, 1997, PRICIPLES PRACTICE E; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wink M, 2006, ADV PHYTOMED, V3, P251; Yoshikawa M, 2000, BIOORGAN MED CHEM, V8, P2071, DOI 10.1016/S0968-0896(00)00127-9; Zeyrek FY, 2005, ANN MICROBIOL, V55, P125	48	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e95530	10.1371/journal.pone.0095530	http://dx.doi.org/10.1371/journal.pone.0095530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747984	Green Submitted, gold, Green Published			2022-12-27	WOS:000335226500121
J	Liu, J; Huang, JS; Su, TX; Bertoldi, K; Clarke, DR				Liu, Jia; Huang, Jiangshui; Su, Tianxiang; Bertoldi, Katia; Clarke, David R.			Structural Transition from Helices to Hemihelices	PLOS ONE			English	Article							NONLINEAR DYNAMICS; TENDRIL PERVERSION; FILAMENTS; LEAVES; INSTABILITIES; KIRCHHOFF; MECHANICS; STRIPS; EDGES; RODS	Helices are amongst the most common structures in nature and in some cases, such as tethered plant tendrils, a more complex but related shape, the hemihelix forms. In its simplest form it consists of two helices of opposite chirality joined by a perversion. A recent, simple experiment using elastomer strips reveals that hemihelices with multiple reversals of chirality can also occur, a richness not anticipated by existing analyses. Here, we show through analysis and experiments that the transition from a helical to a hemihelical shape, as well as the number of perversions, depends on the height to width ratio of the strip's cross-section. Our findings provides the basis for the deterministic manufacture of a variety of complex three-dimensional shapes from flat strips.	[Liu, Jia; Huang, Jiangshui; Su, Tianxiang; Bertoldi, Katia; Clarke, David R.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Bertoldi, Katia; Clarke, David R.] Harvard Univ, Kavli Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University	Bertoldi, K (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	bertoldi@seas.harvard.edu; clarke@seas.harvard.edu	Huang, Jiangshui/G-5833-2010	Huang, Jiangshui/0000-0002-3523-2165; Liu, Jia/0000-0002-5628-8889; Liu, Jianfeng/0000-0003-1172-7080; Clarke, David/0000-0002-5902-7369	Materials Research Science and Engineering Center under NSF [DMR-0820484]; National Science Foundation [CMMI-1149456-CAREER, CMMI-1333835]; Wyss institute through the Seed Grant Program	Materials Research Science and Engineering Center under NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Wyss institute through the Seed Grant Program	This work was supported by the Materials Research Science and Engineering Center under NSF Award No. DMR-0820484. K.B. also acknowledges support from the National Science Foundation (CMMI-1149456-CAREER) and the Wyss institute through the Seed Grant Program. D.R. acknowledges funding from the National Science Foundation (CMMI-1333835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Audoly B, 2002, CR MECANIQUE, V330, P831, DOI 10.1016/S1631-0721(02)01545-0; Audoly B., 2010, ELASTICITY GEOMETRY; Ball P, 1999, SELF MADE TAPESTRY P; Balluffi RW, 2005, KINETICS OF MATERIALS, P1; Bower A.F., 2009, APPL MECH SOLIDS; Chapman RE, 1965, BIOL SKIN HAIR GROWT; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; COLEMAN BD, 1993, ARCH RATION MECH AN, V121, P339, DOI 10.1007/BF00375625; Darwin C, 1888, MOVEMENTS HABITS CLI, P55; Forterre Y, 2011, SCIENCE, V333, P1715, DOI 10.1126/science.1210734; Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357; Gerbode SJ, 2012, SCIENCE, V337, P1087, DOI 10.1126/science.1223304; Goriely A, 1997, PHYSICA D, V105, P20, DOI 10.1016/S0167-2789(96)00290-4; Goriely A, 1997, PHYSICA D, V105, P45, DOI 10.1016/S0167-2789(97)83389-1; Goriely A, 2000, PHYS REV E, V61, P4508, DOI 10.1103/PhysRevE.61.4508; Goriely A, 2000, NONLINEAR DYNAM, V21, P101, DOI 10.1023/A:1008366526875; Goriely A, 1998, PHYS REV LETT, V80, P1564, DOI 10.1103/PhysRevLett.80.1564; Gray A, 1868, GRAYS LESSONS BOT VE, P38; Huang JS, 2012, SOFT MATTER, V8, P6291, DOI 10.1039/c2sm25278c; Kirchhoff G, 1859, J REINE ANGEW MATH, V56, P285, DOI DOI 10.1515/CRLL.1859.56.285; Kirchhoff G., 1876, MECHANIK, V28; Listing JB, 1847, VORSTUDIEN TOPOLOGIE, VI, P811; Marder M, 2003, EUROPHYS LETT, V62, P498, DOI 10.1209/epl/i2003-00334-5; Maxwell MC, 1873, TREATISE ELECT MAGNE, VII, P456; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; Patricio P, 1998, PHYSICA D, V124, P285, DOI 10.1016/S0167-2789(98)00203-6; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Sharon E, 2004, AM SCI, V92, P254, DOI 10.1511/2004.47.932; Sharon E, 2002, NATURE, V419, P579, DOI 10.1038/419579a; Sharon E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046211; Silverberg JL, 2012, P NATL ACAD SCI USA, V109, P16794, DOI 10.1073/pnas.1209287109; Thompson D. W., 1917, GROWTH FORM; Valverde J, 2010, J NONLINEAR SCI, V20, P309, DOI 10.1007/s00332-010-9059-9; Young WC, 2002, ROARKS FORMULAS STRE, VSeventh; Zhou HJ, 1999, J CHEM PHYS, V110, P1247, DOI 10.1063/1.478167	36	76	75	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93183	10.1371/journal.pone.0093183	http://dx.doi.org/10.1371/journal.pone.0093183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24915574	Green Submitted, Green Published, gold			2022-12-27	WOS:000335298200007
J	Kim, H; Choi, K; Kang, H; Lee, SY; Chi, SW; Lee, MS; Song, J; Im, D; Choi, Y; Cho, SC				Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-Wook; Lee, Min-Sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan			Identification of a Novel Function of CX-4945 as a Splicing Regulator	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PRE-MESSENGER-RNA; SERINE-RICH; SR PROTEINS; IN-VIVO; DISEASE; PHOSPHORYLATION; INHIBITOR; FAMILY; PURIFICATION	Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene. The significance of alternative splicing has been confirmed by the increasing number of human diseases that are caused by misregulation of splicing events. Very few compounds, however, have been reported to act as inhibitors of alternative splicing, and their potential clinical use needs to be evaluated. Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a molecule currently in clinical trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner. Transcriptome-wide analysis using exon array also showed a widespread alteration in alternative splicing of numerous genes. We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells. Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date. Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner. Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.	[Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Cheongwon, Chungbuk, South Korea; [Kim, Hyeongki; Cho, Sungchan] Univ Sci & Technol, Dept Biomol Sci, Taejon, South Korea; [Lee, So-Young] Minist Food & Drug Safety, Int Cooperat Off, Cheongwon, Chungbuk, South Korea; [Chi, Seung-Wook; Lee, Min-Sung] Korea Res Inst Biosci & Biotechnol, BioMed Prote Res Ctr, Cheongwon, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ministry of Food & Drug Safety (MFDS), Republic of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Cho, SC (corresponding author), Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Cheongwon, Chungbuk, South Korea.	sungchan@kribb.re.kr		Shin, Ju-Young/0000-0003-1010-7525	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2003182]; KRIBB Research Initiative Program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; KRIBB Research Initiative Program	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2003182) and KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chabot B, 1996, TRENDS GENET, V12, P472, DOI 10.1016/0168-9525(96)10037-8; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Coombs TC, 2013, BIOORG MED CHEM LETT, V23, P3654, DOI 10.1016/j.bmcl.2013.02.096; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; FU XD, 1995, RNA, V1, P663; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kim E, 2008, RNA BIOL, V5, P17, DOI 10.4161/rna.5.1.5944; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Levinson N, 2006, RNA, V12, P925, DOI 10.1261/rna.8306; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Ng B, 2004, J ALLERGY CLIN IMMUN, V114, P1463, DOI 10.1016/j.jaci.2004.09.006; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pilch B, 2001, CANCER RES, V61, P6876; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	53	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94978	10.1371/journal.pone.0094978	http://dx.doi.org/10.1371/journal.pone.0094978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743259	Green Published, gold, Green Submitted			2022-12-27	WOS:000335309100056
J	Lee, YC; Lin, CH; Wu, RM; Lin, JW; Chang, CH; Lai, MS				Lee, Yen-Chieh; Lin, Chin-Hsien; Wu, Ruey-Meei; Lin, Jou-Wei; Chang, Chia-Hsuin; Lai, Mei-Shu			Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME; OXIDATIVE STRESS; BLOOD-PRESSURE; MPTP MODEL; HYPERTENSION; DEGENERATION; ASSOCIATION; INHIBITION; MANAGEMENT	Background and Purpose: Hypertension has been associated with Parkinson's disease (PD), but data on antihypertensive drugs and PD are inconclusive. We aim to evaluate antihypertensive drugs for an association with PD in hypertensive patients. Methods: Hypertensive patients who were free of PD, dementia and stroke were recruited from 2005-2006 using Taiwan National Health Insurance Database. We examined the association between the use of calcium channel blockers (CCBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs) and the incidence of PD using betablockers as the reference. Cox regression model with time-varying medication use was applied. Results: Among 65,001 hypertensive patients with a mean follow-up period of 4.6 years, use of dihydropyridine CCBs, but not non-dihydropyridine CCBs, was associated with a reduced risk of PD (adjusted hazard ratio [aHR] = 0.71; 95% CI, 0.570.90). Additionally, use of central-acting CCBs, rather than peripheral-acting ones, was associated with a decreased risk of PD (aHR =.69 [55-0.87]. Further decreased association was observed for higher cumulative doses of felodipine (aHR = 0.54 [0.36-0.80]) and amlodipine (aHR = 0.60 [0.45-0.79]). There was no association between the use of ACEIs (aHR = 0.80 [0.641.00]) or ARBs (aHR = 0.86 [0.69-1.08]) with PD. A potentially decreased association was only found for higher cumulative use of ACEIs (HR = 0.52 [0.34-0.80]) and ARBs (HR = 0.52 [0.33-0.80]). Conclusions: Our study suggests centrally-acting dihydropyridine CCB use and high cumulative doses of ACEIs and ARBs may associate with a decreased incidence of PD in hypertensive patients. Further long-term follow-up studies are needed to confirm the potential beneficial effects of antihypertensive agents in PD.	[Lee, Yen-Chieh] Cathay Gen Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Chin-Hsien; Wu, Ruey-Meei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Jou-Wei; Chang, Chia-Hsuin] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin County, Taiwan; [Chang, Chia-Hsuin; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan	Cathay General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, JW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan.	jouweilin@yahoo.com; chiahsuin123@yahoo.com.tw	Lee, Yu-Hsuan/AAT-3856-2021	Lee, Yu-Hsuan/0000-0001-7660-3770; Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Beveridge, Ross/0000-0001-6489-6676; Wu, Ruey-Meei/0000-0002-4947-5467; Lin, Chin-Hsien/0000-0001-8566-7573				Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Grammatopoulos TN, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-1; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Louis ED, 2009, NEUROEPIDEMIOLOGY, V33, P286, DOI 10.1159/000235641; Marras C, 2012, ANN NEUROL, V71, P362, DOI 10.1002/ana.22616; Munoz A, 2006, NEUROPHARMACOLOGY, V51, P112, DOI 10.1016/j.neuropharm.2006.03.004; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Pasternak B, 2012, AM J EPIDEMIOL, V175, P627, DOI 10.1093/aje/kwr362; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Reardon KA, 2000, AUST NZ J MED, V30, P48, DOI 10.1111/j.1445-5994.2000.tb01054.x; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schernhammer E, 2011, DIABETES CARE, V34, P1102, DOI 10.2337/dc10-1333; Simon KC, 2010, MOVEMENT DISORD, V25, P1818, DOI 10.1002/mds.23191; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Ton TGN, 2007, PARKINSONISM RELAT D, V13, P165, DOI 10.1016/j.parkreldis.2006.08.011; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wright JW, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/860923	29	135	139	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98961	10.1371/journal.pone.0098961	http://dx.doi.org/10.1371/journal.pone.0098961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	25248126	Green Submitted, Green Published, gold			2022-12-27	WOS:000337165600029
J	Lee, HJ; Cho, JI; Lee, HSH; Kim, CI; Cho, E				Lee, Hae-Jeung; Cho, Jang-ik; Lee, Hye-Seung H.; Kim, Cho-il; Cho, Eunyoung			Intakes of Dairy Products and Calcium and Obesity in Korean Adults: Korean National Health and Nutrition Examination Surveys (KNHANES) 2007-2009	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY CALCIUM; FAT OXIDATION; YOUNG-ADULTS; WEIGHT; CONSUMPTION; OVERWEIGHT; ADIPOSITY; WOMEN; FOODS	Background: The possible effects of dairy product intake against obesity have been suggested in animal studies; however, the association is still not well established in epidemiological studies. Few studies in Asian countries with relatively low intake of dairy products exist. Objective: We investigated the association between dairy products and calcium intake and obesity in Korean population with relatively low intake of dairy products. Subjects and Methods: Our study population consisted of adults (n = 7173) aged 19-64 among participants of the 2007, 2008 and 2009 Korean National Health and Nutrition Examination Survey who had not made any attempt of intentional weight loss. Dietary intake data from food frequency questionnaire (FFQ) and 24-hour recall were used. Dairy products included milk and yogurt in the FFQ. Obesity was defined as BMI >= 25 kg/m(2). Results: Higher frequency of dairy product intake was associated with a reduced prevalence of obesity (OR = 0.63; 95% CI = 0.45-0.89 for >= 2 times/day vs. <= 1 time/month; p for trend = 0.003) using the intake data from FFQ. Similarly, high frequency of milk or yogurt intake had an inverse association with obesity. The association between milk and yogurt intake and obesity was similar when the intake from 24-hour recall was examined. Higher calcium intake from dairy products as well as total dietary calcium intake was associated with a decreased prevalence of obesity (OR = 0.83; 95% CI = 0.71-0.98 for highest vs. lowest quintile of dairy calcium intake; p for trend = 0.02, OR = 0.78; 95% CI = 0.64-0.94 for highest vs. lowest quintile of total calcium intake; p for trend = 0.04). The associations appeared to be stronger in women than in men. Conclusion: These results suggest that high consumption of dairy products is associated with a lower prevalence of obesity and that calcium in dairy products may be one of the components contributing to the association. Further longitudinal studies are warranted to replicate our findings.	[Lee, Hae-Jeung] Eulji Univ, Dept Food & Nutr, Songnam, Gyeonggi Do, South Korea; [Cho, Jang-ik] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lee, Hye-Seung H.; Cho, Eunyoung] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Lee, Hye-Seung H.; Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Cho-il] Korea Hlth Ind Dev Inst, Dept Hlth Ind & Policy, Cheongwon Gun, Chungcheongbuk, South Korea; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA	Eulji University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University	Cho, E (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	eunyoung.cho@channing.harvard.edu	Cho, Eunyoung/AAV-4469-2020; Kim, Cho-il/B-5961-2011	Cho, Eunyoung/0000-0001-6594-2582; Luong, Ngan/0000-0003-0500-007X				Alonso A, 2009, J HUM NUTR DIET, V22, P336, DOI 10.1111/j.1365-277X.2009.00967.x; [Anonymous], 2009, KOR NAT HLTH NUTR EX; Bortolotti M, 2008, AM J CLIN NUTR, V88, P877, DOI 10.1093/ajcn/88.4.877; Brooks BM, 2006, J AM COLL NUTR, V25, P523, DOI 10.1080/07315724.2006.10719568; DENKE MA, 1993, J NUTR, V123, P1047; Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X; Faghih S, 2011, NUTR METAB CARDIOVAS, V21, P499, DOI 10.1016/j.numecd.2009.11.013; Heaney RP, 2002, J AM COLL NUTR, V21, p152S, DOI 10.1080/07315724.2002.10719213; Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785; Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Loos RJF, 2004, J NUTR, V134, P1772, DOI 10.1093/jn/134.7.1772; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; Major GC, 2008, OBES REV, V9, P428, DOI 10.1111/j.1467-789X.2007.00465.x; Marques-Vidal P, 2006, INT J OBESITY, V30, P88, DOI 10.1038/sj.ijo.0803045; Ministry of Health and Welfare, 2005, KOR NAT HLTH NUTR EX; Ministry of Health and Welfare, 2008, KOR NAT HLTH NUTR EX; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Murakami K, 2006, NUTRITION, V22, P490, DOI 10.1016/j.nut.2005.12.003; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Schrager S, 2005, J AM BOARD FAM PRACT, V18, P205, DOI 10.3122/jabfm.18.3.205; Shah NP, 2000, BRIT J NUTR, V84, pS3; St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467; Van Loan M, 2009, J AM COLL NUTR, V28, p120S, DOI 10.1080/07315724.2009.10719805; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810; *WHO W PAC REG OFF, 2000, AS PAC PERSP RED OB; 이계오, 2007, 조사연구, V8, P67; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zemel MB, 2004, AM J CLIN NUTR, V79, P907; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212	35	99	102	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2014	9	6							e99085	10.1371/journal.pone.0099085	http://dx.doi.org/10.1371/journal.pone.0099085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SD	24747984	Green Published, Green Submitted, gold			2022-12-27	WOS:000340947700062
J	Zhang, ZX; Zhao, H; Tang, J; Li, Z; Li, Z; Chen, DM; Lin, WX				Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong			A Proteomic Study on Molecular Mechanism of Poor Grain-Filling of Rice (Oryza sativa L.) Inferior Spikelets	PLOS ONE			English	Article							STARCH BIOSYNTHETIC-ENZYMES; JAPONICA/INDICA HYBRID RICE; 14-3-3 PROTEINS; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; PLANT-METABOLISM; DIFFERENTIAL EXPRESSION; SIGNAL-TRANSDUCTION; DIFFERENT POSITIONS; BARLEY GRAINS	Cultivars of rice (Oryza sativa L.), especially of the type with large spikelets, often fail to reach the yield potential as expected due to the poor grain-filling on the later flowering inferior spikelets (in contrast to the earlier-flowering superior spikelets). The present study showed that the size and grain weight of superior spikelets (SS) was greater than those of inferior spikelets (IS), and the carbohydrate supply should not be the major problem for the poor grain-filling because there was adequate amount of sucrose in IS at the initial grain-filling stage. High resolution two-dimensional gel electrophoresis (2-DE) in combination with Coomassie-brilliant blue (CBB) and Pro-Q Diamond phosphoprotein fluorescence stain revealed that 123 proteins in abundance and 43 phosphoproteins generated from phosphorylation were significantly different between SS and IS. These proteins and phosphoproteins were involved in different cellular and metabolic processes with a prominently functional skew toward metabolism and protein synthesis/destination. Expression analyses of the proteins and phosphoproteins associated with different functional categories/subcategories indicated that the starch synthesis, central carbon metabolism, N metabolism and cell growth/division were closely related to the poor grain-filling of IS. Functional and expression pattern studies also suggested that 14-3-3 proteins played important roles in IS poor grain-filling by regulating the activity of starch synthesis enzymes. The proteome and phosphoproteome obtained from this study provided a better understanding of the molecular mechanism of the IS poor grain-filling. They were also expected to be highly useful for improving the grain filling of rice.	[Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wenxiong181@163.com		liu, chun ming/0000-0002-7271-362X; Hoi, Maggie Pui Man/0000-0003-2630-3707; Zhang, Zhao/0000-0002-7323-5500; Song, Yin/0000-0002-6037-777X	National Natural Science Foundation of China [31271670]; Provincial Natural Science Foundation of Fujian, China [2012J01075, 2013J01092]; Department of Education Science and Technology Project of Fujian, China [JK2011014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Department of Education Science and Technology Project of Fujian, China	This work was sponsored by the National Natural Science Foundation of China (No. 31271670), Provincial Natural Science Foundation of Fujian, China (No. 2012J01075, 2013J01092), and Department of Education Science and Technology Project of Fujian, China (No. JK2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chitteti BR, 2007, PROTEOMICS, V7, P1473, DOI 10.1002/pmic.200600871; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; COHEN P, 1985, EUR J BIOCHEM, V151, P439, DOI 10.1111/j.1432-1033.1985.tb09121.x; Colleoni C., 2003, Journal of Applied Glycoscience, V50, P207; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GARRELS JI, 1983, METHOD ENZYMOL, V100, P411; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Kato T, 2007, PLANT PROD SCI, V10, P442, DOI 10.1626/pps.10.442; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Lin XM, 2008, J PROTEOME RES, V7, P1235, DOI 10.1021/pr7005928; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; MOHAPATRA PK, 1993, AUST J PLANT PHYSIOL, V20, P231, DOI 10.1071/PP9930231; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Ramasamy S, 1997, FIELD CROP RES, V51, P65, DOI 10.1016/S0378-4290(96)01039-8; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rolletschek H, 2004, J EXP BOT, V55, P1351, DOI 10.1093/jxb/erh130; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 1996, CURR BIOL, V6, P1403, DOI 10.1016/S0960-9822(96)00742-7; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Song JianMin, 2009, Acta Agronomica Sinica, V35, P1445, DOI 10.3724/SP.J.1006.2009.01445; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Tao LongXing, 2003, Chinese Journal of Rice Science, V17, P149; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Teo CJ, 2011, ACTA PHYSIOL PLANT, V33, P2259, DOI 10.1007/s11738-011-0765-1; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; van Dongen JT, 2004, PLANT PHYSIOL, V135, P1809, DOI 10.1104/pp.104.040980; Vassileva V. N., 2005, PLANT BIOTECHNOL, V22, P171; Wojtaszek P, 1997, J EXP BOT, V48, P2015, DOI 10.1093/jexbot/48.317.2015; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yoshida S, 1976, ANNU REV PLANT PHYS, P46; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZhiXing, 2012, Australian Journal of Crop Science, V6, P316; Zhang ZX, 2012, PLANT SCI, V185, P259, DOI 10.1016/j.plantsci.2011.11.012; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QS, 1988, ACTA AGRON SIN, V3, P182; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	70	98	104	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89140	10.1371/journal.pone.0089140	http://dx.doi.org/10.1371/journal.pone.0089140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24992590	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900056
